Over	O
ten	O
cell	B-ANAT
passages	O
,	O
however	O
,	O
we	O
found	O
no	O
significant	O
difference	O
in	O
frameshift	O
efficiency	O
between	O
the	O
cell	B-ANAT
types	O
,	O
arguing	O
against	O
a	O
role	O
for	O
Q	O
in	O
frameshifting	O
.	O

Administration	O
of	O
RANTES	O
antisera	O
to	O
MHV	O
-	O
infected	O
C57BL	O
/	O
6	O
mice	O
resulted	O
in	O
a	O
significant	O
reduction	O
in	O
macrophage	B-ANAT
infiltration	O
and	O
demyelination	O
(	O
P	O
<	O
or	O
=	O
0	O
.	O
001	O
)	O
compared	O
to	O
those	O
in	O
control	O
mice	O
.	O

Respiratory	O
mechanics	O
during	O
PLV	O
for	O
dependent	O
lung	B-ANAT
-	O
dominant	O
lung	B-ANAT
injury	O
were	O
optimal	O
at	O
a	O
PFC	O
dose	O
less	O
than	O
the	O
FRC	O
.	O

The	O
odds	O
ratio	O
that	O
a	O
patient	O
with	O
multiple	O
organ	B-ANAT
system	I-ANAT
failure	O
(	O
MOSF	O
)	O
or	O
infection	O
would	O
develop	O
AL	O
was	O
2	O
.	O
96	O
and	O
2	O
.	O
19	O
,	O
respectively	O
.	O

There	O
was	O
a	O
strong	O
positive	O
correlation	O
between	O
the	O
incidence	O
of	O
AL	O
and	O
high	O
ventilatory	O
pressures	O
(	O
PIP	O
36	O
vs	O
.	O
29	O
.	O
7	O
cm	O
H	O
(	O
2	O
)	O
O	O
,	O
P	O
<	O
0	O
.	O
001	O
),	O
or	O
large	O
tidal	O
volumes	O
(	O
V	O
(	O
T	O
)	O
12	O
vs	O
.	O
9	O
mL	O
/	O
kg	O
,	O
P	O
<	O
0	O
.	O
05	O
),	O
suggesting	O
that	O
large	O
volumes	O
might	O
elicit	O
injury	O
to	O
the	O
pulmonary	B-ANAT
epithelium	B-ANAT
.	O

Sepsis	O
,	O
MOSF	O
,	O
and	O
lung	B-ANAT
superinfection	O
with	O
Pseudomonas	O
or	O
Candida	O
species	O
may	O
be	O
also	O
important	O
factors	O
in	O
the	O
development	O
of	O
AL	O
in	O
critically	O
ill	O
children	O
.	O

Expression	O
,	O
deletion	O
,	O
and	O
mutagenesis	O
studies	O
showed	O
that	O
the	O
product	O
encoded	O
between	O
nucleotides	O
2548	O
and	O
8865	O
was	O
further	O
cleaved	B-ANAT
by	O
PLPD	O
-	O
1	O
at	O
the	O
Gly	O
(	O
2265	O
)-	O
Gly	O
(	O
2266	O
)	O
dipeptide	O
bond	O
to	O
release	O
an	O
N	O
-	O
terminal	O
195	O
-	O
kDa	O
and	O
a	O
C	O
-	O
terminal	O
41	O
-	O
kDa	O
cleavage	O
product	O
.	O

Characterization	O
of	O
the	O
cleavage	O
activity	O
revealed	O
that	O
the	O
proteinase	O
is	O
active	O
on	O
this	O
scissile	O
bond	O
when	O
expressed	O
in	O
vitro	O
in	O
rabbit	O
reticulocyte	B-ANAT
lysates	O
and	O
can	O
act	O
on	O
the	O
same	O
substrate	O
in	O
trans	O
when	O
expressed	O
in	O
intact	O
cells	B-ANAT
.	O

Both	O
the	O
N	O
-	O
and	O
C	O
-	O
terminal	O
cleavage	O
products	O
were	O
detected	O
in	O
virus	O
-	O
infected	O
cells	B-ANAT
and	O
were	O
found	O
to	O
be	O
physically	O
associated	O
.	O

This	O
effect	O
depended	O
on	O
cellular	B-ANAT
sialoglycoconjugates	O
bound	O
to	O
the	O
virion	B-ANAT
.	O

CONCLUSIONS	O
:	O
We	O
believe	O
that	O
the	O
efficacy	O
and	O
safety	O
of	O
chelation	O
therapy	O
in	O
severe	O
acute	O
iron	O
poisoning	O
may	O
be	O
improved	O
by	O
targeting	O
the	O
initial	O
high	O
levels	O
of	O
readily	O
chelatable	O
serum	B-ANAT
iron	O
with	O
adequate	O
doses	O
of	O
desferrioxamine	O
without	O
prolonging	O
its	O
use	O
unnecessarily	O
.	O

In	O
this	O
study	O
,	O
we	O
prepared	O
MAb	O
FK50	O
-	O
4	O
that	O
showed	O
a	O
strong	O
neutralizing	O
activity	O
in	O
feline	O
macrophages	B-ANAT
,	O
despite	O
the	O
fact	O
that	O
the	O
MAb	O
belonged	O
to	O
the	O
IgG2a	O
subclass	O
.	O

Using	O
an	O
antiserum	O
to	O
the	O
hydrophilic	O
carboxy	O
terminus	O
of	O
this	O
otherwise	O
hydrophobic	O
protein	O
,	O
we	O
found	O
that	O
the	O
E	O
protein	O
was	O
synthesized	O
in	O
infected	O
cells	B-ANAT
with	O
similar	O
kinetics	O
as	O
the	O
other	O
viral	O
structural	O
proteins	O
.	O

Consistent	O
with	O
the	O
lack	O
of	O
a	O
predicted	O
cleavage	O
site	O
,	O
the	O
protein	O
was	O
found	O
to	O
become	O
integrated	O
in	O
membranes	B-ANAT
without	O
involvement	O
of	O
a	O
cleaved	B-ANAT
signal	O
peptide	O
,	O
nor	O
were	O
any	O
other	O
modifications	O
of	O
the	O
polypeptide	O
observed	O
.	O

The	O
results	O
lead	O
to	O
a	O
topological	O
model	O
in	O
which	O
the	O
polypeptide	O
is	O
buried	O
within	O
the	O
membrane	B-ANAT
,	O
spanning	O
the	O
lipid	B-ANAT
bilayer	I-ANAT
once	O
,	O
possibly	O
twice	O
,	O
and	O
exposing	O
only	O
its	O
carboxy	O
-	O
terminal	O
domain	O
.	O

Initial	O
base	O
deficit	O
was	O
significantly	O
lower	O
in	O
patients	O
who	O
developed	O
acute	O
lung	B-ANAT
injury	O
than	O
in	O
those	O
who	O
did	O
not	O
(-	O
8	O
.	O
8	O
+/-	O
4	O
.	O
5	O
vs	O
.	O
-	O
5	O
.	O
6	O
+/-	O
5	O
.	O
1	O
,	O
p	O
<.	O
01	O
).	O

Myeloperoxidase	O
concentrations	O
were	O
measured	O
as	O
an	O
index	O
of	O
neutrophil	B-ANAT
activation	O
.	O

Protein	O
carbonyl	O
concentrations	O
were	O
also	O
high	O
initially	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
and	O
fell	O
significantly	O
with	O
time	O
.	O

There	O
was	O
a	O
strong	O
correlation	O
between	O
carbonyl	O
concentrations	O
in	O
lavage	O
fluid	O
and	O
plasma	B-ANAT
,	O
and	O
between	O
protein	O
carbonyls	O
,	O
thiobarbituric	O
acid	O
-	O
reactive	O
substances	O
and	O
myeloperoxidase	O
in	O
the	O
lungs	B-ANAT
.	O

The	O
correlation	O
between	O
oxidative	O
measures	O
and	O
myeloperoxidase	O
concentrations	O
in	O
the	O
lung	B-ANAT
indicates	O
that	O
neutrophil	B-ANAT
oxidants	O
could	O
be	O
responsible	O
for	O
the	O
injury	O
.	O

Parameters	O
of	O
oxygenation	O
,	O
lung	B-ANAT
mechanics	O
,	O
and	O
hemodynamics	O
were	O
determined	O
in	O
both	O
the	O
supine	O
and	O
prone	O
positions	O
.	O

PCT	O
may	O
be	O
helpful	O
in	O
the	O
differentiation	O
between	O
infectious	O
and	O
non	O
-	O
infectious	O
origin	O
of	O
systemic	O
inflammatory	O
response	O
syndrome	O
(	O
SIRS	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
pancreatitis	O
,	O
cardiogenic	O
shock	O
and	O
acute	O
rejection	O
of	O
organ	B-ANAT
transplants	I-ANAT
.	O

Patients	O
were	O
young	O
,	O
mean	O
43	O
years	O
,	O
had	O
poor	O
oxygenation	O
(	O
PaO2	O
/	O
FiO2	O
index	O
67	O
mmHG	O
)	O
and	O
a	O
lung	B-ANAT
injury	O
score	O
above	O
2	O
.	O
5	O
.	O

Pre	O
-	O
ECLS	O
predictors	O
,	O
such	O
as	O
pH	O
and	O
variables	O
during	O
ECLS	O
,	O
such	O
as	O
presence	O
of	O
renal	B-ANAT
failure	O
,	O
improvement	O
in	O
compliance	O
,	O
return	O
to	O
dry	O
weight	O
,	O
and	O
the	O
need	O
for	O
inotropes	O
on	O
ECLS	O
,	O
may	O
be	O
useful	O
for	O
predicting	O
outcome	O
.	O

A	O
dose	O
-	O
dependent	O
increase	O
in	O
the	O
secretion	B-ANAT
of	O
IFN	O
by	O
both	O
Mphi	O
and	O
L929	O
cells	B-ANAT
incubated	O
with	O
cocaine	O
,	O
with	O
a	O
concomitant	O
decrease	O
in	O
virus	O
replication	O
,	O
is	O
also	O
reported	O
.	O

None	O
of	O
the	O
seven	O
MAbs	O
were	O
reactive	O
with	O
canine	O
rotavirus	O
,	O
bovine	O
coronavirus	O
,	O
or	O
uninfected	O
Madin	O
-	O
Darby	O
bovine	O
kidney	B-ANAT
cells	B-ANAT
.	O

Submit	O
live	O
pigs	O
or	O
appropriate	O
tissues	B-ANAT
from	O
necropsied	O
pigs	O
to	O
a	O
diagnostic	O
laboratory	O
.	O

Charts	O
of	O
consecutive	O
ARDS	O
patients	O
(	O
lung	B-ANAT
injury	O
score	O
>	O
2	O
)	O
during	O
a	O
2	O
-	O
yr	O
period	O
,	O
tested	O
for	O
both	O
inhaled	O
NO	O
and	O
prone	O
positioning	O
efficacy	O
were	O
retrospectively	O
reviewed	O
.	O

ABSTRACT	O
:	O
Acute	O
severe	O
pancreatitis	O
is	O
often	O
associated	O
with	O
acute	O
lung	B-ANAT
injury	O
,	O
including	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
two	O
pancreatic	B-ANAT
enzymes	O
caused	O
extensive	O
morphologic	O
lung	B-ANAT
damage	O
,	O
which	O
was	O
lessened	O
by	O
lidocaine	O
.	O

We	O
conclude	O
that	O
pretreatment	O
with	O
intravenous	O
lidocaine	O
attenuated	O
the	O
lung	B-ANAT
injury	O
induced	O
by	O
the	O
pancreatic	B-ANAT
enzymes	O
.	O

TITLE	O
:	O
Four	O
proteins	O
processed	O
from	O
the	O
replicase	O
gene	O
polyprotein	O
of	O
mouse	O
hepatitis	O
virus	O
colocalize	O
in	O
the	O
cell	B-ANAT
periphery	I-ANAT
and	O
adjacent	O
to	O
sites	O
of	O
virion	B-ANAT
assembly	O
.	O

Dual	O
-	O
labeling	O
experiments	O
demonstrated	O
colocalization	O
of	O
the	O
majority	O
of	O
p1a	O
-	O
22	O
in	O
replication	O
complexes	O
with	O
the	O
helicase	O
,	O
nucleocapsid	B-ANAT
,	O
and	O
3C	O
-	O
like	O
proteinase	O
,	O
as	O
well	O
as	O
with	O
p1a	O
-	O
10	O
,	O
-	O
12	O
,	O
and	O
-	O
15	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
CD11	O
-	O
CD18	O
complex	O
prevents	O
acute	O
lung	B-ANAT
injury	O
and	O
reduces	O
mortality	O
after	O
peritonitis	O
in	O
rabbits	O
.	O

On	O
Day	O
1	O
control	O
animals	O
had	O
significant	O
leukopenia	O
,	O
whereas	O
anti	O
-	O
CD18	O
-	O
treated	O
animals	O
had	O
a	O
moderate	O
increase	O
of	O
the	O
number	O
of	O
circulating	O
WBC	B-ANAT
compared	O
with	O
baseline	O
values	O
(	O
p	O
<	O
0	O
.	O
05	O
between	O
groups	O
).	O

The	O
lungs	B-ANAT
of	O
the	O
anti	O
-	O
CD18	O
-	O
treated	O
animals	O
showed	O
minor	O
signs	O
of	O
inflammation	O
and	O
PMN	B-ANAT
infiltration	O
whereas	O
controls	O
had	O
interstitial	B-ANAT
and	O
intra	O
-	O
alveolar	B-ANAT
edema	O
and	O
a	O
large	O
number	O
of	O
granulocytes	B-ANAT
.	O

Quantification	O
of	O
PMNs	O
by	O
morphometry	O
showed	O
that	O
there	O
were	O
constantly	O
less	O
granulocytes	B-ANAT
in	O
the	O
lungs	B-ANAT
of	O
the	O
animals	O
treated	O
with	O
the	O
anti	O
-	O
CD18	O
antibody	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

In	O
this	O
particular	O
model	O
of	O
ARDS	O
the	O
monoclonal	O
antibody	O
against	O
the	O
CD11	O
-	O
CD18	O
complex	O
had	O
a	O
beneficial	O
effect	O
,	O
reducing	O
PMN	B-ANAT
infiltration	O
and	O
oxygen	O
radical	O
release	O
in	O
the	O
lungs	B-ANAT
,	O
preventing	O
alveolocapillary	B-ANAT
membrane	I-ANAT
damage	O
,	O
improving	O
gas	O
exchange	O
and	O
,	O
finally	O
,	O
significantly	O
reducing	O
mortality	O
.	O

1	O
.	O
9	O
h	O
)	O
with	O
equivalent	O
proportions	O
of	O
non	O
-	O
rapid	O
eye	B-ANAT
movement	O
(	O
NREM	O
)	O
and	O
rapid	O
eye	B-ANAT
movement	O
(	O
REM	O
)	O
sleep	O
.	O

The	O
kinetics	O
of	O
viral	O
load	O
observed	O
in	O
the	O
lungs	B-ANAT
and	O
kidneys	B-ANAT
correlated	O
with	O
the	O
level	O
of	O
IBV	O
-	O
specific	O
CTL	B-ANAT
activity	O
of	O
effector	O
cells	B-ANAT
prepared	O
from	O
spleens	B-ANAT
of	O
infected	O
chicks	O
.	O

Adoptive	O
transfer	O
of	O
immune	O
T	B-ANAT
cells	I-ANAT
to	O
chicks	O
prior	O
to	O
infection	O
demonstrated	O
that	O
IBV	O
primed	O
CD8	O
(+),	O
alphabeta	O
T	B-ANAT
lymphocytes	I-ANAT
could	O
protect	O
chicks	O
from	O
acute	O
infection	O
.	O

The	O
disease	O
is	O
characterised	O
by	O
splenomegaly	O
,	O
intestinal	B-ANAT
haemorrhage	O
,	O
sudden	O
death	O
and	O
immunosuppression	O
.	O

At	O
1	O
d	O
.	O
p	O
.	O
i	O
.,	O
almost	O
all	O
epithelial	B-ANAT
cells	I-ANAT
were	O
involved	O
in	O
the	O
degeneration	O
.	O

At	O
this	O
time	O
,	O
labelling	O
index	O
of	O
bromodeoxyuridine	O
(	O
BrdU	O
)	O
in	O
the	O
basal	B-ANAT
cells	I-ANAT
showed	O
significantly	O
high	O
value	O
compared	O
with	O
control	O
.	O

TITLE	O
:	O
Unique	O
N	O
-	O
linked	O
glycosylation	O
of	O
murine	O
coronavirus	O
MHV	O
-	O
2	O
membrane	B-ANAT
protein	O
at	O
the	O
conserved	O
O	O
-	O
linked	O
glycosylation	O
site	O
.	O

ABSTRACT	O
:	O
The	O
membrane	B-ANAT
(	O
M	O
)	O
proteins	O
of	O
murine	O
coronavirus	O
(	O
MHV	O
)	O
strains	O
have	O
been	O
reported	O
to	O
contain	O
only	O
O	O
-	O
linked	O
oligosaccharides	O
.	O

The	O
specificity	O
of	O
the	O
neuraminidase	O
rapid	O
-	O
plate	O
HA	O
assay	O
was	O
examined	O
with	O
other	O
avian	O
viruses	O
in	O
individual	O
and	O
dual	O
embryonic	B-ANAT
infections	O
.	O

The	O
rapid	O
-	O
plate	O
HA	O
assay	O
of	O
neuraminidase	O
-	O
treated	O
allantoic	B-ANAT
fluid	I-ANAT
correlated	O
with	O
the	O
RT	O
-	O
PCR	O
during	O
the	O
early	O
stages	O
of	O
IBV	O
detection	O
,	O
identification	O
,	O
and	O
isolation	O
in	O
embryonated	O
eggs	O
.	O

The	O
results	O
suggest	O
that	O
TCV	O
promoted	O
intestinal	B-ANAT
colonization	O
by	O
R98	O
/	O
5	O
;	O
however	O
,	O
R98	O
/	O
5	O
did	O
not	O
appear	O
to	O
alter	O
TCV	O
infection	O
.	O

In	O
addition	O
,	O
a	O
two	O
-	O
way	O
cross	O
-	O
neutralization	O
test	O
was	O
performed	O
in	O
embryonated	O
eggs	O
with	O
the	O
beta	O
method	O
(	O
constant	O
-	O
virus	O
,	O
diluted	O
-	O
serum	B-ANAT
)	O
and	O
the	O
reciprocal	O
neutralization	O
titers	O
were	O
calculated	O
to	O
give	O
the	O
relatedness	O
(	O
r	O
)	O
values	O
.	O

The	O
concentration	O
of	O
mature	O
circulating	O
neutrophils	B-ANAT
rose	O
from	O
0	O
.	O
49	O
+/-	O

2	O
.	O
2	O
x	O
10	O
(	O
9	O
)	O
cells	B-ANAT
/	O
L	O
within	O
6	O
to	O
8	O
hours	O
in	O
the	O
early	O
neutropenia	O
group	O
and	O
from	O
4	O
.	O
6	O
+/-	O

Pulmonary	B-ANAT
interstitial	B-ANAT
emphysema	O
,	O
serious	O
intraventricular	B-ANAT
hemorrhage	O
,	O
and	O
chronic	O
lung	B-ANAT
disease	O
occurred	O
more	O
frequently	O
in	O
patients	O
with	O
early	O
neutropenia	O
.	O

Cleavage	O
of	O
the	O
N	O
protein	O
was	O
inhibited	O
by	O
cell	B-ANAT
-	O
permeative	O
caspase	O
inhibitors	O
,	O
suggesting	O
that	O
this	O
viral	O
structural	O
protein	O
is	O
a	O
target	O
for	O
host	B-ANAT
cell	I-ANAT
caspases	O
.	O

ABSTRACT	O
:	O
Mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)-	O
infected	O
cells	B-ANAT
contain	O
full	O
-	O
length	O
and	O
subgenomic	O
-	O
length	O
positive	O
-	O
and	O
negative	O
-	O
strand	O
RNAs	O
.	O

Multisystem	O
injury	O
,	O
including	O
acute	O
lung	B-ANAT
injury	O
,	O
is	O
a	O
severe	O
complication	O
associated	O
with	O
hepatic	B-ANAT
cryoablation	O
of	O
30	O
%	O
to	O
35	O
%	O
or	O
more	O
of	O
liver	B-ANAT
parenchyma	I-ANAT
,	O
but	O
this	O
complication	O
has	O
not	O
been	O
reported	O
with	O
RFA	O
.	O

Histologic	O
lung	B-ANAT
sections	O
after	O
cryoablation	O
showed	O
multiple	O
foci	O
of	O
perivenular	O
inflammation	O
,	O
with	O
activated	O
lymphocytes	B-ANAT
,	O
foamy	O
macrophages	B-ANAT
,	O
and	O
neutrophils	B-ANAT
.	O

Hepatic	B-ANAT
cryoablation	O
,	O
but	O
not	O
RFA	O
,	O
induces	O
NF	O
-	O
kappaB	O
activation	O
in	O
the	O
nonablated	O
liver	B-ANAT
and	O
lung	B-ANAT
and	O
is	O
associated	O
with	O
acute	O
lung	B-ANAT
injury	O
.	O

Electron	O
microscopy	O
revealed	O
corona	O
-	O
like	O
virus	B-ANAT
particles	I-ANAT
in	O
these	O
necrotic	O
cells	B-ANAT
.	O

To	O
investigate	O
the	O
importance	O
of	O
the	O
overlapping	O
gene	O
arrangement	O
in	O
the	O
viral	O
life	O
-	O
cycle	O
and	O
to	O
facilitate	O
the	O
genetic	O
manipulation	O
of	O
the	O
viral	B-ANAT
genome	I-ANAT
,	O
a	O
series	O
of	O
mutant	O
full	O
-	O
length	O
cDNA	O
clones	O
was	O
constructed	O
in	O
which	O
either	O
EAV	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
4	O
and	O
5	O
or	O
ORFs	O
5	O
and	O
6	O
or	O
ORFs	O
4	O
,	O
5	O
,	O
and	O
6	O
were	O
separated	O
by	O
newly	O
introduced	O
AflII	O
restriction	O
endonuclease	O
cleavage	O
sites	O
.	O

These	O
results	O
hold	O
promise	O
for	O
the	O
development	O
of	O
a	O
gene	O
therapy	O
treatment	O
for	O
chronic	O
viral	O
hepatitis	O
based	O
on	O
liver	B-ANAT
-	O
restricted	O
expression	O
of	O
IFN	O
-	O
alpha2	O
.	O

ABSTRACT	O
:	O
Swine	O
influenza	O
virus	O
(	O
SIV	O
),	O
porcine	O
respiratory	O
coronavirus	O
(	O
PRCV	O
)	O
and	O
porcine	O
reproductive	O
and	O
respiratory	O
syndrome	O
virus	O
(	O
PRRSV	O
)	O
are	O
enzootic	O
viruses	O
causing	O
pulmonary	B-ANAT
infections	O
in	O
pigs	O
.	O

ABSTRACT	O
:	O
Our	O
prior	O
studies	O
showed	O
that	O
polyhydroxylated	O
styrylquinolines	O
are	O
potent	O
HIV	O
-	O
1	O
integrase	O
(	O
IN	O
)	O
inhibitors	O
that	O
block	O
the	O
replication	O
of	O
HIV	O
-	O
1	O
in	O
cell	B-ANAT
culture	O
at	O
nontoxic	O
concentrations	O
.	O

The	O
conventional	O
treatment	O
includes	O
intravenous	O
N	O
-	O
acetylcysteine	O
,	O
L	O
-	O
3	O
,	O
4	O
-	O
dehydroproline	O
,	O
methylene	O
blue	O
,	O
and	O
respiratory	O
support	O
according	O
to	O
the	O
lung	B-ANAT
protective	O
strategy	O
.	O

892	O
gm	O
birth	O
weight	O
,	O
p	O
=	O
0	O
.	O
021	O
),	O
with	O
higher	O
peak	O
postpartum	O
blood	B-ANAT
pressures	O
(<	O
0	O
.	O
001	O
)	O
and	O
with	O
more	O
abnormal	O
laboratory	O
values	O
indicative	O
of	O
multisystem	O
disease	O
,	O
compared	O
with	O
patients	O
without	O
this	O
complication	O
.	O

Therefore	O
we	O
now	O
explore	O
the	O
in	O
vivo	O
effects	O
of	O
elastase	O
on	O
the	O
liver	B-ANAT
.	O

A	O
significant	O
increase	O
in	O
hepatic	B-ANAT
enzymes	O
and	O
MPO	O
activity	O
was	O
induced	O
by	O
AP	O
and	O
mirrored	O
by	O
intraperitoneal	O
elastase	O
.	O

Prevention	O
of	O
inflammatory	O
mediator	O
production	O
by	O
intrahepatic	O
leukocytes	B-ANAT
attenuates	O
injury	O
and	O
supports	O
recent	O
adult	O
respiratory	O
distress	O
syndrome	O
and	O
in	O
vitro	O
data	O
suggesting	O
that	O
elastase	O
is	O
the	O
principal	O
factor	O
that	O
propagates	O
pancreatic	B-ANAT
inflammation	O
into	O
a	O
systemic	O
illness	O
through	O
direct	O
activation	O
of	O
systemic	O
inflammatory	B-ANAT
cells	I-ANAT
.	O

Contamination	O
by	O
fecal	B-ANAT
material	O
of	O
bats	O
in	O
the	O
basement	O
of	O
the	O
house	O
was	O
found	O
to	O
be	O
the	O
most	O
likely	O
cause	O
of	O
this	O
outbreak	O
.	O

TITLE	O
:	O
Assembly	O
of	O
the	O
coronavirus	O
envelope	B-ANAT
:	O
homotypic	O
interactions	O
between	O
the	O
M	O
proteins	O
.	O

Mutant	O
M	O
proteins	O
which	O
were	O
not	O
able	O
to	O
assemble	O
into	O
viruslike	O
particles	O
(	O
VLPs	B-ANAT
)	O
by	O
themselves	O
(	O
C	O
.	O
A	O
.	O
M	O
.	O
de	O
Haan	O
,	O
L	O
.	O
Kuo	O
,	O
P	O
.	O
S	O
.	O
Masters	O
,	O
H	O
.	O
Vennema	O
,	O
and	O
P	O
.	O
J	O
.	O
M	O
.	O
Rottier	O
,	O
J	O
.	O
Virol	O
.	O

Only	O
a	O
mutant	O
M	O
protein	O
in	O
which	O
all	O
three	O
transmembrane	B-ANAT
domains	O
had	O
been	O
replaced	O
lost	O
this	O
ability	O
.	O

We	O
performed	O
histological	O
evaluation	O
by	O
examining	O
stained	O
sections	O
of	O
liver	B-ANAT
blocks	O
from	O
each	O
case	O
.	O

RESULTS	O
:	O
The	O
virus	O
antigen	O
was	O
positive	O
in	O
CD8	O
+	O
T	B-ANAT
lymphocytes	I-ANAT
from	O
the	O
lung	B-ANAT
and	O
spleen	B-ANAT
.	O

ABSTRACT	O
:	O
Cells	B-ANAT
infected	O
with	O
bovine	O
coronavirus	O
(	O
BCV	O
)	O
were	O
solubilized	O
with	O
Triton	O
X	O
-	O
100	O
to	O
yield	O
a	O
cell	B-ANAT
lysate	O
(	O
CL	O
)	O
antigen	O
having	O
high	O
hemagglutinating	O
(	O
HA	O
)	O
titers	O
.	O

The	O
cDNA	O
was	O
derived	O
from	O
an	O
attenuated	O
isolate	O
that	O
replicates	O
exclusively	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
of	O
swine	O
.	O

Two	O
classical	O
models	O
of	O
acute	O
inflammatory	O
response	O
induced	O
in	O
laboratory	O
animals	O
,	O
the	O
Arthus	O
and	O
Shwartzman	O
reactions	O
,	O
could	O
explain	O
the	O
pathogenesis	O
of	O
the	O
severe	O
lung	B-ANAT
lesions	O
that	O
characterize	O
PP	O
.	O

Accumulating	O
data	O
suggest	O
that	O
the	O
maximization	O
and	O
maintenance	O
of	O
lung	B-ANAT
recruitment	O
may	O
reduce	O
lung	B-ANAT
parenchymal	O
injury	O
from	O
positive	O
pressure	O
ventilation	O
in	O
ARDS	O
.	O

ABSTRACT	O
:	O
A	O
20089	O
nucleotide	O
(	O
nt	O
)	O
sequence	O
was	O
determined	O
for	O
the	O
5	O
'	O
end	O
of	O
the	O
(+)-	O
ssRNA	O
genome	O
of	O
gill	B-ANAT
-	O
associated	O
virus	O
(	O
GAV	O
),	O
a	O
yellow	O
head	B-ANAT
-	O
like	O
virus	O
infecting	O
Penaeus	O
monodon	O
prawns	O
.	O

ABSTRACT	O
:	O
Recombinant	O
live	O
oral	B-ANAT
vaccines	O
expressing	O
pathogen	O
-	O
derived	O
antigens	O
offer	O
a	O
unique	O
set	O
of	O
attractive	O
properties	O
.	O

Accordingly	O
,	O
the	O
immune	O
response	O
of	O
mice	O
immunized	O
with	O
a	O
Salmonella	O
enterica	O
serovar	O
Typhimurium	O
vaccine	O
strain	O
expressing	O
the	O
Escherichia	O
coli	O
987P	O
fimbrial	O
antigen	O
on	O
its	O
surface	O
(	O
Fas	O
(+))	O
was	O
compared	O
with	O
the	O
expression	O
in	O
the	O
periplasmic	B-ANAT
compartment	B-ANAT
(	O
Fas	O
(-)).	O

For	O
this	O
,	O
the	O
vaccine	O
strain	O
was	O
genetically	O
engineered	O
to	O
express	O
chimeric	O
fimbriae	B-ANAT
carrying	O
the	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)	O
C	O
(	O
379	O
-	O
388	O
)	O
and	O
A	O
(	O
521	O
-	O
531	O
)	O
epitopes	O
of	O
the	O
spike	O
protein	O
inserted	O
into	O
the	O
987P	O
major	O
fimbrial	O
subunit	O
FasA	O
.	O
BALB	O
/	O
c	O
mice	O
administered	O
orally	B-ANAT
serovar	O
Typhimurium	O
chi4550	O
expressing	O
the	O
chimeric	O
fimbriae	B-ANAT
from	O
the	O
tet	O
promoter	O
in	O
pCS154	O
(	O
fas	O
(+)	O
asd	O
(+))	O
produced	O
systemic	O
antibodies	O
against	O
both	O
fimbria	B-ANAT
and	O
the	O
TGEV	O
C	O
epitope	O
but	O
not	O
against	O
the	O
TGEV	O
A	O
epitope	O
.	O

Hence	O
,	O
immune	O
responses	O
to	O
heterologous	O
chimeric	O
fimbriae	B-ANAT
on	O
Salmonella	O
vaccine	O
vectors	O
can	O
be	O
optimized	O
by	O
using	O
promoters	O
known	O
to	O
be	O
activated	O
in	O
vivo	O
.	O

ARDS	O
due	O
to	O
massive	O
transfusion	O
and	O
prolonged	O
cardiopulmonary	B-ANAT
bypass	O
developed	O
in	O
the	O
early	O
postoperative	O
period	O
.	O

Viral	O
antigen	O
was	O
detected	O
in	O
the	O
cytoplasm	B-ANAT
of	O
tracheal	B-ANAT
epithelium	I-ANAT
from	O
16	O
hr	O
to	O
6	O
days	O
post	O
-	O
inoculation	O
(	O
p	O
.	O
i	O
.)	O
with	O
a	O
peak	O
on	O
4	O
days	O
p	O
.	O
i	O
.	O

A	O
few	O
IgG	O
+,	O
IgM	O
+	O
and	O
IgA	O
+	O
cells	B-ANAT
were	O
detected	O
in	O
the	O
submucosa	B-ANAT
from	O
8	O
hr	O
p	O
.	O
i	O
.	O

LAMP	O
-	O
1	O
,	O
a	O
marker	O
for	O
late	O
endosomes	O
and	O
lysosomes	B-ANAT
,	O
was	O
detected	O
in	O
both	O
membrane	B-ANAT
populations	O
.	O

93	O
of	O
105	O
cattle	O
and	O
106	O
of	O
120	O
cattle	O
developed	O
signs	O
of	O
respiratory	B-ANAT
tract	I-ANAT
disease	O
during	O
1997	O
and	O
1998	O
,	O
respectively	O
,	O
and	O
RBCV	O
was	O
isolated	O
from	O
81	O
and	O
89	O
sick	O
cattle	O
,	O
respectively	O
,	O
while	O
at	O
the	O
order	O
-	O
buyer	O
'	O
s	O
barn	O
or	O
the	O
day	O
after	O
arrival	O
at	O
the	O
feedlot	O
.	O

TITLE	O
:	O
Sleep	O
laboratory	O
studies	O
in	O
restless	O
legs	B-ANAT
syndrome	O
patients	O
as	O
compared	O
with	O
normals	O
and	O
acute	O
effects	O
of	O
ropinirole	O
.	O

ABSTRACT	O
:	O
Systemic	O
hemodynamics	O
,	O
oxygenating	O
function	O
of	O
the	O
lungs	B-ANAT
,	O
and	O
oxygen	O
budgeting	O
were	O
studied	O
in	O
32	O
patients	O
with	O
acute	O
bowel	B-ANAT
obstruction	O
(	O
ABO	O
)	O
with	O
severe	O
endotoxicosis	O
.	O

The	O
diagnosis	O
considered	O
was	O
a	O
hyaline	B-ANAT
membrane	B-ANAT
disease	O
.	O

Review	O
of	O
toxicologic	O
data	O
on	O
glutaraldehyde	O
shows	O
this	O
is	O
a	O
highly	O
irritating	O
chemical	O
for	O
the	O
respiratory	B-ANAT
tract	I-ANAT
,	O
even	O
at	O
low	O
concentrations	O
.	O

TITLE	O
:	O
Causes	O
and	O
outcomes	O
of	O
the	O
acute	O
chest	B-ANAT
syndrome	O
in	O
sickle	B-ANAT
cell	I-ANAT
disease	O
.	O

National	O
Acute	O
Chest	B-ANAT
Syndrome	O
Study	O
Group	O
.	O

When	O
the	O
acute	O
chest	B-ANAT
syndrome	O
was	O
diagnosed	O
,	O
patients	O
had	O
hypoxia	O
,	O
decreasing	O
hemoglobin	O
values	O
,	O
and	O
progressive	O
multilobar	O
pneumonia	O
.	O

A	O
specific	O
cause	O
of	O
the	O
acute	O
chest	B-ANAT
syndrome	O
was	O
identified	O
in	O
38	O
percent	O
of	O
all	O
episodes	O
and	O
70	O
percent	O
of	O
episodes	O
with	O
complete	O
data	O
.	O

Among	O
patients	O
with	O
sickle	B-ANAT
cell	I-ANAT
disease	O
,	O
the	O
acute	O
chest	B-ANAT
syndrome	O
is	O
commonly	O
precipitated	O
by	O
fat	O
embolism	O
and	O
infection	O
,	O
especially	O
community	O
-	O
acquired	O
pneumonia	O
.	O

ABSTRACT	O
:	O
The	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
of	O
many	O
viruses	O
is	O
highly	O
conserved	O
,	O
immunogenic	O
,	O
and	O
abundantly	O
expressed	O
during	O
infection	O
.	O

Sera	B-ANAT
against	O
Australia	O
T	O
,	O
China	O
Ch5	O
,	O
Singapore	O
P4	O
,	O
USA	O
M41	O
and	O
China	O
T3	O
isolates	O
were	O
used	O
to	O
study	O
the	O
conservation	O
and	O
localization	O
of	O
the	O
antigenic	O
region	O
on	O
the	O
IBV	O
nucleocapsid	B-ANAT
protein	O
.	O

Hearts	B-ANAT
were	O
examined	O
using	O
light	O
microscopy	O
for	O
histologic	O
evidence	O
of	O
myocarditis	O
according	O
to	O
the	O
Dallas	O
criteria	O
.	O

To	O
prevent	O
the	O
development	O
of	O
renal	B-ANAT
or	O
cardiopulmonary	B-ANAT
failure	O
in	O
these	O
patients	O
,	O
decompression	O
should	O
be	O
considered	O
for	O
acute	O
,	O
tense	O
abdominal	B-ANAT
distension	O
.	O

Immunofluorescence	O
microscopy	O
and	O
subcellular	O
fractionation	O
studies	O
further	O
show	O
differential	O
subcellular	O
localization	O
of	O
the	O
proteinase	O
in	O
IBV	O
-	O
infected	O
cells	B-ANAT
and	O
in	O
cells	B-ANAT
expressing	O
the	O
3C	O
-	O
like	O
proteinase	O
alone	O
,	O
indicating	O
that	O
additional	O
roles	O
in	O
viral	O
replication	O
might	O
be	O
played	O
by	O
this	O
protein	O
.	O

TITLE	O
:	O
Identifying	O
agent	O
(	O
s	O
)	O
associated	O
with	O
poult	O
enteritis	O
mortality	O
syndrome	O
:	O
importance	O
of	O
the	O
thymus	B-ANAT
.	O

In	O
these	O
studies	O
,	O
naÃ¯ve	O
turkey	O
poults	O
were	O
orally	B-ANAT
inoculated	O
with	O
a	O
bacteria	O
-	O
free	O
filtrate	O
composed	O
of	O
either	O
the	O
intestines	B-ANAT
and	O
feces	B-ANAT
or	O
the	O
thymus	B-ANAT
from	O
PEMS	O
-	O
infected	O
birds	O
and	O
were	O
monitored	O
for	O
clinical	O
signs	O
of	O
PEMS	O
.	O

Specific	O
-	O
pathogen	O
-	O
free	O
and	O
conventional	O
poults	O
were	O
orally	B-ANAT
challenged	O
with	O
SRV	O
and	O
/	O
or	O
turkey	O
coronavirus	O
and	O
monitored	O
for	O
clinical	O
signs	O
.	O

The	O
incidence	O
of	O
lymphocyte	B-ANAT
subpopulations	O
in	O
the	O
peripheral	B-ANAT
blood	I-ANAT
and	O
thymic	O
lymphocytes	B-ANAT
of	O
SRV	O
-	O
challenged	O
poults	O
was	O
examined	O
by	O
flow	O
cytometry	O
.	O

The	O
results	O
of	O
these	O
studies	O
showed	O
that	O
the	O
SRV	O
challenge	O
induced	O
diarrhea	O
,	O
growth	O
suppression	O
,	O
and	O
atrophy	O
of	O
thymus	B-ANAT
and	O
bursa	B-ANAT
resembling	O
those	O
of	O
PEMS	O
in	O
field	O
and	O
/	O
or	O
experimental	O
infections	O
.	O

Evidence	O
suggests	O
the	O
occurrence	O
of	O
rupture	O
of	O
the	O
basement	B-ANAT
membranes	I-ANAT
and	O
interstitial	B-ANAT
matrix	I-ANAT
remodeling	O
during	O
acute	O
lung	B-ANAT
injury	O
.	O

Matrix	O
metalloproteinases	O
(	O
MMPs	O
)	O
represent	O
a	O
group	O
of	O
enzymes	O
involved	O
in	O
the	O
degradation	O
of	O
most	O
of	O
the	O
components	O
of	O
the	O
ECM	B-ANAT
and	O
therefore	O
participate	O
in	O
tissue	B-ANAT
remodeling	O
associated	O
with	O
pathological	O
situations	O
such	O
as	O
acute	O
lung	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
This	O
study	O
examined	O
whether	O
exposure	O
of	O
pigs	O
to	O
both	O
porcine	O
respiratory	O
coronavirus	O
(	O
PRCV	O
)	O
and	O
bacterial	O
lipopolysaccharide	O
(	O
LPS	O
)	O
can	O
potentiate	O
respiratory	O
disease	O
and	O
lung	B-ANAT
secretion	B-ANAT
of	O
tumour	O
necrosis	O
factor	O
-	O
a	O
(	O
TNF	O
-	O
alpha	O
)	O
and	O
interleukin	O
-	O
1	O
(	O
IL	O
-	O
1	O
).	O

Molecular	O
analysis	O
revealed	O
identical	O
T	O
-	O
cell	B-ANAT
clones	I-ANAT
in	O
2	O
or	O
more	O
sites	O
(	O
liver	B-ANAT
,	O
spleen	B-ANAT
,	O
lymph	B-ANAT
node	I-ANAT
)	O
in	O
5	O
cases	O
.	O

Although	O
cytologic	O
atypia	O
is	O
minimal	O
,	O
studies	O
for	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
clonality	O
confirm	O
the	O
diagnosis	O
.	O

(	O
Blood	B-ANAT
.	O

ABSTRACT	O
:	O
We	O
have	O
previously	O
identified	O
a	O
functionally	O
essential	O
bulged	O
stem	B-ANAT
-	O
loop	O
in	O
the	O
3	O
'	O
untranslated	O
region	O
of	O
the	O
positive	O
-	O
stranded	O
RNA	O
genome	O
of	O
mouse	O
hepatitis	O
virus	O
.	O

This	O
68	O
-	O
nucleotide	O
structure	O
is	O
composed	O
of	O
six	O
stem	B-ANAT
segments	O
interrupted	O
by	O
five	O
bulges	O
,	O
and	O
its	O
structure	O
,	O
but	O
not	O
its	O
primary	O
sequence	O
,	O
is	O
entirely	O
conserved	O
in	O
the	O
related	O
bovine	O
coronavirus	O
.	O

These	O
studies	O
were	O
complemented	O
by	O
enzymatic	O
and	O
chemical	O
probing	O
of	O
the	O
stem	B-ANAT
-	O
loop	O
.	O

Three	O
of	O
the	O
stem	B-ANAT
segments	O
were	O
found	O
to	O
be	O
essential	O
for	O
viral	O
replication	O
.	O

Chest	B-ANAT
radiography	O
results	O
showed	O
bilateral	O
and	O
diffuse	O
infiltrate	O
.	O

Physicians	O
caring	O
for	O
patients	O
who	O
have	O
recently	O
traveled	O
to	O
malaria	O
-	O
endemic	O
areas	O
need	O
to	O
anticipate	O
the	O
possible	O
development	O
of	O
malaria	O
with	O
all	O
of	O
its	O
complications	O
,	O
including	O
acute	O
lung	B-ANAT
injury	O
.	O

Pulmonary	B-ANAT
artery	I-ANAT
pressure	O
(	O
PAP	O
)	O
and	O
pulmonary	B-ANAT
capillary	I-ANAT
wedge	O
pressure	O
(	O
PCWP	O
)	O
were	O
monitored	O
.	O

However	O
,	O
whether	O
these	O
recruitment	O
strategies	O
are	O
effective	O
as	O
rescue	O
treatment	O
after	O
established	O
lung	B-ANAT
injury	O
is	O
unknown	O
.	O

Pulmonary	B-ANAT
TNF	O
-	O
alpha	O
protein	O
was	O
detected	O
by	O
immunohistochemistry	O
.	O

Pulmonary	B-ANAT
TNF	O
-	O
alpha	O
protein	O
and	O
serum	B-ANAT
nitrites	O
were	O
decreased	O
with	O
the	O
administration	O
of	O
CNI	O
-	O
1493	O
(	O
p	O
<	O
.	O
005	O
vs	O
.	O
vehicle	O
).	O

A	O
component	O
of	O
pancreatic	B-ANAT
ascites	O
other	O
than	O
endotoxin	O
,	O
bacteria	O
,	O
or	O
cytokines	O
(	O
IL	O
-	O
1beta	O
,	O
TNF	O
,	O
interferon	O
-	O
gamma	O
,	O
or	O
IL	O
-	O
6	O
)	O
is	O
capable	O
of	O
inducing	O
ARDS	O
in	O
healthy	O
animals	O
.	O

TITLE	O
:	O
Pancreatic	B-ANAT
elastase	O
activates	O
pulmonary	B-ANAT
nuclear	O
factor	O
kappa	O
B	O
and	O
inhibitory	O
kappa	O
B	O
,	O
mimicking	O
pancreatitis	O
-	O
associated	O
adult	O
respiratory	O
distress	O
syndrome	O
.	O

ABSTRACT	O
:	O
Select	O
pancreatic	B-ANAT
enzymes	O
,	O
primarily	O
elastase	O
,	O
precipitate	O
pulmonary	B-ANAT
injury	O
similar	O
to	O
pancreatitis	O
-	O
associated	O
adult	O
respiratory	O
distress	O
syndrome	O
and	O
stimulate	O
leukocyte	B-ANAT
cytokine	O
production	O
in	O
vitro	O
via	O
nuclear	O
factor	O
kappa	O
B	O
(	O
NF	O
-	O
kappaB	O
)	O
activation	O
.	O

Mice	O
received	O
pancreatic	B-ANAT
elastase	O
,	O
amylase	O
,	O
lipase	O
,	O
or	O
trypsin	O
intraperitoneally	O
.	O

Furthermore	O
,	O
lung	B-ANAT
injury	O
was	O
markedly	O
reduced	O
in	O
TNF	O
KO	O
animals	O
and	O
PDTC	O
significantly	O
attenuated	O
TNF	O
production	O
and	O
pulmonary	B-ANAT
microvascular	O
leakage	O
.	O

Furthermore	O
,	O
lung	B-ANAT
injury	O
was	O
markedly	O
reduced	O
in	O
TNF	O
KO	O
animals	O
and	O
PDTC	O
significantly	O
attenuated	O
TNF	O
production	O
and	O
pulmonary	B-ANAT
microvascular	O
leakage	O
.	O

In	O
this	O
study	O
,	O
the	O
individual	O
roles	O
of	O
CD4	O
and	O
CD8	O
T	B-ANAT
cells	I-ANAT
in	O
MHV	O
-	O
induced	O
demyelination	O
were	O
investigated	O
using	O
recombination	O
-	O
activating	O
gene	O
1	O
-/-	O
(	O
RAG1	O
-/-)	O
mice	O
infected	O
with	O
an	O
attenuated	O
strain	O
of	O
MHV	O
-	O
JHM	O
.	O

If	O
the	O
effusion	B-ANAT
is	O
exudative	O
,	O
attempts	O
should	O
be	O
made	O
to	O
define	O
the	O
etiology	O
.	O

The	O
diagnosis	O
of	O
pleural	O
malignancy	O
is	O
most	O
easily	O
established	O
via	O
pleural	B-ANAT
fluid	I-ANAT
cytology	O
.	O

If	O
the	O
pleural	B-ANAT
fluid	I-ANAT
cannot	O
be	O
completely	O
evacuated	O
because	O
of	O
loculations	O
,	O
intrapleural	B-ANAT
thrombolytic	O
therapy	O
should	O
be	O
considered	O
.	O

At	O
present	O
,	O
the	O
use	O
of	O
the	O
long	O
-	O
acting	O
prostacyclin	O
analogue	O
ilomedin	O
for	O
ambulant	O
treatment	O
of	O
patients	O
with	O
chronic	O
pulmonary	B-ANAT
hypertension	O
is	O
under	O
investigation	O
.	O

Class	O
I	O
tetramer	O
technology	O
revealed	O
more	O
infiltrating	O
virus	O
-	O
specific	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
during	O
acute	O
V	O
-	O
1	O
compared	O
to	O
V	O
-	O
2	O
infection	O
.	O

Decreasing	O
viral	O
RNA	O
levels	O
in	O
both	O
brains	B-ANAT
and	O
spinal	B-ANAT
cords	I-ANAT
following	O
initial	O
virus	O
clearance	O
coincided	O
with	O
an	O
overall	O
progressive	O
loss	O
of	O
both	O
total	O
and	O
virus	O
-	O
specific	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
.	O

These	O
data	O
indicated	O
that	O
M	O
protein	O
interacted	O
with	O
the	O
nucleocapsid	B-ANAT
,	O
consisting	O
of	O
N	O
protein	O
and	O
mRNA	O
1	O
,	O
in	O
infected	O
cells	B-ANAT
.	O

Virus	O
neutralisation	O
test	O
in	O
tracheal	O
organ	B-ANAT
culture	O
is	O
the	O
best	O
method	O
for	O
antigenic	O
typing	O
.	O

ABSTRACT	O
:	O
Nasopharyngeal	B-ANAT
swabs	O
of	O
50	O
asthmatic	O
children	O
in	O
the	O
symptom	O
-	O
free	O
period	O
were	O
examined	O
for	O
the	O
presence	O
of	O
adenoviruses	O
,	O
rhinoviruses	O
and	O
coronaviruses	O
.	O

There	O
was	O
a	O
purulent	O
bursitis	O
over	O
the	O
olecranon	B-ANAT
.	O

Coronavirus	O
particles	O
were	O
identified	O
in	O
feces	B-ANAT
and	O
jejunal	B-ANAT
enterocytes	B-ANAT
by	O
use	O
of	O
transmission	O
electron	O
microscopy	O
.	O

Antigen	O
staining	O
was	O
not	O
detected	O
in	O
healthy	O
ferrets	O
or	O
ferrets	O
with	O
other	O
gastrointestinal	B-ANAT
tract	I-ANAT
diseases	O
.	O

ABSTRACT	O
:	O
A	O
total	O
of	O
446	O
serum	B-ANAT
samples	O
from	O
88	O
herds	O
in	O
Korea	O
were	O
examined	O
for	O
antibody	O
to	O
porcine	O
respiratory	O
coronavirus	O
(	O
PRCV	O
)	O
using	O
blocking	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
).	O

All	O
serum	B-ANAT
samples	O
were	O
collected	O
from	O
24	O
-	O
to	O
26	O
-	O
week	O
-	O
old	O
finishing	O
pigs	O
between	O
December	O
1998	O
and	O
June	O
1999	O
.	O

Formalin	O
is	O
irritating	O
,	O
corrosive	O
and	O
toxic	O
and	O
absorbed	O
from	O
all	O
surfaces	O
of	O
the	O
body	B-ANAT
.	O

The	O
expression	O
of	O
interferon	O
response	O
gene	O
47	O
and	O
interferon	O
regulatory	O
factor	O
1	O
genes	O
takes	O
place	O
after	O
IFN	O
-	O
gamma	O
activation	O
in	O
both	O
macrophages	B-ANAT
,	O
indicating	O
their	O
activation	O
.	O

ABSTRACT	O
:	O
To	O
describe	O
patterns	O
of	O
seroconversion	O
to	O
bovine	O
coronavirus	O
(	O
BCV	O
)	O
and	O
shedding	O
of	O
BCV	O
from	O
the	O
respiratory	B-ANAT
tract	I-ANAT
in	O
feedlot	O
cattle	O
.	O

Nasal	B-ANAT
swab	O
specimens	O
were	O
obtained	O
at	O
time	O
of	O
arrival	O
(	O
day	O
0	O
)	O
and	O
at	O
various	O
times	O
during	O
the	O
initial	O
28	O
days	O
after	O
arrival	O
at	O
feedlots	O
.	O

Serum	B-ANAT
samples	O
were	O
obtained	O
at	O
arrival	O
and	O
again	O
28	O
days	O
after	O
arrival	O
and	O
tested	O
for	O
antibodies	O
to	O
BCV	O
,	O
using	O
an	O
antibody	O
-	O
detection	O
ELISA	O
.	O

Cattle	O
shedding	O
BCV	O
from	O
the	O
nasal	B-ANAT
cavity	I-ANAT
and	O
developing	O
an	O
antibody	O
response	O
against	O
BCV	O
were	O
1	O
.	O
6	O
times	O
more	O
likely	O
to	O
require	O
treatment	O
for	O
respiratory	B-ANAT
tract	I-ANAT
disease	O
than	O
cattle	O
that	O
did	O
not	O
shed	O
the	O
virus	O
or	O
develop	O
an	O
immune	O
response	O
against	O
BCV	O
.	O

Furthermore	O
,	O
MHV	O
-	O
induced	O
28S	O
rRNA	O
cleavage	O
occurred	O
in	O
MHV	O
-	O
infected	O
DBT	O
cells	B-ANAT
that	O
do	O
not	O
show	O
apoptotic	O
signs	O
,	O
including	O
activation	O
of	O
caspase	O
-	O
3	O
and	O
DNA	O
fragmentation	O
.	O

To	O
distinguish	O
between	O
RNA	O
synthesis	O
and	O
capping	O
defects	O
,	O
we	O
deleted	O
chromosomal	B-ANAT
gene	O
XRN1	O
,	O
encoding	O
the	O
major	O
exonuclease	O
that	O
degrades	O
uncapped	O
mRNAs	O
.	O

When	O
HCoV	O
-	O
229E	O
was	O
applied	O
to	O
the	O
apical	O
or	O
basolateral	O
surface	O
of	O
well	O
-	O
differentiated	O
primary	O
cultures	O
of	O
human	O
airway	B-ANAT
epithelia	O
,	O
infection	O
primarily	O
occurred	O
from	O
the	O
apical	O
side	O
.	O

Thus	O
,	O
HCoV	O
-	O
229E	O
preferentially	O
infects	O
human	O
airway	B-ANAT
epithelia	O
from	O
the	O
apical	O
surface	O
.	O

ABSTRACT	O
:	O
Paradoxical	O
vocal	B-ANAT
cord	I-ANAT
movement	O
(	O
PVCM	O
)	O
is	O
characterized	O
by	O
paradoxical	O
adduction	O
of	O
the	O
vocal	B-ANAT
cords	I-ANAT
during	O
inspiration	O
and	O
/	O
or	O
expiration	O
.	O

As	O
described	O
for	O
MHV	O
,	O
we	O
established	O
that	O
the	O
EAV	O
N	O
protein	O
colocalizes	O
with	O
the	O
viral	B-ANAT
replication	I-ANAT
complex	I-ANAT
,	O
suggesting	O
a	O
role	O
in	O
RNA	O
synthesis	O
.	O

Extracts	O
from	O
potato	O
tubers	B-ANAT
expressing	O
N	O
-	O
gS	O
were	O
inoculated	O
intraperitoneally	O
to	O
mice	O
,	O
and	O
the	O
vaccinated	O
mice	O
developed	O
serum	B-ANAT
IgG	O
specific	O
for	O
TGEV	O
.	O

Serum	B-ANAT
samples	O
of	O
turkeys	O
experimentally	O
infected	O
with	O
TCV	O
collected	O
sequentially	O
from	O
1	O
to	O
63	O
days	O
postinfection	O
were	O
applied	O
to	O
the	O
established	O
antibody	O
-	O
capture	O
ELISA	O
using	O
IBV	O
antigens	O
.	O

These	O
flocks	O
(	O
14	O
chicken	O
and	O
1	O
quail	O
)	O
were	O
experiencing	O
a	O
variety	O
of	O
IB	O
-	O
like	O
conditions	O
including	O
respiratory	O
disease	O
,	O
digestive	O
and	O
kidney	B-ANAT
problems	O
,	O
and	O
drops	O
in	O
egg	B-ANAT
production	O
.	O

The	O
patients	O
also	O
suffered	O
from	O
ischemic	O
heart	B-ANAT
disease	O
(	O
IHD	O
),	O
essential	O
hypertension	O
(	O
EH	O
)	O
and	O
diabetes	O
mellitus	O
(	O
DM	O
).	O

In	O
acute	O
influenza	O
and	O
ARVI	O
the	O
majority	O
of	O
the	O
postcapillary	O
veins	B-ANAT
and	O
capillaries	B-ANAT
were	O
affected	O
with	O
sludge	B-ANAT
syndrome	O
,	O
there	O
were	O
marked	O
perivascular	O
and	O
vascular	B-ANAT
changes	O
.	O

IHD	O
patients	O
had	O
disseminated	O
intravascular	O
red	B-ANAT
cell	I-ANAT
aggregation	O
,	O
slowing	O
of	O
the	O
microflow	O
,	O
hypercoagulation	O
.	O

ABSTRACT	O
:	O
Several	O
studies	O
have	O
established	O
that	O
transport	O
of	O
sodium	O
from	O
the	O
air	O
spaces	O
to	O
the	O
lung	B-ANAT
interstitium	B-ANAT
is	O
a	O
primary	O
mechanism	O
driving	O
alveolar	B-ANAT
fluid	O
clearance	O
,	O
although	O
further	O
work	O
is	O
needed	O
to	O
determine	O
the	O
role	O
of	O
chloride	O
in	O
vectorial	O
fluid	O
transport	O
across	O
the	O
alveolar	B-ANAT
epithelium	I-ANAT
.	O

In	O
some	O
patients	O
,	O
the	O
extent	O
of	O
injury	O
to	O
the	O
alveolar	B-ANAT
epithelial	O
barrier	O
may	O
be	O
too	O
severe	O
for	O
beta	O
-	O
adrenergic	O
agonists	O
to	O
enhance	O
the	O
resolution	O
of	O
alveolar	B-ANAT
edema	O
,	O
although	O
some	O
experimental	O
studies	O
indicate	O
that	O
alveolar	B-ANAT
fluid	O
clearance	O
can	O
be	O
augmented	O
in	O
the	O
presence	O
of	O
moderately	O
severe	O
lung	B-ANAT
injury	O
.	O

Using	O
kinetic	O
RT	O
-	O
PCR	O
analysis	O
of	O
spinal	B-ANAT
cord	I-ANAT
RNA	O
,	O
we	O
found	O
significantly	O
increased	O
levels	O
of	O
FGF2	O
mRNA	O
transcripts	O
,	O
which	O
peaked	O
during	O
the	O
initial	O
stage	O
of	O
remyelination	O
.	O

Histological	O
examination	O
of	O
a	O
transbronchial	O
biopsy	O
revealed	O
an	O
interstitial	B-ANAT
fibrosing	O
process	O
and	O
cuboidalisation	O
of	O
the	O
alveolar	B-ANAT
epithelium	I-ANAT
.	O

ABSTRACT	O
:	O
Continuous	O
renal	B-ANAT
replacement	O
therapies	O
(	O
CRRT	O
)	O
are	O
now	O
being	O
used	O
by	O
nephrologists	O
,	O
intensivists	O
,	O
and	O
anesthesiologists	O
.	O

Experimental	O
and	O
clinical	O
research	O
supports	O
the	O
hypothesis	O
of	O
involvement	O
of	O
the	O
hormone	O
leptin	O
in	O
body	B-ANAT
weight	O
and	O
energy	O
balance	O
homeostasis	O
.	O

On	O
admission	O
,	O
the	O
dietary	O
intake	O
/	O
resting	B-ANAT
energy	O
expenditure	O
(	O
REE	O
)	O
ratio	O
was	O
severely	O
depressed	O
(	O
1	O
.	O
28	O
[	O
0	O
.	O
57	O
]),	O
but	O
gradually	O
restored	O
until	O
Day	O
7	O
(	O
1	O
.	O
65	O
[	O
0	O
.	O
45	O
],	O
p	O
=	O
0	O
.	O
005	O
versus	O
Day	O
1	O
).	O

Glucose	O
and	O
insulin	O
concentrations	O
were	O
elevated	O
on	O
admission	O
,	O
but	O
on	O
Day	O
7	O
only	O
plasma	B-ANAT
glucose	O
was	O
decreased	O
.	O

Also	O
,	O
the	O
polar	O
tubule	O
and	O
the	O
polaroplast	O
membranes	B-ANAT
appeared	O
disarrayed	O
in	O
the	O
sporoblast	O
stage	O
.	O

Mature	O
spores	O
had	O
a	O
complete	O
cytoplasmic	B-ANAT
disorganization	O
and	O
a	O
swollen	O
and	O
delaminated	O
cell	B-ANAT
wall	I-ANAT
.	O

No	O
ultrastructural	O
cell	B-ANAT
damage	O
was	O
observed	O
in	O
uninfected	O
control	O
cultures	O
treated	O
with	O
the	O
drug	O
.	O

There	O
may	O
be	O
differences	O
in	O
obesity	O
and	O
craniofacial	B-ANAT
anatomy	B-ANAT
as	O
risk	O
factors	O
in	O
these	O
two	O
groups	O
.	O

TITLE	O
:	O
Immunoprophylactic	O
effect	O
of	O
chicken	O
egg	B-ANAT
yolk	B-ANAT
immunoglobulin	O
(	O
Ig	O
Y	O
)	O
against	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
in	O
piglets	O
.	O

In	O
this	O
study	O
,	O
the	O
immunoprophylactic	O
effects	O
of	O
chicken	O
egg	B-ANAT
yolk	B-ANAT
immunoglobulin	O
(	O
Ig	O
Y	O
)	O
against	O
PEDV	O
were	O
investigated	O
in	O
neonatal	O
pigs	O
.	O

Plaque	O
-	O
purified	O
virus	O
derived	O
from	O
the	O
infectious	O
construct	O
replicated	O
efficiently	O
and	O
displayed	O
similar	O
plaque	O
morphology	O
in	O
permissive	O
host	O
cells	B-ANAT
.	O

Inflammatory	O
mediators	O
,	O
body	B-ANAT
temperature	O
,	O
heart	B-ANAT
rate	O
,	O
and	O
respiratory	O
index	O
after	O
the	O
surgical	O
procedure	O
were	O
significantly	O
lower	O
in	O
the	O
steroid	O
group	O
.	O

Six	O
hundred	O
eighty	O
-	O
seven	O
children	O
,	O
6	O
to	O
60	O
months	O
old	O
,	O
hospitalized	O
with	O
pneumonia	O
,	O
who	O
received	O
vitamin	O
A	O
or	O
placebo	O
at	O
baseline	O
and	O
at	O
4	O
and	O
8	O
months	O
after	O
discharge	B-ANAT
from	O
hospital	O
.	O

Serious	O
complications	O
associated	O
with	O
VSB	O
occur	O
mainly	O
in	O
patients	O
receiving	O
high	O
-	O
dose	O
chemotherapy	O
with	O
cyclophosphamide	O
before	O
allogeneic	O
bone	B-ANAT
marrow	I-ANAT
transplantation	O
who	O
develop	O
severe	O
oral	B-ANAT
mucositis	O
;	O
these	O
complications	O
are	O
associated	O
with	O
a	O
high	O
mortality	O
rate	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
is	O
a	O
major	O
structural	O
component	O
of	O
virions	B-ANAT
that	O
associates	O
with	O
the	O
genomic	O
RNA	O
to	O
form	O
a	O
helical	O
nucleocapsid	B-ANAT
.	O

Skin	B-ANAT
prick	O
tests	O
and	O
detection	O
of	O
specific	O
IgE	O
were	O
performed	O
in	O
all	O
patients	O
with	O
melon	O
,	O
avocado	O
,	O
kiwi	O
,	O
banana	O
,	O
chestnut	B-ANAT
,	O
latex	O
,	O
pollen	O
,	O
and	O
other	O
offending	O
foods	O
.	O

Rescue	O
of	O
CD	O
-	O
61	O
was	O
also	O
demonstrated	O
for	O
the	O
first	O
time	O
in	O
mammalian	O
cells	B-ANAT
.	O

TITLE	O
:	O
Severe	O
acute	O
lung	B-ANAT
injury	O
caused	O
by	O
Mycoplasma	O
pneumoniae	O
:	O
potential	O
role	O
for	O
steroid	O
pulses	O
in	O
treatment	O
.	O

ABSTRACT	O
:	O
Published	O
evidence	O
of	O
pathogenetic	O
mechanisms	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
mycoplasmal	O
lung	B-ANAT
infections	O
suggests	O
that	O
the	O
pulmonary	B-ANAT
injury	O
is	O
related	O
to	O
a	O
cell	B-ANAT
-	O
mediated	O
immune	O
response	O
.	O

Finally	O
,	O
surgical	O
reconstruction	O
of	O
the	O
aneurysmatic	O
part	O
of	O
the	O
vessel	B-ANAT
was	O
done	O
.	O

This	O
case	O
illustrates	O
the	O
potential	O
risk	O
of	O
a	O
traumatic	O
aneurysm	O
as	O
a	O
potential	O
source	O
of	O
ischemic	O
brain	B-ANAT
infarctions	O
.	O

A	O
total	O
of	O
106	O
patients	O
were	O
identified	O
from	O
hospital	O
notes	O
as	O
having	O
at	O
least	O
one	O
of	O
eight	O
major	O
complications	O
(	O
adult	O
respiratory	O
distress	O
syndrome	O
,	O
sepsis	O
,	O
acute	O
renal	B-ANAT
failure	O
,	O
coagulopathy	O
,	O
wound	O
infection	O
,	O
pneumonia	O
,	O
fat	O
embolism	O
or	O
pulmonary	B-ANAT
embolism	O
).	O

However	O
,	O
because	O
only	O
one	O
-	O
quarter	O
of	O
patients	O
were	O
given	O
fluids	B-ANAT
,	O
and	O
the	O
specific	O
protocol	O
used	O
made	O
little	O
difference	O
to	O
this	O
,	O
average	O
on	O
-	O
scene	O
times	O
were	O
largely	O
unaffected	O
by	O
protocols	O
.	O

All	O
virus	O
strains	O
produced	O
a	O
cytopathic	O
effect	O
(	O
CPE	O
)	O
with	O
cell	B-ANAT
-	O
to	O
-	O
cell	B-ANAT
fusion	O
in	O
B16	O
,	O
DBT	O
,	O
IC	O
-	O
21	O
and	O
J774A	O
.	O
1	O
cells	B-ANAT
.	O

The	O
results	O
indicate	O
that	O
IC	O
-	O
21	O
cells	B-ANAT
were	O
the	O
most	O
sensitive	O
to	O
murine	O
coronaviruses	O
.	O

Region	O
I	O
of	O
the	O
3	O
'	O
UTR	O
,	O
adjacent	O
to	O
the	O
nucleocapsid	B-ANAT
protein	O
gene	O
,	O
comprised	O
212	O
nt	O
and	O
could	O
be	O
removed	O
without	O
impairment	O
of	O
replication	O
or	O
packaging	O
of	O
D	O
-	O
RNAs	O
.	O

Removal	O
of	O
the	O
predicted	O
stem	B-ANAT
-	O
loop	O
structure	O
abolished	O
replication	O
of	O
the	O
D	O
-	O
RNAs	O
.	O

Animals	O
underwent	O
35	O
%	O
hepatic	B-ANAT
resection	O
or	O
a	O
similar	O
volume	O
hepatic	B-ANAT
cryo	O
and	O
were	O
sacrificed	O
at	O
1	O
,	O
2	O
,	O
6	O
,	O
and	O
24	O
h	O
.	O
Pulmonary	B-ANAT
histologic	O
features	O
were	O
assessed	O
using	O
hematoxylin	O
and	O
eosin	O
and	O
immunoperoxidase	O
staining	O
with	O
a	O
macrophage	B-ANAT
-	O
specific	O
antibody	O
(	O
anti	O
-	O
lysozyme	O
,	O
1	O
:	O
200	O
dilution	O
,	O
Dako	O
,	O
Carpinteria	O
,	O
CA	O
).	O

It	O
is	O
characterized	O
by	O
an	O
acute	O
oropharyngeal	B-ANAT
infection	O
,	O
with	O
secondary	O
septic	O
thrombophlebitis	O
of	O
the	O
internal	B-ANAT
jugular	I-ANAT
vein	I-ANAT
and	O
frequent	O
metastatic	O
infections	O
.	O

Neuraminidase	O
treatment	O
of	O
purified	O
virions	B-ANAT
resulted	O
in	O
a	O
shift	O
of	O
the	O
sedimentation	O
value	O
from	O
the	O
higher	O
to	O
the	O
lower	O
density	O
.	O

TITLE	O
:	O
[	O
Acute	O
infection	O
of	O
the	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
:	O
how	O
long	O
to	O
observe	O
?].	O

ABSTRACT	O
:	O
Acute	O
infections	O
of	O
the	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
first	O
require	O
a	O
weighing	O
up	O
of	O
risks	O
,	O
which	O
is	O
of	O
importance	O
in	O
particular	O
for	O
the	O
decision	O
for	O
or	O
against	O
antibiotic	O
therapy	O
.	O

Severe	O
or	O
longlasting	O
exacerbations	O
of	O
a	O
chronic	O
obstructive	O
bronchitis	O
,	O
severe	O
and	O
rapidly	O
progressive	O
bronchial	B-ANAT
asthma	O
or	O
infection	O
associated	O
with	O
bronchiectasis	O
in	O
an	O
underlying	O
antibody	O
deficiency	O
syndrome	O
,	O
primary	O
ciliary	O
dyskinesia	O
and	O
mucoviscidosis	O
.	O

In	O
combination	O
with	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
,	O
serious	O
underlying	O
disease	O
such	O
as	O
left	B-ANAT
heart	I-ANAT
insufficiency	O
or	O
diseases	O
of	O
the	O
lungs	B-ANAT
,	O
may	O
become	O
life	O
-	O
threatening	O
.	O

TITLE	O
:	O
Plasma	B-ANAT
cGMP	O
levels	O
in	O
air	O
embolism	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
.	O

We	O
investigated	O
the	O
hemodynamic	O
changes	O
and	O
the	O
plasma	B-ANAT
levels	O
of	O
cGMP	O
during	O
air	O
embolism	O
-	O
induced	O
ALI	O
in	O
two	O
different	O
models	O
:	O
venous	B-ANAT
air	O
infusion	O
(	O
VAI	O
)	O
and	O
massive	O
air	O
embolism	O
(	O
MAE	O
).	O

The	O
mechanisms	O
that	O
ultimately	O
result	O
in	O
the	O
loss	O
of	O
CNS	B-ANAT
myelin	B-ANAT
appear	O
to	O
be	O
equally	O
diverse	O
as	O
the	O
etiological	O
agents	O
capable	O
of	O
causing	O
diseases	O
which	O
result	O
in	O
demyelination	O
.	O

Although	O
demyelination	O
can	O
be	O
a	O
secondary	O
result	O
of	O
axonal	O
loss	O
,	O
in	O
many	O
examples	O
of	O
viral	O
induced	O
demyelination	O
,	O
myelin	B-ANAT
loss	O
is	O
primary	O
and	O
associated	O
with	O
axonal	O
sparing	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
if	O
there	O
is	O
a	O
relationship	O
between	O
acute	O
improvement	O
in	O
pulmonary	B-ANAT
gas	O
exchange	O
and	O
surfactant	O
use	O
in	O
near	O
-	O
term	O
(	O
35	O
-	O
39	O
weeks	O
'	O
gestation	O
)	O
infants	O
with	O
respiratory	O
distress	O
syndrome	O
(	O
RDS	O
).	O

Data	O
analyzed	O
included	O
:	O
birth	O
weight	O
;	O
gestational	O
age	O
;	O
Apgar	O
scores	O
;	O
calculated	O
alveolar	B-ANAT
to	O
arterial	B-ANAT
oxygen	O
gradient	O
(	O
AaDO2	O
)	O
and	O
oxygenation	O
index	O
(	O
0I	O
);	O
hours	O
of	O
life	O
at	O
intubation	O
;	O
surfactant	O
administration	O
;	O
complications	O
with	O
surfactant	O
administration	O
;	O
use	O
of	O
inotropic	O
medications	O
.	O

Such	O
treatment	O
resulted	O
in	O
a	O
marked	O
increase	O
in	O
mortality	O
that	O
correlated	O
with	O
a	O
>	O
3	O
log	O
increase	O
in	O
viral	O
burden	O
within	O
the	O
brains	B-ANAT
as	O
compared	O
with	O
control	O
mice	O
treated	O
with	O
normal	O
rabbit	O
serum	B-ANAT
.	O

In	O
addition	O
,	O
anti	O
-	O
Mig	O
treatment	O
resulted	O
in	O
a	O
significant	O
decrease	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
levels	O
of	O
IFN	O
-	O
gamma	O
and	O
IFN	O
-	O
beta	O
that	O
coincided	O
with	O
increased	O
(	O
p	O
<	O
0	O
.	O
02	O
)	O
expression	O
of	O
the	O
anti	O
-	O
inflammatory	O
Th2	O
cytokine	O
IL	O
-	O
10	O
within	O
the	O
CNS	B-ANAT
.	O

Eighteen	O
patients	O
with	O
pneumonia	O
and	O
hypotension	O
,	O
or	O
in	O
the	O
absence	O
of	O
shock	O
,	O
two	O
or	O
more	O
end	O
-	O
organ	B-ANAT
dysfunctions	O
,	O
were	O
enrolled	O
and	O
treated	O
.	O

Larger	O
studies	O
to	O
determine	O
the	O
benefit	O
of	O
filgrastim	O
in	O
patients	O
with	O
pneumonia	O
and	O
sepsis	O
or	O
organ	B-ANAT
dysfunction	O
are	O
warranted	O
.	O

Stroke	O
volume	O
index	O
and	O
cardiac	B-ANAT
index	O
did	O
not	O
change	O
.	O

TITLE	O
:	O
Nebulized	O
prostacyclin	O
(	O
PGI2	O
)	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
impact	O
of	O
primary	O
(	O
pulmonary	B-ANAT
injury	O
)	O
and	O
secondary	O
(	O
extrapulmonary	O
injury	O
)	O
disease	O
on	O
gas	O
exchange	O
response	O
.	O

Blood	B-ANAT
gas	O
,	O
gas	O
exchange	O
,	O
and	O
hemodynamic	O
measurements	O
were	O
performed	O
at	O
the	O
following	O
time	O
points	O
:	O
a	O
)	O
baseline	O
;	O
b	O
)	O
during	O
the	O
optimal	O
or	O
maximum	O
dose	O
of	O
PGI2	O
;	O
and	O
c	O
)	O
1	O
hr	O
after	O
withdrawal	O
of	O
the	O
drug	O
.	O

16	O
dyne	O
x	O
sec	O
/	O
cm5	B-ANAT
;	O
oxygenation	O
did	O
not	O
change	O
significantly	O
.	O

Astroviruses	O
have	O
been	O
detected	O
in	O
the	O
stools	B-ANAT
of	O
between	O
1	O
.	O
2	O
%	O
and	O
20	O
%	O
of	O
children	O
with	O
diarrhea	O
requiring	O
medical	O
care	O
in	O
a	O
variety	O
of	O
geographical	O
areas	O
.	O

We	O
diagnosed	O
ARDS	O
,	O
because	O
of	O
the	O
severe	O
respiratory	O
failure	O
resistant	O
to	O
high	O
-	O
dose	O
oxygen	O
,	O
the	O
diffuse	O
bilateral	O
infiltrates	O
without	O
cardiomegaly	O
on	O
chest	B-ANAT
radiography	O
,	O
and	O
the	O
normal	O
pulmonary	B-ANAT
artery	I-ANAT
wedge	O
pressure	O
.	O

TITLE	O
:	O
High	O
survival	O
in	O
adult	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
treated	O
by	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
minimal	O
sedation	O
,	O
and	O
pressure	O
supported	O
ventilation	O
.	O

Four	O
patients	O
with	O
congenital	O
heart	B-ANAT
disease	O
had	O
residual	O
pulmonary	B-ANAT
hypertension	O
.	O

The	O
viruses	O
were	O
isolated	O
from	O
trachea	B-ANAT
,	O
lung	B-ANAT
,	O
kidney	B-ANAT
,	O
and	O
cecal	B-ANAT
tonsils	B-ANAT
of	O
birds	O
that	O
showed	O
respiratory	O
signs	O
in	O
spite	O
of	O
vaccination	O
with	O
Massachusetts	O
(	O
Mass	O
)	O
and	O
Connecticut	O
strains	O
of	O
IBV	O
.	O

In	O
addition	O
,	O
these	O
four	O
isolates	O
did	O
not	O
produce	O
lesions	O
in	O
embryos	B-ANAT
in	O
the	O
first	O
five	O
to	O
seven	O
passes	O
.	O

Ten	O
patients	O
required	O
transfusions	O
with	O
blood	B-ANAT
products	O
.	O

There	O
was	O
one	O
maternal	O
death	O
from	O
multiple	O
organ	B-ANAT
failure	O
.	O

Nasal	B-ANAT
samples	O
and	O
lung	B-ANAT
tissues	I-ANAT
from	O
9	O
of	O
the	O
10	O
fatal	O
cases	O
had	O
high	O
titers	O
of	O
RBCV	O
,	O
but	O
these	O
cattle	O
had	O
only	O
IgM	O
responses	O
to	O
RBCV	O
infections	O
.	O

The	O
HE	O
and	O
S	O
glycoproteins	O
were	O
recognized	O
earliest	O
by	O
the	O
bovine	O
immune	B-ANAT
system	I-ANAT
while	O
the	O
N	O
protein	O
induced	O
antibody	O
responses	O
during	O
the	O
later	O
stage	O
of	O
initial	O
infection	O
and	O
the	O
early	O
stage	O
of	O
reinfection	O
.	O

PLs	O
were	O
isolated	O
by	O
thin	O
-	O
layer	B-ANAT
chromatography	O
,	O
and	O
the	O
FA	O
profile	O
of	O
each	O
PL	O
class	O
was	O
assessed	O
by	O
gas	O
chromatography	O
.	O

Above	O
a	O
threshold	O
dose	O
of	O
bacteria	O
,	O
failure	O
of	O
the	O
local	O
neutrophil	B-ANAT
response	O
is	O
a	O
key	O
mechanism	O
associated	O
with	O
deleterious	O
systemic	O
responses	O
.	O

Bacteremia	O
alone	O
is	O
not	O
sufficient	O
to	O
cause	O
lung	B-ANAT
injury	O
.	O

Post	O
-	O
mortem	O
examination	O
revealed	O
inflammatory	O
lesions	O
in	O
abdominal	B-ANAT
organs	I-ANAT
and	O
in	O
the	O
brain	B-ANAT
compatible	O
with	O
FIP	O
.	O

To	O
test	O
this	O
hypothesis	O
genetically	O
,	O
we	O
initially	O
constructed	O
MHV	O
mutants	O
with	O
a	O
very	O
high	O
-	O
affinity	O
hnRNP	B-ANAT
A1	O
binding	O
site	O
inserted	O
in	O
place	O
of	O
,	O
or	O
adjacent	O
to	O
,	O
an	O
intergenic	O
sequence	O
in	O
the	O
MHV	O
genome	O
.	O

ABSTRACT	O
:	O
Serial	O
passage	O
of	O
virulent	O
transmissible	O
gastroenteritis	O
virus	O
through	O
cell	B-ANAT
culture	O
reduced	O
its	O
virulence	O
in	O
3	O
-	O
day	O
-	O
old	O
piglets	O
.	O

Postmortem	O
examination	O
revealed	O
jaundice	O
,	O
anasarca	O
,	O
massive	O
hepatic	B-ANAT
necrosis	O
,	O
adrenal	O
hemorrhagic	O
necrosis	O
,	O
renal	B-ANAT
medullary	B-ANAT
hemorrhage	O
,	O
hemorrhagic	O
noninflammatory	O
pneumonia	O
,	O
and	O
severe	O
encephalomalacia	O
.	O

The	O
RBCV	O
isolation	O
-	O
positive	O
cattle	O
that	O
developed	O
fatal	O
SFP	O
had	O
minimal	O
serum	B-ANAT
IN	O
and	O
HAI	O
antibodies	O
during	O
the	O
course	O
of	O
disease	O
development	O
.	O

The	O
RBCV	O
-	O
neutralizing	O
activity	O
is	O
associated	O
with	O
serum	B-ANAT
immunoglobulin	O
G	O
(	O
IgG	O
),	O
particularly	O
the	O
IgG2	O
subclass	O
,	O
while	O
RBCV	O
-	O
specific	O
HAI	O
antibody	O
is	O
related	O
to	O
both	O
serum	B-ANAT
IgG	O
and	O
IgM	O
fractions	O
.	O

A	O
cis	O
-	O
acting	O
element	O
previously	O
identified	O
in	O
the	O
3	O
'	O
untranslated	O
region	O
binds	O
to	O
trans	O
-	O
acting	O
host	O
factors	O
from	O
mouse	O
fibroblasts	B-ANAT
and	O
forms	O
at	O
least	O
three	O
RNA	O
-	O
protein	O
complexes	O
.	O

The	O
90	O
-	O
kDa	O
protein	O
has	O
been	O
purified	O
from	O
uninfected	O
mouse	B-ANAT
fibroblast	I-ANAT
crude	O
lysates	O
.	O

ABSTRACT	O
:	O
The	O
two	O
-	O
hit	O
theory	O
has	O
emerged	O
as	O
a	O
mechanism	O
to	O
explain	O
the	O
development	O
of	O
organ	B-ANAT
failure	O
after	O
traumatic	O
injury	O
.	O

The	O
objective	O
of	O
this	O
work	O
was	O
to	O
characterize	O
the	O
IFN	O
-	O
alpha	O
-	O
producing	O
cells	B-ANAT
(	O
IPC	O
)	O
in	O
tissues	B-ANAT
of	O
TGEV	O
-	O
infected	O
piglets	O
.	O

Much	O
further	O
investigation	O
is	O
needed	O
,	O
however	O
,	O
to	O
determine	O
the	O
effects	O
of	O
colloid	B-ANAT
administration	O
on	O
clinically	O
relevant	O
outcomes	O
in	O
a	O
broad	O
range	O
of	O
critically	O
ill	O
patients	O
.	O

Colloids	O
can	O
be	O
considered	O
in	O
patients	O
with	O
severe	O
or	O
acute	O
shock	O
or	O
hypovolaemia	O
resulting	O
from	O
sudden	O
plasma	B-ANAT
loss	O
.	O

There	O
is	O
no	O
single	O
record	O
of	O
blackwater	O
fever	O
,	O
12	O
.	O
5	O
%	O
died	O
due	O
to	O
development	O
of	O
multiple	O
complications	O
like	O
severe	O
haemolytic	O
anaemia	O
,	O
haemolytic	O
jaundice	O
,	O
cerebral	B-ANAT
malaria	O
and	O
acute	O
renal	B-ANAT
failure	O
.	O

Furthermore	O
,	O
CD4	O
+	O
T	B-ANAT
cells	I-ANAT
enhance	O
CD8	O
+	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
survival	O
and	O
effectiveness	O
.	O

Our	O
data	O
were	O
consistent	O
with	O
an	O
E	O
protein	O
topology	O
model	O
,	O
in	O
which	O
the	O
N	O
-	O
terminal	O
two	O
-	O
thirds	O
of	O
the	O
transmembrane	B-ANAT
domain	O
spans	O
the	O
lipid	B-ANAT
bilayer	I-ANAT
twice	O
,	O
exposing	O
the	O
C	O
-	O
terminal	O
region	O
to	O
the	O
cytoplasm	B-ANAT
or	O
virion	B-ANAT
interior	O
.	O

Discontinuation	O
of	O
iNO	O
was	O
attempted	O
three	O
times	O
and	O
was	O
followed	O
by	O
severe	O
desaturation	O
due	O
to	O
right	O
-	O
to	O
-	O
left	O
shunt	O
through	O
the	O
patent	O
ductus	B-ANAT
arteriosus	I-ANAT
and	O
patent	O
foramen	B-ANAT
ovale	I-ANAT
.	O

As	O
a	O
result	O
of	O
iNO	O
dependency	O
state	O
and	O
rebound	O
pulmonary	B-ANAT
hypertension	O
,	O
the	O
neonate	O
was	O
maintained	O
on	O
iNO	O
therapy	O
for	O
dipyridamole	O
alone	O
was	O
unsuccessful	O
.	O

Moreover	O
L	O
-	O
Arginine	O
,	O
the	O
precursor	O
for	O
the	O
formation	O
of	O
endogenous	O
NO	O
,	O
has	O
been	O
found	O
to	O
be	O
deficient	O
in	O
neonates	O
with	O
PPHN	O
,	O
so	O
we	O
speculated	O
that	O
by	O
inhibiting	O
phosphodiesterase	O
and	O
administrating	O
L	O
-	O
Arginine	O
smooth	B-ANAT
muscle	I-ANAT
relaxation	O
occurred	O
,	O
and	O
consequent	O
weaning	O
from	O
iNO	O
was	O
achieved	O
.	O

The	O
latter	O
,	O
characterised	O
severe	O
laminitis	O
,	O
were	O
predominant	O
and	O
could	O
explain	O
a	O
number	O
of	O
secondary	O
symptoms	O
(	O
inflammation	O
of	O
the	O
bursa	B-ANAT
,	O
metastatic	O
processes	O
).	O

All	O
cases	O
but	O
one	O
were	O
found	O
to	O
be	O
without	O
biliary	B-ANAT
stones	I-ANAT
by	O
ultrasonic	O
and	O
CT	O
scans	O
.	O

Further	O
treatment	O
,	O
including	O
gastric	B-ANAT
decompression	O
,	O
irrigation	O
via	O
the	O
drainage	B-ANAT
tubes	O
,	O
antibiotics	O
,	O
somatostatin	O
,	O
and	O
parenteral	O
nutrition	O
,	O
was	O
continued	O
in	O
all	O
patients	O
following	O
the	O
laparoscopic	O
procedures	O
.	O

Vapor	O
generated	O
at	O
ambient	O
temperature	O
may	O
cause	O
sensory	O
irritant	O
effects	O
to	O
the	O
eye	B-ANAT
and	O
respiratory	B-ANAT
tract	I-ANAT
,	O
but	O
not	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
injury	O
.	O

By	O
subchronic	O
vapor	O
exposure	O
,	O
effects	O
are	O
limited	O
to	O
the	O
nasal	B-ANAT
mucosa	I-ANAT
at	O
1	O
.	O
0	O
ppm	O
,	O
with	O
a	O
no	O
-	O
effect	O
concentration	O
generally	O
at	O
0	O
.	O
1	O
ppm	O
.	O

Based	O
on	O
limited	O
data	O
,	O
mucolytics	O
and	O
chest	B-ANAT
physiotherapy	O
do	O
not	O
appear	O
to	O
be	O
of	O
benefit	O
,	O
and	O
oxygen	O
supplementation	O
appears	O
to	O
increase	O
the	O
risk	O
of	O
respiratory	O
failure	O
in	O
an	O
identifiable	O
subgroup	O
of	O
patients	O
.	O

She	O
represents	O
the	O
first	O
patient	O
with	O
overlap	O
syndrome	O
who	O
developed	O
an	O
acute	O
airway	B-ANAT
obstruction	O
due	O
to	O
cricoarytenoid	O
arthritis	O
.	O

Anasarcous	O
skin	B-ANAT
lesions	O
exhibited	O
a	O
separated	O
epidermis	B-ANAT
,	O
expanded	O
scale	O
-	O
sacs	O
,	O
and	O
an	O
edematous	O
dermis	B-ANAT
accompanied	O
by	O
hemorrhage	O
and	O
necrosis	O
.	O

ABSTRACT	O
:	O
The	O
DB2	O
calf	B-ANAT
strain	O
of	O
bovine	O
coronavirus	O
(	O
BCV	O
)	O
was	O
used	O
to	O
inoculate	O
1	O
-	O
day	O
-	O
old	O
specific	O
-	O
pathogen	O
-	O
free	O
(	O
SPF	O
)	O
turkey	O
poults	O
in	O
three	O
trials	O
.	O

Coronavirus	O
particles	O
were	O
detected	O
by	O
immune	O
electron	O
microscopy	O
with	O
BCV	O
antibodies	O
from	O
the	O
intestinal	B-ANAT
contents	I-ANAT
of	O
birds	O
killed	O
at	O
3	O
,	O
5	O
,	O
7	O
,	O
and	O
12	O
DPI	O
.	O

Hemagglutinating	O
antibodies	O
were	O
detected	O
in	O
sera	B-ANAT
of	O
convalescent	O
birds	O
at	O
12	O
DPI	O
.	O

Those	O
macrophages	B-ANAT
also	O
had	O
adequate	O
bactericidal	O
activity	O
,	O
indicating	O
that	O
IBV	O
and	O
IBDV	O
infections	O
had	O
not	O
affected	O
their	O
phagocytic	O
activity	O
or	O
bactericidal	O
function	O
.	O

However	O
,	O
when	O
E	O
.	O
coli	O
antisera	O
raised	O
in	O
IBDV	O
-	O
infected	O
and	O
,	O
especially	O
,	O
that	O
produced	O
in	O
IBDV	O
plus	O
IBV	O
-	O
infected	O
chickens	O
were	O
supplemented	O
,	O
the	O
percentage	O
of	O
phagocytosis	O
and	O
number	O
of	O
bacteria	O
ingested	O
per	O
phagocyte	B-ANAT
were	O
significantly	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
less	O
.	O

TITLE	O
:	O
Heterogeneous	B-ANAT
nuclear	I-ANAT
ribonucleoprotein	I-ANAT
a1	O
binds	O
to	O
the	O
3	O
'-	O
untranslated	O
region	O
and	O
mediates	O
potential	O
5	O
'-	O
3	O
'-	O
end	O
cross	O
talks	O
of	O
mouse	O
hepatitis	O
virus	O
RNA	O
.	O

Several	O
host	B-ANAT
cell	I-ANAT
proteins	O
have	O
previously	O
been	O
shown	O
to	O
interact	O
with	O
this	O
regulatory	O
region	O
.	O

Furthermore	O
,	O
hnRNP	B-ANAT
A1	O
and	O
PTB	O
,	O
both	O
of	O
which	O
also	O
bind	O
to	O
the	O
complementary	O
strands	O
at	O
the	O
5	O
'	O
end	O
of	O
MHV	O
RNA	O
,	O
together	O
mediate	O
the	O
formation	O
of	O
an	O
RNP	B-ANAT
complex	O
involving	O
the	O
5	O
'-	O
and	O
3	O
'-	O
end	O
fragments	O
of	O
MHV	O
RNA	O
in	O
vitro	O
.	O

TITLE	O
:	O
Atrial	B-ANAT
natriuretic	O
peptide	O
infusion	O
and	O
nitric	O
oxide	O
inhalation	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Furthermore	O
,	O
NO	O
inhalation	O
improved	O
pulmonary	B-ANAT
gas	O
exchange	O
,	O
reflected	O
by	O
a	O
decrease	O
in	O
alveolar	B-ANAT
-	O
arterial	B-ANAT
oxygen	O
gradient	O
(	O
from	O
41	O
.	O
9	O
+/-	O

The	O
child	O
showed	O
the	O
presence	O
of	O
small	O
subdural	B-ANAT
and	O
epidural	B-ANAT
hematomas	O
in	O
both	O
frontal	B-ANAT
regions	I-ANAT
24	O
hours	O
after	O
the	O
onset	O
of	O
the	O
problem	O
.	O

The	O
follow	O
-	O
up	O
with	O
MR	O
studies	O
revealed	O
voluminous	O
subdural	B-ANAT
bilateral	O
hygroma	O
that	O
increased	O
the	O
size	O
along	O
the	O
following	O
six	O
months	O
,	O
despite	O
treatment	O
with	O
bilateral	O
subdural	B-ANAT
-	O
peritoneal	B-ANAT
shunt	O
,	O
and	O
the	O
patient	O
showed	O
infantile	O
spasms	O
.	O

Shaken	O
-	O
baby	O
syndrome	O
is	O
not	O
always	O
associated	O
with	O
skull	B-ANAT
fracture	O
nor	O
is	O
necessarily	O
related	O
with	O
battered	O
-	O
child	O
syndrome	O
.	O

Four	O
factors	O
independently	O
predicted	O
mortality	O
:	O
a	O
time	O
from	O
symptom	O
onset	O
to	O
treatment	O
of	O
more	O
than	O
1	O
month	O
(	O
OR	O
,	O
3	O
.	O
49	O
;	O
CI	O
,	O
1	O
.	O
20	O
-	O
10	O
.	O
20	O
),	O
the	O
number	O
of	O
organ	B-ANAT
failures	O
(	O
OR	O
,	O
3	O
.	O
15	O
;	O
CI	O
,	O
1	O
.	O
76	O
-	O
5	O
.	O
76	O
),	O
a	O
serum	B-ANAT
albumin	O
level	O
above	O
20	O
g	O
/	O
l	O
(	O
OR	O
,	O
3	O
.	O
96	O
;	O
CI	O
,	O
1	O
.	O
04	O
-	O
15	O
.	O
10	O
),	O
and	O
a	O
larger	O
number	O
of	O
lobes	B-ANAT
involved	O
on	O
chest	B-ANAT
radiograph	O
(	O
OR	O
,	O
1	O
.	O
83	O
;	O
CI	O
,	O
1	O
.	O
12	O
-	O
2	O
.	O
98	O
).	O

CONCLUSIONS	O
:	O
Delayed	O
clinical	O
suspicion	O
and	O
treatment	O
of	O
active	O
pulmonary	B-ANAT
TB	O
with	O
respiratory	O
failure	O
may	O
contribute	O
to	O
the	O
persistently	O
high	O
mortality	O
rates	O
in	O
ICU	O
patients	O
with	O
these	O
diseases	O
.	O

In	O
normal	O
subjects	O
,	O
during	O
anesthesia	O
and	O
paralysis	O
,	O
prone	O
position	O
determines	O
a	O
more	O
homogeneous	O
distribution	O
of	O
the	O
gravitational	O
gradient	O
of	O
alveolar	B-ANAT
inflation	O
,	O
a	O
ventilation	O
distributed	O
towards	O
the	O
non	O
dependent	O
lung	B-ANAT
regions	O
and	O
a	O
reverse	O
of	O
the	O
gravitational	O
distribution	O
of	O
regional	O
perfusion	O
,	O
even	O
if	O
factors	O
other	O
than	O
gravity	O
are	O
involved	O
.	O

The	O
overall	O
mortality	O
at	O
ICU	O
discharge	B-ANAT
was	O
51	O
%	O
and	O
the	O
ICU	O
stay	O
was	O
similar	O
in	O
survivors	O
and	O
non	O
survivors	O
(	O
17	O
.	O
8	O
+/-	O

Further	O
age	O
-	O
associated	O
differences	O
were	O
a	O
shorter	O
incubation	O
period	O
in	O
the	O
two	O
youngest	O
calves	O
,	O
but	O
with	O
milder	O
fever	O
and	O
milder	O
decrease	O
in	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
counts	O
.	O

Very	O
long	O
-	O
lasting	O
IgA	B-ANAT
antibody	I-ANAT
responses	O
were	O
detected	O
both	O
systemically	O
and	O
locally	O
.	O

Finally	O
,	O
thiophene	O
aryl	O
amides	O
8i	O
-	O
k	O
displayed	O
moderate	O
in	O
vitro	O
activity	O
against	O
certain	O
leukemia	O
,	O
breast	B-ANAT
,	O
and	O
colon	B-ANAT
cancer	B-ANAT
cell	I-ANAT
lines	O
.	O

Chest	B-ANAT
wall	I-ANAT
mechanics	O
and	O
Est	O
,	O
L	O
were	O
unaffected	O
by	O
PaCO2	O
changes	O
.	O

RESULTS	O
:	O
Chest	B-ANAT
wall	I-ANAT
mechanics	O
and	O
Est	O
,	O
L	O
were	O
unaffected	O
by	O
PaCO2	O
changes	O
.	O

The	O
development	O
of	O
the	O
cytopathic	O
effect	O
was	O
,	O
however	O
,	O
much	O
slower	O
than	O
in	O
cells	B-ANAT
that	O
had	O
received	O
equivalent	O
amounts	O
of	O
pBRNX1	O
.	O
38	O
-	O
5	O
/	O
6	O
RNA	O
,	O
indicating	O
that	O
the	O
vector	O
virus	O
had	O
a	O
clear	O
growth	O
disadvantage	O
compared	O
to	O
its	O
direct	O
precursor	O
.	O

It	O
begins	O
as	O
noncardiogenic	O
pulmonary	B-ANAT
edema	O
and	O
develops	O
into	O
a	O
neutrophilic	O
alveolitis	O
,	O
and	O
,	O
later	O
,	O
pulmonary	B-ANAT
fibrosis	O
.	O

Lung	B-ANAT
function	O
improves	O
with	O
time	O
among	O
survivors	O
,	O
but	O
pulmonary	B-ANAT
fibrosis	O
may	O
persist	O
.	O

The	O
mechanism	O
of	O
injury	O
produced	O
by	O
inflicted	O
head	B-ANAT
injuries	O
in	O
these	O
children	O
is	O
most	O
often	O
rotational	O
movement	O
of	O
the	O
brain	B-ANAT
within	O
the	O
cranial	B-ANAT
cavity	I-ANAT
.	O

Recognition	O
of	O
this	O
mechanism	O
of	O
injury	O
may	O
be	O
helpful	O
in	O
severe	O
acute	O
rotational	O
brain	B-ANAT
injuries	O
because	O
it	O
facilitates	O
understanding	O
of	O
such	O
clinical	O
features	O
as	O
the	O
decrease	O
in	O
the	O
level	O
of	O
consciousness	O
and	O
respiratory	O
distress	O
seen	O
in	O
these	O
injured	O
children	O
.	O

The	O
pathologic	O
findings	O
of	O
subdural	B-ANAT
hemorrhage	O
,	O
subarachnoid	O
hemorrhage	O
,	O
and	O
retinal	B-ANAT
hemorrhages	O
are	O
offered	O
as	O
""""	O
markers	O
""""	O
to	O
assist	O
in	O
the	O
recognition	O
of	O
the	O
presence	O
of	O
shearing	O
brain	B-ANAT
injury	O
in	O
young	O
children	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
acute	O
effects	O
of	O
an	O
increase	O
in	O
PCO2	O
on	O
splanchnic	O
tissue	B-ANAT
perfusion	O
and	O
metabolism	O
.	O

Identification	O
of	O
longterm	O
carriers	O
requires	O
that	O
a	O
positive	O
result	O
be	O
obtained	O
by	O
RT	O
-	O
PCR	O
on	O
faecal	B-ANAT
samples	O
for	O
at	O
least	O
eight	O
consecutive	O
months	O
.	O

Gemcitabin	O
can	O
also	O
have	O
severe	O
lung	B-ANAT
toxicity	O
late	O
after	O
or	O
without	O
prior	O
radiotherapy	O
.	O

TITLE	O
:	O
Induction	O
of	O
caspase	O
-	O
dependent	O
apoptosis	O
in	O
cultured	B-ANAT
cells	I-ANAT
by	O
the	O
avian	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
.	O

However	O
,	O
neither	O
the	O
necrotic	O
process	O
nor	O
the	O
productive	O
replication	O
of	O
IBV	O
in	O
Vero	B-ANAT
cells	I-ANAT
was	O
severely	O
affected	O
by	O
the	O
inhibition	O
of	O
apoptosis	O
.	O

A	O
region	O
of	O
the	O
mRNA	O
encoding	O
GFP	O
was	O
amplified	O
by	O
PCR	O
and	O
shown	O
to	O
have	O
the	O
unique	O
mRNA	O
leader	O
-	O
body	B-ANAT
junction	O
indicative	O
of	O
coronavirus	O
-	O
mediated	O
transcription	O
.	O

In	O
this	O
study	O
,	O
immunofluorescence	O
confocal	O
microscopy	O
was	O
used	O
to	O
define	O
the	O
relationship	O
of	O
the	O
membrane	B-ANAT
populations	O
comprising	O
the	O
putative	O
replication	O
complexes	O
at	O
different	O
times	O
of	O
infection	O
in	O
MHV	O
-	O
A59	O
-	O
infected	O
delayed	O
brain	B-ANAT
tumor	B-ANAT
cells	I-ANAT
.	O

At	O
5	O
.	O
5	O
h	O
postinfection	O
(	O
p	O
.	O
i	O
.)	O
the	O
membranes	B-ANAT
containing	O
N	O
and	O
helicase	O
colocalized	O
with	O
the	O
membranes	B-ANAT
containing	O
p1a	O
-	O
22	O
/	O
p65	O
at	O
foci	O
distinct	O
from	O
sites	O
of	O
M	O
accumulation	O
.	O

These	O
data	O
demonstrated	O
that	O
the	O
putative	O
replication	O
complexes	O
separated	O
into	O
component	O
membranes	B-ANAT
that	O
relocalized	O
during	O
the	O
course	O
of	O
infection	O
.	O

Our	O
results	O
suggest	O
that	O
the	O
C	O
-	O
terminal	O
119	O
amino	O
acid	O
of	O
the	O
nucleocapsid	B-ANAT
expressed	O
by	O
FPV	O
is	O
a	O
host	O
-	O
protective	O
antigen	O
and	O
may	O
induce	O
cross	O
-	O
protective	O
immunity	O
against	O
illness	O
among	O
some	O
IBV	O
strains	O
.	O

In	O
a	O
pathogenicity	O
experiment	O
,	O
the	O
clinical	O
signs	O
and	O
related	O
gross	O
lesions	O
resembling	O
those	O
of	O
field	O
outbreaks	O
were	O
reproduced	O
in	O
SPF	O
chickens	O
,	O
and	O
viruses	O
were	O
reisolated	O
from	O
the	O
damaged	O
tissues	B-ANAT
,	O
including	O
trachea	B-ANAT
,	O
proventriculus	B-ANAT
,	O
duodenum	B-ANAT
,	O
and	O
cecal	B-ANAT
tonsil	I-ANAT
.	O

We	O
retrospectively	O
studied	O
28	O
patients	O
,	O
17	O
admitted	O
in	O
our	O
Intensive	O
Care	O
Unit	O
(	O
ICU	O
-	O
patients	O
)	O
and	O
treated	O
by	O
continuous	O
renal	B-ANAT
replacement	O
therapy	O
(	O
particularly	O
by	O
continuous	O
venovenous	O
hemofiltration	O
,	O
continuous	O
venovenous	O
hemodialysis	O
and	O
continuous	O
venovenous	O
hemodiafiltration	O
)	O
and	O
11	O
admitted	O
in	O
our	O
Nephrology	O
Department	O
(	O
NICU	O
-	O
patients	O
)	O
and	O
treated	O
by	O
high	O
-	O
efficiency	O
daily	O
hemodialysis	O
.	O

ABSTRACT	O
:	O
Limb	B-ANAT
vascular	B-ANAT
thrombosis	O
is	O
a	O
severe	O
,	O
rare	O
entity	O
,	O
often	O
needing	O
invasive	O
surgery	O
and	O
sometimes	O
leading	O
to	O
loss	O
of	O
function	O
.	O

Axillary	B-ANAT
artery	I-ANAT
and	O
vein	B-ANAT
thromboses	O
were	O
soon	O
confirmed	O
by	O
ultrasonography	O
and	O
arteriography	O
.	O

ABSTRACT	O
:	O
To	O
explore	O
three	O
aspects	O
of	O
non	O
-	O
invasive	O
pressure	O
support	O
ventilation	O
(	O
NIPSV	O
)	O
applied	O
by	O
face	B-ANAT
mask	O
to	O
patients	O
with	O
acute	O
respiratory	O
failure	O
(	O
ARF	O
)	O
due	O
to	O
severe	O
community	O
-	O
acquired	O
pneumonia	O
(	O
CAP	O
):	O
(	O
1	O
)	O
the	O
initial	O
acute	O
effects	O
on	O
respiratory	O
rate	O
,	O
gas	O
exchange	O
and	O
hemodynamics	O
,	O
(	O
2	O
)	O
the	O
clinical	O
course	O
and	O
outcome	O
during	O
ICU	O
and	O
hospital	O
stay	O
,	O
(	O
3	O
)	O
the	O
nursing	O
workload	O
as	O
measured	O
by	O
the	O
daily	O
PRN	O
87	O
(	O
Project	O
Research	O
in	O
Nursing	O
)	O
score	O
.	O

During	O
the	O
initial	O
NIPSV	O
trial	O
respiratory	O
rate	O
decreased	O
from	O
34	O
+/-	O
8	O
to	O
28	O
+/-	O
10	O
breaths	O
/	O
min	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
arterial	B-ANAT
oxygenation	O
improved	O
(	O
PaO2	O
/	O
FIO2	O
104	O
+/-	O
48	O
vs	O
153	O
+/-	O
49	O
,	O
DA	O
-	O
aO2	O
447	O
+/-	O
120	O
vs	O
370	O
+/-	O
180	O
mmHg	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
while	O
PaCO2	O
remained	O
unchanged	O
.	O

TITLE	O
:	O
Effects	O
of	O
inhalation	O
of	O
perfluorocarbon	O
aerosol	O
on	O
oxygenation	O
and	O
pulmonary	B-ANAT
function	O
compared	O
to	O
PGI2	O
inhalation	O
in	O
a	O
sheep	O
model	O
of	O
oleic	O
acid	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

The	O
lungs	B-ANAT
of	O
the	O
SNO	O
group	O
had	O
significantly	O
alleviated	O
edema	O
and	O
neutrophil	B-ANAT
infiltration	O
compared	O
with	O
the	O
P	O
-	O
Control	O
.	O

This	O
is	O
the	O
first	O
evidence	O
that	O
control	O
of	O
a	O
virus	O
infection	O
in	O
vivo	O
is	O
mediated	O
by	O
a	O
distinct	O
NK	B-ANAT
cell	I-ANAT
subset	O
.	O

One	O
specific	O
site	O
on	O
the	O
S	O
glycoprotein	O
of	O
bovine	O
coronavirus	O
must	O
be	O
cleaved	B-ANAT
by	O
an	O
intracellular	B-ANAT
protease	O
or	O
trypsin	O
to	O
activate	O
viral	O
infectivity	O
and	O
cell	B-ANAT
fusion	O
.	O

Because	O
these	O
processes	O
often	O
demonstrate	O
overlapping	O
clinical	O
and	O
morphologic	O
features	O
requiring	O
multiple	O
diagnostic	O
techniques	O
for	O
resolution	O
,	O
a	O
systematic	O
multimodality	O
approach	O
to	O
diagnosis	O
is	O
advantageous	O
for	O
determining	O
the	O
causes	O
of	O
decline	O
in	O
individual	O
patients	O
and	O
for	O
estimating	O
the	O
incidences	O
of	O
the	O
different	O
causes	O
of	O
early	O
graft	B-ANAT
and	O
patient	O
loss	O
in	O
the	O
lung	B-ANAT
transplant	B-ANAT
population	O
.	O

The	O
resected	O
mass	O
was	O
a	O
mesenchymal	O
hamartoma	O
with	O
a	O
necrotic	O
center	O
and	O
extensive	O
arterial	B-ANAT
collateralization	O
.	O

Results	O
indicated	O
a	O
100	O
%	O
homology	O
of	O
sequence	O
between	O
the	O
protein	O
recognized	O
by	O
the	O
autoAb	O
and	O
liver	B-ANAT
fumarylacetoacetate	O
hydrolase	O
(	O
FAH	O
),	O
the	O
enzyme	O
that	O
mediates	O
the	O
last	O
step	O
of	O
tyrosine	O
catabolism	O
.	O

ABSTRACT	O
:	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
are	O
required	O
to	O
control	O
acute	O
viral	O
replication	O
in	O
the	O
CNS	B-ANAT
following	O
infection	O
with	O
neurotropic	O
coronavirus	O
.	O

Although	O
overall	O
T	B-ANAT
cell	I-ANAT
recruitment	O
into	O
the	O
CNS	B-ANAT
of	O
muMT	O
mice	O
was	O
not	O
impaired	O
,	O
discrepancies	O
in	O
frequencies	O
of	O
virus	O
-	O
specific	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
were	O
most	O
severe	O
during	O
acute	O
infection	O
.	O

Impaired	O
ex	O
vivo	O
cytolytic	O
activity	O
of	O
muMT	O
CNS	B-ANAT
mononuclear	B-ANAT
cells	I-ANAT
,	O
concomitant	O
with	O
reduced	O
frequencies	O
,	O
implicated	O
IFN	O
-	O
gamma	O
as	O
the	O
primary	O
anti	O
viral	O
factor	O
early	O
in	O
infection	O
.	O

In	O
cats	O
with	O
EUE	O
,	O
myeloid	O
/	O
histiocyte	B-ANAT
antigen	O
-	O
positive	O
macrophages	B-ANAT
were	O
relatively	O
numerous	O
,	O
suggesting	O
recruitment	O
of	O
peripheral	B-ANAT
blood	I-ANAT
monocytes	B-ANAT
.	O

The	O
prevalence	O
of	O
alcoholic	O
cirrhosis	O
and	O
the	O
number	O
of	O
potential	O
candidates	O
for	O
liver	B-ANAT
transplantation	O
is	O
unknown	O
but	O
certainly	O
underestimated	O
.	O

Despite	O
physicians	O
'	O
ethical	O
reserves	O
concerning	O
this	O
self	O
-	O
inflicted	O
disease	O
and	O
the	O
public	O
'	O
s	O
misgivings	O
,	O
liver	B-ANAT
transplantation	O
for	O
alcoholic	O
cirrhosis	O
can	O
provide	O
survival	O
rates	O
comparable	O
with	O
those	O
observed	O
for	O
other	O
chronic	O
liver	B-ANAT
diseases	O
.	O

Criteria	O
for	O
liver	B-ANAT
transplantation	O
generally	O
include	O
patients	O
aged	O
under	O
65	O
years	O
,	O
weaned	O
for	O
more	O
than	O
6	O
months	O
,	O
with	O
Child	O
C	O
cirrhosis	O
or	O
less	O
,	O
uncontrollable	O
digestive	B-ANAT
tract	I-ANAT
hemorrhage	O
,	O
spontaneous	O
severe	O
infection	O
,	O
hepatorenal	O
syndrome	O
,	O
hepatopulmonary	O
syndrome	O
,	O
or	O
multifocal	O
hepatocellular	O
carcinoma	O
if	O
the	O
largest	O
nodule	O
measures	O
less	O
than	O
3	O
cm	O
.	O

The	O
principal	O
histological	O
findings	O
were	O
atrophy	O
of	O
small	O
intestinal	B-ANAT
villi	I-ANAT
,	O
lymphoid	O
depletion	O
,	O
hepatitis	O
and	O
bronchopneumonia	O
.	O

TITLE	O
:	O
Management	O
of	O
patients	O
with	O
severe	O
lung	B-ANAT
injury	O
:	O
first	O
,	O
do	O
no	O
harm	O
.	O

Acute	O
lung	B-ANAT
injury	O
results	O
in	O
reduced	O
lung	B-ANAT
compliance	O
and	O
a	O
marked	O
decrease	O
in	O
the	O
volume	O
of	O
functional	O
lung	B-ANAT
.	O

Detection	O
of	O
HCoV	O
-	O
229E	O
and	O
HCoV	O
-	O
OC43	O
in	O
clinical	O
specimens	O
is	O
possible	O
using	O
this	O
method	O
:	O
348	O
respiratory	O
specimens	O
(	O
202	O
sputum	B-ANAT
and	O
146	O
nasal	B-ANAT
aspirates	B-ANAT
)	O
were	O
tested	O
with	O
this	O
RT	O
-	O
PCR	O
-	O
hybridization	O
and	O
12	O
human	O
coronavirus	O
are	O
detected	O
(	O
3	O
%).	O

Manipulation	O
of	O
the	O
Ceacam1	O
gene	O
in	O
mouse	O
embryonic	B-ANAT
stem	I-ANAT
cells	I-ANAT
that	O
contained	O
the	O
Ceacam1a	O
allele	O
yielded	O
a	O
partial	O
knockout	O
.	O

The	O
titers	O
of	O
virus	O
produced	O
in	O
the	O
livers	B-ANAT
were	O
50	O
-	O
to	O
100	O
-	O
fold	O
lower	O
in	O
p	O
/	O
p	O
mice	O
than	O
in	O
+/	O
p	O
or	O
+/+	O
mice	O
.	O

ABSTRACT	O
:	O
The	O
Fas	O
/	O
Fas	O
ligand	O
(	O
FasL	O
)	O
system	O
has	O
been	O
implicated	O
in	O
alveolar	B-ANAT
epithelial	I-ANAT
cell	I-ANAT
apoptosis	O
during	O
pulmonary	B-ANAT
fibrosis	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
Fas	O
/	O
FasL	O
system	O
did	O
not	O
have	O
a	O
major	O
role	O
in	O
the	O
clearance	O
of	O
aerosolized	O
bacteria	O
from	O
the	O
lungs	B-ANAT
at	O
the	O
bacterial	O
doses	O
tested	O
.	O

ACP	O
was	O
associated	O
with	O
pulmonary	B-ANAT
artery	I-ANAT
hypertension	O
,	O
increased	O
heart	B-ANAT
rate	O
,	O
and	O
decreased	O
stroke	O
index	O
.	O

Evaluation	O
of	O
right	O
ventricular	B-ANAT
function	O
by	O
TEE	O
in	O
a	O
group	O
of	O
75	O
ARDS	O
patients	O
submitted	O
to	O
protective	O
ventilation	O
revealed	O
the	O
persistence	O
of	O
a	O
25	O
%	O
incidence	O
of	O
ACP	O
,	O
resulting	O
in	O
detrimental	O
hemodynamic	O
consequences	O
associated	O
with	O
tachycardia	O
.	O

Pulmonary	B-ANAT
hemodynamics	O
and	O
gas	O
exchange	O
are	O
related	O
to	O
changes	O
of	O
arterial	B-ANAT
prostanoid	O
levels	O
in	O
ARDS	O
patients	O
,	O
depending	O
on	O
the	O
rate	O
of	O
fat	O
infusion	O
.	O

Fifty	O
three	O
patients	O
were	O
found	O
to	O
develop	O
ALL	O
and	O
ARDS	O
in	O
the	O
presence	O
of	O
severe	O
pneumonia	O
,	O
postperfusion	O
lung	B-ANAT
disorders	O
,	O
reperfusion	O
syndrome	O
,	O
pulmonary	B-ANAT
embolism	O
,	O
long	O
-	O
term	O
artificial	O
ventilation	O
,	O
combined	O
car	B-ANAT
accident	O
injury	O
and	O
gunshot	O
wounds	O
of	O
the	O
chest	B-ANAT
,	O
heroine	O
intoxication	O
,	O
septic	O
shock	O
,	O
sepsis	O
,	O
postoperative	O
sequels	O
in	O
cancer	O
patients	O
,	O
and	O
after	O
hepatic	B-ANAT
transplantation	O
or	O
massive	O
aspiration	O
of	O
gastric	B-ANAT
contents	I-ANAT
.	O

Patients	O
with	O
OP	O
poisoning	O
may	O
have	O
respiratory	O
failure	O
for	O
many	O
reasons	O
,	O
including	O
aspiration	O
of	O
the	O
gastric	B-ANAT
content	I-ANAT
,	O
excessive	O
secretions	B-ANAT
,	O
pneumonia	O
and	O
septicemia	O
complicating	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

0	O
.	O
3	O
l	O
/	O
min	O
per	O
m2	O
body	B-ANAT
surface	O
area	O
(	O
BSA	O
)	O
for	O
APRV	O
,	O
whereas	O
oxygen	O
delivery	O
increased	O
from	O
997	O
+/-	O

ABSTRACT	O
:	O
Brain	B-ANAT
tissue	I-ANAT
from	O
25	O
patients	O
with	O
clinically	O
definite	O
multiple	O
sclerosis	O
(	O
MS	O
)	O
and	O
as	O
controls	O
brain	B-ANAT
tissue	I-ANAT
from	O
36	O
patients	O
without	O
neurological	O
disease	O
was	O
tested	O
for	O
the	O
presence	O
of	O
human	O
coronaviral	O
RNA	O
.	O

Four	O
PCR	O
assays	O
with	O
primers	O
specific	O
for	O
N	O
-	O
protein	O
of	O
human	O
coronavirus	O
strain	O
229E	O
and	O
three	O
PCR	O
assays	O
with	O
primers	O
specific	O
for	O
the	O
nucleocapsid	B-ANAT
protein	O
of	O
human	O
coronavirus	O
strain	O
OC43	O
were	O
performed	O
.	O

Normal	O
rats	O
had	O
a	O
well	O
-	O
defined	O
upper	O
inflection	O
point	O
(	O
UIP	O
)	O
at	O
low	O
airway	B-ANAT
pressure	O
.	O

Changes	O
in	O
Vuip	O
and	O
in	O
Crs	O
produced	O
by	O
HV	O
were	O
correlated	O
with	O
edema	O
severity	O
in	O
normal	O
rats	O
or	O
rats	O
with	O
lungs	B-ANAT
preinjured	O
with	O
alpha	O
-	O
naphthylthiourea	O
.	O

TITLE	O
:	O
Cooperation	O
of	O
an	O
RNA	O
packaging	O
signal	O
and	O
a	O
viral	B-ANAT
envelope	I-ANAT
protein	O
in	O
coronavirus	O
RNA	O
packaging	O
.	O

ABSTRACT	O
:	O
Patients	O
with	O
acute	O
pancreatitis	O
may	O
develop	O
acute	O
lung	B-ANAT
injury	O
,	O
manifest	O
clinically	O
as	O
the	O
adult	O
respiratory	O
distress	O
syndrome	O
.	O

TITLE	O
:	O
Reduced	O
macrophage	B-ANAT
infiltration	O
and	O
demyelination	O
in	O
mice	O
lacking	O
the	O
chemokine	O
receptor	O
CCR5	O
following	O
infection	O
with	O
a	O
neurotropic	O
coronavirus	O
.	O

In	O
addition	O
,	O
infected	O
CCR5	O
(-/-)	O
mice	O
exhibited	O
reduced	O
(	O
P	O
<	O
or	O
=	O
0	O
.	O
02	O
)	O
macrophage	B-ANAT
(	O
CD45	O
(	O
high	O
)	O
F4	O
/	O
80	O
(+))	O
infiltration	O
,	O
which	O
correlated	O
with	O
a	O
significant	O
reduction	O
(	O
P	O
<	O
or	O
=	O
0	O
.	O
001	O
)	O
in	O
the	O
severity	O
of	O
demyelination	O
compared	O
to	O
CCR5	O
(+/+)	O
mice	O
.	O

ABSTRACT	O
:	O
To	O
examine	O
whether	O
measurement	O
of	O
procalcitonin	O
(	O
PCT	O
)	O
in	O
comparison	O
with	O
interleukin	O
-	O
6	O
is	O
a	O
reliable	O
marker	O
to	O
score	O
the	O
extent	O
of	O
lung	B-ANAT
contusion	O
in	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
)	O
fluids	B-ANAT
in	O
polytrauma	O
patients	O
.	O

Fourteen	O
trauma	O
victims	O
presenting	O
with	O
severe	O
lung	B-ANAT
contusion	O
and	O
acute	O
lung	B-ANAT
injury	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
were	O
enrolled	O
in	O
the	O
study	O
.	O

TITLE	O
:	O
The	O
concept	O
of	O
fillet	O
flaps	B-ANAT
:	O
classification	O
,	O
indications	O
,	O
and	O
analysis	O
of	O
their	O
clinical	O
value	O
.	O

In	O
nine	O
cases	O
,	O
defects	O
of	O
the	O
forefoot	B-ANAT
were	O
covered	O
by	O
adjacent	O
dorsal	O
or	O
plantar	B-ANAT
fillet	O
flaps	B-ANAT
.	O

Four	O
knee	B-ANAT
joints	I-ANAT
were	O
salvaged	O
and	O
one	O
above	O
-	O
knee	B-ANAT
stump	O
was	O
lengthened	O
.	O

Major	O
complications	O
such	O
as	O
flap	B-ANAT
loss	O
,	O
flap	B-ANAT
revision	O
,	O
or	O
severe	O
infection	O
occurred	O
in	O
only	O
7	O
.	O
5	O
percent	O
of	O
cases	O
.	O

Eight	O
patients	O
were	O
healed	O
and	O
1	O
died	O
of	O
septic	O
shock	O
and	O
multiple	O
organ	B-ANAT
failure	O
.	O

Comparison	O
of	O
the	O
TGEV	O
polymerase	O
sequence	O
with	O
that	O
of	O
other	O
RNA	O
viruses	O
revealed	O
high	O
sequence	O
homology	O
with	O
the	O
A	O
-	O
E	O
domains	O
of	O
the	O
palm	B-ANAT
subdomain	O
of	O
nucleic	B-ANAT
acid	O
polymerases	O
.	O

Twenty	O
-	O
seven	O
of	O
48	O
(	O
56	O
%)	O
paired	O
nasal	B-ANAT
swab	O
specimens	O
and	O
fecal	B-ANAT
samples	O
positive	O
for	O
BECV	O
were	O
positive	O
for	O
BRCV	O
.	O

Feedlot	O
cattle	O
infected	O
with	O
BCV	O
after	O
transport	O
shed	O
BCV	O
from	O
the	O
respiratory	B-ANAT
tract	I-ANAT
and	O
in	O
the	O
feces	B-ANAT
.	O

Two	O
patients	O
with	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
died	O
after	O
withdrawal	O
of	O
life	O
support	O
;	O
their	O
mean	O
PaO2	O
/	O
FIO2	O
and	O
OI	O
were	O
178	O
+/-	O

Nasal	B-ANAT
brush	B-ANAT
cells	I-ANAT
were	O
stained	O
immunohistochemically	O
for	O
Langerhans	B-ANAT
cells	I-ANAT
,	O
T	B-ANAT
cells	I-ANAT
,	O
monocytes	B-ANAT
,	O
neutrophils	B-ANAT
,	O
B	B-ANAT
cells	I-ANAT
,	O
macrophages	B-ANAT
,	O
natural	O
killer	O
(	O
NK	O
)	O
cells	B-ANAT
,	I-ANAT
mast	I-ANAT
cells	B-ANAT
,	O
eosinophils	B-ANAT
,	O
eotaxin	O
,	O
and	O
RANTES	O
.	O

Increased	O
numbers	O
of	O
T	B-ANAT
cells	I-ANAT
,	O
monocytes	B-ANAT
,	O
macrophages	B-ANAT
,	O
NK	B-ANAT
cells	I-ANAT
,	O
eosinophils	B-ANAT
,	O
and	O
RANTES	O
-	O
and	O
eotaxin	O
-	O
positive	O
cells	B-ANAT
,	O
but	O
not	O
neutrophils	B-ANAT
,	O
were	O
observed	O
during	O
common	O
cold	O
in	O
allergic	O
and	O
nonallergic	O
patients	O
,	O
and	O
increased	O
numbers	O
of	O
mast	B-ANAT
cells	I-ANAT
in	O
allergic	O
patients	O
.	O

What	O
immunologic	O
factors	O
can	O
induce	O
prolonged	O
eosinophil	B-ANAT
influx	O
and	O
whether	O
this	O
may	O
increase	O
the	O
risk	O
of	O
subsequent	O
allergen	O
-	O
induced	O
hypersensitivity	O
reactions	O
must	O
be	O
studied	O
further	O
.	O

TITLE	O
:	O
A	O
comparison	O
of	O
lymphatic	B-ANAT
tissues	I-ANAT
from	O
cats	O
with	O
spontaneous	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
),	O
cats	O
with	O
FIP	O
virus	O
infection	O
but	O
no	O
FIP	O
,	O
and	O
cats	O
with	O
no	O
infection	O
.	O

Additionally	O
,	O
the	O
formation	O
of	O
granulomatous	O
lesions	O
in	O
lymphatic	B-ANAT
tissues	I-ANAT
in	O
cats	O
with	O
FIP	O
was	O
examined	O
.	O

In	O
general	O
,	O
lymphoid	B-ANAT
tissues	I-ANAT
showed	O
T	O
-	O
and	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
depletion	O
,	O
often	O
including	O
massive	O
to	O
complete	O
thymic	O
involution	O
or	O
atrophy	O
.	O

PCP	O
was	O
diagnosed	O
by	O
examination	O
of	O
the	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
BALF	O
),	O
and	O
the	O
patient	O
was	O
treated	O
with	O
intravenously	O
administered	O
trimethoprim	O
-	O
sulphamethoxazole	O
(	O
TMP	O
-	O
SMX	O
)	O
and	O
methylprednisolone	O
.	O

In	O
a	O
patient	O
with	O
a	O
long	O
history	O
of	O
smoking	O
and	O
emphysema	O
,	O
PCP	O
may	O
trigger	O
-	O
macrophage	B-ANAT
activation	O
and	O
an	O
excessive	O
release	O
of	O
leukocyte	B-ANAT
elastase	O
,	O
leading	O
to	O
elastin	O
destruction	O
in	O
the	O
alveoli	B-ANAT
.	O

We	O
set	O
out	O
to	O
precisely	O
define	O
which	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
cells	B-ANAT
express	O
MHC	B-ANAT
molecules	O
in	O
vivo	O
during	O
infection	O
with	O
a	O
strain	O
of	O
murine	O
hepatitis	O
virus	O
that	O
causes	O
a	O
chronic	O
,	O
inflammatory	O
demyelinating	O
disease	O
.	O

These	O
data	O
indicate	O
that	O
oligodendrocytes	B-ANAT
and	O
neurons	B-ANAT
have	O
the	O
potential	O
to	O
present	O
antigen	O
to	O
T	B-ANAT
cells	I-ANAT
and	O
thus	O
be	O
damaged	O
by	O
direct	O
antigen	O
-	O
specific	O
interactions	O
with	O
CD8	O
+	O
T	B-ANAT
lymphocytes	I-ANAT
.	O

TITLE	O
:	O
Blood	B-ANAT
-	O
retinal	B-ANAT
barrier	O
breakdown	O
in	O
experimental	O
coronavirus	O
retinopathy	O
:	O
association	O
with	O
viral	O
antigen	O
,	O
inflammation	O
,	O
and	O
VEGF	O
in	O
sensitive	O
and	O
resistant	O
strains	O
.	O

ABSTRACT	O
:	O
Intraocular	B-ANAT
coronavirus	O
inoculation	O
results	O
in	O
a	O
biphasic	O
retinal	B-ANAT
disease	O
in	O
susceptible	O
mice	O
(	O
BALB	O
/	O
c	O
)	O
characterized	O
by	O
an	O
acute	O
inflammatory	O
response	O
,	O
followed	O
by	O
retinal	B-ANAT
degeneration	O
associated	O
with	O
autoimmune	O
reactivity	O
.	O

Blood	B-ANAT
-	O
retinal	B-ANAT
barrier	O
(	O
BRB	O
)	O
breakdown	O
occurs	O
in	O
the	O
early	O
phase	O
in	O
both	O
strains	O
,	O
coincident	O
with	O
the	O
onset	O
of	O
inflammation	O
.	O

At	O
the	O
age	O
of	O
20	O
,	O
in	O
a	O
seven	O
months	O
period	O
,	O
she	O
precised	O
urgent	O
abdominal	B-ANAT
surgical	O
intervention	O
in	O
three	O
occasions	O
for	O
acute	O
diffuse	O
peritonitis	O
related	O
to	O
jejunal	B-ANAT
and	O
ileal	B-ANAT
diverticula	O
.	O

ABSTRACT	O
:	O
We	O
have	O
noticed	O
a	O
recent	O
rise	O
in	O
the	O
incidence	O
and	O
severity	O
of	O
acute	O
renal	B-ANAT
failure	O
(	O
ARF	O
)	O
in	O
malaria	O
.	O

Eighteen	O
showed	O
severe	O
ARF	O
(	O
Serum	B-ANAT
creatinine	O
>	O
5	O
mg	O
%).	O

ABSTRACT	O
:	O
Drug	O
abuse	O
is	O
a	O
growing	O
problem	O
in	O
industrialized	O
countries	O
,	O
opening	O
the	O
way	O
to	O
new	O
diseases	O
of	O
the	O
respiratory	B-ANAT
tract	I-ANAT
.	O

Herein	O
,	O
we	O
demonstrate	O
the	O
complexity	O
of	O
the	O
chemokine	O
response	O
to	O
MHV	O
infection	O
of	O
the	O
CNS	B-ANAT
and	O
the	O
delicate	O
balance	O
that	O
exists	O
between	O
host	O
defense	O
and	O
development	O
of	O
disease	O
.	O

We	O
set	O
out	O
to	O
study	O
the	O
etiologic	O
agent	O
and	O
mechanism	O
involved	O
in	O
three	O
children	O
who	O
presented	O
to	O
our	O
hospital	O
,	O
two	O
of	O
whom	O
died	O
and	O
one	O
survived	O
a	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
infection	O
.	O

In	O
addition	O
one	O
of	O
the	O
children	O
presented	O
with	O
hand	O
,	O
foot	B-ANAT
,	O
and	O
mouth	B-ANAT
disease	O
,	O
a	O
syndrome	O
that	O
has	O
not	O
been	O
previously	O
associated	O
with	O
echovirus	O
7	O
infection	O
.	O

TITLE	O
:	O
Intranasal	O
inoculation	O
with	O
the	O
olfactory	B-ANAT
bulb	I-ANAT
line	O
variant	O
of	O
mouse	O
hepatitis	O
virus	O
causes	O
extensive	O
destruction	O
of	O
the	O
olfactory	B-ANAT
bulb	I-ANAT
and	O
accelerated	O
turnover	O
of	O
neurons	B-ANAT
in	O
the	O
olfactory	B-ANAT
epithelium	I-ANAT
of	O
mice	O
.	O

TITLE	O
:	O
A	O
review	O
of	O
coronavirus	O
infection	O
in	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
of	O
cats	O
and	O
mice	O
.	O

Moreover	O
,	O
spleen	B-ANAT
cells	B-ANAT
from	O
these	O
mice	O
showed	O
stronger	O
immune	O
responses	O
than	O
those	O
from	O
live	O
vaccine	O
or	O
parental	O
vector	O
immunized	O
mice	O
.	O

These	O
results	O
suggest	O
that	O
the	O
construct	O
can	O
elicit	O
both	O
humoral	O
and	O
cell	B-ANAT
-	O
mediated	O
immune	O
(	O
CMI	O
)	O
responses	O
against	O
TGEV	O
N	O
protein	O
in	O
mice	O
.	O

Lymphocyte	B-ANAT
proliferation	O
responses	O
of	O
spleen	B-ANAT
cells	B-ANAT
to	O
concanavalin	O
A	O
were	O
higher	O
in	O
TCV	O
-	O
infected	O
turkeys	O
than	O
in	O
noninfected	O
control	O
turkeys	O
with	O
significant	O
differences	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
being	O
noted	O
at	O
14	O
and	O
63	O
d	O
PI	O
in	O
Experiment	O
2	O
and	O
at	O
3	O
and	O
28	O
d	O
PI	O
in	O
Experiment	O
3	O
.	O

Immunofluorescent	O
staining	O
of	O
IBV	O
-	O
infected	O
cells	B-ANAT
and	O
cells	B-ANAT
expressing	O
individual	O
cleavage	O
products	O
showed	O
that	O
the	O
100	O
-,	O
68	O
-,	O
and	O
58	O
-	O
kDa	O
proteins	O
were	O
associated	O
with	O
the	O
membranes	B-ANAT
of	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
,	O
and	O
the	O
39	O
-	O
and	O
35	O
-	O
kDa	O
proteins	O
displayed	O
diffuse	O
distribution	O
patterns	O
.	O

To	O
investigate	O
whether	O
B	B-ANAT
cells	I-ANAT
are	O
important	O
for	O
controlling	O
mouse	O
hepatitis	O
virus	O
strain	O
A59	O
infection	O
,	O
we	O
infected	O
muMT	O
mice	O
who	O
lack	O
membrane	B-ANAT
-	I-ANAT
bound	I-ANAT
IgM	I-ANAT
and	O
therefore	O
mature	O
B	B-ANAT
lymphocytes	I-ANAT
.	O

Infectious	O
virus	O
peaked	O
and	O
was	O
cleared	O
from	O
the	O
livers	B-ANAT
of	O
muMT	O
and	O
wild	O
-	O
type	O
mice	O
.	O

In	O
this	O
group	O
of	O
trials	O
HFOV	O
is	O
associated	O
with	O
a	O
strong	O
trend	O
for	O
an	O
increased	O
rate	O
of	O
gross	O
pulmonary	B-ANAT
ALS	O
(	O
four	O
trials	O
,	O
summary	O
RR	O
1	O
.	O
54	O
(	O
0	O
.	O
98	O
,	O
2	O
.	O
42	O
)]	O
In	O
the	O
subgroup	O
of	O
two	O
trials	O
(	O
HIFI	O
1989	O
,	O
Rettwitz	O
-	O
Volk	O
1998	O
)	O
not	O
using	O
a	O
HVS	O
there	O
is	O
no	O
effect	O
of	O
HFOV	O
on	O
the	O
rate	O
of	O
CLD	O
;	O
however	O
,	O
there	O
is	O
an	O
increase	O
in	O
the	O
rate	O
of	O
periventricular	O
leukomalacia	O
(	O
PVL	O
)	O
[	O
summary	O
RR	O
1	O
.	O
64	O
(	O
1	O
.	O
02	O
,	O
2	O
.	O
64	O
).	O

Biopsy	O
of	O
the	O
ear	B-ANAT
lesion	O
revealed	O
auricular	B-ANAT
chondritis	O
.	O

CONCLUSIONS	O
:	O
TGI	O
appears	O
to	O
be	O
an	O
important	O
component	O
of	O
ventilatory	O
management	O
when	O
ARDS	O
is	O
associated	O
with	O
severe	O
head	B-ANAT
trauma	O
.	O

The	O
major	O
difference	O
was	O
that	O
apoptotic	O
cells	B-ANAT
were	O
frequently	O
encountered	O
in	O
the	O
srr7	O
-	O
infected	O
mouse	B-ANAT
brain	I-ANAT
,	O
but	O
not	O
in	O
wt	O
-	O
infected	O
mice	O
on	O
day	O
2	O
p	O
.	O
i	O
.	O

However	O
,	O
there	O
was	O
no	O
difference	O
between	O
these	O
viruses	O
in	O
the	O
potential	O
to	O
induce	O
apoptosis	O
in	O
cultured	B-ANAT
cells	I-ANAT
.	O

ABSTRACT	O
:	O
To	O
determine	O
whether	O
increases	O
in	O
FiO2	O
or	O
positive	O
end	O
-	O
expiratory	O
pressure	O
will	O
compensate	O
for	O
hypoxemia	O
resulting	O
from	O
exposure	O
to	O
8000	O
feet	B-ANAT
(	O
2440	O
m	O
)	O
of	O
altitude	O
in	O
a	O
model	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
animals	O
were	O
taken	O
to	O
8000	O
feet	B-ANAT
(	O
2440	O
m	O
)	O
in	O
an	O
altitude	O
chamber	B-ANAT
,	O
and	O
then	O
stepwise	O
increases	O
of	O
either	O
5	O
%	O
FiO2	O
(	O
six	O
animals	O
)	O
or	O
2	O
.	O
5	O
cm	O
H2O	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
six	O
animals	O
)	O
were	O
made	O
until	O
PaO2	O
values	O
exceeded	O
75	O
torr	O
(	O
10	O
.	O
0	O
kPa	O
).	O

TITLE	O
:	O
Organization	O
of	O
two	O
transmissible	O
gastroenteritis	O
coronavirus	O
membrane	B-ANAT
protein	O
topologies	O
within	O
the	O
virion	B-ANAT
and	O
core	O
.	O

ABSTRACT	O
:	O
The	O
difference	O
in	O
membrane	B-ANAT
(	O
M	O
)	O
protein	O
compositions	O
between	O
the	O
transmissible	O
gastroenteritis	O
coronavirus	O
(	O
TGEV	O
)	O
virion	B-ANAT
and	O
the	O
core	O
has	O
been	O
studied	O
.	O

All	O
of	O
the	O
M	O
protein	O
was	O
susceptible	O
to	O
N	O
-	O
glycosidase	O
F	O
treatment	O
of	O
the	O
native	O
virions	B-ANAT
,	O
which	O
indicates	O
that	O
all	O
the	O
M	O
protein	O
molecules	O
are	O
exposed	O
to	O
the	O
virus	O
surface	O
.	O

Acute	O
hypoxia	O
also	O
increased	O
rabbit	O
alveolar	B-ANAT
macrophage	I-ANAT
IL	O
-	O
8	O
expression	O
.	O

Ultrastructurally	O
,	O
morphogenesis	O
of	O
virus	O
progeny	O
was	O
detected	O
only	O
in	O
the	O
cytoplasm	B-ANAT
.	O

It	O
reduced	O
pulmonary	B-ANAT
myeloperoxidase	O
activity	O
and	O
peripheral	O
neutropenia	O
and	O
increased	O
neutrophil	B-ANAT
respiratory	O
burst	O
activity	O
.	O

We	O
report	O
a	O
severe	O
form	O
of	O
GBL	O
withdrawal	O
,	O
characterized	O
by	O
delirium	O
,	O
psychosis	O
,	O
autonomic	B-ANAT
instability	O
,	O
and	O
resistance	O
to	O
benzodiazepine	O
therapy	O
.	O

RNA	O
was	O
extracted	O
from	O
the	O
intestines	B-ANAT
and	O
stool	B-ANAT
samples	O
that	O
were	O
collected	O
from	O
the	O
swine	O
with	O
diarrhea	O
.	O

Moreover	O
,	O
in	O
YAC	O
-	O
MHV3	O
-	O
infected	O
mice	O
,	O
the	O
percentages	O
of	O
intrahepatic	O
CD8	O
(+)	O
cells	B-ANAT
slightly	O
decreased	O
at	O
24	O
h	O
pi	O
,	O
then	O
increased	O
until	O
15	O
days	O
pi	O
.	O

However	O
,	O
these	O
cells	B-ANAT
became	O
anergic	O
following	O
Con	O
A	O
or	O
PHA	O
stimulation	O
.	O

They	O
were	O
surrounded	O
by	O
a	O
fringe	O
of	O
regularly	O
spaced	O
petal	O
-	O
shaped	O
projections	O
attached	O
to	O
the	O
particles	O
by	O
a	O
short	O
stalk	B-ANAT
.	O

ABSTRACT	O
:	O
A	O
dietary	O
deficiency	O
of	O
Arg	O
may	O
suppress	O
chick	O
immune	B-ANAT
system	I-ANAT
functions	O
;	O
however	O
,	O
research	O
evaluating	O
immune	O
function	O
responsiveness	O
of	O
commercial	O
broilers	O
fed	O
dietary	O
Arg	O
levels	O
near	O
NRC	O
(	O
1994	O
)	O
recommendations	O
is	O
sparse	O
.	O

VEGF	O
was	O
measured	O
in	O
tracheal	O
aspirates	B-ANAT
from	O
31	O
preterm	O
infants	O
,	O
5	O
intubated	O
term	O
infants	O
without	O
primary	O
lung	B-ANAT
injury	O
,	O
and	O
12	O
infants	O
with	O
PPHN	O
during	O
the	O
first	O
10	O
postnatal	O
days	O
,	O
and	O
from	O
8	O
infants	O
with	O
BPD	O
.	O

Immunohistochemistry	O
for	O
VEGF	O
and	O
Flt	O
-	O
1	O
was	O
similar	O
in	O
fetuses	B-ANAT
,	O
preterm	O
infants	O
,	O
and	O
term	O
infants	O
:	O
for	O
VEGF	O
mostly	O
in	O
bronchial	B-ANAT
epithelium	I-ANAT
and	O
alveolar	B-ANAT
macrophages	I-ANAT
,	O
and	O
for	O
Flt	O
-	O
1	O
mostly	O
in	O
vascular	B-ANAT
endothelial	I-ANAT
cells	I-ANAT
and	O
bronchial	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

In	O
patients	O
with	O
BPD	O
,	O
and	O
PPHN	O
,	O
staining	O
for	O
VEGF	O
and	O
Flt	O
-	O
1	O
appeared	O
also	O
in	O
Type	B-ANAT
II	I-ANAT
pneumocytes	I-ANAT
.	O

TITLE	O
:	O
Toxoplasmic	O
pneumonitis	O
leading	O
to	O
fatal	O
acute	O
respiratory	O
distress	O
syndrome	O
after	O
engraftment	O
in	O
three	O
bone	B-ANAT
marrow	I-ANAT
transplant	B-ANAT
recipients	O
.	O

TITLE	O
:	O
Nanostructured	O
materials	O
designed	O
for	O
cell	B-ANAT
binding	O
and	O
transduction	O
.	O

Ron	O
tk	O
-/-	O
mice	O
succumb	O
to	O
nickel	O
-	O
induced	O
ALI	O
earlier	O
,	O
express	O
larger	O
,	O
early	O
increases	O
in	O
interleukin	O
-	O
6	O
,	O
monocyte	B-ANAT
chemoattractant	O
protein	O
-	O
1	O
,	O
and	O
macrophage	B-ANAT
inflammatory	O
protein	O
-	O
2	O
,	O
display	O
greater	O
serum	B-ANAT
nitrite	O
levels	O
,	O
and	O
exhibit	O
earlier	O
onset	O
of	O
pulmonary	B-ANAT
pathology	O
and	O
augmented	O
pulmonary	B-ANAT
tyrosine	O
nitrosylation	O
.	O

In	O
view	O
of	O
the	O
potential	O
of	O
DNA	O
vaccines	O
to	O
induce	O
cell	B-ANAT
-	O
mediated	O
responses	O
,	O
their	O
efficacy	O
to	O
induce	O
protective	O
immunity	O
in	O
cats	O
was	O
evaluated	O
.	O

TITLE	O
:	O
Effect	O
of	O
methylprednisolone	O
on	O
phospholipase	O
A	O
(	O
2	O
)	O
activity	O
and	O
lung	B-ANAT
surfactant	O
degradation	O
in	O
acute	O
lung	B-ANAT
injury	O
in	O
rabbits	O
.	O

We	O
investigated	O
whether	O
methylprednisolone	O
,	O
a	O
synthetic	O
glucocorticoid	O
,	O
could	O
inhibit	O
increase	O
of	O
phospholipase	O
A	O
(	O
2	O
)	O
activity	O
in	O
the	O
lung	B-ANAT
and	O
lead	O
to	O
protection	O
against	O
a	O
model	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
rabbits	O
.	O

for	O
2	O
h	O
)	O
provoked	O
pulmonary	B-ANAT
hemorrhage	O
and	O
edema	O
,	O
protein	O
leakage	O
and	O
massive	O
neutrophil	B-ANAT
infiltration	O
,	O
resulted	O
in	O
severe	O
hypoxemia	O
and	O
impaired	O
lung	B-ANAT
compliance	O
,	O
accompanying	O
the	O
increase	O
of	O
phospholipase	O
A	O
(	O
2	O
)	O
activity	O
and	O
interleukin	O
-	O
8	O
,	O
and	O
degradation	O
of	O
surfactant	O
in	O
the	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
.	O

By	O
reviewing	O
relevant	O
medical	O
articles	O
on	O
this	O
topic	O
,	O
we	O
tried	O
to	O
find	O
answers	O
on	O
the	O
reasons	O
why	O
many	O
surgical	O
patients	O
have	O
pain	O
in	O
the	O
postoperative	O
period	O
despite	O
implementation	O
of	O
modern	O
and	O
powerful	O
analgesic	O
therapy	O
like	O
patient	O
-	O
controlled	O
analgesia	O
(	O
PCA	B-ANAT
),	O
spinal	O
/	O
epidural	B-ANAT
opioids	O
and	O
regional	O
analgesia	O
.	O

TITLE	O
:	O
Functional	O
genomics	O
of	O
oxidant	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

Enhanced	O
expression	O
occurred	O
mainly	O
in	O
genes	O
associated	O
with	O
oxidative	O
stress	O
,	O
anti	O
-	O
proteolytic	O
function	O
,	O
and	O
repair	O
of	O
the	O
extracellular	B-ANAT
matrix	I-ANAT
.	O

Concomitantly	O
,	O
surfactant	O
proteins	O
and	O
Clara	B-ANAT
cell	I-ANAT
secretory	O
protein	O
mRNA	O
expression	O
decreased	O
.	O

In	O
all	O
investigated	O
time	O
periods	O
,	O
we	O
observed	O
significant	O
increase	O
in	O
serum	B-ANAT
sES	O
concentration	O
among	O
patients	O
from	O
group	O
I	O
,	O
in	O
comparison	O
to	O
initial	O
value	O
and	O
control	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
is	O
characterised	O
by	O
capillary	B-ANAT
permeability	O
and	O
pulmonary	B-ANAT
oedema	O
formation	O
and	O
may	O
complicate	O
a	O
variety	O
of	O
medical	O
and	O
surgical	O
illnesses	O
.	O

Thus	O
,	O
in	O
the	O
presence	O
of	O
soMHVR	O
,	O
JHMV	O
srr7	O
-	O
infected	O
DBT	O
cells	B-ANAT
overlaid	O
onto	O
BHK	O
cells	B-ANAT
induce	O
BHK	O
cell	B-ANAT
syncytia	B-ANAT
and	O
the	O
spread	O
of	O
JHMV	O
srr7	O
infection	O
.	O

Here	O
,	O
we	O
report	O
that	O
neither	O
the	O
transmembrane	B-ANAT
domain	O
nor	O
the	O
short	O
lumenal	O
domain	O
of	O
IBV	O
E	O
is	O
required	O
for	O
Golgi	B-ANAT
targeting	O
.	O

Thus	O
,	O
the	O
cytoplasmic	B-ANAT
tail	I-ANAT
of	O
the	O
E	O
protein	O
is	O
necessary	O
and	O
sufficient	O
for	O
Golgi	B-ANAT
targeting	O
.	O

The	O
IBV	O
E	O
protein	O
is	O
palmitoylated	O
on	O
one	O
or	O
two	O
cysteine	O
residues	O
adjacent	O
to	O
its	O
transmembrane	B-ANAT
domain	O
,	O
but	O
palmitoylation	O
was	O
not	O
required	O
for	O
proper	O
Golgi	B-ANAT
targeting	O
.	O

As	O
the	O
E	O
and	O
M	O
proteins	O
are	O
essential	O
for	O
TGEV	O
virion	B-ANAT
budding	O
,	O
these	O
replicon	O
RNAs	O
should	O
replicate	O
but	O
not	O
result	O
in	O
the	O
production	O
of	O
infectious	O
virus	O
.	O

In	O
both	O
cases	O
,	O
GFP	O
expression	O
and	O
leader	O
-	O
containing	O
GFP	O
transcripts	O
were	O
detected	O
in	O
transfected	O
cells	B-ANAT
.	O

TITLE	O
:	O
An	O
overview	O
of	O
morbidity	O
and	O
mortality	O
in	O
patients	O
with	O
acute	O
renal	B-ANAT
failure	O
due	O
to	O
crush	O
syndrome	O
:	O
the	O
Marmara	O
earthquake	O
experience	O
.	O

Thoracic	B-ANAT
and	O
abdominal	B-ANAT
trauma	O
was	O
observed	O
in	O
110	O
patients	O
(	O
17	O
.	O
2	O
%).	O

We	O
were	O
able	O
to	O
observe	O
an	O
attenuated	O
virulence	O
in	O
vivo	O
,	O
despite	O
the	O
fact	O
that	O
our	O
R120	O
/	O
R121	O
recombinants	O
replicated	O
to	O
comparable	O
(	O
IC	O
)	O
or	O
higher	O
(	O
IN	O
)	O
titers	O
than	O
the	O
S4R29	O
recombinant	O
in	O
the	O
brain	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
ability	O
to	O
obtain	O
entire	O
volume	O
data	O
on	O
infected	O
cells	B-ANAT
will	O
allow	O
us	O
to	O
define	O
much	O
more	O
accurately	O
the	O
interactions	O
of	O
viral	O
proteins	O
with	O
host	O
cell	B-ANAT
structures	I-ANAT
such	O
as	O
ER	O
,	O
Golgi	B-ANAT
,	O
and	O
cytoskeletal	B-ANAT
elements	O
.	O

Finally	O
,	O
the	O
approaches	O
described	O
here	O
will	O
allow	O
us	O
to	O
define	O
protein	O
complementation	O
of	O
defective	O
viruses	O
at	O
a	O
cellular	B-ANAT
level	O
,	O
rather	O
than	O
being	O
dependent	O
on	O
population	O
measurements	O
of	O
RNA	O
,	O
protein	O
,	O
or	O
progeny	O
virus	O
.	O

To	O
examine	O
age	O
as	O
an	O
independent	O
risk	O
factor	O
in	O
recovery	O
and	O
intensive	O
care	O
unit	O
discharge	B-ANAT
after	O
acute	O
lung	B-ANAT
injury	O
.	O

Acute	O
destruction	O
of	O
erythrocytes	B-ANAT
in	O
these	O
infections	O
may	O
have	O
induced	O
systemic	O
hyperplasia	O
of	O
macrophages	B-ANAT
.	O

Both	O
the	O
one	O
-	O
step	O
RT	O
-	O
PCR	O
and	O
the	O
nested	O
PCR	O
amplified	O
cell	B-ANAT
culture	O
-	O
passaged	O
isolates	O
of	O
calf	B-ANAT
diarrhea	O
strains	O
of	O
BCV	O
but	O
none	O
of	O
the	O
15	O
tested	O
TOCVs	O
or	O
transmissible	O
gastroenteritis	O
coronavirus	O
of	O
swine	O
.	O

Initially	O
,	O
the	O
mean	O
absorbed	O
dose	O
was	O
calculated	O
as	O
16	O
-	O
20	O
GyEq	O
for	O
Patient	O
A	O
,	O
mainly	O
based	O
on	O
neutron	O
-	O
activated	O
24Na	O
in	O
the	O
blood	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
prevalence	O
of	O
human	O
rhino	O
-,	O
entero	O
-,	O
and	O
coronaviruses	O
was	O
investigated	O
by	O
RT	O
-	O
PCR	O
in	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
from	O
107	O
children	O
without	O
concurrent	O
respiratory	O
symptoms	O
.	O

In	O
addition	O
,	O
the	O
spleen	B-ANAT
cell	B-ANAT
-	O
derived	O
supernatants	O
(	O
natural	O
IFN	O
)	O
inhibited	O
tracheal	O
ring	O
ciliostasis	O
mediated	O
by	O
the	O
Gray	O
strain	O
of	O
IBV	O
.	O

TITLE	O
:	O
[	O
Peroxynitrite	O
mediated	O
acute	O
lung	B-ANAT
injury	O
induced	O
by	O
lipopolysaccharides	O
in	O
rats	O
].	O

Lung	B-ANAT
coefficient	O
(	O
LC	O
),	O
lung	B-ANAT
wet	O
/	O
dry	O
weight	O
ratio	O
(	O
W	O
/	O
D	O
),	O
the	O
contents	O
of	O
water	O
and	O
Evans	O
blue	O
(	O
EB	O
)	O
in	O
lungs	B-ANAT
were	O
measured	O
after	O
intratracheal	O
insufflation	O
of	O
ONOO	O
(-)	O
with	O
different	O
doses	O
.	O

ABSTRACT	O
:	O
Contributions	O
of	O
humoral	O
and	O
cellular	B-ANAT
immunity	O
in	O
controlling	O
neurotropic	O
mouse	O
hepatitis	O
virus	O
persistence	O
within	O
the	O
CNS	B-ANAT
were	O
determined	O
in	O
B	B-ANAT
cell	I-ANAT
-	O
deficient	O
J	O
(	O
H	O
)	O
D	O
and	O
syngeneic	O
H	O
-	O
2	O
(	O
d	O
)	O
B	B-ANAT
cell	O
+	O
Ab	O
-	O
deficient	O
mice	O
.	O

Epidemiological	O
data	O
revealed	O
that	O
all	O
cases	O
were	O
healthy	O
men	O
aged	O
between	O
40	O
-	O
49	O
,	O
residing	O
in	O
the	O
same	O
geographical	O
area	O
and	O
had	O
a	O
history	O
of	O
raw	O
pork	O
or	O
uncooked	O
pig	O
'	O
s	O
blood	B-ANAT
consumption	O
prior	O
to	O
their	O
illnesses	O
.	O

This	O
can	O
be	O
explained	O
by	O
disorders	O
in	O
immunity	O
,	O
especially	O
structural	O
immunodeficiency	O
,	O
and	O
commissures	B-ANAT
at	O
the	O
sites	O
of	O
hemorrhages	O
.	O

ABSTRACT	O
:	O
A	O
1	O
-	O
step	O
RT	O
-	O
PCR	O
assay	O
,	O
targeting	O
a	O
730	O
bp	O
fragment	O
of	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
gene	O
of	O
bovine	O
coronavirus	O
(	O
BCV	O
),	O
and	O
a	O
nested	O
PCR	O
assay	O
,	O
targeting	O
a	O
407	O
bp	O
fragment	O
of	O
the	O
N	O
gene	O
,	O
were	O
developed	O
to	O
detect	O
BCV	O
in	O
nasal	B-ANAT
swab	O
and	O
fecal	B-ANAT
samples	O
of	O
calves	O
experimentally	O
exposed	O
to	O
BCV	O
.	O

In	O
addition	O
,	O
low	O
amounts	O
of	O
BCV	O
were	O
also	O
detected	O
only	O
by	O
nested	O
PCR	O
in	O
the	O
fecal	B-ANAT
and	O
nasal	B-ANAT
swab	O
samples	O
before	O
and	O
after	O
diarrhea	O
.	O

In	O
addition	O
,	O
the	O
present	O
1	O
-	O
step	O
RT	O
-	O
PCR	O
and	O
nested	O
PCR	O
assays	O
were	O
highly	O
sensitive	O
to	O
detect	O
BCV	O
in	O
nasal	B-ANAT
swab	O
and	O
fecal	B-ANAT
specimens	O
.	O

Moreover	O
,	O
clinical	O
presentation	O
of	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
can	O
be	O
dichotomized	O
,	O
according	O
to	O
patients	O
'	O
pulmonary	B-ANAT
manifestations	O
,	O
into	O
:	O
1	O
)	O
both	O
acute	O
and	O
aggressive	O
lung	B-ANAT
disease	O
similar	O
to	O
Hamman	O
-	O
Rich	O
syndrome	O
;	O
2	O
)	O
slowly	O
progressive	O
lung	B-ANAT
disease	O
;	O
and	O
3	O
)	O
an	O
asymptomatic	O
pattern	O
.	O

Finally	O
,	O
as	O
a	O
guide	O
to	O
both	O
the	O
severity	O
and	O
progress	O
of	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
,	O
the	O
significance	O
of	O
other	O
investigations	O
,	O
notably	O
bronchoalveolar	O
lavage	O
,	O
remains	O
controversial	O
.	O

Corticosteroid	O
therapy	O
is	O
considered	O
the	O
first	O
line	O
of	O
therapy	O
for	O
polymyositis	O
/	O
dermatomyositis	O
patients	O
with	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
.	O

PEDV	O
specific	O
IgM	O
ASC	O
occurred	O
in	O
all	O
the	O
tissues	B-ANAT
between	O
PID	O
4	O
and	O
7	O
,	O
with	O
the	O
strongest	O
response	O
in	O
the	O
intestinal	B-ANAT
lamina	I-ANAT
propria	I-ANAT
.	O

Expression	O
of	O
GUS	O
was	O
detected	O
in	O
the	O
lungs	B-ANAT
,	O
but	O
not	O
in	O
the	O
gut	B-ANAT
,	O
of	O
swine	O
immunized	O
with	O
the	O
virus	O
vector	O
.	O

The	O
large	O
cloning	O
capacity	O
and	O
the	O
tissue	B-ANAT
specificity	O
of	O
the	O
TGEV	O
-	O
derived	O
minigenomes	O
suggest	O
that	O
these	O
virus	O
vectors	O
are	O
very	O
promising	O
for	O
vaccine	O
development	O
.	O

MHV	O
-	O
infected	O
NOS2	O
(-/-)	O
mice	O
displayed	O
a	O
marked	O
decrease	O
in	O
mortality	O
as	O
compared	O
to	O
infected	O
NOS2	O
(+/+)	O
mice	O
that	O
correlated	O
with	O
a	O
significant	O
decrease	O
(	O
P	O
<	O
or	O
=	O
0	O
.	O
001	O
)	O
in	O
the	O
number	O
of	O
apoptotic	O
cells	B-ANAT
(	O
determined	O
by	O
TUNEL	O
staining	O
)	O
present	O
in	O
the	O
brain	B-ANAT
.	O

We	O
tested	O
the	O
hypothesis	O
that	O
adenovectors	O
could	O
efficiently	O
transduce	O
injured	O
alveoli	B-ANAT
by	O
exposing	O
adult	O
,	O
male	O
Sprague	O
-	O
Dawley	O
rats	O
to	O
100	O
%	O
oxygen	O
for	O
48	O
or	O
60	O
h	O
before	O
endotracheal	O
instillation	O
of	O
either	O
1	O
x	O
10	O
(	O
9	O
)	O
or	O
4	O
x	O
10	O
(	O
9	O
)	O
plaque	O
-	O
forming	O
units	O
of	O
an	O
adenovirus	O
that	O
expresses	O
an	O
Escherichia	O
coli	O
lac	O
Z	O
gene	O
(	O
adbeta	O
-	O
gal	O
)	O
in	O
a	O
surfactant	O
-	O
based	O
vehicle	O
(	O
Survanta	O
).	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
mechanisms	O
of	O
CYP1A1	O
regulation	O
by	O
hyperoxia	O
and	O
tested	O
the	O
hypothesis	O
that	O
aryl	O
hydrocarbon	O
receptor	O
(	O
AHR	O
)-	O
dependent	O
mechanisms	O
contribute	O
to	O
induction	O
of	O
CYP1A1	O
and	O
that	O
modulation	O
of	O
CYP1A	O
by	O
hyperoxia	O
may	O
have	O
implications	O
for	O
lung	B-ANAT
injury	O
.	O

In	O
conclusion	O
,	O
our	O
results	O
suggest	O
that	O
induction	O
of	O
CYP1A1	O
by	O
hyperoxia	O
is	O
mediated	O
by	O
AHR	O
-	O
dependent	O
mechanisms	O
and	O
that	O
modulation	O
of	O
CYP1A	O
enzymes	O
by	O
hyperoxia	O
may	O
have	O
implications	O
for	O
hyperoxic	O
lung	B-ANAT
injury	O
.	O

In	O
contrast	O
to	O
B6	O
-	O
GKO	O
mice	O
,	O
BALB	O
-	O
GKO	O
mice	O
died	O
within	O
1	O
week	O
due	O
to	O
acute	O
hepatic	B-ANAT
failure	O
.	O

PROM20	O
infants	O
had	O
an	O
increased	O
acute	O
respiratory	O
morbidity	O
(	O
higher	O
ventilator	O
settings	O
and	O
increased	O
incidence	O
of	O
hypoxemia	O
,	O
hypercapnia	O
,	O
and	O
pulmonary	B-ANAT
hypertension	O
)	O
and	O
a	O
trend	O
to	O
more	O
air	O
leaks	O
.	O

TITLE	O
:	O
Mucosal	B-ANAT
and	O
systemic	O
isotype	O
-	O
specific	O
antibody	O
responses	O
and	O
protection	O
in	O
conventional	O
pigs	O
exposed	O
to	O
virulent	O
or	O
attenuated	O
porcine	O
epidemic	O
diarrhoea	O
virus	O
.	O

Isotype	O
-	O
specific	O
antibody	O
responses	O
in	O
serum	B-ANAT
were	O
investigated	O
by	O
ELISA	O
.	O

Antibody	O
titer	O
to	O
IBV	O
,	O
delayed	O
-	O
type	O
hypersensitivity	O
(	O
DTH	O
)	O
response	O
against	O
bovine	O
serum	B-ANAT
albumin	O
(	O
BSA	O
),	O
the	O
absolute	O
number	O
and	O
percentage	O
of	O
leukocyte	B-ANAT
subpopulations	O
,	O
and	O
interferon	O
-	O
gamma	O
(	O
IFN	O
-	O
gamma	O
)-	O
like	O
cytokine	O
production	O
by	O
splenocytes	O
were	O
evaluated	O
at	O
5	O
-	O
6	O
weeks	O
of	O
age	O
.	O

Lymphopenia	O
was	O
more	O
evident	O
in	O
cats	O
with	O
acute	O
forms	O
,	O
strong	O
intensity	O
of	O
positivity	O
,	O
extracellular	B-ANAT
antigen	O
and	O
negative	O
lymph	B-ANAT
nodes	I-ANAT
.	O

ABSTRACT	O
:	O
An	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
Elisa	O
),	O
using	O
as	O
antigen	O
canine	O
coronavirus	O
-	O
infected	O
CrFK	O
cell	B-ANAT
supernatant	O
,	O
was	O
developed	O
to	O
detect	O
antibodies	O
against	O
canine	O
coronavirus	O
(	O
CCoV	O
).	O

Out	O
of	O
a	O
total	O
of	O
109	O
dog	O
serum	B-ANAT
samples	O
,	O
80	O
which	O
were	O
positive	O
by	O
routine	O
virus	O
neutralisation	O
test	O
were	O
also	O
Elisa	O
positive	O
.	O

To	O
better	O
understand	O
the	O
distinct	O
phases	O
of	O
immune	O
control	O
within	O
the	O
CNS	B-ANAT
,	O
the	O
kinetics	O
of	O
humoral	O
immune	O
responses	O
were	O
determined	O
in	O
infected	O
mice	O
.	O

To	O
unequivocally	O
determine	O
their	O
roles	O
in	O
viral	O
cytopathogenicity	O
,	O
we	O
developed	O
a	O
system	O
in	O
which	O
phenotypically	O
chimeric	O
viruses	O
were	O
generated	O
by	O
infecting	O
a	O
closely	O
related	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
in	O
cells	B-ANAT
that	O
stably	O
express	O
an	O
individual	O
BCV	O
protein	O
(	O
S	O
or	O
HE	O
).	O

1	O
.	O
0	O
x	O
10	O
(	O
5	O
)	O
colony	O
-	O
forming	O
units	O
/	O
mL	O
,	O
p	O
<.	O
05	O
)	O
and	O
in	O
the	O
pulmonary	B-ANAT
parenchyma	B-ANAT
(	O
1	O
.	O
7	O
+/-	O

TITLE	O
:	O
Vascular	B-ANAT
immunotargeting	O
of	O
glucose	O
oxidase	O
to	O
the	O
endothelial	B-ANAT
antigens	O
induces	O
distinct	O
forms	O
of	O
oxidant	O
acute	O
lung	B-ANAT
injury	O
:	O
targeting	O
to	O
thrombomodulin	O
,	O
but	O
not	O
to	O
PECAM	O
-	O
1	O
,	O
causes	O
pulmonary	B-ANAT
thrombosis	O
and	O
neutrophil	B-ANAT
transmigration	O
.	O

ABSTRACT	O
:	O
Oxidative	O
endothelial	B-ANAT
stress	O
,	O
leukocyte	B-ANAT
transmigration	O
,	O
and	O
pulmonary	B-ANAT
thrombosis	O
are	O
important	O
pathological	O
factors	O
in	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ALI	O
/	O
ARDS	O
).	O

Anti	O
-	O
TM	O
/	O
GOX	O
caused	O
markedly	O
more	O
severe	O
pulmonary	B-ANAT
thrombosis	O
than	O
anti	O
-	O
PECAM	O
/	O
GOX	O
,	O
likely	O
because	O
of	O
TM	O
inhibition	O
.	O

ABSTRACT	O
:	O
In	O
Mediterranean	O
areas	O
,	O
oral	B-ANAT
allergy	O
syndrome	O
(	O
OAS	O
)	O
occurs	O
independently	O
of	O
an	O
associated	O
birch	O
pollinosis	O
;	O
moreover	O
,	O
on	O
occasions	O
it	O
presents	O
with	O
no	O
other	O
associated	O
pollinosis	O
.	O

The	O
DMVs	O
were	O
found	O
either	O
as	O
separate	O
entities	O
or	O
as	O
small	O
clusters	O
of	O
vesicles	B-ANAT
.	O

7	O
%,	O
and	O
pulmonary	B-ANAT
vascular	B-ANAT
resistance	O
index	O
(	O
PVRI	O
)	O
from	O
(	O
16	O
+/-	O

Sorbent	O
columns	O
of	O
charcoal	O
and	O
an	O
anion	O
exchanger	O
remove	O
hepatic	B-ANAT
toxins	O
from	O
the	O
albumin	O
dialysate	O
,	O
and	O
a	O
second	O
dialyzer	O
removes	O
water	O
-	O
soluble	O
toxins	O
,	O
such	O
as	O
ammonium	O
.	O

PF	O
-	O
Liver	B-ANAT
Dialysis	O
(	O
Hemocleanse	O
,	O
Inc	O
,	O
W	O
.	O
Lafayette	O
,	O
IN	O
)	O
has	O
been	O
tested	O
in	O
a	O
few	O
patients	O
with	O
hepatic	B-ANAT
failure	O
,	O
grade	O
3	O
-	O
4	O
encephalopathy	O
,	O
and	O
respiratory	O
and	O
kidney	B-ANAT
insufficiency	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
LPS	O
-	O
induced	O
chemokine	O
production	O
in	O
human	O
lung	B-ANAT
endothelial	B-ANAT
cells	I-ANAT
by	O
lipid	O
conjugates	O
anchored	O
to	O
the	O
membrane	B-ANAT
.	O

The	O
present	O
study	O
was	O
undertaken	O
to	O
investigate	O
the	O
role	O
of	O
sPLA	O
(	O
2	O
)	O
in	O
chemokine	O
production	O
in	O
human	O
lung	B-ANAT
microvascular	O
endothelial	B-ANAT
cells	I-ANAT
(	O
LMVEC	O
)	O
stimulated	O
with	O
the	O
endotoxins	O
lipopolysaccharide	O
(	O
LPS	O
)	O
and	O
lipoteichoic	O
acid	O
(	O
LTA	O
).	O

In	O
particular	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
sPLA	O
(	O
2	O
)	O
inhibitors	O
,	O
specifically	O
,	O
the	O
extracellular	B-ANAT
PLA	O
(	O
2	O
)	O
inhibitors	O
(	O
ExPLIs	O
),	O
composed	O
of	O
N	O
-	O
derivatized	O
phosphatidyl	O
-	O
ethanolamine	O
linked	O
to	O
polymeric	O
carriers	O
,	O
and	O
LY311727	O
,	O
a	O
specific	O
inhibitor	O
of	O
non	O
-	O
pancreatic	B-ANAT
sPLA	O
(	O
2	O
).	O

Here	O
we	O
review	O
this	O
field	O
in	O
the	O
context	O
of	O
the	O
immune	O
response	O
to	O
MHV	O
in	O
the	O
liver	B-ANAT
and	O
the	O
CNS	B-ANAT
focusing	O
on	O
studies	O
that	O
have	O
been	O
published	O
in	O
the	O
past	O
5	O
years	O
.	O

Results	O
of	O
mutagenesis	O
and	O
in	O
vitro	O
cleavage	O
assays	O
show	O
that	O
PLP	O
-	O
1	O
was	O
able	O
to	O
cleave	O
in	O
trans	O
when	O
the	O
proposed	O
p50	O
cleavage	O
sequence	O
replaced	O
the	O
p28	B-ANAT
cleavage	O
sequence	O
.	O

This	O
symptomatology	O
seems	O
independent	O
from	O
central	O
hypoventilation	O
syndrome	O
and	O
cerebral	B-ANAT
venous	B-ANAT
thrombosis	O
.	O

CONCLUSIONS	O
:	O
Late	O
onset	O
central	O
hypoventilation	O
syndrome	O
may	O
be	O
associated	O
with	O
cerebral	B-ANAT
venous	B-ANAT
thrombosis	O
.	O

1	O
.	O
66	O
in	O
the	O
5P	O
(	O
m	O
)	O
group	O
,	O
which	O
was	O
less	O
than	O
that	O
in	O
the	O
group	O
of	O
ARDS	O
model	O
6	O
.	O
10	O
+/-	O
0	O
.	O
77	O
.	O
SI	O
with	O
6P	O
(	O
m	O
)	O
led	O
to	O
alveolar	B-ANAT
overdistention	O
.	O

The	O
three	O
strains	O
of	O
mixed	O
pathogenicity	O
induced	O
tracheitis	O
,	O
mild	O
clinical	O
nephritis	O
and	O
kidney	B-ANAT
lesions	O
but	O
no	O
mortality	O
.	O

ABSTRACT	O
:	O
A	O
5	O
-	O
month	O
-	O
old	O
male	O
presented	O
with	O
fever	O
,	O
hepatosplenomegaly	O
,	O
leukocytosis	O
with	O
atypical	O
lymphoblasts	B-ANAT
,	O
anemia	O
and	O
thrombocytopenia	O
.	O

Occurrence	O
of	O
mild	O
/	O
moderate	O
(	O
dyspnea	O
with	O
fever	O
,	O
chills	O
,	O
hypotension	O
,	O
and	O
/	O
or	O
hypoxemia	O
)	O
or	O
severe	O
(	O
acute	O
pulmonary	B-ANAT
edema	O
or	O
need	O
for	O
mechanical	O
ventilation	O
)	O
reaction	O
associated	O
with	O
transfusion	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	O
membrane	B-ANAT
(	O
M	O
)	O
protein	O
is	O
the	O
most	O
abundant	O
virion	B-ANAT
protein	O
and	O
the	O
key	O
component	O
in	O
viral	O
assembly	O
and	O
morphogenesis	O
.	O

These	O
proteins	O
are	O
involved	O
in	O
nucleolar	B-ANAT
assembly	O
and	O
ribosome	B-ANAT
biogenesis	O
and	O
act	O
as	O
chaperones	O
for	O
the	O
import	O
of	O
proteins	O
into	O
the	O
nucleolus	B-ANAT
.	O

Both	O
N	O
protein	O
and	O
a	O
fibrillarin	O
-	O
green	O
fluorescent	O
protein	O
fusion	O
protein	O
colocalized	O
to	O
the	O
perinuclear	O
region	O
and	O
the	O
nucleolus	B-ANAT
.	O

Comparison	O
of	O
cells	B-ANAT
expressing	O
IBV	O
N	O
protein	O
with	O
controls	O
indicated	O
that	O
cells	B-ANAT
expressing	O
N	O
protein	O
had	O
delayed	O
cellular	B-ANAT
growth	O
.	O

Coronaviruses	O
might	O
therefore	O
delay	O
the	O
cell	B-ANAT
cycle	O
in	O
interphase	O
,	O
where	O
maximum	O
translation	O
of	O
viral	O
mRNAs	O
can	O
occur	O
.	O

Our	O
findings	O
again	O
confirm	O
that	O
subcutaneously	O
injected	O
silicone	O
can	O
gain	O
access	O
to	O
the	O
pulmonary	B-ANAT
vascular	B-ANAT
tree	I-ANAT
and	O
cause	O
pulmonary	B-ANAT
embolism	O
.	O

Most	O
streptococci	O
(	O
20	O
/	O
21	O
)	O
were	O
oral	B-ANAT
streptococci	O
(	O
ten	O
Streptococcus	O
mitis	O
,	O
five	O
S	O
.	O
oralis	O
,	O
two	O
S	O
.	O
sanguis	B-ANAT
,	O
three	O
S	O
.	O
pneumoniae	O
).	O

This	O
results	O
demonstrate	O
the	O
interest	O
of	O
species	O
identification	O
to	O
adapt	O
the	O
antibiotic	O
treatment	O
and	O
confirms	O
the	O
frequency	O
of	O
oral	B-ANAT
streptococci	O
in	O
severe	O
bacteremia	O
in	O
neutropenic	O
patients	O
.	O

TITLE	O
:	O
Crystal	B-ANAT
structure	O
of	O
murine	O
sCEACAM1a	O
[	O
1	O
,	O
4	O
]:	O
a	O
coronavirus	O
receptor	O
in	O
the	O
CEA	O
family	O
.	O

The	O
virus	O
was	O
isolated	O
from	O
15	O
/	O
15	O
of	O
the	O
jejunal	B-ANAT
samples	O
from	O
the	O
PEDV	O
-	O
inoculated	O
pigs	O
.	O

Indications	O
for	O
operation	O
were	O
a	O
true	O
or	O
false	O
aneurysm	O
(	O
65	O
.	O
6	O
%),	O
severe	O
calcified	O
aortic	B-ANAT
valve	I-ANAT
stenosis	O
(	O
4	O
.	O
2	O
%)	O
or	O
severe	O
aortic	B-ANAT
insufficiency	O
(	O
2	O
.	O
1	O
%)	O
with	O
dilated	O
ascending	B-ANAT
aorta	I-ANAT
,	O
acute	O
dissection	O
(	O
2	O
.	O
1	O
%),	O
or	O
combination	O
of	O
indications	O
(	O
26	O
%).	O

Univariate	O
predictors	O
of	O
early	O
mortality	O
were	O
low	O
cardiac	B-ANAT
output	O
syndrome	O
(	O
p	O
<	O
0	O
.	O
001	O
),	O
neurologic	O
complication	O
(	O
p	O
=	O
0	O
.	O
03	O
),	O
and	O
renal	B-ANAT
complication	O
(	O
p	O
=	O
0	O
.	O
03	O
).	O

The	O
flanged	O
composite	O
graft	B-ANAT
offers	O
excellent	O
long	O
-	O
term	O
results	O
,	O
with	O
very	O
low	O
prevalence	O
of	O
prosthetic	O
-	O
related	O
complications	O
.	O

It	O
is	O
characterized	O
by	O
the	O
acute	O
onset	O
of	O
diffuse	O
,	O
bilateral	O
pulmonary	B-ANAT
infiltrates	O
secondary	O
to	O
noncardiogenic	O
pulmonary	B-ANAT
edema	O
,	O
refractory	O
hypoxia	O
,	O
and	O
decreased	O
lung	B-ANAT
compliance	O
.	O

Several	O
other	O
MHV	O
-	O
permissive	O
cell	B-ANAT
lines	I-ANAT
also	O
showed	O
activation	O
of	O
both	O
p38	O
MAPK	O
and	O
JNK	O
,	O
which	O
indicated	O
that	O
the	O
MHV	O
-	O
induced	O
stress	O
-	O
kinase	O
activation	O
was	O
not	O
restricted	O
to	O
any	O
particular	O
cell	B-ANAT
type	I-ANAT
.	O

Furthermore	O
,	O
MHV	O
production	O
was	O
suppressed	O
in	O
SB	O
203580	O
-	O
treated	O
cells	B-ANAT
,	O
demonstrating	O
that	O
activated	O
p38	O
MAPK	O
played	O
a	O
role	O
in	O
MHV	O
replication	O
.	O

Finally	O
,	O
use	O
of	O
the	O
assay	O
detected	O
coronavirus	O
RNA	O
in	O
tissues	B-ANAT
,	O
cage	O
swipes	O
,	O
and	O
feces	B-ANAT
obtained	O
from	O
mice	O
experimentally	O
infected	O
with	O
MHV	O
,	O
and	O
in	O
tissues	B-ANAT
and	O
cage	O
swipes	O
obtained	O
from	O
rats	O
naturally	O
infected	O
with	O
RCV	O
.	O

ABSTRACT	O
:	O
As	O
bolus	O
instillation	O
of	O
surfactant	O
can	O
lead	O
to	O
acute	O
pulmonary	B-ANAT
,	O
hemodynamic	O
and	O
cerebral	B-ANAT
side	O
effects	O
,	O
we	O
tested	O
whether	O
pulmonary	B-ANAT
mechanics	O
and	O
gas	O
exchange	O
differ	O
between	O
slow	O
surfactant	O
infusion	O
and	O
bolus	O
administration	O
.	O

These	O
included	O
a	O
massive	O
alveolar	B-ANAT
protein	O
load	O
,	O
a	O
reduced	O
percentage	O
of	O
large	O
surfactant	O
aggregates	O
(	O
LA	O
),	O
a	O
loss	O
of	O
palmitoylated	O
phosphatidylcholine	O
species	O
and	O
a	O
significant	O
reduction	O
of	O
surfactant	O
apoprotein	O
(	O
SP	O
)-	O
A	O
,	O
SP	O
-	O
B	O
and	O
SP	O
-	O
C	O
in	O
the	O
LA	O
fraction	O
.	O

The	O
patients	O
were	O
ventilated	O
with	O
a	O
mean	O
tidal	O
volume	O
of	O
11	O
.	O
0	O
+/-	O
0	O
.	O
5	O
mL	O
x	O
kg	O
(-	O
1	O
)	O
body	B-ANAT
weight	O
(	O
bw	O
),	O
either	O
volume	O
or	O
pressure	O
controlled	O
,	O
with	O
16	O
.	O
3	O
+/-	O
2	O
.	O
8	O
cmH2O	O
positive	O
end	O
-	O
expiratory	O
pressure	O
,	O
for	O
an	O
average	O
of	O
3	O
.	O
5	O
+/-	O
0	O
.	O
3	O
days	O
at	O
study	O
entry	O
.	O

No	O
untoward	O
effects	O
on	O
gas	O
exchange	O
,	O
lung	B-ANAT
mechanics	O
and	O
haemodynamics	O
were	O
noted	O
during	O
the	O
procedure	O
of	O
surfactant	O
administration	O
.	O

ABSTRACT	O
:	O
Abdominal	B-ANAT
Compartment	I-ANAT
Syndrome	O
(	O
ACS	O
)	O
has	O
multiple	O
causes	O
,	O
and	O
decompressive	O
laparotomy	O
has	O
been	O
the	O
most	O
frequent	O
modality	O
to	O
prevent	O
worsening	O
cardiovascular	B-ANAT
,	O
respiratory	O
,	O
and	O
renal	B-ANAT
function	O
.	O

TITLE	O
:	O
[	O
Severe	O
laryngeal	B-ANAT
injury	O
due	O
to	O
a	O
nasogastric	B-ANAT
tube	O
].	O

Both	O
patients	O
were	O
admitted	O
to	O
the	O
pediatric	O
intensive	O
care	O
unit	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
intracranial	B-ANAT
hemorrhage	O
respectively	O
,	O
secondary	O
to	O
leukostasis	O
.	O

3	O
.	O
1	O
years	O
old	O
(	O
the	O
trauma	O
patients	O
were	O
42	O
.	O
9	O
+/-	O
3	O
.	O
2	O
,	O
and	O
the	O
vascular	B-ANAT
/	O
general	O
patients	O
were	O
62	O
+/-	O

TITLE	O
:	O
[	O
ABO	O
-	O
incompatible	O
liver	B-ANAT
transplantation	O
and	O
patients	O
with	O
hepatopulmonary	O
syndrome	O
].	O

Survival	O
data	O
appear	O
to	O
have	O
improved	O
in	O
these	O
years	O
even	O
in	O
adult	O
cases	O
,	O
although	O
acute	O
vascular	B-ANAT
rejection	O
causing	O
hepatic	B-ANAT
necrosis	O
,	O
infection	O
,	O
and	O
intrahepatic	B-ANAT
bile	I-ANAT
duct	I-ANAT
injury	O
are	O
major	O
complications	O
to	O
be	O
resolved	O
.	O

This	O
basic	O
activity	O
was	O
stimulated	O
several	O
-	O
fold	O
when	O
arm	B-ANAT
-	O
type	O
DNA	O
sequences	O
were	O
present	O
in	O
addition	O
to	O
core	O
sites	O
.	O

This	O
corroborates	O
our	O
previous	O
conclusion	O
that	O
sufficient	O
amounts	O
of	O
eukaryotic	O
protein	O
co	O
-	O
factors	O
,	O
which	O
could	O
functionally	O
replace	O
IHF	O
,	O
are	O
not	O
present	O
in	O
human	O
cells	B-ANAT
.	O

Sinusitis	O
was	O
also	O
associated	O
with	O
pasteurella	O
cultured	O
from	O
the	O
sinus	B-ANAT
(	O
P	O
<	O
0	O
.	O
05	O
),	O
antibody	O
to	O
avian	O
pneumovirus	O
(	O
APV	O
)	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
and	O
avian	O
coronaviruses	O
as	O
detected	O
by	O
reverse	O
-	O
transcriptase	O
PCR	O
(	O
P	O
<	O
0	O
.	O
05	O
);	O
there	O
was	O
no	O
association	O
between	O
disease	O
and	O
APV	O
as	O
detected	O
by	O
PCR	O
.	O

Highest	O
mean	O
(	O
SD	O
)	O
SNAP	O
scores	O
occurred	O
in	O
infants	O
ventilated	O
for	O
meconium	B-ANAT
aspiration	O
(	O
18	O
(	O
9	O
)),	O
and	O
perinatal	O
asphyxia	O
(	O
17	O
(	O
9	O
)),	O
compared	O
with	O
pulmonary	B-ANAT
hypertension	O
(	O
14	O
(	O
6	O
))	O
and	O
respiratory	O
distress	O
syndrome	O
(	O
13	O
(	O
5	O
)).	O

Formalin	O
-	O
fixed	B-ANAT
intestinal	B-ANAT
tissues	B-ANAT
were	O
examined	O
by	O
light	O
and	O
electron	O
microscopy	O
for	O
attaching	O
and	O
effacing	O
(	O
AE	O
)	O
lesions	O
characteristic	O
of	O
EPEC	O
,	O
and	O
frozen	O
(-	O
75	O
C	O
)	O
intestinal	B-ANAT
contents	I-ANAT
were	O
examined	O
for	O
presence	O
of	O
EPEC	O
.	O

Intestinal	B-ANAT
sections	O
were	O
prepared	O
from	O
turkey	O
embryos	B-ANAT
infected	O
with	O
different	O
TCV	O
isolates	O
and	O
reacted	O
with	O
polyclonal	O
or	O
monoclonal	O
antibodies	O
to	O
TCV	O
,	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
),	O
bovine	O
coronavirus	O
(	O
BCV	O
),	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
),	O
reovirus	O
,	O
rotavirus	O
,	O
adenovirus	O
,	O
or	O
enterovirus	O
in	O
immunofluorescent	O
antibody	O
staining	O
.	O

The	O
first	O
case	O
occurred	O
in	O
an	O
81	O
-	O
year	O
-	O
old	O
ASA	O
II	O
woman	O
scheduled	O
for	O
emergency	O
abdominal	B-ANAT
surgery	O
.	O

We	O
showed	O
previously	O
that	O
the	O
process	O
of	O
CD8	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
-	O
mediated	O
demyelination	O
was	O
strongly	O
dependent	O
on	O
the	O
expression	O
of	O
gamma	O
interferon	O
(	O
IFN	O
-	O
gamma	O
)	O
by	O
donor	O
cells	B-ANAT
.	O

In	O
this	O
report	O
,	O
we	O
show	O
,	O
in	O
contrast	O
,	O
that	O
demyelination	O
and	O
lymphocyte	B-ANAT
infiltration	O
were	O
increased	O
in	O
recipients	O
of	O
IFN	O
-	O
gamma	O
(-/-)	O
CD4	O
T	B-ANAT
cells	I-ANAT
when	O
compared	O
to	O
levels	O
in	O
mice	O
receiving	O
C57BL	O
/	O
6	O
CD4	O
T	B-ANAT
cells	I-ANAT
.	O

The	O
chest	B-ANAT
radiograph	O
showed	O
bilateral	O
miliary	O
shadows	O
.	O

We	O
conclude	O
that	O
low	O
-	O
dose	O
GM	O
-	O
CSF	B-ANAT
was	O
associated	O
with	O
improved	O
gas	O
exchange	O
without	O
pulmonary	B-ANAT
neutrophil	B-ANAT
infiltration	O
,	O
despite	O
functional	O
activation	O
of	O
both	O
circulating	O
neutrophils	B-ANAT
and	O
pulmonary	B-ANAT
phagocytes	B-ANAT
.	O

Two	O
weeks	O
later	O
,	O
she	O
developed	O
progressive	O
flaccid	O
quadriplegia	O
and	O
facial	B-ANAT
weakness	O
.	O

TITLE	O
:	O
[	O
The	O
pathogenic	O
role	O
of	O
macrophage	B-ANAT
migration	O
inhibitory	O
factor	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
].	O

RESULTS	O
The	O
serum	B-ANAT
level	O
of	O
MIF	O
increased	O
significantly	O
in	O
ARDS	O
patients	O
as	O
compared	O
with	O
normal	O
persons	O
(	O
P	O
<	O
0	O
.	O
01	O
).	O

Infiltrating	O
macrophages	B-ANAT
were	O
almost	O
restricted	O
to	O
the	O
areas	O
of	O
severe	O
tissue	B-ANAT
damage	O
.	O

Using	O
transgenic	O
TCR	B-ANAT
/	O
recombination	O
activation	O
gene	O
2	O
(-/-)	O
mice	O
with	O
only	O
non	O
-	O
mouse	O
hepatitis	O
virus	O
-	O
specific	O
T	B-ANAT
cells	I-ANAT
,	O
we	O
show	O
that	O
CD8	O
T	B-ANAT
cells	I-ANAT
are	O
able	O
to	O
cause	O
demyelination	O
in	O
the	O
absence	O
of	O
cognate	O
Ag	O
in	O
the	O
CNS	B-ANAT
,	O
but	O
only	O
if	O
specifically	O
activated	O
.	O

TITLE	O
:	O
Coagulation	O
and	O
inflammation	O
in	O
acute	O
lung	B-ANAT
injury	O
.	O

This	O
state	O
is	O
Tissue	B-ANAT
Factor	O
(	O
TF	O
)-	O
dependent	O
and	O
associated	O
with	O
increased	O
elaboration	O
of	O
inflammatory	O
cytokines	O
.	O

The	O
overall	O
rates	O
of	O
BCV	O
nasal	B-ANAT
and	O
fecal	B-ANAT
shedding	O
were	O
48	O
%	O
(	O
41	O
/	O
85	O
)	O
and	O
53	O
%	O
(	O
45	O
/	O
85	O
)	O
by	O
ELISA	O
and	O
84	O
%	O
(	O
71	O
/	O
85	O
)	O
and	O
96	O
%	O
(	O
82	O
/	O
85	O
)	O
by	O
RT	O
-	O
PCR	O
,	O
respectively	O
.	O

Lung	B-ANAT
fields	O
were	O
anatomically	O
divided	O
according	O
to	O
functional	O
bronchial	B-ANAT
divisions	O
in	O
ten	O
segments	O
on	O
each	O
side	O
.	O

TITLE	O
:	O
Skin	B-ANAT
necrosis	O
after	O
extravasation	O
of	O
low	O
-	O
dose	O
vasopressin	O
administered	O
for	O
septic	O
shock	O
.	O

There	O
were	O
19	O
patients	O
with	O
a	O
preoperative	O
diagnosis	O
of	O
moderate	O
or	O
severe	O
SAS	O
;	O
15	O
patients	O
received	O
continuous	O
positive	O
airway	B-ANAT
pressure	O
or	O
bilevel	O
positive	O
airway	B-ANAT
pressure	O
noninvasive	O
ventilation	O
,	O
1	O
patient	O
experienced	O
respiratory	O
arrest	O
secondary	O
to	O
intraoperative	O
propafol	O
,	O
and	O
2	O
patients	O
developed	O
postoperative	O
respiratory	O
depression	O
.	O

The	O
cell	B-ANAT
proliferation	O
response	O
detected	O
in	O
blood	B-ANAT
mirrored	O
that	O
detected	O
in	O
the	O
mesenteric	B-ANAT
lymph	I-ANAT
nodes	I-ANAT
,	O
and	O
showed	O
also	O
good	O
correlation	O
with	O
protection	O
.	O

ABSTRACT	O
:	O
Because	O
of	O
its	O
high	O
diffusing	O
capacity	O
through	O
the	O
alveolar	B-ANAT
-	O
blood	B-ANAT
barrier	O
and	O
its	O
high	O
selectivity	O
for	O
the	O
pulmonary	B-ANAT
vasculature	I-ANAT
,	O
inhaled	O
nitric	O
oxide	O
(	O
NO	O
)	O
has	O
been	O
recently	O
shown	O
to	O
be	O
a	O
viable	O
and	O
efficient	O
approach	O
to	O
restore	O
pulmonary	B-ANAT
NO	O
deficiency	O
.	O

The	O
most	O
relevant	O
applications	O
of	O
inhaled	O
NO	O
are	O
in	O
infants	O
with	O
primary	O
pulmonary	B-ANAT
hypertension	O
or	O
hypoxia	O
.	O

On	O
day	O
nine	O
,	O
alveolar	B-ANAT
ventilation	O
was	O
severely	O
compromised	O
and	O
was	O
characterized	O
by	O
hypercapnea	O
(	O
PaCO	O
(	O
2	O
)	O
136	O
mmHg	O
)	O
and	O
acidosis	O
(	O
pH	O
7	O
.	O
10	O
).	O

ABSTRACT	O
:	O
We	O
report	O
a	O
case	O
of	O
a	O
young	O
woman	O
with	O
pyrexia	O
and	O
progressive	O
lung	B-ANAT
disease	O
who	O
developed	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
required	O
prolonged	O
mechanical	O
ventilator	O
support	O
.	O

It	O
is	O
speculated	O
that	O
cysteine	O
residue	O
located	O
upstream	O
and	O
downstream	O
of	O
Cys	O
-	O
Ser	B-ANAT
-	O
Asn	O
-	O
Ala	O
-	O
Ser	B-ANAT
-	O
Cys	O
segment	O
might	O
be	O
involved	O
in	O
the	O
formation	O
of	O
loop	O
structure	O
and	O
disulfide	O
bond	O
that	O
could	O
trigger	O
important	O
epitope	O
changes	O
.	O

TITLE	O
:	O
Transfusion	O
-	O
related	O
acute	O
lung	B-ANAT
injury	O
during	O
plasma	B-ANAT
exchange	O
:	O
Suspecting	O
the	O
unsuspected	O
.	O

There	O
are	O
exceedingly	O
rare	O
reports	O
of	O
TRALI	O
during	O
plasma	B-ANAT
exchange	O
despite	O
the	O
fact	O
that	O
liters	O
of	O
plasma	B-ANAT
may	O
be	O
used	O
for	O
replacement	O
during	O
a	O
single	O
procedure	O
.	O

She	O
developed	O
severe	O
rigors	O
,	O
peripheral	O
cyanosis	O
,	O
hypoxia	O
,	O
and	O
a	O
transient	O
diffuse	O
pulmonary	B-ANAT
infiltrate	O
.	O

ABSTRACT	O
:	O
Rats	O
fed	O
either	O
a	O
cereal	O
-	O
based	O
or	O
purified	O
diet	O
of	O
variable	O
folate	O
content	O
(	O
deficient	O
,	O
replete	O
,	O
or	O
supplemented	O
)	O
inadvertently	O
were	O
infected	O
with	O
sialodacryoadenitis	O
virus	O
,	O
which	O
resulted	O
in	O
an	O
increased	O
frequency	O
of	O
hepatic	B-ANAT
mitochondrial	B-ANAT
DNA	I-ANAT
(	O
mtDNA	B-ANAT
)	O
deletions	O
that	O
persisted	O
for	O
three	O
weeks	O
after	O
the	O
period	O
of	O
acute	O
signs	O
of	O
disease	O
.	O

In	O
conclusion	O
,	O
sialodacryoadenitis	O
virus	O
infection	O
in	O
rats	O
was	O
associated	O
with	O
increased	O
frequency	O
of	O
hepatic	B-ANAT
mtDNA	B-ANAT
deletions	O
.	O

Eighty	O
-	O
eight	O
patients	O
with	O
severe	O
multiple	O
trauma	O
were	O
admitted	O
into	O
Department	O
of	O
Intensive	O
Care	O
Unit	O
(	O
ICU	O
)	O
and	O
the	O
cardiovascular	B-ANAT
,	O
respiratory	O
,	O
renal	B-ANAT
,	O
and	O
coagulation	O
functions	O
,	O
milieu	O
interieur	O
,	O
and	O
infectious	O
sources	O
were	O
monitored	O
.	O

Immune	O
function	O
examined	O
in	O
vitro	O
showed	O
recovery	O
of	O
the	O
autologous	O
immune	B-ANAT
system	I-ANAT
was	O
severely	O
impaired	O
.	O

Brain	B-ANAT
imaging	O
revealed	O
ischemic	O
lesions	O
in	O
the	O
region	O
of	O
the	O
basal	B-ANAT
ganglia	I-ANAT
.	O

Sepsis	O
was	O
induced	O
by	O
cecal	B-ANAT
ligation	O
and	O
puncture	O
(	O
CLP	O
)	O
20	O
h	O
after	O
resuscitation	O
.	O

Because	O
enhanced	O
release	O
of	O
inflammatory	O
mediators	O
by	O
AMPhi	O
may	O
contribute	O
to	O
ARDS	O
after	O
severe	O
trauma	O
,	O
inhibition	O
of	O
intracellular	B-ANAT
signaling	O
pathways	O
represents	O
a	O
target	O
to	O
attenuate	O
organ	B-ANAT
injury	O
under	O
those	O
conditions	O
.	O

TITLE	O
:	O
Optic	B-ANAT
neuromyelitis	O
syndrome	O
in	O
Brazilian	O
patients	O
.	O

ABSTRACT	O
:	O
To	O
report	O
the	O
clinical	O
features	O
and	O
outcome	O
of	O
24	O
Brazilian	O
patients	O
with	O
optic	B-ANAT
neuromyelitis	O
syndrome	O
(	O
ONM	O
);	O
discuss	O
the	O
underlying	O
pathological	O
events	O
associated	O
with	O
the	O
ONM	O
syndrome	O
;	O
review	O
the	O
nosological	O
situation	O
of	O
ONM	O
in	O
the	O
group	O
of	O
inflammatory	O
and	O
demyelinating	O
diseases	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
.	O

Demographic	O
,	O
clinical	O
,	O
magnetic	O
resonance	O
imaging	O
,	O
cerebrospinal	B-ANAT
fluid	I-ANAT
,	O
and	O
pathological	O
data	O
were	O
analysed	O
.	O

Normal	O
cerebrospinal	B-ANAT
fluid	I-ANAT
was	O
found	O
in	O
52	O
%	O
and	O
an	O
inflammatory	O
profile	O
in	O
48	O
%.	O

We	O
report	O
on	O
the	O
intensive	O
care	O
treatment	O
of	O
a	O
young	O
man	O
who	O
suffered	O
severe	O
brain	B-ANAT
injury	O
(	O
Glasgow	O
Coma	O
Scale	O
=	O
3	O
)	O
due	O
to	O
a	O
traffic	O
accident	O
and	O
simultaneously	O
developed	O
ARDS	O
from	O
the	O
aspiration	O
of	O
gastric	B-ANAT
content	I-ANAT
.	O

However	O
,	O
tubular	B-ANAT
cells	I-ANAT
of	O
the	O
kidney	B-ANAT
showed	O
multifocal	O
positive	O
staining	O
with	O
the	O
Wolgemuth	O
strain	O
-,	O
Gray	O
strain	O
-,	O
JMK	O
strain	O
-,	O
and	O
Mass41	O
strain	O
-	O
infected	O
chickens	O
.	O

The	O
results	O
demonstrated	O
strict	O
epitheliotropic	O
nature	O
and	O
wide	O
tissue	B-ANAT
tropism	O
of	O
strains	O
of	O
IBV	O
in	O
the	O
chicken	O
embryo	B-ANAT
and	O
the	O
universality	O
of	O
our	O
riboprobe	O
.	O

Surprisingly	O
,	O
in	O
both	O
models	O
,	O
oligodendrocyte	B-ANAT
repopulation	O
of	O
demyelinated	O
white	B-ANAT
matter	I-ANAT
was	O
significantly	O
increased	O
in	O
FGF2	O
-/-	O
mice	O
compared	O
with	O
wild	O
-	O
type	O
mice	O
and	O
even	O
surpassed	O
the	O
oligodendrocyte	B-ANAT
density	O
of	O
nonlesioned	O
mice	O
.	O

This	O
dramatic	O
result	O
indicated	O
that	O
the	O
absence	O
of	O
FGF2	O
promoted	O
oligodendrocyte	B-ANAT
regeneration	O
,	O
possibly	O
by	O
enhancing	O
oligodendrocyte	B-ANAT
progenitor	O
proliferation	O
and	O
/	O
or	O
differentiation	O
.	O

FGF2	O
-/-	O
and	O
+/+	O
mice	O
had	O
similar	O
oligodendrocyte	B-ANAT
progenitor	O
densities	O
in	O
normal	O
adult	O
CNS	B-ANAT
,	O
as	O
well	O
as	O
similar	O
progenitor	O
proliferation	O
and	O
accumulation	O
during	O
demyelination	O
.	O

Elevating	O
FGF2	O
favored	O
progenitor	O
proliferation	O
,	O
whereas	O
attenuating	O
endogenous	O
FGF2	O
activity	O
promoted	O
the	O
differentiation	O
of	O
progenitors	O
into	O
oligodendrocytes	B-ANAT
.	O

ABSTRACT	O
:	O
Activated	O
neutrophils	B-ANAT
are	O
presumed	O
to	O
injure	O
pulmonary	B-ANAT
endothelium	B-ANAT
by	O
releasing	O
oxygen	O
radicals	O
,	O
proteases	O
,	O
and	O
proinflammatory	O
cytokines	O
.	O

Immunofluorescence	O
microscopy	O
(	O
IF	O
)	O
showed	O
strong	O
deposition	O
of	O
C3	O
and	O
reduced	O
deposition	O
of	O
IgA	O
.	O
Electron	O
microscopy	O
showed	O
a	O
so	O
-	O
called	O
""""	O
hump	O
""""	O
on	O
the	O
epithelial	O
side	O
of	O
the	O
glomerular	B-ANAT
basement	I-ANAT
membrane	I-ANAT
.	O

This	O
pathological	O
process	O
is	O
primarily	O
T	B-ANAT
cell	I-ANAT
-	O
mediated	O
and	O
MHV	O
infection	O
of	O
mice	O
lacking	O
B	O
and	O
T	B-ANAT
cells	I-ANAT
does	O
not	O
result	O
in	O
demyelination	O
.	O

These	O
results	O
show	O
,	O
for	O
the	O
first	O
time	O
,	O
that	O
gamma	O
delta	O
T	B-ANAT
cells	I-ANAT
can	O
substitute	O
for	O
alpha	O
beta	O
T	B-ANAT
cells	I-ANAT
in	O
a	O
virus	O
model	O
of	O
demyelination	O
and	O
further	O
support	O
a	O
pathological	O
role	O
for	O
gamma	O
delta	O
T	B-ANAT
cells	I-ANAT
in	O
patients	O
with	O
multiple	O
sclerosis	O
.	O

TITLE	O
:	O
Amyloid	O
associated	O
with	O
elastin	O
-	O
staining	O
laminar	O
aggregates	O
in	O
the	O
lungs	B-ANAT
of	O
patients	O
diagnosed	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Remarkably	O
,	O
most	O
of	O
the	O
postmortem	O
lungs	B-ANAT
with	O
ELS	O
exhibited	O
no	O
significant	O
acute	O
inflammatory	O
cellular	B-ANAT
response	O
such	O
as	O
neutrophilic	O
reaction	O
,	O
and	O
little	O
evidence	O
of	O
widespread	O
edema	O
except	O
for	O
focal	O
intra	O
-	O
alveolar	B-ANAT
hemorrhage	O
.	O

Postmortem	O
lungs	B-ANAT
that	O
exhibit	O
the	O
ELS	O
constitute	O
a	O
morphologically	O
-	O
identifiable	O
subgroup	O
of	O
ARDS	O
cases	O
.	O

Antibody	O
-	O
coated	O
BEV	O
was	O
eliminated	O
to	O
below	O
detection	O
limit	O
by	O
the	O
50	O
-	O
nm	O
filters	O
(	O
logarithmic	O
reduction	O
factors	O
[	O
LRF	O
]	O
>	O
or	O
=	O
5	O
),	O
while	O
free	O
BEV	O
virions	B-ANAT
passed	O
without	O
restraint	O
through	O
the	O
same	O
filters	O
.	O

These	O
results	O
indicate	O
that	O
viruses	O
with	O
bound	O
antibodies	O
are	O
efficiently	O
eliminated	O
by	O
nanofiltration	O
by	O
use	O
of	O
filters	O
having	O
nominal	O
pore	B-ANAT
sizes	O
larger	O
than	O
the	O
diameter	O
of	O
the	O
respective	O
free	O
virions	B-ANAT
.	O

CONCLUSIONS	O
:	O
These	O
results	O
indicate	O
that	O
viruses	O
with	O
bound	O
antibodies	O
are	O
efficiently	O
eliminated	O
by	O
nanofiltration	O
by	O
use	O
of	O
filters	O
having	O
nominal	O
pore	B-ANAT
sizes	O
larger	O
than	O
the	O
diameter	O
of	O
the	O
respective	O
free	O
virions	B-ANAT
.	O

To	O
risk	O
-	O
adjust	O
patients	O
with	O
longer	O
,	O
more	O
severe	O
illnesses	O
like	O
sepsis	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
several	O
models	O
of	O
organ	B-ANAT
dysfunction	O
or	O
failure	O
have	O
become	O
available	O
,	O
including	O
the	O
Multiple	O
Organ	B-ANAT
Dysfunction	O
Score	O
(	O
MODS	O
),	O
the	O
Sequential	O
Organ	B-ANAT
Failure	O
Assessment	O
(	O
SOFA	O
),	O
and	O
the	O
Logistic	O
Organ	B-ANAT
Dysfunction	O
Score	O
(	O
LODS	O
).	O

The	O
disease	O
appeared	O
in	O
the	O
region	O
in	O
1994	O
,	O
associated	O
with	O
production	O
problems	O
among	O
layers	B-ANAT
of	O
various	O
ages	O
.	O

We	O
detected	O
TdT	O
-	O
mediated	O
dUTP	O
nick	O
-	O
end	O
labeling	O
(	O
TUNEL	O
)	O
staining	O
in	O
the	O
livers	B-ANAT
and	O
meninges	B-ANAT
of	O
MHV	O
-	O
A59	O
-,	O
MHV	O
-	O
2	O
-,	O
and	O
Penn98	O
-	O
1	O
-	O
infected	O
mice	O
.	O

At	O
1	O
month	O
,	O
TUNEL	O
staining	O
was	O
found	O
exclusively	O
in	O
areas	O
of	O
demyelination	O
in	O
the	O
spinal	B-ANAT
cord	I-ANAT
of	O
MHV	O
-	O
A59	O
-	O
infected	O
mice	O
;	O
however	O
,	O
it	O
was	O
not	O
found	O
in	O
nondemyelinated	O
mice	O
infected	O
with	O
MHV	O
-	O
2	O
or	O
Penn98	O
-	O
1	O
,	O
or	O
in	O
mock	O
-	O
infected	O
mice	O
.	O

A	O
natural	O
transmission	O
study	O
was	O
conducted	O
to	O
validate	O
that	O
positive	O
fecal	B-ANAT
RT	O
-	O
PCR	O
results	O
indicated	O
presence	O
of	O
infective	O
virus	O
.	O

Because	O
the	O
application	O
of	O
exogenous	O
surfactant	O
has	O
been	O
proposed	O
as	O
a	O
treatment	O
for	O
ARDS	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
surfactant	O
on	O
ventilation	O
-	O
induced	O
release	O
of	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
),	O
interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
)	O
and	O
6	O
-	O
keto	O
-	O
PGF	O
(	O
1	O
alpha	O
)	O
(	O
the	O
stable	O
metabolite	O
of	O
prostacyclin	O
)	O
in	O
isolated	O
perfused	O
mouse	O
lungs	B-ANAT
ventilated	O
with	O
high	O
end	O
-	O
inspiratory	O
pressures	O
.	O

We	O
hypothesize	O
that	O
ventilation	O
-	O
induced	O
mediator	O
release	O
is	O
explained	O
by	O
stretching	O
of	O
lung	B-ANAT
cells	B-ANAT
,	O
which	O
is	O
reinforced	O
by	O
surfactant	O
.	O

The	O
findings	O
that	O
in	O
this	O
model	O
of	O
ventilation	O
-	O
induced	O
lung	B-ANAT
injury	O
exogenous	O
surfactant	O
at	O
the	O
same	O
time	O
improved	O
lung	B-ANAT
functions	O
and	O
enhanced	O
mediator	O
release	O
suggest	O
that	O
surfactant	O
treatment	O
may	O
prevent	O
barotrauma	O
and	O
augment	O
biotrauma	O
.	O

They	O
argued	O
that	O
""""	O
not	O
all	O
SIDS	O
victims	O
were	O
normal	O
","""	O
and	O
referred	O
to	O
their	O
hypothesis	O
that	O
SIDS	O
results	O
from	O
brain	B-ANAT
abnormalities	O
,	O
which	O
they	O
postulated	O
""""	O
to	O
originate	O
in	O
utero	B-ANAT
and	O
lead	O
to	O
sudden	O
death	O
during	O
a	O
vulnerable	O
postnatal	O
period	O
.	O

Interest	O
in	O
the	O
brainstem	B-ANAT
of	O
SIDS	O
victims	O
began	O
with	O
Naeye	O
'	O
s	O
1976	O
report	O
of	O
astrogliosis	O
in	O
50	O
%	O
of	O
all	O
victims	O
.	O

The	O
study	O
of	O
the	O
medullary	B-ANAT
serotonergic	O
network	O
by	O
Kinney	O
et	O
al	O
(	O
2001	O
)	O
revealed	O
greater	O
reductions	O
in	O
the	O
SIDS	O
victims	O
than	O
in	O
acute	O
controls	O
,	O
but	O
the	O
questions	O
of	O
cause	O
versus	O
effect	O
of	O
the	O
abnormalities	O
,	O
and	O
whether	O
they	O
occurred	O
prenatally	O
or	O
postnatally	O
,	O
remain	O
unanswered	O
.	O

Serum	B-ANAT
and	O
various	O
tissues	B-ANAT
were	O
collected	O
from	O
all	O
animals	O
and	O
assayed	O
for	O
PCV	O
,	O
porcine	O
reproductive	O
and	O
respiratory	O
syndrome	O
virus	O
(	O
PRRSV	O
),	O
porcine	O
parvovirus	O
,	O
porcine	O
enterovirus	O
types	O
1	O
-	O
3	O
,	O
swine	O
influenza	O
virus	O
,	O
porcine	O
respiratory	O
coronavirus	O
,	O
transmissible	O
gastroenteritis	O
virus	O
,	O
porcine	O
endogenous	O
retrovirus	O
,	O
porcine	O
lymphotropic	O
herpesvirus	O
type	O
1	O
,	O
and	O
bovine	O
viral	O
diarrhea	O
virus	O
.	O

Early	O
graft	B-ANAT
biopsy	O
was	O
available	O
in	O
291	O
of	O
the	O
recipients	O
following	O
transplantation	O
.	O

However	O
,	O
recipients	O
with	O
non	O
-	O
immune	O
acute	O
graft	B-ANAT
injury	O
who	O
survive	O
>	O
30	O
days	O
show	O
no	O
significant	O
difference	O
in	O
long	O
-	O
term	O
survival	O
or	O
BOS	O
-	O
free	O
time	O
compared	O
with	O
recipients	O
without	O
early	O
injury	O
.	O

This	O
observation	O
raises	O
questions	O
as	O
to	O
the	O
theory	O
of	O
generalized	O
zymogen	O
activation	O
being	O
a	O
principle	O
mechanism	O
involved	O
in	O
the	O
pathogenesis	O
of	O
distant	O
organ	B-ANAT
damage	O
in	O
acute	O
pancreatitis	O
.	O

Activation	O
of	O
the	O
mitochondria	B-ANAT
-	O
mediated	O
apoptotic	O
pathway	O
was	O
indicated	O
by	O
the	O
activation	O
of	O
caspase	O
-	O
9	O
and	O
delay	O
of	O
apoptosis	O
by	O
Bcl	O
-	O
2	O
overexpression	O
.	O

Upon	O
infection	O
of	O
cells	B-ANAT
with	O
Albany	O
4	O
followed	O
by	O
transfection	O
with	O
synthetic	O
RNA	O
transcribed	O
from	O
the	O
DI	O
-	O
like	O
cDNA	O
construct	O
,	O
recombinant	O
mouse	O
hepatitis	O
viruses	O
as	O
the	O
large	O
plaque	O
forming	O
phenotype	O
were	O
isolated	O
by	O
plaque	O
assays	O
at	O
the	O
non	O
-	O
permissive	O
temperature	O
of	O
391	O
degrees	O
C	O
.	O
By	O
RT	O
-	O
PCR	O
and	O
sequencing	O
,	O
those	O
large	O
plaque	O
phenotypes	O
were	O
confirmed	O
to	O
have	O
contained	O
the	O
thermostable	O
phenotype	O
marker	O
derived	O
from	O
the	O
transfected	O
RNA	O
,	O
demonstrating	O
that	O
recombination	O
occurred	O
between	O
the	O
Albany	O
4	O
genomic	O
RNA	O
and	O
the	O
in	O
vitro	O
RNA	O
transcripts	O
.	O

We	O
speculate	O
that	O
the	O
enhanced	O
lung	B-ANAT
recruitment	O
by	O
HFOV	O
enhances	O
the	O
effects	O
of	O
low	O
dose	O
iNO	O
on	O
gas	O
exchange	O
.	O

Main	O
causes	O
of	O
death	O
were	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
,	O
sepsis	O
,	O
and	O
septic	O
shock	O
;	O
refractory	O
hypoxemia	O
was	O
uncommon	O
.	O

Factors	O
independently	O
associated	O
with	O
mortality	O
were	O
organ	B-ANAT
dysfunctions	O
on	O
day	O
3	O
,	O
Pao2	O
/	O
Fio2	O
on	O
day	O
3	O
,	O
and	O
McCabe	O
score	O
.	O

Seven	O
days	O
after	O
the	O
last	O
passage	O
,	O
embryos	B-ANAT
were	O
harvested	O
and	O
macroscopic	O
lesions	O
in	O
all	O
organs	B-ANAT
were	O
recorded	O
.	O

Proventriculus	B-ANAT
and	O
gizzard	B-ANAT
samples	O
were	O
obtained	O
from	O
all	O
embryos	B-ANAT
and	O
routinely	O
processed	O
for	O
microscopic	O
and	O
ultrastructural	O
examinations	O
.	O

In	O
the	O
proventriculus	B-ANAT
,	O
there	O
was	O
a	O
decrease	O
in	O
the	O
gland	B-ANAT
papillary	O
branching	O
,	O
while	O
the	O
gizzard	B-ANAT
showed	O
a	O
significant	O
reduction	O
in	O
mucosa	B-ANAT
thickness	O
and	O
tubular	O
-	O
to	O
-	O
proliferative	O
-	O
cell	B-ANAT
ratio	O
,	O
as	O
well	O
as	O
an	O
absence	O
of	O
hyaline	B-ANAT
secretion	B-ANAT
in	O
the	O
lumen	B-ANAT
.	O

We	O
present	O
a	O
case	O
of	O
Gemcitabine	O
toxicity	O
in	O
a	O
patient	O
treated	O
for	O
a	O
lung	B-ANAT
cancer	O
.	O

Adoptive	O
transfer	O
of	O
CCR5	O
(+/+)-	O
derived	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
to	O
MHV	O
-	O
infected	O
RAG1	O
(-/-)	O
mice	O
resulted	O
in	O
CD4	O
(+)-	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
entry	O
into	O
the	O
CNS	B-ANAT
and	O
clearance	O
of	O
virus	O
from	O
the	O
brain	B-ANAT
.	O

Conversely	O
,	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
from	O
CCR5	O
(-/-)	O
mice	O
displayed	O
an	O
impaired	O
ability	O
to	O
traffic	O
into	O
the	O
CNS	B-ANAT
of	O
MHV	O
-	O
infected	O
RAG1	O
(-/-)	O
recipients	O
,	O
which	O
correlated	O
with	O
increased	O
viral	O
titers	O
,	O
diminished	O
macrophage	B-ANAT
accumulation	O
,	O
and	O
limited	O
demyelination	O
.	O

Thus	O
,	O
cell	B-ANAT
-	O
mediated	O
immune	O
responses	O
control	O
acute	O
infection	O
,	O
whereas	O
humoral	O
immunity	O
maintains	O
viral	O
persistence	O
.	O

A	O
chicken	O
usually	O
lays	O
about	O
280	O
eggs	O
in	O
a	O
year	O
,	O
and	O
egg	B-ANAT
yolk	B-ANAT
contains	O
100	O
-	O
150	O
mg	O
of	O
IgY	O
per	O
yolk	B-ANAT
,	O
suggesting	O
that	O
more	O
than	O
40	O
g	O
of	O
IgY	O
per	O
year	O
can	O
be	O
obtained	O
from	O
each	O
chicken	O
through	O
eggs	O
.	O

Thus	O
,	O
although	O
T	O
effector	O
function	O
is	O
somewhat	O
impaired	O
,	O
T	B-ANAT
cell	I-ANAT
immunity	O
is	O
largely	O
functional	O
in	O
the	O
absence	O
of	O
IL	O
-	O
2	O
-	O
and	O
IL	O
-	O
15	O
-	O
induced	O
signaling	O
through	O
IL	O
-	O
2Rbeta	O
.	O

1	O
)	O
Is	O
axonal	O
injury	O
exclusively	O
secondary	O
to	O
myelin	B-ANAT
damage	O
or	O
from	O
a	O
direct	O
insult	O
to	O
the	O
axon	B-ANAT
or	O
neurons	B-ANAT
(	O
axonopathy	O
)?	O

The	O
former	O
is	O
raised	O
from	O
the	O
fact	O
that	O
axonal	O
damage	O
has	O
been	O
reported	O
in	O
several	O
virus	O
infections	O
,	O
including	O
human	O
immunodeficiency	O
virus	O
,	O
human	O
T	O
-	O
lymphotropic	O
virus	O
1	O
,	O
herpes	O
simplex	B-ANAT
virus	O
and	O
coronavirus	O
,	O
which	O
also	O
cause	O
demyelination	O
.	O

The	O
initial	O
scale	O
is	O
selected	O
according	O
to	O
the	O
patient	O
'	O
s	O
current	O
subcutaneous	O
insulin	O
dose	O
and	O
advanced	O
if	O
the	O
blood	B-ANAT
glucose	O
is	O
>	O
or	O
=	O
10	O
.	O
1	O
mmol	O
/	O
l	O
for	O
2	O
consecutive	O
hours	O
.	O

Activated	O
STAT1	O
alpha	O
/	O
beta	O
and	O
STAT3	O
alpha	O
/	O
beta	O
ratio	O
in	O
liver	B-ANAT
were	O
similar	O
in	O
resistant	O
and	O
sensitive	O
mouse	O
strains	O
.	O

In	O
the	O
DIC	O
patients	O
,	O
higher	O
DIC	O
scores	O
,	O
lower	O
platelet	B-ANAT
counts	O
,	O
and	O
a	O
longer	O
duration	O
of	O
SIRS	O
were	O
found	O
compared	O
with	O
the	O
non	O
-	O
DIC	O
patients	O
.	O

To	O
investigate	O
signals	O
that	O
regulate	O
OP	O
proliferation	O
in	O
response	O
to	O
demyelination	O
we	O
used	O
murine	O
hepatitis	O
virus	O
-	O
A59	O
(	O
MHV	O
-	O
A59	O
)	O
infection	O
of	O
adult	O
mice	O
to	O
induce	O
focal	O
demyelination	O
throughout	O
the	O
spinal	B-ANAT
cord	I-ANAT
followed	O
by	O
spontaneous	O
remyelination	O
.	O

TITLE	O
:	O
In	O
vivo	O
thymulin	O
treatments	O
enhance	O
avian	O
lung	B-ANAT
natural	B-ANAT
killer	I-ANAT
cell	I-ANAT
cytotoxicity	O
in	O
response	O
to	O
infectious	O
bronchitis	O
virus	O
.	O

Undiluted	O
pulmonary	B-ANAT
edema	O
fluid	O
and	O
plasma	B-ANAT
samples	O
were	O
collected	O
within	O
24	O
hrs	O
of	O
endotracheal	O
intubation	O
in	O
all	O
patients	O
.	O

Severe	O
lung	B-ANAT
injury	O
was	O
induced	O
by	O
repeated	O
saline	O
lung	B-ANAT
lavage	O
.	O

After	O
stabilization	O
,	O
high	O
-	O
frequency	O
oscillation	O
was	O
initiated	O
at	O
a	O
mean	O
airway	B-ANAT
pressure	O
equal	O
to	O
the	O
point	O
of	O
maximum	O
curvature	O
on	O
the	O
deflation	O
limb	B-ANAT
of	O
the	O
pressure	O
-	O
volume	O
curve	O
(	O
26	O
+/-	O

ABSTRACT	O
:	O
Mechanical	O
ventilation	O
is	O
a	O
supportive	O
lifesaving	O
therapy	O
that	O
can	O
potentially	O
cause	O
lung	B-ANAT
injury	O
if	O
periodic	O
alveolar	B-ANAT
overdistension	O
,	O
or	O
cyclic	O
collapse	O
,	O
and	O
reopening	O
occur	O
.	O

Experimental	O
studies	O
have	O
shown	O
that	O
the	O
use	O
of	O
selective	O
tracheal	O
gas	O
insufflation	O
and	O
partial	O
liquid	O
ventilation	O
facilitates	O
low	O
tidal	O
volume	O
with	O
appropriate	O
gas	O
exchange	O
while	O
reducing	O
cyclic	O
lung	B-ANAT
stretch	O
and	O
shear	O
stresses	O
.	O

TITLE	O
:	O
Kinetics	O
of	O
virus	O
-	O
specific	O
CD8	O
+	O
-	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
expansion	O
and	O
trafficking	O
following	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
infection	O
.	O

ABSTRACT	O
:	O
During	O
sepsis	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
the	O
hypothalamic	B-ANAT
pituitary	I-ANAT
adrenal	I-ANAT
axis	I-ANAT
is	O
rapidly	O
activated	O
through	O
a	O
systemic	O
pathway	O
,	O
i	O
.	O
e	O
.	O
by	O
circulating	O
pro	O
-	O
inflammatory	O
cytokines	O
and	O
through	O
the	O
vagus	B-ANAT
nerve	I-ANAT
.	O

Subsequently	O
,	O
the	O
adrenal	B-ANAT
glands	I-ANAT
release	O
cortisol	O
,	O
a	O
hormone	O
which	O
will	O
likely	O
counteract	O
the	O
inflammatory	O
process	O
and	O
restore	O
cardiovascular	B-ANAT
homeostasis	O
.	O

These	O
trials	O
showed	O
consistently	O
that	O
,	O
in	O
these	O
patients	O
,	O
the	O
use	O
of	O
low	O
dose	O
of	O
corticosteroids	O
alleviated	O
inflammation	O
,	O
restored	O
cardiovascular	B-ANAT
homeostasis	O
,	O
reduced	O
organ	B-ANAT
dysfunction	O
,	O
improved	O
survival	O
and	O
was	O
safe	O
.	O

However	O
,	O
use	O
of	O
this	O
technique	O
has	O
adverse	O
effects	O
,	O
including	O
increased	O
risk	O
of	O
pneumonia	O
,	O
impaired	O
cardiac	B-ANAT
performance	O
,	O
and	O
difficulties	O
associated	O
with	O
sedation	O
and	O
paralysis	O
.	O

Moreover	O
,	O
application	O
of	O
pressure	O
to	O
the	O
lung	B-ANAT
,	O
whether	O
positive	O
or	O
negative	O
,	O
can	O
cause	O
damage	O
known	O
as	O
ventilator	O
-	O
associated	O
lung	B-ANAT
injury	O
(	O
VALI	O
).	O

Here	O
,	O
we	O
outline	O
the	O
effects	O
of	O
mechanical	O
ventilation	O
on	O
injured	O
lungs	B-ANAT
and	O
explore	O
the	O
underlying	O
mechanisms	O
.	O

Clinically	O
,	O
it	O
is	O
characterized	O
by	O
dyspnea	O
,	O
profound	O
hypoxemia	O
,	O
decreased	O
lung	B-ANAT
compliance	O
,	O
and	O
diffuse	O
bilateral	O
infiltrates	O
on	O
chest	B-ANAT
radiography	O
.	O

PEDV	O
and	O
TGEV	O
cDNAs	O
were	O
detected	O
in	O
jejunal	B-ANAT
tissues	B-ANAT
from	O
experimentally	O
and	O
naturally	O
infected	O
pigs	O
by	O
multiplex	O
RT	O
-	O
nPCR	O
.	O

Distinct	O
positive	O
signals	O
for	O
PEDV	O
and	O
TGEV	O
were	O
also	O
detected	O
in	O
the	O
same	O
jejunal	B-ANAT
tissues	B-ANAT
by	O
in	O
situ	O
hybridization	O
.	O

17	O
.	O
5	O
yrs	O
,	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
II	O
score	O
of	O
28	O
.	O
6	O
+/-	O
7	O
.	O
1	O
)	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
lung	B-ANAT
injury	O
score	O
,	O
3	O
.	O
5	O
+/-	O
0	O
.	O
4	O
)	O
with	O
Fio2	O
of	O
>	O
or	O
=	O
0	O
.	O
6	O
and	O
mean	O
airway	B-ANAT
pressure	O
of	O
>	O
or	O
=	O
28	O
cm	O
H2O	O
.	O

TITLE	O
:	O
Nucleocapsid	B-ANAT
-	O
independent	O
specific	O
viral	O
RNA	O
packaging	O
via	O
viral	B-ANAT
envelope	I-ANAT
protein	O
and	O
viral	O
RNA	O
signal	O
.	O

In	O
this	O
report	O
we	O
show	O
that	O
expressed	O
coronavirus	O
envelope	B-ANAT
protein	O
M	O
specifically	O
interacted	O
with	O
coexpressed	O
noncoronavirus	O
RNA	O
transcripts	O
containing	O
the	O
short	O
viral	O
packaging	O
signal	O
in	O
the	O
absence	O
of	O
coronavirus	O
N	O
protein	O
.	O

Children	O
after	O
the	O
44th	O
postconceptional	O
week	O
and	O
under	O
14	O
years	O
old	O
,	O
admitted	O
for	O
at	O
least	O
4	O
h	O
,	O
ventilated	O
for	O
12	O
-	O
120	O
h	O
,	O
and	O
without	O
heart	B-ANAT
failure	O
or	O
chronic	O
lung	B-ANAT
disease	O
.	O

Residual	O
sera	B-ANAT
samples	O
from	O
200	O
persons	O
(	O
100	O
men	O
and	O
100	O
women	O
)	O
aged	O
50	O
years	O
or	O
older	O
,	O
randomly	O
selected	O
from	O
a	O
larger	O
population	O
-	O
based	O
survey	O
on	O
cardiovascular	B-ANAT
diseases	O
,	O
were	O
tested	O
for	O
antibodies	O
against	O
HHV8	O
.	O

ABSTRACT	O
:	O
An	O
indirect	O
liquid	O
-	O
phase	O
blocking	O
(	O
LPB	O
)	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
using	O
chicken	O
and	O
rabbit	O
affinity	O
purified	O
immunoglobulin	O
G	O
(	O
IgG	O
)	O
has	O
been	O
developed	O
to	O
detect	O
and	O
estimate	O
avian	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
antigen	O
concentration	O
directly	O
in	O
infected	O
allantoic	B-ANAT
fluid	I-ANAT
.	O

In	O
uninfected	O
macrophages	B-ANAT
and	O
macrophages	B-ANAT
infected	O
with	O
MHV	O
-	O
2	O
,	O
an	O
unidentified	O
protein	O
occupies	O
the	O
HNF4	O
cis	O
-	O
element	O
.	O

TITLE	O
:	O
Plastic	O
bronchitis	O
mimicking	O
foreign	O
body	B-ANAT
aspiration	O
that	O
needs	O
a	O
specific	O
diagnostic	O
procedure	O
.	O

ABSTRACT	O
:	O
Anemia	O
is	O
a	O
major	O
cause	O
of	O
morbidity	O
and	O
mortality	O
among	O
patients	O
with	O
sickle	B-ANAT
cell	I-ANAT
anemia	O
.	O

Her	O
chest	B-ANAT
radiograph	O
revealed	O
consolidation	O
in	O
the	O
right	B-ANAT
lung	I-ANAT
.	O

Her	O
chest	B-ANAT
radiograph	O
showed	O
consolidation	O
in	O
the	O
left	B-ANAT
lung	I-ANAT
.	O

ABSTRACT	O
:	O
Bedside	O
evaluation	O
of	O
pulmonary	B-ANAT
mechanics	O
and	O
thoracic	B-ANAT
computed	O
axial	O
tomography	O
have	O
changed	O
the	O
ventilatory	O
management	O
of	O
patients	O
suffering	O
an	O
acute	O
respiratory	O
failure	O
caused	O
by	O
adult	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Phosphoenolpyruvate	O
(	O
PEP	O
)	O
is	O
an	O
endogenous	O
substance	O
that	O
is	O
one	O
of	O
the	O
ATP	O
precursors	O
and	O
can	O
cross	O
some	O
cell	B-ANAT
membranes	I-ANAT
via	O
anion	O
exchanger	O
.	O

The	O
combination	O
of	O
PEP	O
with	O
ATP	O
(	O
4	O
micromol	O
/	O
kg	O
)	O
showed	O
no	O
additional	O
inhibitory	O
effect	O
on	O
oleic	O
acid	O
-	O
induced	O
lung	B-ANAT
injury	O
,	O
compared	O
with	O
PEP	O
alone	O
.	O

TITLE	O
:	O
Regional	O
and	O
systemic	O
cytokine	O
responses	O
to	O
acute	O
inflammation	O
of	O
the	O
vermiform	B-ANAT
appendix	I-ANAT
.	O

In	O
contrast	O
,	O
IL	O
-	O
6	O
and	O
IL	O
-	O
1	O
receptor	O
antagonist	O
(	O
IL	O
-	O
1ra	O
)	O
were	O
the	O
most	O
abundant	O
cytokines	O
in	O
the	O
PF	O
and	O
plasma	B-ANAT
,	O
and	O
the	O
concentrations	O
of	O
IL	O
-	O
4	O
and	O
IL	O
-	O
10	O
were	O
also	O
elevated	O
in	O
both	O
compartments	B-ANAT
.	O

RESULTS	O
:	O
Of	O
the	O
proinflammatory	O
cytokines	O
,	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
was	O
present	O
in	O
PF	O
but	O
not	O
in	O
plasma	B-ANAT
,	O
interleukin	O
(	O
IL	O
)-	O
1beta	O
and	O
interferon	O
-	O
gamma	O
were	O
found	O
in	O
low	O
concentrations	O
in	O
both	O
PF	O
and	O
plasma	B-ANAT
,	O
and	O
IL	O
-	O
12	O
(	O
p70	O
)	O
was	O
detectable	O
in	O
plasma	B-ANAT
but	O
not	O
PF	O
.	O

TITLE	O
:	O
Early	O
alterations	O
in	O
neutrophil	B-ANAT
activation	O
are	O
associated	O
with	O
outcome	O
in	O
acute	O
lung	B-ANAT
injury	O
.	O

Differential	O
susceptibility	O
of	O
infected	O
cell	B-ANAT
types	O
to	O
clearance	O
by	O
perforin	O
or	O
IFN	O
-	O
gamma	O
uncovered	O
distinct	O
,	O
nonredundant	O
roles	O
for	O
these	O
antiviral	O
mechanisms	O
.	O

To	O
separately	O
evaluate	O
each	O
effector	O
function	O
specifically	O
in	O
the	O
context	O
of	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
,	O
pathogenesis	O
was	O
analyzed	O
in	O
mice	O
deficient	O
in	O
both	O
perforin	O
and	O
IFN	O
-	O
gamma	O
(	O
PKO	O
/	O
GKO	O
)	O
or	O
selectively	O
reconstituted	O
for	O
each	O
function	O
by	O
transfer	O
of	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
.	O

Untreated	O
PKO	O
/	O
GKO	O
mice	O
were	O
unable	O
to	O
control	O
the	O
infection	O
and	O
died	O
of	O
lethal	O
encephalomyelitis	O
within	O
16	O
days	O
,	O
despite	O
substantially	O
higher	O
CD8	O
(+)	O
T	B-ANAT
cell	I-ANAT
accumulation	O
in	O
the	O
CNS	B-ANAT
compared	O
with	O
controls	O
.	O

CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
from	O
perforin	O
-	O
deficient	O
and	O
wild	O
-	O
type	O
donors	O
reduced	O
virus	O
replication	O
in	O
PKO	O
/	O
GKO	O
recipients	O
.	O

However	O
,	O
the	O
effects	O
of	O
chronic	O
alcohol	O
abuse	O
on	O
acute	O
lung	B-ANAT
injury	O
and	O
nonpulmonary	O
organ	B-ANAT
dysfunction	O
are	O
relatively	O
unexplored	O
.	O

After	O
adjusting	O
for	O
differences	O
in	O
the	O
source	O
of	O
infection	O
,	O
sex	O
,	O
age	O
,	O
chronic	O
hepatic	B-ANAT
dysfunction	O
,	O
diabetes	O
,	O
severity	O
of	O
illness	O
,	O
nutritional	O
status	O
,	O
and	O
smoking	O
status	O
,	O
the	O
effects	O
of	O
chronic	O
alcohol	O
abuse	O
on	O
the	O
incidence	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
remained	O
significant	O
(	O
p	O
<	O
.	O
001	O
;	O
odds	O
ratio	O
,	O
3	O
.	O
70	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
1	O
.	O
83	O
-	O
7	O
.	O
71	O
).	O

Based	O
on	O
the	O
highest	O
daily	O
Sequential	O
Organ	B-ANAT
Failure	O
Assessment	O
score	O
,	O
patients	O
with	O
a	O
history	O
of	O
chronic	O
alcohol	O
abuse	O
had	O
more	O
severe	O
nonpulmonary	O
organ	B-ANAT
dysfunction	O
when	O
compared	O
with	O
nonalcoholics	O
(	O
9	O
.	O
42	O
+/-	O

TITLE	O
:	O
Lethal	O
systemic	B-ANAT
capillary	I-ANAT
leak	O
syndrome	O
associated	O
with	O
severe	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
:	O
an	O
experimental	O
study	O
.	O

When	O
total	O
static	O
lung	B-ANAT
compliance	O
decreased	O
to	O
0	O
.	O
15	O
mL	O
(	O
cm	O
H2O	O
)(-	O
1	O
)	O
x	O
kg	O
(-	O
1	O
)	O
(	O
7	O
-	O
30	O
hrs	O
),	O
the	O
sheep	O
were	O
randomized	O
to	O
two	O
groups	O
.	O

The	O
major	O
complications	O
after	O
pulmonary	B-ANAT
thromboendarterectomy	O
(	O
PTE	O
)	O
for	O
CPTE	O
are	O
:	O
reperfusion	O
pulmonary	B-ANAT
edema	O
(	O
RPE	B-ANAT
),	O
pulmonary	B-ANAT
hypertension	O
(	O
PH	O
),	O
hypoxia	O
and	O
bronchial	B-ANAT
bleeding	O
,	O
all	O
of	O
which	O
the	O
patient	O
has	O
demonstrated	O
.	O

Viral	O
distribution	O
in	O
tissues	B-ANAT
of	O
susceptible	O
S	O
and	O
resistant	O
W	O
chicks	O
did	O
not	O
differ	O
,	O
and	O
virus	O
was	O
present	O
in	O
the	O
trachea	B-ANAT
,	O
lung	B-ANAT
and	O
kidney	B-ANAT
of	O
chicks	O
from	O
both	O
lines	O
throughout	O
the	O
acute	O
phase	O
(	O
between	O
days	O
3	O
and	O
7	O
)	O
of	O
infection	O
.	O

These	O
results	O
suggest	O
that	O
CCL3	O
not	O
only	O
mediates	O
macrophage	B-ANAT
chemotaxis	O
but	O
also	O
significantly	O
enhances	O
differentiation	O
of	O
primed	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
into	O
effector	O
cells	B-ANAT
and	O
their	O
release	O
into	O
circulation	O
,	O
thus	O
potentiating	O
effective	O
migration	O
to	O
the	O
site	O
of	O
infection	O
.	O

TITLE	O
:	O
Experimental	O
evaluation	O
of	O
cross	O
-	O
contamination	O
between	O
cryotubes	O
containing	O
mouse	O
2	O
-	O
cell	B-ANAT
embryos	I-ANAT
and	O
murine	O
pathogens	O
in	O
liquid	O
nitrogen	O
tanks	O
.	O

To	O
further	O
investigate	O
the	O
role	O
of	O
memory	O
T	B-ANAT
cells	I-ANAT
in	O
protection	O
,	O
T	B-ANAT
lymphocytes	I-ANAT
collected	O
from	O
B19	O
/	O
B19	O
chicken	O
spleens	B-ANAT
at	O
2	O
,	O
3	O
,	O
4	O
,	O
and	O
6	O
weeks	O
p	O
.	O
i	O
.	O

TITLE	O
:	O
Bronchiolitis	O
obliterans	O
:	O
the	O
Achilles	B-ANAT
heel	B-ANAT
of	O
lung	B-ANAT
transplantation	O
.	O

Loss	O
of	O
normal	O
protective	O
mechanisms	O
--	O
leukocyte	B-ANAT
antiproteases	O
--	O
against	O
this	O
oxidative	O
insult	O
may	O
be	O
an	O
integral	O
part	O
of	O
disease	O
progression	O
.	O

Better	O
understanding	O
of	O
the	O
pathophysiology	O
,	O
and	O
earlier	O
recognition	O
of	O
BO	O
may	O
result	O
in	O
improved	O
long	O
term	O
patient	O
and	O
graft	B-ANAT
survival	O
and	O
function	O
.	O

Samples	O
from	O
septic	O
patients	O
lacked	O
or	O
showed	O
only	O
sparse	O
immunoreaction	O
on	O
bronchial	B-ANAT
and	O
alveolar	B-ANAT
epithelium	I-ANAT
,	O
whereas	O
this	O
reaction	O
was	O
strong	O
in	O
all	O
control	O
samples	O
.	O

ABSTRACT	O
:	O
To	O
study	O
the	O
mechanism	O
of	O
direct	O
lung	B-ANAT
injury	O
by	O
seawater	O
and	O
explore	O
its	O
possible	O
management	O
.	O

Seven	O
days	O
after	O
surgical	O
recovery	O
,	O
sheep	O
were	O
given	O
a	O
burn	O
(	O
40	O
%	O
of	O
total	B-ANAT
body	I-ANAT
surface	I-ANAT
,	O
3rd	O
degree	O
)	O
and	O
insufflated	O
with	O
cotton	O
smoke	O
(	O
48	O
breaths	O
,	O
<	O
40	O
degrees	O
C	O
)	O
under	O
anesthesia	O
.	O

These	O
pathologies	O
were	O
associated	O
with	O
a	O
large	O
increase	O
in	O
tracheal	O
blood	B-ANAT
flow	O
and	O
elevated	O
plasma	B-ANAT
NO2	O
-/	O
NO3	O
-	O
(	O
NOx	O
)	O
levels	O
.	O

The	O
prone	O
position	O
is	O
recommended	O
for	O
severe	O
cases	O
of	O
ARDS	O
and	O
the	O
application	O
of	O
inhaled	O
nitric	O
oxide	O
and	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
is	O
established	O
in	O
specialized	O
centers	O
for	O
patients	O
with	O
imminent	O
hypoxia	O
.	O

Serial	O
chest	B-ANAT
radiographs	O
showed	O
progressive	O
air	O
-	O
space	O
disease	O
.	O

The	O
acute	O
colonic	B-ANAT
pseudo	O
-	O
obstruction	O
,	O
Ogilvie	O
'	O
s	O
Syndrome	O
,	O
most	O
often	O
appears	O
as	O
a	O
complication	O
of	O
other	O
clinical	O
conditions	O
.	O

This	O
case	O
shows	O
the	O
remarkable	O
regenerative	O
capacity	O
of	O
the	O
neonatal	O
liver	B-ANAT
and	O
provides	O
a	O
rationale	O
for	O
conservative	O
management	O
of	O
this	O
rare	O
but	O
morbid	O
PICC	O
complication	O
.	O

Neutrophils	B-ANAT
and	O
their	O
cytotoxic	O
products	O
,	O
including	O
oxidants	O
and	O
proteases	O
,	O
such	O
as	O
elastase	O
,	O
have	O
been	O
implicated	O
as	O
playing	O
a	O
key	O
role	O
in	O
the	O
pathophysiology	O
of	O
ARDS	O
.	O

Although	O
the	O
data	O
support	O
a	O
key	O
role	O
for	O
neutrophil	B-ANAT
elastase	O
in	O
the	O
pathogenesis	O
of	O
ARDS	O
,	O
further	O
study	O
is	O
needed	O
to	O
fully	O
define	O
the	O
actions	O
of	O
neutrophil	B-ANAT
elastase	O
,	O
and	O
how	O
these	O
actions	O
affect	O
host	O
functions	O
,	O
before	O
we	O
can	O
exploit	O
this	O
knowledge	O
for	O
therapeutic	O
benefit	O
.	O

Individuals	O
with	O
a	O
history	O
of	O
chronic	O
alcohol	O
abuse	O
have	O
decreased	O
concentrations	O
of	O
glutathione	O
in	O
the	O
epithelial	O
lining	O
fluid	O
of	O
the	O
lung	B-ANAT
,	O
which	O
do	O
not	O
significantly	O
increase	O
after	O
1	O
wk	O
of	O
abstinence	O
from	O
alcohol	O
.	O

Chronic	O
alcohol	O
abuse	O
is	O
associated	O
with	O
an	O
increased	O
incidence	O
of	O
ARDS	O
and	O
the	O
severity	O
of	O
multiple	O
organ	B-ANAT
dysfunction	O
.	O

ABSTRACT	O
:	O
To	O
review	O
the	O
involvement	O
of	O
coagulation	O
and	O
fibrinolysis	O
in	O
the	O
pathogenesis	O
of	O
acute	O
lung	B-ANAT
injury	O
during	O
severe	O
infection	O
.	O

It	O
is	O
also	O
unclear	O
whether	O
such	O
a	O
response	O
,	O
if	O
present	O
,	O
predisposes	O
patients	O
to	O
ongoing	O
lung	B-ANAT
inflammation	O
and	O
the	O
development	O
of	O
late	O
fibroproliferative	O
ARDS	O
,	O
or	O
if	O
it	O
is	O
predictive	O
of	O
a	O
beneficial	O
response	O
to	O
steroids	O
.	O

ABSTRACT	O
:	O
High	O
-	O
frequency	O
oscillatory	O
ventilation	O
(	O
HFOV	O
)	O
using	O
an	O
open	O
-	O
lung	B-ANAT
strategy	O
has	O
been	O
demonstrated	O
to	O
improve	O
oxygenation	O
in	O
neonatal	O
and	O
pediatric	O
respiratory	O
failure	O
,	O
without	O
increasing	O
barotrauma	O
.	O

ABSTRACT	O
:	O
To	O
review	O
the	O
rationale	O
for	O
evaluating	O
anticoagulant	O
therapies	O
in	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
to	O
review	O
selected	O
data	O
regarding	O
the	O
effectiveness	O
of	O
anticoagulants	O
in	O
animals	O
and	O
human	O
patients	O
with	O
ALI	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Increased	O
pulmonary	B-ANAT
vascular	B-ANAT
permeability	O
and	O
leukocyte	B-ANAT
accumulation	O
have	O
been	O
successfully	O
prevented	O
in	O
animals	O
treated	O
with	O
tissue	B-ANAT
factor	O
/	O
activated	O
factor	O
VII	O
pathway	O
inhibitor	O
.	O

In	O
humans	O
,	O
a	O
phase	O
II	O
study	O
evaluating	O
tissue	B-ANAT
factor	O
pathway	O
inhibitor	O
in	O
the	O
treatment	O
of	O
severe	O
sepsis	O
suggested	O
that	O
lung	B-ANAT
function	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
was	O
improved	O
.	O

TITLE	O
:	O
Selective	O
pulmonary	B-ANAT
vasodilation	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
characterized	O
by	O
a	O
marked	O
maldistribution	O
of	O
pulmonary	B-ANAT
perfusion	O
in	O
favor	O
of	O
nonventilated	O
,	O
atelectatic	O
areas	O
of	O
the	O
lungs	B-ANAT
,	O
and	O
it	O
is	O
the	O
main	O
cause	O
of	O
pulmonary	B-ANAT
right	O
-	O
to	O
-	O
left	O
shunting	O
and	O
hypoxemia	O
.	O

Therapeutic	O
interventions	O
to	O
selectively	O
influence	O
pulmonary	B-ANAT
perfusion	O
in	O
ARDS	O
became	O
feasible	O
with	O
the	O
introduction	O
of	O
inhaled	O
nitric	O
oxide	O
,	O
which	O
provided	O
a	O
means	O
not	O
only	O
to	O
reduce	O
pulmonary	B-ANAT
hypertension	O
,	O
but	O
also	O
to	O
improve	O
matching	O
of	O
ventilation	O
to	O
perfusion	O
and	O
,	O
thus	O
,	O
hypoxemia	O
.	O

Clinical	O
studies	O
in	O
ARDS	O
subsequently	O
demonstrated	O
that	O
the	O
combination	O
of	O
inhaled	O
nitric	O
oxide	O
with	O
other	O
interventions	O
,	O
such	O
as	O
positive	O
end	O
-	O
expiratory	O
pressure	O
and	O
prone	O
positioning	O
,	O
yielded	O
beneficial	O
and	O
additive	O
effects	O
on	O
arterial	B-ANAT
oxygenation	O
.	O

This	O
study	O
shows	O
that	O
an	O
outbreak	O
of	O
HCoV	O
OC43	O
respiratory	O
infection	O
was	O
responsible	O
for	O
the	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
symptoms	O
observed	O
in	O
nearly	O
one	O
-	O
third	O
of	O
patients	O
identified	O
by	O
active	O
surveillance	O
for	O
coronavirus	O
infection	O
.	O

Cytopathological	O
features	O
were	O
noted	O
in	O
Vero	O
E6	O
cells	B-ANAT
inoculated	O
with	O
a	O
throat	B-ANAT
-	O
swab	O
specimen	O
.	O

Recent	O
evidence	O
suggests	O
that	O
cross	O
-	O
reactivity	O
represents	O
the	O
inherent	O
nature	O
of	O
the	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
repertoire	O
.	O

In	O
contrast	O
,	O
we	O
could	O
not	O
detect	O
E6	O
-	O
reactive	O
T	B-ANAT
cells	I-ANAT
in	O
healthy	O
individuals	O
.	O

Fecal	B-ANAT
samples	O
collected	O
on	O
days	O
0	O
,	O
4	O
,	O
14	O
,	O
and	O
35	O
after	O
arrival	O
were	O
tested	O
for	O
BoTV	O
by	O
use	O
of	O
ELISA	O
and	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
assay	O
.	O

Changes	O
in	O
lung	B-ANAT
tissue	I-ANAT
suggest	O
that	O
part	O
of	O
the	O
lung	B-ANAT
damage	O
is	O
due	O
to	O
cytokines	O
induced	O
by	O
the	O
microbial	O
agent	O
,	O
which	O
has	O
led	O
to	O
empirical	O
treatment	O
with	O
corticosteroids	O
,	O
broad	O
spectrum	O
antiviral	O
agent	O
,	O
and	O
antibacterial	O
cover	O
.	O

The	O
recombinant	O
TGEV	O
(	O
rTGEV	O
)	O
replicated	O
in	O
cell	B-ANAT
culture	O
with	O
similar	O
efficiency	O
to	O
the	O
wild	O
-	O
type	O
virus	O
and	O
stably	O
maintained	O
the	O
modifications	O
introduced	O
into	O
the	O
genome	O
.	O

Patients	O
were	O
then	O
stratified	O
according	O
to	O
the	O
severity	O
of	O
head	B-ANAT
injury	O
on	O
the	O
basis	O
of	O
admission	O
Glasgow	O
Coma	O
Scale	O
(	O
GCS	O
)	O
score	O
into	O
three	O
groups	O
:	O
group	O
1	O
,	O
GCS	O
score	O
of	O
13	O
to	O
15	O
(	O
788	O
female	O
patients	O
,	O
769	O
male	O
patients	O
);	O
group	O
2	O
,	O
GCS	O
score	O
of	O
9	O
to	O
12	O
(	O
40	O
female	O
patients	O
,	O
42	O
male	O
patients	O
);	O
and	O
group	O
3	O
,	O
GCS	O
score	O
<	O
9	O
(	O
63	O
female	O
patients	O
,	O
87	O
male	O
patients	O
).	O

This	O
patient	O
could	O
tolerate	O
the	O
transplant	B-ANAT
conditioning	O
regimen	O
commonly	O
used	O
in	O
patients	O
without	O
DS	O
.	O

TCV	O
infection	O
was	O
detected	O
in	O
turkeys	O
placed	O
in	O
contact	O
with	O
TCV	O
-	O
exposed	O
flies	O
at	O
densities	O
as	O
low	O
as	O
one	O
fly	O
/	O
bird	O
(	O
TCV	O
antigens	O
detected	O
at	O
3	O
days	O
post	O
fly	O
contact	O
in	O
tissues	B-ANAT
of	O
3	O
/	O
12	O
turkeys	O
);	O
however	O
,	O
increased	O
rates	O
of	O
infection	O
were	O
observed	O
with	O
higher	O
fly	O
densities	O
(	O
TCV	O
antigens	O
detected	O
in	O
9	O
/	O
12	O
turkeys	O
after	O
contact	O
with	O
10	O
flies	O
/	O
bird	O
).	O

These	O
results	O
show	O
that	O
blockade	O
of	O
coagulation	O
attenuates	O
acute	O
lung	B-ANAT
and	O
renal	B-ANAT
injury	O
in	O
established	O
Gram	O
-	O
negative	O
sepsis	O
accompanied	O
by	O
antiinflammatory	O
effects	O
of	O
therapy	O
.	O

Enteroviral	O
infection	O
may	O
play	O
an	O
important	O
role	O
in	O
coronary	B-ANAT
plaque	O
instability	O
and	O
may	O
precipitate	O
thrombotic	O
occlusion	O
.	O

In	O
addition	O
,	O
following	O
infection	O
of	O
10	O
-	O
day	O
-	O
old	O
chicken	O
embryos	B-ANAT
with	O
IBV	O
containing	O
D	O
-	O
RNAs	O
expressing	O
chIFN	O
-	O
gamma	O
,	O
the	O
allantoic	B-ANAT
fluid	I-ANAT
was	O
shown	O
to	O
contain	O
biologically	O
active	O
chIFN	O
-	O
gamma	O
,	O
demonstrating	O
that	O
IBV	O
D	O
-	O
RNAs	O
can	O
express	O
heterologous	O
genes	O
in	O
vivo	O
.	O

In	O
addition	O
to	O
the	O
standard	O
atropine	O
/	O
oxime	O
regimen	O
,	O
continuous	O
venous	B-ANAT
-	O
venous	B-ANAT
haemofiltration	O
(	O
CVVH	O
)	O
therapy	O
was	O
started	O
;	O
the	O
patient	O
survived	O
this	O
intoxication	O
.	O

TITLE	O
:	O
[	O
Acute	O
intra	O
-	O
abdominal	B-ANAT
hypertension	O
and	O
""""	O
abdominal	B-ANAT
compartment	I-ANAT
syndrome	O
"""]."	O

In	O
summary	O
,	O
BoTV	O
was	O
detected	O
in	O
fecal	B-ANAT
samples	O
from	O
cattle	O
with	O
diarrhea	O
,	O
principally	O
in	O
young	O
calves	O
less	O
than	O
3	O
weeks	O
of	O
age	O
.	O

However	O
,	O
the	O
trachea	B-ANAT
was	O
too	O
stenotic	O
to	O
place	O
the	O
tube	O
in	O
the	O
proper	O
position	O
.	O

Chest	B-ANAT
X	O
-	O
ray	O
immediately	O
after	O
the	O
operation	O
did	O
not	O
show	O
left	B-ANAT
lung	I-ANAT
reexpansion	O
due	O
to	O
severe	O
pulmonary	B-ANAT
edema	O
.	O

Mature	O
RCV	O
particles	O
were	O
distributed	O
around	O
the	O
ER	O
pools	O
,	O
cytoplasm	B-ANAT
,	O
and	O
intercellular	B-ANAT
space	I-ANAT
,	O
and	O
the	O
RCVs	O
in	O
the	O
endosome	B-ANAT
/	O
lysosome	B-ANAT
were	O
devoid	O
of	O
the	O
envelop	O
and	O
nuclear	O
capsid	B-ANAT
.	O

Specific	O
fragments	O
were	O
amplified	O
from	O
the	O
sputum	B-ANAT
samples	O
of	O
SARS	O
patients	O
,	O
which	O
were	O
confirmed	O
by	O
DNA	O
cloning	O
and	O
sequencing	O
to	O
belong	O
to	O
SARS	O
-	O
associated	O
coronavirus	O
.	O

Specific	O
amplicons	O
can	O
be	O
amplified	O
from	O
the	O
sputum	B-ANAT
samples	O
,	O
throat	B-ANAT
swab	I-ANAT
and	O
plasma	B-ANAT
of	O
most	O
SARS	O
patients	O
,	O
and	O
8	O
were	O
random	O
selected	O
and	O
sequenced	O
.	O

ABSTRACT	O
:	O
We	O
have	O
developed	O
an	O
antegradely	O
insertable	O
aortic	B-ANAT
balloon	O
occlusion	O
catheter	O
for	O
aortic	B-ANAT
arch	I-ANAT
repair	O
,	O
and	O
review	O
our	O
experiences	O
of	O
using	O
it	O
.	O

Bovine	O
spongiform	O
encephalopathy	O
and	O
outbreaks	O
of	O
virus	O
infections	O
in	O
the	O
bioindustry	O
,	O
such	O
as	O
swine	O
fever	O
,	O
foot	B-ANAT
-	O
and	O
-	O
mouth	B-ANAT
disease	O
and	O
classical	O
avian	O
influenza	O
,	O
have	O
led	O
to	O
massive	O
killing	O
of	O
cattle	O
,	O
swine	O
and	O
fowl	O
in	O
the	O
Netherlands	O
.	O

Lower	O
lung	B-ANAT
zone	O
(	O
70	O
of	O
108	O
,	O
64	O
.	O
8	O
%)	O
and	O
right	B-ANAT
lung	I-ANAT
(	O
82	O
of	O
108	O
,	O
75	O
.	O
9	O
%)	O
were	O
more	O
commonly	O
involved	O
.	O

No	O
cavitation	O
,	O
lymphadenopathy	O
,	O
or	O
pleural	B-ANAT
effusion	I-ANAT
was	O
demonstrated	O
.	O

Stem	B-ANAT
-	O
loop	O
III	O
maps	O
at	O
nt	O
97	O
through	O
116	O
,	O
has	O
a	O
calculated	O
free	O
energy	O
of	O
-	O
9	O
.	O
1	O
kcal	O
/	O
mol	O
in	O
the	O
positive	O
strand	O
and	O
-	O
3	O
.	O
0	O
kcal	O
/	O
mol	O
in	O
the	O
negative	O
strand	O
,	O
and	O
has	O
associated	O
with	O
it	O
beginning	O
at	O
nt	O
100	O
an	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
potentially	O
encoding	O
an	O
8	O
-	O
amino	O
-	O
acid	O
peptide	O
.	O

Increased	O
use	O
of	O
granulocyte	B-ANAT
colony	O
-	O
stimulating	O
factor	O
in	O
patients	O
receiving	O
chemotherapy	O
has	O
been	O
paralleled	O
by	O
an	O
increased	O
incidence	O
of	O
bleomycin	O
-	O
induced	O
pulmonary	B-ANAT
toxicity	O
.	O

Lung	B-ANAT
morphology	O
with	O
bleomycin	O
+	O
granulocyte	B-ANAT
colony	O
-	O
stimulating	O
factor	O
showed	O
,	O
in	O
addition	O
to	O
the	O
changes	O
observed	O
with	O
bleomycin	O
alone	O
,	O
four	O
patterns	O
indicating	O
more	O
severe	O
disease	O
:	O
honeycomb	O
foci	O
,	O
pleural	O
thickening	O
with	O
hyaline	B-ANAT
fibrosis	O
,	O
interstitial	B-ANAT
granuloma	O
with	O
increased	O
number	O
of	O
macrophages	B-ANAT
but	O
not	O
neutrophils	B-ANAT
,	O
and	O
established	O
interstitial	B-ANAT
fibrosis	O
.	O

After	O
resuscitation	O
,	O
blood	B-ANAT
cytokine	O
levels	O
were	O
measured	O
.	O

In	O
the	O
hemorrhagic	O
shock	O
model	O
,	O
plasma	B-ANAT
concentrations	O
of	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
,	O
interleukin	O
-	O
6	O
,	O
and	O
macrophage	B-ANAT
inflammatory	O
protein	O
-	O
2	O
were	O
significantly	O
lower	O
and	O
interleukin	O
-	O
10	O
was	O
significantly	O
higher	O
in	O
the	O
albumin	O
-	O
treated	O
groups	O
compared	O
with	O
the	O
Ringer	O
'	O
s	O
lactate	O
-	O
treated	O
group	O
.	O

We	O
conclude	O
that	O
resuscitation	O
with	O
albumin	O
may	O
have	O
utility	O
in	O
reducing	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
after	O
hemorrhagic	O
shock	O
,	O
but	O
not	O
after	O
endotoxic	O
shock	O
.	O

These	O
results	O
suggest	O
that	O
the	O
nucleocapsid	B-ANAT
protein	O
is	O
a	O
major	O
immunogen	O
that	O
may	O
be	O
useful	O
for	O
early	O
diagnostics	O
,	O
and	O
that	O
the	O
spike	O
glycoprotein	O
may	O
present	O
a	O
particularly	O
attractive	O
target	O
for	O
prophylactic	O
intervention	O
in	O
combating	O
SARS	O
.	O

The	O
clinical	O
course	O
and	O
successful	O
treatment	O
with	O
convalescent	O
plasma	B-ANAT
,	O
ribavirin	O
,	O
and	O
corticosteroids	O
are	O
discussed	O
.	O

Quantitative	O
reverse	O
-	O
transcriptase	O
(	O
RT	O
)	O
PCR	O
of	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
in	O
14	O
patients	O
(	O
four	O
with	O
ARDS	O
)	O
showed	O
peak	O
viral	O
load	O
at	O
day	O
10	O
,	O
and	O
at	O
day	O
15	O
a	O
load	O
lower	O
than	O
at	O
admission	O
.	O

Morphological	O
changes	O
identified	O
were	O
bronchial	B-ANAT
epithelial	O
denudation	O
,	O
loss	O
of	O
cilia	B-ANAT
,	O
and	O
squamous	O
metaplasia	O
.	O

The	O
patient	O
for	O
whom	O
full	O
autopsy	O
was	O
done	O
had	O
atrophy	O
of	O
the	O
white	B-ANAT
pulp	I-ANAT
of	O
the	O
spleen	B-ANAT
.	O

Shortly	O
after	O
presentation	O
,	O
the	O
patient	O
developed	O
therapy	O
-	O
refractory	O
respiratory	O
failure	O
,	O
cardiac	B-ANAT
arrest	O
,	O
and	O
subsequently	O
suffered	O
five	O
-	O
organ	B-ANAT
system	I-ANAT
failure	O
(	O
lung	B-ANAT
,	O
heart	B-ANAT
,	O
gastrointestinal	O
,	O
liver	B-ANAT
,	O
kidney	B-ANAT
),	O
in	O
addition	O
to	O
burn	O
injury	O
,	O
and	O
ischemia	O
related	O
cerebral	B-ANAT
lesions	O
.	O

ABSTRACT	O
:	O
To	O
describe	O
an	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
occurring	O
after	O
chemotherapy	O
for	O
non	O
-	O
seminomatous	O
germ	O
-	O
cell	B-ANAT
tumors	O
(	O
NSGCT	O
)	O
with	O
diffuse	O
lung	B-ANAT
metastases	O
,	O
we	O
conducted	O
a	O
retrospective	O
study	O
in	O
a	O
15	O
-	O
bed	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
in	O
a	O
comprehensive	O
cancer	O
center	O
.	O

Targeting	O
to	O
the	O
3D	O
model	O
and	O
its	O
X	O
-	O
ray	O
crystal	B-ANAT
structure	O
of	O
the	O
main	O
proteinase	O
(	O
Mpro	O
)	O
of	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
),	O
virtual	O
screening	O
was	O
performed	O
employing	O
molecular	O
docking	O
method	O
to	O
identify	O
possible	O
3CL	O
proteinase	O
inhibitors	O
from	O
small	O
molecular	O
databases	O
.	O

The	O
SARS	O
E	O
protein	O
may	O
fold	O
in	O
water	O
solution	O
in	O
a	O
similar	O
way	O
as	O
it	O
in	O
membrane	B-ANAT
-	O
water	O
mixed	O
environment	O
.	O

She	O
presented	O
in	O
acute	O
respiratory	O
failure	O
with	O
hemoptysis	O
and	O
acute	O
renal	B-ANAT
failure	O
;	O
interestingly	O
,	O
however	O
,	O
the	O
renal	B-ANAT
biopsy	O
was	O
normal	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
use	O
hypergravity	O
to	O
further	O
investigate	O
the	O
mechanisms	O
behind	O
the	O
differences	O
in	O
arterial	B-ANAT
oxygenation	O
between	O
the	O
prone	O
and	O
the	O
supine	O
posture	O
.	O

ABSTRACT	O
:	O
Platelet	B-ANAT
-	O
activating	O
factor	O
(	O
PAF	O
)	O
is	O
a	O
potent	O
proinflammatory	O
mediator	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
both	O
severe	O
sepsis	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

He	O
was	O
diagnosed	O
as	O
acute	O
aortic	B-ANAT
dissection	O
(	O
Stanford	O
type	O
A	O
).	O

In	O
birds	O
vaccinated	O
at	O
day	O
6	O
,	O
90	O
-	O
100	O
%	O
protection	O
at	O
the	O
trachea	B-ANAT
was	O
induced	O
against	O
either	O
homologous	O
or	O
heterologous	O
challenge	O
.	O

Pulmonary	B-ANAT
fibrosis	O
may	O
develop	O
early	O
in	O
patients	O
with	O
SARS	O
who	O
have	O
been	O
discharged	O
after	O
treatment	O
.	O

All	O
three	O
infants	O
exhibited	O
a	O
favorable	O
response	O
to	O
treatment	O
with	O
these	O
agents	O
in	O
terms	O
of	O
improved	O
arterial	B-ANAT
oxygenation	O
as	O
summarized	O
by	O
oxygenation	O
index	O
and	O
all	O
survived	O
to	O
discharge	B-ANAT
home	O
without	O
referral	O
for	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

The	O
chest	B-ANAT
roentgenogram	O
may	O
be	O
normal	O
initially	O
but	O
at	O
a	O
later	O
stage	O
progressive	O
consolidations	O
in	O
the	O
majority	O
of	O
peripheral	O
parts	O
of	O
the	O
lung	B-ANAT
are	O
observed	O
,	O
which	O
cannot	O
be	O
differentiated	O
from	O
pneumonias	O
of	O
other	O
origin	O
.	O

By	O
phylogenetic	O
tree	O
analysis	O
,	O
Korean	O
field	O
TGEV	O
strains	O
were	O
branched	B-ANAT
into	O
different	O
groups	O
from	O
non	O
-	O
Korean	O
TGEV	O
or	O
PRCV	O
strains	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
an	O
antioxidant	O
,	O
such	O
as	O
N	O
-	O
acetylcysteine	O
(	O
NAC	B-ANAT
),	O
has	O
any	O
protective	O
effect	O
.	O

Although	O
low	O
level	O
of	O
CEES	O
exposure	O
(	O
0	O
.	O
5	O
mg	O
/	O
kg	O
body	B-ANAT
weight	O
)	O
produced	O
symptoms	O
of	O
chemical	O
burn	O
in	O
lung	B-ANAT
as	O
early	O
as	O
1	O
h	O
after	O
exposure	O
,	O
the	O
severity	O
of	O
edema	O
,	O
congestion	O
,	O
hemorrhage	O
,	O
and	O
inflammation	O
increased	O
progressively	O
with	O
time	O
(	O
1	O
h	O
to	O
21	O
days	O
).	O

Feeding	O
of	O
single	O
dose	O
of	O
NAC	B-ANAT
(	O
0	O
.	O
5	O
g	O
)	O
by	O
gavage	O
just	O
before	O
the	O
CEES	O
infusion	O
was	O
ineffective	O
to	O
counteract	O
these	O
effects	O
.	O

Low	O
counts	O
of	O
CD4	O
and	O
CD8	B-ANAT
cells	I-ANAT
at	O
presentation	O
were	O
associated	O
with	O
adverse	O
outcomes	O
.	O

Out	O
of	O
the	O
victims	O
,	O
38	O
.	O
9	O
%	O
of	O
them	O
had	O
complications	O
as	O
hypertension	O
,	O
diabetes	O
,	O
heart	B-ANAT
diseases	O
and	O
COPD	O
etc	O
.	O

Proinflammatory	O
cytokines	O
released	O
by	O
stimulated	O
macrophages	B-ANAT
in	O
the	O
alveoli	B-ANAT
could	O
have	O
a	O
prominent	O
role	O
in	O
pathogenesis	O
of	O
SARS	O
.	O

Cardiac	B-ANAT
ultrasounds	O
showed	O
pulmonary	B-ANAT
hypertension	O
,	O
which	O
rapidly	O
resolved	O
with	O
inhaled	O
nitric	O
oxide	O
.	O

Thirty	O
cases	O
were	O
cured	O
(	O
78	O
.	O
9	O
%),	O
of	O
them	O
11	O
cases	O
had	O
pulmonary	B-ANAT
fibrosis	O
(	O
36	O
.	O
7	O
%),	O
8	O
patients	O
died	O
(	O
21	O
.	O
1	O
%)	O
in	O
all	O
cases	O
.	O

Thirty	O
cases	O
were	O
cured	O
(	O
78	O
.	O
9	O
%),	O
of	O
them	O
11	O
cases	O
had	O
pulmonary	B-ANAT
fibrosis	O
(	O
36	O
.	O
7	O
%),	O
8	O
patients	O
died	O
(	O
21	O
.	O
1	O
%)	O
in	O
all	O
cases	O
.	O

ABSTRACT	O
:	O
In	O
vivo	O
(	O
lung	B-ANAT
resistive	O
and	O
viscoelastic	O
pressures	O
and	O
static	O
elastance	O
)	O
and	O
in	O
vitro	O
(	O
tissue	B-ANAT
resistance	O
,	O
elastance	O
,	O
and	O
hysteresivity	O
)	O
respiratory	O
mechanics	O
were	O
analyzed	O
1	O
and	O
30	O
days	O
after	O
saline	O
(	O
control	O
)	O
or	O
paraquat	O
(	O
P	O
[	O
10	O
and	O
25	O
mg	O
/	O
kg	O
intraperitoneally	O
])	O
injection	O
in	O
rats	O
.	O

Tissue	B-ANAT
elastance	O
and	O
resistance	O
augmented	O
from	O
control	O
to	O
P10	O
(	O
1	O
and	O
30	O
days	O
)	O
and	O
P25	O
.	O

In	O
addition	O
,	O
lung	B-ANAT
damage	O
in	O
SARS	O
patients	O
may	O
also	O
play	O
a	O
role	O
on	O
inducing	O
thrombocytopenia	O
by	O
(	O
1	O
)	O
increasing	O
the	O
consumption	O
of	O
platelets	B-ANAT
/	O
megakaryocytes	B-ANAT
;	O
and	O
/	O
or	O
(	O
2	O
)	O
reducing	O
the	O
production	O
of	O
platelets	B-ANAT
in	O
the	O
lungs	B-ANAT
.	O

Systemic	O
toxic	O
changes	O
included	O
degeneration	O
and	O
necrosis	O
of	O
the	O
parenchyma	B-ANAT
cells	B-ANAT
in	O
the	O
lung	B-ANAT
,	O
liver	B-ANAT
,	O
kidney	B-ANAT
,	O
heart	B-ANAT
,	O
and	O
adrenal	B-ANAT
gland	I-ANAT
.	O

The	O
pattern	O
of	O
consolidation	O
tended	O
to	O
be	O
peripheral	O
and	O
poorly	O
marginated	O
and	O
involved	O
middle	O
and	O
lower	O
lung	B-ANAT
zones	O
.	O

One	O
hundred	O
thirty	O
-	O
seven	O
patients	O
with	O
isolated	O
head	B-ANAT
trauma	O
were	O
enrolled	O
in	O
the	O
study	O
over	O
a	O
4	O
-	O
year	O
period	O
.	O

The	O
development	O
of	O
ALI	O
is	O
a	O
critical	O
independent	O
factor	O
affecting	O
mortality	O
in	O
patients	O
suffering	O
traumatic	O
brain	B-ANAT
injury	O
and	O
is	O
associated	O
with	O
a	O
worse	O
long	O
-	O
term	O
neurologic	O
outcome	O
in	O
survivors	O
.	O

CONCLUSIONS	O
:	O
The	O
development	O
of	O
ALI	O
is	O
a	O
critical	O
independent	O
factor	O
affecting	O
mortality	O
in	O
patients	O
suffering	O
traumatic	O
brain	B-ANAT
injury	O
and	O
is	O
associated	O
with	O
a	O
worse	O
long	O
-	O
term	O
neurologic	O
outcome	O
in	O
survivors	O
.	O

Lymphopenia	O
was	O
observed	O
in	O
80	O
%	O
of	O
all	O
patients	O
,	O
and	O
some	O
patients	O
had	O
mildly	O
elevated	O
aminotransferase	O
levels	O
but	O
normal	O
serum	B-ANAT
creatinine	O
levels	O
.	O

Nasal	B-ANAT
lavage	O
and	O
induced	B-ANAT
sputum	I-ANAT
were	O
collected	O
prior	O
to	O
inoculation	O
(	O
day	O
0	O
)	O
and	O
2	O
,	O
4	O
and	O
17	O
days	O
later	O
.	O

In	O
both	O
groups	O
,	O
during	O
colds	O
the	O
volume	O
of	O
nasal	B-ANAT
secretion	B-ANAT
increased	O
as	O
did	O
leucocyte	B-ANAT
counts	O
in	O
both	O
upper	O
and	O
lower	O
respiratory	B-ANAT
tracts	I-ANAT
.	O

IL	O
-	O
8	O
increased	O
in	O
both	O
the	O
upper	O
and	O
lower	O
respiratory	B-ANAT
tracts	I-ANAT
in	O
both	O
EVW	O
and	O
control	O
subjects	O
with	O
colds	O
,	O
the	O
largest	O
change	O
being	O
seen	O
on	O
day	O
4	O
in	O
the	O
sputum	B-ANAT
of	O
those	O
with	O
EVW	O
(	O
mean	O
difference	O
from	O
baseline	O
(	O
95	O
%	O
confidence	O
interval	O
)	O
2	O
.	O
5	O
(	O
0	O
.	O
55	O
-	O
4	O
.	O
46	O
)	O
ng	O
/	O
mL	O
).	O

For	O
patients	O
with	O
chronic	O
(>	O
48	O
-	O
72	O
hours	O
)	O
symptomatic	O
hyponatremia	O
,	O
correction	O
must	O
be	O
rapid	O
during	O
the	O
first	O
few	O
hours	O
(	O
to	O
decrease	O
brain	B-ANAT
edema	O
)	O
followed	O
by	O
a	O
slow	O
correction	O
limited	O
to	O
10	O
mmol	O
/	O
L	O
over	O
24	O
hours	O
to	O
avoid	O
the	O
development	O
of	O
osmotic	O
demyelinating	O
syndrome	O
.	O

TITLE	O
:	O
[	O
Antibody	O
response	O
of	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
to	O
nucleocapsid	B-ANAT
antigen	O
of	O
SARS	O
-	O
associated	O
coronavirus	O
].	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
an	O
emerging	O
infectious	O
disease	O
with	O
a	O
25	O
%	O
incidence	O
of	O
progression	O
to	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
mortality	O
exceeding	O
10	O
%.	O

ABSTRACT	O
:	O
Gastroesophageal	B-ANAT
reflux	O
disease	O
(	O
GERD	O
)	O
may	O
be	O
associated	O
with	O
episodes	O
of	O
bronchoaspiration	O
,	O
sometimes	O
leading	O
to	O
life	O
-	O
threatening	O
respiratory	O
complications	O
.	O

RESULTS	O
:	O
We	O
found	O
7	O
cases	O
(	O
14	O
%)	O
of	O
type	O
2	O
hiatal	O
hernia	O
complicated	O
by	O
pulmonary	B-ANAT
manifestations	O
as	O
the	O
only	O
symptoms	O
of	O
GERD	O
.	O

However	O
,	O
one	O
out	O
of	O
27	O
patients	O
investigated	O
had	O
high	O
levels	O
of	O
aPL	O
antibodies	O
in	O
both	O
BALF	O
and	O
serum	B-ANAT
.	O

The	O
number	O
of	O
affected	O
lung	B-ANAT
fields	O
was	O
1	O
.	O
2	O
+/-	O

The	O
interval	O
from	O
the	O
beginning	O
of	O
fever	O
to	O
the	O
onset	O
of	O
abnormal	O
chest	B-ANAT
radiographs	O
was	O
(	O
3	O
.	O
5	O
+/-	O
2	O
.	O
3	O
)	O
days	O
,	O
which	O
increased	O
in	O
size	O
,	O
extent	O
,	O
and	O
severity	O
to	O
the	O
maximum	O
(	O
6	O
.	O
7	O
+/-	O
3	O
.	O
5	O
)	O
days	O
later	O
.	O

Abnormal	O
CT	O
findings	O
were	O
noted	O
in	O
all	O
the	O
patients	O
,	O
but	O
abnormal	O
chest	B-ANAT
radiographic	O
findings	O
in	O
17	O
cases	O
(	O
60	O
.	O
7	O
%,	O
17	O
/	O
28	O
).	O

RESULTS	O
:	O
The	O
numbers	O
of	O
CD	O
(	O
3	O
)(+),	O
CD	O
(	O
4	O
)(+),	O
and	O
CD	O
(	O
8	O
)(+)	O
lymphocytes	B-ANAT
all	O
significantly	O
decreased	O
in	O
acute	O
phase	O
of	O
patients	O
with	O
SARS	O
[(	O
722	O
+/-	O
533	O
)/	O
microliter	O
,	O
(	O
438	O
+/-	O
353	O
)/	O
microliter	O
,	O
(	O
307	O
+/-	O

Haemorrhagic	O
inflammation	O
exists	O
in	O
extrapulmonary	O
organs	B-ANAT
.	O

The	O
present	O
study	O
describes	O
the	O
case	O
of	O
a	O
56	O
-	O
yr	O
-	O
old	O
male	O
with	O
NSCLC	O
who	O
,	O
4	O
weeks	O
after	O
treatment	O
with	O
gefitinib	O
,	O
suffered	O
from	O
a	O
severe	O
alveolar	B-ANAT
haemorrhage	O
diagnosed	O
by	O
bronchoalveolar	O
lavage	O
.	O

This	O
is	O
the	O
first	O
case	O
report	O
of	O
an	O
acute	O
life	O
-	O
threatening	O
lung	B-ANAT
injury	O
in	O
a	O
patient	O
with	O
nonsmall	O
-	O
cell	B-ANAT
lung	B-ANAT
cancer	O
who	O
had	O
been	O
given	O
gefitinib	O
.	O

Proper	O
operative	O
timing	O
(	O
e	O
.	O
g	O
.	O
when	O
the	O
patient	O
is	O
in	O
sinus	B-ANAT
rhythm	O
and	O
in	O
NYHA	O
functional	O
class	O
II	O
)	O
is	O
of	O
great	O
importance	O
in	O
achieving	O
satisfied	O
long	O
-	O
term	O
results	O
.	O

Part	O
of	O
the	O
lung	B-ANAT
tissue	I-ANAT
specimens	O
were	O
studied	O
further	O
with	O
Macchiavello	O
'	O
s	O
stain	O
,	O
viral	B-ANAT
inclusion	I-ANAT
body	I-ANAT
stain	O
,	O
reticulin	O
and	O
PAS	B-ANAT
stains	O
,	O
immunohistochemistry	O
,	O
thin	O
sections	O
with	O
staining	O
,	O
light	O
microscopy	O
and	O
transmission	O
electronic	O
microscope	O
investigation	O
.	O

Lesions	O
of	O
the	O
immune	O
organs	B-ANAT
included	O
:	O
large	O
patchy	O
necrosis	O
in	O
the	O
spleens	B-ANAT
and	O
localized	O
necrosis	O
in	O
the	O
lymph	B-ANAT
nodes	I-ANAT
were	O
seen	O
.	O

Lungs	B-ANAT
,	O
immune	B-ANAT
system	I-ANAT
and	O
systemic	O
small	B-ANAT
vessels	I-ANAT
are	O
the	O
main	O
target	O
organs	B-ANAT
attacked	O
by	O
the	O
virus	O
.	O

Meanwhile	O
,	O
haemorrhagic	O
necrosis	O
was	O
showed	O
in	O
lymph	B-ANAT
nodes	I-ANAT
and	O
spleen	B-ANAT
with	O
attenuation	O
of	O
lymphocytes	B-ANAT
.	O

Other	O
atypical	O
pathological	O
changes	O
,	O
such	O
as	O
hydropic	O
degeneration	O
,	O
fatty	O
degeneration	O
,	O
interstitial	B-ANAT
cell	I-ANAT
proliferation	O
and	O
some	O
lesions	O
observed	O
in	O
liver	B-ANAT
,	O
heart	B-ANAT
,	O
kidney	B-ANAT
,	O
pancreas	B-ANAT
may	O
have	O
existed	O
before	O
the	O
hospitalization	O
.	O

Severe	O
damages	O
of	O
pulmonary	B-ANAT
and	O
immunological	O
system	O
damage	O
are	O
responsible	O
for	O
clinical	O
features	O
of	O
SARS	O
and	O
may	O
lead	O
to	O
death	O
of	O
patients	O
.	O

Other	O
atypical	O
pathological	O
changes	O
,	O
such	O
as	O
hydropic	O
degeneration	O
,	O
fatty	O
degeneration	O
,	O
interstitial	B-ANAT
cell	I-ANAT
proliferation	O
and	O
some	O
lesions	O
observed	O
in	O
liver	B-ANAT
,	O
heart	B-ANAT
,	O
kidney	B-ANAT
,	O
pancreas	B-ANAT
may	O
have	O
existed	O
before	O
the	O
hospitalization	O
.	O

The	O
specific	O
lesions	O
of	O
SARS	O
consist	O
of	O
lobular	O
intrastitial	O
pneumonia	O
with	O
the	O
formation	O
of	O
hyaline	B-ANAT
membranes	B-ANAT
of	O
lung	B-ANAT
,	O
haemorrhage	O
,	O
necrosis	O
,	O
inflammation	O
of	O
blood	B-ANAT
vessels	I-ANAT
and	O
the	O
damages	O
of	O
extralung	O
lymphohemopioetic	O
system	O
.	O

Elongated	O
,	O
rod	B-ANAT
-,	O
kidney	B-ANAT
-	O
or	O
other	O
irregular	O
shaped	O
virons	O
with	O
the	O
size	O
of	O
100	O
-	O
200	O
nm	O
by	O
60	O
-	O
90	O
nm	O
were	O
also	O
found	O
in	O
the	O
cultured	B-ANAT
cells	I-ANAT
infected	O
with	O
the	O
lung	B-ANAT
samples	O
from	O
the	O
Guangdong	O
patients	O
.	O

Moreover	O
,	O
IFN	O
-	O
gamma	O
mRNA	O
was	O
detected	O
within	O
the	O
retinas	B-ANAT
of	O
infected	O
animals	O
during	O
the	O
acute	O
phase	O
of	O
the	O
disease	O
but	O
was	O
not	O
detected	O
in	O
normal	O
or	O
mock	O
-	O
injected	O
animals	O
.	O

Using	O
biological	O
assays	O
,	O
the	O
HR2	O
peptide	O
was	O
shown	O
to	O
be	O
a	O
potent	O
inhibitor	O
of	O
virus	O
entry	O
into	O
the	O
cell	B-ANAT
,	O
as	O
well	O
as	O
of	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
.	O

Between	O
DNA	O
-	O
vaccinated	O
birds	O
and	O
nonvaccinated	O
control	O
birds	O
,	O
no	O
statistical	O
differences	O
were	O
observed	O
for	O
IBV	O
-	O
specific	O
serum	B-ANAT
antibodies	O
as	O
detected	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
or	O
the	O
virus	O
neutralization	O
test	O
.	O

METHODS	O
:	O
Organ	B-ANAT
samples	O
of	O
7	O
dead	O
cases	O
of	O
SARS	O
were	O
collected	O
from	O
Guangdong	O
,	O
Shanxi	O
,	O
Sichuan	O
Provinces	O
and	O
Beijing	O
for	O
electron	O
microscopic	O
examination	O
.	O

Confocus	O
microscope	O
immunofluorescence	O
was	O
performed	O
to	O
show	O
whether	O
N	O
protein	O
of	O
MHV	O
enters	O
into	O
the	O
nucleus	B-ANAT
of	O
infected	O
cells	B-ANAT
,	O
which	O
is	O
a	O
critical	O
step	O
for	O
the	O
N	O
protein	O
to	O
facilitate	O
its	O
transactivation	O
property	O
.	O

ECRI	O
recommends	O
that	O
breathing	O
-	O
circuit	O
filters	O
be	O
incorporated	O
in	O
the	O
exhalation	O
limb	B-ANAT
of	O
any	O
ventilator	O
used	O
on	O
a	O
patient	O
with	O
SARS	O
.	O

Eight	O
probable	O
but	O
none	O
of	O
the	O
suspected	O
cases	O
died	O
from	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
with	O
multiple	O
organ	B-ANAT
dysfunction	O
after	O
a	O
median	O
of	O
6	O
-	O
day	O
hospital	O
stay	O
(	O
range	O
,	O
1	O
-	O
30	O
days	O
).	O

The	O
chest	B-ANAT
radiograph	O
of	O
these	O
fatal	O
cases	O
consistently	O
showed	O
multifocal	O
infiltration	O
over	O
the	O
unilateral	O
or	O
bilateral	O
lobe	B-ANAT
of	O
the	O
lung	B-ANAT
.	O

Patients	O
received	O
standard	O
fluid	O
management	O
during	O
and	O
after	O
the	O
transplant	B-ANAT
surgery	O
.	O

The	O
liver	B-ANAT
functions	O
of	O
all	O
the	O
patients	O
were	O
measured	O
.	O

RESULTS	O
:	O
The	O
important	O
chest	B-ANAT
X	O
-	O
ray	O
imaging	O
features	O
of	O
36	O
patients	O
with	O
severe	O
SARS	O
included	O
small	O
patch	O
of	O
infiltration	O
(	O
n	O
=	O
27	O
,	O
75	O
.	O
0	O
%),	O
large	O
patch	O
of	O
infiltration	O
(	O
n	O
=	O
22	O
,	O
61	O
.	O
1	O
%),	O
large	O
area	O
of	O
lung	B-ANAT
consolidation	O
(	O
n	O
=	O
10	O
,	O
27	O
.	O
3	O
%),	O
interstitial	B-ANAT
lung	B-ANAT
lesion	O
(	O
n	O
=	O
26	O
,	O
72	O
.	O
2	O
%),	O
ground	O
-	O
glass	O
shadow	O
(	O
n	O
=	O
28	O
,	O
77	O
.	O
8	O
%),	O
irregular	O
linear	O
opacity	O
(	O
n	O
=	O
15	O
,	O
41	O
.	O
7	O
%),	O
diffuse	O
lung	B-ANAT
lesion	O
(	O
n	O
=	O
12	O
,	O
33	O
.	O
3	O
%),	O
with	O
single	O
lung	B-ANAT
involved	O
(	O
n	O
=	O
9	O
,	O
25	O
.	O
0	O
%),	O
and	O
both	O
lungs	B-ANAT
involved	O
(	O
n	O
=	O
32	O
,	O
88	O
.	O
9	O
%).	O

Pulmonary	B-ANAT
alveoli	I-ANAT
thickened	O
with	O
interstitial	B-ANAT
mononuclear	O
inflammatory	O
infiltrates	O
,	O
suffered	O
diffuse	O
alveolar	B-ANAT
damage	O
,	O
experienced	O
desquamation	O
of	O
pneumocytes	B-ANAT
and	O
had	O
hyaline	B-ANAT
-	O
membrane	B-ANAT
formation	O
,	O
fibrinoid	O
materials	O
,	O
and	O
erythrocytes	B-ANAT
in	O
alveolar	B-ANAT
spaces	O
.	O

Other	O
atypical	O
pathological	O
changes	O
,	O
such	O
as	O
hydropic	O
degeneration	O
,	O
fatty	O
degeneration	O
,	O
interstitial	B-ANAT
cell	I-ANAT
proliferation	O
and	O
lesions	O
having	O
existed	O
before	O
hospitalization	O
were	O
observed	O
in	O
the	O
liver	B-ANAT
,	O
heart	B-ANAT
,	O
kidney	B-ANAT
and	O
pancreas	B-ANAT
.	O

Severe	O
damage	O
to	O
the	O
pulmonary	B-ANAT
and	O
immunological	O
systems	O
is	O
responsible	O
for	O
the	O
clinical	O
features	O
of	O
SARS	O
and	O
may	O
lead	O
to	O
the	O
death	O
of	O
patients	O
.	O

The	O
levels	O
of	O
serum	B-ANAT
IL	O
-	O
2	O
,	O
IL	O
-	O
10	O
,	O
IL	O
-	O
12	O
and	O
T	B-ANAT
-	I-ANAT
lymphocyte	I-ANAT
subset	I-ANAT
counts	O
were	O
measured	O
in	O
35	O
clinically	O
diagnosed	O
SARS	O
patients	O
by	O
using	O
enzyme	O
linked	O
immunosorbant	O
assay	O
(	O
ELISA	O
).	O

The	O
decreased	O
CD	O
(	O
3	O
)(+),	O
CD	O
(	O
4	O
)(+)	O
and	O
CD	O
(	O
8	O
)(+)	O
counts	O
were	O
consistent	O
with	O
the	O
decreased	O
WBC	B-ANAT
counts	O
.	O

ABSTRACT	O
:	O
To	O
study	O
the	O
alteration	O
of	O
peripheral	O
lymphocyte	B-ANAT
subsets	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
patients	O
and	O
to	O
help	O
improve	O
the	O
early	O
diagnosis	O
of	O
the	O
disease	O
.	O

The	O
T	B-ANAT
lymphocyte	I-ANAT
subsets	I-ANAT
were	O
counted	O
by	O
flow	O
cytometry	O
using	O
fluorescence	O
-	O
labeled	O
specific	O
monoclonal	O
antibodies	O
.	O

Published	O
experience	O
in	O
adults	O
suggests	O
that	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
can	O
successfully	O
support	O
trauma	O
victims	O
with	O
pulmonary	B-ANAT
failure	O
.	O

Patients	O
were	O
treated	O
with	O
blood	B-ANAT
product	O
replacement	O
,	O
epsilon	O
-	O
aminocaproic	O
acid	O
(	O
EACA	O
),	O
and	O
aprotinin	O
infusions	O
.	O

Interferon	O
gamma	O
was	O
slightly	O
better	O
than	O
interferon	O
alpha	O
in	O
Vero	B-ANAT
cell	I-ANAT
cultures	O
,	O
but	O
was	O
completely	O
ineffective	O
in	O
Caco2	O
cell	B-ANAT
cultures	O
.	O

ABSTRACT	O
:	O
Hopkins	O
syndrome	O
is	O
a	O
motor	B-ANAT
neuron	I-ANAT
disease	O
which	O
leads	O
to	O
a	O
flaccid	O
paralysis	O
affecting	O
one	O
or	O
more	O
limbs	B-ANAT
resembling	O
poliomyelites	O
.	O

Three	O
days	O
later	O
he	O
initiated	O
with	O
loss	O
of	O
strength	O
in	O
the	O
lower	B-ANAT
limbs	I-ANAT
(	O
LL	O
).	O

In	O
2	O
cases	O
in	O
whom	O
typical	O
lung	B-ANAT
opacities	O
could	O
not	O
be	O
found	O
on	O
the	O
initial	O
plain	O
chest	B-ANAT
radiographs	O
,	O
thoracic	B-ANAT
CT	O
proved	O
to	O
be	O
useful	O
.	O

Fever	O
,	O
lymphopenia	O
,	O
low	O
serum	B-ANAT
iron	O
and	O
chest	B-ANAT
radiograph	O
are	O
helpful	O
to	O
diagnose	O
SARS	O
early	O
;	O
age	O
is	O
the	O
independent	O
predictor	O
of	O
an	O
outcome	O
.	O

Common	O
symptoms	O
included	O
fever	O
(	O
98	O
.	O
1	O
%),	O
chills	O
(	O
75	O
.	O
5	O
%),	O
cough	O
(	O
71	O
.	O
7	O
%),	O
headache	O
and	O
breathless	O
(	O
both	O
43	O
.	O
4	O
%),	O
diarrhea	O
(	O
24	O
.	O
5	O
%)	O
and	O
rare	O
rales	O
in	O
the	O
lungs	B-ANAT
(	O
11	O
.	O
2	O
%).	O

The	O
count	O
of	O
WBC	B-ANAT
was	O
increased	O
after	O
treatment	O
(	O
P	O
<	O
0	O
.	O
01	O
).	O

Glucocorticoid	O
increased	O
the	O
level	O
of	O
blood	B-ANAT
glucose	O
(	O
P	O
=	O
0	O
.	O
01	O
),	O
decreased	O
the	O
level	O
of	O
sera	B-ANAT
albumin	O
(	O
P	O
<	O
0	O
.	O
01	O
),	O
and	O
its	O
large	O
dosage	O
decreased	O
the	O
counts	O
of	O
CD	O
(	O
4	O
)(+),	O
CD	O
(	O
8	O
)(+)	O
and	O
CD	O
(	O
3	O
)(+).	O

Continual	O
positive	O
airway	B-ANAT
pressure	O
(	O
CPAP	O
)	O
and	O
glucocorticoid	O
was	O
required	O
that	O
can	O
control	O
deprivation	O
of	O
the	O
disease	O
when	O
toxicosis	O
symptom	O
of	O
patients	O
was	O
severity	O
and	O
shadow	O
of	O
lungs	B-ANAT
diffuse	O
more	O
and	O
more	O
.	O

Infectivity	O
of	O
the	O
illness	O
is	O
evidence	O
and	O
spread	O
by	O
airway	B-ANAT
.	O

Continual	O
positive	O
airway	B-ANAT
pressure	O
(	O
CPAP	O
)	O
and	O
glucocorticoid	O
was	O
required	O
that	O
can	O
control	O
deprivation	O
of	O
the	O
disease	O
when	O
toxicosis	O
symptom	O
of	O
patients	O
was	O
severity	O
and	O
shadow	O
of	O
lungs	B-ANAT
diffuse	O
more	O
and	O
more	O
.	O

The	O
numbers	O
of	O
CD	O
(	O
3	O
)(+),	O
CD	O
(	O
4	O
)(+),	O
and	O
CD	O
(	O
8	O
)(+)	O
lymphocytes	B-ANAT
all	O
significantly	O
decreased	O
in	O
acute	O
phase	O
of	O
SARS	O
patients	O
compared	O
with	O
those	O
in	O
normal	O
persons	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
appearance	O
and	O
dynamic	O
change	O
of	O
chest	B-ANAT
roentgenography	O
and	O
CT	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

Lungs	B-ANAT
complicated	O
infection	O
were	O
found	O
in	O
6	O
patients	O
with	O
a	O
prolonged	O
duration	O
of	O
the	O
illness	O
.	O

The	O
levels	O
of	O
CD3	O
(+),	O
CD4	O
(+)	O
and	O
CD8	O
(+)	O
T	B-ANAT
-	I-ANAT
lymphocytes	I-ANAT
in	O
SARS	O
group	O
[(	O
589	O
+/-	O
435	O
)	O
x	O
10	O
(	O
6	O
)/	O
L	O
,	O
(	O
316	O
+/-	O
267	O
)	O
x	O
10	O
(	O
6	O
)/	O
L	O
and	O
(	O
215	O
+/-	O
165	O
)	O
x	O
10	O
(	O
6	O
)/	O
L	O
,	O
respectively	O
]	O
were	O
significantly	O
lower	O
than	O
those	O
of	O
the	O
normal	O
group	O
(	O
P	O
<	O
0	O
.	O
01	O
).	O

RESULTS	O
:	O
The	O
levels	O
of	O
CD3	O
(+),	O
CD4	O
(+)	O
and	O
CD8	O
(+)	O
T	B-ANAT
-	I-ANAT
lymphocytes	I-ANAT
in	O
SARS	O
group	O
[(	O
589	O
+/-	O
435	O
)	O
x	O
10	O
(	O
6	O
)/	O
L	O
,	O
(	O
316	O
+/-	O
267	O
)	O
x	O
10	O
(	O
6	O
)/	O
L	O
and	O
(	O
215	O
+/-	O
165	O
)	O
x	O
10	O
(	O
6	O
)/	O
L	O
,	O
respectively	O
]	O
were	O
significantly	O
lower	O
than	O
those	O
of	O
the	O
normal	O
group	O
(	O
P	O
<	O
0	O
.	O
01	O
).	O

Involvement	O
of	O
multiple	O
organs	B-ANAT
was	O
often	O
.	O

During	O
the	O
7	O
-	O
12	O
days	O
the	O
pulmonary	B-ANAT
lesion	O
become	O
most	O
serious	O
.	O

ABSTRACT	O
:	O
CTL	B-ANAT
escape	O
mutations	O
have	O
been	O
identified	O
in	O
several	O
chronic	O
infections	O
,	O
including	O
mice	O
infected	O
with	O
mouse	O
hepatitis	O
virus	O
strain	O
JHM	O
.	O

All	O
tissues	B-ANAT
from	O
these	O
cases	O
were	O
routinely	O
processed	O
and	O
carefully	O
studied	O
.	O

Microscopically	O
,	O
the	O
edema	O
and	O
fibrin	O
exudates	B-ANAT
in	O
the	O
alveoli	B-ANAT
was	O
the	O
most	O
common	O
findings	O
,	O
especially	O
in	O
the	O
early	O
phase	O
of	O
the	O
disease	O
.	O

Micro	O
-	O
thrombus	O
were	O
easily	O
found	O
in	O
these	O
lungs	B-ANAT
.	O

In	O
order	O
to	O
keep	O
blood	B-ANAT
glucose	O
within	O
the	O
range	O
4	O
.	O
44	O
-	O
7	O
.	O
78	O
mmol	O
/	O
L	O
(	O
80	O
-	O
140	O
mg	O
/	O
dl	O
),	O
only	O
18	O
.	O
8	O
%	O
of	O
the	O
surviving	O
patients	O
needed	O
insulin	O
intervention	O
as	O
opposed	O
to	O
80	O
.	O
0	O
%	O
of	O
those	O
who	O
died	O
(	O
P	O
=	O
0	O
.	O
03	O
).	O

TITLE	O
:	O
[	O
Detection	O
of	O
SARS	O
-	O
CoV	O
RNA	O
in	O
stool	B-ANAT
samples	O
of	O
SARS	O
patients	O
by	O
nest	O
RT	O
-	O
PCR	O
and	O
its	O
clinical	O
value	O
].	O

Among	O
these	O
46	O
SARS	O
patients	O
,	O
17	O
cases	O
(	O
37	O
.	O
0	O
%)	O
were	O
stool	B-ANAT
SARS	O
-	O
CoV	O
RT	O
-	O
PCR	O
negative	O
,	O
and	O
29	O
cases	O
(	O
63	O
.	O
0	O
%)	O
were	O
SARS	O
-	O
CoV	O
RT	O
-	O
PCR	O
positive	O
.	O

CONCLUSIONS	O
:	O
In	O
the	O
first	O
visiting	O
of	O
the	O
suspectable	O
SARS	O
patients	O
,	O
the	O
contagious	O
history	O
,	O
clinical	O
symptoms	O
,	O
laboratory	O
results	O
and	O
lung	B-ANAT
X	O
-	O
ray	O
should	O
be	O
studied	O
comprehensively	O
and	O
thoroughly	O
to	O
avoid	O
omitted	O
or	O
mistaken	O
diagnosis	O
.	O

The	O
laboratory	O
test	O
show	O
that	O
33	O
%	O
patients	O
with	O
leukopenia	O
and	O
thrombocytopenia	O
,	O
53	O
.	O
3	O
%	O
with	O
elevated	O
serum	B-ANAT
aminotransferase	O
and	O
26	O
.	O
6	O
%	O
with	O
increased	O
creatinine	O
kinase	O
levels	O
.	O

The	O
plasma	B-ANAT
levels	O
of	O
anti	O
-	O
SARS	O
coronavirus	O
IgG	B-ANAT
antibody	I-ANAT
of	O
57	O
normal	O
subjects	O
,	O
127	O
physicians	O
and	O
nurses	O
worked	O
in	O
SARS	O
wards	O
for	O
one	O
month	O
and	O
73	O
SARS	O
patients	O
with	O
different	O
course	O
of	O
SARS	O
were	O
measured	O
by	O
enzyme	O
linked	O
immunosorbent	O
assay	O
.	O

The	O
specific	O
IgG	B-ANAT
antibody	I-ANAT
didn	O
'	O
t	O
emerge	O
in	O
some	O
patients	O
in	O
the	O
early	O
stage	O
of	O
the	O
disease	O
,	O
and	O
the	O
negative	O
results	O
didn	O
'	O
t	O
indicate	O
that	O
they	O
were	O
not	O
infected	O
.	O

CONCLUSIONS	O
:	O
The	O
specificity	O
and	O
sensitivity	O
of	O
ELISA	O
to	O
detect	O
plasma	B-ANAT
anti	O
-	O
SARS	O
IgG	B-ANAT
antibody	I-ANAT
were	O
satisfactory	O
.	O

TITLE	O
:	O
[	O
Chest	B-ANAT
X	O
-	O
ray	O
changes	O
after	O
discontinuation	O
of	O
glucocorticosteroids	O
treatment	O
on	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
5	O
cases	O
report	O
)].	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
effect	O
of	O
glucocorticosteroids	O
on	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
chest	B-ANAT
X	O
ray	O
changes	O
after	O
discontinuation	O
of	O
glucocorticosteroids	O
treatment	O
.	O

Thoracic	B-ANAT
plain	O
film	O
was	O
necessary	O
for	O
diagnosis	O
of	O
SARS	O
,	O
CT	O
could	O
detect	O
the	O
pulmonary	B-ANAT
abnormality	O
of	O
SARS	O
early	O
.	O

The	O
correlation	O
between	O
the	O
score	O
of	O
lung	B-ANAT
involvement	O
and	O
clinical	O
course	O
was	O
also	O
studied	O
.	O

The	O
chest	B-ANAT
X	O
ray	O
of	O
SARS	O
has	O
some	O
features	O
and	O
its	O
changes	O
can	O
reflect	O
the	O
clinical	O
situation	O
.	O

RESULTS	O
:	O
The	O
lung	B-ANAT
involvement	O
was	O
most	O
common	O
in	O
lower	O
lung	B-ANAT
field	I-ANAT
and	O
outer	O
zone	O
both	O
in	O
early	O
and	O
acute	O
stage	O
.	O

The	O
text	O
information	O
was	O
transmitted	O
by	O
TCP	O
/	O
IP	O
protocol	O
,	O
and	O
the	O
chest	B-ANAT
X	O
ray	O
film	O
information	O
was	O
transmitted	O
by	O
DICOM	O
protocol	O
.	O

TITLE	O
:	O
Antiviral	O
activity	O
of	O
limitin	O
against	O
encephalomyocarditis	O
virus	O
,	O
herpes	O
simplex	B-ANAT
virus	O
,	O
and	O
mouse	O
hepatitis	O
virus	O
:	O
diverse	O
requirements	O
by	O
limitin	O
and	O
alpha	O
interferon	O
for	O
interferon	O
regulatory	O
factor	O
1	O
.	O

Among	O
them	O
,	O
13	O
patients	O
were	O
having	O
serious	O
primary	O
diseases	O
,	O
i	O
.	O
e	O
.	O
cardio	O
-	O
cerebral	B-ANAT
-	O
vascular	B-ANAT
disease	O
in	O
9	O
patients	O
,	O
diabetes	O
in	O
2	O
patients	O
,	O
renal	B-ANAT
dysfunction	O
in	O
1	O
patient	O
,	O
and	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
COPD	O
)	O
in	O
1	O
patient	O
.	O

In	O
mice	O
,	O
the	O
recombinant	O
viruses	O
differed	O
in	O
their	O
ability	O
to	O
replicate	O
in	O
the	O
liver	B-ANAT
,	O
but	O
not	O
in	O
the	O
brain	B-ANAT
,	O
whereas	O
their	O
in	O
vivo	O
interferogenic	O
capacity	O
did	O
not	O
appear	O
to	O
be	O
affected	O
by	O
their	O
glycosylation	O
status	O
.	O

T	B-ANAT
cells	I-ANAT
participate	O
in	O
both	O
defense	O
and	O
disease	O
progression	O
following	O
MHV	O
infection	O
.	O

RAG1	O
(-/-)	O
recipients	O
of	O
CCR5	O
(-/-)-	O
derived	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
exhibited	O
a	O
modest	O
,	O
yet	O
significant	O
(	O
P	O
</=	O
0	O
.	O
05	O
),	O
reduction	O
in	O
viral	O
burden	O
within	O
the	O
brain	B-ANAT
which	O
correlated	O
with	O
increased	O
CTL	B-ANAT
activity	O
and	O
IFN	O
-	O
gamma	O
expression	O
.	O

These	O
data	O
indicate	O
that	O
CCR5	O
signaling	O
on	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
modulates	O
antiviral	O
activities	O
but	O
is	O
not	O
essential	O
for	O
entry	O
into	O
the	O
CNS	B-ANAT
.	O

TITLE	O
:	O
[	O
Detection	O
of	O
cell	B-ANAT
apoptosis	O
in	O
the	O
pathological	O
tissues	B-ANAT
of	O
patients	O
with	O
SARS	O
and	O
its	O
significance	O
].	O

ABSTRACT	O
:	O
To	O
study	O
the	O
expression	O
of	O
the	O
immune	O
cell	B-ANAT
markers	O
and	O
their	O
active	O
antigens	O
in	O
the	O
involved	O
tissues	B-ANAT
of	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

3	O
.	O
1	O
)%	O
with	O
supplementary	O
oxygen	O
through	O
a	O
nasal	B-ANAT
cannula	O
.	O

The	O
serum	B-ANAT
levels	O
of	O
creatine	O
kinase	O
(	O
CK	O
),	O
lactate	O
dehydrogenase	O
(	O
LDH	O
),	O
aspartate	O
transaminase	O
(	O
AST	O
),	O
troponin	O
I	O
(	O
TnI	O
),	O
creatine	O
kinase	O
-	O
MB	O
(	O
CK	O
-	O
MB	O
)	O
and	O
myoglobin	O
(	O
MYO	O
)	O
were	O
measured	O
.	O

During	O
CVVH	O
,	O
the	O
patients	O
'	O
conditions	O
and	O
pancreatic	B-ANAT
enzymes	O
(	O
amylase	O
and	O
lipase	O
)	O
were	O
observed	O
,	O
serum	B-ANAT
concentration	O
of	O
endotoxin	O
was	O
measured	O
as	O
well	O
.	O

CONCLUSIONS	O
:	O
CVVH	O
could	O
decrease	O
the	O
mortality	O
rate	O
of	O
SAP	O
with	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
.	O

A	O
SARS	O
-	O
CoV	O
whole	O
-	O
genome	O
approach	O
has	O
been	O
developed	O
aimed	O
at	O
determining	O
the	O
crystal	B-ANAT
structure	O
of	O
all	O
of	O
its	O
proteins	O
or	O
domains	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
major	O
infectious	O
disease	O
pandemic	O
that	O
occurred	O
in	O
early	O
2003	O
,	O
and	O
one	O
of	O
the	O
diagnostic	O
criteria	O
is	O
the	O
presence	O
of	O
chest	B-ANAT
radiographic	O
findings	O
.	O

Abnormal	O
liver	B-ANAT
function	O
was	O
found	O
in	O
27	O
cases	O
(	O
mostly	O
with	O
elevated	O
serum	B-ANAT
ALT	O
),	O
with	O
70	O
%	O
occurred	O
at	O
the	O
3rd	O
or	O
4th	O
week	O
.	O

ABSTRACT	O
:	O
Porcine	O
organs	B-ANAT
,	O
cells	B-ANAT
and	O
tissues	B-ANAT
provide	O
a	O
viable	O
source	O
of	O
transplants	B-ANAT
in	O
humans	O
,	O
though	O
there	O
is	O
some	O
concern	O
of	O
public	O
health	O
risk	O
from	O
adaptation	O
of	O
swine	O
infectious	O
agents	O
in	O
humans	O
.	O

TITLE	O
:	O
Digestive	B-ANAT
system	I-ANAT
manifestations	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

ABSTRACT	O
:	O
To	O
explore	O
digestive	B-ANAT
system	I-ANAT
manifestations	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

Therefore	O
,	O
immunohistochemical	O
analysis	O
of	O
OPR	O
-	O
150	O
in	O
the	O
brain	B-ANAT
of	O
SID	O
cases	O
may	O
be	O
very	O
useful	O
to	O
differentiate	O
between	O
SIDS	O
and	O
acute	O
asphyxia	O
.	O

Treatment	O
is	O
supportive	O
with	O
ventilatory	O
assistance	O
and	O
adjunctive	O
use	O
of	O
supplemental	O
oxygen	O
and	O
end	O
expiratory	O
airway	B-ANAT
pressure	O
(	O
PEEP	O
).	O

TITLE	O
:	O
[	O
The	O
treatment	O
of	O
molecular	O
adsorbents	O
recirculating	O
system	O
artificial	O
liver	B-ANAT
in	O
severe	O
liver	B-ANAT
failure	O
patients	O
with	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
].	O

TITLE	O
:	O
[	O
Clinical	O
characteristics	O
and	O
mechanism	O
of	O
liver	B-ANAT
injury	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
].	O

RESULTS	O
:	O
When	O
being	O
admitted	O
to	O
hospital	O
,	O
serum	B-ANAT
ALT	O
and	O
(	O
or	O
)	O
AST	O
levels	O
were	O
elevated	O
in	O
37	O
.	O
7	O
%	O
SARS	O
patients	O
.	O

The	O
application	O
of	O
4	O
intermittent	O
MARS	O
treatments	O
(	O
8	O
h	O
each	O
,	O
mean	O
blood	B-ANAT
flow	O
rate	O
180	O
ml	O
/	O
min	O
)	O
on	O
4	O
consecutive	O
days	O
resulted	O
in	O
an	O
immediate	O
improvement	O
of	O
clinical	O
conditions	O
within	O
the	O
treatment	O
days	O
.	O

Immunohistochemical	O
examination	O
demonstrated	O
a	O
marked	O
increase	O
in	O
immunoreactivity	O
for	O
intracellular	B-ANAT
adhesion	O
molecule	O
-	O
1	O
(	O
ICAM	O
-	O
1	O
),	O
P	O
-	O
selectin	O
and	O
E	O
-	O
selectin	O
in	O
the	O
pancreas	B-ANAT
and	O
lung	B-ANAT
of	O
cerulein	O
-	O
treated	O
mice	O
.	O

On	O
the	O
basis	O
of	O
the	O
recently	O
published	O
viral	B-ANAT
genome	I-ANAT
and	O
structural	O
features	O
common	O
to	O
the	O
members	O
of	O
the	O
coronavirus	O
family	O
,	O
a	O
model	O
for	O
host	B-ANAT
cell	I-ANAT
-	O
virus	O
interaction	O
and	O
possible	O
targets	O
for	O
antiviral	O
drugs	O
are	O
presented	O
.	O

ABSTRACT	O
:	O
Molecular	O
Adsorbents	O
Recirculating	O
System	O
(	O
MARS	O
)	O
is	O
a	O
new	O
promising	O
artificial	O
liver	B-ANAT
support	O
therapy	O
,	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
effectiveness	O
of	O
MARS	O
to	O
remove	O
nitrous	O
oxide	O
(	O
NO	O
)	O
and	O
cytokines	O
in	O
severe	O
liver	B-ANAT
failure	O
patients	O
with	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
(	O
MODS	O
).	O

RESULTS	O
:	O
The	O
MARS	O
therapy	O
was	O
associated	O
with	O
a	O
significant	O
removal	O
of	O
NO	O
and	O
certain	O
cytokines	O
such	O
as	O
TNF	O
-	O
alpha	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
and	O
INF	O
-	O
gamma	O
,	O
together	O
with	O
marked	O
reduction	O
of	O
other	O
non	O
-	O
water	O
-	O
soluble	O
albumin	O
bound	O
toxins	O
and	O
water	O
-	O
soluble	O
toxins	O
,	O
these	O
were	O
associated	O
with	O
a	O
improvement	O
of	O
the	O
patients	O
'	O
clinical	O
conditions	O
including	O
hepatic	B-ANAT
encephalopathy	O
,	O
deranged	O
hemodynamic	O
situation	O
and	O
as	O
well	O
as	O
renal	B-ANAT
and	O
respiratory	O
function	O
,	O
thus	O
resulted	O
into	O
marked	O
decrease	O
of	O
Sequential	O
Organ	B-ANAT
Failure	O
Assessment	O
(	O
SOFA	O
)	O
score	O
and	O
improved	O
outcome	O
:	O
nine	O
patients	O
were	O
able	O
to	O
be	O
discharged	O
from	O
the	O
hospital	O
or	O
bridged	O
to	O
successful	O
liver	B-ANAT
transplantation	O
,	O
the	O
overall	O
survival	O
of	O
24	O
patients	O
was	O
37	O
.	O
5	O
%.	O

TITLE	O
:	O
Chest	B-ANAT
radiographic	O
findings	O
of	O
a	O
case	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
in	O
Singapore	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
the	O
role	O
of	O
HO	O
-	O
1	O
induction	O
in	O
a	O
rat	O
model	O
of	O
CCl	O
(	O
4	O
)-	O
induced	O
acute	O
liver	B-ANAT
injury	O
.	O

CCl	O
(	O
4	O
)	O
treatment	O
(	O
1	O
mL	O
/	O
kg	O
,	O
intraperitoneally	O
)	O
produced	O
severe	O
hepatic	B-ANAT
injury	O
in	O
rats	O
as	O
revealed	O
by	O
significant	O
increases	O
in	O
serum	B-ANAT
alanine	O
transaminase	O
(	O
ALT	O
)	O
(	O
EC	O
2	O
.	O
6	O
.	O
1	O
.	O
2	O
)	O
activity	O
and	O
hepatic	B-ANAT
malondialdehyde	O
(	O
MDA	O
)	O
content	O
,	O
severe	O
liver	B-ANAT
cell	I-ANAT
injury	O
,	O
and	O
increases	O
in	O
hepatic	B-ANAT
tumor	O
necrosis	O
factor	O
-	O
alpha	O
(	O
TNF	O
-	O
alpha	O
)	O
mRNA	O
expression	O
and	O
DNA	O
binding	O
activity	O
of	O
nuclear	O
factor	O
-	O
kappa	O
B	O
(	O
NF	O
-	O
kappa	O
B	O
).	O

Our	O
findings	O
also	O
suggest	O
that	O
HO	O
-	O
1	O
induction	O
may	O
play	O
an	O
important	O
role	O
in	O
conferring	O
protection	O
on	O
hepatocytes	B-ANAT
from	O
oxidative	O
damage	O
caused	O
by	O
free	O
heme	O
.	O

After	O
entry	O
(	O
10	O
and	O
15	O
min	O
),	O
spherical	O
core	O
particles	O
moved	O
into	O
the	O
cytoplasm	B-ANAT
within	O
large	O
vacuoles	B-ANAT
.	O

They	O
were	O
no	O
longer	O
in	O
large	O
vacuoles	B-ANAT
but	O
packaged	O
into	O
smaller	O
vacuoles	B-ANAT
in	O
the	O
cytoplasm	B-ANAT
,	O
and	O
occasionally	O
in	O
small	O
groups	O
.	O

While	O
increase	O
of	O
HLA	B-ANAT
-	O
B	O
*	O
4601	O
allele	O
frequency	O
was	O
observed	O
in	O
the	O
""""	O
Probable	O
SARS	O
infected	O
""""	O
patient	O
group	O
,	O
a	O
further	O
significant	O
increase	O
of	O
the	O
allele	O
was	O
seen	O
in	O
the	O
""""	O
Severe	O
cases	O
""""	O
patient	O
group	O
.	O

TITLE	O
:	O
Exhaled	O
breath	B-ANAT
condensate	O
nitrite	O
and	O
its	O
relation	O
to	O
tidal	O
volume	O
in	O
acute	O
lung	B-ANAT
injury	O
.	O

Patients	O
were	O
scored	O
according	O
to	O
American	O
and	O
European	O
Consensus	O
Conference	O
on	O
ARDS	O
criteria	O
(	O
AECC	O
)	O
[	O
no	O
lung	B-ANAT
injury	O
,	O
n	O
=	O
7	O
;	O
acute	O
lung	B-ANAT
injury	O
,	O
n	O
=	O
13	O
;	O
ARDS	O
,	O
n	O
=	O
15	O
],	O
as	O
well	O
as	O
the	O
Murray	O
lung	B-ANAT
injury	O
severity	O
score	O
(	O
LISS	O
)	O
[	O
score	O
0	O
,	O
n	O
=	O
3	O
;	O
score	O
0	O
.	O
1	O
to	O
2	O
.	O
5	O
,	O
n	O
=	O
19	O
;	O
score	O
>	O
2	O
.	O
5	O
,	O
n	O
=	O
13	O
].	O

The	O
increased	O
neurovirulence	O
mediated	O
by	O
the	O
virus	O
encoding	O
glycine	O
at	O
position	O
S310	O
was	O
not	O
associated	O
with	O
a	O
different	O
tropism	O
within	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
but	O
was	O
associated	O
with	O
increased	O
lateral	O
spread	O
in	O
the	O
CNS	B-ANAT
,	O
leading	O
to	O
significantly	O
higher	O
brain	B-ANAT
viral	O
titers	O
.	O

TITLE	O
:	O
Characterization	O
of	O
the	O
expression	O
,	O
intracellular	B-ANAT
localization	O
,	O
and	O
replication	O
complex	O
association	O
of	O
the	O
putative	O
mouse	O
hepatitis	O
virus	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
.	O

However	O
,	O
a	O
mouse	O
erythroleukemia	O
cell	B-ANAT
line	I-ANAT
,	O
CB3	O
,	O
does	O
not	O
express	O
hnRNP	B-ANAT
A1	O
but	O
still	O
supports	O
MHV	O
replication	O
,	O
suggesting	O
that	O
alternative	O
proteins	O
can	O
replace	O
hnRNP	B-ANAT
A1	O
in	O
cellular	B-ANAT
functions	O
and	O
viral	O
infection	O
.	O

Our	O
findings	O
demonstrate	O
that	O
the	O
functions	O
of	O
hnRNP	B-ANAT
A1	O
in	O
MHV	O
RNA	O
synthesis	O
can	O
be	O
replaced	O
by	O
other	O
closely	O
related	O
hnRNPs	O
,	O
further	O
supporting	O
the	O
roles	O
of	O
cellular	B-ANAT
proteins	O
in	O
MHV	O
RNA	O
synthesis	O
.	O

Artery	B-ANAT
blood	B-ANAT
gas	O
analysis	O
indexes	O
were	O
determined	O
in	O
38	O
of	O
103	O
cases	O
of	O
SARS	O
patients	O
during	O
acute	O
stage	O
,	O
the	O
relationship	O
between	O
the	O
change	O
of	O
blood	B-ANAT
gas	O
analysis	O
index	O
and	O
prognosis	O
of	O
patients	O
with	O
SARS	O
was	O
analyzed	O
.	O

CONCLUSIONS	O
:	O
The	O
artery	B-ANAT
blood	B-ANAT
gas	O
analysis	O
is	O
useful	O
for	O
judging	O
the	O
conditions	O
and	O
prognosis	O
of	O
patients	O
with	O
SARS	O
,	O
and	O
is	O
beneficial	O
for	O
clinical	O
treatment	O
.	O

The	O
CD	O
4	O
and	O
CD	O
8	O
T	B-ANAT
lymphocytes	I-ANAT
in	O
peripheral	B-ANAT
blood	I-ANAT
were	O
(	O
416	O
.	O
6	O
+/-	O
235	O
.	O
0	O
)	O
cells	B-ANAT
/	O
microl	O
and	O
(	O
296	O
.	O
1	O
+/-	O
181	O
.	O
5	O
)	O
cells	B-ANAT
/	O
microl	O
in	O
survival	O
patients	O
and	O
(	O
143	O
.	O
8	O
+/-	O
78	O
.	O
1	O
)	O
cells	B-ANAT
/	O
microl	O
,	O
(	O
103	O
.	O
6	O
+/-	O
63	O
.	O
2	O
)	O
cells	B-ANAT
/	O
microl	O
in	O
dead	O
patients	O
,	O
they	O
often	O
decreased	O
compared	O
to	O
the	O
normal	O
values	O
,	O
especially	O
in	O
dead	O
cases	O
.	O

In	O
dead	O
group	O
,	O
the	O
occurrence	O
rates	O
of	O
electrolyte	O
maladjustment	O
and	O
kidney	B-ANAT
injury	O
were	O
41	O
.	O
67	O
percent	O
.	O

The	O
data	O
of	O
patients	O
with	O
acute	O
renal	B-ANAT
dysfunction	O
hospitalized	O
in	O
ICU	O
of	O
Peking	O
union	O
medical	O
college	O
hospital	O
during	O
August	O
1999	O
to	O
May	O
2001	O
were	O
retrospectively	O
investigated	O
and	O
the	O
high	O
risk	O
factors	O
related	O
to	O
hospital	O
mortality	O
were	O
analyzed	O
.	O

If	O
the	O
three	O
factors	O
were	O
excluded	O
,	O
sepsis	O
,	O
central	O
nerves	B-ANAT
system	O
dysfunction	O
,	O
oliguria	O
became	O
the	O
risk	O
factors	O
of	O
mortality	O
(	O
all	O
P	O
<	O
0	O
.	O
05	O
).	O

Bad	O
prognosis	O
factors	O
were	O
identified	O
:	O
severe	O
state	O
on	O
admission	O
,	O
shock	O
on	O
admission	O
or	O
subsequently	O
,	O
non	O
adapted	O
initial	O
antibiotherapy	O
,	O
Child	O
'	O
s	O
score	O
B	O
and	O
C	O
,	O
Streptococus	O
pneumoniae	O
,	O
complications	O
:	O
ARDS	O
,	O
superinfections	O
,	O
coagulopathy	O
,	O
multi	O
organ	B-ANAT
failure	O
.	O

The	O
protein	O
responsible	O
for	O
viral	O
-	O
induced	O
membrane	B-ANAT
fusion	O
of	O
HIV	O
-	O
1	O
(	O
gp41	O
)	O
differs	O
in	O
length	O
,	O
and	O
has	O
no	O
sequence	O
homology	O
with	O
S2	O
.	O

The	O
AAV2	O
vector	O
was	O
capable	O
of	O
transducing	O
cells	B-ANAT
in	O
the	O
gray	B-ANAT
matter	I-ANAT
,	O
while	O
the	O
AAV1	O
vector	O
resulted	O
in	O
greater	O
transduction	O
of	O
the	O
gray	B-ANAT
matter	I-ANAT
than	O
AAV2	O
as	O
well	O
as	O
transduction	O
of	O
the	O
white	B-ANAT
matter	I-ANAT
.	O

RESULTS	O
:	O
The	O
symptoms	O
mostly	O
often	O
revealed	O
in	O
patients	O
of	O
early	O
stage	O
were	O
fever	O
in	O
56	O
patients	O
,	O
cough	O
in	O
41	O
and	O
weakness	O
or	O
heaviness	O
of	O
limbs	B-ANAT
in	O
40	O
,	O
which	O
in	O
patients	O
of	O
middle	O
or	O
crisis	O
stage	O
were	O
cough	O
in	O
53	O
and	O
weakness	O
or	O
heaviness	O
of	O
limbs	B-ANAT
in	O
43	O
.	O

Serum	B-ANAT
coronavirus	O
nucleic	B-ANAT
acid	O
was	O
positive	O
in	O
3	O
patients	O
,	O
coronavirus	O
antibody	O
positive	O
in	O
two	O
and	O
both	O
were	O
positive	O
in	O
one	O
.	O

TITLE	O
:	O
Left	O
ventricular	B-ANAT
performance	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
:	O
a	O
30	O
-	O
day	O
echocardiographic	O
follow	O
-	O
up	O
study	O
.	O

Significantly	O
higher	O
left	O
ventricular	B-ANAT
index	O
of	O
myocardial	O
performance	O
(	O
IMP	B-ANAT
)	O
(	O
0	O
.	O
42	O
+/-	O
0	O
.	O
13	O
versus	O
0	O
.	O
33	O
+/-	O
0	O
.	O
09	O
,	O
P	O
<	O
0	O
.	O
001	O
),	O
longer	O
isovolumic	O
relaxation	O
time	O
(	O
102	O
.	O
9	O
+/-	O
15	O
.	O
7	O
versus	O
81	O
.	O
6	O
+/-	O
14	O
.	O
7	O
ms	O
,	O
P	O
<	O
0	O
.	O
001	O
),	O
lower	O
flow	O
propagation	O
velocity	O
(	O
69	O
.	O
6	O
+/-	O
15	O
.	O
7	O
versus	O
83	O
.	O
8	O
+/-	O
19	O
.	O
7	O
cm	O
/	O
s	O
,	O
P	O
=	O
0	O
.	O
011	O
),	O
and	O
Doppler	O
-	O
derived	O
cardiac	B-ANAT
output	O
(	O
4	O
.	O
69	O
+/-	O
1	O
.	O
01	O
versus	O
5	O
.	O
49	O
+/-	O
1	O
.	O
04	O
L	O
/	O
min	O
,	O
P	O
<	O
0	O
.	O
001	O
)	O
were	O
observed	O
during	O
acute	O
infection	O
when	O
compared	O
with	O
those	O
at	O
30	O
days	O
.	O

ABSTRACT	O
:	O
Fas	O
ligand	O
(	O
FasL	O
)-	O
induced	O
lung	B-ANAT
inflammation	O
has	O
recently	O
been	O
suggested	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
acute	O
respiratory	O
disease	O
syndrome	O
(	O
ARDS	O
).	O

Intestinal	B-ANAT
biopsy	O
specimens	O
obtained	O
by	O
colonoscopy	O
or	O
autopsy	O
showed	O
minimal	O
architectural	O
disruption	O
but	O
the	O
presence	O
of	O
active	O
viral	O
replication	O
within	O
both	O
the	O
small	O
and	O
large	B-ANAT
intestine	I-ANAT
.	O

Coronavirus	O
was	O
also	O
isolated	O
by	O
culture	O
from	O
these	O
specimens	O
,	O
and	O
SARS	O
-	O
CoV	O
RNA	O
can	O
be	O
detected	O
in	O
the	O
stool	B-ANAT
of	O
patients	O
for	O
more	O
than	O
10	O
weeks	O
after	O
symptom	O
onset	O
.	O

In	O
a	O
twin	O
-	O
pregnancy	O
1	O
fetus	B-ANAT
was	O
lost	O
while	O
the	O
pregnant	O
'	O
s	O
situation	O
is	O
stable	O
.	O

Peripheral	B-ANAT
blood	I-ANAT
mononuclear	I-ANAT
cells	I-ANAT
collected	O
from	O
SARS	O
cases	O
infected	O
by	O
the	O
same	O
infectious	O
source	O
were	O
tested	O
for	O
both	O
negative	O
-	O
stranded	O
RNA	O
(	O
minus	O
-	O
RNA	O
,	O
""""	O
replicative	O
intermediates	O
""")"	O
and	O
positive	O
-	O
stranded	O
RNA	O
(	O
genomic	O
RNA	O
)	O
of	O
SARS	O
-	O
CoV	O
during	O
the	O
course	O
of	O
hospitalization	O
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
).	O

With	O
the	O
recent	O
surge	O
in	O
the	O
development	O
of	O
genetically	O
engineered	O
mutant	O
mice	O
with	O
alterations	O
in	O
immune	B-ANAT
system	I-ANAT
components	O
,	O
however	O
,	O
MHV	O
clearance	O
may	O
be	O
disrupted	O
.	O

Most	O
proinflammatory	O
cytokines	O
and	O
TGF	O
-	O
beta	O
1	O
were	O
elevated	O
during	O
the	O
early	O
phase	O
of	O
SARS	O
,	O
which	O
may	O
be	O
associated	O
with	O
lung	B-ANAT
infiltration	O
and	O
proliferation	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
determine	O
the	O
underlying	O
cellular	B-ANAT
mechanisms	O
in	O
the	O
pancreas	B-ANAT
after	O
acute	O
pancreatitis	O
and	O
to	O
study	O
the	O
pathogenesis	O
of	O
pancreatitis	O
-	O
associated	O
lung	B-ANAT
injury	O
.	O

CONCLUSIONS	O
:	O
NIP3L	O
may	O
be	O
involved	O
in	O
lung	B-ANAT
injury	O
,	O
which	O
is	O
one	O
of	O
the	O
major	O
causes	O
of	O
death	O
in	O
cases	O
of	O
severe	O
acute	O
pancreatitis	O
.	O

Using	O
seroconversion	O
to	O
CoV	O
as	O
the	O
""""	O
gold	O
standard	O
""""	O
for	O
SARS	O
CoV	O
diagnosis	O
,	O
WHO	O
-	O
HKU	O
and	O
WHO	O
-	O
Hamburg	O
RT	O
-	O
PCR	O
assays	O
exhibited	O
diagnostic	O
sensitivities	O
of	O
61	O
and	O
68	O
%	O
(	O
nasopharyngeal	B-ANAT
aspirate	I-ANAT
specimens	O
),	O
65	O
and	O
72	O
%	O
(	O
throat	B-ANAT
swab	I-ANAT
specimens	O
),	O
50	O
and	O
54	O
%	O
(	O
urine	B-ANAT
specimens	O
),	O
and	O
58	O
and	O
63	O
%	O
(	O
stool	B-ANAT
specimens	O
),	O
respectively	O
,	O
with	O
an	O
overall	O
specificity	O
of	O
100	O
%.	O

ABSTRACT	O
:	O
Pulmonary	B-ANAT
gene	O
therapy	O
offers	O
the	O
hope	O
of	O
treatment	O
for	O
conditions	O
such	O
as	O
cystic	O
fibrosis	O
,	O
lung	B-ANAT
cancer	O
,	O
pulmonary	B-ANAT
fibrosis	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
for	O
which	O
current	O
therapy	O
is	O
inadequate	O
.	O

Although	O
initial	O
clinical	O
trials	O
in	O
cystic	O
fibrosis	O
and	O
non	O
-	O
small	O
cell	B-ANAT
lung	B-ANAT
cancer	O
have	O
shown	O
promise	O
the	O
results	O
have	O
not	O
been	O
as	O
good	O
as	O
might	O
have	O
been	O
anticipated	O
.	O

Blood	B-ANAT
test	O
revealed	O
deep	O
lymphopenia	O
and	O
elevated	O
LDH	O
.	O

A	O
nonenteropathogenic	O
mutant	O
virus	O
that	O
lacked	O
a	O
sialic	O
acid	O
binding	O
activity	O
was	O
unable	O
to	O
bind	O
to	O
MGP	O
and	O
to	O
attach	O
to	O
goblet	B-ANAT
cells	I-ANAT
.	O

Indirect	O
immunofluorescent	O
assay	O
and	O
double	O
-	O
antigen	O
sandwich	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
were	O
used	O
to	O
detect	O
the	O
virus	O
-	O
specific	O
antibodies	O
in	O
sera	B-ANAT
of	O
1	O
,	O
060	O
non	O
-	O
SARS	O
children	O
in	O
Guangzhou	O
.	O

This	O
analysis	O
enhanced	O
understanding	O
of	O
how	O
nurses	O
are	O
portrayed	O
in	O
the	O
media	B-ANAT
,	O
but	O
it	O
indicated	O
the	O
significance	O
of	O
quality	O
of	O
work	O
life	O
and	O
issues	O
about	O
work	O
-	O
home	O
life	O
.	O

ABSTRACT	O
:	O
To	O
analyze	O
diagnostic	O
approach	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
according	O
to	O
the	O
diagnostic	O
criteria	O
issued	O
by	O
the	O
Ministry	O
of	O
Health	O
of	O
China	O
(	O
MHC	B-ANAT
).	O

A	O
chest	B-ANAT
radiograph	O
without	O
infiltrates	O
at	O
the	O
early	O
stage	O
of	O
SARS	O
is	O
an	O
important	O
factor	O
responsible	O
for	O
delayed	O
diagnosis	O
.	O

The	O
various	O
parameters	O
in	O
the	O
treated	O
group	O
were	O
all	O
better	O
than	O
those	O
in	O
the	O
control	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
or	O
P	O
<	O
0	O
.	O
01	O
),	O
the	O
occurrence	O
rate	O
of	O
acute	O
lung	B-ANAT
injury	O
and	O
its	O
mortality	O
in	O
the	O
treated	O
group	O
were	O
7	O
.	O
5	O
%	O
(	O
3	O
/	O
40	O
)	O
and	O
0	O
%	O
(	O
0	O
/	O
3	O
)	O
respectively	O
,	O
while	O
in	O
the	O
control	O
group	O
were	O
19	O
.	O
4	O
%	O
(	O
7	O
/	O
36	O
)	O
and	O
43	O
%	O
(	O
3	O
/	O
7	O
)	O
respectively	O
.	O

To	O
use	O
a	O
back	B-ANAT
projection	O
technique	O
to	O
construct	O
the	O
infection	O
curve	O
of	O
SARS	O
in	O
Hong	O
Kong	O
.	O

The	O
result	O
showed	O
2	O
/	O
66	O
cases	O
(	O
3	O
.	O
0	O
%)	O
were	O
positive	O
of	O
SARS	O
-	O
CoV	O
-	O
IgG	B-ANAT
antibody	I-ANAT
and	O
66	O
cases	O
were	O
negative	O
of	O
SARS	O
-	O
CoV	O
-	O
IgM	B-ANAT
antibody	I-ANAT
in	O
the	O
66	O
cases	O
healthy	O
controls	O
;	O
in	O
31	O
cases	O
with	O
SLE	O
,	O
positive	O
rates	O
of	O
SARS	O
-	O
CoV	O
-	O
IgG	O
and	O
IgM	B-ANAT
antibody	I-ANAT
were	O
58	O
.	O
1	O
%	O
(	O
18	O
/	O
31	O
)	O
and	O
29	O
%	O
(	O
9	O
/	O
31	O
),	O
respectively	O
,	O
in	O
which	O
7	O
cases	O
(	O
22	O
.	O
6	O
%)	O
were	O
positive	O
of	O
both	O
SARS	O
-	O
CoV	O
-	O
IgG	O
and	O
IgM	B-ANAT
antibody	I-ANAT
.	O

Here	O
,	O
we	O
established	O
a	O
rat	O
oligodendrocyte	B-ANAT
culture	O
that	O
is	O
morphologically	O
and	O
phenotypically	O
indistinguishable	O
from	O
the	O
primary	O
rat	O
oligodendrocytes	B-ANAT
.	O

Using	O
this	O
culture	O
,	O
we	O
showed	O
that	O
mature	O
rat	O
oligodendrocytes	B-ANAT
were	O
permissive	O
to	O
MHV	O
infection	O
but	O
did	O
not	O
support	O
productive	O
virus	O
replication	O
.	O

Prior	O
treatment	O
of	O
cells	B-ANAT
with	O
the	O
lysosomotropic	O
agents	O
NH	O
(	O
4	O
)	O
Cl	O
and	O
chloroquine	O
as	O
well	O
as	O
the	O
vacuolar	B-ANAT
proton	O
pump	O
-	O
ATPase	O
inhibitor	O
bafilomycin	O
A1	O
,	O
all	O
of	O
which	O
block	O
the	O
acidification	O
of	O
the	O
endosome	B-ANAT
,	O
prevented	O
oligodendrocytes	B-ANAT
from	O
succumbing	O
to	O
apoptosis	O
induced	O
by	O
MHV	O
mutant	O
OBLV60	O
,	O
which	O
enters	O
cells	B-ANAT
via	O
endocytosis	O
,	O
indicating	O
that	O
fusion	O
between	O
the	O
viral	B-ANAT
envelope	I-ANAT
and	O
cell	B-ANAT
membranes	I-ANAT
triggers	O
the	O
apoptotic	O
cascade	O
.	O

Our	O
results	O
,	O
thus	O
,	O
for	O
the	O
first	O
time	O
provide	O
unequivocal	O
evidence	O
that	O
infection	O
of	O
oligodendrocytes	B-ANAT
with	O
MHV	O
directly	O
results	O
in	O
apoptosis	O
.	O

This	O
finding	O
provides	O
an	O
explanation	O
for	O
the	O
destruction	O
of	O
oligodendrocytes	B-ANAT
and	O
the	O
damage	O
of	O
myelin	B-ANAT
sheath	I-ANAT
in	O
MHV	O
-	O
infected	O
CNS	B-ANAT
and	O
suggests	O
that	O
oligodendrocyte	B-ANAT
apoptosis	O
may	O
be	O
one	O
of	O
the	O
underlying	O
mechanisms	O
for	O
the	O
pathogenesis	O
of	O
MHV	O
-	O
induced	O
demyelinating	O
diseases	O
in	O
animals	O
.	O

Difficulties	O
of	O
diagnosis	O
,	O
infection	O
control	O
,	O
and	O
treatment	O
of	O
SARS	O
in	O
renal	B-ANAT
failure	O
patients	O
are	O
discussed	O
in	O
this	O
report	O
.	O

TITLE	O
:	O
The	O
crystal	B-ANAT
structures	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
virus	O
main	O
protease	O
and	O
its	O
complex	O
with	O
an	O
inhibitor	O
.	O

Here	O
,	O
we	O
report	O
the	O
crystal	B-ANAT
structures	O
of	O
the	O
SARS	O
-	O
CoV	O
main	O
protease	O
at	O
different	O
pH	O
values	O
and	O
in	O
complex	O
with	O
a	O
specific	O
inhibitor	O
.	O

This	O
decrease	O
is	O
most	O
likely	O
due	O
to	O
increased	O
lymphocyte	B-ANAT
apoptotic	O
rate	O
.	O

Lymphocyte	B-ANAT
subsets	O
were	O
analysed	O
by	O
flow	O
cytometry	O
,	O
using	O
a	O
whole	B-ANAT
blood	I-ANAT
indirect	O
immunofluorescence	O
technique	O
and	O
mAbs	O
specific	O
for	O
feline	O
CD5	O
,	O
CD4	O
,	O
CD8	O
,	O
CD21	O
.	O

Cats	O
with	O
diseases	O
other	O
than	O
FIP	O
also	O
had	O
decreased	O
number	O
of	O
lymphocytes	B-ANAT
:	O
as	O
a	O
consequence	O
,	O
the	O
diagnostic	O
relevance	O
of	O
these	O
findings	O
is	O
very	O
low	O
.	O

Daily	O
chest	B-ANAT
radiographs	O
were	O
graded	O
according	O
to	O
percentage	O
of	O
lung	B-ANAT
involvement	O
during	O
20	O
.	O
15	O
days	O
+/-	O

Health	O
workers	O
need	O
training	O
in	O
the	O
use	O
of	O
appropriate	O
barriers	O
against	O
droplets	O
and	O
other	O
body	B-ANAT
fluids	I-ANAT
.	O

Chest	B-ANAT
X	O
-	O
ray	O
examination	O
have	O
to	O
be	O
repeated	O
,	O
because	O
abnormal	O
chest	B-ANAT
X	O
-	O
ray	O
do	O
not	O
always	O
appear	O
at	O
the	O
same	O
time	O
with	O
fever	O
.	O

ARDS	O
,	O
kidney	B-ANAT
failure	O
,	O
and	O
shock	O
occurred	O
within	O
4	O
days	O
,	O
encephalopathy	O
within	O
6	O
days	O
(	O
average	O
4	O
.	O
8	O
+/-	O
0	O
.	O
9	O
days	O
),	O
abscesses	O
after	O
14	O
days	O
,	O
systemic	O
bacterial	O
infection	O
and	O
fungous	O
infection	O
within	O
half	O
a	O
month	O
(	O
average	O
14	O
.	O
6	O
+/-	O
1	O
.	O
1	O
days	O
,	O
14	O
.	O
8	O
+/-	O
0	O
.	O
9	O
days	O
respectively	O
),	O
and	O
death	O
within	O
6	O
days	O
.	O

HSV	O
was	O
detected	O
by	O
oropharyngeal	B-ANAT
swab	O
in	O
the	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
of	O
169	O
(	O
22	O
%)	O
of	O
764	O
patients	O
,	O
within	O
10	O
days	O
of	O
admission	O
for	O
150	O
(	O
89	O
%)	O
of	O
these	O
individuals	O
.	O

Four	O
hours	O
later	O
she	O
developed	O
progressive	O
respiratory	O
distress	O
,	O
diffuse	O
geographical	O
airspace	O
disease	O
and	O
bilateral	O
pulmonary	B-ANAT
edema	O
.	O

Granulocyte	B-ANAT
or	O
human	O
leukocyte	B-ANAT
antigen	O
antibodies	O
in	O
donor	O
plasma	B-ANAT
may	O
confirm	O
a	O
diagnosis	O
of	O
transfusion	O
injury	O
.	O

The	O
clinician	O
should	O
appreciate	O
that	O
erythrocyte	B-ANAT
transfusion	O
to	O
prevent	O
or	O
treat	O
acute	O
chest	B-ANAT
syndrome	O
may	O
cause	O
transfusion	O
related	O
acute	O
lung	B-ANAT
injury	O
,	O
a	O
condition	O
that	O
mimics	O
,	O
exacerbates	O
or	O
possibly	O
triggers	O
the	O
syndrome	O
it	O
was	O
intended	O
to	O
treat	O
.	O

Serum	B-ANAT
protein	O
electrophoresis	O
and	O
the	O
concentration	O
of	O
haptoglobin	O
(	O
Hp	O
),	O
serum	B-ANAT
amyloid	O
A	O
(	O
SAA	O
),	O
alpha	O
(	O
1	O
)-	O
acid	O
glycoprotein	O
(	O
AGP	O
),	O
IgG	O
and	O
IgM	O
were	O
evaluated	O
in	O
cats	O
exposed	O
to	O
feline	O
coronavirus	O
(	O
FCoV	O
)	O
and	O
in	O
cats	O
with	O
FIP	O
.	O

Investigation	O
consisted	O
of	O
local	O
examination	O
of	O
ear	B-ANAT
,	O
nose	B-ANAT
,	O
and	O
throat	B-ANAT
fields	O
;	O
palpation	O
of	O
the	O
nuchal	O
areas	O
;	O
and	O
plain	O
chest	B-ANAT
radiography	O
.	O

ABSTRACT	O
:	O
To	O
explore	O
the	O
distribution	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
in	O
SARS	O
autopsy	O
tissues	B-ANAT
at	O
the	O
molecular	O
level	O
.	O

SARS	O
-	O
CoV	O
invades	O
various	O
organs	B-ANAT
of	O
the	O
body	B-ANAT
and	O
distributes	O
in	O
a	O
similar	O
fashion	O
to	O
CD13	O
,	O
the	O
receptor	O
of	O
human	O
coronavirus	O
229E	O
.	O

There	O
was	O
swollen	O
tongue	B-ANAT
body	I-ANAT
in	O
5	O
patients	O
(	O
7	O
.	O
2	O
%),	O
teeth	B-ANAT
print	O
on	O
tongue	B-ANAT
margin	I-ANAT
in	O
12	O
cases	O
(	O
17	O
.	O
4	O
%).	O

In	O
the	O
155	O
patients	O
of	O
recovery	O
stage	O
,	O
the	O
color	O
of	O
tongue	B-ANAT
proper	O
was	O
mostly	O
dark	O
pale	O
(	O
72	O
patients	O
,	O
46	O
.	O
5	O
%),	O
the	O
second	O
light	O
red	O
(	O
68	O
patients	O
,	O
43	O
.	O
9	O
%),	O
color	O
of	O
tongue	B-ANAT
coating	O
was	O
mostly	O
thin	O
white	O
(	O
80	O
patients	O
,	O
51	O
.	O
6	O
%),	O
which	O
was	O
significantly	O
higher	O
than	O
other	O
colors	O
(	O
P	O
<	O
0	O
.	O
01	O
),	O
the	O
second	O
was	O
yellow	O
in	O
tongue	B-ANAT
root	I-ANAT
region	O
(	O
31	O
patients	O
,	O
20	O
.	O
0	O
%).	O

RESULTS	O
:	O
In	O
the	O
69	O
patients	O
of	O
acute	O
stage	O
,	O
the	O
color	O
of	O
tongue	B-ANAT
proper	O
was	O
mostly	O
light	O
red	O
(	O
51	O
patients	O
,	O
73	O
.	O
9	O
%),	O
with	O
significant	O
difference	O
in	O
comparing	O
with	O
other	O
colors	O
(	O
P	O
<	O
0	O
.	O
01	O
).	O

Throughout	O
the	O
crisis	O
we	O
had	O
to	O
face	B-ANAT
head	B-ANAT
-	O
on	O
the	O
unintended	O
outcomes	O
that	O
flow	O
from	O
a	O
healthcare	O
delivery	O
system	O
designed	O
as	O
a	O
series	O
of	O
unconnected	O
silos	O
.	O

A	O
total	O
of	O
10	O
(	O
6	O
)	O
TCID50	O
viruses	O
were	O
placed	O
in	O
each	O
tested	O
condition	O
,	O
and	O
changes	O
of	O
the	O
viral	O
infectivity	O
in	O
samples	O
after	O
treatments	O
were	O
measured	O
by	O
evaluating	O
cytopathic	O
effect	O
(	O
CPE	O
)	O
in	O
cell	B-ANAT
line	I-ANAT
Vero	O
-	O
E6	O
at	O
48	O
h	O
after	O
infection	O
.	O

Viruses	O
stayed	O
stable	O
at	O
4	O
degrees	O
C	O
,	O
at	O
room	O
temperature	O
(	O
20	O
degrees	O
C	O
)	O
and	O
at	O
37	O
degrees	O
C	O
for	O
at	O
least	O
2	O
h	O
without	O
remarkable	O
change	O
in	O
the	O
infectious	O
ability	O
in	O
cells	B-ANAT
,	O
but	O
were	O
converted	O
to	O
be	O
non	O
-	O
infectious	O
after	O
90	O
-,	O
60	O
-	O
and	O
30	O
-	O
min	O
exposure	O
at	O
56	O
degrees	O
C	O
,	O
at	O
67	O
degrees	O
C	O
and	O
at	O
75	O
degrees	O
C	O
,	O
respectively	O
.	O

In	O
the	O
healthy	O
persons	O
,	O
the	O
antibody	O
titer	O
of	O
serum	B-ANAT
samples	O
obtained	O
from	O
Beijing	O
in	O
May	O
,	O
2003	O
was	O
-	O
1	O
.	O
61	O
+/-	O

Peripheral	B-ANAT
blood	I-ANAT
from	O
162	O
cases	O
of	O
SARS	O
,	O
30	O
cases	O
of	O
mycoplasma	O
pneumonia	O
and	O
30	O
healthy	O
adult	O
volunteers	O
were	O
measured	O
for	O
the	O
number	O
of	O
total	O
B	B-ANAT
cells	I-ANAT
(	O
CD19	O
+	O
B	B-ANAT
cell	I-ANAT
),	O
CD5	O
positive	O
B	B-ANAT
cells	I-ANAT
(	O
B1	O
cell	B-ANAT
)	O
and	O
mean	O
fluorescent	O
intensity	O
of	O
CD40	O
on	O
B	B-ANAT
cell	I-ANAT
(	O
CD40MF	O
)	O
using	O
tri	O
-	O
color	O
flow	O
cytometry	O
to	O
analyze	O
the	O
distribution	O
of	O
the	O
above	O
parameters	O
in	O
SARS	O
,	O
mycoplasma	O
pneumonia	O
and	O
healthy	O
adult	O
volunteers	O
and	O
their	O
relation	O
to	O
the	O
severity	O
of	O
SARS	O
.	O

TITLE	O
:	O
[	O
Cardiac	B-ANAT
arrest	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
:	O
analysis	O
of	O
15	O
cases	O
].	O

TITLE	O
:	O
Quantitative	O
analysis	O
and	O
prognostic	O
implication	O
of	O
SARS	O
coronavirus	O
RNA	O
in	O
the	O
plasma	B-ANAT
and	O
serum	B-ANAT
of	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

Serum	B-ANAT
samples	O
were	O
also	O
obtained	O
from	O
23	O
confirmed	O
SARS	O
patients	O
on	O
the	O
day	O
of	O
hospital	O
admission	O
,	O
11	O
of	O
whom	O
subsequently	O
required	O
intensive	O
care	O
.	O

The	O
RT	O
-	O
PCR	O
system	O
for	O
the	O
polymerase	O
region	O
detected	O
SARS	O
-	O
CoV	O
RNA	O
in	O
50	O
%	O
of	O
plasma	B-ANAT
and	O
78	O
%	O
of	O
serum	B-ANAT
samples	O
from	O
SARS	O
patients	O
during	O
the	O
first	O
week	O
of	O
illness	O
.	O

CONCLUSIONS	O
:	O
Plasma	B-ANAT
/	O
serum	B-ANAT
SARS	O
-	O
CoV	O
quantification	O
represents	O
a	O
potentially	O
useful	O
early	O
diagnostic	O
and	O
prognostic	O
tool	O
for	O
SARS	O
.	O

N385	O
had	O
the	O
highest	O
affinity	O
for	O
forming	O
peptide	O
-	O
antibody	O
complexes	O
with	O
SARS	O
serum	B-ANAT
.	O

Together	O
,	O
these	O
results	O
colocalize	O
FIPV	O
replication	O
,	O
lymphocyte	B-ANAT
depletion	O
in	O
tissues	B-ANAT
,	O
and	O
alterations	O
in	O
cytokine	O
transcription	O
and	O
translation	O
.	O

TITLE	O
:	O
Proliferative	O
growth	O
of	O
SARS	O
coronavirus	O
in	O
Vero	O
E6	O
cells	B-ANAT
.	O

By	O
24	O
to	O
30	O
h	O
p	O
.	O
i	O
.,	O
crystalline	O
arrays	O
of	O
the	O
extracellular	B-ANAT
virus	B-ANAT
particles	I-ANAT
were	O
seen	O
commonly	O
at	O
the	O
cell	B-ANAT
surface	I-ANAT
.	O

ABSTRACT	O
:	O
Spike	O
(	O
S	O
)	O
proteins	O
of	O
coronaviruses	O
,	O
including	O
the	O
coronavirus	O
that	O
causes	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
associate	O
with	O
cellular	B-ANAT
receptors	O
to	O
mediate	O
infection	O
of	O
their	O
target	B-ANAT
cells	I-ANAT
.	O

Six	O
of	O
these	O
patients	O
presented	O
reduced	O
lung	B-ANAT
compliance	O
(	O
four	O
of	O
them	O
had	O
acute	O
respiratory	O
distress	O
syndrome	O
);	O
and	O
twelve	O
patients	O
showed	O
increased	O
airway	B-ANAT
resistance	O
(	O
six	O
of	O
them	O
presented	O
bronchiolitis	O
).	O

TITLE	O
:	O
[	O
Cloning	O
,	O
expression	O
and	O
purification	O
of	O
SARS	O
coronavirus	O
PUMC2	O
strain	O
nucleocapsid	B-ANAT
protein	O
].	O

RESULTS	O
:	O
One	O
hundred	O
and	O
fifty	O
-	O
eight	O
nasal	B-ANAT
and	O
throat	B-ANAT
swabs	O
specimens	O
from	O
79	O
SARS	O
patients	O
in	O
Peking	O
Union	O
Medical	O
College	O
Hospital	O
between	O
April	O
and	O
May	O
,	O
2003	O
were	O
cultured	O
for	O
SARS	O
-	O
coronavirus	O
.	O

Fifty	O
-	O
six	O
normal	O
healthy	O
blood	B-ANAT
donors	O
were	O
also	O
detected	O
as	O
normal	O
controls	O
.	O

The	O
interval	O
between	O
hospital	O
discharge	B-ANAT
and	O
functional	O
assessment	O
was	O
1	O
.	O
75	O
+/-	O

Diffusion	O
capacity	O
for	O
carbon	O
monoxide	O
(	O
DLco	O
)	O
was	O
impaired	O
in	O
38	O
patients	O
(	O
42	O
.	O
7	O
%);	O
in	O
7	O
patients	O
(	O
7	O
.	O
9	O
%),	O
lung	B-ANAT
function	O
was	O
restrictive	O
defect	O
combined	O
DLco	O
impairment	O
;	O
Other	O
patterns	O
of	O
impairment	O
were	O
revealed	O
in	O
3	O
patient	O
.	O

Until	O
the	O
1920s	O
,	O
intestinal	B-ANAT
diseases	O
such	O
as	O
typhoid	O
fever	O
and	O
cholera	O
often	O
spread	O
through	O
water	O
and	O
were	O
a	O
leading	O
cause	O
of	O
death	O
in	O
the	O
United	O
States	O
.	O

Diagnostic	O
utility	O
of	O
these	O
variables	O
was	O
higher	O
when	O
performed	O
on	O
effusion	B-ANAT
.	O

Effusion	B-ANAT
RT	O
-	O
PCR	O
was	O
performed	O
in	O
6	O
cats	O
;	O
it	O
was	O
positive	O
in	O
all	O
5	O
cats	O
with	O
FIP	O
and	O
negative	O
in	O
the	O
cat	O
with	O
another	O
disease	O
.	O

Tissue	B-ANAT
sections	O
were	O
stained	O
with	O
haematoxylin	O
and	O
eosin	O
(	O
H	O
&	O
E	O
),	O
and	O
in	O
situ	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
on	O
lung	B-ANAT
sections	O
was	O
performed	O
using	O
SARS	O
coronavirus	O
-	O
specific	O
primers	O
.	O

In	O
situ	O
RT	O
-	O
PCR	O
detected	O
SARS	O
coronavirus	O
RNA	O
in	O
type	O
II	O
alveolar	B-ANAT
cells	B-ANAT
,	O
interstitial	B-ANAT
cells	B-ANAT
and	O
bronchiolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
from	O
all	O
three	O
patients	O
.	O

Severe	O
immunological	O
damage	O
in	O
lung	B-ANAT
tissue	I-ANAT
is	O
responsible	O
for	O
the	O
clinical	O
features	O
of	O
SARS	O
.	O

ABSTRACT	O
:	O
Recombinant	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	O
nucleocapsid	B-ANAT
protein	O
was	O
employed	O
to	O
establish	O
an	O
antigen	O
-	O
capturing	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
).	O

A	O
group	O
at	O
the	O
Joint	B-ANAT
Centre	O
for	O
Bioethics	O
(	O
JCB	O
)	O
at	O
the	O
University	O
of	O
Toronto	O
formally	O
explored	O
the	O
ethical	O
dimensions	O
of	O
this	O
outbreak	O
.	O

Adoptive	O
transfer	O
of	O
IBV	O
-	O
infection	O
-	O
induced	O
alphabeta	O
T	B-ANAT
cells	I-ANAT
bearing	O
CD8	O
antigen	O
protected	O
chicks	O
from	O
challenge	O
infection	O
.	O

ABSTRACT	O
:	O
In	O
addition	O
to	O
maintaining	O
the	O
GenBank	O
(	O
R	O
)	O
nucleic	B-ANAT
acid	O
sequence	O
database	O
,	O
the	O
National	O
Center	O
for	O
Biotechnology	O
Information	O
(	O
NCBI	O
)	O
provides	O
data	O
analysis	O
and	O
retrieval	O
resources	O
for	O
the	O
data	O
in	O
GenBank	O
and	O
other	O
biological	O
data	O
made	O
available	O
through	O
NCBI	O
'	O
s	O
website	O
.	O

NCBI	O
resources	O
include	O
Entrez	O
,	O
PubMed	O
,	O
PubMed	O
Central	O
,	O
LocusLink	O
,	O
the	O
NCBI	O
Taxonomy	O
Browser	O
,	O
BLAST	B-ANAT
,	O
BLAST	B-ANAT
Link	O
(	O
BLink	O
),	O
Electronic	O
PCR	O
,	O
OrfFinder	O
,	O
Spidey	O
,	O
RefSeq	O
,	O
UniGene	O
,	O
HomoloGene	O
,	O
ProtEST	O
,	O
dbMHC	O
,	O
dbSNP	O
,	O
Cancer	O
Chromosome	B-ANAT
Aberration	O
Project	O
(	O
CCAP	O
),	O
Entrez	O
Genomes	O
and	O
related	O
tools	O
,	O
the	O
Map	O
Viewer	O
,	O
Model	O
Maker	O
,	O
Evidence	O
Viewer	O
,	O
Clusters	O
of	O
Orthologous	O
Groups	O
(	O
COGs	O
)	O
database	O
,	O
Retroviral	O
Genotyping	O
Tools	O
,	O
SARS	O
Coronavirus	O
Resource	O
,	O
SAGEmap	O
,	O
Gene	O
Expression	O
Omnibus	O
(	O
GEO	O
),	O
Online	O
Mendelian	O
Inheritance	O
in	O
Man	O
(	O
OMIM	O
),	O
the	O
Molecular	O
Modeling	O
Database	O
(	O
MMDB	O
),	O
the	O
Conserved	O
Domain	O
Database	O
(	O
CDD	O
)	O
and	O
the	O
Conserved	O
Domain	O
Architecture	O
Retrieval	O
Tool	O
(	O
CDART	O
).	O

The	O
purpose	O
of	O
this	O
article	O
is	O
to	O
describe	O
the	O
chest	B-ANAT
radiographic	O
manifestations	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
in	O
previously	O
uninfected	O
health	O
care	O
workers	O
during	O
the	O
early	O
stages	O
of	O
an	O
outbreak	O
in	O
Toronto	O
,	O
Canada	O
.	O

ABSTRACT	O
:	O
We	O
retrospectively	O
reviewed	O
high	O
-	O
resolution	O
CT	O
(	O
HRCT	O
)	O
examinations	O
of	O
the	O
lungs	B-ANAT
performed	O
in	O
27	O
confirmed	O
cases	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

VOPBA	O
identified	O
a	O
150	O
kDa	O
protein	O
,	O
as	O
a	O
putative	O
PEDV	O
receptor	O
in	O
enterocytes	B-ANAT
and	O
swine	O
testicle	B-ANAT
(	O
ST	O
)	O
cells	B-ANAT
.	O

The	O
neuraminidase	O
inhibitors	O
(	O
NAIs	O
)	O
are	O
a	O
new	O
class	O
of	O
antiviral	O
drug	O
targeting	O
a	O
viral	O
influenza	O
enzyme	O
,	O
the	O
neuraminidase	O
,	O
which	O
acts	O
both	O
to	O
facilitate	O
virus	O
infection	O
of	O
cells	B-ANAT
by	O
clearing	O
a	O
passage	O
through	O
otherwise	O
protective	O
respiratory	O
fluids	B-ANAT
and	O
also	O
by	O
helping	O
release	O
of	O
the	O
virus	O
by	O
cutting	O
the	O
chemical	O
umbilical	B-ANAT
cord	I-ANAT
which	O
links	O
up	O
the	O
virus	O
to	O
the	O
infected	O
cell	B-ANAT
.	O

We	O
report	O
a	O
girl	O
born	O
at	O
37	O
weeks	O
of	O
gestation	O
presenting	O
12	O
hours	O
after	O
birth	O
with	O
hypopnea	O
,	O
bradycardia	O
and	O
a	O
decreased	O
muscular	B-ANAT
tone	O
of	O
unknown	O
origin	O
.	O

Median	O
serum	B-ANAT
electrolyte	O
levels	O
(	O
and	O
range	O
)	O
on	O
admission	O
were	O
10	O
.	O
9	O
mg	O
/	O
dl	O
(	O
9	O
-	O
24	O
)	O
for	O
calcium	O
,	O
4	O
.	O
3	O
mg	O
/	O
dl	O
(	O
1	O
-	O
30	O
)	O
for	O
magnesium	O
,	O
and	O
4	O
.	O
1	O
mg	O
/	O
dl	O
(	O
2	O
-	O
9	O
)	O
for	O
phosphorus	O
.	O

Potential	O
pathogens	O
were	O
isolated	O
from	O
feces	B-ANAT
from	O
32	O
of	O
the	O
45	O
crias	O
.	O

A	O
total	O
of	O
39	O
potential	O
pathogens	O
were	O
obtained	O
,	O
including	O
coronavirus	O
(	O
n	O
=	O
19	O
crias	O
;	O
42	O
%),	O
Giardia	O
spp	O
(	O
8	O
;	O
18	O
%),	O
Eimeria	O
spp	O
(	O
6	O
;	O
13	O
%),	O
Cryptosporidium	O
spp	O
(	O
4	O
;	O
9	O
%),	O
rotavirus	O
(	O
1	O
;	O
2	O
%),	O
and	O
nematode	O
ova	B-ANAT
(	O
1	O
;	O
2	O
%).	O

ABSTRACT	O
:	O
Mice	O
aged	O
1	O
,	O
4	O
or	O
8	O
weeks	O
were	O
inoculated	O
with	O
haemagglutinating	O
encephalomyelitis	O
virus	O
(	O
HEV	B-ANAT
),	O
strain	O
67N	O
,	O
by	O
the	O
intracerebral	O
(	O
i	O
.	O
c	O
.	O

To	O
follow	O
the	O
spread	O
of	O
HEV	B-ANAT
from	O
peripheral	B-ANAT
nerves	I-ANAT
to	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
),	O
the	O
virus	O
was	O
inoculated	O
subcutaneously	O
into	O
the	O
right	O
hind	O
leg	B-ANAT
of	O
4	O
-	O
week	O
-	O
old	O
mice	O
.	O

Clinical	O
parameters	O
,	O
including	O
oxygen	O
saturation	O
and	O
requirement	O
,	O
laboratory	O
measures	O
,	O
and	O
serial	O
chest	B-ANAT
radiography	O
results	O
.	O

In	O
this	O
preliminary	O
,	O
uncontrolled	O
study	O
of	O
patients	O
with	O
SARS	O
,	O
use	O
of	O
interferon	O
alfacon	O
-	O
1	O
plus	O
corticosteroids	O
was	O
associated	O
with	O
reduced	O
disease	O
-	O
associated	O
impaired	O
oxygen	O
saturation	O
,	O
more	O
rapid	O
resolution	O
of	O
radiographic	O
lung	B-ANAT
abnormalities	O
,	O
and	O
lower	O
levels	O
of	O
creatine	O
kinase	O
.	O

Intracerebral	O
infection	O
of	O
RAG1	O
(-/-)	O
mice	O
with	O
a	O
recombinant	O
CXCL10	O
-	O
expressing	O
murine	O
coronavirus	O
(	O
mouse	O
hepatitis	O
virus	O
)	O
resulted	O
in	O
protection	O
from	O
disease	O
and	O
increased	O
survival	O
that	O
correlated	O
with	O
a	O
significant	O
increase	O
in	O
recruitment	O
and	O
activation	O
of	O
natural	O
killer	O
(	O
NK	O
)	O
cells	B-ANAT
within	O
the	O
CNS	B-ANAT
.	O

We	O
recently	O
reported	O
that	O
certain	O
N	O
-	O
methylthio	O
-	O
substituted	O
beta	O
-	O
lactam	O
antibiotics	O
had	O
DNA	O
-	O
damaging	O
and	O
apoptosis	O
-	O
inducing	O
activities	O
in	O
various	O
tumor	B-ANAT
cells	I-ANAT
.	O

Thus	O
,	O
CD28	O
,	O
the	O
costimulatory	O
T	B-ANAT
cell	I-ANAT
molecule	O
,	O
is	O
not	O
required	O
for	O
MHV	O
infection	O
and	O
MHV	O
-	O
induced	O
demyelination	O
.	O

In	O
addition	O
,	O
plasma	B-ANAT
IL	O
-	O
10	O
concentration	O
was	O
significantly	O
lower	O
1	O
to	O
2	O
days	O
and	O
7	O
to	O
10	O
days	O
after	O
corticosteroid	O
treatment	O
,	O
compared	O
with	O
the	O
immediate	O
pretreatment	O
level	O
.	O

It	O
ameliorated	O
both	O
parenchymal	O
and	O
fatty	B-ANAT
tissue	I-ANAT
necrosis	O
of	O
the	O
pancreas	B-ANAT
.	O

RESULTS	O
:	O
Infliximab	O
treatment	O
significantly	O
decreased	O
serum	B-ANAT
amylase	O
activity	O
(	O
11939	O
+/-	O

Final	O
diagnosis	O
of	O
SARS	O
was	O
determined	O
by	O
the	O
results	O
of	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
and	O
paired	O
serum	B-ANAT
.	O

TITLE	O
:	O
Severe	O
maternal	O
respiratory	O
distress	O
due	O
to	O
the	O
amniotic	B-ANAT
fluid	I-ANAT
embolism	O
syndrome	O
in	O
a	O
twin	O
pregnancy	O
.	O

ABSTRACT	O
:	O
A	O
28	O
-	O
year	O
-	O
old	O
female	O
with	O
a	O
twin	O
pregnancy	O
at	O
29	O
6	O
/	O
7	O
weeks	O
who	O
was	O
having	O
premature	O
uterine	B-ANAT
contractions	O
developed	O
acute	O
respiratory	O
failure	O
due	O
to	O
sudden	O
pulmonary	B-ANAT
oedema	O
requiring	O
mechanical	O
ventilation	O
.	O

To	O
investigate	O
the	O
nature	O
of	O
viral	O
RNA	O
molecules	O
in	O
these	O
clinical	O
samples	O
,	O
we	O
determined	O
copy	O
numbers	O
of	O
ORF	O
1b	O
and	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
gene	O
sequences	O
of	O
SARS	O
CoV	O
.	O
The	O
quantitative	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
assay	O
was	O
more	O
sensitive	O
than	O
the	O
conventional	O
RT	O
-	O
PCR	O
assay	O
for	O
detecting	O
SARS	O
CoV	O
in	O
samples	O
collected	O
early	O
in	O
the	O
course	O
of	O
the	O
disease	O
.	O

Lung	B-ANAT
protective	O
strategy	O
was	O
used	O
in	O
all	O
the	O
cases	O
comprising	O
of	O
low	O
tidal	O
volumes	O
at	O
the	O
rate	O
of	O
5	O
-	O
ml	O
/	O
kg	O
-	O
body	B-ANAT
weight	O
.	O

A	O
63	O
-	O
year	O
-	O
old	O
man	O
was	O
admitted	O
to	O
our	O
hospital	O
for	O
intensive	O
care	O
of	O
severe	O
acute	O
respiratory	O
failure	O
with	O
diffuse	O
infiltration	O
in	O
both	O
lungs	B-ANAT
.	O

Concentrations	O
of	O
surfactant	O
protein	O
(	O
SP	O
)-	O
A	O
and	O
SP	O
-	O
D	O
in	O
sera	B-ANAT
reflected	O
the	O
clinical	O
features	O
.	O

ABSTRACT	O
:	O
Fecal	B-ANAT
secretory	O
immunoglobulin	O
A	O
(	O
IgA	O
)	O
antibodies	O
in	O
dogs	O
infected	O
or	O
vaccinated	O
with	O
canine	O
coronavirus	O
(	O
CCV	O
)	O
were	O
evaluated	O
by	O
an	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

The	O
study	O
was	O
carried	O
out	O
with	O
32	O
fecal	B-ANAT
samples	O
collected	O
just	O
before	O
inoculation	O
and	O
at	O
28	O
days	O
postinoculation	O
.	O

TITLE	O
:	O
Profile	O
of	O
antibodies	O
to	O
the	O
nucleocapsid	B-ANAT
protein	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	O
in	O
probable	O
SARS	O
patients	O
.	O

ABSTRACT	O
:	O
Profiles	O
of	O
antibodies	O
to	O
the	O
nucleocapsid	B-ANAT
protein	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	O
in	O
445	O
probable	O
SARS	O
patients	O
and	O
3	O
,	O
749	O
healthy	O
people	O
or	O
non	O
-	O
SARS	O
patients	O
were	O
analyzed	O
by	O
antigen	O
-	O
capturing	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

TITLE	O
:	O
Detection	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
in	O
blood	B-ANAT
of	O
infected	O
patients	O
.	O

Wound	O
debridement	O
and	O
skin	B-ANAT
graft	I-ANAT
cured	O
two	O
cases	O
of	O
necrotizing	O
fasciitis	O
.	O

One	O
of	O
four	O
conservatively	O
managed	O
tubo	O
-	O
ovarian	B-ANAT
masses	O
spontaneously	O
drained	O
rectally	O
.	O

TITLE	O
:	O
The	O
role	O
of	O
nuclear	O
factor	O
kappa	O
B	O
in	O
the	O
pathogenesis	O
of	O
pulmonary	B-ANAT
diseases	O
:	O
implications	O
for	O
therapy	O
.	O

Immunoelectron	O
microscopy	O
showed	O
that	O
CD45RO	O
positive	O
T	B-ANAT
lymphocyte	I-ANAT
decreased	O
to	O
6	O
%	O
-	O
7	O
%.	O

Circulating	O
lymphocytes	B-ANAT
had	O
the	O
highest	O
percentage	O
of	O
infection	O
.	O

Virus	O
entered	O
cells	B-ANAT
by	O
endocytosis	O
or	O
membrane	B-ANAT
fusion	O
and	O
was	O
released	O
through	O
a	O
budding	O
process	O
.	O

Our	O
data	O
suggested	O
that	O
lymphocytes	B-ANAT
,	O
particularly	O
T	B-ANAT
cells	I-ANAT
,	O
were	O
probably	O
the	O
target	B-ANAT
cells	I-ANAT
of	O
SARS	O
CoV	O
.	O
The	O
viruses	O
may	O
actively	O
infected	O
the	O
immune	O
cells	B-ANAT
during	O
SARS	O
CoV	O
acute	O
infection	O
phase	O
and	O
the	O
destruction	O
of	O
target	B-ANAT
cells	I-ANAT
may	O
be	O
one	O
of	O
the	O
important	O
reasons	O
for	O
the	O
death	O
of	O
the	O
circulating	O
leukocytes	B-ANAT
in	O
SARS	O
.	O

By	O
5	O
days	O
postinfection	O
,	O
these	O
mice	O
showed	O
significantly	O
(	O
approximately	O
20	O
-	O
fold	O
)	O
lower	O
titers	O
of	O
infectious	O
virus	O
in	O
the	O
brain	B-ANAT
compared	O
to	O
control	O
mice	O
.	O

Clinical	O
symptoms	O
of	O
BO	O
were	O
cough	O
,	O
tachypnea	O
,	O
and	O
wheezing	O
after	O
acute	O
lung	B-ANAT
injury	O
.	O

Pulmonary	B-ANAT
CT	O
showed	O
bronchial	B-ANAT
wall	I-ANAT
thickening	O
,	O
bronchiectasis	O
,	O
atelectasis	O
,	O
and	O
mosaic	O
perfusion	O
.	O

METHODS	O
:	O
Clinical	O
manifestation	O
,	O
chest	B-ANAT
X	O
-	O
ray	O
,	O
computed	O
tomography	O
(	O
CT	O
)	O
and	O
pulmonary	B-ANAT
function	O
of	O
4	O
cases	O
with	O
bronchiolitis	O
obliterans	O
were	O
retrospectively	O
analyzed	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
dose	O
response	O
of	O
inhaled	O
nitric	O
oxide	O
(	O
iNO	O
)	O
for	O
surfactant	O
-	O
treated	O
rabbits	O
with	O
meconium	B-ANAT
aspiration	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
hypoxemic	O
respiratory	O
failure	O
(	O
HRF	O
),	O
and	O
variation	O
of	O
measured	O
iNO	O
by	O
continuous	O
NO	O
delivery	O
in	O
pressure	O
support	O
ventilation	O
(	O
PSV	O
).	O

The	O
gene	O
mutation	O
rates	O
of	O
replicase	O
1AB	O
,	O
S2	O
domain	O
of	O
spike	O
glycoprotein	O
and	O
nucleocapsid	B-ANAT
protein	O
were	O
lower	O
(	O
0	O
.	O
079	O
%	O
-	O
0	O
.	O
103	O
%).	O

Fever	O
was	O
the	O
initiative	O
symptom	O
,	O
4	O
had	O
a	O
body	B-ANAT
temperature	O
of	O
over	O
38	O
degrees	O
C	O
with	O
the	O
highest	O
being	O
40	O
degrees	O
C	O
;	O
fever	O
sustained	O
from	O
4	O
to	O
7	O
days	O
with	O
an	O
average	O
of	O
5	O
.	O
6	O
days	O
.	O

TITLE	O
:	O
The	O
protective	O
effects	O
of	O
early	O
treatment	O
with	O
propofol	O
on	O
endotoxin	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
in	O
rats	O
.	O

Whereas	O
the	O
lung	B-ANAT
pathology	O
was	O
dominated	O
by	O
diffuse	O
alveolar	B-ANAT
damage	O
,	O
the	O
gut	B-ANAT
was	O
relatively	O
intact	O
.	O

These	O
findings	O
indicated	O
that	O
tissue	B-ANAT
responses	O
to	O
SARS	O
-	O
CoV	O
infection	O
are	O
distinct	O
in	O
different	O
organs	B-ANAT
.	O

ABSTRACT	O
:	O
Infection	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
with	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	O
hepatitis	O
virus	O
produces	O
acute	O
and	O
chronic	O
demyelination	O
.	O

The	O
initial	O
blood	B-ANAT
cells	I-ANAT
count	O
showed	O
that	O
total	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
(	O
WBC	B-ANAT
)	O
count	O
was	O
(	O
2	O
.	O
5	O
-	O
9	O
.	O
7	O
)	O
x	O
10	O
(	O
9	O
)/	O
L	O
.	O
In	O
22	O
(	O
67	O
%)	O
cases	O
the	O
WBC	B-ANAT
count	O
was	O
<	O
5	O
.	O
0	O
x	O
10	O
(	O
9	O
)/	O
L	O
,	O
and	O
in	O
10	O
(	O
30	O
%)	O
WBC	B-ANAT
was	O
(	O
5	O
.	O
0	O
-	O
7	O
.	O
0	O
)	O
x	O
10	O
(	O
9	O
)/	O
L	O
,	O
in	O
18	O
cases	O
most	O
of	O
the	O
WBC	B-ANAT
were	O
lymphocyte	B-ANAT
count	O
.	O

Patients	O
who	O
received	O
long	O
-	O
term	O
ventilation	O
,	O
those	O
who	O
received	O
short	O
-	O
term	O
ventilation	O
,	O
and	O
those	O
who	O
did	O
not	O
receive	O
ventilation	O
had	O
similar	O
pulmonary	B-ANAT
changes	O
at	O
CT	O
.	O

In	O
our	O
HCl	O
ALI	O
model	O
,	O
SL	O
improved	O
oxygenation	O
and	O
quasi	O
-	O
static	O
lung	B-ANAT
compliance	O
over	O
C	O
.	O
The	O
pulmonary	B-ANAT
function	O
effects	O
of	O
SL	O
were	O
further	O
enhanced	O
by	O
the	O
addition	O
of	O
Lidocaine	O
to	O
the	O
surfactant	O
suspension	O
.	O

ABSTRACT	O
:	O
The	O
angiotensin	O
-	O
converting	O
enzyme	O
(	O
ACE	O
)-	O
related	O
carboxypeptidase	O
,	O
ACE2	O
,	O
is	O
a	O
type	O
I	O
integral	O
membrane	B-ANAT
protein	O
of	O
805	O
amino	O
acids	O
that	O
contains	O
one	O
HEXXH	O
+	O
E	O
zinc	O
-	O
binding	O
consensus	O
sequence	O
.	O

Matrix	O
-	O
assisted	O
laser	O
desorption	O
/	O
ionization	O
-	O
mass	O
spectrometry	O
determination	O
showed	O
that	O
relative	O
molecular	O
weight	O
of	O
intact	O
N	O
protein	O
is	O
45	O
929	O
Da	O
,	O
which	O
is	O
very	O
close	O
to	O
its	O
theoretically	O
calculated	O
molecular	O
weight	O
45	O
935	O
Da	O
based	O
on	O
the	O
amino	O
acid	O
sequence	O
deduced	O
from	O
the	O
genome	O
with	O
the	O
first	O
amino	O
acid	O
methionine	O
at	O
the	O
N	O
-	O
terminus	O
depleted	O
and	O
second	O
,	O
serine	O
,	O
acetylated	O
,	O
indicating	O
that	O
phosphorylation	O
does	O
not	O
happen	O
at	O
all	O
in	O
the	O
predicted	O
phosphorylation	O
sites	O
within	O
infected	O
cells	B-ANAT
nor	O
in	O
virus	B-ANAT
particles	I-ANAT
.	O

ABSTRACT	O
:	O
Theiler	O
'	O
s	O
murine	O
encephalomyelitis	O
virus	O
(	O
TMEV	O
)	O
causes	O
demyelination	O
with	O
inflammation	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
in	O
mice	O
and	O
is	O
used	O
as	O
an	O
animal	O
model	O
for	O
multiple	O
sclerosis	O
(	O
MS	O
).	O

Detailed	O
gross	O
and	O
microscopic	O
examination	O
of	O
the	O
autopsy	O
specimen	O
is	O
performed	O
,	O
including	O
lung	B-ANAT
,	O
heart	B-ANAT
,	O
liver	B-ANAT
,	O
kidney	B-ANAT
,	O
spleen	B-ANAT
and	O
lymph	B-ANAT
nodes	I-ANAT
.	O

The	O
alveolar	B-ANAT
spaces	O
are	O
filled	O
with	O
fibrinous	O
exudates	B-ANAT
and	O
lined	O
with	O
hyaline	B-ANAT
membrane	B-ANAT
.	O

It	O
is	O
postulated	O
that	O
viral	O
infection	O
induces	O
severe	O
damage	O
of	O
alveolar	B-ANAT
epithelial	O
and	O
capillary	B-ANAT
endothelial	I-ANAT
cells	I-ANAT
,	O
leads	O
to	O
pulmonary	B-ANAT
edema	O
,	O
intra	O
-	O
alveolar	B-ANAT
fibrin	O
deposit	O
,	O
and	O
hyaline	B-ANAT
membrane	B-ANAT
formation	O
.	O

RESULTS	O
:	O
All	O
of	O
the	O
lungs	B-ANAT
are	O
markedly	O
enlarged	O
and	O
consolidated	O
.	O

A	O
higher	O
mean	O
virus	O
load	O
in	O
nasopharyngeal	B-ANAT
specimens	O
obtained	O
on	O
day	O
10	O
after	O
the	O
onset	O
of	O
symptoms	O
was	O
significantly	O
associated	O
with	O
the	O
occurrence	O
of	O
diarrhea	O
(	O
3	O
.	O
1	O
log10	O
vs	O
.	O
1	O
.	O
8	O
log10	O
copies	O
/	O
mL	O
;	O
P	O
=.	O
01	O
)	O
and	O
mortality	O
(	O
6	O
.	O
2	O
vs	O
.	O
1	O
.	O
7	O
log10	O
copies	O
/	O
mL	O
;	O
P	O
<.	O
01	O
).	O

The	O
patient	O
reported	O
no	O
respiratory	O
complaints	O
,	O
and	O
the	O
findings	O
of	O
serial	O
chest	B-ANAT
radiographs	O
were	O
normal	O
.	O

ABSTRACT	O
:	O
We	O
have	O
expressed	O
a	O
series	O
of	O
truncated	O
spike	O
(	O
S	O
)	O
glycoproteins	O
of	O
SARS	O
-	O
CoV	O
and	O
found	O
that	O
the	O
N	O
-	O
terminus	O
14	O
-	O
502	O
residuals	O
were	O
sufficient	O
to	O
bind	O
to	O
SARS	O
-	O
CoV	O
susceptible	O
Vero	O
E6	O
cells	B-ANAT
.	O

Further	O
studies	O
showed	O
the	O
susceptibility	O
of	O
this	O
cell	B-ANAT
was	O
due	O
to	O
the	O
expression	O
of	O
endogenous	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
which	O
was	O
activated	O
by	O
inserted	O
LTR	O
from	O
retroviral	O
vector	O
used	O
for	O
expression	O
cloning	O
.	O

ABSTRACT	O
:	O
This	O
report	O
demonstrates	O
that	O
a	O
rapid	O
decrease	O
of	O
peripheral	O
T	B-ANAT
cell	I-ANAT
subsets	I-ANAT
is	O
a	O
unique	O
characteristic	O
in	O
patients	O
with	O
SARS	O
during	O
acute	O
infection	O
,	O
although	O
total	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
counts	O
,	O
red	B-ANAT
blood	I-ANAT
cell	I-ANAT
counts	O
,	O
and	O
platelet	B-ANAT
counts	O
remain	O
relatively	O
normal	O
.	O

Although	O
the	O
underlying	O
mechanism	O
of	O
the	O
acute	O
decrease	O
of	O
peripheral	O
T	B-ANAT
cell	I-ANAT
subsets	I-ANAT
observed	O
in	O
patients	O
with	O
SARS	O
during	O
the	O
acute	O
stage	O
remains	O
unknown	O
,	O
this	O
clinical	O
characteristic	O
can	O
facilitate	O
an	O
earlier	O
and	O
more	O
accurate	O
diagnosis	O
of	O
SARS	O
.	O

ABSTRACT	O
:	O
Liver	B-ANAT
impairment	O
is	O
commonly	O
reported	O
in	O
up	O
to	O
60	O
%	O
of	O
patients	O
who	O
suffer	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

Liver	B-ANAT
specimens	O
were	O
examined	O
by	O
light	O
and	O
electron	O
microscopy	O
,	O
and	O
immunohistochemistry	O
.	O

By	O
using	O
the	O
anti	O
-	O
TNFalpha	O
mAb	O
in	O
combination	O
with	O
PE	O
-	O
and	O
FITC	O
-	O
conjugated	O
mAbs	O
against	O
feline	O
CD4	O
and	O
CD8	O
,	O
respectively	O
,	O
antiviral	O
CD4	O
+	O
and	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
could	O
be	O
identified	O
in	O
the	O
peripheral	B-ANAT
blood	I-ANAT
and	O
in	O
the	O
spleens	B-ANAT
of	O
feline	O
infectious	O
peritonitis	O
virus	O
-	O
infected	O
cats	O
.	O

Moreover	O
,	O
feline	O
calicivirus	O
(	O
FCV	O
)-	O
specific	O
CD4	O
+	O
T	B-ANAT
cells	I-ANAT
were	O
detected	O
in	O
the	O
spleens	B-ANAT
of	O
FCV	O
-	O
vaccinated	O
cats	O
.	O

A	O
straightforward	O
protocol	O
,	O
in	O
which	O
splenocyte	B-ANAT
preparations	O
served	O
both	O
as	O
APCs	O
and	O
effector	O
cells	B-ANAT
,	O
consistently	O
yielded	O
best	O
results	O
.	O

In	O
each	O
of	O
these	O
three	O
viral	O
tests	O
,	O
all	O
cats	O
positive	O
for	O
serum	B-ANAT
antibody	O
/	O
antigen	O
were	O
also	O
positive	O
for	O
ascitic	O
antibody	O
/	O
antigen	O
,	O
while	O
cats	O
negative	O
for	O
serum	B-ANAT
antibody	O
/	O
antigen	O
were	O
also	O
negative	O
for	O
ascitic	O
antibody	O
/	O
antigen	O
.	O

Unlike	O
unresolving	O
MHV	O
-	O
JHM	O
infections	O
,	O
the	O
clearance	O
of	O
WTR13	O
and	O
S4R22	O
infections	O
coincided	O
with	O
strong	O
IFN	O
-	O
gamma	O
transcription	O
and	O
an	O
increase	O
in	O
the	O
number	O
of	O
CD8	O
T	B-ANAT
cells	I-ANAT
infiltrating	O
into	O
the	O
CNS	B-ANAT
.	O

Increased	O
apoptosis	O
appeared	O
to	O
contribute	O
to	O
the	O
diminished	O
presence	O
of	O
CD8	O
T	B-ANAT
cells	I-ANAT
in	O
MHV	O
-	O
JHM	O
-	O
infected	O
brain	B-ANAT
with	O
the	O
consequence	O
of	O
a	O
lower	O
potential	O
for	O
IFNgamma	O
production	O
and	O
antiviral	O
activity	O
.	O

In	O
the	O
case	O
of	O
AIDS	O
,	O
the	O
HIV	O
(	O
which	O
has	O
had	O
a	O
long	O
-	O
term	O
symbiotic	O
relationship	O
with	O
primates	O
)	O
has	O
run	O
amuck	O
because	O
the	O
infected	O
cells	B-ANAT
are	O
now	O
substantially	O
more	O
tolerant	O
to	O
the	O
toxins	O
(	O
i	O
.	O
e	O
.,	O
resistant	O
to	O
apoptosis	O
)	O
that	O
they	O
secrete	O
than	O
the	O
uninfected	O
bystander	O
cells	B-ANAT
,	O
which	O
are	O
not	O
unusually	O
resistant	O
to	O
apoptosis	O
.	O

The	O
differences	O
between	O
the	O
two	O
groups	O
were	O
compared	O
in	O
terms	O
of	O
development	O
of	O
illness	O
,	O
time	O
of	O
using	O
corticosteroid	O
and	O
absorption	O
time	O
of	O
pulmonary	B-ANAT
inflammatory	O
lesion	O
,	O
etc	O
.	O

TITLE	O
:	O
Very	O
diverse	O
CD8	O
T	B-ANAT
cell	I-ANAT
clonotypic	O
responses	O
after	O
virus	O
infections	O
.	O

ABSTRACT	O
:	O
We	O
measured	O
CD8	O
T	B-ANAT
cell	I-ANAT
clonotypic	O
diversity	O
to	O
three	O
epitopes	O
recognized	O
in	O
C57BL	O
/	O
6	O
mice	O
infected	O
with	O
mouse	O
hepatitis	O
virus	O
,	O
strain	O
JHM	O
,	O
or	O
lymphocytic	O
choriomeningitis	O
virus	O
.	O

Intense	O
CD8	O
(+)	O
T	B-ANAT
cell	I-ANAT
responses	O
to	O
SNV	O
may	O
be	O
induced	O
by	O
the	O
encounter	O
of	O
the	O
unnatural	O
human	O
host	O
to	O
this	O
zoonotic	O
virus	O
without	O
coevolution	O
.	O

TITLE	O
:	O
Pegylated	O
interferon	O
-	O
alpha	O
protects	O
type	B-ANAT
1	I-ANAT
pneumocytes	I-ANAT
against	O
SARS	O
coronavirus	O
infection	O
in	O
macaques	O
.	O

Replication	O
of	O
this	O
SARS	O
coronavirus	O
(	O
SCV	O
)	O
occurs	O
mainly	O
in	O
the	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
,	O
and	O
causes	O
diffuse	O
alveolar	B-ANAT
damage	O
.	O

Here	O
we	O
show	O
extensive	O
SCV	O
antigen	O
expression	O
in	O
type	B-ANAT
1	I-ANAT
pneumocytes	I-ANAT
of	O
experimentally	O
infected	O
cynomolgus	O
macaques	O
(	O
Macaca	O
fascicularis	O
)	O
at	O
4	O
d	O
postinfection	O
(	O
d	O
.	O
p	O
.	O
i	O
.),	O
indicating	O
that	O
this	O
cell	B-ANAT
type	I-ANAT
is	O
the	O
primary	O
target	O
for	O
SCV	O
infection	O
early	O
in	O
the	O
disease	O
,	O
and	O
explaining	O
the	O
subsequent	O
pulmonary	B-ANAT
damage	O
.	O

CONCLUSIONS	O
:	O
Recruitment	O
maneuver	O
was	O
safe	O
and	O
useful	O
to	O
improve	O
oxygenation	O
and	O
Cs	O
in	O
patients	O
with	O
severe	O
ARDS	O
ventilated	O
with	O
lung	B-ANAT
-	O
protective	O
strategy	O
.	O

TITLE	O
:	O
Geldanamycin	O
,	O
a	O
ligand	O
of	O
heat	O
shock	O
protein	O
90	O
,	O
inhibits	O
the	O
replication	O
of	O
herpes	O
simplex	B-ANAT
virus	O
type	O
1	O
in	O
vitro	O
.	O

ABSTRACT	O
:	O
To	O
assess	O
the	O
effectiveness	O
of	O
the	O
Australian	O
border	B-ANAT
entry	O
screening	O
program	O
to	O
detect	O
arriving	O
travellers	O
with	O
symptoms	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

One	O
person	O
reported	O
as	O
a	O
probable	O
SARS	O
case	O
acknowledged	O
being	O
symptomatic	O
on	O
arrival	O
,	O
but	O
had	O
been	O
missed	O
by	O
border	B-ANAT
screening	O
.	O

Another	O
interesting	O
finding	O
was	O
that	O
mouse	O
antibodies	O
elicited	O
separately	O
by	O
plasmids	O
encoding	O
S1	O
and	O
S2	O
subunits	O
cooperatively	O
neutralized	O
SARS	O
-	O
CoV	O
but	O
neither	O
the	O
S1	O
nor	O
S2	O
specific	O
antibodies	O
did	O
,	O
suggesting	O
the	O
possible	O
role	O
of	O
both	O
S1	O
and	O
S2	O
subunits	O
in	O
host	B-ANAT
cell	I-ANAT
docking	O
and	O
entry	O
.	O

TITLE	O
:	O
Silencing	O
SARS	O
-	O
CoV	O
Spike	O
protein	O
expression	O
in	O
cultured	B-ANAT
cells	I-ANAT
by	O
RNA	O
interference	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
dynamic	O
changes	O
of	O
dendritic	B-ANAT
cell	I-ANAT
subsets	O
in	O
peripheral	B-ANAT
blood	I-ANAT
of	O
patients	O
infected	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
evaluate	O
their	O
roles	O
in	O
the	O
immunopathogenesis	O
of	O
SARS	O
.	O

Fifteen	O
sputum	B-ANAT
samples	O
from	O
patients	O
were	O
compared	O
with	O
25	O
control	O
samples	O
.	O

These	O
macrophages	B-ANAT
frequently	O
showed	O
morphological	O
changes	O
,	O
such	O
as	O
cytoplasmic	B-ANAT
foaminess	O
,	O
vacuole	B-ANAT
formation	O
,	O
and	O
nuclear	O
changes	O
(	O
including	O
multinucleation	O
and	O
a	O
ground	O
glass	O
appearance	O
)	O
when	O
compared	O
with	O
the	O
control	O
samples	O
.	O

RESULTS	O
:	O
Fifteen	O
sputum	B-ANAT
samples	O
from	O
patients	O
were	O
compared	O
with	O
25	O
control	O
samples	O
.	O

Investigations	O
include	O
a	O
review	O
of	O
clinical	O
features	O
,	O
morphological	O
assessment	O
,	O
histochemical	O
and	O
immunohistochemical	O
stainings	O
,	O
ultrastructural	O
study	O
,	O
and	O
virological	O
investigations	O
in	O
postmortem	B-ANAT
tissue	I-ANAT
.	O

Positive	O
viral	O
culture	O
for	O
coronavirus	O
was	O
detected	O
in	O
most	O
premortem	O
nasopharyngeal	B-ANAT
aspirate	I-ANAT
specimens	O
(	O
five	O
of	O
six	O
)	O
and	O
postmortem	O
lung	B-ANAT
tissues	I-ANAT
(	O
two	O
of	O
seven	O
).	O

RESULTS	O
:	O
Positive	O
viral	O
culture	O
for	O
coronavirus	O
was	O
detected	O
in	O
most	O
premortem	O
nasopharyngeal	B-ANAT
aspirate	I-ANAT
specimens	O
(	O
five	O
of	O
six	O
)	O
and	O
postmortem	O
lung	B-ANAT
tissues	I-ANAT
(	O
two	O
of	O
seven	O
).	O

These	O
findings	O
argued	O
against	O
the	O
importance	O
of	O
cholesterol	O
-	O
dependent	O
CEACAM	O
localizations	O
into	O
membrane	B-ANAT
microdomains	O
for	O
MHV	O
entry	O
,	O
instead	O
suggesting	O
that	O
cholesterol	O
had	O
a	O
more	O
direct	O
role	O
.	O

TITLE	O
:	O
Presence	O
of	O
an	O
encephalomyocarditis	O
virus	O
internal	O
ribosome	B-ANAT
entry	O
site	O
sequence	O
in	O
avian	O
infectious	O
bronchitis	O
virus	O
defective	O
RNAs	O
abolishes	O
rescue	O
by	O
helper	O
virus	O
.	O

CAT	O
protein	O
was	O
detected	O
from	O
T7	O
-	O
derived	O
IBV	O
D	O
-	O
RNA	O
transcripts	O
in	O
a	O
cell	B-ANAT
-	O
free	O
protein	O
synthesis	O
system	O
and	O
in	O
situ	O
in	O
avian	O
chick	O
kidney	B-ANAT
(	O
CK	O
)	O
cells	B-ANAT
following	O
T7	O
-	O
derived	O
D	O
-	O
RNA	O
synthesis	O
from	O
a	O
recombinant	O
fowlpox	O
virus	O
expressing	O
the	O
bacteriophage	O
T7	O
DNA	O
-	O
dependent	O
RNA	O
polymerase	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
:	O
temporal	O
lung	B-ANAT
changes	O
at	O
thin	O
-	O
section	O
CT	O
in	O
30	O
patients	O
.	O

RESULTS	O
:	O
Study	O
groups	O
were	O
comparable	O
with	O
regard	O
to	O
baseline	O
physiological	O
and	O
clinical	O
characteristics	O
(	O
age	O
,	O
sex	O
ratio	O
,	O
autonomy	O
,	O
medical	O
history	O
,	O
cause	O
of	O
pulmonary	B-ANAT
edema	O
).	O

By	O
phylogenetic	O
tree	O
analysis	O
,	O
Korean	O
IBV	O
field	O
isolates	O
were	O
branched	B-ANAT
into	O
five	O
clusters	O
in	O
which	O
3	O
clusters	O
were	O
differentiated	O
from	O
non	O
-	O
Korean	O
IBV	O
strains	O
.	O

Pulmonary	B-ANAT
consolidations	O
(	O
odds	O
ratio	O
=	O
7	O
.	O
25	O
)	O
and	O
,	O
especially	O
,	O
ARDS	O
(	O
odds	O
ratio	O
=	O
22	O
.	O
9	O
)	O
were	O
significantly	O
associated	O
with	O
severe	O
baseline	O
hypoxemia	O
(	O
PaO2	O
,	O
<	O
60	O
mm	O
Hg	O
).	O

In	O
both	O
cases	O
lung	B-ANAT
involvement	O
was	O
severe	O
,	O
requiring	O
artificial	O
ventilation	O
.	O

Our	O
objective	O
was	O
to	O
assess	O
exposure	O
to	O
morphine	O
as	O
an	O
etiologic	O
factor	O
for	O
acute	O
chest	B-ANAT
syndrome	O
in	O
sickle	B-ANAT
cell	I-ANAT
disease	O
.	O

Children	O
(	O
aged	O
5	O
-	O
17	O
years	O
)	O
with	O
sickle	B-ANAT
cell	I-ANAT
crisis	O
were	O
randomized	O
to	O
receive	O
oral	B-ANAT
sustained	O
-	O
release	O
morphine	O
,	O
1	O
.	O
9	O
mg	O
.	O

The	O
risk	O
of	O
acute	O
chest	B-ANAT
syndrome	O
is	O
significantly	O
associated	O
with	O
high	O
systemic	O
exposure	O
to	O
morphine	O
and	O
its	O
active	O
metabolite	O
morphine	O
-	O
6	O
-	O
glucuronide	O
after	O
oral	B-ANAT
administration	O
of	O
slow	O
-	O
release	O
morphine	O
.	O

Prone	O
ventilation	O
could	O
improve	O
oxygenation	O
by	O
better	O
ventilation	O
-	O
perfusion	O
(	O
V	O
/	O
Q	O
)	O
matching	O
and	O
improved	O
drainage	B-ANAT
of	O
blood	B-ANAT
from	O
the	O
dorsal	O
lung	B-ANAT
.	O

Both	O
were	O
specific	O
for	O
SARS	O
-	O
CoV	O
as	O
determined	O
by	O
testing	O
against	O
human	O
CoV	O
229E	O
and	O
OC43	O
,	O
specimens	O
from	O
patients	O
without	O
SARS	O
,	O
and	O
by	O
BLAST	B-ANAT
searches	O
of	O
GenBank	O
for	O
primer	O
and	O
probe	O
sequence	O
homology	O
.	O

ABSTRACT	O
:	O
Nosocomial	O
transmission	O
of	O
droplet	O
-	O
borne	O
respiratory	O
infections	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
may	O
be	O
influenced	O
by	O
the	O
choice	O
of	O
oxygen	O
face	B-ANAT
mask	O
.	O

High	O
-	O
level	O
allergen	O
exposure	O
,	O
exposure	O
to	O
tobacco	O
smoke	O
,	O
and	O
lack	O
of	O
breast	B-ANAT
-	O
feeding	O
showed	O
no	O
association	O
with	O
wheezing	O
.	O

SAC	B-ANAT
-	O
induced	O
IL	O
-	O
12	O
secreting	O
cells	B-ANAT
were	O
deficient	O
before	O
,	O
during	O
and	O
long	O
after	O
treatment	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
the	O
most	O
severe	O
lung	B-ANAT
injury	O
caused	O
by	O
many	O
pathologic	O
states	O
.	O

A	O
total	O
of	O
81	O
sera	B-ANAT
,	O
including	O
67	O
from	O
convalescent	O
patients	O
and	O
seven	O
pairs	O
from	O
two	O
time	O
points	O
of	O
infection	O
,	O
were	O
analyzed	O
,	O
and	O
all	O
showed	O
immunoreactivity	O
towards	O
the	O
nucleocapsid	B-ANAT
protein	O
(	O
N	O
).	O

The	O
reactivities	O
of	O
the	O
recombinant	O
proteins	O
to	O
a	O
panel	O
of	O
antibodies	O
containing	O
33	O
SARS	O
coronavirus	O
-	O
positive	O
sera	B-ANAT
and	O
66	O
negative	O
sera	B-ANAT
and	O
to	O
antibodies	O
against	O
other	O
animal	O
coronaviruses	O
were	O
screened	O
.	O

A	O
truncated	O
195	O
-	O
amino	O
-	O
acid	O
fragment	O
from	O
the	O
C	O
terminus	O
of	O
the	O
nucleocapsid	B-ANAT
protein	O
(	O
N195	O
)	O
was	O
identified	O
that	O
had	O
a	O
strong	O
ability	O
to	O
detect	O
antibodies	O
against	O
SARS	O
coronavirus	O
.	O

A	O
panel	O
of	O
S	O
protein	O
-	O
derived	O
peptides	O
was	O
tested	O
for	O
their	O
binding	O
affinity	O
to	O
HLA	B-ANAT
-	O
A	O
*	O
0201	O
molecules	O
.	O

SARS	O
-	O
CoV	O
protein	O
-	O
derived	O
peptide	O
-	O
1	O
(	O
SSp	O
-	O
1	O
RLNEVAKNL	O
),	O
induced	O
peptide	O
-	O
specific	O
CTLs	O
both	O
in	O
vivo	O
(	O
transgenic	O
mice	O
)	O
and	O
in	O
vitro	O
(	O
human	O
PBLs	O
),	O
which	O
specifically	O
released	O
interferon	O
-	O
gamma	O
(	O
IFN	O
-	O
gamma	O
)	O
upon	O
stimulation	O
with	O
SSp	O
-	O
1	O
-	O
pulsed	O
autologous	O
dendritic	B-ANAT
cells	I-ANAT
(	O
DCs	O
)	O
or	O
T2	O
cells	B-ANAT
.	O

TITLE	O
:	O
Coronavirus	O
neurovirulence	O
correlates	O
with	O
the	O
ability	O
of	O
the	O
virus	O
to	O
induce	O
proinflammatory	O
cytokine	O
signals	O
from	O
astrocytes	B-ANAT
and	O
microglia	B-ANAT
.	O

Thus	O
,	O
antibodies	O
,	O
acting	O
alone	O
,	O
can	O
prevent	O
replication	O
of	O
the	O
SARS	O
coronavirus	O
in	O
the	O
lung	B-ANAT
,	O
a	O
promising	O
observation	O
for	O
the	O
development	O
of	O
vaccines	O
,	O
immunotherapy	O
,	O
and	O
immunoprophylaxis	O
regimens	O
.	O

In	O
developing	O
this	O
response	O
,	O
CDC	O
recommends	O
a	O
definition	O
for	O
a	O
clinically	O
confirmed	O
case	O
of	O
AIPH	O
among	O
infants	O
on	O
the	O
basis	O
of	O
evidence	O
of	O
blood	B-ANAT
in	O
the	O
airway	B-ANAT
,	O
age	O
</=	O
1	O
year	O
,	O
absence	O
of	O
medical	O
conditions	O
related	O
to	O
pulmonary	B-ANAT
hemorrhage	O
,	O
and	O
severe	O
acute	O
respiratory	O
distress	O
or	O
respiratory	O
failure	O
.	O

Recently	O
,	O
quantitative	O
measurement	O
of	O
blood	B-ANAT
SARS	O
CoV	O
RNA	O
with	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
technique	O
has	O
been	O
developed	O
with	O
a	O
detection	O
rate	O
of	O
80	O
%	O
as	O
early	O
as	O
day	O
1	O
of	O
hospital	O
admission	O
but	O
the	O
detection	O
rates	O
drop	O
to	O
75	O
%	O
and	O
42	O
%	O
on	O
day	O
7	O
and	O
day	O
14	O
,	O
respectively	O
.	O

Other	O
drug	O
treatments	O
had	O
also	O
been	O
tried	O
in	O
desperate	O
patients	O
,	O
including	O
the	O
use	O
of	O
convalescence	O
serum	B-ANAT
and	O
plasmapheresis	O
.	O

Several	O
adverse	O
prognostic	O
factors	O
have	O
been	O
identified	O
,	O
including	O
advanced	O
age	O
,	O
presence	O
of	O
comorbidity	O
,	O
higher	O
lactose	O
dehydrogenase	O
levels	O
and	O
initial	O
neutrophil	B-ANAT
count	O
,	O
but	O
the	O
impact	O
of	O
viral	O
and	O
other	O
host	O
factors	O
on	O
outcome	O
is	O
unknown	O
.	O

TITLE	O
:	O
Comparisons	O
of	O
envelope	B-ANAT
through	O
5B	O
sequences	O
of	O
infectious	O
bronchitis	O
coronaviruses	O
indicates	O
recombination	O
occurs	O
in	O
the	O
envelope	B-ANAT
and	O
membrane	B-ANAT
genes	O
.	O

N	O
proteins	O
of	O
other	O
coronavirus	O
have	O
been	O
reported	O
to	O
be	O
involved	O
in	O
forming	O
the	O
viral	B-ANAT
core	I-ANAT
and	O
also	O
in	O
the	O
packaging	O
and	O
transcription	O
of	O
the	O
viral	O
RNA	O
.	O

Neuraminidase	O
inhibitors	O
have	O
produced	O
notable	O
progress	O
in	O
the	O
therapeutic	O
approaches	O
to	O
influenza	O
-	O
associated	O
pulmonary	B-ANAT
infections	O
and	O
are	O
at	O
least	O
able	O
to	O
shorten	O
the	O
duration	O
of	O
symptoms	O
in	O
selected	O
patients	O
.	O

Adult	O
Sprague	O
-	O
Dawley	O
rats	O
were	O
assigned	O
to	O
4	O
groups	O
:	O
(	O
1	O
)	O
general	O
anesthetic	O
only	O
,	O
(	O
2	O
)	O
general	O
anesthetic	O
with	O
bilateral	O
femur	B-ANAT
fractures	O
and	O
nailing	O
,	O
(	O
3	O
)	O
general	O
anesthetic	O
and	O
N	O
-	O
acetylcysteine	O
,	O
(	O
4	O
)	O
general	O
anesthetic	O
with	O
bilateral	O
femur	B-ANAT
fractures	O
and	O
nailing	O
and	O
N	O
-	O
acetylcysteine	O
after	O
the	O
injury	O
(	O
n	O
=	O
6	O
in	O
each	O
group	O
).	O

The	O
rats	O
were	O
killed	O
24	O
hours	O
after	O
injury	O
and	O
some	O
parameters	O
of	O
lung	B-ANAT
injury	O
were	O
evaluated	O
--	O
i	O
.	O
e	O
.,	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
),	O
lung	B-ANAT
tissue	I-ANAT
myeloperoxidase	O
levels	O
(	O
MPO	O
)	O
and	O
wet	O
/	O
dry	O
ratios	O
of	O
lung	B-ANAT
tissue	I-ANAT
.	O

N	O
-	O
acetyl	O
cysteine	O
,	O
if	O
given	O
after	O
skeletal	B-ANAT
trauma	O
,	O
is	O
of	O
potential	O
therapeutic	O
benefit	O
,	O
in	O
preventing	O
SIRS	O
,	O
ARDS	O
and	O
MOF	O
.	O

Among	O
31	O
case	O
-	O
patients	O
for	O
whom	O
convalescent	O
-	O
phase	O
(>	O
21	O
days	O
)	O
sera	B-ANAT
were	O
available	O
,	O
26	O
%	O
had	O
immunoglobulin	O
G	O
to	O
SARS	O
-	O
associated	O
coronavirus	O
.	O

TITLE	O
:	O
Possible	O
SARS	O
coronavirus	O
transmission	O
during	O
cardiopulmonary	B-ANAT
resuscitation	O
.	O

However	O
,	O
before	O
intubation	O
,	O
the	O
patient	O
was	O
ventilated	O
with	O
a	O
bag	O
-	O
valve	B-ANAT
-	O
mask	O
that	O
may	O
have	O
contributed	O
to	O
aerosolization	O
of	O
SARS	O
-	O
CoV	O
.	O
On	O
the	O
basis	O
of	O
the	O
results	O
of	O
this	O
investigation	O
and	O
previous	O
reports	O
of	O
SARS	O
transmission	O
during	O
aerosol	O
-	O
generating	O
procedures	O
,	O
a	O
systematic	O
approach	O
to	O
the	O
problem	O
is	O
outlined	O
,	O
including	O
the	O
use	O
of	O
the	O
following	O
:	O
1	O
)	O
administrative	O
controls	O
,	O
2	O
)	O
environmental	O
engineering	O
controls	O
,	O
3	O
)	O
personal	O
protective	O
equipment	O
,	O
and	O
4	O
)	O
quality	O
control	O
.	O

TITLE	O
:	O
Body	B-ANAT
temperature	O
monitoring	O
and	O
SARS	O
fever	O
hotline	O
,	O
Taiwan	O
.	O

T	B-ANAT
cells	I-ANAT
in	O
peripheral	B-ANAT
blood	I-ANAT
of	O
patients	O
were	O
quantified	O
by	O
flow	O
cytometry	O
.	O

We	O
tested	O
31	O
,	O
151	O
blood	B-ANAT
donor	O
samples	O
in	O
minipools	O
of	O
up	O
to	O
96	O
samples	O
.	O

None	O
of	O
31	O
,	O
151	O
blood	B-ANAT
donors	O
were	O
positive	O
for	O
the	O
presence	O
of	O
SARS	O
.	O

Acute	O
respiratory	O
distress	O
syndrome	O
in	O
this	O
case	O
is	O
due	O
to	O
noncardiogenic	O
pulmonary	B-ANAT
oedema	O
without	O
hypervolaemia	O
.	O

Most	O
commonly	O
TRALI	O
may	O
appear	O
during	O
whole	B-ANAT
blood	I-ANAT
,	O
packed	O
cells	B-ANAT
and	O
fresh	B-ANAT
frozen	I-ANAT
plasma	I-ANAT
transfusions	O
.	O

Patients	O
with	O
increased	O
serum	B-ANAT
LD1	O
should	O
be	O
closely	O
monitored	O
to	O
ensure	O
prompt	O
management	O
,	O
and	O
preparation	O
for	O
admission	O
to	O
ICU	O
could	O
be	O
planned	O
ahead	O
for	O
patients	O
with	O
suppressed	O
lymphocyte	B-ANAT
subsets	O
.	O

TITLE	O
:	O
Detection	O
of	O
human	O
Coronavirus	O
229E	O
in	O
nasal	B-ANAT
specimens	O
in	O
large	O
scale	O
studies	O
using	O
an	O
RT	O
-	O
PCR	O
hybridization	O
assay	O
.	O

Included	O
in	O
the	O
talks	O
were	O
state	O
-	O
of	O
-	O
the	O
-	O
art	O
presentations	O
about	O
infectious	O
clone	O
technology	O
and	O
recombinant	O
viruses	O
,	O
pathogen	O
and	O
receptor	O
interactions	O
at	O
the	O
cellular	B-ANAT
and	O
molecular	O
level	O
,	O
genomic	O
responses	O
to	O
infection	O
,	O
and	O
new	O
information	O
on	O
antiviral	O
mechanisms	O
of	O
action	O
.	O

TITLE	O
:	O
[	O
Serum	B-ANAT
levels	O
of	O
luteinizing	O
hormone	O
,	O
testosterone	O
and	O
prolactin	O
in	O
patients	O
with	O
septic	O
shock	O
].	O

Ninety	O
eyes	B-ANAT
from	O
45	O
patients	O
with	O
the	O
diagnosis	O
of	O
SARS	O
during	O
an	O
epidemic	O
outbreak	O
in	O
Hong	O
Kong	O
were	O
analyzed	O
.	O

RESULTS	O
:	O
Only	O
two	O
patients	O
had	O
mild	O
elevated	O
intraocular	B-ANAT
pressure	O
at	O
baseline	O
and	O
at	O
subsequent	O
follow	O
-	O
up	O
.	O

SARS	O
-	O
CoV	O
RNA	O
was	O
detected	O
in	O
stool	B-ANAT
specimens	O
with	O
fluorescent	O
quantitative	O
polymerase	O
chain	O
reactions	O
(	O
FQ	O
-	O
PCR	O
)	O
in	O
101	O
SARS	O
patients	O
on	O
the	O
10	O
to	O
55	O
days	O
after	O
onset	O
,	O
27	O
non	O
-	O
SARS	O
patients	O
and	O
400	O
individuals	O
with	O
health	O
check	O
-	O
up	O
.	O

Positive	O
rate	O
and	O
load	O
of	O
SARS	O
-	O
CoV	O
RNA	O
in	O
stool	B-ANAT
of	O
SARS	O
patients	O
was	O
the	O
highest	O
at	O
their	O
acute	O
phase	O
,	O
and	O
decreased	O
with	O
the	O
extension	O
of	O
its	O
course	O
.	O

TITLE	O
:	O
[	O
Determination	O
of	O
serum	B-ANAT
acute	O
phase	O
reaction	O
protein	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
].	O

Analysis	O
for	O
linear	O
trend	O
in	O
proportions	O
showed	O
that	O
dose	O
response	O
relationship	O
existed	O
in	O
mask	O
,	O
gown	O
,	O
gloves	O
,	O
goggles	O
,	O
footwear	O
,	O
gargle	O
,	O
""""	O
membrane	B-ANAT
protection	O
""""	O
and	O
""""	O
taking	O
shower	O
and	O
changing	O
dree	O
after	O
work	O
""""	O
(	O
P	O
<	O
0	O
.	O
01	O
).	O

Preparation	O
should	O
include	O
correcting	O
coagulopathy	O
,	O
minimizing	O
preexisting	O
encephalopathy	O
,	O
preventing	O
sepsis	O
,	O
and	O
optimizing	O
renal	B-ANAT
function	O
.	O

RESULTS	O
:	O
Patients	O
with	O
end	O
-	O
stage	O
liver	B-ANAT
disease	O
are	O
at	O
high	O
risk	O
of	O
major	O
complications	O
and	O
death	O
following	O
surgery	O
.	O

Inhaled	O
nitric	O
oxide	O
at	O
a	O
dose	O
of	O
5	O
ppm	O
in	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
not	O
due	O
to	O
sepsis	O
and	O
without	O
evidence	O
of	O
nonpulmonary	O
organ	B-ANAT
system	I-ANAT
dysfunction	O
results	O
in	O
short	O
-	O
term	O
oxygenation	O
improvements	O
but	O
has	O
no	O
substantial	O
impact	O
on	O
the	O
duration	O
of	O
ventilatory	O
support	O
or	O
mortality	O
.	O

TITLE	O
:	O
Tissue	B-ANAT
distribution	O
and	O
duration	O
of	O
mouse	O
hepatitis	O
virus	O
in	O
naturally	O
infected	O
immunocompetent	O
ICR	O
(	O
CD	O
-	O
1	O
)	O
and	O
immunodeficient	O
athymic	O
nude	O
-	O
nu	O
mouse	O
strains	O
used	O
for	O
ovarian	B-ANAT
transplantation	O
and	O
in	O
vitro	O
fertilization	O
.	O

The	O
commercial	O
assay	O
was	O
the	O
RealArt	O
HPA	B-ANAT
CoV	O
RT	O
-	O
PCR	O
assay	O
(	O
Artus	O
),	O
which	O
was	O
run	O
in	O
the	O
LC	O
.	O

TITLE	O
:	O
Two	O
genotypes	O
of	O
canine	O
coronavirus	O
simultaneously	O
detected	O
in	O
the	O
fecal	B-ANAT
samples	O
of	O
dogs	O
with	O
diarrhea	O
.	O

The	O
illness	O
spread	O
across	O
the	O
globe	B-ANAT
,	O
caused	O
many	O
major	O
outbreaks	O
,	O
and	O
had	O
an	O
overall	O
mortality	O
rate	O
of	O
11	O
%.	O

We	O
retrospectively	O
identified	O
17	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
due	O
to	O
pulmonary	B-ANAT
contusion	O
who	O
had	O
thoracic	B-ANAT
helical	O
computed	O
tomography	O
scans	O
before	O
and	O
after	O
ventilation	O
with	O
the	O
open	O
lung	B-ANAT
concept	O
.	O

SARS	O
-	O
CoV	O
was	O
detected	O
in	O
all	O
22	O
postmortem	O
lung	B-ANAT
tissues	I-ANAT
(	O
to	O
10	O
(	O
9	O
)	O
viral	O
copies	O
/	O
g	O
)	O
from	O
11	O
patients	O
with	O
probable	O
SARS	O
but	O
was	O
not	O
detected	O
in	O
any	O
of	O
the	O
23	O
lung	B-ANAT
control	O
samples	O
(	O
sample	O
analysis	O
was	O
blinded	O
).	O

TITLE	O
:	O
The	O
involvement	O
of	O
natural	B-ANAT
killer	I-ANAT
cells	I-ANAT
in	O
the	O
pathogenesis	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

TITLE	O
:	O
Relation	O
between	O
pesticide	O
exposure	O
and	O
intrauterine	B-ANAT
growth	O
retardation	O
.	O

To	O
determine	O
the	O
relationship	O
between	O
exposure	O
to	O
pesticides	O
and	O
intrauterine	B-ANAT
growth	O
retardation	O
(	O
IUGR	O
),	O
live	O
newborns	O
from	O
singleton	O
pregnancies	O
,	O
with	O
(	O
n	O
=	O
79	O
)	O
and	O
without	O
(	O
n	O
=	O
292	O
)	O
IUGR	O
were	O
studied	O
.	O

Key	O
recommendations	O
,	O
listed	O
by	O
category	O
and	O
not	O
by	O
hierarchy	O
,	O
include	O
early	O
goal	O
-	O
directed	O
resuscitation	O
of	O
the	O
septic	O
patient	O
during	O
the	O
first	O
6	O
hrs	O
after	O
recognition	O
;	O
appropriate	O
diagnostic	O
studies	O
to	O
ascertain	O
causative	O
organisms	O
before	O
starting	O
antibiotics	O
;	O
early	O
administration	O
of	O
broad	O
-	O
spectrum	O
antibiotic	O
therapy	O
;	O
reassessment	O
of	O
antibiotic	O
therapy	O
with	O
microbiology	O
and	O
clinical	O
data	O
to	O
narrow	O
coverage	O
,	O
when	O
appropriate	O
;	O
a	O
usual	O
7	O
-	O
10	O
days	O
of	O
antibiotic	O
therapy	O
guided	O
by	O
clinical	O
response	O
;	O
source	O
control	O
with	O
attention	O
to	O
the	O
method	O
that	O
balances	O
risks	O
and	O
benefits	O
;	O
equivalence	O
of	O
crystalloid	B-ANAT
and	O
colloid	B-ANAT
resuscitation	O
;	O
aggressive	O
fluid	O
challenge	O
to	O
restore	O
mean	O
circulating	O
filling	O
pressure	O
;	O
vasopressor	O
preference	O
for	O
norepinephrine	O
and	O
dopamine	O
;	O
cautious	O
use	O
of	O
vasopressin	O
pending	O
further	O
studies	O
;	O
avoiding	O
low	O
-	O
dose	O
dopamine	O
administration	O
for	O
renal	B-ANAT
protection	O
;	O
consideration	O
of	O
dobutamine	O
inotropic	O
therapy	O
in	O
some	O
clinical	O
situations	O
;	O
avoidance	O
of	O
supranormal	O
oxygen	O
delivery	O
as	O
a	O
goal	O
of	O
therapy	O
;	O
stress	O
-	O
dose	O
steroid	O
therapy	O
for	O
septic	O
shock	O
;	O
use	O
of	O
recombinant	O
activated	O
protein	O
C	O
in	O
patients	O
with	O
severe	O
sepsis	O
and	O
high	O
risk	O
for	O
death	O
;	O
with	O
resolution	O
of	O
tissue	B-ANAT
hypoperfusion	O
and	O
in	O
the	O
absence	O
of	O
coronary	B-ANAT
artery	I-ANAT
disease	O
or	O
acute	O
hemorrhage	O
,	O
targeting	O
a	O
hemoglobin	O
of	O
7	O
-	O
9	O
g	O
/	O
dL	O
;	O
appropriate	O
use	O
of	O
fresh	B-ANAT
frozen	I-ANAT
plasma	I-ANAT
and	O
platelets	B-ANAT
;	O
a	O
low	O
tidal	O
volume	O
and	O
limitation	O
of	O
inspiratory	O
plateau	O
pressure	O
strategy	O
for	O
acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
;	O
application	O
of	O
a	O
minimal	O
amount	O
of	O
positive	O
end	O
-	O
expiratory	O
pressure	O
in	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
;	O
a	O
semirecumbent	O
bed	O
position	O
unless	O
contraindicated	O
;	O
protocols	O
for	O
weaning	O
and	O
sedation	O
/	O
analgesia	O
,	O
using	O
either	O
intermittent	O
bolus	O
sedation	O
or	O
continuous	O
infusion	O
sedation	O
with	O
daily	O
interruptions	O
/	O
lightening	O
;	O
avoidance	O
of	O
neuromuscular	O
blockers	O
,	O
if	O
at	O
all	O
possible	O
;	O
maintenance	O
of	O
blood	B-ANAT
glucose	O
<	O
150	O
mg	O
/	O
dL	O
after	O
initial	O
stabilization	O
;	O
equivalence	O
of	O
continuous	O
veno	O
-	O
veno	O
hemofiltration	O
and	O
intermittent	O
hemodialysis	O
;	O
lack	O
of	O
utility	O
of	O
bicarbonate	O
use	O
for	O
pH	O
>	O
or	O
=	O
7	O
.	O
15	O
;	O
use	O
of	O
deep	B-ANAT
vein	I-ANAT
thrombosis	O
/	O
stress	O
ulcer	O
prophylaxis	O
;	O
and	O
consideration	O
of	O
limitation	O
of	O
support	O
where	O
appropriate	O
.	O

Secondary	O
analysis	O
of	O
prospectively	O
collected	O
clinical	O
data	O
and	O
archived	O
serum	B-ANAT
.	O

Five	O
of	O
the	O
six	O
patients	O
had	O
normal	O
chest	B-ANAT
radiographs	O
,	O
and	O
four	O
had	O
symptoms	O
such	O
as	O
myalgia	O
,	O
chills	O
,	O
coughing	O
,	O
and	O
feeling	O
feverish	O
.	O

Cells	B-ANAT
infected	O
with	O
MVA	O
/	O
Sor	O
MVA	O
/	O
S	O
-	O
HA	O
synthesized	O
a	O
200	O
-	O
kDa	O
protein	O
,	O
which	O
was	O
recognized	O
by	O
antibody	O
raised	O
against	O
a	O
synthetic	O
peptide	O
of	O
SARS	O
-	O
CoV	O
S	O
or	O
the	O
epitope	O
tag	O
in	O
Western	O
blot	O
analyses	O
.	O

Comparison	O
of	O
nasal	B-ANAT
/	O
fecal	B-ANAT
PRCV	O
pairs	O
from	O
individual	O
pigs	O
revealed	O
different	O
deletions	O
in	O
the	O
spike	O
(	O
S	O
)	O
gene	O
(	O
648	O
or	O
681	O
nt	O
)	O
in	O
2	O
pairs	O
and	O
a	O
consistent	O
change	O
in	O
nt	O
790	O
/	O
791	O
(	O
aa	O
T	O
to	O
V	O
)	O
for	O
all	O
pairs	O
.	O

At	O
the	O
heart	B-ANAT
of	O
every	O
safety	O
policy	O
is	O
a	O
risk	O
assessment	O
based	O
on	O
the	O
exact	O
manipulations	O
employed	O
.	O

In	O
total	O
140	O
patients	O
(	O
70	O
per	O
cent	O
)	O
survived	O
until	O
discharge	B-ANAT
or	O
referral	O
.	O

We	O
describe	O
an	O
outbreak	O
of	O
SARS	O
in	O
a	O
chest	B-ANAT
ward	O
of	O
a	O
medical	O
center	O
in	O
southern	O
Taiwan	O
and	O
seek	O
to	O
identify	O
the	O
risk	O
factors	O
of	O
those	O
SARS	O
patients	O
who	O
required	O
mechanical	O
ventilation	O
.	O

Further	O
,	O
much	O
work	O
is	O
now	O
underway	O
to	O
design	O
better	O
methods	O
to	O
assess	O
the	O
virucidal	O
activity	O
of	O
microbicides	O
used	O
to	O
decontaminate	O
hands	B-ANAT
,	O
reusable	O
medical	O
devices	O
and	O
environmental	O
surfaces	O
in	O
critical	O
areas	O
of	O
healthcare	O
settings	O
.	O

While	O
traditional	O
media	B-ANAT
provided	O
the	O
primary	O
source	O
of	O
information	O
on	O
anthrax	O
and	O
bioterrorism	O
,	O
21	O
%	O
(	O
95	O
%	O
CI	O
,	O
15	O
%-	O
27	O
%)	O
of	O
respondents	O
reported	O
searching	O
the	O
Internet	O
for	O
this	O
information	O
during	O
late	O
2001	O
.	O

TITLE	O
:	O
Feline	O
leucocyte	B-ANAT
antigen	O
class	O
II	O
polymorphism	O
and	O
susceptibility	O
to	O
feline	O
infectious	O
peritonitis	O
.	O

Tissue	B-ANAT
samples	O
collected	O
at	O
necropsy	O
were	O
examined	O
for	O
viral	O
load	O
and	O
histopathological	O
changes	O
.	O

Pathological	O
findings	O
were	O
restricted	O
to	O
generalized	O
lymphatic	B-ANAT
hyperplasia	O
.	O

FCV	O
was	O
isolated	O
from	O
the	O
oral	B-ANAT
fauces	B-ANAT
of	O
11	O
%	O
of	O
healthy	O
cats	O
upon	O
entry	O
,	O
and	O
isolation	O
rates	O
were	O
highest	O
for	O
kittens	O
(	O
33	O
%).	O

Diffuse	O
fAGPrP	O
positivity	O
within	O
the	O
lesions	O
,	O
likely	O
due	O
to	O
vascular	B-ANAT
plasma	B-ANAT
leakage	O
,	O
endothelial	B-ANAT
and	O
epithelial	O
lining	O
were	O
detectable	O
.	O

She	O
was	O
given	O
corticosteroids	O
with	O
progressive	O
normalization	O
of	O
her	O
renal	B-ANAT
function	O
.	O

TITLE	O
:	O
Thrombolysis	O
for	O
central	O
venous	B-ANAT
occlusion	O
causing	O
bilateral	O
chylothorax	O
in	O
a	O
patient	O
with	O
down	O
syndrome	O
.	O

This	O
report	O
illustrates	O
the	O
angiographic	O
findings	O
,	O
demonstrates	O
the	O
successful	O
vascular	B-ANAT
recanalization	O
,	O
and	O
discusses	O
the	O
etiology	O
and	O
management	O
of	O
central	O
venous	B-ANAT
thrombosis	O
and	O
chylothorax	O
.	O

ABSTRACT	O
:	O
Community	O
studies	O
have	O
shown	O
that	O
approximately	O
30	O
%	O
of	O
patients	O
with	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
symptoms	O
have	O
no	O
identifiable	O
infective	O
aetiology	O
.	O

80	O
.	O
6	O
%	O
patients	O
(	O
208	O
of	O
258	O
patients	O
)	O
were	O
positive	O
for	O
SARS	O
-	O
Co	O
virus	O
IgG	O
.	O
21	O
.	O
3	O
%	O
patients	O
(	O
55	O
of	O
258	O
patients	O
)	O
showed	O
lung	B-ANAT
diffusion	O
abnormity	O
(	O
D	O
(	O
LCO	O
)	O
<	O
80	O
%	O
pred	O
).	O

Here	O
we	O
report	O
a	O
method	O
for	O
eliminating	O
false	O
-	O
negative	O
results	O
and	O
increasing	O
test	O
sensitivity	O
,	O
based	O
on	O
the	O
hypothesis	O
that	O
the	O
message	O
encoded	O
by	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
gene	O
is	O
the	O
most	O
abundant	O
during	O
viral	O
infection	O
.	O

In	O
clinical	O
samples	O
the	O
median	O
concentrations	O
of	O
R	O
-	O
and	O
N	O
-	O
gene	O
RNA	O
,	O
respectively	O
,	O
were	O
1	O
.	O
2	O
x	O
10	O
(	O
6	O
)	O
and	O
2	O
.	O
8	O
x	O
10	O
(	O
6	O
)	O
copies	O
/	O
ml	O
(	O
sputum	B-ANAT
and	O
endotracheal	O
aspirates	B-ANAT
),	O
4	O
.	O
3	O
x	O
10	O
(	O
4	O
)	O
and	O
5	O
.	O
5	O
x	O
10	O
(	O
4	O
)	O
copies	O
/	O
ml	O
(	O
stool	B-ANAT
),	O
and	O
5	O
.	O
5	O
x	O
10	O
(	O
2	O
)	O
and	O
5	O
.	O
2	O
x	O
10	O
(	O
2	O
)	O
copies	O
/	O
sample	O
(	O
throat	B-ANAT
swabs	O
and	O
saliva	B-ANAT
).	O

Histopathology	O
of	O
liver	B-ANAT
was	O
non	O
-	O
specific	O
hepatitis	O
.	O

Histopathology	O
of	O
liver	B-ANAT
was	O
non	O
-	O
specific	O
hepatitis	O
.	O

Of	O
the	O
different	O
clinical	O
specimens	O
,	O
positive	O
rate	O
in	O
the	O
stools	B-ANAT
appeared	O
to	O
be	O
the	O
highest	O
(	O
21	O
.	O
55	O
%).	O

TITLE	O
:	O
[	O
Dynamics	O
of	O
peripheral	B-ANAT
blood	I-ANAT
lymphocytes	B-ANAT
and	O
their	O
subpopulations	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
].	O

The	O
absolute	O
numbers	O
of	O
peripheral	B-ANAT
blood	I-ANAT
lymphocytes	B-ANAT
and	O
their	O
subpopulations	O
(	O
CD45	O
,	O
CD3	O
,	O
CD4	O
,	O
CD8	O
)	O
were	O
1298	O
+/-	O

The	O
absolute	O
numbers	O
of	O
peripheral	B-ANAT
blood	I-ANAT
lymphocytes	B-ANAT
and	O
their	O
subpopulations	O
in	O
SARS	O
patients	O
might	O
be	O
used	O
as	O
one	O
of	O
the	O
methods	O
for	O
diagnosis	O
on	O
the	O
severity	O
and	O
prognosis	O
of	O
the	O
disease	O
.	O

ABSTRACT	O
:	O
Porcine	O
hemagglutinating	O
encephalomyelitis	O
virus	O
(	O
HEV	B-ANAT
)	O
causes	O
encephalomyelitis	O
,	O
or	O
vomiting	O
and	O
wasting	O
disease	O
,	O
in	O
suckling	O
piglets	O
.	O

Recently	O
,	O
the	O
risk	O
of	O
an	O
HEV	B-ANAT
outbreak	O
has	O
increased	O
in	O
the	O
pig	O
industry	O
,	O
because	O
of	O
widely	O
using	O
specific	O
pathogen	O
-	O
free	O
pigs	O
that	O
have	O
no	O
antibodies	O
to	O
HEV	B-ANAT
.	O

Expression	O
of	O
SARS	O
protein	O
3a	O
was	O
detected	O
at	O
8	O
-	O
12	O
h	O
after	O
infection	O
and	O
reached	O
a	O
higher	O
level	O
after	O
approximately	O
24	O
h	O
in	O
SARS	O
-	O
CoV	O
-	O
infected	O
Vero	O
E6	O
cells	B-ANAT
.	O

Protein	O
3a	O
was	O
also	O
detected	O
in	O
the	O
alveolar	B-ANAT
lining	O
pneumocytes	B-ANAT
and	O
some	O
intra	O
-	O
alveolar	B-ANAT
cells	B-ANAT
of	O
a	O
SARS	O
-	O
CoV	O
-	O
infected	O
patient	O
'	O
s	O
lung	B-ANAT
specimen	O
.	O

Nevertheless	O
,	O
no	O
interference	O
with	O
SARS	O
-	O
CoV	O
replication	O
was	O
observed	O
in	O
Vero	B-ANAT
cells	I-ANAT
stably	O
expressing	O
MxA	O
.	O
Therefore	O
,	O
other	O
interferon	O
-	O
induced	O
proteins	O
must	O
be	O
responsible	O
for	O
the	O
strong	O
inhibitory	O
effect	O
of	O
interferon	O
-	O
beta	O
against	O
SARS	O
-	O
CoV	O
.	O

Among	O
the	O
peptides	O
used	O
in	O
the	O
study	O
,	O
the	O
affinity	O
of	O
peptides	O
from	O
HCoV	O
-	O
229e	O
(	O
H77	O
and	O
H881	O
)	O
and	O
peptides	O
from	O
SARS	O
-	O
CoV	O
(	O
S978	O
and	O
S1203	O
)	O
for	O
binding	O
to	O
HLA	B-ANAT
-	O
A2	O
was	O
higher	O
than	O
that	O
of	O
other	O
sequences	O
.	O

TITLE	O
:	O
Murine	O
coronavirus	O
replication	O
induces	O
cell	B-ANAT
cycle	O
arrest	O
in	O
G0	O
/	O
G1	O
phase	O
.	O

While	O
the	O
amounts	O
of	O
the	O
cellular	B-ANAT
cyclin	O
-	O
dependent	O
kinase	O
(	O
Cdk	O
)	O
inhibitors	O
p21	O
(	O
Cip1	O
),	O
p27	O
(	O
Kip1	O
),	O
and	O
p16	O
(	O
INK4a	O
)	O
did	O
not	O
change	O
in	O
infected	O
cells	B-ANAT
,	O
MHV	O
infection	O
in	O
asynchronous	O
cultures	O
induced	O
a	O
clear	O
reduction	O
in	O
the	O
amounts	O
of	O
Cdk4	O
and	O
G	O
(	O
1	O
)	O
cyclins	O
(	O
cyclins	O
D1	O
,	O
D2	O
,	O
D3	O
,	O
and	O
E	O
)	O
in	O
both	O
DBT	O
and	O
17Cl	O
-	O
1	O
cells	B-ANAT
and	O
a	O
reduction	O
in	O
Cdk6	O
levels	O
in	O
17Cl	O
-	O
1	O
cells	B-ANAT
.	O

Oligomer	O
administered	O
at	O
micromolar	O
concentrations	O
was	O
delivered	O
to	O
>	O
80	O
%	O
of	O
cells	B-ANAT
and	O
inhibited	O
virus	O
titers	O
10	O
-	O
to	O
100	O
-	O
fold	O
in	O
a	O
sequence	O
-	O
specific	O
and	O
dose	O
-	O
responsive	O
manner	O
.	O

Here	O
we	O
demonstrate	O
that	O
the	O
spike	O
(	O
S	O
)	O
protein	O
from	O
the	O
group	O
3	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
contains	O
a	O
canonical	O
dilysine	O
endoplasmic	B-ANAT
reticulum	I-ANAT
retrieval	O
signal	O
(-	O
KKXX	O
-	O
COOH	O
)	O
in	O
its	O
cytoplasmic	B-ANAT
tail	I-ANAT
.	O

Mutations	O
predicted	O
to	O
allow	O
cleavage	O
at	O
CS1	O
yielded	O
viable	O
virus	O
that	O
grew	O
to	O
wild	O
-	O
type	O
MHV	O
titers	O
and	O
showed	O
normal	O
expression	O
and	O
processing	O
of	O
p28	B-ANAT
and	O
p65	O
.	O

However	O
,	O
proteolytic	O
separation	O
of	O
p28	B-ANAT
from	O
p65	O
is	O
necessary	O
for	O
optimal	O
RNA	O
synthesis	O
and	O
virus	O
growth	O
,	O
suggesting	O
important	O
roles	O
for	O
these	O
proteins	O
in	O
the	O
formation	O
or	O
function	O
of	O
viral	O
replication	O
complexes	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
used	O
a	O
murine	O
monoclonal	O
antibody	O
specific	O
for	O
SARS	O
-	O
CoV	O
nucleoprotein	O
,	O
and	O
probes	O
specific	O
for	O
a	O
SARS	O
-	O
CoV	O
RNA	O
polymerase	O
gene	O
fragment	O
,	O
for	O
immunohistochemistry	O
and	O
in	O
situ	O
hybridization	O
,	O
respectively	O
,	O
to	O
detect	O
SARS	O
-	O
CoV	O
systematically	O
in	O
tissues	B-ANAT
from	O
patients	O
who	O
died	O
of	O
SARS	O
.	O

SARS	O
-	O
CoV	O
was	O
found	O
in	O
lung	B-ANAT
,	O
trachea	B-ANAT
/	O
bronchus	B-ANAT
,	O
stomach	B-ANAT
,	O
small	B-ANAT
intestine	I-ANAT
,	O
distal	B-ANAT
convoluted	I-ANAT
renal	I-ANAT
tubule	I-ANAT
,	O
sweat	O
gland	B-ANAT
,	I-ANAT
parathyroid	I-ANAT
,	O
pituitary	B-ANAT
,	O
pancreas	B-ANAT
,	O
adrenal	B-ANAT
gland	I-ANAT
,	O
liver	B-ANAT
and	O
cerebrum	B-ANAT
,	O
but	O
was	O
not	O
detected	O
in	O
oesophagus	B-ANAT
,	O
spleen	B-ANAT
,	O
lymph	B-ANAT
node	I-ANAT
,	O
bone	B-ANAT
marrow	I-ANAT
,	O
heart	B-ANAT
,	O
aorta	B-ANAT
,	O
cerebellum	B-ANAT
,	O
thyroid	B-ANAT
,	O
testis	B-ANAT
,	O
ovary	B-ANAT
,	O
uterus	B-ANAT
or	O
muscle	B-ANAT
.	O

These	O
results	O
suggest	O
that	O
,	O
in	O
addition	O
to	O
the	O
respiratory	B-ANAT
system	I-ANAT
,	O
the	O
gastrointestinal	B-ANAT
tract	I-ANAT
and	O
other	O
organs	B-ANAT
with	O
detectable	O
SARS	O
-	O
CoV	O
may	O
also	O
be	O
targets	O
of	O
SARS	O
-	O
CoV	O
infection	O
.	O

TITLE	O
:	O
Tissue	B-ANAT
distribution	O
of	O
ACE2	O
protein	O
,	O
the	O
functional	O
receptor	O
for	O
SARS	O
coronavirus	O
.	O

Since	O
identifying	O
the	O
possible	O
route	O
of	O
infection	O
has	O
major	O
implications	O
for	O
understanding	O
the	O
pathogenesis	O
and	O
future	O
treatment	O
strategies	O
for	O
SARS	O
,	O
the	O
present	O
study	O
investigated	O
the	O
localization	O
of	O
ACE2	O
protein	O
in	O
various	O
human	O
organs	B-ANAT
(	O
oral	B-ANAT
and	O
nasal	B-ANAT
mucosa	I-ANAT
,	O
nasopharynx	B-ANAT
,	O
lung	B-ANAT
,	O
stomach	B-ANAT
,	O
small	B-ANAT
intestine	I-ANAT
,	O
colon	B-ANAT
,	O
skin	B-ANAT
,	O
lymph	B-ANAT
nodes	I-ANAT
,	O
thymus	B-ANAT
,	O
bone	B-ANAT
marrow	I-ANAT
,	O
spleen	B-ANAT
,	O
liver	B-ANAT
,	O
kidney	B-ANAT
,	O
and	O
brain	B-ANAT
).	O

However	O
,	O
the	O
ability	O
of	O
glial	B-ANAT
cell	I-ANAT
preparations	O
to	O
remyelinate	O
in	O
such	O
models	O
does	O
not	O
necessarily	O
indicate	O
that	O
their	O
transplantation	O
into	O
demyelinated	O
lesions	O
in	O
clinical	O
disease	O
will	O
be	O
successful	O
.	O

Transplantation	O
of	O
glial	B-ANAT
-	O
committed	O
progenitor	B-ANAT
cells	I-ANAT
into	O
the	O
T8	O
spinal	B-ANAT
cord	I-ANAT
of	O
MHV	O
-	O
infected	O
mice	O
demonstrating	O
complete	O
hindlimb	B-ANAT
paralysis	O
resulted	O
in	O
migration	O
of	O
cells	B-ANAT
up	O
to	O
12	O
mm	O
from	O
the	O
implantation	O
site	O
and	O
remyelination	O
of	O
up	O
to	O
67	O
%	O
of	O
axons	B-ANAT
.	O

We	O
found	O
that	O
the	O
membrane	B-ANAT
and	O
envelope	B-ANAT
proteins	O
are	O
sufficient	O
for	O
the	O
efficient	O
formation	O
of	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
and	O
could	O
be	O
visualized	O
by	O
electron	O
microscopy	O
.	O

TITLE	O
:	O
Effect	O
of	O
temperature	O
on	O
the	O
detection	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
and	O
transmissible	O
gastroenteritis	O
virus	O
in	O
fecal	B-ANAT
samples	O
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
.	O

The	O
diagnosis	O
is	O
suggested	O
by	O
the	O
paucity	O
of	O
clinical	O
signs	O
with	O
an	O
abnormal	O
chest	B-ANAT
radiograph	O
,	O
and	O
laboratory	O
evidence	O
of	O
leucopenia	O
,	O
lymphopenia	O
,	O
and	O
thrombocytopenia	O
.	O

ABSTRACT	O
:	O
We	O
have	O
generated	O
a	O
mouse	O
strain	O
carrying	O
a	O
transgene	O
driven	O
by	O
a	O
strong	O
and	O
ubiquitous	O
promoter	O
(	O
human	O
cytomegalovirus	O
hCMV	O
/	O
beta	O
-	O
actin	O
)	O
and	O
containing	O
an	O
enhanced	O
green	O
fluorescent	O
protein	O
(	O
eGFP	O
)	O
coding	O
sequence	O
upstream	O
of	O
the	O
3	O
'	O
untranslated	O
region	O
(	O
3	O
'	O
UTR	O
)	O
of	O
tissue	B-ANAT
-	O
type	O
plasminogen	O
activator	O
(	O
t	O
-	O
PA	O
)	O
mRNA	O
.	O

From	O
this	O
perspective	O
,	O
we	O
analyzed	O
eGFP	O
mRNA	O
expression	O
and	O
eGFP	O
fluorescence	O
in	O
experimental	O
models	O
of	O
nervous	B-ANAT
system	I-ANAT
lesions	O
,	O
such	O
as	O
motoneuron	B-ANAT
axotomy	O
and	O
cerebral	B-ANAT
stroke	O
induced	O
by	O
middle	B-ANAT
cerebral	I-ANAT
artery	I-ANAT
occlusion	O
.	O

In	O
many	O
countries	O
,	O
blood	B-ANAT
-	O
borne	O
occupational	O
infections	O
with	O
hepatitis	O
C	O
virus	O
(	O
HCV	O
)	O
is	O
the	O
major	O
epidemiological	O
problem	O
among	O
health	O
care	O
workers	O
,	O
mostly	O
because	O
no	O
vaccine	O
against	O
this	O
virus	O
has	O
been	O
produced	O
to	O
date	O
.	O

IgM	B-ANAT
antibody	I-ANAT
was	O
negative	O
in	O
all	O
the	O
samples	O
.	O

Coronavirus	O
envelope	B-ANAT
spike	O
protein	O
S	O
is	O
a	O
class	O
I	O
viral	O
fusion	O
protein	O
which	O
is	O
characterized	O
by	O
the	O
existence	O
of	O
two	O
heptad	O
repeat	O
regions	O
(	O
HR1	O
and	O
HR2	O
)	O
(	O
forming	O
a	O
complex	O
called	O
fusion	O
core	O
).	O

ABSTRACT	O
:	O
A	O
protocol	O
for	O
obtaining	O
small	O
amounts	O
of	O
highly	O
pure	O
virus	O
preparations	O
starting	O
from	O
reduced	O
volumes	O
(<	O
5	O
ml	O
)	O
of	O
infected	O
tissue	B-ANAT
culture	O
supernatants	O
is	O
described	O
.	O

355	O
(	O
45	O
%)	O
specimens	O
of	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
and	O
150	O
(	O
28	O
%)	O
of	O
faeces	B-ANAT
were	O
positive	O
for	O
SARS	O
coronavirus	O
RNA	O
.	O

One	O
hundred	O
and	O
eighty	O
-	O
two	O
patients	O
with	O
SARS	O
were	O
employed	O
in	O
a	O
retrospective	O
study	O
that	O
investigated	O
hepatic	B-ANAT
dysfunction	O
.	O

Abnormal	O
liver	B-ANAT
functions	O
were	O
common	O
in	O
patients	O
with	O
SARS	O
and	O
could	O
be	O
associated	O
with	O
virus	O
replication	O
in	O
the	O
liver	B-ANAT
.	O

There	O
was	O
no	O
statistically	O
significant	O
correlation	O
between	O
the	O
duration	O
of	O
Ribavirin	O
treatment	O
and	O
hepatic	B-ANAT
dysfunction	O
.	O

Infection	O
of	O
the	O
hepatoma	B-ANAT
cell	I-ANAT
line	O
Huh	O
-	O
7	O
was	O
also	O
observed	O
with	O
replication	O
-	O
competent	O
SARS	O
-	O
CoV	O
,	O
indicating	O
that	O
hepatocytes	B-ANAT
might	O
be	O
targeted	O
by	O
SARS	O
-	O
CoV	O
in	O
vivo	O
.	O

Once	O
SIRS	O
occurs	O
,	O
people	O
may	O
often	O
die	O
from	O
serious	O
complications	O
such	O
as	O
adult	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
),	O
disseminated	O
intravascular	O
coagulation	O
(	O
DIC	O
)	O
and	O
multiple	O
organ	B-ANAT
failure	O
(	O
MOF	O
).	O

Since	O
its	O
discovery	O
in	O
2000	O
,	O
ACE2	O
has	O
been	O
implicated	O
in	O
heart	B-ANAT
function	O
,	O
hypertension	O
and	O
diabetes	O
,	O
with	O
its	O
effects	O
being	O
mediated	O
,	O
in	O
part	O
,	O
through	O
its	O
ability	O
to	O
convert	O
angiotensin	O
II	O
to	O
angiotensin	O
-(	O
1	O
-	O
7	O
).	O

Unexpectedly	O
,	O
ACE2	O
also	O
serves	O
as	O
the	O
cellular	B-ANAT
entry	O
point	O
for	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
virus	O
and	O
the	O
enzyme	O
is	O
therefore	O
a	O
prime	O
target	O
for	O
pharmacological	O
intervention	O
on	O
several	O
disease	O
fronts	O
.	O

TITLE	O
:	O
Epidemiology	O
of	O
acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
diseases	O
with	O
a	O
significant	O
influence	O
in	O
the	O
public	O
health	O
.	O

The	O
only	O
recent	O
innovation	O
is	O
the	O
hypothesis	O
that	O
pulmonary	B-ANAT
ARDS	O
and	O
extrapulmonary	O
ARDS	O
could	O
be	O
different	O
clinical	O
entities	O
.	O

This	O
wide	O
range	O
could	O
stem	B-ANAT
from	O
differences	O
in	O
the	O
methodology	O
used	O
to	O
calculate	O
the	O
incidence	O
or	O
could	O
be	O
a	O
true	O
variation	O
due	O
to	O
regional	O
differences	O
.	O

Worldwide	O
collaboration	O
led	O
to	O
the	O
rapid	O
identification	O
and	O
gene	O
sequencing	O
of	O
the	O
etiologic	O
virus	O
,	O
SARS	O
-	O
CoV	O
.	O
SARS	O
is	O
a	O
predominantly	O
respiratory	O
illness	O
,	O
spread	O
through	O
droplets	O
from	O
respiratory	O
secretions	B-ANAT
and	O
possibly	O
via	O
a	O
fecal	B-ANAT
-	O
oral	B-ANAT
route	O
.	O

The	O
websites	O
of	O
the	O
Ontario	O
Ministry	O
of	O
Health	O
and	O
Long	O
-	O
Term	O
Care	O
,	O
Ontario	O
Ministry	O
of	O
Public	O
Safety	O
and	O
Security	O
,	O
Centers	O
for	O
Disease	O
Control	O
and	O
Canadian	O
Population	O
and	O
Public	O
Health	O
Branch	B-ANAT
of	I-ANAT
Health	O
Canada	O
were	O
searched	O
for	O
articles	O
relating	O
to	O
bioterrorism	O
and	O
syndromic	O
surveillance	O
.	O

In	O
a	O
murine	O
model	O
we	O
measured	O
NF	O
-	O
kappaB	O
activation	O
,	O
expression	O
of	O
intercellular	O
adhesion	O
molecule	O
(	O
ICAM	O
)	O
1	O
,	O
nitrotyrosine	O
,	O
inducible	O
nitric	O
oxide	O
synthase	O
(	O
iNOS	O
),	O
nuclear	O
enzyme	O
poly	O
(	O
ADP	O
-	O
ribose	O
)	O
synthetase	O
(	O
PARS	O
),	O
myeloperoxidase	O
,	O
malondialdehyde	O
,	O
amylase	O
and	O
lipase	O
and	O
determined	O
histological	O
evidence	O
of	O
lung	B-ANAT
and	O
pancreas	B-ANAT
injury	O
in	O
four	O
groups	O
:	O
control	O
(	O
saline	O
only	O
),	O
cerulein	O
,	O
calpain	O
I	O
inhibitor	O
plus	O
cerulein	O
and	O
calpain	O
I	O
inhibitor	O
plus	O
saline	O
.	O

It	O
causes	O
serious	O
damage	O
to	O
the	O
respiratory	B-ANAT
system	I-ANAT
yet	O
the	O
mechanism	O
is	O
not	O
clear	O
.	O

This	O
observation	O
has	O
some	O
implications	O
for	O
the	O
SARS	O
-	O
CoV	O
pathogenicity	O
:	O
SARS	O
-	O
CoV	O
does	O
induce	O
apoptosis	O
in	O
cell	B-ANAT
cultures	O
and	O
might	O
have	O
the	O
same	O
effect	O
in	O
vivo	O
,	O
responsible	O
for	O
the	O
severe	O
damage	O
of	O
the	O
respiratory	B-ANAT
system	I-ANAT
.	O

Serial	O
serum	B-ANAT
specimens	O
from	O
12	O
RT	O
-	O
PCR	O
-	O
confirmed	O
SARS	O
patients	O
were	O
assayed	O
by	O
ELISA	O
using	O
the	O
recombinant	O
N	O
protein	O
as	O
coated	O
antigen	O
.	O

Chronic	O
pulmonary	B-ANAT
hypertension	O
may	O
develop	O
due	O
to	O
either	O
cardiopulmonary	B-ANAT
or	O
systemic	O
diseases	O
whereas	O
acute	O
and	O
acute	O
-	O
on	O
-	O
chronic	O
pulmonary	B-ANAT
hypertension	O
often	O
occur	O
in	O
the	O
course	O
of	O
cardiothoracic	O
surgery	O
.	O

Thus	O
,	O
besides	O
basic	O
treatment	O
of	O
the	O
underlying	O
disease	O
the	O
use	O
of	O
vasodilators	O
is	O
a	O
valuable	O
therapeutic	O
option	O
to	O
decrease	O
right	O
ventricular	B-ANAT
afterload	O
,	O
but	O
intravenous	O
vasodilators	O
may	O
provoke	O
systemic	O
arterial	B-ANAT
hypotension	O
and	O
impair	O
gas	O
exchange	O
due	O
to	O
vasodilation	O
of	O
pulmonary	B-ANAT
shunt	O
areas	O
.	O

TITLE	O
:	O
Common	O
respiratory	O
manifestations	O
of	O
food	O
allergy	O
:	O
a	O
critical	O
focus	O
on	O
otitis	O
media	B-ANAT
.	O

The	O
role	O
of	O
food	O
allergy	O
in	O
otitis	O
media	B-ANAT
is	O
controversial	O
,	O
probably	O
uncommon	O
,	O
and	O
further	O
studies	O
are	O
needed	O
.	O

A	O
24	O
-	O
hour	O
heavy	O
metal	O
urine	B-ANAT
,	O
nail	B-ANAT
and	O
hair	B-ANAT
analysis	O
was	O
performed	O
.	O

Each	O
of	O
the	O
N	O
pairs	O
of	O
reagents	O
X	O
(	O
j	O
)	O
and	O
Y	O
(	O
j	O
)	O
defines	O
an	O
axis	B-ANAT
in	O
an	O
N	O
-	O
dimensional	O
shape	O
space	O
.	O

The	O
definition	O
of	O
these	O
axes	O
facilitates	O
proteomic	O
analysis	O
of	O
diverse	O
biological	O
samples	O
,	O
for	O
example	O
,	O
mixtures	O
of	O
proteins	O
such	O
as	O
serum	B-ANAT
samples	O
or	O
T	O
cell	B-ANAT
extracts	I-ANAT
.	O

Several	O
proteins	O
known	O
to	O
be	O
cleaved	B-ANAT
by	O
other	O
viruses	O
were	O
submitted	O
to	O
prediction	O
as	O
well	O
as	O
proteins	O
suspected	O
relevant	O
in	O
coronavirus	O
pathology	O
.	O

ABSTRACT	O
:	O
To	O
establish	O
a	O
clinical	O
staging	O
system	O
for	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
based	O
on	O
clinical	O
feature	O
,	O
laboratory	O
tests	O
as	O
well	O
as	O
dynamic	O
changes	O
of	O
chest	B-ANAT
X	O
-	O
ray	O
images	O
.	O

The	O
appearance	O
of	O
pan	B-ANAT
-	O
consolidation	O
in	O
the	O
lung	B-ANAT
in	O
less	O
than	O
7	O
days	O
and	O
/	O
or	O
unable	O
to	O
recover	O
the	O
number	O
of	O
lymphocytes	B-ANAT
and	O
T	B-ANAT
lymphocyte	I-ANAT
subset	O
will	O
be	O
associated	O
with	O
poor	O
prognosis	O
.	O

METHODS	O
:	O
Dynamic	O
changes	O
of	O
chest	B-ANAT
X	O
-	O
ray	O
images	O
and	O
laboratory	O
tests	O
in	O
45	O
SARS	O
patients	O
managed	O
from	O
March	O
to	O
May	O
,	O
2003	O
were	O
analyzed	O
.	O

Here	O
,	O
we	O
provide	O
evidences	O
that	O
RNAi	O
targeting	O
at	O
coronavirus	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
(	O
RDRP	O
)	O
using	O
short	O
hairpin	O
RNA	O
(	O
shRNA	O
)	O
expression	O
plasmids	O
can	O
specifically	O
inhibit	O
expression	O
of	O
extraneous	O
coronavirus	O
RDRP	O
in	O
293	O
and	O
HeLa	B-ANAT
cells	I-ANAT
.	O

There	O
was	O
no	O
correlation	O
between	O
the	O
genotype	O
of	O
any	O
region	O
of	O
the	O
replicase	O
gene	O
and	O
pathotype	O
,	O
suggesting	O
that	O
the	O
replicase	O
is	O
not	O
the	O
sole	B-ANAT
determinant	O
of	O
IBV	O
pathogenicity	O
.	O

Blood	B-ANAT
TNF	O
-	O
alpha	O
,	O
IL	O
-	O
6	O
,	O
and	O
IL	O
-	O
10	O
,	O
and	O
nitrite	O
/	O
nitrate	O
levels	O
were	O
not	O
significantly	O
elevated	O
.	O

Five	O
of	O
the	O
15	O
SARS	O
patients	O
had	O
detectable	O
coronaviruses	O
in	O
blood	B-ANAT
,	O
but	O
patients	O
with	O
detectable	O
and	O
undetectable	O
viremia	O
had	O
no	O
different	O
profiles	O
of	O
immune	O
mediators	O
.	O

Patients	O
with	O
extensive	O
lung	B-ANAT
injury	O
,	O
as	O
indicated	O
by	O
severe	O
clinical	O
courses	O
,	O
and	O
in	O
particular	O
high	O
neutrophil	B-ANAT
counts	O
,	O
appear	O
to	O
be	O
most	O
at	O
risk	O
.	O

A	O
subunit	O
vaccine	O
candidate	O
directed	O
against	O
porcine	O
transmissible	O
gastroenteritis	O
virus	O
and	O
expressed	O
in	O
corn	O
seed	O
has	O
been	O
developed	O
for	O
oral	B-ANAT
delivery	O
to	O
swine	O
.	O

Deletion	O
of	O
a	O
major	O
portion	O
of	O
the	O
cytoplasmic	B-ANAT
domain	I-ANAT
of	O
ACE2	O
had	O
no	O
effect	O
on	O
S	O
-	O
driven	O
infection	O
,	O
indicating	O
that	O
this	O
domain	O
is	O
not	O
important	O
for	O
receptor	O
function	O
.	O

Understanding	O
the	O
molecular	O
mechanisms	O
of	O
SARS	O
-	O
induced	O
cytopathic	O
effects	O
(	O
CPEs	O
)	O
is	O
a	O
rational	O
approach	O
for	O
the	O
prevention	O
of	O
SARS	O
,	O
and	O
an	O
understanding	O
of	O
the	O
cellular	B-ANAT
stress	O
responses	O
induced	O
by	O
viral	O
infection	O
is	O
important	O
for	O
understanding	O
the	O
CPEs	O
.	O

These	O
are	O
the	O
replicase	O
gene	O
1a	O
/	O
1b	O
and	O
the	O
four	O
structural	O
proteins	O
,	O
nucleocapsid	B-ANAT
(	O
N	O
),	O
spike	O
(	O
S	O
),	O
membrane	B-ANAT
(	O
M	O
),	O
and	O
envelope	B-ANAT
(	O
E	O
),	O
and	O
these	O
proteins	O
are	O
expected	O
to	O
be	O
essential	O
for	O
the	O
replication	O
of	O
the	O
virus	O
.	O

The	O
largest	O
among	O
these	O
is	O
the	O
first	O
ORF	O
of	O
the	O
second	O
longest	O
subgenomic	O
RNA	O
,	O
and	O
this	O
protein	O
(	O
termed	O
U274	O
in	O
the	O
present	O
study	O
)	O
consists	O
of	O
274	O
amino	O
acids	O
and	O
contains	O
three	O
putative	O
transmembrane	B-ANAT
domains	O
.	O

TITLE	O
:	O
Cleavage	O
and	O
serum	B-ANAT
reactivity	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
spike	O
protein	O
.	O

TITLE	O
:	O
Murine	O
viral	O
hepatitis	O
involves	O
NK	B-ANAT
cell	I-ANAT
depletion	O
associated	O
with	O
virus	O
-	O
induced	O
apoptosis	O
.	O

ABSTRACT	O
:	O
Mechanical	O
ventilation	O
is	O
necessary	O
for	O
treating	O
patients	O
with	O
severe	O
brain	B-ANAT
injury	O
because	O
it	O
guarantees	O
the	O
airway	B-ANAT
(	O
through	O
endotracheal	O
intubation	O
),	O
permits	O
sedation	O
(	O
and	O
even	O
curarization	O
),	O
and	O
prevents	O
hypoxemia	O
and	O
/	O
or	O
hypercapnia	O
.	O

Nevertheless	O
,	O
the	O
weight	O
of	O
scientific	O
evidence	O
to	O
date	O
suggests	O
that	O
it	O
should	O
not	O
be	O
applied	O
prophylactically	O
during	O
the	O
first	O
24	O
hours	O
and	O
that	O
patients	O
should	O
not	O
be	O
hyperventilated	O
for	O
prolonged	O
periods	O
in	O
the	O
absence	O
of	O
intracranial	B-ANAT
hypertension	O
.	O

Pooled	O
throat	B-ANAT
and	O
nasal	B-ANAT
swabs	O
,	O
rectal	B-ANAT
swab	I-ANAT
,	O
nasal	B-ANAT
swab	O
,	O
throat	B-ANAT
swab	I-ANAT
,	O
and	O
nasopharyngeal	B-ANAT
aspirate	I-ANAT
specimens	O
provided	O
a	O
moderate	O
yield	O
(	O
29	O
.	O
7	O
%-	O
40	O
.	O
0	O
%),	O
whereas	O
throat	B-ANAT
washing	O
and	O
urine	B-ANAT
specimens	O
showed	O
a	O
lower	O
yield	O
(	O
17	O
.	O
3	O
%	O
and	O
4	O
.	O
5	O
%).	O

Complete	O
inhibition	O
of	O
cytopathic	O
effects	O
of	O
SARS	O
-	O
CoV	O
in	O
culture	O
was	O
observed	O
for	O
interferon	O
subtypes	O
,	O
b	O
-	O
1b	O
,	O
a	O
-	O
n1	O
,	O
a	O
-	O
n3	O
,	O
and	O
human	O
leukocyte	B-ANAT
interferon	O
a	O
.	O
These	O
findings	O
support	O
clinical	O
testing	O
of	O
approved	O
interferons	O
for	O
the	O
treatment	O
of	O
SARS	O
.	O

TITLE	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
in	O
tears	B-ANAT
.	O

Detection	O
of	O
ocular	B-ANAT
infection	O
from	O
tears	B-ANAT
using	O
the	O
PCR	O
technique	O
has	O
been	O
widely	O
used	O
by	O
ophthalmologists	O
to	O
diagnose	O
infections	O
for	O
other	O
viruses	O
.	O

Three	O
patients	O
with	O
probable	O
SARS	O
(	O
one	O
female	O
and	O
two	O
male	O
patients	O
)	O
had	O
positive	O
results	O
from	O
their	O
tear	B-ANAT
samples	O
.	O

Many	O
healthcare	O
workers	O
are	O
in	O
close	O
proximity	O
to	O
the	O
eyes	B-ANAT
of	O
patients	O
and	O
this	O
may	O
be	O
a	O
source	O
of	O
spread	O
among	O
healthcare	O
workers	O
and	O
inoculating	O
patients	O
.	O

Western	O
blot	O
analysis	O
showed	O
that	O
the	O
reaction	O
of	O
GST	O
-	O
N	O
to	O
anti	O
-	O
SARS	O
-	O
CoV	O
sera	B-ANAT
was	O
positive	O
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
two	O
homology	O
models	O
(	O
denoted	O
as	O
MproST	O
and	O
MproSH	O
)	O
of	O
main	O
proteinase	O
(	O
Mpro	O
)	O
from	O
the	O
novel	O
coronavirus	O
associated	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
-	O
CoV	O
)	O
were	O
constructed	O
based	O
on	O
the	O
crystal	B-ANAT
structures	O
of	O
Mpro	O
from	O
transmissible	O
gastroenteritis	O
coronavirus	O
(	O
TGEV	O
)	O
(	O
MproT	O
)	O
and	O
human	O
coronavirus	O
HcoV	O
-	O
229E	O
(	O
MproH	O
),	O
respectively	O
.	O

Convalescent	O
plasma	B-ANAT
was	O
obtained	O
from	O
recovered	O
patients	O
after	O
informed	O
consent	O
.	O

TITLE	O
:	O
Antibody	O
response	O
of	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
targets	O
the	O
viral	B-ANAT
nucleocapsid	I-ANAT
.	O

In	O
addition	O
to	O
demonstrating	O
receptor	O
expression	O
on	O
CNS	B-ANAT
resident	O
cells	B-ANAT
,	O
these	O
data	O
suggest	O
that	O
transient	O
receptor	O
down	O
regulation	O
on	O
microglia	B-ANAT
aids	O
in	O
establishing	O
persistence	O
in	O
the	O
CNS	B-ANAT
by	O
assisting	O
virus	O
infection	O
of	O
other	O
glial	B-ANAT
cell	I-ANAT
types	O
.	O

We	O
report	O
on	O
a	O
new	O
system	O
,	O
which	O
is	O
characterised	O
by	O
a	O
short	O
circuit	O
arterio	B-ANAT
-	I-ANAT
venous	I-ANAT
shunt	O
using	O
arterio	B-ANAT
-	I-ANAT
venous	I-ANAT
pressure	O
gradient	O
as	O
driving	O
force	O
(	O
pumpless	O
extracorporeal	O
lung	B-ANAT
assist	O
[	O
pECLA	O
]).	O

Furthermore	O
,	O
studies	O
in	O
a	O
new	O
human	O
cell	B-ANAT
culture	O
model	O
have	O
indicated	O
that	O
the	O
presence	O
of	O
ACE2	O
alone	O
is	O
not	O
sufficient	O
for	O
maintaining	O
viral	O
infection	O
.	O

Methylprednisolone	O
therapy	O
caused	O
a	O
dramatic	O
improvement	O
of	O
pulmonary	B-ANAT
and	O
systemic	O
organ	B-ANAT
function	O
.	O

ABSTRACT	O
:	O
This	O
study	O
aimed	O
to	O
examine	O
the	O
significance	O
of	O
interactions	O
between	O
Escherichia	O
coli	O
and	O
various	O
respiratory	O
pathogens	O
during	O
outbreaks	O
of	O
colibacillosis	O
-	O
associated	O
mortality	O
in	O
layer	B-ANAT
hen	O
flocks	O
under	O
field	O
conditions	O
.	O

In	O
a	O
pathogenicity	O
experiment	O
,	O
the	O
clinical	O
signs	O
and	O
related	O
gross	O
lesions	O
resembling	O
those	O
of	O
field	O
outbreak	O
were	O
reproduced	O
and	O
the	O
virus	O
isolate	O
SC021202	O
was	O
re	O
-	O
isolated	O
from	O
the	O
kidneys	B-ANAT
of	O
the	O
infected	O
chicken	O
.	O

One	O
week	O
after	O
the	O
second	O
immunization	O
,	O
mice	O
sera	B-ANAT
were	O
collected	O
to	O
detect	O
serum	B-ANAT
neutralizing	O
antibodies	O
.	O

CONCLUSIONS	O
:	O
Job	O
that	O
dealing	O
with	O
palm	B-ANAT
civets	O
was	O
the	O
main	O
risk	O
factor	O
of	O
SARS	O
-	O
CoV	O
infection	O
in	O
animal	O
market	O
workers	O
.	O

Dealing	O
with	O
the	O
urgent	O
public	O
health	O
problems	O
and	O
emerging	O
infectious	O
diseases	O
outbreak	O
,	O
epidemiologists	O
need	O
to	O
keep	O
good	O
relations	O
with	O
media	B-ANAT
,	O
and	O
making	O
use	O
of	O
modern	O
electronic	O
technologies	O
to	O
communicate	O
with	O
the	O
public	O
.	O

The	O
average	O
numbers	O
of	O
abnormal	O
lung	B-ANAT
field	I-ANAT
(	O
the	O
lung	B-ANAT
were	O
divided	O
into	O
6	O
fields	O
)	O
were	O
1	O
.	O
7	O
,	O
1	O
.	O
9	O
,	O
2	O
.	O
5	O
and	O
2	O
.	O
6	O
(	O
P	O
<	O
0	O
.	O
001	O
);	O
The	O
numbers	O
of	O
cases	O
receiving	O
continuous	O
oxygen	O
supply	O
treatment	O
were	O
33	O
.	O
6	O
%,	O
50	O
.	O
0	O
%,	O
53	O
.	O
7	O
%	O
and	O
74	O
.	O
0	O
%	O
(	O
P	O
<	O
0	O
.	O
001	O
),	O
and	O
the	O
numbers	O
of	O
cases	O
receiving	O
glucocorticosteroids	O
treatment	O
were	O
28	O
.	O
2	O
%,	O
35	O
.	O
9	O
%,	O
53	O
.	O
7	O
%	O
and	O
62	O
.	O
0	O
%	O
(	O
P	O
<	O
0	O
.	O
001	O
),	O
respectively	O
.	O

The	O
survival	O
rate	O
of	O
SARS	O
-	O
CoV	O
infected	O
cells	B-ANAT
was	O
greatly	O
increased	O
by	O
the	O
treatment	O
with	O
SNAP	O
,	O
and	O
the	O
concentration	O
of	O
this	O
compound	O
needed	O
to	O
inhibit	O
the	O
viral	O
cytopathic	O
effect	O
to	O
50	O
%	O
was	O
222	O
microM	O
,	O
with	O
a	O
selectivity	O
index	O
of	O
3	O
.	O

RESULTS	O
:	O
The	O
absorbance	O
(	O
A	O
)	O
value	O
of	O
SARS	O
-	O
CoV	O
IgG	B-ANAT
antibody	I-ANAT
ranged	O
from	O
0	O
.	O
81	O
to	O
2	O
.	O
06	O
in	O
patients	O
after	O
half	O
an	O
year	O
of	O
SARS	O
onset	O
,	O
and	O
form	O
0	O
.	O
79	O
to	O
2	O
.	O
01	O
in	O
patients	O
before	O
half	O
an	O
year	O
of	O
SARS	O
onset	O
.	O

The	O
time	O
of	O
seroconversion	O
detected	O
by	O
the	O
recombinant	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
protein	O
-	O
based	O
ELISA	O
and	O
that	O
detected	O
by	O
indirect	O
immunofluorescence	O
assay	O
were	O
similar	O
.	O

Further	O
studies	O
should	O
be	O
performed	O
to	O
see	O
whether	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
protein	O
antibody	O
positivity	O
has	O
any	O
prognostic	O
significance	O
.	O

When	O
tested	O
with	O
120	O
nasopharyngeal	B-ANAT
aspirate	I-ANAT
,	O
100	O
urine	B-ANAT
,	O
and	O
100	O
fecal	B-ANAT
specimens	O
from	O
hospitalized	O
patients	O
without	O
SARS	O
,	O
the	O
assay	O
was	O
shown	O
to	O
have	O
high	O
specificities	O
-	O
96	O
.	O
7	O
,	O
99	O
,	O
and	O
96	O
%,	O
respectively	O
.	O

Since	O
the	O
present	O
ELISA	O
is	O
more	O
convenient	O
and	O
economical	O
than	O
reverse	O
transcription	O
-	O
PCR	O
,	O
it	O
may	O
serve	O
as	O
an	O
alternative	O
tool	O
for	O
the	O
early	O
diagnosis	O
of	O
SARS	O
CoV	O
infection	O
in	O
laboratories	O
with	O
limited	O
resources	O
and	O
expertise	O
and	O
for	O
mass	O
screening	O
for	O
the	O
reservoir	O
of	O
SARS	O
CoV	O
.	O
Further	O
studies	O
on	O
serial	O
clinical	O
specimens	O
should	O
reveal	O
the	O
duration	O
of	O
nucleocapsid	B-ANAT
protein	O
shedding	O
and	O
may	O
reveal	O
a	O
higher	O
detection	O
rate	O
in	O
SARS	O
patients	O
.	O

In	O
this	O
study	O
,	O
we	O
analyzed	O
the	O
effect	O
of	O
aurintricarboxylic	O
acid	O
(	O
ATA	O
)	O
on	O
SARS	O
-	O
CoV	O
replication	O
in	O
cell	B-ANAT
culture	O
,	O
and	O
found	O
that	O
ATA	O
could	O
drastically	O
inhibit	O
SARS	O
-	O
CoV	O
replication	O
,	O
with	O
viral	O
production	O
being	O
1000	O
-	O
fold	O
less	O
than	O
that	O
in	O
the	O
untreated	O
control	O
.	O

Usual	O
regulatory	O
mechanisms	O
cannot	O
shepherd	O
research	O
protocols	O
with	O
benefits	O
that	O
can	O
only	O
be	O
characterized	O
as	O
""""	O
uncertain	O
""""	O
in	O
the	O
face	B-ANAT
of	O
more	O
than	O
minimal	O
risk	O
.	O

Compared	O
with	O
the	O
GGO	O
group	O
,	O
the	O
GGO	O
+	O
F	O
group	O
showed	O
significantly	O
lower	O
FEV	O
(	O
1	O
),	O
FVC	O
,	O
total	O
lung	B-ANAT
capacity	O
,	O
residual	O
volume	O
,	O
and	O
DLCO	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
therapeutic	O
effect	O
of	O
integrative	O
Chinese	O
and	O
western	O
medicine	O
(	O
ICWM	O
)	O
in	O
treating	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
its	O
influence	O
on	O
T	B-ANAT
-	I-ANAT
lymphocyte	I-ANAT
subsets	I-ANAT
.	O

The	O
increased	O
consumption	O
of	O
platelets	B-ANAT
and	O
/	O
or	O
the	O
decreased	O
production	O
of	O
platelets	B-ANAT
in	O
the	O
damaged	O
lungs	B-ANAT
are	O
a	O
potential	O
alternative	O
but	O
often	O
overlooked	O
mechanism	O
that	O
can	O
contribute	O
to	O
thrombocytopenia	O
in	O
severe	O
critical	O
pulmonary	B-ANAT
conditions	O
.	O

In	O
contrast	O
to	O
Vero	B-ANAT
cells	I-ANAT
,	O
SARS	O
-	O
CoV	O
did	O
not	O
produce	O
cytopathic	O
effects	O
on	O
LoVo	O
cells	B-ANAT
.	O

Pseudoviruses	O
infected	O
Vero	O
E6	O
cells	B-ANAT
in	O
a	O
pH	O
-	O
independent	O
manner	O
and	O
the	O
infection	O
could	O
be	O
specifically	O
inhibited	O
by	O
convalescent	O
sera	B-ANAT
.	O

TITLE	O
:	O
Prediction	O
of	O
class	O
I	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
epitopes	O
:	O
evidence	O
of	O
presence	O
of	O
immunological	O
hot	O
spots	O
inside	O
antigens	O
.	O

MULTIPRED	O
,	O
a	O
computational	O
system	O
for	O
promiscuous	O
prediction	O
of	O
HLA	B-ANAT
class	O
I	O
binders	O
,	O
uses	O
artificial	O
neural	O
networks	O
(	O
ANN	O
)	O
and	O
hidden	O
Markov	O
models	O
(	O
HMM	O
)	O
as	O
predictive	O
engines	O
.	O

The	O
analysis	O
of	O
proteins	O
E6	O
and	O
E7	O
showed	O
that	O
ANN	O
models	O
appear	O
to	O
be	O
more	O
accurate	O
for	O
prediction	O
of	O
HLA	B-ANAT
-	O
A3	O
hot	O
spots	O
and	O
HMM	O
models	O
for	O
HLA	B-ANAT
-	O
A2	O
predictions	O
.	O

Totally	O
531	O
samples	O
(	O
including	O
urine	B-ANAT
,	O
stool	B-ANAT
,	O
and	O
OWF	O
)	O
were	O
collected	O
from	O
177	O
convalescence	O
patients	O
with	O
positive	O
SARS	O
antibody	O
which	O
were	O
confirmed	O
by	O
ELISA	O
method	O
.	O

No	O
significant	O
difference	O
was	O
found	O
among	O
urine	B-ANAT
,	O
stool	B-ANAT
,	O
and	O
OWF	O
on	O
the	O
difference	O
grade	O
quantity	O
of	O
SARS	O
-	O
CoV	O
RNA	O
quantity	O
.	O

No	O
significant	O
difference	O
was	O
found	O
among	O
urine	B-ANAT
,	O
stool	B-ANAT
,	O
and	O
OWF	O
on	O
the	O
difference	O
grade	O
quantity	O
of	O
SARS	O
-	O
CoV	O
RNA	O
quantity	O
.	O

TITLE	O
:	O
Life	O
-	O
threatening	O
Dobrava	O
hantavirus	O
infection	O
with	O
unusually	O
extended	O
pulmonary	B-ANAT
involvement	O
.	O

We	O
report	O
on	O
a	O
female	O
patient	O
from	O
Northern	O
Germany	O
,	O
who	O
suffered	O
primarily	O
from	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
-	O
like	O
pulmonary	B-ANAT
failure	O
due	O
to	O
Dobrava	O
hantavirus	O
infection	O
that	O
was	O
complicated	O
by	O
acute	O
renal	B-ANAT
insufficiency	O
.	O

The	O
serum	B-ANAT
concentrations	O
of	O
interleukin	O
-	O
1	O
(	O
IL	O
-	O
1	O
),	O
IL	O
-	O
4	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
IL	O
-	O
10	O
,	O
tumor	O
growth	O
factor	O
beta	O
(	O
TGF	O
-	O
beta	O
),	O
tumor	O
necrosis	O
factor	O
alpha	O
(	O
TNF	O
-	O
alpha	O
),	O
and	O
gamma	O
interferon	O
(	O
IFN	O
-	O
gamma	O
)	O
were	O
measured	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assays	O
(	O
ELISA	O
).	O

The	O
IL	O
-	O
6	O
concentration	O
was	O
increased	O
in	O
SARS	O
patients	O
and	O
was	O
significantly	O
elevated	O
in	O
severe	O
SARS	O
patients	O
,	O
but	O
the	O
IL	O
-	O
6	O
concentrations	O
were	O
similar	O
in	O
convalescent	O
patients	O
and	O
control	O
subjects	O
,	O
suggesting	O
that	O
there	O
was	O
a	O
positive	O
relationship	O
between	O
the	O
serum	B-ANAT
IL	O
-	O
6	O
concentration	O
and	O
SARS	O
severity	O
.	O

TITLE	O
:	O
Pulmonary	B-ANAT
pathology	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
in	O
Toronto	O
.	O

Histologically	O
,	O
all	O
patients	O
showed	O
varying	O
degrees	O
of	O
exudative	O
and	O
proliferative	O
phase	O
acute	O
lung	B-ANAT
injury	O
,	O
evidenced	O
in	O
conventional	O
and	O
immunohistochemical	O
stains	O
by	O
edema	O
,	O
inflammatory	O
infiltrate	O
,	O
pneumocyte	B-ANAT
hyperplasia	O
,	O
fibrinous	O
exudates	B-ANAT
,	O
and	O
organization	O
.	O

Special	O
stains	O
demonstrated	O
vascular	B-ANAT
endothelial	B-ANAT
damage	O
of	O
both	O
small	O
-	O
and	O
mid	O
-	O
sized	O
pulmonary	B-ANAT
vessels	B-ANAT
.	O

TITLE	O
:	O
Disease	O
-	O
specific	O
B	B-ANAT
Cell	I-ANAT
epitopes	O
for	O
serum	B-ANAT
antibodies	O
from	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
serologic	O
detection	O
of	O
SARS	O
antibodies	O
by	O
epitope	O
-	O
based	O
peptide	O
antigens	O
.	O

Stepwise	O
reduction	O
of	O
the	O
mean	O
airway	B-ANAT
pressure	O
(	O
26	O
cm	O
H	O
(	O
2	O
)	O
O	O
),	O
and	O
oscillating	O
frequencies	O
(	O
3	O
.	O
5	O
Hz	O
),	O
as	O
well	O
as	O
increasing	O
the	O
oscillating	O
amplitudes	O
(	O
95	O
cm	O
H	O
(	O
2	O
)	O
O	O
)	O
resulted	O
in	O
an	O
unchanged	O
Pa	O
(	O
co	O
(	O
2	O
)),	O
but	O
oxygenation	O
worsened	O
.	O

Neutralizing	O
viral	O
antibodies	O
were	O
demonstrated	O
in	O
the	O
sera	B-ANAT
from	O
all	O
of	O
the	O
patients	O
with	O
SARS	O
symptoms	O
.	O

TITLE	O
:	O
A	O
highly	O
unusual	O
palindromic	O
transmembrane	B-ANAT
helical	O
hairpin	O
formed	O
by	O
SARS	O
coronavirus	O
E	O
protein	O
.	O

ABSTRACT	O
:	O
Sera	B-ANAT
from	O
38	O
free	O
-	O
ranging	O
spotted	O
hyenas	O
(	O
Crocuta	O
crocuta	O
)	O
in	O
the	O
Serengeti	O
ecosystem	O
,	O
Tanzania	O
,	O
were	O
screened	O
for	O
exposure	O
to	O
coronavirus	O
of	O
antigenic	O
group	O
1	O
.	O

Application	O
of	O
RT	O
-	O
PCR	O
to	O
27	O
fecal	B-ANAT
samples	O
revealed	O
viral	O
RNA	O
in	O
three	O
samples	O
(	O
11	O
%).	O

All	O
three	O
positive	O
fecal	B-ANAT
samples	O
were	O
from	O
the	O
15	O
juvenile	O
animals	O
(<	O
24	O
months	O
of	O
age	O
)	O
sampled	O
,	O
and	O
none	O
from	O
the	O
12	O
adults	O
sampled	O
.	O

In	O
the	O
present	O
paper	O
,	O
we	O
show	O
that	O
SARS	O
-	O
CoV	O
N	O
is	O
capable	O
of	O
inducing	O
apoptosis	O
of	O
COS	B-ANAT
-	I-ANAT
1	I-ANAT
monkey	O
kidney	B-ANAT
cells	B-ANAT
in	O
the	O
absence	O
of	O
growth	O
factors	O
by	O
down	O
-	O
regulating	O
ERK	O
(	O
extracellular	B-ANAT
-	O
signal	O
-	O
regulated	O
kinase	O
),	O
up	O
-	O
regulating	O
JNK	O
(	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
)	O
and	O
p38	O
MAPK	O
(	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
)	O
pathways	O
,	O
and	O
affecting	O
their	O
downstream	O
effectors	O
.	O

ABSTRACT	O
:	O
Impaired	O
active	O
fluid	O
transport	O
of	O
alveolar	B-ANAT
epithelium	I-ANAT
may	O
involve	O
in	O
the	O
pathogenesis	O
and	O
resolution	O
of	O
alveolar	B-ANAT
edema	O
.	O

Active	O
fluid	O
transport	O
of	O
alveolar	B-ANAT
epithelium	I-ANAT
might	O
play	O
a	O
role	O
in	O
the	O
pathogenesis	O
of	O
lung	B-ANAT
edema	O
in	O
acute	O
lung	B-ANAT
injury	O
.	O

RESULTS	O
:	O
At	O
24	O
h	O
after	O
the	O
infusion	O
of	O
oleic	O
acid	O
,	O
the	O
rats	O
developed	O
pulmonary	B-ANAT
edema	O
and	O
severe	O
hypoxemia	O
,	O
with	O
EVLW	O
increased	O
by	O
47	O
.	O
9	O
%	O
and	O
ALC	O
decreased	O
by	O
49	O
.	O
2	O
%.	O

Bio	O
-	O
panning	O
was	O
carried	O
out	O
against	O
immobilized	O
purified	O
envelope	B-ANAT
(	O
E	O
)	O
and	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
proteins	O
of	O
SARS	O
-	O
CoV	O
.	O
Their	O
binding	O
activity	O
and	O
specificity	O
to	O
E	O
or	O
N	O
protein	O
of	O
SARS	O
-	O
CoV	O
were	O
characterized	O
by	O
phage	O
-	O
ELISA	O
.	O

The	O
acute	O
phase	O
is	O
marked	O
by	O
an	O
abrupt	O
rise	O
in	O
the	O
secretion	B-ANAT
of	O
so	O
-	O
called	O
stress	O
hormones	O
with	O
an	O
associated	O
increase	O
in	O
mitochondrial	B-ANAT
and	O
metabolic	O
activity	O
.	O

The	O
combination	O
of	O
severe	O
inflammation	O
and	O
secondary	O
changes	O
in	O
endocrine	O
profile	O
diminish	O
energy	O
production	O
,	O
metabolic	O
rate	O
,	O
and	O
normal	O
cellular	B-ANAT
processes	O
,	O
leading	O
to	O
multiple	O
organ	B-ANAT
dysfunction	O
.	O

Second	O
,	O
the	O
decline	O
in	O
organ	B-ANAT
function	O
is	O
triggered	O
by	O
a	O
decrease	O
in	O
mitochondrial	B-ANAT
activity	O
and	O
oxidative	O
phosphorylation	O
,	O
leading	O
to	O
reduced	O
cellular	B-ANAT
metabolism	O
.	O

TITLE	O
:	O
A	O
single	O
amino	O
acid	O
mutation	O
in	O
the	O
spike	O
protein	O
of	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
hampers	O
its	O
maturation	O
and	O
incorporation	O
into	O
virions	B-ANAT
at	O
the	O
nonpermissive	O
temperature	O
.	O

Throat	B-ANAT
or	O
nasopharyngeal	B-ANAT
swab	I-ANAT
for	O
SARS	O
-	O
CoV	O
by	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
and	O
real	O
-	O
time	O
PCR	O
was	O
positive	O
in	O
40	O
of	O
the	O
47	O
patients	O
(	O
85	O
%)	O
in	O
whom	O
the	O
test	O
was	O
performed	O
.	O

Throat	B-ANAT
or	O
nasopharyngeal	B-ANAT
swab	I-ANAT
for	O
SARS	O
-	O
CoV	O
by	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
and	O
real	O
-	O
time	O
PCR	O
was	O
positive	O
in	O
40	O
of	O
the	O
47	O
patients	O
(	O
85	O
%)	O
in	O
whom	O
the	O
test	O
was	O
performed	O
.	O

TITLE	O
:	O
A	O
novel	O
sorting	O
signal	O
for	O
intracellular	B-ANAT
localization	O
is	O
present	O
in	O
the	O
S	O
protein	O
of	O
a	O
porcine	O
coronavirus	O
but	O
absent	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
.	O

Corresponding	O
tyrosine	O
residues	O
are	O
present	O
in	O
the	O
cytoplasmic	B-ANAT
tails	B-ANAT
of	O
the	O
S	O
proteins	O
of	O
other	O
animal	O
CoV	O
but	O
not	O
in	O
the	O
tail	O
portion	O
of	O
the	O
S	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
CoV	O
.	O
Changing	O
the	O
SEPV	O
tetrapeptide	O
in	O
the	O
cytoplasmic	B-ANAT
tail	I-ANAT
to	O
YEPI	O
resulted	O
in	O
intracellular	B-ANAT
retention	O
of	O
the	O
S	O
protein	O
of	O
SARS	O
-	O
CoV	O
.	O
As	O
the	O
S	O
proteins	O
of	O
CoV	O
have	O
receptor	O
binding	O
and	O
fusion	O
activities	O
and	O
are	O
the	O
main	O
target	O
of	O
neutralizing	O
antibodies	O
,	O
the	O
differences	O
in	O
the	O
transport	O
behavior	O
of	O
the	O
S	O
proteins	O
suggest	O
different	O
strategies	O
in	O
the	O
virus	O
host	O
interactions	O
between	O
SARS	O
-	O
CoV	O
and	O
other	O
coronaviruses	O
.	O

Our	O
study	O
suggested	O
that	O
coronavirus	O
causing	O
SARS	O
might	O
induce	O
liver	B-ANAT
damage	O
.	O

TITLE	O
:	O
Value	O
of	O
initial	O
chest	B-ANAT
radiographs	O
for	O
predicting	O
clinical	O
outcomes	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

Interestingly	O
,	O
PK	O
-	O
15	O
,	O
a	O
porcine	O
kidney	B-ANAT
cell	I-ANAT
line	O
,	O
and	O
primary	O
porcine	O
kidney	B-ANAT
cells	B-ANAT
were	O
also	O
highly	O
permissive	O
for	O
SARS	O
S	O
pseudotypes	O
and	O
wild	O
-	O
type	O
SARS	O
CoV	O
.	O
This	O
finding	O
suggests	O
that	O
swine	O
may	O
be	O
susceptible	O
to	O
SARS	O
infection	O
and	O
may	O
be	O
a	O
source	O
for	O
infection	O
of	O
humans	O
.	O

Leptospirosis	O
should	O
be	O
considered	O
in	O
patients	O
with	O
features	O
of	O
pulmonary	B-ANAT
-	O
renal	B-ANAT
syndrome	O
,	O
particularly	O
in	O
regions	O
known	O
to	O
be	O
endemic	O
for	O
leptospirosis	O
.	O

We	O
observed	O
that	O
the	O
effects	O
of	O
receiving	O
low	O
tidal	O
volume	O
+	O
PEEP	O
ventilation	O
were	O
not	O
as	O
good	O
as	O
prone	O
position	O
+	O
low	O
tidal	O
volume	O
+	O
PEEP	O
ventilation	O
in	O
the	O
dorsal	O
area	O
of	O
the	O
rabbit	O
lung	B-ANAT
compared	O
to	O
the	O
results	O
of	O
effective	O
local	O
area	O
lung	B-ANAT
blood	B-ANAT
perfusion	O
index	O
between	O
two	O
ventilation	O
modes	O
,	O
there	O
showed	O
significantly	O
differences	O
in	O
statistics	O
.	O

Data	O
also	O
showed	O
the	O
following	O
characteristics	O
in	O
those	O
severe	O
cases	O
:	O
sustained	O
fever	O
,	O
tachycardia	O
(	O
pulse	O
rate	O
being	O
over	O
100	O
per	O
minute	O
),	O
persistent	O
decrease	O
in	O
lymphocytes	B-ANAT
(<	O
0	O
.	O
9	O
x	O
10	O
(	O
9	O
)/	O
L	O
),	O
increase	O
in	O
neutrophils	B-ANAT
(>	O
7	O
.	O
1	O
x	O
10	O
(	O
9	O
)/	O
L	O
,	O
80	O
%),	O
and	O
rapid	O
changes	O
in	O
abnormal	O
chest	B-ANAT
X	O
-	O
ray	O
.	O

The	O
Cox	O
proportional	O
hazard	O
multi	O
-	O
variable	O
stepwise	O
analysis	O
showed	O
the	O
prediction	O
model	O
of	O
severe	O
SARS	O
included	O
age	O
,	O
comorbid	O
disease	O
,	O
body	B-ANAT
temperature	O
being	O
still	O
abnormal	O
after	O
2	O
days	O
of	O
hospitalization	O
,	O
neutrophil	B-ANAT
percentage	O
began	O
to	O
increase	O
steadily	O
to	O
more	O
than	O
80	O
%	O
after	O
3	O
days	O
of	O
hospitalization	O
,	O
counts	O
of	O
lymphocytes	B-ANAT
persisted	O
<	O
0	O
.	O
9	O
x	O
10	O
(	O
9	O
)/	O
L	O
after	O
4	O
days	O
of	O
hospitalization	O
.	O

The	O
amounts	O
of	O
CD	O
(	O
4	O
)(+),	O
CD	O
(	O
8	O
)(+),	O
and	O
CD	O
(	O
3	O
)(+)	O
of	O
peripheral	B-ANAT
blood	I-ANAT
were	O
decreased	O
at	O
the	O
early	O
stage	O
and	O
recovered	O
after	O
2	O
or	O
3	O
weeks	O
.	O

With	O
descending	O
in	O
infectious	O
generation	O
,	O
cases	O
treated	O
with	O
methylprednisolone	O
,	O
human	O
gamma	O
-	O
immunoglobulin	O
,	O
interferon	O
-	O
alpha	O
,	O
and	O
antiviral	O
drugs	O
(	O
oral	B-ANAT
ribavirin	O
or	O
oseltamivir	O
)	O
increased	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
the	O
duration	O
of	O
their	O
use	O
also	O
increased	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

TITLE	O
:	O
Characterization	O
of	O
the	O
3a	O
protein	O
of	O
SARS	O
-	O
associated	O
coronavirus	O
in	O
infected	O
vero	O
E6	O
cells	B-ANAT
and	O
SARS	O
patients	O
.	O

The	O
group	O
included	O
16	O
patients	O
(	O
9	O
%	O
of	O
total	O
;	O
10	O
bilateral	O
,	O
5	O
single	O
,	O
1	O
living	O
lobar	O
)	O
treated	O
with	O
ECMO	O
for	O
primary	O
allograft	O
failure	O
after	O
single	O
or	O
bilateral	O
single	O
-	O
lung	B-ANAT
transplantation	O
.	O

(	O
1	O
)	O
The	O
thermal	O
scanner	O
can	O
be	O
used	O
as	O
a	O
first	O
line	O
tool	O
for	O
the	O
mass	O
blind	O
screening	O
of	O
hyperthermia	O
,	O
(	O
2	O
)	O
the	O
readings	O
from	O
the	O
scanner	O
suggest	O
good	O
correlation	O
with	O
the	O
ear	B-ANAT
temperature	O
readings	O
,	O
(	O
3	O
)	O
an	O
imager	O
temperature	O
threshold	O
should	O
be	O
determined	O
by	O
the	O
environmental	O
factors	O
,	O
outdoor	O
condition	O
in	O
particular	O
,	O
the	O
physiological	O
site	O
offset	O
and	O
the	O
performance	O
characteristics	O
of	O
thermal	O
imager	O
to	O
warrant	O
the	O
most	O
accurate	O
and	O
reliable	O
screening	O
operation	O
.	O

Its	O
deletion	O
abolished	O
S	O
-	O
mediated	O
cell	B-ANAT
membrane	I-ANAT
fusion	O
but	O
retained	O
the	O
SU	O
-	O
receptor	O
-	O
binding	O
function	O
indicating	O
the	O
possibility	O
for	O
a	O
role	O
in	O
post	O
-	O
receptor	O
binding	O
steps	O
of	O
the	O
virus	O
entry	O
mechanism	O
.	O

We	O
observed	O
that	O
the	O
UV	O
-	O
inactivated	O
SARS	O
-	O
CoV	O
virion	B-ANAT
elicited	O
a	O
high	O
level	O
of	O
humoral	O
immunity	O
,	O
resulting	O
in	O
the	O
generation	O
of	O
long	O
-	O
term	O
antibody	O
secreting	O
and	O
memory	O
B	B-ANAT
cells	I-ANAT
.	O

TITLE	O
:	O
Imaging	O
of	O
unusual	O
diffuse	O
lung	B-ANAT
diseases	O
.	O

A	O
normal	O
HRCT	O
rules	O
out	O
the	O
diagnosis	O
of	O
Pneumocystis	O
carinii	O
pneumonia	O
while	O
a	O
normal	O
chest	B-ANAT
radiograph	O
does	O
not	O
.	O

Though	O
several	O
studies	O
reported	O
that	O
the	O
responsiveness	O
to	O
recruitment	O
maneuvers	O
resulted	O
in	O
a	O
marked	O
improvement	O
of	O
oxygenation	O
with	O
a	O
concomitant	O
decrease	O
in	O
airway	B-ANAT
pressure	O
and	O
/	O
or	O
inspiratory	O
fraction	O
of	O
oxygen	O
,	O
the	O
performance	O
of	O
recruitment	O
maneuvers	O
still	O
remains	O
a	O
matter	O
of	O
dispute	O
,	O
especially	O
in	O
patients	O
ventilated	O
with	O
a	O
lung	B-ANAT
protective	O
ventilation	O
strategy	O
.	O

Successful	O
recruitment	O
depends	O
on	O
several	O
factors	O
like	O
the	O
applied	O
recruitment	O
pressure	O
,	O
the	O
level	O
of	O
PEEP	O
set	O
before	O
and	O
after	O
the	O
recruitment	O
maneuver	O
,	O
the	O
stage	O
and	O
the	O
underlying	O
disease	O
of	O
the	O
ARDS	O
,	O
chest	B-ANAT
wall	I-ANAT
mechanics	O
and	O
the	O
transpulmonary	O
pressure	O
as	O
well	O
as	O
the	O
positioning	O
of	O
the	O
patient	O
.	O

Furthermore	O
,	O
APC	B-ANAT
reduces	O
the	O
ischemia	O
/	O
reperfusion	O
-	O
induced	O
renal	B-ANAT
injury	O
and	O
the	O
stress	O
-	O
induced	O
gastric	B-ANAT
mucosal	B-ANAT
injury	O
in	O
rats	O
.	O

APC	B-ANAT
inhibits	O
ET	O
-	O
induced	O
TNF	O
-	O
alpha	O
production	O
in	O
vitro	O
in	O
human	O
monocytes	B-ANAT
by	O
inhibiting	O
activation	O
of	O
NFkappaB	O
and	O
AP	O
-	O
1	O
by	O
inhibiting	O
degradation	O
of	O
IkappaB	O
and	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
pathways	O
,	O
respectively	O
.	O

Recombinant	O
APC	B-ANAT
was	O
reported	O
to	O
reduce	O
the	O
mortality	O
of	O
patients	O
with	O
severe	O
sepsis	O
.	O

The	O
maximal	O
Trp	O
emission	B-ANAT
wavelength	O
occurs	O
near	O
331	O
nm	O
,	O
suggesting	O
substantial	O
burial	O
of	O
Trp	O
residues	O
.	O

We	O
examined	O
oral	B-ANAT
specimens	O
,	O
including	O
throat	B-ANAT
wash	O
and	O
saliva	B-ANAT
,	O
and	O
found	O
large	O
amounts	O
of	O
SARS	O
-	O
CoV	O
RNA	O
in	O
both	O
throat	B-ANAT
wash	O
(	O
9	O
.	O
58	O
x	O
10	O
(	O
2	O
)	O
to	O
5	O
.	O
93	O
x	O
10	O
(	O
6	O
)	O
copies	O
/	O
mL	O
)	O
and	O
saliva	B-ANAT
(	O
7	O
.	O
08	O
x	O
10	O
(	O
3	O
)	O
to	O
6	O
.	O
38	O
x	O
10	O
(	O
8	O
)	O
copies	O
/	O
mL	O
)	O
from	O
all	O
specimens	O
of	O
17	O
consecutive	O
probable	O
SARS	O
case	O
-	O
patients	O
,	O
supporting	O
the	O
possibility	O
of	O
transmission	O
through	O
oral	B-ANAT
droplets	O
.	O

A	O
high	O
neutrophil	B-ANAT
count	O
,	O
the	O
extremes	O
of	O
age	O
,	O
and	O
sputum	B-ANAT
production	O
were	O
associated	O
with	O
a	O
lower	O
probability	O
of	O
SARS	O
.	O

The	O
results	O
indicate	O
that	O
CCL3	O
participates	O
in	O
an	O
effective	O
host	O
response	O
to	O
MHV	O
infection	O
by	O
contributing	O
to	O
CD11c	O
+	O
CD11b	O
+	O
CD8alpha	O
-	O
DC	O
maturation	O
,	O
activation	O
,	O
and	O
migration	O
to	O
cervical	B-ANAT
lymph	I-ANAT
nodes	I-ANAT
(	O
CLN	O
).	O

He	O
was	O
found	O
to	O
have	O
severe	O
methemoglobinemia	O
(	O
serum	B-ANAT
methemoglobin	O
fraction	O
9	O
%;	O
reference	O
range	O
0	O
-	O
0	O
.	O
2	O
).	O

Immunofluorescence	O
microscopy	O
detected	O
similar	O
patterns	O
of	O
punctate	O
perinuclear	O
and	O
distributed	O
cytoplasmic	B-ANAT
foci	I-ANAT
with	O
all	O
replicase	O
antibodies	O
and	O
as	O
early	O
as	O
6	O
h	O
postinfection	O
.	O

Whereas	O
virus	O
-	O
inoculated	O
wild	O
-	O
type	O
+/+	O
C57BL	O
/	O
6	O
mice	O
showed	O
profound	O
liver	B-ANAT
damage	O
and	O
spinal	B-ANAT
cord	I-ANAT
demyelination	O
under	O
these	O
conditions	O
,	O
Ceacam1a	O
-/-	O
mice	O
displayed	O
normal	O
livers	B-ANAT
and	O
spinal	B-ANAT
cords	I-ANAT
.	O

Descriptive	O
discussion	O
of	O
media	B-ANAT
reports	O
,	O
analysis	O
of	O
ethical	O
principles	O
and	O
political	O
decisions	O
discussed	O
in	O
the	O
outbreak	O
,	O
with	O
particular	O
emphasis	O
on	O
the	O
events	O
in	O
mainland	O
China	O
and	O
Taiwan	O
.	O

The	O
prevention	O
and	O
treatment	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
can	O
be	O
under	O
the	O
guidance	O
of	O
the	O
doctrines	O
for	O
treating	O
febrile	O
diseases	O
of	O
traditional	O
Chinese	O
medicine	O
,	O
treatment	O
based	O
on	O
syndrome	O
differentiation	O
,	O
such	O
as	O
syndrome	O
differentiation	O
of	O
triple	O
energizer	O
,	O
syndrome	O
differentiation	O
according	O
to	O
defensive	O
phase	O
,	O
qi	O
phase	O
,	O
nutrient	O
phase	O
and	O
blood	B-ANAT
phase	O
.	O

Upon	O
the	O
successful	O
treatment	O
of	O
the	O
eight	O
cases	O
of	O
SARS	O
in	O
Shanghai	O
,	O
it	O
is	O
demonstrated	O
that	O
the	O
triple	O
-	O
energizer	O
syndrome	O
differentiation	O
and	O
defensive	O
-	O
qi	O
-	O
nutrient	O
-	O
blood	B-ANAT
syndrome	O
differentiation	O
in	O
traditional	O
Chinese	O
medicine	O
are	O
of	O
high	O
value	O
in	O
treating	O
SARS	O
patients	O
.	O

TITLE	O
:	O
Preventive	O
effect	O
of	O
tranilast	O
on	O
oleic	O
acid	O
-	O
induced	O
lung	B-ANAT
injury	O
in	O
guinea	O
pigs	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
or	O
acute	O
lung	B-ANAT
injury	O
(	O
ARDS	O
)/(	O
ALI	O
)	O
involve	O
the	O
severe	O
lung	B-ANAT
injury	O
with	O
pulmonary	B-ANAT
vascular	B-ANAT
hyper	O
-	O
permeability	O
and	O
hypoxemia	O
induced	O
by	O
inflammatory	O
reactions	O
.	O

The	O
increase	O
in	O
pulmonary	B-ANAT
and	O
airway	B-ANAT
vascular	B-ANAT
permeability	O
and	O
the	O
decrease	O
in	O
partial	O
oxygen	O
pressure	O
of	O
arterial	B-ANAT
blood	I-ANAT
induced	O
by	O
an	O
intravenous	O
injection	O
of	O
OA	O
were	O
drastically	O
ameliorated	O
by	O
the	O
oral	B-ANAT
administration	O
of	O
tranilast	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

After	O
15th	O
day	O
of	O
disease	O
course	O
,	O
the	O
counts	O
gradually	O
returned	O
to	O
normal	O
CD3	O
+,	O
CD4	O
+,	O
CD8	B-ANAT
+	I-ANAT
T	I-ANAT
-	I-ANAT
lymphocyte	I-ANAT
counts	O
of	O
non	O
-	O
SARS	O
patients	O
were	O
normal	O
.	O

CONCLUSIONS	O
:	O
With	O
or	O
without	O
treatment	O
with	O
glucocorticoids	O
,	O
the	O
lowered	O
CD3	O
+,	O
CD4	O
+,	O
CD8	B-ANAT
+	I-ANAT
T	I-ANAT
-	I-ANAT
lymphocyte	I-ANAT
counts	O
in	O
the	O
early	O
stage	O
are	O
of	O
very	O
important	O
significance	O
in	O
differential	O
diagnosis	O
between	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
common	O
atypical	O
pneumonia	O
.	O

Routine	O
blood	B-ANAT
test	O
during	O
the	O
first	O
to	O
the	O
fifth	O
day	O
of	O
the	O
disease	O
revealed	O
WBCs	O
less	O
than	O
4	O
.	O
0x10	O
(	O
9	O
)	O
/	O
L	O
in	O
33	O
patients	O
(	O
62	O
.	O
3	O
%),	O
4	O
.	O
0	O
-	O
10	O
.	O
0x10	O
(	O
9	O
)/	O
L	O
in	O
18	O
patients	O
(	O
34	O
.	O
0	O
%),	O
lymphopenia	O
in	O
36	O
patients	O
(	O
67	O
.	O
9	O
%),	O
and	O
PLT	O
less	O
than	O
100	O
.	O
0x10	O
(	O
9	O
)	O
in	O
7	O
patients	O
(	O
13	O
.	O
2	O
%).	O

The	O
damage	O
of	O
several	O
organs	B-ANAT
was	O
common	O
,	O
including	O
the	O
elevated	O
ALT	O
or	O
AST	O
in	O
20	O
patients	O
(	O
37	O
.	O
7	O
%),	O
elevated	O
BUN	O
or	O
SCR	O
in	O
6	O
patients	O
(	O
11	O
.	O
3	O
%)	O
and	O
elevated	O
LDH	O
or	O
CK	O
or	O
HBDH	O
in	O
23	O
patients	O
(	O
43	O
.	O
4	O
%).	O

Persistent	O
low	O
counts	O
of	O
lymphocytes	B-ANAT
and	O
platelets	B-ANAT
at	O
presentation	O
might	O
be	O
associated	O
with	O
adverse	O
outcomes	O
.	O

CONCLUSIONS	O
:	O
All	O
the	O
tested	O
recombinant	O
interferons	O
showed	O
anti	O
-	O
SARS	O
virus	O
activities	O
on	O
the	O
Rda	O
cell	B-ANAT
culture	O
with	O
different	O
sensitivities	O
.	O

The	O
distribution	O
and	O
quantity	O
of	O
lymphocyte	B-ANAT
subpopulations	O
in	O
the	O
lungs	B-ANAT
and	O
immune	O
organs	B-ANAT
from	O
SARS	O
patients	O
were	O
analyzed	O
by	O
immunohistochemistry	O
.	O

ABSTRACT	O
:	O
Most	O
patients	O
with	O
end	O
-	O
stage	O
renal	B-ANAT
disease	O
(	O
ERSD	O
)	O
visiting	O
our	O
hospital	O
for	O
hemodialysis	O
treatment	O
during	O
the	O
SARS	O
outbreak	O
wore	O
an	O
N95	O
mask	O
.	O

The	O
fusion	O
core	O
is	O
a	O
six	O
-	O
helix	O
bundle	O
with	O
three	O
HR2	O
helices	O
packed	O
against	O
the	O
hydrophobic	O
grooves	B-ANAT
on	O
the	O
surface	O
of	O
central	O
coiled	O
coil	O
formed	O
by	O
three	O
parallel	O
HR1	O
helices	O
in	O
an	O
oblique	O
antiparallel	O
manner	O
.	O

These	O
represented	O
individual	O
patient	O
samples	O
,	O
serial	O
in	O
vitro	O
passages	O
in	O
cell	B-ANAT
culture	O
,	O
and	O
paired	O
human	O
and	O
cell	B-ANAT
culture	O
isolates	O
.	O

The	O
greater	O
sequence	O
divergence	O
in	O
the	O
structural	O
and	O
antigenic	O
proteins	O
and	O
consistent	O
deletions	O
in	O
the	O
3	O
'--	O
most	O
portion	O
of	O
the	O
viral	B-ANAT
genome	I-ANAT
suggest	O
that	O
certain	O
selection	O
pressures	O
are	O
interacting	O
with	O
the	O
functional	O
nature	O
of	O
these	O
validated	O
and	O
putative	O
ORFs	O
.	O

The	O
test	O
results	O
showed	O
that	O
17	O
positive	O
samples	O
were	O
obtained	O
among	O
18	O
samples	O
of	O
nasopharyngeal	B-ANAT
swabs	O
from	O
clinically	O
diagnosed	O
SARS	O
patients	O
.	O

TITLE	O
:	O
The	O
role	O
of	O
aquaporin	O
-	O
1	O
(	O
AQP1	O
)	O
expression	O
in	O
a	O
murine	O
model	O
of	O
lipopolysaccharide	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
.	O

Lung	B-ANAT
wet	O
-	O
to	O
-	O
dry	O
weight	O
ratio	O
and	O
lung	B-ANAT
vascular	B-ANAT
permeability	O
were	O
also	O
measured	O
in	O
the	O
AQP1	O
knockout	O
mice	O
(	O
n	O
=	O
9	O
)	O
that	O
received	O
IT	O
LPS	O
(	O
5	O
mg	O
/	O
kg	O
)	O
at	O
2	O
days	O
.	O

The	O
results	O
suggest	O
that	O
although	O
AQP1	O
expression	O
is	O
decreased	O
after	O
lung	B-ANAT
injury	O
,	O
depletion	O
of	O
AQP1	O
does	O
not	O
alter	O
lung	B-ANAT
inflammation	O
and	O
lung	B-ANAT
edema	O
induced	O
by	O
LPS	O
.	O

TITLE	O
:	O
Characterization	O
of	O
protein	O
-	O
protein	O
interactions	O
between	O
the	O
nucleocapsid	B-ANAT
protein	O
and	O
membrane	B-ANAT
protein	O
of	O
the	O
SARS	O
coronavirus	O
.	O

We	O
tested	O
chloroquine	O
phosphate	O
for	O
its	O
antiviral	O
potential	O
against	O
SARS	O
-	O
CoV	O
-	O
induced	O
cytopathicity	O
in	O
Vero	O
E6	O
cell	B-ANAT
culture	O
.	O

Common	O
presenting	O
features	O
of	O
SARS	O
are	O
high	O
fever	O
,	O
chills	O
,	O
rigor	O
,	O
malaise	O
,	O
nonproductive	O
cough	O
,	O
lymphopenia	O
and	O
pulmonary	B-ANAT
infiltrates	O
,	O
followed	O
by	O
rapidly	O
progressive	O
respiratory	O
failure	O
in	O
some	O
cases	O
.	O

ABSTRACT	O
:	O
Since	O
Kapakian	O
first	O
identified	O
a	O
virus	O
in	O
the	O
stool	B-ANAT
of	O
a	O
patient	O
with	O
diarrhoea	O
in	O
1972	O
,	O
many	O
viruses	O
have	O
been	O
described	O
that	O
cause	O
diarrhoea	O
directly	O
or	O
indirectly	O
.	O

7	O
.	O
6	O
degrees	O
C	O
,	O
suggesting	O
that	O
coronary	B-ANAT
virus	O
infection	O
,	O
which	O
has	O
been	O
considered	O
to	O
cause	O
SARS	O
by	O
now	O
,	O
may	O
be	O
most	O
active	O
at	O
9	O
degrees	O
C	O
-	O
24	O
degrees	O
C	O
.	O
(	O
2	O
)	O
Occupational	O
hygiene	O
in	O
hospital	O
proved	O
to	O
be	O
an	O
important	O
socio	O
-	O
behavior	O
factor	O
for	O
SARS	O
outbreak	O
.	O

These	O
data	O
indicate	O
that	O
C57BL	O
/	O
6	O
mice	O
support	O
transient	O
nonfatal	O
systemic	O
infection	O
with	O
SARS	O
-	O
CoV	O
in	O
the	O
lung	B-ANAT
,	O
which	O
is	O
able	O
to	O
disseminate	O
to	O
brain	B-ANAT
.	O

ABSTRACT	O
:	O
Ampligen	O
[	O
polyI	O
:	O
polyC12U	O
]	O
is	O
a	O
mismatched	O
double	O
-	O
stranded	O
RNA	O
that	O
acts	O
by	O
inducing	O
interferon	O
production	O
(	O
immunomodulator	O
)	O
and	O
by	O
activating	O
an	O
intracellular	B-ANAT
enzyme	O
(	O
RNase	O
-	O
L	O
)	O
against	O
viral	O
RNA	O
transcripts	O
(	O
antiviral	O
).	O

Many	O
SARS	O
patients	O
suffer	O
respiratory	O
distress	O
brought	O
on	O
by	O
interstitial	B-ANAT
infiltration	O
and	O
frequently	O
show	O
peripheral	B-ANAT
blood	I-ANAT
lymphopenia	O
and	O
occasional	O
leucopenia	O
.	O

TITLE	O
:	O
Nucleocapsid	B-ANAT
protein	O
of	O
SARS	O
coronavirus	O
tightly	O
binds	O
to	O
human	O
cyclophilin	O
A	O
.	O
ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
is	O
responsible	O
for	O
SARS	O
infection	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrated	O
the	O
expression	O
of	O
the	O
SARS	O
-	O
CoV	O
3CLpro	O
in	O
Escherichia	O
coli	O
and	O
Vero	B-ANAT
cells	I-ANAT
,	O
and	O
then	O
characterized	O
the	O
in	O
vitro	O
trans	O
-	O
cleavage	O
and	O
the	O
cell	B-ANAT
-	O
based	O
cis	O
-	O
cleavage	O
by	O
the	O
3CLpro	O
.	O

Comparison	O
of	O
the	O
measured	O
exercise	O
capacity	O
with	O
resting	B-ANAT
pulmonary	B-ANAT
function	O
tests	O
showed	O
many	O
cases	O
of	O
discordance	O
in	O
impairment	O
.	O

ABSTRACT	O
:	O
We	O
have	O
expressed	O
and	O
characterized	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
spike	O
protein	O
in	O
cDNA	O
-	O
transfected	O
mammalian	O
cells	B-ANAT
.	O

Characterization	O
of	O
various	O
cellular	B-ANAT
proteins	O
that	O
are	O
involved	O
in	O
regulating	O
cell	B-ANAT
cycle	O
progression	O
demonstrated	O
that	O
p28	B-ANAT
expression	O
resulted	O
in	O
an	O
accumulation	O
of	O
hypophosphorylated	O
retinoblastoma	O
protein	O
(	O
pRb	O
),	O
tumor	O
suppressor	O
p53	O
,	O
and	O
cyclin	O
-	O
dependent	O
kinase	O
(	O
Cdk	O
)	O
inhibitor	O
p21	O
(	O
Cip1	O
).	O

Our	O
present	O
data	O
suggest	O
the	O
following	O
model	O
of	O
p28	B-ANAT
-	O
induced	O
G	O
(	O
0	O
)/	O
G	O
(	O
1	O
)	O
cell	B-ANAT
cycle	O
arrest	O
.	O

TITLE	O
:	O
Retroviruses	O
pseudotyped	O
with	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
spike	O
protein	O
efficiently	O
infect	O
cells	B-ANAT
expressing	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
.	O

ABSTRACT	O
:	O
Infection	O
of	O
receptor	O
-	O
bearing	O
cells	B-ANAT
by	O
coronaviruses	O
is	O
mediated	O
by	O
their	O
spike	O
(	O
S	O
)	O
proteins	O
.	O

The	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
that	O
causes	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
infects	O
cells	B-ANAT
expressing	O
the	O
receptor	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
).	O

ABSTRACT	O
:	O
The	O
adhesion	O
of	O
microbial	O
pathogens	O
to	O
host	O
cells	B-ANAT
is	O
mediated	O
by	O
adhesins	O
.	O

Simulations	O
were	O
performed	O
in	O
five	O
grades	O
of	O
ARDS	O
in	O
the	O
presence	O
of	O
pure	O
alveolar	B-ANAT
or	O
combined	O
alveolar	B-ANAT
-	O
small	O
airway	B-ANAT
closure	O
as	O
well	O
complete	O
or	O
incomplete	O
lung	B-ANAT
volume	O
recruitability	O
.	O

Simultaneous	O
alveolar	B-ANAT
recruitment	O
and	O
overstretching	O
during	O
inflation	O
were	O
more	O
pronounced	O
than	O
alveolar	B-ANAT
derecruitment	O
and	O
overstretching	O
during	O
deflation	O
.	O

RESULTS	O
:	O
Simultaneous	O
alveolar	B-ANAT
recruitment	O
and	O
overstretching	O
during	O
inflation	O
were	O
more	O
pronounced	O
than	O
alveolar	B-ANAT
derecruitment	O
and	O
overstretching	O
during	O
deflation	O
.	O

Extracorporeal	O
life	O
support	O
(	O
ECLS	O
)	O
during	O
severe	O
ARDS	O
maintains	O
oxygen	O
and	O
carbon	O
dioxide	O
gas	O
exchange	O
while	O
providing	O
an	O
optimal	O
environment	O
for	O
recovery	O
of	O
pulmonary	B-ANAT
function	O
.	O

Sixty	O
-	O
seven	O
percent	O
were	O
weaned	O
off	O
ECLS	O
,	O
and	O
52	O
%	O
survived	O
to	O
hospital	O
discharge	B-ANAT
.	O

TITLE	O
:	O
Isoflurane	O
inhalation	O
enhances	O
increased	O
physiologic	O
deadspace	O
volume	O
associated	O
with	O
positive	O
pressure	O
ventilation	O
and	O
compromises	O
arterial	B-ANAT
oxygenation	O
.	O

Forty	O
patients	O
with	O
no	O
history	O
of	O
pulmonary	B-ANAT
pathology	O
undergoing	O
elective	O
surgery	O
in	O
the	O
supine	O
position	O
were	O
studied	O
.	O

These	O
findings	O
may	O
apply	O
to	O
subjects	O
with	O
compromised	O
pulmonary	B-ANAT
function	O
(	O
i	O
.	O
e	O
.,	O
acute	O
respiratory	O
distress	O
syndrome	O
or	O
severe	O
inhalational	O
burn	O
injury	O
).	O

When	O
S2	O
Ab	O
was	O
used	O
to	O
perform	O
immune	O
precipitation	O
with	O
lysate	O
of	O
SARS	O
-	O
CoV	O
infected	O
cells	B-ANAT
,	O
a	O
cleaved	B-ANAT
S2	O
fragment	O
was	O
detected	O
with	O
S2	O
-	O
specific	O
mAb	O
by	O
Western	O
blot	O
analysis	O
.	O

While	O
previous	O
studies	O
demonstrated	O
that	O
effector	O
and	O
memory	O
CD8	O
(+)	O
T	B-ANAT
lymphocytes	I-ANAT
are	O
critical	O
in	O
controlling	O
acute	O
IBV	O
infection	O
and	O
disease	O
in	O
chickens	O
,	O
here	O
chicken	O
anti	O
-	O
IBV	O
antibody	O
(	O
IgG	O
)	O
secreting	O
cells	B-ANAT
(	O
ASC	O
)	O
in	O
both	O
peripheral	B-ANAT
blood	I-ANAT
mononuclear	I-ANAT
cells	I-ANAT
(	O
PBMC	O
)	O
and	O
spleens	B-ANAT
collected	O
following	O
IBV	O
Gray	O
infection	O
were	O
evaluated	O
using	O
an	O
ELISPOT	O
assay	O
.	O

Evaluation	O
of	O
sera	B-ANAT
from	O
healthy	O
controls	O
(	O
n	O
=	O
60	O
)	O
resulted	O
in	O
two	O
weakly	O
positive	O
ELISA	O
results	O
with	O
the	O
remainder	O
being	O
negative	O
while	O
the	O
S2	O
protein	O
WB	O
demonstrated	O
three	O
positive	O
results	O
from	O
the	O
20	O
controls	O
with	O
a	O
history	O
of	O
SARS	O
contact	O
and	O
no	O
positive	O
results	O
in	O
40	O
noncontact	O
controls	O
.	O

Animals	O
resistant	O
to	O
the	O
effects	O
of	O
interferons	O
by	O
virtue	O
of	O
a	O
deficiency	O
in	O
Stat1	O
demonstrated	O
a	O
markedly	O
different	O
course	O
following	O
intranasal	O
inhalation	O
of	O
SARS	O
CoV	O
,	O
one	O
characterized	O
by	O
replication	O
of	O
virus	O
in	O
lungs	B-ANAT
and	O
progressively	O
worsening	O
pulmonary	B-ANAT
disease	O
with	O
inflammation	O
of	O
small	O
airways	O
and	O
alveoli	B-ANAT
and	O
systemic	O
spread	O
of	O
the	O
virus	O
to	O
livers	B-ANAT
and	O
spleens	B-ANAT
.	O

These	O
enzymes	O
are	O
capable	O
of	O
removing	O
cellular	B-ANAT
receptors	O
from	O
the	O
surface	O
of	O
target	B-ANAT
cells	I-ANAT
.	O

Clinical	O
data	O
,	O
including	O
elements	O
of	O
cardiovascular	B-ANAT
,	O
renal	B-ANAT
,	O
hepatic	B-ANAT
,	O
hematologic	O
,	O
neurologic	O
,	O
and	O
pulmonary	B-ANAT
function	O
,	O
were	O
collected	O
daily	O
.	O

These	O
data	O
provide	O
further	O
evidence	O
of	O
an	O
association	O
between	O
BCV	O
and	O
respiratory	B-ANAT
tract	I-ANAT
disease	O
in	O
feedlot	O
calves	O
.	O

Long	O
-	O
term	O
neurologic	O
sequelae	O
(	O
varying	O
degrees	O
of	O
irreversible	O
brain	B-ANAT
injury	O
)	O
occur	O
in	O
approximately	O
20	O
%	O
of	O
patients	O
.	O

Infections	O
may	O
occur	O
by	O
direct	O
contact	O
with	O
blood	B-ANAT
or	O
tissues	B-ANAT
of	O
infected	O
animal	O
during	O
handling	O
and	O
cutting	O
up	O
preys	O
and	O
when	O
preparing	O
or	O
eating	O
meat	O
,	O
or	O
also	O
when	O
bitten	O
by	O
injured	O
animal	O
.	O

This	O
demonstrated	O
clearly	O
that	O
when	O
both	O
these	O
vaccines	O
are	O
administered	O
there	O
is	O
a	O
transient	O
reduction	O
in	O
the	O
replication	O
of	O
both	O
viruses	O
,	O
probably	O
due	O
to	O
their	O
competition	O
for	O
the	O
same	O
target	O
epithelial	B-ANAT
cells	I-ANAT
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
.	O

Tissue	B-ANAT
samples	O
from	O
the	O
respiratory	B-ANAT
tract	I-ANAT
as	O
well	O
as	O
paired	O
serum	B-ANAT
samples	O
were	O
collected	O
for	O
analysis	O
.	O

Multivariate	O
analysis	O
confirmed	O
the	O
strong	O
role	O
of	O
contact	O
with	O
respiratory	O
secretions	B-ANAT
(	O
adjusted	O
OR	O
21	O
.	O
8	O
,	O
95	O
%	O
CI	O
1	O
.	O
7	O
274	O
.	O
8	O
,	O
P	O
=	O
0	O
.	O
017	O
).	O

ABSTRACT	O
:	O
Virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
(	O
VLPs	B-ANAT
)	O
produced	O
by	O
recombinant	O
expression	O
of	O
the	O
major	O
viral	O
structural	O
proteins	O
could	O
be	O
an	O
attractive	O
method	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
control	O
.	O

In	O
this	O
sense	O
,	O
the	O
SARS	O
scare	O
,	O
despite	O
the	O
remarkable	O
speed	O
with	O
which	O
it	O
was	O
played	O
out	O
in	O
the	O
modern	O
global	O
news	O
media	B-ANAT
,	O
resonates	O
with	O
the	O
meanings	O
attributed	O
to	O
other	O
epidemics	O
of	O
infectious	O
diseases	O
throughout	O
history	O
.	O

In	O
addition	O
,	O
we	O
introduced	O
a	O
31	O
-	O
mer	O
peptide	O
containing	O
an	O
auto	O
-	O
cleavage	O
site	O
to	O
the	O
N	O
-	O
terminal	O
of	O
the	O
proteases	O
and	O
found	O
the	O
peptide	O
could	O
be	O
cleaved	B-ANAT
efficiently	O
by	O
3CLsc	O
itself	O
,	O
but	O
,	O
among	O
the	O
four	O
mutants	O
,	O
only	O
the	O
mutant	O
Cys145	O
-->	O
Ser	B-ANAT
showed	O
residual	O
activity	O
as	O
detected	O
by	O
the	O
auto	O
-	O
cleavage	O
assay	O
.	O

Combination	O
of	O
lopinavir	O
/	O
ritonavir	O
plus	O
ribavirin	O
significantly	O
reduced	O
the	O
virus	O
load	O
of	O
SARS	O
-	O
CoV	O
in	O
nasopharyngeal	B-ANAT
,	O
serum	B-ANAT
,	O
stool	B-ANAT
and	O
urine	B-ANAT
specimens	O
taken	O
between	O
day	O
10	O
and	O
15	O
after	O
symptom	O
onset	O
when	O
compared	O
with	O
the	O
historical	O
control	O
group	O
treated	O
with	O
ribavirin	O
.	O

The	O
performance	O
of	O
a	O
microplate	O
enzyme	O
immunoassay	O
,	O
DETECT	O
-	O
SARS	O
was	O
evaluated	O
for	O
the	O
detection	O
of	O
anti	O
-	O
SARS	O
-	O
CoV	O
IgG	B-ANAT
antibody	I-ANAT
.	O

The	O
results	O
showed	O
that	O
the	O
assay	O
provided	O
a	O
high	O
degree	O
of	O
sensitivity	O
(	O
95	O
.	O
9	O
%)	O
for	O
convalescent	O
serum	B-ANAT
samples	O
.	O

Thrombocytosis	O
developed	O
in	O
36	O
patients	O
(	O
20	O
.	O
4	O
%)	O
at	O
a	O
mean	O
(	O
sd	O
)	O
time	O
of	O
14	O
.	O
0	O
(	O
4	O
.	O
0	O
)	O
days	O
and	O
the	O
platelet	B-ANAT
count	O
normalized	O
35	O
.	O
0	O
(	O
13	O
.	O
0	O
)	O
days	O
after	O
admission	O
to	O
the	O
ICU	O
.	O

To	O
express	O
the	O
membrane	B-ANAT
(	O
M	O
)	O
protein	O
of	O
SARS	O
-	O
CoV	O
at	O
high	O
-	O
level	O
in	O
vitro	O
,	O
the	O
M	O
gene	O
fragment	O
was	O
amplified	O
and	O
cloned	O
it	O
into	O
the	O
Pichia	O
Pastoris	O
expression	O
vector	O
pPICZalphaA	O
.	O
SDS	O
-	O
PAGE	O
and	O
Western	O
blotting	O
analysis	O
of	O
the	O
induced	O
products	O
of	O
recombinant	O
yeast	O
transformant	O
indicated	O
that	O
successful	O
high	O
-	O
level	O
expression	O
of	O
M	O
protein	O
was	O
achieved	O
,	O
and	O
that	O
the	O
expression	O
product	O
was	O
similar	O
antigenically	O
to	O
the	O
natural	O
protein	O
.	O

Initial	O
blood	B-ANAT
glucose	O
,	O
systolic	O
pressure	O
(	O
SBP	O
),	O
and	O
diastolic	O
pressure	O
(	O
DBP	O
)	O
were	O
no	O
significant	O
difference	O
between	O
GCS	O
group	O
and	O
non	O
-	O
GCS	O
group	O
.	O

The	O
levels	O
of	O
blood	B-ANAT
glucose	O
were	O
correlated	O
with	O
the	O
initial	O
,	O
maximum	O
,	O
and	O
cumulative	O
GCS	O
dosages	O
.	O

Average	O
blood	B-ANAT
glucose	O
was	O
increased	O
markedly	O
in	O
groups	O
with	O
MP	O
(	O
Initial	O
)	O
>	O
or	O
=	O
80	O
mg	O
/	O
d	O
(	O
Methyprednisonlone	O
),	O
MP	O
(	O
Maximal	O
)	O
>	O
or	O
=	O
160	O
mg	O
/	O
d	O
,	O
or	O
MP	O
(	O
Cumulative	O
)	O
>	O
or	O
=	O
3000	O
mg	O
.	O

Serum	B-ANAT
potassium	O
reached	O
its	O
nadir	O
in	O
the	O
first	O
week	O
of	O
GCS	O
treatment	O
and	O
then	O
grew	O
up	O
in	O
the	O
second	O
week	O
.	O

No	O
specific	O
pathological	O
change	O
was	O
seen	O
in	O
the	O
gastrointestinal	B-ANAT
tract	I-ANAT
and	O
kidneys	B-ANAT
.	O

The	O
research	O
presented	O
here	O
used	O
computational	O
models	O
of	O
the	O
lung	B-ANAT
to	O
analyze	O
the	O
effect	O
of	O
altitude	O
on	O
the	O
PaO2	O
/	O
FIO2	O
ratio	O
and	O
pulmonary	B-ANAT
shunt	O
.	O

Samples	O
used	O
for	O
the	O
detection	O
of	O
coronavirus	O
RNA	O
by	O
RT	O
-	O
PCR	O
were	O
collected	O
from	O
throat	B-ANAT
and	O
rectal	O
swabs	O
during	O
acute	O
phase	O
.	O

The	O
median	O
time	O
for	O
SARS	O
-	O
CoV	O
to	O
become	O
undetectable	O
in	O
plasma	B-ANAT
was	O
12	O
days	O
(	O
11	O
-	O
20	O
days	O
)	O
versus	O
8	O
days	O
(	O
8	O
-	O
15	O
days	O
),	O
respectively	O
.	O

The	O
median	O
time	O
for	O
SARS	O
-	O
CoV	O
to	O
become	O
undetectable	O
in	O
plasma	B-ANAT
was	O
12	O
days	O
(	O
11	O
-	O
20	O
days	O
)	O
versus	O
8	O
days	O
(	O
8	O
-	O
15	O
days	O
),	O
respectively	O
.	O

Uncontrolled	O
studies	O
in	O
adults	O
have	O
shown	O
improvement	O
in	O
gas	O
exchange	O
and	O
lung	B-ANAT
compliance	O
with	O
partial	O
liquid	O
ventilation	O
.	O

Forty	O
-	O
two	O
peptides	O
among	O
them	O
were	O
reactive	O
to	O
the	O
sera	B-ANAT
from	O
all	O
three	O
patients	O
.	O

ABSTRACT	O
:	O
To	O
examine	O
the	O
media	B-ANAT
response	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O

One	O
mechanism	O
involves	O
the	O
presence	O
of	O
antibodies	O
to	O
white	B-ANAT
blood	I-ANAT
cells	I-ANAT
,	O
usually	O
in	O
a	O
transfused	O
blood	B-ANAT
component	I-ANAT
.	O

The	O
number	O
of	O
visits	O
that	O
underwent	O
chest	B-ANAT
radiological	O
examination	O
increased	O
(	O
p	O
=	O
0	O
.	O
000	O
)	O
and	O
upper	B-ANAT
abdomen	I-ANAT
sonography	O
(	O
p	O
=	O
0	O
.	O
007	O
)	O
decreased	O
significantly	O
in	O
May	O
.	O
SARS	O
had	O
an	O
impact	O
on	O
the	O
medical	O
service	O
system	O
and	O
decreased	O
visits	O
by	O
40	O
%	O
in	O
the	O
ED	O
.	O

Viral	O
load	O
in	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
(	O
n	O
=	O
142	O
)	O
from	O
day	O
10	O
to	O
day	O
15	O
after	O
onset	O
of	O
symptoms	O
was	O
associated	O
with	O
oxygen	O
desaturation	O
,	O
mechanical	O
ventilation	O
,	O
diarrhea	O
,	O
hepatic	B-ANAT
dysfunction	O
,	O
and	O
death	O
.	O

Stool	B-ANAT
viral	O
load	O
(	O
n	O
=	O
94	O
)	O
was	O
associated	O
with	O
diarrhea	O
,	O
and	O
urine	B-ANAT
viral	O
load	O
(	O
n	O
=	O
111	O
)	O
was	O
associated	O
with	O
abnormal	O
urinalysis	O
results	O
.	O

The	O
catalytic	O
dyad	O
His	O
-	O
41	O
and	O
Cys	O
-	O
145	O
in	O
the	O
active	O
pocket	O
between	O
domain	O
I	O
and	O
II	O
seem	O
to	O
polarize	O
the	O
pi	O
-	O
electron	O
density	O
of	O
the	O
peptide	O
bond	O
between	O
Gln	O
and	O
Ser	B-ANAT
in	O
the	O
octapeptide	O
,	O
leading	O
to	O
an	O
increase	O
of	O
positive	O
charge	O
on	O
C	O
(	O
CO	O
)	O
of	O
Gln	O
and	O
negative	O
charge	O
on	O
N	O
(	O
NH	O
)	O
of	O
Ser	B-ANAT
.	O

ABSTRACT	O
:	O
This	O
study	O
investigated	O
the	O
long	O
-	O
term	O
excretion	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
in	O
sputum	B-ANAT
and	O
stool	B-ANAT
specimens	O
from	O
56	O
infected	O
patients	O
.	O

We	O
concluded	O
that	O
the	O
pathogenic	O
consequences	O
and	O
immunological	O
responses	O
of	O
pigs	O
to	O
PRRSV	O
are	O
directly	O
related	O
to	O
viral	O
load	O
in	O
acute	O
infection	O
as	O
reflected	O
in	O
viral	O
titers	O
in	O
blood	B-ANAT
.	O

TITLE	O
:	O
Expression	O
,	O
purification	O
and	O
sublocalization	O
of	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
protein	O
in	O
insect	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
causative	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
previously	O
unidentified	O
coronavirus	O
,	O
SARS	O
-	O
CoV	O
.	O
The	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
of	O
SARS	O
-	O
CoV	O
is	O
a	O
major	O
viral	O
protein	O
recognized	O
by	O
acute	O
and	O
early	O
convalescent	O
sera	B-ANAT
from	O
SARS	O
patients	O
.	O

In	O
addition	O
,	O
we	O
examined	O
the	O
subcellular	O
localization	O
of	O
the	O
N	O
protein	O
by	O
confocal	O
microscopy	O
in	O
Trichoplusia	O
ni	O
BT1	O
Tn	O
5B1	O
-	O
4	O
cells	B-ANAT
infected	O
with	O
recombinant	O
baculovirus	O
.	O

Mild	O
pulmonary	B-ANAT
abnormalities	O
were	O
detected	O
on	O
HRCT	O
in	O
16	O
(	O
34	O
.	O
0	O
%)	O
subjects	O
,	O
including	O
residual	O
ground	O
-	O
glass	O
opacification	O
(	O
n	O
=	O
5	O
),	O
air	O
trapping	O
(	O
n	O
=	O
8	O
),	O
and	O
a	O
combination	O
of	O
ground	O
-	O
glass	O
changes	O
and	O
air	O
trapping	O
(	O
n	O
=	O
3	O
).	O

In	O
contrast	O
,	O
CCR2	O
(-/-)	O
mice	O
displayed	O
an	O
impaired	O
ability	O
to	O
clear	O
virus	O
from	O
the	O
brain	B-ANAT
that	O
was	O
accompanied	O
by	O
a	O
reduction	O
in	O
the	O
numbers	O
of	O
antigen	O
-	O
specific	O
T	B-ANAT
cells	I-ANAT
as	O
compared	O
to	O
both	O
CCL2	O
(-/-)	O
and	O
wild	O
-	O
type	O
mice	O
.	O

Emergency	O
departments	O
,	O
being	O
the	O
primary	O
portal	B-ANAT
of	O
entry	O
into	O
the	O
hospitals	O
,	O
had	O
to	O
come	O
up	O
with	O
rapid	O
strategic	O
changes	O
and	O
modifications	O
to	O
accommodate	O
and	O
manage	O
this	O
public	O
health	O
problem	O
effectively	O
.	O

TITLE	O
:	O
[	O
Severe	O
pulmonary	B-ANAT
complications	O
of	O
massive	O
intoxication	O
with	O
calcium	O
channel	O
blockers	O
and	O
isosorbide	O
mononitrate	O
--	O
a	O
case	O
report	O
].	O

Pulmonary	B-ANAT
barotrauma	O
(	O
pneumothorax	O
,	O
pneumomediastinum	O
,	O
pneumoperitoneum	O
and	O
soft	B-ANAT
tissue	I-ANAT
emphysema	O
)	O
was	O
a	O
secondary	O
complication	O
to	O
mechanical	O
ventilation	O
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
the	O
envelope	B-ANAT
(	O
E	O
)	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
can	O
induce	O
membrane	B-ANAT
permeability	O
changes	O
when	O
expressed	O
in	O
Escherichia	O
coli	O
.	O

Site	O
-	O
directed	O
mutagenesis	O
studies	O
revealed	O
that	O
two	O
cysteine	O
residues	O
of	O
the	O
E	O
protein	O
were	O
essential	O
for	O
oligomerization	O
,	O
leading	O
to	O
induction	O
of	O
membrane	B-ANAT
permeability	O
.	O

Six	O
studies	O
(	O
n	O
=	O
366	O
)	O
fulfilling	O
the	O
inclusion	O
criteria	O
were	O
found	O
,	O
of	O
which	O
the	O
quality	O
of	O
one	O
study	O
was	O
graded	O
as	O
B	O
,	O
the	O
remaining	O
five	O
were	O
graded	O
as	O
C	O
.	O
Two	O
studies	O
were	O
performed	O
with	O
meta	O
-	O
analysis	O
,	O
the	O
other	O
four	O
studies	O
existed	O
some	O
heterogeneity	O
for	O
which	O
meta	O
-	O
analysis	O
could	O
not	O
be	O
performed	O
,	O
a	O
significant	O
effect	O
on	O
lung	B-ANAT
infiltrate	O
absorption	O
was	O
found	O
in	O
the	O
treatment	O
groups	O
of	O
these	O
two	O
studies	O
(	O
RR	O
6	O
.	O
68	O
,	O
95	O
%	O
CI	O
(	O
2	O
.	O
93	O
,	O
15	O
.	O
24	O
),	O
P	O
<	O
0	O
.	O
01	O
),	O
there	O
was	O
no	O
significant	O
differences	O
between	O
the	O
mortality	O
(	O
RR	O
0	O
.	O
86	O
,	O
95	O
%	O
CI	O
(	O
0	O
.	O
22	O
,	O
3	O
.	O
29	O
),	O
P	O
=	O
0	O
.	O
82	O
)	O
and	O
the	O
average	O
dosage	O
of	O
corticosteroid	O
(	O
WMD	O
-	O
39	O
.	O
65	O
,	O
95	O
%	O
CI	O
(-	O
116	O
.	O
84	O
,	O
37	O
.	O
54	O
),	O
P	O
=	O
0	O
.	O
31	O
).	O

In	O
addition	O
to	O
phosphorylation	O
of	O
p38	O
MAPK	O
in	O
virus	O
-	O
infected	O
cells	B-ANAT
,	O
other	O
MAPKs	O
,	O
i	O
.	O
e	O
.,	O
extracellular	B-ANAT
signal	O
-	O
regulated	O
kinase	O
(	O
ERK	O
)	O
1	O
/	O
2	O
and	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
(	O
JNK	O
),	O
were	O
phosphorylated	O
.	O

Unlike	O
primary	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
,	O
persisting	O
secondary	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
retained	O
ex	O
vivo	O
cytolytic	O
activity	O
and	O
expressed	O
high	O
levels	O
of	O
IFN	O
-	O
gamma	O
following	O
Ag	O
stimulation	O
.	O

ABSTRACT	O
:	O
Antigenic	O
sites	O
on	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
were	O
mapped	O
by	O
Pepscan	O
analysis	O
with	O
overlapping	O
peptides	O
that	O
span	O
the	O
N	O
protein	O
sequence	O
.	O

Several	O
minor	O
immunodominant	O
epitopes	O
were	O
reactive	O
with	O
about	O
50	O
%	O
of	O
the	O
SARS	O
sera	B-ANAT
.	O

Antisera	O
from	O
mice	O
immunized	O
with	O
inactivated	O
SARS	O
-	O
CoV	O
recognized	O
the	O
two	O
major	O
immunodominant	O
epitopes	O
and	O
one	O
antigenic	O
site	O
located	O
adjacent	O
to	O
the	O
N	O
-	O
terminal	O
region	O
(	O
aa	O
76	O
to	O
101	O
),	O
which	O
did	O
not	O
react	O
with	O
the	O
sera	B-ANAT
from	O
SARS	O
patients	O
.	O

The	O
primer	O
pairs	O
were	O
successfully	O
used	O
in	O
a	O
multiplex	O
RT	O
-	O
PCR	O
to	O
detect	O
nucleic	B-ANAT
acid	O
of	O
TAstV	O
-	O
2	O
and	O
TCV	O
.	O

Two	O
women	O
experienced	O
motor	O
-	O
predominant	O
peripheral	B-ANAT
nerve	I-ANAT
disorders	O
.	O

CONCLUSIONS	O
:	O
Active	O
recombinant	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	O
nucleocapsid	B-ANAT
(	O
rSCoVN	O
)	O
protein	O
can	O
be	O
successfully	O
expressed	O
in	O
recombinant	O
methylotrophic	O
yeast	O
P	O
.	O
pastoris	O
GS115	O
.	O

Beetles	O
were	O
fed	O
virus	O
-	O
infected	O
feces	B-ANAT
mixed	O
with	O
chicken	O
feed	O
.	O

The	O
causes	O
of	O
MODS	O
in	O
SARS	O
are	O
probably	O
injury	O
to	O
the	O
immune	B-ANAT
system	I-ANAT
and	O
systemic	O
inflammatory	O
response	O
syndrome	O
.	O

CONCLUSIONS	O
:	O
Dysfunction	O
of	O
organs	B-ANAT
are	O
closely	O
correlated	O
with	O
prognosis	O
of	O
SARS	O
.	O

The	O
peripheral	B-ANAT
blood	I-ANAT
picture	O
and	O
liver	B-ANAT
function	O
of	O
169	O
cases	O
with	O
SARS	O
were	O
analyzed	O
.	O

But	O
serum	B-ANAT
total	O
protein	O
remained	O
normal	O
during	O
the	O
whole	O
clinical	O
course	O
.	O

Serum	B-ANAT
total	O
protein	O
(	O
TP	O
),	O
albumin	O
(	O
Alb	O
),	O
total	O
cholesterol	O
(	O
TC	O
),	O
triglyceride	O
(	O
TG	O
),	O
calcium	O
(	O
Ca	O
),	O
ferrum	O
(	O
Fe	O
),	O
lactate	O
dehydrogenase	O
(	O
LDH	O
),	O
creatine	O
kinase	O
(	O
CK	O
),	O
alanine	O
aminotransferase	O
(	O
ALT	O
)	O
and	O
aspartate	O
aminotransferase	O
(	O
AST	O
)	O
between	O
SARS	O
and	O
other	O
viral	O
pneumonias	O
were	O
examined	O
by	O
Roche	O
Diagnostics	O
assay	O
,	O
HITACHI7600	O
automatic	O
analyzer	O
.	O

CONCLUSIONS	O
:	O
The	O
changes	O
in	O
serum	B-ANAT
biochemistry	O
are	O
more	O
marked	O
in	O
SARS	O
patients	O
compared	O
with	O
patients	O
suffering	O
from	O
other	O
viral	O
pneumonias	O
,	O
the	O
decrease	O
of	O
Fe	O
as	O
well	O
as	O
the	O
inhibition	O
of	O
TC	O
may	O
be	O
caused	O
by	O
the	O
treatment	O
of	O
anti	O
-	O
virus	O
.	O

Serum	B-ANAT
of	O
60	O
SARS	O
patients	O
,	O
20	O
samples	O
of	O
serum	B-ANAT
and	O
20	O
samples	O
of	O
gargling	O
fluid	O
of	O
medical	O
staff	O
of	O
the	O
""""	O
Fever	O
Clinic	O
""","	O
and	O
one	O
cDNA	O
specimen	O
obtained	O
from	O
one	O
SARS	O
suspect	O
patient	O
were	O
examined	O
with	O
F	O
-	O
PCR	O
diagnosis	O
kit	O
and	O
gene	O
-	O
chip	O
technique	O
for	O
SARS	O
coronavirus	O
.	O

Three	O
methods	O
,	O
including	O
DR	O
Chip	O
and	O
two	O
F	O
-	O
PCR	O
kit	O
from	O
Zhongshan	O
College	O
Da	O
'	O
an	O
gene	O
stock	O
company	O
and	O
Shanghai	O
Fortune	O
industrial	O
joint	B-ANAT
-	O
stock	O
Co	O
,	O
Ltd	O
,	O
were	O
used	O
,	O
and	O
the	O
results	O
were	O
all	O
negative	O
for	O
all	O
specimens	O
,	O
except	O
one	O
cDNA	O
specimen	O
,	O
which	O
was	O
obtained	O
from	O
one	O
SARS	O
suspect	O
patient	O
,	O
virus	O
could	O
be	O
amplified	O
by	O
F	O
-	O
PCR	O
.	O

ABSTRACT	O
:	O
Various	O
low	O
triiodothyronine	O
(	O
T3	O
)	O
states	O
have	O
been	O
described	O
in	O
severe	O
nonthyroidal	O
diseases	O
and	O
associated	O
with	O
a	O
poor	O
prognosis	O
in	O
cardiovascular	B-ANAT
disease	O
patients	O
.	O

Plasma	B-ANAT
fT3	O
was	O
correlated	O
with	O
PaO	O
(	O
2	O
)/	O
FiO	O
(	O
2	O
)	O
(	O
P	O
<	O
0	O
.	O
001	O
),	O
and	O
with	O
APACHE	O
II	O
score	O
(	O
P	O
=	O
0	O
.	O
003	O
).	O

Our	O
preliminary	O
data	O
suggest	O
that	O
the	O
low	O
T3	O
state	O
is	O
a	O
predictor	O
of	O
outcome	O
in	O
pulmonary	B-ANAT
patients	O
with	O
respiratory	O
failure	O
.	O

ABSTRACT	O
:	O
A	O
Western	O
immunoblot	O
assay	O
for	O
confirmatory	O
serodiagnosis	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
was	O
developed	O
utilizing	O
viral	O
lysate	O
antigens	O
combined	O
with	O
a	O
recombinant	O
nucleocapsid	B-ANAT
protein	O
,	O
GST	O
-	O
N	O
(	O
glutathione	O
S	O
-	O
transferase	O
-	O
nucleocapsid	B-ANAT
)	O
of	O
the	O
SARS	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
).	O

The	O
viral	O
lysate	O
antigens	O
were	O
separated	O
by	O
electrophoresis	O
and	O
transblotted	O
onto	O
nitrocellulose	O
membranes	B-ANAT
.	O

Potential	O
protection	O
of	O
fetus	B-ANAT
from	O
infection	O
was	O
suggested	O
.	O

TITLE	O
:	O
SYNCRIP	O
,	O
a	O
member	O
of	O
the	O
heterogeneous	B-ANAT
nuclear	I-ANAT
ribonucleoprotein	I-ANAT
family	O
,	O
is	O
involved	O
in	O
mouse	O
hepatitis	O
virus	O
RNA	O
synthesis	O
.	O

The	O
overexpression	O
of	O
either	O
form	O
of	O
SYNCRIP	O
inhibited	O
syncytium	B-ANAT
formation	O
induced	O
by	O
MHV	O
infection	O
.	O

ARDS	O
results	O
in	O
significant	O
neurocognitive	O
and	O
emotional	O
morbidity	O
and	O
decreased	O
quality	O
of	O
life	O
that	O
persists	O
at	O
least	O
2	O
years	O
after	O
hospital	O
discharge	B-ANAT
.	O

The	O
findings	O
indicate	O
that	O
antisense	O
knockdown	O
of	O
SARS	O
could	O
be	O
a	O
useful	O
strategy	O
for	O
treatment	O
of	O
SARS	O
,	O
and	O
could	O
also	O
be	O
suitable	O
for	O
studies	O
of	O
the	O
pathological	O
function	O
of	O
SARS	O
genes	O
in	O
a	O
cellular	B-ANAT
model	O
system	O
.	O

RESULTS	O
:	O
The	O
most	O
common	O
presenting	O
symptoms	O
in	O
our	O
14	O
patients	O
with	O
hospital	O
-	O
acquired	O
SARS	O
were	O
fever	O
,	O
dyspnea	O
,	O
dizziness	O
,	O
malaise	O
,	O
diarrhea	O
,	O
dry	O
cough	O
,	O
muscle	B-ANAT
pain	O
,	O
and	O
chills	O
.	O

RESULTS	O
:	O
Optimal	O
correlations	O
were	O
found	O
between	O
conventionally	O
measured	O
body	B-ANAT
temperatures	O
and	O
IRT	O
readings	O
from	O
(	O
1	O
)	O
the	O
front	O
of	O
the	O
face	B-ANAT
at	O
1	O
.	O
5m	O
with	O
the	O
mouth	B-ANAT
open	O
(	O
r	O
=	O
0	O
.	O
80	O
),	O
(	O
2	O
)	O
the	O
ear	B-ANAT
at	O
0	O
.	O
5	O
m	O
(	O
r	O
=	O
0	O
.	O
79	O
),	O
and	O
(	O
3	O
)	O
the	O
side	O
of	O
the	O
face	B-ANAT
at	O
1	O
.	O
5m	O
(	O
r	O
=	O
0	O
.	O
76	O
).	O

We	O
used	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
and	O
conventional	O
methods	O
of	O
cell	B-ANAT
culture	O
and	O
antigen	O
detection	O
to	O
establish	O
the	O
viral	O
etiology	O
of	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
in	O
75	O
hospitalized	O
children	O
.	O

A	O
survey	O
was	O
carried	O
out	O
at	O
the	O
Hong	O
Kong	O
-	O
China	O
cross	O
border	B-ANAT
checkpoint	O
in	O
the	O
middle	O
of	O
the	O
epidemic	O
.	O

Northern	O
blot	O
analysis	O
indicated	O
that	O
the	O
expression	O
level	O
among	O
the	O
sg	O
mRNAs	O
differs	O
significantly	O
,	O
with	O
the	O
sg	O
mRNA	O
encoding	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
being	O
the	O
most	O
abundant	O
.	O

The	O
value	O
of	O
border	B-ANAT
screening	O
in	O
deterring	O
travel	O
by	O
ill	O
persons	O
and	O
in	O
building	O
public	O
confidence	O
remains	O
unquantified	O
.	O

We	O
performed	O
a	O
systematic	O
review	O
of	O
six	O
electronic	O
databases	O
and	O
a	O
manual	O
search	O
for	O
clinical	O
studies	O
comparing	O
outcomes	O
of	O
multiply	O
injured	O
patients	O
(	O
Injury	O
Severity	O
Score	O
>	O
or	O
=	O
16	O
)	O
depending	O
on	O
their	O
early	O
sCD62L	O
blood	B-ANAT
concentrations	O
.	O

Weighted	O
mean	O
differences	O
(	O
WMDs	O
)	O
in	O
sCD62L	O
concentrations	O
were	O
calculated	O
between	O
individuals	O
with	O
and	O
without	O
complications	O
by	O
fixed	B-ANAT
-	O
and	O
random	O
-	O
effects	O
models	O
.	O

Serum	B-ANAT
samples	O
were	O
grouped	O
into	O
acute	O
SARS	O
(	O
n	O
=	O
74	O
;	O
<	O
7	O
days	O
after	O
onset	O
of	O
fever	O
)	O
and	O
non	O
-	O
SARS	O
[	O
n	O
=	O
1067	O
;	O
fever	O
and	O
influenza	O
A	O
(	O
n	O
=	O
203	O
),	O
pneumonia	O
(	O
n	O
=	O
176	O
);	O
lung	B-ANAT
cancer	O
(	O
n	O
=	O
29	O
);	O
and	O
healthy	O
controls	O
(	O
n	O
=	O
659	O
)]	O
cohorts	O
.	O

Analysis	O
of	O
the	O
crystal	B-ANAT
structures	O
indicated	O
that	O
the	O
interfacial	O
ionic	O
interaction	O
was	O
attributed	O
to	O
the	O
Arg	O
-	O
4	O
...	O

Pneumonia	O
,	O
common	O
cold	O
and	O
lung	B-ANAT
infection	O
were	O
the	O
leading	O
causes	O
for	O
correction	O
in	O
the	O
1211	O
excluded	O
cases	O
.	O

ALI	O
is	O
characterized	O
by	O
the	O
expression	O
of	O
proinflammatory	O
mediators	O
and	O
extensive	O
neutrophil	B-ANAT
influx	O
into	O
the	O
lung	B-ANAT
,	O
followed	O
by	O
severe	O
lung	B-ANAT
damage	O
.	O

TITLE	O
:	O
Gene	O
expression	O
in	O
IFN	O
-	O
gamma	O
-	O
activated	O
murine	O
macrophages	B-ANAT
.	O

ABSTRACT	O
:	O
Macrophages	B-ANAT
are	O
critical	O
for	O
natural	O
immunity	O
and	O
play	O
a	O
central	O
role	O
in	O
specific	O
acquired	O
immunity	O
.	O

The	O
SARS	O
outbreak	O
has	O
demonstrated	O
the	O
vulnerability	O
of	O
an	O
organ	B-ANAT
transplantation	O
service	O
and	O
reminds	O
us	O
of	O
the	O
fearful	O
possibility	O
of	O
zoonoses	O
in	O
future	O
xeno	O
-	O
transplantation	O
.	O

7a	O
induces	O
apoptosis	O
via	O
a	O
caspase	O
-	O
dependent	O
pathway	O
and	O
in	O
cell	B-ANAT
lines	I-ANAT
derived	O
from	O
different	O
organs	B-ANAT
,	O
including	O
lung	B-ANAT
,	O
kidney	B-ANAT
,	O
and	O
liver	B-ANAT
.	O

BALF	O
was	O
also	O
collected	O
from	O
patients	O
with	O
pulmonary	B-ANAT
fibrosis	O
and	O
cardiogenic	O
pulmonary	B-ANAT
edema	O
.	O

Human	O
lung	B-ANAT
fibroblasts	B-ANAT
were	O
transfected	O
with	O
a	O
procollagen	O
I	O
promoter	O
-	O
luciferase	O
construct	O
and	O
incubated	O
with	O
BALF	O
;	O
procollagen	O
I	O
promoter	O
activity	O
was	O
then	O
measured	O
.	O

Femoral	B-ANAT
and	O
jugular	B-ANAT
veins	I-ANAT
,	O
and	O
femoral	B-ANAT
and	O
carotid	B-ANAT
arteries	I-ANAT
were	O
instrumented	O
for	O
the	O
AV	O
-	O
ECMO	O
circuit	O
,	O
systemic	O
and	O
pulmonary	B-ANAT
artery	I-ANAT
blood	I-ANAT
pressure	O
monitoring	O
,	O
gas	O
exchange	O
,	O
and	O
cardiac	B-ANAT
output	O
determination	O
(	O
thermodilution	O
technique	O
).	O

The	O
molecular	O
mechanisms	O
of	O
neutrophil	B-ANAT
recruitment	O
in	O
the	O
lung	B-ANAT
differ	O
fundamentally	O
from	O
those	O
in	O
other	O
tissues	B-ANAT
.	O

Recent	O
investigations	O
have	O
questioned	O
the	O
utility	O
of	O
sedation	O
,	O
muscle	B-ANAT
paralysis	O
and	O
mechanical	O
control	O
of	O
ventilation	O
.	O

These	O
results	O
suggest	O
that	O
SARS	O
-	O
CoV	O
,	O
like	O
human	O
CoV	O
OC43	O
,	O
poorly	O
infects	O
human	O
PM	O
,	O
and	O
production	O
of	O
IFN	O
-	O
alpha	O
by	O
these	O
cells	B-ANAT
further	O
limits	O
the	O
infection	O
.	O

The	O
mean	O
IgG	O
level	O
peaked	O
in	O
July	O
(	O
1	O
.	O
203	O
),	O
about	O
35	O
days	O
after	O
discharge	B-ANAT
,	O
and	O
then	O
gradually	O
declined	O
to	O
0	O
.	O
857	O
in	O
December	O
,	O
a	O
decline	O
by	O
27	O
.	O
3	O
%.	O

After	O
that	O
,	O
serum	B-ANAT
antibody	O
levels	O
remained	O
at	O
a	O
plateau	O
or	O
had	O
a	O
slight	O
decrease	O
,	O
though	O
two	O
boosters	O
were	O
given	O
in	O
the	O
succedent	O
4	O
to	O
5	O
weeks	O
.	O

The	O
results	O
showed	O
that	O
the	O
level	O
of	O
plasma	B-ANAT
peroxiredoxin	O
II	O
in	O
patients	O
with	O
SARS	O
is	O
significantly	O
high	O
and	O
could	O
be	O
secreted	O
by	O
T	B-ANAT
cells	I-ANAT
.	O

Multivariate	O
analysis	O
identified	O
3	O
laboratory	O
features	O
that	O
together	O
are	O
highly	O
predictive	O
of	O
a	O
diagnosis	O
of	O
dengue	O
and	O
able	O
to	O
rule	O
out	O
the	O
possibility	O
of	O
SARS	O
:	O
platelet	B-ANAT
count	O
of	O
<	O
140	O
x	O
10	O
(	O
9	O
)	O
platelets	B-ANAT
/	O
L	O
,	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
count	O
of	O
<	O
5x10	O
(	O
9	O
)	O
cells	B-ANAT
/	O
L	O
,	O
and	O
aspartate	O
aminotransferase	O
level	O
of	O
>	O
34	O
IU	O
/	O
L	O
.	O
A	O
combination	O
of	O
these	O
parameters	O
has	O
a	O
sensitivity	O
of	O
75	O
%	O
and	O
a	O
specificity	O
of	O
100	O
%.	O

Very	O
few	O
morphological	O
changes	O
were	O
noted	O
in	O
other	O
organs	B-ANAT
despite	O
the	O
presence	O
of	O
viral	O
RNA	O
as	O
detected	O
by	O
polymerase	O
chain	O
reaction	O
.	O

TITLE	O
:	O
Exogenous	O
nitric	O
oxide	O
donor	O
and	O
related	O
compounds	O
protect	O
against	O
lung	B-ANAT
inflammatory	O
response	O
after	O
hemorrhagic	O
shock	O
and	O
resuscitation	O
.	O

This	O
study	O
investigated	O
the	O
capability	O
of	O
an	O
exogenous	O
nitric	O
oxide	O
(	O
NO	O
)	O
donor	O
,	O
sodium	O
nitroprusside	O
(	O
NP	O
);	O
a	O
NO	O
substrate	O
,	O
L	O
-	O
arginine	O
;	O
and	O
an	O
inducible	O
NO	O
synthase	O
inhibitor	O
,	O
L	O
-	O
N6	O
-(	O
1	O
-	O
iminoethyl	O
)	O
lysine	O
(	O
L	O
-	O
NIL	O
)	O
to	O
reduce	O
lung	B-ANAT
injury	O
in	O
an	O
animal	O
model	O
of	O
mixed	O
controlled	O
and	O
uncontrolled	O
hemorrhagic	O
shock	O
.	O

In	O
order	O
to	O
study	O
the	O
spike	O
(	O
S	O
)	O
protein	O
of	O
this	O
highly	O
contagious	O
virus	O
,	O
we	O
established	O
a	O
clonal	B-ANAT
cell	B-ANAT
-	O
line	O
,	O
CHO	B-ANAT
-	O
SG	O
,	O
from	O
the	O
Chinese	O
hamster	O
ovary	B-ANAT
cells	B-ANAT
that	O
stably	O
expresses	O
C	O
-	O
terminally	O
EGFP	O
-	O
tagged	O
SARS	O
-	O
CoV	O
S	O
protein	O
(	O
S	O
-	O
EGFP	O
).	O

However	O
,	O
the	O
different	O
composition	O
of	O
the	O
tested	O
samples	O
affected	O
the	O
heat	O
sensitivity	O
of	O
the	O
virus	O
strain	O
:	O
the	O
infectivity	O
of	O
the	O
virus	O
in	O
Antithrombin	O
III	O
preparation	O
still	O
remained	O
after	O
heating	O
for	O
30	O
min	O
at	O
60	O
degrees	O
C	O
.	O
If	O
by	O
rare	O
chance	O
SARS	O
-	O
CoV	O
contaminates	O
source	O
plasma	B-ANAT
,	O
there	O
should	O
be	O
no	O
or	O
only	O
minor	O
risk	O
of	O
this	O
virus	O
infection	O
,	O
due	O
to	O
sufficient	O
inactivation	O
by	O
the	O
60	O
degrees	O
C	O
10	O
h	O
liquid	O
heating	O
step	O
,	O
although	O
we	O
must	O
pay	O
attention	O
to	O
the	O
composition	O
used	O
for	O
blood	B-ANAT
product	O
preparation	O
.	O

The	O
incidence	O
of	O
respiratory	O
failure	O
,	O
heart	B-ANAT
injury	O
,	O
brain	B-ANAT
injury	O
,	O
and	O
atropine	O
poisoning	O
were	O
also	O
lower	O
in	O
pre	O
-	O
hospital	O
group	O
compared	O
with	O
in	O
-	O
patient	O
group	O
(	O
all	O
P	O
<	O
0	O
.	O
01	O
).	O

ABSTRACT	O
:	O
A	O
characteristic	O
feature	O
of	O
all	O
inflammatory	O
disorders	O
is	O
the	O
excessive	O
recruitment	O
of	O
leukocytes	B-ANAT
to	O
the	O
site	O
of	O
inflammation	O
.	O

The	O
clinical	O
hallmarks	O
of	O
ARDS	O
are	O
severe	O
hypoxemia	O
,	O
diffuse	O
bilateral	O
pulmonary	B-ANAT
infiltrates	O
,	O
and	O
normal	O
intracardiac	B-ANAT
filling	O
pressures	O
.	O

TITLE	O
:	O
Expression	O
of	O
cellular	B-ANAT
oncogene	O
Bcl	O
-	O
xL	O
prevents	O
coronavirus	O
-	O
induced	O
cell	B-ANAT
death	O
and	O
converts	O
acute	O
infection	O
to	O
persistent	O
infection	O
in	O
progenitor	O
rat	O
oligodendrocytes	B-ANAT
.	O

This	O
finding	O
indicates	O
that	O
intracellular	B-ANAT
factors	O
rather	O
than	O
viral	B-ANAT
components	I-ANAT
play	O
a	O
critical	O
role	O
in	O
establishing	O
viral	O
persistence	O
in	O
CNS	B-ANAT
cells	B-ANAT
.	O

The	O
evaluation	O
of	O
a	O
commercial	O
recombinant	O
nucleocapsid	B-ANAT
protein	O
-	O
based	O
microtitre	O
plate	O
enzyme	O
immunoassay	O
,	O
ELISARS	O
is	O
described	O
.	O

A	O
vast	O
majority	O
of	O
SARS	O
patients	O
developed	O
antibodies	O
against	O
the	O
nucleocapsid	B-ANAT
protein	O
.	O

The	O
implication	O
of	O
differences	O
in	O
antibody	O
response	O
to	O
the	O
nucleocapsid	B-ANAT
protein	O
deserves	O
further	O
investigation	O
.	O

The	O
titer	O
of	O
serum	B-ANAT
neutralizing	O
antibodies	O
was	O
up	O
to	O
1	O
:	O
640	O
.	O

ABSTRACT	O
:	O
Monoclonal	O
antibodies	O
to	O
porcine	O
epidemic	O
diarrhoea	O
virus	O
(	O
PEDV	O
)	O
membrane	B-ANAT
protein	O
M	O
were	O
prepared	O
and	O
used	O
for	O
the	O
comparative	O
assessment	O
of	O
three	O
blocking	O
ELISA	O
variants	O
to	O
detect	O
PEDV	O
.	O

Like	O
many	O
other	O
RNA	O
viruses	O
,	O
coronavirus	O
may	O
subvert	O
these	O
cellular	B-ANAT
proteins	O
from	O
cellular	B-ANAT
RNA	O
processing	O
or	O
translation	O
machineries	O
to	O
play	O
a	O
role	O
in	O
viral	O
replication	O
.	O

The	O
large	O
cloning	O
capacity	O
of	O
coronaviruses	O
(>	O
5	O
kb	O
)	O
and	O
the	O
possibility	O
of	O
engineering	O
the	O
tissue	B-ANAT
and	O
species	O
tropism	O
to	O
target	O
expression	O
to	O
different	O
organs	B-ANAT
and	O
animal	O
species	O
,	O
including	O
humans	O
,	O
has	O
increased	O
the	O
potential	O
of	O
coronaviruses	O
as	O
vectors	O
for	O
vaccine	O
development	O
and	O
,	O
possibly	O
,	O
gene	O
therapy	O
.	O

Consistently	O
,	O
no	O
viral	O
RNA	O
synthesis	O
was	O
detected	O
after	O
transfection	O
of	O
EAV	O
full	O
-	O
length	O
RNAs	O
encoding	O
ATPase	O
/	O
helicase	O
-	O
deficient	O
nsp10	O
into	O
susceptible	O
cells	B-ANAT
.	O

Isolation	O
of	O
the	O
virus	O
by	O
using	O
various	O
cell	B-ANAT
lines	I-ANAT
,	O
mixed	O
neuron	B-ANAT
-	O
glia	B-ANAT
culture	O
,	O
and	O
intracerebral	O
inoculation	O
of	O
suckling	O
mice	O
was	O
unsuccessful	O
.	O

Cellular	B-ANAT
receptors	O
play	O
an	O
important	O
role	O
in	O
virus	O
attachment	O
and	O
entry	O
.	O

In	O
50	O
%	O
of	O
the	O
fatal	O
cases	O
,	O
renal	B-ANAT
insuficiency	O
,	O
requiring	O
the	O
use	O
of	O
the	O
extracorporeal	O
elimination	O
method	O
was	O
reported	O
while	O
,	O
on	O
the	O
other	O
hand	O
,	O
none	O
of	O
the	O
survivors	O
suffered	O
from	O
renal	B-ANAT
insufficiency	O
.	O

ABSTRACT	O
:	O
This	O
study	O
examined	O
findings	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
on	O
chest	B-ANAT
radiographs	O
and	O
presented	O
a	O
classification	O
scheme	O
using	O
quantitative	O
radiographic	O
data	O
supported	O
by	O
clinical	O
parameters	O
.	O

The	O
most	O
common	O
initial	O
findings	O
were	O
unifocal	O
air	O
-	O
space	O
disease	O
in	O
the	O
periphery	O
of	O
the	O
lower	O
lungs	B-ANAT
occurring	O
a	O
mean	O
of	O
3	O
.	O
6	O
+/-	O
2	O
.	O
4	O
(	O
SD	O
)	O
days	O
from	O
symptoms	O
onset	O
.	O

A	O
higher	O
day	O
-	O
22	O
discharge	B-ANAT
rate	O
was	O
observed	O
among	O
patients	O
who	O
were	O
given	O
convalescent	O
plasma	B-ANAT
before	O
day	O
14	O
of	O
illness	O
(	O
58	O
.	O
3	O
%	O
vs	O
15	O
.	O
6	O
%;	O
P	O
<	O
0	O
.	O
001	O
)	O
and	O
among	O
those	O
who	O
were	O
PCR	O
positive	O
and	O
seronegative	O
for	O
coronavirus	O
at	O
the	O
time	O
of	O
plasma	B-ANAT
infusion	O
(	O
66	O
.	O
7	O
%	O
vs	O
20	O
%;	O
P	O
=	O
0	O
.	O
001	O
).	O

A	O
second	O
renal	B-ANAT
biopsy	O
revealed	O
severe	O
segmental	O
endocapillary	O
proliferative	O
and	O
exudative	O
glomerulonephritis	O
,	O
with	O
fibrocellular	O
crescents	O
in	O
about	O
40	O
%	O
of	O
the	O
glomeruli	O
.	O

In	O
those	O
with	O
unsatisfactory	O
resolution	O
of	O
the	O
pulmonary	B-ANAT
infiltrates	O
,	O
corticosteroid	O
therapy	O
was	O
associated	O
with	O
rapid	O
radiographic	O
improvement	O
.	O

TITLE	O
:	O
Surgical	O
treatment	O
of	O
tracheoesophageal	O
fistula	O
in	O
a	O
patient	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
complicated	O
with	O
extensive	O
pulmonary	B-ANAT
fibrosis	O
.	O

Methylprednisolone	O
pulse	O
therapy	O
followed	O
by	O
a	O
maintenance	O
dosage	O
was	O
given	O
due	O
to	O
persistence	O
of	O
bilateral	O
pulmonary	B-ANAT
fibrosis	O
.	O

In	O
SARS	O
patients	O
with	O
persistent	O
pulmonary	B-ANAT
fibrosis	O
and	O
under	O
prolonged	O
corticosteroid	O
treatment	O
,	O
special	O
care	O
should	O
be	O
given	O
to	O
avoid	O
intubation	O
-	O
related	O
tracheal	O
injury	O
during	O
the	O
period	O
of	O
ventilatory	O
support	O
.	O

A	O
17	O
-	O
nt	O
segment	O
of	O
this	O
extra	O
sequence	O
is	O
identical	O
to	O
a	O
segment	O
of	O
the	O
same	O
size	O
in	O
two	O
human	O
mRNA	O
sequences	O
that	O
may	O
interfere	O
with	O
viral	O
replication	O
and	O
transcription	O
in	O
the	O
cytosol	B-ANAT
of	O
the	O
infected	O
cells	B-ANAT
.	O

Another	O
profound	O
finding	O
is	O
that	O
three	O
disulfide	O
bonds	O
are	O
defined	O
at	O
the	O
C	O
-	O
terminus	O
with	O
the	O
N	O
-	O
terminus	O
of	O
the	O
E	O
(	O
envelope	B-ANAT
)	O
protein	O
,	O
based	O
on	O
the	O
typical	O
sequence	O
and	O
positions	O
,	O
thus	O
establishing	O
the	O
structural	O
connection	O
with	O
these	O
two	O
important	O
structural	O
proteins	O
,	O
if	O
confirmed	O
.	O

TITLE	O
:	O
The	O
E	O
protein	O
is	O
a	O
multifunctional	O
membrane	B-ANAT
protein	O
of	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
The	O
E	O
(	O
envelope	B-ANAT
)	O
protein	O
is	O
the	O
smallest	O
structural	O
protein	O
in	O
all	O
coronaviruses	O
and	O
is	O
the	O
only	O
viral	O
structural	O
protein	O
in	O
which	O
no	O
variation	O
has	O
been	O
detected	O
.	O

The	O
most	O
striking	O
physiochemical	O
feature	O
of	O
the	O
N	O
protein	O
of	O
SARS	O
-	O
CoV	O
is	O
that	O
it	O
is	O
a	O
typical	O
basic	O
protein	O
with	O
a	O
high	O
predicted	O
pI	O
and	O
high	O
hydrophilicity	O
,	O
which	O
is	O
consistent	O
with	O
its	O
function	O
of	O
binding	O
to	O
the	O
ribophosphate	O
backbone	B-ANAT
of	O
the	O
RNA	O
molecule	O
.	O

TITLE	O
:	O
The	O
C	O
-	O
terminal	O
portion	O
of	O
the	O
nucleocapsid	B-ANAT
protein	O
demonstrates	O
SARS	O
-	O
CoV	O
antigenicity	O
.	O

ABSTRACT	O
:	O
In	O
order	O
to	O
develop	O
clinical	O
diagnostic	O
tools	O
for	O
rapid	O
detection	O
of	O
the	O
SARS	O
-	O
CoV	O
(	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
)	O
and	O
to	O
identify	O
candidate	O
proteins	O
for	O
vaccine	O
development	O
,	O
the	O
C	O
-	O
terminal	O
portion	O
of	O
the	O
nucleocapsid	B-ANAT
(	O
NC	O
)	O
gene	O
was	O
amplified	O
using	O
RT	O
-	O
PCR	O
from	O
the	O
SARS	O
-	O
CoV	O
genome	O
,	O
cloned	O
into	O
a	O
yeast	O
expression	O
vector	O
(	O
pEGH	O
),	O
and	O
expressed	O
as	O
a	O
glutathione	O
S	O
-	O
transferase	O
(	O
GST	O
)	O
and	O
Hisx6	O
double	O
-	O
tagged	O
fusion	O
protein	O
under	O
the	O
control	O
of	O
an	O
inducible	O
promoter	O
.	O

To	O
determine	O
its	O
antigenicity	O
,	O
the	O
fusion	O
protein	O
was	O
challenged	O
with	O
serum	B-ANAT
samples	O
from	O
SARS	O
patients	O
and	O
normal	O
controls	O
.	O

All	O
patient	O
sera	B-ANAT
in	O
this	O
study	O
displayed	O
strong	O
positive	O
immunoreactivities	O
against	O
the	O
recombinant	O
N	O
proteins	O
,	O
whereas	O
normal	O
sera	B-ANAT
gave	O
negative	O
immunoresponses	O
to	O
these	O
proteins	O
,	O
indicating	O
that	O
the	O
N	O
protein	O
of	O
SARS	O
-	O
CoV	O
is	O
an	O
antigenic	O
protein	O
.	O

Furthermore	O
,	O
the	O
epitope	O
sites	O
in	O
the	O
N	O
protein	O
were	O
determined	O
by	O
competition	O
experiments	O
,	O
in	O
which	O
the	O
recombinant	O
proteins	O
or	O
the	O
synthesized	O
peptides	O
competed	O
against	O
the	O
SARS	O
-	O
CoV	O
proteins	O
to	O
bind	O
to	O
the	O
antibodies	O
raised	O
in	O
SARS	O
sera	B-ANAT
.	O

TITLE	O
:	O
[	O
Analyses	O
of	O
subset	O
,	O
activated	O
state	O
and	O
expression	O
pattern	O
of	O
24	O
repertoire	O
TCR	B-ANAT
Vbeta	O
of	O
peripheral	B-ANAT
blood	I-ANAT
T	B-ANAT
lymphocytes	I-ANAT
in	O
convalescence	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)].	O

The	O
increased	O
Ta	O
and	O
Ba	O
expressions	O
may	O
be	O
associated	O
with	O
activation	O
of	O
T	O
and	O
B	B-ANAT
cells	I-ANAT
.	O

ABSTRACT	O
:	O
We	O
have	O
solved	O
the	O
three	O
-	O
dimensional	O
crystal	B-ANAT
structure	O
of	O
the	O
stem	B-ANAT
-	O
loop	O
II	O
motif	O
(	O
s2m	O
)	O
RNA	O
element	O
of	O
the	O
SARS	O
virus	O
genome	O
to	O
2	O
.	O
7	O
-	O
A	O
resolution	O
.	O

(	O
3	O
)	O
The	O
IgG	B-ANAT
antibody	I-ANAT
emerged	O
in	O
one	O
of	O
24	O
children	O
,	O
whose	O
mother	O
,	O
a	O
nurse	O
,	O
had	O
suffered	O
from	O
SARS	O
(	O
4	O
%).	O

The	O
hybridomas	B-ANAT
were	O
tested	O
to	O
have	O
specific	O
reactions	O
with	O
SARS	O
-	O
CoV	O
and	O
no	O
cross	O
-	O
reactivates	O
with	O
other	O
common	O
respiratory	O
disease	O
causing	O
pathogens	O
.	O

An	O
anti	O
-	O
MHV3	O
state	O
was	O
observed	O
only	O
in	O
A	O
/	O
J	O
Mphi	O
upon	O
activation	O
with	O
IL	O
-	O
12	O
/	O
IL	O
-	O
18	O
or	O
IFNgamma	O
regardless	O
of	O
their	O
origin	O
from	O
the	O
peritoneum	B-ANAT
or	O
bone	B-ANAT
marrow	I-ANAT
.	O

IL	O
-	O
12	O
/	O
IL	O
-	O
18	O
or	O
IFNgamma	O
activation	O
,	O
mainly	O
in	O
MHV3	O
infected	O
cells	B-ANAT
,	O
led	O
to	O
a	O
decreased	O
synthesis	O
of	O
polyamines	O
,	O
notably	O
spermine	O
,	O
only	O
in	O
A	O
/	O
J	O
BMMphi	O
.	O

The	O
intent	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
recovery	O
of	O
individuals	O
who	O
had	O
been	O
hospitalized	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
in	O
the	O
year	O
following	O
their	O
discharge	B-ANAT
from	O
the	O
hospital	O
.	O

ABSTRACT	O
:	O
High	O
mobility	O
group	O
box	O
1	O
(	O
HMGB1	O
)	O
is	O
a	O
novel	O
late	O
mediator	O
of	O
inflammatory	O
responses	O
that	O
contributes	O
to	O
endotoxin	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
and	O
sepsis	O
-	O
associated	O
lethality	O
.	O

Although	O
acute	O
lung	B-ANAT
injury	O
is	O
a	O
frequent	O
complication	O
of	O
severe	O
blood	B-ANAT
loss	O
,	O
the	O
contribution	O
of	O
HMGB1	O
to	O
organ	B-ANAT
system	I-ANAT
dysfunction	O
in	O
this	O
setting	O
has	O
not	O
been	O
investigated	O
.	O

Plasma	B-ANAT
concentrations	O
of	O
HMGB1	O
also	O
increased	O
after	O
hemorrhage	O
.	O

These	O
results	O
demonstrate	O
that	O
hemorrhage	O
results	O
in	O
increased	O
HMGB1	O
expression	O
in	O
the	O
lungs	B-ANAT
,	O
primarily	O
through	O
neutrophil	B-ANAT
sources	O
,	O
and	O
that	O
HMGB1	O
participates	O
in	O
hemorrhage	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
.	O

For	O
patients	O
with	O
positive	O
RT	O
-	O
PCR	O
on	O
discharge	B-ANAT
,	O
the	O
median	O
(	O
range	O
)	O
time	O
to	O
RT	O
-	O
PCR	O
conversion	O
after	O
discharge	B-ANAT
was	O
13	O
days	O
(	O
2	O
-	O
60	O
).	O

It	O
is	O
prudent	O
to	O
advise	O
patients	O
to	O
adhere	O
to	O
strict	O
personal	O
hygiene	O
on	O
discharge	B-ANAT
until	O
RT	O
-	O
PCR	O
becomes	O
negative	O
.	O

Decreased	O
production	O
of	O
vascular	B-ANAT
endothelial	B-ANAT
growth	O
factor	O
(	O
VEGF	O
)	O
in	O
ARDS	O
may	O
favour	O
vascular	B-ANAT
lesions	O
,	O
since	O
VEGF	O
promotes	O
endothelial	B-ANAT
survival	O
by	O
inhibiting	O
apoptosis	O
.	O

Lung	B-ANAT
specimens	O
were	O
obtained	O
by	O
open	O
biopsy	O
or	O
autopsy	O
from	O
29	O
patients	O
with	O
severe	O
ARDS	O
(	O
two	O
survivors	O
)	O
and	O
five	O
controls	O
.	O

VEGF	O
levels	O
were	O
negatively	O
correlated	O
to	O
apoptotic	O
endothelial	B-ANAT
cell	I-ANAT
counts	O
.	O

This	O
result	O
suggested	O
that	O
S1	O
domain	O
could	O
be	O
an	O
effective	O
subunit	O
vaccines	O
against	O
SARS	O
-	O
CoV	O
.	O
RESULTS	O
:	O
S1	O
domain	O
of	O
SARS	O
-	O
CoV	O
spike	O
,	O
which	O
has	O
been	O
demonstrated	O
harboring	O
the	O
receptor	O
binding	O
domain	O
,	O
successfully	O
elicited	O
SARS	O
-	O
CoV	O
specific	O
IgG	B-ANAT
antibody	I-ANAT
in	O
mouse	O
after	O
combined	O
immunization	O
with	O
DNA	O
and	O
purified	O
S1	O
protein	O
;	O
the	O
antibody	O
elicited	O
solely	O
by	O
S1	O
could	O
potently	O
neutralize	O
SARS	O
-	O
CoV	O
(	O
HKU	O
-	O
39849	O
)	O
in	O
vitro	O
,	O
50	O
%	O
of	O
1	O
000	O
TCID50	O
SARS	O
-	O
CoV	O
challenged	O
cells	B-ANAT
were	O
protected	O
from	O
viral	O
infection	O
by	O
a	O
1	O
:	O
1499	O
.	O
68	O
dilution	O
of	O
mice	O
sera	B-ANAT
immunized	O
with	O
S1	O
protein	O
,	O
but	O
negative	O
control	O
sera	B-ANAT
showed	O
no	O
protection	O
.	O

CONCLUSIONS	O
:	O
The	O
X	O
-	O
ray	O
results	O
of	O
SARS	O
were	O
closely	O
related	O
to	O
the	O
severity	O
of	O
the	O
disease	O
(	O
hyperpyrexia	O
and	O
bilateral	O
lung	B-ANAT
field	I-ANAT
lesion	O
).	O

A	O
total	O
of	O
207	O
oral	B-ANAT
swab	I-ANAT
samples	O
were	O
obtained	O
in	O
16	O
collections	O
from	O
SARS	O
patients	O
and	O
suspected	O
influenza	O
outbreak	O
cases	O
.	O

Out	O
of	O
207	O
samples	O
,	O
79	O
(	O
38	O
.	O
16	O
%)	O
were	O
positive	O
for	O
influenza	O
viruses	O
when	O
tested	O
by	O
fluorescent	O
real	O
-	O
time	O
PCR	O
,	O
and	O
62	O
(	O
29	O
.	O
95	O
%)	O
positive	O
when	O
tested	O
by	O
MDCK	B-ANAT
cell	I-ANAT
culture	O
.	O

Bacterial	O
inclusion	B-ANAT
bodies	I-ANAT
containing	O
the	O
recombinant	O
S450	O
-	O
650	O
were	O
solubilized	O
with	O
8	O
M	O
urea	O
and	O
then	O
applied	O
onto	O
a	O
Ni	O
-	O
nitrilotriacetic	O
acid	O
column	B-ANAT
.	O

ABSTRACT	O
:	O
In	O
order	O
to	O
define	O
and	O
characterize	O
target	B-ANAT
cells	I-ANAT
of	O
SARS	O
-	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
we	O
studied	O
the	O
susceptibility	O
of	O
23	O
different	O
permanent	O
and	O
primary	O
eukaryotic	B-ANAT
cell	I-ANAT
lines	O
to	O
SARS	O
-	O
coronavirus	O
.	O

We	O
propose	O
that	O
HCoV	O
-	O
NL63	O
is	O
a	O
global	O
and	O
seasonal	O
pathogen	O
of	O
both	O
children	O
and	O
adults	O
associated	O
with	O
severe	O
LRT	B-ANAT
illness	O
.	O

In	O
the	O
region	O
between	O
the	O
spike	O
and	O
membrane	B-ANAT
protein	O
genes	O
,	O
a	O
290	O
-	O
nucleotide	O
deletion	O
is	O
present	O
,	O
corresponding	O
to	O
the	O
absence	O
of	O
BCoV	O
ORFs	O
ns4	O
.	O
9	O
and	O
ns4	O
.	O
8	O
.	O

ABSTRACT	O
:	O
Nitric	O
oxide	O
(	O
NO	O
)	O
is	O
an	O
important	O
signaling	O
molecule	O
between	O
cells	B-ANAT
which	O
has	O
been	O
shown	O
to	O
have	O
an	O
inhibitory	O
effect	O
on	O
some	O
virus	O
infections	O
.	O

RESULTS	O
:	O
After	O
cell	B-ANAT
fusion	O
and	O
three	O
rounds	O
of	O
cell	B-ANAT
cloning	I-ANAT
,	O
six	O
hybridoma	B-ANAT
cell	B-ANAT
lines	I-ANAT
secreting	O
monoclonal	O
antibodies	O
specifically	O
against	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
were	O
obtained	O
.	O

SARS	O
coronavirus	O
IgG	B-ANAT
antibody	I-ANAT
was	O
detected	O
positive	O
in	O
6	O
of	O
the	O
9	O
patients	O
,	O
it	O
was	O
still	O
positive	O
in	O
the	O
sera	B-ANAT
twelve	O
months	O
after	O
recovery	O
;	O
1	O
of	O
the	O
closely	O
contacted	O
persons	O
and	O
3	O
normal	O
subjects	O
were	O
found	O
positive	O
.	O

ABSTRACT	O
:	O
Primary	O
graft	B-ANAT
failure	O
(	O
PGF	O
)	O
is	O
a	O
severe	O
acute	O
lung	B-ANAT
injury	O
syndrome	O
that	O
occurs	O
following	O
lung	B-ANAT
transplantation	O
.	O

The	O
median	O
best	O
6MWT	O
distance	O
achieved	O
within	O
the	O
first	O
12	O
months	O
was	O
1	O
,	O
196	O
feet	B-ANAT
in	O
patients	O
with	O
PGF	O
vs	O
1	O
,	O
546	O
feet	B-ANAT
in	O
those	O
without	O
PGF	O
(	O
p	O
=	O
0	O
.	O
009	O
).	O

RSV	O
antigen	O
was	O
identified	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
performed	O
on	O
nasopharyngeal	B-ANAT
specimens	O
from	O
children	O
meeting	O
clinical	O
case	O
definitions	O
.	O

Here	O
,	O
we	O
characterize	O
an	O
aromatic	O
amino	O
acid	O
rich	O
region	O
within	O
the	O
ectodomain	O
of	O
the	O
S2	O
subunit	O
that	O
both	O
partitions	O
into	O
lipid	O
membranes	B-ANAT
and	O
has	O
the	O
capacity	O
to	O
perturb	O
lipid	O
vesicle	B-ANAT
integrity	O
.	O

Our	O
study	O
shows	O
for	O
the	O
first	O
time	O
how	O
the	O
immune	B-ANAT
system	I-ANAT
responds	O
to	O
the	O
SARS	O
infection	O
,	O
and	O
opens	O
new	O
possibilities	O
for	O
designing	O
new	O
diagnostics	O
and	O
treatments	O
for	O
this	O
new	O
life	O
-	O
threatening	O
disease	O
.	O

Both	O
MAbs	O
bound	O
to	O
S	O
glycoprotein	O
expressed	O
on	O
transfected	O
cells	B-ANAT
but	O
differed	O
in	O
their	O
ability	O
to	O
block	O
binding	O
of	O
S	O
glycoprotein	O
to	O
Vero	O
E6	O
cells	B-ANAT
.	O

RESULTS	O
:	O
Both	O
MAbs	O
bound	O
to	O
S	O
glycoprotein	O
expressed	O
on	O
transfected	O
cells	B-ANAT
but	O
differed	O
in	O
their	O
ability	O
to	O
block	O
binding	O
of	O
S	O
glycoprotein	O
to	O
Vero	O
E6	O
cells	B-ANAT
.	O

The	O
recent	O
literature	O
has	O
refined	O
some	O
of	O
the	O
current	O
indications	O
for	O
noninvasive	O
ventilation	O
in	O
the	O
acute	O
-	O
care	O
setting	O
,	O
including	O
chronic	O
pulmonary	B-ANAT
obstructive	O
disease	O
and	O
cardiogenic	O
pulmonary	B-ANAT
edema	O
.	O

This	O
recombinant	O
N	O
protein	O
(	O
hGST	O
-	O
N	O
)	O
was	O
purified	O
and	O
used	O
to	O
measure	O
the	O
SARS	O
-	O
CoV	O
N	O
-	O
specific	O
antibody	O
in	O
the	O
sera	B-ANAT
of	O
eight	O
SARS	O
patients	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

Specific	O
antibody	O
response	O
to	O
this	O
purified	O
recombinant	O
N	O
protein	O
was	O
100	O
%	O
positive	O
in	O
the	O
SARS	O
patients	O
'	O
sera	B-ANAT
,	O
while	O
none	O
of	O
the	O
control	O
sera	B-ANAT
from	O
30	O
healthy	O
people	O
gave	O
a	O
positive	O
reaction	O
in	O
the	O
same	O
assay	O
.	O

The	O
N	O
-	O
producing	O
strain	O
MG1363	O
/	O
pSECN	O
and	O
the	O
purified	O
hGST	O
-	O
N	O
protein	O
were	O
respectively	O
administered	O
to	O
mice	O
,	O
either	O
orally	B-ANAT
or	O
intranasally	O
.	O

The	O
S	O
glycoprotein	O
was	O
cloned	O
into	O
a	O
Lactobacillus	O
/	O
E	O
.	O
coli	O
shuttle	O
vector	O
(	O
pLP500	O
)	O
where	O
expression	O
and	O
secretion	B-ANAT
of	O
the	O
glycoprotein	O
S	O
from	O
the	O
recombinant	O
lactobacilli	O
was	O
detected	O
via	O
immunoblotting	O
.	O

Oral	B-ANAT
immunization	O
of	O
BALB	O
/	O
c	O
mice	O
with	O
recombinant	O
LcS	O
that	O
constitutively	O
expresses	O
the	O
75	O
kDa	O
fragment	O
of	O
the	O
glycoprotein	O
S	O
,	O
induced	O
both	O
local	O
mucosal	B-ANAT
and	O
systemic	O
immune	O
responses	O
against	O
TGEV	O
.	O

Additionally	O
,	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
was	O
obtained	O
for	O
protein	O
concentration	O
and	O
cytokine	O
levels	O
.	O

By	O
closely	O
paralleling	O
the	O
clinical	O
development	O
of	O
pulmonary	B-ANAT
injury	O
,	O
this	O
model	O
should	O
prove	O
invaluable	O
in	O
the	O
study	O
of	O
human	O
ARDS	O
.	O

Testis	B-ANAT
weight	O
was	O
significantly	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
reduced	O
in	O
vaccinated	O
roosters	O
with	O
epididymal	B-ANAT
stones	O
(	O
12	O
.	O
1	O
+/-	O

0	O
.	O
76	O
g	O
),	O
as	O
compared	O
with	O
nonvaccinated	O
roosters	O
without	O
epididymal	B-ANAT
stones	O
(	O
15	O
.	O
2	O
+/-	O

0	O
.	O
31	O
x	O
10	O
(	O
8	O
)	O
sperm	B-ANAT
/	O
testis	B-ANAT
/	O
day	O
)	O
when	O
compared	O
with	O
nonvaccinated	O
roosters	O
without	O
epididymal	B-ANAT
stones	O
(	O
7	O
.	O
43	O
+/-	O
0	O
.	O
52	O
x	O
10	O
(	O
8	O
)	O
sperm	B-ANAT
/	O
testis	B-ANAT
/	O
day	O
).	O

Comparing	O
daily	O
sperm	B-ANAT
production	O
on	O
a	O
per	O
gram	O
basis	O
,	O
vaccinated	O
roosters	O
with	O
epididymal	B-ANAT
stones	O
had	O
4	O
.	O
38	O
+/-	O

0	O
.	O
14	O
x	O
10	O
(	O
7	O
)	O
sperm	B-ANAT
/	O
g	O
of	O
testis	B-ANAT
,	O
which	O
was	O
significantly	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
smaller	O
than	O
nonvaccinated	O
roosters	O
without	O
epididymal	B-ANAT
stones	O
,	O
which	O
had	O
5	O
.	O
17	O
+/-	O

0	O
.	O
17	O
x	O
10	O
(	O
7	O
)	O
sperm	B-ANAT
/	O
g	O
of	O
testis	B-ANAT
.	O

ABSTRACT	O
:	O
In	O
patients	O
with	O
severe	O
brain	B-ANAT
injury	O
and	O
acute	O
lung	B-ANAT
injury	O
the	O
use	O
of	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
is	O
limited	O
by	O
conflicting	O
results	O
on	O
its	O
effect	O
on	O
intracranial	B-ANAT
pressure	O
.	O

Intracranial	B-ANAT
pressure	O
,	O
Doppler	O
flow	O
velocity	O
,	O
and	O
jugular	O
saturation	O
remained	O
constant	O
in	O
recruiters	O
but	O
significantly	O
increased	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
in	O
non	O
-	O
recruiters	O
.	O

Evidence	O
of	O
exposure	O
to	O
Leptospira	O
was	O
obtained	O
by	O
serologic	O
testing	O
,	O
and	O
diagnosis	O
of	O
leptospirosis	O
was	O
confirmed	O
in	O
pulmonary	B-ANAT
cases	O
by	O
culture	O
or	O
quantitative	O
real	O
-	O
time	O
PCR	O
assay	O
.	O

Data	O
suggest	O
that	O
the	O
proteins	O
of	O
SARS	O
-	O
CoV	O
with	O
toxic	O
motifs	O
might	O
play	O
crucial	O
roles	O
in	O
targeting	O
host	O
cells	B-ANAT
and	O
interfering	O
with	O
the	O
immune	B-ANAT
system	I-ANAT
.	O

ABSTRACT	O
:	O
Findings	O
coming	O
from	O
autopsies	O
and	O
serum	B-ANAT
of	O
SARS	O
patients	O
suggest	O
an	O
important	O
immune	O
-	O
inflammatory	O
implication	O
in	O
the	O
evolution	O
to	O
respiratory	O
distress	O
.	O

(	O
2	O
)	O
The	O
evidence	O
for	O
immune	O
implication	O
in	O
distress	O
strongly	O
supports	O
immunomodulators	O
for	O
therapy	O
:	O
phosphodiesterase	O
inhibitors	O
(	O
due	O
to	O
their	O
down	O
-	O
modulating	O
activity	O
on	O
proinflammatory	O
cytokines	O
);	O
inhaled	O
corticoids	O
(	O
aimed	O
at	O
producing	O
a	O
local	O
immunomodulation	O
);	O
teophylline	O
or	O
nedocromil	O
sodium	O
(	O
which	O
prevents	O
inflammatory	B-ANAT
cell	I-ANAT
recruitment	O
into	O
the	O
airway	B-ANAT
wall	O
).	O

Eventually	O
,	O
33	O
SARS	O
patients	O
(	O
91	O
.	O
7	O
%)	O
with	O
acute	O
renal	B-ANAT
impairment	O
died	O
.	O

The	O
adjusted	O
relative	O
risk	O
of	O
mortality	O
associated	O
with	O
the	O
development	O
of	O
acute	O
renal	B-ANAT
impairment	O
was	O
4	O
.	O
057	O
(	O
P	O
<	O
0	O
.	O
001	O
).	O

The	O
development	O
of	O
acute	O
renal	B-ANAT
impairment	O
is	O
an	O
important	O
negative	O
prognostic	O
indicator	O
for	O
survival	O
with	O
SARS	O
.	O

Her	O
blood	B-ANAT
pressure	O
was	O
180	O
/	O
100	O
mmHg	O
.	O

Experiments	O
were	O
done	O
to	O
compare	O
the	O
pathogenesis	O
of	O
enterotropic	O
strain	O
MHV	O
-	O
Y	O
in	O
immunocompetent	O
BALB	O
/	O
c	O
and	O
C57BL	O
/	O
6	O
mice	O
with	O
that	O
in	O
B	O
and	O
T	B-ANAT
cell	I-ANAT
-	O
deficient	O
mice	O
.	O

Infected	O
B	B-ANAT
cell	I-ANAT
-	O
deficient	O
mice	O
developed	O
chronic	O
subclinical	O
infection	O
also	O
restricted	O
to	O
the	O
gastrointestinal	B-ANAT
tract	I-ANAT
.	O

Three	O
to	O
four	O
weeks	O
after	O
virus	O
inoculation	O
,	O
T	B-ANAT
cell	I-ANAT
-	O
deficient	O
mice	O
became	O
moribund	O
and	O
viral	O
RNA	O
was	O
detected	O
in	O
multiple	O
organ	B-ANAT
systems	I-ANAT
.	O

Intraperitoneal	O
injection	O
of	O
aspirin	O
or	O
dexamethasone	O
had	O
only	O
marginal	O
effects	O
on	O
LPS	O
-	O
induced	O
platelet	B-ANAT
responses	O
and	O
lethality	O
.	O

The	O
full	O
-	O
length	O
S	O
gene	O
was	O
cloned	O
into	O
the	O
eukaryotic	O
expression	O
plasmid	O
pSecTagB	O
to	O
prepare	O
recombinant	O
plasmid	O
pSecS	O
as	O
the	O
DNA	O
vaccine	O
to	O
immunize	O
BALB	O
/	O
c	O
mice	O
for	O
inducing	O
the	O
secretion	B-ANAT
of	O
anti	O
-	O
SARS	O
-	O
CoV	O
protein	O
.	O

1	O
.	O
46	O
days	O
and	O
the	O
mean	O
absorption	O
time	O
of	O
gross	O
pulmonary	B-ANAT
infiltration	O
was	O
10	O
.	O
87	O
+/-	O

METHODS	O
:	O
Twelve	O
TCM	O
prescriptions	O
of	O
herbal	O
drugs	O
(	O
orally	B-ANAT
or	O
i	O
.	O
v	O
.)	O
were	O
used	O
to	O
treat	O
16	O
cases	O
of	O
SARS	O
without	O
using	O
glucocorticoids	O
,	O
anti	O
-	O
viral	O
agents	O
,	O
immune	O
-	O
regulators	O
or	O
antibiotics	O
(	O
in	O
case	O
there	O
was	O
no	O
definite	O
bacterial	O
infections	O
).	O

None	O
became	O
lame	O
,	O
but	O
all	O
developed	O
foreign	O
body	B-ANAT
granulomatous	O
myositis	O
similar	O
to	O
those	O
in	O
the	O
affected	O
herd	O
.	O

Based	O
on	O
the	O
""""	O
distorted	O
key	O
theory	O
""""	O
[	O
K	O
.	O
C	O
.	O
Chou	O
,	O
Anal	B-ANAT
.	O

It	O
has	O
been	O
found	O
that	O
the	O
chemical	O
bond	O
between	O
Gln	O
and	O
Ser	B-ANAT
will	O
become	O
much	O
stronger	O
and	O
no	O
longer	O
cleavable	O
by	O
the	O
SARS	O
enzyme	O
after	O
either	O
changing	O
the	O
carbonyl	O
group	O
CO	O
of	O
Gln	O
to	O
CH2	O
or	O
CF2	O
or	O
changing	O
the	O
NH	O
of	O
Ser	B-ANAT
to	O
CH2	O
or	O
CF2	O
.	O

TITLE	O
:	O
Clinical	O
characteristics	O
of	O
chronic	O
lung	B-ANAT
disease	O
without	O
preceding	O
respiratory	O
distress	O
syndrome	O
in	O
preterm	O
infants	O
.	O

Our	O
findings	O
of	O
the	O
high	O
detection	O
rate	O
of	O
SARS	O
-	O
CoV	O
RNA	O
in	O
plasma	B-ANAT
before	O
day	O
11	O
,	O
together	O
with	O
the	O
relative	O
convenience	O
of	O
collecting	O
and	O
handling	O
plasma	B-ANAT
,	O
suggest	O
that	O
plasma	B-ANAT
can	O
be	O
used	O
for	O
early	O
diagnosis	O
of	O
SARS	O
.	O

Renal	B-ANAT
hypouricemia	O
is	O
an	O
ominous	O
sign	O
in	O
patients	O
with	O
SARS	O
.	O

Parents	O
'	O
fear	O
of	O
transmitting	O
HIV	O
to	O
their	O
children	O
,	O
fear	O
of	O
catching	O
an	O
illness	O
or	O
opportunistic	O
infection	O
from	O
their	O
children	O
,	O
and	O
avoidance	O
of	O
4	O
types	O
of	O
interactions	O
(	O
kissing	O
on	O
the	O
lips	B-ANAT
,	O
kissing	O
on	O
the	O
cheeks	B-ANAT
,	O
hugging	O
,	O
and	O
sharing	O
utensils	O
)	O
because	O
of	O
these	O
fears	O
.	O

Our	O
data	O
showed	O
that	O
the	O
newly	O
developed	O
IFA	O
could	O
detect	O
SARS	O
-	O
CoV	O
in	O
22	O
of	O
the	O
23	O
SARS	O
-	O
CoV	O
-	O
positive	O
serum	B-ANAT
samples	O
and	O
gave	O
no	O
false	O
-	O
positive	O
results	O
when	O
the	O
sera	B-ANAT
from	O
patients	O
with	O
autoimmune	O
diseases	O
and	O
healthy	O
individuals	O
were	O
tested	O
.	O

By	O
transforming	O
the	O
symbolic	O
sequence	O
codes	O
into	O
the	O
digital	B-ANAT
codes	O
,	O
and	O
using	O
some	O
optimal	O
space	O
-	O
time	O
evolvement	O
rules	O
of	O
cellular	B-ANAT
automata	O
,	O
a	O
biological	O
sequence	O
can	O
be	O
represented	O
by	O
a	O
unique	O
image	O
,	O
the	O
so	O
-	O
called	O
cellular	B-ANAT
automata	O
image	O
.	O

The	O
virus	O
is	O
thought	O
to	O
be	O
of	O
zoonotic	O
origin	O
from	O
a	O
wild	O
animal	O
reservoir	O
(	O
Himalayan	O
palm	B-ANAT
civets	O
[	O
Paguma	O
larvata	O
]	O
are	O
suspected	O
),	O
but	O
the	O
definitive	O
host	O
is	O
unknown	O
.	O

TITLE	O
:	O
Osteonecrosis	O
of	O
hip	B-ANAT
and	O
knee	B-ANAT
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
treated	O
with	O
steroids	O
.	O

RESULTS	O
:	O
One	O
hundred	O
thirty	O
-	O
four	O
(	O
53	O
%)	O
of	O
254	O
patients	O
had	O
recent	O
onset	O
of	O
large	O
joint	B-ANAT
pain	O
,	O
but	O
211	O
(	O
80	O
%)	O
of	O
264	O
painful	O
joints	B-ANAT
were	O
not	O
associated	O
with	O
abnormality	O
on	O
MR	O
images	O
.	O

Shortness	O
of	O
breath	B-ANAT
,	O
vomiting	O
,	O
diarrhea	O
,	O
progressive	O
bilateral	O
infiltrates	O
on	O
chest	B-ANAT
radiograph	O
,	O
and	O
need	O
for	O
supplemental	O
oxygen	O
were	O
significantly	O
associated	O
with	O
confirmed	O
SARS	O
-	O
CoV	O
infection	O
.	O

Diagnosis	O
is	O
based	O
on	O
antibody	O
screening	O
in	O
blood	B-ANAT
components	I-ANAT
and	O
on	O
specific	O
-	O
antigen	O
detection	O
in	O
the	O
recipient	O
.	O

In	O
a	O
mouse	O
model	O
of	O
neurological	O
infection	O
,	O
the	O
recombinant	O
and	O
parental	O
viruses	O
are	O
equally	O
virulent	O
,	O
they	O
replicate	O
to	O
the	O
same	O
titers	O
in	O
brain	B-ANAT
and	O
liver	B-ANAT
,	O
and	O
they	O
induce	O
similar	O
patterns	O
of	O
acute	O
hepatitis	O
,	O
acute	O
meningoencephalitis	O
,	O
and	O
chronic	O
demyelination	O
.	O

These	O
modifications	O
facilitate	O
(	O
i	O
)	O
the	O
mutagenesis	O
of	O
cloned	O
cDNA	O
by	O
using	O
vaccinia	O
virus	O
-	O
mediated	O
homologous	O
recombination	O
and	O
(	O
ii	O
)	O
the	O
rescue	O
of	O
recombinant	O
coronaviruses	O
by	O
using	O
a	O
stable	O
nucleocapsid	B-ANAT
protein	O
-	O
expressing	O
cell	B-ANAT
line	I-ANAT
for	O
the	O
electroporation	O
of	O
infectious	O
full	O
-	O
length	O
genomes	O
.	O

3a	O
protein	O
appeared	O
to	O
undergo	O
posttranslational	O
modifications	O
in	O
infected	O
cells	B-ANAT
and	O
was	O
incorporated	O
into	O
SCoV	O
particles	O
,	O
establishing	O
that	O
3a	O
protein	O
was	O
a	O
SCoV	O
structural	O
protein	O
.	O

Using	O
the	O
recombinant	O
His	O
-	O
Tagged	O
3CL	O
-	O
protease	O
(	O
3CLpro	O
)	O
as	O
a	O
model	O
for	O
attachment	O
to	O
chips	O
containing	O
D	O
-/	O
L	O
-	O
Glu	O
,	O
Asp	O
,	O
Orn	O
,	O
Ser	B-ANAT
via	O
different	O
transitional	O
metal	O
ions	O
,	O
it	O
was	O
found	O
that	O
the	O
Orn	O
chip	O
was	O
the	O
best	O
of	O
affinity	O
binding	O
and	O
stability	O
by	O
which	O
Zn2	O
+	O
was	O
the	O
best	O
metal	O
ion	O
for	O
affinity	O
while	O
Co2	O
+	O
was	O
the	O
best	O
metal	O
ion	O
for	O
stability	O
.	O

Computed	O
tomographs	O
(	O
CTs	O
)	O
are	O
better	O
than	O
normal	O
chest	B-ANAT
radiographs	O
in	O
the	O
detection	O
of	O
other	O
pulmonary	B-ANAT
lesions	O
such	O
as	O
pulmonary	B-ANAT
contusion	O
(	O
9	O
,	O
10	O
).	O

It	O
is	O
also	O
limited	O
by	O
the	O
fact	O
that	O
the	O
thermal	O
imager	O
measures	O
the	O
skin	B-ANAT
temperature	O
and	O
not	O
the	O
core	O
body	B-ANAT
temperature	O
.	O

Two	O
important	O
conclusions	O
were	O
drawn	O
from	O
the	O
analysis	O
:	O
the	O
best	O
region	O
on	O
the	O
face	B-ANAT
to	O
obtain	O
temperature	O
readings	O
and	O
the	O
optimal	O
preset	O
threshold	O
temperature	O
for	O
the	O
thermal	O
imager	O
.	O

TITLE	O
:	O
Chest	B-ANAT
radiograph	O
scores	O
as	O
potential	O
prognostic	O
indicators	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

Chest	B-ANAT
radiographs	O
that	O
had	O
been	O
obtained	O
from	O
presentation	O
until	O
the	O
death	O
or	O
discharge	B-ANAT
of	O
313	O
patients	O
with	O
SARS	O
were	O
scored	O
on	O
the	O
basis	O
of	O
the	O
percentage	O
area	O
and	O
location	O
of	O
lung	B-ANAT
opacification	O
.	O

By	O
day	O
7	O
,	O
crude	O
odds	O
ratio	O
of	O
death	O
was	O
1	O
.	O
73	O
per	O
5	O
%	O
of	O
AO	O
%	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
or	O
2	O
.	O
93	O
per	O
lung	B-ANAT
zone	O
opacified	O
(	O
p	O
<	O
0	O
.	O
0001	O
).	O

The	O
numbers	O
of	O
peripheral	O
white	B-ANAT
blood	I-ANAT
cells	I-ANAT
and	O
lymphocytes	B-ANAT
were	O
in	O
the	O
normal	O
range	O
without	O
any	O
specific	O
changes	O
typical	O
of	O
SARS	O
.	O

The	O
serial	O
laboratory	O
data	O
of	O
liver	B-ANAT
function	O
test	O
and	O
hepatic	B-ANAT
histological	O
examination	O
from	O
168	O
patients	O
with	O
SARS	O
were	O
retrospectively	O
analyzed	O
.	O

Liver	B-ANAT
damage	O
of	O
patients	O
with	O
SARS	O
usually	O
occurs	O
in	O
the	O
early	O
stage	O
of	O
the	O
disease	O
with	O
a	O
high	O
occurrence	O
rate	O
and	O
a	O
prolonged	O
profile	O
,	O
which	O
can	O
be	O
characterized	O
by	O
early	O
,	O
obvious	O
decrease	O
of	O
albumin	O
levels	O
and	O
slightly	O
abnormal	O
levels	O
of	O
ALT	O
.	O

Hepatotoxic	O
drugs	O
may	O
play	O
a	O
role	O
in	O
increasing	O
the	O
severity	O
of	O
liver	B-ANAT
damage	O
or	O
prolonging	O
the	O
time	O
of	O
liver	B-ANAT
function	O
recovery	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
induced	O
by	O
lipopolysaccharide	O
(	O
LPS	O
)	O
is	O
a	O
major	O
cause	O
of	O
mortality	O
among	O
humans	O
.	O

ALI	O
is	O
characterized	O
by	O
microvascular	O
protein	O
leakage	O
,	O
neutrophil	B-ANAT
influx	O
,	O
and	O
expression	O
of	O
proinflammatory	O
mediators	O
,	O
followed	O
by	O
severe	O
lung	B-ANAT
damage	O
.	O

Indirect	O
immunofluorescence	O
performed	O
on	O
fixed	B-ANAT
but	O
unpermeabilized	O
cells	B-ANAT
showed	O
that	O
these	O
antibodies	O
can	O
recognize	O
the	O
mature	O
form	O
of	O
S	O
on	O
the	O
cell	B-ANAT
surface	I-ANAT
.	O

We	O
developed	O
an	O
adoptive	O
-	O
transfer	O
model	O
to	O
more	O
clearly	O
elucidate	O
the	O
role	O
of	O
virus	O
-	O
specific	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
during	O
the	O
acute	O
and	O
chronic	O
phases	O
of	O
infection	O
with	O
A59	O
that	O
is	O
described	O
as	O
follows	O
.	O

C57BL	O
/	O
6	O
mice	O
were	O
infected	O
with	O
a	O
recombinant	O
A59	O
virus	O
expressing	O
the	O
gp33	O
epitope	O
,	O
an	O
H	O
-	O
2Db	O
-	O
restricted	O
CD8	O
+	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
epitope	O
encoded	O
in	O
the	O
glycoprotein	O
of	O
lymphocytic	O
choriomeningitis	O
virus	O
,	O
as	O
a	O
fusion	O
with	O
the	O
enhanced	O
green	O
fluorescent	O
protein	O
(	O
RA59	O
-	O
gfp	O
/	O
gp33	O
).	O

P14	O
splenocytes	O
(	O
transgenic	O
for	O
a	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
receptor	O
specific	O
for	O
the	O
gp33	O
epitope	O
)	O
were	O
transferred	O
at	O
different	O
times	O
pre	O
-	O
and	O
postinfection	O
(	O
p	O
.	O
i	O
.).	O

The	O
""""	O
in	O
vitro	O
-	O
assembled	O
""""	O
wild	O
-	O
type	O
MHV	O
-	O
A59	O
virus	O
(	O
icMHV	O
-	O
A59	O
)	O
demonstrated	O
replication	O
identical	O
to	O
laboratory	O
strains	O
of	O
MHV	O
-	O
A59	O
in	O
tissue	B-ANAT
culture	O
;	O
however	O
,	O
icMHV	O
-	O
A59	O
was	O
avirulent	O
following	O
intracranial	B-ANAT
inoculation	O
of	O
C57BL	O
/	O
6	O
mice	O
.	O

Immunoassays	O
found	O
that	O
most	O
of	O
the	O
patients	O
who	O
had	O
recovered	O
from	O
SARS	O
developed	O
complementary	O
antibodies	O
to	O
the	O
epitope	O
-	O
rich	O
region	O
on	O
the	O
spike	O
S2	O
protein	O
,	O
indicating	O
that	O
this	O
is	O
an	O
immunodominant	O
site	O
on	O
the	O
viral	B-ANAT
envelope	I-ANAT
comprising	O
the	O
spike	O
,	O
matrix	O
,	O
and	O
small	O
envelope	B-ANAT
glycoproteins	O
.	O

Among	O
the	O
27	O
children	O
,	O
five	O
died	O
of	O
relapse	O
5	O
months	O
after	O
transplantation	O
,	O
and	O
one	O
case	O
of	O
NHL	O
had	O
CNS	B-ANAT
involvement	O
3	O
months	O
after	O
transplantation	O
but	O
has	O
got	O
17	O
months	O
of	O
survival	O
till	O
now	O
.	O

Autologous	O
stem	B-ANAT
cell	I-ANAT
transplantation	O
might	O
be	O
effective	O
in	O
the	O
treatment	O
advanced	O
solid	O
tumors	O
in	O
children	O
.	O

CONCLUSIONS	O
:	O
Autologous	O
stem	B-ANAT
cell	I-ANAT
transplantation	O
might	O
be	O
effective	O
in	O
the	O
treatment	O
advanced	O
solid	O
tumors	O
in	O
children	O
.	O

TITLE	O
:	O
Prone	O
position	O
reduces	O
lung	B-ANAT
stress	O
and	O
strain	O
in	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Compared	O
with	O
SR	O
(	O
BAS	O
),	O
pronation	O
/	O
SR	O
(	O
PP	O
)	O
resulted	O
in	O
reduced	O
peak	O
/	O
plateau	O
P	O
(	O
L	O
)	O
at	O
V	O
(	O
T	O
)	O
s	O
>	O
or	O
=	O
0	O
.	O
6	O
L	O
;	O
static	O
lung	B-ANAT
elastance	O
and	O
additional	O
lung	B-ANAT
resistance	O
decreased	O
and	O
chest	B-ANAT
wall	I-ANAT
elastance	O
(	O
in	O
prone	O
position	O
)	O
increased	O
;	O
EELV	O
increased	O
(	O
23	O
-	O
33	O
%);	O
V	O
(	O
T	O
)/	O
EELV	O
decreased	O
(	O
27	O
-	O
33	O
%);	O
arterial	B-ANAT
oxygen	O
tension	O
/	O
inspiratory	O
oxygen	O
fraction	O
and	O
arterial	B-ANAT
carbon	O
dioxide	O
tension	O
improved	O
(	O
21	O
-	O
43	O
/	O
10	O
-	O
14	O
%,	O
respectively	O
),	O
and	O
shunt	O
fraction	O
/	O
physiological	O
dead	O
space	O
decreased	O
(	O
21	O
-	O
50	O
/	O
20	O
-	O
47	O
%,	O
respectively	O
).	O

Early	O
isolation	O
of	O
febrile	O
patients	O
with	O
a	O
positive	O
contact	O
history	O
must	O
be	O
undertaken	O
,	O
even	O
in	O
the	O
face	B-ANAT
of	O
another	O
identifiable	O
cause	O
.	O

TITLE	O
:	O
Virus	O
-	O
specific	O
antibody	O
,	O
in	O
the	O
absence	O
of	O
T	B-ANAT
cells	I-ANAT
,	O
mediates	O
demyelination	O
in	O
mice	O
infected	O
with	O
a	O
neurotropic	O
coronavirus	O
.	O

These	O
data	O
demonstrate	O
that	O
JHM	O
-	O
specific	O
antibodies	O
are	O
sufficient	O
to	O
cause	O
demyelination	O
and	O
that	O
myelin	B-ANAT
destruction	O
in	O
the	O
presence	O
of	O
anti	O
-	O
virus	O
antibodies	O
results	O
from	O
a	O
combination	O
of	O
complement	O
-	O
and	O
Fc	O
receptor	O
-	O
dependent	O
mechanisms	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrated	O
that	O
the	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
S	O
protein	O
is	O
an	O
important	O
immunogenic	O
site	O
in	O
patients	O
with	O
SARS	O
and	O
rabbits	O
immunized	O
with	O
inactivated	O
SARS	O
-	O
CoV	O
.	O
Serum	B-ANAT
samples	O
from	O
convalescent	O
SARS	O
patients	O
and	O
immunized	O
rabbits	O
had	O
potent	O
neutralizing	O
activities	O
against	O
infection	O
by	O
pseudovirus	O
expressing	O
SARS	O
-	O
CoV	O
S	O
protein	O
.	O

In	O
areas	O
where	O
N95	O
masks	O
are	O
not	O
available	O
,	O
multiple	O
layers	B-ANAT
of	O
surgical	O
masks	O
have	O
been	O
tried	O
to	O
prevent	O
transmission	O
of	O
SARS	O
.	O

The	O
best	O
combination	O
of	O
five	O
surgical	O
masks	O
scored	O
a	O
fit	O
factor	O
of	O
13	O
.	O
7	O
,	O
which	O
is	O
well	O
below	O
the	O
minimum	O
level	O
of	O
100	O
required	O
for	O
a	O
half	O
face	B-ANAT
respirator	O
.	O

At	O
12h	O
post	O
-	O
infection	O
,	O
the	O
intracellular	B-ANAT
viral	O
RNA	O
load	O
was	O
3x10	O
(	O
2	O
)-	O
fold	O
higher	O
than	O
at	O
the	O
time	O
of	O
infection	O
,	O
and	O
the	O
extracellular	B-ANAT
viral	O
RNA	O
load	O
was	O
increased	O
with	O
a	O
factor	O
of	O
2	O
x	O
10	O
(	O
3	O
).	O

Intracellular	B-ANAT
viral	O
RNA	O
levels	O
started	O
to	O
rise	O
at	O
6h	O
post	O
-	O
infection	O
.	O

Here	O
,	O
we	O
describe	O
a	O
healthy	O
donor	O
for	O
allogeneic	O
hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplantation	O
who	O
developed	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
after	O
4	O
days	O
of	O
G	O
-	O
CSF	B-ANAT
administration	O
.	O

Adverse	O
events	O
from	O
G	O
-	O
CSF	B-ANAT
use	O
in	O
healthy	O
donors	O
have	O
been	O
described	O
in	O
approximately	O
30	O
%	O
of	O
cases	O
,	O
and	O
are	O
comprised	O
predominantly	O
of	O
bone	B-ANAT
pain	O
,	O
headache	O
,	O
and	O
general	O
fatigue	O
.	O

The	O
present	O
report	O
describes	O
a	O
healthy	O
donor	O
for	O
allo	O
-	O
HSCT	O
with	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
after	O
4	O
days	O
of	O
G	O
-	O
CSF	B-ANAT
administration	O
.	O

This	O
modality	O
utilizes	O
high	O
mean	O
airway	B-ANAT
pressures	O
to	O
maintain	O
an	O
open	O
lung	B-ANAT
and	O
low	O
tidal	O
volumes	O
at	O
a	O
high	O
frequency	O
that	O
allow	O
for	O
adequate	O
ventilation	O
while	O
at	O
the	O
same	O
time	O
preventing	O
alveolar	B-ANAT
overdistension	O
.	O

With	O
the	O
current	O
understanding	O
that	O
excessive	O
lung	B-ANAT
stretch	O
and	O
inadequate	O
end	O
-	O
expiratory	O
ventilatory	O
volume	O
may	O
be	O
injurious	O
to	O
the	O
lungs	B-ANAT
,	O
HFOV	O
seems	O
to	O
be	O
the	O
ideal	O
lung	B-ANAT
-	O
protective	O
ventilatory	O
mode	O
.	O

Although	O
a	O
pressure	O
-	O
and	O
volume	O
-	O
limited	O
strategy	O
aimed	O
at	O
mitigating	O
ventilator	O
-	O
associated	O
lung	B-ANAT
injury	O
has	O
demonstrated	O
mortality	O
benefit	O
,	O
patients	O
with	O
severe	O
ARDS	O
may	O
still	O
develop	O
life	O
-	O
threatening	O
hypoxemia	O
.	O

This	O
modality	O
has	O
been	O
used	O
to	O
manage	O
severe	O
lung	B-ANAT
disease	O
in	O
the	O
neonatal	O
and	O
pediatric	O
population	O
,	O
treat	O
inhalation	O
injury	O
in	O
pediatric	O
and	O
adult	O
patients	O
,	O
and	O
as	O
salvage	O
therapy	O
in	O
adult	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Six	O
of	O
19	O
patients	O
transitioned	O
to	O
conventional	O
ventilation	O
(	O
32	O
%)	O
were	O
deemed	O
intolerant	O
and	O
were	O
switched	O
back	B-ANAT
to	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
.	O

Additionally	O
PMNL	O
diapedesis	O
and	O
interstitial	B-ANAT
lung	B-ANAT
oedema	O
were	O
determined	O
by	O
histological	O
analysis	O
.	O

This	O
was	O
exacerbated	O
in	O
the	O
presence	O
of	O
lung	B-ANAT
contusion	O
along	O
with	O
increased	O
PMNL	O
activation	O
.	O

In	O
the	O
absence	O
of	O
effective	O
vaccines	O
,	O
nucleic	B-ANAT
acid	O
-	O
based	O
immunomodulators	O
have	O
the	O
potential	O
to	O
offer	O
effective	O
,	O
broad	O
-	O
spectrum	O
protection	O
against	O
these	O
deadly	O
pathogens	O
.	O

In	O
contrast	O
,	O
immunized	O
ferrets	O
(	O
particularly	O
those	O
immunized	O
with	O
rMVA	O
-	O
spike	O
)	O
exhibited	O
significantly	O
stronger	O
inflammatory	O
responses	O
and	O
focal	O
necrosis	O
in	O
liver	B-ANAT
tissue	I-ANAT
after	O
SARS	O
-	O
CoV	O
challenge	O
than	O
control	O
animals	O
.	O

Neutralization	O
titers	O
measured	O
by	O
this	O
assay	O
are	O
highly	O
correlated	O
to	O
those	O
measured	O
by	O
an	O
assay	O
using	O
replication	O
-	O
competent	O
SARS	O
-	O
CoV	O
.	O
No	O
cross	O
-	O
neutralization	O
occurred	O
with	O
human	O
sera	B-ANAT
known	O
to	O
contain	O
antibodies	O
to	O
coronavirus	O
strains	O
OC43	O
and	O
229E	O
.	O

TITLE	O
:	O
Biochemical	O
and	O
immunological	O
studies	O
of	O
nucleocapsid	B-ANAT
proteins	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
229E	O
human	O
coronaviruses	O
.	O

Furthermore	O
,	O
pretreatment	O
with	O
oxymatrine	O
significantly	O
alleviated	O
oleic	O
acid	O
-	O
induced	O
lung	B-ANAT
injury	O
accompanied	O
by	O
reduction	O
of	O
lung	B-ANAT
index	O
and	O
wet	O
-	O
to	O
-	O
dry	O
weight	O
ratio	O
,	O
decreases	O
in	O
serum	B-ANAT
TNF	O
-	O
alpha	O
level	O
and	O
inhibition	O
of	O
phosphorylated	O
p38	O
MAPK	O
.	O

All	O
patients	O
hospitalized	O
in	O
the	O
ICU	O
for	O
>	O
24	O
h	O
meeting	O
the	O
criteria	O
for	O
severe	O
sepsis	O
(	O
SS	O
),	O
either	O
with	O
only	O
one	O
organ	B-ANAT
dysfunction	O
present	O
during	O
the	O
ICU	O
stay	O
(	O
SS1	O
;	O
n	O
=	O
5	O
,	O
675	O
)	O
or	O
with	O
at	O
least	O
two	O
organ	B-ANAT
dysfunction	O
present	O
during	O
the	O
ICU	O
stay	O
(	O
SS2	O
;	O
n	O
=	O
12	O
,	O
598	O
),	O
were	O
compared	O
to	O
all	O
other	O
patients	O
hospitalized	O
for	O
>	O
24	O
h	O
in	O
the	O
ICU	O
over	O
the	O
same	O
time	O
period	O
(	O
n	O
=	O
47	O
,	O
637	O
).	O

We	O
collected	O
information	O
on	O
demographic	O
characteristics	O
,	O
type	O
of	O
admission	O
,	O
underlying	O
disease	O
,	O
organ	B-ANAT
dysfunction	O
,	O
organ	B-ANAT
support	O
,	O
McCabe	O
and	O
Charlson	O
-	O
Deyo	O
scores	O
,	O
simplified	O
acute	O
physiology	O
score	O
II	O
,	O
length	O
of	O
stay	O
,	O
and	O
outcome	O
.	O

To	O
elucidate	O
the	O
correlation	O
of	O
clinical	O
presentation	O
to	O
the	O
pathogenesis	O
and	O
course	O
of	O
the	O
disease	O
,	O
we	O
reviewed	O
the	O
pulmonary	B-ANAT
pathologic	O
specimens	O
of	O
SARS	O
patients	O
taken	O
at	O
different	O
stages	O
of	O
the	O
disease	O
.	O

Few	O
CD68	O
-	O
positive	O
syncytial	O
multinucleated	B-ANAT
giant	I-ANAT
cells	I-ANAT
were	O
also	O
seen	O
in	O
the	O
specimens	O
but	O
no	O
viral	B-ANAT
inclusion	I-ANAT
body	I-ANAT
could	O
be	O
identified	O
in	O
these	O
cells	B-ANAT
.	O

The	O
number	O
of	O
CD3	O
-	O
positive	O
lymphocytes	B-ANAT
and	O
of	O
CD68	O
-	O
positive	O
macrophages	B-ANAT
in	O
this	O
specimen	O
from	O
a	O
patient	O
in	O
the	O
fibrotic	O
phase	O
of	O
diffuse	O
alveolar	B-ANAT
damage	O
(	O
DAD	O
)	O
whose	O
condition	O
deteriorated	O
was	O
less	O
than	O
in	O
the	O
specimen	O
from	O
case	O
3	O
who	O
was	O
in	O
the	O
early	O
proliferative	O
phase	O
of	O
DAD	O
and	O
eventually	O
recovered	O
.	O

RESULTS	O
:	O
The	O
autopsy	O
lung	B-ANAT
tissue	I-ANAT
from	O
patient	O
1	O
,	O
who	O
died	O
7	O
days	O
after	O
symptoms	O
onset	O
due	O
to	O
the	O
complication	O
of	O
acute	O
myocardial	O
infarction	O
,	O
revealed	O
mild	O
histologic	O
change	O
in	O
the	O
lung	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
ability	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
to	O
generate	O
innate	O
immune	O
responses	O
was	O
investigated	O
in	O
an	O
in	O
vitro	O
model	O
of	O
CNS	B-ANAT
infection	O
.	O

Failure	O
of	O
treatment	O
identified	O
as	O
both	O
lack	O
of	O
clinical	O
response	O
and	O
evidence	O
of	O
continued	O
venous	B-ANAT
thrombosis	O
occurred	O
3	O
of	O
25	O
patients	O
(	O
12	O
%).	O

TITLE	O
:	O
Coronary	B-ANAT
plaque	O
instability	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

Using	O
EGFP	O
and	O
RFP	O
reporter	O
genes	O
fused	O
with	O
the	O
cloned	O
SARS	O
-	O
CoV	O
Leader	O
sequence	O
,	O
we	O
demonstrated	O
that	O
the	O
siRNA	O
targeting	O
the	O
Leader	O
sequence	O
decreased	O
the	O
mRNA	O
abundance	O
and	O
protein	O
expression	O
levels	O
of	O
the	O
reporter	O
genes	O
in	O
293T	O
cells	B-ANAT
.	O

TITLE	O
:	O
Extravascular	O
lung	B-ANAT
water	O
in	O
patients	O
with	O
severe	O
sepsis	O
:	O
a	O
prospective	O
cohort	O
study	O
.	O

More	O
than	O
half	O
of	O
the	O
patients	O
with	O
severe	O
sepsis	O
but	O
without	O
ARDS	O
had	O
increased	O
EVLW	O
,	O
possibly	O
representing	O
subclinical	O
lung	B-ANAT
injury	O
.	O

An	O
indirect	O
antibody	O
ELISA	O
method	O
was	O
developed	O
and	O
clinical	O
positive	O
and	O
negative	O
sera	B-ANAT
for	O
their	O
antibodies	O
against	O
GST	O
-	O
N2	O
fusion	O
protein	O
were	O
assayed	O
.	O

Lung	B-ANAT
histology	O
showed	O
marked	O
improvement	O
by	O
iloprost	O
compared	O
to	O
the	O
IR	O
group	O
in	O
this	O
study	O
.	O

We	O
employed	O
cDNA	O
microarray	O
analysis	O
to	O
characterize	O
the	O
cellular	B-ANAT
transcriptional	O
responses	O
of	O
homologous	O
human	O
genes	O
at	O
12	O
h	O
post	O
-	O
infection	O
.	O

We	O
observed	O
the	O
interplay	O
between	O
various	O
mechanisms	O
to	O
favor	O
virus	O
multiplication	O
before	O
full	O
-	O
blown	O
apoptosis	O
and	O
the	O
triggering	O
of	O
several	O
pathways	O
in	O
host	O
cells	B-ANAT
in	O
an	O
attempt	O
to	O
eliminate	O
the	O
pathogen	O
.	O

Vero	B-ANAT
cells	I-ANAT
were	O
dually	O
infected	O
with	O
ca	O
-	O
PEDV	O
and	O
one	O
of	O
the	O
three	O
chlamydial	O
strains	O
Chlamydia	O
trachomatis	O
S45	O
,	O
Chlamydophila	O
abortus	B-ANAT
S26	O
/	O
3	O
or	O
Chlamydophila	O
pecorum	O
1710S	O
.	O

Some	O
syncytial	O
cells	B-ANAT
contained	O
enlarged	O
C	O
.	O
abortus	B-ANAT
or	O
C	O
.	O
pecorum	O
inclusions	O
with	O
abnormally	O
large	O
developmental	O
forms	O
.	O

Here	O
,	O
we	O
studied	O
the	O
effects	O
of	O
synthetic	O
siRNA	O
duplexes	O
targeted	O
to	O
SARS	O
coronavirus	O
structural	O
proteins	O
E	O
,	O
M	O
,	O
and	O
N	O
in	O
a	O
cell	B-ANAT
culture	O
system	O
.	O

However	O
,	O
the	O
best	O
results	O
were	O
obtained	O
with	O
QS21	O
and	O
protein	O
,	O
which	O
provided	O
the	O
highest	O
antibody	O
as	O
well	O
as	O
complete	O
protection	O
of	O
the	O
upper	O
and	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
.	O

We	O
show	O
that	O
the	O
cytoplasmic	B-ANAT
domain	I-ANAT
,	O
not	O
the	O
transmembrane	B-ANAT
domain	O
,	O
determines	O
the	O
association	O
with	O
the	O
M	O
protein	O
and	O
suffices	O
to	O
effect	O
the	O
incorporation	O
into	O
viral	B-ANAT
particles	I-ANAT
of	O
chimeric	O
spikes	O
as	O
well	O
as	O
of	O
foreign	O
viral	O
glycoproteins	O
.	O

The	O
essential	O
sequence	O
was	O
mapped	O
to	O
the	O
membrane	B-ANAT
-	O
proximal	O
region	O
of	O
the	O
cytoplasmic	B-ANAT
domain	I-ANAT
,	O
which	O
is	O
also	O
known	O
to	O
be	O
of	O
critical	O
importance	O
for	O
the	O
fusion	O
function	O
of	O
the	O
S	O
protein	O
.	O

3a	O
was	O
detected	O
in	O
virions	B-ANAT
purified	O
from	O
SARS	O
-	O
CoV	O
infected	O
Vero	O
E6	O
cells	B-ANAT
although	O
two	O
truncated	O
products	O
were	O
present	O
predominantly	O
instead	O
of	O
the	O
full	O
-	O
length	O
protein	O
.	O

During	O
the	O
1970th	O
and	O
80th	O
,	O
many	O
new	O
agents	O
were	O
characterized	O
from	O
diagnostic	O
cell	B-ANAT
cultures	O
and	O
clinical	O
specimens	O
.	O

The	O
overall	O
rate	O
of	O
BCoV	O
faecal	B-ANAT
shedding	O
was	O
28	O
.	O
1	O
%	O
(	O
27	O
/	O
96	O
)	O
in	O
the	O
cattle	O
examined	O
.	O

There	O
was	O
no	O
statistically	O
significant	O
association	O
between	O
seroconversion	O
and	O
nasal	B-ANAT
or	O
faecal	B-ANAT
BCoV	O
shedding	O
.	O

To	O
define	O
the	O
dynamics	O
of	O
the	O
immune	O
spectrum	O
in	O
SARS	O
,	O
serum	B-ANAT
levels	O
of	O
cytokines	O
,	O
chemokines	O
,	O
immunoglobulins	O
,	O
complement	O
and	O
specific	O
antibodies	O
against	O
SARS	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
were	O
assayed	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
),	O
and	O
phenotypes	O
of	O
peripheral	O
lymphocytes	B-ANAT
were	O
analyzed	O
by	O
flow	O
cytometry	O
in	O
95	O
SARS	O
-	O
infected	O
patients	O
.	O

The	O
presence	O
of	O
viral	B-ANAT
particles	I-ANAT
in	O
passage	O
11	O
cells	B-ANAT
was	O
assessed	O
by	O
electron	O
microscopy	O
.	O

Electron	O
microscopy	O
confirmed	O
the	O
presence	O
of	O
viral	B-ANAT
particles	I-ANAT
in	O
passage	O
11	O
cells	B-ANAT
.	O

We	O
also	O
compare	O
S	O
proteins	O
of	O
SARS	O
-	O
CoV	O
isolated	O
during	O
the	O
2002	O
-	O
2003	O
SARS	O
outbreak	O
and	O
during	O
the	O
much	O
less	O
severe	O
2003	O
-	O
2004	O
outbreak	O
,	O
and	O
from	O
palm	B-ANAT
civets	O
,	O
a	O
possible	O
source	O
of	O
SARS	O
-	O
CoV	O
found	O
in	O
humans	O
.	O

All	O
three	O
S	O
proteins	O
bound	O
to	O
and	O
utilized	O
palm	B-ANAT
-	O
civet	O
ACE2	O
efficiently	O
,	O
but	O
the	O
latter	O
two	O
S	O
proteins	O
utilized	O
human	O
ACE2	O
markedly	O
less	O
efficiently	O
than	O
did	O
the	O
S	O
protein	O
obtained	O
during	O
the	O
earlier	O
human	O
outbreak	O
.	O

Collectively	O
,	O
these	O
data	O
describe	O
molecular	O
interactions	O
important	O
to	O
the	O
adaptation	O
of	O
SARS	O
-	O
CoV	O
to	O
human	O
cells	B-ANAT
,	O
and	O
provide	O
insight	O
into	O
the	O
severity	O
of	O
the	O
2002	O
-	O
2003	O
SARS	O
epidemic	O
.	O

Routine	O
laboratory	O
tests	O
,	O
including	O
determination	O
of	O
absolute	O
lymphocyte	B-ANAT
count	O
,	O
should	O
not	O
be	O
used	O
in	O
the	O
diagnosis	O
of	O
SARS	O
or	O
incorporated	O
into	O
current	O
case	O
definitions	O
of	O
SARS	O
.	O

Electron	O
microscopic	O
examination	O
also	O
revealed	O
coronavirus	O
particles	O
in	O
the	O
pneumocytes	B-ANAT
,	O
and	O
their	O
identity	O
was	O
confirmed	O
as	O
SARS	O
-	O
CoV	O
by	O
immunogold	O
labeling	O
electron	O
microscopy	O
.	O

Nevertheless	O
,	O
coronavirus	O
-	O
specific	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
were	O
preferentially	O
retained	O
.	O

Furthermore	O
,	O
in	O
contrast	O
to	O
highly	O
activated	O
pN	O
-	O
specific	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
,	O
bystander	O
p18	O
-	O
specific	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
recruited	O
to	O
the	O
site	O
of	O
inflammation	O
maintained	O
a	O
nonactivated	O
memory	O
phenotype	O
and	O
did	O
not	O
express	O
ex	O
vivo	O
cytolytic	O
activity	O
.	O

By	O
contrast	O
,	O
in	O
the	O
immunosuppressed	O
host	O
TIMP	O
-	O
1	O
mRNA	O
was	O
expressed	O
by	O
CNS	B-ANAT
resident	O
cells	B-ANAT
.	O

None	O
of	O
the	O
serum	B-ANAT
samples	O
from	O
100	O
healthy	O
blood	B-ANAT
donors	O
was	O
positive	O
in	O
the	O
S450	O
-	O
650	O
-	O
based	O
assay	O
.	O

22	O
.	O
2	O
percent	O
of	O
probable	O
SARS	O
patients	O
had	O
normal	O
chest	B-ANAT
radiographs	O
when	O
they	O
first	O
presented	O
to	O
the	O
ED	O
.	O

In	O
contrast	O
to	O
depletion	O
of	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
,	O
inhibition	O
of	O
IL	O
-	O
2	O
signaling	O
did	O
not	O
influence	O
CD8	O
(+)	O
T	B-ANAT
cell	I-ANAT
infiltration	O
,	O
effector	B-ANAT
cell	I-ANAT
function	O
or	O
survival	O
within	O
the	O
CNS	B-ANAT
.	O

TITLE	O
:	O
Clinical	O
significance	O
of	O
hepatic	B-ANAT
derangement	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

Serial	O
assay	O
of	O
serum	B-ANAT
ALT	O
was	O
followed	O
in	O
patients	O
who	O
fulfilled	O
the	O
WHO	O
criteria	O
of	O
SARS	O
.	O

ABSTRACT	O
:	O
West	O
syndrome	O
(	O
WS	O
)	O
is	O
one	O
of	O
the	O
catastrophic	O
epileptic	O
syndromes	O
in	O
infancy	O
characterized	O
by	O
a	O
triad	B-ANAT
of	O
infantile	O
spasms	O
,	O
psychomotor	O
deterioration	O
and	O
hypsarrhythmic	O
EEG	O
pattern	O
.	O

In	O
26	O
(	O
81	O
.	O
2	O
%)	O
symptomatic	O
cases	O
,	O
hypoxic	O
-	O
ischemic	O
encephalopathy	O
(	O
69	O
.	O
2	O
%)	O
was	O
the	O
most	O
common	O
etiologic	O
factor	O
,	O
followed	O
by	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
anomaly	O
including	O
malformation	O
of	O
cortical	B-ANAT
development	O
(	O
11	O
.	O
5	O
%),	O
and	O
Sturge	O
Weber	O
syndrome	O
(	O
3	O
.	O
8	O
%),	O
and	O
chromosomal	B-ANAT
translocation	O
with	O
Down	O
syndrome	O
(	O
11	O
.	O
5	O
%).	O

In	O
one	O
child	O
synthetic	O
ACTH	O
was	O
stopped	O
because	O
of	O
arterial	B-ANAT
hypertension	O
.	O

TITLE	O
:	O
Hepatic	B-ANAT
failure	O
in	O
a	O
child	O
with	O
anti	O
-	O
epileptic	O
hypersensitivity	O
syndrome	O
.	O

We	O
provide	O
some	O
tentative	O
explanations	O
for	O
this	O
shift	O
in	O
linguistic	O
framing	O
by	O
relating	O
it	O
to	O
local	O
political	O
concerns	O
,	O
media	B-ANAT
cultures	O
,	O
and	O
spatial	O
factors	O
.	O

Recently	O
,	O
a	O
small	O
fragment	O
on	O
the	O
SARS	O
-	O
CoV	O
S	O
protein	O
(	O
residues	O
318	O
-	O
510	O
)	O
was	O
characterized	O
as	O
a	O
minimal	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
),	O
which	O
mediates	O
virus	O
binding	O
to	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
,	O
the	O
functional	O
receptor	O
on	O
susceptible	O
cells	B-ANAT
.	O

A	O
case	O
of	O
a	O
25	O
-	O
year	O
-	O
old	O
male	O
with	O
a	O
severe	O
chest	B-ANAT
pain	O
associated	O
with	O
ST	O
segment	O
changes	O
,	O
elevated	O
serum	B-ANAT
C	O
-	O
reactive	O
protein	O
,	O
myocardial	O
necrosis	O
markers	O
and	O
normal	O
epicardial	O
coronary	B-ANAT
arteries	I-ANAT
is	O
presented	O
.	O

New	O
techniques	O
such	O
as	O
new	O
generations	O
of	O
Polymerase	O
Chain	O
Reaction	O
(	O
PCR	O
),	O
rapid	O
methods	O
for	O
nucleic	B-ANAT
acid	O
sequence	O
analyses	O
and	O
microarrays	O
have	O
enabled	O
more	O
rapid	O
identification	O
of	O
organisms	O
and	O
provide	O
powerful	O
tools	O
in	O
the	O
epidemiological	O
analysis	O
of	O
an	O
outbreak	O
.	O

The	O
results	O
suggest	O
that	O
cDNA	O
RDA	O
with	O
non	O
-	O
ribosomal	B-ANAT
primers	O
can	O
be	O
used	O
for	O
species	O
-	O
independent	O
detection	O
of	O
viruses	O
,	O
including	O
new	O
viruses	O
.	O

A	O
photochemical	O
treatment	O
(	O
PCT	O
)	O
process	O
with	O
amotosalen	O
-	O
HCl	O
and	O
long	O
-	O
wavelength	O
ultraviolet	O
light	O
(	O
UVA	O
),	O
which	O
cross	O
-	O
links	O
nucleic	B-ANAT
acids	O
,	O
was	O
developed	O
to	O
inactivate	O
viruses	O
and	O
other	O
pathogens	O
in	O
PLT	O
concentrates	O
.	O

Log	O
reduction	O
of	O
enveloped	O
viruses	O
for	O
cell	B-ANAT
-	O
free	O
HIV	O
-	O
1	O
was	O
>	O
6	O
.	O
2	O
;	O
for	O
cell	B-ANAT
-	O
associated	O
HIV	O
-	O
1	O
,	O
>	O
6	O
.	O
1	O
;	O
for	O
clinical	O
isolate	O
HIV	O
-	O
1	O
,	O
>	O
3	O
.	O
4	O
;	O
for	O
clinical	O
isolate	O
HIV	O
-	O
2	O
,	O
>	O
2	O
.	O
5	O
;	O
for	O
HBV	O
,	O
>	O
5	O
.	O
5	O
;	O
for	O
HCV	O
,	O
>	O
4	O
.	O
5	O
;	O
for	O
DHBV	O
,	O
>	O
6	O
.	O
2	O
;	O
for	O
BVDV	O
,	O
>	O
6	O
.	O
0	O
;	O
for	O
HTLV	O
-	O
I	O
,	O
4	O
.	O
2	O
;	O
for	O
HTLV	O
-	O
II	O
,	O
4	O
.	O
6	O
;	O
for	O
CMV	O
,	O
>	O
5	O
.	O
9	O
;	O
for	O
WNV	O
,	O
>	O
5	O
.	O
5	O
;	O
for	O
SARS	O
-	O
HCoV	O
,	O
>	O
5	O
.	O
8	O
;	O
and	O
for	O
vaccinia	O
virus	O
,	O
>	O
4	O
.	O
7	O
.	O

CD8	O
T	B-ANAT
cells	I-ANAT
play	O
an	O
important	O
role	O
in	O
controlling	O
diseases	O
caused	O
by	O
other	O
coronaviruses	O
and	O
in	O
mediating	O
vaccine	O
-	O
induced	O
protective	O
immunity	O
in	O
corresponding	O
animal	O
models	O
.	O

CD8	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
responses	O
were	O
mapped	O
to	O
two	O
H	O
-	O
2	O
(	O
b	O
)-	O
restricted	O
epitopes	O
(	O
S436	O
-	O
443	O
and	O
S525	O
-	O
532	O
)	O
and	O
one	O
H	O
-	O
2	O
(	O
d	O
)-	O
restricted	O
epitope	O
(	O
S366	O
-	O
374	O
).	O

Severe	O
acute	O
respiratory	O
distress	O
syndrome	O
after	O
aspiration	O
with	O
septic	O
shock	O
and	O
acute	O
renal	B-ANAT
failure	O
at	O
the	O
beginning	O
.	O

In	O
the	O
following	O
course	O
,	O
repeated	O
severe	O
systemic	O
infections	O
with	O
phases	O
of	O
septicemia	O
or	O
rather	O
septic	O
shock	O
and	O
detection	O
of	O
Candida	O
in	O
several	O
positive	O
blood	B-ANAT
cultures	O
and	O
bronchoalveolar	O
lavages	O
.	O

The	O
histopathologic	O
demonstrable	O
invasion	O
of	O
blood	B-ANAT
vessels	I-ANAT
is	O
remarkable	O
for	O
a	O
fungal	O
infection	O
.	O

These	O
findings	O
required	O
surgical	O
intervention	O
,	O
resection	O
of	O
the	O
lower	B-ANAT
lobe	I-ANAT
of	I-ANAT
the	I-ANAT
right	I-ANAT
lung	I-ANAT
and	O
within	O
the	O
same	O
operation	O
of	O
the	O
renal	B-ANAT
graft	B-ANAT
because	O
of	O
rejection	O
.	O

ABSTRACT	O
:	O
To	O
review	O
the	O
current	O
data	O
about	O
anaesthetic	O
management	O
in	O
prostate	B-ANAT
surgery	O
with	O
special	O
regards	O
on	O
analysis	O
and	O
prevention	O
of	O
specific	O
risks	O
,	O
appropriate	O
anaesthetic	O
procedure	O
keeping	O
with	O
surgery	O
and	O
patient	O
,	O
recognition	O
and	O
treatment	O
of	O
adverse	O
events	O
.	O

MDA	O
levels	O
of	O
the	O
plasma	B-ANAT
,	O
neutrophil	B-ANAT
and	O
platelet	B-ANAT
counts	O
,	O
and	O
arterial	B-ANAT
blood	I-ANAT
gases	O
were	O
recorded	O
at	O
the	O
beginning	O
of	O
the	O
study	O
and	O
then	O
at	O
two	O
and	O
five	O
hours	O
.	O

As	O
early	O
as	O
30	O
min	O
post	O
-	O
entry	O
into	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
,	O
high	O
-	O
mannosylated	O
S	O
assembles	O
into	O
trimers	O
prior	O
to	O
acquisition	O
of	O
complex	O
N	O
-	O
glycans	O
in	O
the	O
Golgi	B-ANAT
.	O

E	O
protein	O
is	O
found	O
in	O
bright	O
perinuclear	O
patches	O
colocalizing	O
with	O
endoplasmic	B-ANAT
reticulum	I-ANAT
markers	O
.	O

ABSTRACT	O
:	O
Foreign	O
viral	O
proteins	O
expressed	O
by	O
rabies	O
virus	O
(	O
RV	O
)	O
have	O
been	O
shown	O
to	O
induce	O
potent	O
humoral	O
and	O
cellular	B-ANAT
immune	O
responses	O
in	O
immunized	O
animals	O
.	O

For	O
this	O
approach	O
,	O
the	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
protein	O
(	O
N	O
)	O
or	O
envelope	B-ANAT
spike	O
protein	O
(	O
S	O
)	O
genes	O
were	O
cloned	O
between	O
the	O
RV	O
glycoprotein	O
G	O
and	O
polymerase	O
L	O
genes	O
.	O

TITLE	O
:	O
Molecular	O
advances	O
in	O
the	O
cell	B-ANAT
biology	O
of	O
SARS	O
-	O
CoV	O
and	O
current	O
disease	O
prevention	O
strategies	O
.	O

Concordingly	O
,	O
an	O
important	O
activation	O
of	O
auto	O
-	O
reactive	O
T	B-ANAT
cells	I-ANAT
specific	O
to	O
myelin	B-ANAT
basic	O
protein	O
was	O
demonstrated	O
.	O

Altogether	O
,	O
these	O
results	O
indicate	O
that	O
an	O
MHV	O
infection	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
leads	O
to	O
an	O
important	O
host	O
genomic	O
response	O
implicating	O
immunity	O
-	O
related	O
genes	O
and	O
to	O
the	O
activation	O
of	O
myelin	B-ANAT
-	O
reactive	O
autoimmune	O
T	B-ANAT
cells	I-ANAT
.	O

Secondly	O
,	O
wild	O
-	O
type	O
virus	O
buds	B-ANAT
only	O
from	O
the	O
apical	O
domain	O
of	O
bronchial	B-ANAT
epithelium	I-ANAT
,	O
releasing	O
virus	O
into	O
the	O
lumen	B-ANAT
of	O
the	O
respiratory	B-ANAT
tract	I-ANAT
,	O
whereas	O
F1	O
-	O
R	O
buds	B-ANAT
from	O
both	O
apical	O
and	O
basolateral	O
domains	O
.	O

Western	O
blot	O
assay	O
further	O
demonstrated	O
the	O
specificity	O
of	O
the	O
induced	O
serum	B-ANAT
antibodies	O
.	O

After	O
3	O
weeks	O
,	O
they	O
were	O
challenged	O
with	O
the	O
NS	O
-	O
1	O
strain	O
of	O
SARS	O
-	O
CoV	O
.	O
The	O
humoral	O
and	O
mucosal	B-ANAT
immune	O
responses	O
,	O
clinical	O
signs	O
,	O
chemical	O
indices	O
and	O
viremia	O
were	O
monitored	O
following	O
the	O
immunization	O
and	O
challenge	O
.	O

The	O
results	O
show	O
that	O
this	O
inactivated	O
vaccine	O
can	O
induce	O
effective	O
concomitant	O
humoral	O
and	O
mucosal	B-ANAT
immunity	O
against	O
SARS	O
-	O
CoV	O
infection	O
,	O
is	O
safe	O
in	O
monkeys	O
,	O
and	O
the	O
vaccine	O
maybe	O
a	O
good	O
candidate	O
for	O
clinical	O
trials	O
.	O

ABSTRACT	O
:	O
We	O
studied	O
the	O
adjuvanticity	O
of	O
recombinant	O
Onchocerca	O
volvulus	O
activation	O
associated	O
protein	O
-	O
1	O
(	O
rOv	O
-	O
ASP	O
-	O
1	O
)	O
for	O
ovalbumin	O
(	O
OVA	B-ANAT
)	O
in	O
mice	O
.	O

ABSTRACT	O
:	O
We	O
investigated	O
the	O
feasibility	O
of	O
using	O
Flinders	O
Technology	O
Associates	O
(	O
FTA	O
)	O
filter	O
cards	O
for	O
the	O
storage	B-ANAT
of	O
allantoic	B-ANAT
fluid	I-ANAT
containing	O
an	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
),	O
such	O
as	O
Arkansas	O
-	O
DPI	O
,	O
Connecticut	O
,	O
and	O
Massachusetts	O
,	O
and	O
for	O
their	O
identification	O
by	O
reverse	O
transcriptase	O
(	O
RT	O
)-	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
and	O
characterization	O
by	O
restriction	O
fragment	O
length	O
polymorphism	O
(	O
RFLP	O
)	O
or	O
nucleotide	O
sequencing	O
.	O

TITLE	O
:	O
In	O
vitro	O
analysis	O
of	O
a	O
hammerhead	O
ribozyme	O
targeted	O
to	O
infectious	O
bronchitis	O
virus	O
nucleocapsid	B-ANAT
mRNA	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	O
spike	O
glycoprotein	O
is	O
a	O
class	O
I	O
membrane	B-ANAT
fusion	O
protein	O
with	O
two	O
characteristic	O
heptad	O
repeat	O
regions	O
(	O
HR1	O
and	O
HR2	O
)	O
in	O
its	O
ectodomain	O
.	O

Of	O
42	O
patients	O
with	O
cystic	O
or	O
/	O
and	O
urethral	B-ANAT
injury	O
,	O
35	O
underwent	O
cystostomy	O
and	O
delayed	O
reconstruction	O
,	O
and	O
7	O
received	O
a	O
primary	O
realignment	O
.	O

Next	O
,	O
we	O
investigated	O
whether	O
FIPV	O
and	O
fMHV	O
could	O
be	O
targeted	O
to	O
human	O
cancer	B-ANAT
cells	I-ANAT
by	O
constructing	O
a	O
bispecific	O
single	O
-	O
chain	O
antibody	O
directed	O
on	O
the	O
one	O
hand	O
against	O
the	O
feline	O
coronavirus	O
spike	O
protein	O
--	O
responsible	O
for	O
receptor	O
binding	O
and	O
subsequent	O
cell	B-ANAT
entry	O
through	O
virus	O
-	O
cell	B-ANAT
membrane	I-ANAT
fusion	O
--	O
and	O
on	O
the	O
other	O
hand	O
against	O
the	O
human	O
epidermal	B-ANAT
growth	O
factor	O
receptor	O
(	O
EGFR	O
).	O

CONCLUSIONS	O
:	O
Leptospirosis	O
is	O
an	O
important	O
infection	O
associated	O
with	O
high	O
mortality	O
when	O
associated	O
with	O
organ	B-ANAT
dysfunction	O
.	O

TITLE	O
:	O
Effects	O
of	O
cold	O
storage	B-ANAT
on	O
detection	O
of	O
avian	O
infectious	O
bronchitis	O
virus	O
in	O
chicken	O
carcasses	O
and	O
local	O
antibodies	O
in	O
tracheal	O
washes	O
.	O

ABSTRACT	O
:	O
In	O
order	O
to	O
test	O
the	O
survivability	O
of	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
in	O
dead	O
chicken	O
carcasses	O
during	O
24	O
h	O
of	O
cold	O
storage	B-ANAT
,	O
7	O
week	O
-	O
old	O
specific	O
-	O
pathogen	O
-	O
free	O
chickens	O
were	O
infected	O
with	O
virulent	O
IBV	O
Massachusetts	O
strain	O
M41	O
,	O
and	O
were	O
killed	O
humanely	O
10	O
days	O
later	O
.	O

Carcasses	O
were	O
stored	O
in	O
a	O
cold	O
room	O
at	O
4	O
degrees	O
C	O
.	O
After	O
1	O
,	O
3	O
,	O
6	O
,	O
9	O
,	O
12	O
or	O
24	O
h	O
of	O
storage	B-ANAT
,	O
necropsies	O
were	O
carried	O
out	O
.	O

For	O
ECE	O
,	O
isolation	O
was	O
obtained	O
at	O
all	O
sampling	O
points	O
,	O
except	O
at	O
1	O
and	O
24	O
h	O
of	O
storage	B-ANAT
in	O
lungs	B-ANAT
.	O

In	O
addition	O
to	O
sampling	O
for	O
virus	O
,	O
tracheal	O
washes	O
were	O
collected	O
from	O
each	O
carcass	O
to	O
measure	O
the	O
ability	O
to	O
detect	O
local	O
antibodies	O
after	O
storage	B-ANAT
.	O

TITLE	O
:	O
Sumoylation	O
of	O
the	O
nucleocapsid	B-ANAT
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
.	O

The	O
expression	O
vector	O
of	O
this	O
siRNA	O
was	O
constructed	O
and	O
confirmed	O
to	O
reduce	O
N	O
and	O
EGFP	O
expression	O
efficiently	O
in	O
both	O
cultured	B-ANAT
cells	I-ANAT
and	O
adult	O
mouse	O
muscles	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
causative	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
the	O
SARS	O
-	O
associated	O
coronavirus	O
,	O
SARS	O
-	O
CoV	O
.	O
The	O
viral	B-ANAT
nucleocapsid	I-ANAT
(	O
N	O
)	O
protein	O
plays	O
an	O
essential	O
role	O
in	O
viral	O
RNA	O
packaging	O
.	O

ABSTRACT	O
:	O
Concurrent	O
failure	O
of	O
multiple	O
organs	B-ANAT
in	O
patients	O
of	O
sickle	B-ANAT
cell	I-ANAT
disease	O
(	O
SCD	O
)	O
has	O
rarely	O
been	O
reported	O
.	O

Ten	O
episodes	O
of	O
multiorgan	O
failure	O
were	O
identified	O
with	O
sickle	B-ANAT
cell	I-ANAT
disease	O
and	O
defining	O
criteria	O
of	O
organ	B-ANAT
failure	O
of	O
two	O
or	O
more	O
organs	B-ANAT
that	O
is	O
lung	B-ANAT
,	O
liver	B-ANAT
,	O
or	O
renal	B-ANAT
were	O
established	O
according	O
to	O
Acute	O
Physiological	O
and	O
Chronic	O
Health	O
Evaluation	O
-	O
II	O
(	O
APACHE	O
-	O
II	O
)	O
criteria	O
.	O

Respiratory	O
,	O
hepatic	B-ANAT
,	O
and	O
kidney	B-ANAT
failure	O
(	O
all	O
the	O
three	O
organs	B-ANAT
)	O
were	O
present	O
in	O
three	O
of	O
the	O
ten	O
patients	O
who	O
were	O
in	O
sickle	O
crisis	O
.	O

Respiratory	O
failure	O
with	O
renal	B-ANAT
involvement	O
was	O
seen	O
in	O
two	O
patients	O
whereas	O
hepatic	B-ANAT
and	O
renal	B-ANAT
failure	O
was	O
present	O
in	O
only	O
one	O
patient	O
.	O

Acute	O
multiorgan	O
failure	O
is	O
a	O
life	O
threatening	O
complication	O
of	O
SCD	O
,	O
which	O
can	O
exhibit	O
without	O
any	O
evidence	O
of	O
chronic	O
organ	B-ANAT
damage	O
and	O
is	O
easily	O
reversed	O
by	O
prompt	O
and	O
aggressive	O
transfusion	O
therapy	O
.	O

In	O
mixed	O
neural	B-ANAT
cell	I-ANAT
cultures	O
,	O
srr7	O
infected	O
a	O
limited	O
number	O
of	O
cells	B-ANAT
and	O
infection	O
did	O
not	O
spread	O
,	O
although	O
wt	O
JHMV	O
induced	O
syncytia	B-ANAT
in	O
most	O
of	O
the	O
cells	B-ANAT
.	O

TITLE	O
:	O
Infectious	O
bronchitis	O
virus	O
3a	O
protein	O
localizes	O
to	O
a	O
novel	O
domain	O
of	O
the	O
smooth	B-ANAT
endoplasmic	I-ANAT
reticulum	I-ANAT
.	O

IBV	O
3a	O
protein	O
is	O
expressed	O
in	O
infected	O
cells	B-ANAT
but	O
is	O
not	O
detected	O
in	O
virions	B-ANAT
.	O

Sequence	O
analysis	O
predicted	O
that	O
IBV	O
3a	O
was	O
a	O
membrane	B-ANAT
protein	O
;	O
however	O
,	O
only	O
a	O
fraction	O
behaved	O
like	O
an	O
integral	O
membrane	B-ANAT
protein	O
.	O

Hydrogen	O
cyanamide	O
is	O
highly	O
toxic	O
,	O
and	O
adverse	O
health	O
effects	O
from	O
contact	O
include	O
severe	O
irritation	O
and	O
ulceration	O
of	O
the	O
eyes	B-ANAT
,	O
skin	B-ANAT
,	O
and	O
respiratory	B-ANAT
tract	I-ANAT
.	O

The	O
initial	O
syndrome	O
can	O
suggest	O
an	O
abdominal	B-ANAT
or	O
urological	O
surgical	O
emergency	O
,	O
which	O
is	O
source	O
of	O
diagnostic	O
and	O
therapeutic	O
errors	O
.	O

Using	O
cytopathic	O
assays	O
,	O
no	O
increase	O
in	O
virus	O
titer	O
was	O
detected	O
in	O
infected	O
DCs	O
and	O
cell	B-ANAT
-	O
culture	O
supernatant	O
,	O
confirming	O
that	O
virus	O
replication	O
was	O
incomplete	O
.	O

ABSTRACT	O
:	O
To	O
examine	O
the	O
impact	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
on	O
pulmonary	B-ANAT
function	O
,	O
exercise	O
capacity	O
,	O
and	O
health	O
-	O
related	O
quality	O
of	O
life	O
(	O
HRQoL	O
)	O
among	O
survivors	O
.	O

Heterogeneous	B-ANAT
nuclear	I-ANAT
ribonucleoprotein	I-ANAT
A1	O
(	O
hnRNP	B-ANAT
A1	O
)	O
is	O
related	O
to	O
the	O
pre	O
-	O
mRNA	O
splicing	O
in	O
the	O
nucleus	B-ANAT
and	O
translation	O
regulation	O
in	O
the	O
cytoplasm	B-ANAT
.	O

Bt	O
-	O
peptides	O
were	O
used	O
to	O
assess	O
if	O
selected	O
regions	O
were	O
antigenic	O
and	O
contained	O
B	O
-	O
or	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
epitopes	O
and	O
dt	O
-	O
peptides	O
if	O
regions	O
induced	O
an	O
antibody	O
response	O
and	O
protection	O
against	O
virulent	O
challenge	O
.	O

Three	O
S1	O
-	O
and	O
one	O
S2	O
-	O
bt	O
peptides	O
also	O
induced	O
a	O
delayed	O
type	O
hypersensitivity	O
response	O
indicating	O
the	O
presence	O
of	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
epitopes	O
.	O

Two	O
S1	O
(	O
Sp4	B-ANAT
and	O
Sp6	B-ANAT
)	O
and	O
one	O
S2	O
peptide	O
(	O
Sp7	B-ANAT
),	O
protected	O
kidney	B-ANAT
tissue	B-ANAT
against	O
virulent	O
challenge	O
.	O

However	O
,	O
the	O
results	O
of	O
quantification	O
of	O
SARS	O
-	O
CoV	O
obtained	O
by	O
using	O
a	O
few	O
available	O
throat	B-ANAT
swab	I-ANAT
specimens	O
from	O
SARS	O
patients	O
and	O
the	O
N	O
gene	O
as	O
the	O
target	O
were	O
almost	O
10	O
times	O
higher	O
than	O
those	O
obtained	O
by	O
using	O
ORF	O
3	O
and	O
ORF	O
8	O
.	O

Monocytes	B-ANAT
as	O
well	O
as	O
perivascular	O
macrophages	B-ANAT
were	O
activated	O
because	O
they	O
were	O
strongly	O
positive	O
for	O
CD18	O
and	O
expressed	O
cytokines	O
(	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
and	O
interleukin	O
-	O
1beta	O
)	O
and	O
matrix	O
metalloproteinase	O
-	O
9	O
.	O

ABSTRACT	O
:	O
Monoclonal	O
antibodies	O
(	O
mAb	O
)	O
to	O
the	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)	O
nucleoprotein	O
(	O
N	O
)	O
and	O
membrane	B-ANAT
protein	O
(	O
M	O
)	O
were	O
prepared	O
and	O
used	O
for	O
the	O
comparative	O
assessment	O
of	O
three	O
blocking	O
ELISA	O
variants	O
to	O
detect	O
TGEV	O
.	O

In	O
this	O
study	O
,	O
13	O
recombinant	O
proteins	O
associated	O
with	O
four	O
structural	O
proteins	O
(	O
S	O
,	O
E	O
,	O
M	O
and	O
N	O
)	O
and	O
five	O
putative	O
uncharacterized	O
proteins	O
(	O
3a	O
,	O
3b	O
,	O
6	O
,	O
7a	O
and	O
9b	O
)	O
of	O
the	O
SARS	O
-	O
CoV	O
were	O
prepared	O
and	O
used	O
for	O
screening	O
and	O
monitoring	O
their	O
specific	O
IgG	O
antibodies	O
in	O
SARS	O
patient	O
sera	B-ANAT
by	O
protein	O
microarray	O
.	O

In	O
this	O
observational	O
study	O
,	O
we	O
report	O
on	O
the	O
prevalence	O
of	O
GERD	O
in	O
this	O
population	O
,	O
including	O
all	O
pediatric	O
patients	O
undergoing	O
single	O
(	O
SLTx	O
)	O
or	O
double	O
(	O
DLTx	O
)	O
lung	B-ANAT
transplantation	O
or	O
heart	B-ANAT
-	O
lung	B-ANAT
(	O
HLTx	O
)	O
transplantation	O
from	O
January	O
2003	O
-	O
May	O
2004	O
.	O

These	O
findings	O
support	O
our	O
hypothesis	O
that	O
the	O
manner	O
in	O
which	O
CMV	O
and	O
the	O
host	O
immune	B-ANAT
system	I-ANAT
interact	O
is	O
critical	O
in	O
determining	O
the	O
IRP	O
and	O
hence	O
is	O
predictive	O
of	O
mortality	O
.	O

Inspection	O
of	O
the	O
overlap	O
regions	O
between	O
ORF1a	O
and	O
ORF1b	O
of	O
the	O
SARS	O
-	O
CoV	O
genome	O
revealed	O
that	O
,	O
similar	O
to	O
all	O
coronaviruses	O
,	O
a	O
programmed	O
-	O
1	O
ribosomal	B-ANAT
frameshift	O
could	O
be	O
used	O
by	O
the	O
virus	O
to	O
produce	O
a	O
fusion	O
protein	O
.	O

Computational	O
analyses	O
of	O
the	O
frameshift	O
signal	O
predicted	O
the	O
presence	O
of	O
an	O
mRNA	O
pseudoknot	O
containing	O
three	O
double	O
-	O
stranded	O
RNA	O
stem	B-ANAT
structures	O
rather	O
than	O
two	O
.	O

Electron	O
microscopy	O
of	O
purified	O
influenza	O
A	O
virus	O
showed	O
extensive	O
clumping	O
and	O
morphological	O
changes	O
in	O
spike	O
configuration	O
after	O
contact	O
with	O
the	O
virucidal	O
mixture	O
,	O
but	O
no	O
overt	O
destruction	O
of	O
the	O
viral	B-ANAT
membrane	I-ANAT
.	O

A	O
fusion	O
peptide	O
present	O
at	O
the	O
N	O
-	O
terminal	O
region	O
of	O
class	O
I	O
viral	O
fusion	O
proteins	O
is	O
believed	O
to	O
initiate	O
viral	O
and	O
cell	B-ANAT
membrane	I-ANAT
interactions	O
and	O
subsequent	O
fusion	O
.	O

Likewise	O
,	O
only	O
SARS	O
(	O
WW	O
-	O
I	O
)	O
induced	O
the	O
fusion	O
of	O
LUV	O
and	O
caused	O
membrane	B-ANAT
leakage	O
of	O
vesicle	B-ANAT
contents	O
at	O
peptide	O
/	O
lipid	O
ratios	O
of	O
1	O
:	O
50	O
and	O
1	O
:	O
100	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
Lipopeptide	O
lipid	O
moieties	O
induce	O
dendritic	B-ANAT
cell	I-ANAT
(	O
DC	O
)	O
internalization	O
and	O
epitopes	O
are	O
recognized	O
by	O
MHC	B-ANAT
,	O
the	O
major	B-ANAT
histocompatibility	I-ANAT
complex	I-ANAT
.	O

Mp	O
-	O
and	O
Dp	O
-	O
MART	O
(	O
anti	O
-	O
melanoma	O
lipopeptides	O
)	O
induce	O
strong	O
CTL	B-ANAT
(	O
cytolytic	O
T	B-ANAT
lymphocyte	I-ANAT
)	O
response	O
.	O

S	O
-	O
A5D5	O
reacted	O
specifically	O
react	O
with	O
both	O
recombinant	O
and	O
native	O
nucleocapsid	B-ANAT
protein	O
of	O
SARS	O
CoV	O
.	O
The	O
reactivity	O
of	O
S	O
-	O
A5D5	O
with	O
purified	O
N195	O
protein	O
and	O
utilization	O
of	O
the	O
MAb	O
as	O
a	O
detector	O
antibody	O
to	O
develop	O
an	O
antigen	O
capture	O
ELISA	O
was	O
assessed	O
.	O

N	O
protein	O
was	O
detected	O
in	O
18	O
IFA	O
IgM	O
-	O
positive	O
serum	B-ANAT
samples	O
collected	O
from	O
SARS	O
confirmed	O
patients	O
,	O
but	O
not	O
in	O
nine	O
samples	O
collected	O
from	O
SARS	O
recovery	O
patient	O
.	O

Survival	O
studies	O
,	O
lung	B-ANAT
weights	O
,	O
x	O
-	O
ray	O
computed	O
tomographic	O
scanning	O
,	O
light	O
and	O
electron	O
microscopy	O
,	O
bronchoalveolar	O
lavage	O
,	O
lung	B-ANAT
uptake	O
of	O
((	O
18	O
)	O
F	O
)	O
fluorodeoxyglucose	O
,	O
tissue	B-ANAT
myeloperoxidase	O
,	O
arterial	B-ANAT
blood	I-ANAT
gases	O
,	O
mean	O
arterial	B-ANAT
pressure	O
,	O
and	O
lung	B-ANAT
tissue	I-ANAT
prostanoids	O
were	O
measured	O
in	O
separate	O
groups	O
of	O
C57Bl	O
/	O
6	O
mice	O
(	O
normal	O
animals	O
,	O
endotoxin	O
only	O
[	O
20	O
microg	O
/	O
g	O
],	O
oleic	O
acid	O
only	O
[	O
0	O
.	O
15	O
microl	O
/	O
g	O
],	O
or	O
endotoxin	O
+	O
oleic	O
acid	O
).	O

TITLE	O
:	O
Plasma	B-ANAT
cytokine	O
measurements	O
augment	O
prognostic	O
scores	O
as	O
indicators	O
of	O
outcome	O
in	O
patients	O
with	O
severe	O
sepsis	O
.	O

The	O
eukaryotic	O
expression	O
vector	O
(	O
pCI	O
-	O
neo	O
/	O
nsp2	O
)	O
was	O
constructed	O
and	O
expressed	O
the	O
protein	O
in	O
COS	B-ANAT
-	I-ANAT
7	I-ANAT
cells	I-ANAT
successfully	O
.	O

We	O
retrospectively	O
analyzed	O
data	O
from	O
n	O
=	O
25	O
ARDS	O
patients	O
who	O
received	O
iNO	O
,	O
and	O
underwent	O
chest	B-ANAT
CT	O
within	O
72	O
h	O
prior	O
to	O
inhaled	O
treatment	O
.	O

Inhaled	O
NO	O
was	O
most	O
beneficial	O
in	O
injured	O
lungs	B-ANAT
characterized	O
by	O
many	O
small	O
consolidated	O
areas	O
surrounded	O
by	O
normal	O
lung	B-ANAT
tissue	I-ANAT
.	O

All	O
patients	O
had	O
infiltrates	O
on	O
chest	B-ANAT
radiograph	O
or	O
CT	O
,	O
some	O
even	O
with	O
multi	O
-	O
infiltrates	O
.	O

Two	O
weeks	O
later	O
,	O
patients	O
'	O
respiratory	O
symptoms	O
started	O
to	O
alleviate	O
,	O
the	O
infiltrates	O
on	O
the	O
lung	B-ANAT
began	O
to	O
absorb	O
gradually	O
,	O
the	O
counts	O
of	O
WBC	B-ANAT
,	O
lymphocyte	B-ANAT
and	O
CD3	O
,	O
CD4	O
,	O
CD8	O
positive	O
T	B-ANAT
cells	I-ANAT
were	O
restored	O
to	O
normality	O
.	O

ABSTRACT	O
:	O
A	O
male	O
infant	O
(	O
gestational	O
age	O
,	O
26	O
weeks	O
and	O
1	O
day	O
;	O
birthweight	O
,	O
752	O
g	O
)	O
was	O
treated	O
for	O
respiratory	O
distress	O
syndrome	O
and	O
thereafter	O
required	O
mechanical	O
ventilation	O
due	O
to	O
chronic	O
pulmonary	B-ANAT
insufficiency	O
.	O

There	O
has	O
been	O
no	O
previous	O
report	O
of	O
a	O
case	O
accompanied	O
by	O
cerebral	B-ANAT
infarction	O
.	O

TITLE	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
is	O
a	O
serious	O
complication	O
of	O
microwave	O
coagulation	O
therapy	O
for	O
liver	B-ANAT
tumors	O
.	O

Sukumo	O
extract	O
was	O
found	O
to	O
interact	O
with	O
both	O
the	O
viral	B-ANAT
envelope	I-ANAT
glycoprotein	O
and	O
cellular	B-ANAT
receptors	O
,	O
thus	O
blocking	O
virus	O
-	O
cell	B-ANAT
binding	O
and	O
virus	O
-	O
induced	O
syncytium	B-ANAT
formation	O
.	O

Our	O
results	O
indicate	O
that	O
the	O
gene	O
chip	O
-	O
based	O
molecular	O
test	O
is	O
specific	O
for	O
SARS	O
-	O
CoV	O
and	O
allows	O
early	O
detection	O
of	O
patients	O
with	O
SARS	O
with	O
detection	O
rate	O
about	O
8	O
%	O
higher	O
than	O
the	O
single	O
PCR	O
test	O
when	O
the	O
sputum	B-ANAT
sample	I-ANAT
is	O
available	O
.	O

Furosemide	O
has	O
been	O
shown	O
to	O
improve	O
pulmonary	B-ANAT
gas	O
exchange	O
and	O
intrapulmonary	O
shunt	O
by	O
a	O
nondiuretic	O
mechanism	O
in	O
animal	O
models	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
current	O
study	O
was	O
undertaken	O
to	O
clarify	O
whether	O
furosemide	O
attenuates	O
the	O
inflammatory	O
response	O
by	O
changing	O
the	O
epidermal	B-ANAT
growth	O
factor	O
level	O
in	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
.	O

The	O
ratio	O
of	O
partial	O
pressure	O
of	O
arterial	B-ANAT
oxygen	O
(	O
PaO2	O
)	O
to	O
fraction	O
of	O
inspired	O
oxygen	O
(	O
FIO2	O
)	O
improved	O
in	O
the	O
furosemide	O
-	O
treated	O
group	O
within	O
24	O
hours	O
(	O
from	O
180	O
to	O
264	O
;	O
P	O
=	O
.	O
01	O
).	O

Strategies	O
to	O
eradicate	O
oropharyngeal	B-ANAT
and	O
/	O
or	O
intestinal	B-ANAT
microbial	O
colonization	O
,	O
such	O
as	O
with	O
chlorhexidine	O
oral	B-ANAT
care	O
,	O
prophylactic	O
aerosolization	O
of	O
antimicrobials	O
,	O
selective	O
aerodigestive	O
mucosal	B-ANAT
antimicrobial	O
decontamination	O
,	O
or	O
the	O
use	O
of	O
sucralfate	O
rather	O
than	O
H	O
(	O
2	O
)	O
antagonists	O
for	O
stress	O
ulcer	O
prophylaxis	O
,	O
and	O
measures	O
to	O
prevent	O
aspiration	O
,	O
such	O
as	O
semirecumbent	O
positioning	O
or	O
continuous	O
subglottic	B-ANAT
suctioning	O
,	O
have	O
all	O
been	O
shown	O
to	O
reduce	O
the	O
risk	O
of	O
VAP	O
.	O

Hospital	O
water	O
should	O
be	O
Legionella	O
-	O
free	O
,	O
and	O
high	O
-	O
risk	O
patients	O
,	O
especially	O
those	O
with	O
prolonged	O
granulocytopenia	O
or	O
organ	B-ANAT
transplants	I-ANAT
,	O
should	O
be	O
cared	O
for	O
in	O
hospital	O
units	O
with	O
high	O
-	O
efficiency	O
-	O
particulate	O
-	O
arrestor	O
(	O
HEPA	O
)	O
filtered	O
air	O
.	O

They	O
also	O
highlight	O
the	O
synergistic	O
roles	O
of	O
inconsistent	O
health	O
policy	O
responses	O
and	O
risk	O
miscommunication	O
by	O
the	O
media	B-ANAT
in	O
rapidly	O
amplifying	O
stigma	O
toward	O
an	O
unfamiliar	O
illness	O
.	O

ABSTRACT	O
:	O
Persistence	O
was	O
established	O
after	O
most	O
of	O
the	O
SARS	O
-	O
CoV	O
-	O
infected	O
Vero	O
E6	O
cells	B-ANAT
died	O
.	O

Interestingly	O
,	O
a	O
viral	O
receptor	O
,	O
angiotensin	O
converting	O
enzyme	O
(	O
ACE	O
)-	O
2	O
,	O
was	O
down	O
-	O
regulated	O
in	O
persistently	O
infected	O
cells	B-ANAT
.	O

These	O
results	O
indicated	O
that	O
two	O
signaling	O
pathways	O
of	O
JNK	O
and	O
PI3K	O
/	O
Akt	O
were	O
important	O
for	O
the	O
establishment	O
of	O
persistence	O
in	O
Vero	O
E6	O
cells	B-ANAT
.	O

Immature	O
but	O
mature	O
Hsp60	O
causes	O
in	O
vitro	O
the	O
release	O
of	O
NO	O
by	O
macrophages	B-ANAT
,	O
suggesting	O
that	O
the	O
extracellular	B-ANAT
release	O
of	O
the	O
immature	O
Hsp60	O
associated	O
with	O
traumatic	O
cell	B-ANAT
necrosis	O
could	O
be	O
involved	O
in	O
the	O
release	O
of	O
NO	O
by	O
immune	O
competent	O
cells	B-ANAT
,	O
leading	O
to	O
an	O
activation	O
of	O
the	O
inflammatory	O
response	O
within	O
the	O
lung	B-ANAT
or	O
other	O
organs	B-ANAT
.	O

RESULTS	O
:	O
Among	O
674	O
patients	O
,	O
71	O
%	O
suffered	O
respiratory	O
insufficiency	O
,	O
43	O
%	O
were	O
unconscious	O
and	O
32	O
%	O
had	O
congestive	O
heart	B-ANAT
failure	O
during	O
the	O
24h	O
before	O
death	O
.	O

RESULTS	O
:	O
Pulmonary	B-ANAT
involvement	O
was	O
reported	O
in	O
150	O
of	O
220	O
patients	O
with	O
catastrophic	O
APS	O
(	O
68	O
%)	O
and	O
47	O
patients	O
(	O
21	O
%)	O
were	O
diagnosed	O
as	O
having	O
ARDS	O
.	O

These	O
in	O
vitro	O
isolated	O
mutants	O
encoded	O
two	O
amino	O
acids	O
substitutions	O
in	O
the	O
spike	O
(	O
S	O
)	O
gene	O
:	O
Q159L	O
lies	O
in	O
the	O
putative	O
receptor	O
binding	O
domain	O
of	O
S	O
,	O
and	O
H716D	O
,	O
within	O
the	O
cleavage	O
signal	O
of	O
S	O
.	O
Here	O
,	O
we	O
show	O
that	O
hepatotropic	O
revertant	O
variants	O
may	O
be	O
selected	O
from	O
these	O
in	O
vitro	O
isolated	O
mutants	O
(	O
Q159L	O
-	O
H716D	O
)	O
by	O
multiple	O
passages	O
in	O
the	O
mouse	B-ANAT
liver	I-ANAT
.	O

TITLE	O
:	O
Coronaviral	O
hypothetical	O
and	O
structural	O
proteins	O
were	O
found	O
in	O
the	O
intestinal	B-ANAT
surface	I-ANAT
enterocytes	B-ANAT
and	O
pneumocytes	B-ANAT
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

Structural	O
proteins	O
and	O
the	O
functionally	O
undefined	O
hypothetical	O
proteins	O
were	O
expressed	O
in	O
coronavirus	O
-	O
infected	O
cells	B-ANAT
with	O
distinct	O
expression	O
pattern	O
in	O
different	O
organs	B-ANAT
in	O
SARS	O
patients	O
.	O

Animals	O
at	O
live	O
animal	O
market	O
were	O
sampled	O
for	O
rectal	O
and	O
throat	B-ANAT
swabs	O
in	O
triplicate	O
.	O

Withdrawal	O
of	O
FP	O
in	O
COPD	O
patients	O
using	O
SFC	O
resulted	O
in	O
acute	O
and	O
persistent	O
deterioration	O
in	O
lung	B-ANAT
function	O
and	O
dyspnoea	O
and	O
in	O
an	O
increase	O
in	O
mild	O
exacerbations	O
and	O
percentage	O
of	O
disturbed	O
nights	O
.	O

Serum	B-ANAT
neopterin	O
level	O
in	O
SARS	O
patients	O
was	O
associated	O
with	O
fever	O
period	O
and	O
thus	O
the	O
clinical	O
progression	O
of	O
the	O
disease	O
,	O
while	O
there	O
was	O
no	O
significant	O
correlation	O
between	O
the	O
CRP	O
level	O
and	O
the	O
fever	O
period	O
.	O

The	O
decrease	O
of	O
neopterin	O
level	O
was	O
found	O
after	O
steroid	O
treatment	O
,	O
which	O
indicates	O
that	O
blood	B-ANAT
samples	I-ANAT
should	O
be	O
collected	O
before	O
steroid	O
treatment	O
for	O
the	O
neopterin	O
measurement	O
.	O

ABSTRACT	O
:	O
To	O
study	O
the	O
pathological	O
characteristics	O
of	O
thyroid	B-ANAT
gland	I-ANAT
and	O
the	O
changes	O
on	O
hormone	O
content	O
of	O
thyroid	B-ANAT
cells	B-ANAT
in	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
patients	O
.	O

Immunohistochemistry	O
was	O
used	O
,	O
with	O
monoclonal	O
antibodies	O
,	O
to	O
detect	O
the	O
thyroglobulin	O
(	O
TG	O
),	O
calcitonin	O
and	O
parathyroid	B-ANAT
hormone	O
(	O
PTH	O
)	O
in	O
the	O
thyroid	B-ANAT
glands	I-ANAT
.	O

Deformation	O
,	O
enlargement	O
,	O
and	O
dystrophy	O
of	O
follicular	B-ANAT
cells	B-ANAT
in	O
thyroid	B-ANAT
glands	I-ANAT
were	O
found	O
in	O
the	O
SARS	O
patients	O
.	O

This	O
report	O
describes	O
the	O
first	O
case	O
of	O
pulmonary	B-ANAT
artery	I-ANAT
thrombosis	O
in	O
a	O
patient	O
with	O
laboratory	O
confirmed	O
SARS	O
.	O

The	O
virally	O
encoded	O
3C	O
-	O
like	O
protease	O
(	O
3CL	O
(	O
Pro	O
))	O
has	O
been	O
presumed	O
critical	O
for	O
the	O
viral	O
replication	O
of	O
SARS	O
-	O
CoV	O
in	O
infected	O
host	O
cells	B-ANAT
.	O

The	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
is	O
defined	O
as	O
the	O
inflammation	O
syndrome	O
and	O
increased	O
permeability	O
,	O
which	O
is	O
associated	O
with	O
radiological	O
and	O
physiological	O
disorders	O
.	O

Non	O
-	O
immune	O
TRALI	O
,	O
which	O
occurs	O
mainly	O
after	O
the	O
transfusion	O
of	O
stored	O
platelet	B-ANAT
and	O
erythrocyte	B-ANAT
concentrates	O
,	O
seems	O
to	O
be	O
characterized	O
by	O
a	O
more	O
benign	O
clinical	O
course	O
,	O
with	O
oxygen	O
support	O
sufficient	O
as	O
a	O
form	O
of	O
therapy	O
in	O
most	O
cases	O
,	O
and	O
a	O
lower	O
mortality	O
than	O
immune	O
TRALI	O
.	O

Serum	B-ANAT
CRP	O
levels	O
,	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
(	O
WBC	B-ANAT
)	O
counts	O
and	O
body	B-ANAT
temperature	O
were	O
measured	O
serially	O
for	O
at	O
least	O
4	O
days	O
.	O

ABSTRACT	O
:	O
To	O
examine	O
the	O
RNA	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
in	O
the	O
blood	B-ANAT
and	O
excretion	O
of	O
convalescent	O
patient	O
with	O
SARS	O
for	O
prevention	O
and	O
treatment	O
of	O
the	O
disease	O
.	O

However	O
,	O
immunologic	O
alterations	O
of	O
circulating	O
and	O
resident	O
immune	O
cell	B-ANAT
populations	O
contributing	O
to	O
the	O
posttraumatic	O
immunosuppression	O
are	O
poorly	O
understood	O
.	O

To	O
address	O
the	O
significance	O
of	O
the	O
immunosuppression	O
associated	O
with	O
lung	B-ANAT
contusion	O
,	O
we	O
investigated	O
how	O
the	O
consecutive	O
addition	O
of	O
moderate	O
or	O
severe	O
sepsis	O
affected	O
survival	O
after	O
blunt	O
chest	B-ANAT
trauma	O
.	O

Sepsis	O
was	O
induced	O
via	O
cecal	B-ANAT
ligation	O
and	O
puncture	O
24	O
hrs	O
after	O
lung	B-ANAT
contusion	O
.	O

These	O
results	O
indicate	O
that	O
pulmonary	B-ANAT
contusion	O
causes	O
severe	O
immunodysfunction	O
of	O
splenocytes	O
,	O
macrophages	B-ANAT
,	O
and	O
monocytes	B-ANAT
in	O
different	O
local	O
compartments	B-ANAT
and	O
systemically	O
.	O

1	O
.	O
5	O
mL	O
/	O
kg	O
;	O
p	O
<	O
.	O
05	O
),	O
and	O
lung	B-ANAT
mechanics	O
were	O
improved	O
.	O

11	O
.	O
6	O
%)	O
among	O
serum	B-ANAT
samples	O
collected	O
<	O
or	O
=	O
50	O
days	O
after	O
fever	O
onset	O
,	O
intermediate	O
(	O
mean	O
+/-	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
and	O
the	O
innate	O
immune	O
responses	O
:	O
modulation	O
of	O
effector	B-ANAT
cell	I-ANAT
function	O
without	O
productive	O
infection	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
caused	O
by	O
a	O
novel	O
human	O
coronavirus	O
(	O
CoV	O
),	O
designated	O
SARS	O
-	O
CoV	O
,	O
is	O
a	O
highly	O
contagious	O
respiratory	O
disease	O
with	O
the	O
lungs	B-ANAT
as	O
a	O
major	O
target	O
.	O

We	O
investigated	O
the	O
interaction	O
of	O
SARS	O
-	O
CoV	O
with	O
human	O
macrophages	B-ANAT
(	O
Mphi	O
)	O
and	O
dendritic	B-ANAT
cells	I-ANAT
(	O
DC	O
),	O
two	O
key	O
innate	O
immune	O
cells	B-ANAT
of	O
the	O
host	O
immune	B-ANAT
system	I-ANAT
,	O
by	O
focusing	O
on	O
their	O
susceptibility	O
to	O
viral	O
infection	O
and	O
subsequent	O
responses	O
(	O
e	O
.	O
g	O
.,	O
phenotypic	O
maturation	O
,	O
T	B-ANAT
cell	I-ANAT
-	O
priming	O
activity	O
,	O
phagocytosis	O
,	O
and	O
cytokine	O
production	O
).	O

Strikingly	O
,	O
live	O
SARS	O
-	O
CoV	O
could	O
further	O
prime	O
cell	B-ANAT
types	O
to	O
respond	O
to	O
a	O
suboptimal	O
dose	O
of	O
bacterial	O
LPS	O
(	O
100	O
ng	O
/	O
ml	O
),	O
resulting	O
in	O
massive	O
release	O
of	O
IL	O
-	O
6	O
and	O
IL	O
-	O
12	O
.	O

The	O
tissue	B-ANAT
tropism	O
of	O
SARS	O
-	O
CoV	O
includes	O
not	O
only	O
the	O
lung	B-ANAT
,	O
but	O
also	O
the	O
gastrointestinal	B-ANAT
tract	I-ANAT
,	O
kidney	B-ANAT
and	O
liver	B-ANAT
.	O

Our	O
experiments	O
contribute	O
to	O
the	O
hypothesis	O
that	O
IFN	O
-	O
gamma	O
activation	O
of	O
macrophages	B-ANAT
plays	O
an	O
important	O
role	O
against	O
MHV3	O
infection	O
by	O
downregulating	O
the	O
expression	O
of	O
viral	O
receptors	O
.	O

The	O
values	O
of	O
6MWT	O
distance	O
,	O
predicted	O
Vo	O
2	O
max	O
,	O
proximal	O
and	O
distal	B-ANAT
muscle	I-ANAT
strength	O
,	O
and	O
the	O
scores	O
from	O
all	O
SF	O
-	O
36	O
domains	O
,	O
particularly	O
perceived	O
role	O
-	O
physical	O
,	O
were	O
significantly	O
lower	O
than	O
the	O
normative	O
data	O
(	O
P	O
<.	O
05	O
).	O

Mammalian	O
cells	B-ANAT
are	O
also	O
readily	O
permeabilized	O
by	O
the	O
expression	O
of	O
MHV	O
E	O
protein	O
.	O

During	O
the	O
initial	O
period	O
of	O
the	O
epidemic	O
,	O
public	O
communication	O
was	O
effected	O
through	O
press	O
releases	O
and	O
media	B-ANAT
coverage	O
of	O
the	O
epidemic	O
.	O

On	O
admission	O
the	O
patient	O
presented	O
with	O
pyrexia	O
associated	O
with	O
lymphopenia	O
and	O
liver	B-ANAT
cell	I-ANAT
necrosis	O
but	O
no	O
respiratory	O
symptoms	O
.	O

RNA	O
interference	O
(	O
RNAi	O
)	O
is	O
a	O
process	O
in	O
cell	B-ANAT
to	O
degradation	O
specific	O
target	O
mRNA	O
by	O
double	O
-	O
stranded	O
RNA	O
.	O

Pulmonary	B-ANAT
function	O
tests	O
were	O
performed	O
in	O
26	O
SARS	O
convalescent	O
patients	O
regularly	O
every	O
3	O
months	O
after	O
their	O
discharge	B-ANAT
from	O
hospital	O
.	O

CONCLUSIONS	O
:	O
Pulmonary	B-ANAT
dysfunction	O
is	O
found	O
among	O
some	O
SARS	O
patients	O
after	O
convalescence	O
presenting	O
mainly	O
as	O
restrictive	O
ventilatory	O
function	O
and	O
diffusing	O
capacity	O
abnormality	O
.	O

SARS	O
coronary	B-ANAT
virus	O
(	O
SARS	O
-	O
CoV	O
)	O
RNA	O
was	O
detected	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
in	O
pharyngeal	B-ANAT
swabs	O
only	O
in	O
1	O
patient	O
.	O

In	O
the	O
1	O
st	O
,	O
3	O
rd	O
,	O
6	O
th	O
month	O
after	O
their	O
discharge	B-ANAT
,	O
eg	O
.	O

During	O
the	O
6	O
months	O
after	O
discharge	B-ANAT
,	O
the	O
titers	O
of	O
SARS	O
-	O
antibodies	O
were	O
high	O
,	O
but	O
they	O
lowered	O
along	O
with	O
passage	O
of	O
time	O
.	O

SARS	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)-	O
specific	O
CTL	B-ANAT
responses	O
,	O
in	O
particular	O
their	O
magnitude	O
and	O
duration	O
of	O
postinfection	O
immunity	O
,	O
have	O
not	O
been	O
extensively	O
studied	O
.	O

However	O
,	O
compared	O
with	O
the	O
high	O
avidity	O
of	O
SSp	O
-	O
1	O
-	O
specific	O
CTLs	O
derived	O
from	O
memory	O
T	B-ANAT
cells	I-ANAT
of	O
recovered	O
SARS	O
patients	O
,	O
SSp	O
-	O
1	O
-	O
specific	O
CTLs	O
from	O
the	O
five	O
exceptional	O
healthy	O
donors	O
were	O
of	O
low	O
avidity	O
,	O
as	O
determined	O
by	O
their	O
rapid	O
tetramer	O
dissociation	O
kinetics	O
and	O
reduced	O
cytotoxic	O
reactivity	O
,	O
IFN	O
-	O
gamma	O
secretion	B-ANAT
,	O
and	O
intracellular	B-ANAT
production	O
of	O
IFN	O
-	O
gamma	O
,	O
TNF	O
-	O
alpha	O
,	O
perforin	O
,	O
and	O
granzyme	O
A	O
.	O
These	O
results	O
indicate	O
that	O
SARS	O
-	O
CoV	O
infection	O
induces	O
strong	O
and	O
long	O
-	O
lasting	O
CTL	B-ANAT
-	O
mediated	O
immunity	O
in	O
surviving	O
SARS	O
patients	O
,	O
and	O
that	O
cross	O
-	O
reactive	O
memory	O
T	B-ANAT
cells	I-ANAT
to	O
SARS	O
-	O
CoV	O
may	O
exist	O
in	O
the	O
T	B-ANAT
cell	I-ANAT
repertoire	O
of	O
a	O
small	O
subset	O
of	O
healthy	O
individuals	O
and	O
can	O
be	O
reactivated	O
by	O
SARS	O
-	O
CoV	O
infection	O
.	O

We	O
identified	O
the	O
immunodominant	O
antigenic	O
sites	O
responsible	O
for	O
the	O
antibodies	O
in	O
sera	B-ANAT
from	O
SARS	O
patients	O
and	O
antisera	O
from	O
small	O
animals	O
and	O
differentiated	O
the	O
linear	O
from	O
the	O
conformational	O
antibody	O
-	O
combining	O
sites	O
comprising	O
the	O
natural	O
epitopes	O
by	O
use	O
of	O
yeast	O
surface	O
display	O
.	O

Seven	O
of	O
these	O
mutations	O
were	O
recurrent	O
mutation	O
and	O
all	O
located	O
at	O
the	O
spike	O
,	O
membrane	B-ANAT
,	O
and	O
Orf	O
8a	O
protein	O
encoding	O
sequences	O
.	O

Pulse	O
labeling	O
with	O
32P	O
-	O
orthophosphate	O
indicated	O
that	O
the	O
IBV	O
N	O
protein	O
was	O
phosphorylated	O
in	O
the	O
virion	B-ANAT
,	O
as	O
well	O
as	O
at	O
all	O
times	O
during	O
infection	O
in	O
either	O
chicken	O
embryo	B-ANAT
kidney	B-ANAT
cells	B-ANAT
or	O
Vero	B-ANAT
cells	I-ANAT
.	O

Data	O
revealed	O
a	O
range	O
of	O
disease	O
conditions	O
from	O
mild	O
to	O
severe	O
with	O
heterogeneities	O
and	O
airway	B-ANAT
closures	O
.	O

Lumped	O
parameter	O
models	O
provided	O
additional	O
insight	O
on	O
heterogeneous	O
airway	B-ANAT
and	O
tissue	B-ANAT
disease	O
.	O

The	O
patients	O
in	O
each	O
group	O
were	O
equally	O
matched	O
in	O
terms	O
of	O
age	O
,	O
Pediatric	O
Risk	O
of	O
Mortality	O
,	O
and	O
number	O
with	O
dengue	O
hemorrhage	O
fever	O
grade	O
IV	O
,	O
although	O
the	O
platelet	B-ANAT
counts	O
were	O
higher	O
in	O
the	O
W	O
group	O
compared	O
with	O
the	O
P	O
group	O
(	O
geometric	O
mean	O
42	O
.	O
2	O
,	O
confidence	O
interval	O
36	O
.	O
9	O
,	O
48	O
.	O
4	O
vs	O
.	O
geometric	O
mean	O
36	O
.	O
7	O
,	O
confidence	O
interval	O
33	O
.	O
3	O
,	O
40	O
.	O
5	O
,	O
p	O
<	O
.	O
05	O
).	O

ACE2	O
is	O
a	O
type	O
I	O
transmembrane	B-ANAT
protein	O
,	O
with	O
an	O
extracellular	B-ANAT
N	O
-	O
terminal	O
domain	O
containing	O
the	O
active	O
site	O
and	O
a	O
short	O
intracellular	B-ANAT
C	O
-	O
terminal	O
tail	O
.	O

Ten	O
nurses	O
who	O
had	O
suffered	O
from	O
SARS	O
were	O
interviewed	O
,	O
either	O
face	B-ANAT
-	O
to	O
-	O
face	B-ANAT
or	O
by	O
telephone	O
,	O
about	O
their	O
subjective	O
experiences	O
.	O

ABSTRACT	O
:	O
Adaptation	O
to	O
air	O
breathing	O
at	O
birth	O
requires	O
the	O
precise	O
orchestration	O
of	O
cellular	B-ANAT
processes	O
to	O
initiate	O
fluid	O
clearance	O
,	O
enhance	O
pulmonary	B-ANAT
blood	B-ANAT
flow	O
,	O
and	O
to	O
synthesize	O
and	O
secrete	O
pulmonary	B-ANAT
surfactant	O
needed	O
to	O
reduce	O
surface	O
tension	O
at	O
the	O
air	O
-	O
liquid	O
interface	O
in	O
the	O
alveoli	B-ANAT
.	O

Expression	O
of	O
SP	O
-	O
B	O
,	O
-	O
C	O
,	O
and	O
ABCA3	O
are	O
coregulated	O
during	O
late	O
gestation	O
by	O
transcriptional	O
programs	O
influenced	O
by	O
thyroid	B-ANAT
transcription	O
factor	O
-	O
1	O
and	O
forkhead	O
box	O
a2	O
,	O
transcription	O
factors	O
that	O
regulate	O
both	O
differentiation	O
of	O
the	O
respiratory	B-ANAT
epithelium	I-ANAT
and	O
transcription	O
of	O
genes	O
required	O
for	O
perinatal	O
adaptation	O
to	O
air	O
breathing	O
.	O

TITLE	O
:	O
The	O
isolated	O
perfused	O
liver	B-ANAT
response	O
to	O
a	O
'	O
second	O
hit	O
'	O
of	O
portal	B-ANAT
endotoxin	O
during	O
severe	O
acute	O
pancreatitis	O
.	O

Neutrophil	B-ANAT
activation	O
by	O
the	O
perfusate	O
was	O
assayed	O
using	O
dihydrorhodamine	O
-	O
123	O
fluorescence	O
.	O

Two	O
outbreaks	O
,	O
West	O
Nile	O
virus	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
have	O
recently	O
provided	O
important	O
lessons	O
on	O
how	O
transplant	B-ANAT
patients	O
are	O
affected	O
,	O
and	O
how	O
transplant	B-ANAT
programmes	O
must	O
adapt	O
and	O
evolve	O
in	O
the	O
face	B-ANAT
of	O
emerging	O
infections	O
.	O

ABSTRACT	O
:	O
61	O
fecal	B-ANAT
samples	O
from	O
healthy	O
foxes	O
and	O
24	O
from	O
healthy	O
raccoon	O
dogs	O
were	O
examined	O
by	O
RT	O
-	O
nested	O
PCR	O
assays	O
for	O
the	O
presence	O
and	O
genotypic	O
identification	O
of	O
Canine	O
coronaviruses	O
(	O
CCVs	O
).	O

ABSTRACT	O
:	O
Pathological	O
characterization	O
of	O
autopsied	O
tissues	B-ANAT
from	O
patients	O
with	O
SARS	O
revealed	O
severe	O
damage	O
in	O
restricted	O
tissues	B-ANAT
,	O
such	O
as	O
lung	B-ANAT
,	O
with	O
no	O
apparent	O
cell	B-ANAT
damage	O
in	O
other	O
tissues	B-ANAT
,	O
such	O
as	O
intestine	B-ANAT
and	O
brain	B-ANAT
.	O

Here	O
,	O
we	O
examined	O
the	O
susceptibility	O
of	O
neural	B-ANAT
cell	I-ANAT
lines	O
of	O
human	O
(	O
OL	O
)	O
and	O
rat	O
(	O
C6	O
)	O
origins	O
to	O
SARS	O
-	O
associated	O
coronavirus	O
.	O

In	O
conclusion	O
,	O
the	O
pulmonary	B-ANAT
manifestation	O
of	O
HIV	O
-	O
related	O
multicentric	O
Castleman	O
'	O
s	O
disease	O
is	O
an	O
acute	O
reticulo	O
-	O
nodular	O
interstitial	B-ANAT
pneumonitis	O
,	O
associated	O
with	O
severe	O
systemic	O
symptoms	O
and	O
peripheral	O
lymphadenopathy	O
.	O

In	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
,	O
cellularity	O
is	O
not	O
specific	O
and	O
human	O
herpesvirus	O
-	O
8	O
DNA	O
is	O
detected	O
.	O

72	O
:	O
5912	O
-	O
5918	O
,	O
1998	O
),	O
RJHM	O
(	O
N514S	O
)	O
was	O
not	O
more	O
virulent	O
than	O
the	O
parental	O
,	O
RJHM	O
,	O
in	O
4	O
-	O
week	O
-	O
old	O
C57BL	O
/	O
6	O
(	O
H	O
-	O
2b	O
)	O
mice	O
after	O
intracranial	B-ANAT
injection	O
.	O

ABSTRACT	O
:	O
Recent	O
major	O
disease	O
outbreaks	O
,	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
foot	B-ANAT
-	O
and	O
-	O
mouth	B-ANAT
disease	O
in	O
the	O
UK	O
,	O
coupled	O
with	O
fears	O
of	O
emergence	O
of	O
human	O
-	O
to	O
-	O
human	O
transmissible	O
variants	O
of	O
avian	O
influenza	O
,	O
have	O
highlighted	O
the	O
importance	O
of	O
accurate	O
quantification	O
of	O
disease	O
threat	O
when	O
relatively	O
few	O
cases	O
have	O
occurred	O
.	O

Blood	B-ANAT
gases	O
were	O
measured	O
in	O
the	O
PP	O
and	O
supine	O
(	O
SP	O
)	O
positions	O
3	O
h	O
after	O
each	O
turn	O
,	O
for	O
36	O
h	O
,	O
yielding	O
six	O
measurement	O
sets	O
(	O
SP1	B-ANAT
,	O
PP1	O
,	O
SP2	B-ANAT
,	O
PP2	O
,	O
SP3	B-ANAT
,	O
and	O
PP3	O
).	O

The	O
tracheal	B-ANAT
aspirate	I-ANAT
volume	O
improved	O
significantly	O
from	O
SP1	B-ANAT
to	O
PP1	O
.	O

Hypocapnia	O
could	O
be	O
a	O
compensatory	O
mechanism	O
or	O
the	O
result	O
of	O
the	O
activation	O
of	O
central	O
respiratory	O
centres	O
by	O
non	O
-	O
depurated	O
substances	O
by	O
the	O
liver	B-ANAT
.	O

TITLE	O
:	O
Evaluation	O
of	O
inapparent	O
nosocomial	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
infection	O
in	O
Vietnam	O
by	O
use	O
of	O
highly	O
specific	O
recombinant	O
truncated	O
nucleocapsid	B-ANAT
protein	O
-	O
based	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

The	O
(	O
N	O
)	O
Delta	O
(	O
121	O
)	O
protein	O
-	O
based	O
ELISA	O
,	O
with	O
a	O
nonspecific	O
reaction	O
drastically	O
reduced	O
compared	O
to	O
that	O
of	O
the	O
nearly	O
-	O
whole	O
-	O
length	O
N	O
'	O
protein	O
-	O
based	O
ELISA	O
,	O
resulted	O
in	O
higher	O
rates	O
of	O
positive	O
reactions	O
,	O
higher	O
titers	O
,	O
and	O
earlier	O
detection	O
than	O
the	O
SARS	O
-	O
CoV	O
-	O
infected	O
cell	B-ANAT
lysate	O
-	O
based	O
ELISA	O
.	O

In	O
this	O
case	O
,	O
isolation	O
of	O
infected	O
nodes	B-ANAT
is	O
the	O
dominant	O
factor	O
in	O
determining	O
disease	O
epidemic	O
size	O
and	O
duration	O
.	O

When	O
only	O
the	O
lung	B-ANAT
was	O
perfused	O
,	O
endotoxin	O
caused	O
pulmonary	B-ANAT
hypertension	O
and	O
neutropenia	O
;	O
but	O
oxygenation	O
was	O
maintained	O
;	O
TNF	O
-	O
alpha	O
,	O
IL	O
-	O
6	O
,	O
and	O
8	O
-	O
isoprostane	O
levels	O
were	O
minimally	O
elevated	O
;	O
and	O
there	O
was	O
no	O
lung	B-ANAT
edema	O
.	O

When	O
both	O
the	O
liver	B-ANAT
and	O
lung	B-ANAT
were	O
perfused	O
,	O
endotoxin	O
caused	O
marked	O
hypoxemia	O
,	O
large	O
increases	O
in	O
perfusate	O
TNF	O
-	O
alpha	O
,	O
IL	O
-	O
6	O
,	O
and	O
8	O
-	O
isoprostane	O
concentrations	O
,	O
and	O
severe	O
lung	B-ANAT
edema	O
.	O

A	O
new	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
was	O
identified	O
as	O
the	O
SARS	O
pathogen	O
,	O
which	O
triggered	O
severe	O
pneumonia	O
and	O
acute	O
,	O
often	O
lethal	O
,	O
lung	B-ANAT
failure	O
.	O

Notably	O
,	O
injection	O
of	O
SARS	O
-	O
CoV	O
Spike	O
into	O
mice	O
worsens	O
acute	O
lung	B-ANAT
failure	O
in	O
vivo	O
that	O
can	O
be	O
attenuated	O
by	O
blocking	O
the	O
renin	O
-	O
angiotensin	O
pathway	O
.	O

Viral	O
cultures	O
for	O
coronavirus	O
and	O
examination	O
for	O
viral	B-ANAT
particles	I-ANAT
under	O
electron	O
microscopy	O
were	O
performed	O
in	O
2	O
patients	O
.	O

The	O
mean	O
absolute	O
neutrophil	B-ANAT
count	O
of	O
patients	O
was	O
398	O
.	O
2	O
+/-	O

TITLE	O
:	O
Microbiological	O
control	O
in	O
stem	B-ANAT
cell	I-ANAT
banks	O
:	O
approaches	O
to	O
standardisation	O
.	O

In	O
donors	O
,	O
the	O
presence	O
of	O
infectious	O
micro	O
-	O
organisms	O
,	O
like	O
human	O
immunodeficiency	O
virus	O
,	O
hepatitis	O
B	O
virus	O
,	O
hepatitis	O
C	O
virus	O
and	O
human	O
T	B-ANAT
cell	I-ANAT
lymphotrophic	O
virus	O
,	O
should	O
be	O
evaluated	O
in	O
addition	O
to	O
the	O
possibility	O
of	O
other	O
new	O
infectious	O
agents	O
(	O
e	O
.	O
g	O
.	O
transmissible	O
spongiform	O
encephalopathies	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
).	O

The	O
specificity	O
of	O
monoclonal	O
antibodies	O
were	O
tested	O
with	O
a	O
commercial	O
ELISA	O
kit	O
for	O
detecting	O
antibody	O
against	O
SARS	O
-	O
CoV	O
.	O
The	O
results	O
showed	O
that	O
two	O
peptides	O
with	O
molecular	O
weights	O
of	O
34kD	O
and	O
35kD	O
expressed	O
by	O
the	O
two	O
chimeric	O
genes	O
could	O
be	O
recognized	O
by	O
SARS	O
patient	O
convalescent	O
serum	B-ANAT
in	O
Western	O
blot	O
.	O

Six	O
positive	O
hybridoma	B-ANAT
cell	B-ANAT
lines	I-ANAT
stably	O
secreting	O
monoclonal	O
antibodies	O
were	O
selected	O
.	O

Most	O
strikingly	O
,	O
our	O
results	O
also	O
show	O
a	O
major	O
role	O
for	O
NKG2D	O
,	O
expressed	O
on	O
gammadelta	O
T	B-ANAT
cells	I-ANAT
,	O
in	O
the	O
demyelinating	O
process	O
with	O
in	O
vivo	O
blockade	O
of	O
NKG2D	O
interactions	O
resulting	O
in	O
a	O
60	O
%	O
reduction	O
in	O
demyelination	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
caused	O
by	O
a	O
novel	O
coronavirus	O
(	O
CoV	O
)	O
known	O
as	O
SARS	O
-	O
CoV	O
,	O
is	O
a	O
contagious	O
and	O
life	O
-	O
threatening	O
respiratory	O
illness	O
with	O
pneumocytes	B-ANAT
as	O
its	O
main	O
target	O
.	O

Progeny	O
virus	O
was	O
released	O
into	O
the	O
apical	O
chamber	B-ANAT
at	O
titers	O
up	O
to	O
5	O
logs	O
higher	O
than	O
those	O
recovered	O
from	O
the	O
basolateral	O
chambers	O
of	O
polarized	O
cultures	O
.	O

Moreover	O
,	O
the	O
buoyant	O
density	O
of	O
the	O
virion	B-ANAT
was	O
not	O
changed	O
when	O
MHV	O
was	O
produced	O
from	O
the	O
cholesterol	O
-	O
depleted	O
cells	B-ANAT
,	O
suggesting	O
that	O
MHV	O
does	O
not	O
incorporate	O
lipid	B-ANAT
rafts	I-ANAT
into	O
the	O
virion	B-ANAT
.	O

TITLE	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
3a	O
protein	O
up	O
-	O
regulates	O
expression	O
of	O
fibrinogen	B-ANAT
in	O
lung	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

Our	O
results	O
showed	O
that	O
the	O
expression	O
of	O
3a	O
up	O
-	O
regulates	O
the	O
mRNA	O
levels	O
of	O
all	O
three	O
subunits	O
,	O
Aalpha	O
,	O
Bbeta	O
,	O
and	O
gamma	O
,	O
of	O
fibrinogen	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
subjects	O
of	O
the	O
study	O
were	O
149	O
patients	O
with	O
severe	O
pyo	O
-	O
septic	O
complications	O
of	O
abdominal	B-ANAT
diseases	O
,	O
resulting	O
in	O
multiple	O
organ	B-ANAT
failure	O
syndrome	O
(	O
MOFS	O
)	O
with	O
clinical	O
and	O
laboratory	O
manifestations	O
.	O

Our	O
results	O
showed	O
that	O
all	O
of	O
the	O
immunized	O
animals	O
generated	O
humoral	O
immunity	O
against	O
the	O
SARS	O
-	O
CoV	O
spike	O
protein	O
,	O
and	O
the	O
sera	B-ANAT
of	O
immunized	O
rats	O
showed	O
strong	O
capable	O
of	O
protecting	O
from	O
SARS	O
-	O
CoV	O
infection	O
in	O
vitro	O
.	O

Thermal	O
aggregation	O
of	O
SARS	O
-	O
CoV	O
membrane	B-ANAT
protein	O
may	O
be	O
one	O
of	O
the	O
reasons	O
for	O
the	O
inactivation	O
of	O
this	O
virus	O
by	O
heat	O
.	O

During	O
the	O
first	O
10	O
days	O
after	O
onset	O
,	O
anti	O
-	O
SARS	O
-	O
CoV	O
IgG	O
,	O
SARS	O
-	O
CoV	O
RNA	O
and	O
the	O
N	O
protein	O
were	O
detected	O
in	O
21	O
.	O
4	O
,	O
42	O
.	O
9	O
,	O
and	O
90	O
%	O
of	O
the	O
patients	O
'	O
sera	B-ANAT
,	O
respectively	O
.	O

ABSTRACT	O
:	O
Two	O
genotype	O
-	O
specific	O
fluorogenic	O
RT	O
-	O
PCR	O
assays	O
were	O
developed	O
for	O
the	O
detection	O
and	O
quantitation	O
of	O
canine	O
coronavirus	O
(	O
CCoV	O
)	O
type	O
I	O
and	O
type	O
II	O
RNA	O
in	O
the	O
faeces	B-ANAT
of	O
dogs	O
with	O
diarrhoea	O
.	O

TITLE	O
:	O
Cytarabine	O
-	O
induced	O
lung	B-ANAT
injury	O
:	O
case	O
report	O
.	O

Autoantibodies	O
against	O
cell	B-ANAT
nuclei	I-ANAT
(	O
ANA	O
),	O
autoantibodies	O
against	O
smooth	B-ANAT
muscles	I-ANAT
(	O
SMA	O
),	O
autoantibodies	O
against	O
parietal	O
cells	B-ANAT
(	O
PCA	B-ANAT
),	O
autoantibodies	O
against	O
heart	B-ANAT
cells	B-ANAT
(	O
HRA	O
)	O
were	O
detected	O
by	O
using	O
immunofluorescence	O
,	O
and	O
autoantibodies	O
against	O
live	O
-	O
kidney	B-ANAT
microsomes	B-ANAT
(	O
LKM	O
)	O
and	O
anti	O
-	O
M2	O
antibodies	O
were	O
detected	O
by	O
ELISA	O
in	O
sera	B-ANAT
taken	O
from	O
27	O
SARS	O
patients	O
and	O
18	O
healthy	O
controls	O
.	O

CONCLUSIONS	O
:	O
No	O
antibodies	O
against	O
organs	B-ANAT
but	O
lung	B-ANAT
were	O
found	O
in	O
SARS	O
patients	O
.	O

RESULTS	O
:	O
The	O
positive	O
rate	O
of	O
patient	O
serum	B-ANAT
and	O
mouthwash	O
was	O
33	O
.	O
6	O
%,	O
(	O
12	O
/	O
36	O
)	O
and	O
67	O
.	O
5	O
%,	O
(	O
27	O
/	O
40	O
),	O
respectively	O
,	O
while	O
the	O
positive	O
rate	O
of	O
healthy	O
people	O
was	O
zero	O
(	O
0	O
/	O
160	O
).	O

The	O
purpose	O
of	O
the	O
study	O
was	O
to	O
evaluate	O
the	O
use	O
of	O
chest	B-ANAT
radiography	O
for	O
the	O
screening	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

In	O
this	O
study	O
,	O
the	O
development	O
of	O
autoantibodies	O
against	O
human	O
epithelial	B-ANAT
cells	I-ANAT
and	O
endothelial	B-ANAT
cells	I-ANAT
in	O
patients	O
with	O
SARS	O
at	O
different	O
time	O
periods	O
(	O
the	O
first	O
week	O
:	O
phase	O
I	O
,	O
1	O
month	O
after	O
the	O
disease	O
onset	O
:	O
phase	O
II	O
/	O
phase	O
III	O
)	O
were	O
investigated	O
.	O

It	O
is	O
concluded	O
that	O
some	O
autoantibodies	O
against	O
human	O
epithelial	B-ANAT
cells	I-ANAT
and	O
endothelial	B-ANAT
cells	I-ANAT
would	O
be	O
developed	O
after	O
SARS	O
-	O
CoV	O
infection	O
and	O
this	O
phenomenon	O
may	O
indicate	O
post	O
-	O
infectious	O
cellular	B-ANAT
injury	O
and	O
also	O
induce	O
SARS	O
-	O
induced	O
immunopathology	O
.	O

TITLE	O
:	O
Phosphorylation	O
and	O
subcellular	O
localization	O
of	O
transmissible	O
gastroenteritis	O
virus	O
nucleocapsid	B-ANAT
protein	O
in	O
infected	O
cells	B-ANAT
.	O

Green	O
fluorescent	O
protein	O
expression	O
was	O
demonstrated	O
as	O
early	O
as	O
7	O
h	O
after	O
infection	O
of	O
Vero	O
E6	O
cells	B-ANAT
with	O
VSV	O
-	O
SARS	O
-	O
St19	B-ANAT
.	O

Lesions	O
typical	O
of	O
a	O
mixed	O
form	O
(	O
effusive	O
and	O
non	O
-	O
effusive	O
)	O
of	O
FIP	O
were	O
observed	O
and	O
by	O
RT	O
-	O
PCR	O
a	O
feline	O
coronavirus	O
(	O
FCoV	O
)	O
type	O
I	O
strain	O
was	O
detected	O
in	O
several	O
tissues	B-ANAT
.	O

Nucleic	B-ANAT
acid	O
of	O
SARS	O
-	O
CoV	O
can	O
be	O
excreted	O
through	O
the	O
stool	B-ANAT
of	O
patients	O
into	O
sewage	O
system	O
,	O
and	O
the	O
possibility	O
of	O
SARS	O
-	O
CoV	O
transmitting	O
through	O
digestive	B-ANAT
system	I-ANAT
cannot	O
be	O
excluded	O
.	O

The	O
RNA	O
could	O
not	O
be	O
detected	O
in	O
urine	B-ANAT
and	O
stool	B-ANAT
samples	O
from	O
patients	O
recovered	O
from	O
SARS	O
.	O

SARS	O
patients	O
with	O
normal	O
initial	O
chest	B-ANAT
radiographs	O
are	O
not	O
uncommon	O
and	O
abnormal	O
radiographic	O
findings	O
may	O
appear	O
to	O
be	O
late	O
after	O
onset	O
of	O
fever	O
.	O

TITLE	O
:	O
Retinal	B-ANAT
degeneration	O
in	O
experimental	O
coronavirus	O
retinopathy	O
(	O
ECOR	O
)	O
is	O
associated	O
with	O
increased	O
TNF	O
-	O
alpha	O
,	O
soluble	O
TNFR2	O
and	O
altered	O
TNF	O
-	O
alpha	O
signaling	O
.	O

DNA	O
sequencing	O
revealed	O
nucleic	B-ANAT
acid	O
and	O
predicted	O
amino	O
acid	O
sequences	O
that	O
were	O
99	O
%	O
aligned	O
with	O
the	O
one	O
published	O
sequence	O
for	O
chicken	O
H	O
-	O
PGDS	O
of	O
the	O
spleen	B-ANAT
.	O

In	O
this	O
study	O
,	O
it	O
was	O
shown	O
that	O
3b	O
protein	O
was	O
predominately	O
localized	O
to	O
nucleus	B-ANAT
with	O
EGFP	O
tag	O
at	O
its	O
N	O
-	O
or	O
C	O
-	O
terminus	O
.	O

The	O
localization	O
patterns	O
were	O
similar	O
in	O
different	O
transfected	O
cells	B-ANAT
.	O

C23	O
,	O
B23	O
and	O
fibrillarin	O
all	O
are	O
important	O
nucleolar	B-ANAT
proteins	O
,	O
which	O
localize	O
in	O
the	O
region	O
of	O
the	O
nucleolus	B-ANAT
.	O

Post	O
-	O
operatively	O
,	O
mediastinopleural	O
irrigation	O
with	O
saline	O
was	O
performed	O
once	O
or	O
twice	O
a	O
day	O
until	O
a	O
culture	O
of	O
pleural	B-ANAT
effusion	I-ANAT
became	O
negative	O
.	O

Five	O
patients	O
suffered	O
from	O
severe	O
complications	O
including	O
septic	O
shock	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
disseminated	O
intravascular	O
coagulation	O
,	O
and	O
pan	B-ANAT
-	O
peritonitis	O
due	O
to	O
duodenal	B-ANAT
perforation	O
.	O

RESULTS	O
:	O
The	O
mean	O
duration	O
of	O
chest	B-ANAT
tube	O
retention	O
was	O
26	O
.	O
7	O
+/-	O
17	O
.	O
0	O
days	O
,	O
and	O
the	O
mean	O
hospital	O
stay	O
was	O
62	O
.	O
3	O
+/-	O
33	O
.	O
9	O
days	O
.	O

ABSTRACT	O
:	O
One	O
of	O
the	O
hallmark	O
findings	O
in	O
patients	O
suffering	O
from	O
SARS	O
(	O
severe	O
acute	O
respiratory	O
syndrome	O
)	O
is	O
lymphopenia	O
,	O
which	O
is	O
the	O
result	O
of	O
massive	O
lymphocyte	B-ANAT
death	O
.	O

A	O
skin	B-ANAT
biopsy	O
was	O
performed	O
and	O
immunohistochemical	O
examination	O
identified	O
a	O
type	O
-	O
2	O
HSV	O
infection	O
.	O

At	O
autopsy	O
,	O
a	O
severe	O
interstitial	B-ANAT
type	O
-	O
2	O
HSV	O
pneumonitis	O
with	O
extensive	O
necrotic	O
areas	O
was	O
found	O
,	O
in	O
association	O
with	O
gastro	B-ANAT
-	O
intestinal	B-ANAT
involvement	O
.	O

Two	O
groups	O
of	O
C	O
.	O
jacchus	O
were	O
inoculated	O
intratracheally	O
with	O
cell	B-ANAT
culture	O
supernatant	O
containing	O
SARS	O
-	O
CoV	O
.	O
In	O
a	O
time	O
course	O
pathogenesis	O
study	O
,	O
animals	O
were	O
evaluated	O
at	O
2	O
,	O
4	O
,	O
and	O
7	O
days	O
after	O
infection	O
for	O
morphological	O
changes	O
and	O
evidence	O
of	O
viral	O
replication	O
.	O

Hepatic	B-ANAT
inflammation	O
was	O
observed	O
in	O
most	O
animals	O
,	O
predominantly	O
as	O
a	O
multifocal	O
lymphocytic	O
hepatitis	O
accompanied	O
by	O
necrosis	O
of	O
individual	O
hepatocytes	B-ANAT
.	O

Chest	B-ANAT
radiographs	O
with	O
infective	O
changes	O
increased	O
significantly	O
(	O
p	O
-	O
value	O
equals	O
0	O
.	O
009	O
)	O
from	O
16	O
percent	O
to	O
52	O
.	O
4	O
percent	O
over	O
the	O
two	O
ED	O
visits	O
.	O

Emerging	O
agents	O
are	O
threats	O
not	O
only	O
to	O
the	O
general	O
population	O
,	O
but	O
also	O
to	O
recipients	O
of	O
blood	B-ANAT
transfusions	O
.	O

In	O
this	O
study	O
,	O
infection	O
kinetics	O
(	O
titres	O
and	O
antigen	O
expression	O
)	O
of	O
FIPV	O
79	O
-	O
1146	O
,	O
and	O
FECV	O
79	O
-	O
1683	O
,	O
were	O
determined	O
in	O
peripheral	B-ANAT
blood	I-ANAT
monocytes	B-ANAT
from	O
3	O
donor	O
cats	O
and	O
compared	O
to	O
those	O
in	O
Crandell	O
feline	O
kidney	B-ANAT
(	O
CrFK	O
)	O
cells	B-ANAT
.	O

The	O
rest	O
could	O
be	O
infected	O
with	O
FECV	O
and	O
FIPV	O
but	O
10	O
/	O
22	O
cats	O
had	O
monocytes	B-ANAT
that	O
only	O
sustained	O
FIPV	O
infection	O
and	O
9	O
/	O
22	O
sustained	O
neither	O
FIPV	O
nor	O
FECV	O
infection	O
.	O

Late	O
pulmonary	B-ANAT
hypertension	O
(	O
weeks	O
to	O
months	O
after	O
birth	O
)	O
is	O
increasingly	O
recognized	O
in	O
this	O
population	O
,	O
and	O
chronic	O
pulmonary	B-ANAT
vascular	B-ANAT
abnormalities	O
(	O
months	O
to	O
years	O
after	O
birth	O
)	O
are	O
now	O
being	O
discovered	O
.	O

Different	O
pathophysiological	O
mechanisms	O
of	O
severe	O
acute	O
pancreatitis	O
-	O
associated	O
lung	B-ANAT
injury	O
have	O
been	O
described	O
.	O

Prior	O
to	O
abdominal	B-ANAT
closure	O
,	O
he	O
developed	O
copious	O
pulmonary	B-ANAT
secretions	B-ANAT
,	O
hypoxemia	O
,	O
and	O
hypotension	O
.	O

Extensive	O
noncardiogenic	O
pulmonary	B-ANAT
edema	O
.	O

ACE2	O
is	O
a	O
type	O
I	O
integral	O
membrane	B-ANAT
protein	O
with	O
its	O
active	O
site	O
domain	O
exposed	O
to	O
the	O
extracellular	B-ANAT
surface	O
of	O
endothelial	B-ANAT
cells	I-ANAT
and	O
the	O
renal	B-ANAT
tubular	O
epithelium	B-ANAT
.	O

The	O
skin	B-ANAT
lesions	O
were	O
caused	O
by	O
a	O
pyogranulomatous	O
-	O
necrotising	O
dermal	O
phlebitis	O
and	O
periphlebitis	O
.	O

ABSTRACT	O
:	O
The	O
-	O
1	O
ribosomal	B-ANAT
frameshifting	O
requires	O
the	O
existence	O
of	O
an	O
in	O
cis	O
RNA	O
slippery	O
sequence	O
and	O
is	O
promoted	O
by	O
a	O
downstream	O
stimulator	O
RNA	O
.	O

Here	O
,	O
we	O
have	O
applied	O
serine	O
-	O
scanning	O
mutagenesis	O
to	O
the	O
C	O
-	O
terminal	O
-	O
most	O
heptad	O
-	O
repeat	O
region	O
in	O
the	O
SARS	O
-	O
CoV	O
S	O
glycoprotein	O
to	O
investigate	O
the	O
functional	O
role	O
of	O
this	O
region	O
in	O
membrane	B-ANAT
fusion	O
.	O

In	O
addition	O
,	O
SARS	O
-	O
CoV	O
infection	O
was	O
blocked	O
by	O
specific	O
inhibitors	O
of	O
the	O
pH	O
-	O
sensitive	O
endosomal	O
protease	O
cathepsin	O
L	O
.	O
A	O
cell	B-ANAT
-	O
free	O
membrane	B-ANAT
-	O
fusion	O
system	O
demonstrates	O
that	O
engagement	O
of	O
receptor	O
followed	O
by	O
proteolysis	O
is	O
required	O
for	O
SARS	O
-	O
CoV	O
membrane	B-ANAT
fusion	O
and	O
indicates	O
that	O
cathepsin	O
L	O
is	O
sufficient	O
to	O
activate	O
membrane	B-ANAT
fusion	O
by	O
SARS	O
-	O
CoV	O
S	O
.	O
These	O
results	O
suggest	O
that	O
SARS	O
-	O
CoV	O
infection	O
results	O
from	O
a	O
unique	O
,	O
three	O
-	O
step	O
process	O
:	O
receptor	O
binding	O
and	O
induced	O
conformational	O
changes	O
in	O
S	O
glycoprotein	O
followed	O
by	O
cathepsin	O
L	O
proteolysis	O
within	O
endosomes	O
.	O

TITLE	O
:	O
Identification	O
of	O
immunodominant	O
epitopes	O
on	O
the	O
membrane	B-ANAT
protein	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
.	O

ARDS	O
is	O
defined	O
by	O
(	O
1	O
)	O
acute	O
onset	O
,	O
(	O
2	O
)	O
bilateral	O
infiltrates	O
in	O
chest	B-ANAT
x	O
-	O
rays	O
,	O
(	O
3	O
)	O
absence	O
of	O
left	O
ventricular	B-ANAT
failure	O
,	O
and	O
(	O
4	O
)	O
severe	O
arterial	B-ANAT
hypoxemia	O
with	O
a	O
PaO2	O
/	O
FiO2	O
ratio	O
less	O
than	O
200	O
mmHg	O
.	O

rNH	O
and	O
rEH	O
proteins	O
differed	O
markedly	O
with	O
respect	O
to	O
expression	O
levels	O
,	O
cell	B-ANAT
death	O
kinetics	O
and	O
subcellular	O
localizations	O
that	O
led	O
to	O
different	O
extraction	O
and	O
purification	O
schemes	O
.	O

Virus	O
replication	O
is	O
not	O
necessary	O
for	O
IFN	O
induction	O
since	O
efficient	O
IFN	O
expression	O
could	O
be	O
obtained	O
also	O
by	O
the	O
cocultivation	O
of	O
normal	O
PBMC	O
with	O
fixed	B-ANAT
SARS	O
-	O
CoV	O
-	O
infected	O
cells	B-ANAT
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
effect	O
of	O
a	O
neutrophil	B-ANAT
elastase	O
inhibitor	O
,	O
sivelestat	O
,	O
on	O
lipopolysaccharide	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
through	O
analysis	O
of	O
hemodynamic	O
changes	O
in	O
the	O
pulmonary	B-ANAT
microcirculation	O
.	O

Twenty	O
-	O
seven	O
Wistar	O
rats	O
(	O
15	O
rats	O
for	O
microspectroscopic	O
observations	O
,	O
12	O
rats	O
for	O
measurements	O
of	O
neutrophil	B-ANAT
elastase	O
activity	O
and	O
wet	O
-	O
to	O
-	O
dry	O
ratio	O
).	O

TITLE	O
:	O
Transfusions	O
result	O
in	O
pulmonary	B-ANAT
morbidity	O
and	O
death	O
after	O
a	O
moderate	O
degree	O
of	O
injury	O
.	O

However	O
,	O
these	O
studies	O
are	O
difficult	O
to	O
interpret	O
because	O
of	O
small	O
sample	O
size	O
,	O
inclusion	O
of	O
severely	O
injured	O
patients	O
in	O
traumatic	O
shock	O
,	O
and	O
combination	O
of	O
a	O
variety	O
of	O
unrelated	O
low	O
-	O
morbidity	O
/	O
mortality	O
infections	O
,	O
such	O
as	O
wound	O
,	O
catheter	O
-	O
related	O
,	O
and	O
urinary	B-ANAT
tract	I-ANAT
infection	O
as	O
outcomes	O
.	O

VAP	O
required	O
quantitative	O
bronchoalveolar	O
lavage	O
culture	O
(>	O
or	O
=	O
10	O
(	O
5	O
)	O
colonies	O
/	O
mL	O
),	O
and	O
ARDS	O
required	O
Pao2	O
/	O
Fio2	O
ratio	O
<	O
200	O
mm	O
Hg	O
,	O
***	O
no	O
congestive	O
heart	B-ANAT
failure	O
,	O
diffuse	O
bilateral	O
infiltrates	O
,	O
and	O
peak	O
airway	B-ANAT
pressure	O
>	O
50	O
cm	O
H2O	O
for	O
diagnosis	O
.	O

This	O
genetic	O
analysis	O
reveals	O
that	O
the	O
SARS	O
-	O
CoV	O
S	O
glycoprotein	O
contains	O
extracellular	B-ANAT
domains	O
that	O
regulate	O
cell	B-ANAT
fusion	O
as	O
well	O
as	O
distinct	O
endodomains	O
that	O
function	O
in	O
intracellular	B-ANAT
transport	O
,	O
cell	B-ANAT
-	O
surface	O
expression	O
,	O
and	O
cell	B-ANAT
fusion	O
.	O

The	O
animal	O
inoculated	O
with	O
ReoV	O
developed	O
diffuse	O
alveolar	B-ANAT
damage	O
similar	O
to	O
the	O
exudative	O
and	O
leakage	O
inflammation	O
found	O
in	O
SARS	O
patients	O
,	O
and	O
was	O
characterized	O
by	O
diffuse	O
hemorrhage	O
,	O
fibroid	O
exudation	O
,	O
hyaline	B-ANAT
membrane	B-ANAT
formation	O
,	O
and	O
type	B-ANAT
II	I-ANAT
pneumocytes	I-ANAT
hyperplasia	O
in	O
alveolar	B-ANAT
interstitia	O
.	O

To	O
examine	O
potential	O
apoptotic	O
mechanisms	O
related	O
to	O
SARS	O
,	O
we	O
investigated	O
features	O
of	O
apoptosis	O
induced	O
by	O
the	O
SARS	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
in	O
host	O
cells	B-ANAT
.	O

The	O
serum	B-ANAT
IgG	O
level	O
of	O
the	O
vaccine	O
group	O
mice	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
corresponding	O
control	O
group	O
at	O
day	O
14	O
after	O
vaccination	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

TITLE	O
:	O
Profiles	O
of	O
IgG	O
antibodies	O
to	O
nucleocapsid	B-ANAT
and	O
spike	O
proteins	O
of	O
the	O
SARS	O
-	O
associated	O
coronavirus	O
in	O
SARS	O
patients	O
.	O

Mixing	O
SARS	O
-	O
CoV	O
with	O
APC	B-ANAT
in	O
the	O
absence	O
of	O
any	O
treatment	O
decreased	O
viral	O
infectivity	O
by	O
approximately	O
0	O
.	O
5	O
-	O
1	O
log10	O
.	O

After	O
IA	O
or	O
I	O
/	O
R	O
,	O
experimental	O
and	O
control	O
(	O
nonischemic	O
)	O
contralateral	O
hind	O
limbs	B-ANAT
were	O
harvested	O
for	O
analysis	O
of	O
protein	O
content	O
,	O
messenger	O
RNA	O
(	O
mRNA	O
),	O
tissue	B-ANAT
edema	O
,	O
and	O
viability	O
.	O

Within	O
the	O
time	O
periods	O
studied	O
in	O
these	O
experiments	O
,	O
the	O
chemokine	O
component	O
of	O
the	O
inflammatory	O
response	O
remained	O
in	O
the	O
reperfused	O
,	O
rather	O
than	O
the	O
systemic	O
nonreperfused	O
,	O
tissue	B-ANAT
.	O

Despite	O
this	O
shortcoming	O
,	O
these	O
data	O
provide	O
potential	O
temporal	O
and	O
quantitative	O
information	O
regarding	O
the	O
location	O
and	O
magnitude	O
of	O
chemokine	O
synthesis	O
in	O
skeletal	B-ANAT
muscle	I-ANAT
during	O
reperfusion	O
.	O

Tissue	B-ANAT
viability	O
decreased	O
52	O
%	O
after	O
4	O
hours	O
of	O
reperfusion	O
and	O
did	O
not	O
change	O
significantly	O
by	O
24	O
hours	O
.	O

ABSTRACT	O
:	O
Numerous	O
emerging	O
respiratory	B-ANAT
tract	I-ANAT
viruses	O
have	O
been	O
identified	O
as	O
significant	O
causes	O
of	O
acute	O
upper	O
and	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
illness	O
in	O
children	O
.	O

Several	O
zoonotic	O
paramyxoviruses	O
,	O
including	O
Nipah	O
and	O
Hendra	O
viruses	O
,	O
have	O
emerged	O
as	O
occasional	O
causes	O
of	O
sever	O
outbreaks	O
of	O
respiratory	B-ANAT
tract	I-ANAT
illness	O
in	O
children	O
and	O
adults	O
.	O

The	O
phosphoprotein	O
is	O
stable	O
and	O
localizes	O
in	O
the	O
cytoplasm	B-ANAT
and	O
coprecipitates	O
with	O
the	O
membrane	B-ANAT
fraction	I-ANAT
.	O

TITLE	O
:	O
Intracellular	B-ANAT
localization	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
nucleocapsid	B-ANAT
protein	O
:	O
absence	O
of	O
nucleolar	B-ANAT
accumulation	O
during	O
infection	O
and	O
after	O
expression	O
as	O
a	O
recombinant	O
protein	O
in	O
vero	B-ANAT
cells	I-ANAT
.	O

However	O
,	O
confocal	O
microscopy	O
of	O
N	O
protein	O
localization	O
in	O
Vero	B-ANAT
cells	I-ANAT
infected	O
with	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
or	O
transfected	O
with	O
the	O
SARS	O
-	O
CoV	O
N	O
gene	O
failed	O
to	O
show	O
the	O
presence	O
of	O
N	O
in	O
the	O
nucleoplasm	B-ANAT
or	O
nucleolus	B-ANAT
.	O

Nine	O
hundred	O
forty	O
-	O
nine	O
samples	O
of	O
nasopharyngeal	B-ANAT
secretions	B-ANAT
from	O
children	O
under	O
3	O
y	O
of	O
age	O
with	O
LRTIs	O
were	O
analysed	O
by	O
a	O
quantitative	O
HCoV	O
-	O
NL63	O
-	O
specific	O
real	O
-	O
time	O
PCR	O
.	O

The	O
use	O
of	O
a	O
shell	B-ANAT
vial	O
assay	O
and	O
PCR	O
identified	O
a	O
pathogen	O
in	O
103	O
(	O
39	O
%)	O
of	O
the	O
patients	O
,	O
including	O
influenza	O
A	O
or	O
B	O
in	O
54	O
,	O
picornavirus	O
in	O
28	O
(	O
including	O
rhinovirus	O
in	O
24	O
),	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
)	O
in	O
12	O
,	O
human	O
metapneumovirus	O
in	O
4	O
,	O
human	O
coronavirus	O
OC43	O
in	O
2	O
,	O
adenovirus	O
in	O
2	O
,	O
parainfluenza	O
virus	O
type	O
1	O
in	O
1	O
,	O
and	O
coinfection	O
with	O
influenza	O
and	O
parainfluenza	O
virus	O
type	O
1	O
in	O
2	O
.	O

The	O
use	O
of	O
a	O
shell	B-ANAT
vial	O
assay	O
and	O
PCR	O
identified	O
a	O
pathogen	O
in	O
103	O
(	O
39	O
%)	O
of	O
the	O
patients	O
,	O
including	O
influenza	O
A	O
or	O
B	O
in	O
54	O
,	O
picornavirus	O
in	O
28	O
(	O
including	O
rhinovirus	O
in	O
24	O
),	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
)	O
in	O
12	O
,	O
human	O
metapneumovirus	O
in	O
4	O
,	O
human	O
coronavirus	O
OC43	O
in	O
2	O
,	O
adenovirus	O
in	O
2	O
,	O
parainfluenza	O
virus	O
type	O
1	O
in	O
1	O
,	O
and	O
coinfection	O
with	O
influenza	O
and	O
parainfluenza	O
virus	O
type	O
1	O
in	O
2	O
.	O

The	O
results	O
showed	O
that	O
,	O
all	O
five	O
species	O
of	O
small	O
animals	O
chosed	O
were	O
not	O
susceptible	O
to	O
SARS	O
-	O
CoV	O
,	O
no	O
characterized	O
changes	O
in	O
clinical	O
sign	O
and	O
histopathology	O
were	O
observed	O
after	O
infection	O
,	O
but	O
from	O
the	O
lung	B-ANAT
samples	O
of	O
large	O
rat	O
and	O
pig	O
guinea	O
,	O
the	O
genomic	O
RNA	O
of	O
SARS	O
-	O
CoV	O
could	O
be	O
detected	O
by	O
RT	O
-	O
PCR	O
at	O
day	O
14	O
post	O
infection	O
,	O
this	O
suggested	O
that	O
SARS	O
-	O
CoV	O
could	O
replicate	O
in	O
these	O
animals	O
.	O

TITLE	O
:	O
Inflammatory	O
response	O
on	O
the	O
pancreatic	B-ANAT
acinar	I-ANAT
cell	I-ANAT
injury	O
.	O

Median	O
IgG	O
levels	O
in	O
convalescent	O
-	O
phase	O
sera	B-ANAT
(	O
collected	O
within	O
30	O
days	O
)	O
were	O
compared	O
among	O
patients	O
with	O
different	O
disease	O
severities	O
.	O

Higher	O
IgG	O
levels	O
were	O
detected	O
in	O
patients	O
who	O
required	O
supplemental	O
oxygen	O
(	O
Mann	O
-	O
Whitney	O
;	O
p	O
=	O
0	O
.	O
002	O
),	O
ICU	O
-	O
admission	O
(	O
p	O
=	O
0	O
.	O
001	O
),	O
had	O
negative	O
pre	O
-	O
discharge	B-ANAT
fecal	B-ANAT
RT	O
-	O
PCR	O
results	O
(	O
p	O
=	O
0	O
.	O
004	O
),	O
and	O
lymphopenia	O
at	O
presentation	O
(	O
p	O
=	O
0	O
.	O
028	O
).	O

In	O
this	O
study	O
,	O
we	O
raised	O
monoclonal	O
antibodies	O
(	O
mAbs	O
)	O
against	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
of	O
SARS	O
-	O
CoV	O
and	O
mapped	O
epitopes	O
by	O
using	O
different	O
truncated	O
N	O
protein	O
fragments	O
.	O

Chloroquine	O
is	O
effective	O
in	O
preventing	O
the	O
spread	O
of	O
SARS	O
CoV	O
in	O
cell	B-ANAT
culture	O
.	O

Sinigrin	O
(	O
IC50	O
:	O
217	O
microM	O
)	O
was	O
more	O
efficient	O
in	O
blocking	O
the	O
cleavage	O
processing	O
of	O
the	O
3CLpro	O
than	O
indigo	O
(	O
IC50	O
:	O
752	O
microM	O
)	O
and	O
beta	O
-	O
sitosterol	O
(	O
IC50	O
:	O
1210	O
microM	O
)	O
in	O
the	O
cell	B-ANAT
-	O
based	O
assay	O
.	O

The	O
denatured	O
inclusion	B-ANAT
bodies	I-ANAT
were	O
purified	O
with	O
Ni	O
-	O
NTA	O
chelate	O
agarose	O
and	O
its	O
purity	O
can	O
reach	O
90	O
%.	O

TITLE	O
:	O
A	O
serological	O
survey	O
on	O
neutralizing	O
antibody	O
titer	O
of	O
SARS	O
convalescent	O
sera	B-ANAT
.	O

Eighty	O
-	O
seven	O
serum	B-ANAT
samples	O
were	O
confirmed	O
to	O
be	O
positive	O
for	O
SARS	O
antibodies	O
.	O

The	O
sensitivity	O
of	O
this	O
assay	O
was	O
evaluated	O
using	O
cell	B-ANAT
culture	O
-	O
derived	O
viruses	O
,	O
in	O
vitro	O
transcribed	O
viral	O
RNA	O
,	O
and	O
clinical	O
specimens	O
.	O

In	O
addition	O
,	O
SARS	O
-	O
S	O
and	O
SARS	O
-	O
M	O
also	O
demonstrated	O
equivalent	O
sensitivity	O
to	O
the	O
commercially	O
available	O
RealArt	O
HPA	B-ANAT
-	O
Coronavirus	O
reagents	O
(	O
Artus	O
).	O

The	O
relative	O
sensitivity	O
of	O
these	O
primer	O
/	O
probe	O
sets	O
was	O
also	O
examined	O
using	O
human	O
sera	B-ANAT
spiked	O
viruses	O
and	O
clinical	O
specimens	O
from	O
four	O
confirmed	O
SARS	O
patients	O
.	O

ABSTRACT	O
:	O
The	O
entry	O
of	O
the	O
SARS	O
coronavirus	O
(	O
SCV	O
)	O
into	O
cells	B-ANAT
is	O
initiated	O
by	O
binding	O
of	O
its	O
spike	O
envelope	B-ANAT
glycoprotein	O
(	O
S	O
)	O
to	O
a	O
receptor	O
,	O
ACE2	O
.	O

TITLE	O
:	O
Gene	O
expression	O
profiles	O
in	O
peripheral	B-ANAT
blood	I-ANAT
mononuclear	I-ANAT
cells	I-ANAT
of	O
SARS	O
patients	O
.	O

Different	O
host	O
receptors	O
for	O
cellular	B-ANAT
entry	O
,	O
poorly	O
conserved	O
structural	O
proteins	O
(	O
antigens	O
),	O
and	O
the	O
high	O
mutation	O
and	O
recombination	O
rates	O
of	O
CoVs	O
pose	O
a	O
significant	O
problem	O
in	O
the	O
development	O
of	O
wide	O
-	O
spectrum	O
anti	O
-	O
CoV	O
drugs	O
and	O
vaccines	O
.	O

While	O
similar	O
effects	O
were	O
obtained	O
on	O
fibroblasts	B-ANAT
,	O
concentrations	O
of	O
IFN	O
-	O
gamma	O
4	O
--	O
8	O
-	O
fold	O
greater	O
were	O
required	O
.	O

Based	O
on	O
the	O
clinical	O
data	O
collected	O
previously	O
,	O
the	O
available	O
literature	O
and	O
our	O
in	O
vitro	O
experimentation	O
,	O
we	O
propose	O
that	O
IFN	O
-	O
gamma	O
may	O
be	O
responsible	O
for	O
acute	O
lung	B-ANAT
injury	O
in	O
the	O
late	O
phase	O
of	O
the	O
SARS	O
pathology	O
.	O

The	O
incidence	O
of	O
IAH	O
(	O
defined	O
as	O
intra	O
-	O
abdominal	B-ANAT
pressure	O
>	O
or	O
=	O
15	O
mmHg	O
)	O
was	O
recorded	O
.	O

IAH	O
is	O
a	O
frequent	O
finding	O
in	O
patients	O
admitted	O
to	O
the	O
ICU	O
because	O
of	O
SAP	O
,	O
and	O
is	O
associated	O
with	O
a	O
high	O
occurrence	O
rate	O
of	O
organ	B-ANAT
dysfunction	O
.	O

We	O
and	O
others	O
previously	O
demonstrated	O
that	O
a	O
major	O
mechanism	O
for	O
neutralizing	O
SARS	O
-	O
CoV	O
was	O
through	O
blocking	O
the	O
interaction	O
between	O
the	O
S	O
glycoprotein	O
and	O
the	O
cellular	B-ANAT
receptor	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
).	O

ABSTRACT	O
:	O
The	O
primary	O
modes	O
of	O
transmission	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
appear	O
to	O
be	O
direct	O
mucus	B-ANAT
membrane	B-ANAT
contact	O
with	O
infectious	O
droplets	O
and	O
through	O
exposure	O
to	O
formites	O
.	O

SARS	O
-	O
CoV	O
GVU6109	O
can	O
survive	O
for	O
4	O
days	O
in	O
diarrheal	O
stool	B-ANAT
samples	O
with	O
an	O
alkaline	O
pH	O
,	O
and	O
it	O
can	O
remain	O
infectious	O
in	O
respiratory	O
specimens	O
for	O
>	O
7	O
days	O
at	O
room	O
temperature	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
possible	O
regulatory	O
interaction	O
between	O
the	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
and	O
NF	O
-	O
kappaB	O
by	O
luciferase	O
activity	O
assay	O
.	O

The	O
majority	O
of	O
outpatients	O
(	O
86	O
%)	O
had	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
,	O
while	O
the	O
majority	O
of	O
inpatients	O
(	O
58	O
%)	O
had	O
bronchiolitis	O
.	O

TITLE	O
:	O
[	O
Sleep	O
apnea	O
syndromes	O
and	O
cardiovascular	B-ANAT
disease	O
].	O

ABSTRACT	O
:	O
Sleep	O
-	O
disordered	O
breathing	O
is	O
very	O
common	O
and	O
is	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
cardiovascular	B-ANAT
disease	O
,	O
cardiac	B-ANAT
arrhythmia	O
and	O
stroke	O
.	O

Autonomic	B-ANAT
abnormalities	O
include	O
an	O
increased	O
resting	B-ANAT
heart	B-ANAT
rate	O
,	O
decreased	O
cardiac	B-ANAT
rhythm	O
activity	O
,	O
and	O
increased	O
blood	B-ANAT
pressure	O
variability	O
.	O

Recent	O
mid	O
-	O
terms	O
trials	O
showed	O
that	O
nocturnal	O
use	O
of	O
positive	O
airway	B-ANAT
pressure	O
in	O
patients	O
with	O
the	O
two	O
types	O
of	O
apnea	O
alleviates	O
symptoms	O
,	O
reduces	O
sympathetic	O
activity	O
,	O
improves	O
ventricular	B-ANAT
function	O
and	O
quality	O
of	O
life	O
,	O
and	O
reduces	O
daytime	O
drowsiness	O
.	O

The	O
conditioning	O
regimen	O
consisted	O
of	O
a	O
busulfan	O
-	O
cyclophosphamide	O
combination	O
(	O
n	O
=	O
6	O
)	O
or	O
total	O
body	B-ANAT
irradiation	O
plus	O
chemotherapy	O
(	O
n	O
=	O
4	O
).	O

We	O
conclude	O
that	O
HSCT	O
is	O
feasible	O
for	O
patients	O
with	O
SDS	O
who	O
develop	O
bone	B-ANAT
marrow	I-ANAT
failure	O
or	O
malignant	O
transformation	O
.	O

Acute	O
lung	B-ANAT
injury	O
with	O
intravenous	O
oleic	O
acid	O
.	O

ABSTRACT	O
:	O
Viral	O
infection	O
can	O
result	O
in	O
alterations	O
to	O
the	O
host	O
subcellular	B-ANAT
membrane	I-ANAT
.	O

This	O
is	O
often	O
reported	O
when	O
using	O
transmission	O
electron	O
microscopy	O
(	O
TEM	O
),	O
resulting	O
in	O
a	O
description	O
of	O
tubuloreticular	O
membrane	B-ANAT
subcellular	O
ultrastructure	O
rather	O
than	O
a	O
definition	O
based	O
on	O
3	O
-	O
D	O
morphology	O
.	O

The	O
2	O
-	O
D	O
gyroid	O
computer	O
-	O
simulated	O
image	O
that	O
was	O
used	O
to	O
match	O
the	O
electron	O
micrograph	O
of	O
interest	O
was	O
derived	O
from	O
a	O
mathematically	O
well	O
-	O
defined	O
3	O
-	O
D	O
structure	O
,	O
and	O
it	O
is	O
from	O
this	O
3	O
-	O
D	O
derivative	O
that	O
allows	O
us	O
to	O
make	O
inferences	O
about	O
the	O
3	O
-	O
D	O
structure	O
of	O
this	O
membrane	B-ANAT
.	O

Possible	O
mechanisms	O
for	O
this	O
cubic	O
membrane	B-ANAT
change	O
are	O
discussed	O
with	O
respect	O
to	O
viral	O
severity	O
,	O
persistence	O
and	O
free	O
radical	O
production	O
.	O

These	O
results	O
together	O
indicate	O
that	O
stem	B-ANAT
-	O
loop	O
IV	O
in	O
the	O
BCoV	O
5	O
'	O
UTR	O
is	O
a	O
cis	O
-	O
acting	O
element	O
for	O
DI	O
RNA	O
replication	O
and	O
that	O
it	O
might	O
function	O
through	O
interactions	O
with	O
cellular	B-ANAT
proteins	O
.	O

ABSTRACT	O
:	O
More	O
often	O
we	O
are	O
faced	O
with	O
the	O
cases	O
of	O
young	O
people	O
(	O
who	O
are	O
in	O
a	O
serious	O
condition	O
)	O
who	O
land	B-ANAT
in	O
ICU	O
,	O
because	O
of	O
severe	O
narcotics	O
intoxication	O
,	O
which	O
they	O
took	O
occasionally	O
on	O
the	O
concerts	O
,	O
discotheques	O
and	O
social	O
events	O
.	O

The	O
presence	O
of	O
high	O
concentration	O
of	O
amphetamine	O
,	O
MDMA	O
and	O
THC	O
in	O
blood	B-ANAT
,	O
extreme	O
dehydration	O
and	O
electrolytes	O
disturbances	O
caused	O
rhabdomyolysis	O
,	O
DIC	O
syndrome	O
and	O
acute	O
renal	B-ANAT
failure	O
which	O
make	O
the	O
prognosis	O
worse	O
and	O
complicate	O
the	O
treatment	O
.	O

TITLE	O
:	O
1	O
-	O
year	O
pulmonary	B-ANAT
function	O
and	O
health	O
status	O
in	O
survivors	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

ABSTRACT	O
:	O
To	O
characterize	O
the	O
long	O
-	O
term	O
pulmonary	B-ANAT
function	O
and	O
health	O
status	O
in	O
a	O
prospectively	O
identified	O
cohort	O
of	O
patients	O
who	O
survived	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

TITLE	O
:	O
Acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
15	O
foals	O
.	O

This	O
assay	O
allows	O
for	O
the	O
testing	O
of	O
multiple	O
proteins	O
or	O
peptides	O
at	O
a	O
single	O
time	O
and	O
provides	O
a	O
quantitative	O
and	O
phenotypic	O
assessment	O
of	O
CD4	O
(+)	O
and	O
CD8	O
(+)	O
responding	O
cells	B-ANAT
.	O

The	O
human	O
synthetic	O
single	O
-	O
chain	O
fragment	O
variable	O
(	O
scFv	O
)	O
ETH	O
-	O
2	O
phage	O
antibody	O
library	O
was	O
used	O
for	O
the	O
isolation	O
of	O
scFvs	O
against	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
of	O
SARS	O
-	O
CoV	O
using	O
a	O
bio	O
panning	O
-	O
based	O
strategy	O
.	O

Corticosteroids	O
are	O
effective	O
in	O
lowering	O
the	O
fever	O
and	O
reversing	O
changes	O
in	O
the	O
chest	B-ANAT
radiograph	O
but	O
have	O
the	O
caveat	O
of	O
encouraging	O
viral	O
replication	O
.	O

RESULTS	O
:	O
Based	O
on	O
changes	O
in	O
gene	O
expression	O
of	O
peripheral	B-ANAT
blood	I-ANAT
,	O
we	O
identified	O
52	O
signature	O
genes	O
that	O
accurately	O
discriminated	O
acute	O
SARS	O
patients	O
from	O
non	O
-	O
SARS	O
controls	O
.	O

TITLE	O
:	O
Rhabdomyolysis	O
associated	O
with	O
acute	O
renal	B-ANAT
failure	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

Two	O
patients	O
died	O
from	O
multiple	O
organ	B-ANAT
failure	O
,	O
and	O
one	O
patient	O
fully	O
recovered	O
from	O
rhabdomyolysis	O
with	O
acute	O
renal	B-ANAT
failure	O
.	O

The	O
inclusion	O
of	O
an	O
internal	O
control	O
provides	O
a	O
way	O
to	O
detect	O
assay	O
inhibition	O
in	O
faecal	B-ANAT
samples	O
and	O
failure	O
of	O
nucleic	B-ANAT
acid	O
extraction	O
that	O
allow	O
reduction	O
of	O
the	O
number	O
of	O
false	O
-	O
negative	O
results	O
.	O

ABSTRACT	O
:	O
Sirolimus	O
is	O
a	O
new	O
potent	O
immunosuppressive	O
drug	O
used	O
in	O
organ	B-ANAT
transplantation	O
;	O
its	O
major	O
advantage	O
is	O
the	O
absence	O
of	O
deterioration	O
in	O
renal	B-ANAT
function	O
.	O

In	O
this	O
paper	O
,	O
a	O
stable	O
chicken	O
embryo	B-ANAT
-	O
related	O
(	O
CER	O
)	O
cell	B-ANAT
line	I-ANAT
was	O
adapted	O
and	O
maintained	O
in	O
serum	B-ANAT
free	O
(	O
SF	O
)	O
or	O
animal	O
protein	O
free	O
(	O
APF	O
)	O
medium	O
after	O
a	O
direct	O
switch	O
of	O
the	O
medium	O
.	O

Tears	B-ANAT
were	O
collected	O
using	O
micropipettes	O
or	O
on	O
filter	O
paper	O
.	O

TITLE	O
:	O
Acute	O
lung	B-ANAT
injury	O
after	O
peppermint	O
oil	O
injection	O
.	O

CONCLUSIONS	O
:	O
DWI	O
can	O
provide	O
valuable	O
information	O
regarding	O
the	O
diffusion	O
properties	O
of	O
femoral	B-ANAT
head	I-ANAT
AVN	O
,	O
and	O
markedly	O
increased	O
diffusion	O
was	O
identified	O
in	O
AVN	O
.	O

TITLE	O
:	O
Influence	O
of	O
intron	O
and	O
exon	O
splicing	O
enhancers	O
on	O
mammalian	B-ANAT
cell	I-ANAT
expression	O
of	O
a	O
truncated	O
spike	O
protein	O
of	O
SARS	O
-	O
CoV	O
and	O
its	O
implication	O
for	O
subunit	O
vaccine	O
development	O
.	O

Results	O
of	O
the	O
present	O
study	O
can	O
provide	O
an	O
optimal	O
strategy	O
to	O
enhance	O
SARS	O
-	O
CoV	O
S	O
protein	O
expression	O
in	O
mammalian	O
cells	B-ANAT
and	O
may	O
contribute	O
to	O
the	O
development	O
of	O
SARS	O
-	O
CoV	O
subunit	O
vaccine	O
.	O

Previous	O
studies	O
on	O
chemokines	O
have	O
included	O
only	O
small	O
numbers	O
of	O
patients	O
,	O
and	O
the	O
utility	O
of	O
plasma	B-ANAT
chemokines	O
as	O
prognostic	O
indicators	O
is	O
unclear	O
.	O

Three	O
hours	O
later	O
,	O
the	O
rats	O
were	O
sacrificed	O
,	O
and	O
blood	B-ANAT
and	O
lung	B-ANAT
tissue	I-ANAT
samples	O
were	O
obtained	O
.	O

Oxidative	O
stress	O
was	O
assessed	O
by	O
measuring	O
the	O
levels	O
of	O
erythrocyte	B-ANAT
reduced	O
glutathione	O
(	O
GSH	O
),	O
tissue	B-ANAT
malondialdehyde	O
(	O
MDA	O
),	O
myeloperoxidase	O
(	O
MPO	O
)	O
and	O
Na	O
(+)-	O
K	O
(+)	O
ATPase	O
.	O

CONCLUSIONS	O
:	O
These	O
results	O
suggest	O
that	O
high	O
-	O
dose	O
acute	O
alcohol	O
administration	O
aggravates	O
systemic	O
and	O
local	O
oxidative	O
stress	O
leading	O
to	O
acute	O
lung	B-ANAT
injury	O
,	O
ranging	O
from	O
mild	O
pulmonary	B-ANAT
dysfunction	O
to	O
severe	O
lung	B-ANAT
injury	O
.	O

Novel	O
findings	O
included	O
hyaline	B-ANAT
membrane	B-ANAT
formation	O
in	O
respiratory	B-ANAT
system	I-ANAT
cases	O
that	O
is	O
similar	O
to	O
acute	O
(	O
adult	O
)	O
respiratory	O
distress	O
syndrome	O
and	O
evidence	O
of	O
primary	O
gastrointestinal	O
involvement	O
,	O
showing	O
the	O
ability	O
of	O
the	O
organism	O
to	O
pass	O
the	O
gastric	B-ANAT
barrier	O
.	O

Front	O
-	O
line	O
physicians	O
will	O
face	B-ANAT
ethical	O
dilemmas	O
during	O
public	O
health	O
emergencies	O
when	O
patients	O
disagree	O
with	O
these	O
measures	O
.	O

Results	O
from	O
the	O
ESCAPE	O
trial	O
of	O
patients	O
with	O
severe	O
heart	B-ANAT
failure	O
were	O
also	O
included	O
.	O

ABSTRACT	O
:	O
Since	O
the	O
outbreak	O
of	O
a	O
SARS	O
epidemic	O
last	O
year	O
,	O
significant	O
advances	O
have	O
been	O
made	O
on	O
our	O
understanding	O
of	O
the	O
mechanisms	O
of	O
interaction	O
between	O
the	O
SARS	O
coronavirus	O
(	O
CoV	O
)	O
and	O
the	O
immune	B-ANAT
system	I-ANAT
.	O

The	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
and	O
spike	O
(	O
S	O
)	O
proteins	O
of	O
SARS	O
-	O
CoV	O
appear	O
to	O
be	O
the	O
dominant	O
antigens	O
recognized	O
by	O
serum	B-ANAT
Abs	O
.	O

Misexpression	O
of	O
3a	O
in	O
Drosophila	O
caused	O
a	O
dominant	O
rough	O
eye	B-ANAT
phenotype	O
.	O

A	O
total	O
of	O
343	O
results	O
for	O
RT	O
-	O
PCR	O
and	O
439	O
results	O
for	O
serology	O
were	O
analysed	O
and	O
compared	O
with	O
the	O
final	O
discharge	B-ANAT
diagnosis	O
.	O

In	O
order	O
to	O
validate	O
this	O
plausible	O
anti	O
-	O
inflammatory	O
property	O
,	O
the	O
chemical	O
composition	O
of	O
HCI	O
has	O
been	O
analysed	O
by	O
GC	O
/	O
MS	O
,	O
22	O
components	O
were	O
identified	O
,	O
and	O
the	O
inflammation	O
induced	O
by	O
carrageenan	O
in	O
the	O
rat	O
pleurisy	O
model	O
and	O
by	O
xylene	O
in	O
the	O
mice	O
ear	B-ANAT
edema	O
model	O
was	O
adopted	O
to	O
study	O
the	O
anti	O
-	O
inflammatory	O
activity	O
of	O
HCI	O
.	O

Moreover	O
,	O
the	O
vaccine	O
confers	O
protective	O
immunity	O
as	O
demonstrated	O
by	O
prevention	O
of	O
SARS	O
-	O
CoV	O
replication	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
of	O
mice	O
after	O
intranasal	O
challenge	O
with	O
SARS	O
-	O
CoV	O
.	O
Protection	O
of	O
mice	O
was	O
correlated	O
to	O
antibody	O
titre	O
against	O
the	O
SARS	O
-	O
CoV	O
S	O
protein	O
and	O
neutralising	O
antibody	O
titre	O
.	O

Neutrophil	B-ANAT
counts	O
were	O
higher	O
in	O
the	O
supine	O
-	O
HFOV	O
group	O
than	O
in	O
the	O
prone	O
-	O
CV	O
group	O
.	O

Anti	O
-	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
antibody	O
had	O
no	O
effect	O
on	O
gut	B-ANAT
epithelial	O
proliferation	O
or	O
death	O
.	O

Overexpression	O
of	O
Bcl	O
-	O
2	O
did	O
not	O
change	O
proliferation	O
despite	O
decreasing	O
gut	B-ANAT
apoptosis	O
.	O

SARS	O
-	O
specific	O
IgG	B-ANAT
antibody	I-ANAT
is	O
generated	O
in	O
the	O
second	O
week	O
and	O
persists	O
for	O
a	O
long	O
time	O
,	O
whereas	O
IgM	O
is	O
expressed	O
transiently	O
.	O

After	O
induction	O
of	O
severe	O
lung	B-ANAT
injury	O
by	O
repeated	O
saline	O
lung	B-ANAT
lavage	O
,	O
19	O
adult	O
white	O
Japanese	O
rabbits	O
were	O
randomized	O
into	O
two	O
groups	O
that	O
received	O
PLV	O
with	O
HFO	O
(	O
n	O
=	O
9	O
)	O
or	O
HFO	O
gas	O
ventilation	O
(	O
n	O
=	O
10	O
).	O

In	O
addition	O
,	O
resistance	O
to	O
infection	O
of	O
zona	O
-	O
intact	O
and	O
laser	O
-	O
microdissected	O
oocytes	B-ANAT
was	O
compared	O
.	O

Various	O
types	O
of	O
cells	B-ANAT
damaged	O
by	O
SARS	O
-	O
CoV	O
and	O
inflammatory	O
mediators	O
released	O
by	O
those	O
cells	B-ANAT
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
lung	B-ANAT
injury	O
in	O
SARS	O
.	O

RESULTS	O
:	O
Three	O
hybridoma	B-ANAT
cell	B-ANAT
lines	I-ANAT
(	O
8A5	O
,	O
8H6	O
and	O
4A2	O
)	O
stable	O
in	O
secreting	O
specific	O
monoclonal	O
antibodies	O
were	O
successfully	O
obtained	O
.	O

Infectious	O
MHVDeltansp2	O
and	O
SARSDeltansp2	O
viruses	O
recovered	O
from	O
electroporated	O
cells	B-ANAT
had	O
0	O
.	O
5	O
to	O
1	O
log10	O
reductions	O
in	O
peak	O
titers	O
in	O
single	O
-	O
cycle	O
growth	O
assays	O
,	O
as	O
well	O
as	O
a	O
reduction	O
in	O
viral	O
RNA	O
synthesis	O
that	O
was	O
not	O
specific	O
for	O
any	O
positive	O
-	O
stranded	O
RNA	O
species	O
.	O

Our	O
data	O
strongly	O
suggest	O
that	O
SCV	O
fails	O
to	O
activate	O
host	B-ANAT
cell	I-ANAT
cytokine	O
gene	O
expression	O
in	O
human	O
macrophages	B-ANAT
and	O
DCs	O
.	O

We	O
report	O
the	O
crystal	B-ANAT
structure	O
of	O
the	O
hexadecameric	O
nsp7	O
-	O
nsp8	O
supercomplex	O
from	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
at	O
2	O
.	O
4	O
-	O
angstroms	O
resolution	O
.	O

The	O
positive	O
rate	O
of	O
PCR	O
for	O
nasal	B-ANAT
and	O
fecal	B-ANAT
swabs	O
from	O
109	O
major	O
wild	O
animals	O
is	O
44	O
.	O
04	O
%,	O
but	O
the	O
positive	O
rate	O
of	O
145	O
wild	O
live	O
-	O
animals	O
is	O
0	O
.	O

The	O
positive	O
rate	O
of	O
PCR	O
for	O
nasal	B-ANAT
and	O
fecal	B-ANAT
swabs	O
from	O
109	O
major	O
wild	O
animals	O
is	O
44	O
.	O
04	O
%,	O
but	O
the	O
positive	O
rate	O
of	O
145	O
wild	O
live	O
-	O
animals	O
is	O
0	O
.	O

These	O
patients	O
often	O
have	O
delayed	O
onset	O
of	O
clinical	O
manifestation	O
,	O
severe	O
symptoms	O
of	O
long	O
duration	O
,	O
with	O
high	O
rate	O
of	O
pulmonary	B-ANAT
infection	O
and	O
pleural	O
effusions	O
,	O
and	O
variable	O
manifestations	O
in	O
chest	B-ANAT
X	O
-	O
ray	O
easily	O
confused	O
with	O
pulmonary	B-ANAT
infections	O
.	O

Low	O
tide	O
volume	O
lung	B-ANAT
-	O
protective	O
ventilation	O
strategy	O
and	O
lung	B-ANAT
recruitment	O
measures	O
may	O
prove	O
beneficial	O
.	O

Prevention	O
and	O
management	O
of	O
ventilator	O
-	O
associated	O
pneumonia	O
,	O
pulmonary	B-ANAT
infection	O
and	O
wound	O
infection	O
,	O
along	O
with	O
improvement	O
of	O
microcirculation	O
,	O
organ	B-ANAT
function	O
protection	O
and	O
intensive	O
nutrition	O
support	O
,	O
are	O
effective	O
treatments	O
for	O
patients	O
with	O
blast	B-ANAT
injury	O
of	O
the	O
lungs	B-ANAT
and	O
extensive	O
burns	O
.	O

There	O
were	O
39	O
male	O
and	O
58	O
female	O
patients	O
,	O
and	O
63	O
patients	O
(	O
70	O
%)	O
were	O
health	O
-	O
care	O
workers	O
(	O
mean	O
age	O
,	O
36	O
.	O
9	O
years	O
[	O
SD	O
,	O
9	O
.	O
5	O
years	O
];	O
body	B-ANAT
mass	O
index	O
,	O
23	O
.	O
7	O
kg	O
/	O
m2	O
[	O
SD	O
,	O
4	O
.	O
0	O
kg	O
/	O
m2	O
]).	O

Here	O
,	O
we	O
assess	O
the	O
conformational	O
flexibility	O
of	O
the	O
M	O
(	O
pro	O
)	O
by	O
analysis	O
of	O
multiple	O
crystal	B-ANAT
structures	O
(	O
including	O
two	O
new	O
crystal	B-ANAT
forms	O
)	O
and	O
by	O
molecular	O
dynamics	O
(	O
MD	O
)	O
calculations	O
.	O

At	O
the	O
time	O
of	O
hospital	O
admission	O
,	O
jaundice	O
(	O
62	O
%),	O
hyperparasitemia	O
(	O
56	O
%),	O
and	O
prostration	O
(	O
52	O
%)	O
were	O
the	O
most	O
frequent	O
findings	O
,	O
followed	O
by	O
acute	O
renal	B-ANAT
failure	O
(	O
31	O
%).	O

Of	O
these	O
23	O
,	O
five	O
non	O
-	O
immune	O
persons	O
subsequently	O
developed	O
coma	O
,	O
shock	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
or	O
acute	O
renal	B-ANAT
failure	O
;	O
this	O
led	O
to	O
death	O
in	O
2	O
of	O
these	O
cases	O
.	O

However	O
,	O
when	O
extensive	O
lung	B-ANAT
injury	O
is	O
present	O
,	O
this	O
technique	O
may	O
not	O
be	O
sufficient	O
to	O
prevent	O
hypoxia	O
,	O
and	O
furthermore	O
,	O
may	O
exacerbate	O
pulmonary	B-ANAT
damage	O
by	O
barotrauma	O
.	O

Most	O
patients	O
had	O
long	B-ANAT
bone	I-ANAT
fractures	O
,	O
blunt	O
chest	B-ANAT
trauma	O
,	O
or	O
combined	O
injuries	O
.	O

In	O
early	O
/	O
severe	O
/	O
diffuse	O
ARDS	O
prone	O
position	O
reduces	O
lower	O
inflection	O
point	O
pressure	O
and	O
increases	O
upper	O
inflection	O
point	O
UIP	O
volume	O
of	O
the	O
lung	B-ANAT
PV	O
curve	O
.	O

These	O
neuromuscular	O
disorders	O
in	O
SARS	O
patients	O
were	O
considered	O
as	O
critical	O
illness	O
neuropathy	O
and	O
myopathy	O
,	O
but	O
the	O
possibility	O
of	O
direct	O
attack	O
by	O
SARS	O
coronavirus	O
on	O
the	O
nerve	B-ANAT
and	O
muscle	B-ANAT
could	O
not	O
be	O
excluded	O
.	O

Western	O
blot	O
analysis	O
of	O
the	O
culture	O
medium	O
from	O
transfection	O
experiments	O
revealed	O
that	O
both	O
E	O
and	O
M	O
expressed	O
alone	O
could	O
be	O
released	O
in	O
sedimentable	O
particles	O
and	O
that	O
E	O
and	O
M	O
proteins	O
are	O
likely	O
to	O
form	O
VLPs	B-ANAT
when	O
they	O
are	O
coexpressed	O
.	O

The	O
SARS	O
-	O
CoV	O
VLPs	B-ANAT
thus	O
produced	O
were	O
designated	O
VLP	B-ANAT
(	O
GFP	O
-	O
PS580	O
).	O

The	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
response	O
was	O
altered	O
by	O
different	O
prime	O
-	O
boost	O
immunizations	O
,	O
with	O
the	O
optimal	O
CD8	O
immunity	O
induced	O
by	O
DNA	O
priming	O
and	O
replication	O
-	O
defective	O
adenoviral	O
vector	O
boosting	O
.	O

Because	O
both	O
cellular	B-ANAT
and	O
humoral	O
immune	O
responses	O
are	O
generated	O
by	O
gene	O
-	O
based	O
vaccination	O
and	O
inactivated	O
viral	O
boosting	O
,	O
this	O
strategy	O
may	O
prove	O
useful	O
in	O
the	O
generation	O
of	O
SARS	O
-	O
CoV	O
vaccines	O
.	O

ABSTRACT	O
:	O
In	O
feline	O
coronavirus	O
(	O
FCoV	O
)	O
pathogenesis	O
,	O
the	O
ability	O
to	O
infect	O
macrophages	B-ANAT
is	O
an	O
essential	O
virulence	O
factor	O
.	O

To	O
identify	O
the	O
genetic	O
determinants	O
of	O
the	O
FIPV	O
79	O
-	O
1146	O
macrophage	B-ANAT
tropism	O
,	O
we	O
exchanged	O
regions	O
of	O
its	O
genome	O
with	O
the	O
corresponding	O
parts	O
of	O
FECV	O
79	O
-	O
1683	O
,	O
after	O
which	O
the	O
ability	O
of	O
the	O
FIPV	O
/	O
FECV	O
hybrid	O
viruses	O
to	O
infect	O
macrophages	B-ANAT
was	O
tested	O
.	O

However	O
,	O
significant	O
differences	O
on	O
vaginal	B-ANAT
anti	O
-	O
HIV	O
-	O
1	O
gp120	O
IgA	O
and	O
IgG	O
antibodies	O
were	O
not	O
found	O
after	O
intravaginal	O
or	O
intranasal	O
immunization	O
with	O
different	O
sized	O
HIV	O
-	O
NS	O
.	O

TITLE	O
:	O
[	O
Preventive	O
and	O
therapeutic	O
effects	O
of	O
recombinant	O
IFN	O
-	O
alpha2b	O
nasal	B-ANAT
spray	O
on	O
SARS	O
-	O
CoV	O
infection	O
in	O
Macaca	O
mulata	O
].	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
safety	O
of	O
recombinant	O
human	O
interferon	O
alpha	O
-	O
2b	O
for	O
nasal	B-ANAT
spray	O
for	O
the	O
prevention	O
of	O
SARS	O
and	O
other	O
upper	O
respiratory	O
viral	O
infections	O
.	O

During	O
the	O
period	O
of	O
using	O
interferon	O
,	O
body	B-ANAT
temperature	O
of	O
the	O
experimental	O
group	O
was	O
normal	O
compared	O
to	O
the	O
control	O
group	O
.	O

RESULTS	O
:	O
During	O
the	O
period	O
of	O
using	O
interferon	O
,	O
body	B-ANAT
temperature	O
of	O
the	O
experimental	O
group	O
was	O
normal	O
compared	O
to	O
the	O
control	O
group	O
.	O

No	O
statistically	O
significant	O
difference	O
in	O
serum	B-ANAT
SARS	O
IgG	B-ANAT
antibody	I-ANAT
positive	O
rate	O
was	O
found	O
between	O
the	O
interferon	O
and	O
control	O
groups	O
among	O
2	O
,	O
757	O
serum	B-ANAT
samples	O
.	O

On	O
the	O
other	O
hand	O
,	O
after	O
using	O
interferon	O
,	O
all	O
four	O
respiratory	O
viruses	O
(	O
parainfluenza	O
virus	O
types	O
1	O
-	O
3	O
influenza	O
B	O
,	O
adenovirus	O
types	O
3	O
,	O
7	O
and	O
respiratory	O
syncytial	O
virus	O
)	O
in	O
interferon	O
group	O
had	O
lower	O
IgM	B-ANAT
antibody	I-ANAT
positive	O
rates	O
than	O
those	O
in	O
control	O
group	O
.	O

Fusion	O
proteins	O
with	O
relative	O
molecular	O
mass	O
of	O
26	O
,	O
700	O
,	O
22	O
,	O
500	O
and	O
46	O
,	O
000	O
dalton	O
were	O
successfully	O
expressed	O
with	O
amounts	O
of	O
35	O
%,	O
35	O
%	O
and	O
30	O
%	O
of	O
total	O
cell	B-ANAT
protein	O
and	O
purified	O
by	O
Ni	O
affinity	O
chromatography	O
,	O
respectively	O
.	O

Sequence	O
analysis	O
indicated	O
that	O
two	O
of	O
the	O
isolated	O
anti	O
-	O
N	O
scFv	O
clones	O
were	O
identical	O
and	O
displayed	O
a	O
high	O
homology	O
with	O
an	O
scFv	O
specific	O
for	O
interleukin	O
11	O
(	O
IL	O
-	O
11	O
),	O
an	O
anti	O
-	O
inflammatory	O
cytokine	O
derived	O
from	O
bone	B-ANAT
marrow	I-ANAT
stroma	I-ANAT
cells	B-ANAT
.	O

We	O
are	O
beginning	O
to	O
identify	O
those	O
processes	O
that	O
contribute	O
to	O
the	O
cellular	B-ANAT
derangements	O
which	O
are	O
the	O
hallmark	O
of	O
ALI	O
.	O

The	O
pol	O
,	O
spike	O
(	O
S	O
),	O
and	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
genes	O
were	O
also	O
sequenced	O
.	O

In	O
the	O
6	O
patients	O
from	O
whom	O
serum	B-ANAT
samples	O
were	O
available	O
,	O
all	O
had	O
a	O
4	O
-	O
fold	O
change	O
in	O
immunoglobulin	O
(	O
Ig	O
)	O
G	O
titer	O
and	O
/	O
or	O
presence	O
of	O
IgM	O
against	O
CoV	O
-	O
HKU1	O
.	O

There	O
was	O
also	O
impaired	O
alveolar	B-ANAT
-	O
capillary	B-ANAT
membrane	B-ANAT
function	I-ANAT
in	O
patients	O
with	O
severe	O
malaria	O
but	O
not	O
in	O
those	O
with	O
uncomplicated	O
malaria	O
.	O

TITLE	O
:	O
Leptospirosis	O
and	O
its	O
pulmonary	B-ANAT
complications	O
.	O

Delayed	O
antibiotic	O
treatment	O
and	O
thrombocytopenia	O
are	O
risk	O
factors	O
for	O
the	O
development	O
of	O
pulmonary	B-ANAT
involvement	O
in	O
leptospirosis	O
.	O

OA	O
infusion	O
induced	O
a	O
moderate	O
increase	O
in	O
mean	O
pulmonary	B-ANAT
arterial	B-ANAT
pressure	O
and	O
a	O
decrease	O
in	O
PaO2	O
/	O
Fraction	O
inspired	O
O2	O
(	O
P	O
/	O
F	O
)	O
ratio	O
,	O
giving	O
evidence	O
of	O
severe	O
lung	B-ANAT
injury	O
.	O

Western	O
blot	O
analysis	O
as	O
well	O
as	O
electron	O
microscopy	O
indicated	O
that	O
the	O
ratios	O
of	O
spike	O
to	O
nucleocapsid	B-ANAT
protein	O
in	O
clone	O
#	O
21	O
as	O
well	O
as	O
its	O
parental	O
persistently	O
infected	O
cells	B-ANAT
were	O
lower	O
than	O
that	O
in	O
the	O
cells	B-ANAT
in	O
the	O
acute	O
phase	O
of	O
infection	O
.	O

The	O
objectives	O
of	O
this	O
study	O
were	O
to	O
develop	O
a	O
rapid	O
immunoturbidimetric	O
assay	O
for	O
measurement	O
of	O
AGP	O
in	O
feline	O
serum	B-ANAT
and	O
peritoneal	B-ANAT
fluid	I-ANAT
and	O
to	O
compare	O
the	O
results	O
with	O
those	O
obtained	O
by	O
RID	O
.	O

ABSTRACT	O
:	O
The	O
detection	O
of	O
typical	O
lesions	O
and	O
feline	O
coronavirus	O
(	O
FCoV	O
)	O
antigen	O
in	O
tissues	B-ANAT
is	O
the	O
only	O
conclusive	O
method	O
for	O
making	O
a	O
diagnosis	O
of	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
).	O

The	O
diagnostic	O
sensitivity	O
of	O
TCB	O
and	O
FNAB	O
for	O
detecting	O
liver	B-ANAT
and	O
kidney	B-ANAT
histologic	O
lesions	O
caused	O
by	O
FIP	O
was	O
evaluated	O
.	O

TITLE	O
:	O
Transfer	O
of	O
the	O
hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplant	B-ANAT
patient	O
to	O
the	O
intensive	O
care	O
unit	O
:	O
does	O
it	O
really	O
matter	O
?	O

This	O
encouraging	O
outcome	O
trend	O
reflects	O
evolving	O
advances	O
such	O
as	O
use	O
of	O
recombinant	O
hematopoietic	O
growth	O
factors	O
,	O
use	O
of	O
mobilized	O
blood	B-ANAT
cells	I-ANAT
rather	O
than	O
marrow	O
,	O
protective	O
strategies	O
for	O
acute	O
lung	B-ANAT
injury	O
and	O
early	O
goal	O
-	O
directed	O
therapy	O
for	O
sepsis	O
syndrome	O
.	O

Fibrinogen	B-ANAT
was	O
decreased	O
.	O

Apoptosis	O
degree	O
of	O
blood	B-ANAT
vessel	I-ANAT
endothelium	I-ANAT
was	O
increased	O
too	O
.	O

SARS	O
patients	O
might	O
need	O
anticoagulant	O
therapy	O
or	O
fibrinolytic	O
therapy	O
in	O
order	O
to	O
reverse	O
intraalveolar	O
coagulation	O
,	O
microthrombi	O
formation	O
,	O
alveolar	B-ANAT
and	O
interstitial	B-ANAT
fibrin	O
deposition	O
.	O

Blood	B-ANAT
samples	I-ANAT
of	O
patients	O
and	O
household	O
contacts	O
were	O
collected	O
at	O
least	O
28	O
days	O
after	O
symptom	O
onset	O
in	O
the	O
index	O
patients	O
or	O
household	O
exposure	O
in	O
the	O
contacts	O
for	O
SARS	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
IgG	O
testing	O
.	O

In	O
contrast	O
,	O
neutralizing	O
antibody	O
and	O
SARS	O
CoV	O
IgGAM	O
and	O
IgG	B-ANAT
antibody	I-ANAT
titers	O
remained	O
stable	O
over	O
this	O
period	O
.	O

There	O
was	O
no	O
change	O
in	O
IF	O
IgG	O
titer	O
for	O
virus	O
capsid	B-ANAT
antigen	O
from	O
the	O
herpesvirus	O
that	O
was	O
used	O
as	O
an	O
unrelated	O
control	O
,	O
Epstein	O
-	O
Barr	O
virus	O
.	O

By	O
implementing	O
ANN	O
as	O
a	O
classification	O
engine	O
,	O
we	O
enabled	O
both	O
the	O
prediction	O
of	O
peptides	O
binding	O
to	O
multiple	O
individual	O
HLA	B-ANAT
-	O
A2	O
molecules	O
and	O
the	O
prediction	O
of	O
promiscuous	O
binders	O
using	O
a	O
single	O
model	O
.	O

Data	O
on	O
annual	O
patient	O
-	O
days	O
and	O
annual	O
consumption	O
(	O
defined	O
daily	O
dose	O
(	O
DDD	O
)	O
per	O
1000	O
patient	O
-	O
days	O
)	O
of	O
extended	O
-	O
spectrum	O
cephalosporins	O
(	O
cefotaxime	O
,	O
ceftriaxone	O
,	O
ceftazidime	O
,	O
flumoxef	O
,	O
cefepime	O
and	O
cefpirome	O
),	O
beta	O
-	O
lactam	O
-	O
beta	O
-	O
lactamase	O
inhibitor	O
combinations	O
(	O
ticarcillin	O
/	O
clavulanic	O
acid	O
and	O
piperacillin	O
/	O
tazobactam	O
),	O
carbapenems	O
(	O
imipenem	O
and	O
meropenem	O
),	O
aminoglycosides	O
(	O
amikacin	O
,	O
gentamicin	O
and	O
tobramycin	O
),	O
fluoroquinolones	O
(	O
ciprofloxacin	O
(	O
oral	B-ANAT
and	O
injectable	O
)	O
and	O
oral	B-ANAT
levofloxacin	O
and	O
moxifloxacin	O
)	O
from	O
1991	O
to	O
2003	O
were	O
analysed	O
.	O

ABSTRACT	O
:	O
Studies	O
of	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
demonstrate	O
that	O
the	O
respiratory	B-ANAT
tract	I-ANAT
is	O
a	O
major	O
site	O
of	O
SARS	O
-	O
coronavirus	O
(	O
CoV	O
)	O
infection	O
and	O
disease	O
morbidity	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
group	O
-	O
specific	O
open	O
reading	O
frames	O
encode	O
nonessential	O
functions	O
for	O
replication	O
in	O
cell	B-ANAT
cultures	O
and	O
mice	O
.	O

Our	O
data	O
suggests	O
that	O
coronavirus	O
NL63	O
causes	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
symptoms	O
and	O
is	O
acquired	O
in	O
early	O
life	O
.	O

The	O
Three	O
-	O
phase	O
design	O
involved	O
a	O
)	O
salient	O
beliefs	O
generated	O
from	O
clinical	O
nurses	O
(	O
n	O
=	O
43	O
)	O
b	O
)	O
content	O
validation	O
by	O
expert	O
panel	O
evaluations	O
(	O
n	O
=	O
5	O
)	O
c	O
)	O
face	B-ANAT
validation	O
by	O
plot	O
testing	O
(	O
n	O
=	O
10	O
)	O
d	O
)	O
and	O
instrument	O
validation	O
in	O
a	O
cross	O
sectional	O
survey	O
(	O
n	O
=	O
299	O
).	O

Six	O
health	O
horses	O
were	O
immunized	O
4	O
times	O
and	O
serum	B-ANAT
was	O
collected	O
periodically	O
to	O
measure	O
the	O
profile	O
of	O
specific	O
IgG	O
and	O
neutralizing	O
antibodies	O
using	O
indirect	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
and	O
a	O
microneutralization	O
test	O
.	O

At	O
all	O
air	O
,	O
sea	O
and	O
land	B-ANAT
points	O
-	O
of	O
-	O
entry	O
,	O
exit	O
and	O
entry	O
screening	O
took	O
place	O
that	O
resulted	O
in	O
zero	O
importation	O
and	O
exportation	O
of	O
SARS	O
cases	O
after	O
implementation	O
of	O
screening	O
.	O

As	O
the	O
environment	O
dictates	O
the	O
success	O
or	O
failure	O
of	O
remyelination	O
,	O
it	O
is	O
critical	O
to	O
understand	O
the	O
role	O
that	O
the	O
immune	B-ANAT
system	I-ANAT
plays	O
in	O
transplant	B-ANAT
-	O
mediated	O
remyelination	O
.	O

Treatment	O
did	O
not	O
alter	O
accumulation	O
of	O
T	B-ANAT
cells	I-ANAT
or	O
macrophages	B-ANAT
within	O
the	O
CNS	B-ANAT
as	O
compared	O
to	O
control	O
mice	O
.	O

Finally	O
,	O
remyelination	O
associated	O
with	O
transplantation	O
did	O
not	O
result	O
in	O
an	O
imbalance	O
of	O
T	O
(	O
H	O
)	O
1	O
-	O
associated	O
cytokine	O
production	O
by	O
virus	O
-	O
specific	O
T	B-ANAT
cells	I-ANAT
.	O

TITLE	O
:	O
Differential	O
localization	O
and	O
turnover	O
of	O
infectious	O
bronchitis	O
virus	O
3b	O
protein	O
in	O
mammalian	O
versus	O
avian	O
cells	B-ANAT
.	O

Our	O
results	O
highlight	O
the	O
importance	O
of	O
using	O
cells	B-ANAT
derived	O
from	O
the	O
natural	O
host	O
when	O
studying	O
coronavirus	O
non	O
-	O
structural	O
proteins	O
.	O

TITLE	O
:	O
Subcellular	O
localization	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
nucleocapsid	B-ANAT
protein	O
.	O

TITLE	O
:	O
Interhospital	O
transportation	O
of	O
patients	O
with	O
severe	O
lung	B-ANAT
failure	O
on	O
pumpless	O
extracorporeal	O
lung	B-ANAT
assist	O
.	O

Previously	O
,	O
the	O
differences	O
between	O
virulent	O
field	O
PEDV	O
strains	O
and	O
a	O
Vero	B-ANAT
cell	I-ANAT
culture	O
adapted	O
PEDV	O
DR13	O
strain	O
were	O
determined	O
using	O
restriction	O
fragment	O
length	O
polymorphism	O
analysis	O
(	O
RFLP	O
),	O
and	O
PEDV	O
shedding	O
patterns	O
in	O
pigs	O
were	O
reported	O
.	O

ABSTRACT	O
:	O
We	O
performed	O
a	O
pilot	O
study	O
in	O
which	O
22	O
kidney	B-ANAT
recipients	O
(	O
14	O
LD	O
:	O
8	O
DCD	O
)	O
were	O
given	O
alemtuzumab	O
induction	O
(	O
30	O
mg	O
day	O
0	O
and	O
1	O
),	O
steroids	O
(	O
500	O
mg	O
mp	O
day	O
0	O
and	O
1	O
,	O
none	O
thereafter	O
),	O
mycophenolate	O
mofetil	O
(	O
MMF	O
)	O
maintenance	O
(	O
500	O
mg	O
b	O
.	O
i	O
.	O
d	O
)	O
and	O
sirolimus	O
(	O
concentration	O
controlled	O
8	O
-	O
12	O
ng	O
/	O
mL	O
).	O

TITLE	O
:	O
SARS	O
coronavirus	O
7a	O
protein	O
blocks	O
cell	B-ANAT
cycle	O
progression	O
at	O
G0	O
/	O
G1	O
phase	O
via	O
the	O
cyclin	O
D3	O
/	O
pRb	O
pathway	O
.	O

Here	O
,	O
we	O
observed	O
that	O
transient	O
expression	O
of	O
ORF7a	O
protein	O
fused	O
with	O
myc	O
or	O
GFP	O
tags	O
at	O
its	O
N	O
or	O
C	O
terminus	O
inhibited	O
cell	B-ANAT
growth	O
and	O
prevented	O
BrdU	O
incorporation	O
in	O
different	O
cultural	O
cells	B-ANAT
,	O
suggesting	O
that	O
ORF7a	O
expression	O
may	O
regulate	O
cell	B-ANAT
cycle	O
progression	O
.	O

Similar	O
results	O
were	O
observed	O
in	O
COS	O
-	O
7	O
and	O
Vero	B-ANAT
cells	I-ANAT
.	O

Our	O
findings	O
suggest	O
that	O
the	O
properties	O
of	O
S	O
receptor	O
utilization	O
and	O
/	O
or	O
fusogenicity	O
mainly	O
determine	O
organ	B-ANAT
and	O
host	B-ANAT
cell	I-ANAT
tropism	O
but	O
that	O
HE	O
enhances	O
the	O
efficiency	O
of	O
infection	O
and	O
promotes	O
viral	O
dissemination	O
,	O
at	O
least	O
in	O
some	O
tissues	B-ANAT
,	O
presumably	O
by	O
serving	O
as	O
a	O
second	O
receptor	O
-	O
binding	O
protein	O
.	O

TITLE	O
:	O
Soluble	O
receptor	O
-	O
mediated	O
targeting	O
of	O
mouse	O
hepatitis	O
coronavirus	O
to	O
the	O
human	O
epidermal	B-ANAT
growth	O
factor	O
receptor	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
infection	O
of	O
human	O
ciliated	O
airway	B-ANAT
epithelia	O
:	O
role	O
of	O
ciliated	O
cells	B-ANAT
in	O
viral	O
spread	O
in	O
the	O
conducting	O
airways	O
of	O
the	O
lungs	B-ANAT
.	O

TITLE	O
:	O
Programmed	O
ribosomal	B-ANAT
frameshifting	O
in	O
HIV	O
-	O
1	O
and	O
the	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
Ribosomal	B-ANAT
frameshifting	O
is	O
a	O
mechanism	O
of	O
gene	O
expression	O
used	O
by	O
several	O
RNA	O
viruses	O
to	O
express	O
replicase	O
enzymes	O
.	O

The	O
role	O
of	O
interferon	O
and	O
systemic	O
steroid	O
in	O
preventing	O
immune	O
-	O
mediated	O
lung	B-ANAT
injury	O
deserves	O
further	O
investigation	O
.	O

To	O
explore	O
whether	O
the	O
stool	B-ANAT
of	O
SARS	O
patients	O
or	O
the	O
sewage	O
containing	O
the	O
stool	B-ANAT
of	O
patients	O
would	O
transmit	O
SARS	O
-	O
CoV	O
or	O
not	O
,	O
we	O
used	O
a	O
style	O
of	O
electropositive	O
filter	O
media	B-ANAT
particle	O
to	O
concentrate	O
the	O
SARS	O
-	O
CoV	O
from	O
the	O
sewage	O
of	O
two	O
hospitals	O
receiving	O
SARS	O
patients	O
in	O
Beijing	O
,	O
as	O
well	O
as	O
cell	B-ANAT
culture	O
,	O
semi	O
-	O
nested	O
RT	O
-	O
PCR	O
and	O
sequencing	O
of	O
genes	O
to	O
detect	O
and	O
identify	O
the	O
viruses	O
from	O
sewage	O
.	O

In	O
conclusion	O
,	O
this	O
study	O
demonstrates	O
that	O
the	O
RNA	O
of	O
SARS	O
-	O
CoV	O
could	O
be	O
detected	O
from	O
the	O
concentrates	O
of	O
sewage	O
of	O
both	O
hospitals	O
receiving	O
SARS	O
patients	O
before	O
disinfection	O
and	O
occasionally	O
after	O
disinfection	O
though	O
there	O
was	O
no	O
live	O
SARS	O
-	O
CoV	O
;	O
thus	O
much	O
attention	O
should	O
be	O
paid	O
to	O
the	O
treatment	O
of	O
stools	B-ANAT
of	O
patients	O
and	O
the	O
sewage	O
of	O
hospitals	O
receiving	O
SARS	O
patients	O
.	O

Adaptation	O
of	O
the	O
human	O
virus	O
to	O
murine	O
cells	B-ANAT
led	O
to	O
successful	O
infection	O
of	O
the	O
humanized	O
transgenic	O
mice	O
.	O

The	O
patients	O
present	O
mainly	O
with	O
multiorgan	O
failure	O
resulting	O
from	O
predominantly	O
small	B-ANAT
vessel	I-ANAT
occlusions	O
affecting	O
mainly	O
intra	O
-	O
abdominal	B-ANAT
organs	I-ANAT
such	O
as	O
bowel	B-ANAT
,	O
liver	B-ANAT
,	O
pancreas	B-ANAT
,	O
and	O
adrenals	B-ANAT
,	O
although	O
large	B-ANAT
vessel	I-ANAT
occlusions	O
do	O
occur	O
and	O
comprise	O
mainly	O
deep	B-ANAT
vein	I-ANAT
thromboses	O
(	O
DVT	O
)	O
of	O
the	O
veins	B-ANAT
of	O
the	O
lower	B-ANAT
limbs	I-ANAT
and	O
arterial	B-ANAT
occlusions	O
causing	O
strokes	O
and	O
peripheral	O
gangrene	O
.	O

TITLE	O
:	O
The	O
nucleocapsid	B-ANAT
protein	O
of	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
:	O
crystal	B-ANAT
structure	O
of	O
its	O
N	O
-	O
terminal	O
domain	O
and	O
multimerization	O
properties	O
.	O

Angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
is	O
a	O
cellular	B-ANAT
receptor	O
for	O
two	O
divergent	O
coronaviruses	O
,	O
SARS	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
and	O
human	O
coronavirus	O
NL63	O
(	O
HCoV	O
-	O
NL63	O
).	O

The	O
regulated	O
production	O
of	O
nitric	O
oxide	O
(	O
NO	O
)	O
by	O
the	O
endothelium	B-ANAT
plays	O
a	O
central	O
role	O
in	O
normal	O
vascular	B-ANAT
function	O
,	O
and	O
alterations	O
in	O
NO	O
production	O
have	O
been	O
implicated	O
in	O
barrier	O
dysfunction	O
.	O

Finally	O
,	O
our	O
analysis	O
of	O
viral	O
RNA	O
synthesis	O
in	O
ts	O
mutant	O
virus	O
-	O
infected	O
cells	B-ANAT
allows	O
us	O
to	O
discriminate	O
three	O
phenotypes	O
with	O
regard	O
to	O
the	O
inability	O
of	O
specific	O
mutants	O
to	O
synthesize	O
viral	O
RNA	O
at	O
the	O
non	O
-	O
permissive	O
temperature	O
.	O

Kinetic	O
assays	O
indicated	O
that	O
the	O
endodomain	O
(	O
aa102	O
-	O
221	O
)	O
of	O
the	O
membrane	B-ANAT
protein	O
interacts	O
with	O
the	O
nucleocapsid	B-ANAT
protein	O
with	O
high	O
affinity	O
(	O
K	O
(	O
D	O
)=	O
0	O
.	O
55	O
+/-	O
0	O
.	O
04	O
microM	O
),	O
however	O
,	O
this	O
interaction	O
could	O
be	O
weakened	O
greatly	O
by	O
acidification	O
,	O
higher	O
salt	O
concentration	O
(	O
400	O
mM	O
NaCl	O
)	O
and	O
divalent	O
cation	O
(	O
50	O
mM	O
Ca2	O
+),	O
which	O
suggests	O
that	O
electrostatic	O
attraction	O
might	O
play	O
an	O
important	O
role	O
in	O
this	O
interaction	O
.	O

Here	O
,	O
we	O
show	O
that	O
electrostatic	O
interactions	O
between	O
the	O
carboxyl	O
termini	O
of	O
SARS	O
-	O
CoV	O
membrane	B-ANAT
protein	O
and	O
nucleocapsid	B-ANAT
protein	O
largely	O
mediate	O
the	O
interaction	O
of	O
these	O
two	O
proteins	O
.	O

The	O
presence	O
of	O
the	O
YxxPhi	O
and	O
diacidic	O
motifs	O
,	O
located	O
within	O
the	O
cytoplasmic	B-ANAT
tail	I-ANAT
of	O
the	O
3a	O
protein	O
,	O
was	O
not	O
required	O
for	O
its	O
efficient	O
release	O
.	O

ABSTRACT	O
:	O
A	O
previous	O
study	O
demonstrated	O
that	O
infection	O
of	O
rat	O
oligodendrocytes	B-ANAT
by	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
resulted	O
in	O
apoptosis	O
,	O
which	O
is	O
caspase	O
dependent	O
(	O
Y	O
.	O
Liu	O
,	O
Y	O
.	O
Cai	O
,	O
and	O
X	O
.	O
Zhang	O
,	O
J	O
.	O
Virol	O
.	O

Here	O
we	O
determined	O
the	O
involvement	O
of	O
the	O
mitochondrial	B-ANAT
pathway	O
in	O
MHV	O
-	O
induced	O
oligodendrocyte	B-ANAT
apoptosis	O
.	O

Analyses	O
of	O
cytochrome	O
c	O
release	O
further	O
revealed	O
an	O
activation	O
of	O
the	O
mitochondrial	B-ANAT
apoptotic	O
pathway	O
.	O

in	O
virus	O
-	O
infected	O
cells	B-ANAT
,	O
suggesting	O
that	O
Bid	O
may	O
serve	O
as	O
a	O
messenger	O
to	O
relay	O
the	O
signals	O
from	O
caspase	O
-	O
8	O
to	O
mitochondria	B-ANAT
.	O

in	O
cells	B-ANAT
infected	O
with	O
both	O
live	O
and	O
UV	O
-	O
inactivated	O
viruses	O
and	O
that	O
Bax	O
activation	O
was	O
partially	O
blocked	O
by	O
treatment	O
with	O
the	O
caspase	O
-	O
8	O
inhibitor	O
.	O

However	O
,	O
when	O
multiple	O
members	O
of	O
a	O
cardiac	B-ANAT
arrest	O
team	O
were	O
dressing	O
simultaneously	O
,	O
the	O
time	O
to	O
don	O
the	O
PPS	O
increased	O
to	O
between	O
3	O
1	O
/	O
2	O
and	O
5	O
1	O
/	O
2	O
minutes	O
.	O

Errors	O
in	O
infection	O
control	O
as	O
well	O
as	O
in	O
medical	O
management	O
of	O
advanced	O
cardiac	B-ANAT
life	O
support	O
(	O
ACLS	O
)	O
were	O
corrected	O
.	O

Starter	O
intake	O
from	O
d	O
1	O
to	O
56	O
was	O
reduced	O
from	O
919	O
to	O
717	O
g	O
/	O
d	O
in	O
calves	O
fed	O
fixed	B-ANAT
and	O
variable	O
amounts	O
of	O
milk	O
replacer	O
,	O
respectively	O
.	O

Dietary	O
supplement	O
containing	O
bovine	O
serum	B-ANAT
had	O
no	O
effect	O
on	O
any	O
parameter	O
measured	O
.	O

ABSTRACT	O
:	O
Patients	O
with	O
major	O
trauma	O
necessitating	O
the	O
transfusion	O
of	O
packed	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
(	O
PRBCs	O
)	O
are	O
at	O
increased	O
risk	O
for	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

The	O
association	O
between	O
the	O
amount	O
of	O
transfused	O
blood	B-ANAT
and	O
the	O
development	O
of	O
ARDS	O
remained	O
significant	O
in	O
a	O
multivariable	O
logistic	O
regression	O
model	O
accounting	O
for	O
differences	O
in	O
severity	O
of	O
illness	O
,	O
type	O
of	O
trauma	O
,	O
race	O
,	O
gender	O
,	O
and	O
base	O
deficit	O
(	O
p	O
=	O
0	O
.	O
002	O
;	O
odds	O
ratio	O
,	O
14	O
.	O
4	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
3	O
.	O
2	O
-	O
78	O
.	O
7	O
).	O

The	O
simvastatin	O
and	O
control	O
groups	O
underwent	O
60	O
min	O
of	O
superior	B-ANAT
mesenteric	I-ANAT
artery	I-ANAT
occlusion	O
and	O
90	O
min	O
of	O
reperfusion	O
.	O

Compared	O
with	O
the	O
simvastatin	O
group	O
,	O
the	O
control	O
group	O
exhibited	O
significantly	O
more	O
severe	O
intestinal	B-ANAT
I	O
/	O
R	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
,	O
as	O
indicated	O
by	O
lower	O
Pao2	O
and	O
oxygen	O
saturation	O
(	O
P	O
=	O
0	O
.	O
01	O
and	O
P	O
=	O
0	O
.	O
005	O
,	O
respectively	O
)	O
and	O
higher	O
mean	O
values	O
for	O
neutrophil	B-ANAT
infiltration	O
of	O
the	O
lungs	B-ANAT
(	O
P	O
=	O
0	O
.	O
003	O
),	O
total	O
lung	B-ANAT
histopathologic	O
injury	O
score	O
(	O
P	O
=	O
0	O
.	O
003	O
),	O
lung	B-ANAT
wet	O
-	O
to	O
-	O
dry	O
weight	O
ratio	O
(	O
P	O
=	O
0	O
.	O
009	O
),	O
and	O
lung	B-ANAT
-	O
tissue	B-ANAT
malondialdehyde	O
levels	O
(	O
P	O
=	O
0	O
.	O
016	O
).	O

L	O
-	O
SIGN	O
,	O
encoded	O
by	O
CLEC4M	O
(	O
also	O
known	O
as	O
CD209L	O
),	O
is	O
a	O
SARS	O
-	O
CoV	O
binding	O
receptor	O
that	O
has	O
polymorphism	O
in	O
its	O
extracellular	B-ANAT
neck	B-ANAT
region	I-ANAT
encoded	O
by	O
the	O
tandem	O
repeat	O
domain	O
in	O
exon	O
4	O
.	O

TITLE	O
:	O
Intestinal	B-ANAT
invasion	O
and	O
disseminated	O
disease	O
associated	O
with	O
Penicillium	O
chrysogenum	O
.	O

A	O
51	O
year	O
old	O
African	O
-	O
American	O
female	O
presented	O
with	O
an	O
acute	O
abdomen	B-ANAT
and	O
underwent	O
an	O
exploratory	O
laparotomy	O
which	O
revealed	O
an	O
incarcerated	O
peristomal	O
hernia	O
.	O

After	O
all	O
conventional	O
treatment	O
strategies	O
failed	O
,	O
we	O
inserted	O
a	O
pumpless	O
extracorporeal	O
lung	B-ANAT
assist	O
device	O
.	O

CONCLUSIONS	O
:	O
In	O
this	O
case	O
of	O
a	O
severely	O
damaged	O
lung	B-ANAT
,	O
an	O
arteriovenous	O
pumpless	O
extracorporeal	O
lung	B-ANAT
assist	O
was	O
a	O
helpful	O
device	O
to	O
remove	O
elevated	O
CO	O
(	O
2	O
)	O
and	O
reduce	O
mechanical	O
stress	O
by	O
applying	O
minimal	O
ventilation	O
.	O

Research	O
is	O
needed	O
to	O
determine	O
the	O
causes	O
of	O
acute	O
lung	B-ANAT
injury	O
in	O
this	O
population	O
and	O
whether	O
these	O
patients	O
are	O
candidates	O
for	O
evidence	O
-	O
based	O
ventilator	O
strategies	O
to	O
reduce	O
mortality	O
.	O

These	O
viruses	O
are	O
associated	O
with	O
both	O
upper	O
and	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
disease	O
and	O
are	O
likely	O
common	O
human	O
pathogens	O
.	O

We	O
developed	O
a	O
monoclonal	O
antibody	O
against	O
the	O
SARS	O
-	O
CoV	O
nucleoprotein	O
and	O
used	O
it	O
together	O
with	O
in	O
situ	O
hybridization	O
(	O
ISH	O
)	O
to	O
analyze	O
the	O
autopsy	O
lung	B-ANAT
tissues	I-ANAT
of	O
32	O
patients	O
with	O
SARS	O
from	O
Hong	O
Kong	O
and	O
Toronto	O
.	O

SARS	O
-	O
CoV	O
nucleoprotein	O
and	O
RNA	O
were	O
detected	O
by	O
immunohistochemistry	O
and	O
ISH	O
,	O
respectively	O
,	O
primarily	O
in	O
alveolar	B-ANAT
pneumocytes	B-ANAT
and	O
,	O
less	O
frequently	O
,	O
in	O
macrophages	B-ANAT
.	O

The	O
timing	O
of	O
elevations	O
in	O
inflammatory	O
cytokines	O
and	O
CRP	O
is	O
correlated	O
with	O
progression	O
of	O
pulmonary	B-ANAT
infiltrates	O
of	O
SARS	O
patients	O
.	O

The	O
8	O
patients	O
who	O
died	O
tended	O
to	O
have	O
higher	O
peak	O
levels	O
of	O
serum	B-ANAT
TNF	O
-	O
alpha	O
compared	O
to	O
those	O
who	O
survived	O
(	O
14	O
vs	O
9	O
.	O
1	O
pg	O
/	O
mL	O
;	O
p	O
=	O
0	O
.	O
06	O
).	O

In	O
the	O
majority	O
of	O
patients	O
T	B-ANAT
cell	I-ANAT
subsets	I-ANAT
recovered	O
completely	O
to	O
normal	O
range	O
at	O
the	O
second	O
examination	O
.	O

The	O
rate	O
of	O
abnormal	O
chest	B-ANAT
CT	O
was	O
30	O
%	O
at	O
the	O
4	O
fourth	O
examination	O
.	O

The	O
strongest	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
IFN	O
-	O
gamma	O
and	O
CTL	B-ANAT
responses	O
were	O
to	O
the	O
LAMP	O
-	O
N	O
chimera	O
followed	O
by	O
the	O
pN	O
immunogen	O
.	O

A	O
wide	O
variety	O
of	O
pyridine	O
N	O
-	O
oxide	O
derivatives	O
have	O
been	O
found	O
to	O
be	O
inhibitory	O
against	O
feline	O
coronavirus	O
(	O
FIPV	O
strain	O
)	O
and	O
human	O
SARS	O
-	O
CoV	O
(	O
Frankfurt	O
strain	O
-	O
1	O
)	O
in	O
CRFK	O
and	O
simian	O
kidney	B-ANAT
(	O
Vero	O
)	O
cell	B-ANAT
cultures	O
,	O
respectively	O
.	O

The	O
cultures	O
of	O
SARS	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
BJ	O
-	O
01	O
strain	O
infected	O
Vero	B-ANAT
cells	I-ANAT
were	O
inactivated	O
with	O
beta	O
-	O
propiolactone	O
.	O

CNS	B-ANAT
administration	O
of	O
AAV2	O
CUhCLN2	O
did	O
not	O
result	O
in	O
any	O
pathological	O
changes	O
in	O
the	O
brain	B-ANAT
that	O
were	O
attributable	O
to	O
the	O
vector	O
,	O
although	O
microscopic	O
changes	O
were	O
observed	O
along	O
the	O
track	O
consistent	O
with	O
needle	O
trauma	O
.	O

Specific	O
best	O
-	O
fit	O
mediators	O
or	O
mediator	O
pairs	O
varied	O
with	O
aspirate	B-ANAT
type	O
,	O
animal	O
type	O
,	O
and	O
time	O
of	O
injury	O
.	O

The	O
improvements	O
in	O
pulmonary	B-ANAT
gas	O
exchange	O
,	O
systemic	O
blood	B-ANAT
flow	O
and	O
oxygen	O
supply	O
to	O
the	O
tissue	B-ANAT
which	O
have	O
been	O
observed	O
when	O
spontaneous	O
breathing	O
has	O
been	O
maintained	O
during	O
mechanical	O
ventilation	O
are	O
reflected	O
in	O
the	O
clinical	O
improvement	O
in	O
the	O
patient	O
'	O
s	O
condition	O
.	O

In	O
view	O
of	O
the	O
recently	O
available	O
data	O
,	O
it	O
can	O
be	O
concluded	O
that	O
maintained	O
spontaneous	O
breathing	O
during	O
mechanical	O
ventilation	O
should	O
not	O
be	O
suppressed	O
even	O
in	O
patients	O
with	O
severe	O
pulmonary	B-ANAT
functional	O
disorders	O
.	O

A	O
digital	B-ANAT
ring	O
fence	O
is	O
constructed	O
around	O
each	O
location	O
(	O
hot	O
-	O
spot	O
)	O
using	O
Non	O
-	O
Homogeneous	O
Poisson	O
Process	O
(	O
NHPP	O
)	O
modeling	O
based	O
on	O
data	O
of	O
individuals	O
coming	O
into	O
contact	O
with	O
each	O
probable	O
case	O
.	O

ABSTRACT	O
:	O
Sixteen	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
isolates	O
were	O
recovered	O
from	O
broilers	O
and	O
layers	B-ANAT
from	O
five	O
geographic	O
poultry	O
regions	O
in	O
Colombia	O
.	O

ABSTRACT	O
:	O
The	O
reproduction	O
of	O
the	O
new	O
coronavirus	O
HCoV	O
/	O
SPb	B-ANAT
/	O
01	O
/	O
03	O
in	O
the	O
cultured	O
human	B-ANAT
embryo	I-ANAT
lung	B-ANAT
fibroblasts	B-ANAT
(	O
HELFBs	O
)	O
was	O
electron	O
microscopically	O
studied	O
.	O

The	O
pulmonary	B-ANAT
inflammatory	O
reaction	O
in	O
rat	O
models	O
were	O
induced	O
by	O
intratracheal	O
instillation	O
of	O
N	O
-	O
protein	O
of	O
SARS	O
-	O
CoV	O
with	O
a	O
dose	O
of	O
0	O
.	O
2	O
mg	O
/	O
kg	O
.	O

Compared	O
with	O
the	O
total	O
WBC	B-ANAT
of	O
peripheral	B-ANAT
blood	I-ANAT
in	O
Nc	O
group	O
[(	O
5	O
.	O
86	O
+/-	O

Analysis	O
of	O
BALF	O
differential	O
cell	B-ANAT
counts	O
showed	O
that	O
the	O
majority	O
of	O
cells	B-ANAT
were	O
alveolar	B-ANAT
macrophages	I-ANAT
in	O
all	O
groups	O
.	O

Postmortem	B-ANAT
tissue	I-ANAT
samples	O
show	O
high	O
levels	O
of	O
viral	O
antigen	O
within	O
the	O
respiratory	O
endothelium	B-ANAT
,	O
but	O
it	O
is	O
not	O
clear	O
how	O
the	O
virus	O
can	O
traverse	O
the	O
respiratory	B-ANAT
epithelium	I-ANAT
in	O
order	O
to	O
initiate	O
infection	O
in	O
the	O
microvasculature	B-ANAT
.	O

ABSTRACT	O
:	O
Murine	O
hepatitis	O
coronavirus	O
(	O
MHV	O
)-	O
A59	O
infection	O
depends	O
on	O
the	O
interaction	O
of	O
its	O
spike	O
(	O
S	O
)	O
protein	O
with	O
the	O
cellular	B-ANAT
receptor	O
mCEACAM1a	O
present	O
on	O
murine	O
cells	B-ANAT
.	O

Preincubation	O
of	O
MHV	O
with	O
the	O
adapter	O
proteins	O
and	O
subsequent	O
inoculation	O
of	O
human	O
cells	B-ANAT
expressing	O
an	O
artificial	O
His	O
receptor	O
resulted	O
in	O
infection	O
of	O
these	O
otherwise	O
nonsusceptible	O
cells	B-ANAT
and	O
led	O
to	O
subsequent	O
production	O
of	O
progeny	O
virus	O
.	O

Furthermore	O
,	O
inoculation	O
of	O
human	O
target	B-ANAT
cells	I-ANAT
with	O
the	O
virus	O
resulted	O
in	O
a	O
His	O
receptor	O
-	O
specific	O
infection	O
that	O
was	O
multiround	O
.	O

Extensive	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
and	O
rapid	O
cell	B-ANAT
killing	O
of	O
infected	O
target	B-ANAT
cells	I-ANAT
was	O
observed	O
.	O

The	O
cytoplasmic	B-ANAT
tail	I-ANAT
of	O
S	O
has	O
previously	O
been	O
shown	O
to	O
be	O
required	O
for	O
assembly	O
.	O

In	O
contrast	O
,	O
the	O
S260	O
-	O
600	O
protein	O
did	O
not	O
bind	O
NIH3T3	O
cells	B-ANAT
.	O

TITLE	O
:	O
Impact	O
of	O
human	O
metapneumovirus	O
and	O
human	O
cytomegalovirus	O
versus	O
other	O
respiratory	O
viruses	O
on	O
the	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
of	O
lung	B-ANAT
transplant	B-ANAT
recipients	O
.	O

In	O
bronchoalveolar	O
lavage	O
samples	O
,	O
hMPV	O
predominated	O
by	O
far	O
over	O
the	O
other	O
viruses	O
,	O
being	O
responsible	O
for	O
60	O
%	O
of	O
positive	O
specimens	O
,	O
whereas	O
other	O
viruses	O
were	O
present	O
in	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
at	O
a	O
comparable	O
rate	O
.	O

Finally	O
,	O
some	O
mouse	O
strains	O
resist	O
experimental	O
infections	O
by	O
the	O
mouse	O
cytomegalovirus	O
1	O
(	O
MCMV	O
-	O
1	O
)	O
because	O
,	O
once	O
infected	O
,	O
these	O
mice	O
synthesise	O
a	O
molecule	O
at	O
the	O
surface	O
of	O
infected	O
cells	B-ANAT
which	O
allows	O
immediate	O
recognition	O
and	O
killing	O
by	O
natural	O
killer	O
(	O
NK	O
)	O
cells	B-ANAT
.	O

Embryo	B-ANAT
transfers	O
were	O
successful	O
only	O
in	O
one	O
affected	O
line	O
.	O

In	O
18	O
patients	O
,	O
serum	B-ANAT
antibody	O
profiles	O
were	O
investigated	O
and	O
antibody	O
neutralization	O
tests	O
were	O
performed	O
from	O
7	O
to	O
720	O
days	O
after	O
the	O
onset	O
of	O
symptoms	O
.	O

Neutralizing	O
viral	O
antibodies	O
were	O
demonstrated	O
in	O
the	O
convalescence	O
sera	B-ANAT
from	O
SARS	O
patients	O
.	O

Injection	O
of	O
20mug	O
of	O
the	O
mixture	O
of	O
pVAX1	O
-	O
M	O
and	O
pVAX1	O
-	O
N	O
into	O
the	O
Balb	O
/	O
c	O
mice	O
could	O
elicit	O
the	O
humoral	O
and	O
cellular	B-ANAT
responses	O
.	O

ABSTRACT	O
:	O
To	O
report	O
the	O
efficacy	O
and	O
findings	O
of	O
a	O
large	O
-	O
scale	O
preventive	O
screening	O
program	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
using	O
amplification	O
of	O
the	O
virus	O
from	O
a	O
nasopharyngeal	B-ANAT
swab	I-ANAT
(	O
NPS	O
)	O
obtained	O
from	O
the	O
health	O
-	O
care	O
workers	O
(	O
HCWs	O
).	O

TITLE	O
:	O
Underuse	O
of	O
lung	B-ANAT
protective	O
ventilation	O
:	O
analysis	O
of	O
potential	O
factors	O
to	O
explain	O
physician	O
behavior	O
.	O

ABSTRACT	O
:	O
The	O
induction	O
of	O
mucosal	B-ANAT
immunity	O
is	O
very	O
important	O
in	O
conferring	O
protection	O
against	O
pathogens	O
that	O
typically	O
invade	O
via	O
mucosal	B-ANAT
surfaces	O
.	O

Thus	O
,	O
dose	O
levels	O
for	O
protein	O
subunit	O
vaccines	O
are	O
likely	O
to	O
be	O
very	O
high	O
and	O
the	O
antigen	O
may	O
need	O
to	O
be	O
protected	O
from	O
proteolysis	O
for	O
oral	B-ANAT
delivery	O
to	O
be	O
efficacious	O
.	O

Fusions	O
to	O
carrier	O
molecules	O
can	O
stabilize	O
the	O
expressed	O
antigen	O
,	O
aid	O
in	O
antigen	O
enrichment	O
or	O
purification	O
strategies	O
,	O
and	O
facilitate	O
delivery	O
to	O
effector	O
sites	O
in	O
the	O
gastrointestinal	B-ANAT
tract	I-ANAT
.	O

Therefore	O
,	O
the	O
short	O
extracellular	B-ANAT
domain	O
may	O
be	O
a	O
valuable	O
immunogen	O
in	O
the	O
development	O
of	O
a	O
vaccine	O
for	O
infectious	O
SARS	O
.	O

Even	O
when	O
there	O
is	O
clinical	O
and	O
radiologic	O
evidence	O
of	O
catheter	O
positioning	O
,	O
vascular	B-ANAT
perforation	O
should	O
be	O
suspected	O
in	O
patients	O
with	O
a	O
central	O
venous	B-ANAT
catheter	O
and	O
bilateral	O
pleural	B-ANAT
effusion	I-ANAT
who	O
present	O
respiratory	O
insufficiency	O
and	O
hemodynamic	O
instability	O
.	O

Whereas	O
cellular	B-ANAT
immunity	O
controls	O
acute	O
infection	O
,	O
humoral	O
immunity	O
regulates	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
persistence	O
.	O

Nevertheless	O
,	O
virus	O
-	O
specific	O
ASC	O
induced	O
by	O
peripheral	O
infection	O
localized	O
to	O
both	O
spleen	B-ANAT
and	O
BM	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
caused	O
by	O
pneumonia	O
after	O
renal	B-ANAT
transplantation	O
was	O
usually	O
associated	O
with	O
overimmunosuppression	O
and	O
high	O
mortality	O
rate	O
.	O

Recombinant	O
M	O
was	O
transported	O
to	O
the	O
plasma	B-ANAT
membrane	I-ANAT
and	O
gained	O
complex	O
-	O
type	O
N	O
-	O
glycosylation	O
.	O

HCoV	O
-	O
HKU1	O
can	O
be	O
detected	O
in	O
respiratory	O
and	O
stool	B-ANAT
samples	O
from	O
children	O
and	O
adults	O
in	O
a	O
part	O
of	O
the	O
world	O
other	O
than	O
Hong	O
Kong	O
.	O

CONCLUSIONS	O
:	O
HCoV	O
-	O
HKU1	O
can	O
be	O
detected	O
in	O
respiratory	O
and	O
stool	B-ANAT
samples	O
from	O
children	O
and	O
adults	O
in	O
a	O
part	O
of	O
the	O
world	O
other	O
than	O
Hong	O
Kong	O
.	O

ABSTRACT	O
:	O
A	O
study	O
was	O
undertaken	O
to	O
investigate	O
the	O
aerobic	O
capacity	O
and	O
pulmonary	B-ANAT
function	O
of	O
children	O
6	O
and	O
15	O
months	O
after	O
the	O
diagnosis	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

Residual	O
high	O
resolution	O
computed	O
tomography	O
of	O
thorax	B-ANAT
(	O
HRCT	O
)	O
abnormalities	O
were	O
present	O
in	O
14	O
patients	O
.	O

Absolute	O
and	O
mass	O
related	O
peak	O
V	O
o	O
(	O
2	O
)	O
in	O
the	O
patient	O
group	O
remained	O
impaired	O
at	O
15	O
months	O
despite	O
normalisation	O
of	O
lung	B-ANAT
function	O
in	O
all	O
patients	O
.	O

Absolute	O
and	O
mass	O
related	O
peak	O
V	O
o	O
(	O
2	O
)	O
in	O
the	O
patient	O
group	O
remained	O
impaired	O
at	O
15	O
months	O
despite	O
normalisation	O
of	O
lung	B-ANAT
function	O
in	O
all	O
patients	O
.	O

Pressure	O
-	O
volume	O
(	O
PV	O
)	O
curves	O
of	O
the	O
respiratory	B-ANAT
system	I-ANAT
were	O
obtained	O
,	O
and	O
upper	O
and	O
lower	O
inflection	O
points	O
(	O
UIP	O
,	O
LIP	B-ANAT
)	O
and	O
recruitment	O
were	O
estimated	O
.	O

TITLE	O
:	O
Acute	O
and	O
sustained	O
effects	O
of	O
lucinactant	O
versus	O
poractant	O
-	O
alpha	O
on	O
pulmonary	B-ANAT
gas	O
exchange	O
and	O
mechanics	O
in	O
premature	O
lambs	O
with	O
respiratory	O
distress	O
syndrome	O
.	O

Among	O
preterm	O
lambs	O
with	O
severe	O
RDS	O
,	O
lucinactant	O
produced	O
improvements	O
in	O
gas	O
exchange	O
and	O
lung	B-ANAT
mechanics	O
similar	O
to	O
those	O
observed	O
with	O
a	O
porcine	O
-	O
derived	O
surfactant	O
.	O

Two	O
to	O
7	O
days	O
after	O
infection	O
,	O
the	O
hamsters	O
were	O
killed	O
,	O
and	O
their	O
lungs	B-ANAT
were	O
collected	O
for	O
evaluation	O
of	O
viral	O
titers	O
and	O
pathological	O
findings	O
.	O

Although	O
it	O
is	O
highly	O
possible	O
that	O
direct	O
pulmonary	B-ANAT
damage	O
might	O
be	O
the	O
cause	O
of	O
ARDS	O
,	O
there	O
is	O
no	O
preclinical	O
information	O
about	O
the	O
pulmonary	B-ANAT
toxicity	O
of	O
CHX	O
.	O

The	O
fibrotic	O
changes	O
and	O
intra	O
-	O
alveolar	B-ANAT
inflammatory	B-ANAT
cells	I-ANAT
had	O
decreased	O
but	O
were	O
still	O
observed	O
sporadically	O
28	O
and	O
84	O
days	O
after	O
exposure	O
.	O

Identified	O
SARS	O
-	O
CoV	O
infection	O
risk	O
factors	O
include	O
working	O
in	O
the	O
same	O
building	O
as	O
the	O
hospital	O
'	O
s	O
emergency	O
room	O
and	O
infection	O
ward	O
,	O
providing	O
direct	O
care	O
to	O
SARS	O
patients	O
,	O
and	O
carrying	O
a	O
Cw	O
*	O
0801	O
HLA	B-ANAT
allele	O
.	O

The	O
ATS	O
/	O
ERS	O
classification	O
of	O
2002	O
comprises	O
seven	O
entities	O
:	O
usual	O
interstitial	B-ANAT
pneumonia	O
(	O
UIP	O
),	O
non	O
-	O
specific	O
interstitial	B-ANAT
pneumonia	O
(	O
NSIP	O
),	O
desquamative	O
interstitial	B-ANAT
pneumonia	O
(	O
DIP	O
),	O
respiratory	O
bronchiolitis	O
-	O
associated	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
(	O
RB	O
-	O
ILD	O
),	O
cryptogenic	O
organizing	O
pneumonia	O
(	O
COP	O
),	O
lymphocyte	B-ANAT
interstitial	B-ANAT
pneumonia	O
(	O
LIP	B-ANAT
),	O
and	O
acute	O
interstitial	B-ANAT
pneumonia	O
(	O
AIP	O
).	O

Our	O
recent	O
study	O
demonstrated	O
that	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
coronavirus	O
(	O
CoV	O
)	O
infection	O
of	O
monkey	O
kidney	B-ANAT
Vero	O
E6	O
cells	B-ANAT
induces	O
phosphorylation	O
and	O
dephosphorylation	O
of	O
signaling	O
pathways	O
,	O
resulting	O
in	O
apoptosis	O
.	O

TITLE	O
:	O
The	O
contribution	O
of	O
biophysical	O
lung	B-ANAT
injury	O
to	O
the	O
development	O
of	O
biotrauma	O
.	O

According	O
to	O
this	O
hypothesis	O
,	O
mechanical	O
ventilation	O
per	O
se	O
,	O
by	O
altering	O
both	O
the	O
magnitude	O
and	O
the	O
pattern	O
of	O
lung	B-ANAT
stretch	O
,	O
can	O
cause	O
changes	O
in	O
gene	O
expression	O
and	O
/	O
or	O
cellular	B-ANAT
metabolism	O
that	O
ultimately	O
can	O
lead	O
to	O
the	O
development	O
of	O
an	O
overwhelming	O
inflammatory	O
response	O
-	O
even	O
in	O
the	O
absence	O
of	O
overt	O
structural	O
damage	O
.	O

RESULTS	O
:	O
Epitopes	O
at	O
the	O
N	O
-	O
terminus	O
of	O
the	O
membrane	B-ANAT
protein	O
and	O
the	O
C	O
-	O
terminus	O
of	O
nucleocapsid	B-ANAT
protein	O
elicited	O
strong	O
antibody	O
responses	O
.	O

We	O
amplified	O
,	O
by	O
RT	O
-	O
PCR	O
,	O
group	O
2	O
coronavirus	O
-	O
specific	O
hemagglutination	O
/	O
esterase	O
genes	O
in	O
the	O
oral	B-ANAT
swabs	O
of	O
a	O
total	O
of	O
10	O
young	O
pups	O
presenting	O
with	O
or	O
having	O
recovered	O
from	O
respiratory	O
signs	O
,	O
or	O
having	O
anti	O
-	O
BCoV	O
antibodies	O
,	O
with	O
the	O
result	O
that	O
2	O
pups	O
were	O
positive	O
for	O
the	O
hemagglutination	O
/	O
esterase	O
genes	O
.	O

ABSTRACT	O
:	O
Inhibition	O
of	O
viral	O
assembly	O
(	O
protease	O
inhibitors	O
)	O
and	O
of	O
fusion	O
of	O
viral	O
and	O
target	O
membranes	B-ANAT
(	O
fusion	O
inhibitors	O
)	O
are	O
general	O
approaches	O
to	O
antiviral	O
treatment	O
,	O
not	O
specific	O
for	O
HIV	O
.	O

TITLE	O
:	O
Automated	O
extraction	O
protocol	O
for	O
quantification	O
of	O
SARS	O
-	O
coronavirus	O
RNA	O
in	O
serum	B-ANAT
:	O
an	O
evaluation	O
study	O
.	O

ABSTRACT	O
:	O
We	O
have	O
previously	O
developed	O
a	O
test	O
for	O
the	O
diagnosis	O
and	O
prognostic	O
assessment	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
based	O
on	O
the	O
detection	O
of	O
the	O
SARS	O
-	O
coronavirus	O
RNA	O
in	O
serum	B-ANAT
by	O
real	O
-	O
time	O
quantitative	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
).	O

We	O
developed	O
a	O
modified	O
protocol	O
in	O
compliance	O
with	O
the	O
recommended	O
biosafety	O
guidelines	O
from	O
the	O
World	O
Health	O
Organization	O
based	O
on	O
the	O
use	O
of	O
the	O
MagNA	O
Pure	O
total	O
nucleic	B-ANAT
acid	O
large	O
volume	O
isolation	O
kit	O
for	O
the	O
extraction	O
of	O
SARS	O
-	O
coronavirus	O
RNA	O
.	O

The	O
modified	O
protocol	O
was	O
compared	O
with	O
a	O
column	B-ANAT
-	O
based	O
extraction	O
kit	O
(	O
QIAamp	O
viral	O
RNA	O
mini	O
kit	O
,	O
Qiagen	O
)	O
for	O
quantitative	O
performance	O
,	O
analytical	O
sensitivity	O
and	O
precision	O
.	O

As	O
the	O
diagnostic	O
efficiency	O
and	O
prognostic	O
value	O
of	O
the	O
serum	B-ANAT
SARS	O
-	O
CoV	O
RNA	O
RT	O
-	O
PCR	O
test	O
is	O
critically	O
associated	O
with	O
the	O
analytical	O
sensitivity	O
and	O
quantitative	O
performance	O
contributed	O
both	O
by	O
the	O
RNA	O
extraction	O
and	O
RT	O
-	O
PCR	O
components	O
of	O
the	O
test	O
,	O
we	O
recommend	O
the	O
use	O
of	O
the	O
column	B-ANAT
-	O
based	O
manual	O
RNA	O
extraction	O
method	O
.	O

Then	O
the	O
recombinant	O
plasmids	O
were	O
transfected	O
into	O
HepG2	B-ANAT
cells	I-ANAT
and	O
the	O
luciferase	O
activities	O
were	O
detected	O
.	O

A	O
set	O
of	O
deletion	O
mutant	O
plasmids	O
,	O
of	O
which	O
pGL3	O
-	O
5	O
'	O
UTR	O
-	O
1	O
,	O
pGL3	O
-	O
5	O
'	O
UTR	O
-	O
2	O
,	O
pGL3	O
-	O
5	O
'	O
UTR	O
-	O
3	O
and	O
pGL3	O
-	O
5	O
'	O
UTR	O
-	O
4	O
are	O
with	O
3	O
,	O
2	O
,	O
1	O
,	O
and	O
0	O
residual	O
stem	B-ANAT
-	O
loops	O
of	O
3	O
'	O
termini	O
respectively	O
,	O
were	O
constructed	O
from	O
pGL3	O
-	O
5	O
'	O
UTR	O
and	O
were	O
transfected	O
into	O
HepG2	B-ANAT
cells	I-ANAT
to	O
express	O
reporter	O
gene	O
luc	O
+,	O
with	O
pGL3	O
-	O
5	O
'	O
UTR	O
containing	O
full	O
sequence	O
as	O
control	O
.	O

The	O
SARS	O
-	O
CoV	O
5	O
'	O
UTR	O
RNA	O
folded	O
to	O
form	O
a	O
stable	O
secondary	O
structure	O
containing	O
four	O
stem	B-ANAT
-	O
loop	O
domains	O
.	O

However	O
,	O
when	O
lost	O
stem	B-ANAT
-	O
loop	O
I	O
and	O
II	O
,	O
the	O
pGL3	O
-	O
5	O
'	O
UTR	O
-	O
2	O
,	O
pGL3	O
-	O
5	O
'	O
UTR	O
-	O
3	O
and	O
pGL3	O
-	O
5	O
'	O
UTR	O
-	O
4	O
almost	O
didn	O
'	O
t	O
express	O
luciferase	O
.	O

casei	O
was	O
detected	O
specifically	O
in	O
the	O
intestinal	B-ANAT
chyme	B-ANAT
of	O
chickens	O
(	O
10	O
d	O
of	O
age	O
,	O
Julia	O
strain	O
)	O
fed	O
ad	O
libitum	O
on	O
a	O
diet	O
supplemented	O
with	O
75	O
mg	O
dextran	O
/	O
kg	O
(	O
dextran	O
-	O
supplemented	O
diet	O
,	O
DSD	O
)	O
and	O
administered	O
orally	B-ANAT
with	O
10	O
(	O
7	O
)	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
)	O
L	O
.	O
casei	O
subsp	O
.	O

DC	O
function	O
was	O
impaired	O
after	O
MHV	O
-	O
JHM	O
infection	O
,	O
resulting	O
in	O
decreased	O
stimulation	O
of	O
CD8	O
T	B-ANAT
cells	I-ANAT
in	O
vitro	O
.	O

Although	O
we	O
could	O
not	O
detect	O
infected	O
DCs	O
in	O
vivo	O
,	O
both	O
CD8	O
(+)	O
and	O
CD11b	O
(+)	O
splenic	B-ANAT
DCs	O
were	O
susceptible	O
to	O
infection	O
with	O
MHV	O
-	O
JHM	O
directly	O
ex	O
vivo	O
.	O

Histopathology	O
on	O
intestines	B-ANAT
showed	O
scattered	O
dilated	O
crypts	O
with	O
necrotic	O
cellular	B-ANAT
debris	O
and	O
neutrophils	B-ANAT
.	O

Necropsy	O
revealed	O
a	O
severe	O
ileo	B-ANAT
-	O
cecal	B-ANAT
intussusception	O
and	O
segmental	O
necrotic	O
enteritis	O
of	O
the	O
small	B-ANAT
intestine	I-ANAT
.	O

ABSTRACT	O
:	O
Mathematical	O
models	O
are	O
used	O
to	O
quantify	O
the	O
effect	O
of	O
border	B-ANAT
control	O
measures	O
in	O
reducing	O
the	O
international	O
spread	O
of	O
SARS	O
.	O

This	O
protective	O
ability	O
of	O
the	O
WKV	O
vaccine	O
correlated	O
with	O
the	O
induction	O
of	O
high	O
serum	B-ANAT
neutralizing	O
-	O
antibody	O
titres	O
,	O
but	O
not	O
with	O
cellular	B-ANAT
immune	O
responses	O
as	O
measured	O
by	O
gamma	O
interferon	O
secretion	B-ANAT
by	O
mouse	O
splenocytes	O
.	O

The	O
compliance	O
of	O
the	O
respiratory	B-ANAT
system	I-ANAT
obtained	O
from	O
the	O
pressure	O
-	O
volume	O
curves	O
was	O
significantly	O
correlated	O
with	O
markers	O
for	O
collagen	B-ANAT
turn	O
-	O
over	O
(	O
type	O
III	O
procollagen	O
peptide	O
and	O
matrix	O
metalloproteinase	O
2	O
)	O
and	O
with	O
markers	O
of	O
surfactant	O
degradation	O
(	O
type	O
-	O
IIA	O
secretory	O
phospholipase	O
A2	O
).	O

These	O
preliminary	O
data	O
suggest	O
that	O
a	O
severe	O
reduction	O
in	O
compliance	O
in	O
the	O
early	O
phase	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
is	O
associated	O
with	O
both	O
collagen	B-ANAT
deposition	O
and	O
surfactant	O
degradation	O
.	O

Following	O
intracranial	B-ANAT
(	O
i	O
.	O
c	O
.)	O
infection	O
of	O
susceptible	O
mice	O
with	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
),	O
mice	O
develop	O
an	O
acute	O
encephalomyelitis	O
followed	O
by	O
a	O
chronic	O
demyelinating	O
disease	O
.	O

We	O
studied	O
nasopharyngeal	B-ANAT
viral	O
load	O
of	O
SARS	O
patients	O
on	O
admission	O
and	O
their	O
geographic	O
distribution	O
.	O

Nevertheless	O
,	O
despite	O
earlier	O
and	O
prolonged	O
T	B-ANAT
cell	I-ANAT
-	O
mediated	O
control	O
in	O
the	O
CNS	B-ANAT
of	O
vaccinated	O
mice	O
,	O
virus	O
ultimately	O
reactivated	O
.	O

We	O
found	O
that	O
peptides	O
corresponding	O
to	O
residues	O
1	O
-	O
30	O
,	O
86	O
-	O
100	O
,	O
306	O
-	O
320	O
,	O
and	O
351	O
-	O
365	O
contained	O
murine	O
immunodominant	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
epitopes	O
.	O

ABSTRACT	O
:	O
A	O
recombinant	O
SARS	O
-	O
CoV	O
spike	O
(	O
S	O
)	O
glycoprotein	O
vaccine	O
produced	O
in	O
insect	O
cells	B-ANAT
in	O
a	O
pre	O
-	O
clinical	O
development	O
stage	O
is	O
described	O
.	O

TITLE	O
:	O
Disseminated	O
adenovirus	O
infection	O
with	O
respiratory	O
failure	O
in	O
pediatric	O
liver	B-ANAT
transplant	B-ANAT
recipients	O
:	O
impact	O
of	O
intravenous	O
cidofovir	O
and	O
inhaled	O
nitric	O
oxide	O
.	O

TITLE	O
:	O
Acute	O
lung	B-ANAT
infections	O
in	O
normal	O
and	O
immunocompromised	O
hosts	O
.	O

TITLE	O
:	O
Insulin	O
attenuates	O
endotoxin	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
in	O
conscious	O
rats	O
.	O

The	O
protein	O
can	O
be	O
translocated	O
to	O
the	O
cell	B-ANAT
surface	I-ANAT
and	O
is	O
partially	O
associated	O
with	O
lipid	B-ANAT
rafts	I-ANAT
.	O

However	O
,	O
the	O
CNS	B-ANAT
inflammatory	B-ANAT
cell	I-ANAT
composition	O
and	O
CD8	O
(+)	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
effector	O
functions	O
were	O
similar	O
between	O
transgenic	O
and	O
wild	O
-	O
type	O
mice	O
,	O
supporting	O
unimpaired	O
peripheral	O
and	O
CNS	B-ANAT
immune	O
responses	O
in	O
transgenic	O
mice	O
.	O

In	O
addition	O
,	O
the	O
absence	O
of	O
a	O
correlation	O
between	O
increased	O
oligodendroglial	O
infection	O
and	O
the	O
extent	O
of	O
demyelination	O
suggests	O
a	O
complex	O
pathobiology	O
of	O
myelin	B-ANAT
loss	O
in	O
which	O
infection	O
of	O
oligodendroglia	B-ANAT
is	O
required	O
but	O
not	O
sufficient	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
caused	O
by	O
a	O
novel	O
coronavirus	O
,	O
SARS	O
-	O
CoV	O
.	O
Virus	O
entry	O
into	O
cells	B-ANAT
is	O
mediated	O
through	O
interactions	O
between	O
spike	O
(	O
S	O
)	O
glycoprotein	O
and	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
).	O

Clinical	O
disease	O
,	O
CNS	B-ANAT
inflammation	O
and	O
demyelination	O
in	O
infected	O
IL	O
-	O
15	O
-/-	O
mice	O
were	O
similar	O
to	O
wild	O
-	O
type	O
mice	O
.	O

IL	O
-	O
15	O
and	O
NK	B-ANAT
cells	I-ANAT
thus	O
appear	O
dispensable	O
for	O
anti	O
-	O
viral	O
immunity	O
and	O
CNS	B-ANAT
pathogenesis	O
during	O
acute	O
JHMV	O
infection	O
.	O

With	O
a	O
view	O
to	O
facilitating	O
the	O
development	O
of	O
such	O
compounds	O
,	O
crystals	B-ANAT
were	O
obtained	O
of	O
the	O
enzyme	O
at	O
pH	O
6	O
.	O
5	O
in	O
the	O
orthorhombic	O
space	O
group	O
P2	O
(	O
1	O
)	O
2	O
(	O
1	O
)	O
2	O
that	O
diffract	O
to	O
a	O
resolution	O
of	O
1	O
.	O
9	O
A	O
.	O
These	O
crystals	B-ANAT
contain	O
one	O
monomer	O
per	O
asymmetric	O
unit	O
and	O
the	O
biologically	O
active	O
dimer	O
is	O
generated	O
via	O
the	O
crystallographic	O
twofold	O
axis	B-ANAT
.	O

The	O
results	O
showed	O
(	O
i	O
)	O
identical	O
sequences	O
from	O
different	O
animals	O
in	O
the	O
same	O
herds	O
and	O
from	O
paired	O
nasal	B-ANAT
and	O
fecal	B-ANAT
samples	O
,	O
suggesting	O
a	O
dominant	O
virus	O
circulating	O
in	O
each	O
herd	O
at	O
a	O
given	O
time	O
;	O
(	O
ii	O
)	O
sequence	O
differences	O
among	O
four	O
outbreaks	O
in	O
different	O
years	O
in	O
the	O
same	O
herd	O
,	O
indicating	O
new	O
introduction	O
of	O
virus	O
;	O
(	O
iii	O
)	O
identical	O
sequences	O
in	O
four	O
different	O
Danish	O
herds	O
in	O
samples	O
obtained	O
within	O
2	O
months	O
,	O
implying	O
virus	O
transmission	O
between	O
herds	O
;	O
and	O
(	O
iv	O
)	O
that	O
at	O
least	O
two	O
different	O
virus	O
strains	O
were	O
involved	O
in	O
the	O
outbreaks	O
of	O
BCoV	O
in	O
Denmark	O
during	O
the	O
spring	O
of	O
2003	O
.	O

The	O
lack	O
of	O
effect	O
of	O
furin	O
cleavage	O
on	O
virion	B-ANAT
infectivity	O
mirrors	O
that	O
observed	O
in	O
the	O
normally	O
cleaved	B-ANAT
S	O
glycoprotein	O
of	O
the	O
murine	O
coronavirus	O
and	O
highlights	O
an	O
additional	O
level	O
of	O
complexity	O
in	O
coronavirus	O
entry	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
the	O
association	O
between	O
body	B-ANAT
mass	O
index	O
(	O
BMI	O
)	O
and	O
hospital	O
mortality	O
for	O
critically	O
ill	O
adults	O
.	O

ABSTRACT	O
:	O
To	O
review	O
the	O
involvement	O
of	O
coagulation	O
and	O
fibrinolysis	O
in	O
the	O
pathogenesis	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
pulmonary	B-ANAT
infection	O
,	O
and	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
(	O
VILI	O
).	O

Intracerebral	O
inoculation	O
of	O
HCoV	O
-	O
OC43	O
into	O
BALB	O
/	O
c	O
mice	O
led	O
to	O
an	O
acute	O
encephalitis	O
with	O
neuronal	O
cell	B-ANAT
death	O
by	O
necrosis	O
and	O
apoptosis	O
.	O

Herein	O
,	O
we	O
report	O
a	O
two	O
years	O
old	O
girl	O
that	O
developed	O
acute	O
renal	B-ANAT
failure	O
due	O
to	O
an	O
hemolytic	O
uremic	O
syndrome	O
.	O

Proteinorahia	O
in	O
liquor	B-ANAT
was	O
found	O
among	O
10	O
cases	O
(	O
4	O
during	O
first	O
and	O
6	O
during	O
the	O
second	O
week	O
of	O
illness	O
).	O

Important	O
developments	O
in	O
the	O
identification	O
,	O
characterization	O
and	O
clinical	O
utility	O
of	O
inhibitors	O
of	O
human	O
immunodeficiency	O
virus	O
;	O
the	O
hepatitis	O
viruses	O
,	O
hepatitis	O
B	O
,	O
hepatitis	O
C	O
;	O
the	O
herpes	O
family	O
of	O
viruses	O
,	O
herpes	O
simplex	B-ANAT
viruses	O
1	O
and	O
2	O
,	O
varicella	O
zoster	O
virus	O
,	O
Epstein	O
-	O
Barr	O
virus	O
and	O
human	O
cytomegalovirus	O
;	O
the	O
respiratory	O
viruses	O
,	O
influenza	O
,	O
respiratory	O
syncytial	O
virus	O
,	O
human	O
metapneumovirus	O
,	O
picornaviruses	O
,	O
measles	O
and	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
;	O
human	O
papilloma	O
virus	O
;	O
rotavirus	O
;	O
Ebola	O
virus	O
and	O
West	O
Nile	O
virus	O
,	O
are	O
reviewed	O
.	O

Four	O
of	O
six	O
patients	O
had	O
serological	O
and	O
RT	O
-	O
PCR	O
evidence	O
of	O
recent	O
infection	O
of	O
SARS	O
-	O
CoV	O
.	O
Morphologic	O
changes	O
are	O
summarized	O
as	O
follows	O
:	O
(	O
1	O
)	O
Diffuse	O
and	O
bilateral	O
lung	B-ANAT
consolidation	O
was	O
seen	O
in	O
all	O
patients	O
(	O
6	O
/	O
6	O
)	O
with	O
increasing	O
lung	B-ANAT
weight	O
.	O

In	O
addition	O
,	O
electron	O
microscopy	O
revealed	O
viral	B-ANAT
particles	I-ANAT
in	O
the	O
cytoplasm	B-ANAT
of	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
and	O
endothelial	B-ANAT
cells	I-ANAT
corresponding	O
to	O
coronavirus	O
.	O

RESULTS	O
:	O
The	O
patients	O
with	O
ARDS	O
and	O
brain	B-ANAT
imaging	O
had	O
cognitive	O
impairments	O
,	O
significant	O
brain	B-ANAT
atrophy	O
,	O
ventricular	B-ANAT
enlargement	O
and	O
53	O
%	O
had	O
atrophy	O
or	O
lesions	O
by	O
radiological	O
report	O
.	O

These	O
microarrays	O
were	O
used	O
to	O
screen	O
approximately	O
400	O
Canadian	O
sera	B-ANAT
from	O
the	O
SARS	O
outbreak	O
,	O
including	O
samples	O
from	O
confirmed	O
SARS	O
-	O
CoV	O
cases	O
,	O
respiratory	O
illness	O
patients	O
,	O
and	O
healthcare	O
professionals	O
.	O

Therefore	O
,	O
the	O
molecular	O
basis	O
of	O
coronavirus	O
fusion	O
during	O
entry	O
into	O
host	O
cells	B-ANAT
remains	O
incompletely	O
defined	O
.	O

These	O
data	O
are	O
the	O
first	O
direct	O
measure	O
of	O
virus	O
-	O
cell	B-ANAT
fusion	O
for	O
any	O
coronavirus	O
and	O
demonstrate	O
that	O
the	O
coronavirus	O
IBV	O
employs	O
a	O
direct	O
,	O
low	O
-	O
pH	O
-	O
dependent	O
virus	O
-	O
cell	B-ANAT
fusion	O
activation	O
reaction	O
.	O

ABSTRACT	O
:	O
To	O
understand	O
the	O
roles	O
of	O
heptad	O
repeat	O
1	O
(	O
HR1	O
)	O
and	O
HR2	O
of	O
the	O
spike	O
(	O
S	O
)	O
protein	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
in	O
virus	O
-	O
cell	B-ANAT
interactions	O
,	O
the	O
conserved	O
Leu	O
or	O
Ile	O
residues	O
located	O
at	O
positions	O
913	O
,	O
927	O
,	O
941	O
,	O
and	O
955	O
in	O
HR1	O
and	O
1151	O
,	O
1165	O
,	O
and	O
1179	O
in	O
HR2	O
were	O
individually	O
replaced	O
with	O
an	O
alpha	O
-	O
helix	O
-	O
breaker	O
Pro	O
residue	O
.	O

The	O
first	O
step	O
consisted	O
in	O
the	O
introduction	O
of	O
each	O
end	O
of	O
the	O
viral	B-ANAT
genome	I-ANAT
into	O
the	O
BAC	O
with	O
accessory	O
sequences	O
allowing	O
proper	O
transcription	O
.	O

ABSTRACT	O
:	O
A	O
67	O
-	O
year	O
-	O
old	O
patient	O
with	O
newly	O
diagnosed	O
acute	O
myeloid	O
leukemia	O
developed	O
acute	O
respiratory	O
failure	O
with	O
high	O
-	O
grade	O
fever	O
and	O
bilateral	O
pulmonary	B-ANAT
infiltrates	O
.	O

One	O
week	O
after	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
admission	O
,	O
erythematous	O
skin	B-ANAT
lesions	O
appeared	O
at	O
the	O
vascular	B-ANAT
catheter	O
puncture	O
sites	O
.	O

CONCLUSIONS	O
:	O
We	O
speculate	O
that	O
corticosteroid	O
with	O
higher	O
in	O
-	O
vitro	O
inflammatory	O
potency	O
administered	O
at	O
timing	O
and	O
dosages	O
commensurate	O
with	O
disease	O
severity	O
may	O
be	O
conducive	O
to	O
better	O
outcome	O
from	O
SARS	O
as	O
a	O
consequence	O
of	O
more	O
effective	O
control	O
of	O
immunopathological	O
lung	B-ANAT
damage	O
.	O

209	O
patients	O
(	O
139	O
male	O
,	O
70	O
female	O
,	O
age	O
10	O
-	O
88	O
years	O
,	O
53	O
+/-	O
19	O
years	O
)	O
who	O
underwent	O
liver	B-ANAT
function	O
monitoring	O
for	O
clinical	O
indication	O
.	O

The	O
functional	O
Fab	O
antibodies	O
were	O
converted	O
to	O
full	O
human	O
IgG	O
antibodies	O
with	O
recombinant	O
baculovirus	O
/	O
insect	O
cell	B-ANAT
systems	O
and	O
their	O
neutralizing	O
activities	O
were	O
further	O
determined	O
.	O

Most	O
of	O
these	O
were	O
identified	O
to	O
recognize	O
both	O
natural	O
and	O
recombinant	O
SARS	O
spike	O
(	O
S	O
)	O
proteins	O
,	O
two	O
Fab	O
antibodies	O
were	O
specific	O
for	O
the	O
virus	O
membrane	B-ANAT
(	O
M	O
)	O
protein	O
,	O
only	O
one	O
bound	O
to	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
protein	O
.	O

ABSTRACT	O
:	O
To	O
prepare	O
and	O
characterize	O
monoclonal	O
antibodies	O
(	O
mAbs	O
)	O
against	O
the	O
recombinant	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
of	O
3	O
human	O
coronaviruses	O
SARS	O
-	O
CoV	O
,	O
229E	O
and	O
OC43	O
and	O
study	O
the	O
antigenic	O
relationship	O
between	O
the	O
3	O
N	O
proteins	O
.	O

APTT	O
,	O
PC	O
,	O
AT	O
-	O
III	O
,	O
PAI	O
,	O
APC	B-ANAT
-	O
R	O
,	O
and	O
PLG	O
were	O
significantly	O
different	O
between	O
the	O
two	O
groups	O
.	O

Besides	O
strongly	O
reduced	O
genome	O
replication	O
,	O
specific	O
defects	O
in	O
sg	O
RNA	O
synthesis	O
,	O
such	O
as	O
aberrant	O
sizes	O
of	O
specific	O
sg	O
RNAs	O
and	O
changes	O
in	O
the	O
molar	B-ANAT
ratios	O
between	O
individual	O
sg	O
RNA	O
species	O
,	O
were	O
observed	O
.	O

The	O
prevalence	O
of	O
serum	B-ANAT
antibodies	O
to	O
CRCoV	O
,	O
in	O
a	O
population	O
of	O
dogs	O
in	O
the	O
south	O
east	O
of	O
England	O
,	O
has	O
been	O
shown	O
previously	O
to	O
be	O
30	O
.	O
1	O
%	O
on	O
the	O
first	O
day	O
of	O
entry	O
to	O
a	O
rehoming	O
kennel	O
[	O
Erles	O
,	O
K	O
.,	O
Toomey	O
,	O
C	O
.,	O
Brooks	O
,	O
H	O
.	O
W	O
.,	O
Brownlie	O
,	O
J	O
.,	O
2003	O
.	O

Following	O
that	O
,	O
each	O
of	O
the	O
patient	O
'	O
s	O
other	O
organ	B-ANAT
systems	I-ANAT
at	O
risk	O
needs	O
to	O
be	O
addressed	O
:	O
Renal	B-ANAT
/	O
metabolic	O
,	O
gastrointestinal	O
,	O
hematological	O
,	O
and	O
endocrine	O
.	O

CONCLUSIONS	O
:	O
The	O
high	O
-	O
level	O
expression	O
of	O
S	O
-	O
protein	O
in	O
HEK293	O
cells	B-ANAT
mediated	O
by	O
adenovirus	O
can	O
be	O
achieved	O
under	O
the	O
optimized	O
expression	O
conditions	O
.	O

Evidence	O
for	O
inflammation	O
-	O
induced	O
target	O
tissue	B-ANAT
resistance	O
to	O
glucocorticoids	O
.	O

ABSTRACT	O
:	O
To	O
test	O
the	O
hypothesis	O
that	O
the	O
interaction	O
between	O
nuclear	O
factor	O
-	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
and	O
glucocorticoid	O
receptor	O
alpha	O
(	O
GRalpha	O
)	O
is	O
a	O
key	O
pathogenetic	O
mechanism	O
regulating	O
the	O
progression	O
of	O
systemic	O
and	O
pulmonary	B-ANAT
inflammation	O
in	O
sepsis	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
we	O
used	O
an	O
ex	O
vivo	O
model	O
of	O
systemic	O
inflammation	O
.	O

Recently	O
,	O
we	O
identified	O
cyclooxygenase	O
-	O
2	O
(	O
COX	O
-	O
2	O
)-	O
derived	O
prostaglandin	O
E	O
(	O
2	O
)	O
(	O
PGE	O
(	O
2	O
))	O
and	O
lipoxin	O
A	O
(	O
4	O
)	O
(	O
LXA	O
(	O
4	O
))	O
as	O
pivotal	O
mediators	O
in	O
vivo	O
for	O
resolution	O
of	O
acid	O
-	O
initiated	O
acute	O
lung	B-ANAT
injury	O
.	O

Clinical	O
features	O
of	O
gemcitabine	O
-	O
associated	O
lung	B-ANAT
injury	O
included	O
dyspnea	O
,	O
fever	O
,	O
pulmonary	B-ANAT
infiltrate	O
,	O
and	O
cough	O
with	O
recognition	O
of	O
toxicity	O
occurring	O
after	O
a	O
median	O
duration	O
of	O
48	O
(	O
range	O
,	O
1	O
-	O
529	O
)	O
days	O
after	O
initiation	O
of	O
gemcitabine	O
.	O

High	O
rates	O
of	O
gemcitabine	O
-	O
associated	O
severe	O
lung	B-ANAT
injury	O
were	O
observed	O
when	O
gemcitabine	O
was	O
combined	O
with	O
other	O
therapies	O
known	O
to	O
also	O
cause	O
lung	B-ANAT
injury	O
.	O

Strong	O
expression	O
of	O
inducible	O
nitric	O
oxide	O
synthase	O
(	O
iNOS	O
)	O
was	O
detected	O
in	O
the	O
alveolar	B-ANAT
macrophages	I-ANAT
.	O

Thus	O
far	O
,	O
standard	O
repeated	O
-	O
dose	O
toxicology	O
studies	O
have	O
not	O
identified	O
any	O
target	O
organs	B-ANAT
for	O
toxicity	O
(	O
other	O
than	O
the	O
injection	O
site	O
)	O
for	O
our	O
DNA	O
plasmid	O
vaccines	O
at	O
doses	O
up	O
to	O
8	O
mg	O
per	O
immunization	O
,	O
regardless	O
of	O
disease	O
indication	O
(	O
i	O
.	O
e	O
.,	O
expressed	O
gene	O
-	O
insert	O
)	O
and	O
despite	O
differences	O
(	O
strengths	O
)	O
in	O
the	O
promoters	O
used	O
to	O
drive	O
this	O
expression	O
.	O

To	O
examine	O
the	O
mechanism	O
of	O
inhibition	O
of	O
dengue	O
virus	O
,	O
we	O
developed	O
two	O
replicon	O
systems	O
for	O
dengue	O
type	O
1	O
virus	O
:	O
(	O
i	O
)	O
a	O
stable	B-ANAT
cell	I-ANAT
line	I-ANAT
that	O
harbored	O
replicons	O
containing	O
a	O
luciferase	O
reporter	O
and	O
a	O
neomycin	O
phosphotransferase	O
selection	O
marker	O
and	O
(	O
ii	O
)	O
a	O
luciferase	O
-	O
expressing	O
replicon	O
that	O
could	O
differentiate	O
between	O
viral	O
translation	O
and	O
RNA	O
replication	O
.	O

Reported	O
side	O
effects	O
include	O
severe	O
cardiopulmonary	B-ANAT
reactions	O
,	O
adult	O
respiratory	O
distress	O
syndrome	O
and	O
hematological	O
disorders	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
cytokine	O
gene	O
expression	O
and	O
induction	O
of	O
chemokine	O
genes	O
in	O
non	O
-	O
lymphatic	B-ANAT
cells	B-ANAT
infected	O
with	O
SARS	O
coronavirus	O
.	O

Orally	B-ANAT
immunized	O
mice	O
mounted	O
a	O
greater	O
neutralizing	O
-	O
antibody	O
response	O
than	O
those	O
immunized	O
intranasally	O
.	O

These	O
viruses	O
resemble	O
influenza	O
C	O
viruses	O
because	O
they	O
share	O
not	O
only	O
the	O
receptor	O
determinant	O
,	O
but	O
also	O
the	O
presence	O
of	O
an	O
acetylesterase	O
that	O
releases	O
the	O
9	O
-	O
O	O
-	O
acetyl	O
group	O
from	O
sialic	O
acid	O
and	O
thus	O
abolishes	O
the	O
ability	O
of	O
the	O
respective	O
sialoglycoconjugate	O
to	O
function	O
as	O
a	O
receptor	O
for	O
BCoV	O
.	O
As	O
in	O
the	O
case	O
of	O
influenza	O
viruses	O
,	O
the	O
receptor	O
-	O
destroying	O
enzyme	O
of	O
BCoV	O
is	O
believed	O
to	O
facilitate	O
the	O
spread	O
of	O
virus	O
infection	O
by	O
removing	O
receptor	O
determinants	O
from	O
the	O
surface	O
of	O
infected	O
cells	B-ANAT
and	O
by	O
preventing	O
the	O
formation	O
of	O
virus	O
aggregates	O
.	O

TITLE	O
:	O
Localisation	O
and	O
distribution	O
of	O
O	O
-	O
acetylated	O
N	O
-	O
acetylneuraminic	O
acids	O
,	O
the	O
endogenous	O
substrates	O
of	O
the	O
hemagglutinin	O
-	O
esterases	O
of	O
murine	O
coronaviruses	O
,	O
in	O
mouse	O
tissue	B-ANAT
.	O

ABSTRACT	O
:	O
Infections	O
by	O
mouse	O
hepatitis	O
viruses	O
result	O
in	O
disease	O
of	O
the	O
liver	B-ANAT
,	O
the	O
gastrointestinal	B-ANAT
tract	I-ANAT
,	O
respiratory	B-ANAT
tract	I-ANAT
,	O
and	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
.	O

Indeed	O
,	O
increasing	O
ACE2	O
activity	O
might	O
be	O
a	O
novel	O
approach	O
for	O
the	O
treatment	O
of	O
acute	O
lung	B-ANAT
failure	O
in	O
several	O
diseases	O
.	O

In	O
this	O
study	O
,	O
51	O
stool	B-ANAT
samples	O
of	O
calves	O
from	O
10	O
Brazilian	O
dairy	O
farms	O
were	O
analysed	O
by	O
an	O
RT	O
-	O
PCR	O
that	O
amplifies	O
a	O
488	O
-	O
bp	O
fragment	O
of	O
the	O
hypervariable	O
region	O
of	O
the	O
spike	O
glycoprotein	O
gene	O
.	O

Respiratory	O
findings	O
including	O
cough	O
,	O
dyspnea	O
and	O
pulmonary	B-ANAT
infiltrates	O
evolved	O
later	O
and	O
were	O
present	O
in	O
only	O
59	O
,	O
37	O
and	O
68	O
%	O
of	O
patients	O
,	O
respectively	O
,	O
at	O
admission	O
.	O

The	O
ensuing	O
targeted	O
destruction	O
of	O
viral	O
RNA	O
should	O
interfere	O
with	O
viral	O
replication	O
without	O
entailing	O
negative	O
effects	O
on	O
ongoing	O
cellular	B-ANAT
processes	O
.	O

Due	O
to	O
the	O
severity	O
of	O
his	O
chest	B-ANAT
trauma	O
,	O
a	O
transoesophageal	O
echocardiograph	O
was	O
performed	O
which	O
revealed	O
a	O
partial	O
dehiscence	O
and	O
prolapse	O
of	O
the	O
left	B-ANAT
coronary	I-ANAT
cusp	I-ANAT
of	O
the	O
aortic	B-ANAT
valve	I-ANAT
with	O
mild	O
to	O
moderate	O
aortic	B-ANAT
regurgitation	O
.	O

Inhaled	O
nitric	O
oxide	O
(	O
NO	O
)	O
dilates	O
pulmonary	B-ANAT
blood	B-ANAT
vessels	I-ANAT
and	O
has	O
been	O
used	O
to	O
reduce	O
pulmonary	B-ANAT
vascular	B-ANAT
resistance	O
in	O
patients	O
with	O
chronic	O
thromboembolic	O
pulmonary	B-ANAT
hypertension	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

In	O
the	O
present	O
study	O
,	O
therefore	O
,	O
we	O
analyzed	O
the	O
other	O
structure	O
genes	O
,	O
the	O
hemagglutinin	O
/	O
esterase	O
(	O
HE	O
)	O
protein	O
,	O
the	O
transmembrane	B-ANAT
(	O
M	O
)	O
protein	O
and	O
the	O
small	O
membrane	B-ANAT
(	O
E	O
)	O
protein	O
to	O
characterize	O
10	O
WD	O
BCoV	O
circulated	O
in	O
Korea	O
during	O
2002	O
-	O
2003	O
and	O
compared	O
the	O
nucleotide	O
and	O
deduced	O
amino	O
acid	O
sequences	O
with	O
the	O
other	O
known	O
BCoV	O
.	O
Phylogenetic	O
analysis	O
indicated	O
that	O
the	O
HE	O
gene	O
among	O
BCoV	O
could	O
be	O
divided	O
into	O
three	O
groups	O
.	O

Adult	O
ewes	O
were	O
subjected	O
to	O
a	O
40	O
%	O
body	B-ANAT
surface	O
area	O
third	O
-	O
degree	O
flame	O
burn	O
and	O
smoke	O
inhalation	O
injury	O
after	O
tracheostomy	O
.	O

Comorbidities	O
of	O
diabetes	O
and	O
heart	B-ANAT
failure	O
were	O
more	O
common	O
in	O
patients	O
who	O
developed	O
ARF	O
(	O
38	O
%	O
vs	O
6	O
%,	O
p	O
<	O
0	O
.	O
01	O
and	O
38	O
%	O
vs	O
2	O
%,	O
p	O
<	O
0	O
.	O
001	O
,	O
respectively	O
)	O
and	O
the	O
incidence	O
of	O
respiratory	O
failure	O
(	O
85	O
%	O
vs	O
26	O
%,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
mortality	O
(	O
77	O
%	O
vs	O
8	O
%,	O
p	O
<	O
0	O
.	O
001	O
)	O
were	O
also	O
higher	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
characterized	O
by	O
arterial	B-ANAT
hypoxemia	O
,	O
and	O
prone	O
position	O
(	O
PP	O
)	O
is	O
one	O
possible	O
management	O
strategy	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
prevalence	O
of	O
pulmonary	B-ANAT
hypertension	O
associated	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
to	O
asses	O
the	O
value	O
of	O
pulmonary	B-ANAT
artery	I-ANAT
trunk	B-ANAT
diameter	O
(	O
PAT	O
)	O
to	O
predict	O
pulmonary	B-ANAT
hypertension	O
.	O

103	O
patients	O
with	O
ARDS	O
,	O
who	O
received	O
both	O
right	B-ANAT
heart	I-ANAT
catheterization	O
and	O
chest	B-ANAT
computed	O
tomography	O
.	O

Measurement	O
of	O
PAT	O
diameter	O
on	O
admission	O
CT	O
scan	O
is	O
an	O
unreliable	O
tool	O
for	O
identification	O
of	O
ARDS	O
patients	O
with	O
pulmonary	B-ANAT
hypertension	O
.	O

The	O
viral	O
spike	O
(	O
S	O
)	O
glycoprotein	O
is	O
responsible	O
for	O
mediating	O
receptor	O
binding	O
and	O
membrane	B-ANAT
fusion	O
.	O

For	O
healthcare	O
administrators	O
,	O
this	O
means	O
that	O
a	O
likely	O
strategy	O
for	O
assuaging	O
the	O
negative	O
outcomes	O
of	O
stress	O
should	O
address	O
nurses	O
'	O
psychosocial	O
concerns	O
and	O
the	O
working	O
conditions	O
that	O
they	O
face	B-ANAT
during	O
novel	O
times	O
of	O
crisis	O
.	O

The	O
spleen	B-ANAT
,	O
mesenteric	B-ANAT
lymph	I-ANAT
nodes	I-ANAT
and	O
bone	B-ANAT
marrow	I-ANAT
from	O
naturally	O
FCoV	O
-	O
infected	O
cats	O
with	O
and	O
without	O
FIP	O
and	O
specific	O
pathogen	O
-	O
free	O
(	O
SPF	O
)	O
control	O
cats	O
were	O
examined	O
for	O
the	O
quantity	O
and	O
activation	O
state	O
of	O
monocytes	B-ANAT
/	O
macrophages	B-ANAT
both	O
by	O
immunohistology	O
and	O
by	O
quantitative	O
real	O
time	O
PCR	O
for	O
the	O
transcription	O
of	O
interleukin	O
(	O
IL	O
)-	O
1beta	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
10	O
,	O
IL	O
-	O
12	O
p40	B-ANAT
,	O
tumour	O
necrosis	O
factor	O
(	O
TNF	O
),	O
granulocyte	B-ANAT
colony	O
stimulating	O
factor	O
(	O
G	O
-	O
CSF	B-ANAT
),	O
macrophage	B-ANAT
-	O
CSF	B-ANAT
(	O
M	O
-	O
CSF	B-ANAT
)	O
and	O
GM	O
-	O
CSF	B-ANAT
.	O

TITLE	O
:	O
[	O
Expression	O
and	O
significance	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)-	O
X4	O
protein	O
in	O
lungs	B-ANAT
of	O
SARS	O
patients	O
].	O

CONCLUSIONS	O
:	O
S2	O
gene	O
of	O
GD322	O
SARS	O
-	O
CoV	O
is	O
relatively	O
stable	O
during	O
the	O
epidemic	O
spread	O
of	O
the	O
virus	O
,	O
and	O
mutation	O
at	O
the	O
57th	O
amino	O
acids	O
of	O
S2	O
protein	O
may	O
affect	O
the	O
T	B-ANAT
cell	I-ANAT
antigen	O
epitope	O
.	O

Partial	O
ventilatory	O
support	O
can	O
effectively	O
unload	O
the	O
respiratory	O
workload	O
and	O
improve	O
pulmonary	B-ANAT
gas	O
exchange	O
with	O
less	O
hemodynamic	O
compromise	O
.	O

The	O
genome	O
was	O
directly	O
accessed	O
from	O
the	O
stool	B-ANAT
sample	I-ANAT
of	O
a	O
patient	O
in	O
Beijing	O
.	O

First	O
,	O
we	O
screened	O
SARS	O
N	O
and	O
S	O
amino	O
acid	O
sequences	O
for	O
allele	O
-	O
specific	O
motif	O
matching	O
those	O
in	O
human	O
HLA	B-ANAT
-	O
A2	O
.	O
1	O
MHC	B-ANAT
-	O
I	O
molecules	O
.	O

From	O
HLA	B-ANAT
peptide	O
binding	O
predictions	O
(	O
http	O
://	O
thr	O
.	O
cit	O
.	O
nih	O
.	O
gov	O
/	O
molbio	O
/	O
hla_bind	O
/),	O
ten	O
each	O
potential	O
N	O
-	O
and	O
S	O
-	O
specific	O
HLA	B-ANAT
-	O
A2	O
.	O
1	O
-	O
binding	O
peptides	O
were	O
synthesized	O
.	O

The	O
high	O
affinity	O
HLA	B-ANAT
-	O
A2	O
.	O
1	O
peptides	O
were	O
validated	O
by	O
T2	O
-	O
cell	B-ANAT
stabilization	O
assays	O
,	O
with	O
immunogenicity	O
assays	O
revealing	O
peptides	O
N223	O
-	O
231	O
,	O
N227	O
-	O
235	O
,	O
and	O
N317	O
-	O
325	O
to	O
be	O
the	O
first	O
identified	O
HLA	B-ANAT
-	O
A	O
*	O
0201	O
-	O
restricted	O
CTL	B-ANAT
epitopes	O
of	O
SARS	O
-	O
CoV	O
N	O
protein	O
.	O

In	O
addition	O
,	O
previous	O
reports	O
identified	O
three	O
HLA	B-ANAT
-	O
A	O
*	O
0201	O
-	O
restricted	O
CTL	B-ANAT
epitopes	O
of	O
S	O
protein	O
(	O
S978	O
-	O
986	O
,	O
S1203	O
-	O
1211	O
,	O
and	O
S1167	O
-	O
1175	O
),	O
here	O
we	O
found	O
two	O
novel	O
peptides	O
S787	O
-	O
795	O
and	O
S1042	O
-	O
1050	O
as	O
S	O
-	O
specific	O
CTL	B-ANAT
epitopes	O
.	O

Thus	O
,	O
in	O
the	O
present	O
study	O
,	O
we	O
tried	O
to	O
see	O
whether	O
wt	O
JHMV	O
virions	B-ANAT
that	O
are	O
attached	O
on	O
MHVR	O
-	O
negative	O
cells	B-ANAT
are	O
able	O
to	O
infect	O
those	O
cells	B-ANAT
.	O

Virions	B-ANAT
of	O
both	O
wt	O
and	O
srr7	O
attached	O
on	O
MHVR	O
-	O
negative	O
cells	B-ANAT
by	O
spinoculation	O
were	O
facilitated	O
for	O
infection	O
in	O
the	O
presence	O
of	O
a	O
soluble	O
form	O
of	O
MHVR	O
that	O
induces	O
conformational	O
changes	O
of	O
both	O
wt	O
and	O
srr7	O
.	O

ABSTRACT	O
:	O
We	O
here	O
report	O
a	O
case	O
of	O
71	O
-	O
year	O
-	O
old	O
man	O
with	O
acute	O
extensive	O
anterior	O
myocardial	O
infarction	O
,	O
who	O
was	O
complicated	O
with	O
ventricular	B-ANAT
tachycardia	O
(	O
VT	O
)	O
even	O
after	O
successful	O
percutaneous	O
coronary	B-ANAT
intervention	O
.	O

However	O
,	O
glucocorticoid	O
therapy	O
induced	O
hyperglycemia	O
with	O
an	O
increase	O
in	O
plasma	B-ANAT
osmolality	O
,	O
complicated	O
with	O
hypoalbuminemia	O
,	O
and	O
gastrointestinal	O
bleeding	O
.	O

Among	O
309	O
bats	O
of	O
13	O
species	O
captured	O
from	O
20	O
different	O
locations	O
in	O
rural	O
areas	O
of	O
Hong	O
Kong	O
over	O
a	O
16	O
-	O
month	O
period	O
,	O
coronaviruses	O
were	O
amplified	O
from	O
anal	B-ANAT
swabs	O
of	O
37	O
(	O
12	O
%)	O
bats	O
by	O
RT	O
-	O
PCR	O
.	O

TITLE	O
:	O
Assembly	O
of	O
HCV	O
E1	O
and	O
E2	O
glycoproteins	O
into	O
coronavirus	O
VLPs	B-ANAT
.	O

Since	O
all	O
the	O
up	O
-	O
regulated	O
proteins	O
identified	O
above	O
are	O
well	O
-	O
known	O
inflammation	O
inhibitors	O
,	O
these	O
results	O
strongly	O
suggest	O
that	O
the	O
body	B-ANAT
starts	O
inflammation	O
inhibition	O
to	O
sustain	O
the	O
inflammatory	O
response	O
balance	O
in	O
the	O
progression	O
of	O
SARS	O
.	O

Titers	O
of	O
SARS	O
-	O
CoV	O
shed	O
in	O
nasopharyngeal	B-ANAT
specimens	O
varied	O
widely	O
,	O
ranging	O
from	O
nondetectable	O
to	O
10	O
(	O
8	O
)	O
SARS	O
-	O
CoV	O
RNA	O
copies	O
/	O
mL	O
,	O
and	O
they	O
were	O
correlated	O
positively	O
with	O
a	O
high	O
mortality	O
rate	O
(	O
P	O
<.	O
0001	O
,	O
by	O
trend	O
test	O
)	O
and	O
with	O
early	O
death	O
(	O
i	O
.	O
e	O
.,	O
death	O
occurring	O
within	O
2	O
weeks	O
of	O
the	O
onset	O
of	O
illness	O
)	O
(	O
P	O
=.	O
0015	O
,	O
by	O
trend	O
test	O
).	O

Chest	B-ANAT
123	O
(	O
5	O
),	O
1664	O
-	O
1672	O
;	O
Rotbart	O
,	O
H	O
.	O
A	O
.,	O
2002	O
.	O

HRV	O
-	O
induced	O
colds	O
are	O
the	O
important	O
predisposing	O
factors	O
to	O
acute	O
otitis	O
media	B-ANAT
,	O
sinusitis	O
,	O
and	O
are	O
the	O
major	O
factors	O
in	O
the	O
induction	O
of	O
exacerbations	O
of	O
asthma	O
in	O
adults	O
and	O
children	O
.	O

2	O
positive	O
clones	O
that	O
having	O
specific	O
affinity	O
to	O
SARS	O
sera	B-ANAT
were	O
obtained	O
.	O

Nasal	B-ANAT
airway	B-ANAT
stenosis	O
or	O
atresia	O
could	O
account	O
for	O
a	O
number	O
of	O
unexplained	O
deaths	O
in	O
the	O
delivery	O
room	O
.	O

In	O
106	O
cases	O
treated	O
with	O
steroid	O
of	O
the	O
148	O
health	O
care	O
workers	O
,	O
femoral	B-ANAT
head	I-ANAT
osteonecrosis	O
was	O
found	O
in	O
4	O
cases	O
,	O
bilateral	O
femoral	B-ANAT
marrow	O
edema	O
in	O
2	O
cases	O
,	O
femoral	B-ANAT
marrow	O
infarction	O
in	O
1	O
case	O
.	O

Hilar	O
or	O
mediastinal	B-ANAT
lymphadenopathy	O
and	O
pleural	B-ANAT
effusion	I-ANAT
was	O
not	O
found	O
.	O

Fast	O
peripheral	O
venous	O
blood	B-ANAT
samples	I-ANAT
were	O
collected	O
from	O
61	O
post	O
-	O
SARS	O
patients	O
with	O
osteonecrosis	O
,	O
25	O
males	O
and	O
36	O
females	O
,	O
aged	O
30	O
.	O
4	O
(	O
20	O
-	O
60	O
),	O
and	O
52	O
sex	O
and	O
age	O
-	O
matched	O
healthy	O
persons	O
as	O
controls	O
.	O

These	O
results	O
indicate	O
that	O
the	O
potent	O
immune	O
response	O
elicited	O
by	O
subcutaneous	O
injection	O
of	O
rDIs	O
containing	O
S	O
is	O
able	O
to	O
control	O
mucosal	B-ANAT
infection	O
by	O
SARS	O
-	O
CoV	O
.	O
Thus	O
,	O
replication	O
-	O
deficient	O
DIs	O
constructs	O
hold	O
promise	O
for	O
the	O
development	O
of	O
a	O
safe	O
and	O
potent	O
SARS	O
vaccine	O
.	O

In	O
addition	O
,	O
we	O
provide	O
an	O
overview	O
of	O
the	O
mechanisms	O
thought	O
to	O
contribute	O
to	O
ARDS	O
and	O
multiple	O
organ	B-ANAT
dysfunction	O
.	O

Intriguingly	O
,	O
a	O
minor	O
proportion	O
of	O
the	O
SARS	O
-	O
CoV	O
E	O
protein	O
was	O
found	O
to	O
be	O
modified	O
by	O
N	O
-	O
linked	O
glycosylation	O
on	O
Asn	O
66	O
and	O
inserted	O
into	O
the	O
membranes	B-ANAT
once	O
with	O
the	O
C	O
-	O
terminus	O
exposed	O
to	O
the	O
luminal	O
side	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
effect	O
of	O
high	O
-	O
volume	O
continuous	O
hemofiltration	O
on	O
experimental	O
pancreatitis	O
associated	O
lung	B-ANAT
injury	O
(	O
PALI	O
)	O
in	O
pigs	O
.	O

Plasma	B-ANAT
cytokines	O
in	O
the	O
high	O
-	O
volume	O
group	O
were	O
significantly	O
lower	O
than	O
in	O
the	O
LV	O
and	O
control	O
groups	O
.	O

The	O
beneficial	O
effects	O
of	O
CVVH	O
on	O
arterial	B-ANAT
oxygenation	O
and	O
pulmonary	B-ANAT
function	O
may	O
be	O
connected	O
with	O
improvements	O
in	O
systemic	O
hemodynamics	O
,	O
reduction	O
in	O
plasma	B-ANAT
cytokine	O
concentration	O
and	O
decreased	O
activity	O
of	O
NF	O
-	O
Ãª	O
B	O
in	O
peripheral	B-ANAT
blood	I-ANAT
mononuclear	I-ANAT
cells	I-ANAT
.	O

Three	O
patients	O
died	O
as	O
a	O
result	O
of	O
adverse	O
events	O
believed	O
to	O
be	O
possibly	O
related	O
to	O
treatment	O
:	O
ventricular	B-ANAT
arrhythmia	O
,	O
adult	O
respiratory	O
distress	O
syndrome	O
,	O
and	O
pneumonitis	O
.	O

Three	O
patients	O
died	O
as	O
a	O
result	O
of	O
adverse	O
events	O
believed	O
to	O
be	O
possibly	O
related	O
to	O
treatment	O
:	O
ventricular	B-ANAT
arrhythmia	O
,	O
adult	O
respiratory	O
distress	O
syndrome	O
,	O
and	O
pneumonitis	O
.	O

Most	O
models	O
proposed	O
over	O
the	O
past	O
25	O
years	O
assume	O
co	O
-	O
transcriptional	O
fusion	O
of	O
subgenomic	O
RNA	O
leader	O
and	O
body	B-ANAT
sequences	O
,	O
but	O
there	O
has	O
been	O
controversy	O
over	O
the	O
question	O
of	O
whether	O
this	O
occurs	O
during	O
plus	O
-	O
or	O
minus	O
-	O
strand	O
synthesis	O
.	O

The	O
internalization	O
was	O
also	O
induced	O
by	O
mAbs	O
against	O
the	O
Spike	O
and	O
Membrane	B-ANAT
proteins	O
,	O
suggesting	O
that	O
both	O
proteins	O
play	O
a	O
role	O
in	O
the	O
process	O
.	O

TITLE	O
:	O
From	O
the	O
similarity	O
analysis	O
of	O
protein	O
cavities	B-ANAT
to	O
the	O
functional	O
classification	O
of	O
protein	O
families	O
using	O
cavbase	O
.	O

Udder	B-ANAT
infections	O
are	O
primarily	O
due	O
to	O
Streptococcus	O
agalactiae	O
and	O
Staphylococcus	O
aureus	O
.	O

Eighteen	O
surface	O
residues	O
from	O
two	O
regions	O
of	O
HRN	O
and	O
HRC	O
were	O
incorporated	O
into	O
the	O
template	O
and	O
used	O
to	O
generate	O
four	O
anti	O
-	O
sera	B-ANAT
,	O
HRN1	O
,	O
HRN2	O
,	O
HRC1	O
,	O
and	O
HRC2	O
.	O

Cell	B-ANAT
-	O
associated	O
CD14	O
in	O
lung	B-ANAT
tissue	I-ANAT
increased	O
up	O
to	O
15	O
times	O
throughout	O
the	O
infection	O
,	O
due	O
to	O
an	O
increase	O
in	O
highly	O
CD14	O
+	O
monocyte	B-ANAT
-	O
macrophages	B-ANAT
from	O
1	O
to	O
12DPI	O
and	O
CD14	O
+	O
type	B-ANAT
2	I-ANAT
pneumocytes	I-ANAT
from	O
7	O
to	O
9DPI	O
.	O

Patients	O
with	O
metastatic	O
breast	B-ANAT
cancer	O
were	O
enrolled	O
into	O
a	O
multicenter	O
phase	O
I	O
dose	O
-	O
escalating	O
trial	O
.	O

ABSTRACT	O
:	O
Infection	O
by	O
different	O
coronaviruses	O
(	O
CoVs	O
)	O
causes	O
alterations	O
in	O
the	O
transcriptional	O
and	O
translational	O
patterns	O
,	O
cell	B-ANAT
cycle	O
,	O
cytoskeleton	B-ANAT
,	O
and	O
apoptosis	O
pathways	O
of	O
the	O
host	O
cells	B-ANAT
.	O

Both	O
viral	O
and	O
cellular	B-ANAT
proteins	O
are	O
required	O
for	O
replication	O
and	O
transcription	O
,	O
and	O
the	O
role	O
of	O
selected	O
proteins	O
is	O
addressed	O
.	O

TITLE	O
:	O
Characterization	O
of	O
HCoV	O
-	O
229E	O
fusion	O
core	O
:	O
implications	O
for	O
structure	O
basis	O
of	O
coronavirus	O
membrane	B-ANAT
fusion	O
.	O

ABSTRACT	O
:	O
Human	O
coronavirus	O
229E	O
(	O
HCoV	O
-	O
229E	O
),	O
a	O
member	O
of	O
group	O
I	O
coronaviruses	O
,	O
has	O
been	O
identified	O
as	O
one	O
of	O
the	O
major	O
viral	O
agents	O
causing	O
respiratory	B-ANAT
tract	I-ANAT
diseases	O
in	O
humans	O
for	O
nearly	O
40	O
years	O
.	O

Patients	O
'	O
clinical	O
information	O
,	O
the	O
extent	O
of	O
radiographic	O
opacification	O
during	O
the	O
acute	O
phase	O
of	O
illness	O
,	O
and	O
conventional	O
pulmonary	B-ANAT
function	O
test	O
results	O
on	O
follow	O
-	O
up	O
were	O
obtained	O
for	O
correlation	O
.	O

ABSTRACT	O
:	O
Replication	O
-	O
deficient	O
human	O
adenovirus	O
type	O
5	O
(	O
AdH5	O
)	O
vectors	O
can	O
induce	O
strong	O
transgene	O
product	O
-	O
specific	O
cellular	B-ANAT
and	O
humoral	O
responses	O
.	O

Efficacy	O
was	O
assessed	O
after	O
intramuscular	O
injection	O
of	O
the	O
vector	O
into	O
mice	O
and	O
was	O
measured	O
as	O
the	O
frequency	O
of	O
SARS	O
-	O
CoV	O
-	O
specific	O
T	B-ANAT
cells	I-ANAT
and	O
NAbs	O
against	O
SARS	O
-	O
CoV	O
.	O
Immunogenicity	O
of	O
the	O
AdH5	O
-	O
based	O
vaccine	O
was	O
significantly	O
attenuated	O
or	O
completely	O
abolished	O
when	O
the	O
preexisting	O
anti	O
-	O
AdH5	O
NAb	O
titer	O
was	O
higher	O
than	O
40	O
.	O

Lower	O
predominated	O
over	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
in	O
each	O
age	O
group	O
.	O

A	O
case	O
of	O
a	O
75	O
year	O
old	O
patient	O
with	O
intravesical	O
BCG	O
instillations	O
after	O
a	O
transurethral	O
resection	O
of	O
bladder	B-ANAT
cancer	O
is	O
presented	O
.	O

The	O
MHV	O
type	O
2	O
(	O
MHV	O
-	O
2	O
)	O
strain	O
of	O
murine	O
coronavirus	O
differs	O
from	O
other	O
strains	O
in	O
that	O
it	O
expresses	O
an	O
uncleaved	O
spike	O
and	O
cannot	O
induce	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
at	O
neutral	O
pH	O
values	O
.	O

TITLE	O
:	O
Ultrastructure	O
and	O
origin	O
of	O
membrane	B-ANAT
vesicles	B-ANAT
associated	O
with	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
replication	O
complex	O
.	O

Electron	O
microscopy	O
revealed	O
the	O
early	O
formation	O
and	O
accumulation	O
of	O
typical	O
double	O
-	O
membrane	B-ANAT
vesicles	B-ANAT
,	O
which	O
probably	O
carry	O
the	O
viral	B-ANAT
replication	I-ANAT
complex	I-ANAT
.	O

The	O
vesicles	B-ANAT
appear	O
to	O
be	O
fragile	O
,	O
and	O
their	O
preservation	O
was	O
significantly	O
improved	O
by	O
using	O
cryofixation	O
protocols	O
and	O
freeze	O
substitution	O
methods	O
.	O

ABSTRACT	O
:	O
To	O
study	O
the	O
dynamic	O
changes	O
of	O
T	B-ANAT
lymphocyte	I-ANAT
subsets	I-ANAT
in	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
patients	O
.	O

The	O
periphery	O
T	B-ANAT
lymphocyte	I-ANAT
subsets	I-ANAT
in	O
SARS	O
infection	O
shows	O
transient	O
decrease	O
and	O
then	O
rapid	O
recovery	O
.	O

The	O
avian	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
),	O
coronavirus	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
,	O
localizes	O
to	O
the	O
cytoplasm	B-ANAT
and	O
the	O
nucleolus	B-ANAT
.	O

UC	O
should	O
at	O
times	O
be	O
viewed	O
within	O
the	O
context	O
of	O
a	O
more	O
generalized	O
immune	O
imbalance	O
affecting	O
multiple	O
organs	B-ANAT
,	O
and	O
not	O
as	O
an	O
isolated	O
pathological	O
entity	O
.	O

Testing	O
for	O
alpha1	O
-	O
antitrypsin	O
deficiency	O
in	O
UC	O
patients	O
may	O
detect	O
individuals	O
at	O
higher	O
risk	O
of	O
severe	O
extra	O
-	O
intestinal	B-ANAT
involvement	O
.	O

In	O
the	O
paper	O
,	O
according	O
to	O
the	O
intensity	O
properties	O
of	O
the	O
chest	B-ANAT
radiograph	O
,	O
the	O
chest	B-ANAT
radiographic	O
image	O
is	O
divided	O
into	O
three	O
subregions	O
,	O
and	O
a	O
piecewise	O
linear	O
transformation	O
model	O
is	O
established	O
.	O

Physical	O
examination	O
showed	O
a	O
normally	O
-	O
developed	O
,	O
well	O
-	O
nourished	O
female	O
in	O
severe	O
distress	O
with	O
an	O
extremely	O
distended	O
abdomen	B-ANAT
.	O

A	O
total	O
of	O
seven	O
placentas	B-ANAT
were	O
studied	O
.	O

In	O
three	O
placentas	B-ANAT
delivered	O
in	O
the	O
acute	O
stage	O
of	O
SARS	O
,	O
there	O
were	O
increases	O
in	O
intervillous	O
or	O
subchorionic	O
fibrin	O
which	O
might	O
be	O
related	O
to	O
disturbances	O
in	O
maternal	O
placental	B-ANAT
blood	B-ANAT
flow	O
due	O
to	O
the	O
hypoxic	O
respiratory	O
disease	O
.	O

Extensive	O
fetal	B-ANAT
thrombotic	O
vasculopathy	O
(	O
FTV	O
)	O
with	O
sharply	O
demarcated	O
zones	O
of	O
avascular	O
fibrotic	O
villi	O
was	O
noted	O
in	O
the	O
placentas	B-ANAT
of	O
two	O
patients	O
convalescent	O
from	O
SARS	O
in	O
the	O
third	O
trimester	O
.	O

Both	O
pregnancies	O
had	O
intrauterine	B-ANAT
growth	O
retardation	O
,	O
oligohydramnios	O
and	O
newborns	O
small	O
for	O
gestation	O
.	O

RESULTS	O
:	O
A	O
total	O
of	O
seven	O
placentas	B-ANAT
were	O
studied	O
.	O

Biochemical	O
markers	O
of	O
bone	B-ANAT
metabolism	O
were	O
analysed	O
retrospectively	O
using	O
serial	O
clotted	O
blood	B-ANAT
samples	I-ANAT
collected	O
from	O
each	O
patient	O
during	O
the	O
course	O
of	O
hospital	O
admission	O
to	O
discharge	B-ANAT
and	O
subsequent	O
follow	O
-	O
up	O
at	O
out	O
-	O
patient	O
clinic	O
using	O
the	O
arbitrary	O
time	O
periods	O
:	O
(	O
i	O
)	O
Day	O
<	O
10	O
;	O
(	O
ii	O
)	O
Day	O
28	O
-	O
44	O
;	O
(	O
iii	O
)	O
Day	O
51	O
-	O
84	O
;	O
and	O
(	O
iv	O
)	O
Day	O
>	O
90	O
after	O
the	O
onset	O
of	O
fever	O
.	O

Magnetic	O
resonance	O
imaging	O
of	O
the	O
knee	B-ANAT
and	O
hip	B-ANAT
joints	I-ANAT
were	O
performed	O
post	O
-	O
admission	O
to	O
evaluate	O
the	O
prevalence	O
of	O
osteonecrosis	O
amongst	O
these	O
SARS	O
patients	O
.	O

Both	O
bone	B-ANAT
resorption	O
and	O
formation	O
markers	O
were	O
unable	O
to	O
predict	O
the	O
subsequent	O
development	O
of	O
osteonecrosis	O
.	O

Further	O
,	O
they	O
were	O
only	O
10	O
-	O
15	O
-	O
fold	O
less	O
inhibitory	O
against	O
human	O
HBV	O
in	O
2	O
.	O
2	O
.	O
15	O
cells	B-ANAT
than	O
the	O
reference	O
drug	O
,	O
lamivudine	O
.	O

Monocyte	B-ANAT
-	O
derived	O
DCs	O
were	O
infected	O
with	O
SARS	O
-	O
CoV	O
and	O
analysed	O
for	O
viability	O
,	O
surface	O
-	O
marker	O
expression	O
and	O
alpha	O
interferon	O
(	O
IFN	O
-	O
alpha	O
)	O
induction	O
.	O

Fibroblast	B-ANAT
-	O
like	O
L	O
cells	B-ANAT
were	O
infected	O
at	O
high	O
multiplicity	O
in	O
order	O
to	O
study	O
the	O
direct	O
effects	O
of	O
a	O
synchronized	O
lytic	O
coronavirus	O
infection	O
.	O

Blood	B-ANAT
samples	I-ANAT
were	O
tested	O
for	O
total	O
antibodies	O
to	O
SARS	O
-	O
CoV	O
by	O
immunofluorescence	O
antibody	O
test	O
.	O

Our	O
aim	O
was	O
to	O
study	O
the	O
effects	O
of	O
wearing	O
of	O
personal	O
protective	O
equipment	O
(	O
PPE	O
)	O
and	O
powered	O
air	O
-	O
purifying	O
respirator	O
(	O
PAPR	O
)	O
and	O
the	O
restriction	O
in	O
the	O
number	O
of	O
resuscitation	O
personnel	O
on	O
airway	B-ANAT
management	O
during	O
the	O
SARS	O
crisis	O
.	O

Both	O
diseases	O
are	O
characterised	O
by	O
alveolar	B-ANAT
instability	O
,	O
fluid	O
filled	O
airspace	O
and	O
some	O
degree	O
of	O
airway	B-ANAT
obstruction	O
.	O

This	O
study	O
may	O
provide	O
an	O
effective	O
way	O
to	O
interfere	O
with	O
the	O
potential	O
therapeutic	O
target	O
fgl2	O
gene	O
for	O
fulminant	O
viral	O
hepatitis	O
and	O
other	O
diseases	O
with	O
similar	O
pathological	O
characteristics	O
of	O
microcirculation	O
disorders	O
,	O
including	O
acute	O
rejection	O
of	O
xeno	O
-	O
or	O
allograft	O
transplantation	O
and	O
fetal	B-ANAT
loss	O
syndrome	O
,	O
in	O
which	O
studies	O
show	O
fgl2	O
plays	O
an	O
important	O
role	O
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
the	O
cytokine	O
profiles	O
of	O
clinically	O
healthy	O
cats	O
naturally	O
infected	O
with	O
feline	O
coronavirus	O
(	O
FCoV	O
),	O
of	O
cats	O
with	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
)	O
and	O
of	O
specific	O
pathogen	O
-	O
free	O
(	O
SPF	O
)	O
cats	O
were	O
investigated	O
in	O
whole	B-ANAT
blood	I-ANAT
using	O
a	O
traditional	O
reverse	O
-	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
assay	O
and	O
a	O
semi	O
-	O
quantitative	O
method	O
of	O
analysis	O
based	O
on	O
computerised	O
quantification	O
of	O
positive	O
bands	O
.	O

Three	O
days	O
later	O
an	O
abnormal	O
chest	B-ANAT
shadow	O
was	O
pointed	O
out	O
.	O

Considering	O
the	O
clinical	O
course	O
and	O
laboratory	O
data	O
,	O
this	O
was	O
probably	O
drug	O
-	O
induced	O
lung	B-ANAT
injury	O
caused	O
by	O
oseltamivir	O
.	O

One	O
hundred	O
and	O
seventy	O
-	O
seven	O
serum	B-ANAT
specimens	O
were	O
collected	O
during	O
the	O
period	O
of	O
June	O
to	O
August	O
,	O
2003	O
from	O
children	O
and	O
adults	O
who	O
had	O
been	O
clinically	O
diagnosed	O
as	O
SARS	O
and	O
who	O
closely	O
contacted	O
with	O
those	O
diagnosed	O
as	O
SARS	O
during	O
SARS	O
epidemic	O
in	O
Beijing	O
.	O

Serum	B-ANAT
specimens	O
collected	O
from	O
90	O
healthy	O
kindergarten	O
children	O
in	O
Beijing	O
in	O
September	O
2002	O
were	O
included	O
in	O
the	O
study	O
.	O

None	O
of	O
the	O
serum	B-ANAT
specimens	O
collected	O
from	O
healthy	O
children	O
before	O
and	O
during	O
epidemic	O
in	O
Beijing	O
and	O
children	O
from	O
non	O
-	O
epidemic	O
region	O
was	O
positive	O
when	O
IFA	O
methods	O
and	O
ELISA	O
with	O
Beier	O
kits	O
were	O
used	O
for	O
detection	O
,	O
but	O
some	O
were	O
positive	O
when	O
ELISA	O
with	O
the	O
diagnostic	O
kit	O
from	O
other	O
source	O
was	O
applied	O
.	O

TITLE	O
:	O
Long	O
-	O
lived	O
effector	O
/	O
central	O
memory	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
responses	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
S	O
antigen	O
in	O
recovered	O
SARS	O
patients	O
.	O

ABSTRACT	O
:	O
The	O
role	O
of	O
cell	B-ANAT
-	O
mediated	O
immunity	O
in	O
human	O
SARS	O
-	O
CoV	O
infection	O
is	O
still	O
not	O
well	O
understood	O
.	O

This	O
evidence	O
strongly	O
implicates	O
complement	O
factors	O
in	O
the	O
development	O
of	O
lung	B-ANAT
injury	O
associated	O
with	O
systemic	O
complement	O
activation	O
and	O
identifies	O
complement	O
inhibition	O
as	O
a	O
potential	O
therapeutic	O
target	O
for	O
acute	O
syndromes	O
such	O
as	O
ARDS	O
and	O
other	O
severe	O
systemic	O
shock	O
states	O
mediated	O
by	O
activation	O
of	O
complement	O
.	O

Reduction	O
of	O
inspiratory	O
flow	O
and	O
respiratory	O
rate	O
with	O
large	O
tidal	O
volume	O
ventilation	O
may	O
provide	O
pulmonary	B-ANAT
protection	O
.	O

A	O
mixture	O
of	O
3	O
pairs	O
of	O
published	O
primers	O
was	O
used	O
for	O
amplification	O
of	O
viral	O
nucleic	B-ANAT
acids	O
,	O
yielding	O
3	O
different	O
amplicons	O
with	O
sizes	O
of	O
859	O
bp	O
,	O
651	O
bp	O
,	O
and	O
309	O
bp	O
for	O
TGEV	O
,	O
PEDV	O
,	O
and	O
porcine	O
GAR	O
,	O
respectively	O
.	O

This	O
was	O
regarded	O
as	O
full	O
lung	B-ANAT
inflation	O
.	O

CONCLUSIONS	O
:	O
A	O
sustained	O
inflation	O
followed	O
by	O
an	O
incremental	O
mean	O
airway	B-ANAT
pressure	O
trial	O
in	O
HFOV	O
improved	O
oxygenation	O
at	O
a	O
lower	O
mPaw	O
than	O
during	O
conventional	O
lung	B-ANAT
protective	O
ventilation	O
.	O

TITLE	O
:	O
Accelerated	O
induction	O
of	O
apoptosis	O
in	O
insect	O
cells	B-ANAT
by	O
baculovirus	O
-	O
expressed	O
SARS	O
-	O
CoV	O
membrane	B-ANAT
protein	O
.	O

Initial	O
neutrophil	B-ANAT
count	O
,	O
CRP	O
and	O
LDH	O
levels	O
are	O
important	O
predictors	O
of	O
mortality	O
from	O
SARS	O
.	O

ABSTRACT	O
:	O
As	O
with	O
all	O
viruses	O
,	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
utilizes	O
specific	O
host	B-ANAT
cell	I-ANAT
factors	O
during	O
its	O
infection	O
cycle	O
.	O

TITLE	O
:	O
Vascular	B-ANAT
endothelial	B-ANAT
growth	O
factor	O
(	O
VEGF	O
)	O
in	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
):	O
paradox	O
or	O
paradigm	O
?	O

It	O
is	O
characterised	O
by	O
alveolar	B-ANAT
injury	O
and	O
increased	O
pulmonary	B-ANAT
vascular	B-ANAT
permeability	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
enters	O
cells	B-ANAT
through	O
the	O
activities	O
of	O
a	O
spike	O
protein	O
(	O
S	O
)	O
which	O
has	O
receptor	O
-	O
binding	O
(	O
S1	O
)	O
and	O
membrane	B-ANAT
fusion	O
(	O
S2	O
)	O
regions	O
.	O

The	O
states	O
and	O
transitions	O
of	O
S	O
suggest	O
conformational	O
changes	O
that	O
mediate	O
viral	O
entry	O
into	O
cells	B-ANAT
.	O

From	O
hemagglutinin	O
esterase	O
(	O
HE	O
)	O
to	O
nucleocapsid	B-ANAT
(	O
N	O
),	O
the	O
genotype	O
B	O
strains	O
were	O
clustered	O
closely	O
with	O
the	O
genotype	O
C	O
strains	O
.	O

ABSTRACT	O
:	O
All	O
coronaviruses	O
encode	O
a	O
small	O
hydrophobic	O
envelope	B-ANAT
(	O
E	O
)	O
protein	O
,	O
which	O
mediates	O
viral	O
assembly	O
and	O
morphogenesis	O
by	O
an	O
unknown	O
mechanism	O
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
host	O
response	O
to	O
a	O
single	O
JHMV	O
-	O
specific	O
immunodominant	O
CD4	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
epitope	O
is	O
critical	O
for	O
severe	O
disease	O
.	O

Using	O
confocal	O
microscopy	O
coupled	O
with	O
fluorescent	O
labelled	O
nucleolar	B-ANAT
marker	O
proteins	O
we	O
observed	O
changes	O
in	O
the	O
morphology	O
of	O
the	O
nucleolus	B-ANAT
including	O
an	O
enlarged	O
fibrillar	B-ANAT
centre	I-ANAT
.	O

ABSTRACT	O
:	O
Pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
a	O
severe	O
lung	B-ANAT
injury	O
caused	O
by	O
pneumonia	O
,	O
sepsis	O
,	O
and	O
trauma	O
.	O

One	O
hundred	O
and	O
twenty	O
healthy	O
adult	O
male	O
Sprague	O
-	O
Dawley	O
rats	O
were	O
randomizedly	O
assigned	O
into	O
normal	O
saline	O
(	O
NS	O
)	O
group	O
(	O
n	O
=	O
24	O
),	O
paraquat	O
poisoning	O
induced	O
lung	B-ANAT
tissue	I-ANAT
injury	O
model	O
(	O
PQ	O
)	O
group	O
(	O
n	O
=	O
48	O
)	O
and	O
ambroxol	O
treatment	O
(	O
AT	O
)	O
group	O
(	O
n	O
=	O
48	O
).	O

These	O
are	O
probably	O
bound	O
by	O
two	O
Zn	O
-	O
finger	B-ANAT
-	O
like	O
motifs	O
.	O

A	O
highly	O
conserved	O
RNA	O
structure	O
in	O
the	O
3	O
'	O
non	O
-	O
translated	O
region	O
of	O
the	O
SARS	O
virus	O
was	O
cleaved	B-ANAT
preferentially	O
at	O
one	O
of	O
the	O
unpaired	O
uridylate	O
bases	O
,	O
demonstrating	O
that	O
both	O
RNA	O
structure	O
and	O
base	O
-	O
pairing	O
can	O
affect	O
cleavage	O
by	O
Nsp15	O
.	O

Cardiovascular	B-ANAT
symptoms	O
,	O
including	O
hypotension	O
,	O
cardiac	B-ANAT
arrhythmia	O
and	O
chest	B-ANAT
pain	O
,	O
are	O
presumably	O
linked	O
to	O
cardiac	B-ANAT
mast	B-ANAT
cell	I-ANAT
mediator	O
release	O
.	O

Clinical	O
(	O
temperature	O
,	O
FiO2	O
)	O
and	O
laboratory	O
[	O
leukocyte	B-ANAT
,	O
lymphocyte	B-ANAT
,	O
neutrophil	B-ANAT
,	O
platelet	B-ANAT
,	O
lactate	O
dehydrogenase	O
(	O
LDH	O
),	O
albumin	O
]	O
trends	O
in	O
groups	O
with	O
and	O
without	O
an	O
adversarial	O
event	O
were	O
presented	O
.	O

RESULTS	O
:	O
Clinical	O
(	O
temperature	O
,	O
FiO2	O
)	O
and	O
laboratory	O
[	O
leukocyte	B-ANAT
,	O
lymphocyte	B-ANAT
,	O
neutrophil	B-ANAT
,	O
platelet	B-ANAT
,	O
lactate	O
dehydrogenase	O
(	O
LDH	O
),	O
albumin	O
]	O
trends	O
in	O
groups	O
with	O
and	O
without	O
an	O
adversarial	O
event	O
were	O
presented	O
.	O

TITLE	O
:	O
Photochemical	O
treatment	O
of	O
plasma	B-ANAT
with	O
amotosalen	O
and	O
long	O
-	O
wavelength	O
ultraviolet	O
light	O
inactivates	O
pathogens	O
while	O
retaining	O
coagulation	O
function	O
.	O

The	O
levels	O
of	O
inactivation	O
expressed	O
as	O
log	O
-	O
reduction	O
were	O
as	O
follows	O
:	O
cell	B-ANAT
-	O
free	O
human	O
immunodeficiency	O
virus	O
-	O
1	O
(	O
HIV	O
-	O
1	O
),	O
greater	O
than	O
6	O
.	O
8	O
;	O
cell	B-ANAT
-	O
associated	O
HIV	O
-	O
1	O
,	O
greater	O
than	O
6	O
.	O
4	O
;	O
human	O
T	O
-	O
lymphotropic	O
virus	O
-	O
I	O
(	O
HTLV	O
-	O
I	O
),	O
4	O
.	O
5	O
;	O
HTLV	O
-	O
II	O
,	O
greater	O
than	O
5	O
.	O
7	O
;	O
hepatitis	O
B	O
virus	O
(	O
HBV	O
)	O
and	O
hepatitis	O
C	O
virus	O
,	O
greater	O
than	O
4	O
.	O
5	O
;	O
duck	O
HBV	O
,	O
4	O
.	O
4	O
to	O
4	O
.	O
5	O
;	O
bovine	O
viral	O
diarrhea	O
virus	O
,	O
6	O
.	O
0	O
;	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
,	O
5	O
.	O
5	O
;	O
West	O
Nile	O
virus	O
,	O
6	O
.	O
8	O
;	O
bluetongue	O
virus	O
,	O
5	O
.	O
1	O
;	O
human	O
adenovirus	O
5	O
,	O
6	O
.	O
8	O
;	O
Klebsiella	O
pneumoniae	O
,	O
greater	O
than	O
7	O
.	O
4	O
;	O
Staphylococcus	O
epidermidis	O
and	O
Yersinia	O
enterocolitica	O
,	O
greater	O
than	O
7	O
.	O
3	O
;	O
Treponema	O
pallidum	B-ANAT
,	O
greater	O
than	O
5	O
.	O
9	O
;	O
Borrelia	O
burgdorferi	O
,	O
greater	O
than	O
10	O
.	O
6	O
;	O
Plasmodium	O
falciparum	O
,	O
6	O
.	O
9	O
;	O
Trypanosoma	O
cruzi	O
,	O
greater	O
than	O
5	O
.	O
0	O
;	O
and	O
Babesia	O
microti	O
,	O
greater	O
than	O
5	O
.	O
3	O
.	O

Coexpression	O
of	O
7a	O
protein	O
with	O
SCoV	O
S	O
,	O
M	O
,	O
N	O
,	O
and	O
E	O
proteins	O
resulted	O
in	O
production	O
of	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
(	O
VLPs	B-ANAT
)	O
carrying	O
7a	O
protein	O
,	O
while	O
7a	O
protein	O
was	O
not	O
released	O
from	O
cells	B-ANAT
expressing	O
7a	O
protein	O
alone	O
.	O

This	O
cavity	B-ANAT
is	O
likely	O
to	O
be	O
involved	O
in	O
membrane	B-ANAT
attachment	O
and	O
,	O
in	O
mammalian	O
cells	B-ANAT
,	O
ORF	O
-	O
9b	O
associates	O
with	O
intracellular	B-ANAT
vesicles	B-ANAT
,	O
consistent	O
with	O
a	O
role	O
in	O
the	O
assembly	O
of	O
the	O
virion	B-ANAT
.	O

Moreover	O
,	O
the	O
majority	O
of	O
IFN	O
-	O
gamma	B-ANAT
+	I-ANAT
CD4	I-ANAT
+	I-ANAT
T	I-ANAT
cells	I-ANAT
were	O
central	O
memory	B-ANAT
cells	I-ANAT
expressing	O
CD45RO	O
+	O
CCR7	O
+	O
CD62L	O
-;	O
whereas	O
IFN	O
-	O
gamma	O
+	O
CD8	O
+	O
memory	O
T	B-ANAT
cells	I-ANAT
were	O
mostly	O
effector	O
memory	B-ANAT
cells	I-ANAT
expressing	O
CD45RO	O
-	O
CCR7	O
-	O
CD62L	O
-.	O

We	O
then	O
studied	O
the	O
severity	O
of	O
acute	O
pancreatitis	O
-	O
associated	O
lung	B-ANAT
injury	O
over	O
18h	O
in	O
rats	O
that	O
had	O
taurocholic	O
acid	O
injection	O
in	O
the	O
pancreatic	B-ANAT
duct	I-ANAT
and	O
determined	O
whether	O
blood	B-ANAT
collected	O
from	O
rats	O
with	O
pancreatitis	O
is	O
toxic	O
enough	O
to	O
induce	O
injury	O
in	O
normal	O
lungs	B-ANAT
.	O

Taurocholic	O
acid	O
injection	O
induced	O
a	O
severe	O
pancreatic	B-ANAT
injury	O
that	O
started	O
as	O
early	O
as	O
2h	O
after	O
the	O
injection	O
and	O
persisted	O
without	O
recovery	O
over	O
the	O
18	O
-	O
h	O
study	O
period	O
.	O

In	O
contrast	O
,	O
the	O
pulmonary	B-ANAT
injury	O
was	O
transient	O
,	O
appearing	O
at	O
the	O
6	O
-	O
h	O
time	O
point	O
with	O
recovery	O
by	O
the	O
end	O
of	O
the	O
study	O
.	O

The	O
recovery	O
of	O
lung	B-ANAT
injury	O
by	O
18h	O
might	O
be	O
explained	O
by	O
a	O
decrease	O
in	O
the	O
overall	O
toxicity	O
of	O
pancreatic	B-ANAT
blood	B-ANAT
over	O
time	O
.	O

ABSTRACT	O
:	O
SARS	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
induced	O
cell	B-ANAT
apoptosis	O
and	O
its	O
structural	O
proteins	O
may	O
play	O
a	O
role	O
in	O
this	O
process	O
.	O

We	O
found	O
that	O
in	O
the	O
absence	O
of	O
serum	B-ANAT
about	O
16	O
.	O
34	O
%	O
of	O
cells	B-ANAT
transfected	O
by	O
pcDNA3	O
.	O
1	O
-	O
M	O
and	O
21	O
.	O
72	O
%	O
of	O
N	O
-	O
transfected	O
cells	B-ANAT
showed	O
typical	O
apoptotic	O
characteristics	O
,	O
significantly	O
different	O
from	O
mock	O
-	O
transfected	O
cells	B-ANAT
(	O
only	O
6	O
.	O
23	O
%,	O
p	O
<	O
0	O
.	O
01	O
).	O

The	O
results	O
show	O
that	O
M	O
and	O
N	O
proteins	O
of	O
SARS	O
-	O
CoV	O
can	O
induce	O
apoptosis	O
of	O
HPF	O
cells	B-ANAT
.	O

The	O
cases	O
were	O
classified	O
as	O
dry	O
-	O
bite	O
(	O
n	O
=	O
1	O
,	O
caused	O
by	O
M	O
.	O
lemniscatus	O
;	O
did	O
not	O
receive	O
antivenom	O
),	O
mild	O
(	O
n	O
=	O
2	O
,	O
local	O
manifestations	O
with	O
no	O
acute	O
myasthenic	O
syndrome	O
;	O
M	O
.	O
frontalis	B-ANAT
and	O
Micrurus	O
spp	O
.),	O
moderate	O
(	O
n	O
=	O
5	O
,	O
mild	O
myasthenia	O
)	O
or	O
severe	O
(	O
n	O
=	O
3	O
,	O
important	O
myasthenia	O
;	O
one	O
of	O
them	O
caused	O
by	O
M	O
.	O
frontalis	B-ANAT
).	O

In	O
serious	O
bites	O
by	O
M	O
.	O
frontalis	B-ANAT
or	O
M	O
.	O
lemniscatus	O
,	O
the	O
venom	O
of	O
which	O
acts	O
postsynaptically	O
,	O
anticholinesterases	O
may	O
be	O
useful	O
as	O
an	O
ancillary	O
measure	O
if	O
antivenom	O
is	O
unavailable	O
,	O
if	O
there	O
is	O
a	O
delay	O
in	O
obtaining	O
a	O
sufficient	O
amount	O
,	O
or	O
in	O
those	O
patients	O
given	O
the	O
highest	O
recommended	O
doses	O
of	O
antivenom	O
without	O
improvement	O
of	O
the	O
paralysis	O
or	O
with	O
delayed	O
recovery	O
.	O

HRVs	O
were	O
the	O
sole	B-ANAT
microbe	O
detected	O
in	O
37	O
.	O
8	O
%	O
(	O
n	O
=	O
31	O
)	O
of	O
patients	O
with	O
suspected	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
(	O
LRTI	O
).	O

Most	O
of	O
the	O
genotyped	O
HAdV	O
strains	O
were	O
found	O
to	O
be	O
type	O
C	O
.	O
This	O
study	O
describes	O
the	O
high	O
microbial	O
burden	O
imposed	O
by	O
HRVs	O
,	O
HMPV	O
,	O
HRSV	O
,	O
HCoVs	O
,	O
and	O
the	O
newly	O
identified	O
virus	O
,	O
HBoV	O
on	O
a	O
predominantly	O
paediatric	O
hospital	O
population	O
with	O
suspected	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
and	O
proposes	O
a	O
new	O
formulation	O
of	O
viral	O
targets	O
for	O
future	O
diagnostic	O
research	O
studies	O
.	O

TITLE	O
:	O
Pulmonary	B-ANAT
surfactant	O
in	O
patients	O
with	O
Pneumocystis	O
pneumonia	O
and	O
acquired	O
immunodeficiency	O
syndrome	O
.	O

We	O
analyzed	O
pulmonary	B-ANAT
surfactant	O
composition	O
and	O
function	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
BALF	O
)	O
from	O
ventilated	O
and	O
spontaneously	O
breathing	O
HIV	O
-	O
positive	O
patients	O
with	O
PCP	O
.	O

Further	O
egg	B-ANAT
passage	O
of	O
the	O
BeauR	O
-	O
M41	O
(	O
S	O
)	O
strain	O
(	O
BeauR	O
-	O
M41	O
(	O
S	O
)	O
EP10	O
)	O
did	O
not	O
increase	O
its	O
pathogenicity	O
though	O
it	O
did	O
improve	O
its	O
efficacy	O
,	O
based	O
on	O
serology	O
and	O
protection	O
against	O
a	O
virulent	O
challenge	O
.	O

Oxygenation	O
parameters	O
(	O
oxygenation	O
index	O
,	O
OI	O
;	O
Pao	O
(	O
2	O
)/	O
Fio	O
(	O
2	O
)	O
ratio	O
,	O
P	O
/	O
F	O
)	O
and	O
mean	O
airway	B-ANAT
pressures	O
(	O
mPaw	O
)	O
were	O
recorded	O
at	O
baseline	O
and	O
at	O
1	O
to	O
4	O
,	O
8	O
to	O
12	O
,	O
and	O
12	O
to	O
24	O
hours	O
after	O
initiation	O
of	O
HFPV	O
.	O

Indeed	O
,	O
binding	O
of	O
recombinant	O
SARS	O
-	O
CoV	O
spike	O
protein	O
to	O
Vero	O
E6	O
cells	B-ANAT
was	O
diminished	O
on	O
cells	B-ANAT
treated	O
with	O
IL	O
-	O
4	O
,	O
but	O
also	O
on	O
cells	B-ANAT
exposed	O
to	O
IFN	O
-	O
gamma	O
.	O

Besides	O
diminished	O
ACE2	O
cell	B-ANAT
surface	I-ANAT
expression	O
,	O
ACE2	O
mRNA	O
levels	O
were	O
also	O
decreased	O
after	O
treatment	O
with	O
these	O
cytokines	O
.	O

Nasopharyngeal	B-ANAT
aspirates	B-ANAT
from	O
379	O
children	O
attended	O
at	O
Hospital	O
de	O
ClÃ­nicas	O
(	O
HC	O
/	O
UFU	O
),	O
from	O
2001	O
to	O
2004	O
,	O
with	O
acute	O
respiratory	O
disease	O
,	O
were	O
collected	O
and	O
tested	O
by	O
immunofluorescence	O
assay	O
(	O
IFA	O
)	O
to	O
detect	O
RSV	O
,	O
FLU	O
A	O
and	O
B	O
,	O
PIV	O
1	O
,	O
2	O
,	O
and	O
3	O
and	O
AdV	O
,	O
and	O
RT	O
-	O
PCR	O
to	O
detect	O
HRV	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
presence	O
of	O
the	O
Arkansas	O
(	O
Ark	O
)	O
and	O
Massachusetts	O
(	O
Mass	O
)	O
serotypes	O
of	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
in	O
the	O
tracheas	B-ANAT
and	O
cecal	B-ANAT
tonsils	B-ANAT
of	O
commercial	O
broilers	O
after	O
vaccination	O
at	O
1	O
day	O
of	O
age	O
by	O
coarse	O
spray	O
.	O

When	O
both	O
strains	O
were	O
given	O
in	O
the	O
mixed	O
vaccine	O
,	O
the	O
Mass	O
strain	O
was	O
more	O
consistently	O
detected	O
by	O
RT	O
-	O
PCR	O
-	O
RFLP	O
in	O
the	O
tracheas	B-ANAT
and	O
cecal	B-ANAT
tonsils	B-ANAT
at	O
early	O
stages	O
of	O
infection	O
(	O
up	O
to	O
14	O
days	O
)	O
and	O
the	O
Arkansas	O
strain	O
was	O
more	O
consistently	O
detected	O
at	O
late	O
stages	O
of	O
infection	O
(	O
21	O
and	O
28	O
days	O
).	O

nsp10	O
is	O
a	O
single	O
domain	O
protein	O
consisting	O
of	O
a	O
pair	O
of	O
antiparallel	O
N	O
-	O
terminal	O
helices	O
stacked	O
against	O
an	O
irregular	O
beta	O
-	O
sheet	O
,	O
a	O
coil	O
-	O
rich	O
C	O
terminus	O
,	O
and	O
two	O
Zn	O
fingers	B-ANAT
.	O

nsp10	O
represents	O
a	O
novel	O
fold	O
and	O
is	O
the	O
first	O
structural	O
representative	O
of	O
this	O
family	O
of	O
Zn	O
finger	B-ANAT
proteins	O
found	O
so	O
far	O
exclusively	O
in	O
coronaviruses	O
.	O

Plasma	B-ANAT
BNP	O
and	O
ANP	O
levels	O
were	O
measured	O
by	O
radioimmunoassay	O
.	O

TITLE	O
:	O
[	O
Pilot	O
study	O
of	O
a	O
strategy	O
combining	O
coronary	B-ANAT
angioplasty	O
with	O
valvular	O
and	O
/	O
or	O
coronary	B-ANAT
surgery	O
on	O
the	O
same	O
day	O
].	O

ABSTRACT	O
:	O
A	O
strategy	O
combining	O
percutaneous	O
coronary	B-ANAT
angioplasty	O
followed	O
by	O
valvular	O
and	O
/	O
or	O
coronary	B-ANAT
surgery	O
was	O
recently	O
proposed	O
as	O
an	O
alternative	O
to	O
the	O
classical	O
surgical	O
only	O
approach	O
.	O

There	O
were	O
no	O
additional	O
deaths	O
,	O
coronary	B-ANAT
events	O
nor	O
haemorrhage	O
at	O
the	O
end	O
of	O
an	O
average	O
follow	O
-	O
up	O
of	O
15	O
+/-	O

Nasal	B-ANAT
swab	O
specimens	O
,	O
fecal	B-ANAT
samples	O
,	O
and	O
serum	B-ANAT
samples	O
were	O
obtained	O
before	O
shipping	O
,	O
at	O
arrival	O
,	O
and	O
periodically	O
thereafter	O
.	O

NM	O
calves	O
had	O
a	O
high	O
geometric	O
mean	O
titer	O
for	O
BCV	O
antibody	O
at	O
arrival	O
(	O
GMT	O
,	O
1	O
,	O
928	O
);	O
only	O
2	O
%	O
shed	O
BCV	O
in	O
nasal	B-ANAT
secretions	B-ANAT
and	O
1	O
%	O
in	O
feces	B-ANAT
.	O

Detection	O
of	O
BCV	O
in	O
nasal	B-ANAT
secretions	B-ANAT
preceded	O
detection	O
in	O
feces	B-ANAT
before	O
shipping	O
AR	O
calves	O
,	O
but	O
at	O
arrival	O
,	O
73	O
%	O
of	O
AR	O
calves	O
were	O
shedding	O
BCV	O
in	O
nasal	B-ANAT
secretions	B-ANAT
and	O
feces	B-ANAT
.	O

Following	O
immunohistochemical	O
examination	O
,	O
all	O
cryptosporidiosis	O
cases	O
were	O
confirmed	O
by	O
positive	O
immunostaining	O
of	O
intestinal	B-ANAT
sections	O
.	O

All	O
donor	O
kidneys	B-ANAT
were	O
recovered	O
laparoscopically	O
.	O

The	O
incidence	O
of	O
acute	O
cellular	B-ANAT
rejection	O
(	O
ACR	O
)	O
at	O
1	O
year	O
was	O
6	O
.	O
8	O
%	O
in	O
the	O
alemtuzumab	O
group	O
and	O
17	O
.	O
0	O
%	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
the	O
historic	O
control	O
group	O
.	O

We	O
conducted	O
a	O
multicenter	O
evaluation	O
of	O
four	O
automated	O
and	O
four	O
manual	O
extraction	O
methods	O
using	O
dilutions	O
of	O
viral	O
lysate	O
in	O
replicate	O
mock	O
stool	B-ANAT
samples	O
,	O
followed	O
by	O
quantitation	O
of	O
SARS	O
CoV	O
RNA	O
using	O
real	O
-	O
time	O
reverse	O
transcriptase	O
PCR	O
.	O

TITLE	O
:	O
AIDS	O
:	O
caused	O
by	O
development	O
of	O
resistance	O
to	O
drugs	O
in	O
a	O
non	O
-	O
target	O
intracellular	B-ANAT
parasite	O
.	O

Both	O
major	O
camps	O
in	O
the	O
argument	O
presume	O
that	O
humans	O
are	O
normally	O
free	O
of	O
such	O
viruses	O
and	O
assume	O
that	O
once	O
the	O
simian	O
virus	O
was	O
transmitted	O
,	O
it	O
immediately	O
infected	O
some	O
T	B-ANAT
-	I-ANAT
cells	I-ANAT
and	O
caused	O
the	O
release	O
of	O
toxic	O
agents	O
that	O
killed	O
off	O
bystander	O
(	O
uninfected	O
)	O
T	B-ANAT
-	I-ANAT
cells	I-ANAT
resulting	O
in	O
AIDS	O
.	O

The	O
putative	O
ion	O
channel	O
activity	O
of	O
this	O
protein	O
was	O
assessed	O
in	O
3a	O
-	O
complement	O
RNA	O
-	O
injected	O
Xenopus	O
oocytes	B-ANAT
by	O
two	O
-	O
electrode	O
voltage	O
clamp	O
.	O

ABSTRACT	O
:	O
A	O
novel	O
group	O
1	O
coronavirus	O
was	O
previously	O
identified	O
in	O
bent	O
-	O
winged	B-ANAT
bats	O
(	O
Miniopterus	O
spp	O
.).	O

Fertile	O
eggs	O
were	O
used	O
for	O
antibody	O
extraction	O
from	O
the	O
egg	B-ANAT
yolks	O
and	O
egg	B-ANAT
whites	O
(	O
4	O
to	O
5	O
eggs	O
/	O
dam	O
)	O
and	O
for	O
hatching	O
.	O

Egg	B-ANAT
yolk	B-ANAT
IgY	O
and	O
IgA	O
,	O
as	O
well	O
as	O
egg	B-ANAT
white	I-ANAT
IgY	O
,	O
IgA	O
,	O
and	O
IgM	O
levels	O
were	O
higher	O
in	O
line	O
2	O
compared	O
with	O
line	O
1	O
(	O
P	O
<	O
0	O
.	O
0001	O
).	O

Independent	O
of	O
line	O
of	O
chicken	O
,	O
the	O
percentage	O
dam	O
-	O
to	O
-	O
chick	O
(	O
3	O
d	O
)	O
plasma	B-ANAT
transfer	O
of	O
IgY	O
was	O
estimated	O
to	O
be	O
approximately	O
30	O
%,	O
with	O
that	O
for	O
IgM	O
and	O
IgA	O
less	O
than	O
1	O
%.	O

Astrocytes	B-ANAT
are	O
one	O
of	O
the	O
major	O
targets	O
for	O
MHV	O
infection	O
in	O
the	O
CNS	B-ANAT
,	O
and	O
respond	O
to	O
MHV	O
infection	O
by	O
expressing	O
diverse	O
molecules	O
that	O
may	O
contribute	O
to	O
CNS	B-ANAT
pathogenesis	O
.	O

Experiments	O
with	O
ultraviolet	O
light	O
-	O
inactivated	O
virus	O
revealed	O
that	O
the	O
induction	O
of	O
Egr	O
-	O
1	O
did	O
not	O
require	O
virus	O
replication	O
and	O
was	O
likely	O
mediated	O
during	O
cell	B-ANAT
entry	O
.	O

This	O
finding	O
may	O
provide	O
an	O
explanation	O
for	O
our	O
previously	O
observed	O
down	O
-	O
regulation	O
of	O
BNip3	O
by	O
MHV	O
infection	O
in	O
astrocytoma	O
cells	B-ANAT
(	O
Cai	O
,	O
Liu	O
,	O
Yu	O
,	O
and	O
Zhang	O
,	O
Virology	O
316	O
:	O
104	O
-	O
115	O
,	O
2003	O
).	O

It	O
should	O
be	O
taken	O
into	O
consideration	O
at	O
any	O
time	O
when	O
cardiopulmonary	B-ANAT
instability	O
occurs	O
after	O
transfusion	O
of	O
blood	B-ANAT
products	O
,	O
which	O
is	O
a	O
frequent	O
event	O
on	O
surgical	O
Intensive	O
Care	O
Units	O
.	O

This	O
review	O
summarizes	O
our	O
current	O
understanding	O
of	O
the	O
pathophysiology	O
of	O
what	O
is	O
now	O
termed	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
its	O
less	O
severe	O
form	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
),	O
with	O
an	O
emphasis	O
on	O
cellular	B-ANAT
and	O
molecular	O
mechanisms	O
of	O
injury	O
that	O
may	O
represent	O
potential	O
therapeutic	O
targets	O
.	O

Based	O
on	O
the	O
insight	O
gained	O
from	O
these	O
studies	O
,	O
ongoing	O
trials	O
have	O
modified	O
these	O
factors	O
to	O
optimize	O
outcome	O
,	O
including	O
one	O
trial	O
that	O
is	O
focusing	O
on	O
patients	O
with	O
direct	O
lung	B-ANAT
insults	O
such	O
as	O
pneumonia	O
and	O
aspiration	O
.	O

Systemic	O
heparinization	O
is	O
a	O
mainstay	O
of	O
ECLS	O
therapy	O
because	O
of	O
platelet	B-ANAT
activation	O
in	O
the	O
circuit	O
.	O

Here	O
,	O
we	O
show	O
that	O
expression	O
of	O
DC	O
-	O
SIGN	O
augments	O
NL63	O
spike	O
(	O
S	O
)-	O
protein	O
-	O
driven	O
infection	O
of	O
susceptible	O
cells	B-ANAT
,	O
while	O
only	O
expression	O
of	O
ACE2	O
but	O
not	O
DC	O
-	O
SIGN	O
is	O
sufficient	O
for	O
entry	O
into	O
nonpermissive	O
cells	B-ANAT
,	O
indicating	O
that	O
ACE2	O
fulfills	O
the	O
criteria	O
of	O
a	O
bona	O
fide	O
hCoV	O
-	O
NL63	O
receptor	O
.	O

ABSTRACT	O
:	O
Protein	O
ubiquitination	O
has	O
been	O
identified	O
as	O
a	O
regulatory	O
mechanism	O
in	O
key	O
cellular	B-ANAT
activities	O
,	O
and	O
deubiquitination	O
is	O
recognized	O
as	O
an	O
important	O
step	O
in	O
processes	O
governed	O
by	O
ubiquitin	O
and	O
ubiquitin	O
-	O
like	O
modifiers	O
.	O

Although	O
most	O
of	O
the	O
assays	O
have	O
initially	O
been	O
focused	O
on	O
RNA	O
extracted	O
from	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
,	O
urine	B-ANAT
,	O
and	O
stools	B-ANAT
,	O
several	O
of	O
the	O
more	O
recently	O
developed	O
assays	O
have	O
been	O
based	O
on	O
the	O
analysis	O
of	O
RNA	O
extracted	O
from	O
plasma	B-ANAT
and	O
serum	B-ANAT
.	O

In	O
order	O
to	O
avoid	O
the	O
high	O
risks	O
involved	O
in	O
handling	O
SARS	O
-	O
CoV	O
and	O
to	O
facilitate	O
the	O
study	O
of	O
viral	O
fusion	O
mechanism	O
,	O
we	O
established	O
the	O
cell	B-ANAT
lines	I-ANAT
:	O
SR	O
-	O
COS7	O
cells	B-ANAT
that	O
stably	O
express	O
both	O
SARS	O
-	O
CoV	O
S	O
protein	O
and	O
red	O
fluorescence	O
protein	O
,	O
R	O
-	O
COS7	O
cells	B-ANAT
that	O
stably	O
express	O
red	O
fluorescence	O
protein	O
,	O
and	O
AG	O
-	O
COS7	O
cells	B-ANAT
that	O
stably	O
express	O
both	O
ACE2	O
and	O
green	O
fluorescence	O
protein	O
,	O
respectively	O
.	O

The	O
cell	B-ANAT
-	O
to	O
-	O
cell	B-ANAT
fusion	O
efficiency	O
was	O
simply	O
determined	O
for	O
quantitative	O
analysis	O
based	O
on	O
the	O
number	O
of	O
syncytium	B-ANAT
detected	O
by	O
flow	O
cytometry	O
.	O

RESULTS	O
:	O
Our	O
data	O
showed	O
that	O
H5N1	O
viral	O
infection	O
in	O
mice	O
resulted	O
in	O
typical	O
ARDS	O
,	O
which	O
was	O
characterized	O
by	O
the	O
following	O
features	O
:	O
(	O
1	O
)	O
about	O
80	O
%	O
of	O
mice	O
(	O
13	O
of	O
16	O
)	O
dead	O
on	O
Days	O
6	O
to	O
8	O
postinoculation	O
;	O
(	O
2	O
)	O
highly	O
edematous	O
lungs	B-ANAT
and	O
dramatically	O
increased	O
lung	B-ANAT
wet	O
:	O
dry	O
weight	O
ratios	O
and	O
lung	B-ANAT
wet	O
weight	O
:	O
body	B-ANAT
weight	O
ratios	O
;	O
(	O
3	O
)	O
inflammatory	O
cellular	B-ANAT
infiltration	O
,	O
alveolar	B-ANAT
and	O
interstitial	B-ANAT
edema	O
,	O
and	O
hemorrhage	O
in	O
lungs	B-ANAT
;	O
(	O
4	O
)	O
progressive	O
and	O
severe	O
hypoxemia	O
;	O
and	O
(	O
5	O
)	O
significant	O
increase	O
in	O
neutrophils	B-ANAT
,	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
,	O
and	O
interleukin	O
-	O
6	O
in	O
BALF	O
.	O

The	O
S	O
protein	O
fragment	O
was	O
purified	O
from	O
the	O
culture	O
supernatant	O
of	O
stably	O
transformed	O
HEK293T	O
cells	B-ANAT
secreting	O
a	O
tagged	O
version	O
of	O
the	O
protein	O
.	O

TITLE	O
:	O
Severe	O
pneumonia	O
with	O
pneumatoceles	O
and	O
patent	O
foramen	B-ANAT
ovale	I-ANAT
in	O
an	O
infant	O
:	O
optimal	O
ventilation	O
strategy	O
?	O

Application	O
of	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
of	O
10	O
cmH	O
(	O
2	O
)	O
O	O
at	O
FIO	O
(	O
2	O
)	O
of	O
0	O
.	O
7	O
worsened	O
oxygenation	O
,	O
and	O
transthoracic	O
echocardiography	O
showed	O
right	O
-	O
to	O
-	O
left	O
shunting	O
of	O
blood	B-ANAT
through	O
the	O
patent	O
foramen	B-ANAT
ovale	I-ANAT
.	O

Therefore	O
,	O
PEEP	O
had	O
to	O
be	O
tapered	O
to	O
6	O
cmH	O
(	O
2	O
)	O
O	O
,	O
and	O
ventilation	O
carried	O
out	O
at	O
FIO	O
(	O
2	O
)	O
of	O
1	O
until	O
the	O
lung	B-ANAT
condition	O
improved	O
.	O

TITLE	O
:	O
Leptospirosis	O
leads	O
to	O
dysregulation	O
of	O
sodium	O
transporters	O
in	O
the	O
kidney	B-ANAT
and	O
lung	B-ANAT
.	O

A	O
thickened	O
gallbladder	B-ANAT
wall	I-ANAT
was	O
found	O
in	O
19	O
cases	O
,	O
all	O
were	O
women	O
,	O
and	O
periportal	O
tracking	O
and	O
a	O
dilated	O
inferior	B-ANAT
vena	I-ANAT
cava	I-ANAT
in	O
17	O
CTs	O
.	O

Alternatively	O
,	O
APN	O
should	O
be	O
included	O
in	O
the	O
differential	O
diagnosis	O
of	O
systemic	O
diseases	O
that	O
cause	O
gallbladder	B-ANAT
wall	I-ANAT
thickening	O
to	O
avoid	O
misdiagnosing	O
it	O
as	O
acute	O
cholecystitis	O
.	O

We	O
further	O
show	O
that	O
the	O
RBD	O
of	O
S1	O
forms	O
dimers	O
via	O
an	O
extensive	O
interface	O
that	O
is	O
disrupted	O
in	O
receptor	O
-	O
and	O
antibody	O
-	O
bound	O
crystal	B-ANAT
structures	O
,	O
and	O
we	O
propose	O
a	O
role	O
for	O
the	O
dimer	O
in	O
virus	O
stability	O
and	O
infectivity	O
.	O

Bovine	O
coronavirus	O
-	O
positive	O
reactions	O
were	O
detected	O
for	O
107	O
(	O
58	O
.	O
2	O
%)	O
diarrheic	O
fecal	B-ANAT
samples	O
(	O
in	O
47	O
/	O
75	O
herds	O
).	O

Extended	O
-	O
host	O
-	O
range	O
variants	O
of	O
MHV	O
strain	O
A59	O
were	O
previously	O
obtained	O
from	O
persistently	O
infected	O
cells	B-ANAT
(	O
J	O
.	O
H	O
.	O
Schickli	O
,	O
B	O
.	O
D	O
.	O
Zelus	O
,	O
D	O
.	O
E	O
.	O
Wentworth	O
,	O
S	O
.	O
G	O
.	O
Sawicki	O
,	O
and	O
K	O
.	O
V	O
.	O
Holmes	O
,	O
J	O
.	O
Virol	O
.	O

It	O
was	O
postulated	O
that	O
this	O
respiratory	O
failure	O
was	O
due	O
to	O
the	O
occlusion	O
of	O
the	O
pulmonary	B-ANAT
microcirculation	O
by	O
the	O
microclots	O
of	O
disseminated	O
intravascular	O
coagulation	O
(	O
DIC	O
).	O

Animal	O
studies	O
showed	O
that	O
pulmonary	B-ANAT
failure	O
and	O
death	O
could	O
be	O
caused	O
by	O
intravenous	O
injection	O
of	O
a	O
killed	O
culture	O
of	O
either	O
Escherichia	O
coli	O
or	O
pneumococcal	O
organisms	O
or	O
by	O
severe	O
muscle	B-ANAT
contusion	O
.	O

We	O
herein	O
report	O
a	O
33	O
-	O
year	O
-	O
old	O
man	O
who	O
presented	O
with	O
chronic	O
pulmonary	B-ANAT
complications	O
after	O
a	O
recovery	O
from	O
TEN	O
.	O

TITLE	O
:	O
Identification	O
of	O
cell	B-ANAT
lines	I-ANAT
permissive	O
for	O
human	O
coronavirus	O
NL63	O
.	O

In	O
response	O
to	O
the	O
WHO	O
request	O
we	O
conducted	O
a	O
systematic	O
review	O
of	O
the	O
published	O
literature	O
on	O
ribavirin	O
,	O
corticosteroids	O
,	O
lopinavir	O
and	O
ritonavir	O
(	O
LPV	O
/	O
r	O
),	O
type	O
I	O
interferon	O
(	O
IFN	O
),	O
intravenous	O
immunoglobulin	O
(	O
IVIG	O
),	O
and	O
SARS	O
convalescent	O
plasma	B-ANAT
from	O
both	O
in	O
vitro	O
studies	O
and	O
in	O
SARS	O
patients	O
.	O

ABSTRACT	O
:	O
The	O
benefits	O
of	O
lung	B-ANAT
-	O
protective	O
ventilation	O
strategies	O
used	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
subjects	O
with	O
normal	O
lungs	B-ANAT
are	O
uncertain	O
.	O

Their	O
impact	O
as	O
a	O
cause	O
of	O
respiratory	B-ANAT
tract	I-ANAT
disease	O
in	O
adults	O
at	O
risk	O
for	O
complications	O
needs	O
to	O
be	O
established	O
.	O

The	O
most	O
frequent	O
final	O
diagnosis	O
was	O
a	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
.	O

RESULTS	O
:	O
Univariate	O
analysis	O
yielded	O
significant	O
differences	O
in	O
parity	O
(	O
P	O
=	O
0	O
.	O
034	O
),	O
maternal	O
platelet	B-ANAT
counts	O
(	O
P	O
=	O
0	O
.	O
02	O
),	O
and	O
maternal	O
serum	B-ANAT
potassium	O
levels	O
(	O
P	O
=	O
0	O
.	O
016	O
)	O
among	O
the	O
groups	O
.	O

ABSTRACT	O
:	O
Severe	O
human	O
infection	O
with	O
Hantavirus	O
is	O
characterized	O
by	O
high	O
fever	O
,	O
cold	O
chills	O
,	O
thrombocytopenia	O
,	O
arterial	B-ANAT
hypotension	O
,	O
acute	O
renal	B-ANAT
failure	O
,	O
and	O
/	O
or	O
adult	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)-	O
like	O
pulmonary	B-ANAT
involvement	O
,	O
but	O
the	O
clinical	O
course	O
varies	O
greatly	O
between	O
individuals	O
.	O

To	O
find	O
out	O
the	O
molecular	O
mechanism	O
underlying	O
this	O
phenomenon	O
,	O
we	O
analyzed	O
the	O
transcription	O
profile	O
stimulated	O
by	O
IFN	O
-	O
alpha	O
and	O
IFN	O
-	O
gamma	O
in	O
Huh	O
-	O
7	O
cells	B-ANAT
and	O
found	O
that	O
the	O
transcription	O
of	O
a	O
subset	O
of	O
IFN	O
stimulated	O
genes	O
(	O
ISGs	O
)	O
including	O
BclG	O
,	O
XAF1	O
,	O
TRAIL	O
and	O
TAP1	O
was	O
enhanced	O
when	O
IFN	O
-	O
alpha	O
and	O
gamma	O
were	O
both	O
present	O
.	O

ORF1a	O
encodes	O
several	O
membrane	B-ANAT
domains	O
,	O
a	O
putative	O
ADP	O
-	O
ribose	O
1	O
"""-"	O
phosphatase	O
,	O
and	O
a	O
chymotrypsin	O
-	O
like	O
serine	O
protease	O
whose	O
activity	O
was	O
established	O
in	O
this	O
study	O
.	O

Accumulating	O
evidence	O
in	O
recent	O
years	O
has	O
demonstrated	O
a	O
physiological	O
and	O
pathological	O
role	O
of	O
ACE2	O
in	O
the	O
cardiovascular	B-ANAT
systems	I-ANAT
.	O

Recently	O
,	O
it	O
has	O
been	O
shown	O
that	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	O
,	O
the	O
cause	O
of	O
SARS	O
,	O
utilizes	O
ACE2	O
as	O
an	O
essential	O
receptor	O
for	O
cell	B-ANAT
fusion	O
and	O
in	O
vivo	O
infections	O
in	O
mice	O
.	O

Acute	O
respiratory	O
distress	O
syndrome	O
development	O
was	O
associated	O
(	O
P	O
<	O
.	O
001	O
)	O
with	O
fractures	O
of	O
femur	B-ANAT
(	O
International	O
Classification	O
of	O
Diseases	O
,	O
Ninth	O
Revision	O
[	O
ICD	O
-	O
9	O
]	O
codes	O
820	O
,	O
821	O
),	O
tibia	B-ANAT
(	O
ICD	O
-	O
9	O
code	O
823	O
),	O
humerus	B-ANAT
,	O
and	O
pelvis	B-ANAT
,	O
with	O
a	O
number	O
(>	O
or	O
=	O
2	O
)	O
of	O
long	B-ANAT
bone	I-ANAT
fractures	O
,	O
and	O
with	O
chest	B-ANAT
injuries	O
(	O
rib	B-ANAT
/	O
sternal	O
fracture	O
[	O
ICD	O
-	O
9	O
code	O
807	O
]	O
and	O
hemo	O
/	O
pneumothorax	O
[	O
ICD	O
-	O
9	O
code	O
860	O
/	O
861	O
]).	O

Multivariate	O
analysis	O
showed	O
that	O
ARDS	O
was	O
related	O
to	O
chest	B-ANAT
trauma	O
diagnosis	O
(	O
ICD	O
-	O
9	O
code	O
807	O
)	O
(	O
odds	O
ratio	O
[	O
OR	O
],	O
3	O
.	O
85	O
),	O
femoral	B-ANAT
fracture	O
(	O
OR	O
,	O
3	O
.	O
16	O
),	O
APACHE	O
II	O
score	O
(	O
OR	O
,	O
1	O
.	O
05	O
),	O
and	O
blood	B-ANAT
transfusion	O
during	O
resuscitation	O
(	O
OR	O
,	O
1	O
.	O
32	O
).	O

However	O
,	O
to	O
date	O
,	O
little	O
has	O
been	O
reported	O
about	O
the	O
effects	O
of	O
this	O
infection	O
on	O
the	O
thyroid	B-ANAT
gland	I-ANAT
.	O

The	O
terminal	O
deoxynucleotidyl	O
transferase	O
-	O
mediated	O
dUPT	O
nick	O
end	O
-	O
labeling	O
assay	O
demonstrated	O
many	O
cells	B-ANAT
undergoing	O
apoptosis	O
.	O

In	O
conclusion	O
,	O
both	O
parafollicular	O
and	O
follicular	B-ANAT
cells	B-ANAT
were	O
injured	O
.	O

Apoptosis	O
may	O
play	O
a	O
role	O
in	O
the	O
pathogenesis	O
of	O
SARS	O
associated	O
coronavirus	O
infection	O
in	O
the	O
thyroid	B-ANAT
gland	I-ANAT
.	O

The	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
is	O
an	O
important	O
structural	O
and	O
functional	O
protein	O
.	O

ABSTRACT	O
:	O
The	O
performances	O
of	O
four	O
multiplex	O
PCR	O
(	O
m	O
-	O
PCR	O
)	O
were	O
compared	O
to	O
direct	O
immunofluorescence	O
assay	O
(	O
DFA	O
)	O
and	O
HuH7	O
cell	B-ANAT
culture	O
for	O
the	O
detection	O
of	O
viruses	O
in	O
263	O
children	O
admitted	O
to	O
hospital	O
with	O
an	O
acute	O
respiratory	O
illness	O
.	O

Analysis	O
of	O
crude	O
plant	O
extracts	O
revealed	O
that	O
both	O
the	O
plant	O
-	O
expressed	O
alphaSIP	O
and	O
IgA	O
molecules	O
could	O
bind	O
to	O
and	O
neutralize	O
TGEV	O
in	O
tissue	B-ANAT
culture	O
,	O
indicating	O
that	O
active	O
molecules	O
were	O
produced	O
.	O

ABSTRACT	O
:	O
The	O
present	O
study	O
investigated	O
the	O
presence	O
and	O
location	O
of	O
fluorescent	O
microspheres	O
having	O
the	O
size	O
of	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
and	O
of	O
mouse	O
minute	O
virus	O
(	O
MMV	O
)	O
in	O
the	O
zona	B-ANAT
pellucida	I-ANAT
(	O
ZP	O
)	O
of	O
in	O
vivo	O
-	O
produced	O
murine	O
embryos	B-ANAT
,	O
the	O
transmission	O
of	O
these	O
viruses	O
by	O
embryos	B-ANAT
during	O
embryo	B-ANAT
transfer	O
,	O
and	O
the	O
time	O
of	O
seroconversion	O
of	O
recipients	O
and	O
pups	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)	O
isolates	O
that	O
have	O
been	O
adapted	O
to	O
passage	O
in	O
cell	B-ANAT
culture	O
maintain	O
their	O
infectivity	O
in	O
vitro	O
but	O
may	O
lose	O
their	O
pathogenicity	O
in	O
vivo	O
.	O

Particularly	O
noteworthy	O
,	O
the	O
serine	O
to	O
alanine	O
mutation	O
resides	O
in	O
the	O
region	O
of	O
the	O
major	O
antigenic	O
site	O
A	O
/	O
B	O
(	O
aa	O
506	O
-	O
706	O
)	O
that	O
elicits	O
neutralizing	O
antibodies	O
and	O
within	O
the	O
domain	O
mediating	O
the	O
cell	B-ANAT
surface	I-ANAT
receptor	O
aminopeptidase	O
N	O
binding	O
(	O
aa	O
522	O
-	O
744	O
).	O

ABSTRACT	O
:	O
In	O
(+)	O
RNA	O
coronaviruses	O
,	O
replication	O
and	O
transcription	O
of	O
the	O
giant	O
approximately	O
30	O
kb	O
genome	O
to	O
produce	O
genome	O
-	O
and	O
subgenome	O
-	O
size	O
RNAs	O
of	O
both	O
polarities	O
are	O
mediated	O
by	O
a	O
cognate	O
membrane	B-ANAT
-	O
bound	O
enzymatic	O
complex	O
.	O

Our	O
aim	O
was	O
to	O
study	O
the	O
prevalence	O
of	O
adverse	O
skin	B-ANAT
reactions	O
to	O
PPE	O
among	O
healthcare	O
workers	O
in	O
Singapore	O
during	O
the	O
SARS	O
outbreak	O
.	O

109	O
(	O
35	O
.	O
5	O
%)	O
of	O
the	O
307	O
staff	O
who	O
used	O
masks	O
regularly	O
reported	O
acne	O
(	O
59	O
.	O
6	O
%),	O
facial	B-ANAT
itch	O
(	O
51	O
.	O
4	O
%),	O
and	O
rash	O
(	O
35	O
.	O
8	O
%)	O
from	O
N95	O
mask	O
use	O
.	O

TITLE	O
:	O
Expression	O
of	O
elevated	O
levels	O
of	O
pro	O
-	O
inflammatory	O
cytokines	O
in	O
SARS	O
-	O
CoV	O
-	O
infected	O
ACE2	O
+	O
cells	B-ANAT
in	O
SARS	O
patients	O
:	O
relation	O
to	O
the	O
acute	O
lung	B-ANAT
injury	O
and	O
pathogenesis	O
of	O
SARS	O
.	O

In	O
1918	O
,	O
Toronto	O
'	O
s	O
MOH	O
Charles	O
Hastings	O
was	O
the	O
acknowledged	O
leader	O
of	O
efforts	O
to	O
contain	O
the	O
disease	O
,	O
care	O
for	O
the	O
sick	O
,	O
and	O
develop	O
an	O
effective	O
vaccine	O
,	O
because	O
neither	O
a	O
federal	O
health	O
department	O
nor	O
an	O
international	O
body	B-ANAT
like	O
WHO	O
existed	O
.	O

Pulmonary	B-ANAT
recruitment	O
of	O
uremic	O
neutrophils	B-ANAT
,	O
however	O
,	O
was	O
significantly	O
attenuated	O
compared	O
with	O
that	O
of	O
normal	O
neutrophils	B-ANAT
.	O

Oxygenation	O
and	O
lung	B-ANAT
compliance	O
improved	O
rapidly	O
and	O
aeration	O
of	O
the	O
entire	B-ANAT
lung	I-ANAT
was	O
confirmed	O
by	O
computed	O
tomography	O
27	O
h	O
after	O
the	O
recruitment	O
manoeuvre	O
.	O

32	O
months	O
after	O
discharge	B-ANAT
from	O
ICU	O
.	O

The	O
latter	O
displayed	O
a	O
less	O
severe	O
infection	O
and	O
presented	O
detectable	O
levels	O
of	O
nitric	O
oxide	O
as	O
nitrosyl	O
complexes	O
in	O
blood	B-ANAT
and	O
liver	B-ANAT
at	O
72	O
hpi	O
.	O

The	O
results	O
of	O
this	O
study	O
suggest	O
that	O
TNF	O
-	O
alpha	O
,	O
produced	O
by	O
virus	O
-	O
infected	O
macrophages	B-ANAT
,	O
is	O
responsible	O
for	O
induction	O
of	O
apoptosis	O
in	O
uninfected	O
T	B-ANAT
cells	I-ANAT
,	O
primarily	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
.	O

Serum	B-ANAT
levels	O
of	O
11	O
cytokines	O
and	O
chemokines	O
,	O
in	O
14	O
patients	O
with	O
SARS	O
and	O
24	O
patients	O
with	O
CAP	O
,	O
were	O
serially	O
checked	O
using	O
a	O
bead	O
-	O
based	O
multiassay	O
system	O
.	O

Sera	B-ANAT
from	O
12	O
healthy	O
subjects	O
were	O
used	O
as	O
normal	O
controls	O
.	O

The	O
early	O
induction	O
of	O
IP	O
-	O
10	O
and	O
IL	O
-	O
2	O
,	O
as	O
well	O
as	O
the	O
subsequent	O
over	O
-	O
production	O
of	O
IL	O
-	O
6	O
and	O
lack	O
of	O
IL	O
-	O
10	O
production	O
,	O
probably	O
contribute	O
to	O
the	O
main	O
immuno	O
-	O
pathological	O
processes	O
involved	O
in	O
lung	B-ANAT
injury	O
in	O
SARS	O
.	O

RESULTS	O
:	O
The	O
serum	B-ANAT
levels	O
of	O
interferon	O
-	O
gamma	O
-	O
inducible	O
protein	O
-	O
10	O
(	O
IP	O
-	O
10	O
),	O
IL	O
-	O
2	O
and	O
IL	O
-	O
6	O
were	O
significantly	O
elevated	O
during	O
SARS	O
infection	O
.	O

TITLE	O
:	O
Characterisation	O
of	O
the	O
RNA	O
binding	O
properties	O
of	O
the	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
nucleocapsid	B-ANAT
protein	O
amino	O
-	O
terminal	O
region	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
binds	O
viral	O
RNA	O
to	O
form	O
the	O
ribonucleocapsid	O
and	O
regulate	O
RNA	O
synthesis	O
.	O

TITLE	O
:	O
Respiratory	O
mechanics	O
in	O
brain	B-ANAT
-	O
damaged	O
patients	O
.	O

Twenty	O
-	O
one	O
consecutive	O
mechanically	O
ventilated	O
patients	O
with	O
severe	O
brain	B-ANAT
damage	O
and	O
no	O
acute	O
lung	B-ANAT
injury	O
were	O
randomly	O
assigned	O
to	O
be	O
ventilated	O
with	O
ZEEP	O
(	O
n	O
=	O
10	O
)	O
or	O
with	O
8	O
cmH	O
(	O
2	O
)	O
O	O
of	O
PEEP	O
(	O
n	O
=	O
11	O
).	O

TITLE	O
:	O
Sequencing	O
the	O
whole	O
genome	O
of	O
infected	O
human	O
cells	B-ANAT
obtained	O
from	O
diseased	O
patients	O
--	O
a	O
proposed	O
strategy	O
for	O
understanding	O
and	O
overcoming	O
AIDS	O
or	O
other	O
deadest	O
virus	O
-	O
infected	O
diseases	O
.	O

Unlike	O
patient	O
sera	B-ANAT
,	O
however	O
,	O
the	O
mouse	O
antisera	O
were	O
unable	O
to	O
inhibit	O
the	O
infectivity	O
of	O
S	O
protein	O
-	O
expressing	O
(	O
SARS	O
-	O
CoV	O
-	O
S	O
)	O
pseudovirus	O
.	O

TITLE	O
:	O
Capillary	B-ANAT
zone	O
electrophoresis	O
method	O
for	O
fingerprint	O
of	O
allantoic	B-ANAT
fluid	I-ANAT
in	O
normal	O
and	O
infected	O
SPF	O
embryonated	O
chicken	O
eggs	O
.	O

Phylogenetic	O
analyses	O
performed	O
on	O
both	O
replicase	O
gene	O
and	O
nucleocapsid	B-ANAT
protein	O
could	O
not	O
add	O
support	O
to	O
a	O
close	O
relationship	O
between	O
avian	O
and	O
SARS	O
coronaviruses	O
,	O
but	O
all	O
the	O
novel	O
avian	O
coronaviruses	O
were	O
found	O
to	O
harbour	O
s2m	O
.	O

ALI	O
post	O
liver	B-ANAT
transplantation	O
should	O
be	O
diagnosed	O
and	O
treated	O
in	O
early	O
stage	O
.	O

CONCLUSIONS	O
:	O
ALI	O
post	O
liver	B-ANAT
transplantation	O
should	O
be	O
diagnosed	O
and	O
treated	O
in	O
early	O
stage	O
.	O

ABSTRACT	O
:	O
The	O
so	O
-	O
called	O
systemic	O
inflammatory	O
response	O
syndrome	O
(	O
SIRS	O
)	O
represents	O
the	O
cellular	B-ANAT
inflammatory	O
and	O
neuroendocrine	B-ANAT
systemic	O
reaction	O
in	O
response	O
to	O
many	O
adverse	O
events	O
.	O

The	O
endothelial	B-ANAT
cell	I-ANAT
is	O
the	O
target	O
of	O
the	O
systemic	O
phlogistic	O
reaction	O
;	O
its	O
stimulation	O
is	O
followed	O
by	O
the	O
production	O
of	O
many	O
vasoactive	O
paracrine	O
and	O
systemic	O
agents	O
.	O

The	O
combination	O
of	O
acute	O
renal	B-ANAT
failure	O
and	O
sepsis	O
is	O
associated	O
with	O
a	O
high	O
mortality	O
rate	O
,	O
namely	O
in	O
patients	O
with	O
a	O
nitric	O
oxide	O
-	O
induced	O
systemic	O
reduction	O
in	O
peripheral	O
vascular	B-ANAT
resistances	O
and	O
septic	O
shock	O
.	O

We	O
further	O
show	O
that	O
serum	B-ANAT
cytokine	O
levels	O
become	O
elevated	O
in	O
telomere	B-ANAT
dysfunctional	O
mice	O
as	O
a	O
function	O
of	O
age	O
.	O

We	O
performed	O
autopsies	O
on	O
six	O
confirmed	O
SARS	O
cases	O
,	O
with	O
six	O
normal	O
subjects	O
as	O
controls	O
;	O
spleen	B-ANAT
samples	O
from	O
these	O
autopsies	O
were	O
examined	O
with	O
hematoxylin	O
and	O
eosin	O
(	O
H	O
&	O
E	O
)	O
sections	O
,	O
in	O
situ	O
hybridization	O
for	O
SARS	O
virus	O
genomic	O
sequences	O
,	O
and	O
immunohistochemistry	O
with	O
seven	O
monoclonal	O
antibodies	O
to	O
five	O
cell	B-ANAT
types	O
.	O

These	O
results	O
are	O
consistent	O
with	O
the	O
notion	O
that	O
double	O
-	O
stranded	O
RNA	O
,	O
produced	O
during	O
MHV	O
infection	O
,	O
is	O
not	O
accessible	O
to	O
cellular	B-ANAT
PRRs	O
.	O

TITLE	O
:	O
The	O
ORF7b	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
is	O
expressed	O
in	O
virus	O
-	O
infected	O
cells	B-ANAT
and	O
incorporated	O
into	O
SARS	O
-	O
CoV	O
particles	O
.	O

ABSTRACT	O
:	O
Synthetic	O
decapeptides	O
(	O
N	O
=	O
206	O
)	O
covering	O
the	O
entire	O
sequence	O
of	O
mouse	B-ANAT
liver	I-ANAT
fumarylacetoacetate	O
hydrolase	O
(	O
FAH	O
)	O
were	O
used	O
to	O
analyze	O
the	O
specificities	O
of	O
the	O
autoantibodies	O
(	O
autoAb	O
)	O
elicited	O
towards	O
this	O
enzyme	O
in	O
mice	O
infected	O
with	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
).	O

The	O
data	O
were	O
expressed	O
corrected	O
and	O
uncorrected	O
for	O
urine	B-ANAT
creatinine	O
(	O
Cr	O
).	O

Similar	O
results	O
were	O
obtained	O
using	O
urine	B-ANAT
NO	O
alone	O
.	O

Contrary	O
to	O
our	O
hypothesis	O
,	O
higher	O
urine	B-ANAT
NO	O
was	O
associated	O
with	O
improved	O
outcomes	O
in	O
ALI	O
at	O
baseline	O
and	O
after	O
treatment	O
with	O
the	O
6	O
ml	O
/	O
kg	O
VT	O
strategy	O
.	O

In	O
addition	O
to	O
being	O
public	O
,	O
the	O
NP366	O
-	O
specific	O
response	O
is	O
dominated	O
by	O
a	O
few	O
clonotypes	O
,	O
when	O
T	B-ANAT
cell	I-ANAT
clonotypes	O
expressing	O
the	O
Vbeta8	O
.	O
3	O
element	O
are	O
analyzed	O
.	O

Herein	O
,	O
we	O
show	O
that	O
this	O
response	O
is	O
similarly	O
public	O
when	O
the	O
NP366	O
+	O
Vbeta4	O
+	O
CD8	O
T	B-ANAT
cell	I-ANAT
response	O
is	O
analyzed	O
.	O

Of	O
the	O
9	O
children	O
,	O
2	O
died	O
of	O
MODS	O
(	O
1	O
intussusception	O
complicated	O
with	O
intestine	B-ANAT
necrosis	O
,	O
1	O
severe	O
scald	O
)	O
and	O
1	O
was	O
given	O
up	O
because	O
of	O
severe	O
intestinal	B-ANAT
fistula	O
,	O
the	O
other	O
6	O
children	O
recovered	O
at	O
the	O
end	O
.	O

CBP	O
was	O
effective	O
in	O
treatment	O
of	O
pediatric	O
septic	O
shock	O
by	O
improving	O
the	O
oxygenation	O
,	O
correcting	O
metabolic	O
acidosis	O
,	O
stabilizing	O
BP	O
,	O
increasing	O
the	O
tissue	B-ANAT
perfusion	O
and	O
eliminating	O
the	O
medium	O
molecule	O
substances	O
.	O

RESULTS	O
:	O
Of	O
the	O
9	O
children	O
,	O
6	O
had	O
acute	O
renal	B-ANAT
failure	O
(	O
ARF	O
),	O
3	O
had	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
5	O
were	O
blood	B-ANAT
culture	O
positive	O
and	O
all	O
the	O
9	O
needed	O
vasopressors	O
to	O
keep	O
BP	O
before	O
CVVH	O
.	O

Both	O
cohorts	O
completed	O
standardized	O
rating	O
scales	B-ANAT
on	O
depression	O
,	O
anxiety	O
,	O
and	O
social	O
support	O
.	O

Forty	O
years	O
of	O
clinical	O
and	O
basic	O
science	O
research	O
have	O
elaborated	O
many	O
of	O
the	O
pathophysiologic	O
mechanisms	O
that	O
link	O
initiating	O
insults	O
to	O
the	O
development	O
of	O
alveolar	B-ANAT
membrane	B-ANAT
failure	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ALI	O
/	O
ARDS	O
)	O
is	O
a	O
clinical	O
syndrome	O
that	O
has	O
an	O
ever	O
-	O
growing	O
list	O
of	O
potential	O
causes	O
.	O

The	O
transfusion	O
of	O
blood	B-ANAT
products	O
is	O
often	O
a	O
life	O
-	O
saving	O
therapy	O
,	O
but	O
it	O
can	O
be	O
associated	O
with	O
the	O
development	O
of	O
ALI	O
/	O
ARDS	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
are	O
inflammatory	O
conditions	O
involving	O
a	O
broad	O
spectrum	O
of	O
lung	B-ANAT
injury	O
from	O
mild	O
respiratory	O
abnormality	O
to	O
severe	O
respiratory	O
derangement	O
.	O

TITLE	O
:	O
Ligustrazine	O
alleviates	O
acute	O
lung	B-ANAT
injury	O
in	O
a	O
rat	O
model	O
of	O
acute	O
necrotizing	O
pancreatitis	O
.	O

The	O
blood	B-ANAT
flow	O
in	O
the	O
P	O
group	O
was	O
significantly	O
lower	O
than	O
that	O
of	O
the	O
C	O
group	O
,	O
while	O
the	O
blood	B-ANAT
flow	O
in	O
the	O
T	O
group	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
P	O
group	O
but	O
showed	O
no	O
significant	O
difference	O
from	O
the	O
C	O
group	O
.	O

After	O
induction	O
of	O
the	O
ANP	O
model	O
,	O
the	O
pancreas	B-ANAT
showed	O
mild	O
edema	O
and	O
congestion	O
;	O
the	O
longer	O
the	O
time	O
,	O
the	O
more	O
severe	O
this	O
became	O
.	O

The	O
pulmonary	B-ANAT
pathological	O
changes	O
were	O
aggravated	O
significantly	O
in	O
the	O
P	O
group	O
.	O

RESULTS	O
:	O
The	O
blood	B-ANAT
flow	O
in	O
the	O
P	O
group	O
was	O
significantly	O
lower	O
than	O
that	O
of	O
the	O
C	O
group	O
,	O
while	O
the	O
blood	B-ANAT
flow	O
in	O
the	O
T	O
group	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
P	O
group	O
but	O
showed	O
no	O
significant	O
difference	O
from	O
the	O
C	O
group	O
.	O

No	O
special	O
findings	O
were	O
observed	O
in	O
the	O
lung	B-ANAT
tissue	I-ANAT
obtained	O
by	O
transbronchial	O
lung	B-ANAT
biopsy	O
.	O

A	O
typical	O
type	B-ANAT
II	I-ANAT
pneumocyte	I-ANAT
hyperplasia	O
and	O
fibrogranulomatous	O
tissue	B-ANAT
formation	O
in	O
the	O
alveolar	B-ANAT
septae	O
were	O
observed	O
both	O
in	O
the	O
animals	O
inoculated	O
simultaneously	O
with	O
these	O
two	O
viruses	O
and	O
in	O
the	O
animals	O
inoculated	O
firstly	O
with	O
SARS	O
-	O
CoV	O
,	O
followed	O
by	O
ReoV	O
.	O
The	O
animals	O
inoculated	O
firstly	O
with	O
ReoV	O
,	O
followed	O
with	O
SARS	O
-	O
CoV	O
displayed	O
scattered	O
hemorrhage	O
in	O
the	O
alveolar	B-ANAT
septa	O
.	O

Furthermore	O
,	O
other	O
lesions	O
in	O
above	O
two	O
combination	O
groups	O
included	O
depletion	O
of	O
lymphocytes	B-ANAT
in	O
the	O
germinal	B-ANAT
center	I-ANAT
of	O
lymph	B-ANAT
nodes	I-ANAT
in	O
the	O
lung	B-ANAT
hilus	O
and	O
the	O
spleen	B-ANAT
,	O
hemorrhagic	O
necrosis	O
in	O
white	B-ANAT
pulp	I-ANAT
of	I-ANAT
spleen	I-ANAT
,	O
hydroid	O
degeneration	O
,	O
and	O
fatty	O
degeneration	O
in	O
the	O
liver	B-ANAT
and	O
kidney	B-ANAT
.	O

Acute	O
physiology	O
and	O
chronic	O
health	O
evaluation	O
II	O
(	O
APACHEII	O
)	O
scores	O
,	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
(	O
MODS	O
)	O
evaluation	O
scores	O
and	O
PaO	O
(	O
2	O
)/	O
FiO	O
(	O
2	O
)	O
were	O
observed	O
before	O
and	O
after	O
HVHF	O
.	O

CONCLUSIONS	O
:	O
Continuous	O
HVHF	O
shows	O
significant	O
beneficial	O
effects	O
on	O
pulmonary	B-ANAT
function	O
of	O
severe	O
sepsis	O
patients	O
with	O
ARDS	O
as	O
a	O
result	O
of	O
removal	O
of	O
cytokines	O
,	O
decrease	O
of	O
TFC	O
and	O
amelioration	O
of	O
disturbance	O
in	O
respiration	O
,	O
hemodynamics	O
and	O
oxygen	O
metabolism	O
.	O

ABSTRACT	O
:	O
Canine	O
respiratory	O
coronavirus	O
(	O
CRCoV	O
)	O
has	O
frequently	O
been	O
detected	O
in	O
respiratory	B-ANAT
samples	I-ANAT
from	O
dogs	O
by	O
RT	O
-	O
PCR	O
.	O

Four	O
of	O
five	O
vaccinated	O
mice	O
were	O
protected	O
from	O
subsequent	O
SARS	O
-	O
CoV	O
challenge	O
because	O
no	O
significant	O
virus	O
replication	O
,	O
and	O
no	O
obvious	O
histopathological	O
changes	O
were	O
found	O
in	O
the	O
lung	B-ANAT
tissues	I-ANAT
of	O
the	O
vaccinated	O
mice	O
challenged	O
with	O
SARS	O
-	O
CoV	O
.	O
Only	O
one	O
vaccinated	O
mouse	O
had	O
mild	O
alveolar	B-ANAT
damage	O
in	O
the	O
lung	B-ANAT
tissues	I-ANAT
.	O

TITLE	O
:	O
Alveolar	B-ANAT
recruitment	O
versus	O
hyperinflation	O
:	O
A	O
balancing	O
act	O
.	O

ABSTRACT	O
:	O
To	O
address	O
lung	B-ANAT
recruitment	O
according	O
to	O
pressure	O
/	O
volume	O
curves	O
,	O
along	O
with	O
regional	O
recruitment	O
versus	O
hyperinflation	O
evidence	O
from	O
computed	O
tomography	O
and	O
electrical	O
impedance	O
tomography	O
.	O

Bone	B-ANAT
marrow	I-ANAT
aspiration	O
disclosed	O
numerous	O
hemophagocytic	O
histiocytes	B-ANAT
,	O
thus	O
suggesting	O
her	O
condition	O
to	O
be	O
hemophagocytic	O
syndrome	O
.	O

Pulsed	O
methylprednisolone	O
,	O
gamma	O
-	O
globulin	O
,	O
granulocyte	B-ANAT
colony	O
-	O
stimulating	O
factor	O
and	O
sivelestat	O
sodium	O
hydrate	O
were	O
administrated	O
,	O
and	O
thereafter	O
the	O
patient	O
recovered	O
from	O
cytopenia	O
and	O
organ	B-ANAT
failure	O
.	O

ABSTRACT	O
:	O
A	O
deletion	O
mutant	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
has	O
been	O
engineered	O
by	O
deleting	O
the	O
structural	O
E	O
gene	O
in	O
an	O
infectious	O
cDNA	O
clone	O
that	O
was	O
constructed	O
as	O
a	O
bacterial	O
artificial	O
chromosome	B-ANAT
(	O
BAC	O
).	O

Furthermore	O
,	O
protein	O
6	O
coimmunoprecipitated	O
with	O
viral	O
RNAs	O
and	O
colocalized	O
on	O
cytoplasmic	B-ANAT
vesicles	B-ANAT
with	O
replicating	O
viral	O
RNAs	O
.	O

The	O
pancreatic	B-ANAT
and	O
lung	B-ANAT
tissues	I-ANAT
were	O
collected	O
at	O
1	O
,	O
6	O
,	O
12	O
,	O
and	O
24	O
h	O
after	O
the	O
completion	O
of	O
caerulein	O
administration	O
.	O

Tissue	B-ANAT
leukocyte	B-ANAT
sequestration	O
was	O
assessed	O
by	O
myeloperoxidase	O
(	O
MPO	O
)	O
activity	O
.	O

Standard	O
histological	O
staining	O
hematoxylin	O
and	O
eosin	O
was	O
performed	O
and	O
blindly	O
scored	O
by	O
a	O
pathologist	O
for	O
evidence	O
of	O
lung	B-ANAT
injury	O
(	O
pulmonary	B-ANAT
edema	O
,	O
accumulations	O
of	O
neutrophils	B-ANAT
and	O
mononuclear	B-ANAT
cells	I-ANAT
,	O
thickness	O
of	O
alveolar	B-ANAT
-	O
capillary	B-ANAT
membrane	B-ANAT
,	O
perivascular	O
infiltrate	O
,	O
and	O
hemorrhage	O
).	O

As	O
compared	O
to	O
wild	O
-	O
type	O
,	O
STAT6	O
-	O
deficient	O
mice	O
had	O
increased	O
lung	B-ANAT
injury	O
from	O
1	O
to	O
6	O
h	O
,	O
with	O
full	O
recovery	O
by	O
12	O
h	O
.	O
An	O
opposite	O
pattern	O
was	O
observed	O
in	O
STAT4	O
-	O
deficient	O
mice	O
with	O
mild	O
injury	O
seen	O
at	O
1	O
and	O
6	O
h	O
,	O
and	O
maximal	O
injury	O
at	O
12	O
h	O
.	O
MPO	O
activity	O
was	O
significantly	O
increased	O
at	O
6	O
h	O
in	O
caerulein	O
-	O
treated	O
wild	O
-	O
type	O
mice	O
compared	O
to	O
saline	O
-	O
treated	O
controls	O
.	O

RESULTS	O
:	O
Caerulein	O
-	O
treated	O
wild	O
-	O
type	O
mice	O
exhibited	O
increased	O
lung	B-ANAT
injury	O
score	O
at	O
1	O
through	O
12	O
h	O
,	O
as	O
compared	O
to	O
saline	O
controls	O
.	O

Indirect	O
immunofluorescence	O
assays	O
showed	O
that	O
in	O
the	O
infected	O
cells	B-ANAT
expressing	O
each	O
of	O
the	O
siRNAs	O
,	O
there	O
was	O
aspecific	O
silencing	O
of	O
S	O
,	O
3a	O
and	O
7a	O
,	O
respectively	O
,	O
but	O
the	O
expression	O
of	O
nucleocapsid	B-ANAT
protein	O
was	O
not	O
affected	O
.	O

Unique	O
genomic	O
features	O
distinguishing	O
between	O
these	O
four	O
subgroups	O
,	O
including	O
the	O
number	O
of	O
papain	O
-	O
like	O
proteases	O
,	O
the	O
presence	O
or	O
absence	O
of	O
hemagglutinin	O
esterase	O
,	O
small	O
ORFs	O
between	O
the	O
membrane	B-ANAT
and	O
nucleocapsid	B-ANAT
genes	O
and	O
ORFs	O
(	O
NS7a	O
and	O
NS7b	O
),	O
bulged	O
stem	B-ANAT
-	O
loop	O
and	O
pseudoknot	O
structures	O
downstream	O
of	O
the	O
nucleocapsid	B-ANAT
gene	O
,	O
transcription	O
regulatory	O
sequence	O
,	O
and	O
ribosomal	B-ANAT
recognition	O
signal	O
for	O
the	O
envelope	B-ANAT
gene	O
,	O
were	O
also	O
observed	O
.	O

Chemokines	O
/	O
cytokines	O
in	O
the	O
blood	B-ANAT
of	O
patients	O
with	O
SARS	O
were	O
dynamically	O
screened	O
by	O
liquid	O
chip	O
system	O
.	O

Levels	O
of	O
chemokines	O
/	O
cytokines	O
involved	O
in	O
immunoreaction	O
in	O
response	O
to	O
virus	O
infection	O
were	O
detected	O
in	O
the	O
supernatants	O
of	O
those	O
cells	B-ANAT
cultured	I-ANAT
with	O
the	O
Spike	O
glycoprotein	O
by	O
liquid	O
chip	O
system	O
.	O

Interferon	O
-	O
gamma	O
inducible	O
protein	O
10	O
(	O
IP	O
-	O
10	O
)	O
was	O
markedly	O
elevated	O
in	O
the	O
blood	B-ANAT
during	O
the	O
early	O
stage	O
of	O
SARS	O
[(	O
7	O
,	O
600	O
+/-	O
2	O
,	O
400	O
)	O
ng	O
/	O
L	O
,	O
P	O
<	O
0	O
.	O
01	O
],	O
and	O
remained	O
at	O
a	O
high	O
level	O
in	O
the	O
progressive	O
stage	O
[(	O
8	O
,	O
100	O
+/-	O

(	O
1	O
)	O
A	O
significant	O
increase	O
of	O
IP	O
-	O
10	O
activity	O
in	O
the	O
blood	B-ANAT
was	O
found	O
in	O
patients	O
with	O
SARS	O
-	O
CoV	O
infection	O
,	O
and	O
remained	O
at	O
a	O
high	O
level	O
until	O
the	O
stage	O
of	O
convalescence	O
.	O

ABSTRACT	O
:	O
Acute	O
pancreatitis	O
in	O
its	O
severe	O
form	O
is	O
complicated	O
by	O
multiple	O
organ	B-ANAT
system	I-ANAT
dysfunction	O
,	O
most	O
importantly	O
by	O
pulmonary	B-ANAT
complications	O
which	O
include	O
hypoxia	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
atelectasis	O
,	O
and	O
pleural	B-ANAT
effusion	I-ANAT
.	O

The	O
cytoplasmic	B-ANAT
portion	O
of	O
the	O
S	O
glycoprotein	O
contains	O
four	O
cysteine	O
-	O
rich	O
amino	O
acid	O
clusters	O
.	O

Ascaridia	O
galli	O
,	O
Heterakis	O
gallinarum	O
and	O
Syngamus	O
trachea	B-ANAT
were	O
found	O
in	O
some	O
birds	O
.	O

The	O
levels	O
of	O
viral	O
mRNAs	O
and	O
viral	O
proteins	O
of	O
the	O
targets	O
were	O
significantly	O
decreased	O
or	O
completely	O
inhibited	O
in	O
cell	B-ANAT
lines	I-ANAT
after	O
being	O
infected	O
with	O
the	O
recombinant	O
adenoviruses	O
that	O
expressed	O
specific	O
shRNA	O
molecules	O
.	O

In	O
addition	O
,	O
we	O
performed	O
this	O
study	O
in	O
order	O
to	O
delineate	O
the	O
prevalence	O
,	O
the	O
potential	O
clinical	O
impacts	O
and	O
evaluation	O
of	O
the	O
genetic	O
characterization	O
of	O
this	O
pathogen	O
in	O
young	O
children	O
who	O
presented	O
with	O
acute	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
(	O
ALRI	O
).	O

All	O
patients	O
had	O
hepatic	B-ANAT
failure	O
with	O
median	O
peak	O
bilirubin	O
being	O
22	O
.	O
1	O
+/-	O

TITLE	O
:	O
Prevalence	O
of	O
viral	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
in	O
children	O
with	O
asthma	O
.	O

Adoptive	O
transfer	O
of	O
splenocytes	O
acquired	O
from	O
MHV	O
-	O
immunized	O
CXCL10	O
(-/-)	O
mice	O
into	O
MHV	O
-	O
infected	O
RAG1	O
(-/-)	O
mice	O
resulted	O
in	O
T	B-ANAT
cell	I-ANAT
infiltration	O
into	O
the	O
CNS	B-ANAT
,	O
reduced	O
viral	O
burden	O
,	O
and	O
demyelination	O
comparable	O
to	O
RAG1	O
(-/-)	O
recipients	O
of	O
immune	O
CXCL10	O
(+/+)	O
splenocytes	O
.	O

The	O
city	O
group	O
expressed	O
the	O
highest	O
favor	O
to	O
the	O
government	O
and	O
media	B-ANAT
,	O
71	O
.	O
8	O
%	O
of	O
them	O
gave	O
the	O
credit	O
on	O
the	O
control	O
of	O
SARS	O
to	O
the	O
effective	O
method	O
taken	O
by	O
the	O
government	O
and	O
65	O
.	O
0	O
%	O
of	O
them	O
showed	O
that	O
they	O
had	O
enough	O
confidence	O
on	O
the	O
governmental	O
ability	O
of	O
dealing	O
with	O
crises	O
while	O
the	O
countryside	O
group	O
trusted	O
the	O
hospitals	O
and	O
relative	O
specialists	O
the	O
most	O
.	O

The	O
city	O
group	O
expressed	O
the	O
highest	O
favor	O
to	O
the	O
government	O
and	O
media	B-ANAT
,	O
71	O
.	O
8	O
%	O
of	O
them	O
gave	O
the	O
credit	O
on	O
the	O
control	O
of	O
SARS	O
to	O
the	O
effective	O
method	O
taken	O
by	O
the	O
government	O
and	O
65	O
.	O
0	O
%	O
of	O
them	O
showed	O
that	O
they	O
had	O
enough	O
confidence	O
on	O
the	O
governmental	O
ability	O
of	O
dealing	O
with	O
crises	O
while	O
the	O
countryside	O
group	O
trusted	O
the	O
hospitals	O
and	O
relative	O
specialists	O
the	O
most	O
.	O

CONCLUSIONS	O
:	O
It	O
is	O
essential	O
for	O
the	O
government	O
to	O
interact	O
and	O
communicate	O
with	O
the	O
publics	O
through	O
media	B-ANAT
,	O
medical	O
and	O
related	O
institutions	O
when	O
confronting	O
with	O
the	O
public	O
health	O
emergencies	O
.	O

ABSTRACT	O
:	O
We	O
previously	O
showed	O
that	O
infection	O
of	O
rat	O
oligodendrocytes	B-ANAT
by	O
ultraviolet	O
light	O
-	O
inactivated	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
resulted	O
in	O
apoptosis	O
,	O
suggesting	O
that	O
the	O
apoptosis	O
is	O
triggered	O
during	O
cell	B-ANAT
entry	O
.	O

First	O
,	O
the	O
receptor	O
of	O
HCoV	O
229E	O
,	O
human	O
aminopeptidase	O
N	O
(	O
hAPN	O
or	O
CD13	O
)	O
is	O
expressed	O
mainly	O
on	O
human	O
dendritic	B-ANAT
cells	I-ANAT
(	O
DCs	O
)	O
and	O
macrophages	B-ANAT
indicating	O
that	O
targeting	O
of	O
HCoV	O
229E	O
-	O
based	O
vectors	O
to	O
professional	O
antigen	B-ANAT
presenting	I-ANAT
cells	I-ANAT
can	O
be	O
achieved	O
by	O
receptor	O
-	O
mediated	O
transduction	O
.	O

Finally	O
,	O
coronavirus	O
infections	O
are	O
associated	O
with	O
mainly	O
respiratory	O
and	O
enteric	O
diseases	O
,	O
and	O
natural	O
transmission	O
of	O
coronaviruses	O
occurs	O
via	O
mucosal	B-ANAT
surfaces	O
.	O

All	O
of	O
the	O
results	O
suggested	O
that	O
DIP	O
liposomes	O
have	O
the	O
potential	O
efficacy	O
in	O
treating	O
ALI	O
/	O
ARDS	O
due	O
to	O
their	O
obvious	O
lung	B-ANAT
targeting	O
.	O

Only	O
one	O
patient	O
required	O
nitric	O
oxide	O
therapy	O
for	O
transient	O
pulmonary	B-ANAT
hypertension	O
.	O

But	O
the	O
treatment	O
has	O
no	O
influence	O
on	O
pulmonary	B-ANAT
surfactant	O
(	O
PS	O
),	O
surface	O
tension	O
and	O
lung	B-ANAT
pathology	O
of	O
ARDS	O
in	O
piglets	O
challenged	O
with	O
intraperitoneal	O
E	O
.	O
coli	O
.	O

In	O
support	O
of	O
this	O
,	O
we	O
found	O
that	O
the	O
dibasic	O
motif	O
on	O
the	O
SARS	O
S	O
protein	O
was	O
required	O
for	O
its	O
localization	O
to	O
the	O
ERGIC	B-ANAT
/	O
Golgi	B-ANAT
region	O
when	O
coexpressed	O
with	O
SARS	O
membrane	B-ANAT
(	O
M	O
)	O
protein	O
.	O

TITLE	O
:	O
Essential	O
role	O
for	O
collectrin	O
in	O
renal	B-ANAT
amino	O
acid	O
transport	O
.	O

However	O
,	O
when	O
BALB	O
/	O
c	O
mice	O
were	O
orally	B-ANAT
immunized	O
with	O
the	O
Salmonella	O
vector	O
expressing	O
the	O
TGEV	O
epitopes	O
from	O
either	O
one	O
of	O
the	O
fusion	O
constructs	O
or	O
both	O
together	O
,	O
the	O
highest	O
level	O
of	O
anti	O
-	O
TGEV	O
antibody	O
was	O
obtained	O
with	O
the	O
987P	O
-	O
TGEV	O
immunogen	O
-	O
displaying	O
vector	O
.	O

In	O
summary	O
,	O
the	O
data	O
suggest	O
that	O
induction	O
of	O
IFN	O
by	O
mismatched	O
dsRNA	O
or	O
actual	O
treatment	O
with	O
exogenous	O
IFN	O
-	O
alpha	O
can	O
inhibit	O
SARS	O
-	O
CoV	O
replication	O
in	O
the	O
lungs	B-ANAT
of	O
mice	O
.	O

Finally	O
,	O
we	O
demonstrated	O
that	O
probe	O
-	O
coated	O
nanowires	O
retain	O
their	O
selectivity	O
and	O
sensitivity	O
in	O
a	O
triplexed	O
assay	O
after	O
storage	B-ANAT
for	O
over	O
3	O
months	O
.	O

The	O
Harderian	B-ANAT
gland	I-ANAT
and	O
trachea	B-ANAT
of	O
hens	O
and	O
cockerels	O
in	O
both	O
T	O
-	O
and	O
N1	O
/	O
88	O
-	O
infected	O
groups	O
were	O
damaged	O
to	O
a	O
similar	O
extent	O
.	O

The	O
sequential	O
histopathological	O
changes	O
in	O
hens	O
revealed	O
that	O
IBV	O
multiplies	O
initially	O
in	O
the	O
Harderian	B-ANAT
gland	I-ANAT
,	O
then	O
in	O
the	O
tracheal	B-ANAT
mucosa	I-ANAT
and	O
simultaneously	O
in	O
the	O
kidney	B-ANAT
and	O
regions	O
of	O
the	O
oviduct	B-ANAT
such	O
as	O
the	O
magnum	O
,	O
tubular	O
shell	B-ANAT
gland	I-ANAT
,	O
and	O
shell	B-ANAT
gland	I-ANAT
pouch	O
.	O

The	O
Harderian	B-ANAT
gland	I-ANAT
showed	O
similar	O
histopathology	O
in	O
T	O
-	O
and	O
N1	O
/	O
88	O
-	O
infected	O
hens	O
.	O

The	O
trachea	B-ANAT
and	O
kidney	B-ANAT
of	O
challenged	O
vaccinated	O
hens	O
were	O
protected	O
to	O
a	O
moderate	O
extent	O
,	O
but	O
the	O
oviduct	B-ANAT
was	O
protected	O
to	O
only	O
a	O
small	O
extent	O
.	O

The	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
gene	O
rescued	O
VVDeltaE3L	O
from	O
IFN	O
sensitivity	O
.	O

TITLE	O
:	O
Long	O
-	O
term	O
persistence	O
of	O
robust	O
antibody	O
and	O
cytotoxic	B-ANAT
T	I-ANAT
cell	I-ANAT
responses	O
in	O
recovered	O
patients	O
infected	O
with	O
SARS	O
coronavirus	O
.	O

Blunt	O
and	O
penetrating	O
trauma	O
patients	O
were	O
randomly	O
assigned	O
to	O
rFVIIa	O
(	O
200	O
+	O
100	O
+	O
100	O
microg	O
/	O
kg	O
)	O
at	O
0	O
,	O
1	O
,	O
and	O
3	O
hours	O
after	O
transfusion	O
of	O
8	O
units	O
of	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
(	O
RBCs	B-ANAT
)	O
or	O
to	O
placebo	O
.	O

High	O
-	O
frequency	O
oscillatory	O
ventilation	O
(	O
HFOV	O
)	O
is	O
an	O
unconventional	O
form	O
of	O
ventilation	O
that	O
may	O
improve	O
oxygenation	O
in	O
patients	O
with	O
ARDS	O
,	O
while	O
limiting	O
further	O
lung	B-ANAT
injury	O
associated	O
with	O
high	O
ventilatory	O
pressures	O
and	O
volumes	O
delivered	O
during	O
conventional	O
ventilation	O
.	O

TITLE	O
:	O
Absence	O
of	O
surface	O
expression	O
of	O
feline	O
infectious	O
peritonitis	O
virus	O
(	O
FIPV	O
)	O
antigens	O
on	O
infected	O
cells	B-ANAT
isolated	O
from	O
cats	O
with	O
FIP	O
.	O

These	O
cells	B-ANAT
belong	O
mainly	O
to	O
the	O
monocyte	B-ANAT
/	O
macrophage	B-ANAT
lineage	O
.	O

In	O
this	O
study	O
,	O
FIPV	O
positive	O
cells	B-ANAT
were	O
isolated	O
from	O
pyogranulomas	O
and	O
exudates	B-ANAT
of	O
12	O
naturally	O
FIPV	O
-	O
infected	O
cats	O
and	O
the	O
presence	O
of	O
two	O
immunologic	O
targets	O
,	O
viral	O
antigens	O
and	O
MHC	B-ANAT
I	O
,	O
on	O
their	O
surface	O
was	O
determined	O
.	O

First	O
,	O
ATA	O
blocks	O
the	O
phosphorylation	O
of	O
extracellular	B-ANAT
signal	O
-	O
regulated	O
kinase	O
1	O
/	O
2	O
,	O
an	O
event	O
shown	O
to	O
be	O
essential	O
for	O
vaccinia	O
virus	O
replication	O
.	O

Using	O
Venezuelan	O
equine	O
encephalitis	O
virus	O
replicon	O
particles	O
(	O
VRP	O
)	O
expressing	O
the	O
2003	O
epidemic	O
Urbani	O
SARS	O
-	O
CoV	O
strain	O
spike	O
(	O
S	O
)	O
glycoprotein	O
(	O
VRP	O
-	O
S	O
)	O
or	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
from	O
the	O
same	O
strain	O
(	O
VRP	O
-	O
N	O
),	O
we	O
demonstrate	O
that	O
VRP	O
-	O
S	O
,	O
but	O
not	O
VRP	O
-	O
N	O
vaccines	O
provide	O
complete	O
short	O
-	O
and	O
long	O
-	O
term	O
protection	O
against	O
homologous	O
strain	O
challenge	O
in	O
young	O
and	O
senescent	O
mice	O
.	O

TITLE	O
:	O
Acute	O
and	O
repeated	O
inhalation	O
lung	B-ANAT
injury	O
by	O
3	O
-	O
methoxybutyl	O
chloroformate	O
in	O
rats	O
:	O
CT	O
-	O
pathologic	O
correlation	O
.	O

On	O
the	O
follow	O
-	O
up	O
study	O
,	O
the	O
groups	O
exposed	O
for	O
3	O
days	O
showed	O
diffusely	O
increased	O
parenchymal	O
density	O
on	O
the	O
7	O
days	O
study	O
,	O
but	O
the	O
lung	B-ANAT
densities	O
were	O
lower	O
at	O
14	O
and	O
28	O
days	O
than	O
at	O
3	O
days	O
.	O

Decreased	O
parenchymal	O
density	O
of	O
the	O
lung	B-ANAT
was	O
a	O
common	O
CT	O
finding	O
in	O
acute	O
and	O
repeated	O
inhalation	O
injury	O
.	O

Cholesterol	O
depletion	O
by	O
pretreatment	O
of	O
Vero	O
E6	O
cells	B-ANAT
with	O
methyl	O
-	O
beta	O
-	O
cyclodextrin	O
(	O
MbetaCD	O
)	O
inhibited	O
the	O
production	O
of	O
SARS	O
-	O
CoV	O
particles	O
released	O
from	O
the	O
infected	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
febrile	O
,	O
respiratory	B-ANAT
tract	I-ANAT
illness	O
caused	O
by	O
infection	O
with	O
the	O
newly	O
identified	O
SARS	O
-	O
associated	O
coronavirus	O
.	O

No	O
deaths	O
were	O
reported	O
among	O
children	O
or	O
adolescents	O
with	O
SARS	O
,	O
and	O
at	O
6	O
months	O
after	O
illness	O
only	O
mild	O
residual	O
changes	O
were	O
reported	O
in	O
exercise	O
tolerance	O
and	O
pulmonary	B-ANAT
function	O
.	O

Criteria	O
of	O
admission	O
were	O
impaired	O
consciousness	O
(	O
7	O
),	O
acute	O
renal	B-ANAT
failure	O
(	O
4	O
),	O
and	O
respiratory	O
distress	O
(	O
3	O
).	O

TITLE	O
:	O
The	O
contribution	O
of	O
arterio	B-ANAT
-	I-ANAT
venous	I-ANAT
extracorporeal	O
lung	B-ANAT
assist	O
to	O
gas	O
exchange	O
in	O
a	O
porcine	O
model	O
of	O
lavage	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
The	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
of	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
localizes	O
to	O
the	O
cytoplasm	B-ANAT
and	O
nucleolus	B-ANAT
and	O
contains	O
an	O
eight	O
-	O
amino	O
-	O
acid	O
nucleolar	B-ANAT
retention	O
motif	O
.	O

TITLE	O
:	O
Recombinant	O
truncated	O
nucleocapsid	B-ANAT
protein	O
as	O
antigen	O
in	O
a	O
novel	O
immunoglobulin	O
M	O
capture	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
for	O
diagnosis	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
infection	O
.	O

Using	O
serial	O
serum	B-ANAT
samples	O
collected	O
from	O
SARS	O
patients	O
,	O
the	O
times	O
to	O
seroconversion	O
were	O
determined	O
by	O
IgM	B-ANAT
antibody	I-ANAT
detection	O
after	O
SARS	O
-	O
CoV	O
infection	O
.	O

Our	O
newly	O
developed	O
MAC	B-ANAT
-	O
ELISA	O
system	O
offers	O
a	O
new	O
alternative	O
for	O
the	O
confirmation	O
of	O
SARS	O
-	O
CoV	O
infection	O
.	O

ABSTRACT	O
:	O
Amniotic	B-ANAT
fluid	I-ANAT
embolism	O
(	O
AFE	O
)	O
syndrome	O
,	O
a	O
catastrophic	O
cause	O
of	O
respiratory	O
failure	O
typically	O
occurs	O
during	O
labour	O
,	O
or	O
soon	O
after	O
delivery	O
.	O

More	O
marked	O
changes	O
in	O
metabolic	O
variables	O
indicated	O
severer	O
organ	B-ANAT
dysfunction	O
,	O
reaching	O
their	O
peak	O
values	O
before	O
death	O
.	O

Using	O
EM	O
techniques	O
,	O
we	O
found	O
that	O
these	O
putative	O
viral	O
replication	O
sites	O
were	O
associated	O
with	O
characteristic	O
membrane	B-ANAT
tubules	O
and	O
double	O
membrane	B-ANAT
vesicles	B-ANAT
that	O
most	O
probably	O
originated	O
from	O
ER	O
cisternae	O
.	O

Serological	O
investigations	O
on	O
216	O
dog	O
sera	B-ANAT
,	O
carried	O
out	O
by	O
an	O
ELISA	O
test	O
using	O
the	O
strictly	O
related	O
bovine	O
coronavirus	O
(	O
BCoV	O
)	O
as	O
antigen	O
,	O
revealed	O
an	O
overall	O
CRCoV	O
seroprevalence	O
of	O
32	O
.	O
06	O
%	O
in	O
the	O
last	O
2	O
years	O
.	O

RT	O
-	O
PCR	O
targeting	O
the	O
S	O
-	O
gene	O
of	O
CRCoV	O
was	O
carried	O
out	O
on	O
109	O
lung	B-ANAT
samples	O
collected	O
from	O
carcasses	O
of	O
dogs	O
submitted	O
for	O
diagnostic	O
investigations	O
.	O

This	O
review	O
focuses	O
on	O
the	O
epidemiology	O
and	O
the	O
pathophysiology	O
of	O
alcohol	O
-	O
induced	O
lung	B-ANAT
dysfunction	O
and	O
discusses	O
potential	O
new	O
treatments	O
suggested	O
by	O
recent	O
experimental	O
findings	O
.	O

Overall	O
,	O
48	O
/	O
426	O
(	O
11	O
.	O
3	O
%)	O
patients	O
were	O
found	O
to	O
be	O
infected	O
by	O
hCoV	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
(	O
ARTI	O
).	O

Biochemical	O
analysis	O
revealed	O
that	O
nsp3	O
is	O
an	O
integral	O
membrane	B-ANAT
protein	O
that	O
is	O
inserted	O
into	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
)	O
membranes	B-ANAT
co	O
-	O
translationally	O
and	O
glycosylated	O
at	O
asparagine	O
-	O
2357	O
.	O

Proteinase	O
K	O
digestion	O
experiments	O
indicate	O
that	O
the	O
TM	O
domain	O
of	O
nsp3	O
has	O
4	O
membrane	B-ANAT
-	O
spanning	O
helices	O
.	O

CSF	B-ANAT
and	O
serum	B-ANAT
samples	O
were	O
allocated	O
into	O
4	O
groups	O
:	O
cats	O
with	O
FIP	O
involving	O
the	O
CNS	B-ANAT
(	O
n	O
=	O
10	O
),	O
cats	O
with	O
FIP	O
not	O
involving	O
the	O
CNS	B-ANAT
(	O
13	O
),	O
cats	O
with	O
CNS	B-ANAT
disorders	O
caused	O
by	O
diseases	O
other	O
than	O
FIP	O
(	O
29	O
),	O
and	O
cats	O
with	O
diseases	O
other	O
than	O
FIP	O
and	O
not	O
involving	O
the	O
CNS	B-ANAT
(	O
15	O
).	O

Cerebrospinal	B-ANAT
fluid	I-ANAT
was	O
evaluated	O
for	O
concentrations	O
of	O
erythrocytes	B-ANAT
,	O
leukocytes	B-ANAT
,	O
and	O
total	O
protein	O
.	O

CSF	B-ANAT
IgG	O
(	O
range	O
of	O
titers	O
,	O
1	O
:	O
32	O
to	O
1	O
:	O
4	O
,	O
096	O
)	O
was	O
detected	O
in	O
12	O
cats	O
,	O
including	O
6	O
cats	O
with	O
neurologic	O
manifestation	O
of	O
FIP	O
,	O
4	O
cats	O
with	O
FIP	O
not	O
involving	O
the	O
CNS	B-ANAT
,	O
and	O
2	O
cats	O
with	O
brain	B-ANAT
tumors	O
.	O

Blood	B-ANAT
contamination	O
of	O
CSF	B-ANAT
resulted	O
in	O
<	O
or	O
=	O
333	O
erythrocytes	B-ANAT
/	O
microL	O
in	O
cats	O
with	O
CSF	B-ANAT
IgG	O
.	O

These	O
approaches	O
were	O
able	O
to	O
achieve	O
or	O
induce	O
antibody	O
titers	O
sufficient	O
to	O
reduce	O
viral	O
load	O
,	O
protect	O
from	O
weight	O
loss	O
and	O
reduce	O
or	O
eliminate	O
histopathologic	O
changes	O
in	O
the	O
lungs	B-ANAT
of	O
aged	O
mice	O
.	O

Hypotension	O
ensued	O
shortly	O
afterwards	O
and	O
pulmonary	B-ANAT
artery	I-ANAT
catheterization	O
showed	O
a	O
decreased	O
cardiac	B-ANAT
index	O
.	O

Comparison	O
of	O
crystal	B-ANAT
packing	O
of	O
SARS	O
-	O
CoV	O
and	O
IBV	O
N	O
-	O
NTDs	O
suggests	O
a	O
common	O
mode	O
of	O
RNA	O
recognition	O
,	O
but	O
they	O
probably	O
associate	O
differently	O
in	O
vivo	O
during	O
the	O
formation	O
of	O
the	O
ribonucleoprotein	B-ANAT
complex	I-ANAT
.	O

An	O
HVAC	O
test	O
facility	O
constructed	O
according	O
to	O
ASHRAE	O
Standard	O
52	O
.	O
2	O
-	O
1999	O
was	O
used	O
for	O
the	O
controlled	O
loading	O
of	O
HVAC	O
filter	O
media	B-ANAT
with	O
aerosolized	O
bacteria	O
and	O
virus	O
.	O

Morphologic	O
and	O
biochemical	O
features	O
of	O
apoptosis	O
,	O
such	O
as	O
blebbing	O
of	O
the	O
plasma	B-ANAT
membrane	I-ANAT
,	O
translocation	O
of	O
phosphatidilserine	O
to	O
cell	B-ANAT
surface	I-ANAT
and	O
annexin	O
V	O
positive	O
staining	O
,	O
nuclear	O
fragmentation	O
,	O
apoptotic	O
bodies	O
formation	O
and	O
DNA	O
laddering	O
,	O
were	O
detected	O
in	O
CCoV	O
-	O
infected	O
cells	B-ANAT
.	O

Propidium	O
iodide	O
staining	O
of	O
infected	O
culture	O
indicated	O
the	O
appearance	O
of	O
hypodiploid	O
DNA	O
peak	O
corresponding	O
to	O
apoptotic	O
cell	B-ANAT
population	O
.	O

ABSTRACT	O
:	O
In	O
order	O
to	O
investigate	O
immunogenicity	O
in	O
the	O
induction	O
of	O
humoral	O
and	O
cellular	B-ANAT
immune	O
responses	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)-	O
N	O
gene	O
recombinant	O
replication	O
-	O
defective	O
adenoviral	O
vector	O
,	O
rAd	O
-	O
N	O
,	O
was	O
generated	O
and	O
immunized	O
BALB	O
/	O
c	O
mice	O
in	O
a	O
pcDNA3	O
.	O
1	O
-	O
N	O
prime	O
-	O
rAd	O
-	O
N	O
boost	O
regimen	O
.	O

In	O
the	O
induction	O
of	O
IFN	O
-	O
gamma	O
production	O
,	O
the	O
homologous	O
combination	O
of	O
rAd	O
-	O
N	O
/	O
rAd	O
-	O
N	O
/	O
rAd	O
-	O
N	O
/	O
rAd	O
-	O
N	O
was	O
significantly	O
stronger	O
than	O
that	O
of	O
pcDNA3	O
.	O
1	O
-	O
N	O
/	O
pcDNA3	O
.	O
1	O
-	O
N	O
/	O
pcDNA3	O
.	O
1	O
-	O
N	O
/	O
pcDNA3	O
.	O
1	O
-	O
N	O
,	O
but	O
was	O
relatively	O
weaker	O
than	O
the	O
heterogeneous	O
combination	O
of	O
pcDAN3	O
.	O
1	O
-	O
N	O
/	O
pcDAN3	O
.	O
1	O
-	O
N	O
/	O
pcDAN3	O
.	O
1	O
-	O
N	O
/	O
rAd	O
-	O
N	O
.	O
This	O
combination	O
was	O
a	O
most	O
efficient	O
immunization	O
regimen	O
in	O
induction	O
of	O
SARS	O
-	O
CoV	O
-	O
N	O
-	O
specific	O
(	O
IFN	O
-	O
gamma	O
)	O
secretion	B-ANAT
just	O
as	O
the	O
antibody	O
response	O
.	O

ABSTRACT	O
:	O
Eighty	O
-	O
four	O
calves	O
with	O
respiratory	O
disease	O
from	O
18	O
herds	O
in	O
different	O
parts	O
of	O
Finland	O
were	O
chosen	O
for	O
a	O
study	O
evaluating	O
the	O
capacity	O
of	O
different	O
respiratory	O
pathogens	O
to	O
cause	O
changes	O
in	O
different	O
acute	O
phase	O
protein	O
concentrations	O
,	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
(	O
WBC	B-ANAT
)	O
count	O
and	O
clinical	O
signs	O
.	O

ABSTRACT	O
:	O
In	O
order	O
to	O
find	O
effective	O
peptide	O
inhibitors	O
against	O
SARS	O
CoV	O
M	O
(	O
pro	O
),	O
an	O
analysis	O
was	O
performed	O
for	O
11	O
oligo	O
-	O
peptides	O
that	O
can	O
be	O
cleaved	B-ANAT
by	O
the	O
SARS	O
coronavirus	O
main	O
protease	O
(	O
CoV	O
M	O
(	O
pro	O
),	O
or	O
3CL	O
(	O
pro	O
)).	O

TITLE	O
:	O
Invasive	O
pulmonary	B-ANAT
aspergillosis	O
in	O
patients	O
with	O
decompensated	O
cirrhosis	O
:	O
case	O
series	O
.	O

In	O
all	O
cases	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
was	O
positive	O
for	O
Aspergillus	O
fumigatus	O
.	O

CONCLUSIONS	O
:	O
Invasive	O
aspergillosis	O
should	O
be	O
among	O
rapidly	O
raised	O
hypothesis	O
in	O
cirrhotic	O
patients	O
developing	O
acute	O
respiratory	O
symptoms	O
and	O
alveolar	B-ANAT
opacities	O
.	O

ABSTRACT	O
:	O
We	O
developed	O
a	O
microfabricated	O
electrochemical	O
DNA	O
chip	O
for	O
detection	O
of	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
products	O
from	O
16S	O
rRNA	O
sequences	O
of	O
Clostridium	O
piliforme	O
(	O
Cp	O
),	O
Helicobacter	O
bilis	O
(	O
Hb	O
)	O
and	O
Helicobacter	O
hepaticus	O
(	O
Hh	O
),	O
and	O
the	O
nucleocapsid	B-ANAT
protein	O
gene	O
of	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
).	O

ABSTRACT	O
:	O
We	O
have	O
previously	O
shown	O
that	O
the	O
nucleocapsid	B-ANAT
protein	O
of	O
SARS	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
activated	O
cyclooxygenase	O
-	O
2	O
(	O
COX	O
-	O
2	O
)	O
expression	O
.	O

We	O
found	O
that	O
an	O
upstream	O
calcium	O
-	O
dependent	O
PKC	O
isozyme	O
PKC	O
alpha	O
that	O
modulates	O
the	O
downstream	O
ERK	O
/	O
NF	O
-	O
kappaB	O
pathway	O
through	O
an	O
influx	O
of	O
extracellular	B-ANAT
Ca2	O
+	O
is	O
induced	O
by	O
the	O
spike	O
protein	O
of	O
SARS	O
-	O
CoV	O
.	O
The	O
ERK	O
/	O
NF	O
-	O
kappaB	O
was	O
identified	O
to	O
be	O
involved	O
in	O
the	O
activation	O
of	O
COX	O
-	O
2	O
promoter	O
and	O
production	O
of	O
COX	O
-	O
2	O
protein	O
in	O
HEK293T	O
cells	B-ANAT
.	O

Particulate	O
adjuvants	O
(	O
e	O
.	O
g	O
.	O
micro	O
/	O
nanoparticles	O
,	O
emulsions	O
,	O
ISCOMS	O
,	O
liposomes	O
,	O
virosomes	O
,	O
and	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
)	O
have	O
been	O
widely	O
investigated	O
as	O
HIV	O
-	O
1	O
vaccine	O
delivery	O
systems	O
.	O

The	O
adjuvant	O
effect	O
of	O
micro	O
/	O
nanoparticles	O
appears	O
to	O
largely	O
be	O
a	O
consequence	O
of	O
their	O
uptake	O
into	O
APC	B-ANAT
.	O

ABSTRACT	O
:	O
Molecular	O
analysis	O
of	O
15	O
Brazilian	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
isolates	O
,	O
obtained	O
from	O
clinical	O
outbreaks	O
of	O
the	O
disease	O
in	O
chickens	O
(	O
broilers	O
or	O
layers	B-ANAT
)	O
in	O
the	O
state	O
of	O
Minas	O
Gerais	O
(	O
Brazil	O
)	O
between	O
1972	O
and	O
1989	O
,	O
is	O
reported	O
.	O

Furthermore	O
,	O
the	O
present	O
study	O
suggests	O
that	O
rhinoviruses	O
can	O
cause	O
olfactory	O
dysfunction	O
through	O
mechanisms	O
other	O
than	O
nasal	B-ANAT
obstruction	O
and	O
that	O
rhinoviruses	O
can	O
induce	O
various	O
severities	O
and	O
different	O
time	O
courses	O
of	O
olfactory	O
dysfunction	O
.	O

TITLE	O
:	O
Enhancement	O
of	O
cytotoxicity	O
against	O
Vero	O
E6	O
cells	B-ANAT
persistently	O
infected	O
with	O
SARS	O
-	O
CoV	O
by	O
Mycoplasma	O
fermentans	O
.	O

ABSTRACT	O
:	O
We	O
previously	O
reported	O
that	O
cells	B-ANAT
with	O
persistent	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
infection	O
were	O
established	O
after	O
apoptotic	O
events	O
.	O

Apoptosis	O
was	O
induced	O
easily	O
in	O
M	O
.	O
fermentans	O
-	O
infected	O
cells	B-ANAT
,	O
indicating	O
that	O
they	O
were	O
primed	O
for	O
apoptosis	O
.	O

TITLE	O
:	O
Therapeutic	O
effects	O
of	O
caspase	O
-	O
1	O
inhibitors	O
on	O
acute	O
lung	B-ANAT
injury	O
in	O
experimental	O
severe	O
acute	O
pancreatitis	O
.	O

A	O
real	O
-	O
time	O
quantitative	O
RT	O
-	O
PCR	O
further	O
confirmed	O
that	O
the	O
amounts	O
of	O
viral	O
RNAs	O
in	O
cell	B-ANAT
cultures	O
pre	O
-	O
transfected	O
with	O
the	O
two	O
plasmids	O
were	O
reduced	O
by	O
95	O
.	O
2	O
%	O
and	O
up	O
to	O
100	O
%,	O
respectively	O
.	O

The	O
results	O
from	O
chicken	O
embryo	B-ANAT
cross	O
-	O
neutralization	O
assays	O
showed	O
that	O
all	O
the	O
four	O
isolates	O
were	O
relative	O
to	O
strain	O
A2	O
of	O
IBV	O
,	O
which	O
was	O
isolated	O
in	O
1996	O
in	O
Beijing	O
and	O
related	O
to	O
strain	O
4	O
/	O
91	O
.	O

The	O
qualitative	O
analysis	O
of	O
the	O
58	O
included	O
studies	O
(	O
1	O
,	O
500	O
patients	O
returned	O
prone	O
,	O
4	O
,	O
000	O
episodes	O
of	O
PP	O
)	O
led	O
to	O
the	O
following	O
main	O
conclusions	O
:	O
1	O
)	O
the	O
PP	O
improves	O
oxygenation	O
in	O
the	O
majority	O
of	O
ARDS	O
patients	O
(	O
level	O
of	O
evidence	O
I	O
);	O
2	O
)	O
the	O
PP	O
improves	O
the	O
pulmonary	B-ANAT
haemodynamics	O
without	O
altering	O
the	O
systemic	O
haemodynamics	O
(	O
level	O
of	O
evidence	O
III	O
);	O
3	O
)	O
the	O
PP	O
enhances	O
the	O
recruitment	O
maneuvers	O
(	O
level	O
of	O
evidence	O
III	O
);	O
4	O
)	O
because	O
there	O
are	O
no	O
formal	O
predictive	O
criteria	O
for	O
response	O
to	O
the	O
PP	O
,	O
a	O
""""	O
trial	O
of	O
PP	O
""""	O
or	O
better	O
two	O
PP	O
trials	O
are	O
necessary	O
to	O
look	O
for	O
the	O
responders	O
;	O
5	O
)	O
the	O
PP	O
should	O
be	O
performed	O
as	O
early	O
as	O
possible	O
in	O
the	O
course	O
of	O
severe	O
ARDS	O
;	O
6	O
)	O
the	O
optimal	O
duration	O
of	O
PP	O
is	O
18	O
to	O
23	O
hours	O
daily	O
,	O
and	O
it	O
should	O
be	O
continued	O
until	O
improvement	O
of	O
arterial	B-ANAT
oxygenation	O
,	O
or	O
loss	O
of	O
the	O
positive	O
effect	O
of	O
PP	O
on	O
arterial	B-ANAT
oxygenation	O
or	O
evidently	O
patient	O
'	O
s	O
death	O
.	O

ABSTRACT	O
:	O
The	O
association	O
between	O
body	B-ANAT
mass	O
index	O
(	O
BMI	O
)	O
and	O
outcomes	O
in	O
critically	O
ill	O
patients	O
is	O
unclear	O
.	O

Our	O
objective	O
was	O
to	O
determine	O
the	O
association	O
between	O
BMI	O
and	O
outcomes	O
in	O
a	O
population	O
-	O
based	O
cohort	O
of	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
).	O

TITLE	O
:	O
Epidemiology	O
and	O
outcomes	O
of	O
acute	O
lung	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
Human	O
coronavirus	O
NL63	O
(	O
HCoV	O
-	O
NL63	O
)	O
is	O
a	O
global	O
respiratory	B-ANAT
tract	I-ANAT
pathogen	O
;	O
however	O
,	O
the	O
epidemiology	O
of	O
this	O
virus	O
in	O
subtropical	O
area	O
is	O
not	O
well	O
known	O
.	O

Every	O
enrolled	O
child	O
had	O
a	O
nasopharyngeal	B-ANAT
aspirate	I-ANAT
(	O
NPA	O
)	O
sample	O
taken	O
.	O

In	O
conclusion	O
,	O
HCoV	O
-	O
NL63	O
is	O
an	O
important	O
respiratory	B-ANAT
tract	I-ANAT
pathogen	O
as	O
the	O
main	O
cause	O
in	O
children	O
admitted	O
to	O
the	O
hospital	O
in	O
Taiwan	O
.	O

The	O
first	O
was	O
a	O
13	O
-	O
year	O
-	O
old	O
boy	O
with	O
a	O
suspected	O
diagnosis	O
of	O
high	O
-	O
grade	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
non	O
-	O
Hodgkin	O
lymphoma	O
,	O
lymph	B-ANAT
node	I-ANAT
disease	O
,	O
and	O
an	O
anterior	O
mediastinal	B-ANAT
mass	O
.	O

He	O
developed	O
severe	O
airway	B-ANAT
obstruction	O
in	O
the	O
early	O
postoperative	O
period	O
.	O

SARS	O
-	O
CoV	O
was	O
grown	O
in	O
monkey	O
VERO	B-ANAT
cells	I-ANAT
and	O
human	O
lung	B-ANAT
epithelial	O
A549	O
cells	B-ANAT
,	O
while	O
canine	O
coronavirus	O
(	O
CCoV	O
)	O
was	O
grown	O
in	O
A72	O
canine	O
cells	B-ANAT
.	O

We	O
further	O
showed	O
that	O
M	O
protein	O
-	O
induced	O
apoptosis	O
involved	O
mitochondrial	B-ANAT
release	O
of	O
cytochrome	O
c	O
protein	O
,	O
and	O
could	O
be	O
suppressed	O
by	O
caspase	O
inhibitors	O
.	O

Over	O
-	O
expression	O
of	O
M	O
caused	O
a	O
dominant	O
rough	O
-	O
eye	B-ANAT
phenotype	O
in	O
adult	O
Drosophila	O
.	O

Infection	O
of	O
fibroblasts	B-ANAT
with	O
the	O
murine	O
hepatitis	O
coronavirus	O
(	O
MHV	O
)	O
and	O
SARS	O
-	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
did	O
not	O
result	O
in	O
nuclear	O
translocation	O
of	O
interferon	O
-	O
regulatory	O
factor	O
3	O
(	O
IRF3	O
),	O
a	O
key	O
transcription	O
factor	O
involved	O
in	O
IFN	O
induction	O
,	O
and	O
induction	O
of	O
IFN	O
mRNA	O
transcription	O
.	O

ABSTRACT	O
:	O
Epidemiologic	O
studies	O
have	O
shown	O
that	O
there	O
is	O
an	O
association	O
between	O
acute	O
respiratory	O
infection	O
and	O
acute	O
coronary	B-ANAT
syndrome	O
.	O

In	O
preclinical	O
studies	O
,	O
ranpirnase	O
demonstrated	O
significant	O
activity	O
against	O
neuroblastoma	O
,	O
rhabdomyosarcoma	O
and	O
chemotherapy	O
-	O
resistant	O
variants	O
of	O
these	O
cancer	B-ANAT
cells	I-ANAT
.	O

TITLE	O
:	O
Inhibition	O
of	O
inducible	O
nitric	O
oxide	O
synthase	O
attenuates	O
acute	O
endotoxin	O
-	O
induced	O
lung	B-ANAT
injury	O
in	O
rats	O
.	O

Here	O
we	O
show	O
that	O
,	O
whereas	O
both	O
transient	O
transfection	O
and	O
constitutive	O
expression	O
of	O
fAPN	O
on	O
BHK	O
-	O
21	O
cells	B-ANAT
can	O
rescue	O
FIPV	O
and	O
TGEV	O
infection	O
in	O
non	O
-	O
permissive	O
BHK	O
cells	B-ANAT
,	O
fAPN	O
expression	O
does	O
not	O
rescue	O
infection	O
by	O
the	O
prototype	O
IBV	O
strain	O
Mass41	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	O
membrane	B-ANAT
(	O
M	O
)	O
protein	O
carboxy	O
tail	O
interacts	O
with	O
the	O
nucleocapsid	B-ANAT
during	O
virus	O
assembly	O
.	O

Previous	O
studies	O
demonstrated	O
that	O
the	O
two	O
terminal	O
residues	O
are	O
important	O
,	O
and	O
the	O
charged	O
residue	O
(	O
R227	O
)	O
in	O
the	O
penultimate	O
position	O
in	O
the	O
mouse	O
hepatitis	O
coronavirus	O
(	O
MHV	O
)	O
A59	O
M	O
protein	O
was	O
suggested	O
to	O
participate	O
in	O
intermolecular	O
interactions	O
with	O
negative	O
charges	O
in	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
.	O

Western	O
blot	O
analysis	O
of	O
transfected	O
CHO	B-ANAT
homogenates	O
showed	O
the	O
same	O
band	B-ANAT
using	O
both	O
patient	O
purified	O
IgG	O
and	O
anti	O
-	O
GABA	O
(	O
B	O
)	O
R1	O
antibody	O
.	O

In	O
order	O
to	O
verify	O
the	O
pathogenic	O
role	O
of	O
these	O
purified	O
antibodies	O
,	O
we	O
injected	O
patient	O
IgG	O
intrathecally	O
into	O
cisterna	B-ANAT
magna	I-ANAT
of	O
C57BL	O
/	O
6	O
mice	O
pre	O
-	O
implanted	O
with	O
EEG	O
electrodes	O
and	O
we	O
observed	O
severe	O
ataxia	O
followed	O
by	O
breathing	O
depression	O
and	O
total	O
suppression	O
of	O
slow	O
wave	O
sleep	O
,	O
as	O
evidenced	O
by	O
EEG	O
recording	O
,	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

TITLE	O
:	O
Serum	B-ANAT
alpha1	O
-	O
acid	O
glycoprotein	O
(	O
AGP	O
)	O
concentration	O
in	O
non	O
-	O
symptomatic	O
cats	O
with	O
feline	O
coronavirus	O
(	O
FCoV	O
)	O
infection	O
.	O

CoV	O
particles	O
were	O
detected	O
by	O
immune	O
electron	O
microscopy	O
in	O
fecal	B-ANAT
samples	O
from	O
three	O
giraffes	O
with	O
mild	O
-	O
to	O
-	O
severe	O
diarrhea	O
.	O

The	O
point	O
mutations	O
identified	O
in	O
the	O
structural	O
proteins	O
(	O
by	O
comparing	O
GiCoV	O
-	O
OH3	O
,	O
BCoV	O
-	O
ENT	B-ANAT
,	O
BCoV	O
-	O
DB2	O
,	O
and	O
BCoV	O
-	O
Mebus	O
)	O
were	O
most	O
conserved	O
among	O
GiCoV	O
-	O
OH3	O
,	O
BCoV	O
-	O
ENT	B-ANAT
,	O
and	O
BCoV	O
-	O
DB2	O
,	O
whereas	O
most	O
of	O
the	O
point	O
mutations	O
in	O
the	O
nonstructural	O
proteins	O
were	O
unique	O
to	O
GiCoV	O
-	O
OH3	O
.	O

Ten	O
P	O
-	O
PMOs	O
directed	O
against	O
various	O
target	O
sites	O
in	O
the	O
viral	B-ANAT
genome	I-ANAT
were	O
tested	O
in	O
cell	B-ANAT
culture	O
,	O
and	O
one	O
of	O
these	O
(	O
5TERM	O
),	O
which	O
was	O
complementary	O
to	O
the	O
5	O
'	O
terminus	O
of	O
the	O
genomic	O
RNA	O
,	O
was	O
effective	O
against	O
six	O
strains	O
of	O
MHV	O
.	O

Viral	O
infection	O
and	O
shedding	O
by	O
index	O
mice	O
was	O
confirmed	O
by	O
serology	O
and	O
fecal	B-ANAT
polymerase	O
chain	O
reaction	O
assay	O
.	O

More	O
detailed	O
microbiological	O
investigations	O
of	O
affected	O
children	O
even	O
without	O
apparent	O
signs	O
of	O
a	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
may	O
help	O
to	O
clarify	O
the	O
etiology	O
in	O
some	O
patients	O
and	O
extend	O
our	O
understanding	O
of	O
the	O
pathogenesis	O
.	O

Examples	O
of	O
CBAs	O
include	O
the	O
procaryotic	O
cyanovirin	O
-	O
N	O
(	O
CV	O
-	O
N	O
),	O
plant	O
lectins	O
such	O
as	O
HHA	O
,	O
GNA	O
,	O
NPA	O
,	O
CA	O
and	O
UDA	O
,	O
the	O
monoclonal	O
antibody	O
2G12	O
directed	O
against	O
a	O
glycan	O
-	O
containing	O
epitope	O
on	O
HIV	O
envelope	B-ANAT
gp120	O
,	O
and	O
the	O
mannose	O
-	O
specific	O
non	O
-	O
peptidic	O
antibiotic	O
Pradimicin	O
A	O
,	O
which	O
inhibits	O
the	O
entry	O
of	O
HIV	O
-	O
1	O
into	O
its	O
target	B-ANAT
cells	I-ANAT
.	O

Long	O
-	O
term	O
exposure	O
of	O
HIV	O
to	O
CBAs	O
in	O
cell	B-ANAT
culture	O
results	O
in	O
the	O
progressive	O
deletion	O
of	O
N	O
-	O
glycans	O
of	O
HIV	O
gpl20	O
in	O
an	O
attempt	O
of	O
the	O
virus	O
to	O
escape	O
drug	O
pressure	O
.	O

Thus	O
,	O
COPD	O
/	O
emphysema	O
and	O
severe	O
angioproliferative	O
PH	O
are	O
on	O
the	O
opposite	O
ends	O
of	O
a	O
spectrum	O
of	O
vascular	B-ANAT
biology	O
responses	O
.	O

TITLE	O
:	O
Lung	B-ANAT
complications	O
in	O
acute	O
pancreatitis	O
.	O

Over	O
a	O
period	O
of	O
one	O
year	O
,	O
60	O
patients	O
referred	O
to	O
us	O
with	O
a	O
diagnosis	O
of	O
acute	O
pancreatitis	O
on	O
the	O
basis	O
of	O
clinical	O
findings	O
,	O
CT	O
and	O
elevated	O
serum	B-ANAT
amylase	O
level	O
were	O
studied	O
prospectively	O
.	O

Arterial	B-ANAT
blood	I-ANAT
gas	O
analysis	O
and	O
chest	B-ANAT
X	O
-	O
rays	O
were	O
performed	O
in	O
all	O
patients	O
at	O
admission	O
and	O
at	O
intervals	O
,	O
when	O
clinically	O
indicated	O
.	O

In	O
contrast	O
to	O
the	O
SARS	O
-	O
coronavirus	O
,	O
IBV	O
nucleocapsid	B-ANAT
protein	O
did	O
not	O
interact	O
with	O
cyclin	O
D1	O
.	O

Truncated	O
fragments	O
of	O
SARS	O
-	O
CoV	O
spike	O
protein	O
were	O
cloned	O
in	O
pET	O
-	O
21	O
vector	O
and	O
expressed	O
in	O
BL	O
-	O
21	O
Escherichia	O
coli	O
(	O
E	O
.	O
coli	O
)	O
cells	B-ANAT
.	O

Electrical	O
and	O
multiple	O
defibrillation	O
shocks	O
can	O
cause	O
cutaneous	O
burns	O
and	O
blunt	O
chest	B-ANAT
trauma	O
.	O

These	O
results	O
demonstrate	O
that	O
DRAK2	O
signaling	O
is	O
dispensable	O
for	O
T	B-ANAT
cell	I-ANAT
recruitment	O
into	O
the	O
CNS	B-ANAT
following	O
viral	O
infection	O
,	O
suggesting	O
that	O
the	O
resistance	O
of	O
Drak2	O
-	O
/	O
-	O
mice	O
to	O
EAE	O
is	O
not	O
due	O
to	O
overt	O
T	B-ANAT
cell	I-ANAT
trafficking	O
defects	O
.	O

The	O
direct	O
immunohistochemical	O
positive	O
signal	O
was	O
present	O
in	O
all	O
intestine	B-ANAT
slides	O
.	O

The	O
same	O
six	O
sites	O
were	O
also	O
phosphorylated	O
on	O
the	O
extracellular	B-ANAT
mature	O
virion	B-ANAT
N	O
protein	O
.	O

ABSTRACT	O
:	O
As	O
a	O
critical	O
adaptive	O
mechanism	O
,	O
amino	O
acid	O
replacements	O
on	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
spike	O
protein	O
could	O
alter	O
the	O
receptor	O
-	O
binding	O
specificity	O
of	O
this	O
envelope	B-ANAT
glycoprotein	O
and	O
in	O
turn	O
lead	O
to	O
the	O
emergence	O
or	O
reemergence	O
of	O
this	O
viral	O
zoonosis	O
.	O

Taken	O
together	O
,	O
these	O
results	O
indicated	O
that	O
nucleocapsid	B-ANAT
protein	O
may	O
be	O
a	O
useful	O
antigen	O
for	O
the	O
sera	B-ANAT
-	O
diagnosis	O
of	O
PEDV	O
and	O
it	O
was	O
also	O
suggested	O
that	O
the	O
ELISA	O
is	O
a	O
highly	O
sensitive	O
and	O
specific	O
test	O
for	O
detecting	O
antibodies	O
to	O
PEDV	O
.	O

Diagnosis	O
was	O
confirmed	O
by	O
2	O
-	O
D	O
echocardiogram	O
visualization	O
with	O
right	O
to	O
left	O
shunt	O
through	O
the	O
foramen	B-ANAT
ovale	I-ANAT
or	O
patent	O
ductus	B-ANAT
arteriosus	I-ANAT
.	O

Chronic	O
lung	B-ANAT
diseases	O
,	O
delayed	O
development	O
and	O
severe	O
hearing	O
loss	O
in	O
long	O
-	O
term	O
follow	O
up	O
were	O
found	O
in	O
10	O
,	O
5	O
,	O
and	O
2	O
cases	O
,	O
respectively	O
.	O

After	O
primary	O
successful	O
resuscitation	O
the	O
baby	O
died	O
after	O
49	O
days	O
due	O
to	O
large	O
intracranial	B-ANAT
hemorrages	O
.	O

In	O
the	O
setting	O
of	O
severe	O
brain	B-ANAT
injury	O
associated	O
with	O
refractory	O
hypotension	O
,	O
terlipressin	O
may	O
have	O
a	O
role	O
as	O
a	O
rescue	O
therapy	O
.	O

CONCLUSIONS	O
:	O
In	O
the	O
setting	O
of	O
severe	O
brain	B-ANAT
injury	O
associated	O
with	O
refractory	O
hypotension	O
,	O
terlipressin	O
may	O
have	O
a	O
role	O
as	O
a	O
rescue	O
therapy	O
.	O

Here	O
,	O
we	O
report	O
that	O
the	O
C	O
-	O
terminal	O
domain	O
(	O
CTD	O
),	O
spanning	O
residues	O
248	O
-	O
365	O
(	O
NP248	O
-	O
365	O
),	O
had	O
stronger	O
nucleic	B-ANAT
acid	O
-	O
binding	O
activity	O
than	O
the	O
NTD	O
.	O

TITLE	O
:	O
Early	O
tumor	O
regression	O
following	O
severe	O
lung	B-ANAT
injury	O
after	O
allogeneic	O
stem	B-ANAT
cell	I-ANAT
transplantation	O
in	O
a	O
patient	O
with	O
renal	B-ANAT
cell	I-ANAT
carcinoma	O
.	O

TITLE	O
:	O
Using	O
patient	O
-	O
collected	O
clinical	O
samples	O
and	O
sera	B-ANAT
to	O
detect	O
and	O
quantify	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
).	O

It	O
seems	O
that	O
both	O
abnormal	O
immune	O
responses	O
and	O
injury	O
to	O
immune	O
cells	B-ANAT
may	O
be	O
key	O
factors	O
in	O
the	O
pathogenesis	O
of	O
this	O
new	O
disease	O
.	O

Viable	O
mutant	O
nsp10	O
-	O
E2	O
was	O
compromised	O
in	O
its	O
ability	O
to	O
process	O
the	O
nascent	O
polyprotein	O
,	O
as	O
processing	O
intermediates	O
were	O
detected	O
in	O
cells	B-ANAT
infected	O
with	O
this	O
virus	O
that	O
were	O
not	O
detectable	O
in	O
wild	O
-	O
type	O
infections	O
.	O

Mapping	O
the	O
mutations	O
onto	O
the	O
crystal	B-ANAT
structure	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
virus	O
nsp10	O
identified	O
a	O
central	B-ANAT
core	I-ANAT
resistant	O
to	O
mutation	O
.	O

All	O
mutations	O
resulting	O
in	O
viable	O
phenotypes	O
mapped	O
to	O
loops	O
outside	O
the	O
central	B-ANAT
core	I-ANAT
and	O
were	O
characterized	O
by	O
a	O
global	O
decrease	O
in	O
RNA	O
synthesis	O
.	O

We	O
generated	O
polyclonal	O
antisera	O
directed	O
against	O
two	O
of	O
the	O
predicted	O
replicase	O
nonstructural	O
proteins	O
(	O
nsp3	O
and	O
nsp4	O
)	O
and	O
detected	O
replicase	O
proteins	O
from	O
HCoV	O
-	O
NL63	O
-	O
infected	O
LLC	B-ANAT
-	O
MK2	O
cells	B-ANAT
by	O
immunofluorescence	O
,	O
immunoprecipitation	O
,	O
and	O
Western	O
blot	O
assays	O
.	O

All	O
of	O
these	O
peptides	O
were	O
able	O
to	O
stimulate	O
the	O
proliferation	O
of	O
NP	O
-	O
specific	O
T	O
-	O
cell	B-ANAT
lines	I-ANAT
or	O
freshly	O
isolated	O
lymph	B-ANAT
node	I-ANAT
cells	B-ANAT
from	O
mice	O
immunized	O
with	O
recombinant	O
NP	O
.	O

This	O
article	O
presents	O
the	O
problems	O
that	O
may	O
be	O
encountered	O
in	O
patients	O
who	O
have	O
severe	O
abdominal	B-ANAT
and	O
lung	B-ANAT
injuries	O
,	O
and	O
the	O
current	O
management	O
concepts	O
used	O
in	O
caring	O
for	O
these	O
patients	O
in	O
the	O
critical	O
care	O
setting	O
,	O
to	O
provide	O
guidelines	O
for	O
the	O
anesthetist	O
faced	O
with	O
these	O
patients	O
in	O
the	O
operating	O
room	O
.	O

No	O
serum	B-ANAT
was	O
tested	O
positive	O
for	O
persons	O
who	O
were	O
employed	O
after	O
palm	B-ANAT
civets	O
and	O
raccoon	O
dogs	O
were	O
culled	O
from	O
market	O
.	O

Serum	B-ANAT
antibodies	O
were	O
tested	O
in	O
some	O
of	O
the	O
close	O
contacts	O
.	O

A	O
variety	O
of	O
viruses	O
,	O
bacteria	O
and	O
fungi	O
are	O
associated	O
with	O
respiratory	B-ANAT
tract	I-ANAT
illness	O
.	O

When	O
bone	B-ANAT
marrow	I-ANAT
from	O
wild	O
-	O
type	O
mice	O
was	O
transplanted	B-ANAT
into	O
irradiated	O
LysM	O
-	O
DTR	O
mice	O
,	O
the	O
alveolar	B-ANAT
macrophages	I-ANAT
became	O
resistant	O
to	O
DT	O
but	O
the	O
mice	O
still	O
suffered	O
from	O
acute	O
lung	B-ANAT
injury	O
by	O
DT	O
administration	O
.	O

ABSTRACT	O
:	O
Hemangioma	O
is	O
a	O
common	O
benign	O
tumor	O
of	O
the	O
liver	B-ANAT
that	O
is	O
usually	O
asymptomatic	O
.	O

TITLE	O
:	O
Proteomic	O
analysis	O
of	O
up	O
-	O
regulated	O
proteins	O
in	O
human	O
promonocyte	B-ANAT
cells	B-ANAT
expressing	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
3C	O
-	O
like	O
protease	O
.	O

Thirty	O
-	O
six	O
percent	O
of	O
identified	O
up	O
-	O
regulated	O
proteins	O
were	O
located	O
in	O
the	O
mitochondria	B-ANAT
,	O
including	O
apoptosis	O
-	O
inducing	O
factor	O
,	O
ATP	O
synthase	O
beta	O
chain	O
and	O
cytochrome	O
c	O
oxidase	O
.	O

In	O
addition	O
,	O
confocal	O
image	O
analysis	O
has	O
shown	O
release	O
of	O
mitochondrial	B-ANAT
apoptogenic	O
apoptosis	O
-	O
inducing	O
factor	O
and	O
cytochrome	O
c	O
into	O
the	O
cytosol	B-ANAT
.	O

Our	O
results	O
revealed	O
that	O
SARS	O
CoV	O
3CLpro	O
could	O
be	O
considered	O
to	O
induce	O
mitochondrial	B-ANAT
-	O
mediated	O
apoptosis	O
.	O

TITLE	O
:	O
The	O
SARS	O
coronavirus	O
spike	O
glycoprotein	O
is	O
selectively	O
recognized	O
by	O
lung	B-ANAT
surfactant	O
protein	O
D	O
and	O
activates	O
macrophages	B-ANAT
.	O

It	O
was	O
not	O
secreted	O
in	O
the	O
presence	O
of	O
tunicamycin	O
and	O
was	O
detected	O
as	O
a	O
130	O
kDa	O
protein	O
in	O
the	O
cell	B-ANAT
lysate	O
.	O

Mutation	O
analysis	O
of	O
3a	O
revealed	O
that	O
C	O
-	O
terminal	O
region	O
(	O
176	O
aa	O
approximately	O
274	O
aa	O
),	O
including	O
a	O
potential	O
calcium	O
ATPase	O
motif	O
,	O
was	O
essential	O
for	O
induction	O
of	O
cell	B-ANAT
cycle	O
arrest	O
.	O

It	O
has	O
been	O
observed	O
that	O
pulmonary	B-ANAT
infection	O
with	O
Leishmania	O
donovani	O
can	O
occur	O
in	O
immunodeficient	O
and	O
lung	B-ANAT
transplant	B-ANAT
patients	O
.	O

Pulmonary	B-ANAT
hypertension	O
has	O
been	O
reported	O
in	O
Schistosoma	O
hematobium	O
,	O
S	O
.	O
mansoni	O
and	O
S	O
.	O
japonicum	O
infections	O
.	O

RESULTS	O
:	O
Both	O
cohorts	O
were	O
comparable	O
with	O
regard	O
to	O
demographic	O
data	O
,	O
ISS	O
,	O
AIS	O
score	O
in	O
the	O
thoracic	B-ANAT
region	I-ANAT
,	O
and	O
incidence	O
and	O
severity	O
of	O
brain	B-ANAT
injury	O
.	O

Diabetic	O
liver	B-ANAT
lesions	O
include	O
glycogenic	O
hepatopathy	O
(	O
in	O
which	O
poor	O
diabetic	O
control	O
leads	O
to	O
swollen	O
,	O
glycogen	O
-	O
filled	O
hepatocytes	B-ANAT
without	O
fat	O
,	O
steatohepatitis	O
or	O
fibrosis	O
)	O
and	O
diabetic	O
hepatosclerosis	O
in	O
which	O
there	O
is	O
diffuse	O
perisinusoidal	O
fibrosis	O
(	O
type	O
IV	O
collagen	B-ANAT
)	O
without	O
zonal	O
predilection	O
.	O

More	O
importantly	O
,	O
the	O
antibody	O
could	O
reduce	O
viral	O
titers	O
or	O
copies	O
by	O
approximately	O
10	O
(	O
3	O
)-	O
to	O
10	O
(	O
4	O
)-	O
fold	O
in	O
animal	O
lung	B-ANAT
after	O
virus	O
exposure	O
,	O
compared	O
with	O
negative	O
control	O
.	O

The	O
nucleolar	B-ANAT
proteome	O
varies	O
particularly	O
with	O
regard	O
to	O
the	O
cell	B-ANAT
cycle	O
.	O

RESULTS	O
:	O
From	O
1986	O
to	O
2004	O
,	O
we	O
identified	O
11	O
cases	O
of	O
post	O
-	O
transplant	B-ANAT
blastomycosis	O
with	O
64	O
%	O
occurring	O
between	O
2000	O
and	O
2004	O
.	O

The	O
hairpin	O
is	O
composed	O
of	O
six	O
copies	O
of	O
a	O
repeating	O
structural	O
subunit	O
that	O
consists	O
of	O
2	O
-	O
nt	O
bulges	O
and	O
5	O
-	O
bp	O
stems	B-ANAT
.	O

BALB	O
/	O
c	O
mice	O
were	O
immunized	O
orally	B-ANAT
with	O
SL7207	O
harboring	O
recombinant	O
plasmid	O
at	O
the	O
dosage	O
of	O
109	O
and	O
boosted	O
two	O
weeks	O
later	O
with	O
the	O
same	O
dose	O
,	O
for	O
a	O
total	O
of	O
three	O
times	O
.	O

The	O
antibodies	O
against	O
MHV	O
were	O
also	O
detected	O
in	O
small	B-ANAT
intestinal	I-ANAT
mucosal	B-ANAT
samples	O
from	O
immunized	O
mice	O
at	O
2	O
w	O
post	O
-	O
three	O
immunization	O
.	O

This	O
created	O
noncomparable	O
subgroups	O
in	O
both	O
study	O
arms	B-ANAT
that	O
received	O
care	O
different	O
and	O
opposite	O
from	O
titrated	O
care	O
,	O
that	O
is	O
,	O
practice	O
misalignments	O
.	O

RESULTS	O
:	O
Publications	O
before	O
TRICC	O
indicated	O
that	O
clinicians	O
used	O
higher	O
transfusion	O
thresholds	O
in	O
patients	O
with	O
ischemic	O
heart	B-ANAT
disease	O
compared	O
with	O
younger	O
,	O
healthier	O
patients	O
(	O
p	O
=	O
.	O
001	O
).	O

ABSTRACT	O
:	O
Post	O
-	O
emetic	O
spontaneous	O
rupture	O
of	O
the	O
esophagus	B-ANAT
(	O
Boerhaave	O
'	O
s	O
syndrome	O
)	O
is	O
still	O
a	O
life	O
-	O
threatening	O
condition	O
,	O
despite	O
recent	O
advances	O
in	O
thoracic	B-ANAT
surgery	O
and	O
critical	O
care	O
medicine	O
.	O

He	O
suddenly	O
developed	O
severe	O
back	B-ANAT
pain	O
and	O
acute	O
respiratory	O
distress	O
after	O
vomiting	O
during	O
dinner	O
and	O
was	O
brought	O
to	O
our	O
emergency	O
department	O
.	O

Examination	O
on	O
admission	O
revealed	O
an	O
increased	O
respiratory	O
rate	O
of	O
20	O
min	O
(-	O
1	O
)	O
with	O
SpO2	O
97	O
%	O
with	O
a	O
facemask	O
(	O
O2	O
,	O
3	O
l	O
x	O
min	O
(-	O
1	O
)),	O
a	O
pulse	O
rate	O
of	O
100	O
min	O
(-	O
1	O
),	O
and	O
a	O
blood	B-ANAT
pressure	O
of	O
138	O
/	O
88	O
mmHg	O
.	O

A	O
transmural	O
tear	B-ANAT
in	O
the	O
anterior	O
wall	O
of	O
the	O
esophagus	B-ANAT
was	O
found	O
and	O
the	O
foreign	O
body	B-ANAT
(	O
boiled	O
meat	O
)	O
was	O
removed	O
.	O

Consequently	O
,	O
TNF	O
production	O
is	O
enhanced	O
,	O
leading	O
to	O
the	O
development	O
of	O
multi	O
-	O
organ	B-ANAT
failure	O
in	O
sepsis	O
.	O

Penile	B-ANAT
TB	O
is	O
extremely	O
rare	O
comprising	O
less	O
than	O
1	O
%	O
of	O
all	O
genital	B-ANAT
TB	O
cases	O
in	O
males	O
.	O

The	O
receptors	O
of	O
those	O
two	O
viruses	O
have	O
been	O
identified	O
and	O
their	O
cell	B-ANAT
entry	O
mechanism	O
has	O
been	O
actively	O
investigated	O
.	O

Our	O
findings	O
have	O
promising	O
implications	O
in	O
the	O
investigation	O
of	O
the	O
role	O
of	O
molecular	O
mimicry	O
between	O
coronaviruses	O
and	O
myelin	B-ANAT
in	O
MS	O
as	O
a	O
mechanism	O
related	O
to	O
disease	O
initiation	O
or	O
relapses	O
.	O

Major	O
complications	O
during	O
ECMO	O
included	O
hemorrhage	O
(	O
52	O
%),	O
hemodialysis	O
(	O
42	O
%),	O
neurologic	O
(	O
12	O
%),	O
and	O
cardiac	B-ANAT
(	O
28	O
%)	O
complications	O
,	O
inotropic	O
support	O
(	O
77	O
%),	O
and	O
sepsis	O
(	O
15	O
%).	O

These	O
diseases	O
are	O
,	O
amongst	O
others	O
Severe	O
and	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
),	O
Rabies	O
,	O
Lyme	O
disease	O
,	O
African	O
Horse	O
Sickness	O
,	O
Blue	O
Tongue	B-ANAT
,	O
African	O
Swine	O
Fever	O
,	O
Ebola	O
Hemorrhagic	O
Fever	O
,	O
Hantavirosis	O
,	O
and	O
Avian	O
Influenza	O
.	O

Our	O
data	O
suggests	O
that	O
the	O
SARS	O
-	O
CoV	O
uses	O
specific	O
strategies	O
to	O
evade	O
and	O
antagonize	O
the	O
sensing	O
and	O
signaling	O
arms	B-ANAT
of	O
the	O
interferon	O
pathway	O
.	O

ABSTRACT	O
:	O
SARS	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
emerged	O
in	O
2002	O
as	O
an	O
important	O
cause	O
of	O
severe	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
in	O
humans	O
and	O
in	O
vitro	O
models	O
of	O
the	O
lung	B-ANAT
are	O
needed	O
to	O
elucidate	O
cellular	B-ANAT
targets	O
and	O
the	O
consequences	O
of	O
viral	O
infection	O
.	O

pCDNA3	O
.	O
1	O
(-)/	O
his	O
-	O
myc	O
vector	O
containing	O
the	O
SARS	O
coronavirus	O
nucleocapsid	B-ANAT
gene	O
(	O
N	O
),	O
matric	O
gene	O
(	O
M	O
),	O
spike	O
gene	O
(	O
S	O
)	O
were	O
transfected	O
into	O
COS	B-ANAT
-	I-ANAT
1	I-ANAT
,	O
Huh	O
-	O
7	O
and	O
HepG2	B-ANAT
cells	I-ANAT
.	O

TITLE	O
:	O
Multiple	O
organ	B-ANAT
failure	O
following	O
lamp	O
oil	O
aspiration	O
.	O

Many	O
studies	O
showed	O
that	O
this	O
inflammatory	O
process	O
is	O
not	O
restricted	O
to	O
the	O
respiratory	B-ANAT
system	I-ANAT
but	O
might	O
result	O
in	O
non	O
pulmonary	B-ANAT
organ	B-ANAT
failure	O
and	O
hemodynamic	O
compromise	O
as	O
well	O
.	O

Mechanical	O
ventilation	O
is	O
considered	O
the	O
hallmark	O
treatment	O
for	O
ALI	O
patients	O
aimed	O
to	O
recruit	O
lung	B-ANAT
tissue	I-ANAT
and	O
thereby	O
reverse	O
hypoxemia	O
without	O
causing	O
additional	O
lung	B-ANAT
injury	O
potentially	O
resulting	O
from	O
overdistention	O
or	O
cycling	O
collapse	O
during	O
expiration	O
.	O

Phylogenetic	O
analysis	O
suggests	O
that	O
ACoV	O
shares	O
the	O
same	O
ancestor	O
as	O
BCoV	O
ENT	B-ANAT
and	O
LUN	O
.	O

ABSTRACT	O
:	O
Alpha	O
-	O
1	O
-	O
acid	O
glycoprotein	O
(	O
AGP	O
)	O
increases	O
in	O
the	O
blood	B-ANAT
of	O
cats	O
with	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
),	O
a	O
lethal	O
disease	O
caused	O
by	O
feline	O
coronavirus	O
(	O
FCoV	O
).	O

The	O
comparison	O
of	O
serum	B-ANAT
AGP	O
levels	O
in	O
the	O
different	O
groups	O
and	O
the	O
analysis	O
of	O
the	O
ROC	O
curve	O
confirmed	O
that	O
serum	B-ANAT
AGP	O
is	O
a	O
powerful	O
discriminating	O
marker	O
for	O
FIP	O
.	O

Phylogenetic	O
analyses	O
revealed	O
that	O
the	O
envelope	B-ANAT
,	O
membrane	B-ANAT
,	O
and	O
nucleoprotein	O
structural	O
proteins	O
and	O
the	O
two	O
conserved	O
replicase	O
domains	O
,	O
putative	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
and	O
RNA	O
helicase	O
,	O
of	O
these	O
novel	O
coronaviruses	O
were	O
most	O
closely	O
related	O
to	O
those	O
of	O
group	O
3	O
coronaviruses	O
identified	O
from	O
birds	O
,	O
while	O
the	O
spike	O
protein	O
gene	O
was	O
most	O
closely	O
related	O
to	O
that	O
of	O
group	O
1	O
coronaviruses	O
from	O
mammals	O
.	O

TITLE	O
:	O
SARS	O
wars	O
:	O
an	O
examination	O
of	O
the	O
quantity	O
and	O
construction	O
of	O
health	O
information	O
in	O
the	O
news	O
media	B-ANAT
.	O

The	O
media	B-ANAT
may	O
influence	O
an	O
individual	O
'	O
s	O
tendency	O
to	O
overestimate	O
the	O
risk	O
of	O
some	O
health	O
issues	O
while	O
underestimating	O
the	O
risk	O
of	O
others	O
,	O
ultimately	O
influencing	O
health	O
choices	O
.	O

METHODS	O
:	O
Back	B-ANAT
-	O
projection	O
method	O
.	O

Overall	O
,	O
9	O
.	O
3	O
%	O
of	O
the	O
diarrheic	O
fecal	B-ANAT
samples	O
tested	O
positive	O
for	O
BNoVs	O
by	O
either	O
RT	O
-	O
PCR	O
or	O
nested	O
PCR	O
,	O
of	O
which	O
5	O
.	O
9	O
%	O
samples	O
also	O
tested	O
positive	O
for	O
other	O
enteric	O
pathogens	O
including	O
the	O
bovine	O
coronavirus	O
,	O
bovine	O
viral	O
diarrhea	O
virus	O
,	O
bovine	O
torovirus	O
,	O
bovine	O
groups	O
A	O
,	O
B	O
and	O
C	O
rotaviruses	O
,	O
bovine	O
enteric	O
Nebraska	O
-	O
like	O
calicivirus	O
and	O
Escherichia	O
coli	O
.	O

Despite	O
negative	O
anti	O
-	O
GBM	B-ANAT
antibodies	O
,	O
he	O
was	O
treated	O
similarly	O
to	O
a	O
relapse	O
and	O
after	O
the	O
second	O
course	O
of	O
plasmapheresis	O
the	O
patients	O
'	O
general	O
condition	O
improved	O
and	O
hemoptysis	O
subsided	O
.	O

In	O
these	O
patients	O
,	O
one	O
-	O
year	O
survival	O
rate	O
is	O
67	O
%	O
and	O
5	O
%	O
for	O
kidney	B-ANAT
function	O
.	O

We	O
observed	O
that	O
(	O
i	O
)	O
the	O
5	O
'-	O
terminal	O
186	O
nt	O
of	O
the	O
nsp1	O
coding	O
region	O
are	O
necessary	O
and	O
sufficient	O
for	O
DI	O
RNA	O
replication	O
,	O
(	O
ii	O
)	O
two	O
Mfold	O
-	O
predicted	O
stem	B-ANAT
-	O
loops	O
within	O
the	O
186	O
-	O
nt	O
sequence	O
,	O
named	O
SLV	O
(	O
nt	O
239	O
to	O
310	O
)	O
and	O
SLVI	O
(	O
nt	O
311	O
to	O
340	O
),	O
are	O
supported	O
by	O
RNase	O
structure	O
probing	O
and	O
by	O
nucleotide	O
covariation	O
among	O
closely	O
related	O
group	O
2	O
coronaviruses	O
,	O
and	O
(	O
iii	O
)	O
SLVI	O
is	O
a	O
required	O
higher	O
-	O
order	O
structure	O
for	O
DI	O
RNA	O
replication	O
based	O
on	O
mutation	O
analyses	O
.	O

TITLE	O
:	O
Comparison	O
of	O
immunoglobulin	O
G	O
responses	O
to	O
the	O
spike	O
and	O
nucleocapsid	B-ANAT
proteins	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	O
in	O
patients	O
with	O
SARS	O
.	O

All	O
33	O
serum	B-ANAT
samples	O
from	O
set	O
2	O
were	O
strongly	O
positive	O
for	O
N	O
-	O
protein	O
-	O
specific	O
IgG	O
,	O
while	O
27	O
(	O
82	O
%)	O
were	O
positive	O
for	O
anti	O
-	O
S450	O
-	O
650	O
IgG	O
.	O
Two	O
of	O
the	O
serum	B-ANAT
samples	O
from	O
set	O
3	O
were	O
strongly	O
positive	O
for	O
anti	O
-	O
N	O
-	O
protein	O
IgG	O
but	O
not	O
anti	O
-	O
S450	O
-	O
650	O
IgG	O
.	O
Similar	O
levels	O
of	O
IgG	O
responses	O
to	O
the	O
S	O
and	O
N	O
proteins	O
were	O
observed	O
in	O
SARS	O
patients	O
during	O
the	O
manifestation	O
and	O
convalescent	O
stages	O
.	O

During	O
laparoscopic	O
laparotomy	O
,	O
abundant	O
pus	B-ANAT
was	O
found	O
in	O
the	O
peritoneal	B-ANAT
cavity	I-ANAT
.	O

Our	O
findings	O
suggest	O
that	O
FCoVs	O
may	O
be	O
present	O
in	O
the	O
blood	B-ANAT
samples	I-ANAT
from	O
healthy	O
cats	O
as	O
well	O
as	O
cats	O
with	O
clinical	O
FIP	O
.	O

Host	B-ANAT
cell	I-ANAT
protein	O
synthesis	O
still	O
took	O
place	O
in	O
LiCl	O
-	O
treated	O
cells	B-ANAT
and	O
the	O
level	O
of	O
a	O
standard	O
cellular	B-ANAT
housekeeping	O
protein	O
remained	O
unchanged	O
,	O
indicating	O
that	O
the	O
effect	O
of	O
LiCl	O
was	O
specifically	O
against	O
IBV	O
.	O

TITLE	O
:	O
Type	O
I	O
feline	O
coronavirus	O
spike	O
glycoprotein	O
fails	O
to	O
recognize	O
aminopeptidase	O
N	O
as	O
a	O
functional	O
receptor	O
on	O
feline	O
cell	B-ANAT
lines	I-ANAT
.	O

An	O
important	O
determinant	O
of	O
coronavirus	O
infection	O
,	O
in	O
vivo	O
and	O
in	O
cell	B-ANAT
culture	O
,	O
is	O
the	O
interaction	O
of	O
the	O
virus	O
surface	O
glycoprotein	O
with	O
a	O
cellular	B-ANAT
receptor	O
.	O

Our	O
results	O
show	O
that	O
type	O
I	O
feline	O
coronavirus	O
surface	O
glycoprotein	O
fails	O
to	O
recognize	O
feline	O
aminopeptidase	O
N	O
as	O
a	O
functional	O
receptor	O
on	O
three	O
continuous	O
feline	O
cell	B-ANAT
lines	I-ANAT
.	O

Bronchial	B-ANAT
rupture	O
and	O
mediastinal	B-ANAT
emphysema	O
was	O
found	O
in	O
one	O
of	O
them	O
.	O

Quantitative	O
trait	O
locus	O
(	O
QTL	O
)	O
analyses	O
of	O
the	O
total	O
F2	O
population	O
identified	O
three	O
highly	O
significant	O
(	O
named	O
Shali1	O
,	O
Shali2	O
and	O
Shali3	O
,	O
for	O
Survival	O
to	O
hyperoxic	O
acute	O
lung	B-ANAT
injury	O
)	O
and	O
one	O
significant	O
(	O
Shali4	O
)	O
linkage	O
.	O

In	O
this	O
study	O
we	O
performed	O
genome	O
-	O
wide	O
microarray	O
analyses	O
of	O
the	O
expression	O
patterns	O
of	O
mouse	O
hepatitis	O
coronavirus	O
(	O
MHV	O
)-	O
infected	O
cells	B-ANAT
.	O

Concomitantly	O
,	O
phosphorylation	O
of	O
the	O
eukaryotic	O
translation	O
initiation	O
factor	O
2alpha	O
was	O
increased	O
in	O
MHV	O
-	O
infected	O
cells	B-ANAT
.	O

TITLE	O
:	O
Nucleocapsid	B-ANAT
protein	O
of	O
SARS	O
-	O
CoV	O
activates	O
interleukin	O
-	O
6	O
expression	O
through	O
cellular	B-ANAT
transcription	O
factor	O
NF	O
-	O
kappaB	O
.	O
ABSTRACT	O
:	O
High	O
levels	O
of	O
interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
)	O
in	O
the	O
acute	O
stage	O
associated	O
with	O
lung	B-ANAT
lesions	O
were	O
found	O
in	O
SARS	O
patients	O
.	O

This	O
cell	B-ANAT
cycle	O
arrest	O
was	O
catalyzed	O
by	O
the	O
modulation	O
of	O
various	O
cell	B-ANAT
cycle	O
regulatory	O
genes	O
and	O
the	O
accumulation	O
of	O
hypophosphorylated	O
RB	O
,	O
but	O
was	O
independent	O
of	O
p53	O
.	O

Our	O
data	O
also	O
showed	O
that	O
cell	B-ANAT
cycle	O
arrest	O
at	O
both	O
S	O
-	O
and	O
G	O
(	O
2	O
)/	O
M	O
-	O
phases	O
was	O
manipulated	O
by	O
IBV	O
for	O
the	O
enhancement	O
of	O
viral	O
replication	O
.	O

ABSTRACT	O
:	O
DNA	O
vaccines	O
induce	O
humoral	O
and	O
cellular	B-ANAT
immune	O
responses	O
in	O
animal	O
models	O
and	O
humans	O
.	O

The	O
cellular	B-ANAT
and	O
humoral	O
immune	O
responses	O
were	O
assessed	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assays	O
,	O
lymphocyte	B-ANAT
proliferation	O
assays	O
,	O
enzyme	O
-	O
linked	O
immunospot	O
assays	O
,	O
and	O
fluorescence	O
-	O
activated	O
cell	B-ANAT
sorter	O
analyses	O
.	O

Our	O
findings	O
show	O
that	O
the	O
spike	O
DNA	O
vaccine	O
has	O
good	O
immunogenicity	O
and	O
can	O
induce	O
specific	O
humoral	O
and	O
cellular	B-ANAT
immunities	O
in	O
BALB	O
/	O
c	O
mice	O
,	O
while	O
IL	O
-	O
2	O
plays	O
an	O
immunoadjuvant	O
role	O
and	O
enhances	O
the	O
humoral	O
and	O
cellular	B-ANAT
immune	O
responses	O
.	O

We	O
hypothesized	O
that	O
recombinant	O
factor	O
VIIa	O
(	O
rFVIIa	O
)	O
administered	O
to	O
massive	O
transfusion	O
patients	O
before	O
transfusion	O
of	O
8	O
units	O
of	O
blood	B-ANAT
(	O
early	O
)	O
would	O
reduce	O
transfusion	O
requirements	O
compared	O
with	O
rFVIIa	O
after	O
8	O
units	O
(	O
late	O
).	O

Complete	O
records	O
for	O
blood	B-ANAT
transfusions	O
were	O
available	O
for	O
61	O
patients	O
:	O
90	O
%	O
had	O
penetrating	O
trauma	O
,	O
17	O
received	O
rFVIIa	O
early	O
,	O
and	O
44	O
received	O
it	O
late	O
.	O

To	O
facilitate	O
the	O
studies	O
on	O
the	O
function	O
and	O
antigenicity	O
of	O
the	O
SARS	O
-	O
CoV	O
N	O
protein	O
,	O
6x	O
histidine	O
-	O
tagged	O
recombinant	O
SARS	O
-	O
CoV	O
N	O
(	O
rSARS	O
-	O
N	O
)	O
with	O
a	O
molecular	O
mass	O
of	O
46	O
and	O
48kDa	O
was	O
successfully	O
produced	O
using	O
the	O
recombinant	O
baculovirus	O
system	O
in	O
insect	O
cells	B-ANAT
.	O

A	O
fully	O
matured	O
S	O
glycoprotein	O
will	O
be	O
modified	O
with	O
complex	O
oligosaccharides	O
which	O
makes	O
it	O
resistant	O
to	O
cleavage	O
by	O
EndoH	O
but	O
not	O
by	O
N	O
-	O
Gly	O
F	O
.	O
By	O
exploiting	O
this	O
characteristic	O
,	O
it	O
is	O
then	O
possible	O
to	O
determine	O
which	O
forms	O
of	O
the	O
immunoprecipitated	O
S	O
protein	O
are	O
properly	O
processed	O
by	O
the	O
host	B-ANAT
cell	I-ANAT
.	O

The	O
highly	O
immunogenic	O
D2	O
peptide	O
contains	O
both	O
neutralizing	O
and	O
Th	B-ANAT
cell	I-ANAT
epitopes	O
.	O

Two	O
clinical	O
cases	O
of	O
a	O
severe	O
obstructive	O
pneumonia	O
,	O
which	O
were	O
associated	O
with	O
the	O
presence	O
of	O
RNA	O
of	O
a	O
novel	O
variant	O
(	O
subtype	O
)	O
of	O
HKU1	O
coronavirus	O
in	O
the	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
,	O
were	O
identified	O
.	O

RESULTS	O
:	O
Two	O
clinical	O
cases	O
of	O
a	O
severe	O
obstructive	O
pneumonia	O
,	O
which	O
were	O
associated	O
with	O
the	O
presence	O
of	O
RNA	O
of	O
a	O
novel	O
variant	O
(	O
subtype	O
)	O
of	O
HKU1	O
coronavirus	O
in	O
the	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
,	O
were	O
identified	O
.	O

TITLE	O
:	O
Simultaneous	O
detection	O
and	O
high	O
-	O
throughput	O
identification	O
of	O
a	O
panel	O
of	O
RNA	O
viruses	O
causing	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
.	O

The	O
two	O
systems	O
can	O
process	O
80	O
(	O
NGEN	O
)	O
and	O
96	O
(	O
ResPlex	O
II	O
)	O
tests	O
per	O
run	O
,	O
with	O
a	O
hands	B-ANAT
-	O
on	O
time	O
of	O
approximately	O
60	O
min	O
and	O
test	O
turnaround	O
times	O
of	O
6	O
h	O
(	O
ResPlex	O
II	O
)	O
and	O
9	O
h	O
(	O
NGEN	O
).	O

Spike	O
-	O
pseudotyped	O
HIV	O
vector	O
was	O
generated	O
and	O
evaluated	O
in	O
vitro	O
on	O
well	O
-	O
differentiated	O
human	O
airway	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
and	O
bronchial	B-ANAT
explants	O
and	O
in	O
vivo	O
in	O
murine	O
airways	O
.	O

In	O
addition	O
,	O
this	O
study	O
shows	O
that	O
spike	O
-	O
pseudotyped	O
HIV	O
-	O
based	O
vector	O
can	O
efficiently	O
transduce	O
human	O
dendritic	B-ANAT
cells	I-ANAT
and	O
epithelial	B-ANAT
cells	I-ANAT
of	O
the	O
esophagus	B-ANAT
,	O
which	O
may	O
have	O
implications	O
in	O
investigating	O
mechanisms	O
of	O
SARS	O
-	O
CoV	O
pathogenesis	O
.	O

Pretreatment	O
with	O
rupatadine	O
has	O
a	O
beneficial	O
effect	O
on	O
acute	O
lung	B-ANAT
injury	O
induced	O
by	O
oleic	O
acid	O
in	O
rabbits	O
.	O

Ventilated	O
and	O
blood	B-ANAT
-	O
free	O
-	O
perfused	O
lungs	B-ANAT
of	O
wild	O
-	O
type	O
and	O
PAF	O
receptor	O
-	O
deficient	O
mice	O
were	O
challenged	O
with	O
recombinant	O
PLY	O
.	O

The	O
first	O
ORF	O
(	O
1a	O
and	O
1b	O
)	O
encodes	O
a	O
large	O
polyprotein	O
that	O
is	O
cleaved	B-ANAT
into	O
nonstructural	O
proteins	O
(	O
nsp	O
).	O

TITLE	O
:	O
Spontaneous	O
exocrine	B-ANAT
pancreas	I-ANAT
hypoplasia	O
in	O
specific	O
pathogen	O
-	O
free	O
C3HeB	O
/	O
FeJ	O
and	O
101	O
/	O
H	O
mouse	O
pups	O
causes	O
steatorrhea	O
and	O
runting	O
.	O

Endocrine	B-ANAT
pancreas	I-ANAT
islets	O
were	O
unremarkable	O
and	O
contained	O
insulin	O
-	O
positive	O
beta	O
cells	B-ANAT
and	O
glucagon	O
-	O
positive	O
alpha	O
cells	B-ANAT
.	O

We	O
report	O
here	O
the	O
first	O
successful	O
expression	O
and	O
purification	O
of	O
an	O
arterivirus	O
RdRp	O
that	O
is	O
catalytically	O
active	O
in	O
the	O
absence	O
of	O
other	O
viral	O
or	O
cellular	B-ANAT
proteins	O
.	O

Data	O
from	O
experimental	O
models	O
of	O
sepsis	O
,	O
ALI	O
,	O
and	O
ARDS	O
indicate	O
that	O
some	O
of	O
these	O
agents	O
improve	O
lung	B-ANAT
function	O
and	O
oxygenation	O
.	O

In	O
16	O
patients	O
,	O
a	O
veno	O
-	O
venous	B-ANAT
bypass	O
was	O
constructed	O
;	O
in	O
7	O
patients	O
,	O
the	O
initial	O
bypass	O
was	O
venoarterial	O
.	O

RESULTS	O
:	O
13	O
patients	O
were	O
considered	O
immunocompetent	O
and	O
10	O
were	O
immunocompromised	O
when	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
was	O
started	O
.	O

TITLE	O
:	O
Pulmonary	B-ANAT
-	O
renal	B-ANAT
syndromes	O
.	O

Serologic	O
testing	O
is	O
important	O
in	O
the	O
diagnostic	O
work	O
-	O
up	O
of	O
patients	O
presenting	O
with	O
a	O
pulmonary	B-ANAT
-	O
renal	B-ANAT
syndrome	O
.	O

TITLE	O
:	O
Isolation	O
and	O
identification	O
of	O
an	O
scFv	O
antibody	O
against	O
nucleocapsid	B-ANAT
protein	O
of	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
To	O
develop	O
reagents	O
for	O
early	O
diagnosis	O
and	O
therapeutic	O
drugs	O
against	O
SARS	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
),	O
a	O
large	O
(	O
3	O
x	O
10	O
(	O
9	O
))	O
immunized	O
human	O
antibody	O
library	O
was	O
constructed	O
from	O
peripheral	B-ANAT
blood	I-ANAT
mononuclear	I-ANAT
cells	I-ANAT
from	O
six	O
SARS	O
convalescent	O
patients	O
.	O

TITLE	O
:	O
Pulmonary	B-ANAT
stromal	O
-	O
derived	O
factor	O
-	O
1	O
expression	O
and	O
effect	O
on	O
neutrophil	B-ANAT
recruitment	O
during	O
acute	O
lung	B-ANAT
injury	O
.	O

TITLE	O
:	O
Human	O
papillomavirus	O
prevalence	O
and	O
type	O
distribution	O
in	O
male	O
anogenital	O
sites	O
and	O
semen	B-ANAT
.	O

Eligible	O
men	O
acknowledged	O
no	O
history	O
of	O
genital	B-ANAT
warts	O
and	O
had	O
sexual	O
intercourse	O
with	O
a	O
woman	O
within	O
the	O
past	O
year	O
.	O

Ninety	O
-	O
nine	O
diarrheic	O
and	O
114	O
normal	O
fecal	B-ANAT
samples	O
from	O
calves	O
in	O
Hokkaido	O
Prefecture	O
and	O
38	O
diarrheic	O
fecal	B-ANAT
samples	O
from	O
calves	O
in	O
10	O
other	O
prefectures	O
were	O
examined	O
by	O
reverse	O
transcription	O
(	O
RT	O
)-	O
PCR	O
with	O
primers	O
designed	O
in	O
the	O
spike	O
(	O
S	O
)	O
gene	O
for	O
the	O
presence	O
of	O
BoTV	O
.	O

The	O
factors	O
associated	O
with	O
the	O
presence	O
of	O
coagulopathy	O
were	O
the	O
following	O
:	O
severity	O
of	O
the	O
traumatic	O
brain	B-ANAT
injury	O
(	O
OR	O
=	O
2	O
.	O
83	O
;	O
95	O
%	O
CI	O
1	O
.	O
58	O
-	O
5	O
.	O
07	O
),	O
diagnosis	O
of	O
brain	B-ANAT
swelling	O
on	O
cranial	B-ANAT
computed	O
tomography	O
(	O
OR	O
=	O
2	O
.	O
11	O
;	O
95	O
%	O
CI	O
1	O
.	O
13	O
-	O
4	O
.	O
07	O
)	O
and	O
occurrence	O
of	O
chest	B-ANAT
and	O
/	O
or	O
abdominal	B-ANAT
injury	O
(	O
OR	O
=	O
2	O
.	O
07	O
;	O
95	O
%	O
CI	O
1	O
.	O
11	O
-	O
4	O
.	O
00	O
).	O

CONCLUSIONS	O
:	O
The	O
development	O
of	O
coagulopathy	O
is	O
a	O
frequent	O
complication	O
in	O
patients	O
with	O
moderate	O
to	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
Adrenomedullin	O
(	O
AM	O
),	O
an	O
endogenous	O
peptide	O
,	O
has	O
been	O
shown	O
to	O
have	O
a	O
variety	O
of	O
protective	O
effects	O
on	O
the	O
cardiovascular	B-ANAT
system	I-ANAT
.	O

LPS	O
instillation	O
caused	O
severe	O
acute	O
lung	B-ANAT
injury	O
,	O
as	O
indicated	O
by	O
the	O
histological	O
findings	O
and	O
the	O
lung	B-ANAT
wet	O
/	O
dry	O
weight	O
ratio	O
.	O

AM	O
decreased	O
the	O
numbers	O
of	O
total	O
cells	B-ANAT
and	O
neutrophils	B-ANAT
and	O
the	O
levels	O
of	O
TNF	O
-	O
alpha	O
and	O
CINC	O
in	O
BALF	O
.	O

Accumulating	O
evidence	O
has	O
demonstrated	O
a	O
physiological	O
and	O
pathological	O
role	O
of	O
ACE2	O
in	O
the	O
cardiovascular	B-ANAT
systems	I-ANAT
.	O

TITLE	O
:	O
Pathophysiological	O
mechanism	O
of	O
lung	B-ANAT
injury	O
in	O
patients	O
with	O
leptospirosis	O
.	O

Pathological	O
examinations	O
revealed	O
alveolar	B-ANAT
haemorrhage	O
and	O
necrotic	O
lesions	O
in	O
various	O
organs	B-ANAT
.	O

These	O
changes	O
suggest	O
that	O
leptospirosis	O
causes	O
severe	O
hypotension	O
and	O
bradycardia	O
accompanied	O
by	O
autonomic	B-ANAT
dysfunction	O
.	O

If	O
this	O
fails	O
,	O
intermittent	O
oral	B-ANAT
leukotriene	O
receptor	O
antagonists	O
or	O
short	O
courses	O
of	O
very	O
high	O
dose	O
inhaled	O
corticosteroids	O
could	O
be	O
considered	O
.	O

Patients	O
admitted	O
to	O
our	O
burn	O
unit	O
between	O
2002	O
and	O
2005	O
with	O
burns	O
affecting	O
40	O
%	O
or	O
more	O
of	O
the	O
total	B-ANAT
body	I-ANAT
surface	I-ANAT
area	O
without	O
severe	O
inhalation	O
injury	O
were	O
analyzed	O
.	O

Hemodynamic	O
parameters	O
,	O
blood	B-ANAT
gas	O
analysis	O
,	O
and	O
intrabladder	O
pressure	O
as	O
intra	O
-	O
abdominal	B-ANAT
pressure	O
were	O
recorded	O
.	O

Serum	B-ANAT
interleukin	O
(	O
IL	O
)-	O
8	O
and	O
IL	O
-	O
6	O
concentrations	O
were	O
measured	O
in	O
20	O
of	O
these	O
patients	O
.	O

RESULTS	O
:	O
Fourteen	O
of	O
38	O
patients	O
developed	O
intra	O
-	O
abdominal	B-ANAT
hypertension	O
in	O
22	O
.	O
9	O
+/-	O

In	O
this	O
study	O
,	O
colostrum	B-ANAT
-	O
deprived	O
calves	O
were	O
experimentally	O
infected	O
with	O
a	O
Korean	O
WD	O
-	O
BCoV	O
strain	O
and	O
examined	O
for	O
viremia	O
,	O
enteric	O
and	O
nasal	B-ANAT
virus	O
shedding	O
as	O
well	O
as	O
for	O
viral	O
antigen	O
expression	O
and	O
virus	O
-	O
associated	O
lesions	O
in	O
the	O
small	O
and	O
large	O
intestines	B-ANAT
and	O
the	O
upper	O
and	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
from	O
1	O
to	O
8	O
days	O
after	O
an	O
oral	B-ANAT
infection	O
.	O

TITLE	O
:	O
[	O
Expression	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
receptors	O
,	O
ACE2	O
and	O
CD209L	O
in	O
different	O
organ	B-ANAT
derived	O
microvascular	O
endothelial	B-ANAT
cells	I-ANAT
].	O

Both	O
SARS	O
-	O
CoV	O
receptors	O
of	O
ACE2	O
and	O
CD209L	O
were	O
expressed	O
in	O
the	O
8	O
organ	B-ANAT
/	O
tissue	B-ANAT
-	O
derived	O
endothelial	B-ANAT
cells	I-ANAT
.	O

CONCLUSIONS	O
:	O
The	O
organ	B-ANAT
derived	O
microvascular	O
endothelial	B-ANAT
cells	I-ANAT
are	O
the	O
important	O
target	O
of	O
SARS	O
-	O
CoV	O
.	O
The	O
pathological	O
injury	O
of	O
lung	B-ANAT
and	O
lymph	B-ANAT
system	O
induced	O
by	O
SARS	O
-	O
CoV	O
may	O
be	O
mediated	O
respectively	O
by	O
different	O
receptors	O
of	O
SARS	O
-	O
CoV	O
.	O

It	O
is	O
proposed	O
that	O
the	O
syndrome	O
may	O
be	O
caused	O
by	O
either	O
a	O
direct	O
mitochondrial	B-ANAT
respiratory	I-ANAT
chain	I-ANAT
inhibition	O
or	O
impaired	O
mitochondrial	B-ANAT
fatty	O
acid	O
metabolism	O
mediated	O
by	O
propofol	O
.	O

An	O
early	O
sign	O
of	O
cardiac	B-ANAT
instability	O
associated	O
with	O
the	O
syndrome	O
is	O
the	O
development	O
of	O
right	B-ANAT
bundle	I-ANAT
branch	I-ANAT
block	O
with	O
convex	O
-	O
curved	O
('	O
coved	O
type	O
')	O
ST	O
elevation	O
in	O
the	O
right	O
praecordial	O
leads	O
(	O
V1	O
to	O
V3	O
)	O
of	O
the	O
electrocardiogram	O
.	O

In	O
a	O
serological	O
survey	O
of	O
serum	B-ANAT
samples	O
from	O
355	O
calves	O
at	O
33	O
farms	O
,	O
92	O
%	O
of	O
calves	O
were	O
positive	O
for	O
neutralizing	O
antibodies	O
to	O
the	O
isolate	O
.	O

We	O
investigated	O
the	O
role	O
of	O
extracranial	O
predisposing	O
factors	O
,	O
including	O
hemodynamic	O
and	O
ventilatory	O
management	O
,	O
as	O
independent	O
predictors	O
of	O
acute	O
lung	B-ANAT
injury	O
in	O
brain	B-ANAT
-	O
injured	O
patients	O
.	O

Eighty	O
-	O
six	O
severely	O
brain	B-ANAT
-	O
injured	O
patients	O
enrolled	O
in	O
13	O
months	O
.	O

In	O
addition	O
to	O
a	O
lower	O
Pao2	O
/	O
Fio2	O
(	O
odds	O
ratio	O
0	O
.	O
98	O
,	O
95	O
%	O
confidence	O
interval	O
0	O
.	O
98	O
-	O
0	O
.	O
99	O
),	O
the	O
use	O
of	O
high	O
tidal	O
volume	O
(	O
odds	O
ratio	O
5	O
.	O
4	O
,	O
95	O
%	O
confidence	O
interval	O
1	O
.	O
54	O
-	O
19	O
.	O
24	O
)	O
and	O
relatively	O
high	O
respiratory	O
rate	O
(	O
odds	O
ratio	O
1	O
.	O
8	O
,	O
95	O
%	O
confidence	O
interval	O
1	O
.	O
13	O
-	O
2	O
.	O
86	O
)	O
were	O
independent	O
predictors	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
p	O
<	O
.	O
01	O
).	O

In	O
this	O
patient	O
population	O
,	O
alternative	O
ventilator	O
strategies	O
should	O
be	O
considered	O
to	O
protect	O
the	O
lung	B-ANAT
and	O
guarantee	O
a	O
tight	O
CO2	O
control	O
.	O

TITLE	O
:	O
Effects	O
of	O
epidermal	B-ANAT
growth	O
factor	O
on	O
atrophic	O
enteritis	O
in	O
piglets	O
induced	O
by	O
experimental	O
porcine	O
epidemic	O
diarrhoea	O
virus	O
.	O

ABSTRACT	O
:	O
Epidermal	B-ANAT
growth	O
factor	O
(	O
EGF	O
)	O
promotes	O
gastrointestinal	O
mucosal	B-ANAT
recovery	O
by	O
stimulating	O
the	O
mitogenic	O
activity	O
of	O
intestinal	B-ANAT
crypt	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

TITLE	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
due	O
to	O
chronic	O
necrotizing	O
pulmonary	B-ANAT
aspergillosis	O
.	O

ABSTRACT	O
:	O
A	O
focus	O
formation	O
assay	O
(	O
FFA	O
)	O
for	O
detection	O
and	O
titration	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
in	O
a	O
micro	O
-	O
culture	O
system	O
using	O
Vero	B-ANAT
cells	I-ANAT
and	O
PAP	O
staining	O
technique	O
was	O
evaluated	O
.	O

Adrenal	O
insufficiency	O
,	O
as	O
defined	O
in	O
the	O
sepsis	O
/	O
shock	O
literature	O
,	O
is	O
a	O
plasma	B-ANAT
cortisol	O
rise	O
of	O
at	O
least	O
9	O
microg	O
dl	O
(-	O
1	O
)	O
following	O
a	O
250	O
microg	O
dose	O
of	O
adrenocorticotropin	O
hormone	O
(	O
ACTH	O
),	O
or	O
reaching	O
a	O
plasma	B-ANAT
cortisol	O
concentration	O
of	O
>	O
25	O
microg	O
dl	O
(-	O
1	O
)	O
following	O
a	O
1	O
-	O
2	O
microg	O
dose	O
of	O
ACTH	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
generated	O
anti	O
-	O
KC	O
(	O
KC	O
=	O
chemokine	O
(	O
CXC	O
motif	O
)	O
ligand	O
1	O
(	O
CXCL1	O
))	O
autoantibody	O
:	O
KC	O
immune	O
complexes	O
(	O
KC	O
-	O
functional	O
IL	O
-	O
8	O
)	O
in	O
lungs	B-ANAT
of	O
mice	O
to	O
develop	O
a	O
mouse	O
model	O
of	O
autoimmune	O
complex	O
-	O
induced	O
lung	B-ANAT
inflammation	O
.	O

Blood	B-ANAT
samples	I-ANAT
were	O
obtained	O
for	O
the	O
determination	O
of	O
amylase	O
,	O
lipase	O
,	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)-	O
alpha	O
,	O
interleukin	O
(	O
IL	O
)-	O
1beta	O
,	O
macrophage	B-ANAT
inflammatory	O
peptide	O
(	O
MIP	O
)-	O
2	O
and	O
soluble	O
intercellular	O
adhesion	O
molecule	O
(	O
sICAM	O
)-	O
1	O
levels	O
,	O
while	O
pancreatic	B-ANAT
and	O
lung	B-ANAT
tissues	I-ANAT
were	O
removed	O
for	O
myeloperoxidase	O
(	O
MPO	O
)	O
activity	O
,	O
nitric	O
oxide	O
(	O
NOx	O
)	O
level	O
,	O
CD40	O
expression	O
and	O
histological	O
evaluation	O
.	O

RESULTS	O
:	O
Cerulein	O
injection	O
caused	O
severe	O
AP	O
,	O
confirmed	O
by	O
an	O
increase	O
in	O
serum	B-ANAT
amylase	O
and	O
lipase	O
levels	O
,	O
histopathological	O
findings	O
of	O
severe	O
AP	O
,	O
and	O
pancreatic	B-ANAT
MPO	O
activity	O
,	O
compared	O
to	O
the	O
values	O
obtained	O
in	O
the	O
sham	O
group	O
.	O

The	O
plasmid	O
,	O
pEGFP	O
-	O
M	O
,	O
encoding	O
SCoV	O
M	O
protein	O
as	O
a	O
fusion	O
protein	O
with	O
EGFP	O
,	O
was	O
used	O
for	O
silencing	O
and	O
for	O
reporter	O
gene	O
detection	O
in	O
HEK	O
293T	O
cells	B-ANAT
transfected	O
with	O
siRNA	O
constructs	O
.	O

At	O
1	O
year	O
after	O
hospital	O
discharge	B-ANAT
,	O
pulmonary	B-ANAT
function	O
measures	O
were	O
in	O
the	O
normal	O
range	O
,	O
but	O
18	O
%	O
of	O
patients	O
had	O
a	O
significant	O
reduction	O
in	O
distance	O
walked	O
in	O
6	O
minutes	O
.	O

Using	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
as	O
a	O
model	O
,	O
we	O
demonstrate	O
that	O
SARS	O
-	O
COV	O
ORF6	O
protein	O
is	O
localized	O
to	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
)/	O
Golgi	B-ANAT
membrane	I-ANAT
in	O
infected	O
cells	B-ANAT
,	O
where	O
it	O
binds	O
to	O
and	O
disrupts	O
nuclear	O
import	O
complex	O
formation	O
by	O
tethering	O
karyopherin	O
alpha	O
2	O
and	O
karyopherin	O
beta	O
1	O
to	O
the	O
membrane	B-ANAT
.	O

Moreover	O
,	O
this	O
recombinant	O
live	O
vaccine	O
induced	O
significantly	O
high	O
levels	O
of	O
specific	O
cytotoxic	B-ANAT
T	I-ANAT
-	I-ANAT
lymphocyte	I-ANAT
activities	O
and	O
increased	O
gamma	O
interferon	O
-	O
producing	O
T	B-ANAT
cells	I-ANAT
compared	O
with	O
the	O
parental	O
strain	O
.	O

Confocal	O
microscopy	O
and	O
several	O
mitochondria	B-ANAT
-	O
related	O
tests	O
were	O
used	O
to	O
study	O
the	O
function	O
of	O
ORF8a	O
.	O

ORF8a	O
was	O
found	O
to	O
be	O
localized	O
in	O
mitochondria	B-ANAT
,	O
and	O
overexpression	O
resulted	O
in	O
increases	O
in	O
mitochondrial	B-ANAT
transmembrane	B-ANAT
potential	O
,	O
reactive	O
oxygen	O
species	O
production	O
,	O
caspase	O
3	O
activity	O
,	O
and	O
cellular	B-ANAT
apoptosis	O
.	O

Dysfunction	O
of	O
the	O
hypothalamic	B-ANAT
-	I-ANAT
pituitary	I-ANAT
-	I-ANAT
adrenal	I-ANAT
axis	I-ANAT
with	O
decreased	O
glucocorticoid	O
activity	O
is	O
being	O
increasingly	O
recognized	O
in	O
critically	O
ill	O
patients	O
,	O
particularly	O
those	O
with	O
sepsis	O
.	O

Here	O
,	O
we	O
present	O
three	O
crystal	B-ANAT
structures	O
of	O
SARS	O
3CL	O
(	O
pro	O
)	O
in	O
complex	O
with	O
each	O
of	O
two	O
members	O
of	O
a	O
new	O
class	O
of	O
peptide	O
-	O
based	O
phthalhydrazide	O
inhibitors	O
.	O

Transgenic	O
mice	O
expressing	O
green	O
fluorescent	O
protein	O
under	O
control	O
of	O
the	O
astrocyte	B-ANAT
-	O
specific	O
glial	B-ANAT
fibrillary	I-ANAT
acidic	I-ANAT
protein	I-ANAT
promoter	O
were	O
infected	O
with	O
a	O
neurotropic	O
coronavirus	O
to	O
facilitate	O
phenotypic	O
characterization	O
of	O
astrocytes	B-ANAT
and	O
microglia	B-ANAT
using	O
flow	O
cytometry	O
.	O

Class	O
II	O
was	O
barely	O
detectable	O
on	O
astrocytes	B-ANAT
,	O
in	O
contrast	O
to	O
potent	O
up	O
-	O
regulation	O
on	O
microglia	B-ANAT
.	O

These	O
data	O
demonstrate	O
distinct	O
regulation	O
of	O
both	O
class	O
I	O
and	O
class	O
II	O
expression	O
by	O
microglia	B-ANAT
and	O
astrocytes	B-ANAT
in	O
vivo	O
following	O
viral	O
induced	O
inflammation	O
.	O

Furthermore	O
,	O
prolonged	O
MHC	B-ANAT
expression	O
subsequent	O
to	O
viral	O
clearance	O
implies	O
a	O
potential	O
for	O
ongoing	O
presentation	O
.	O

In	O
addition	O
,	O
a	O
blood	B-ANAT
sample	I-ANAT
was	O
taken	O
from	O
each	O
calf	B-ANAT
upon	O
enrollment	O
in	O
the	O
study	O
,	O
for	O
assessment	O
of	O
maternal	O
antibody	O
transfer	O
and	O
for	O
polymerase	O
chain	O
reaction	O
testing	O
for	O
persistent	O
bovine	O
viral	O
diarrhea	O
virus	O
infection	O
.	O

Significant	O
predictors	O
of	O
the	O
calf	B-ANAT
-	O
level	O
risk	O
of	O
C	O
.	O
parvum	O
shedding	O
included	O
the	O
use	O
of	O
calf	B-ANAT
diarrhea	O
prophylaxis	O
in	O
pregnant	O
cows	O
,	O
and	O
the	O
type	O
of	O
maternity	O
facilities	O
in	O
which	O
the	O
calves	O
were	O
born	O
.	O

These	O
data	O
provide	O
the	O
foundation	O
for	O
a	O
rational	O
small	O
-	O
molecule	O
inhibitor	O
design	O
effort	O
based	O
upon	O
the	O
inhibitor	O
scaffold	O
identified	O
,	O
the	O
crystal	B-ANAT
structure	O
of	O
the	O
complex	O
,	O
and	O
a	O
more	O
complete	O
understanding	O
of	O
P1	O
-	O
P4	O
substrate	O
specificity	O
.	O

TITLE	O
:	O
Quantitative	O
temporal	O
-	O
spatial	O
distribution	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
in	O
post	O
-	O
mortem	O
tissues	B-ANAT
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
quantitative	O
temporal	O
-	O
spatial	O
distribution	O
of	O
SARS	O
-	O
CoV	O
in	O
the	O
post	O
-	O
mortem	O
tissue	B-ANAT
samples	O
of	O
seven	O
patients	O
.	O

Quantitation	O
of	O
a	O
house	O
-	O
keeping	O
gene	O
,	O
glyceraldehyde	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
(	O
GAPDH	O
)	O
was	O
undertaken	O
to	O
standardize	O
the	O
amount	O
of	O
tissue	B-ANAT
tested	O
.	O

TITLE	O
:	O
Emerging	O
occupational	O
lung	B-ANAT
infections	O
.	O

TITLE	O
:	O
Heat	O
shock	O
protein	O
90	O
inhibitors	O
prolong	O
survival	O
,	O
attenuate	O
inflammation	O
,	O
and	O
reduce	O
lung	B-ANAT
injury	O
in	O
murine	O
sepsis	O
.	O

Mice	O
pretreated	O
with	O
vehicle	O
and	O
receiving	O
endotoxin	O
exhibited	O
100	O
%	O
24	O
-	O
hour	O
lethality	O
,	O
a	O
dramatic	O
increase	O
in	O
all	O
parameters	O
of	O
systemic	O
and	O
pulmonary	B-ANAT
inflammation	O
,	O
increased	O
capillary	B-ANAT
leak	O
,	O
and	O
reduced	O
lung	B-ANAT
function	O
.	O

Expression	O
of	O
virally	O
encoded	O
CXCL10	O
within	O
the	O
brain	B-ANAT
protected	O
mice	O
from	O
death	O
and	O
correlated	O
with	O
increased	O
infiltration	O
of	O
T	B-ANAT
lymphocytes	I-ANAT
,	O
enhanced	O
IFN	O
-	O
gamma	O
secretion	B-ANAT
,	O
and	O
accelerated	O
viral	O
clearance	O
when	O
compared	O
with	O
mice	O
infected	O
with	O
an	O
isogenic	O
control	O
virus	O
,	O
MHV	O
.	O

These	O
studies	O
highlight	O
that	O
CXCL10	O
expression	O
promotes	O
protection	O
from	O
coronavirus	O
-	O
induced	O
neurological	O
and	O
liver	B-ANAT
disease	O
.	O

The	O
main	O
sites	O
of	O
primary	O
tumor	O
were	O
oral	B-ANAT
cavity	I-ANAT
(	O
30	O
%),	O
larynx	B-ANAT
(	O
25	O
%),	O
pharynx	B-ANAT
(	O
14	O
%)	O
and	O
thyroid	B-ANAT
(	O
9	O
%).	O

TITLE	O
:	O
Peripheral	O
infusion	O
of	O
rat	B-ANAT
bone	I-ANAT
marrow	I-ANAT
derived	O
endothelial	B-ANAT
progenitor	B-ANAT
cells	I-ANAT
leads	O
to	O
homing	O
in	O
acute	O
lung	B-ANAT
injury	O
.	O

Besides	O
mature	O
endothelial	B-ANAT
cells	I-ANAT
(	O
EC	O
)	O
that	O
compose	O
the	O
adult	O
vasculature	B-ANAT
,	O
endothelial	B-ANAT
progenitor	B-ANAT
cells	I-ANAT
(	O
EPC	O
)	O
are	O
supposed	O
to	O
be	O
released	O
from	O
the	O
bone	B-ANAT
marrow	I-ANAT
into	O
the	O
peripheral	B-ANAT
blood	I-ANAT
after	O
stimulation	O
by	O
distinct	O
inflammatory	O
injuries	O
.	O

EPC	O
were	O
tested	O
further	O
for	O
their	O
involvement	O
in	O
vasculogenesis	O
processes	O
occurring	O
in	O
subcutaneously	O
applied	O
Matrigel	O
in	O
transplanted	B-ANAT
animals	O
.	O

EPC	O
were	O
localized	O
in	O
vessel	B-ANAT
walls	O
as	O
well	O
as	O
in	O
destructed	O
lung	B-ANAT
tissue	I-ANAT
.	O

RESULTS	O
:	O
We	O
demonstrate	O
the	O
integration	O
of	O
intravenously	O
injected	O
EPC	O
into	O
the	O
tissue	B-ANAT
of	O
the	O
transplanted	B-ANAT
left	B-ANAT
lung	I-ANAT
suffering	O
from	O
acute	O
lung	B-ANAT
injury	O
.	O

However	O
,	O
few	O
EPC	O
were	O
found	O
in	O
subcutaneous	O
Matrigel	O
in	O
transplanted	B-ANAT
rats	O
.	O

Trypsin	O
was	O
not	O
the	O
determinant	O
for	O
the	O
viral	O
replication	O
,	O
suggesting	O
that	O
the	O
restriction	O
of	O
IBV	O
replication	O
in	O
HeLa	B-ANAT
cells	I-ANAT
is	O
the	O
result	O
of	O
intracellular	B-ANAT
events	O
rather	O
than	O
the	O
binding	O
to	O
or	O
fusion	O
with	O
host	O
cells	B-ANAT
.	O

These	O
results	O
indicated	O
that	O
the	O
virus	O
adaptation	O
would	O
probably	O
be	O
determined	O
by	O
host	B-ANAT
cell	I-ANAT
modification	O
such	O
as	O
receptor	O
glycosylation	O
and	O
different	O
receptor	O
utilization	O
instead	O
of	O
viral	O
gene	O
mutation	O
.	O

ABSTRACT	O
:	O
The	O
inflammatory	O
response	O
after	O
severe	O
blunt	O
chest	B-ANAT
trauma	O
often	O
leads	O
to	O
acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
which	O
are	O
associated	O
with	O
high	O
mortality	O
rates	O
.	O

The	O
following	O
time	O
-	O
points	O
were	O
investigated	O
posttrauma	O
:	O
sham	O
,	O
1	O
,	O
6	O
,	O
12	O
,	O
and	O
24	O
h	O
.	O
There	O
was	O
a	O
time	O
-	O
dependent	O
systemic	O
activation	O
of	O
complement	O
as	O
determined	O
by	O
CH	O
-	O
50	O
and	O
presence	O
of	O
C5a	O
-	O
dependent	O
chemotactic	O
plasma	B-ANAT
activity	O
.	O

ABSTRACT	O
:	O
Infection	O
by	O
the	O
coronavirus	O
mouse	O
hepatitis	O
virus	O
strain	O
A59	O
(	O
MHV	O
-	O
A59	O
)	O
requires	O
the	O
release	O
of	O
the	O
viral	B-ANAT
genome	I-ANAT
by	O
fusion	O
with	O
the	O
respective	O
target	O
membrane	B-ANAT
of	O
the	O
host	B-ANAT
cell	I-ANAT
.	O

No	O
fusion	O
with	O
the	O
plasma	B-ANAT
membrane	I-ANAT
was	O
observed	O
at	O
neutral	O
pH	O
conditions	O
.	O

Very	O
likely	O
,	O
these	O
alterations	O
are	O
irreversible	O
because	O
low	O
-	O
pH	O
treatment	O
of	O
viruses	O
in	O
the	O
absence	O
of	O
target	O
membranes	B-ANAT
caused	O
an	O
irreversible	O
loss	O
of	O
the	O
fusion	O
activity	O
.	O

GenBank	O
BLAST	B-ANAT
database	O
search	O
and	O
phylogenetic	O
analysis	O
of	O
the	O
hypervariable	O
region	O
of	O
the	O
S1	O
subunit	O
of	O
the	O
spike	O
gene	O
to	O
determine	O
the	O
most	O
closely	O
related	O
viruses	O
to	O
the	O
three	O
variants	O
showed	O
the	O
CA557	O
/	O
03	O
variant	O
to	O
be	O
81	O
.	O
8	O
%	O
similar	O
to	O
the	O
CAV	O
/	O
CA56b	O
/	O
91	O
whereas	O
the	O
CA706	O
/	O
03	O
and	O
CA1737	O
/	O
04	O
variant	O
viruses	O
were	O
only	O
distantly	O
related	O
to	O
Dutch	O
/	O
D1466	O
/	O
81	O
(	O
72	O
.	O
2	O
%),	O
a	O
vaccine	O
strain	O
used	O
in	O
Europe	O
,	O
and	O
Korea	O
/	O
K142	O
/	O
02	O
(	O
72	O
.	O
7	O
%),	O
a	O
Korean	O
field	O
isolate	O
,	O
respectively	O
.	O

Seventeen	O
out	O
of	O
fifty	O
-	O
four	O
(	O
31	O
.	O
48	O
%)	O
peafowl	O
serum	B-ANAT
samples	O
were	O
tested	O
positive	O
for	O
specific	O
antibodies	O
against	O
IBV	O
.	O

However	O
,	O
she	O
developed	O
respiratory	O
failure	O
again	O
after	O
resuming	O
infusion	O
of	O
the	O
graft	B-ANAT
.	O

ABSTRACT	O
:	O
Here	O
we	O
report	O
a	O
case	O
of	O
leptospirosis	O
without	O
fever	O
during	O
the	O
late	O
stage	O
of	O
pregnancy	O
in	O
which	O
the	O
initial	O
clinical	O
presentation	O
was	O
more	O
suggestive	O
of	O
a	O
pregnancy	O
-	O
related	O
liver	B-ANAT
dysfunction	O
rather	O
than	O
an	O
infectious	O
disease	O
.	O

Serum	B-ANAT
IFN	O
-	O
concentration	O
was	O
increased	O
significantly	O
but	O
the	O
concentrations	O
of	O
Il	O
-	O
2	O
,	O
IL	O
-	O
4	O
and	O
IL	O
-	O
10	O
had	O
no	O
significant	O
change	O
.	O

ABSTRACT	O
:	O
Epitopes	O
often	O
require	O
co	O
-	O
delivery	O
with	O
adjuvant	O
and	O
targeting	O
proteins	O
to	O
enable	O
recognition	O
by	O
the	O
immune	B-ANAT
system	I-ANAT
,	O
and	O
this	O
approach	O
may	O
also	O
increase	O
the	O
efficacy	O
of	O
the	O
antigen	O
.	O

ABSTRACT	O
:	O
Acute	O
tracheobronchitis	O
is	O
a	O
rare	O
clinical	O
manifestation	O
of	O
respiratory	B-ANAT
tract	I-ANAT
invasive	O
aspergillosis	O
,	O
sporadically	O
reported	O
in	O
patients	O
with	O
hematological	O
malignancies	O
against	O
the	O
background	O
of	O
conventional	O
chemotherapy	O
.	O

The	O
clinical	O
evolution	O
is	O
gradual	O
:	O
from	O
mild	O
non	O
-	O
specific	O
manifestations	O
of	O
acute	O
tracheobronchitis	O
against	O
the	O
background	O
of	O
a	O
prolonged	O
fever	O
unaffected	O
by	O
antibiotic	O
therapy	O
to	O
the	O
onset	O
of	O
severe	O
acute	O
respiratory	O
insufficiency	O
and	O
unilateral	O
bronchial	B-ANAT
obstruction	O
syndrome	O
.	O

Moreover	O
,	O
productive	O
HCoV	O
-	O
229E	O
infection	O
of	O
primary	O
monocytes	B-ANAT
and	O
of	O
the	O
THP	O
-	O
1	O
monocytic	B-ANAT
cell	B-ANAT
line	I-ANAT
led	O
to	O
their	O
activation	O
,	O
as	O
indicated	O
by	O
the	O
production	O
of	O
pro	O
-	O
inflammatory	O
mediators	O
,	O
including	O
TNF	O
-	O
alpha	O
,	O
CCL5	O
,	O
CXCL10	O
and	O
CXCL11	O
and	O
MMP	O
-	O
9	O
.	O

BCoV	O
strains	O
with	O
99	O
-	O
100	O
%	O
nucleotide	O
identity	O
in	O
the	O
S	O
gene	O
were	O
isolated	O
from	O
nasal	B-ANAT
,	O
ocular	B-ANAT
and	O
rectal	O
swabs	O
,	O
thus	O
proving	O
the	O
absence	O
of	O
separate	O
clusters	O
of	O
virus	O
on	O
the	O
basis	O
of	O
tissue	B-ANAT
tropism	O
.	O

Imaging	O
with	O
chest	B-ANAT
X	O
-	O
ray	O
with	O
/	O
without	O
a	O
CT	O
scan	O
picked	O
up	O
the	O
lesion	O
in	O
all	O
cases	O
.	O

TITLE	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
in	O
severe	O
acute	O
respiratory	O
failure	O
in	O
postpartum	O
woman	O
with	O
rheumatic	O
mitral	B-ANAT
valve	I-ANAT
disease	O
:	O
benefit	O
,	O
factors	O
furthering	O
the	O
success	O
of	O
this	O
procedure	O
,	O
and	O
review	O
of	O
the	O
literature	O
.	O

Indeed	O
,	O
ECMO	O
cardiopulmonary	B-ANAT
bypass	O
(	O
CPB	O
)	O
support	O
could	O
help	O
pulmonary	B-ANAT
recovery	O
if	O
the	O
mitral	O
pathology	O
is	O
involved	O
.	O

Transesophageal	O
echocardiography	O
showed	O
a	O
severe	O
mitral	O
stenosis	O
,	O
mild	O
mitral	O
insufficiency	O
,	O
and	O
diminished	O
left	O
ventricular	B-ANAT
function	O
,	O
hypokinetic	O
,	O
dilated	O
right	B-ANAT
ventricle	I-ANAT
,	O
and	O
a	O
severe	O
tricuspid	O
regurgitation	O
.	O

TITLE	O
:	O
Impaired	O
heart	B-ANAT
contractility	O
in	O
Apelin	O
gene	O
-	O
deficient	O
mice	O
associated	O
with	O
aging	O
and	O
pressure	O
overload	O
.	O

Importantly	O
,	O
in	O
pressure	O
overload	O
-	O
induced	O
heart	B-ANAT
failure	O
,	O
loss	O
of	O
Apelin	O
did	O
not	O
significantly	O
affect	O
the	O
hypertrophy	O
response	O
,	O
but	O
Apelin	O
mutant	O
mice	O
developed	O
progressive	O
heart	B-ANAT
failure	O
.	O

Global	O
gene	O
expression	O
arrays	O
and	O
hierarchical	O
clustering	O
of	O
differentially	O
expressed	O
genes	O
in	O
hearts	B-ANAT
of	O
banded	O
Apelin	O
(-/	O
y	O
)	O
and	O
Apelin	O
(+/	O
y	O
)	O
mice	O
showed	O
concerted	O
upregulation	O
of	O
genes	O
involved	O
in	O
extracellular	B-ANAT
matrix	I-ANAT
remodeling	O
and	O
muscle	B-ANAT
contraction	O
.	O

TITLE	O
:	O
High	O
incidence	O
of	O
acute	O
lung	B-ANAT
injury	O
in	O
children	O
with	O
Down	O
syndrome	O
.	O

The	O
severe	O
course	O
of	O
disease	O
in	O
CDS	O
may	O
be	O
related	O
to	O
a	O
higher	O
incidence	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
).	O

The	O
serum	B-ANAT
isoantibody	O
test	O
for	O
the	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
)	O
virus	O
was	O
1	O
:	O
3	O
,	O
200	O
.	O

These	O
cytokines	O
induce	O
fever	O
,	O
leucocytosis	O
and	O
release	O
of	O
serum	B-ANAT
acute	O
phase	O
proteins	O
(	O
APPs	O
).	O

In	O
cats	O
with	O
inflammatory	O
conditions	O
,	O
fever	O
is	O
a	O
common	O
finding	O
,	O
with	O
leucocytosis	O
due	O
to	O
the	O
release	O
of	O
cells	B-ANAT
from	O
the	O
marginal	O
pool	O
,	O
followed	O
by	O
activation	O
of	O
myelopoiesis	O
.	O

Recombinant	O
SARS	O
-	O
CoVs	O
bearing	O
deletions	O
in	O
gene	O
7	O
were	O
used	O
to	O
assess	O
the	O
contribution	O
of	O
gene	O
7	O
to	O
virus	O
replication	O
and	O
apoptosis	O
in	O
several	O
transformed	B-ANAT
cell	I-ANAT
lines	I-ANAT
,	O
as	O
well	O
as	O
to	O
replication	O
and	O
pathogenesis	O
in	O
golden	O
Syrian	O
hamsters	O
.	O

ABSTRACT	O
:	O
A	O
highly	O
neurovirulent	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
JHMV	O
strain	O
(	O
wt	O
)	O
with	O
receptor	O
(	O
MHVR	O
)-	O
independent	O
infection	O
activity	O
and	O
its	O
low	O
-	O
virulent	O
mutant	O
srr7	O
without	O
such	O
activity	O
were	O
found	O
to	O
attach	O
to	O
MHVR	O
-	O
negative	O
,	O
non	O
-	O
permissive	O
BHK	O
cells	B-ANAT
.	O

TITLE	O
:	O
Human	O
CD4	O
(+)	O
memory	O
T	B-ANAT
-	I-ANAT
lymphocyte	I-ANAT
responses	O
to	O
SARS	O
coronavirus	O
infection	O
.	O

In	O
both	O
patients	O
,	O
the	O
frequency	O
of	O
CD4	O
(+)	O
memory	O
T	B-ANAT
-	I-ANAT
cells	I-ANAT
to	O
virus	O
structural	O
proteins	O
and	O
anti	O
-	O
SARS	O
coronavirus	O
IgG	O
levels	O
were	O
low	O
by	O
12	O
months	O
after	O
infection	O
.	O

In	O
either	O
clinical	O
presentation	O
,	O
vascular	B-ANAT
permeability	O
is	O
a	O
major	O
component	O
of	O
the	O
pathologic	O
process	O
.	O

TITLE	O
:	O
Duodenal	B-ANAT
angiosarcoma	O
:	O
an	O
unusual	O
cause	O
of	O
severe	O
gastrointestinal	O
bleeding	O
.	O

Within	O
1	O
h	O
,	O
17	O
particles	O
were	O
bound	O
per	O
cell	B-ANAT
and	O
,	O
within	O
1	O
min	O
,	O
89	O
%	O
of	O
the	O
bound	O
particles	O
were	O
internalized	O
.	O

Age	O
,	O
gender	O
,	O
AKI	O
severity	O
,	O
APACHE	O
score	O
,	O
serum	B-ANAT
urea	O
,	O
and	O
time	O
to	O
recovery	O
of	O
renal	B-ANAT
function	O
were	O
assessed	O
.	O

ABSTRACT	O
:	O
Macroautophagy	O
(	O
herein	O
autophagy	O
)	O
is	O
a	O
cellular	B-ANAT
process	O
,	O
requiring	O
ATG5	O
,	O
by	O
which	O
cells	B-ANAT
deliver	O
double	O
membrane	B-ANAT
-	O
bound	O
packets	O
containing	O
cytoplasm	B-ANAT
or	O
cytoplasmic	B-ANAT
organelles	B-ANAT
to	O
the	O
lysosome	B-ANAT
.	O

A	O
45	O
-	O
year	O
-	O
old	O
man	O
with	O
oesophageal	O
cancer	O
submitted	O
to	O
a	O
total	O
oesophagectomy	O
with	O
intrathoracic	O
transposition	O
of	O
the	O
stomach	B-ANAT
developed	O
post	O
-	O
operatively	O
respiratory	O
failure	O
and	O
pneumothorax	O
,	O
which	O
were	O
worsened	O
by	O
unilateral	O
pleural	O
rupture	O
and	O
severe	O
subcutaneous	O
emphysema	O
produced	O
after	O
an	O
attempt	O
to	O
introduce	O
through	O
anterior	B-ANAT
chest	I-ANAT
wall	I-ANAT
a	O
second	O
drainage	B-ANAT
tube	O
.	O

In	O
a	O
patient	O
that	O
underwent	O
a	O
major	O
thoracic	B-ANAT
surgery	O
the	O
addition	O
of	O
prone	O
positioning	O
to	O
protective	O
lung	B-ANAT
ventilation	O
rendered	O
possible	O
not	O
only	O
the	O
healing	O
of	O
the	O
acute	O
lung	B-ANAT
injury	O
,	O
but	O
also	O
the	O
quick	O
repair	O
of	O
a	O
lung	B-ANAT
rupture	O
owing	O
to	O
a	O
thoracic	B-ANAT
drainage	B-ANAT
attempt	O
.	O

These	O
glycoproteins	O
are	O
key	O
to	O
the	O
infection	O
process	O
as	O
they	O
are	O
mediators	O
of	O
the	O
receptor	O
binding	O
and	O
membrane	B-ANAT
fusion	O
of	O
the	O
virion	B-ANAT
with	O
the	O
host	B-ANAT
cell	I-ANAT
.	O

Different	O
strains	O
of	O
two	O
coronaviruses	O
,	O
mouse	O
hepatitis	O
virus	O
and	O
feline	O
infectious	O
peritonitis	O
virus	O
,	O
were	O
exposed	O
to	O
CBA	O
:	O
the	O
plant	O
lectins	O
Galanthus	O
nivalis	O
agglutinin	O
,	O
Hippeastrum	O
hybrid	O
agglutinin	O
and	O
Urtica	O
dioica	O
agglutinin	O
(	O
UDA	O
)	O
and	O
the	O
non	O
-	O
peptidic	O
mannose	O
-	O
binding	O
antibiotic	O
pradimicin	O
A	O
.	O
Our	O
results	O
indicate	O
that	O
CBA	O
target	O
the	O
two	O
glycosylated	O
envelope	B-ANAT
glycoproteins	O
,	O
the	O
spike	O
(	O
S	O
)	O
and	O
membrane	B-ANAT
(	O
M	O
)	O
protein	O
,	O
of	O
mouse	O
hepatitis	O
virus	O
and	O
feline	O
infectious	O
peritonitis	O
virus	O
.	O

Although	O
the	O
nonpathogenic	O
SIV	O
infection	O
of	O
SMs	O
induces	O
the	O
same	O
pattern	O
of	O
mucosal	B-ANAT
target	B-ANAT
cell	I-ANAT
depletion	O
observed	O
during	O
pathogenic	O
HIV	O
/	O
SIV	O
infections	O
,	O
the	O
depletion	O
in	O
SMs	O
occurs	O
in	O
the	O
context	O
of	O
limited	O
local	O
and	O
systemic	O
immune	O
activation	O
and	O
can	O
be	O
reverted	O
if	O
virus	O
replication	O
is	O
suppressed	O
by	O
antiretroviral	O
treatment	O
.	O

The	O
frequencies	O
of	O
severe	O
deviations	O
from	O
the	O
desired	O
values	O
of	O
the	O
physiological	O
variables	O
for	O
at	O
least	O
one	O
treatment	O
day	O
were	O
:	O
hypotensive	O
episodes	O
(	O
systolic	O
BP	O
<	O
90	O
mmHg	O
)	O
-	O
20	O
%,	O
anaemia	O
(	O
hgb	O
<	O
8	O
g	O
/	O
dL	O
)	O
-	O
22	O
%,	O
blood	B-ANAT
glucose	O
>	O
10	O
mmol	O
/	O
l	O
-	O
26	O
%,	O
serum	B-ANAT
sodium	O
concentration	O
<	O
130	O
mmol	O
/	O
l	O
-	O
10	O
%,	O
serum	B-ANAT
albumin	O
<	O
25	O
g	O
/	O
l	O
(-	O
1	O
)-	O
31	O
%	O
and	O
hyperthermia	O
>	O
39	O
degrees	O
C	O
-	O
24	O
%.	O

This	O
effect	O
was	O
associated	O
with	O
an	O
81	O
%	O
reduction	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
of	O
the	O
AUC	O
(	O
area	O
under	O
the	O
curve	O
)	O
of	O
the	O
oxidized	O
metabolite	O
APC	B-ANAT
(	O
7	O
-	O
ethyl	O
-	O
10	O
-[	O
4	O
-	O
N	O
-(	O
5	O
-	O
aminopentanoic	O
-	O
acid	O
)-	O
1	O
-	O
piperidino	O
]-	O
carbonyloxycamptothecin	O
).	O

Complications	O
of	O
acute	O
pancreatitis	O
included	O
lung	B-ANAT
edema	O
and	O
/	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
peritonitis	O
,	O
disseminated	O
intravascular	O
coagulation	O
,	O
and	O
sepsis	O
.	O

While	O
gallstones	B-ANAT
represent	O
the	O
main	O
etiologic	O
factor	O
in	O
most	O
larger	O
clinical	O
series	O
,	O
biliary	O
etiology	O
seems	O
to	O
play	O
only	O
a	O
minor	O
role	O
in	O
outpatient	O
deaths	O
undergoing	O
medicolegal	O
autopsies	O
.	O

Radiographic	O
appearances	O
include	O
bilateral	O
patchy	O
air	O
space	O
and	O
interstitial	B-ANAT
opacities	O
.	O

The	O
combination	O
of	O
the	O
surgical	O
approach	O
,	O
pre	O
-	O
existing	O
pulmonary	B-ANAT
disorders	O
,	O
poor	O
nutritional	O
status	O
and	O
the	O
release	O
of	O
pro	O
-	O
inflammatory	O
cytokines	O
may	O
be	O
contributing	O
factors	O
.	O

These	O
prospectively	O
collected	O
data	O
were	O
compared	O
with	O
data	O
of	O
a	O
matched	O
,	O
retrospective	O
group	O
without	O
NAC	B-ANAT
treatment	O
.	O

The	O
so	O
-	O
called	O
""""	O
antibody	O
-	O
dependent	O
enhancement	O
""""	O
can	O
improve	O
viral	O
uptake	O
into	O
host	O
cells	B-ANAT
resulting	O
in	O
increased	O
viral	O
load	O
and	O
exacerbation	O
of	O
disease	O
.	O

NPAs	O
negative	O
for	O
influenza	O
virus	O
,	O
parainfluenza	O
virus	O
,	O
respiratory	O
syncytial	O
virus	O
,	O
adenovirus	O
,	O
and	O
coronavirus	O
and	O
fecal	B-ANAT
samples	O
from	O
patients	O
with	O
acute	O
gastroenteritis	O
were	O
included	O
.	O

HBoV	O
was	O
detected	O
in	O
fecal	B-ANAT
specimens	O
in	O
children	O
with	O
acute	O
gastroenteritis	O
.	O

For	O
maternal	O
outcomes	O
,	O
a	O
history	O
of	O
lactation	O
was	O
associated	O
with	O
a	O
reduced	O
risk	O
of	O
type	O
2	O
diabetes	O
,	O
breast	B-ANAT
,	O
and	O
ovarian	B-ANAT
cancer	O
.	O

Also	O
,	O
there	O
is	O
a	O
wide	O
range	O
of	O
quality	O
of	O
the	O
body	B-ANAT
of	O
evidence	O
across	O
different	O
health	O
outcomes	O
.	O

The	O
micro	O
-	O
meso	O
-	O
macro	O
analytical	O
framework	O
that	O
we	O
have	O
developed	O
can	O
guide	O
the	O
articulation	B-ANAT
of	O
accepted	O
norms	O
of	O
duty	O
to	O
care	O
during	O
epidemics	O
and	O
the	O
development	O
of	O
policy	O
for	O
public	O
health	O
crises	O
.	O

Abnormality	O
rate	O
of	O
DLCO	O
in	O
the	O
SARS	O
patients	O
within	O
three	O
years	O
after	O
discharge	B-ANAT
was	O
significantly	O
decreased	O
(	O
32	O
.	O
4	O
%	O
vs	O
.	O
5	O
.	O
4	O
%,	O
P	O
<	O
0	O
.	O
05	O
),	O
but	O
no	O
significant	O
differences	O
in	O
FVC	O
,	O
VC	O
,	O
25	O
%-	O
75	O
%	O
FEF	O
among	O
SARS	O
patients	O
discharged	O
one	O
month	O
and	O
three	O
years	O
from	O
the	O
hospital	O
(	O
all	O
P	O
>	O
0	O
.	O
05	O
).	O

The	O
lung	B-ANAT
functions	O
of	O
most	O
patients	O
have	O
recovered	O
gradually	O
,	O
but	O
in	O
a	O
minority	O
of	O
patients	O
they	O
may	O
be	O
impaired	O
.	O

To	O
evaluate	O
this	O
hypothesis	O
,	O
PBMC	O
and	O
PDC	O
were	O
repeatedly	O
isolated	O
from	O
nine	O
patients	O
with	O
acute	O
retinal	B-ANAT
necrosis	O
(	O
ARN	O
),	O
caused	O
by	O
herpes	O
simplex	B-ANAT
or	O
varicella	O
zoster	O
virus	O
.	O

The	O
median	O
percentage	O
of	O
isolated	O
PDC	O
was	O
significantly	O
lower	O
in	O
patients	O
compared	O
with	O
18	O
age	O
-	O
matched	O
healthy	O
controls	O
(	O
p	O
<	O
0	O
.	O
001	O
),	O
confirmed	O
by	O
FACS	O
analysis	O
using	O
peripheral	B-ANAT
blood	I-ANAT
,	O
and	O
was	O
extremely	O
low	O
during	O
acute	O
disease	O
.	O

CD8	O
+	O
cell	B-ANAT
responses	O
were	O
significantly	O
lower	O
in	O
patients	O
vs	O
controls	O
(	O
p	O
=	O
0	O
.	O
04	O
).	O

We	O
hypothesized	O
that	O
mesenchymal	B-ANAT
stem	I-ANAT
cells	I-ANAT
(	O
MSCs	O
),	O
with	O
or	O
without	O
transfection	O
with	O
the	O
vasculoprotective	O
gene	O
angiopoietin	O
1	O
(	O
ANGPT1	O
)	O
would	O
have	O
beneficial	O
effects	O
in	O
experimental	O
ALI	O
in	O
mice	O
.	O

ABSTRACT	O
:	O
We	O
analyzed	O
the	O
ability	O
of	O
two	O
rat	O
coronavirus	O
(	O
RCoV	O
)	O
strains	O
,	O
sialodacryoadenitis	O
virus	O
(	O
SDAV	O
)	O
and	O
Parker	O
'	O
s	O
RCoV	O
(	O
RCoV	O
-	O
P	O
),	O
to	O
infect	O
rat	O
alveolar	B-ANAT
type	O
I	O
cells	B-ANAT
and	O
induce	O
chemokine	O
expression	O
.	O

ABSTRACT	O
:	O
Respiratory	B-ANAT
tract	I-ANAT
infections	O
can	O
be	O
caused	O
by	O
a	O
heterogeneous	O
group	O
of	O
viruses	O
and	O
bacteria	O
that	O
produce	O
similar	O
clinical	O
presentations	O
.	O

ABSTRACT	O
:	O
Adult	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
can	O
be	O
a	O
common	O
problem	O
associated	O
with	O
the	O
treatment	O
of	O
acute	O
brain	B-ANAT
injury	O
.	O

We	O
describe	O
the	O
effects	O
of	O
HFOV	O
on	O
hemodynamics	O
,	O
respiratory	O
function	O
,	O
and	O
intracranial	B-ANAT
pressure	O
in	O
five	O
patients	O
with	O
acute	O
brain	B-ANAT
injury	O
being	O
treated	O
for	O
ARDS	O
.	O

TITLE	O
:	O
Skin	B-ANAT
fragility	O
syndrome	O
in	O
a	O
cat	O
with	O
feline	O
infectious	O
peritonitis	O
and	O
hepatic	B-ANAT
lipidosis	O
.	O

TITLE	O
:	O
Cytomegalovirus	O
and	O
Clostridium	O
difficile	O
ischemic	O
colitis	O
in	O
a	O
renal	B-ANAT
transplant	B-ANAT
recipient	O
:	O
a	O
lethal	O
complication	O
of	O
anti	O
-	O
rejection	O
therapy	O
?	O

Little	O
is	O
known	O
about	O
the	O
biogenesis	O
of	O
these	O
complexes	O
,	O
the	O
membrane	B-ANAT
anchoring	O
of	O
which	O
is	O
probably	O
mediated	O
by	O
nsp3	O
,	O
nsp4	O
,	O
and	O
nsp6	O
,	O
as	O
they	O
contain	O
several	O
putative	O
transmembrane	B-ANAT
domains	O
.	O

TITLE	O
:	O
COQ2	O
nephropathy	O
:	O
a	O
newly	O
described	O
inherited	O
mitochondriopathy	O
with	O
primary	O
renal	B-ANAT
involvement	O
.	O

ABSTRACT	O
:	O
Primary	O
coenzyme	O
Q	O
(	O
10	O
)	O
(	O
CoQ	O
(	O
10	O
))	O
deficiency	O
includes	O
a	O
group	O
of	O
rare	O
autosomal	B-ANAT
recessive	O
disorders	O
primarily	O
characterized	O
by	O
neurological	O
and	O
muscular	B-ANAT
symptoms	O
.	O

Biochemical	O
analyses	O
demonstrated	O
decreased	O
activities	O
of	O
respiratory	B-ANAT
chain	I-ANAT
complexes	O
[	O
II	O
+	O
III	O
]	O
and	O
decreased	O
CoQ	O
(	O
10	O
)	O
concentrations	O
in	O
skeletal	B-ANAT
muscle	I-ANAT
and	O
renal	B-ANAT
cortex	I-ANAT
.	O

Flow	O
cytometric	O
analysis	O
showed	O
that	O
both	O
CD4	O
+	O
and	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
were	O
involved	O
in	O
cellular	B-ANAT
responses	O
to	O
SARS	O
-	O
CoV	O
M	O
antigen	O
.	O

Strong	O
activation	O
of	O
TLR3	O
,	O
IL	O
-	O
6	O
and	O
p65	O
was	O
observed	O
in	O
BRV	O
-	O
infected	O
host	O
tissues	B-ANAT
,	O
but	O
not	O
in	O
tissues	B-ANAT
infected	O
with	O
BCV	O
.	O

From	O
103	O
consecutive	O
patients	O
the	O
study	O
included	O
20	O
undergoing	O
NPPV	O
and	O
20	O
CMV	O
,	O
matched	O
for	O
age	O
,	O
simplified	O
acute	O
physiology	O
score	O
II	O
,	O
and	O
baseline	O
arterial	B-ANAT
blood	I-ANAT
gases	O
.	O

The	O
two	O
unvaccinated	O
control	O
dogs	O
had	O
moderate	O
enteritis	O
,	O
and	O
virus	O
was	O
detected	O
in	O
cell	B-ANAT
cultures	O
starting	O
from	O
three	O
days	O
postchallenge	O
(	O
dog	O
1	O
)	O
and	O
two	O
days	O
postchallenge	O
(	O
dog	O
2	O
),	O
and	O
by	O
PCR	O
for	O
23	O
median	O
days	O
.	O

This	O
study	O
showed	O
the	O
efficacy	O
of	O
a	O
high	O
-	O
cell	B-ANAT
-	O
passage	O
canine	O
coronavirus	O
vaccine	O
in	O
preventing	O
infection	O
of	O
dogs	O
by	O
virulent	O
virus	O
and	O
,	O
specifically	O
,	O
its	O
ability	O
to	O
induce	O
sterilising	O
immunity	O
.	O

Cytosine	O
deamination	O
and	O
selection	O
of	O
CpG	O
suppressed	O
clones	O
by	O
the	O
immune	B-ANAT
system	I-ANAT
are	O
the	O
two	O
major	O
independent	O
biochemical	O
and	O
biological	O
selective	O
forces	O
that	O
shape	O
codon	O
usage	O
bias	O
in	O
coronavirus	O
genomes	O
.	O

As	O
in	O
other	O
coronaviruses	O
,	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
is	O
one	O
of	O
the	O
most	O
crucial	O
structural	O
components	O
of	O
the	O
SARS	O
-	O
CoV	O
.	O
Hence	O
major	O
attention	O
has	O
been	O
focused	O
on	O
characterization	O
of	O
this	O
protein	O
.	O

Mechanisms	O
for	O
antiviral	O
activity	O
of	O
Glycyrrhiza	O
spp	O
.	O
include	O
reduced	O
transport	O
to	O
the	O
membrane	B-ANAT
and	O
sialylation	O
of	O
hepatitis	O
B	O
virus	O
surface	O
antigen	O
,	O
reduction	O
of	O
membrane	B-ANAT
fluidity	O
leading	O
to	O
inhibition	O
of	O
fusion	O
of	O
the	O
viral	B-ANAT
membrane	I-ANAT
of	O
HIV	O
-	O
1	O
with	O
the	O
cell	B-ANAT
,	O
induction	O
of	O
interferon	O
gamma	O
in	O
T	B-ANAT
-	I-ANAT
cells	I-ANAT
,	O
inhibition	O
of	O
phosphorylating	O
enzymes	O
in	O
vesicular	O
stomatitis	O
virus	O
infection	O
and	O
reduction	O
of	O
viral	O
latency	O
.	O

This	O
article	O
reports	O
a	O
23	O
-	O
month	O
-	O
old	O
boy	O
with	O
acute	O
myelitis	O
and	O
optic	B-ANAT
neuritis	O
who	O
was	O
diagnosed	O
with	O
Devic	O
'	O
s	O
neuromyelitis	O
optica	O
.	O

The	O
expression	O
of	O
full	O
length	O
recombinant	O
SARS	O
spike	O
protein	O
(	O
rSS	O
)	O
in	O
HeLa	B-ANAT
cells	I-ANAT
possessing	O
specific	O
reaction	O
ability	O
to	O
chicken	O
anti	O
-	O
sera	B-ANAT
was	O
confirmed	O
by	O
SDS	O
-	O
PAGE	O
and	O
Western	O
-	O
blot	O
(	O
190	O
kD	O
).	O

Intrauterine	B-ANAT
environmental	O
factors	O
,	O
genetics	O
,	O
inflammation	O
,	O
oxygen	O
toxicity	O
and	O
ventilator	O
treatment	O
in	O
acute	O
Respiratory	O
Distress	O
Syndrome	O
are	O
also	O
of	O
importance	O
.	O

Concerning	O
lymphocyte	B-ANAT
disorder	O
,	O
there	O
were	O
some	O
previous	O
studies	O
reported	O
the	O
low	O
lymphocyte	B-ANAT
in	O
the	O
patients	O
with	O
SARS	O
.	O

These	O
so	O
-	O
called	O
""""	O
CTL	B-ANAT
escape	O
variant	O
viruses	O
""""	O
are	O
commonly	O
selected	O
during	O
persistent	O
infections	O
and	O
are	O
associated	O
with	O
rapid	O
disease	O
progression	O
and	O
increased	O
disease	O
severity	O
.	O

ABSTRACT	O
:	O
Infection	O
of	O
mice	O
with	O
variants	O
of	O
mouse	O
hepatitis	O
virus	O
,	O
strain	O
JHM	O
(	O
MHV	O
-	O
JHM	O
),	O
provide	O
models	O
of	O
acute	O
and	O
chronic	O
viral	O
infection	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
).	O

Partially	O
protective	O
anti	O
-	O
viral	O
immune	O
responses	O
may	O
result	O
in	O
persistent	O
infection	O
and	O
chronic	O
demyelinating	O
disease	O
characterized	O
by	O
myelin	B-ANAT
removal	O
from	O
axons	B-ANAT
of	O
the	O
CNS	B-ANAT
and	O
associated	O
with	O
dense	O
macrophage	B-ANAT
/	O
microglial	B-ANAT
infiltration	O
.	O

The	O
presence	O
of	O
ARDS	O
was	O
not	O
associated	O
with	O
higher	O
mortality	O
or	O
worse	O
discharge	B-ANAT
disability	O
.	O

RESULTS	O
:	O
Before	O
PP	O
,	O
21	O
patients	O
(	O
50	O
%)	O
had	O
acute	O
cor	B-ANAT
pulmonale	O
,	O
defined	O
by	O
RV	O
enlargement	O
associated	O
with	O
septal	O
dyskinesia	O
(	O
group	O
1	O
),	O
whereas	O
21	O
patients	O
had	O
a	O
normal	O
RV	O
(	O
group	O
2	O
).	O

Skin	B-ANAT
lesions	O
were	O
delayed	O
and	O
appeared	O
3	O
days	O
later	O
.	O

SARS	O
-	O
CoV	O
could	O
propagate	O
effectively	O
and	O
sustain	O
high	O
levels	O
for	O
1	O
wk	O
in	O
animal	O
lungs	B-ANAT
.	O

TITLE	O
:	O
Role	O
of	O
phosphorylation	O
clusters	O
in	O
the	O
biology	O
of	O
the	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
nucleocapsid	B-ANAT
protein	O
.	O

Based	O
on	O
the	O
chemical	O
structure	O
of	O
a	O
lead	O
compound	O
from	O
a	O
previous	O
screening	O
,	O
we	O
have	O
designed	O
and	O
synthesized	O
a	O
number	O
of	O
non	O
-	O
peptidyl	O
inhibitors	O
,	O
some	O
of	O
which	O
have	O
shown	O
significantly	O
improved	O
inhibitory	O
activity	O
against	O
SARS	O
-	O
CoV	O
M	O
(	O
pro	O
)	O
with	O
IC	O
(	O
50	O
)	O
values	O
of	O
approximately	O
60	O
nM	O
.	O
In	O
the	O
absence	O
of	O
SARS	O
-	O
CoV	O
M	O
(	O
pro	O
)	O
crystal	B-ANAT
structures	O
in	O
complex	O
with	O
these	O
synthetic	O
inhibitors	O
,	O
molecular	O
docking	O
tools	O
have	O
been	O
employed	O
to	O
study	O
possible	O
interactions	O
between	O
these	O
inhibitors	O
and	O
SARS	O
-	O
CoV	O
M	O
(	O
pro	O
).	O

All	O
available	O
nasopharyngeal	B-ANAT
aspirate	I-ANAT
(	O
NPA	O
)	O
collected	O
from	O
confirmed	O
patients	O
during	O
the	O
first	O
8	O
weeks	O
of	O
the	O
SARS	O
outbreak	O
in	O
2003	O
were	O
tested	O
for	O
hMPV	O
by	O
a	O
nested	O
RT	O
-	O
PCR	O
assay	O
targeting	O
the	O
F	O
-	O
gene	O
.	O

TITLE	O
:	O
Trauma	O
-	O
associated	O
lung	B-ANAT
injury	O
differs	O
clinically	O
and	O
biologically	O
from	O
acute	O
lung	B-ANAT
injury	O
due	O
to	O
other	O
clinical	O
disorders	O
.	O

We	O
sought	O
to	O
determine	O
the	O
outcome	O
of	O
consecutive	O
acute	O
lung	B-ANAT
injury	O
patients	O
after	O
the	O
implementation	O
of	O
these	O
interventions	O
.	O

The	O
investigators	O
collected	O
detailed	O
information	O
about	O
comorbidities	O
,	O
severity	O
of	O
pulmonary	B-ANAT
and	O
nonpulmonary	O
organ	B-ANAT
failures	O
,	O
complications	O
,	O
respiratory	O
support	O
,	O
and	O
other	O
interventions	O
.	O

TITLE	O
:	O
[	O
Protocols	O
for	O
treatment	O
of	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
/	O
severe	O
sepsis	O
combined	O
of	O
traditional	O
Chinese	O
medicine	O
and	O
Western	O
medicine	O
].	O

On	O
evidence	O
-	O
based	O
medicine	O
,	O
We	O
undertook	O
some	O
large	O
-	O
sample	O
randomized	O
clinical	O
trials	O
in	O
immunity	O
regulation	O
,	O
anticoagulant	O
therapy	O
,	O
promoting	O
motility	O
of	O
intestinal	B-ANAT
tract	I-ANAT
in	O
patients	O
with	O
severe	O
sepsis	O
and	O
mechanical	O
ventilation	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Differences	O
in	O
sperm	B-ANAT
analysis	O
among	O
treatment	O
groups	O
were	O
limited	O
.	O

In	O
conclusion	O
,	O
pre	O
-	O
pubertal	O
vaccination	O
against	O
AIBV	O
and	O
subsequent	O
epididymal	B-ANAT
stone	B-ANAT
formation	O
had	O
a	O
limited	O
effect	O
on	O
sperm	B-ANAT
concentration	O
,	O
sperm	B-ANAT
quality	O
and	O
plasma	B-ANAT
testosterone	O
concentrations	O
.	O

In	O
spite	O
of	O
successful	O
resuscitation	O
and	O
prophylaxis	O
against	O
myoglobulin	O
-	O
induced	O
renal	B-ANAT
failure	O
,	O
1	O
out	O
of	O
every	O
3	O
patients	O
develops	O
kidney	B-ANAT
damage	O
and	O
requires	O
continuous	O
replacement	O
therapy	O
.	O

Our	O
results	O
suggest	O
that	O
a	O
specific	O
,	O
receptor	O
CEACAM1	O
-	O
independent	O
mechanism	O
restricting	O
coronaviral	O
RNA	O
synthesis	O
and	O
CPE	O
is	O
present	O
in	O
NIH	O
3T3	O
and	O
,	O
possibly	O
,	O
other	O
cells	B-ANAT
with	O
preserved	O
contact	O
inhibition	O
.	O

The	O
organism	O
and	O
its	O
toxins	O
(	O
TcdA	O
and	O
TcdB	O
),	O
respectively	O
,	O
were	O
found	O
in	O
25	O
.	O
3	O
%	O
and	O
22	O
.	O
9	O
%	O
of	O
stool	B-ANAT
samples	O
from	O
diarrheic	O
calves	O
.	O

A	O
mono	O
-	O
DNA	O
enzyme	O
(	O
Dz	O
-	O
104	O
)	O
possessing	O
the	O
10	O
-	O
23	O
catalytic	O
motif	O
was	O
synthesized	O
and	O
tested	O
both	O
in	O
vitro	O
and	O
in	O
cell	B-ANAT
culture	O
.	O

After	O
induction	O
of	O
severe	O
lung	B-ANAT
injury	O
by	O
repeated	O
saline	O
lung	B-ANAT
lavage	O
,	O
18	O
adult	O
white	O
Japanese	O
rabbits	O
were	O
randomly	O
assigned	O
to	O
3	O
groups	O
:	O
Group	O
1	O
,	O
CNEP	O
(	O
extra	O
thoracic	B-ANAT
negative	O
pressure	O
,	O
-	O
10	O
cmH2O	O
)	O
with	O
HFO	O
(	O
mean	O
airway	B-ANAT
pressure	O
(	O
MAP	O
),	O
10	O
cmH2O	O
);	O
Group	O
2	O
,	O
HFO	O
(	O
MAP	O
,	O
10	O
cmH2O	O
);	O
and	O
Group	O
3	O
,	O
HFO	O
(	O
MAP	O
,	O
15	O
cmH2O	O
).	O

The	O
mean	O
value	O
of	O
plasma	B-ANAT
fibrinogen	B-ANAT
(	O
x	O
+/-	O

RESULTS	O
:	O
The	O
mean	O
value	O
of	O
plasma	B-ANAT
fibrinogen	B-ANAT
(	O
x	O
+/-	O

There	O
were	O
significant	O
differences	O
between	O
the	O
initial	O
stage	O
and	O
after	O
initial	O
stage	O
groups	O
,	O
between	O
the	O
common	O
and	O
severe	O
type	O
groups	O
,	O
and	O
among	O
the	O
unilobar	O
,	O
bilobar	O
and	O
diffuse	O
lung	B-ANAT
involvement	O
groups	O
(	O
p	O
less	O
than	O
0	O
.	O
05	O
).	O

In	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
exposed	O
to	O
severe	O
hypoxia	O
,	O
we	O
have	O
reported	O
that	O
increased	O
production	O
of	O
mitochondrial	B-ANAT
reactive	O
oxygen	O
species	O
leads	O
to	O
Na	O
,	O
K	O
-	O
ATPase	O
endocytosis	O
and	O
degradation	O
.	O

A	O
strong	O
humoral	O
immune	O
response	O
as	O
supported	O
by	O
the	O
significantly	O
up	O
-	O
regulated	O
immunoglobulin	O
(	O
Ig	O
)	O
gamma	O
chain	O
was	O
observed	O
in	O
the	O
absence	O
of	O
innate	O
,	O
Th1	O
adaptive	O
immunity	O
,	O
or	O
IgA	O
up	O
-	O
regulation	O
after	O
the	O
secondary	O
immunization	O
,	O
indicating	O
that	O
the	O
local	O
memory	O
response	O
is	O
dominated	O
by	O
IgG	O
.	O
Overall	O
,	O
the	O
results	O
provided	O
the	O
first	O
detailed	O
kinetics	O
on	O
the	O
molecular	O
basis	O
underlying	O
the	O
development	O
of	O
primary	O
and	O
secondary	O
mucosal	B-ANAT
immunity	O
.	O

Z	O
gene	O
was	O
cloned	O
into	O
vector	O
pET	O
-	O
28a	O
(+),	O
expressed	O
in	O
E	O
.	O
coli	O
BL21	B-ANAT
(	O
DE3	O
)	O
and	O
purified	O
by	O
Ni	O
(	O
2	O
+)	O
affinity	O
method	O
.	O

ELISA	O
analysis	O
indicated	O
the	O
SARS	O
-	O
CoV	O
antigen	O
prepared	O
from	O
SARS	O
-	O
CoV	O
lysates	O
can	O
be	O
detected	O
by	O
anti	O
-	O
Z	O
sera	B-ANAT
.	O

We	O
did	O
not	O
identify	O
factors	O
that	O
would	O
reliably	O
predict	O
which	O
SIDS	O
cases	O
might	O
be	O
discovered	O
soon	O
enough	O
to	O
allow	O
earlier	O
and	O
more	O
effective	O
CPR	O
and	O
survival	O
without	O
permanent	O
brain	B-ANAT
injury	O
.	O

Post	O
hoc	O
analyses	O
did	O
not	O
reveal	O
any	O
significant	O
differences	O
in	O
the	O
incidences	O
of	O
chronic	O
lung	B-ANAT
disease	O
(	O
CLD	O
),	O
intracranial	B-ANAT
hemorrhage	O
(	O
ICH	O
),	O
patent	O
ductus	B-ANAT
arteriosus	I-ANAT
(	O
PDA	B-ANAT
),	O
retinopathy	O
of	O
prematurity	O
(	O
ROP	O
)	O
or	O
duration	O
of	O
intubation	O
between	O
the	O
iNO	O
-	O
treated	O
and	O
the	O
control	O
groups	O
.	O

Intestinal	B-ANAT
contents	I-ANAT
were	O
collected	O
from	O
turkeys	O
prior	O
to	O
placement	O
,	O
with	O
each	O
flock	O
resampled	O
at	O
2	O
,	O
4	O
,	O
6	O
,	O
8	O
,	O
10	O
,	O
and	O
12	O
wk	O
of	O
age	O
.	O

MHC	B-ANAT
B	O
genotypes	O
were	O
determined	O
by	O
DNA	O
sequence	O
-	O
based	O
typing	O
of	O
BF2	O
alleles	O
.	O

IBV	O
genomes	O
were	O
present	O
in	O
the	O
tears	B-ANAT
of	O
vaccinated	O
and	O
challenged	O
birds	O
,	O
and	O
the	O
incidence	O
of	O
detectable	O
IBV	O
genomes	O
did	O
not	O
vary	O
significantly	O
with	O
MHC	B-ANAT
B	O
genotype	O
.	O

ABSTRACT	O
:	O
Alterations	O
in	O
coagulation	O
,	O
including	O
elevated	O
pulmonary	B-ANAT
and	O
systemic	O
concentrations	O
of	O
urokinase	O
,	O
are	O
frequent	O
in	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
).	O

The	O
significant	O
difference	O
in	O
clinical	O
presentation	O
between	O
the	O
three	O
coronavirus	O
groups	O
was	O
the	O
very	O
low	O
association	O
between	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
illness	O
and	O
HKU1	O
detection	O
.	O

This	O
study	O
shows	O
that	O
infection	O
and	O
spread	O
of	O
MHV	O
-	O
JHM	O
in	O
the	O
brain	B-ANAT
are	O
dependent	O
upon	O
the	O
viral	O
spike	O
glycoprotein	O
.	O

RJHM	O
can	O
initiate	O
infection	O
in	O
the	O
brains	B-ANAT
of	O
Ceacam1a	O
(-/-)	O
mice	O
,	O
but	O
expression	O
of	O
mCEACAM1a	O
increases	O
susceptibility	O
to	O
infection	O
.	O

While	O
mechanical	O
ventilation	O
is	O
integral	O
to	O
the	O
care	O
of	O
these	O
patients	O
,	O
its	O
adverse	O
consequences	O
including	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
are	O
determinants	O
of	O
disease	O
progression	O
and	O
prognosis	O
.	O

Compression	O
-	O
only	O
CPR	O
was	O
preferred	O
to	O
SCPR	O
to	O
resuscitate	O
strangers	O
experiencing	O
cardiac	B-ANAT
arrest	O
after	O
the	O
emergence	O
of	O
SARS	O
.	O

As	O
it	O
has	O
been	O
already	O
suggested	O
for	O
other	O
viral	O
fusion	O
proteins	O
such	O
as	O
HIV	O
gp41	O
,	O
the	O
region	O
of	O
the	O
SARS	O
-	O
CoV	O
protein	O
where	O
the	O
PTM	O
peptide	O
resides	O
could	O
be	O
involved	O
in	O
the	O
merging	O
of	O
the	O
viral	O
and	O
target	O
cell	B-ANAT
membranes	I-ANAT
working	O
synergistically	O
with	O
other	O
membrane	B-ANAT
-	O
active	O
regions	O
of	O
the	O
SARS	O
-	O
CoV	O
S	O
glycoprotein	O
to	O
heighten	O
the	O
fusion	O
process	O
and	O
therefore	O
might	O
be	O
essential	O
for	O
the	O
assistance	O
and	O
enhancement	O
of	O
the	O
viral	O
and	O
cell	B-ANAT
fusion	O
process	O
.	O

NIa	O
proteases	O
from	O
tobacco	O
etch	O
virus	O
(	O
TEV	O
)	O
and	O
tomato	O
vein	B-ANAT
mottling	O
virus	O
(	O
TVMV	O
)	O
have	O
been	O
shown	O
to	O
process	O
recombinant	O
proteins	O
successfully	O
in	O
vitro	O
.	O

She	O
remained	O
hyperglycemic	O
(	O
blood	B-ANAT
glucose	O
levels	O
16	O
.	O
7	O
-	O
27	O
.	O
8	O
mmol	O
/	O
l	O
),	O
despite	O
intravenous	O
insulin	O
at	O
doses	O
as	O
high	O
as	O
30	O
,	O
000	O
U	O
/	O
day	O
.	O

Aggressive	O
management	O
was	O
practiced	O
with	O
continuous	O
transfusion	O
of	O
blood	B-ANAT
products	O
and	O
administration	O
of	O
vasocopressors	O
.	O

ABSTRACT	O
:	O
This	O
study	O
was	O
conducted	O
to	O
evaluate	O
the	O
effects	O
of	O
4	O
Chinese	O
herbal	O
polysaccharides	O
on	O
the	O
production	O
of	O
serum	B-ANAT
antibodies	O
and	O
the	O
proliferation	O
of	O
peripheral	O
T	B-ANAT
lymphocytes	I-ANAT
,	O
including	O
subpopulations	O
in	O
vaccinated	O
chickens	O
.	O

This	O
finding	O
may	O
have	O
direct	O
application	O
in	O
vaccine	O
design	O
and	O
other	O
strategies	O
designed	O
to	O
potentiate	O
immune	B-ANAT
system	I-ANAT
development	O
and	O
function	O
in	O
chickens	O
.	O

In	O
a	O
healthcare	O
environment	O
that	O
is	O
increasingly	O
focused	O
on	O
the	O
need	O
for	O
evidence	O
upon	O
which	O
to	O
base	O
change	O
in	O
practice	O
,	O
are	O
we	O
possibly	O
dragging	O
our	O
heels	B-ANAT
in	O
raising	O
our	O
preparedness	O
for	O
a	O
future	O
pandemic	O
?	O

ABSTRACT	O
:	O
General	O
theories	O
on	O
the	O
inactivation	O
of	O
viruses	O
in	O
the	O
presence	O
of	O
a	O
concentrated	O
protein	O
,	O
such	O
as	O
the	O
allantoic	B-ANAT
fluid	I-ANAT
of	O
chicken	O
eggs	O
,	O
are	O
not	O
useful	O
.	O

TITLE	O
:	O
In	O
vitro	O
inhibition	O
of	O
coronavirus	O
replications	O
by	O
the	O
traditionally	O
used	O
medicinal	O
herbal	O
extracts	O
,	O
Cimicifuga	O
rhizoma	O
,	O
Meliae	O
cortex	B-ANAT
,	O
Coptidis	O
rhizoma	O
,	O
and	O
Phellodendron	O
cortex	B-ANAT
.	O

Northern	O
and	O
Western	O
blot	O
analyzes	O
were	O
performed	O
to	O
investigate	O
antiviral	O
activity	O
in	O
MHV	O
-	O
infected	O
DBT	O
cells	B-ANAT
,	O
including	O
virus	O
entry	O
,	O
viral	O
RNA	O
and	O
protein	O
expression	O
,	O
and	O
virus	O
release	O
.	O

RESULTS	O
:	O
Cimicifuga	O
rhizoma	O
,	O
Meliae	O
cortex	B-ANAT
,	O
Coptidis	O
rhizoma	O
,	O
Phellodendron	O
cortex	B-ANAT
and	O
Sophora	O
subprostrata	O
radix	O
decreased	O
the	O
MHV	O
production	O
and	O
the	O
intracellular	B-ANAT
viral	O
RNA	O
and	O
protein	O
expression	O
with	O
EC50	O
values	O
ranging	O
from	O
2	O
.	O
0	O
to	O
27	O
.	O
5	O
microg	O
/	O
ml	O
.	O

ABSTRACT	O
:	O
Mouse	O
hepatitis	O
virus	O
induces	O
a	O
biphasic	O
disease	O
in	O
BALB	O
/	O
c	O
mice	O
that	O
consists	O
of	O
an	O
acute	O
retinitis	O
followed	O
by	O
progression	O
to	O
a	O
chronic	O
retinal	B-ANAT
degeneration	O
with	O
autoimmune	O
reactivity	O
.	O

Lung	B-ANAT
tissue	I-ANAT
and	O
/	O
or	O
fluid	O
and	O
/	O
or	O
the	O
peribronchial	O
lymph	B-ANAT
node	I-ANAT
of	O
the	O
intratracheally	O
inoculated	O
animals	O
had	O
high	O
TNF	O
-	O
alpha	O
,	O
IL	O
-	O
8	O
and	O
IL	O
-	O
12	O
levels	O
.	O

The	O
patient	O
'	O
s	O
treatment	O
course	O
was	O
further	O
complicated	O
by	O
interstitial	B-ANAT
pneumonitis	O
and	O
hypoxic	O
respiratory	O
failure	O
that	O
ultimately	O
led	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

A	O
significant	O
body	B-ANAT
of	O
evidence	O
has	O
accumulated	O
in	O
the	O
area	O
of	O
SARS	O
-	O
CoV	O
and	O
host	O
interactions	O
that	O
indicate	O
that	O
the	O
accessory	O
proteins	O
might	O
play	O
an	O
important	O
role	O
in	O
modulating	O
the	O
host	O
response	O
to	O
virus	O
infection	O
and	O
thereby	O
,	O
contribute	O
to	O
pathogenesis	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
human	O
coronavirus	O
229E	O
infection	O
in	O
human	O
epithelial	O
lung	B-ANAT
cells	B-ANAT
(	O
L132	O
)	O
by	O
chloroquine	O
:	O
involvement	O
of	O
p38	O
MAPK	O
and	O
ERK	O
.	O

ABSTRACT	O
:	O
The	O
antiviral	O
effects	O
of	O
chloroquine	O
(	O
CQ	O
)	O
on	O
human	O
coronavirus	O
229E	O
(	O
HCoV	O
-	O
229E	O
)	O
infection	O
of	O
human	O
fetal	B-ANAT
lung	I-ANAT
cell	B-ANAT
line	I-ANAT
,	O
L132	O
are	O
reported	O
.	O

Key	O
recommendations	O
,	O
listed	O
by	O
category	O
,	O
include	O
:	O
early	O
goal	O
-	O
directed	O
resuscitation	O
of	O
the	O
septic	O
patient	O
during	O
the	O
first	O
6	O
hrs	O
after	O
recognition	O
(	O
1C	O
);	O
blood	B-ANAT
cultures	O
prior	O
to	O
antibiotic	O
therapy	O
(	O
1C	O
);	O
imaging	O
studies	O
performed	O
promptly	O
to	O
confirm	O
potential	O
source	O
of	O
infection	O
(	O
1C	O
);	O
administration	O
of	O
broad	O
-	O
spectrum	O
antibiotic	O
therapy	O
within	O
1	O
hr	O
of	O
diagnosis	O
of	O
septic	O
shock	O
(	O
1B	O
)	O
and	O
severe	O
sepsis	O
without	O
septic	O
shock	O
(	O
1D	O
);	O
reassessment	O
of	O
antibiotic	O
therapy	O
with	O
microbiology	O
and	O
clinical	O
data	O
to	O
narrow	O
coverage	O
,	O
when	O
appropriate	O
(	O
1C	O
);	O
a	O
usual	O
7	O
-	O
10	O
days	O
of	O
antibiotic	O
therapy	O
guided	O
by	O
clinical	O
response	O
(	O
1D	O
);	O
source	O
control	O
with	O
attention	O
to	O
the	O
balance	O
of	O
risks	O
and	O
benefits	O
of	O
the	O
chosen	O
method	O
(	O
1C	O
);	O
administration	O
of	O
either	O
crystalloid	B-ANAT
or	O
colloid	B-ANAT
fluid	O
resuscitation	O
(	O
1B	O
);	O
fluid	O
challenge	O
to	O
restore	O
mean	O
circulating	O
filling	O
pressure	O
(	O
1C	O
);	O
reduction	O
in	O
rate	O
of	O
fluid	O
administration	O
with	O
rising	O
filing	O
pressures	O
and	O
no	O
improvement	O
in	O
tissue	B-ANAT
perfusion	O
(	O
1D	O
);	O
vasopressor	O
preference	O
for	O
norepinephrine	O
or	O
dopamine	O
to	O
maintain	O
an	O
initial	O
target	O
of	O
mean	O
arterial	B-ANAT
pressure	O
>	O
or	O
=	O
65	O
mm	O
Hg	O
(	O
1C	O
);	O
dobutamine	O
inotropic	O
therapy	O
when	O
cardiac	B-ANAT
output	O
remains	O
low	O
despite	O
fluid	O
resuscitation	O
and	O
combined	O
inotropic	O
/	O
vasopressor	O
therapy	O
(	O
1C	O
);	O
stress	O
-	O
dose	O
steroid	O
therapy	O
given	O
only	O
in	O
septic	O
shock	O
after	O
blood	B-ANAT
pressure	O
is	O
identified	O
to	O
be	O
poorly	O
responsive	O
to	O
fluid	O
and	O
vasopressor	O
therapy	O
(	O
2C	O
);	O
recombinant	O
activated	O
protein	O
C	O
in	O
patients	O
with	O
severe	O
sepsis	O
and	O
clinical	O
assessment	O
of	O
high	O
risk	O
for	O
death	O
(	O
2B	O
except	O
2C	O
for	O
post	O
-	O
operative	O
patients	O
).	O

ABSTRACT	O
:	O
The	O
administration	O
of	O
hyper	O
immune	O
sera	B-ANAT
to	O
prevent	O
or	O
treat	O
life	O
-	O
threatening	O
infections	O
is	O
a	O
remarkable	O
milestone	O
in	O
medicine	O
and	O
biotechnology	O
that	O
has	O
been	O
achieved	O
more	O
than	O
a	O
century	O
ago	O
.	O

Previously	O
proposed	O
mechanisms	O
of	O
IMS	O
include	O
different	O
susceptibility	O
of	O
various	O
cholinergic	O
receptors	O
,	O
muscle	B-ANAT
necrosis	O
,	O
prolonged	O
acetylcholinesterase	O
inhibition	O
,	O
inadequate	O
oxime	O
therapy	O
,	O
downregulation	O
or	O
desensitization	O
of	O
postsynaptic	O
acetylcholine	O
receptors	O
,	O
failure	O
of	O
postsynaptic	O
acetylcholine	O
release	O
,	O
and	O
oxidative	O
stress	O
-	O
related	O
myopathy	O
.	O

TITLE	O
:	O
Conventional	O
surgical	O
repair	O
and	O
endovascular	B-ANAT
treatment	O
of	O
acute	O
traumatic	O
aortic	B-ANAT
rupture	O
.	O

Two	O
patients	O
were	O
operated	O
upon	O
without	O
cardiopulmonary	B-ANAT
bypass	O
.	O

ANHTRs	O
range	O
from	O
urticaria	O
to	O
transfusion	O
-	O
related	O
acute	O
lung	B-ANAT
injury	O
(	O
TRALI	O
).	O

ABSTRACT	O
:	O
Tissues	B-ANAT
from	O
nine	O
ferrets	O
with	O
granulomatous	O
lesions	O
similar	O
to	O
those	O
seen	O
in	O
feline	O
infectious	O
peritonitis	O
were	O
examined	O
histopathologically	O
and	O
immunohistochemically	O
.	O

TITLE	O
:	O
A	O
correlation	O
between	O
the	O
severity	O
of	O
lung	B-ANAT
lesions	O
on	O
radiographs	O
and	O
clinical	O
findings	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

Two	O
experienced	O
radiologists	O
reviewed	O
chest	B-ANAT
radiographs	O
of	O
28	O
patients	O
with	O
SARS	O
.	O

Gas	O
exchange	O
was	O
severely	O
impaired	O
and	O
a	O
chest	B-ANAT
x	O
-	O
ray	O
indicated	O
chemical	O
pneumonitis	O
.	O

Unfortunately	O
,	O
the	O
patient	O
developed	O
multi	O
-	O
organ	B-ANAT
dysfunction	O
syndrome	O
(	O
MODS	O
)	O
complicated	O
by	O
life	O
-	O
threatening	O
severe	O
vasoplegia	O
within	O
24	O
hours	O
after	O
gasoline	O
injection	O
.	O

Despite	O
fluid	O
replacement	O
,	O
renal	B-ANAT
function	O
worsened	O
and	O
required	O
hemofiltration	O
on	O
5	O
sequential	O
days	O
.	O

TITLE	O
:	O
Aerosolized	O
anticoagulants	O
ameliorate	O
acute	O
lung	B-ANAT
injury	O
in	O
sheep	O
after	O
exposure	O
to	O
burn	O
and	O
smoke	O
inhalation	O
.	O

In	O
this	O
study	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
aerosolized	O
anticoagulants	O
will	O
reduce	O
the	O
degree	O
of	O
airway	B-ANAT
obstruction	O
and	O
improve	O
pulmonary	B-ANAT
function	O
in	O
sheep	O
with	O
severe	O
combined	O
burn	O
and	O
smoke	O
inhalation	O
injury	O
by	O
preventing	O
the	O
formation	O
of	O
airway	B-ANAT
fibrin	O
clots	O
.	O

The	O
walls	O
of	O
the	O
alveoli	B-ANAT
were	O
thicker	O
,	O
infiltrated	O
with	O
inflammation	O
cells	B-ANAT
and	O
an	O
exudative	O
fluid	O
was	O
found	O
in	O
the	O
alveolar	B-ANAT
spaces	O
.	O

Chronic	O
alcoholism	O
and	O
alcoholic	O
liver	B-ANAT
disease	O
are	O
both	O
associated	O
with	O
an	O
important	O
degree	O
of	O
immunosuppression	O
.	O

The	O
lung	B-ANAT
itself	O
is	O
rarely	O
sampled	O
directly	O
,	O
and	O
sputum	B-ANAT
representing	O
lower	O
-	O
airway	B-ANAT
secretions	B-ANAT
can	O
rarely	O
be	O
obtained	O
from	O
children	O
.	O

The	O
development	O
of	O
techniques	O
to	O
detect	O
antigens	O
of	O
the	O
causative	O
agent	O
in	O
nasopharyngeal	B-ANAT
secretions	B-ANAT
,	O
nucleic	B-ANAT
acid	O
by	O
means	O
of	O
the	O
polymerise	O
-	O
chain	O
reaction	O
assays	O
has	O
significantly	O
improved	O
the	O
identification	O
of	O
the	O
responsible	O
pathogen	O
and	O
the	O
choice	O
of	O
appropriate	O
treatment	O
.	O

Surface	O
expression	O
was	O
analyzed	O
by	O
immunofluorescence	O
microscopy	O
,	O
by	O
surface	O
biotinylation	O
,	O
and	O
by	O
syncytium	B-ANAT
formation	O
by	O
S	O
-	O
expressing	O
cells	B-ANAT
.	O

Tyr1143	O
in	O
the	O
cytoplasmic	B-ANAT
tail	I-ANAT
was	O
shown	O
to	O
be	O
a	O
crucial	O
component	O
of	O
the	O
retention	O
signal	O
.	O

CD4	O
(+)	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
-	O
mediated	O
antiviral	O
activity	O
correlated	O
with	O
diminished	O
clinical	O
symptoms	O
,	O
pathology	O
,	O
and	O
demyelination	O
.	O

TITLE	O
:	O
[	O
Techniques	O
used	O
for	O
the	O
diagnostic	O
of	O
upper	O
and	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
viral	O
infections	O
].	O

The	O
approach	O
is	O
applicable	O
for	O
monitoring	O
open	O
-	O
source	O
(	O
public	O
-	O
domain	O
)	O
media	B-ANAT
for	O
indications	O
and	O
warnings	O
of	O
such	O
events	O
,	O
and	O
specifically	O
for	O
markers	O
of	O
the	O
social	O
disruption	O
that	O
commonly	O
occur	O
as	O
these	O
events	O
unfold	O
.	O

Surprisingly	O
,	O
we	O
found	O
that	O
PGE2	O
produced	O
by	O
IL	O
-	O
1beta	O
-	O
stimulated	O
fibroblasts	B-ANAT
enhances	O
fibroblast	B-ANAT
proliferation	O
.	O

Indications	O
were	O
severe	O
postresectional	O
and	O
unresponsive	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
hemodynamic	O
stability	O
,	O
and	O
no	O
significant	O
peripheral	O
arterial	B-ANAT
occlusive	O
disease	O
or	O
heparin	O
-	O
induced	O
thrombocytopenia	O
.	O

The	O
integration	O
of	O
this	O
device	O
to	O
near	O
static	O
mechanical	O
ventilation	O
of	O
the	O
residual	O
native	O
lung	B-ANAT
(	O
s	O
)	O
is	O
feasible	O
and	O
highly	O
effective	O
in	O
patients	O
with	O
severe	O
and	O
unresponsive	O
acute	O
respiratory	O
distress	O
syndrome	O
after	O
pulmonary	B-ANAT
resection	O
.	O

3	O
days	O
after	O
removal	O
of	O
the	O
interventional	O
lung	B-ANAT
-	O
assist	O
membrane	B-ANAT
ventilator	O
,	O
and	O
all	O
of	O
them	O
were	O
discharged	O
from	O
the	O
hospital	O
.	O

Direct	O
inhibition	O
by	O
TB	O
lipids	O
could	O
worsen	O
surfactant	O
dysfunction	O
caused	O
by	O
plasma	B-ANAT
proteins	O
or	O
other	O
endogenous	O
substances	O
induced	O
by	O
inflammatory	O
injury	O
in	O
the	O
infected	O
lungs	B-ANAT
.	O

To	O
understand	O
the	O
function	O
of	O
MBL	O
in	O
relation	O
to	O
infectious	O
viral	O
diseases	O
two	O
chicken	O
lines	O
were	O
selected	O
for	O
high	O
and	O
low	O
concentrations	O
of	O
MBL	O
in	O
serum	B-ANAT
for	O
several	O
generations	O
.	O

The	O
N199	O
protein	O
proved	O
to	O
be	O
more	O
specific	O
in	O
swine	O
sera	B-ANAT
screening	O
than	O
whole	O
viral	O
and	O
N	O
protein	O
(	O
P	O
<	O
0	O
.	O
001	O
).	O

Acute	O
respiratory	O
distress	O
and	O
hypoxaemia	O
developed	O
in	O
the	O
patient	O
following	O
extubation	O
of	O
the	O
trachea	B-ANAT
.	O

Tricuspid	O
jet	O
velocity	O
showed	O
significant	O
positive	O
correlations	O
with	O
B	O
-	O
type	O
natriuretic	O
peptide	O
(	O
rho	O
=	O
0	O
.	O
54	O
,	O
P	O
<	O
0	O
.	O
01	O
)	O
and	O
cardiac	B-ANAT
troponin	O
I	O
(	O
rho	O
=	O
0	O
.	O
42	O
,	O
P	O
<	O
0	O
.	O
01	O
).	O

These	O
residues	O
are	O
involved	O
in	O
dimerization	O
through	O
hydrogen	O
bonding	O
and	O
broadly	O
located	O
in	O
the	O
N	O
-	O
terminal	O
finger	B-ANAT
,	O
the	O
alpha	O
-	O
helix	O
A	O
'	O
of	O
domain	O
I	O
,	O
and	O
the	O
oxyanion	O
loop	O
near	O
the	O
S1	O
substrate	O
-	O
binding	O
subsite	O
in	O
domain	O
II	O
.	O

To	O
determine	O
whether	O
specific	O
palmitoylations	O
influence	O
coronavirus	O
assembly	O
,	O
we	O
introduced	O
plasmid	O
DNAs	O
encoding	O
mouse	O
hepatitis	O
coronavirus	O
(	O
MHV	O
)	O
S	O
,	O
E	O
,	O
M	O
,	O
and	O
N	O
(	O
nucleocapsid	B-ANAT
)	O
into	O
293T	O
cells	B-ANAT
and	O
found	O
that	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
(	O
VLPs	B-ANAT
)	O
were	O
robustly	O
assembled	O
and	O
secreted	O
into	O
culture	O
medium	O
.	O

Both	O
native	O
E	O
and	O
E	O
.	O
T	O
proteins	O
localized	O
at	O
identical	O
perinuclear	O
locations	O
,	O
and	O
both	O
copurified	O
with	O
M	O
proteins	O
,	O
but	O
E	O
.	O
T	O
was	O
entirely	O
incompetent	O
for	O
VLP	B-ANAT
production	O
.	O

In	O
the	O
presence	O
of	O
the	O
E	O
.	O
T	O
proteins	O
,	O
the	O
M	O
protein	O
subunits	O
accumulated	O
into	O
detergent	O
-	O
insoluble	O
complexes	O
that	O
failed	O
to	O
secrete	O
from	O
cells	B-ANAT
,	O
while	O
native	O
E	O
proteins	O
mobilized	O
M	O
into	O
detergent	O
-	O
soluble	O
secreted	O
forms	O
.	O

Coexpression	O
of	O
SCoV	O
S	O
protein	O
and	O
E	O
,	O
M	O
and	O
N	O
proteins	O
of	O
mouse	O
hepatitis	O
virus	O
in	O
293T	O
or	O
CHO	B-ANAT
cells	I-ANAT
resulted	O
in	O
the	O
efficient	O
production	O
of	O
chimeric	O
VLPs	B-ANAT
carrying	O
SCoV	O
S	O
protein	O
.	O

Despite	O
some	O
differences	O
in	O
the	O
cellular	B-ANAT
composition	O
of	O
inflammatory	O
infiltrates	O
,	O
we	O
did	O
not	O
observe	O
any	O
overt	O
lung	B-ANAT
pathology	O
in	O
the	O
chimeric	O
-	O
VLP	B-ANAT
-	O
treated	O
mice	O
,	O
when	O
compared	O
to	O
the	O
negative	O
control	O
mice	O
.	O

Our	O
results	O
show	O
that	O
chimeric	O
VLP	B-ANAT
can	O
be	O
an	O
effective	O
vaccine	O
strategy	O
against	O
SCoV	O
infection	O
.	O

Using	O
a	O
membrane	B-ANAT
-	O
strip	O
based	O
Western	O
blot	O
approach	O
,	O
the	O
reactivity	O
of	O
each	O
antigen	O
fragment	O
against	O
a	O
panel	O
of	O
animal	O
sera	B-ANAT
was	O
determined	O
.	O

There	O
was	O
no	O
statistically	O
significant	O
difference	O
in	O
the	O
survival	O
time	O
of	O
cats	O
treated	O
with	O
FeIFN	O
-	O
omega	O
versus	O
placebo	O
or	O
in	O
any	O
other	O
variable	O
evaluated	O
(	O
with	O
the	O
exception	O
of	O
the	O
lymphocyte	B-ANAT
count	O
).	O

Ninety	O
-	O
five	O
percent	O
of	O
patients	O
had	O
varying	O
degrees	O
of	O
restrictive	O
ventilation	O
impairment	O
,	O
and	O
85	O
%	O
of	O
these	O
patients	O
had	O
a	O
significantly	O
reduced	O
diffusion	O
capacity	O
in	O
the	O
lungs	B-ANAT
.	O

Seventy	O
percent	O
of	O
these	O
patients	O
had	O
transient	O
impairment	O
of	O
liver	B-ANAT
function	O
,	O
which	O
did	O
not	O
correlate	O
to	O
disease	O
severity	O
.	O

TITLE	O
:	O
Aromatic	O
amino	O
acids	O
in	O
the	O
juxtamembrane	B-ANAT
domain	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
spike	O
glycoprotein	O
are	O
important	O
for	O
receptor	O
-	O
dependent	O
virus	O
entry	O
and	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
.	O

S	O
Delta19	O
proteins	O
with	O
other	O
double	O
alanine	O
substitutions	O
reduced	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
further	O
,	O
from	O
40	O
%	O
to	O
less	O
than	O
20	O
%	O
of	O
wild	O
-	O
type	O
levels	O
.	O

These	O
conditions	O
are	O
differentiated	O
from	O
one	O
another	O
by	O
the	O
ratio	O
of	O
the	O
partial	O
pressure	O
of	O
oxygen	O
in	O
the	O
arterial	B-ANAT
blood	I-ANAT
to	O
the	O
inspired	O
fraction	O
of	O
oxygen	O
;	O
ARDS	O
requires	O
a	O
more	O
severe	O
oxygenation	O
defect	O
.	O

ALI	O
and	O
ARDS	O
may	O
occur	O
in	O
association	O
with	O
a	O
number	O
of	O
clinical	O
disorders	O
,	O
including	O
sepsis	O
,	O
pneumonia	O
,	O
aspiration	O
,	O
trauma	O
including	O
inhalational	O
injury	O
,	O
and	O
blood	B-ANAT
transfusions	O
.	O

Infection	O
induced	O
modest	O
mRNA	O
increases	O
in	O
microglia	B-ANAT
,	O
but	O
dramatic	O
transcriptional	O
upregulation	O
in	O
oligodendroglia	B-ANAT
coincident	O
with	O
IFN	O
alpha	O
or	O
IFN	O
gamma	O
mRNA	O
increases	O
in	O
infected	O
tissue	B-ANAT
.	O

Ultimately	O
mRNAs	O
reached	O
similar	O
levels	O
in	O
both	O
cell	B-ANAT
types	O
at	O
their	O
respective	O
time	O
points	O
of	O
maximal	O
Class	O
I	O
expression	O
.	O

These	O
data	O
suggest	O
an	O
innate	O
immune	O
preparedness	O
of	O
microglia	B-ANAT
to	O
present	O
antigen	O
and	O
engage	O
CD8	O
T	B-ANAT
cells	I-ANAT
early	O
following	O
infection	O
.	O

Children	O
surviving	O
meconium	B-ANAT
aspiration	O
syndrome	O
tend	O
to	O
develop	O
alveolar	B-ANAT
hyperinflation	O
and	O
airway	B-ANAT
hyperreactivity	O
to	O
exercise	O
.	O

Patients	O
admitted	O
during	O
an	O
L1	O
designation	O
with	O
a	O
severe	O
head	B-ANAT
,	O
chest	B-ANAT
,	O
or	O
abdominal	B-ANAT
or	O
pelvic	B-ANAT
injury	O
diagnosis	O
had	O
a	O
significant	O
decrease	O
in	O
mortality	O
(	O
9	O
.	O
96	O
%	O
vs	O
14	O
.	O
51	O
%	O
[	O
P	O
=	O
.	O
005	O
],	O
7	O
.	O
14	O
%	O
vs	O
11	O
.	O
27	O
%	O
[	O
P	O
=	O
.	O
01	O
],	O
and	O
6	O
.	O
76	O
%	O
vs	O
17	O
.	O
05	O
%	O
[	O
P	O
=	O
.	O
002	O
],	O
respectively	O
),	O
as	O
did	O
patients	O
who	O
developed	O
acute	O
respiratory	O
distress	O
syndrome	O
during	O
their	O
hospital	O
stay	O
(	O
9	O
.	O
51	O
%	O
vs	O
26	O
.	O
87	O
%;	O
P	O
=	O
.	O
02	O
).	O

The	O
membrane	B-ANAT
(	O
M	O
)	O
protein	O
genes	O
of	O
six	O
PEDV	O
isolates	O
were	O
amplified	O
by	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
),	O
then	O
cloned	O
,	O
sequenced	O
,	O
and	O
compared	O
with	O
each	O
other	O
as	O
well	O
as	O
those	O
ten	O
PEDV	O
reference	O
strains	O
.	O

The	O
M	O
protein	O
of	O
six	O
isolates	O
had	O
three	O
main	O
transmembrane	B-ANAT
domains	O
(	O
aa20	O
-	O
38	O
,	O
aa43	O
-	O
65	O
,	O
aa75	O
-	O
97	O
).	O

Understanding	O
the	O
risks	O
involved	O
and	O
the	O
airway	B-ANAT
techniques	O
required	O
for	O
each	O
possible	O
scenario	O
will	O
be	O
key	O
to	O
planning	O
and	O
preparation	O
.	O

The	O
serum	B-ANAT
profiling	O
spectra	O
in	O
SARS	O
patients	O
were	O
acquired	O
,	O
baseline	O
subtracted	O
and	O
analyzed	O
in	O
parallel	O
with	O
those	O
from	O
the	O
control	O
subjects	O
by	O
Ciphergen	O
ProteinChip	O
Software	O
3	O
.	O
0	O
.	O
2	O
with	O
their	O
peak	O
intensities	O
compared	O
by	O
a	O
nonparametric	O
two	O
sample	O
Mann	O
-	O
Whitney	O
-	O
U	O
test	O
.	O

The	O
literature	O
was	O
searched	O
for	O
clinical	O
studies	O
on	O
lung	B-ANAT
-	O
protective	O
mechanical	O
ventilation	O
using	O
lower	O
tidal	O
volumes	O
in	O
patients	O
not	O
suffering	O
from	O
ALI	O
/	O
ARDS	O
.	O

We	O
have	O
found	O
that	O
SARS	O
-	O
CoV	O
enters	O
cells	B-ANAT
via	O
pH	O
-	O
and	O
receptor	O
-	O
dependent	O
endocytosis	O
.	O

In	O
addition	O
,	O
the	O
spike	O
-	O
bearing	O
pseudoviruses	O
and	O
early	B-ANAT
endosome	I-ANAT
antigen	O
1	O
were	O
found	O
to	O
colocalize	O
in	O
endosomes	O
.	O

Further	O
analyses	O
using	O
specific	O
endocytic	O
pathway	O
inhibitors	O
and	O
dominant	O
-	O
negative	O
Eps15	O
as	O
well	O
as	O
caveolin	O
-	O
1	O
colocalization	O
study	O
suggested	O
that	O
virus	O
entry	O
was	O
mediated	O
by	O
a	O
clathrin	O
-	O
and	O
caveolae	B-ANAT
-	O
independent	O
mechanism	O
.	O

Moreover	O
,	O
cholesterol	O
-	O
and	O
sphingolipid	O
-	O
rich	O
lipid	B-ANAT
raft	I-ANAT
microdomains	O
in	O
the	O
plasma	B-ANAT
membrane	I-ANAT
,	O
which	O
have	O
been	O
shown	O
to	O
act	O
as	O
platforms	O
for	O
many	O
physiological	O
signaling	O
pathways	O
,	O
were	O
shown	O
to	O
be	O
involved	O
in	O
virus	O
entry	O
.	O

In	O
41	O
cases	O
,	O
15	O
cases	O
were	O
congenital	O
laryngeal	B-ANAT
stridor	O
,	O
accounting	O
for	O
31	O
.	O
9	O
%,	O
involving	O
6	O
cases	O
accompanied	O
by	O
the	O
gastroesophageal	B-ANAT
reflux	O
.	O

Others	O
were	O
6	O
cases	O
of	O
acute	O
membrane	B-ANAT
laryngotracheobronchitis	O
,	O
3	O
cases	O
of	O
congenital	O
main	O
respiratory	B-ANAT
tract	I-ANAT
stenosis	O
,	O
2	O
cases	O
of	O
congenital	O
laryngeal	B-ANAT
webs	O
,	O
2	O
cases	O
of	O
vocal	B-ANAT
cord	I-ANAT
paralysis	O
,	O
3	O
cases	O
of	O
Pierre	O
Robin	O
syndrome	O
,	O
2	O
cases	O
of	O
Cri	O
-	O
du	O
-	O
chat	O
syndrome	O
.	O

TITLE	O
:	O
Coronavirus	O
spike	O
protein	O
inhibits	O
host	B-ANAT
cell	I-ANAT
translation	O
by	O
interaction	O
with	O
eIF3f	O
.	O

Interestingly	O
,	O
IBV	O
-	O
infected	O
cells	B-ANAT
stably	O
expressing	O
a	O
Flag	O
-	O
tagged	O
eIF3f	O
showed	O
much	O
higher	O
translation	O
of	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
,	O
suggesting	O
that	O
the	O
interaction	O
between	O
coronavirus	O
S	O
protein	O
and	O
eIF3f	O
plays	O
a	O
functional	O
role	O
in	O
controlling	O
the	O
expression	O
of	O
host	O
genes	O
,	O
especially	O
genes	O
that	O
are	O
induced	O
during	O
coronavirus	O
infection	O
cycles	O
.	O

High	O
risk	O
of	O
intestinal	B-ANAT
fistulas	O
and	O
frequent	O
inability	O
to	O
close	O
the	O
fascia	B-ANAT
with	O
ensuing	O
planned	O
ventral	O
hernia	O
has	O
prompted	O
the	O
search	O
for	O
alternative	O
techniques	O
.	O

Diagnosis	O
of	O
ARDS	O
was	O
based	O
on	O
the	O
following	O
criterias	O
:	O
(	O
1	O
)	O
Gestational	O
age	O
>	O
or	O
=	O
35	O
weeks	O
of	O
gestation	O
;	O
(	O
2	O
)	O
Severe	O
and	O
immediate	O
respiratory	O
distress	O
requiring	O
mechanical	O
ventilation	O
with	O
PEEP	O
>	O
or	O
=	O
4	O
cmH2O	O
and	O
FiO2	O
>	O
or	O
=	O
0	O
.	O
5	O
during	O
at	O
least	O
6	O
hours	O
;	O
(	O
3	O
)	O
Dependence	O
on	O
oxygen	O
>	O
or	O
=	O
48	O
hours	O
;	O
(	O
4	O
)	O
Diffuse	O
alveolar	B-ANAT
damage	O
in	O
the	O
chest	B-ANAT
radiograph	O
;	O
(	O
5	O
)	O
PaO2	O
<	O
or	O
=	O
60	O
mmHg	O
under	O
FiO2	O
>	O
or	O
=	O
0	O
.	O
5	O
.	O

Therefore	O
,	O
it	O
is	O
time	O
to	O
explore	O
broad	O
spectrum	O
agents	O
that	O
can	O
target	O
either	O
the	O
lipid	O
portion	O
of	O
the	O
envelope	B-ANAT
or	O
the	O
sugar	O
moieties	O
of	O
the	O
glycoproteins	O
or	O
the	O
rafts	O
(	O
regions	O
within	O
viral	O
and	O
cell	B-ANAT
envelopes	O
where	O
a	O
higher	O
concentration	O
of	O
the	O
glycoproteins	O
exist	O
).	O

The	O
association	O
between	O
MS	O
and	O
neurogenic	O
pulmonary	B-ANAT
oedema	O
is	O
not	O
clear	O
,	O
nor	O
is	O
the	O
correlation	O
between	O
neurological	O
insults	O
and	O
myocardial	O
dysfunction	O
.	O

Whatever	O
the	O
case	O
,	O
neurogenic	O
pulmonary	B-ANAT
oedema	O
should	O
always	O
be	O
in	O
the	O
differential	O
diagnosis	O
when	O
patients	O
with	O
presumed	O
neurogenic	O
pathology	O
develop	O
cardiopulmonary	B-ANAT
compromise	O
.	O

Unilateral	O
pulmonary	B-ANAT
oedema	O
is	O
also	O
a	O
very	O
rare	O
occurrence	O
,	O
and	O
has	O
not	O
,	O
to	O
our	O
knowledge	O
,	O
been	O
reported	O
in	O
acute	O
MS	O
exacerbation	O
in	O
the	O
past	O
.	O

TITLE	O
:	O
Equine	O
coronavirus	O
induces	O
apoptosis	O
in	O
cultured	B-ANAT
cells	I-ANAT
.	O

Total	O
RNA	O
was	O
extracted	O
from	O
faecal	B-ANAT
suspensions	O
and	O
FCoV	O
RNA	O
was	O
quantified	O
using	O
a	O
real	O
-	O
time	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
assay	O
.	O

However	O
,	O
experiments	O
in	O
which	O
RNA	O
extracted	O
from	O
FCoV	O
-	O
infected	O
cell	B-ANAT
culture	O
supernatants	O
was	O
combined	O
with	O
RNA	O
extracted	O
from	O
faecal	B-ANAT
suspensions	O
revealed	O
the	O
presence	O
of	O
faecal	B-ANAT
factors	O
that	O
significantly	O
inhibited	O
the	O
reverse	O
transcription	O
reaction	O
.	O

We	O
,	O
therefore	O
,	O
conclude	O
that	O
although	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
provides	O
an	O
excellent	O
method	O
for	O
detecting	O
the	O
presence	O
of	O
viral	O
shedding	O
,	O
quantification	O
of	O
FCoV	O
RNA	O
in	O
faecal	B-ANAT
material	O
has	O
to	O
take	O
into	O
account	O
the	O
possible	O
effects	O
of	O
RT	O
-	O
PCR	O
inhibitors	O
.	O

Overall	O
,	O
16	O
patients	O
(	O
28	O
%)	O
developed	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
.	O

Samples	O
of	O
testis	B-ANAT
,	O
trachea	B-ANAT
,	O
and	O
lungs	B-ANAT
from	O
breeder	O
males	O
aged	O
57	O
wk	O
were	O
positive	O
for	O
IBV	O
by	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
),	O
and	O
virus	O
isolation	O
and	O
testis	B-ANAT
samples	O
were	O
also	O
positive	O
for	O
aMPV	O
by	O
RT	O
-	O
PCR	O
.	O

The	O
allantoic	B-ANAT
fluid	I-ANAT
was	O
positive	O
by	O
RT	O
-	O
PCR	O
aimed	O
to	O
amplify	O
the	O
region	O
coding	O
for	O
the	O
S1	O
subunit	O
of	O
the	O
IBV	O
S	O
gene	O
,	O
but	O
it	O
was	O
not	O
positive	O
for	O
aMPV	O
.	O

We	O
detected	O
antibody	O
reactive	O
with	O
SARS	O
-	O
CoV	O
antigen	O
in	O
47	O
(	O
6	O
.	O
7	O
%)	O
of	O
705	O
bat	O
serum	B-ANAT
specimens	O
comprising	O
26	O
species	O
collected	O
in	O
Africa	O
;	O
thus	O
,	O
African	O
bats	O
may	O
harbor	O
agents	O
related	O
to	O
putative	O
group	O
4	O
CoV	O
.	O

It	O
is	O
,	O
in	O
fact	O
,	O
the	O
outcome	O
of	O
an	O
imbalance	O
-	O
decompensation	O
of	O
the	O
organism	O
'	O
s	O
defence	O
mechanisms	O
,	O
in	O
which	O
the	O
oxygen	O
supply	O
to	O
the	O
mitochondria	B-ANAT
is	O
hampered	O
by	O
a	O
macro	O
and	O
/	O
or	O
microcirculation	O
failure	O
.	O

The	O
coronavirus	O
replication	O
/	O
transcription	O
complex	O
is	O
an	O
assembly	O
of	O
viral	O
and	O
,	O
most	O
probably	O
,	O
cellular	B-ANAT
proteins	O
that	O
mediate	O
the	O
synthesis	O
of	O
both	O
the	O
unusually	O
large	O
(	O
approximately	O
30	O
kb	O
)	O
RNA	O
genome	O
and	O
an	O
extensive	O
set	O
of	O
subgenomic	O
mRNAs	O
.	O

The	O
viral	B-ANAT
components	I-ANAT
of	O
the	O
complex	O
are	O
encoded	O
by	O
the	O
giant	O
replicase	O
gene	O
,	O
which	O
is	O
expressed	O
in	O
the	O
form	O
of	O
two	O
polyproteins	O
(	O
pp1a	O
and	O
pp1ab	O
)	O
that	O
are	O
processed	O
into	O
16	O
cleavage	O
products	O
(	O
nonstructural	O
proteins	O
1	O
-	O
16	O
).	O

Compared	O
to	O
the	O
cell	B-ANAT
culture	O
results	O
,	O
the	O
RespiFinder	O
assay	O
showed	O
specificities	O
and	O
sensitivities	O
of	O
98	O
.	O
2	O
%	O
and	O
100	O
%,	O
respectively	O
,	O
for	O
adenovirus	O
;	O
96	O
.	O
4	O
%	O
and	O
100	O
%,	O
respectively	O
,	O
for	O
human	O
metapneumovirus	O
;	O
98	O
.	O
2	O
%	O
and	O
100	O
%,	O
respectively	O
,	O
for	O
influenza	O
A	O
virus	O
(	O
InfA	O
);	O
99	O
.	O
1	O
%	O
and	O
100	O
%,	O
respectively	O
,	O
for	O
parainfluenza	O
virus	O
type	O
1	O
(	O
PIV	O
-	O
1	O
);	O
99	O
.	O
1	O
%	O
and	O
80	O
%,	O
respectively	O
,	O
for	O
PIV	O
-	O
3	O
;	O
90	O
.	O
1	O
%	O
and	O
100	O
%,	O
respectively	O
,	O
for	O
rhinovirus	O
;	O
and	O
94	O
.	O
6	O
%	O
and	O
100	O
%,	O
respectively	O
,	O
for	O
RSV	O
.	O

Research	O
over	O
the	O
last	O
10	O
years	O
indicates	O
that	O
in	O
addition	O
to	O
their	O
role	O
as	O
genome	O
guardians	O
,	O
viral	B-ANAT
capsid	I-ANAT
proteins	O
modulate	O
host	B-ANAT
cell	I-ANAT
signaling	O
networks	O
.	O

The	O
resulting	O
cell	B-ANAT
secretes	O
not	O
only	O
the	O
immunoglobulins	O
of	O
both	O
parents	O
but	O
also	O
hybrid	O
molecules	O
manifesting	O
the	O
binding	O
characteristics	O
of	O
the	O
individual	O
fusion	O
partners	O
.	O

The	O
quadroma	O
culture	O
supernatant	O
was	O
initially	O
processed	O
on	O
a	O
Protein	O
-	O
G	O
column	B-ANAT
to	O
isolate	O
all	O
the	O
species	O
of	O
immunoglobulins	O
.	O

TITLE	O
:	O
Severity	O
of	O
lymphocytic	O
bronchiolitis	O
predicts	O
long	O
-	O
term	O
outcome	O
after	O
lung	B-ANAT
transplantation	O
.	O

Transbronchial	O
biopsies	O
showed	O
grade	O
B0	O
(	O
normal	O
)	O
(	O
n	O
=	O
501	O
),	O
B1	O
(	O
minimal	O
)	O
(	O
n	O
=	O
762	O
),	O
B2	O
(	O
mild	O
)	O
(	O
n	O
=	O
176	O
),	O
B3	O
(	O
moderate	O
)	O
(	O
n	O
=	O
70	O
),	O
B4	O
(	O
severe	O
)	O
(	O
n	O
=	O
4	O
)	O
lymphocytic	O
bronchiolitis	O
,	O
and	O
Bx	O
(	O
no	O
bronchiolar	B-ANAT
tissue	B-ANAT
)	O
(	O
n	O
=	O
75	O
).	O

Pathological	O
findings	O
consisted	O
of	O
mesenteric	B-ANAT
lymphadenopathy	O
,	O
splenomegaly	O
,	O
hypergammaglobulinaemia	O
and	O
non	O
-	O
regenerative	O
anaemia	O
.	O

TITLE	O
:	O
Advances	O
in	O
mechanisms	O
of	O
repair	O
and	O
remodelling	O
in	O
acute	O
lung	B-ANAT
injury	O
.	O

Factors	O
influencing	O
progression	O
to	O
fibroproliferative	O
ARDS	O
vs	O
.	O
resolution	O
and	O
reconstitution	O
of	O
the	O
normal	O
pulmonary	B-ANAT
parenchymal	O
architecture	O
are	O
poorly	O
understood	O
.	O

TITLE	O
:	O
[	O
Extracorporeal	O
lung	B-ANAT
support	O
procedures	O
(	O
ECMO	O
/	O
iLA	O
)].	O

ABSTRACT	O
:	O
Abstract	O
:	O
Candidate	O
IBV	O
vaccines	O
should	O
elicit	O
cellular	B-ANAT
responses	O
as	O
well	O
as	O
humoral	O
responses	O
.	O

TITLE	O
:	O
The	O
beneficial	O
effects	O
of	O
inhaled	O
nitric	O
oxide	O
in	O
patients	O
with	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
complicated	O
by	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
a	O
hypothesis	O
.	O

Detailed	O
analysis	O
of	O
the	O
point	O
mutants	O
of	O
these	O
two	O
amino	O
acid	O
residues	O
and	O
their	O
nearby	O
hydrogen	O
bond	O
partner	O
Ser	B-ANAT
-	O
123	O
and	O
Ser	B-ANAT
-	O
139	O
revealed	O
a	O
strong	O
correlation	O
between	O
the	O
enzyme	O
activity	O
loss	O
and	O
dimer	O
dissociation	O
.	O

Here	O
,	O
we	O
report	O
that	O
lipid	B-ANAT
rafts	I-ANAT
in	O
Vero	O
E6	O
cells	B-ANAT
are	O
involved	O
in	O
the	O
entry	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
).	O

Plasma	B-ANAT
levels	O
of	O
pseudo	O
cholinesterase	O
were	O
initially	O
very	O
low	O
in	O
both	O
patients	O
.	O

ABSTRACT	O
:	O
Idiopathic	O
chronic	O
eosinophilic	O
pneumonia	O
(	O
ICEP	O
)	O
is	O
one	O
of	O
the	O
idiopathic	O
hypereosinophilic	O
lung	B-ANAT
diseases	O
.	O

ABSTRACT	O
:	O
Mass	O
media	B-ANAT
are	O
a	O
leading	O
source	O
of	O
health	O
information	O
for	O
general	O
public	O
.	O

We	O
wished	O
to	O
examine	O
the	O
relationship	O
between	O
the	O
intensity	O
of	O
media	B-ANAT
coverage	O
for	O
selected	O
health	O
topics	O
and	O
their	O
actual	O
risk	O
to	O
public	O
health	O
.	O

Emerging	O
health	O
hazards	O
are	O
over	O
-	O
reported	O
in	O
mass	O
media	B-ANAT
by	O
comparison	O
to	O
common	O
threats	O
to	O
public	O
health	O
.	O

RESULTS	O
:	O
The	O
number	O
of	O
media	B-ANAT
reports	O
inversely	O
correlated	O
with	O
the	O
actual	O
number	O
of	O
deaths	O
for	O
the	O
health	O
risks	O
evaluated	O
.	O

ABSTRACT	O
:	O
Up	O
to	O
a	O
little	O
while	O
ago	O
there	O
was	O
no	O
uniform	O
definition	O
for	O
acute	O
kidney	B-ANAT
injury	O
(	O
AKI	O
).	O

To	O
determine	O
if	O
chemokine	O
expression	O
corresponds	O
with	O
the	O
cellular	B-ANAT
infiltrate	O
,	O
chemokine	O
protein	O
and	O
RNA	O
levels	O
from	O
the	O
brains	B-ANAT
of	O
infected	O
mice	O
were	O
quantified	O
.	O

ABSTRACT	O
:	O
Chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
is	O
a	O
major	O
cause	O
of	O
morbidity	O
and	O
mortality	O
worldwide	O
.	O

Coronavirus	O
,	O
influenza	O
,	O
respiratory	O
syncytial	O
virus	O
,	O
parainfluenza	O
,	O
adenovirus	O
,	O
and	O
metapneumovirus	O
are	O
other	O
important	O
viral	O
causes	O
of	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
exacerbations	O
.	O

These	O
data	O
revealed	O
that	O
nsp1	O
indeed	O
promoted	O
host	O
mRNA	O
degradation	O
and	O
contributed	O
to	O
host	O
protein	O
translation	O
inhibition	O
in	O
infected	O
cells	B-ANAT
.	O

TITLE	O
:	O
RNase	O
-	O
resistant	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
containing	O
long	O
chimeric	O
RNA	O
sequences	O
produced	O
by	O
two	O
-	O
plasmid	O
coexpression	O
system	O
.	O

We	O
should	O
keep	O
in	O
mind	O
that	O
,	O
especially	O
following	O
sepsis	O
,	O
sudden	O
massive	O
pulmonary	B-ANAT
capillary	I-ANAT
leak	O
can	O
occur	O
during	O
elective	O
surgery	O
,	O
even	O
though	O
the	O
patient	O
'	O
s	O
condition	O
is	O
well	O
controlled	O
.	O

Relationships	O
of	O
TNF	O
-	O
alpha	O
gene	O
polymorphisms	O
with	O
interstitial	B-ANAT
lung	B-ANAT
fibrosis	O
and	O
femoral	B-ANAT
head	I-ANAT
osteonecrosis	O
were	O
carried	O
out	O
in	O
two	O
case	O
-	O
case	O
studies	O
in	O
discharged	O
SARS	O
patients	O
.	O

At	O
the	O
same	O
time	O
,	O
the	O
-	O
863	O
AC	O
genotype	O
was	O
manifested	O
as	O
another	O
risk	O
effect	O
associated	O
with	O
femoral	B-ANAT
head	I-ANAT
necrosis	O
with	O
OR	O
(	O
95	O
%	O
CI	O
)	O
of	O
6	O
.	O
42	O
(	O
1	O
.	O
53	O
-	O
26	O
.	O
88	O
)	O
and	O
the	O
adjusted	O
OR	O
was	O
8	O
.	O
40	O
(	O
95	O
%	O
CI	O
1	O
.	O
76	O
-	O
40	O
.	O
02	O
)	O
in	O
cured	O
SARS	O
patients	O
compared	O
to	O
CC	O
genotype	O
.	O

In	O
all	O
CTL	B-ANAT
epitopes	O
prone	O
to	O
escape	O
,	O
only	O
a	O
subset	O
of	O
all	O
potential	O
variants	O
is	O
generally	O
detected	O
,	O
even	O
though	O
many	O
of	O
the	O
changes	O
that	O
are	O
not	O
selected	O
would	O
result	O
in	O
evasion	O
of	O
the	O
T	B-ANAT
cell	I-ANAT
response	O
.	O

TITLE	O
:	O
[	O
Ovarian	B-ANAT
overstimulation	O
syndrome	O
:	O
problem	O
of	O
intensive	O
care	O
].	O

When	O
the	O
DNA	O
vaccines	O
were	O
administered	O
to	O
the	O
quadriceps	B-ANAT
muscle	B-ANAT
of	O
chickens	O
,	O
the	O
induced	O
humoral	O
and	O
cellular	B-ANAT
responses	O
were	O
evaluated	O
.	O

The	O
percentage	O
of	O
CD3	O
+,	O
CD3	O
+	O
CD8	O
+	O
and	O
CD3	O
+	O
CD4	O
+	O
subgroups	O
of	O
peripheral	B-ANAT
blood	I-ANAT
T	B-ANAT
-	I-ANAT
lymphocytes	I-ANAT
in	O
chickens	O
immunized	O
with	O
bicistronic	O
DNA	O
vaccine	O
were	O
higher	O
than	O
those	O
in	O
chickens	O
immunized	O
with	O
monocistronic	O
DNA	O
vaccine	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
therapeutic	O
effect	O
of	O
Yihuo	O
Qingxia	O
method	O
,	O
a	O
traditional	O
Chinese	O
medicine	O
therapeutic	O
method	O
for	O
replenishing	O
qi	O
to	O
activate	O
blood	B-ANAT
,	O
clearing	O
away	O
heat	O
and	O
dredging	O
intestines	B-ANAT
,	O
in	O
treating	O
hyperlipoidemia	O
-	O
related	O
severe	O
acute	O
pancreatitis	O
(	O
SAP	O
)	O
in	O
early	O
stage	O
.	O

The	O
incidences	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
acute	O
renal	B-ANAT
failure	O
,	O
hepatic	B-ANAT
inadequacy	O
,	O
congestive	O
heart	B-ANAT
failure	O
,	O
shock	O
,	O
encephalopathy	O
,	O
infection	O
and	O
alimentary	B-ANAT
tract	I-ANAT
hemorrhage	O
in	O
early	O
group	O
were	O
higher	O
than	O
those	O
in	O
late	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

The	O
numbers	O
of	O
CD4	O
+	O
forkhead	O
box	O
P3	O
+	O
cells	B-ANAT
increased	O
in	O
the	O
livers	B-ANAT
from	O
low	O
pathogenic	O
CL12	O
-	O
MHV3	O
and	O
YAC	O
-	O
MHV3	O
-	O
infected	O
mice	O
.	O

The	O
nucleic	B-ANAT
acid	O
of	O
IBV	O
was	O
detected	O
in	O
105	O
out	O
174	O
(	O
60	O
%)	O
broiler	O
flocks	O
by	O
RT	O
-	O
PCR	O
.	O

Gene	O
and	O
protein	O
expression	O
of	O
lung	B-ANAT
Na	O
,	O
K	O
-	O
ATPase	O
alpha1	O
,	O
alpha2	O
,	O
and	O
beta1	O
subunits	O
were	O
quantified	O
via	O
real	O
-	O
time	O
PCR	O
and	O
immunobiological	O
analyses	O
,	O
respectively	O
.	O

Alcohol	O
-	O
induced	O
,	O
Na	O
,	O
K	O
-	O
ATPase	O
-	O
dependent	O
epithelial	O
barrier	O
dysfunction	O
was	O
determined	O
by	O
calculating	O
lung	B-ANAT
tissue	I-ANAT
wet	O
:	O
dry	O
ratios	O
following	O
an	O
ex	O
vivo	O
buffer	O
-	O
perfused	O
challenge	O
for	O
2	O
hours	O
in	O
the	O
presence	O
of	O
ouabain	O
(	O
10	O
(-	O
4	O
)	O
M	O
),	O
a	O
Na	O
,	O
K	O
-	O
ATPase	O
inhibitor	O
.	O

These	O
results	O
indicate	O
that	O
SARS	O
-	O
CoV	O
causes	O
multi	O
-	O
organ	B-ANAT
pathology	O
in	O
civets	O
,	O
similar	O
to	O
that	O
observed	O
in	O
human	O
SARS	O
patients	O
.	O

Those	O
who	O
received	O
SAV	O
late	O
had	O
a	O
higher	O
risk	O
of	O
developing	O
acute	O
renal	B-ANAT
failure	O
.	O

CONCLUSIONS	O
:	O
Despite	O
lung	B-ANAT
-	O
protective	O
ventilation	O
,	O
abnormalities	O
in	O
plasma	B-ANAT
levels	O
of	O
markers	O
of	O
inflammation	O
,	O
coagulation	O
and	O
fibrinolysis	O
predict	O
mortality	O
in	O
ALI	O
patients	O
,	O
indicating	O
more	O
severe	O
activation	O
of	O
these	O
biologic	O
pathways	O
in	O
nonsurvivors	O
.	O

ACE2	O
mRNA	O
in	O
human	O
femoral	B-ANAT
head	I-ANAT
was	O
detected	O
by	O
nested	O
RT	O
-	O
PCR	O
with	O
human	O
beta	O
actin	O
gene	O
as	O
the	O
positive	O
control	O
.	O

The	O
mRNA	O
of	O
human	O
ACE2	O
was	O
expressed	O
efficiently	O
in	O
the	O
normal	O
lung	B-ANAT
tissue	I-ANAT
,	O
but	O
not	O
in	O
the	O
cartilage	B-ANAT
and	O
cancellous	B-ANAT
bone	I-ANAT
under	O
the	O
weight	O
-	O
bearing	O
area	O
of	O
the	O
femoral	B-ANAT
head	I-ANAT
.	O

In	O
addition	O
to	O
the	O
toxicities	O
of	O
carbon	O
monoxide	O
,	O
concomitant	O
inhalation	O
of	O
formic	O
acid	O
fumes	O
can	O
cause	O
severe	O
lung	B-ANAT
injury	O
,	O
which	O
may	O
complicate	O
the	O
management	O
of	O
carbon	O
monoxide	O
poisoning	O
.	O

TITLE	O
:	O
Pulmonary	B-ANAT
coccidioidomycosis	O
.	O

Pulmonary	B-ANAT
coccidioidomycosis	O
occurs	O
in	O
95	O
%	O
of	O
all	O
cases	O
and	O
can	O
be	O
divided	O
into	O
three	O
main	O
categories	O
:	O
primary	O
,	O
complicated	O
,	O
and	O
residual	O
pulmonary	B-ANAT
coccidioidomycosis	O
.	O

We	O
used	O
published	O
interaction	O
data	O
to	O
identify	O
hubs	O
of	O
connectivity	O
with	O
potential	O
significance	O
for	O
virion	B-ANAT
formation	O
.	O

In	O
order	O
to	O
investigate	O
the	O
potential	O
SARS	O
-	O
CoV	O
kidney	B-ANAT
tropism	O
,	O
we	O
have	O
evaluated	O
the	O
susceptibility	O
of	O
human	O
renal	B-ANAT
cells	B-ANAT
of	O
tubular	O
and	O
glomerular	B-ANAT
origin	O
to	O
in	O
vitro	O
SARS	O
-	O
CoV	O
infection	O
.	O

This	O
SARS	O
-	O
CoV	O
variant	O
acquired	O
a	O
single	O
nonconservative	O
amino	O
acid	O
change	O
from	O
glutamic	O
acid	O
(	O
E	O
)	O
to	O
alanine	O
(	O
A	O
)	O
at	O
position	O
11	O
in	O
the	O
viral	B-ANAT
membrane	I-ANAT
(	O
M	O
)	O
protein	O
.	O

ABSTRACT	O
:	O
To	O
characterize	O
species	O
and	O
quantitative	O
composition	O
of	O
intestinal	B-ANAT
microflora	O
in	O
lingering	O
and	O
complicated	O
course	O
of	O
community	O
pneumonia	O
(	O
CP	O
).	O

TITLE	O
:	O
Materno	O
-	O
fetal	B-ANAT
transmission	O
of	O
human	O
coronaviruses	O
:	O
a	O
prospective	O
pilot	O
study	O
.	O

Oleic	O
acid	O
resulted	O
in	O
sepsis	O
-	O
like	O
responses	O
including	O
ALI	O
,	O
inflammatory	O
reaction	O
,	O
and	O
increased	O
neutrophil	B-ANAT
-	O
derived	O
factors	O
.	O

Notably	O
,	O
sera	B-ANAT
demonstrated	O
cross	O
-	O
reactivity	O
against	O
nucleocapsid	B-ANAT
peptide	O
sequences	O
common	O
to	O
HCoV	O
-	O
OC43	O
and	O
SARS	O
-	O
CoV	O
.	O
These	O
findings	O
underscore	O
the	O
virulence	O
of	O
human	O
CoV	O
-	O
OC43	O
in	O
elderly	O
populations	O
and	O
confirm	O
that	O
cross	O
-	O
reactivity	O
to	O
antibody	O
against	O
nucleocapsid	B-ANAT
proteins	O
from	O
these	O
viruses	O
must	O
be	O
considered	O
when	O
interpreting	O
serological	O
tests	O
for	O
SARS	O
-	O
CoV	O
.	O
RESULTS	O
:	O
Ninety	O
-	O
five	O
of	O
142	O
residents	O
(	O
67	O
%)	O
and	O
53	O
of	O
160	O
staff	O
members	O
(	O
33	O
%)	O
experienced	O
symptoms	O
of	O
respiratory	O
infection	O
.	O

Here	O
we	O
demonstrate	O
that	O
these	O
strains	O
also	O
differ	O
in	O
their	O
abilities	O
to	O
infect	O
a	O
particular	O
cell	B-ANAT
type	I-ANAT
(	O
s	O
)	O
in	O
the	O
brain	B-ANAT
.	O

TITLE	O
:	O
The	O
nucleocapsid	B-ANAT
protein	O
of	O
SARS	O
-	O
CoV	O
induces	O
transcription	O
of	O
hfgl2	O
prothrombinase	O
gene	O
dependent	O
on	O
C	O
/	O
EBP	O
alpha	O
.	O

To	O
investigate	O
whether	O
and	O
which	O
structural	O
protein	O
of	O
SARS	O
-	O
CoV	O
induced	O
transcription	O
of	O
hfgl2	O
prothrombinase	O
gene	O
,	O
three	O
eukaryotic	O
expression	O
plasmids	O
expressing	O
nucleocapsid	B-ANAT
protein	O
(	O
N	O
),	O
membrane	B-ANAT
protein	O
(	O
M	O
)	O
and	O
spike	O
protein	O
2	O
(	O
S2	O
)	O
of	O
SARS	O
-	O
CoV	O
were	O
co	O
-	O
transfected	O
with	O
hfgl2	O
promoter	O
luciferase	O
-	O
reporter	O
plasmids	O
and	O
beta	O
-	O
galactosidase	O
plasmid	O
in	O
CHO	B-ANAT
cells	I-ANAT
,	O
respectively	O
.	O

Site	O
-	O
directed	O
mutagenesis	O
and	O
EMSA	O
assay	O
further	O
demonstrated	O
that	O
transcription	O
factor	O
C	O
/	O
EBP	O
alpha	O
band	B-ANAT
with	O
its	O
cognate	O
cis	O
-	O
element	O
in	O
hfgl2	O
promoter	O
.	O

TITLE	O
:	O
Molecular	O
analysis	O
of	O
the	O
bovine	O
coronavirus	O
S1	O
gene	O
by	O
direct	O
sequencing	O
of	O
diarrheic	O
fecal	B-ANAT
specimens	O
.	O

The	O
BCoV	O
S	O
protein	O
plays	O
a	O
fundamental	O
role	O
in	O
viral	O
attachment	O
and	O
entry	O
into	O
the	O
host	B-ANAT
cell	I-ANAT
,	O
and	O
is	O
cleaved	B-ANAT
into	O
two	O
subunits	O
termed	O
S1	O
(	O
amino	O
terminal	O
)	O
and	O
S2	O
(	O
carboxy	O
terminal	O
).	O

The	O
samples	O
did	O
not	O
undergo	O
cell	B-ANAT
culture	O
passage	O
prior	O
to	O
PCR	O
amplification	O
and	O
sequencing	O
.	O

ABSTRACT	O
:	O
Avian	O
Infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
is	O
a	O
coronavirus	O
that	O
infects	O
chickens	O
via	O
the	O
respiratory	B-ANAT
epithelium	I-ANAT
as	O
primary	O
target	B-ANAT
cells	I-ANAT
.	O

EVLI	O
,	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
(	O
APACHE	O
)	O
II	O
score	O
,	O
development	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
chest	B-ANAT
X	O
-	O
ray	O
score	O
,	O
lung	B-ANAT
injury	O
score	O
,	O
body	B-ANAT
mass	O
index	O
,	O
prior	O
24h	O
fluid	O
balance	O
,	O
albumin	O
,	O
and	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
counts	O
were	O
shown	O
to	O
be	O
predictors	O
of	O
in	O
-	O
hospital	O
survival	O
by	O
a	O
bivariate	O
analysis	O
.	O

TITLE	O
:	O
Expression	O
and	O
membrane	B-ANAT
integration	O
of	O
SARS	O
-	O
CoV	O
M	O
protein	O
.	O

The	O
second	O
and	O
third	O
trans	O
-	O
membrane	B-ANAT
regions	O
(	O
a	O
.	O
a	O
.	O

46	O
-	O
68	O
and	O
78	O
-	O
100	O
)	O
are	O
predicted	O
to	O
be	O
the	O
primary	O
type	O
helices	O
,	O
which	O
will	O
be	O
able	O
to	O
penetrate	O
into	O
membrane	B-ANAT
by	O
themselves	O
,	O
while	O
the	O
first	O
trans	O
-	O
membrane	B-ANAT
region	O
(	O
a	O
.	O
a	O
.	O

Proliferative	O
and	O
necrotising	O
pneumonia	O
(	O
PNP	O
)	O
was	O
diagnosed	O
in	O
two	O
animals	O
,	O
while	O
severe	O
acute	O
interstitial	B-ANAT
pneumonia	O
characterised	O
by	O
the	O
presence	O
of	O
abundant	O
hyaline	B-ANAT
membrane	B-ANAT
in	O
the	O
alveoli	B-ANAT
and	O
fibrin	O
in	O
the	O
bronchioles	B-ANAT
was	O
found	O
in	O
one	O
pig	O
.	O

Workers	O
at	O
risk	O
include	O
those	O
who	O
are	O
in	O
contact	O
with	O
live	O
or	O
dead	O
infected	O
animals	O
,	O
with	O
aerosols	O
,	O
dust	O
or	O
surfaces	O
contaminated	O
by	O
animal	O
secretions	B-ANAT
,	O
persons	O
engaged	O
in	O
animal	O
breeding	O
and	O
trade	O
,	O
veterinaries	O
,	O
and	O
others	O
.	O

An	O
adoptive	O
transfer	O
model	O
was	O
used	O
to	O
elucidate	O
the	O
kinetics	O
of	O
CD8	O
(+)	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
priming	O
during	O
CNS	B-ANAT
infection	O
with	O
RJHM	O
as	O
well	O
as	O
with	O
two	O
MHV	O
strains	O
that	O
induce	O
a	O
robust	O
CD8	O
(+)	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
response	O
(	O
RA59	O
and	O
SJHM	O
/	O
RA59	O
,	O
a	O
recombinant	O
A59	O
virus	O
expressing	O
the	O
JHM	O
spike	O
).	O

The	O
pursuit	O
of	O
lung	B-ANAT
-	O
protective	O
ventilation	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
is	O
a	O
leading	O
cause	O
of	O
death	O
in	O
people	O
infected	O
with	O
H5N1	O
avian	O
influenza	O
virus	O
or	O
the	O
SARS	O
-	O
coronavirus	O
.	O

TITLE	O
:	O
Identification	O
of	O
oxidative	O
stress	O
and	O
Toll	O
-	O
like	O
receptor	O
4	O
signaling	O
as	O
a	O
key	O
pathway	O
of	O
acute	O
lung	B-ANAT
injury	O
.	O

Western	O
blot	O
showed	O
that	O
both	O
anti	O
-	O
CCoV	O
mAbs	O
only	O
reacted	O
with	O
a	O
protein	O
of	O
50	O
kD	O
,	O
a	O
weight	O
consistent	O
with	O
the	O
feline	O
coronavirus	O
(	O
FCoV	O
)	O
viral	B-ANAT
nucleocapsid	I-ANAT
.	O

Formalin	O
-	O
fixed	B-ANAT
,	O
paraffin	O
-	O
embedded	O
sections	O
from	O
brains	B-ANAT
of	O
15	O
cats	O
with	O
the	O
dry	O
form	O
of	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
)	O
were	O
examined	O
by	O
immunohistochemistry	O
.	O

Electron	O
microscopic	O
examination	O
of	O
inflammatory	O
lesions	O
identified	O
particles	O
with	O
coronavirus	O
morphology	O
in	O
the	O
cytoplasm	B-ANAT
of	O
macrophages	B-ANAT
.	O

When	O
evaluating	O
epidemiologically	O
high	O
-	O
risk	O
patients	O
with	O
community	O
-	O
acquired	O
pneumonia	O
and	O
no	O
immediate	O
alternative	O
diagnosis	O
,	O
a	O
low	O
absolute	O
neutrophil	B-ANAT
count	O
on	O
presentation	O
,	O
along	O
with	O
poor	O
responses	O
after	O
72	O
h	O
of	O
antibiotic	O
treatment	O
,	O
may	O
raise	O
the	O
index	O
of	O
suspicion	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

The	O
most	O
promising	O
compounds	O
include	O
carbohydrate	O
-	O
binding	O
agents	O
,	O
neutralizing	O
antibodies	O
and	O
drugs	O
targeting	O
a	O
coronaviral	O
envelope	B-ANAT
protein	O
.	O

The	O
lung	B-ANAT
weight	O
was	O
about	O
two	O
-	O
fold	O
the	O
normal	O
value	O
.	O

The	O
clinical	O
investigation	O
and	O
analysis	O
suggest	O
direct	O
endothelial	B-ANAT
cell	I-ANAT
invasion	O
of	O
the	O
organism	O
and	O
marked	O
iNOS	O
expression	O
may	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
ARDS	O
associated	O
with	O
scrub	O
typhus	O
.	O

The	O
protein	O
was	O
named	O
human	B-ANAT
embryo	I-ANAT
lung	B-ANAT
cellular	B-ANAT
protein	O
interacting	O
with	O
SARS	O
-	O
CoV	O
nsp	O
-	O
10	O
(	O
HEPIS	O
),	O
and	O
it	O
is	O
composed	O
of	O
147	O
amino	O
acids	O
with	O
several	O
CK	O
II	O
phosphorylation	O
sites	O
.	O

Furthermore	O
,	O
we	O
co	O
-	O
immunoprecipitated	O
HEPIS	O
with	O
BTF3	O
,	O
a	O
component	O
of	O
the	O
RNA	O
pol	O
II	O
initiation	O
complex	O
,	O
and	O
observed	O
reduced	O
proliferation	O
of	O
HeLa	B-ANAT
cells	I-ANAT
transfected	O
with	O
the	O
HEPIS	O
gene	O
.	O

Our	O
analysis	O
suggests	O
that	O
the	O
scale	O
of	O
the	O
SARS	O
impact	O
on	O
affected	O
economies	O
was	O
far	O
smaller	O
than	O
suggested	O
by	O
contemporary	O
media	B-ANAT
reports	O
and	O
model	O
estimates	O
.	O

We	O
conclude	O
that	O
scrub	O
typhus	O
should	O
be	O
taken	O
into	O
consideration	O
among	O
patients	O
of	O
acute	O
systemic	O
febrile	O
illness	O
,	O
especially	O
those	O
with	O
suspected	O
exposure	O
history	O
and	O
typical	O
skin	B-ANAT
lesion	O
.	O

Specific	O
humoral	O
and	O
cellular	B-ANAT
immunity	O
in	O
mice	O
could	O
be	O
induced	O
significantly	O
by	O
inoculating	O
SARS	O
-	O
CoV	O
N1	O
and	O
N3	O
DNA	O
vaccine	O
.	O

Treatment	O
with	O
ethyl	O
pyruvate	O
has	O
been	O
shown	O
to	O
improve	O
survival	O
and	O
ameliorate	O
organ	B-ANAT
dysfunction	O
in	O
a	O
wide	O
variety	O
of	O
preclinical	O
models	O
of	O
critical	O
illnesses	O
,	O
such	O
as	O
severe	O
sepsis	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
burn	O
injury	O
,	O
acute	O
pancreatitis	O
and	O
stroke	O
.	O

Blood	B-ANAT
and	O
turbinate	B-ANAT
wash	O
samples	O
,	O
and	O
lung	B-ANAT
tissue	I-ANAT
were	O
collected	O
from	O
each	O
animal	O
at	O
different	O
time	O
points	O
after	O
SARS	O
coronavirus	O
(	O
CoV	O
)	O
infection	O
for	O
determining	O
the	O
growth	O
curve	O
of	O
virus	O
,	O
if	O
any	O
,	O
by	O
the	O
standard	O
infectivity	O
assay	O
in	O
Vero	O
E6	O
cells	B-ANAT
.	O

SARS	O
-	O
CoV	O
protein	O
6	O
increases	O
MHV	O
neurovirulence	O
and	O
accelerates	O
MHV	O
infection	O
kinetics	O
in	O
tissue	B-ANAT
culture	O
.	O

TITLE	O
:	O
siRNA	O
silencing	O
of	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
reduced	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
replications	O
in	O
Vero	O
E6	O
cells	B-ANAT
.	O

Our	O
data	O
establish	O
a	O
vital	O
functional	O
dependence	O
of	O
SARS	O
-	O
CoV	O
RNA	O
synthesis	O
on	O
virus	O
-	O
induced	O
membrane	B-ANAT
structures	O
.	O

Multiple	O
-	O
factor	O
Logistic	O
regression	O
analysis	O
indicated	O
that	O
the	O
MODS	O
(	O
OR	O
=	O
67	O
.	O
358	O
,	O
P	O
<	O
0	O
.	O
01	O
),	O
APACHE	O
II	O
score	O
(	O
OR	O
=	O
9	O
.	O
716	O
,	O
P	O
<	O
0	O
.	O
01	O
)	O
and	O
ACS	O
(	O
OR	O
=	O
5	O
.	O
775	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
were	O
the	O
independent	O
risk	O
factors	O
affecting	O
the	O
prognosis	O
of	O
SAP	O
during	O
its	O
early	O
stage	O
,	O
whereas	O
pancreatic	B-ANAT
infection	O
(	O
OR	O
=	O
9	O
.	O
652	O
,	O
P	O
<	O
0	O
.	O
01	O
),	O
MODS	O
(	O
OR	O
=	O
5	O
.	O
212	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
celiac	O
hemorrhage	O
(	O
OR	O
=	O
4	O
.	O
707	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
were	O
the	O
independent	O
risk	O
factors	O
during	O
the	O
advanced	O
stage	O
of	O
SAP	O
.	O

The	O
culprit	O
,	O
SARS	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
),	O
was	O
detected	O
in	O
patient	O
specimens	O
by	O
traditional	O
cell	B-ANAT
culture	O
using	O
an	O
unusual	O
cell	B-ANAT
line	I-ANAT
for	O
respiratory	O
viruses	O
,	O
Vero	O
E6	O
,	O
and	O
by	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
targeting	O
the	O
polymerase	O
1	O
B	O
region	O
of	O
the	O
genome	O
.	O

Plasma	B-ANAT
cytokine	O
and	O
chemokine	O
profiles	O
showed	O
markedly	O
elevated	O
Th1	O
cytokine	O
interferon	O
(	O
IFN	O
)-	O
gamma	O
,	O
inflammatory	O
cytokines	O
interleukin	O
(	O
IL	O
)-	O
1beta	O
,	O
IL	O
-	O
6	O
and	O
IL	O
-	O
12	O
,	O
neutrophil	B-ANAT
chemokine	O
IL	O
-	O
8	O
,	O
monocyte	B-ANAT
chemoattractant	O
protein	O
-	O
1	O
(	O
MCP	O
-	O
1	O
),	O
and	O
Th1	O
chemokine	O
IFN	O
-	O
gamma	O
-	O
inducible	O
protein	O
-	O
10	O
(	O
IP	O
-	O
10	O
)	O
for	O
at	O
least	O
two	O
weeks	O
after	O
disease	O
onset	O
,	O
but	O
there	O
was	O
no	O
significant	O
elevation	O
of	O
inflammatory	O
cytokine	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)-	O
alpha	O
and	O
anti	O
-	O
inflammatory	O
cytokine	O
IL	O
-	O
10	O
.	O

Moribund	O
adult	O
mice	O
showed	O
severe	O
pulmonary	B-ANAT
edema	O
and	O
diffuse	O
alveolar	B-ANAT
damage	O
accompanied	O
by	O
virus	O
replication	O
.	O

TITLE	O
:	O
Improved	O
microarray	O
gene	O
expression	O
profiling	O
of	O
virus	O
-	O
infected	O
cells	B-ANAT
after	O
removal	O
of	O
viral	O
RNA	O
.	O

RESULTS	O
:	O
Results	O
showed	O
that	O
HC	O
water	O
extract	O
could	O
stimulate	O
the	O
proliferation	O
of	O
mouse	O
splenic	B-ANAT
lymphocytes	B-ANAT
significantly	O
and	O
dose	O
-	O
dependently	O
.	O

The	O
aim	O
of	O
this	O
work	O
is	O
to	O
report	O
on	O
moderate	O
to	O
severe	O
respiratory	O
dysfunction	O
after	O
normal	O
oral	B-ANAT
doses	O
of	O
quetiapine	O
in	O
two	O
obese	O
patients	O
with	O
sleep	O
apnea	O
syndrome	O
(	O
SAS	O
).	O

TITLE	O
:	O
The	O
fetal	B-ANAT
brain	I-ANAT
in	O
bovine	O
viral	O
diarrhea	O
virus	O
-	O
infected	O
calves	O
:	O
lesions	O
,	O
distribution	O
,	O
and	O
cellular	B-ANAT
heterogeneity	O
of	O
viral	O
antigen	O
at	O
190	O
days	O
gestation	O
.	O

From	O
fluorescence	O
and	O
infrared	O
spectroscopies	O
,	O
the	O
peptide	O
ability	O
to	O
induce	O
membrane	B-ANAT
leakage	O
,	O
aggregation	O
and	O
fusion	O
,	O
as	O
well	O
as	O
its	O
affinity	O
toward	O
specific	O
phospholipids	O
,	O
was	O
assessed	O
.	O

Interestingly	O
,	O
peptide	O
organization	O
is	O
different	O
depending	O
if	O
SARS	O
FP	O
is	O
in	O
water	O
or	O
bound	O
to	O
the	O
membrane	B-ANAT
.	O

The	O
modulation	O
of	O
TACE	O
activity	O
by	O
SARS	O
-	O
S	O
depended	O
on	O
the	O
cytoplasmic	B-ANAT
domain	I-ANAT
of	O
ACE2	O
,	O
because	O
deletion	O
mutants	O
of	O
ACE2	O
lacking	O
the	O
carboxyl	O
-	O
terminal	O
region	O
did	O
not	O
induce	O
ACE2	O
shedding	O
or	O
TNF	O
-	O
alpha	O
production	O
.	O

Brain	B-ANAT
infection	O
may	O
result	O
in	O
long	O
-	O
term	O
neurological	O
sequelae	O
,	O
but	O
little	O
is	O
known	O
about	O
the	O
pathogenesis	O
of	O
SARS	O
-	O
CoV	O
in	O
this	O
organ	B-ANAT
.	O

Death	O
of	O
the	O
animal	O
likely	O
results	O
from	O
dysfunction	O
and	O
/	O
or	O
death	O
of	O
infected	O
neurons	B-ANAT
,	O
especially	O
those	O
located	O
in	O
cardiorespiratory	O
centers	O
in	O
the	O
medulla	B-ANAT
.	O

Our	O
results	O
show	O
that	O
neurons	B-ANAT
are	O
a	O
highly	O
susceptible	O
target	O
for	O
SARS	O
-	O
CoV	O
and	O
that	O
only	O
the	O
absence	O
of	O
the	O
host	B-ANAT
cell	I-ANAT
receptor	O
prevents	O
severe	O
murine	O
brain	B-ANAT
disease	O
.	O

EVLW	O
was	O
measured	O
for	O
7	O
days	O
by	O
PiCCO	O
transpulmonary	O
thermodilution	O
;	O
225	O
measurements	O
of	O
EVLW	O
indexed	O
to	O
actual	O
body	B-ANAT
weight	O
(	O
ActBW	O
)	O
were	O
compared	O
with	O
EVLW	O
indexed	O
to	O
predicted	O
body	B-ANAT
weight	O
(	O
PBW	O
)	O
and	O
adjusted	O
body	B-ANAT
weight	O
(	O
AdjBW	O
).	O

In	O
the	O
H5N1	O
/	O
PR8	O
-	O
5B19	O
virus	O
,	O
the	O
HA	O
cleavage	O
site	O
was	O
modified	O
to	O
resemble	O
that	O
of	O
low	O
-	O
pathogenic	O
avian	O
strains	O
and	O
a	O
portion	O
of	O
the	O
NA	O
stalk	B-ANAT
region	O
was	O
replaced	O
by	O
the	O
immunodominant	O
5B19	O
epitope	O
of	O
the	O
S2	O
glycoprotein	O
of	O
murine	O
hepatitis	O
virus	O
(	O
MHV	O
).	O

The	O
distribution	O
of	O
aquaporin	O
-	O
4	O
(	O
AQP	O
-	O
4	O
)	O
on	O
the	O
cell	B-ANAT
membrane	I-ANAT
was	O
observed	O
with	O
immunohistochemistry	O
,	O
and	O
the	O
expression	O
of	O
AQP	O
-	O
4	O
mRNA	O
was	O
detected	O
with	O
RT	O
-	O
PCR	O
.	O

The	O
level	O
of	O
APQ	O
-	O
4	O
whole	O
-	O
cell	B-ANAT
currents	O
was	O
decreased	O
in	O
AT	O
II	O
cell	B-ANAT
membrane	I-ANAT
and	O
increased	O
in	O
cytoplasm	B-ANAT
in	O
ALI	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Pathophysiological	O
changes	O
occurs	O
in	O
early	O
stage	O
of	O
oleic	O
acid	O
-	O
induced	O
AMI	O
,	O
and	O
AQP	O
-	O
4	O
mRNA	O
expression	O
is	O
up	O
-	O
regulated	O
on	O
the	O
AT	O
II	O
cell	B-ANAT
membrane	I-ANAT
to	O
regulate	O
the	O
exchange	O
of	O
fluid	O
between	O
the	O
alveolar	B-ANAT
space	O
and	O
alveolar	B-ANAT
epithelium	I-ANAT
barrier	O
and	O
play	O
an	O
important	O
compensational	O
role	O
in	O
pulmonary	B-ANAT
liquid	O
clearance	O
in	O
the	O
event	O
of	O
sodium	O
transport	O
damages	O
in	O
ALI	O
.	O

We	O
present	O
the	O
case	O
of	O
a	O
34	O
-	O
year	O
-	O
old	O
healthy	O
woman	O
with	O
a	O
twin	O
pregnancy	O
at	O
31	O
weeks	O
and	O
6	O
days	O
who	O
experienced	O
acute	O
respiratory	O
failure	O
,	O
a	O
few	O
hours	O
after	O
administration	O
of	O
tocolysis	O
(	O
ritodrine	O
),	O
due	O
to	O
preterm	O
premature	O
rupture	O
of	O
the	O
membranes	B-ANAT
.	O

Complications	O
occurred	O
in	O
7	O
patients	O
including	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
3	O
cases	O
,	O
thrombosis	O
of	O
right	B-ANAT
common	I-ANAT
iliac	I-ANAT
artery	I-ANAT
in	O
1	O
,	O
subphernic	O
abscess	O
in	O
2	O
and	O
infection	O
of	O
deep	O
wound	O
in	O
lower	B-ANAT
extremity	I-ANAT
in	O
1	O
.	O

The	O
role	O
of	O
the	O
immune	B-ANAT
system	I-ANAT
is	O
to	O
contain	O
and	O
control	O
the	O
spread	O
of	O
virus	O
within	O
the	O
CNS	B-ANAT
,	O
and	O
paradoxically	O
,	O
this	O
response	O
may	O
also	O
be	O
pathological	O
.	O

The	O
frameshifting	O
signal	O
encoded	O
in	O
the	O
viral	B-ANAT
genome	I-ANAT
has	O
additional	O
features	O
that	O
are	O
not	O
essential	O
for	O
frameshifting	O
.	O

E1	O
-	O
deleted	O
adenoviruses	O
replicate	O
to	O
high	O
titer	O
in	O
PER	O
.	O
C6	O
cells	B-ANAT
whereas	O
subsequent	O
deletion	O
of	O
E2A	O
from	O
the	O
vector	O
results	O
in	O
absence	O
of	O
replication	O
in	O
PER	O
.	O
C6	O
cells	B-ANAT
and	O
drastically	O
lowers	O
the	O
expression	O
of	O
adenovirus	O
proteins	O
in	O
such	O
cells	B-ANAT
.	O

After	O
the	O
animals	O
were	O
anesthetized	O
with	O
ketamine	O
and	O
xylazine	O
,	O
the	O
abdominal	B-ANAT
cavity	I-ANAT
was	O
opened	O
and	O
ligated	O
just	O
below	O
the	O
ileocaecal	B-ANAT
valve	I-ANAT
with	O
3	O
-	O
0	O
silk	O
.	O

The	O
lung	B-ANAT
MPO	O
,	O
malondialdehyde	O
(	O
MDA	O
),	O
protein	O
carbonyl	O
and	O
NO	O
levels	O
were	O
higher	O
in	O
the	O
sepsis	O
group	O
when	O
compared	O
to	O
group	O
control	O
,	O
sham	O
,	O
leflunomide	O
and	O
sepsis	O
+	O
leflunomide	O
(	O
P	O
<	O
0	O
.	O
05	O
),	O
and	O
MPO	O
,	O
MDA	O
and	O
NO	O
levels	O
were	O
higher	O
in	O
the	O
sepsis	O
+	O
leflunomide	O
group	O
than	O
in	O
the	O
sham	O
,	O
control	O
and	O
leflunomide	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

The	O
eschar	O
on	O
his	O
chest	B-ANAT
wall	I-ANAT
caused	O
us	O
to	O
suspect	O
Tsutsugamushi	O
disease	O
and	O
a	O
blood	B-ANAT
test	O
confirmed	O
our	O
suspicion	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
epidemiology	O
and	O
outcomes	O
of	O
intra	O
-	O
abdominal	B-ANAT
hypertension	O
in	O
a	O
heterogeneous	O
intensive	O
care	O
unit	O
population	O
.	O

Of	O
these	O
,	O
45	O
(	O
31	O
.	O
7	O
%)	O
a	O
pulmonary	B-ANAT
aetiology	O
of	O
SPRF	O
was	O
identified	O
.	O

A	O
DNA	O
prime	O
-	O
protein	O
boost	O
strategy	O
greatly	O
enhanced	O
the	O
antibody	O
generation	O
and	O
the	O
immune	O
sera	B-ANAT
not	O
only	O
reacted	O
with	O
the	O
lysates	O
of	O
SARS	O
-	O
CoV	O
-	O
infected	O
Vero	B-ANAT
cells	I-ANAT
but	O
also	O
neutralized	O
the	O
cytopathic	O
effect	O
of	O
SARS	O
by	O
75	O
%	O
at	O
1	O
:	O
160	O
dilution	O
.	O

TITLE	O
:	O
Use	O
of	O
albumin	O
quotient	O
and	O
IgG	O
index	O
to	O
differentiate	O
blood	B-ANAT
-	O
vs	O
brain	B-ANAT
-	O
derived	O
proteins	O
in	O
the	O
cerebrospinal	B-ANAT
fluid	I-ANAT
of	O
cats	O
with	O
feline	O
infectious	O
peritonitis	O
.	O

ABSTRACT	O
:	O
Inflammation	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
is	O
a	O
frequent	O
condition	O
in	O
cats	O
but	O
etiology	O
often	O
remains	O
unsolved	O
.	O

The	O
results	O
indicate	O
that	O
the	O
impact	O
of	O
pulmonary	B-ANAT
contusion	O
,	O
APACHE	O
II	O
score	O
,	O
gastrointestinal	O
haemorrhage	O
and	O
disseminated	O
intravascular	O
coagulation	O
may	O
help	O
to	O
predict	O
conversion	O
from	O
ALI	O
to	O
ARDS	O
in	O
the	O
early	O
phase	O
after	O
multiple	O
-	O
trauma	O
injury	O
.	O

Fecal	B-ANAT
shedding	O
,	O
as	O
determined	O
by	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
from	O
rectal	O
swabs	O
,	O
appeared	O
within	O
a	O
week	O
and	O
was	O
significantly	O
higher	O
in	O
kittens	O
than	O
older	O
cats	O
.	O

Here	O
,	O
the	O
crystal	B-ANAT
structure	O
of	O
HLA	B-ANAT
-	O
B	O
*	O
1501	O
in	O
complex	O
with	O
a	O
SARS	O
coronavirus	O
-	O
derived	O
nonapeptide	O
(	O
VQQESSFVM	O
)	O
has	O
been	O
determined	O
at	O
high	O
resolution	O
(	O
1	O
.	O
87	O
A	O
).	O

4	O
%	O
of	O
the	O
cardiac	B-ANAT
output	O
,	O
permitted	O
an	O
oxygen	O
transfer	O
and	O
carbon	O
dioxide	O
removal	O
of	O
298	O
.	O
4	O
+/-	O

ABSTRACT	O
:	O
Coronaviruses	O
induce	O
in	O
infected	O
cells	B-ANAT
the	O
formation	O
of	O
double	O
membrane	B-ANAT
vesicles	B-ANAT
,	O
which	O
are	O
the	O
sites	O
of	O
RNA	O
replication	O
.	O

Not	O
much	O
is	O
known	O
about	O
the	O
formation	O
of	O
these	O
vesicles	B-ANAT
,	O
although	O
recent	O
observations	O
indicate	O
an	O
important	O
role	O
for	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
in	O
the	O
formation	O
of	O
the	O
mouse	O
hepatitis	O
coronavirus	O
(	O
MHV	O
)	O
replication	O
complexes	O
(	O
RCs	O
).	O

MHV	O
RNA	O
replication	O
was	O
not	O
sensitive	O
to	O
BFA	O
in	O
MDCK	B-ANAT
cells	I-ANAT
,	O
which	O
are	O
known	O
to	O
express	O
the	O
BFA	O
-	O
resistant	O
guanine	O
nucleotide	O
exchange	O
factor	O
GBF1	O
.	O

Upon	O
loading	O
the	O
cell	B-ANAT
samples	O
and	O
lysis	O
solution	O
into	O
the	O
mixing	O
chamber	B-ANAT
,	O
the	O
integrated	O
microfluidic	O
device	O
allows	O
efficient	O
cell	B-ANAT
disruption	O
by	O
rotation	O
of	O
a	O
micromagnetic	O
disk	B-ANAT
and	O
control	O
of	O
mixing	O
time	O
using	O
the	O
Teflon	O
-	O
coated	O
hydrophobic	O
film	O
as	O
a	O
microvalve	O
.	O

This	O
inflow	O
is	O
followed	O
by	O
separating	O
the	O
cell	B-ANAT
debris	O
and	O
contaminated	O
proteins	O
from	O
the	O
cell	B-ANAT
lysate	O
sample	O
using	O
the	O
acrylamide	O
(	O
AAm	O
)-	O
functionalized	O
SPE	O
.	O

The	O
inflow	O
of	O
partially	O
purified	O
cell	B-ANAT
lysate	O
sample	O
containing	O
the	O
gold	O
binding	O
polypeptide	O
(	O
GBP	O
)-	O
fusion	O
protein	O
was	O
bound	O
onto	O
the	O
gold	O
micropatterns	O
by	O
means	O
of	O
its	O
metal	O
binding	O
affinity	O
.	O

The	O
etiology	O
of	O
the	O
sudden	O
increase	O
in	O
capillary	B-ANAT
permeability	O
remains	O
unclear	O
.	O

Decompressive	O
laparotomy	O
leads	O
to	O
a	O
rapid	O
improvement	O
in	O
pulmonary	B-ANAT
parameters	O
and	O
oxygen	O
delivery	O
.	O

ABSTRACT	O
:	O
To	O
test	O
whether	O
an	O
acute	O
transfusion	O
practice	O
of	O
packed	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
(	O
pRBC	O
)	O
:	O
fresh	B-ANAT
-	O
frozen	O
plasma	B-ANAT
(	O
FFP	O
)	O
1	O
:	O
1	O
would	O
be	O
associated	O
with	O
reduced	O
mortality	O
in	O
acute	O
bleeding	O
multiply	O
injury	O
.	O

The	O
frequency	O
for	O
septic	O
complications	O
and	O
organ	B-ANAT
failure	O
was	O
higher	O
in	O
the	O
pRBC	O
:	O
FFP	O
0	O
.	O
9	O
-	O
1	O
.	O
1	O
(	O
1	O
:	O
1	O
)	O
group	O
,	O
ventilator	O
days	O
and	O
length	O
of	O
stays	O
for	O
intensive	O
care	O
unit	O
and	O
overall	O
in	O
-	O
hospital	O
were	O
highest	O
in	O
the	O
pRBC	O
:	O
FFP	O
<	O
0	O
.	O
9	O
ratio	O
group	O
(	O
P	O
<	O
0	O
.	O
0005	O
).	O

Here	O
we	O
present	O
crystal	B-ANAT
structures	O
of	O
SARS	O
-	O
CoV	O
M	O
(	O
pro	O
),	O
the	O
active	O
-	O
site	O
cysteine	O
of	O
which	O
has	O
been	O
acylated	O
by	O
benzotriazole	O
esters	O
that	O
act	O
as	O
suicide	O
inhibitors	O
.	O

The	O
NMR	O
structure	O
is	O
almost	O
identical	O
with	O
the	O
previously	O
solved	O
crystal	B-ANAT
structure	O
,	O
except	O
for	O
a	O
disordered	O
putative	O
RNA	O
-	O
binding	O
domain	O
at	O
the	O
N	O
-	O
terminus	O
.	O

ABSTRACT	O
:	O
Unlike	O
other	O
class	O
I	O
viral	O
fusion	O
proteins	O
,	O
spike	O
proteins	O
on	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
virions	B-ANAT
are	O
uncleaved	O
.	O

As	O
we	O
and	O
others	O
have	O
demonstrated	O
,	O
infection	O
by	O
this	O
virus	O
depends	O
on	O
cathepsin	O
proteases	O
present	O
in	O
endosomal	O
compartments	B-ANAT
of	O
the	O
target	B-ANAT
cell	I-ANAT
,	O
suggesting	O
that	O
the	O
spike	O
protein	O
acquires	O
its	O
fusion	O
competence	O
by	O
cleavage	O
during	O
cell	B-ANAT
entry	O
rather	O
than	O
during	O
virion	B-ANAT
biogenesis	O
.	O

Significantly	O
altered	O
levels	O
of	O
IL	O
-	O
4	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
7	O
,	O
IL	O
-	O
10	O
,	O
and	O
IL	O
-	O
13	O
were	O
detected	O
within	O
the	O
first	O
7	O
days	O
after	O
admission	O
in	O
serum	B-ANAT
from	O
burn	O
pediatric	O
patients	O
with	O
concomitant	O
inhalation	O
injury	O
who	O
did	O
not	O
survive	O
when	O
compared	O
with	O
similar	O
patients	O
who	O
did	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

APC	B-ANAT
increased	O
plasma	B-ANAT
protein	O
C	O
levels	O
(	O
P	O
=	O
0	O
.	O
002	O
)	O
and	O
decreased	O
pulmonary	B-ANAT
dead	O
space	O
fraction	O
(	O
P	O
=	O
0	O
.	O
02	O
).	O

However	O
,	O
there	O
was	O
no	O
statistically	O
significant	O
difference	O
between	O
patients	O
receiving	O
placebo	O
(	O
n	O
=	O
38	O
)	O
or	O
APC	B-ANAT
(	O
n	O
=	O
37	O
)	O
in	O
the	O
number	O
of	O
ventilator	O
-	O
free	O
days	O
(	O
median	O
[	O
25	O
-	O
75	O
%	O
interquartile	O
range	O
]:	O
19	O
[	O
0	O
-	O
24	O
]	O
vs	O
.	O
19	O
[	O
14	O
-	O
22	O
],	O
respectively	O
;	O
P	O
=	O
0	O
.	O
78	O
)	O
or	O
in	O
60	O
-	O
day	O
mortality	O
(	O
5	O
/	O
38	O
vs	O
.	O
5	O
/	O
37	O
patients	O
,	O
respectively	O
;	O
P	O
=	O
1	O
.	O
0	O
).	O

Potentially	O
exposed	O
laboratory	O
workers	O
or	O
animal	O
handlers	O
with	O
rapidly	O
progressive	O
pneumonia	O
not	O
responding	O
to	O
standard	O
antibacterial	O
coverage	O
must	O
be	O
isolated	O
with	O
contact	O
and	O
droplet	O
,	O
and	O
for	O
specific	O
situations	O
,	O
airborne	O
precautions	O
,	O
till	O
rapid	O
tests	O
of	O
respiratory	O
and	O
faecal	B-ANAT
samples	O
are	O
negative	O
for	O
SARS	O
-	O
CoV	O
.	O
Generally	O
,	O
the	O
viral	O
loads	O
collected	O
at	O
different	O
anatomical	B-ANAT
sites	I-ANAT
correlate	O
with	O
the	O
severity	O
of	O
symptoms	O
and	O
mortality	O
.	O

In	O
addition	O
,	O
similar	O
with	O
experimental	O
results	O
,	O
the	O
complex	O
between	O
N3	O
and	O
3CL	O
(	O
Pro	O
)	O
is	O
578	O
kcal	O
/	O
mol	O
more	O
stable	O
than	O
N1	O
-	O
3CL	O
(	O
Pro	O
)	O
using	O
Own	O
N	O
-	O
layer	B-ANAT
Integrated	O
molecular	O
Orbital	O
molecular	O
Mechanics	O
(	O
ONIOM	O
)	O
approach	O
.	O

Identification	O
of	O
IBV	O
was	O
by	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
of	O
RNA	O
extracted	O
from	O
oropharyngeal	B-ANAT
swabs	O
taken	O
from	O
poultry	O
flocks	O
exhibiting	O
signs	O
of	O
clinical	O
disease	O
thought	O
to	O
be	O
attributable	O
to	O
IBV	O
.	O

For	O
three	O
of	O
the	O
four	O
ArkDPI	O
-	O
derived	O
vaccines	O
,	O
a	O
single	O
subpopulation	O
with	O
an	O
S	O
gene	O
sequence	O
distinct	O
from	O
the	O
vaccine	O
majority	O
consensus	O
at	O
5	O
to	O
11	O
codons	O
was	O
selected	O
in	O
chickens	O
within	O
3	O
days	O
after	O
ocular	B-ANAT
vaccination	O
.	O

We	O
demonstrate	O
that	O
MHV	O
-	O
A59	O
,	O
a	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
strain	O
that	O
causes	O
brain	B-ANAT
and	I-ANAT
spinal	I-ANAT
cord	I-ANAT
inflammation	O
and	O
demyelination	O
,	O
induces	O
ON	O
by	O
promoting	O
mixed	O
inflammatory	B-ANAT
cell	I-ANAT
infiltration	O
.	O

Virus	O
sequence	O
data	O
suggest	O
that	O
the	O
palm	B-ANAT
civet	O
served	O
as	O
an	O
amplification	O
host	O
in	O
which	O
civet	O
and	O
human	O
interaction	O
fostered	O
the	O
evolution	O
of	O
the	O
epidemic	O
SARS	O
Urbani	O
strain	O
.	O

Urbani	O
grew	O
with	O
similar	O
kinetics	O
in	O
both	O
the	O
DBT	O
-	O
cACE2	O
and	O
the	O
DBT	O
-	O
hACE2	O
cells	B-ANAT
,	O
while	O
icSZ16	O
-	O
S	O
only	O
grew	O
in	O
DBT	O
-	O
cACE2	O
cells	B-ANAT
.	O

In	O
a	O
cohort	O
of	O
33	O
lung	B-ANAT
transplant	B-ANAT
recipients	O
(	O
LTRs	O
)	O
we	O
assessed	O
early	O
post	O
-	O
transplant	B-ANAT
(<	O
or	O
=	O
3	O
months	O
)	O
graft	B-ANAT
deposition	O
of	O
the	O
complement	O
factors	O
C3d	O
and	O
C4d	O
and	O
correlated	O
staining	O
with	O
clinical	O
outcome	O
.	O

Biopsies	O
were	O
graded	O
0	O
to	O
3	O
based	O
on	O
extent	O
of	O
septal	O
capillary	B-ANAT
complement	O
staining	O
.	O

We	O
observed	O
SARS	O
-	O
CoV	O
antigen	O
expression	O
and	O
lesions	O
in	O
the	O
respiratory	B-ANAT
tracts	I-ANAT
of	O
4	O
cats	O
and	O
4	O
ferrets	O
at	O
4	O
days	O
postinoculation	O
and	O
ACE2	O
expression	O
in	O
the	O
respiratory	B-ANAT
tracts	I-ANAT
of	O
3	O
cats	O
and	O
3	O
ferrets	O
without	O
infection	O
.	O

ACE2	O
expression	O
occurred	O
mainly	O
in	O
type	O
I	O
and	O
II	O
pneumocytes	B-ANAT
,	O
tracheo	O
-	O
bronchial	B-ANAT
goblet	B-ANAT
cells	I-ANAT
,	O
serous	O
epithelial	B-ANAT
cells	I-ANAT
of	O
tracheo	O
-	O
bronchial	B-ANAT
submucosal	O
glands	B-ANAT
in	O
cats	O
,	O
and	O
type	B-ANAT
II	I-ANAT
pneumocytes	I-ANAT
and	O
serous	O
epithelial	B-ANAT
cells	I-ANAT
of	O
tracheo	O
-	O
bronchial	B-ANAT
submucosal	O
glands	B-ANAT
in	O
ferrets	O
.	O

TITLE	O
:	O
The	O
effectiveness	O
of	O
combined	O
treatment	O
with	O
methylprednisolone	O
and	O
cyclophosphamide	O
in	O
oral	B-ANAT
paraquat	O
poisoning	O
.	O

When	O
co	O
-	O
expressed	O
with	O
SARS	O
-	O
CoV	O
N	O
,	O
chimeras	O
containing	O
the	O
N	O
carboxyl	O
-	O
terminal	O
half	O
sequence	O
efficiently	O
packaged	O
N	O
.	O
However	O
,	O
the	O
same	O
was	O
not	O
true	O
for	O
the	O
chimera	O
bearing	O
the	O
N	O
amino	O
-	O
terminal	O
half	O
sequence	O
,	O
despite	O
its	O
production	O
of	O
substantial	O
amounts	O
of	O
VLPs	B-ANAT
.	O

We	O
concluded	O
that	O
lipoid	O
pneumonia	O
is	O
characterized	O
by	O
prolonged	O
elevatation	O
of	O
pulmonary	B-ANAT
vascular	B-ANAT
permeability	O
.	O

Results	O
from	O
a	O
capture	O
assay	O
show	O
that	O
DC	O
-	O
SIGN	O
-	O
expressing	O
cells	B-ANAT
(	O
including	O
B	O
-	O
THP	O
-	O
1	O
/	O
DC	O
-	O
SIGN	O
and	O
T	O
-	O
THP	O
-	O
1	O
/	O
DC	O
-	O
SIGN	O
)	O
and	O
peripheral	B-ANAT
blood	I-ANAT
dendritic	B-ANAT
cells	I-ANAT
are	O
capable	O
of	O
transferring	O
H5N1	O
pseudotyped	O
and	O
RG	O
virus	B-ANAT
particles	I-ANAT
to	O
target	B-ANAT
cells	I-ANAT
;	O
this	O
action	O
can	O
be	O
blocked	O
by	O
anti	O
-	O
DC	O
-	O
SIGN	O
monoclonal	O
antibodies	O
.	O

ABSTRACT	O
:	O
Experimental	O
and	O
clinical	O
studies	O
support	O
the	O
key	O
role	O
of	O
interleukin	O
6	O
(	O
IL	O
-	O
6	O
),	O
a	O
potent	O
proinflammatory	O
cytokine	O
,	O
in	O
the	O
development	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
).	O

Acute	O
lung	B-ANAT
injury	O
is	O
the	O
response	O
of	O
the	O
lung	B-ANAT
to	O
a	O
local	O
or	O
systemic	O
aggression	O
,	O
resulting	O
in	O
local	O
inflammation	O
and	O
coagulation	O
disorders	O
,	O
this	O
leading	O
to	O
increased	O
inflammatory	O
pulmonary	B-ANAT
edema	O
.	O

ABSTRACT	O
:	O
Five	O
known	O
human	O
coronaviruses	O
infect	O
the	O
human	O
respiratory	B-ANAT
tract	I-ANAT
:	O
HCoV	O
-	O
OC43	O
,	O
HCoV	O
-	O
229E	O
,	O
SARS	O
-	O
CoV	O
,	O
HCoV	O
-	O
NL63	O
and	O
HCoV	O
-	O
HKU1	O
.	O

A	O
discrete	O
time	O
stochastic	O
model	O
that	O
uses	O
a	O
back	B-ANAT
-	O
projection	O
approach	O
is	O
proposed	O
.	O

Biophysical	O
characterization	O
and	O
membrane	B-ANAT
interaction	O
.	O

Therefore	O
,	O
we	O
have	O
carried	O
out	O
a	O
study	O
of	O
the	O
binding	O
and	O
interaction	O
with	O
model	O
membranes	B-ANAT
of	O
a	O
peptide	O
corresponding	O
to	O
segment	O
873	O
-	O
888	O
of	O
the	O
SARS	O
-	O
CoV	O
S	O
glycoprotein	O
,	O
peptide	O
SARS	O
IFP	O
,	O
as	O
well	O
as	O
the	O
structural	O
changes	O
taking	O
place	O
in	O
both	O
the	O
phospholipid	O
and	O
the	O
peptide	O
induced	O
by	O
the	O
binding	O
of	O
the	O
peptide	O
to	O
the	O
membrane	B-ANAT
.	O

These	O
data	O
support	O
its	O
role	O
in	O
SARS	O
-	O
mediated	O
membrane	B-ANAT
fusion	O
and	O
suggest	O
that	O
the	O
regions	O
where	O
this	O
peptide	O
resides	O
might	O
assist	O
the	O
fusion	O
peptide	O
and	O
/	O
or	O
the	O
pretransmembrane	O
segment	O
of	O
the	O
SARS	O
-	O
CoV	O
spike	O
glycoprotein	O
in	O
the	O
fusion	O
process	O
.	O

To	O
achieve	O
better	O
outcomes	O
of	O
ECLS	O
in	O
this	O
high	O
risk	O
group	O
,	O
an	O
understanding	O
of	O
the	O
real	O
impact	O
of	O
preexisting	O
organ	B-ANAT
dysfunction	O
on	O
ECLS	O
-	O
associated	O
mortality	O
is	O
necessary	O
.	O

Patients	O
having	O
cardiac	B-ANAT
arrest	O
requiring	O
CPR	O
or	O
acute	O
renal	B-ANAT
failure	O
requiring	O
dialysis	O
before	O
ECLS	O
may	O
have	O
inferior	O
ECLS	O
outcomes	O
.	O

Nucleocapsid	B-ANAT
protein	O
(	O
NP	O
)	O
is	O
the	O
most	O
predominant	O
virus	O
derived	O
structural	O
protein	O
which	O
is	O
shed	O
in	O
high	O
amounts	O
in	O
serum	B-ANAT
and	O
nasopharyngeal	B-ANAT
aspirate	I-ANAT
during	O
the	O
first	O
week	O
of	O
infection	O
.	O

BsMAb	O
-	O
based	O
immunoswabs	O
detected	O
an	O
NP	O
concentration	O
of	O
20	O
pg	O
/	O
mL	O
in	O
saline	O
,	O
500	O
pg	O
/	O
mL	O
in	O
rabbit	O
serum	B-ANAT
and	O
20	O
-	O
200	O
pg	O
/	O
mL	O
in	O
pig	O
nasopharyngeal	B-ANAT
aspirate	I-ANAT
.	O

The	O
key	O
feature	O
of	O
this	O
simple	O
immunoswab	O
diagnostic	O
assay	O
is	O
its	O
ability	O
to	O
detect	O
the	O
presence	O
of	O
the	O
SARS	O
-	O
CoV	O
antigen	O
within	O
45	O
-	O
60	O
min	O
with	O
the	O
availability	O
of	O
the	O
body	B-ANAT
fluid	I-ANAT
samples	O
.	O

Tubular	O
function	O
alterations	O
precede	O
a	O
decrease	O
in	O
the	O
glomerular	B-ANAT
filtration	O
rate	O
,	O
which	O
could	O
explain	O
the	O
high	O
frequency	O
of	O
hypokalemia	O
.	O

Confirming	O
these	O
findings	O
,	O
Western	O
blot	O
studies	O
have	O
shown	O
lower	O
renal	B-ANAT
expression	O
of	O
the	O
sodium	O
/	O
hydrogen	O
exchanger	O
isoform	O
3	O
and	O
of	O
aquaporin	O
2	O
,	O
together	O
with	O
higher	O
renal	B-ANAT
expression	O
of	O
the	O
Na	O
-	O
K	O
-	O
2Cl	O
cotransporter	O
NKCC2	O
,	O
in	O
infected	O
animals	O
.	O

The	O
ability	O
of	O
the	O
ribosome	B-ANAT
to	O
change	O
translational	O
reading	O
frames	O
in	O
the	O
-	O
1	O
direction	O
(-	O
1	O
PRF	O
)	O
is	O
employed	O
by	O
many	O
positive	O
strand	O
RNA	O
viruses	O
,	O
including	O
economically	O
important	O
plant	O
viruses	O
and	O
many	O
human	O
pathogens	O
,	O
such	O
as	O
retroviruses	O
,	O
e	O
.	O
g	O
.,	O
HIV	O
-	O
1	O
,	O
and	O
coronaviruses	O
,	O
e	O
.	O
g	O
.,	O
the	O
causative	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
in	O
order	O
to	O
properly	O
express	O
their	O
genomes	O
.	O

The	O
precise	O
mechanism	O
by	O
which	O
the	O
downstream	O
RNA	O
stimulates	O
-	O
1	O
PRF	O
by	O
the	O
translocating	O
ribosome	B-ANAT
remains	O
unclear	O
.	O

Bordetella	O
bronchiseptica	O
(	O
B	O
.	O
b	O
.)	O
was	O
most	O
frequently	O
detected	O
from	O
nasal	B-ANAT
and	O
oropharynx	B-ANAT
sites	O
of	O
7	O
dogs	O
(	O
10	O
.	O
3	O
%).	O

Such	O
BVLPs	O
up	O
-	O
regulated	O
the	O
level	O
of	O
CD40	O
,	O
CD80	O
,	O
CD86	O
,	O
CD83	O
,	O
and	O
enhanced	O
the	O
secretion	B-ANAT
of	O
IL	O
-	O
6	O
,	O
IL	O
-	O
10	O
and	O
TNF	O
-	O
alpha	O
in	O
immature	O
dendritic	B-ANAT
cells	I-ANAT
(	O
DCs	O
).	O

Further	O
study	O
indicated	O
that	O
IFN	O
-	O
gamma	O
+	O
and	O
IL	O
-	O
4	O
+	O
populations	O
in	O
CD4	O
+	O
T	B-ANAT
cells	I-ANAT
increased	O
upon	O
co	O
-	O
cultivation	O
with	O
DCs	O
pre	O
-	O
exposed	O
with	O
BVLPs	O
or	O
SARS	O
-	O
CoV	O
VLPs	B-ANAT
.	O

The	O
nucleocapsid	B-ANAT
protein	O
lacking	O
the	O
RS	O
motif	O
formed	O
high	O
-	O
order	O
RNP	B-ANAT
complexes	O
,	O
which	O
may	O
also	O
account	O
for	O
its	O
enhanced	O
stress	B-ANAT
granule	I-ANAT
localization	O
.	O

Scanning	O
alanine	O
mutagenesis	O
identified	O
two	O
regions	O
in	O
the	O
carboxy	O
-	O
terminal	O
portion	O
of	O
the	O
TMD	O
that	O
eliminated	O
the	O
Golgi	B-ANAT
complex	I-ANAT
localization	O
of	O
the	O
chimeric	O
CD4	O
proteins	O
or	O
ORF7b	O
protein	O
.	O

Collectively	O
,	O
these	O
data	O
demonstrate	O
that	O
the	O
Golgi	B-ANAT
complex	I-ANAT
retention	O
signal	O
of	O
the	O
ORF7b	O
protein	O
resides	O
solely	O
within	O
the	O
TMD	O
.	O

This	O
was	O
the	O
result	O
of	O
increased	O
Bax	O
oligomerization	O
and	O
higher	O
levels	O
of	O
p53	O
in	O
3a	O
protein	O
-	O
expressing	O
cells	B-ANAT
,	O
which	O
depended	O
on	O
the	O
activation	O
of	O
p38	O
MAP	O
kinase	O
(	O
MAPK	O
)	O
in	O
these	O
cells	B-ANAT
.	O

In	O
direct	O
Annexin	O
V	O
staining	O
assays	O
,	O
the	O
3a	O
protein	O
-	O
expressing	O
cells	B-ANAT
showed	O
increased	O
apoptosis	O
that	O
was	O
attenuated	O
with	O
the	O
p38	O
MAPK	O
inhibitor	O
SB203580	O
.	O

Recent	O
reports	O
have	O
suggested	O
that	O
direct	O
hemoperfusion	O
with	O
a	O
polymyxin	O
B	O
-	O
immobilized	O
fiber	B-ANAT
column	B-ANAT
(	O
DHP	O
-	O
PMX	O
)	O
may	O
improve	O
the	O
oxygenation	O
in	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Coronaviruses	O
were	O
detected	O
in	O
the	O
intestinal	B-ANAT
contents	I-ANAT
of	O
chickens	O
,	O
but	O
not	O
turkeys	O
.	O

ABSTRACT	O
:	O
Sudden	O
severe	O
upper	O
-	O
airway	B-ANAT
obstruction	O
occurring	O
in	O
a	O
hospital	O
setting	O
can	O
sometimes	O
precipitate	O
an	O
episode	O
of	O
acute	O
haemorrhagic	O
pulmonary	B-ANAT
oedema	O
.	O

If	O
what	O
looks	O
like	O
blood	B-ANAT
is	O
seen	O
in	O
,	O
or	O
coming	O
from	O
,	O
the	O
mouth	B-ANAT
or	O
nose	B-ANAT
of	O
a	O
previously	O
healthy	O
young	O
child	O
who	O
has	O
suddenly	O
become	O
distressed	O
and	O
started	O
to	O
struggle	O
for	O
breath	B-ANAT
,	O
that	O
child	O
has	O
most	O
probably	O
suffered	O
an	O
episode	O
of	O
acute	O
pulmonary	B-ANAT
oedema	O
,	O
and	O
the	O
commonest	O
precipitating	O
cause	O
is	O
sudden	O
upper	O
-	O
airway	B-ANAT
obstruction	O
.	O

TITLE	O
:	O
Structural	O
flexibility	O
of	O
the	O
pentameric	O
SARS	O
coronavirus	O
envelope	B-ANAT
protein	O
ion	O
channel	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
contain	O
a	O
small	O
envelope	B-ANAT
membrane	B-ANAT
protein	O
with	O
cation	O
-	O
selective	O
ion	O
channel	O
activity	O
mediated	O
by	O
its	O
transmembrane	B-ANAT
domain	O
(	O
ETM	O
).	O

We	O
thus	O
report	O
the	O
correct	O
backbone	B-ANAT
model	O
for	O
the	O
pentameric	O
alpha	O
-	O
helical	O
bundle	O
of	O
ETM	O
.	O

It	O
is	O
essentially	O
important	O
to	O
recognize	O
and	O
treat	O
MAS	B-ANAT
earlier	O
in	O
order	O
to	O
lower	O
the	O
mortality	O
.	O

Interestingly	O
,	O
MHV	O
induced	O
IFN	O
-	O
beta	O
in	O
the	O
brains	B-ANAT
and	O
livers	B-ANAT
,	O
two	O
main	O
targets	O
of	O
MHV	O
replication	O
,	O
of	O
infected	O
wild	O
-	O
type	O
mice	O
.	O

Furthermore	O
,	O
macrophages	B-ANAT
and	O
microglia	B-ANAT
,	O
but	O
not	O
neurons	B-ANAT
or	O
astrocytes	B-ANAT
,	O
are	O
responsible	O
for	O
IFN	O
-	O
beta	O
production	O
in	O
the	O
brain	B-ANAT
.	O

To	O
determine	O
the	O
pathway	O
by	O
which	O
MHV	O
is	O
recognized	O
in	O
macrophages	B-ANAT
,	O
IFN	O
-	O
beta	O
mRNA	O
expression	O
was	O
quantified	O
following	O
MHV	O
infection	O
of	O
a	O
panel	O
of	O
primary	O
bone	B-ANAT
marrow	I-ANAT
-	I-ANAT
derived	I-ANAT
macrophages	I-ANAT
generated	O
from	O
mice	O
lacking	O
different	O
pattern	O
recognition	O
receptors	O
(	O
PRRs	O
).	O

TITLE	O
:	O
Implication	O
of	O
receptor	O
for	O
advanced	O
glycation	O
end	O
product	O
(	O
RAGE	O
)	O
in	O
pulmonary	B-ANAT
health	O
and	O
pathophysiology	O
.	O

However	O
,	O
typically	O
higher	O
than	O
basal	O
level	O
expression	O
of	O
RAGE	O
may	O
indicate	O
the	O
existence	O
of	O
severe	O
pathophysiological	O
condition	O
in	O
lung	B-ANAT
,	O
e	O
.	O
g	O
.	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Typical	O
avascular	O
necrosis	O
at	O
different	O
stages	O
and	O
severities	O
was	O
found	O
on	O
bone	B-ANAT
scintigraphy	O
at	O
31	O
femoral	B-ANAT
heads	I-ANAT
of	O
16	O
SARS	O
patients	O
,	O
97	O
%	O
of	O
which	O
were	O
MRI	O
positive	O
.	O

Suspicious	O
necrosis	O
was	O
found	O
at	O
42	O
femoral	B-ANAT
heads	I-ANAT
of	O
23	O
patients	O
,	O
67	O
%	O
of	O
which	O
were	O
MRI	O
negative	O
.	O

ABSTRACT	O
:	O
Non	O
-	O
structural	O
protein	O
9	O
(	O
Nsp9	O
)	O
of	O
coronaviruses	O
is	O
believed	O
to	O
bind	O
single	O
-	O
stranded	O
RNA	O
in	O
the	O
viral	B-ANAT
replication	I-ANAT
complex	I-ANAT
.	O

In	O
this	O
study	O
,	O
the	O
antioxidant	O
effects	O
of	O
conventional	O
N	O
-	O
acetylcysteine	O
(	O
NAC	B-ANAT
)	O
and	O
liposomally	O
entrapped	O
N	O
-	O
acetylcysteine	O
(	O
L	O
-	O
NAC	B-ANAT
)	O
were	O
evaluated	O
in	O
experimental	O
animals	O
challenged	O
with	O
lipopolysaccharide	O
(	O
LPS	O
).	O

Our	O
results	O
suggested	O
that	O
the	O
delivery	O
of	O
NAC	B-ANAT
as	O
a	O
liposomal	O
formulation	O
improved	O
its	O
prophylactic	O
effectiveness	O
against	O
LPS	O
-	O
induced	O
lung	B-ANAT
injuries	O
.	O

High	O
frequency	O
oscillatory	O
ventilation	O
(	O
HFOV	O
)	O
is	O
a	O
ventilatory	O
mode	O
that	O
employs	O
a	O
lung	B-ANAT
protective	O
strategy	O
consistent	O
with	O
the	O
ARDSNet	O
low	O
tidal	O
volume	O
ventilation	O
strategy	O
and	O
may	O
result	O
in	O
reduced	O
morbidity	O
.	O

The	O
objective	O
of	O
this	O
report	O
is	O
to	O
examine	O
the	O
impact	O
of	O
HFOV	O
on	O
blunt	O
trauma	O
patients	O
with	O
severe	O
pulmonary	B-ANAT
contusions	O
who	O
failed	O
or	O
were	O
at	O
a	O
high	O
risk	O
of	O
failing	O
conventional	O
mechanical	O
ventilation	O
.	O

We	O
undertook	O
a	O
retrospective	O
chart	O
review	O
of	O
all	O
patients	O
at	O
our	O
institution	O
who	O
received	O
HFOV	O
for	O
severe	O
pulmonary	B-ANAT
contusions	O
.	O

Their	O
natural	O
inhibitor	O
cystatin	O
C	O
is	O
a	O
secreted	O
protein	O
,	O
suggesting	O
that	O
it	O
functions	O
to	O
control	O
extracellular	B-ANAT
protease	O
activity	O
.	O

Later	O
,	O
we	O
screened	O
his	O
sera	B-ANAT
for	O
antibodies	O
to	O
anti	O
-	O
aminoacyl	O
tRNA	O
synthetase	O
to	O
diagnose	O
anti	O
-	O
aminoacyl	O
tRNA	O
synthetase	O
syndrome	O
because	O
anti	O
-	O
PL	O
-	O
12	O
antibodies	O
were	O
positive	O
.	O

AGP	O
was	O
purified	O
from	O
serum	B-ANAT
and	O
Western	O
blotting	O
followed	O
by	O
lectin	O
-	O
staining	O
of	O
alpha	O
(	O
2	O
,	O
3	O
)-	O
linked	O
and	O
alpha	O
(	O
2	O
,	O
6	O
)-	O
linked	O
sialic	O
acid	O
.	O

The	O
adjusted	O
ORs	O
with	O
95	O
%	O
CI	O
were	O
denoted	O
with	O
respect	O
to	O
surviving	O
beyond	O
96	O
hours	O
EICU	O
admission	O
(	O
APACHE	O
II	O
score	O
,	O
duration	O
of	O
trauma	O
factor	O
,	O
aspiration	O
of	O
gastric	B-ANAT
contents	I-ANAT
),	O
APACHE	O
II	O
score	O
beyond	O
20	O
EICU	O
admission	O
(	O
duration	O
of	O
trauma	O
factor	O
,	O
sepsis	O
,	O
duration	O
of	O
mechanical	O
ventilation	O
)	O
and	O
mechanical	O
ventilation	O
beyond	O
7	O
days	O
EICU	O
admission	O
(	O
duration	O
of	O
trauma	O
factor	O
and	O
sepsis	O
).	O

The	O
results	O
show	O
that	O
flap	B-ANAT
closing	O
was	O
clearly	O
observed	O
when	O
the	O
inhibitors	O
bind	O
to	O
the	O
active	O
site	O
of	O
SARS	O
-	O
CoV	O
3CL	O
(	O
pro	O
).	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
the	O
Antheraea	O
pernyi	O
nuclear	O
polyhedrosis	O
virus	O
(	O
ApNPV	O
),	O
a	O
member	O
of	O
the	O
baculovirus	O
family	O
,	O
is	O
evaluated	O
for	O
its	O
stimulation	O
of	O
chicken	O
peripheral	B-ANAT
blood	I-ANAT
mononuclear	I-ANAT
cells	I-ANAT
(	O
PBMC	O
)	O
and	O
macrophage	B-ANAT
cell	B-ANAT
line	I-ANAT
HD	O
11	O
in	O
vitro	O
,	O
and	O
protection	O
against	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
in	O
neonatal	O
chickens	O
in	O
vivo	O
.	O

This	O
study	O
showed	O
that	O
ApNPV	O
significantly	O
enhanced	O
inflammatory	O
cytokine	O
mRNA	O
expression	O
in	O
chicken	O
PBMC	O
and	O
HD	O
11	O
cells	B-ANAT
through	O
the	O
clathrin	O
-	O
dependent	O
endocytic	O
and	O
endosomal	O
maturation	O
pathway	O
,	O
and	O
up	O
-	O
regulated	O
nitric	O
oxide	O
production	O
in	O
HD	O
11	O
cells	B-ANAT
.	O

The	O
cellular	B-ANAT
localisation	O
and	O
function	O
of	O
the	O
SARS	O
-	O
CoV	O
accessory	O
proteins	O
was	O
determined	O
.	O

Challenge	O
of	O
lymphocytes	B-ANAT
and	O
monocytes	B-ANAT
with	O
infectious	O
SARS	O
-	O
CoV	O
,	O
inactivated	O
virions	B-ANAT
,	O
and	O
receptor	O
-	O
binding	O
fragment	O
of	O
spike	O
protein	O
does	O
not	O
trigger	O
apoptosis	O
.	O

Intranasal	O
vaccination	O
with	O
RBD	O
-	O
rAAV	O
induced	O
local	O
IgA	O
and	O
systemic	O
IgG	O
neutralising	O
antibodies	O
and	O
specific	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
responses	O
,	O
able	O
to	O
protect	O
against	O
SARS	O
-	O
CoV	O
infection	O
in	O
animal	O
models	O
.	O

Serological	O
tests	O
and	O
bone	B-ANAT
marrow	I-ANAT
examination	O
with	O
in	O
-	O
situ	O
hybridisation	O
revealed	O
severe	O
acquired	O
haemophagocytic	O
lymphohistiocytosis	O
secondary	O
to	O
acute	O
Epstein	O
-	O
Barr	O
virus	O
infection	O
.	O

Both	O
patients	O
died	O
despite	O
full	O
supportive	O
therapy	O
;	O
the	O
first	O
due	O
to	O
pulmonary	B-ANAT
haemorrhage	O
,	O
the	O
second	O
due	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
refractory	O
to	O
high	O
frequency	O
oscillatory	O
ventilation	O
.	O

TITLE	O
:	O
Post	O
-	O
mortem	O
histological	O
pulmonary	B-ANAT
analysis	O
in	O
patients	O
with	O
HIV	O
/	O
AIDS	O
.	O

ABSTRACT	O
:	O
Certain	O
aspects	O
of	O
pulmonary	B-ANAT
pathology	O
observed	O
in	O
autopsies	O
of	O
HIV	O
/	O
AIDS	O
patients	O
are	O
still	O
unknown	O
.	O

CONCLUSIONS	O
:	O
In	O
contrast	O
with	O
previous	O
studies	O
,	O
we	O
successfully	O
used	O
lung	B-ANAT
protective	O
ventilation	O
with	O
HFO	O
immediately	O
.	O

Like	O
other	O
coronaviruses	O
,	O
the	O
SARS	O
virus	O
also	O
utilizes	O
a	O
surface	O
glycoprotein	O
,	O
namely	O
the	O
spike	O
protein	O
,	O
to	O
infect	O
host	O
cells	B-ANAT
.	O

TITLE	O
:	O
Importance	O
of	O
cholesterol	O
for	O
infection	O
of	O
cells	B-ANAT
by	O
transmissible	O
gastroenteritis	O
virus	O
.	O

The	O
ferret	O
may	O
be	O
a	O
good	O
model	O
for	O
SARS	O
-	O
CoV	O
infection	O
because	O
it	O
is	O
the	O
only	O
model	O
that	O
replicates	O
the	O
fever	O
seen	O
in	O
human	O
patients	O
,	O
as	O
well	O
as	O
replicating	O
other	O
SARS	O
disease	O
features	O
including	O
infection	O
by	O
the	O
respiratory	O
route	O
,	O
clinical	O
signs	O
,	O
viral	O
replication	O
in	O
upper	O
and	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
and	O
lung	B-ANAT
damage	O
.	O

In	O
this	O
study	O
,	O
the	O
pathway	O
of	O
internalization	O
is	O
characterized	O
by	O
evaluating	O
the	O
effect	O
of	O
chemical	O
inhibitors	O
and	O
/	O
or	O
expression	O
of	O
dominant	O
-	O
negative	O
(	O
DN	O
)	O
proteins	O
on	O
the	O
percentage	O
of	O
internalized	O
virions	B-ANAT
per	O
cell	B-ANAT
and	O
infection	O
.	O

The	O
inhibitor	O
strongly	O
reduced	O
uptake	O
to	O
20	O
.	O
3	O
+/-	O
1	O
.	O
1	O
%	O
of	O
uptake	O
in	O
untreated	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
To	O
determine	O
whether	O
expression	O
of	O
feline	O
coronavirus	O
(	O
FCoV	O
)	O
7b	O
protein	O
,	O
as	O
indicated	O
by	O
the	O
presence	O
of	O
specific	O
serum	B-ANAT
antibodies	O
,	O
consistently	O
correlated	O
with	O
occurrence	O
of	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
)	O
in	O
cats	O
.	O

Serum	B-ANAT
from	O
cats	O
with	O
FIP	O
had	O
antibodies	O
against	O
the	O
7b	O
protein	O
,	O
including	O
cats	O
with	O
negative	O
results	O
via	O
conventional	O
IFA	O
.	O

2	O
.	O
4	O
mL	O
/	O
kg	O
predicted	O
body	B-ANAT
weight	O
.	O

Faeces	B-ANAT
were	O
taken	O
from	O
the	O
rectums	B-ANAT
of	O
all	O
the	O
calves	O
and	O
were	O
subjected	O
to	O
bacterial	O
culture	O
.	O

ABSTRACT	O
:	O
Localisation	O
of	O
both	O
viral	O
and	O
cellular	B-ANAT
proteins	O
to	O
the	O
nucleolus	B-ANAT
is	O
determined	O
by	O
a	O
variety	O
of	O
factors	O
including	O
nucleolar	B-ANAT
localisation	O
signals	O
(	O
NoLSs	O
),	O
but	O
how	O
these	O
signals	O
operate	O
is	O
not	O
clearly	O
understood	O
.	O

A	O
total	O
of	O
158	O
nasopharyngeal	B-ANAT
swab	I-ANAT
specimens	O
collected	O
from	O
adult	O
patients	O
with	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
in	O
Beijing	O
were	O
screened	O
for	O
the	O
presence	O
of	O
human	O
coronavirus	O
NL63	O
and	O
HKU1	O
by	O
using	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
and	O
conventional	O
RT	O
-	O
PCR	O
method	O
.	O

Here	O
we	O
describe	O
a	O
discovery	O
platform	O
that	O
utilizes	O
self	O
-	O
inactivating	O
(	O
SIN	O
)	O
lentiviral	O
vectors	O
for	O
the	O
surface	O
display	O
of	O
high	O
-	O
affinity	O
single	O
-	O
chain	O
variable	O
region	O
(	O
scFv	O
)	O
antibody	O
fragments	O
on	O
human	O
cells	B-ANAT
and	O
lentivirus	O
particles	O
.	O

High	O
level	O
scFvFc	O
expression	O
and	O
stable	O
integration	O
was	O
achieved	O
in	O
human	O
cells	B-ANAT
following	O
transduction	O
with	O
IRES	O
containing	O
bicistronic	O
SIN	O
lentivectors	O
encoding	O
ZsGreen	O
when	O
scFvFc	O
fusion	O
proteins	O
were	O
expressed	O
from	O
the	O
first	O
cassette	O
.	O

This	O
suggests	O
that	O
SARS	O
-	O
CoV	O
bearing	O
a	O
cleaved	B-ANAT
form	O
of	O
the	O
S	O
protein	O
can	O
enter	O
cells	B-ANAT
directly	O
from	O
the	O
cell	B-ANAT
surface	I-ANAT
without	O
trypsin	O
treatment	O
.	O

A	O
heptad	O
repeat	O
peptide	O
,	O
derived	O
from	O
a	O
SARS	O
-	O
CoV	O
S	O
protein	O
that	O
is	O
known	O
to	O
efficiently	O
block	O
infections	O
from	O
the	O
cell	B-ANAT
surface	I-ANAT
,	O
blocked	O
the	O
infection	O
by	O
a	O
pseudotype	O
with	O
a	O
cleaved	B-ANAT
S	O
protein	O
but	O
not	O
that	O
with	O
an	O
uncleaved	O
S	O
protein	O
.	O

However	O
,	O
SARS	O
-	O
CoV	O
M	O
protein	O
is	O
co	O
-	O
localized	O
almost	O
entirely	O
with	O
S	O
,	O
E	O
,	O
or	O
NC	O
protein	O
when	O
co	O
-	O
expressed	O
in	O
the	O
cells	B-ANAT
.	O

In	O
the	O
last	O
3	O
months	O
,	O
17	O
.	O
9	O
%	O
of	O
the	O
respondents	O
received	O
IV	O
;	O
36	O
.	O
6	O
%	O
of	O
those	O
presenting	O
ILI	O
symptoms	O
often	O
used	O
face	B-ANAT
mask	O
in	O
public	O
venues	O
.	O

Membrane	B-ANAT
structures	O
supporting	O
viral	O
RNA	O
synthesis	O
range	O
from	O
distinct	O
spherular	O
membrane	B-ANAT
invaginations	O
to	O
more	O
elaborate	O
webs	O
of	O
packed	O
membranes	B-ANAT
and	O
vesicles	B-ANAT
.	O

Treatment	O
with	O
mannan	O
considerably	O
reduced	O
infection	O
of	O
feline	O
monocyte	B-ANAT
-	O
derived	O
cells	B-ANAT
expressing	O
DC	O
-	O
SIGN	O
,	O
indicating	O
a	O
role	O
for	O
FIPV	O
infection	O
in	O
vivo	O
.	O

The	O
respiratory	O
situation	O
of	O
the	O
patients	O
was	O
significantly	O
improved	O
after	O
decompression	O
laparotomy	O
(	O
DL	O
)	O
and	O
lung	B-ANAT
protective	O
ventilation	O
was	O
re	O
-	O
achieved	O
.	O

TITLE	O
:	O
A	O
prime	O
-	O
boost	O
vaccination	O
protocol	O
optimizes	O
immune	O
responses	O
against	O
the	O
nucleocapsid	B-ANAT
protein	O
of	O
the	O
SARS	O
coronavirus	O
.	O

TITLE	O
:	O
Acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
malaria	O
.	O

There	O
is	O
as	O
yet	O
no	O
generally	O
recognized	O
definition	O
of	O
acute	O
or	O
chronic	O
right	O
ventricular	B-ANAT
failure	O
.	O

ABSTRACT	O
:	O
We	O
conducted	O
a	O
study	O
on	O
throat	B-ANAT
swabs	O
obtained	O
from	O
a	O
group	O
of	O
hospitalized	O
patients	O
with	O
community	O
acquired	O
pneumonia	O
(	O
CAP	O
).	O

ABSTRACT	O
:	O
Acute	O
liver	B-ANAT
injury	O
(	O
ALI	O
)	O
following	O
acetaminophen	O
overdose	O
(	O
AO	O
)	O
occurs	O
in	O
less	O
than	O
10	O
%	O
of	O
cases	O
,	O
but	O
that	O
risk	O
is	O
increased	O
among	O
alcoholics	O
and	O
those	O
with	O
chronic	O
alcoholic	O
liver	B-ANAT
disease	O
.	O

The	O
expression	O
of	O
CD69	O
on	O
liver	B-ANAT
NK	B-ANAT
cells	I-ANAT
was	O
highly	O
up	O
-	O
regulated	O
after	O
the	O
infection	O
and	O
the	O
cytotoxic	O
activity	O
of	O
hepatic	B-ANAT
NK	B-ANAT
cells	I-ANAT
at	O
48	O
h	O
was	O
also	O
significantly	O
enhanced	O
.	O

Episodes	O
were	O
defined	O
""""	O
asymptomatic	O
""""	O
if	O
no	O
symptoms	O
of	O
any	O
respiratory	B-ANAT
tract	I-ANAT
illness	O
were	O
present	O
between	O
1	O
week	O
before	O
and	O
1	O
week	O
after	O
sampling	O
.	O

SARS	O
-	O
CoV	O
-	O
specific	O
CD4	O
+	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
responses	O
were	O
detected	O
in	O
all	O
vaccinees	O
,	O
and	O
CD8	O
+	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
responses	O
in	O
approximately	O
20	O
%	O
of	O
individuals	O
.	O

We	O
tested	O
the	O
association	O
of	O
MYLK	O
gene	O
variation	O
in	O
the	O
development	O
of	O
acute	O
lung	B-ANAT
injury	O
in	O
major	O
trauma	O
patients	O
.	O

Multivariate	O
analyses	O
demonstrated	O
the	O
association	O
of	O
each	O
MYLK	O
single	O
nucleotide	O
polymorphism	O
with	O
acute	O
lung	B-ANAT
injury	O
to	O
be	O
independent	O
of	O
age	O
,	O
injury	O
severity	O
score	O
,	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
III	O
,	O
and	O
the	O
mechanism	O
of	O
trauma	O
.	O

Finally	O
,	O
haplotype	O
analyses	O
revealed	O
strong	O
acute	O
lung	B-ANAT
injury	O
associations	O
with	O
2	O
-	O
4	O
single	O
nucleotide	O
polymorphism	O
haplotypes	O
,	O
all	O
involving	O
His21Pro	O
(	O
p	O
<	O
0	O
.	O
008	O
).	O

CD8	O
(+)	O
T	B-ANAT
cell	I-ANAT
responses	O
were	O
more	O
frequent	O
and	O
of	O
a	O
greater	O
magnitude	O
than	O
CD4	O
(+)	O
T	B-ANAT
cell	I-ANAT
responses	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

Polychromatic	O
cytometry	O
analysis	O
indicated	O
that	O
the	O
virus	O
-	O
specific	O
T	B-ANAT
cells	I-ANAT
from	O
the	O
severe	O
group	O
tended	O
to	O
be	O
a	O
central	O
memory	O
phenotype	O
(	O
CD27	O
(+)/	O
CD45RO	O
(+))	O
with	O
a	O
significantly	O
higher	O
frequency	O
of	O
polyfunctional	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
producing	O
IFN	O
-	O
gamma	O
,	O
TNF	O
-	O
alpha	O
,	O
and	O
IL	O
-	O
2	O
,	O
and	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
producing	O
IFN	O
-	O
gamma	O
,	O
TNF	O
-	O
alpha	O
,	O
and	O
CD107a	O
(	O
degranulation	O
),	O
as	O
compared	O
with	O
the	O
mild	O
-	O
moderate	O
group	O
.	O

In	O
the	O
face	B-ANAT
of	O
substantial	O
increases	O
in	O
ARO	O
rates	O
in	O
Canada	O
,	O
continued	O
efforts	O
to	O
train	O
ICPs	O
and	O
support	O
hospital	O
infection	O
control	O
programs	O
are	O
necessary	O
.	O

ABSTRACT	O
:	O
Epitope	O
-	O
based	O
vaccines	O
designed	O
to	O
induce	O
cellular	B-ANAT
immune	O
response	O
and	O
antibody	O
responses	O
specific	O
for	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
are	O
being	O
developed	O
as	O
a	O
means	O
for	O
increasing	O
vaccine	O
potency	O
.	O

Moreover	O
,	O
viral	O
genes	O
were	O
detected	O
from	O
the	O
nasal	B-ANAT
sample	O
of	O
the	O
contact	O
pig	O
.	O

A	O
66	O
-	O
year	O
-	O
old	O
man	O
developed	O
delayed	O
-	O
onset	O
pulmonary	B-ANAT
edema	O
,	O
ARDS	O
,	O
and	O
fatal	O
circulatory	O
collapse	O
53	O
h	O
after	O
occupational	O
exposure	O
to	O
HNO	O
(	O
3	O
).	O

ABSTRACT	O
:	O
Coronaviruses	O
express	O
two	O
very	O
large	O
replicase	O
polyproteins	O
,	O
the	O
16	O
autoproteolytic	O
cleavage	O
products	O
of	O
which	O
collectively	O
form	O
the	O
membrane	B-ANAT
-	O
anchored	O
replication	O
complexes	O
.	O

To	O
look	O
into	O
this	O
incongruity	O
,	O
we	O
studied	O
the	O
membrane	B-ANAT
disposition	O
of	O
nsp3	O
and	O
nsp6	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
and	O
murine	O
hepatitis	O
virus	O
by	O
analyzing	O
tagged	O
forms	O
of	O
the	O
proteins	O
expressed	O
in	O
cultured	B-ANAT
cells	I-ANAT
.	O

We	O
established	O
that	O
two	O
of	O
the	O
three	O
hydrophobic	O
domains	O
in	O
nsp3	O
and	O
six	O
of	O
the	O
seven	O
in	O
nsp6	O
are	O
membrane	B-ANAT
spanning	O
.	O

Subsequently	O
,	O
we	O
verified	O
that	O
in	O
nsp4	O
,	O
all	O
four	O
hydrophobic	O
domains	O
span	O
the	O
lipid	B-ANAT
bilayer	I-ANAT
.	O

The	O
occurrence	O
of	O
conserved	O
non	O
-	O
membrane	B-ANAT
-	O
spanning	O
hydrophobic	O
domains	O
in	O
nsp3	O
and	O
nsp6	O
suggests	O
an	O
important	O
function	O
for	O
these	O
domains	O
in	O
coronavirus	O
replication	O
.	O

TITLE	O
:	O
Memory	O
CD4	O
+	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
-	O
mediated	O
protection	O
from	O
lethal	O
coronavirus	O
encephalomyelitis	O
.	O

ABSTRACT	O
:	O
The	O
antiviral	O
role	O
of	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
in	O
virus	O
-	O
induced	O
pathologies	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
has	O
not	O
been	O
explored	O
extensively	O
.	O

All	O
three	O
donor	O
CD4	O
(+)	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
populations	O
controlled	O
CNS	B-ANAT
virus	O
replication	O
at	O
8	O
days	O
postinfection	O
,	O
indicating	O
IFN	O
-	O
gamma	O
-	O
and	O
perforin	O
-	O
independent	O
antiviral	O
function	O
.	O

ABSTRACT	O
:	O
We	O
sequenced	O
and	O
analyzed	O
the	O
full	O
-	O
length	O
genomes	O
of	O
four	O
coronaviruses	O
(	O
CoVs	O
),	O
each	O
from	O
a	O
distinct	O
wild	O
-	O
ruminant	O
species	O
in	O
Ohio	O
:	O
sambar	O
deer	O
(	O
Cervus	O
unicolor	O
),	O
a	O
waterbuck	O
(	O
Kobus	O
ellipsiprymnus	O
),	O
a	O
sable	O
antelope	O
(	O
Hippotragus	O
niger	O
),	O
and	O
a	O
white	O
-	O
tailed	B-ANAT
deer	O
(	O
Odocoileus	O
virginianus	O
).	O

High	O
nucleotide	O
identities	O
(	O
99	O
.	O
4	O
to	O
99	O
.	O
6	O
%)	O
among	O
the	O
wild	O
-	O
ruminant	O
strains	O
and	O
recent	O
BCoV	O
strains	O
(	O
BCoV	O
-	O
LUN	O
and	O
BCoV	O
-	O
ENT	B-ANAT
,	O
isolated	O
in	O
1998	O
)	O
further	O
confirm	O
the	O
close	O
relatedness	O
.	O

Despite	O
therapy	O
his	O
urine	B-ANAT
output	O
decreased	O
.	O

DPD	O
activity	O
was	O
evaluated	O
by	O
Peripheral	B-ANAT
Blood	I-ANAT
Mononuclear	I-ANAT
Cell	I-ANAT
(	O
PBMC	O
)	O
radioassay	O
,	O
genotyping	O
of	O
DPYD	O
gene	O
by	O
Denaturing	O
High	O
Performance	O
Liquid	O
Chromatography	O
(	O
DHPLC	O
),	O
or	O
2	O
-(	O
13	O
)	O
C	O
uracil	O
breath	B-ANAT
test	O
(	O
UraBT	O
).	O

Toxicities	O
included	O
mucositis	O
(	O
71	O
%),	O
diarrhea	O
(	O
43	O
%),	O
skin	B-ANAT
rash	O
(	O
43	O
%),	O
memory	O
loss	O
/	O
altered	O
mental	O
status	O
(	O
43	O
%),	O
cytopenias	O
(	O
43	O
%),	O
nausea	O
(	O
29	O
%),	O
hypotension	O
(	O
14	O
%),	O
respiratory	O
distress	O
(	O
14	O
%)	O
and	O
acute	O
renal	B-ANAT
failure	O
(	O
14	O
%)	O
Re	O
-	O
challenge	O
with	O
capecitabine	O
in	O
one	O
patient	O
after	O
the	O
Mayo	O
regimen	O
caused	O
grade	O
3	O
hand	O
-	O
foot	B-ANAT
syndrome	O
.	O

TITLE	O
:	O
Cortical	B-ANAT
gray	B-ANAT
matter	I-ANAT
lesions	O
in	O
acute	O
encephalopathy	O
with	O
febrile	O
convulsive	O
status	O
epilepticus	O
.	O

Immunofluorescence	O
analysis	O
visualized	O
S	O
along	O
the	O
secretory	O
pathway	O
from	O
endoplasmic	B-ANAT
reticulum	I-ANAT
to	O
plasma	B-ANAT
membrane	I-ANAT
.	O

This	O
unique	O
protease	O
is	O
not	O
only	O
responsible	O
for	O
processing	O
the	O
viral	O
polyprotein	O
into	O
its	O
functional	O
units	O
but	O
is	O
also	O
capable	O
of	O
cleaving	O
ubiquitin	O
and	O
ISG15	O
conjugates	O
and	O
plays	O
a	O
significant	O
role	O
in	O
helping	O
SARS	O
-	O
CoV	O
evade	O
the	O
human	O
immune	B-ANAT
system	I-ANAT
.	O

In	O
the	O
current	O
study	O
,	O
we	O
report	O
the	O
impact	O
on	O
gene	O
expression	O
induced	O
by	O
lipopolysaccharide	O
(	O
LPS	O
)	O
stimulation	O
of	O
THP	O
-	O
1	O
cells	B-ANAT
treated	O
with	O
an	O
antisense	O
oligonucleotide	O
(	O
ASODN	O
)	O
against	O
the	O
IRAK	O
-	O
1	O
gene	O
using	O
cDNA	O
microarrays	O
and	O
quantitative	O
RT	O
-	O
PCR	O
.	O

The	O
therapeutic	O
ASODN	O
was	O
delivered	O
using	O
a	O
pH	O
-	O
sensitive	O
,	O
membrane	B-ANAT
-	O
interactive	O
polymer	O
that	O
destabilizes	O
the	O
endosomal	O
membrane	B-ANAT
to	O
enhance	O
access	O
cytoplasmic	B-ANAT
delivery	O
in	O
targeted	O
cells	B-ANAT
.	O

This	O
case	O
report	O
describes	O
a	O
9	O
-	O
year	O
-	O
old	O
girl	O
presenting	O
with	O
respiratory	O
distress	O
,	O
weakness	O
,	O
limb	B-ANAT
pain	O
,	O
and	O
hypertension	O
.	O

Compared	O
with	O
supine	O
position	O
,	O
lung	B-ANAT
recruited	O
volume	O
(	O
RV	O
)	O
was	O
elevated	O
in	O
prone	O
position	O
at	O
PEEP20	O
[(	O
378	O
.	O
55	O
+/-	O
101	O
.	O
80	O
)	O
ml	O
vs	O
.	O
(	O
302	O
.	O
95	O
+/-	O
34	O
.	O
31	O
)	O
ml	O
,	O
P	O
<	O
0	O
.	O
05	O
],	O
but	O
not	O
at	O
PEEP10	O
.	O

Redistribution	O
of	O
lung	B-ANAT
injury	O
may	O
be	O
one	O
of	O
the	O
mechanisms	O
of	O
its	O
beneficial	O
effect	O
.	O

ABSTRACT	O
:	O
A	O
7	O
-	O
month	O
-	O
old	O
-	O
intact	O
male	O
domestic	O
shorthair	O
cat	O
was	O
presented	O
with	O
fever	O
,	O
anterior	O
uveitis	O
in	O
the	O
right	B-ANAT
eye	I-ANAT
and	O
respiratory	O
distress	O
when	O
handled	O
.	O

Using	O
a	O
wholly	O
recombinant	O
system	O
,	O
we	O
have	O
investigated	O
the	O
ability	O
of	O
each	O
virus	O
receptor	O
-	O
binding	O
protein	O
,	O
spike	O
or	O
S	O
protein	O
,	O
to	O
bind	O
to	O
ACE	O
-	O
2	O
in	O
solution	O
and	O
on	O
the	O
cell	B-ANAT
surface	I-ANAT
.	O

ABSTRACT	O
:	O
Human	O
PP11	O
(	O
placental	B-ANAT
protein	O
11	O
)	O
was	O
previously	O
described	O
as	O
a	O
serine	O
protease	O
specifically	O
expressed	O
in	O
the	O
syncytiotrophoblast	B-ANAT
and	O
in	O
numerous	O
tumor	O
tissues	B-ANAT
.	O

Proinflammatory	O
activity	O
of	O
gastric	B-ANAT
juice	I-ANAT
from	O
17	O
intensive	O
care	O
unit	O
patients	O
and	O
12	O
controls	O
undergoing	O
elective	O
surgery	O
was	O
measured	O
based	O
on	O
a	O
target	B-ANAT
cell	I-ANAT
activation	O
assay	O
.	O

Nasal	B-ANAT
discharge	B-ANAT
was	O
recorded	O
,	O
and	O
antibody	O
response	O
and	O
virus	O
shedding	O
were	O
measured	O
.	O

TITLE	O
:	O
Prior	O
immunization	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
nucleocapsid	B-ANAT
protein	O
causes	O
severe	O
pneumonia	O
in	O
mice	O
infected	O
with	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
The	O
details	O
of	O
the	O
mechanism	O
by	O
which	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
causes	O
severe	O
pneumonia	O
are	O
unclear	O
.	O

The	O
LC16m8rVV	O
-	O
NMES	O
-	O
immunized	O
group	O
exhibited	O
as	O
severe	O
pneumonia	O
as	O
the	O
control	O
groups	O
,	O
although	O
LC16m8rVV	O
-	O
NMES	O
significantly	O
decreased	O
the	O
pulmonary	B-ANAT
SARS	O
-	O
CoV	O
titer	O
to	O
the	O
same	O
extent	O
as	O
LC16m8rVV	O
-	O
S	O
.	O
To	O
identify	O
the	O
cause	O
of	O
the	O
exacerbated	O
pneumonia	O
,	O
BALB	O
/	O
c	O
mice	O
were	O
immunized	O
with	O
recombinant	O
VV	O
that	O
expressed	O
the	O
individual	O
structural	O
proteins	O
of	O
SARS	O
-	O
CoV	O
(	O
LC16mOrVV	O
-	O
N	O
,	O
-	O
M	O
,	O
-	O
E	O
,	O
-	O
S	O
)	O
with	O
or	O
without	O
LC16mOrVV	O
-	O
S	O
(	O
i	O
.	O
e	O
.,	O
LC16mOrVV	O
-	O
N	O
,	O
LC16mOrVV	O
-	O
M	O
,	O
LC16mOrVV	O
-	O
E	O
,	O
or	O
LC16mOrVV	O
-	O
S	O
alone	O
or	O
LC16mOrVV	O
-	O
N	O
+	O
LC16mOrVV	O
-	O
S	O
,	O
LC16mOrVV	O
-	O
M	O
+	O
LC16mOrVV	O
-	O
S	O
,	O
or	O
LC16mOrVV	O
-	O
E	O
+	O
LC16mOrVV	O
-	O
S	O
),	O
and	O
infected	O
with	O
SARS	O
-	O
CoV	O
more	O
than	O
4	O
wk	O
later	O
.	O

We	O
screened	O
sera	B-ANAT
from	O
10	O
children	O
and	O
196	O
adults	O
and	O
established	O
primary	O
cutoff	O
points	O
based	O
on	O
immunoglobulin	O
G	O
(	O
IgG	O
)	O
antibody	O
levels	O
of	O
the	O
predominantly	O
seronegative	O
children	O
.	O

Significant	O
associations	O
of	O
coronavirus	O
seropositivity	O
and	O
antibody	O
levels	O
with	O
age	O
,	O
gender	O
,	O
race	O
,	O
socioeconomic	O
status	O
,	O
smoking	O
status	O
,	O
and	O
season	O
of	O
the	O
blood	B-ANAT
draw	O
were	O
tested	O
with	O
chi	O
-	O
square	O
and	O
regression	O
analyses	O
.	O

Epitope	O
enhancement	O
can	O
elicit	O
more	O
potent	O
T	B-ANAT
cell	I-ANAT
responses	O
and	O
can	O
subsequently	O
lead	O
to	O
a	O
stronger	O
memory	O
pool	O
;	O
however	O
,	O
the	O
molecular	O
basis	O
of	O
such	O
enhancement	O
is	O
unclear	O
.	O

In	O
ELISA	O
using	O
N1	O
or	O
N3	O
as	O
the	O
antigens	O
,	O
positive	O
results	O
were	O
observed	O
in	O
10	O
of	O
10	O
(	O
100	O
%)	O
SARS	O
-	O
CoV	O
-	O
positive	O
human	O
sera	B-ANAT
.	O

The	O
70	O
-	O
years	O
-	O
old	O
patient	O
had	O
an	O
acute	O
renal	B-ANAT
failure	O
too	O
.	O

This	O
method	O
takes	O
advantages	O
of	O
the	O
amino	O
-	O
modified	O
silica	O
-	O
coated	O
magnetic	O
nanoparticles	O
prepared	O
using	O
water	O
-	O
in	O
-	O
oil	O
microemulsion	O
technique	O
,	O
which	O
employs	O
amino	O
-	O
modified	O
silica	O
as	O
the	O
shell	B-ANAT
and	O
iron	O
oxide	O
as	O
the	O
core	O
of	O
the	O
magnetic	O
nanoparticles	O
.	O

These	O
findings	O
suggest	O
that	O
229E	O
takes	O
an	O
endosomal	O
pathway	O
for	O
cell	B-ANAT
entry	O
and	O
that	O
proteases	O
like	O
CPL	O
are	O
involved	O
in	O
this	O
mode	O
of	O
entry	O
.	O

In	O
phylogenetic	O
trees	O
constructed	O
using	O
chymotrypsin	O
-	O
like	O
protease	O
(	O
3CL	O
(	O
pro	O
)),	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
(	O
Pol	O
),	O
helicase	O
,	O
spike	O
,	O
and	O
nucleocapsid	B-ANAT
proteins	O
,	O
BuCoV	O
HKU11	O
,	O
ThCoV	O
HKU12	O
,	O
and	O
MuCoV	O
HKU13	O
formed	O
a	O
cluster	O
distantly	O
related	O
to	O
infectious	O
bronchitis	O
virus	O
and	O
turkey	O
CoV	O
(	O
group	O
3a	O
CoVs	O
).	O

In	O
addition	O
,	O
infection	O
of	O
RAG1	O
-/-	O
or	O
CXCL9	O
-/-	O
mice	O
with	O
a	O
recombinant	O
MHV	O
expressing	O
CXCL9	O
(	O
MHV	O
-	O
CXCL9	O
)	O
resulted	O
in	O
protection	O
from	O
disease	O
that	O
correlated	O
with	O
reduced	O
viral	O
titers	O
within	O
the	O
brain	B-ANAT
and	O
NK	B-ANAT
cell	I-ANAT
-	O
mediated	O
protection	O
in	O
the	O
liver	B-ANAT
.	O

In	O
trachea	B-ANAT
,	O
lungs	B-ANAT
and	O
airsacs	O
the	O
CD4	O
+	O
and	O
CD8	O
+	O
populations	O
were	O
significantly	O
larger	O
than	O
in	O
the	O
E	O
.	O
coli	O
and	O
PBS	O
groups	O
.	O

Median	O
Apgar	O
scores	O
were	O
9	O
(	O
3	O
-	O
9	O
)	O
and	O
10	O
(	O
8	O
-	O
10	O
)	O
at	O
1	O
and	O
5	O
min	O
;	O
median	O
cord	B-ANAT
pH	O
was	O
7	O
.	O
29	O
(	O
7	O
.	O
18	O
-	O
7	O
.	O
34	O
).	O

In	O
this	O
study	O
,	O
we	O
have	O
identified	O
the	O
major	B-ANAT
histocompatibility	I-ANAT
complex	I-ANAT
class	O
I	O
C	O
molecule	O
(	O
HLA	B-ANAT
-	O
C	O
)	O
as	O
an	O
attachment	O
factor	O
in	O
facilitating	O
HCoV	O
-	O
HKU1	O
spike	O
(	O
S	O
)-	O
mediated	O
infection	O
.	O

Sequencing	O
of	O
two	O
independent	O
clones	O
revealed	O
cDNA	O
inserts	O
encoding	O
HLA	B-ANAT
-	O
C	O
.	O
Inhibition	O
of	O
HLA	B-ANAT
-	O
C	O
expression	O
or	O
function	O
by	O
RNAi	O
silencing	O
and	O
anti	O
-	O
HLA	B-ANAT
-	O
C	O
antibody	O
decreased	O
HCoV	O
-	O
HKU1	O
S	O
pseudotyped	O
virus	O
infection	O
of	O
A549	O
cells	B-ANAT
by	O
62	O
to	O
65	O
%,	O
whereas	O
pretreatment	O
of	O
cells	B-ANAT
with	O
neuraminidase	O
decreased	O
such	O
infection	O
by	O
only	O
13	O
%.	O

However	O
,	O
other	O
unknown	O
surface	O
proteins	O
on	O
A549	O
cells	B-ANAT
may	O
be	O
concomitantly	O
utilized	O
by	O
S	O
glycoprotein	O
of	O
HCoV	O
-	O
HKU1	O
during	O
viral	O
entry	O
.	O

A	O
detailed	O
examination	O
of	O
SARS	O
-	O
CoV	O
infected	O
animal	O
and	O
human	O
convalescent	O
sera	B-ANAT
could	O
provide	O
evidence	O
of	O
nAb	O
pressure	O
which	O
,	O
if	O
found	O
,	O
may	O
lead	O
to	O
strategies	O
to	O
effectively	O
block	O
virus	O
evolution	O
pathways	O
by	O
broadening	O
the	O
activity	O
of	O
nAbs	O
.	O

Its	O
spike	O
glycoprotein	O
(	O
S	O
)	O
is	O
processed	O
by	O
host	O
furin	O
enzyme	O
to	O
produce	O
S1	O
and	O
S2	O
fragments	O
,	O
the	O
latter	O
being	O
crucial	O
for	O
fusion	O
with	O
the	O
host	O
membrane	B-ANAT
.	O

Tissue	B-ANAT
samples	O
were	O
taken	O
at	O
3h	O
post	O
-	O
inoculation	O
(	O
hpi	O
),	O
and	O
1	O
,	O
2	O
,	O
4	O
and	O
7	O
days	O
post	O
-	O
inoculation	O
(	O
dpi	O
)	O
with	O
E	O
.	O
coli	O
.	O

IBV	O
antigen	O
was	O
detected	O
in	O
secondary	B-ANAT
bronchi	I-ANAT
and	O
airsacs	O
up	O
to	O
2	O
dpi	O
and	O
in	O
the	O
trachea	B-ANAT
up	O
to	O
4	O
dpi	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
which	O
is	O
caused	O
by	O
a	O
novel	O
coronavirus	O
(	O
CoV	O
),	O
is	O
a	O
highly	O
communicable	O
disease	O
with	O
the	O
lungs	B-ANAT
as	O
the	O
major	O
pathological	O
target	O
.	O

Interventional	O
lung	B-ANAT
assist	O
eliminates	O
approximately	O
50	O
%	O
of	O
calculated	O
total	O
carbon	O
dioxide	O
production	O
with	O
rapid	O
normalisation	O
of	O
respiratory	O
acidosis	O
.	O

The	O
ORF7b	O
from	O
the	O
peritoneal	B-ANAT
/	O
pleural	O
effusions	O
of	O
FIP	O
cats	O
and	O
from	O
the	O
rectal	O
swabs	O
of	O
healthy	O
cats	O
was	O
amplified	O
.	O

It	O
was	O
also	O
detected	O
in	O
the	O
lung	B-ANAT
,	O
and	O
bronchial	B-ANAT
lymph	I-ANAT
node	I-ANAT
.	O

The	O
TCoV	O
nsp15	O
cleaved	B-ANAT
single	O
-	O
stranded	O
(	O
ss	O
)	O
RNA	O
at	O
the	O
uridylate	O
site	O
.	O

Human	O
airway	B-ANAT
epithelial	O
(	O
HAE	O
)	O
cultures	O
,	O
which	O
effectively	O
mimic	O
the	O
human	O
bronchial	B-ANAT
environment	O
,	O
allow	O
for	O
cultivation	O
of	O
a	O
wide	O
variety	O
of	O
human	O
respiratory	O
viral	O
pathogens	O
.	O

Initial	O
propagation	O
of	O
human	O
respiratory	O
secretions	B-ANAT
onto	O
HAE	O
cultures	O
followed	O
by	O
TEM	O
and	O
WTA	O
of	O
culture	O
supernatant	O
may	O
be	O
a	O
useful	O
approach	O
for	O
visualization	O
and	O
detection	O
of	O
new	O
human	O
respiratory	O
pathogens	O
that	O
have	O
eluded	O
identification	O
by	O
traditional	O
approaches	O
.	O

The	O
chest	B-ANAT
X	O
-	O
ray	O
showed	O
some	O
signs	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
spite	O
of	O
normal	O
blood	B-ANAT
gas	O
values	O
.	O

The	O
non	O
-	O
G	O
-	O
quadruplex	O
aptamer	O
with	O
the	O
strongest	O
inhibitory	O
potency	O
was	O
modified	O
at	O
the	O
3	O
'-	O
end	O
with	O
biotin	O
or	O
inverted	O
thymidine	O
,	O
and	O
the	O
modification	O
increased	O
its	O
stability	O
in	O
serum	B-ANAT
,	O
particularly	O
for	O
the	O
inverted	O
thymidine	O
modification	O
.	O

A	O
membranous	B-ANAT
structure	O
composed	O
of	O
single	O
cells	B-ANAT
and	O
clusters	O
of	O
cells	B-ANAT
covered	O
large	O
areas	O
of	O
the	O
PMP	O
fibers	O
.	O

The	O
other	O
two	O
events	O
included	O
cardiac	B-ANAT
arrest	O
secondary	O
to	O
central	O
line	O
placement	O
and	O
Demerol	O
overdose	O
.	O

CONCLUSIONS	O
:	O
There	O
were	O
differentially	O
expressed	O
serum	B-ANAT
proteins	O
in	O
three	O
groups	O
.	O

High	O
titers	O
of	O
antibodies	O
to	O
SRASCoV	O
appeared	O
in	O
the	O
immunized	O
mice	O
and	O
the	O
neutralization	O
test	O
showed	O
that	O
antibodies	O
to	O
the	O
fusion	O
protein	O
could	O
inhibit	O
SARSCoV	O
.	O
The	O
T	B-ANAT
cell	I-ANAT
proliferation	O
showed	O
that	O
the	O
fusion	O
protein	O
could	O
induce	O
an	O
antigen	O
-	O
specific	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
response	O
.	O

TITLE	O
:	O
Development	O
of	O
an	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
-	O
based	O
test	O
with	O
a	O
cocktail	O
of	O
nucleocapsid	B-ANAT
and	O
spike	O
proteins	O
for	O
detection	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
-	O
specific	O
antibody	O
.	O

ABSTRACT	O
:	O
A	O
new	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)-	O
based	O
immunoglobulin	O
G	O
(	O
IgG	O
)-	O
plus	O
-	O
IgM	B-ANAT
antibody	I-ANAT
detection	O
test	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
has	O
been	O
developed	O
by	O
using	O
a	O
cocktail	O
of	O
four	O
recombinant	O
polypeptides	O
as	O
the	O
antigen	O
.	O

In	O
these	O
,	O
the	O
detection	O
rate	O
for	O
any	O
virus	O
was	O
88	O
%	O
(	O
wash	O
),	O
79	O
%	O
(	O
aspirate	B-ANAT
),	O
77	O
%	O
(	O
swab	O
)	O
and	O
74	O
%	O
(	O
brush	O
).	O

These	O
data	O
suggest	O
that	O
virus	O
-	O
infected	O
macrophages	B-ANAT
overproduce	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
differentiation	O
/	O
survival	O
factors	O
,	O
and	O
these	O
factors	O
act	O
on	O
B	B-ANAT
-	I-ANAT
cells	I-ANAT
and	O
promote	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
differentiation	O
into	O
plasma	B-ANAT
cells	I-ANAT
in	O
FIPV	O
-	O
infected	O
cats	O
.	O

Sivelestat	O
is	O
a	O
small	O
molecular	O
weight	O
neutrophil	B-ANAT
elastase	O
inhibitor	O
.	O

The	O
histopathological	O
findings	O
(	O
H	O
-	O
E	O
stain	O
)	O
of	O
the	O
autopsied	O
lungs	B-ANAT
showed	O
hyaline	B-ANAT
membrane	B-ANAT
formation	O
and	O
hyperplasia	O
of	O
type	O
II	O
alveolar	B-ANAT
epithelium	I-ANAT
cells	B-ANAT
,	O
so	O
-	O
called	O
,	O
diffuse	O
alveolar	B-ANAT
damage	O
.	O

ABSTRACT	O
:	O
The	O
pharyngeal	B-ANAT
-	O
cervical	B-ANAT
-	O
brachial	O
variant	O
of	O
Guillain	O
-	O
Barre	O
syndrome	O
(	O
GBS	O
)	O
is	O
rare	O
.	O

The	O
pharyngeal	B-ANAT
-	O
cervical	B-ANAT
-	O
brachial	O
variant	O
is	O
a	O
clinical	O
condition	O
with	O
its	O
own	O
clinical	O
characteristics	O
and	O
well	O
-	O
established	O
diagnostic	O
criteria	O
that	O
allow	O
it	O
to	O
be	O
distinguished	O
from	O
the	O
other	O
variants	O
of	O
GBS	O
.	O

by	O
means	O
of	O
fecal	B-ANAT
PCR	O
at	O
4	O
,	O
8	O
,	O
and	O
12	O
wk	O
.	O

We	O
demonstrated	O
a	O
strategy	O
,	O
tetramer	O
-	O
guided	O
epitope	O
mapping	O
,	O
that	O
specific	O
CD4	O
+	O
T	B-ANAT
cell	I-ANAT
epitopes	O
can	O
be	O
identified	O
by	O
using	O
PBMC	O
from	O
subjects	O
that	O
have	O
not	O
been	O
exposed	O
to	O
the	O
infectious	O
organism	O
.	O

Sixteen	O
HLA	B-ANAT
-	O
DR0401	O
-	O
and	O
14	O
HLA	B-ANAT
-	O
DR0701	O
-	O
restricted	O
epitopes	O
within	O
spike	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
were	O
identified	O
.	O

Susceptible	O
cells	B-ANAT
are	O
inoculated	O
with	O
serial	O
logarithmic	O
dilutions	O
of	O
samples	O
in	O
a	O
96	O
-	O
well	O
plate	O
.	O

After	O
viral	O
growth	O
,	O
viral	O
detection	O
by	O
IPA	O
yields	O
the	O
infectious	O
virus	O
titer	O
,	O
expressed	O
as	O
""""	O
Tissue	B-ANAT
Culture	O
Infectious	O
Dose	O
""""	O
(	O
TCID50	O
).	O

In	O
this	O
chapter	O
we	O
describe	O
the	O
use	O
of	O
these	O
oligonucleotides	O
in	O
a	O
one	O
-	O
step	O
(	O
single	O
-	O
tube	O
)	O
RT	O
-	O
PCR	O
,	O
and	O
describe	O
the	O
procedure	O
that	O
we	O
used	O
to	O
extract	O
RNA	O
from	O
turkey	O
feces	B-ANAT
.	O

Thus	O
,	O
VSV	O
pseudotyped	O
with	O
SARS	O
-	O
CoV	O
S	O
protein	O
is	O
useful	O
for	O
developing	O
a	O
rapid	O
detection	O
system	O
for	O
neutralizing	O
antibody	O
specific	O
for	O
SARS	O
-	O
CoV	O
infection	O
as	O
well	O
as	O
studying	O
the	O
S	O
-	O
mediated	O
cell	B-ANAT
entry	O
of	O
SARS	O
-	O
CoV	O
.	O

This	O
was	O
shown	O
by	O
performing	O
a	O
virus	O
overlay	O
binding	O
assay	O
with	O
proteins	O
obtained	O
from	O
brush	B-ANAT
border	I-ANAT
membranes	B-ANAT
by	O
lectin	O
precipitation	O
.	O

ABSTRACT	O
:	O
The	O
construction	O
of	O
coronavirus	O
(	O
CoV	O
)	O
infectious	O
clones	O
had	O
been	O
hampered	O
by	O
the	O
large	O
size	O
of	O
the	O
viral	B-ANAT
genome	I-ANAT
(	O
around	O
30kb	O
)	O
and	O
the	O
instability	O
of	O
plasmids	O
carrying	O
CoV	O
replicase	O
sequences	O
in	O
Escherichia	O
coli	O
.	O

Since	O
the	O
etiology	O
of	O
a	O
relatively	O
large	O
percentage	O
of	O
respiratory	B-ANAT
tract	I-ANAT
diseases	O
remains	O
unidentified	O
,	O
it	O
is	O
possible	O
that	O
for	O
a	O
certain	O
number	O
of	O
these	O
illnesses	O
,	O
a	O
yet	O
unknown	O
viral	O
causative	O
agent	O
may	O
be	O
found	O
.	O

Two	O
-	O
hundred	O
and	O
ninety	O
-	O
four	O
specimens	O
from	O
42	O
men	O
who	O
tested	O
positive	O
for	O
HPV	O
-	O
16	O
at	O
one	O
or	O
more	O
anatomic	B-ANAT
sites	I-ANAT
were	O
evaluated	O
.	O

In	O
this	O
chapter	O
,	O
I	O
describe	O
specific	O
protein	O
-	O
protein	O
interactions	O
suggested	O
by	O
a	O
novel	O
model	O
of	O
immune	O
signaling	O
,	O
the	O
Signaling	O
Chain	O
HOmoOLigomerization	O
(	O
SCHOOL	O
)	O
model	O
,	O
to	O
be	O
critical	O
for	O
cell	B-ANAT
activation	O
mediated	O
by	O
multichain	O
immune	O
recognition	O
receptors	O
(	O
MIRRs	O
)	O
expressed	O
on	O
different	O
cells	B-ANAT
of	O
the	O
hematopoietic	B-ANAT
system	I-ANAT
.	O

However	O
,	O
a	O
mosaic	O
pattern	O
attenuation	O
in	O
the	O
lung	B-ANAT
parenchyma	I-ANAT
on	O
Chest	B-ANAT
CT	O
remained	O
and	O
ultrasonic	O
cardiography	O
showed	O
dilation	O
of	O
right	B-ANAT
ventricle	I-ANAT
.	O

In	O
contrast	O
,	O
intranasal	O
infection	O
of	O
young	O
10	O
-	O
week	O
-	O
old	O
C57BL	O
/	O
6	O
mice	O
with	O
rMA15	O
results	O
in	O
a	O
nonlethal	O
infection	O
characterized	O
by	O
high	O
titer	O
replication	O
within	O
the	O
lungs	B-ANAT
,	O
lung	B-ANAT
inflammation	O
,	O
destruction	O
of	O
lung	B-ANAT
tissue	I-ANAT
,	O
and	O
loss	O
of	O
body	B-ANAT
weight	O
,	O
thus	O
providing	O
a	O
useful	O
model	O
to	O
identify	O
host	O
mediators	O
of	O
protection	O
.	O

Despite	O
increased	O
viral	O
loads	O
,	O
the	O
expression	O
of	O
multiple	O
proinflammatory	O
cytokines	O
and	O
chemokines	O
within	O
lung	B-ANAT
tissue	I-ANAT
and	O
recruitment	O
of	O
inflammatory	O
monocytes	B-ANAT
/	O
macrophages	B-ANAT
to	O
the	O
lung	B-ANAT
was	O
severely	O
impaired	O
in	O
MyD88	O
(-/-)	O
mice	O
compared	O
to	O
wild	O
-	O
type	O
mice	O
.	O

TITLE	O
:	O
Globalisation	O
and	O
blood	B-ANAT
safety	O
.	O

TITLE	O
:	O
The	O
novel	O
CD4	O
+	O
CD25	O
+	O
regulatory	B-ANAT
T	I-ANAT
cell	I-ANAT
effector	O
molecule	O
fibrinogen	B-ANAT
-	O
like	O
protein	O
2	O
contributes	O
to	O
the	O
outcome	O
of	O
murine	O
fulminant	O
viral	O
hepatitis	O
.	O

Treatment	O
with	O
anti	O
-	O
FGL2	O
antibody	O
completely	O
inhibited	O
Treg	O
activity	O
and	O
protected	O
susceptible	O
BALB	O
/	O
cJ	O
mice	O
against	O
MHV	O
-	O
3	O
-	O
liver	B-ANAT
injury	O
and	O
mortality	O
.	O

In	O
an	O
earlier	O
study	O
using	O
sentinel	O
chickens	O
we	O
determined	O
the	O
incidence	O
of	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
in	O
Ontario	O
commercial	O
layer	B-ANAT
flocks	O
.	O

Adjusted	O
odds	O
ratios	O
(	O
AORs	O
)	O
for	O
any	O
HPV	O
genotype	O
and	O
circumcision	O
were	O
0	O
.	O
53	O
(	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
],	O
0	O
.	O
28	O
-	O
0	O
.	O
99	O
)	O
for	O
any	O
anatomic	B-ANAT
site	I-ANAT
/	O
specimen	O
,	O
0	O
.	O
17	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
05	O
-	O
0	O
.	O
56	O
)	O
for	O
the	O
urethra	B-ANAT
,	O
0	O
.	O
44	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
23	O
-	O
0	O
.	O
82	O
)	O
for	O
the	O
glans	O
/	O
corona	O
,	O
and	O
0	O
.	O
53	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
28	O
-	O
0	O
.	O
99	O
)	O
for	O
the	O
penile	B-ANAT
shaft	O
.	O

Pretreatment	O
of	O
cells	B-ANAT
with	O
beta	O
interferon	O
prior	O
to	O
SARS	O
-	O
CoV	O
infection	O
led	O
to	O
a	O
significant	O
decrease	O
in	O
PERK	O
activation	O
,	O
eIF2alpha	O
phosphorylation	O
,	O
and	O
SARS	O
-	O
CoV	O
replication	O
.	O

ABSTRACT	O
:	O
Human	O
LSECtin	O
(	O
liver	B-ANAT
and	O
lymph	B-ANAT
node	I-ANAT
sinusoidal	O
endothelial	B-ANAT
cell	I-ANAT
C	O
-	O
type	O
lectin	O
,	O
CLEC4G	O
)	O
is	O
a	O
C	O
-	O
type	O
lectin	O
encoded	O
within	O
the	O
L	O
-	O
SIGN	O
/	O
DC	O
-	O
SIGN	O
/	O
CD23	O
gene	O
cluster	O
.	O

Life	O
-	O
threatening	O
clinical	O
presentations	O
of	O
pertussis	O
can	O
associate	O
multiple	O
organ	B-ANAT
system	I-ANAT
failure	O
with	O
respiratory	O
distress	O
.	O

Coexpression	O
of	O
either	O
S	O
or	O
E	O
protein	O
with	O
human	O
alpha	O
-,	O
beta	O
-,	O
and	O
gamma	O
-	O
ENaC	O
in	O
Xenopus	O
oocytes	B-ANAT
led	O
to	O
significant	O
decreases	O
of	O
both	O
amiloride	O
-	O
sensitive	O
Na	O
(+)	O
currents	O
and	O
gamma	O
-	O
ENaC	O
protein	O
levels	O
at	O
their	O
plasma	B-ANAT
membranes	I-ANAT
.	O

Serology	O
results	O
,	O
from	O
a	O
neutralizing	O
antibody	O
assay	O
,	O
were	O
considered	O
positive	O
if	O
the	O
sera	B-ANAT
inhibited	O
the	O
development	O
of	O
a	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
-	O
specific	O
cytopathic	O
effect	O
at	O
a	O
dilution	O
of	O
>	O
or	O
=	O
1	O
:	O
8	O
.	O

Using	O
a	O
rabbit	O
polyclonal	O
antibody	O
specific	O
to	O
the	O
N	O
protein	O
,	O
N	O
-	O
protein	O
-	O
containing	O
particles	O
similar	O
in	O
size	O
to	O
the	O
VLP	B-ANAT
were	O
also	O
observed	O
by	O
immunoelectron	O
microscopy	O
,	O
indicating	O
that	O
the	O
VLP	B-ANAT
contained	O
the	O
N	O
protein	O
.	O

Antibody	O
dependent	O
enhancement	O
(	O
ADE	O
)	O
of	O
macrophage	B-ANAT
infection	O
occurs	O
in	O
the	O
presence	O
of	O
antibodies	O
to	O
FIPV	O
S	O
protein	O
,	O
and	O
a	O
close	O
relationship	O
between	O
ADE	O
and	O
neutralizing	O
epitopes	O
has	O
been	O
reported	O
.	O

Plasmacytoid	B-ANAT
dendritic	I-ANAT
cell	I-ANAT
-	O
derived	O
type	O
I	O
IFNs	O
are	O
of	O
prime	O
importance	O
for	O
the	O
initial	O
control	O
of	O
highly	O
cytopathic	O
viruses	O
such	O
as	O
the	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
).	O

Nevertheless	O
,	O
few	O
data	O
are	O
available	O
about	O
the	O
clinical	O
course	O
and	O
resolution	O
of	O
lung	B-ANAT
injury	O
in	O
adult	O
victims	O
of	O
near	O
-	O
drowning	O
.	O

Previously	O
,	O
we	O
showed	O
that	O
this	O
disease	O
is	O
partially	O
CD4	O
T	B-ANAT
cell	I-ANAT
-	O
mediated	O
since	O
infection	O
with	O
a	O
recombinant	O
JHMV	O
(	O
rJ	O
)	O
mutated	O
in	O
only	O
a	O
single	O
immunodominant	O
CD4	O
T	B-ANAT
cell	I-ANAT
epitope	O
(	O
epitope	O
M133	O
,	O
rJ	O
.	O
M	O
(	O
Y135Q	O
))	O
results	O
in	O
a	O
nonlethal	O
disease	O
.	O

These	O
results	O
support	O
the	O
notion	O
that	O
clinical	O
disease	O
in	O
coronavirus	O
-	O
induced	O
acute	O
encephalitis	O
results	O
from	O
a	O
balance	O
between	O
factors	O
critical	O
for	O
virus	O
clearance	O
,	O
such	O
as	O
virus	O
-	O
specific	O
effector	O
T	B-ANAT
cells	I-ANAT
and	O
anti	O
-	O
inflammatory	O
elements	O
,	O
such	O
as	O
Tregs	O
.	O

TITLE	O
:	O
Production	O
of	O
protective	O
gamma	O
interferon	O
by	O
natural	B-ANAT
killer	I-ANAT
cells	I-ANAT
during	O
early	O
mouse	O
hepatitis	O
virus	O
infection	O
.	O

IFN	O
-	O
gamma	O
production	O
reaches	O
a	O
maximum	O
level	O
2	O
days	O
after	O
viral	O
inoculation	O
,	O
especially	O
in	O
liver	B-ANAT
immune	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
effects	O
of	O
the	O
combination	O
of	O
a	O
'	O
lowest	O
'	O
lung	B-ANAT
ventilation	O
with	O
extracorporeal	O
elimination	O
of	O
carbon	O
dioxide	O
by	O
interventional	O
lung	B-ANAT
assist	O
are	O
described	O
in	O
a	O
patient	O
presenting	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
due	O
to	O
fulminant	O
pneumonia	O
.	O

Several	O
crystal	B-ANAT
structures	O
of	O
3C	O
(	O
pro	O
)	O
from	O
CVB3	O
and	O
3CL	O
(	O
pro	O
)	O
from	O
CoV	O
-	O
229E	O
and	O
SARS	O
-	O
CoV	O
in	O
complex	O
with	O
the	O
inhibitors	O
were	O
solved	O
.	O

The	O
G104V	O
mutant	O
produced	O
highly	O
debilitated	O
virus	O
and	O
eventually	O
reverted	O
back	B-ANAT
to	O
the	O
wild	O
-	O
type	O
protein	O
sequence	O
through	O
a	O
codon	O
transversion	O
.	O

We	O
applied	O
a	O
""""	O
next	O
-	O
generation	O
""""	O
parallel	O
sequencing	O
platform	O
for	O
viral	O
detection	O
in	O
nasopharyngeal	B-ANAT
and	O
fecal	B-ANAT
samples	O
collected	O
during	O
seasonal	O
influenza	O
virus	O
(	O
Flu	O
)	O
infections	O
and	O
norovirus	O
outbreaks	O
from	O
2005	O
to	O
2007	O
in	O
Osaka	O
,	O
Japan	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
contribute	O
to	O
the	O
morbidity	O
and	O
mortality	O
of	O
intensive	O
care	O
patients	O
worldwide	O
,	O
and	O
have	O
large	O
associated	O
human	O
and	O
financial	O
costs	O
.	O

TITLE	O
:	O
The	O
identification	O
of	O
a	O
calmodulin	O
-	O
binding	O
domain	O
within	O
the	O
cytoplasmic	B-ANAT
tail	I-ANAT
of	O
angiotensin	O
-	O
converting	O
enzyme	O
-	O
2	O
.	O

Using	O
a	O
cross	O
-	O
sectional	O
survey	O
,	O
EMTs	O
in	O
Toronto	O
,	O
Ont	O
.,	O
were	O
surveyed	O
1	O
year	O
after	O
the	O
SARS	O
outbreak	O
during	O
mandatory	O
training	O
on	O
the	O
use	O
of	O
personal	O
protective	O
equipment	O
in	O
airway	B-ANAT
management	O
during	O
the	O
outbreak	O
and	O
just	O
before	O
taking	O
the	O
survey	O
.	O

TITLE	O
:	O
Delivery	O
to	O
the	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
is	O
required	O
for	O
effective	O
immunization	O
with	O
Newcastle	O
disease	O
virus	O
-	O
vectored	O
vaccines	O
intended	O
for	O
humans	O
.	O

There	O
was	O
no	O
drop	O
in	O
egg	B-ANAT
production	O
in	O
any	O
of	O
the	O
groups	O
.	O

However	O
,	O
there	O
was	O
visual	O
loss	O
of	O
shell	B-ANAT
colour	O
in	O
the	O
unvaccinated	O
hens	O
challenged	O
with	O
the	O
Vic	O
S	O
strain	O
.	O

Both	O
the	O
A3	O
and	O
Vic	O
S	O
vaccine	O
strains	O
were	O
detected	O
in	O
the	O
oviduct	B-ANAT
of	O
vaccinated	O
and	O
unvaccinated	O
hens	O
,	O
mainly	O
on	O
the	O
12th	O
day	O
p	O
.	O
i	O
.	O

Lung	B-ANAT
contusion	O
is	O
also	O
a	O
risk	O
factor	O
for	O
the	O
development	O
of	O
pneumonia	O
,	O
severe	O
clinical	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
),	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

This	O
increase	O
corresponded	O
with	O
activation	O
of	O
integrin	O
CD11b	O
mRNA	O
and	O
lung	B-ANAT
inflammatory	O
chemokine	O
mRNA	O
expression	O
;	O
macrophage	B-ANAT
inflammatory	O
protein	O
-	O
1	O
(	O
MIP	O
-	O
1	O
),	O
monocyte	B-ANAT
chemotactic	O
peptide	O
-	O
1	O
(	O
MCP	O
-	O
1	O
),	O
and	O
cytokine	O
-	O
induced	O
neutrophil	B-ANAT
chemoattractant	O
-	O
1	O
(	O
CINC	O
-	O
1	O
).	O

The	O
relatively	O
higher	O
inhibition	O
of	O
chemokine	O
mRNAs	O
compared	O
with	O
reduction	O
in	O
MPO	O
activity	O
and	O
CD11b	O
is	O
in	O
accordance	O
with	O
an	O
antioxidant	O
effect	O
of	O
NACA	B-ANAT
on	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
accumulation	O
,	O
rather	O
than	O
by	O
an	O
effect	O
on	O
neutrophil	B-ANAT
sequestration	O
.	O

All	O
of	O
the	O
mutant	O
viruses	O
replicate	O
in	O
mouse	O
17	O
clone	O
1	O
fibroblast	B-ANAT
cells	B-ANAT
and	O
mouse	O
embryonic	B-ANAT
cells	B-ANAT
to	O
the	O
same	O
extent	O
as	O
the	O
parental	O
wild	O
-	O
type	O
recombinant	O
virus	O
,	O
inf	O
-	O
MHV	O
-	O
A59	O
.	O

Immunization	O
of	O
dams	O
can	O
provide	O
passive	O
protection	O
in	O
neonatal	O
calves	O
;	O
antibodies	O
transferred	O
through	O
colostrum	B-ANAT
block	O
colonization	O
of	O
bacteria	O
,	O
thereby	O
preventing	O
disease	O
.	O

TITLE	O
:	O
Crystal	B-ANAT
structures	O
of	O
the	O
X	O
-	O
domains	O
of	O
a	O
Group	O
-	O
1	O
and	O
a	O
Group	O
-	O
3	O
coronavirus	O
reveal	O
that	O
ADP	O
-	O
ribose	O
-	O
binding	O
may	O
not	O
be	O
a	O
conserved	O
property	O
.	O

The	O
most	O
important	O
results	O
regarding	O
the	O
use	O
of	O
extracorporeal	O
gas	O
exchange	O
are	O
expected	O
from	O
the	O
Conventional	O
Ventilatory	O
Support	O
vs	O
.	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
for	O
Severe	O
Adult	O
Respiratory	O
Failure	O
(	O
CESAR	O
)	O
study	O
,	O
a	O
randomized	O
clinical	O
trial	O
assessing	O
the	O
effectiveness	O
of	O
extracorporeal	O
lung	B-ANAT
assist	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
.	O

Further	O
developments	O
may	O
come	O
from	O
low	O
invasive	O
techniques	O
with	O
high	O
efficiency	O
of	O
CO2	O
removal	O
from	O
low	O
blood	B-ANAT
flow	O
.	O

ABSTRACT	O
:	O
Acute	O
exacerbation	O
(	O
AE	O
)	O
is	O
currently	O
established	O
as	O
a	O
distinct	O
condition	O
with	O
acute	O
deterioration	O
of	O
respiratory	O
status	O
in	O
idiopathic	O
pulmonary	B-ANAT
fibrosis	O
(	O
IPF	O
).	O

TITLE	O
:	O
Pumpless	O
extracorporeal	O
interventional	O
lung	B-ANAT
assist	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
a	O
prospective	O
pilot	O
study	O
.	O

Patients	O
with	O
cardiac	B-ANAT
insufficiency	O
or	O
severe	O
peripheral	O
vascular	B-ANAT
disease	O
were	O
not	O
considered	O
suitable	O
for	O
iLA	O
.	O

Ten	O
consecutive	O
late	O
-	O
phase	O
ALI	O
/	O
ARDS	O
patients	O
with	O
low	O
pulmonary	B-ANAT
compliance	O
,	O
and	O
severe	O
hypercapnia	O
.	O

TITLE	O
:	O
The	O
role	O
of	O
egg	B-ANAT
drop	O
syndrome	O
virus	O
in	O
acute	O
respiratory	O
disease	O
of	O
goslings	O
.	O

TITLE	O
:	O
Innovation	O
and	O
discovery	O
:	O
the	O
application	O
of	O
nucleic	B-ANAT
acid	O
-	O
based	O
technology	O
to	O
avian	O
virus	O
detection	O
and	O
characterization	O
.	O

In	O
this	O
review	O
,	O
I	O
highlight	O
some	O
recent	O
developments	O
with	O
many	O
avian	O
viruses	O
:	O
Newcastle	O
disease	O
virus	O
;	O
circoviruses	O
in	O
canary	O
and	O
pigeon	O
;	O
infectious	O
bursal	O
disease	O
virus	O
(	O
Gumboro	O
disease	O
virus	O
);	O
avian	O
adenoviruses	O
,	O
including	O
Angara	O
disease	O
/	O
infectious	O
hydropericardium	O
virus	O
,	O
haemorrhagic	O
enteritis	O
virus	O
of	O
turkeys	O
,	O
and	O
egg	B-ANAT
drop	O
syndrome	O
virus	O
;	O
avian	O
herpesviruses	O
,	O
including	O
infectious	O
laryngotracheitis	O
virus	O
,	O
duck	O
plague	O
virus	O
,	O
psittacine	O
herpesvirus	O
(	O
Pacheco	O
'	O
s	O
parrot	O
disease	O
virus	O
),	O
Marek	O
'	O
s	O
disease	O
virus	O
and	O
herpesvirus	O
of	O
turkeys	O
;	O
avian	O
leukosis	O
virus	O
(	O
associated	O
with	O
lymphoid	O
leukosis	O
or	O
myeloid	O
leukosis	O
,	O
and	O
egg	B-ANAT
transmission	O
);	O
avian	O
pneumoviruses	O
(	O
turkey	O
rhinotracheitis	O
virus	O
);	O
avian	O
coronaviruses	O
,	O
including	O
infectious	O
bronchitis	O
virus	O
,	O
turkey	O
coronavirus	O
and	O
pheasant	O
coronavirus	O
;	O
astrovirus	O
,	O
in	O
the	O
context	O
of	O
poult	O
enteritis	O
and	O
mortality	O
syndrome	O
,	O
and	O
avian	O
nephritis	O
virus	O
;	O
and	O
avian	O
encephalomyelitis	O
virus	O
,	O
a	O
picornavirus	O
related	O
to	O
hepatitis	O
A	O
virus	O
.	O

TITLE	O
:	O
SARS	O
coronavirus	O
spike	O
protein	O
-	O
induced	O
innate	O
immune	O
response	O
occurs	O
via	O
activation	O
of	O
the	O
NF	O
-	O
kappaB	O
pathway	O
in	O
human	O
monocyte	B-ANAT
macrophages	B-ANAT
in	O
vitro	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
immunogenicity	O
of	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
DNA	O
vaccine	O
,	O
induced	O
by	O
using	O
the	O
current	O
routine	O
vaccination	O
routes	O
(	O
intramuscularly	O
,	O
by	O
electroporation	O
,	O
or	O
orally	B-ANAT
using	O
live	O
-	O
attenuated	O
Salmonella	O
typhimurium	O
),	O
was	O
compared	O
in	O
mouse	O
model	O
.	O

The	O
comparison	O
between	O
the	O
three	O
vaccination	O
routes	O
indicated	O
that	O
immunization	O
intramuscularly	O
induced	O
a	O
moderate	O
T	B-ANAT
cell	I-ANAT
response	O
and	O
antibody	O
response	O
.	O

After	O
a	O
tracheotomy	O
had	O
been	O
performed	O
,	O
ALI	O
was	O
produced	O
in	O
the	O
control	O
and	O
APC	B-ANAT
groups	O
by	O
infusion	O
of	O
Escherichia	O
coli	O
endotoxin	O
100	O
microg	O
/	O
kg	O
per	O
hour	O
intravenously	O
for	O
1	O
hour	O
.	O

Thrombocytopenia	O
was	O
observed	O
in	O
5	O
(	O
12	O
.	O
5	O
%)	O
patients	O
,	O
and	O
multi	O
-	O
organ	B-ANAT
dysfunction	O
was	O
detected	O
in	O
19	O
(	O
47	O
.	O
5	O
%)	O
patients	O
.	O

Most	O
importantly	O
,	O
we	O
found	O
infection	O
of	O
vasculature	B-ANAT
and	O
smooth	B-ANAT
muscle	I-ANAT
of	O
the	O
proventriculus	B-ANAT
which	O
has	O
not	O
seen	O
before	O
with	O
IBV	O
strain	O
M41	O
.	O

The	O
S	O
protein	O
plays	O
key	O
parts	O
in	O
the	O
induction	O
of	O
neutralizing	O
-	O
antibody	O
and	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
responses	O
,	O
as	O
well	O
as	O
protective	O
immunity	O
,	O
during	O
infection	O
with	O
SARS	O
-	O
CoV	O
.	O
In	O
this	O
Review	O
,	O
we	O
highlight	O
recent	O
advances	O
in	O
the	O
development	O
of	O
vaccines	O
and	O
therapeutics	O
based	O
on	O
the	O
S	O
protein	O
.	O

Although	O
there	O
are	O
over	O
100	O
viruses	O
that	O
can	O
cause	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
,	O
only	O
a	O
fraction	O
of	O
those	O
have	O
been	O
defined	O
in	O
the	O
context	O
of	O
healthcare	O
-	O
associated	O
atypical	O
pneumonia	O
:	O
adenovirus	O
and	O
human	O
bocavirus	O
(	O
HBoV	O
);	O
rhinovirus	O
;	O
human	O
coronaviruses	O
(	O
HCoV	O
),	O
including	O
HCoV	O
229E	O
,	O
HCoV	O
OC43	O
,	O
HCoV	O
NL63	O
,	O
HCoV	O
HKU1	O
;	O
members	O
of	O
the	O
paramyxoviridae	O
(	O
parainfluenza	O
viruses	O
,	O
human	O
metapneumovirus	O
,	O
and	O
respiratory	O
syncytial	O
virus	O
);	O
hantavirus	O
;	O
influenza	O
;	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
Co	O
-	O
V	O
.	O
Our	O
knowledge	O
about	O
healthcare	O
-	O
associated	O
atypical	O
pneumonia	O
will	O
continue	O
to	O
evolve	O
as	O
newer	O
pathogens	O
are	O
identified	O
and	O
as	O
newer	O
diagnostic	O
modalities	O
such	O
as	O
multiplex	O
polymerase	O
chain	O
reaction	O
are	O
introduced	O
.	O

RESULTS	O
:	O
The	O
three	O
major	O
diagnostic	O
methods	O
available	O
for	O
SARS	O
includes	O
viral	O
RNA	O
detection	O
by	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
),	O
virus	O
induced	O
antibodies	O
by	O
immunofluorescence	O
assay	O
(	O
IFA	O
)	O
or	O
by	O
enzyme	O
linked	O
immunosorbant	O
assay	O
(	O
ELISA	O
)	O
of	O
nucleocapsid	B-ANAT
protein	O
(	O
NP	O
).	O

Upon	O
intranasal	O
inoculation	O
,	O
virus	O
replication	O
could	O
initially	O
be	O
observed	O
in	O
the	O
nasal	B-ANAT
cavity	I-ANAT
and	O
the	O
cervical	B-ANAT
lymph	I-ANAT
nodes	I-ANAT
,	O
after	O
which	O
the	O
infection	O
spread	O
to	O
the	O
brain	B-ANAT
and	O
frequently	O
to	O
the	O
eyes	B-ANAT
.	O

ABSTRACT	O
:	O
Use	O
of	O
inhaled	O
nitric	O
oxide	O
in	O
humans	O
with	O
traumatic	O
brain	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
has	O
twice	O
previously	O
been	O
reported	O
to	O
be	O
beneficial	O
.	O

We	O
propose	O
that	O
INO	O
may	O
decrease	O
the	O
inflammatory	O
response	O
in	O
patients	O
with	O
increased	O
intracranial	B-ANAT
pressure	O
caused	O
by	O
traumatic	O
brain	B-ANAT
injury	O
accompanied	O
by	O
acute	O
respiratory	O
distress	O
syndrome	O
thereby	O
contributing	O
to	O
improved	O
outcomes	O
.	O

ABSTRACT	O
:	O
A	O
high	O
survival	O
rate	O
can	O
be	O
achieved	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
using	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
).	O

RESULTS	O
:	O
The	O
majority	O
of	O
patients	O
had	O
residual	O
lung	B-ANAT
parenchymal	O
changes	O
on	O
HRCT	O
suggestive	O
of	O
fibrosis	O
,	O
but	O
the	O
extension	O
of	O
morphologic	O
abnormalities	O
was	O
limited	O
and	O
without	O
the	O
typical	O
anterior	O
localization	O
presumed	O
to	O
indicate	O
ventilator	O
-	O
associated	O
lung	B-ANAT
injury	O
.	O

Serum	B-ANAT
or	O
lung	B-ANAT
homogenate	O
levels	O
of	O
some	O
cytokines	O
such	O
as	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
(	O
TNF	O
-	O
alpha	O
)	O
and	O
interferon	O
-	O
gamma	O
(	O
IFN	O
-	O
gamma	O
)	O
along	O
with	O
acute	O
injury	O
lung	B-ANAT
index	O
and	O
histology	O
were	O
also	O
analyzed	O
.	O

RESULTS	O
:	O
Histopathological	O
analysis	O
of	O
adult	O
male	O
BALB	O
/	O
C	O
mice	O
after	O
N	O
-	O
protein	O
infection	O
showed	O
progressive	O
inflammatory	O
reactions	O
,	O
especially	O
pulmonary	B-ANAT
edema	O
,	O
in	O
accordance	O
with	O
a	O
moderately	O
(	O
approximately	O
13	O
%)	O
elevated	O
level	O
of	O
W	O
/	O
D	O
ratio	O
at	O
24	O
h	O
.	O
Although	O
adult	O
groups	O
underwent	O
a	O
progressive	O
lung	B-ANAT
inflammation	O
in	O
the	O
acute	O
phase	O
accompanied	O
by	O
raised	O
levels	O
of	O
TNF	O
-	O
alpha	O
in	O
serum	B-ANAT
,	O
no	O
significant	O
changes	O
in	O
lung	B-ANAT
TNF	O
-	O
alpha	O
level	O
were	O
reported	O
simultaneously	O
.	O

Each	O
hip	B-ANAT
was	O
treated	O
with	O
6000	O
impulses	O
of	O
ESWT	O
at	O
0	O
.	O
62	O
mJ	O
/	O
mm2	O
energy	O
flux	O
density	O
in	O
a	O
single	O
session	O
.	O

CONCLUSIONS	O
:	O
Cocktail	O
therapy	O
seems	O
promising	O
in	O
delaying	O
the	O
disease	O
progression	O
of	O
SARS	O
-	O
associated	O
femoral	B-ANAT
head	I-ANAT
necrosis	O
in	O
the	O
short	O
-	O
term	O
.	O

A	O
59	O
year	O
-	O
old	O
patient	O
presented	O
with	O
a	O
history	O
of	O
thoracic	B-ANAT
spondylodiscitis	O
resistant	O
to	O
antibiotic	O
treatment	O
for	O
6	O
weeks	O
,	O
progressive	O
severe	O
back	B-ANAT
pain	O
,	O
and	O
a	O
new	O
onset	O
of	O
bilateral	O
lower	B-ANAT
extremity	I-ANAT
weakness	O
.	O

An	O
emergent	O
MRI	O
revealed	O
a	O
kyphotic	O
wedge	O
compression	O
fracture	O
at	O
T7	O
/	O
T8	O
with	O
significant	O
spinal	B-ANAT
cord	I-ANAT
compression	O
,	O
paravertebral	O
and	O
epidural	B-ANAT
abscess	O
,	O
and	O
signs	O
of	O
myelopathy	O
.	O

The	O
patient	O
underwent	O
surgical	O
debridement	O
with	O
stabilization	O
of	O
the	O
anterior	O
column	B-ANAT
from	O
T6	O
-	O
T9	O
using	O
an	O
expandable	O
titanium	O
cage	O
,	O
autologous	O
bone	B-ANAT
graft	B-ANAT
,	O
and	O
an	O
anterolateral	O
locking	O
plate	O
.	O

She	O
underwent	O
antero	O
-	O
posterior	O
revision	O
fixation	O
with	O
hardware	O
removal	O
,	O
correction	O
of	O
kyphotic	O
malunion	O
,	O
evacuation	O
of	O
a	O
recurrent	O
epidural	B-ANAT
abscess	O
,	O
decompression	O
of	O
the	O
spinal	B-ANAT
canal	I-ANAT
,	O
and	O
360	O
degrees	O
fusion	O
from	O
T2	O
-	O
T11	B-ANAT
.	O

TITLE	O
:	O
Thermostability	O
of	O
the	O
N	O
-	O
terminal	O
RNA	O
-	O
binding	O
domain	O
of	O
the	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
protein	O
:	O
experiments	O
and	O
numerical	O
simulations	O
.	O

Rats	O
were	O
intravenously	O
injected	O
with	O
oleic	O
acid	O
(	O
OA	O
)	O
to	O
induce	O
ALI	O
and	O
30	O
minutes	O
later	O
they	O
were	O
divided	O
into	O
five	O
groups	O
:	O
model	O
(	O
injury	O
only	O
),	O
PPS	O
aerosol	O
(	O
PPS	O
-	O
aer	B-ANAT
),	O
saline	O
aerosol	O
(	O
saline	O
-	O
aer	B-ANAT
),	O
PPS	O
instillation	O
(	O
PPS	O
-	O
inst	O
),	O
and	O
saline	O
instillation	O
(	O
Saline	O
-	O
Inst	O
).	O

A	O
recombinant	O
adenovirus	O
encoding	O
SARS	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
nucleocapsid	B-ANAT
protein	O
(	O
rAd	O
-	O
N	O
)	O
was	O
constructed	O
.	O

The	O
ability	O
of	O
the	O
rAd	O
-	O
N	O
to	O
induce	O
anti	O
-	O
SARS	O
-	O
CoV	O
N	O
antibody	O
production	O
and	O
cellular	B-ANAT
immune	O
responses	O
was	O
evaluated	O
in	O
an	O
HLA	B-ANAT
-	O
A2	O
.	O
1	O
/	O
Kb	O
transgenic	O
mouse	O
model	O
.	O

Electromyography	O
and	O
nerve	B-ANAT
conduction	O
studies	O
showed	O
absence	O
of	O
compound	O
muscle	B-ANAT
action	O
potentials	O
and	O
sural	O
nerve	B-ANAT
sensory	I-ANAT
action	O
potential	O
,	O
which	O
was	O
suggestive	O
of	O
a	O
severe	O
Guillain	O
-	O
BarrÃ©	O
syndrome	O
.	O

Continuous	O
renal	B-ANAT
replacement	O
therapy	O
(	O
CRRT	O
)	O
has	O
become	O
the	O
preferred	O
method	O
of	O
renal	B-ANAT
support	O
in	O
these	O
patients	O
though	O
there	O
is	O
limited	O
data	O
to	O
support	O
its	O
safety	O
.	O

Furthermore	O
,	O
exacerbations	O
of	O
cerebral	B-ANAT
edema	O
have	O
been	O
reported	O
.	O

CRRT	O
is	O
an	O
option	O
for	O
the	O
treatment	O
of	O
hypervolemia	O
and	O
in	O
theory	O
may	O
improve	O
intracranial	B-ANAT
compliance	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
poly	O
-	O
trauma	O
patient	O
with	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
(	O
TBI	O
)	O
in	O
which	O
CRRT	O
was	O
implemented	O
solely	O
for	O
refractory	O
intracranial	B-ANAT
hypertension	O
.	O

ABSTRACT	O
:	O
Lung	B-ANAT
abscesses	O
(	O
LA	O
)	O
carry	O
with	O
them	O
severe	O
clinical	O
and	O
social	O
implications	O
.	O

They	O
displayed	O
hypercalcemia	O
and	O
metastatic	O
calcification	O
in	O
the	O
kidney	B-ANAT
and	O
stomach	B-ANAT
.	O

ABSTRACT	O
:	O
Red	B-ANAT
blood	I-ANAT
cell	I-ANAT
transfusions	O
have	O
been	O
widely	O
associated	O
with	O
the	O
transmission	O
of	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
especially	O
prior	O
to	O
1985	O
when	O
testing	O
for	O
HIV	O
was	O
not	O
available	O
.	O

TITLE	O
:	O
Interaction	O
of	O
the	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
membrane	B-ANAT
protein	O
with	O
beta	O
-	O
actin	O
and	O
its	O
implication	O
in	O
virion	B-ANAT
assembly	O
and	O
budding	O
.	O

The	O
emergence	O
of	O
one	O
or	O
multiple	O
organ	B-ANAT
dysfunctions	O
is	O
the	O
hallmark	O
of	O
severe	O
sepsis	O
.	O

ABSTRACT	O
:	O
We	O
used	O
convection	O
-	O
enhanced	O
delivery	O
(	O
CED	O
)	O
to	O
characterize	O
gene	O
delivery	O
mediated	O
by	O
adeno	O
-	O
associated	O
virus	O
type	O
1	O
(	O
AAV1	O
)	O
by	O
tracking	O
expression	O
of	O
hrGFP	O
(	O
humanized	O
green	O
fluorescent	O
protein	O
from	O
Renilla	O
reniformis	O
)	O
into	O
the	O
striatum	B-ANAT
,	O
basal	B-ANAT
forebrain	I-ANAT
,	O
and	O
corona	B-ANAT
radiata	I-ANAT
of	O
monkey	O
brain	B-ANAT
.	O

The	O
other	O
group	O
(	O
n	O
=	O
4	O
)	O
received	O
infusions	O
into	O
basal	B-ANAT
forebrain	I-ANAT
.	O

In	O
addition	O
to	O
neuronal	O
transduction	O
,	O
a	O
significant	O
nonneuronal	O
cell	B-ANAT
population	O
was	O
transduced	O
by	O
AAV1	O
vector	O
;	O
for	O
example	O
,	O
oligodendrocytes	B-ANAT
in	O
corona	B-ANAT
radiata	I-ANAT
and	O
astrocytes	B-ANAT
in	O
the	O
striatum	B-ANAT
.	O

He	O
was	O
diagnosed	O
with	O
subclinical	O
measles	O
infection	O
since	O
no	O
anthema	O
was	O
observed	O
despite	O
the	O
fact	O
that	O
his	O
serum	B-ANAT
and	O
cerebrospinal	B-ANAT
fluid	I-ANAT
samples	O
were	O
positive	O
for	O
measles	O
IgM	O
antibodies	O
.	O

Our	O
data	O
provide	O
the	O
first	O
biochemical	O
evidence	O
of	O
endoribonuclease	O
activity	O
associated	O
with	O
arterivirus	O
nsp11	O
and	O
support	O
the	O
conclusion	O
that	O
this	O
remarkable	O
RNA	O
-	O
processing	O
enzyme	O
,	O
whose	O
substrate	O
in	O
the	O
infected	O
cell	B-ANAT
remains	O
to	O
be	O
identified	O
,	O
distinguishes	O
nidoviruses	O
from	O
all	O
other	O
RNA	O
viruses	O
.	O

TITLE	O
:	O
Intestinal	B-ANAT
mucosal	B-ANAT
immune	O
response	O
against	O
virulent	O
duck	O
enteritis	O
virus	O
infection	O
in	O
ducklings	O
.	O

The	O
results	O
indicate	O
that	O
the	O
DVE	O
infection	O
can	O
stimulate	O
both	O
IgA	O
-	O
dominated	O
antibody	O
immune	O
responses	O
in	O
the	O
intestinal	B-ANAT
tract	I-ANAT
,	O
and	O
IgG	O
-	O
dominated	O
antibody	O
systemic	O
immunity	O
in	O
the	O
serum	B-ANAT
of	O
ducklings	O
orally	B-ANAT
inoculated	O
with	O
virulent	O
DEV	O
.	O

Chest	B-ANAT
computed	O
tomography	O
scan	O
revealed	O
multiple	O
bilateral	O
peripheral	O
pulmonary	B-ANAT
nodules	B-ANAT
with	O
small	O
bilateral	O
pleural	O
effusions	O
.	O

Thus	O
,	O
IMS	O
can	O
be	O
regarded	O
as	O
a	O
spectrum	O
disorder	O
affecting	O
the	O
neuromuscular	B-ANAT
junction	I-ANAT
(	O
NMJ	O
)	O
with	O
two	O
main	O
forms	O
:	O
a	O
forme	O
fruste	O
variety	O
associated	O
with	O
mild	O
weakness	O
and	O
the	O
classical	O
IMS	O
with	O
weakness	O
of	O
3	O
/	O
5	O
or	O
less	O
than	O
3	O
/	O
5	O
on	O
the	O
Medical	O
Research	O
Council	O
(	O
MRC	O
)	O
grading	O
;	O
patients	O
in	O
the	O
latter	O
category	O
are	O
at	O
risk	O
of	O
developing	O
late	O
onset	O
respiratory	O
failure	O
.	O

Blood	B-ANAT
culture	O
was	O
negative	O
in	O
all	O
except	O
patient	O
no	O
.	O
1	O
,	O
who	O
was	O
found	O
positive	O
for	O
coagulase	O
-	O
negative	O
staphylococci	O
.	O

Detection	O
of	O
37	O
HPV	O
types	O
in	O
male	O
anogenital	O
epithelium	B-ANAT
and	O
semen	B-ANAT
was	O
completed	O
in	O
463	O
men	O
in	O
two	O
U	O
.	O
S	O
.	O
cities	O
.	O

The	O
viruses	O
were	O
isolated	O
from	O
the	O
tracheas	B-ANAT
,	O
lungs	B-ANAT
,	O
and	O
caecal	O
tonsils	B-ANAT
of	O
birds	O
that	O
were	O
showing	O
respiratory	O
signs	O
.	O

TITLE	O
:	O
Minimally	O
cultured	O
bone	B-ANAT
marrow	I-ANAT
mesenchymal	B-ANAT
stem	I-ANAT
cells	I-ANAT
ameliorate	O
fibrotic	O
lung	B-ANAT
injury	O
.	O

Significant	O
elevations	O
in	O
oxygen	O
saturation	O
,	O
serum	B-ANAT
creatinine	O
,	O
lactate	O
dehydrogenase	O
,	O
creatine	O
kinase	O
MB	O
isoenzyme	O
,	O
and	O
fasting	O
plasma	B-ANAT
glucose	O
(	O
FPG	O
),	O
but	O
not	O
in	O
alanine	O
transaminase	O
were	O
predictors	O
for	O
death	O
.	O

The	O
localization	O
of	O
ACE2	O
expression	O
in	O
the	O
endocrine	O
part	O
of	O
the	O
pancreas	B-ANAT
suggests	O
that	O
SARS	O
coronavirus	O
enters	O
islets	O
using	O
ACE2	O
as	O
its	O
receptor	O
and	O
damages	O
islets	O
causing	O
acute	O
diabetes	O
.	O

CD4	O
-	O
CD8	O
-	O
T	B-ANAT
cells	I-ANAT
have	O
significant	O
cytotoxic	O
effect	O
on	O
virus	O
specific	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
in	O
MHV	O
-	O
3	O
infected	O
C3H	O
/	O
Hej	O
mice	O
,	O
which	O
suggests	O
that	O
CD4	O
-	O
CD8	O
-	O
T	B-ANAT
cells	I-ANAT
have	O
immune	O
modulatory	O
functions	O
in	O
the	O
development	O
of	O
chronic	O
viral	O
hepatitis	O
.	O

ABSTRACT	O
:	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
(	O
ARDS	O
)	O
is	O
a	O
frequent	O
and	O
severe	O
complication	O
after	O
trauma	O
,	O
caused	O
by	O
an	O
excessive	O
inflammatory	O
response	O
mediated	O
by	O
polymorphonuclear	O
granulocytes	B-ANAT
(	O
PMNs	O
).	O

It	O
was	O
previously	O
demonstrated	O
that	O
patients	O
with	O
activated	O
PMNs	O
in	O
the	O
lungs	B-ANAT
have	O
PMNs	O
in	O
the	O
peripheral	O
circulation	O
with	O
a	O
reduced	O
active	O
FcgammaRII	O
up	O
-	O
regulating	O
capacity	O
.	O

The	O
extent	O
of	O
the	O
sustained	O
injury	O
and	O
the	O
subsequent	O
cellular	B-ANAT
innate	O
immune	O
response	O
is	O
reflected	O
by	O
changes	O
in	O
a	O
functional	O
PMN	B-ANAT
phenotype	O
of	O
fMLP	O
-	O
induced	O
active	O
FcgammaRII	O
in	O
the	O
peripheral	B-ANAT
blood	I-ANAT
.	O

In	O
addition	O
,	O
decreasing	O
responsiveness	O
of	O
active	O
FcgammaRII	O
on	O
PMNs	O
was	O
found	O
in	O
patients	O
who	O
developed	O
systemic	O
inflammatory	O
response	O
syndrome	O
(	O
SIRS	O
)	O
or	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)/	O
ARDS	O
.	O

Infection	O
of	O
mice	O
defective	O
in	O
both	O
IL	O
-	O
12	O
and	O
IL	O
-	O
23	O
(	O
p40	B-ANAT
(-/-)),	O
in	O
IL	O
-	O
12	O
alone	O
(	O
p35	B-ANAT
(-/-)),	O
and	O
in	O
IL	O
-	O
23	O
alone	O
(	O
p19	B-ANAT
(-/-))	O
revealed	O
that	O
the	O
symptoms	O
of	O
coronavirus	O
-	O
induced	O
encephalitis	O
are	O
regulated	O
by	O
IL	O
-	O
12	O
.	O

Furthermore	O
,	O
although	O
transforming	O
growth	O
factor	O
beta	O
mRNA	O
was	O
not	O
affected	O
,	O
IL	O
-	O
10	O
was	O
increased	O
in	O
the	O
CNS	B-ANAT
in	O
the	O
absence	O
of	O
IL	O
-	O
12	O
.	O

TITLE	O
:	O
Neutrophil	B-ANAT
survival	O
factors	O
(	O
TNF	O
-	O
alpha	O
,	O
GM	O
-	O
CSF	B-ANAT
,	O
and	O
G	O
-	O
CSF	B-ANAT
)	O
produced	O
by	O
macrophages	B-ANAT
in	O
cats	O
infected	O
with	O
feline	O
infectious	O
peritonitis	O
virus	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
granulomatous	O
lesions	O
.	O

TITLE	O
:	O
Ethyl	O
pyruvate	O
modulates	O
adhesive	O
and	O
secretory	O
reactions	O
in	O
human	O
lung	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

Neutrophil	B-ANAT
adhesion	O
to	O
,	O
surface	O
expression	O
of	O
ICAM	O
-	O
1	O
and	O
VCAM	O
-	O
1	O
on	O
,	O
and	O
release	O
of	O
IL	O
-	O
8	O
and	O
G	O
-	O
CSF	B-ANAT
from	O
A549	O
cells	B-ANAT
were	O
measured	O
by	O
ELISA	O
after	O
stimulation	O
with	O
IL	O
-	O
1	O
beta	O
or	O
TNFalpha	O
.	O

In	O
this	O
study	O
we	O
demonstrate	O
that	O
these	O
chimeras	O
are	O
capable	O
of	O
packaging	O
large	O
amounts	O
of	O
human	O
APOBEC3G	O
(	O
hA3G	O
),	O
and	O
that	O
an	O
HIV	O
-	O
1	O
Gag	O
chimera	O
containing	O
the	O
carboxyl	O
-	O
terminal	O
half	O
of	O
human	O
coronavirus	O
229E	O
(	O
HCoV	O
-	O
229E	O
)	O
N	O
as	O
a	O
substitute	O
for	O
NC	O
is	O
capable	O
of	O
directing	O
VLP	B-ANAT
assembly	O
and	O
efficiently	O
packaging	O
hA3G	O
.	O

When	O
co	O
-	O
expressed	O
with	O
SARS	O
-	O
CoV	O
N	O
and	O
M	O
(	O
membrane	B-ANAT
)	O
proteins	O
,	O
hA3G	O
was	O
efficiently	O
incorporated	O
into	O
SARS	O
-	O
CoV	O
VLPs	B-ANAT
.	O

Bone	B-ANAT
marrow	I-ANAT
biopsy	O
revealed	O
necrotizing	O
epithelioid	O
granuloma	O
and	O
acid	O
-	O
fast	O
bacilli	O
.	O

The	O
investigation	O
indicated	O
that	O
the	O
neonates	O
with	O
severe	O
RDS	O
had	O
increases	O
in	O
peak	O
blood	B-ANAT
flow	O
velocity	O
and	O
in	O
peak	O
pressure	O
gradient	O
through	O
the	O
valves	B-ANAT
of	O
the	O
great	B-ANAT
vessels	I-ANAT
:	O
the	O
aorta	B-ANAT
and	O
pulmonary	B-ANAT
trunk	I-ANAT
,	O
and	O
abnormal	O
regurgitation	O
flow	O
mainly	O
through	O
the	O
pulmonary	B-ANAT
arterial	I-ANAT
valve	I-ANAT
,	O
which	O
was	O
a	O
sign	O
of	O
intensive	O
hemodynamic	O
adaptation	O
in	O
the	O
acute	O
phase	O
of	O
disease	O
.	O

It	O
can	O
be	O
achieved	O
with	O
full	O
-	O
thickness	O
laparostomy	O
(	O
midline	B-ANAT
or	O
transverse	O
subcostal	B-ANAT
)	O
or	O
through	O
a	O
subcutaneous	O
linea	B-ANAT
alba	I-ANAT
fasciotomy	O
.	O

In	O
order	O
to	O
assess	O
the	O
role	O
of	O
activated	O
neutrophils	B-ANAT
,	O
pro	O
-	O
and	O
anti	O
-	O
inflammatory	O
cytokines	O
and	O
adhesion	O
molecules	O
at	O
the	O
onset	O
and	O
development	O
of	O
respiratory	O
complications	O
and	O
respiratory	O
failure	O
,	O
we	O
measured	O
the	O
serum	B-ANAT
levels	O
of	O
pro	O
-	O
inflammatory	O
(	O
IL	O
-	O
1	O
beta	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
IL	O
-	O
18	O
,	O
TNF	O
-	O
alpha	O
)	O
and	O
anti	O
-	O
inflammatory	O
(	O
IL	O
-	O
1	O
ra	O
,	O
IL	O
-	O
10	O
)	O
cytokines	O
in	O
51	O
AP	O
patients	O
who	O
had	O
been	O
diagnosed	O
with	O
pancreatitis	O
-	O
associated	O
lung	B-ANAT
injury	O
with	O
and	O
without	O
the	O
development	O
of	O
organ	B-ANAT
dysfunction	O
.	O

TITLE	O
:	O
Bovine	O
coronavirus	O
nonstructural	O
protein	O
1	O
(	O
p28	B-ANAT
)	O
is	O
an	O
RNA	O
binding	O
protein	O
that	O
binds	O
terminal	O
genomic	O
cis	O
-	O
replication	O
elements	O
.	O

TITLE	O
:	O
Expression	O
of	O
newly	O
identified	O
secretory	O
CEACAM1	O
(	O
a	O
)	O
isoforms	O
in	O
the	O
intestinal	B-ANAT
epithelium	I-ANAT
.	O

However	O
,	O
precise	O
expression	O
patterns	O
of	O
CEACAM1	O
isoforms	O
remain	O
poorly	O
understood	O
in	O
the	O
intestinal	B-ANAT
epithelia	O
.	O

TITLE	O
:	O
Air	O
transport	O
of	O
patients	O
with	O
severe	O
lung	B-ANAT
injury	O
:	O
development	O
and	O
utilization	O
of	O
the	O
Acute	O
Lung	B-ANAT
Rescue	O
Team	O
.	O

Intravenous	O
immunoglobulins	O
were	O
thus	O
initiated	O
with	O
excellent	O
response	O
as	O
of	O
the	O
first	O
cycle	O
regarding	O
trunk	B-ANAT
mobility	O
and	O
dysphagia	O
.	O

ABSTRACT	O
:	O
The	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	O
plays	O
important	O
roles	O
in	O
both	O
viral	O
replication	O
and	O
modulation	O
of	O
host	O
cell	B-ANAT
processes	I-ANAT
.	O

Our	O
previous	O
study	O
indicated	O
that	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
nucleocapsid	B-ANAT
protein	O
forms	O
self	O
-	O
multimers	O
through	O
a	O
serine	O
-	O
arginine	O
(	O
SR	O
)-	O
rich	O
motif	O
(	O
SSRSSSRSRGNSR	O
)	O
by	O
using	O
a	O
mammalian	O
two	O
-	O
hybrid	O
system	O
.	O

A	O
total	O
of	O
282	O
stool	B-ANAT
samples	O
from	O
1	O
to	O
60	O
-	O
day	O
-	O
old	O
calves	O
were	O
evaluated	O
for	O
the	O
presence	O
of	O
BCoV	O
by	O
a	O
semi	O
-	O
nested	O
(	O
SN	O
)	O
PCR	O
assay	O
.	O

The	O
GFP	O
tag	O
enables	O
a	O
relatively	O
quick	O
confirmation	O
of	O
antigen	O
expression	O
in	O
plant	O
cells	B-ANAT
by	O
fluorescent	O
microscopy	O
.	O

TITLE	O
:	O
Perioperative	O
anaesthetic	O
management	O
of	O
mediastinal	B-ANAT
mass	O
in	O
adults	O
.	O

We	O
have	O
found	O
it	O
helpful	O
to	O
assign	O
'	O
severity	O
grade	O
'	O
(	O
using	O
a	O
three	O
-	O
grade	O
clinical	O
classification	O
scale	O
:	O
'	O
safe	O
',	O
'	O
uncertain	O
',	O
'	O
unsafe	O
'),	O
whereby	O
each	O
stage	O
triggers	O
appropriate	O
action	O
in	O
terms	O
of	O
staffing	O
and	O
apparatus	B-ANAT
,	O
such	O
as	O
the	O
provision	O
of	O
alternatives	O
for	O
airway	B-ANAT
management	O
,	O
cardiopulmonary	B-ANAT
bypass	O
and	O
additional	O
specialists	O
.	O

The	O
veterinary	O
literature	O
contains	O
numerous	O
reports	O
detailing	O
the	O
impact	O
of	O
systemic	O
disease	O
on	O
the	O
nervous	B-ANAT
system	I-ANAT
.	O

The	O
most	O
recent	O
reports	O
of	O
clinical	O
trials	O
with	O
Talpha	O
(	O
1	O
)	O
are	O
pointing	O
to	O
important	O
,	O
hitherto	O
unrecognized	O
,	O
applications	O
in	O
a	O
number	O
of	O
diseases	O
and	O
disorders	O
,	O
including	O
septic	O
shock	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
peritonitis	O
,	O
acute	O
cytomegalovirus	O
infection	O
,	O
TB	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
and	O
lung	B-ANAT
infections	O
in	O
critically	O
ill	O
patients	O
.	O

ABSTRACT	O
:	O
Idiopathic	O
nephrotic	O
syndrome	O
is	O
the	O
most	O
frequent	O
glomerular	B-ANAT
disease	O
during	O
childhood	O
.	O

Surfactant	O
inactivation	O
--	O
and	O
dysfunction	O
--	O
is	O
also	O
a	O
hallmark	O
in	O
newborns	O
with	O
meconium	B-ANAT
aspiration	O
syndrome	O
(	O
MAS	B-ANAT
),	O
pneumonia	O
and	O
other	O
disorders	O
affecting	O
the	O
pulmonary	B-ANAT
function	O
.	O

Our	O
observations	O
provide	O
insights	O
into	O
the	O
cellular	B-ANAT
localization	O
of	O
ORF	O
3b	O
that	O
may	O
enhance	O
our	O
understanding	O
of	O
the	O
mechanisms	O
by	O
which	O
ORF	O
3b	O
contributes	O
to	O
SARS	O
-	O
CoV	O
pathogenesis	O
.	O

RESULTS	O
:	O
Overall	O
,	O
the	O
28	O
-	O
day	O
mortality	O
was	O
significantly	O
lower	O
in	O
the	O
CVVH	O
arm	B-ANAT
(	O
n	O
=	O
29	O
)	O
compared	O
with	O
controls	O
(	O
n	O
=	O
28	O
)	O
(	O
38	O
%	O
vs	O
.	O
71	O
%,	O
P	O
=	O
0	O
.	O
011	O
)	O
as	O
was	O
the	O
in	O
-	O
hospital	O
mortality	O
(	O
62	O
%	O
vs	O
.	O
86	O
%,	O
P	O
=	O
0	O
.	O
04	O
).	O

For	O
unstable	O
viruses	O
,	O
the	O
loss	O
of	O
expression	O
of	O
the	O
inserted	O
genes	O
was	O
found	O
to	O
result	O
from	O
a	O
large	O
deletion	O
of	O
the	O
inserted	O
gene	O
and	O
even	O
IBV	O
backbone	B-ANAT
sequences	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
envelope	B-ANAT
spike	O
(	O
S	O
)	O
glycoprotein	O
is	O
responsible	O
for	O
the	O
fusion	O
between	O
the	O
membranes	B-ANAT
of	O
the	O
virus	O
and	O
the	O
target	B-ANAT
cell	I-ANAT
.	O

These	O
data	O
would	O
support	O
its	O
role	O
in	O
SARS	O
-	O
CoV	O
mediated	O
membrane	B-ANAT
fusion	O
and	O
suggest	O
that	O
the	O
region	O
where	O
this	O
peptide	O
resides	O
could	O
be	O
involved	O
in	O
the	O
merging	O
of	O
the	O
viral	O
and	O
target	O
cell	B-ANAT
membranes	I-ANAT
.	O

TITLE	O
:	O
Acute	O
lung	B-ANAT
injury	O
review	O
.	O

ABSTRACT	O
:	O
The	O
first	O
report	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
was	O
published	O
in	O
1967	O
,	O
and	O
even	O
now	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
ARDS	O
are	O
severe	O
forms	O
of	O
diffuse	O
lung	B-ANAT
disease	O
that	O
impose	O
a	O
substantial	O
health	O
burden	O
all	O
over	O
the	O
world	O
.	O

Ten	O
-	O
day	O
-	O
old	O
mice	O
pups	O
were	O
immunized	O
with	O
MAb	O
,	O
inoculated	O
with	O
the	O
10	O
(	O
5	O
)	O
tissue	B-ANAT
culture	O
-	O
infective	O
dose	O
of	O
HEV	B-ANAT
at	O
3	O
days	O
after	O
immunization	O
,	O
and	O
then	O
examined	O
to	O
determine	O
the	O
viral	O
inhibition	O
.	O

These	O
MAbs	O
would	O
be	O
a	O
useful	O
tool	O
for	O
rapid	O
and	O
specific	O
diagnosis	O
of	O
HEV	B-ANAT
and	O
also	O
for	O
antibody	O
-	O
based	O
treatment	O
of	O
the	O
disease	O
.	O

Effects	O
of	O
the	O
chimeric	O
ribozyme	O
on	O
expression	O
of	O
SARS	O
-	O
CoV	O
were	O
evaluated	O
in	O
cultured	O
3T3	O
cells	B-ANAT
.	O

The	O
synthetic	O
ribozyme	O
cleaved	B-ANAT
the	O
synthetic	O
target	O
MHV	O
and	O
SARS	O
-	O
CoV	O
RNA	O
into	O
fragments	O
of	O
predicted	O
length	O
.	O

The	O
chimeric	O
DNA	O
-	O
RNA	O
hammerhead	O
ribozyme	O
targeting	O
SARS	O
-	O
CoV	O
significantly	O
inhibited	O
the	O
expression	O
of	O
SARS	O
-	O
CoV	O
RNA	O
in	O
3T3	O
cells	B-ANAT
transfected	O
with	O
the	O
recombinant	O
plasmid	O
.	O

Bacterial	O
and	O
viral	O
infections	O
can	O
directly	O
promote	O
pulmonary	B-ANAT
endothelial	B-ANAT
hyperpermeability	O
and	O
indirectly	O
decrease	O
the	O
function	O
and	O
/	O
or	O
expression	O
of	O
ion	O
transporters	O
regulating	O
ALC	O
in	O
type	O
II	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
,	O
by	O
means	O
of	O
inducing	O
a	O
strong	O
inflammatory	O
and	O
oxidative	O
stress	O
response	O
in	O
the	O
infected	O
lungs	B-ANAT
.	O

The	O
inhibition	O
on	O
pseudovirus	O
was	O
also	O
seen	O
in	O
cells	B-ANAT
pretreated	O
with	O
the	O
CC	O
and	O
CC	O
/	O
Fr	O
.	O
2	O
(	O
IC	O
(	O
50S	O
),	O
283	O
.	O
4	O
+/-	O
16	O
.	O
3	O
and	O
149	O
.	O
5	O
+/-	O
13	O
.	O
5	O
microg	O
/	O
ml	O
,	O
respectively	O
),	O
however	O
the	O
highest	O
activities	O
on	O
wtSARS	O
-	O
CoV	O
were	O
observed	O
when	O
the	O
viruses	O
were	O
treated	O
by	O
the	O
extracts	O
before	O
challenging	O
(	O
IC	O
(	O
50S	O
),	O
43	O
.	O
1	O
+/-	O
2	O
.	O
8	O
and	O
7	O
.	O
8	O
+/-	O
0	O
.	O
3	O
microg	O
/	O
ml	O
;	O
SIs	O
,	O
8	O
.	O
4	O
and	O
23	O
.	O
1	O
,	O
respectively	O
).	O

This	O
result	O
demonstrated	O
that	O
E	O
.	O
coli	O
expressing	O
scFvs	O
on	O
the	O
cell	B-ANAT
surface	I-ANAT
retained	O
functional	O
potency	O
of	O
parent	O
antibody	O
and	O
therefore	O
blocked	O
PEDV	O
infection	O
into	O
target	B-ANAT
cells	I-ANAT
in	O
vitro	O
.	O

The	O
cytotoxic	O
effect	O
of	O
extracts	O
on	O
swine	O
peripheral	B-ANAT
blood	I-ANAT
mononuclear	I-ANAT
cells	I-ANAT
(	O
PBMCs	O
)	O
and	O
HL	B-ANAT
-	I-ANAT
60	I-ANAT
was	O
assessed	O
by	O
MTT	O
method	O
.	O

Consequently	O
,	O
TSA	O
could	O
support	O
a	O
diagnosis	O
of	O
FIP	O
only	O
at	O
extremely	O
high	O
serum	B-ANAT
concentration	O
(>	O
800	O
mg	O
/	O
L	O
)	O
or	O
when	O
the	O
pre	O
-	O
test	O
probability	O
of	O
FIP	O
is	O
high	O
.	O

TITLE	O
:	O
Elevated	O
plasma	B-ANAT
surfactant	O
protein	O
D	O
(	O
SP	O
-	O
D	O
)	O
levels	O
and	O
a	O
direct	O
correlation	O
with	O
anti	O
-	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
-	O
specific	O
IgG	B-ANAT
antibody	I-ANAT
in	O
SARS	O
patients	O
.	O

Anticoronavirals	O
targeting	O
viral	O
entry	O
were	O
reviewed	O
in	O
part	O
I	O
.	O
Here	O
we	O
review	O
anticoronaviral	O
therapies	O
directed	O
against	O
the	O
intracellular	B-ANAT
life	O
cycle	O
,	O
with	O
an	O
emphasis	O
on	O
allowed	O
patents	O
and	O
pending	O
patents	O
.	O

Other	O
agents	O
responsible	O
for	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
include	O
Coronavirus	O
(	O
severe	O
acute	O
respiratory	O
syndrome	O
),	O
Bocavirus	O
,	O
and	O
others	O
.	O

This	O
lead	O
to	O
an	O
improvement	O
in	O
arterial	B-ANAT
oxygenation	O
and	O
reduction	O
in	O
respiratory	O
rate	O
of	O
the	O
patient	O
and	O
gradual	O
disappearance	O
of	O
fetal	B-ANAT
distress	O
.	O

Most	O
patients	O
had	O
a	O
diagnosis	O
of	O
pneumonia	O
or	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
(	O
6	O
/	O
9	O
;	O
67	O
%).	O

Most	O
patients	O
had	O
a	O
diagnosis	O
of	O
pneumonia	O
or	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
(	O
6	O
/	O
9	O
;	O
67	O
%).	O

Macrophage	B-ANAT
-	O
specific	O
staining	O
showed	O
a	O
marked	O
increase	O
in	O
macrophage	B-ANAT
infiltration	O
with	O
evidence	O
of	O
myocardial	O
damage	O
in	O
patients	O
who	O
had	O
SARS	O
-	O
CoV	O
in	O
their	O
hearts	B-ANAT
.	O

The	O
presence	O
of	O
SARS	O
-	O
CoV	O
in	O
the	O
heart	B-ANAT
was	O
also	O
associated	O
with	O
marked	O
reductions	O
in	O
ACE2	O
protein	O
expression	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
characterised	O
by	O
lung	B-ANAT
inflammation	O
with	O
severe	O
hypoxia	O
,	O
which	O
usually	O
develops	O
over	O
4	O
-	O
48	O
hours	O
and	O
persists	O
for	O
days	O
or	O
weeks	O
.	O

However	O
,	O
these	O
hospitalizations	O
were	O
associated	O
with	O
38	O
%	O
of	O
hospitalizations	O
with	O
acute	O
renal	B-ANAT
failure	O
and	O
19	O
%	O
or	O
more	O
of	O
hospitalizations	O
with	O
ventilation	O
,	O
disseminated	O
intravascular	O
coagulation	O
syndrome	O
,	O
pulmonary	B-ANAT
edema	O
,	O
puerperal	O
cerebrovascular	O
disorders	O
,	O
and	O
respiratory	O
distress	O
syndrome	O
.	O

ABSTRACT	O
:	O
The	O
protein	O
C	O
system	O
is	O
an	O
important	O
natural	O
anticoagulant	O
mechanism	O
mediated	O
by	O
activated	O
protein	O
C	O
(	O
APC	B-ANAT
)	O
that	O
regulates	O
the	O
activity	O
of	O
factors	O
VIIIa	O
and	O
Va	O
.	O
Besides	O
well	O
-	O
defined	O
anticoagulant	O
properties	O
,	O
APC	B-ANAT
also	O
demonstrates	O
anti	O
-	O
inflammatory	O
,	O
anti	O
-	O
apoptotic	O
and	O
endothelial	B-ANAT
barrier	O
-	O
stabilizing	O
effects	O
that	O
are	O
collectively	O
referred	O
to	O
as	O
the	O
cytoprotective	O
effects	O
of	O
APC	B-ANAT
.	O

This	O
leads	O
to	O
microvascular	O
thrombosis	O
and	O
organ	B-ANAT
injury	O
.	O

Our	O
results	O
showed	O
that	O
GD	O
had	O
a	O
direct	O
antiviral	O
activity	O
,	O
leading	O
to	O
complete	O
inhibition	O
of	O
cell	B-ANAT
infection	O
.	O

TITLE	O
:	O
[	O
Acute	O
respiratory	O
failure	O
in	O
a	O
16	O
-	O
yr	O
-	O
old	O
girl	O
with	O
alveolar	B-ANAT
soft	O
part	O
sarcoma	O
].	O

TITLE	O
:	O
Rapid	O
pulmonary	B-ANAT
fibrosis	O
induced	O
by	O
acute	O
lung	B-ANAT
injury	O
via	O
a	O
lipopolysaccharide	O
three	O
-	O
hit	O
regimen	O
.	O

The	O
integrin	O
-	O
binding	O
motif	O
Arg	O
-	O
Gly	O
-	O
Asp	O
(	O
RGD	O
)	O
was	O
incorporated	O
into	O
the	O
pcDNA	O
3	O
.	O
1	O
mammalian	O
expression	O
vector	O
expressing	O
the	O
codon	O
-	O
optimized	O
extracellular	B-ANAT
domain	O
of	O
SARS	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
spike	O
protein	O
,	O
and	O
tested	O
by	O
immunizing	O
C57BL	O
/	O
6	O
mice	O
.	O

ABSTRACT	O
:	O
Human	B-ANAT
embryonic	I-ANAT
stem	I-ANAT
cell	I-ANAT
-	O
derived	O
oligodendrocyte	B-ANAT
progenitors	O
(	O
OPCs	O
)	O
were	O
transplanted	B-ANAT
into	O
mice	O
persistently	O
infected	O
with	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	O
hepatitis	O
virus	O
with	O
established	O
demyelination	O
.	O

Engrafted	O
cells	B-ANAT
did	O
not	O
survive	O
past	O
2	O
weeks	O
following	O
transplantation	O
despite	O
treatment	O
with	O
high	O
dose	O
cyclosporine	O
A	O
.	O
While	O
T	B-ANAT
cell	I-ANAT
infiltration	O
into	O
the	O
CNS	B-ANAT
was	O
dampened	O
,	O
elevated	O
numbers	O
of	O
macrophage	B-ANAT
/	O
microglia	B-ANAT
and	O
endogenous	O
OPCs	O
were	O
evident	O
surrounding	O
the	O
implantation	O
site	O
and	O
this	O
was	O
associated	O
with	O
increased	O
remyelination	O
.	O

At	O
the	O
time	O
of	O
writing	O
,	O
there	O
is	O
no	O
non	O
-	O
invasive	O
confirmatory	O
test	O
available	O
for	O
cats	O
without	O
effusion	B-ANAT
.	O

TITLE	O
:	O
Sivelestat	O
(	O
selective	O
neutrophil	B-ANAT
elastase	O
inhibitor	O
)	O
improves	O
the	O
mortality	O
rate	O
of	O
sepsis	O
associated	O
with	O
both	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
disseminated	O
intravascular	O
coagulation	O
patients	O
.	O

Sivelestat	O
is	O
a	O
selective	O
neutrophil	B-ANAT
elastase	O
inhibitor	O
.	O

ABSTRACT	O
:	O
We	O
investigated	O
whether	O
the	O
surface	O
-	O
linked	O
liposomal	O
peptide	O
was	O
applicable	O
to	O
a	O
vaccine	O
based	O
on	O
cytotoxic	B-ANAT
T	I-ANAT
lymphocytes	I-ANAT
(	O
CTLs	O
)	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
).	O

We	O
first	O
identified	O
four	O
HLA	B-ANAT
-	O
A	O
*	O
0201	O
-	O
restricted	O
CTL	B-ANAT
epitopes	O
derived	O
from	O
SARS	O
-	O
CoV	O
using	O
HLA	B-ANAT
-	O
A	O
*	O
0201	O
transgenic	O
mice	O
and	O
recombinant	O
adenovirus	O
expressing	O
predicted	O
epitopes	O
.	O

Addition	O
of	O
doxycycline	O
significantly	O
reduced	O
TNF	O
-	O
alpha	O
-	O
induced	O
PMN	B-ANAT
transmigration	O
across	O
Matrigel	O
membrane	B-ANAT
(	O
12	O
.	O
6	O
+/-	O
2	O
.	O
6	O
vs	O
.	O
20	O
.	O
1	O
+/-	O

SAP	O
+	O
Dox	O
showed	O
decreased	O
concentration	O
of	O
active	O
MMP	O
-	O
9	O
in	O
lung	B-ANAT
tissue	I-ANAT
(	O
37	O
.	O
89	O
+/-	O
1	O
.	O
75	O
vs	O
.	O
46	O
.	O
29	O
+/-	O

These	O
findings	O
were	O
paralleled	O
by	O
reduced	O
pulmonary	B-ANAT
expression	O
of	O
active	O
MMP	O
-	O
9	O
.	O

RESULTS	O
:	O
Addition	O
of	O
doxycycline	O
significantly	O
reduced	O
TNF	O
-	O
alpha	O
-	O
induced	O
PMN	B-ANAT
transmigration	O
across	O
Matrigel	O
membrane	B-ANAT
(	O
12	O
.	O
6	O
+/-	O
2	O
.	O
6	O
vs	O
.	O
20	O
.	O
1	O
+/-	O

Renal	B-ANAT
dysfunction	O
was	O
seen	O
in	O
17	O
patients	O
with	O
serum	B-ANAT
creatinine	O
ranging	O
from	O
1	O
.	O
3	O
-	O
10	O
.	O
65	O
mg	O
/	O
dl	O
.	O

RESULTS	O
:	O
The	O
SARS	O
epidemic	O
in	O
mainland	O
China	O
spanned	O
a	O
large	O
geographical	O
extent	O
but	O
clustered	O
in	O
two	O
areas	O
:	O
first	O
in	O
Guangdong	O
Province	O
,	O
and	O
about	O
3	O
months	O
later	O
in	O
Beijing	O
with	O
its	O
surrounding	O
areas	O
in	O
Shanxi	O
Province	O
,	O
Inner	O
Mongolia	O
Autonomic	B-ANAT
Region	O
,	O
Hebei	O
Province	O
and	O
Tianjin	O
.	O

The	O
average	O
duration	O
of	O
onset	O
of	O
symptoms	O
to	O
hospital	O
admission	O
was	O
3	O
.	O
8	O
days	O
,	O
of	O
admission	O
to	O
discharge	B-ANAT
for	O
those	O
who	O
survived	O
was	O
29	O
.	O
7	O
days	O
,	O
while	O
admission	O
to	O
death	O
for	O
casualties	O
was	O
17	O
.	O
4	O
days	O
.	O

Regarding	O
admission	O
to	O
discharge	B-ANAT
,	O
particularly	O
young	O
patients	O
and	O
patients	O
from	O
Guangdong	O
had	O
the	O
shortest	O
duration	O
.	O

RESULTS	O
:	O
The	O
average	O
duration	O
of	O
onset	O
of	O
symptoms	O
to	O
hospital	O
admission	O
was	O
3	O
.	O
8	O
days	O
,	O
of	O
admission	O
to	O
discharge	B-ANAT
for	O
those	O
who	O
survived	O
was	O
29	O
.	O
7	O
days	O
,	O
while	O
admission	O
to	O
death	O
for	O
casualties	O
was	O
17	O
.	O
4	O
days	O
.	O

Magnetic	O
resonance	O
images	O
(	O
MRI	O
)	O
and	O
X	O
-	O
rays	O
of	O
hips	B-ANAT
,	O
knees	B-ANAT
,	O
shoulders	B-ANAT
,	O
ankles	B-ANAT
and	O
wrists	B-ANAT
were	O
taken	O
as	O
part	O
of	O
the	O
post	O
-	O
SARS	O
follow	O
-	O
up	O
assessments	O
.	O

Two	O
more	O
cases	O
of	O
hip	B-ANAT
necrosis	O
were	O
seen	O
after	O
1	O
year	O
and	O
another	O
11	O
cases	O
of	O
AVN	O
were	O
diagnosed	O
after	O
3	O
years	O
,	O
one	O
with	O
hip	B-ANAT
necrosis	O
and	O
10	O
with	O
necrosis	O
in	O
other	O
joints	B-ANAT
.	O

Significant	O
toxicity	O
of	O
neonicotinoids	O
can	O
occur	O
following	O
large	O
amount	O
of	O
oral	B-ANAT
ingestion	O
.	O

Rats	O
with	O
LC	O
+	O
CASP	O
versus	O
LC	O
had	O
more	O
severe	O
inflammation	O
based	O
on	O
higher	O
levels	O
of	O
PMN	B-ANAT
in	O
BAL	O
at	O
5	O
h	O
,	O
increased	O
whole	O
lung	B-ANAT
myeloperoxidase	O
(	O
MPO	O
)	O
activity	O
at	O
5	O
and	O
24	O
h	O
,	O
and	O
increased	O
levels	O
of	O
inflammatory	O
mediators	O
in	O
BAL	O
(	O
TNFalpha	O
,	O
IL	O
-	O
1beta	O
,	O
and	O
MCP	O
-	O
1	O
at	O
5	O
and	O
24	O
h	O
;	O
IL	O
-	O
10	O
,	O
MIP	O
-	O
2	O
,	O
and	O
CINC	O
-	O
1	O
at	O
5	O
h	O
).	O

The	O
changes	O
in	O
cardiopulmonary	B-ANAT
function	O
are	O
mediated	O
by	O
reactive	O
oxygen	O
and	O
nitrogen	O
species	O
.	O

In	O
addition	O
,	O
present	O
data	O
support	O
a	O
major	O
role	O
of	O
the	O
bronchial	B-ANAT
circulation	O
in	O
the	O
injury	O
,	O
as	O
blockage	O
of	O
bronchial	B-ANAT
blood	B-ANAT
flow	O
will	O
also	O
minimize	O
the	O
pulmonary	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
The	O
phenomenon	O
of	O
cerebellar	B-ANAT
mutism	O
with	O
subsequent	O
dysarthria	O
is	O
most	O
commonly	O
described	O
as	O
a	O
part	O
of	O
posterior	B-ANAT
fossa	I-ANAT
syndrome	O
after	O
surgery	O
for	O
neoplasms	O
in	O
childhood	O
.	O

It	O
lost	O
immunogenicity	O
and	O
kidney	B-ANAT
tropism	O
at	O
P110	O
and	O
P70	O
,	O
respectively	O
.	O

Here	O
,	O
we	O
demonstrated	O
that	O
the	O
post	O
-	O
transcriptional	O
gene	O
silencing	O
suppressor	O
p19	B-ANAT
protein	O
from	O
tomato	O
bushy	O
stunt	O
virus	O
substantially	O
enhanced	O
the	O
transient	O
expression	O
of	O
recombinant	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
(	O
rN	O
)	O
protein	O
in	O
Nicotiana	O
benthamiana	O
.	O

The	O
rN	O
protein	O
-	O
specific	O
IgG	O
in	O
the	O
mouse	O
sera	B-ANAT
attained	O
a	O
titer	O
about	O
1	O
:	O
1	O
,	O
800	O
following	O
three	O
doses	O
of	O
immunization	O
,	O
which	O
suggested	O
effective	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
maturation	O
and	O
differentiation	O
in	O
mice	O
.	O

ABSTRACT	O
:	O
SARS	O
-	O
CoV	O
infection	O
of	O
human	O
results	O
in	O
antigen	O
-	O
specific	O
cellular	B-ANAT
and	O
humoral	O
immune	O
responses	O
.	O

Promising	O
therapies	O
for	O
pediatric	O
ALI	O
/	O
ARDS	O
based	O
on	O
pediatric	O
studies	O
include	O
endotracheal	O
surfactant	O
,	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
,	O
noninvasive	O
ventilation	O
,	O
and	O
use	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
as	O
a	O
rescue	O
therapy	O
.	O

Promising	O
therapies	O
based	O
on	O
adult	O
trials	O
include	O
use	O
of	O
corticosteroids	O
for	O
lung	B-ANAT
inflammation	O
and	O
fibrosis	O
,	O
use	O
of	O
4	O
to	O
6	O
mL	O
/	O
kg	O
tidal	O
volumes	O
and	O
restrictive	O
fluid	O
management	O
.	O

Prone	O
positioning	O
,	O
bronchodilators	O
,	O
inhaled	O
nitric	O
oxide	O
,	O
tight	O
glucose	O
control	O
,	O
and	O
high	O
-	O
flow	O
nasal	B-ANAT
cannula	O
(	O
HFNC	O
)	O
oxygen	O
are	O
therapies	O
that	O
require	O
further	O
study	O
before	O
they	O
can	O
be	O
recommended	O
for	O
children	O
with	O
ALI	O
/	O
ARDS	O
.	O

The	O
membrane	B-ANAT
topology	O
of	O
SARS	O
-	O
CoV	O
M	O
and	O
the	O
functional	O
significance	O
of	O
its	O
N	O
-	O
glycosylation	O
are	O
not	O
completely	O
understood	O
as	O
is	O
its	O
interaction	O
with	O
the	O
surface	O
glycoprotein	O
S	O
.	O
Using	O
biochemical	O
and	O
immunofluorescence	O
analyses	O
we	O
found	O
that	O
M	O
consists	O
of	O
a	O
short	O
glycosylated	O
N	O
-	O
terminal	O
ectodomain	O
,	O
three	O
transmembrane	B-ANAT
segments	O
and	O
a	O
long	O
,	O
immunogenic	O
C	O
-	O
terminal	O
endodomain	O
.	O

TITLE	O
:	O
[	O
Effect	O
on	O
mRNA	O
and	O
secretion	B-ANAT
levels	O
of	O
proinflammatory	O
cytokines	O
in	O
DC	O
infected	O
by	O
SARS	O
-	O
CoV	O
N	O
gene	O
recombinant	O
adenovirus	O
].	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
characterized	O
by	O
substantial	O
acute	O
pulmonary	B-ANAT
inflammation	O
with	O
a	O
high	O
mortality	O
rate	O
.	O

All	O
the	O
newly	O
synthesized	O
derivatives	O
were	O
evaluated	O
in	O
vitro	O
for	O
cytotoxicity	O
and	O
antiviral	O
activity	O
in	O
Crandell	O
-	O
Rees	O
Feline	O
Kidney	B-ANAT
cell	I-ANAT
,	O
human	O
embryonic	B-ANAT
lung	B-ANAT
(	O
HEL	O
)	O
cell	B-ANAT
,	I-ANAT
HeLa	I-ANAT
cell	B-ANAT
and	O
Vero	B-ANAT
cell	I-ANAT
cultures	O
against	O
different	O
viruses	O
.	O

TITLE	O
:	O
Comparative	O
study	O
of	O
synonymous	O
codon	O
usage	O
variations	O
between	O
the	O
nucleocapsid	B-ANAT
and	O
spike	O
genes	O
of	O
coronavirus	O
,	O
and	O
C	O
-	O
type	O
lectin	O
domain	O
genes	O
of	O
human	O
and	O
mouse	O
.	O

TITLE	O
:	O
Lung	B-ANAT
pathology	O
and	O
infectious	O
agents	O
in	O
fatal	O
feedlot	O
pneumonias	O
and	O
relationship	O
with	O
mortality	O
,	O
disease	O
onset	O
,	O
and	O
treatments	O
.	O

Lesions	O
included	O
the	O
following	O
:	O
1	O
)	O
duration	O
:	O
acute	O
(	O
21	O
%),	O
subacute	O
(	O
15	O
%),	O
chronic	O
(	O
40	O
.	O
2	O
%),	O
healing	O
(	O
2	O
.	O
8	O
%),	O
normal	O
(	O
18	O
.	O
1	O
%),	O
and	O
autolyzed	O
(	O
2	O
.	O
8	O
%);	O
2	O
)	O
type	O
of	O
pneumonia	O
:	O
lobar	O
bronchopneumonia	O
(	O
LBP	O
;	O
27	O
.	O
1	O
%),	O
LBP	O
with	O
pleuritis	O
(	O
49	O
.	O
1	O
%),	O
interstitial	B-ANAT
pneumonia	O
(	O
5	O
.	O
1	O
%),	O
bronchointerstitial	O
pneumonia	O
(	O
1	O
.	O
4	O
%),	O
septic	O
(	O
0	O
.	O
9	O
%),	O
embolic	O
foci	O
(	O
0	O
.	O
5	O
%),	O
other	O
(	O
2	O
.	O
8	O
%),	O
normal	O
(	O
10	O
.	O
3	O
%),	O
and	O
autolyzed	O
(	O
2	O
.	O
8	O
%);	O
and	O
3	O
)	O
bronchiolar	B-ANAT
lesions	O
:	O
bronchiolitis	O
obliterans	O
(	O
39	O
.	O
7	O
%),	O
bronchiolar	B-ANAT
necrosis	O
(	O
26	O
.	O
6	O
%),	O
bronchiolitis	O
obliterans	O
/	O
bronchiolar	B-ANAT
necrosis	O
(	O
1	O
.	O
4	O
%),	O
other	O
bronchiolar	B-ANAT
lesions	O
(	O
6	O
.	O
5	O
%),	O
and	O
bronchiolar	B-ANAT
lesion	O
negative	O
(	O
25	O
.	O
7	O
%).	O

TITLE	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
support	O
for	O
59	O
days	O
without	O
changing	O
the	O
ECMO	O
circuit	O
:	O
a	O
case	O
of	O
Legionella	O
pneumonia	O
.	O

ABSTRACT	O
:	O
We	O
report	O
the	O
successful	O
use	O
of	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
in	O
a	O
53	O
-	O
year	O
-	O
old	O
patient	O
with	O
Legionella	O
pneumonia	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
with	O
severe	O
barotraumas	O
.	O

The	O
flail	O
immobile	O
upper	B-ANAT
limbs	I-ANAT
produced	O
the	O
appearance	O
that	O
the	O
boy	O
was	O
restrained	O
in	O
a	O
narrow	O
barrel	O
.	O

Blood	B-ANAT
DNA	O
samples	O
were	O
evaluated	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
for	O
feline	O
leukemia	O
virus	O
(	O
FeLV	O
)	O
proviral	O
DNA	O
,	O
whereas	O
reverse	O
transcriptase	O
-	O
PCR	O
was	O
run	O
on	O
fecal	B-ANAT
samples	O
for	O
detection	O
of	O
coronavirus	O
RNA	O
.	O

To	O
determine	O
whether	O
the	O
spike	O
protein	O
is	O
responsible	O
for	O
the	O
difference	O
,	O
a	O
recombinant	O
virus	O
,	O
Penn	O
-	O
98	O
-	O
1	O
,	O
that	O
contains	O
the	O
A59	O
genome	O
with	O
a	O
spike	O
from	O
MHV	O
-	O
2	O
was	O
used	O
to	O
infect	O
DBT	O
cells	B-ANAT
.	O

While	O
both	O
A59	O
and	O
Penn	O
-	O
98	O
-	O
1	O
entered	O
cells	B-ANAT
at	O
similar	O
levels	O
,	O
viral	O
RNA	O
and	O
protein	O
syntheses	O
were	O
significantly	O
delayed	O
for	O
A59	O
.	O

TITLE	O
:	O
Host	B-ANAT
cell	I-ANAT
proteins	O
interacting	O
with	O
the	O
3	O
'	O
end	O
of	O
TGEV	O
coronavirus	O
genome	O
influence	O
virus	O
replication	O
.	O

Gene	O
silencing	O
of	O
PABP	O
,	O
hnRNP	B-ANAT
Q	O
,	O
and	O
glutamyl	O
-	O
prolyl	O
-	O
tRNA	O
synthetase	O
(	O
EPRS	O
)	O
caused	O
a	O
significant	O
2	O
to	O
3	O
-	O
fold	O
reduction	O
of	O
viral	O
RNA	O
synthesis	O
.	O

During	O
the	O
vaccination	O
course	O
,	O
the	O
candidate	O
peptide	O
vaccines	O
induced	O
strong	O
humoral	O
and	O
cellular	B-ANAT
response	O
,	O
and	O
provided	O
up	O
to	O
80	O
.	O
0	O
%	O
immune	O
protection	O
,	O
while	O
all	O
non	O
-	O
immunized	O
chickens	O
in	O
the	O
negative	O
control	O
group	O
manifested	O
obvious	O
typical	O
symptoms	O
and	O
died	O
after	O
virus	O
challenge	O
.	O

Patients	O
were	O
categorized	O
into	O
nonobese	O
(	O
body	B-ANAT
mass	O
index	O
[	O
BMI	O
]	O
<	O
or	O
=	O
29	O
kg	O
/	O
m	O
),	O
obese	O
(	O
BMI	O
30	O
-	O
39	O
kg	O
/	O
m	O
),	O
and	O
severely	O
obese	O
(	O
BMI	O
>	O
or	O
=	O
40	O
kg	O
/	O
m	O
)	O
groups	O
.	O

TITLE	O
:	O
Structure	O
and	O
inhibition	O
of	O
the	O
SARS	O
coronavirus	O
envelope	B-ANAT
protein	O
ion	O
channel	O
.	O

Apart	O
from	O
its	O
morphogenetic	O
properties	O
,	O
protein	O
E	O
has	O
been	O
reported	O
to	O
have	O
membrane	B-ANAT
permeabilizing	O
activity	O
.	O

Full	O
length	O
SARS	O
-	O
CoV	O
E	O
displayed	O
channel	O
activity	O
when	O
transiently	O
expressed	O
in	O
human	O
embryonic	B-ANAT
kidney	B-ANAT
293	O
(	O
HEK	O
-	O
293	O
)	O
cells	B-ANAT
in	O
a	O
whole	O
-	O
cell	B-ANAT
patch	O
clamp	O
set	O
-	O
up	O
.	O

Nsp4	O
is	O
localized	O
to	O
the	O
ER	B-ANAT
membrane	I-ANAT
when	O
expressed	O
alone	O
but	O
is	O
recruited	O
into	O
the	O
replication	O
complex	O
in	O
infected	O
cells	B-ANAT
.	O

And	O
10	O
cases	O
of	O
them	O
were	O
involved	O
in	O
the	O
primary	O
and	O
critical	O
infection	O
with	O
acute	O
inflammation	O
,	O
hemorrhage	O
and	O
necrosis	O
of	O
adrenal	B-ANAT
glands	I-ANAT
.	O

However	O
,	O
systematic	O
autopsy	O
confirmed	O
that	O
7	O
cases	O
died	O
of	O
acute	O
lymphocytic	O
pancarditis	O
,	O
2	O
cases	O
acute	O
and	O
lymphocytic	O
interstitial	B-ANAT
pneumonia	O
and	O
1	O
case	O
epidemic	O
cerebrospinal	O
meningitis	O
with	O
septicemia	O
.	O

Cases	O
of	O
novel	O
influenza	O
A	O
(	O
H1N1	O
)	O
virus	O
infection	O
have	O
included	O
rapidly	O
progressive	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
disease	O
resulting	O
in	O
respiratory	O
failure	O
,	O
development	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
and	O
prolonged	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
admission	O
.	O

P	O
-	O
TMA	O
Cl	O
significantly	O
decreased	O
P	O
(	O
DA	O
)	O
in	O
normal	O
and	O
inflamed	O
cells	B-ANAT
and	O
attenuated	O
pressure	O
-	O
induced	O
increases	O
in	O
L	O
(	O
p	O
).	O

The	O
nsps	O
assemble	O
into	O
the	O
viral	O
replication	O
-	O
transcription	O
complex	O
and	O
nsp3	O
,	O
nsp4	O
and	O
nsp6	O
are	O
believed	O
to	O
anchor	O
this	O
enzyme	O
complex	O
to	O
modified	O
intracellular	B-ANAT
membranes	B-ANAT
.	O

Sera	B-ANAT
and	O
feces	B-ANAT
samples	O
were	O
collected	O
once	O
a	O
week	O
for	O
7	O
weeks	O
.	O

The	O
amino	O
acid	O
sequence	O
of	O
rdACE2	O
has	O
identities	O
of	O
99	O
.	O
3	O
,	O
89	O
.	O
2	O
,	O
83	O
.	O
9	O
and	O
80	O
.	O
4	O
%	O
to	O
ACE2	O
proteins	O
from	O
dog	O
,	O
masked	O
palm	B-ANAT
civet	O
(	O
pcACE2	O
),	O
human	O
(	O
huACE2	O
)	O
and	O
bat	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
Chronic	O
expression	O
of	O
CXC	O
chemokine	O
ligand	O
10	O
(	O
CXCL10	O
)	O
in	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
following	O
infection	O
with	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	O
hepatitis	O
virus	O
(	O
JHMV	O
)	O
is	O
associated	O
with	O
an	O
immune	O
-	O
mediated	O
demyelinating	O
disease	O
.	O

Our	O
data	O
raise	O
the	O
possibility	O
that	O
HCoV	O
may	O
play	O
a	O
role	O
in	O
gastrointestinal	O
and	O
CNS	B-ANAT
disease	O
.	O

In	O
addition	O
,	O
CpG	O
ODN	O
administration	O
to	O
chicken	O
embryos	B-ANAT
24	O
hr	O
before	O
the	O
challenge	O
with	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
was	O
capable	O
of	O
limiting	O
IBV	O
propagation	O
in	O
different	O
embryonic	B-ANAT
tissues	B-ANAT
.	O

The	O
abdomen	B-ANAT
was	O
irrigated	O
via	O
a	O
subhepatic	O
and	O
retroperitoneal	B-ANAT
presacral	O
approach	O
,	O
and	O
broad	O
-	O
spectrum	O
antibiotic	O
therapy	O
was	O
started	O
.	O

Patients	O
with	O
a	O
platelet	B-ANAT
count	O
significantly	O
lower	O
than	O
their	O
baseline	O
on	O
admission	O
had	O
an	O
increased	O
risk	O
of	O
mechanical	O
ventilation	O
.	O

Despite	O
prompt	O
diagnosis	O
and	O
appropriate	O
treatment	O
with	O
antimicrobial	O
agents	O
active	O
against	O
Legionella	O
,	O
the	O
lethal	O
complications	O
of	O
Legionella	O
pneumonia	O
are	O
septic	O
shock	O
/	O
MODS	O
and	O
interstitial	B-ANAT
pneumonia	O
/	O
pulmonary	B-ANAT
fibrosis	O
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
RS3PE	O
syndrome	O
complicated	O
by	O
pulmonary	B-ANAT
lesions	O
and	O
accompanied	O
by	O
severe	O
acute	O
respiratory	O
failure	O
requiring	O
noninvasive	O
positive	O
-	O
pressure	O
ventilation	O
has	O
not	O
previously	O
been	O
reported	O
,	O
and	O
this	O
rare	O
case	O
is	O
discussed	O
with	O
reference	O
to	O
the	O
literature	O
.	O

Eleven	O
different	O
viruses	O
were	O
identified	O
in	O
91	O
nasopharyngeal	B-ANAT
swabs	O
of	O
children	O
with	O
acute	O
respiratory	O
infection	O
,	O
influenza	O
A	O
(	O
IAV	O
)	O
and	O
B	O
,	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
),	O
human	O
rhinovirus	O
(	O
hRhV	O
),	O
human	O
echovirus	O
,	O
parainfluenza	O
viruses	O
(	O
PIV	O
)	O
1	O
,	O
2	O
,	O
3	O
and	O
4	O
,	O
human	O
metapneumovirus	O
(	O
hMPV	O
),	O
and	O
human	O
coronavirus	O
NL63	O
.	O

The	O
major	O
virus	O
misdiagnosed	O
by	O
mRT	B-ANAT
-	O
PCR	O
was	O
IAV	O
whereas	O
the	O
major	O
viruses	O
misdiagnosed	O
by	O
Resplex	O
II	O
were	O
PIV1	O
,	O
3	O
and	O
4	O
.	O

Coronaviruses	O
are	O
being	O
associated	O
increasingly	O
with	O
severe	O
diseases	O
in	O
the	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
.	O

TITLE	O
:	O
Cor	B-ANAT
pulmonale	O
.	O

ABSTRACT	O
:	O
Although	O
low	O
-	O
tidal	O
ventilation	O
may	O
reduce	O
mortality	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
it	O
can	O
also	O
result	O
in	O
severe	O
respiratory	O
acidosis	O
and	O
lung	B-ANAT
derecruitment	O
.	O

We	O
performed	O
a	O
clinicopathologic	O
investigation	O
of	O
26	O
autopsy	O
cases	O
of	O
diffuse	O
alveolar	B-ANAT
damage	O
.	O

Nonthrombotic	O
emboli	O
may	O
also	O
lead	O
to	O
a	O
severe	O
inflammatory	O
reaction	O
both	O
in	O
the	O
systemic	O
and	O
pulmonary	B-ANAT
circulation	O
,	O
as	O
well	O
as	O
in	O
the	O
lung	B-ANAT
.	O

While	O
CoVs	O
are	O
poor	O
inducers	O
of	O
type	O
I	O
IFNs	O
in	O
tissue	B-ANAT
culture	O
,	O
several	O
studies	O
have	O
demonstrated	O
the	O
importance	O
of	O
the	O
type	O
I	O
IFN	O
response	O
in	O
controlling	O
MHV	O
infection	O
in	O
animals	O
.	O

This	O
should	O
take	O
place	O
at	O
all	O
levels	O
of	O
response	O
,	O
from	O
public	O
information	O
and	O
communication	O
messages	O
to	O
individual	O
face	B-ANAT
-	O
to	O
-	O
face	B-ANAT
advice	O
and	O
support	O
.	O

A	O
quantile	O
regression	O
model	O
was	O
applied	O
to	O
estimate	O
reference	O
ranges	O
of	O
normal	O
oral	B-ANAT
temperatures	O
for	O
students	O
with	O
adjustment	O
for	O
potential	O
confounding	O
factors	O
.	O

Temperatures	O
of	O
37	O
.	O
8	O
degrees	O
C	O
and	O
37	O
.	O
5	O
degrees	O
C	O
are	O
therefore	O
recommended	O
as	O
the	O
oral	B-ANAT
temperature	O
cut	O
-	O
offs	O
for	O
those	O
<	O
or	O
=	O
12	O
years	O
old	O
and	O
>	O
12	O
years	O
old	O
,	O
respectively	O
.	O

Acidosis	O
and	O
hypercapnia	O
induced	O
by	O
tidal	O
volume	O
reduction	O
and	O
increase	O
in	O
PEEP	O
at	O
constant	O
P	O
(	O
plat	O
)	O
were	O
associated	O
with	O
impaired	O
RV	O
function	O
and	O
hemodynamics	O
despite	O
positive	O
effects	O
on	O
oxygenation	O
and	O
alveolar	B-ANAT
recruitment	O
(	O
ClinicalTrials	O
.	O
gov	O
#	O
NCT00236262	O
).	O

The	O
decrease	O
in	O
stroke	O
index	O
tended	O
to	O
be	O
negatively	O
correlated	O
to	O
the	O
increase	O
in	O
alveolar	B-ANAT
recruitment	O
with	O
high	O
PEEP	O
.	O

Significant	O
suppression	O
of	O
innate	O
immune	O
responses	O
[	O
reduced	O
alpha	O
interferon	O
(	O
IFN	O
-	O
alpha	O
)	O
levels	O
in	O
the	O
lungs	B-ANAT
and	O
reduced	O
blood	B-ANAT
natural	B-ANAT
killer	I-ANAT
cell	I-ANAT
cytotoxicity	O
]	O
by	O
the	O
ongoing	O
PRRSV	O
infection	O
was	O
observed	O
in	O
dual	O
-	O
infected	O
pigs	O
,	O
which	O
coincided	O
with	O
exacerbated	O
pneumonia	O
during	O
early	O
PRCV	O
infection	O
.	O

Multivariate	O
modeling	O
revealed	O
no	O
statistical	O
difference	O
in	O
elevated	O
antibody	O
titers	O
against	O
HEV	B-ANAT
between	O
the	O
two	O
groups	O
.	O

TITLE	O
:	O
Safety	O
and	O
tolerability	O
of	O
ribosome	B-ANAT
-	O
component	O
immune	O
modulator	O
in	O
adults	O
and	O
children	O
.	O

Given	O
the	O
fact	O
that	O
VASP	O
expression	O
is	O
reduced	O
during	O
periods	O
of	O
cellular	B-ANAT
hypoxia	O
,	O
we	O
investigated	O
the	O
role	O
of	O
VASP	O
during	O
ALI	O
.	O

The	O
virus	O
titers	O
and	O
log	O
reductions	O
were	O
determined	O
by	O
the	O
Reed	O
and	O
Muench	O
tissue	B-ANAT
culture	O
infective	O
dose	O
(	O
TCID	O
)	O
50	O
end	O
point	O
method	O
.	O

He	O
developed	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
renal	B-ANAT
failure	O
,	O
and	O
severe	O
inflammatory	O
response	O
syndrome	O
.	O

Microscopically	O
,	O
the	O
lung	B-ANAT
specimen	O
showed	O
prominent	O
cellular	B-ANAT
alveolar	B-ANAT
exudate	B-ANAT
and	O
partial	O
hyaline	B-ANAT
membrane	B-ANAT
with	O
suppurative	O
pneumonia	O
.	O

In	O
Syrian	O
Golden	O
Hamsters	O
inoculated	O
intranasally	O
with	O
10e4	O
plaque	O
forming	O
units	O
of	O
either	O
virus	O
,	O
mean	O
titers	O
of	O
infectious	O
virus	O
and	O
viral	O
RNA	O
in	O
the	O
lungs	B-ANAT
after	O
24	O
h	O
were	O
increased	O
23	O
-	O
and	O
94	O
.	O
8	O
-	O
fold	O
,	O
respectively	O
,	O
with	O
the	O
deleted	O
virus	O
.	O

During	O
the	O
course	O
of	O
management	O
the	O
patient	O
'	O
s	O
oral	B-ANAT
condition	O
improved	O
with	O
some	O
re	O
-	O
epithelialization	O
being	O
noted	O
.	O

We	O
find	O
that	O
accounting	O
for	O
population	O
-	O
determined	O
heterogeneity	O
is	O
essential	O
for	O
interpreting	O
differences	O
between	O
the	O
activity	O
levels	O
of	O
cell	B-ANAT
populations	O
.	O

Based	O
on	O
available	O
predictive	O
models	O
,	O
we	O
propose	O
that	O
the	O
conserved	O
domain	O
flanked	O
by	O
cysteines	O
822	O
and	O
833	O
forms	O
a	O
loop	O
structure	O
that	O
interacts	O
with	O
components	O
of	O
the	O
SARS	O
-	O
CoV	O
S	O
trimer	O
to	O
control	O
the	O
activation	O
of	O
membrane	B-ANAT
fusion	O
.	O

Rabies	O
control	O
in	O
carnivores	O
by	O
parenteral	O
(	O
dog	O
)	O
or	O
oral	B-ANAT
(	O
wild	O
carnivores	O
)	O
vaccination	O
is	O
efficacious	O
and	O
campaigns	O
start	O
to	O
be	O
more	O
widely	O
applied	O
.	O

ADCML	O
assays	O
,	O
using	O
FIPV	O
strain	O
79	O
-	O
1146	O
and	O
its	O
deletion	O
mutant	O
strain	O
Delta	O
3abc	O
/	O
Delta	O
7ab	O
,	O
were	O
performed	O
on	O
:	O
(	O
i	O
)	O
CrFK	O
cells	B-ANAT
that	O
show	O
surface	O
-	O
expressed	O
viral	O
antigens	O
,	O
(	O
ii	O
)	O
monocytes	B-ANAT
without	O
surface	O
-	O
expressed	O
viral	O
proteins	O
due	O
to	O
retention	O
and	O
(	O
iii	O
)	O
monocytes	B-ANAT
with	O
surface	O
-	O
expressed	O
viral	O
proteins	O
since	O
the	O
antibody	O
-	O
mediated	O
internalization	O
of	O
these	O
proteins	O
was	O
blocked	O
.	O

In	O
8	O
survival	O
patients	O
with	O
CMV	O
pneumonia	O
,	O
the	O
number	O
of	O
CD4	O
(+)	O
T	B-ANAT
cell	I-ANAT
rose	O
slowly	O
,	O
on	O
21	O
day	O
after	O
the	O
withdrawal	O
increased	O
to	O
the	O
normal	O
level	O
.	O

But	O
in	O
4	O
non	O
-	O
survival	O
patients	O
,	O
the	O
number	O
of	O
CD4	O
(+)	O
T	B-ANAT
cell	I-ANAT
kept	O
continuously	O
in	O
lower	O
level	O
.	O

Determination	O
of	O
CD4	O
(+)	O
T	B-ANAT
cell	I-ANAT
could	O
reflect	O
the	O
status	O
of	O
cellular	B-ANAT
immunity	O
and	O
give	O
directions	O
of	O
the	O
withdrawal	O
.	O

CONCLUSIONS	O
:	O
CMV	O
pneumonia	O
is	O
associated	O
with	O
lower	O
CD4	O
(+)	O
T	B-ANAT
cell	I-ANAT
level	O
in	O
kidney	B-ANAT
transplant	I-ANAT
recipients	O
.	O

ABSTRACT	O
:	O
In	O
our	O
previous	O
study	O
by	O
Gupta	O
et	O
al	O
,	O
dominant	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
epitopes	O
of	O
SARS	O
CoV	O
-	O
N	O
(	O
N	O
)	O
protein	O
were	O
predicted	O
by	O
software	O
.	O

For	O
each	O
charging	O
scenario	O
,	O
samples	O
were	O
collected	O
from	O
the	O
effluent	O
air	O
stream	O
and	O
assayed	O
for	O
viable	O
phages	O
using	O
plaque	O
assays	O
and	O
for	O
nucleic	B-ANAT
acids	O
using	O
quantitative	O
polymerase	O
chain	O
reaction	O
(	O
qPCR	O
)	O
assays	O
.	O

Goal	O
-	O
directed	O
hemodynamic	O
therapy	O
has	O
been	O
shown	O
to	O
be	O
of	O
benefit	O
to	O
patients	O
with	O
severe	O
sepsis	O
and	O
septic	O
shock	O
,	O
acute	O
lung	B-ANAT
injury	O
and	O
adult	O
respiratory	O
distress	O
syndrome	O
,	O
and	O
for	O
surgical	O
patients	O
in	O
the	O
operating	O
room	O
.	O

Static	O
measures	O
of	O
fluid	O
status	O
,	O
central	O
venous	B-ANAT
pressure	O
(	O
CVP	O
),	O
and	O
pulmonary	B-ANAT
artery	I-ANAT
occlusion	O
pressure	O
(	O
PAOP	O
)	O
are	O
not	O
useful	O
in	O
predicting	O
volume	O
responsiveness	O
.	O

TITLE	O
:	O
Macrophage	B-ANAT
interleukin	O
-	O
6	O
and	O
tumour	O
necrosis	O
factor	O
-	O
alpha	O
are	O
induced	O
by	O
coronavirus	O
fixation	O
to	O
Toll	O
-	O
like	O
receptor	O
2	O
/	O
heparan	O
sulphate	O
receptors	O
but	O
not	O
carcinoembryonic	O
cell	B-ANAT
adhesion	O
antigen	O
1a	O
.	O

SDAV	O
inoculation	O
produced	O
a	O
7	O
%	O
body	B-ANAT
weight	O
loss	O
over	O
a	O
5	O
day	O
period	O
that	O
was	O
followed	O
by	O
recovery	O
over	O
the	O
next	O
7	O
days	O
.	O

TITLE	O
:	O
Efficient	O
induction	O
of	O
cytotoxic	B-ANAT
T	I-ANAT
lymphocytes	I-ANAT
specific	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	O
by	O
immunization	O
with	O
surface	O
-	O
linked	O
liposomal	O
peptides	O
derived	O
from	O
a	O
non	O
-	O
structural	O
polyprotein	O
1a	O
.	O

Here	O
,	O
we	O
attempted	O
to	O
identify	O
HLA	B-ANAT
-	O
A	O
*	O
0201	O
-	O
restricted	O
CTL	B-ANAT
epitopes	O
derived	O
from	O
a	O
non	O
-	O
structural	O
polyprotein	O
1a	O
(	O
pp1a	O
)	O
of	O
SARS	O
-	O
CoV	O
,	O
and	O
investigated	O
whether	O
liposomal	O
peptides	O
derived	O
from	O
pp1a	O
were	O
effective	O
for	O
CTL	B-ANAT
induction	O
.	O

Six	O
liposomal	O
peptides	O
effectively	O
induced	O
IFN	O
-	O
gamma	O
-	O
producing	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
and	O
seven	O
liposomal	O
peptides	O
including	O
the	O
six	O
peptides	O
primed	O
CTLs	O
showing	O
in	O
vivo	O
killing	O
activities	O
.	O

These	O
data	O
suggest	O
that	O
surface	O
-	O
linked	O
liposomal	O
peptides	O
derived	O
from	O
pp1a	O
might	O
offer	O
an	O
efficient	O
CTL	B-ANAT
-	O
based	O
vaccine	O
against	O
SARS	O
.	O

We	O
show	O
that	O
mAbs	O
recognizing	O
epitopes	O
within	O
the	O
RBD	O
inhibit	O
infection	O
by	O
preventing	O
viral	O
attachment	O
to	O
the	O
cellular	B-ANAT
receptor	O
.	O

Fecal	B-ANAT
samples	O
from	O
calves	O
with	O
(	O
n	O
=	O
68	O
)	O
or	O
without	O
(	O
n	O
=	O
691	O
)	O
diarrhea	O
were	O
analyzed	O
for	O
the	O
presence	O
of	O
Cryptosporidium	O
,	O
Giardia	O
,	O
and	O
Eimeria	O
species	O
.	O

Blood	B-ANAT
samples	I-ANAT
(	O
n	O
=	O
1	O
,	O
348	O
)	O
were	O
analyzed	O
for	O
antibodies	O
against	O
BCoV	O
and	O
rotavirus	O
.	O

Blood	B-ANAT
samples	I-ANAT
from	O
calves	O
of	O
>	O
150	O
d	O
of	O
age	O
(	O
n	O
=	O
1	O
,	O
348	O
)	O
were	O
analyzed	O
for	O
antibodies	O
against	O
parainfluenza	O
virus	O
3	O
,	O
bovine	O
coronavirus	O
(	O
BCoV	O
),	O
bovine	O
respiratory	O
syncytial	O
virus	O
(	O
BRSV	O
),	O
and	O
Mycoplasma	O
bovis	O
.	O

TITLE	O
:	O
Glycogen	O
content	O
is	O
affected	O
differently	O
in	O
acute	O
pulmonary	B-ANAT
and	O
extra	O
-	O
pulmonary	B-ANAT
lung	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
the	O
most	O
severe	O
form	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
).	O

This	O
measurement	O
could	O
indicate	O
performance	O
limitations	O
of	O
tissues	B-ANAT
,	O
a	O
new	O
biochemical	O
aspect	O
of	O
ARDS	O
.	O

ALI	O
-	O
EX	O
caused	O
a	O
greater	O
thickening	O
of	O
the	O
alveolar	B-ANAT
walls	O
,	O
more	O
areas	O
of	O
atelectasis	O
and	O
a	O
greater	O
abundance	O
of	O
inflammatory	B-ANAT
cells	I-ANAT
in	O
comparison	O
to	O
ALI	O
-	O
P	O
.	O
These	O
results	O
demonstrate	O
that	O
glycogen	O
content	O
in	O
ALI	O
,	O
induced	O
by	O
an	O
herbicide	O
that	O
is	O
highly	O
toxic	O
to	O
humans	O
and	O
animals	O
,	O
is	O
altered	O
in	O
different	O
tissues	B-ANAT
depending	O
on	O
the	O
location	O
of	O
the	O
injury	O
.	O

TITLE	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
in	O
adults	O
with	O
severe	O
respiratory	O
failure	O
:	O
a	O
multi	O
-	O
center	O
database	O
.	O

Chest	B-ANAT
X	O
-	O
ray	O
showed	O
lung	B-ANAT
infiltrates	O
and	O
/	O
or	O
lung	B-ANAT
consolidation	O
in	O
97	O
.	O
3	O
%.	O

It	O
maps	O
the	O
political	O
context	O
of	O
the	O
media	B-ANAT
discourse	O
and	O
explores	O
the	O
construction	O
of	O
a	O
collective	O
past	O
to	O
foster	O
national	O
cohesion	O
in	O
postcolonial	O
Hong	O
Kong	O
.	O

However	O
,	O
the	O
signaling	O
events	O
that	O
trigger	O
TNF	O
-	O
alpha	O
and	O
IL	O
-	O
6	O
induction	O
in	O
these	O
cells	B-ANAT
upon	O
MHV	O
infection	O
remain	O
unknown	O
.	O

These	O
results	O
illustrate	O
the	O
complexity	O
of	O
the	O
regulatory	O
mechanism	O
by	O
which	O
MHV	O
induces	O
proinflammatory	O
cytokines	O
in	O
primary	O
astrocytes	B-ANAT
.	O

In	O
this	O
report	O
,	O
we	O
show	O
that	O
phosphorylation	O
of	O
eIF	O
-	O
2alpha	O
was	O
severely	O
suppressed	O
in	O
human	O
and	O
animal	O
cells	B-ANAT
infected	O
with	O
the	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
).	O

Inhibition	O
of	O
the	O
PP1	O
activity	O
by	O
okadaic	O
acid	O
and	O
overexpression	O
of	O
GADD34	O
,	O
eIF	O
-	O
2alpha	O
,	O
and	O
PKR	O
,	O
as	O
well	O
as	O
their	O
mutant	O
constructs	O
in	O
virus	O
-	O
infected	O
cells	B-ANAT
,	O
showed	O
that	O
these	O
viral	O
regulatory	O
strategies	O
played	O
a	O
synergistic	O
role	O
in	O
facilitating	O
coronavirus	O
replication	O
.	O

We	O
found	O
that	O
CCoV	O
-	O
II	O
triggers	O
apoptosis	O
in	O
A	O
-	O
72	O
cells	B-ANAT
by	O
activating	O
initiator	O
(	O
caspase	O
-	O
8	O
and	O
-	O
9	O
)	O
and	O
executioner	O
(	O
caspase	O
-	O
3	O
and	O
-	O
6	O
)	O
caspases	O
.	O

High	O
-	O
dose	O
pulse	O
therapy	O
with	O
methylprednisolone	O
induced	O
a	O
marked	O
improvement	O
in	O
pulmonary	B-ANAT
conditions	O
.	O

Examination	O
of	O
affected	O
tissues	B-ANAT
revealed	O
abnormalities	O
in	O
the	O
liver	B-ANAT
,	O
spleen	B-ANAT
,	O
kidney	B-ANAT
,	O
lung	B-ANAT
and	O
trachea	B-ANAT
of	O
chickens	O
vaccinated	O
with	O
the	O
attenuated	O
live	O
IB	O
vaccine	O
and	O
the	O
rFPV	O
-	O
IBVS1	O
vaccine	O
.	O

Further	O
,	O
virus	O
-	O
specific	O
T	B-ANAT
cell	I-ANAT
numbers	O
at	O
this	O
site	O
of	O
infection	O
are	O
maintained	O
by	O
recruitment	O
from	O
peripheral	O
Ag	O
-	O
experienced	O
and	O
naive	O
T	B-ANAT
cell	I-ANAT
pools	O
.	O

TITLE	O
:	O
Ultrasound	O
-	O
guided	O
percutaneous	O
drainage	B-ANAT
may	O
decrease	O
the	O
mortality	O
of	O
severe	O
acute	O
pancreatitis	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
efficacy	O
and	O
safety	O
of	O
ultrasound	O
-	O
guided	O
percutaneous	O
catheter	O
drainage	B-ANAT
(	O
PCD	O
)	O
treatment	O
for	O
severe	O
acute	O
pancreatitis	O
compared	O
to	O
conservative	O
and	O
conventional	O
surgical	O
treatments	O
.	O

We	O
further	O
show	O
that	O
ATE	O
cells	B-ANAT
support	O
the	O
replication	O
and	O
spread	O
of	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
).	O

Furthermore	O
,	O
increased	O
morbidity	O
and	O
mortality	O
could	O
not	O
be	O
attributed	O
to	O
altered	O
proinflammatory	O
signals	O
or	O
composition	O
of	O
cells	B-ANAT
infiltrating	O
the	O
CNS	B-ANAT
.	O

The	O
unique	O
phenotype	O
of	O
infected	O
RL	O
(-/-)	O
mice	O
was	O
rather	O
manifested	O
in	O
earlier	O
onset	O
and	O
increased	O
severity	O
of	O
demyelination	O
and	O
axonal	O
damage	O
in	O
brain	B-ANAT
stem	I-ANAT
and	O
spinal	B-ANAT
cord	I-ANAT
without	O
evidence	O
for	O
enhanced	O
neuronal	O
infection	O
.	O

Increased	O
tissue	B-ANAT
damage	O
coincided	O
with	O
sustained	O
brain	B-ANAT
stem	I-ANAT
infection	O
,	O
foci	O
of	O
microglia	B-ANAT
infection	O
in	O
grey	B-ANAT
matter	I-ANAT
,	O
and	O
increased	O
apoptotic	O
cells	B-ANAT
.	O

After	O
A	O
/	O
H5N1	O
infection	O
was	O
confirmed	O
,	O
antiviral	O
treatment	O
with	O
oseltamivir	O
and	O
A	O
/	O
H5N1	O
vaccinated	O
plasma	B-ANAT
were	O
used	O
on	O
day	O
11	O
.	O

A	O
44	O
-	O
year	O
-	O
old	O
woman	O
with	O
pneuminian	O
was	O
diagnosed	O
as	O
A	O
/	O
H5N1	O
infection	O
by	O
reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
in	O
laboratory	O
from	O
the	O
sample	O
of	O
secretion	B-ANAT
of	O
respiratory	B-ANAT
tracts	I-ANAT
.	O

Then	O
,	O
bronchopleural	O
fistula	O
on	O
the	O
surface	O
of	O
visceral	B-ANAT
pleura	I-ANAT
was	O
successfully	O
blocked	O
by	O
biogel	O
and	O
OB	O
gel	O
through	O
pleural	B-ANAT
cavity	I-ANAT
by	O
fibrobronchoscopy	O
.	O

The	O
S	O
proteins	O
are	O
set	O
apart	O
from	O
other	O
viral	O
and	O
cellular	B-ANAT
membrane	I-ANAT
fusion	O
proteins	O
by	O
their	O
extensively	O
palmitoylated	O
membrane	B-ANAT
-	O
associated	O
tails	B-ANAT
.	O

To	O
obtain	O
additional	O
insights	O
into	O
the	O
S	O
-	O
mediated	O
membrane	B-ANAT
fusion	O
process	O
,	O
we	O
focused	O
on	O
these	O
acylated	O
carboxyl	O
-	O
terminal	O
intravirion	O
tails	B-ANAT
.	O

TITLE	O
:	O
Hantavirus	O
pulmonary	B-ANAT
syndrome	O
in	O
Brasilia	O
periphery	O
:	O
a	O
diagnostic	O
challenge	O
.	O

Serum	B-ANAT
samples	O
from	O
251	O
dogs	O
of	O
varying	O
age	O
,	O
breed	O
and	O
clinical	O
histories	O
were	O
tested	O
for	O
the	O
presence	O
of	O
antibodies	O
to	O
CRCoV	O
and	O
CIV	O
,	O
using	O
indirect	O
fluorescent	O
antibody	O
(	O
IFA	O
)	O
analysis	O
.	O

TITLE	O
:	O
Hemagglutinin	O
-	O
dependent	O
tropism	O
of	O
H5N1	O
avian	O
influenza	O
virus	O
for	O
human	O
endothelial	B-ANAT
cells	I-ANAT
.	O

In	O
the	O
present	O
study	O
,	O
we	O
demonstrate	O
that	O
human	O
pulmonary	B-ANAT
microvascular	O
endothelial	B-ANAT
cells	I-ANAT
(	O
hPMEC	O
)	O
had	O
a	O
clearly	O
higher	O
susceptibility	O
to	O
infection	O
by	O
H5N1	O
HPAIV	O
than	O
to	O
infection	O
by	O
human	O
influenza	O
viruses	O
.	O

Then	O
the	O
resulting	O
articles	O
were	O
further	O
read	O
through	O
to	O
select	O
the	O
SARS	O
detection	O
results	O
using	O
ELISA	O
methods	O
of	O
serum	B-ANAT
samples	O
collected	O
at	O
least	O
1	O
month	O
after	O
disease	O
onset	O
.	O

White	B-ANAT
blood	I-ANAT
cell	I-ANAT
counts	O
,	O
and	O
percentages	O
of	O
neutrophilic	O
granulocytes	B-ANAT
and	O
neutrophilic	O
lymphocytes	B-ANAT
were	O
measured	O
.	O

ABSTRACT	O
:	O
We	O
have	O
previously	O
demonstrated	O
that	O
the	O
replacement	O
of	O
the	O
S	O
gene	O
from	O
an	O
avirulent	O
strain	O
(	O
Beaudette	O
)	O
of	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
with	O
an	O
S	O
gene	O
from	O
a	O
virulent	O
strain	O
(	O
M41	O
)	O
resulted	O
in	O
a	O
recombinant	O
virus	O
(	O
BeauR	O
-	O
M41	O
(	O
S	O
))	O
with	O
the	O
in	O
vitro	O
cell	B-ANAT
tropism	O
of	O
the	O
virulent	O
virus	O
but	O
that	O
was	O
still	O
avirulent	O
.	O

The	O
three	O
CRCoV	O
-	O
positive	O
samples	O
were	O
found	O
to	O
be	O
competent	O
for	O
viral	O
propagation	O
and	O
isolation	O
,	O
using	O
human	O
rectal	O
tumor	B-ANAT
cells	I-ANAT
(	O
HRT	O
-	O
18	O
),	O
and	O
the	O
structure	O
and	O
nonstructure	O
proteins	O
encoded	O
in	O
the	O
3	O
'-	O
end	O
of	O
the	O
CRCoV	O
genome	O
were	O
sequenced	O
.	O

The	O
small	O
open	O
reading	O
frames	O
situated	O
between	O
the	O
spike	O
and	O
envelope	B-ANAT
genes	O
of	O
the	O
three	O
Korean	O
CRCoV	O
isolates	O
were	O
found	O
to	O
encode	O
three	O
nonstructural	O
proteins	O
(	O
4	O
.	O
9	O
kDa	O
,	O
2	O
.	O
7	O
kDa	O
,	O
and	O
12	O
.	O
8	O
kDa	O
in	O
size	O
),	O
as	O
were	O
the	O
British	O
(	O
CRCoV	O
G9142	O
)	O
and	O
Italian	O
(	O
CRCoV	O
240	O
-	O
05	O
)	O
strains	O
.	O

The	O
probability	O
of	O
detecting	O
each	O
one	O
of	O
five	O
enteropathogens	O
given	O
a	O
calf	B-ANAT
with	O
'	O
custard	O
-	O
like	O
'	O
faeces	B-ANAT
or	O
diarrhoea	O
was	O
estimated	O
using	O
Bayes	O
'	O
rule	O
and	O
was	O
based	O
on	O
the	O
predicted	O
probabilities	O
from	O
a	O
multinominal	O
model	O
including	O
each	O
of	O
five	O
enteropathogens	O
as	O
independent	O
variables	O
.	O

TITLE	O
:	O
Hemocompatibility	O
of	O
a	O
miniaturized	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
and	O
a	O
pumpless	O
interventional	O
lung	B-ANAT
assist	O
in	O
experimental	O
lung	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
is	O
used	O
for	O
most	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
cases	O
in	O
specialized	O
centers	O
.	O

In	O
all	O
groups	O
,	O
hemolysis	O
remained	O
negligible	O
,	O
indicated	O
by	O
low	O
plasma	B-ANAT
hemoglobin	O
concentration	O
.	O

Both	O
devices	O
demonstrated	O
adequate	O
hemocompatibility	O
for	O
safe	O
clinical	O
application	O
,	O
although	O
a	O
missing	O
blood	B-ANAT
pump	O
did	O
not	O
increase	O
hemocompatibility	O
.	O

Infants	O
underwent	O
nasal	B-ANAT
washing	I-ANAT
for	O
the	O
detection	O
of	O
RSV	O
,	O
influenza	O
virus	O
A	O
and	O
B	O
,	O
human	O
coronavirus	O
OC43	O
,	O
229E	O
,	O
NL	O
-	O
63	O
,	O
HUK1	O
,	O
adenovirus	O
,	O
RV	O
,	O
parainfluenza	O
1	O
-	O
3	O
,	O
human	O
metapneumovirus	O
and	O
hBoV	O
.	O
Demographic	O
,	O
clinical	O
and	O
laboratory	O
data	O
were	O
obtained	O
from	O
parents	O
and	O
from	O
patient	O
medical	O
files	O
.	O

Main	O
outcome	O
measurements	O
were	O
age	O
,	O
breastfeeding	O
history	O
,	O
family	O
smoking	O
habits	O
,	O
family	O
history	O
for	O
asthma	O
and	O
atopy	O
,	O
blood	B-ANAT
eosinophil	I-ANAT
count	O
,	O
chest	B-ANAT
radiological	O
findings	O
,	O
clinical	O
severity	O
score	O
and	O
number	O
of	O
days	O
of	O
hospitalisation	O
.	O

Infants	O
with	O
RV	O
infection	O
had	O
higher	O
blood	B-ANAT
eosinophil	I-ANAT
counts	O
than	O
infants	O
with	O
bronchiolitis	O
from	O
RSV	O
and	O
hBoV	O
(	O
307	O
+/-	O
436	O
vs	O
138	O
+/-	O
168	O
vs	O
89	O
+/-	O
19	O
n	O
/	O
mm	O
(	O
3	O
);	O
p	O
<	O
0	O
.	O
05	O
).	O

ABSTRACT	O
:	O
The	O
nuclear	O
magnetic	O
resonance	O
(	O
NMR	O
)	O
structure	O
of	O
a	O
globular	O
domain	O
of	O
residues	O
1071	O
to	O
1178	O
within	O
the	O
previously	O
annotated	O
nucleic	B-ANAT
acid	O
-	O
binding	O
region	O
(	O
NAB	O
)	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
nonstructural	O
protein	O
3	O
(	O
nsp3	O
)	O
has	O
been	O
determined	O
,	O
and	O
N	O
-	O
and	O
C	O
-	O
terminally	O
adjoining	O
polypeptide	O
segments	O
of	O
37	O
and	O
25	O
residues	O
,	O
respectively	O
,	O
have	O
been	O
shown	O
to	O
form	O
flexibly	O
extended	O
linkers	O
to	O
the	O
preceding	O
globular	O
domain	O
and	O
to	O
the	O
following	O
,	O
as	O
yet	O
uncharacterized	O
domain	O
.	O

We	O
report	O
on	O
a	O
75	O
-	O
year	O
-	O
old	O
patient	O
with	O
long	O
-	O
lasting	O
hepatitis	O
C	O
virus	O
infection	O
[	O
18	O
years	O
],	O
a	O
long	O
-	O
lasting	O
cryoglobulinemia	O
[	O
7	O
years	O
]	O
resistant	O
to	O
common	O
antiviral	O
therapy	O
,	O
diabetes	O
mellitus	O
and	O
deep	O
skin	B-ANAT
ulcers	O
,	O
successfully	O
treated	O
with	O
the	O
combination	O
therapy	O
of	O
Rituximab	O
and	O
plasma	B-ANAT
exchange	O
.	O

CONCLUSIONS	O
:	O
Plasma	B-ANAT
exchange	O
in	O
combination	O
with	O
Rituximab	O
may	O
be	O
useful	O
to	O
heal	O
skin	B-ANAT
in	O
those	O
patients	O
who	O
are	O
non	O
responsive	O
to	O
Rituximab	O
alone	O
,	O
by	O
avoiding	O
a	O
leg	B-ANAT
amputation	O
.	O

ABSTRACT	O
:	O
Benign	O
acute	O
childhood	O
myositis	O
(	O
BACM	O
)	O
is	O
a	O
rare	O
transient	O
condition	O
usually	O
occurring	O
at	O
the	O
early	O
convalescent	O
phase	O
of	O
a	O
viral	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
illness	O
,	O
normally	O
influenza	O
A	O
,	O
and	O
,	O
more	O
frequently	O
,	O
influenza	O
B	O
infection	O
.	O

ABSTRACT	O
:	O
One	O
in	O
every	O
7	O
pregnancies	O
ends	O
with	O
meconium	B-ANAT
-	O
stained	O
amniotic	B-ANAT
fluid	I-ANAT
and	O
approximately	O
5	O
%	O
of	O
these	O
infants	O
develop	O
the	O
meconium	B-ANAT
aspiration	O
syndrome	O
(	O
MAS	B-ANAT
).	O

The	O
detection	O
limits	O
for	O
the	O
IBV	O
RT	O
-	O
LAMP	O
assay	O
were	O
10	O
(	O
1	O
)	O
50	O
%	O
egg	B-ANAT
infection	O
dose	O
(	O
EID	O
(	O
50	O
))	O
per	O
50	O
microl	O
of	O
titrated	O
viruses	O
and	O
no	O
cross	O
-	O
reaction	O
of	O
IBV	O
RT	O
-	O
LAMP	O
was	O
found	O
when	O
tested	O
with	O
other	O
viruses	O
including	O
Newcastle	O
disease	O
virus	O
(	O
NDV	O
),	O
avian	O
reovirus	O
(	O
ARV	O
),	O
and	O
infectious	O
laryngotrachietis	O
virus	O
(	O
ILTV	O
)	O
due	O
to	O
their	O
mismatch	O
with	O
IBV	O
RT	O
-	O
LAMP	O
primers	O
.	O

A	O
total	O
of	O
187	O
clinical	O
tissues	B-ANAT
samples	O
(	O
88	O
blood	B-ANAT
,	O
62	O
kidney	B-ANAT
and	O
37	O
lung	B-ANAT
)	O
were	O
evaluated	O
and	O
compared	O
to	O
conventional	O
RT	O
-	O
PCR	O
.	O

ABSTRACT	O
:	O
For	O
therapy	O
of	O
blunt	O
thoracic	B-ANAT
trauma	O
in	O
multiple	O
injured	O
patients	O
,	O
some	O
studies	O
have	O
recommended	O
prophylactic	O
ventilation	O
with	O
kinetic	O
therapy	O
for	O
3	O
-	O
5	O
days	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
its	O
more	O
severe	O
form	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
are	O
important	O
critical	O
care	O
syndromes	O
for	O
which	O
the	O
treatment	O
options	O
are	O
limited	O
once	O
the	O
condition	O
is	O
fully	O
established	O
.	O

Unusual	O
inclusions	O
were	O
present	O
in	O
infected	O
cells	B-ANAT
including	O
tubular	O
and	O
laminated	O
structures	O
.	O

The	O
virus	O
was	O
released	O
via	O
exocytosis	O
and	O
cell	B-ANAT
lysis	O
.	O

There	O
was	O
a	O
major	O
contribution	O
of	O
the	O
IRE1	O
/	O
XBP1	O
pathway	O
,	O
followed	O
by	O
caspase	O
-	O
3	O
activation	O
and	O
nuclear	O
fragmentation	O
,	O
with	O
no	O
significant	O
role	O
of	O
the	O
ATF6	O
and	O
eIF2	B-ANAT
-	O
alpha	O
/	O
ATF4	O
pathways	O
.	O

Electron	O
microscopic	O
analysis	O
of	O
ultrastructure	O
from	O
infected	O
cells	B-ANAT
demonstrated	O
that	O
the	O
nsp4	O
mutants	O
had	O
aberrant	O
morphology	O
of	O
virus	O
-	O
induced	O
double	O
-	O
membrane	B-ANAT
vesicles	B-ANAT
(	O
DMVs	O
)	O
compared	O
to	O
those	O
infected	O
with	O
wt	O
virus	O
.	O

In	O
addition	O
,	O
ventilation	O
-	O
perfusion	O
distribution	O
of	O
the	O
lung	B-ANAT
tissue	I-ANAT
was	O
assessed	O
by	O
the	O
multiple	O
inert	O
gas	O
elimination	O
technique	O
.	O

In	O
intergroup	O
comparisons	O
,	O
there	O
were	O
no	O
differences	O
in	O
pulmonary	B-ANAT
blood	B-ANAT
flow	O
to	O
lung	B-ANAT
units	O
with	O
subnormal	O
ventilation	O
/	O
perfusion	O
ratios	O
.	O

TITLE	O
:	O
Evasion	O
by	O
stealth	O
:	O
inefficient	O
immune	O
activation	O
underlies	O
poor	O
T	B-ANAT
cell	I-ANAT
response	O
and	O
severe	O
disease	O
in	O
SARS	O
-	O
CoV	O
-	O
infected	O
mice	O
.	O

ABSTRACT	O
:	O
This	O
report	O
describes	O
the	O
identification	O
of	O
a	O
novel	O
linear	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
epitope	O
at	O
the	O
C	O
-	O
terminus	O
of	O
the	O
membrane	B-ANAT
(	O
M	O
)	O
protein	O
of	O
avian	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
).	O

Finally	O
,	O
SARS	O
-	O
CoV	O
but	O
not	O
NL63	O
replicated	O
efficiently	O
in	O
ACE2	O
-	O
positive	O
Vero	B-ANAT
cells	I-ANAT
and	O
reduced	O
ACE2	O
expression	O
,	O
indicating	O
robust	O
receptor	O
interference	O
in	O
the	O
context	O
of	O
SARS	O
-	O
CoV	O
but	O
not	O
NL63	O
infection	O
.	O

Compared	O
to	O
pre	O
-	O
ICU	O
baseline	O
test	O
data	O
,	O
her	O
intellectual	O
function	O
declined	O
approximately	O
2	O
standard	O
deviations	O
from	O
139	O
to	O
106	O
(	O
from	O
the	O
99	O
to	O
the	O
61	O
percentile	O
)	O
on	O
a	O
standardized	O
intelligence	O
test	O
8	O
months	O
post	O
-	O
discharge	B-ANAT
,	O
with	O
little	O
subsequent	O
improvement	O
.	O

We	O
have	O
developed	O
a	O
pulmonary	B-ANAT
formulation	O
of	O
tissue	B-ANAT
plasminogen	O
activator	O
(	O
pf	O
-	O
tPA	O
)	O
that	O
withstands	O
nebulization	O
and	O
reaches	O
the	O
lower	O
airways	O
.	O

Predominant	O
bacteria	O
that	O
cause	O
otitis	O
media	B-ANAT
are	O
Streptococcus	O
pneumoniae	O
,	O
Moraxella	O
catarrhalis	O
,	O
and	O
non	O
-	O
typeable	O
Haemophilus	O
influenzae	O
.	O

Antibiotic	O
therapy	O
does	O
not	O
significantly	O
benefit	O
most	O
patients	O
with	O
AOM	O
,	O
but	O
long	O
-	O
term	O
prophylactic	O
antibiotic	O
therapy	O
can	O
reduce	O
the	O
risk	O
of	O
otitis	O
media	B-ANAT
recurrence	O
among	O
children	O
at	O
high	O
risk	O
.	O

In	O
line	O
with	O
these	O
observations	O
,	O
plasmacytoid	B-ANAT
dendritic	I-ANAT
cells	I-ANAT
have	O
been	O
shown	O
to	O
produce	O
interferons	O
upon	O
SARS	O
-	O
CoV	O
infection	O
in	O
vitro	O
.	O

The	O
presence	O
of	O
viral	O
RNA	O
in	O
lymphoid	B-ANAT
tissues	I-ANAT
was	O
observed	O
only	O
in	O
dogs	O
euthanised	O
in	O
the	O
early	O
stages	O
of	O
infection	O
and	O
the	O
clinical	O
course	O
of	O
the	O
infection	O
was	O
unrelated	O
to	O
the	O
viral	O
dose	O
administered	O
.	O

TITLE	O
:	O
The	O
open	O
reading	O
frame	O
3a	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
promotes	O
membrane	B-ANAT
rearrangement	O
and	O
cell	B-ANAT
death	O
.	O

Apparently	O
,	O
3c	O
-	O
inactivated	O
viruses	O
replicate	O
not	O
at	O
all	O
--	O
or	O
only	O
poorly	O
--	O
in	O
the	O
gut	B-ANAT
,	O
explaining	O
the	O
rare	O
incidence	O
of	O
FIP	O
outbreaks	O
.	O

They	O
characteristically	O
form	O
promiscuous	O
associations	O
with	O
one	O
another	O
and	O
with	O
other	O
membrane	B-ANAT
proteins	O
and	O
lipids	O
to	O
generate	O
a	O
specialized	O
type	O
of	O
microdomain	O
:	O
the	O
tetraspanin	O
-	O
enriched	O
microdomain	O
(	O
TEM	O
).	O

Increasing	O
evidence	O
demonstrates	O
that	O
tetraspanins	O
are	O
used	O
by	O
intracellular	B-ANAT
pathogens	O
as	O
a	O
means	O
of	O
entering	O
and	O
replicating	O
within	O
human	O
cells	B-ANAT
.	O

TITLE	O
:	O
Crystal	B-ANAT
structure	O
of	O
NL63	O
respiratory	O
coronavirus	O
receptor	O
-	O
binding	O
domain	O
complexed	O
with	O
its	O
human	O
receptor	O
.	O

Secondary	O
outcomes	O
were	O
6	O
-	O
month	O
mortality	O
and	O
mortality	O
at	O
intensive	O
care	O
unit	O
discharge	B-ANAT
,	O
organ	B-ANAT
dysfunctions	O
,	O
and	O
the	O
complication	O
rate	O
related	O
to	O
prone	O
positioning	O
.	O

Our	O
data	O
demonstrate	O
that	O
recombinant	O
FCoVs	O
expressing	O
a	O
type	O
II	O
FCoV	O
S	O
protein	O
acquire	O
the	O
ability	O
to	O
efficiently	O
use	O
fAPN	O
for	O
host	B-ANAT
cell	I-ANAT
entry	O
and	O
corroborate	O
the	O
notion	O
that	O
type	O
I	O
FCoVs	O
use	O
another	O
main	O
host	B-ANAT
cell	I-ANAT
receptor	O
.	O

At	O
this	O
time	O
,	O
a	O
second	O
wave	O
of	O
enhanced	O
production	O
of	O
cytokines	O
(	O
TNF	O
-	O
alpha	O
,	O
IL	O
-	O
6	O
,	O
gamma	O
interferon	O
[	O
IFN	O
-	O
gamma	O
],	O
IL	O
-	O
2	O
,	O
and	O
IL	O
-	O
5	O
),	O
chemokines	O
(	O
CXCL9	O
,	O
CXCL10	O
,	O
CCL2	O
,	O
CCL3	O
,	O
and	O
CCL5	O
),	O
and	O
receptors	O
(	O
CXCR3	O
,	O
CCR2	O
,	O
and	O
CCR5	O
),	O
was	O
detected	O
in	O
the	O
lungs	B-ANAT
,	O
associated	O
with	O
an	O
influx	O
of	O
T	B-ANAT
lymphocytes	I-ANAT
.	O

However	O
,	O
depletion	O
of	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
resulted	O
in	O
an	O
enhanced	O
immune	O
-	O
mediated	O
interstitial	B-ANAT
pneumonitis	O
and	O
delayed	O
clearance	O
of	O
SARS	O
-	O
CoV	O
from	O
the	O
lungs	B-ANAT
,	O
which	O
was	O
associated	O
with	O
reduced	O
neutralizing	O
antibody	O
and	O
cytokine	O
production	O
and	O
reduced	O
pulmonary	B-ANAT
recruitment	O
of	O
lymphocytes	B-ANAT
.	O

Most	O
notable	O
is	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
a	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
disease	O
of	O
humans	O
that	O
was	O
first	O
reported	O
in	O
late	O
2002	O
in	O
Guangdong	O
Province	O
,	O
China	O
.	O

Concomitant	O
challenge	O
with	O
endotoxin	O
after	O
priming	O
with	O
oleic	O
acid	O
(	O
OA	O
)	O
induced	O
a	O
marked	O
elevation	O
of	O
CXCL8	O
level	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
.	O

The	O
assay	O
was	O
highly	O
sensitive	O
and	O
could	O
quantitate	O
between	O
10	O
(	O
2	O
)	O
and	O
10	O
(	O
10	O
)	O
copies	O
/	O
microl	O
of	O
viral	B-ANAT
genome	I-ANAT
.	O

TITLE	O
:	O
Cleavage	O
of	O
the	O
SARS	O
coronavirus	O
spike	O
glycoprotein	O
by	O
airway	B-ANAT
proteases	O
enhances	O
virus	O
entry	O
into	O
human	O
bronchial	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
in	O
vitro	O
.	O

TITLE	O
:	O
H1N1	O
influenza	O
A	O
virus	O
-	O
associated	O
acute	O
lung	B-ANAT
injury	O
:	O
response	O
to	O
combination	O
oseltamivir	O
and	O
prolonged	O
corticosteroid	O
treatment	O
.	O

By	O
day	O
7	O
of	O
treatment	O
,	O
patients	O
experienced	O
a	O
significant	O
improvement	O
in	O
lung	B-ANAT
injury	O
and	O
multiple	O
organ	B-ANAT
dysfunction	O
scores	O
(	O
P	O
<	O
0	O
.	O
001	O
).	O

Twelve	O
patients	O
(	O
92	O
%)	O
improved	O
lung	B-ANAT
function	O
,	O
were	O
extubated	O
,	O
and	O
discharged	O
alive	O
from	O
the	O
ICU	O
.	O

His	O
body	B-ANAT
temperature	O
was	O
38	O
.	O
4	O
C	O
,	O
with	O
a	O
heart	B-ANAT
rate	O
of	O
124	O
/	O
min	O
,	O
a	O
blood	B-ANAT
pressure	O
of	O
120	O
/	O
70	O
mmHg	O
and	O
a	O
positive	O
shock	O
index	O
.	O

At	O
auscultation	O
of	O
the	O
chest	B-ANAT
fine	O
rales	O
were	O
heard	O
over	O
both	O
lungs	B-ANAT
with	O
diminished	O
percussion	O
sounds	O
basal	O
.	O

TITLE	O
:	O
Expression	O
of	O
beta	O
-	O
defensins	O
in	O
the	O
canine	O
respiratory	B-ANAT
tract	I-ANAT
and	O
antimicrobial	O
activity	O
against	O
Bordetella	O
bronchiseptica	O
.	O

ABSTRACT	O
:	O
During	O
the	O
novel	O
influenza	O
A	O
(	O
H1N1	O
)	O
pandemic	O
,	O
some	O
patients	O
developed	O
acute	O
respiratory	O
distress	O
syndrome	O
or	O
severe	O
cardiopulmonary	B-ANAT
failure	O
despite	O
the	O
use	O
of	O
conventional	O
management	O
.	O

A	O
32	O
-	O
year	O
-	O
old	O
man	O
had	O
acute	O
onset	O
of	O
fever	O
,	O
dry	O
cough	O
,	O
rhinorrhea	O
,	O
and	O
sore	O
throat	B-ANAT
2	O
days	O
after	O
returning	O
from	O
Dongguan	O
,	O
China	O
.	O

In	O
addition	O
,	O
blood	B-ANAT
cultures	O
collected	O
at	O
Hospital	O
A	O
yielded	O
Streptococcus	O
pneumoniae	O
,	O
and	O
beta	O
-	O
hemolytic	O
Streptococcus	O
other	O
than	O
group	O
A	O
,	O
B	O
or	O
D	O
.	O
Hospital	O
course	O
was	O
uneventful	O
and	O
he	O
was	O
discharged	O
26	O
days	O
after	O
transfer	O
to	O
Hospital	O
B	O
.	O
This	O
experience	O
showed	O
that	O
ECMO	O
can	O
be	O
life	O
-	O
saving	O
for	O
severe	O
novel	O
H1N1	O
infection	O
.	O

TITLE	O
:	O
Pulmonary	B-ANAT
/	O
renal	B-ANAT
interaction	O
.	O

ABSTRACT	O
:	O
Acute	O
kidney	B-ANAT
injury	O
contributes	O
to	O
the	O
development	O
of	O
acute	O
lung	B-ANAT
injury	O
and	O
vice	O
-	O
versa	O
.	O

Extracorporeal	O
CO2	O
removal	O
and	O
renal	B-ANAT
replacement	O
associated	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
might	O
be	O
interesting	O
options	O
for	O
a	O
future	O
approach	O
to	O
pulmonary	B-ANAT
/	O
renal	B-ANAT
syndrome	O
.	O

TITLE	O
:	O
Infection	O
with	O
a	O
pathogenic	O
turkey	O
coronavirus	O
isolate	O
negatively	O
affects	O
growth	O
performance	O
and	O
intestinal	B-ANAT
morphology	O
of	O
young	O
turkey	O
poults	O
in	O
Canada	O
.	O

Mean	O
body	B-ANAT
weights	O
of	O
birds	O
infected	O
at	O
2	O
or	O
28	O
days	O
of	O
age	O
were	O
significantly	O
reduced	O
compared	O
with	O
uninfected	O
birds	O
by	O
7	O
d	O
.	O
p	O
.	O
i	O
.	O
and	O
remained	O
significantly	O
lower	O
for	O
the	O
duration	O
of	O
the	O
study	O
.	O

The	O
ability	O
of	O
the	O
strains	O
to	O
inhibit	O
trachea	B-ANAT
epithelium	B-ANAT
ciliary	O
activity	O
,	O
to	O
induce	O
immune	O
response	O
,	O
to	O
replicate	O
and	O
to	O
cause	O
histopathological	O
lesions	O
in	O
designated	O
organs	B-ANAT
was	O
followed	O
by	O
repeated	O
samplings	O
during	O
a	O
period	O
of	O
42	O
days	O
post	O
infection	O
.	O

Strain	O
793	O
/	O
B	O
had	O
the	O
least	O
capacity	O
to	O
invade	O
the	O
investigated	O
organs	B-ANAT
,	O
while	O
it	O
produced	O
a	O
good	O
humoral	O
response	O
as	O
measured	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

Clinically	O
it	O
is	O
characterized	O
by	O
spiking	O
fever	O
,	O
arthritis	O
,	O
rash	O
,	O
and	O
impairment	O
of	O
multiple	O
organs	B-ANAT
.	O

TITLE	O
:	O
[	O
Pulmonary	B-ANAT
manifestations	O
of	O
leptospirosis	O
].	O

All	O
the	O
animals	O
were	O
sacrificed	O
at	O
4h	O
of	O
experimental	O
interventional	O
therapy	O
for	O
the	O
examination	O
of	O
pulmonary	B-ANAT
pathology	O
.	O

(	O
4	O
)	O
The	O
lung	B-ANAT
injury	O
score	O
in	O
the	O
PS	O
group	O
,	O
the	O
RM	O
group	O
and	O
the	O
PS	O
+	O
RM	O
group	O
(	O
3	O
.	O
9	O
+/-	O
0	O
.	O
8	O
,	O
6	O
.	O
1	O
+/-	O
0	O
.	O
7	O
,	O
4	O
.	O
2	O
+/-	O
0	O
.	O
6	O
,	O
respectively	O
)	O
were	O
significantly	O
lower	O
than	O
that	O
in	O
the	O
control	O
group	O
(	O
13	O
.	O
5	O
+/-	O
0	O
.	O
7	O
,	O
F	O
=	O
369	O
.	O
6	O
,	O
P	O
<	O
0	O
.	O
01	O
).	O

The	O
lung	B-ANAT
injury	O
in	O
the	O
RM	O
group	O
was	O
more	O
severe	O
than	O
that	O
in	O
the	O
PS	O
and	O
PS	O
+	O
RM	O
group	O
(	O
q	O
=	O
6	O
.	O
35	O
,	O
5	O
.	O
70	O
,	O
all	O
P	O
<	O
0	O
.	O
01	O
).	O

The	O
7	O
-	O
day	O
and	O
28	O
-	O
day	O
mortality	O
,	O
the	O
days	O
in	O
ICU	O
and	O
the	O
length	O
of	O
stay	O
,	O
the	O
changes	O
of	O
oxygenation	O
index	O
,	O
the	O
days	O
of	O
mechanical	O
ventilation	O
and	O
the	O
rates	O
of	O
disseminated	O
intravascular	O
coagulation	O
(	O
DIC	O
),	O
acute	O
renal	B-ANAT
failure	O
(	O
ARF	O
),	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
(	O
MODS	O
)	O
were	O
observed	O
.	O

Regulatory	O
network	O
is	O
constructed	O
to	O
be	O
a	O
hopfield	O
-	O
like	O
network	O
with	O
nodes	B-ANAT
representing	O
biomarkers	O
and	O
directional	O
connections	O
to	O
be	O
regulations	O
in	O
between	O
.	O

In	O
the	O
tetragonal	O
crystal	B-ANAT
form	O
,	O
glycerol	O
-	O
3	O
-	O
phosphate	O
was	O
observed	O
in	O
the	O
ADP	O
-	O
ribose	O
-	O
binding	O
site	O
.	O

It	O
has	O
been	O
definitely	O
confirmed	O
that	O
opening	O
pressures	O
are	O
different	O
throughout	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
lung	B-ANAT
parenchyma	I-ANAT
,	O
ranging	O
from	O
5	O
-	O
10	O
up	O
to	O
30	O
-	O
40	O
cmH2O	O
.	O

Methods	O
of	O
detection	O
and	O
the	O
role	O
for	O
cattle	O
persistently	O
infected	O
bovine	O
viral	O
diarrhea	O
virus	O
(	O
BVDV	O
)	O
were	O
identified	O
;	O
viral	O
subunits	O
,	O
cellular	B-ANAT
components	O
and	O
bacterial	O
products	O
have	O
been	O
characterized	O
.	O

Importantly	O
,	O
expression	O
of	O
the	O
JHM	O
nucleocapsid	B-ANAT
in	O
the	O
context	O
of	O
the	O
A59	O
genome	O
conferred	O
increased	O
mortality	O
and	O
spread	O
of	O
viral	O
antigen	O
in	O
the	O
mouse	B-ANAT
central	I-ANAT
nervous	I-ANAT
system	I-ANAT
compared	O
to	O
the	O
parental	O
A59	O
strain	O
,	O
while	O
having	O
little	O
effect	O
on	O
the	O
induction	O
of	O
hepatitis	O
.	O

Anti	O
-	O
annexin	O
A2	O
antibodies	O
bound	O
to	O
purified	O
S2	O
proteins	O
,	O
and	O
anti	O
-	O
S2	O
bound	O
to	O
immunoprecipitated	O
annexin	O
A2	O
from	O
A549	O
cell	B-ANAT
lysate	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

Efficiency	O
,	O
side	O
effects	O
and	O
outcome	O
of	O
treatment	O
with	O
a	O
new	O
miniaturized	O
device	O
for	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
gas	O
transfer	O
were	O
analysed	O
in	O
60	O
consecutive	O
patients	O
with	O
life	O
-	O
threatening	O
respiratory	O
failure	O
.	O

Among	O
hospitalizations	O
without	O
myocardial	O
disorders	O
,	O
the	O
rate	O
of	O
severe	O
complications	O
ranged	O
from	O
0	O
.	O
07	O
to	O
1	O
.	O
9	O
and	O
from	O
0	O
.	O
4	O
to	O
65	O
.	O
5	O
for	O
cardiac	B-ANAT
arrest	O
and	O
for	O
fluid	O
and	O
electrolyte	O
disorders	O
per	O
1	O
,	O
000	O
hospitalizations	O
,	O
in	O
delivery	O
and	O
postpartum	O
periods	O
,	O
respectively	O
.	O

TITLE	O
:	O
Vitamin	O
K3	O
attenuates	O
lipopolysaccharide	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
through	O
inhibition	O
of	O
nuclear	O
factor	O
-	O
kappaB	O
activation	O
.	O

Moreover	O
,	O
the	O
addition	O
of	O
vitamin	O
K3	O
before	O
and	O
after	O
LPS	O
administration	O
attenuated	O
the	O
severity	O
of	O
lung	B-ANAT
injury	O
in	O
an	O
animal	O
model	O
of	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
which	O
occurs	O
in	O
the	O
setting	O
of	O
acute	O
severe	O
illness	O
complicated	O
by	O
systemic	O
inflammation	O
.	O

To	O
assess	O
the	O
distribution	O
of	O
the	O
TGEV	O
-	O
like	O
CCoV	O
subtype	O
,	O
during	O
2001	O
-	O
2008	O
we	O
tested	O
fecal	B-ANAT
samples	O
from	O
dogs	O
with	O
gastroenteritis	O
.	O

TITLE	O
:	O
Mutagenesis	O
of	O
the	O
transmembrane	B-ANAT
domain	O
of	O
the	O
SARS	O
coronavirus	O
spike	O
glycoprotein	O
:	O
refinement	O
of	O
the	O
requirements	O
for	O
SARS	O
coronavirus	O
cell	B-ANAT
entry	O
.	O

This	O
was	O
investigated	O
using	O
the	O
previously	O
described	O
SARS	O
pseudotyped	O
particles	O
system	O
(	O
SARSpp	O
)	O
and	O
by	O
fluorescence	O
-	O
based	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
assays	O
.	O

The	O
results	O
indicate	O
that	O
tempol	O
ameliorates	O
murine	O
viral	O
encephalomyelitis	O
by	O
altering	O
the	O
redox	O
status	O
of	O
the	O
infectious	O
environment	O
that	O
contributes	O
to	O
an	O
attenuated	O
CNS	B-ANAT
inflammatory	O
response	O
.	O

These	O
data	O
indicate	O
that	O
IFN	O
-	O
gamma	O
signaling	O
by	O
oligodendroglia	B-ANAT
reduces	O
viral	O
replication	O
but	O
affects	O
both	O
demyelination	O
and	O
tissue	B-ANAT
destruction	O
in	O
a	O
host	O
-	O
specific	O
manner	O
.	O

TITLE	O
:	O
Novel	O
2009	O
H1N1	O
influenza	O
virus	O
infection	O
requiring	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
in	O
a	O
pediatric	O
heart	B-ANAT
transplant	B-ANAT
recipient	O
.	O

Three	O
expression	O
plasmids	O
each	O
targeting	O
spike	O
protein	O
(	O
S1	O
),	O
nucleocapsid	B-ANAT
protein	O
(	O
N	O
),	O
and	O
membrane	B-ANAT
protein	O
(	O
M	O
)	O
of	O
IBV	O
were	O
prepared	O
.	O

However	O
the	O
mucosal	B-ANAT
antigen	O
-	O
specific	O
immune	O
response	O
is	O
weak	O
because	O
most	O
protein	O
antigens	O
can	O
evoke	O
only	O
a	O
weak	O
immune	O
response	O
when	O
they	O
are	O
applied	O
mucosally	O
.	O

Initial	O
viral	O
antigens	O
were	O
detected	O
between	O
12	O
and	O
24	O
h	O
post	O
-	O
inoculation	O
(	O
p	O
.	O
i	O
)	O
in	O
the	O
infiltrating	O
cells	B-ANAT
that	O
appeared	O
in	O
the	O
subarachnoidal	B-ANAT
space	O
of	O
mouse	O
brains	B-ANAT
infected	O
with	O
viruses	O
.	O

However	O
,	O
48	O
h	O
after	O
infection	O
with	O
cl	O
-	O
2	O
,	O
viral	O
antigen	O
-	O
positive	O
cells	B-ANAT
in	O
the	O
grey	B-ANAT
matter	I-ANAT
with	O
the	O
shape	O
of	O
neurons	B-ANAT
,	O
which	O
do	O
not	O
express	O
MHVR	O
,	O
were	O
detected	O
,	O
while	O
srr7	O
infection	O
was	O
observed	O
primarily	O
in	O
the	O
white	B-ANAT
matter	I-ANAT
.	O

Syncytial	O
giant	B-ANAT
cells	I-ANAT
(	O
SGCs	O
)	O
expressing	O
viral	O
and	O
CD11b	O
antigens	O
were	O
also	O
detected	O
among	O
these	O
inflammatory	B-ANAT
cells	I-ANAT
.	O

Ascitic	B-ANAT
fluids	I-ANAT
and	O
/	O
or	O
biopsy	O
samples	O
were	O
subjected	O
to	O
a	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
targeted	O
for	O
a	O
conserved	O
region	O
of	O
3	O
'	O
untranslated	O
region	O
(	O
3	O
'	O
UTR	O
)	O
of	O
the	O
FCoV	O
genome	O
.	O

We	O
hypothesize	O
that	O
early	O
infection	O
of	O
the	O
respiratory	B-ANAT
tract	I-ANAT
with	O
a	O
common	O
cold	O
virus	O
makes	O
the	O
lungs	B-ANAT
a	O
target	O
for	O
alloimmunity	O
.	O

Although	O
the	O
initial	O
chest	B-ANAT
radiographs	O
were	O
similar	O
,	O
the	O
mechanisms	O
of	O
obstruction	O
were	O
different	O
.	O

To	O
reliably	O
test	O
for	O
H1N1	O
in	O
intubated	O
patients	O
we	O
recommend	O
performing	O
viral	O
PCR	O
on	O
endobronchial	O
secretions	B-ANAT
.	O

Remarkably	O
,	O
it	O
was	O
found	O
that	O
they	O
utilize	O
distinct	O
cultured	B-ANAT
cell	I-ANAT
lines	O
for	O
in	O
vitro	O
virus	O
propagation	O
,	O
since	O
PEDV	O
could	O
not	O
be	O
replicated	O
in	O
swine	O
testis	B-ANAT
(	O
ST	O
)	O
cells	B-ANAT
expressing	O
native	O
porcine	O
APN	O
(	O
pAPN	O
),	O
which	O
are	O
highly	O
susceptible	O
to	O
TGEV	O
.	O

In	O
conclusion	O
,	O
a	O
larger	O
number	O
of	O
PES	B-ANAT
cases	O
was	O
positive	O
for	O
rotavirus	O
,	O
TAstV	O
-	O
2	O
,	O
and	O
reovirus	O
by	O
RT	O
-	O
PCR	O
than	O
with	O
EM	O
.	O

In	O
-	O
silico	O
analysis	O
of	O
the	O
225	O
amino	O
acid	O
sequence	O
of	O
hCoV	O
-	O
NL63	O
ORF	O
3	O
predicted	O
a	O
triple	O
membrane	B-ANAT
-	O
spanning	O
protein	O
.	O

The	O
protein	O
was	O
detected	O
within	O
the	O
endoplasmatic	O
reticulum	B-ANAT
/	O
Golgi	B-ANAT
intermediate	O
compartment	B-ANAT
(	O
ERGIC	B-ANAT
)	O
where	O
coronavirus	O
assembly	O
and	O
budding	O
takes	O
place	O
.	O

Comparative	O
sequence	O
analysis	O
of	O
the	O
distal	O
one	O
-	O
third	O
of	O
the	O
genomes	O
of	O
one	O
FRSCV	O
and	O
one	O
FRECV	O
strain	O
showed	O
that	O
these	O
two	O
ferret	O
coronaviruses	O
share	O
>	O
96	O
%	O
nucleotide	O
sequence	O
identities	O
in	O
the	O
membrane	B-ANAT
(	O
M	O
),	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
and	O
non	O
-	O
structural	O
protein	O
genes	O
(	O
partial	O
polymerase	O
,	O
open	O
reading	O
frames	O
[	O
ORFs	O
]	O
3	O
and	O
7b	O
).	O

Therefore	O
,	O
this	O
implicit	O
membrane	B-ANAT
environment	O
,	O
though	O
in	O
lattice	O
space	O
,	O
can	O
make	O
an	O
elaborate	O
balance	O
between	O
different	O
driving	O
forces	O
for	O
the	O
membrane	B-ANAT
protein	O
'	O
s	O
folding	O
,	O
thus	O
offering	O
a	O
potential	O
means	O
for	O
the	O
simulation	O
of	O
transmembrane	B-ANAT
protein	O
oligomers	O
in	O
feasible	O
time	O
.	O

The	O
results	O
from	O
the	O
analyses	O
of	O
clinical	O
signs	O
,	O
histopathology	O
,	O
indirect	O
immunofluorescence	O
(	O
IIF	O
)	O
and	O
RT	O
-	O
PCR	O
show	O
that	O
the	O
two	O
shRNA	O
-	O
expressing	O
plasmids	O
could	O
significantly	O
decrease	O
the	O
quantity	O
of	O
TGEV	O
in	O
different	O
organs	B-ANAT
and	O
protect	O
mini	O
-	O
pigs	O
from	O
TGEV	O
infection	O
.	O

But	O
it	O
can	O
rarely	O
and	O
rapidly	O
evolve	O
to	O
pulmonary	B-ANAT
parenchymal	O
involvement	O
,	O
independently	O
of	O
any	O
bacterial	O
superinfection	O
or	O
co	O
-	O
infection	O
.	O

This	O
suggests	O
that	O
variation	O
in	O
this	O
gene	O
may	O
play	O
less	O
of	O
a	O
role	O
in	O
lung	B-ANAT
injury	O
in	O
children	O
or	O
adults	O
with	O
community	O
-	O
acquired	O
pneumonia	O
than	O
in	O
adults	O
with	O
sepsis	O
or	O
trauma	O
.	O

TITLE	O
:	O
Qualitative	O
and	O
quantitative	O
ultrastructural	O
analysis	O
of	O
the	O
membrane	B-ANAT
rearrangements	O
induced	O
by	O
coronavirus	O
.	O

We	O
found	O
limited	O
evidence	O
that	O
N95	O
respirators	O
were	O
superior	O
to	O
simple	O
surgical	O
masks	O
,	O
but	O
were	O
more	O
expensive	O
,	O
uncomfortable	O
,	O
and	O
caused	O
skin	B-ANAT
irritation	O
.	O

At	O
autopsy	O
,	O
both	O
lungs	B-ANAT
were	O
voluminous	O
and	O
microscopic	O
examination	O
revealed	O
acute	O
-	O
stage	O
,	O
severe	O
diffuse	O
alveolar	B-ANAT
damage	O
with	O
remarkable	O
mononuclear	B-ANAT
cell	I-ANAT
infiltration	O
and	O
hyaline	B-ANAT
membrane	B-ANAT
formation	O
in	O
the	O
lungs	B-ANAT
.	O

CD8	O
-	O
positive	O
T	B-ANAT
lymphocytes	I-ANAT
were	O
dominantly	O
observed	O
.	O

In	O
the	O
majority	O
of	O
studies	O
,	O
important	O
confounders	O
included	O
the	O
unrecognized	O
impact	O
of	O
concurrent	O
bundling	O
of	O
other	O
infection	O
control	O
measures	O
,	O
mask	O
compliance	O
,	O
contamination	O
from	O
improper	O
doffing	O
of	O
masks	O
,	O
and	O
ocular	B-ANAT
inoculation	O
.	O

Pathohistological	O
analysis	O
of	O
the	O
samples	O
retrieved	O
by	O
bronchoscopy	O
pointed	O
to	O
a	O
pneumonia	O
,	O
and	O
diagnosis	O
of	O
LD	O
was	O
confirmed	O
by	O
positive	O
urine	B-ANAT
test	O
for	O
LP	O
antigen	O
.	O

Extracorporeal	O
membrane	B-ANAT
oxygenation	O
was	O
downgraded	O
to	O
pumpless	O
extracorporeal	O
lung	B-ANAT
assist	O
for	O
another	O
10	O
+/-	O

The	O
SARS	O
-	O
CoV	O
3CL	O
protease	O
was	O
purified	O
from	O
a	O
colon	B-ANAT
bacillus	O
recombinant	O
.	O

ABSTRACT	O
:	O
In	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
inhaled	O
vasodilator	O
can	O
result	O
in	O
important	O
physiologic	O
benefits	O
(	O
eg	O
,	O
improved	O
hypoxemia	O
,	O
lower	O
pulmonary	B-ANAT
arterial	B-ANAT
pressure	O
,	O
and	O
improved	O
right	O
-	O
ventricular	B-ANAT
function	O
and	O
cardiac	B-ANAT
output	O
)	O
without	O
systemic	O
hemodynamic	O
effects	O
.	O

A	O
variable	O
increase	O
(	O
of	O
up	O
to	O
50	O
%)	O
on	O
the	O
release	O
of	O
NO	O
(-)	O
and	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
(	O
ROS	O
)	O
was	O
obtained	O
when	O
LAB	O
strains	O
were	O
co	O
-	O
incubated	O
with	O
the	O
cell	B-ANAT
lines	I-ANAT
,	O
but	O
the	O
results	O
were	O
found	O
to	O
be	O
LAB	O
strain	O
and	O
cell	B-ANAT
line	I-ANAT
specific	O
,	O
apart	O
from	O
a	O
small	O
number	O
of	O
strains	O
which	O
were	O
able	O
to	O
induce	O
strong	O
ROS	O
release	O
in	O
more	O
than	O
one	O
cell	B-ANAT
line	I-ANAT
.	O

Further	O
,	O
while	O
the	O
C	O
-	O
terminal	O
region	O
is	O
required	O
for	O
preventing	O
STAT1	O
translocation	O
to	O
the	O
nucleus	B-ANAT
,	O
our	O
results	O
also	O
indicated	O
that	O
the	O
N	O
-	O
terminal	O
18	O
amino	O
acids	O
were	O
necessary	O
for	O
maximal	O
inhibition	O
.	O

12	O
needed	O
mechanical	O
ventilation	O
and	O
two	O
extra	O
corporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
).	O

Key	O
words	O
:	O
influenza	O
A	O
,	O
pneumonia	O
,	O
multiple	O
organ	B-ANAT
failure	O
,	O
death	O
rate	O
,	O
intensive	O
care	O
,	O
ventilator	O
therapy	O
,	O
ECMO	O
.	O

We	O
conclude	O
that	O
RS	O
cells	B-ANAT
irrespective	O
of	O
LMP1	O
expression	O
are	O
end	O
-	O
stage	O
tumor	B-ANAT
cells	I-ANAT
in	O
which	O
the	O
extent	O
of	O
their	O
inability	O
to	O
divide	O
further	O
is	O
proportional	O
to	O
the	O
increase	O
of	O
very	O
short	O
telomeres	B-ANAT
,	O
telomere	B-ANAT
loss	O
,	O
aggregate	O
formation	O
and	O
the	O
generation	O
of	O
'	B-ANAT
ghost	I-ANAT
'	O
nuclei	O
.	O

We	O
have	O
found	O
that	O
increasing	O
mitochondrial	B-ANAT
hexokinase	O
II	O
activity	O
can	O
prevent	O
cell	B-ANAT
death	O
in	O
neuronal	O
cultures	O
treated	O
with	O
rotenone	O
.	O

As	O
a	O
result	O
,	O
we	O
have	O
studied	O
the	O
effects	O
of	O
hexokinase	O
II	O
gene	O
transfer	O
in	O
vivo	O
using	O
a	O
herpes	O
simplex	B-ANAT
virus	O
type	O
1	O
(	O
HSV	O
-	O
1	O
)	O
amplicon	O
vector	O
.	O

Ap4A	O
-	O
hydrolase	O
is	O
responsible	O
for	O
metabolizing	O
the	O
""""	O
allarmone	O
""""	O
nucleotide	O
Ap4A	O
and	O
therefore	O
likely	O
involved	O
in	O
regulation	O
of	O
cell	B-ANAT
proliferation	O
,	O
DNA	O
replication	O
,	O
RNA	O
processing	O
,	O
apoptosis	O
and	O
DNA	O
repair	O
.	O

Infant	O
with	O
SNAP	O
>	O
or	O
=	O
10	O
had	O
a	O
diminished	O
thyroid	B-ANAT
-	O
stimulating	O
hormone	O
at	O
birth	O
.	O

High	O
-	O
growth	O
properties	O
and	O
narrow	O
tissue	B-ANAT
tropisms	O
(	O
limited	O
replication	O
in	O
respiratory	B-ANAT
tracts	I-ANAT
)	O
were	O
achieved	O
by	O
the	O
adaptation	O
process	O
.	O

The	O
majority	O
of	O
patients	O
had	O
a	O
pure	O
motor	O
variant	O
of	O
GBS	O
(	O
92	O
%)	O
with	O
relatively	O
infrequent	O
cranial	B-ANAT
nerve	I-ANAT
involvement	O
(	O
30	O
%).	O

TITLE	O
:	O
Plasma	B-ANAT
levels	O
of	O
surfactant	O
protein	O
D	O
and	O
KL	O
-	O
6	O
for	O
evaluation	O
of	O
lung	B-ANAT
injury	O
in	O
critically	O
ill	O
mechanically	O
ventilated	O
patients	O
.	O

In	O
the	O
present	O
study	O
we	O
investigated	O
whether	O
plasma	B-ANAT
levels	O
of	O
lung	B-ANAT
-	O
specific	O
biological	O
markers	O
can	O
be	O
used	O
to	O
evaluate	O
lung	B-ANAT
injury	O
in	O
patients	O
with	O
ALI	O
/	O
ARDS	O
and	O
patients	O
without	O
lung	B-ANAT
injury	O
at	O
onset	O
of	O
mechanical	O
ventilation	O
.	O

In	O
ALI	O
/	O
ARDS	O
patients	O
,	O
SP	O
-	O
D	O
and	O
KL	O
-	O
6	O
levels	O
increased	O
over	O
time	O
,	O
which	O
was	O
attenuated	O
by	O
lung	B-ANAT
-	O
protective	O
mechanical	O
ventilation	O
using	O
lower	O
tidal	O
volumes	O
(	O
P	O
=	O
0	O
.	O
02	O
for	O
both	O
biological	O
markers	O
).	O

In	O
these	O
patients	O
,	O
with	O
either	O
ventilation	O
strategy	O
no	O
changes	O
over	O
time	O
were	O
observed	O
for	O
plasma	B-ANAT
levels	O
of	O
CC16	O
and	O
sRAGE	O
.	O

In	O
patients	O
without	O
lung	B-ANAT
injury	O
,	O
no	O
changes	O
of	O
plasma	B-ANAT
levels	O
of	O
any	O
of	O
the	O
measured	O
biological	O
markers	O
were	O
observed	O
.	O

CONCLUSIONS	O
:	O
Plasma	B-ANAT
levels	O
of	O
SP	O
-	O
D	O
and	O
KL	O
-	O
6	O
rise	O
with	O
potentially	O
injurious	O
ventilator	O
settings	O
,	O
and	O
thus	O
may	O
serve	O
as	O
biological	O
markers	O
of	O
VALI	O
in	O
patients	O
with	O
ALI	O
/	O
ARDS	O
.	O

TITLE	O
:	O
Pathology	O
and	O
tissue	B-ANAT
distribution	O
of	O
turkey	O
coronavirus	O
in	O
experimentally	O
infected	O
chicks	O
and	O
turkey	O
poults	O
.	O

The	O
average	O
number	O
of	O
apoptotic	O
cells	B-ANAT
in	O
the	O
intermediate	O
and	O
late	O
phases	O
measured	O
using	O
the	O
TUNEL	O
method	O
was	O
9	O
.	O
8	O
+/-	O
0	O
.	O
7	O
.	O

ABSTRACT	O
:	O
In	O
retroviruses	O
and	O
the	O
double	O
-	O
stranded	O
RNA	O
totiviruses	O
,	O
the	O
efficiency	O
of	O
programmed	O
-	O
1	O
ribosomal	B-ANAT
frameshifting	O
is	O
critical	O
for	O
ensuring	O
the	O
proper	O
ratios	O
of	O
upstream	O
-	O
encoded	O
capsid	B-ANAT
proteins	O
to	O
downstream	O
-	O
encoded	O
replicase	O
enzymes	O
.	O

ABSTRACT	O
:	O
Amniotic	B-ANAT
fluid	I-ANAT
embolism	O
is	O
one	O
of	O
the	O
most	O
severe	O
complications	O
in	O
the	O
peripartum	O
period	O
.	O

Because	O
its	O
onset	O
is	O
abrupt	O
and	O
fulminant	O
,	O
it	O
is	O
unlikely	O
that	O
there	O
will	O
be	O
time	O
to	O
examine	O
the	O
condition	O
using	O
thoracic	B-ANAT
computed	O
tomography	O
(	O
CT	O
).	O

Many	O
of	O
these	O
glycoproteins	O
,	O
including	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
spike	O
(	O
S	O
)	O
protein	O
form	O
trimeric	O
units	O
in	O
the	O
membrane	B-ANAT
of	O
the	O
native	O
virion	B-ANAT
.	O

Among	O
seven	O
lung	B-ANAT
transplantation	O
patients	O
with	O
invasive	O
cytomegalovirus	O
disease	O
,	O
the	O
four	O
who	O
developed	O
BOS	O
(	O
P	O
=	O
.	O
04	O
)	O
showed	O
the	O
worst	O
survival	O
(	O
P	O
=	O
.	O
05	O
).	O

A	O
complex	O
interaction	O
between	O
the	O
coronavirus	O
and	O
the	O
feline	O
immune	B-ANAT
system	I-ANAT
causes	O
disseminated	O
vasculitis	O
,	O
which	O
is	O
the	O
hallmark	O
of	O
FIP	O
.	O

TITLE	O
:	O
Swine	O
intestine	B-ANAT
antimicrobial	O
peptides	O
inhibit	O
infectious	O
bronchitis	O
virus	O
infectivity	O
in	O
chick	B-ANAT
embryos	I-ANAT
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
the	O
more	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
forms	O
of	O
pulmonary	B-ANAT
edema	O
that	O
result	O
from	O
robust	O
local	O
and	O
systemic	O
inflammatory	O
states	O
,	O
such	O
as	O
sepsis	O
.	O

TITLE	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
after	O
percutaneous	O
cryotherapy	O
for	O
a	O
pulmonary	B-ANAT
metastatic	O
lesion	O
.	O

Coronaviruses	O
were	O
detected	O
in	O
63	O
(	O
6	O
%)	O
of	O
984	O
children	O
with	O
acute	O
gastro	B-ANAT
-	O
enteritis	O
and	O
were	O
more	O
commonly	O
detected	O
in	O
outpatients	O
(	O
47	O
/	O
423	O
,	O
11	O
%)	O
than	O
in	O
inpatients	O
(	O
16	O
/	O
561	O
,	O
3	O
%).	O

This	O
discrepancy	O
can	O
only	O
be	O
explained	O
by	O
the	O
fact	O
,	O
that	O
hypoxemia	O
is	O
not	O
equivalent	O
to	O
tissue	B-ANAT
hypoxia	O
.	O

Whereas	O
,	O
the	O
most	O
common	O
complications	O
observed	O
were	O
raised	O
Alanine	O
aminotransferases	O
(	O
ALT	O
)	O
levels	O
(	O
51	O
.	O
9	O
%)	O
and	O
the	O
levels	O
were	O
greater	O
than	O
10	O
-	O
folds	O
of	O
normal	O
value	O
in	O
4	O
.	O
9	O
%,	O
thrombocytopenia	O
(	O
42	O
.	O
1	O
%),	O
varicella	O
pneumonia	O
(	O
28	O
.	O
4	O
%),	O
skin	B-ANAT
infection	O
(	O
25	O
.	O
4	O
%),	O
septicaemia	O
(	O
10	O
.	O
7	O
%),	O
Encephalitis	O
/	O
Meningitis	O
(	O
8	O
.	O
8	O
%),	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
(	O
ARDS	O
)	O
(	O
6	O
.	O
8	O
%),	O
acute	O
renal	B-ANAT
failure	O
(	O
2	O
.	O
9	O
%)	O
and	O
acute	O
hepatic	B-ANAT
failure	O
(	O
1	O
.	O
9	O
%).	O

Herein	O
,	O
we	O
describe	O
an	O
infant	O
with	O
a	O
constitutional	O
14q12	O
-	O
21	O
.	O
3	O
haploid	O
deletion	O
encompassing	O
the	O
TTF	O
-	O
1	O
gene	O
locus	O
who	O
had	O
cerebral	B-ANAT
dysgenesis	O
,	O
thyroidal	O
dysfunction	O
,	O
and	O
respiratory	O
insufficiency	O
.	O

Although	O
immunoreactivity	O
for	O
surfactant	O
protein	O
SP	O
-	O
A	O
and	O
ABCA3	O
was	O
diminished	O
,	O
that	O
for	O
SP	O
-	O
B	O
and	O
proSP	O
-	O
C	O
was	O
robust	O
,	O
although	O
irregularly	O
distributed	O
,	O
corresponding	O
to	O
the	O
distribution	O
of	O
type	B-ANAT
II	I-ANAT
pneumocytes	I-ANAT
.	O

These	O
findings	O
are	O
consistent	O
with	O
experimental	O
evidence	O
documenting	O
the	O
important	O
role	O
of	O
TTF	O
-	O
1	O
in	O
pulmonary	B-ANAT
morphogenesis	O
and	O
surfactant	O
metabolism	O
.	O

Patients	O
with	O
2009	O
influenza	O
A	O
(	O
H1N1	O
)	O
requiring	O
mechanical	O
ventilation	O
were	O
mostly	O
middle	O
-	O
aged	O
adults	O
,	O
often	O
with	O
comorbidities	O
,	O
and	O
frequently	O
developed	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
multiorgan	O
failure	O
requiring	O
advanced	O
organ	B-ANAT
support	O
.	O

ABSTRACT	O
:	O
A	O
joint	B-ANAT
study	O
group	O
on	O
cow	O
'	O
s	O
milk	O
allergy	O
was	O
convened	O
by	O
the	O
Emilia	O
-	O
Romagna	O
Working	O
Group	O
for	O
Paediatric	O
Allergy	O
and	O
by	O
the	O
Emilia	O
-	O
Romagna	O
Working	O
Group	O
for	O
Paediatric	O
Gastroenterology	O
to	O
focus	O
best	O
practice	O
for	O
diagnosis	O
,	O
management	O
and	O
follow	O
-	O
up	O
of	O
cow	O
'	O
s	O
milk	O
allergy	O
in	O
children	O
and	O
to	O
offer	O
a	O
common	O
approach	O
for	O
allergologists	O
,	O
gastroenterologists	O
,	O
general	O
paediatricians	O
and	O
primary	O
care	O
physicians	O
.	O

CONCLUSIONS	O
:	O
QYD	O
could	O
markedly	O
improve	O
the	O
prognosis	O
of	O
SAP	O
patients	O
by	O
way	O
of	O
lowering	O
the	O
blood	B-ANAT
levels	O
of	O
TNF	O
-	O
alpha	O
,	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
.	O

On	O
testing	O
of	O
263	O
VN	O
antibody	O
-	O
positive	O
sera	B-ANAT
from	O
27	O
farms	O
with	O
a	O
commercial	O
blocking	O
ELISA	O
to	O
distinguish	O
TGEV	O
and	O
porcine	O
respiratory	O
coronavirus	O
(	O
PRCV	O
)	O
antibodies	O
,	O
78	O
.	O
3	O
%	O
were	O
positive	O
for	O
PRCV	O
antibody	O
only	O
,	O
while	O
12	O
.	O
5	O
%	O
were	O
positive	O
for	O
TGEV	O
antibody	O
only	O
or	O
both	O
TGEV	O
and	O
PRCV	O
antibodies	O
.	O

Fasting	O
blood	B-ANAT
samples	I-ANAT
were	O
collected	O
from	O
all	O
the	O
subjects	O
through	O
cubital	O
veins	B-ANAT
.	O

TITLE	O
:	O
[	O
Cell	B-ANAT
entry	O
mechanisms	O
of	O
coronaviruses	O
].	O

ABSTRACT	O
:	O
Enveloped	O
viruses	O
enter	O
into	O
cells	B-ANAT
via	O
fusion	O
of	O
their	O
envelope	B-ANAT
and	O
cellular	B-ANAT
membrane	I-ANAT
.	O

Both	O
IFN	O
-	O
gamma	O
and	O
IL	O
-	O
4	O
in	O
chicken	O
'	O
s	O
lymphocytes	B-ANAT
were	O
produced	O
by	O
this	O
strategy	O
.	O

The	O
most	O
frequent	O
complications	O
were	O
acute	O
renal	B-ANAT
failure	O
(	O
n	O
=	O
13	O
),	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
n	O
=	O
12	O
)	O
and	O
ventilator	O
associated	O
pneumonia	O
(	O
n	O
=	O
10	O
).	O

TITLE	O
:	O
Murine	O
Coronavirus	O
Cell	B-ANAT
Type	I-ANAT
Dependent	O
Interaction	O
with	O
the	O
Type	O
I	O
Interferon	O
Response	O
.	O

Other	O
primary	O
cell	B-ANAT
types	O
such	O
as	O
neurons	B-ANAT
,	O
astrocytes	B-ANAT
and	O
hepatocytes	B-ANAT
fail	O
to	O
produce	O
IFN	O
following	O
infection	O
and	O
,	O
in	O
vivo	O
,	O
likely	O
depend	O
on	O
IFN	O
produced	O
by	O
pDCs	O
and	O
macrophages	B-ANAT
for	O
protection	O
from	O
MHV	O
.	O

We	O
also	O
used	O
this	O
ELISA	O
system	O
to	O
evaluate	O
77	O
murine	O
serum	B-ANAT
samples	O
obtained	O
from	O
15	O
conventional	O
mouse	O
rooms	O
in	O
research	O
facilities	O
in	O
Japan	O
and	O
found	O
that	O
approximately	O
half	O
of	O
the	O
serum	B-ANAT
samples	O
contained	O
antibody	O
to	O
MNV	O
-	O
S7	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
first	O
evaluated	O
the	O
efficacy	O
of	O
IFN	O
-	O
alfacon	O
1	O
in	O
Calu	O
-	O
3	O
cells	B-ANAT
during	O
the	O
first	O
7	O
days	O
of	O
virus	O
infection	O
.	O

A	O
potent	O
,	O
prolonged	O
inhibition	O
of	O
SARS	O
-	O
CoV	O
replication	O
in	O
Calu	O
-	O
3	O
cells	B-ANAT
with	O
IFN	O
-	O
alfacon	O
1	O
was	O
observed	O
.	O

IP	O
-	O
10	O
expression	O
was	O
detected	O
in	O
the	O
lungs	B-ANAT
of	O
SARS	O
-	O
CoV	O
-	O
infected	O
BALB	O
/	O
c	O
mice	O
.	O

TITLE	O
:	O
Extracorporeal	O
gas	O
exchange	O
in	O
acute	O
lung	B-ANAT
injury	O
:	O
step	O
by	O
step	O
towards	O
expanded	O
indications	O
?	O

Mitochondrial	B-ANAT
DNA	I-ANAT
-	O
associated	O
Leigh	O
syndrome	O
and	O
NARP	O
are	O
transmitted	O
by	O
maternal	O
inheritance	O
.	O

Prenatal	O
diagnosis	O
and	O
preimplantation	O
genetic	O
diagnosis	O
for	O
couples	O
at	O
increased	O
risk	O
of	O
having	O
children	O
with	O
mtDNA	B-ANAT
-	O
associated	O
Leigh	O
syndrome	O
or	O
NARP	O
are	O
possible	O
by	O
analysis	O
of	O
mtDNA	B-ANAT
extracted	O
from	O
non	O
-	O
cultured	O
fetal	B-ANAT
cells	B-ANAT
or	O
from	O
single	O
blastomeres	B-ANAT
,	O
respectively	O
.	O

Kidney	B-ANAT
injury	O
,	O
kidney	B-ANAT
failure	O
,	O
and	O
need	O
for	O
dialysis	O
occurred	O
in	O
66	O
.	O
7	O
%,	O
66	O
%,	O
and	O
11	O
%	O
of	O
patients	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
At	O
present	O
,	O
the	O
poultry	O
meat	O
and	O
egg	B-ANAT
industry	O
has	O
gained	O
a	O
lot	O
of	O
ground	O
,	O
being	O
viewed	O
as	O
a	O
provider	O
of	O
a	O
healthy	O
alternative	O
to	O
red	O
meat	O
and	O
other	O
protein	O
sources	O
.	O

Currently	O
,	O
we	O
are	O
investigating	O
immune	O
and	O
endocrine	O
interactions	O
in	O
the	O
chicken	O
,	O
in	O
particular	O
the	O
cells	B-ANAT
and	O
molecules	O
that	O
are	O
known	O
to	O
be	O
involved	O
in	O
such	O
interactions	O
in	O
mammals	O
.	O

We	O
have	O
evaluated	O
the	O
effects	O
of	O
corticosterone	O
administration	O
in	O
drinking	O
water	O
on	O
peripheral	O
lymphocyte	B-ANAT
and	O
heterophil	B-ANAT
cytokine	O
and	O
chemokine	O
gene	O
profiles	O
.	O

ABSTRACT	O
:	O
The	O
most	O
serious	O
complication	O
of	O
novel	O
influenza	O
virus	O
(	O
H1N1	O
)	O
infections	O
is	O
the	O
progressive	O
respiratory	O
insufficiency	O
caused	O
by	O
diffuse	O
alveolar	B-ANAT
damage	O
(	O
DAD	O
)	O
which	O
can	O
be	O
overinfected	O
by	O
opportunistic	O
pathogens	O
.	O

Relapse	O
occurred	O
in	O
one	O
case	O
because	O
of	O
incomplete	O
pericardial	B-ANAT
resection	O
.	O

Constrictive	O
pericarditis	O
should	O
be	O
confirmed	O
as	O
soon	O
as	O
possible	O
with	O
actively	O
surgery	O
,	O
and	O
the	O
extent	O
of	O
pericardial	B-ANAT
resection	O
should	O
be	O
decided	O
according	O
to	O
the	O
individual	O
conditions	O
.	O

RESULTS	O
:	O
Two	O
early	O
postoperative	O
death	O
occurred	O
in	O
this	O
group	O
due	O
to	O
severe	O
low	O
cardiac	B-ANAT
output	O
syndrome	O
,	O
with	O
the	O
mortality	O
rate	O
of	O
1	O
.	O
57	O
%.	O

TITLE	O
:	O
Lambda	O
interferon	O
renders	O
epithelial	B-ANAT
cells	I-ANAT
of	O
the	O
respiratory	O
and	O
gastrointestinal	B-ANAT
tracts	I-ANAT
resistant	O
to	O
viral	O
infections	O
.	O

In	O
contrast	O
,	O
Lassa	O
fever	O
virus	O
,	O
which	O
infects	O
via	O
the	O
respiratory	B-ANAT
tract	I-ANAT
but	O
primarily	O
replicates	O
in	O
the	O
liver	B-ANAT
,	O
was	O
not	O
influenced	O
by	O
the	O
IFN	O
-	O
lambda	O
receptor	O
defect	O
.	O

ABSTRACT	O
:	O
The	O
live	O
replication	O
-	O
competent	O
modified	O
vaccinia	O
virus	O
Tiantan	O
(	O
MVTT	O
)	O
is	O
an	O
attractive	O
vaccine	O
vector	O
,	O
yet	O
little	O
is	O
known	O
about	O
its	O
tissue	B-ANAT
tropism	O
and	O
pathology	O
in	O
vivo	O
.	O

injection	O
of	O
MVTT	O
-	O
S	O
primarily	O
targeted	O
draining	O
inguinal	B-ANAT
lymph	I-ANAT
nodes	I-ANAT
,	O
whereas	O
mucosal	B-ANAT
inoculation	O
had	O
broader	O
range	O
of	O
tissue	B-ANAT
infections	O
.	O

Recruitment	O
of	O
atelectatic	O
lung	B-ANAT
areas	O
may	O
improve	O
responsiveness	O
and	O
preservation	O
of	O
spontaneous	O
breathing	O
(	O
SB	O
)	O
may	O
cause	O
recruitment	O
.	O

This	O
study	O
aimed	O
to	O
quantify	O
the	O
variation	O
in	O
individual	O
test	O
-	O
day	O
milk	O
yield	O
and	O
somatic	B-ANAT
cell	I-ANAT
count	O
,	O
risk	O
of	O
reproductive	O
failure	O
after	O
first	O
service	O
of	O
dairy	O
cows	O
,	O
and	O
risk	O
of	O
death	O
of	O
calves	O
and	O
heifers	O
according	O
to	O
the	O
BCV	O
and	O
BRSV	O
status	O
of	O
the	O
herd	O
.	O

TITLE	O
:	O
Practical	O
use	O
of	O
airway	B-ANAT
pressure	O
release	O
ventilation	O
for	O
severe	O
ARDS	O
--	O
a	O
preliminary	O
report	O
in	O
comparison	O
with	O
a	O
conventional	O
ventilatory	O
support	O
.	O

ABSTRACT	O
:	O
Airway	B-ANAT
pressure	O
release	O
ventilation	O
(	O
APRV	O
)	O
is	O
a	O
ventilatory	O
mode	O
that	O
allows	O
unsupported	O
spontaneous	O
breathing	O
at	O
any	O
phase	O
of	O
the	O
ventilatory	O
cycle	O
with	O
high	O
mean	O
airway	B-ANAT
pressures	O
.	O

ABSTRACT	O
:	O
The	O
development	O
of	O
effective	O
therapies	O
for	O
acute	O
liver	B-ANAT
failure	O
(	O
ALF	O
)	O
is	O
limited	O
by	O
our	O
knowledge	O
of	O
the	O
pathophysiology	O
of	O
this	O
condition	O
,	O
and	O
the	O
lack	O
of	O
suitable	O
large	O
animal	O
models	O
of	O
acetaminophen	O
toxicity	O
.	O

Injured	O
animals	O
developed	O
hypotension	O
(	O
mean	O
arterial	B-ANAT
pressure	O
;	O
40	O
.	O
8	O
+/-	O

Intracranial	B-ANAT
hypertension	O
was	O
not	O
seen	O
(	O
ICP	O
monitoring	O
),	O
but	O
there	O
was	O
biochemical	O
evidence	O
of	O
encephalopathy	O
by	O
the	O
reduction	O
of	O
Fischer	O
'	O
s	O
ratio	O
from	O
5	O
.	O
6	O
+/-	O

Curiously	O
,	O
we	O
observed	O
no	O
block	O
in	O
the	O
well	O
-	O
defined	O
IFN	O
-	O
beta	O
signaling	O
pathway	O
that	O
leads	O
to	O
STAT1	O
-	O
STAT2	O
phosphorylation	O
and	O
translocation	O
to	O
the	O
nucleus	B-ANAT
in	O
cultures	O
infected	O
with	O
MHV	O
.	O

TITLE	O
:	O
From	O
neurogenic	O
pulmonary	B-ANAT
edema	O
to	O
fat	O
embolism	O
syndrome	O
:	O
a	O
brief	O
review	O
of	O
experimental	O
and	O
clinical	O
investigations	O
of	O
acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
alveolar	B-ANAT
macrophages	I-ANAT
are	O
the	O
major	O
source	O
of	O
iNOS	O
.	O

Later	O
study	O
also	O
found	O
that	O
neutrophil	B-ANAT
elastase	O
and	O
myeloperoxidase	O
were	O
elevated	O
following	O
fat	O
embolism	O
.	O

The	O
protein	O
chip	O
was	O
used	O
to	O
test	O
known	O
serum	B-ANAT
samples	O
of	O
the	O
four	O
poultry	O
diseases	O
and	O
field	O
serum	B-ANAT
samples	O
.	O

Coronaviruses	O
as	O
a	O
group	O
are	O
not	O
commonly	O
identified	O
in	O
stool	B-ANAT
samples	O
of	O
patients	O
presenting	O
with	O
gastrointestinal	O
illness	O
.	O

HCoV	O
-	O
HKU1	O
can	O
be	O
identified	O
in	O
stool	B-ANAT
samples	O
from	O
children	O
and	O
adults	O
with	O
gastrointestinal	O
disease	O
,	O
with	O
most	O
individuals	O
having	O
respiratory	O
findings	O
as	O
well	O
.	O

Based	O
on	O
ethnographic	O
data	O
from	O
participant	O
observation	O
in	O
a	O
chronic	O
renal	B-ANAT
disease	O
patient	O
self	O
-	O
help	O
alliance	O
and	O
semistructured	O
interviews	O
with	O
its	O
30	O
members	O
,	O
I	O
demonstrate	O
that	O
the	O
participants	O
'	O
knowledge	O
perceptions	O
of	O
and	O
the	O
adoption	O
of	O
the	O
preventive	O
health	O
behaviors	O
against	O
H1N1	O
were	O
greatly	O
influenced	O
by	O
their	O
past	O
experiences	O
of	O
being	O
stigmatized	O
in	O
the	O
2003	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
outbreak	O
.	O

TITLE	O
:	O
Pathogenesis	O
of	O
murine	O
coronavirus	O
in	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
.	O

The	O
child	O
was	O
discharged	O
after	O
72	O
days	O
with	O
moderate	O
renal	B-ANAT
function	O
impairment	O
(	O
blood	B-ANAT
urea	O
-	O
53	O
mg	O
%,	O
creatinine	O
-	O
1	O
,	O
2	O
mg	O
%),	O
mild	O
hypertension	O
and	O
proteinuria	O
.	O

Diabetes	O
mellitus	O
as	O
a	O
rare	O
immunological	O
complication	O
of	O
haemolytic	O
uremic	O
syndrome	O
was	O
suspected	O
on	O
the	O
following	O
evidence	O
:	O
positive	O
anti	O
-	O
GAD	O
antibodies	O
(	O
ELISA	O
),	O
elevated	O
levels	O
of	O
glycosylated	O
haemoglobin	O
A1c	O
,	O
three	O
-	O
fold	O
reduction	O
of	O
blood	B-ANAT
C	O
-	O
peptide	O
concentration	O
,	O
negative	O
family	O
history	O
for	O
diabetes	O
.	O

TITLE	O
:	O
Extrapulmonary	O
tissue	B-ANAT
responses	O
in	O
cynomolgus	O
macaques	O
(	O
Macaca	O
fascicularis	O
)	O
infected	O
with	O
highly	O
pathogenic	O
avian	O
influenza	O
A	O
(	O
H5N1	O
)	O
virus	O
.	O

We	O
propose	O
that	O
this	O
motif	O
is	O
a	O
linear	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
epitope	O
of	O
N	O
protein	O
,	O
and	O
is	O
the	O
core	O
sequence	O
for	O
reactivity	O
,	O
as	O
demonstrated	O
by	O
binding	O
of	O
2D2	O
to	O
the	O
truncated	O
peptides	O
and	O
different	O
IBV	O
strains	O
.	O

The	O
patient	O
group	O
whose	O
fractures	O
were	O
stabilized	O
after	O
48	O
hours	O
had	O
more	O
clinical	O
complications	O
,	O
alterations	O
of	O
lung	B-ANAT
parameters	O
and	O
a	O
longer	O
hospital	O
stay	O
.	O

The	O
method	O
was	O
useful	O
,	O
convenient	O
and	O
efficient	O
for	O
rapid	O
identification	O
of	O
CTL	B-ANAT
epitopes	O
derived	O
from	O
SARS	O
-	O
CoV	O
proteins	O
and	O
will	O
be	O
possibly	O
applicable	O
for	O
other	O
pathogens	O
to	O
develop	O
a	O
peptide	O
-	O
based	O
vaccine	O
.	O

ABSTRACT	O
:	O
Death	O
to	O
trauma	O
is	O
caused	O
by	O
disastrous	O
injuries	O
on	O
scene	O
,	O
bleeding	O
shock	O
or	O
acute	O
respiratory	O
failure	O
(	O
ARDS	O
)	O
induced	O
by	O
trauma	O
and	O
massive	O
blood	B-ANAT
transfusion	O
.	O

Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
can	O
be	O
effective	O
in	O
severe	O
cardiopulmonary	B-ANAT
failure	O
,	O
but	O
preexisting	O
bleeding	O
is	O
still	O
a	O
contraindication	O
for	O
its	O
use	O
.	O

No	O
obvious	O
recurrence	O
was	O
observed	O
even	O
after	O
the	O
cessation	O
of	O
antituberculosis	O
chemotherapy	O
,	O
although	O
pulmonary	B-ANAT
nodules	B-ANAT
on	O
chest	B-ANAT
radiography	O
remained	O
.	O

Similar	O
to	O
SPF	O
egg	B-ANAT
layers	B-ANAT
,	O
the	O
mean	O
daily	O
egg	B-ANAT
production	O
per	O
hen	O
was	O
significantly	O
reduced	O
by	O
the	O
M	O
.	O
synoviae	O
EAA	O
strain	O
and	O
there	O
was	O
a	O
general	O
negative	O
effect	O
on	O
eggshell	O
strength	O
by	O
this	O
strain	O
,	O
suggesting	O
it	O
could	O
also	O
have	O
a	O
detrimental	O
effect	O
on	O
hatching	O
egg	B-ANAT
quality	O
.	O

However	O
,	O
relatively	O
little	O
is	O
known	O
about	O
the	O
cellular	B-ANAT
proteome	O
changes	O
that	O
occur	O
during	O
SARS	O
-	O
CoV	O
replication	O
.	O

To	O
identify	O
host	O
proteins	O
important	O
for	O
SARS	O
-	O
CoV	O
RNA	O
replication	O
,	O
the	O
protein	O
profiles	O
of	O
the	O
SARS	O
-	O
CoV	O
replicon	O
cells	B-ANAT
and	O
parental	O
BHK21	O
cells	B-ANAT
were	O
compared	O
using	O
a	O
quantitative	O
proteomic	O
strategy	O
termed	O
""""	O
stable	O
-	O
isotope	O
labeling	O
by	O
amino	O
acids	O
in	O
cell	B-ANAT
culture	O
-	O
mass	O
spectrometry	O
""""	O
(	O
SILAC	O
-	O
MS	O
).	O

TITLE	O
:	O
Comparative	O
host	O
gene	O
transcription	O
by	O
microarray	O
analysis	O
early	O
after	O
infection	O
of	O
the	O
Huh7	O
cell	B-ANAT
line	I-ANAT
by	O
SARS	O
coronavirus	O
and	O
human	O
coronavirus	O
229E	O
.	O

Secretions	B-ANAT
in	O
genital	B-ANAT
tract	O
washes	O
from	O
the	O
i	O
.	O
n	O
.	O

In	O
summary	O
,	O
our	O
study	O
indicates	O
that	O
mucosal	B-ANAT
immunization	O
with	O
rBV	O
SARS	O
-	O
CoV	O
VLPs	B-ANAT
represent	O
an	O
effective	O
means	O
for	O
eliciting	O
protective	O
systemic	O
and	O
mucosal	B-ANAT
immune	O
responses	O
against	O
SARS	O
-	O
CoV	O
,	O
providing	O
important	O
information	O
for	O
vaccine	O
design	O
.	O

ABSTRACT	O
:	O
To	O
analyze	O
the	O
proteins	O
interacting	O
with	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
envelope	B-ANAT
(	O
E	O
)	O
protein	O
,	O
a	O
SARS	O
-	O
CoV	O
was	O
engineered	O
including	O
two	O
tags	O
associated	O
to	O
the	O
E	O
protein	O
.	O

We	O
detected	O
a	O
large	O
increase	O
in	O
NO	O
levels	O
in	O
BAL	O
fluids	B-ANAT
of	O
PRCV	O
-	O
infected	O
pigs	O
,	O
but	O
not	O
in	O
PRRSV	O
-	O
infected	O
pigs	O
.	O

Serum	B-ANAT
antibodies	O
for	O
both	O
viruses	O
were	O
detected	O
in	O
6	O
of	O
the	O
483	O
dogs	O
sampled	O
,	O
suggesting	O
that	O
these	O
viruses	O
are	O
present	O
in	O
dogs	O
in	O
Korea	O
.	O

His	O
severe	O
thoracic	B-ANAT
insufficiency	O
necessitated	O
an	O
urgent	O
life	O
-	O
saving	O
surgical	O
intervention	O
for	O
a	O
progressively	O
worsening	O
sleep	O
apnoea	O
and	O
respiratory	O
distress	O
.	O

Our	O
surgical	O
strategy	O
for	O
the	O
management	O
of	O
severe	O
thoracic	B-ANAT
insufficiency	O
syndrome	O
in	O
Adam	O
Robert	O
Wright	O
Syndrome	O
provided	O
symptomatic	O
relief	O
and	O
favourable	O
long	O
-	O
term	O
results	O
.	O

ABSTRACT	O
:	O
The	O
murine	O
coronavirus	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
induced	O
the	O
expression	O
of	O
type	O
I	O
interferon	O
(	O
alpha	O
/	O
beta	O
interferon	O
[	O
IFN	O
-	O
alpha	O
/	O
beta	O
])	O
in	O
mouse	O
oligodendrocytic	O
N20	O
.	O
1	O
cells	B-ANAT
.	O

Among	O
those	O
admitted	O
to	O
ICUs	O
,	O
the	O
pandemic	O
was	O
associated	O
with	O
a	O
mortality	O
of	O
approximately	O
16	O
%,	O
a	O
high	O
incidence	O
of	O
acute	O
lung	B-ANAT
injury	O
and	O
,	O
in	O
some	O
cases	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
severe	O
enough	O
to	O
require	O
support	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

Once	O
the	O
diagnosis	O
of	O
GBS	O
is	O
established	O
or	O
suspected	O
the	O
treatment	O
with	O
plasma	B-ANAT
exchange	O
or	O
intravenous	O
immune	O
globulin	O
is	O
indicated	O
.	O

Treatment	O
with	O
plasma	B-ANAT
exchange	O
was	O
conducted	O
and	O
the	O
patient	O
had	O
satisfactory	O
recovery	O
.	O

Twenty	O
-	O
nine	O
patients	O
required	O
mechanical	O
ventilation	O
(	O
96	O
.	O
6	O
%);	O
only	O
one	O
required	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
;	O
and	O
19	O
(	O
63	O
%)	O
had	O
respiratory	O
complications	O
.	O

ABSTRACT	O
:	O
Respiratory	O
viruses	O
frequently	O
are	O
recovered	O
in	O
the	O
upper	O
-	O
respiratory	B-ANAT
tract	I-ANAT
during	O
acute	O
exacerbations	O
of	O
COPD	O
(	O
AECOPD	O
),	O
but	O
their	O
role	O
as	O
contributing	O
pathogens	O
remains	O
unclear	O
.	O

A	O
formula	O
including	O
fish	O
oil	O
,	O
borage	O
oil	O
and	O
antioxidants	O
has	O
demonstrated	O
marked	O
benefits	O
on	O
gas	O
exchange	O
,	O
ventilation	O
requirement	O
,	O
new	O
organ	B-ANAT
failures	O
,	O
ICU	O
stay	O
and	O
mortality	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
acute	O
lung	B-ANAT
injury	O
or	O
severe	O
sepsis	O
.	O

On	O
0	O
,	O
7	O
,	O
14	O
,	O
21	O
,	O
28	O
and	O
35	O
post	O
first	O
vaccination	O
,	O
the	O
dynamic	O
changes	O
of	O
peripheral	O
lymphocyte	B-ANAT
proliferation	O
,	O
cytokine	O
assays	O
and	O
serum	B-ANAT
antibody	O
titers	O
were	O
assayed	O
respectively	O
by	O
MTT	O
method	O
,	O
ELISA	O
and	O
hemagglutination	O
inhibition	O
assay	O
(	O
HI	O
).	O

Widespread	O
lung	B-ANAT
inflammation	O
and	O
increased	O
pulmonary	B-ANAT
vascular	B-ANAT
permeability	O
has	O
been	O
noted	O
on	O
autopsy	O
.	O

All	O
patients	O
were	O
on	O
mechanical	O
ventilation	O
and	O
inhaled	O
nitric	O
oxide	O
,	O
and	O
one	O
patient	O
was	O
on	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

Because	O
these	O
procedures	O
used	O
the	O
filtration	O
exchange	O
method	O
,	O
it	O
was	O
performed	O
in	O
a	O
timely	O
fashion	O
by	O
intensive	O
care	O
unit	O
personnel	O
and	O
on	O
equipment	O
already	O
available	O
in	O
the	O
intensive	O
care	O
unit	O
for	O
renal	B-ANAT
support	O
.	O

This	O
very	O
limited	O
case	O
series	O
suggest	O
there	O
may	O
be	O
a	O
role	O
for	O
therapeutic	O
plasma	B-ANAT
exchange	O
as	O
a	O
rescue	O
therapy	O
in	O
severe	O
shock	O
and	O
acute	O
lung	B-ANAT
injury	O
related	O
to	O
pH1N1	O
that	O
has	O
not	O
responded	O
to	O
traditional	O
therapy	O
.	O

In	O
both	O
cases	O
the	O
cause	O
of	O
death	O
was	O
cardio	O
-	O
respiratory	O
failure	O
following	O
an	O
acute	O
bilateral	O
pneumonia	O
with	O
diffuse	O
alveolar	B-ANAT
damage	O
and	O
ARDS	O
associated	O
with	O
sepsis	O
and	O
disseminated	O
intravascular	O
coagulation	O
.	O

Pleural	B-ANAT
effusion	I-ANAT
was	O
present	O
in	O
three	O
of	O
four	O
patients	O
undergoing	O
ECMO	O
therapy	O
.	O

Here	O
we	O
detail	O
a	O
high	O
throughput	O
quantitative	O
proteomics	O
analysis	O
of	O
Vero	B-ANAT
cells	I-ANAT
infected	O
with	O
the	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
),	O
a	O
positive	O
strand	O
RNA	O
virus	O
that	O
replicates	O
in	O
the	O
cytoplasm	B-ANAT
.	O

Immunofluorescence	O
was	O
used	O
to	O
validate	O
changes	O
in	O
the	O
subcellular	O
localization	O
of	O
vimentin	B-ANAT
and	O
myosin	O
VI	O
in	O
IBV	O
-	O
infected	O
cells	B-ANAT
.	O

Compounds	O
were	O
tested	O
in	O
cell	B-ANAT
-	O
based	O
assays	O
against	O
viruses	O
representative	O
of	O
:	O
i	O
)	O
two	O
of	O
the	O
three	O
genera	O
of	O
the	O
Flaviviridae	O
family	O
,	O
i	O
.	O
e	O
.	O
Pestiviruses	O
and	O
Flaviviruses	O
;	O
ii	O
)	O
other	O
RNA	O
virus	O
families	O
,	O
such	O
as	O
Retroviridae	O
,	O
Picornaviridae	O
,	O
Paramyxoviridae	O
,	O
Rhabdoviridae	O
and	O
Reoviridae	O
;	O
iii	O
)	O
two	O
DNA	O
virus	O
families	O
(	O
Herpesviridae	O
and	O
Poxviridae	O
)	O
as	O
well	O
as	O
for	O
cytotoxicity	O
tests	O
,	O
run	O
in	O
parallel	O
with	O
antiviral	O
assays	O
,	O
against	O
MDBK	O
,	O
BHK	O
and	O
Vero	O
76	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
Blood	B-ANAT
purification	O
in	O
critical	O
care	O
can	O
perform	O
2	O
main	O
functions	O
:	O
as	O
an	O
artificial	O
support	O
for	O
failing	O
organs	B-ANAT
(	O
such	O
as	O
artificial	O
kidney	B-ANAT
or	O
liver	B-ANAT
support	O
)	O
and	O
as	O
a	O
remover	O
of	O
causative	O
humoral	O
mediators	O
of	O
critical	O
illness	O
(	O
such	O
as	O
severe	O
sepsis	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
).	O

Mechanically	O
ventilated	O
medical	O
intensive	O
care	O
unit	O
patients	O
who	O
were	O
assessed	O
daily	O
for	O
delirium	O
while	O
in	O
the	O
intensive	O
care	O
unit	O
and	O
who	O
underwent	O
comprehensive	O
cognitive	O
assessments	O
3	O
and	O
12	O
mos	O
after	O
discharge	B-ANAT
.	O

Containment	O
strategies	O
included	O
the	O
triage	O
of	O
febrile	O
patients	O
at	O
frontline	O
healthcare	O
settings	O
,	O
admission	O
and	O
isolation	O
of	O
confirmed	O
cases	O
,	O
mandatory	O
Quarantine	O
Orders	O
(	O
QO	O
)	O
for	O
close	O
contacts	O
,	O
and	O
temperature	O
screening	O
at	O
border	B-ANAT
entry	O
points	O
.	O

Exciting	O
new	O
studies	O
reveal	O
that	O
the	O
alcoholic	O
lung	B-ANAT
is	O
characterized	O
by	O
discrete	O
changes	O
in	O
cellular	B-ANAT
function	O
within	O
the	O
lower	O
airways	O
,	O
mediated	O
via	O
oxidant	O
stress	O
and	O
altered	O
signaling	O
pathways	O
and	O
,	O
in	O
experimental	O
models	O
,	O
is	O
highly	O
amenable	O
to	O
targeted	O
therapies	O
.	O

Using	O
surface	O
plasmon	O
resonance	O
biomolecular	O
interaction	O
analysis	O
(	O
SPR	O
/	O
BIA	O
)	O
and	O
matrix	O
-	O
assisted	O
laser	O
desorption	O
/	O
ionization	O
time	O
of	O
flight	O
(	O
MALDI	O
-	O
TOF	O
)	O
mass	O
spectrometry	O
,	O
we	O
found	O
that	O
only	O
the	O
proteasome	O
subunit	O
p42	O
from	O
human	O
fetal	B-ANAT
lung	I-ANAT
diploid	O
fibroblast	B-ANAT
(	O
2BS	O
)	O
cells	B-ANAT
bound	O
to	O
SARS	O
-	O
CoV	O
NP	O
.	O

The	O
co	O
-	O
localization	O
signal	O
of	O
SARS	O
-	O
CoV	O
NP	O
and	O
proteasome	O
subunit	O
p42	O
in	O
2BS	O
cells	B-ANAT
was	O
detected	O
using	O
indirect	O
immunofluorescence	O
and	O
confocal	O
microscopy	O
.	O

Exposure	O
of	O
NSCLC	O
cells	B-ANAT
to	O
TSL	O
-	O
1	O
caused	O
cell	B-ANAT
-	O
cycle	O
arrest	O
in	O
subG1	O
phase	O
and	O
caused	O
apoptosis	O
.	O

Nonetheless	O
,	O
the	O
amount	O
of	O
DNA	O
and	O
the	O
number	O
of	O
viral	B-ANAT
particles	I-ANAT
were	O
lower	O
than	O
those	O
that	O
have	O
been	O
found	O
in	O
MS	O
patients	O
with	O
R	O
/	O
R	O
at	O
the	O
time	O
of	O
relapse	O
,	O
but	O
higher	O
than	O
those	O
found	O
during	O
remission	O
.	O

Three	O
strains	O
adapted	O
to	O
the	O
in	O
vitro	O
grow	O
on	O
human	O
rectal	O
tumour	B-ANAT
cells	I-ANAT
were	O
also	O
evaluated	O
for	O
their	O
ability	O
to	O
replicate	O
in	O
a	O
bovine	O
cell	B-ANAT
line	I-ANAT
(	O
Madin	O
Darby	O
bovine	O
kidney	B-ANAT
)	O
and	O
to	O
cause	O
haemagglutination	O
of	O
chicken	O
erythrocytes	B-ANAT
and	O
all	O
displayed	O
biological	O
properties	O
similar	O
to	O
those	O
already	O
described	O
for	O
the	O
prototype	O
BuCoV	O
.	O
The	O
present	O
report	O
shows	O
that	O
albeit	O
genetically	O
heterogeneous	O
,	O
the	O
different	O
BuCoV	O
strains	O
possess	O
a	O
common	O
biological	O
pattern	O
which	O
is	O
different	O
from	O
most	O
BCoV	O
and	O
BCoV	O
-	O
like	O
isolates	O
.	O

To	O
understand	O
the	O
pathogenesis	O
of	O
SARS	O
-	O
CoV	O
,	O
human	O
type	B-ANAT
II	I-ANAT
pneumocyte	I-ANAT
(	O
A549	O
)	O
cells	B-ANAT
were	O
incubated	O
with	O
the	O
viral	O
spike	O
protein	O
or	O
with	O
SARS	O
-	O
CoV	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
containing	O
the	O
viral	O
spike	O
protein	O
to	O
examine	O
cytokine	O
modulation	O
in	O
lung	B-ANAT
cells	B-ANAT
.	O

Furthermore	O
,	O
ACE2	O
receptor	O
was	O
activated	O
by	O
casein	O
kinase	O
II	O
-	O
mediated	O
phosphorylation	O
in	O
cells	B-ANAT
pretreated	O
with	O
the	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
containing	O
spike	O
protein	O
.	O

Under	O
these	O
conditions	O
,	O
the	O
susceptibility	O
of	O
the	O
cells	B-ANAT
to	O
virus	O
infection	O
was	O
,	O
however	O
,	O
not	O
affected	O
,	O
excluding	O
an	O
important	O
role	O
of	O
ubiquitination	O
in	O
virus	O
entry	O
.	O

ABSTRACT	O
:	O
Like	O
most	O
other	O
positive	O
-	O
strand	O
RNA	O
viruses	O
,	O
hepatitis	O
C	O
virus	O
(	O
HCV	O
)	O
induces	O
changes	O
in	O
the	O
host	B-ANAT
cell	I-ANAT
'	O
s	O
membranes	B-ANAT
,	O
resulting	O
in	O
a	O
membranous	B-ANAT
web	O
.	O

Preparations	O
enriched	O
in	O
these	O
structures	O
were	O
separated	O
from	O
other	O
endoplasmic	B-ANAT
reticulum	I-ANAT
-	O
derived	O
membranes	B-ANAT
by	O
cell	B-ANAT
cytoplasm	B-ANAT
homogenization	O
and	O
ultracentrifugation	O
on	O
a	O
sucrose	O
gradient	O
.	O

TITLE	O
:	O
Extracorporeal	O
life	O
support	O
for	O
management	O
of	O
refractory	O
cardiac	B-ANAT
or	O
respiratory	O
failure	O
:	O
initial	O
experience	O
in	O
a	O
tertiary	O
centre	O
.	O

Attenuated	O
Salmonella	O
vaccine	O
(	O
chi8501	O
)	O
containing	O
swIFN	O
-	O
alpha	O
-	O
encoding	O
pYA3560	O
vector	O
(	O
chi8501	O
/	O
swIFN	O
-	O
alpha	O
)	O
successfully	O
induced	O
the	O
secretion	B-ANAT
of	O
swIFN	O
-	O
alpha	O
protein	O
into	O
the	O
culture	O
supernatants	O
,	O
as	O
confirmed	O
by	O
SDS	O
-	O
PAGE	O
and	O
Western	O
blot	O
.	O

In	O
addition	O
,	O
oral	B-ANAT
administration	O
of	O
chi8501	O
/	O
swIFN	O
-	O
alpha	O
reduced	O
the	O
severity	O
of	O
clinical	O
signs	O
caused	O
by	O
TGEV	O
infection	O
with	O
the	O
effect	O
more	O
apparent	O
at	O
6	O
-	O
8	O
days	O
post	O
-	O
infection	O
,	O
and	O
reduced	O
excretion	O
of	O
TGEV	O
in	O
feces	B-ANAT
.	O

ABSTRACT	O
:	O
Nitric	O
oxide	O
(	O
NO	O
)	O
plays	O
an	O
important	O
role	O
in	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
),	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
and	O
in	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
(	O
VILI	O
).	O

Models	O
of	O
oleic	O
acid	O
induced	O
ALI	O
were	O
established	O
in	O
dogs	O
;	O
these	O
models	O
were	O
then	O
randomized	O
into	O
three	O
groups	O
undergone	O
different	O
tidal	O
volume	O
(	O
VT	O
)	O
mechanical	O
ventilation	O
,	O
which	O
included	O
a	O
VT6	O
group	O
(	O
VT	O
equaled	O
to	O
6	O
ml	O
/	O
kg	O
body	B-ANAT
weight	O
,	O
positive	O
end	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
equaled	O
to	O
10	O
cmH2O	O
,	O
n	O
=	O
6	O
),	O
a	O
VT10	O
group	O
(	O
VT	O
equaled	O
to	O
10	O
ml	O
/	O
kg	O
body	B-ANAT
weight	O
,	O
PEEP	O
equaled	O
to	O
10	O
cmH2O	O
,	O
n	O
=	O
4	O
)	O
and	O
a	O
VT20	O
group	O
(	O
VT	O
equaled	O
to	O
20	O
ml	O
/	O
kg	O
body	B-ANAT
weight	O
,	O
PEEP	O
equaled	O
to	O
10	O
cmH2O	O
,	O
n	O
=	O
6	O
)	O
for	O
6	O
-	O
hour	O
ventilation	O
.	O

The	O
magnitudes	O
of	O
lung	B-ANAT
injury	O
in	O
the	O
VT20	O
group	O
were	O
more	O
severe	O
than	O
those	O
in	O
the	O
VT6	O
group	O
and	O
the	O
VT10	O
group	O
.	O

The	O
levels	O
of	O
ET	O
-	O
1	O
and	O
NO	O
in	O
the	O
lung	B-ANAT
were	O
increased	O
after	O
ventilation	O
.	O

In	O
the	O
lung	B-ANAT
tissue	I-ANAT
,	O
the	O
ratio	O
of	O
ET	O
-	O
1	O
/	O
NO	O
was	O
significantly	O
higher	O
in	O
the	O
VT20	O
group	O
than	O
in	O
the	O
VT6	O
group	O
and	O
VT10	O
group	O
after	O
the	O
6	O
-	O
hour	O
ventilation	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
as	O
there	O
was	O
a	O
significant	O
positive	O
relationship	O
between	O
ET	O
-	O
1	O
and	O
NO	O
in	O
the	O
lung	B-ANAT
(	O
r	O
=	O
0	O
.	O
54	O
,	O
P	O
<	O
0	O
.	O
05	O
).	O

Among	O
109	O
hospitalized	O
individuals	O
with	O
A	O
/	O
H1N1	O
infection	O
,	O
eight	O
(	O
7	O
%)	O
developed	O
severe	O
pulmonary	B-ANAT
complications	O
,	O
and	O
one	O
of	O
this	O
patient	O
died	O
.	O

CONCLUSIONS	O
:	O
Close	O
contact	O
with	O
the	O
airway	B-ANAT
of	O
severely	O
ill	O
patients	O
and	O
failure	O
of	O
infection	O
control	O
practices	O
to	O
prevent	O
exposure	O
to	O
respiratory	O
secretions	B-ANAT
were	O
associated	O
with	O
transmission	O
of	O
SARS	O
-	O
CoV	O
.	O
Rates	O
of	O
transmission	O
of	O
SARS	O
-	O
CoV	O
varied	O
widely	O
among	O
patients	O
.	O

ABSTRACT	O
:	O
The	O
spectrum	O
of	O
the	O
clinical	O
presentation	O
and	O
severity	O
of	O
malaria	O
infections	O
is	O
broad	O
,	O
ranging	O
from	O
uncomplicated	O
febrile	O
illness	O
to	O
severe	O
forms	O
of	O
disease	O
such	O
as	O
cerebral	B-ANAT
malaria	O
(	O
CM	O
),	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
),	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
pregnancy	O
-	O
associated	O
malaria	O
(	O
PAM	O
)	O
or	O
severe	O
anemia	O
(	O
SA	O
).	O

In	O
addition	O
,	O
either	O
splenectomization	O
or	O
administration	O
of	O
the	O
anti	O
-	O
inflammatory	O
molecule	O
carbon	O
monoxide	O
led	O
to	O
a	O
significant	O
reduction	O
in	O
the	O
levels	O
of	O
sera	B-ANAT
VEGF	O
and	O
to	O
protection	O
from	O
ALI	O
.	O

ABSTRACT	O
:	O
We	O
describe	O
the	O
case	O
of	O
an	O
immunosuppressed	O
transplant	B-ANAT
recipient	O
with	O
disseminated	O
blastomycosis	O
(	O
cutaneous	O
,	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
,	O
and	O
pulmonary	B-ANAT
infection	O
)	O
complicated	O
by	O
septic	O
shock	O
and	O
severe	O
,	O
refractory	O
acute	O
respiratory	O
distress	O
syndrome	O
that	O
improved	O
markedly	O
and	O
rapidly	O
after	O
the	O
addition	O
of	O
corticosteroids	O
to	O
the	O
antifungal	O
regimen	O
.	O

ABSTRACT	O
:	O
Sanjad	O
--	O
Sakati	O
syndrome	O
(	O
SSS	O
)	O
is	O
a	O
genetic	O
disease	O
confined	O
to	O
Arab	O
populations	O
in	O
the	O
Middle	O
-	O
East	O
countries	O
and	O
characterized	O
by	O
hypoparathyroidism	O
,	O
hypocalcaemia	O
and	O
hyperphosphataemia	O
,	O
severe	O
intrauterine	B-ANAT
and	O
postnatal	O
growth	O
failure	O
,	O
respiratory	O
infection	O
susceptibility	O
prone	O
,	O
dwarfism	O
,	O
mental	O
retardation	O
,	O
seizures	O
,	O
craniofacial	B-ANAT
dysmorphic	O
features	O
as	O
retromicrognathia	O
and	O
abnormal	O
dentition	B-ANAT
.	O

Lung	B-ANAT
tissue	I-ANAT
was	O
submitted	O
for	O
viral	O
and	O
bacteriological	O
analyses	O
by	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
,	O
and	O
autopsy	O
was	O
conducted	O
on	O
all	O
patients	O
who	O
died	O
.	O

Other	O
lung	B-ANAT
findings	O
were	O
necrotizing	O
bronchiolitis	O
or	O
extensive	O
hemorrhage	O
.	O

Extracellular	B-ANAT
signal	O
-	O
regulated	O
kinases	O
1	O
/	O
2	O
activation	O
is	O
impaired	O
,	O
which	O
may	O
depress	O
monocytes	B-ANAT
'	O
transmigration	O
and	O
may	O
consequently	O
increase	O
risk	O
of	O
infection	O
.	O

We	O
hypothesised	O
that	O
critically	O
ill	O
patients	O
with	O
H1N1	O
infection	O
would	O
have	O
a	O
higher	O
incidence	O
of	O
right	O
and	O
left	B-ANAT
heart	I-ANAT
failure	O
than	O
is	O
seen	O
in	O
unselected	O
populations	O
of	O
patients	O
with	O
septic	O
shock	O
and	O
/	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

These	O
patients	O
have	O
less	O
left	B-ANAT
heart	I-ANAT
failure	O
than	O
expected	O
on	O
the	O
basis	O
of	O
prior	O
descriptions	O
of	O
influenza	O
myopericarditis	O
or	O
of	O
general	O
populations	O
of	O
septic	O
patients	O
.	O

The	O
protein	O
has	O
been	O
crystallized	O
and	O
the	O
crystals	B-ANAT
diffracted	O
X	O
-	O
rays	O
to	O
2	O
.	O
44	O
A	O
resolution	O
.	O

Positive	O
herds	O
had	O
a	O
higher	O
(	O
P	O
=	O
0	O
.	O
001	O
)	O
bulk	O
tank	O
milk	O
somatic	B-ANAT
cell	I-ANAT
count	O
(	O
BMSCC	O
)	O
compared	O
with	O
negative	O
herds	O
.	O

TITLE	O
:	O
Proteomic	O
analysis	O
of	O
purified	O
coronavirus	O
infectious	O
bronchitis	O
virus	B-ANAT
particles	I-ANAT
.	O

Interestingly	O
,	O
21	O
of	O
the	O
total	O
host	O
proteins	O
have	O
not	O
been	O
reported	O
to	O
be	O
present	O
in	O
virions	B-ANAT
of	O
other	O
virus	O
families	O
,	O
such	O
as	O
major	O
vault	O
protein	O
,	O
TENP	O
protein	O
,	O
ovalbumin	O
,	O
and	O
scavenger	O
receptor	O
protein	O
.	O

These	O
problems	O
suggest	O
deficiencies	O
in	O
recruiting	O
and	O
/	O
or	O
maturation	O
of	O
oligodendrocyte	B-ANAT
progentior	O
cells	B-ANAT
(	O
OPCs	O
)	O
and	O
highlight	O
cell	B-ANAT
replacement	O
therapies	O
to	O
promote	O
remyelination	O
.	O

We	O
have	O
used	O
a	O
model	O
of	O
viral	O
-	O
induced	O
demyelination	O
to	O
characterize	O
signaling	O
cues	O
associated	O
with	O
positional	O
migration	O
of	O
transplanted	B-ANAT
remyelination	O
-	O
competent	O
cells	B-ANAT
.	O

However	O
,	O
the	O
news	O
media	B-ANAT
coverage	O
did	O
vary	O
in	O
accordance	O
with	O
the	O
mortality	O
of	O
'	O
cancer	O
,'	O
'	O
diabetes	O
,'	O
and	O
'	O
hypertension	O
.'	O

The	O
news	O
media	B-ANAT
reduced	O
the	O
relative	O
level	O
of	O
attention	O
given	O
to	O
pneumonia	O
and	O
tuberculosis	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
is	O
an	O
avian	O
coronavirus	O
affecting	O
the	O
respiratory	B-ANAT
tract	I-ANAT
of	O
chickens	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
(	O
CoV	O
),	O
including	O
SARS	O
and	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
),	O
are	O
enveloped	O
RNA	O
viruses	O
that	O
induce	O
formation	O
of	O
double	O
-	O
membrane	B-ANAT
vesicles	B-ANAT
(	O
DMVs	O
)	O
and	O
target	O
their	O
replication	O
and	O
transcription	O
complexes	O
(	O
RTCs	O
)	O
on	O
the	O
DMV	O
-	O
limiting	O
membranes	B-ANAT
.	O

We	O
show	O
that	O
MHV	O
co	O
-	O
opts	O
the	O
host	B-ANAT
cell	I-ANAT
machinery	O
for	O
COPII	O
-	O
independent	O
vesicular	O
ER	O
export	O
of	O
a	O
short	O
-	O
living	O
regulator	O
of	O
ER	O
-	O
associated	O
degradation	O
(	O
ERAD	O
),	O
EDEM1	O
,	O
to	O
derive	O
cellular	B-ANAT
membranes	B-ANAT
for	O
replication	O
.	O

Our	O
study	O
identifies	O
the	O
host	O
cellular	B-ANAT
pathway	O
hijacked	O
for	O
supplying	O
CoV	O
replication	O
membranes	B-ANAT
and	O
describes	O
an	O
autophagy	O
-	O
independent	O
role	O
for	O
nonlipidated	O
LC3	O
-	O
I	O
.	O

Virus	O
with	O
the	O
longest	O
incubation	O
time	O
that	O
produced	O
lesions	O
in	O
the	O
embryos	B-ANAT
was	O
harvested	O
,	O
again	O
incubated	O
at	O
56	O
degrees	O
C	O
as	O
described	O
and	O
passaged	O
in	O
embryonated	O
eggs	O
.	O

However	O
,	O
adverse	O
effects	O
,	O
especially	O
potentially	O
fatal	O
and	O
non	O
-	O
reversible	O
acute	O
and	O
chronic	O
pulmonary	B-ANAT
toxicity	O
,	O
continue	O
to	O
be	O
observed	O
.	O

Lung	B-ANAT
adverse	O
effects	O
occur	O
in	O
approximately	O
5	O
%	O
of	O
treated	O
patients	O
.	O

Pleural	O
/	O
pericardial	B-ANAT
involvement	O
may	O
be	O
observed	O
.	O

To	O
investigate	O
the	O
impact	O
of	O
pulmonary	B-ANAT
vascular	B-ANAT
dysfunction	O
in	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
.	O

Patients	O
with	O
an	O
elevated	O
baseline	O
TPG	O
had	O
an	O
increased	O
60	O
-	O
day	O
mortality	O
(	O
30	O
versus	O
19	O
%;	O
P	O
=	O
0	O
.	O
02	O
),	O
and	O
lower	O
numbers	O
of	O
median	O
ventilator	O
-	O
[	O
25	O
-	O
75	O
%	O
quartiles	O
]	O
(	O
15	O
[	O
0	O
-	O
22	O
]	O
versus	O
19	O
[	O
7	O
-	O
24	O
];	O
P	O
=	O
0	O
.	O
005	O
),	O
ICU	O
-	O
(	O
14	O
[	O
0	O
-	O
21	O
]	O
versus	O
18	O
[	O
5	O
-	O
22	O
];	O
P	O
=	O
0	O
.	O
005	O
),	O
and	O
cardiovascular	B-ANAT
-	O
free	O
days	O
(	O
23	O
[	O
12	O
-	O
27	O
]	O
versus	O
25	O
[	O
18	O
-	O
27	O
];	O
P	O
=	O
0	O
.	O
03	O
).	O

ABSTRACT	O
:	O
In	O
the	O
management	O
of	O
patients	O
with	O
severe	O
acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
clinicians	O
are	O
sometimes	O
challenged	O
to	O
maintain	O
acceptable	O
gas	O
exchange	O
while	O
avoiding	O
harmful	O
mechanical	O
ventilation	O
practices	O
.	O

CONCLUSIONS	O
:	O
The	O
combination	O
of	O
SIRS	O
score	O
on	O
admission	O
and	O
IL	O
-	O
6	O
serum	B-ANAT
concentration	O
can	O
be	O
early	O
,	O
predictor	O
of	O
illness	O
severity	O
and	O
outcome	O
in	O
SAP	O
.	O

We	O
sought	O
to	O
determine	O
the	O
effects	O
of	O
telbivudine	O
on	O
the	O
immune	B-ANAT
system	I-ANAT
,	O
particularly	O
on	O
cytokine	O
production	O
and	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
response	O
,	O
using	O
an	O
animal	O
model	O
with	O
mouse	O
hepatitis	O
virus	O
strain	O
3	O
(	O
MHV	O
-	O
3	O
)-	O
induced	O
hepatitis	O
.	O

Serum	B-ANAT
levels	O
of	O
interferon	O
-	O
gamma	O
were	O
elevated	O
significantly	O
after	O
telbivudine	O
treatment	O
in	O
MHV	O
-	O
3	O
-	O
infected	O
C3H	O
mice	O
.	O

Obtaining	O
influenza	O
virus	O
sequences	O
from	O
the	O
months	O
/	O
years	O
in	O
which	O
death	O
from	O
P	O
&	O
I	O
was	O
excessive	O
,	O
we	O
investigated	O
molecular	O
variation	O
in	O
vaccine	O
-	O
mismatched	O
influenza	O
viruses	O
by	O
comparing	O
hemagglutinin	O
1	O
(	O
HA1	B-ANAT
)	O
of	O
the	O
circulating	O
and	O
vaccine	O
strains	O
.	O

Furthermore	O
,	O
vaccine	O
-	O
mismatched	O
H3N2	O
viruses	O
circulating	O
in	O
the	O
years	O
with	O
high	O
excess	O
P	O
&	O
I	O
mortality	O
exhibited	O
both	O
a	O
lower	O
amino	O
acid	O
identity	O
percentage	O
of	O
HA1	B-ANAT
between	O
vaccine	O
and	O
circulating	O
strains	O
and	O
a	O
higher	O
numbers	O
of	O
variations	O
at	O
epitope	O
B	O
.	O
Our	O
model	O
can	O
help	O
future	O
decision	O
makers	O
to	O
estimate	O
excess	O
P	O
&	O
I	O
mortality	O
effectively	O
,	O
select	O
and	O
test	O
virus	O
strains	O
for	O
antigenic	O
variation	O
,	O
and	O
evaluate	O
public	O
health	O
strategy	O
effectiveness	O
.	O

Partial	O
protection	O
in	O
challenged	O
animals	O
was	O
observed	O
,	O
as	O
vaccinated	O
pigs	O
showed	O
decreased	O
lung	B-ANAT
damage	O
when	O
compared	O
with	O
the	O
non	O
-	O
vaccinated	O
ones	O
.	O

ABSTRACT	O
:	O
The	O
nsp1	O
protein	O
of	O
the	O
highly	O
pathogenic	O
SARS	O
coronavirus	O
suppresses	O
host	O
protein	O
synthesis	O
,	O
including	O
genes	O
involved	O
in	O
the	O
innate	O
immune	B-ANAT
system	I-ANAT
.	O

BCoV	O
is	O
the	O
cause	O
of	O
3	O
distinct	O
clinical	O
syndromes	O
in	O
cattle	O
:	O
(	O
1	O
)	O
calf	B-ANAT
diarrhea	O
,	O
(	O
2	O
)	O
winter	O
dysentery	O
with	O
hemorrhagic	O
diarrhea	O
in	O
adults	O
,	O
and	O
(	O
3	O
)	O
respiratory	O
infections	O
in	O
cattle	O
of	O
various	O
ages	O
including	O
the	O
bovine	O
respiratory	O
disease	O
complex	O
or	O
shipping	O
fever	O
of	O
feedlot	O
cattle	O
.	O

Improved	O
medical	O
countermeasures	O
would	O
increase	O
survivability	O
and	O
improve	O
the	O
quality	O
of	O
recovery	O
of	O
lung	B-ANAT
damaged	O
casualties	O
.	O

The	O
development	O
of	O
effective	O
pharmacological	O
approaches	O
to	O
assist	O
the	O
recovery	O
of	O
casualties	O
suffering	O
from	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
may	O
improve	O
the	O
prognosis	O
of	O
such	O
patients	O
(	O
which	O
is	O
currently	O
poor	O
)	O
and	O
would	O
ideally	O
be	O
used	O
as	O
a	O
means	O
of	O
preventing	O
subjects	O
from	O
developing	O
the	O
pulmonary	B-ANAT
oedema	O
characteristic	O
of	O
ALI	O
/	O
ARDS	O
.	O

ABSTRACT	O
:	O
Calf	B-ANAT
diarrhea	O
is	O
a	O
major	O
economic	O
burden	O
to	O
the	O
bovine	O
industry	O
.	O

Glasgow	O
Coma	O
Scale	O
(	O
GCS	O
)	O
scores	O
and	O
the	O
need	O
for	O
cardiopulmonary	B-ANAT
resuscitation	O
(	O
CPR	O
)	O
at	O
the	O
scene	O
of	O
injury	O
were	O
associated	O
with	O
eventual	O
patient	O
mortality	O
(	O
100	O
%	O
mortality	O
for	O
an	O
initial	O
GCS	O
score	O
of	O
3	O
and	O
75	O
%	O
mortality	O
for	O
on	O
-	O
scene	O
CPR	O
).	O

The	O
inhibition	O
of	O
transmissible	O
gastroenteritis	O
coronavirus	O
and	O
enteric	O
bacterial	O
pathogens	O
as	O
well	O
as	O
the	O
bile	B-ANAT
tolerance	O
,	O
high	O
survival	O
in	O
gastric	B-ANAT
juice	I-ANAT
,	O
and	O
the	O
antibiotic	O
resistance	O
indicate	O
that	O
the	O
two	O
isolated	O
bacterial	O
strains	O
are	O
ideal	O
probiotic	O
candidates	O
for	O
animal	O
application	O
after	O
proper	O
in	O
vivo	O
experiments	O
.	O

In	O
addition	O
,	O
the	O
potential	O
role	O
for	O
chemokines	O
in	O
positional	O
migration	O
of	O
transplanted	B-ANAT
cells	B-ANAT
is	O
addressed	O
.	O

Sequential	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
)	O
fluids	B-ANAT
from	O
all	O
patients	O
hospitalised	O
with	O
acute	O
respiratory	O
illness	O
over	O
12	O
months	O
(	O
n	O
=	O
283	O
)	O
were	O
tested	O
for	O
the	O
presence	O
of	O
17	O
respiratory	O
viruses	O
by	O
multiplex	O
PCR	O
assay	O
and	O
for	O
newly	O
discovered	O
respiratory	O
viruses	O
(	O
bocavirus	O
,	O
WU	O
and	O
KI	O
polyomaviruses	O
)	O
by	O
single	O
-	O
target	O
PCR	O
.	O

The	O
results	O
show	O
that	O
SIMCA	O
was	O
able	O
to	O
differentiate	O
viruses	O
with	O
and	O
without	O
envelope	B-ANAT
with	O
>	O
95	O
%	O
of	O
classification	O
accuracy	O
,	O
while	O
PCA	B-ANAT
presented	O
clear	O
spectral	O
data	O
segregations	O
between	O
different	O
virus	O
strains	O
.	O

Furthermore	O
,	O
the	O
progesterone	O
receptor	B-ANAT
complex	I-ANAT
was	O
examined	O
.	O

Oviduct	B-ANAT
and	O
fecal	B-ANAT
samples	O
were	O
collected	O
at	O
regular	O
intervals	O
after	O
N1	O
/	O
88	O
challenge	O
.	O

After	O
indirect	O
lung	B-ANAT
injury	O
,	O
there	O
was	O
a	O
2	O
-	O
fold	O
increase	O
in	O
the	O
number	O
of	O
pulmonary	B-ANAT
monocyte	B-ANAT
/	O
macrophages	B-ANAT
in	O
the	O
Sftpd	O
(-/-)	O
mice	O
when	O
compared	O
with	O
wild	O
-	O
type	O
mice	O
,	O
whereas	O
pulmonary	B-ANAT
neutrophils	B-ANAT
were	O
not	O
increased	O
.	O

Mortality	O
rate	O
was	O
14	O
.	O
2	O
percent	O
and	O
was	O
attributed	O
to	O
septic	O
complications	O
and	O
irreversible	O
brain	B-ANAT
damage	O
.	O

Here	O
,	O
we	O
show	O
that	O
mutations	O
in	O
the	O
viral	O
spike	O
glycoprotein	O
,	O
reproducibly	O
acquired	O
during	O
viral	O
persistence	O
in	O
human	O
neural	B-ANAT
cell	I-ANAT
cultures	O
,	O
led	O
to	O
a	O
drastically	O
modified	O
virus	O
-	O
induced	O
neuropathology	O
in	O
BALB	O
/	O
c	O
mice	O
,	O
characterized	O
by	O
flaccid	O
paralysis	O
and	O
demyelination	O
.	O

Therefore	O
,	O
interaction	O
of	O
a	O
human	O
respiratory	O
coronavirus	O
with	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
may	O
modulate	O
virus	O
and	O
host	O
factors	O
resulting	O
in	O
a	O
modified	O
neuropathogenesis	O
in	O
genetically	O
susceptible	O
individuals	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
sequential	O
nearest	O
-	O
neighbor	O
effects	O
on	O
quantum	O
-	O
chemical	O
calculations	O
of	O
(	O
13	O
)	O
C	O
(	O
alpha	O
)	O
chemical	O
shifts	O
,	O
we	O
selected	O
the	O
structure	O
of	O
the	O
nucleic	B-ANAT
acid	O
binding	O
(	O
NAB	O
)	O
protein	O
from	O
the	O
SARS	O
coronavirus	O
determined	O
by	O
NMR	O
in	O
solution	O
(	O
PDB	O
id	O
2K87	O
).	O

A	O
new	O
ensemble	O
of	O
20	O
conformers	O
representing	O
the	O
NMR	O
structure	O
of	O
the	O
NAB	O
,	O
which	O
was	O
calculated	O
with	O
an	O
input	O
containing	O
backbone	B-ANAT
torsion	O
angle	O
constraints	O
derived	O
from	O
the	O
theoretical	O
(	O
13	O
)	O
C	O
(	O
alpha	O
)	O
chemical	O
shifts	O
as	O
supplementary	O
data	O
to	O
the	O
NOE	O
distance	O
constraints	O
,	O
exhibits	O
very	O
similar	O
topology	O
and	O
comparable	O
agreement	O
with	O
the	O
NOE	O
constraints	O
as	O
the	O
published	O
NMR	O
structure	O
.	O

TITLE	O
:	O
Pros	O
and	O
cons	O
of	O
recruitment	O
maneuvers	O
in	O
acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

However	O
,	O
such	O
a	O
strategy	O
may	O
result	O
in	O
alveolar	B-ANAT
collapse	O
,	O
leading	O
to	O
cyclic	O
opening	O
and	O
closing	O
of	O
atelectatic	O
alveoli	B-ANAT
and	O
distal	O
airways	O
.	O

The	O
efficiency	O
of	O
RMs	O
may	O
be	O
affected	O
by	O
different	O
factors	O
,	O
including	O
the	O
nature	O
and	O
extent	O
of	O
lung	B-ANAT
injury	O
,	O
capability	O
of	O
increasing	O
inspiratory	O
transpulmonary	O
pressures	O
,	O
patient	O
positioning	O
and	O
cardiac	B-ANAT
preload	O
.	O

During	O
a	O
vascular	B-ANAT
occlusion	O
test	O
,	O
the	O
microcirculation	O
was	O
moderately	O
to	O
severely	O
compromised	O
with	O
a	O
NIRS	O
ascending	O
slope	O
of	O
2	O
.	O
39	O
%Â·	O
sec	O
(-	O
1	O
)	O

Study	O
participants	O
who	O
were	O
female	O
(	O
OR	O
:	O
1	O
.	O
79	O
-	O
3	O
.	O
90	O
)	O
who	O
perceived	O
of	O
hand	O
washing	O
to	O
be	O
effective	O
(	O
OR	O
:	O
1	O
.	O
34	O
-	O
12	O
.	O
15	O
)	O
and	O
illness	O
severity	O
to	O
be	O
greater	O
(	O
OR	O
:	O
1	O
.	O
00	O
-	O
3	O
.	O
12	O
)	O
washed	O
their	O
hands	B-ANAT
more	O
frequently	O
.	O

ABSTRACT	O
:	O
Massive	O
aggregations	O
of	O
macrophages	B-ANAT
are	O
frequently	O
detected	O
in	O
afflicted	O
lungs	B-ANAT
of	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
infection	O
.	O

We	O
transduced	O
SARS	O
-	O
CoV	O
spike	O
protein	O
-	O
displayed	O
recombinant	O
baculovirus	O
(	O
SSDRB	O
),	O
vAtEpGS688	O
,	O
into	O
peripheral	O
B	B-ANAT
cells	I-ANAT
and	O
B	O
lymphoma	B-ANAT
cells	I-ANAT
.	O

Cell	B-ANAT
surface	I-ANAT
expression	O
of	O
CD19	O
or	O
Mac	B-ANAT
-	O
1	O
(	O
CD11b	O
)	O
was	O
determined	O
by	O
flow	O
cytometry	O
.	O

In	O
this	O
report	O
,	O
we	O
showed	O
that	O
spike	O
protein	O
of	O
SARS	O
virus	O
could	O
induce	O
phenotypic	O
conversion	O
of	O
human	O
B	B-ANAT
cells	I-ANAT
,	O
either	O
from	O
peripheral	B-ANAT
blood	I-ANAT
or	O
B	O
lymphoma	B-ANAT
cells	I-ANAT
,	O
to	O
macrophage	B-ANAT
-	O
like	O
cells	B-ANAT
that	O
were	O
steadily	O
losing	O
the	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
marker	O
CD19	O
and	O
in	O
turn	O
expressing	O
the	O
macrophage	B-ANAT
-	O
specific	O
marker	O
Mac	B-ANAT
-	O
1	O
.	O

Transmission	O
electron	O
microscopy	O
showed	O
that	O
,	O
compared	O
to	O
revertant	O
virus	O
,	O
the	O
number	O
of	O
double	O
-	O
membrane	B-ANAT
vesicles	B-ANAT
in	O
MHV	O
-	O
Brts31	O
-	O
infected	O
cells	B-ANAT
is	O
reduced	O
at	O
the	O
nonpermissive	O
temperature	O
.	O

TITLE	O
:	O
Forsythoside	O
a	O
inhibits	O
the	O
avian	O
infectious	O
bronchitis	O
virus	O
in	O
cell	B-ANAT
culture	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
effects	O
of	O
forsythoside	O
A	O
on	O
cell	B-ANAT
infection	O
by	O
avian	O
infectious	O
bronchitis	O
virus	O
were	O
assessed	O
.	O

The	O
pretreatment	O
of	O
cells	B-ANAT
with	O
forsythoside	O
A	O
,	O
adding	O
forsythoside	O
A	O
post	O
infection	O
of	O
cells	B-ANAT
,	O
and	O
treatment	O
of	O
virus	O
with	O
forsythoside	O
A	O
were	O
analysed	O
.	O

This	O
report	O
describes	O
a	O
severe	O
case	O
of	O
atypical	O
pneumonia	O
due	O
to	O
M	O
.	O
pneumoniae	O
in	O
a	O
formerly	O
healthy	O
young	O
woman	O
who	O
developed	O
high	O
grade	O
fever	O
and	O
cough	O
leading	O
to	O
severe	O
disseminated	O
lung	B-ANAT
disease	O
and	O
finally	O
to	O
fatal	O
ARDS	O
.	O

ABSTRACT	O
:	O
We	O
present	O
the	O
successful	O
use	O
of	O
perioperative	O
non	O
-	O
invasive	O
mechanical	O
ventilation	O
in	O
a	O
morbidly	O
obese	O
pregnant	O
woman	O
with	O
bronchial	B-ANAT
asthma	O
,	O
severe	O
preeclampsia	O
and	O
pulmonary	B-ANAT
edema	O
undergoing	O
an	O
emergency	O
cesarean	O
delivery	O
with	O
spinal	O
anesthesia	O
.	O

STAT1	O
-/-	O
mice	O
exhibited	O
dysregulation	O
of	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
and	O
macrophage	B-ANAT
differentiation	O
,	O
leading	O
to	O
a	O
TH2	O
-	O
biased	O
immune	O
response	O
and	O
the	O
development	O
of	O
alternatively	O
activated	O
macrophages	B-ANAT
that	O
mediate	O
a	O
profibrotic	O
environment	O
within	O
the	O
lung	B-ANAT
.	O

TITLE	O
:	O
The	O
successful	O
use	O
of	O
extra	O
-	O
corporeal	O
membrane	B-ANAT
oxygenation	O
in	O
the	O
management	O
of	O
a	O
pregnant	O
woman	O
with	O
severe	O
H1N1	O
2009	O
influenza	O
complicated	O
by	O
pneumonitis	O
and	O
adult	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
overall	O
results	O
allowed	O
the	O
determination	O
of	O
the	O
pathogenic	O
nature	O
of	O
the	O
field	O
isolates	O
and	O
a	O
vaccination	O
program	O
based	O
on	O
the	O
use	O
of	O
the	O
only	O
Massachusetts	O
H120	O
strain	O
did	O
not	O
reduce	O
tracheal	O
and	O
kidney	B-ANAT
lesions	O
.	O

A	O
structural	O
model	O
of	O
a	O
pentameric	O
bundle	O
is	O
proposed	O
with	O
cysteines	O
,	O
serines	O
and	O
threonines	O
facing	O
the	O
pore	B-ANAT
.	O

ABSTRACT	O
:	O
Cytotoxic	O
CD8	O
(+)	O
T	B-ANAT
lymphocytes	I-ANAT
(	O
CTLs	O
)	O
play	O
an	O
important	O
role	O
in	O
antiviral	O
immunity	O
.	O

The	O
phenotype	O
of	O
the	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
was	O
characterized	O
based	O
on	O
the	O
expression	O
of	O
IFN	O
-	O
Î³	O
.	O

ABSTRACT	O
:	O
The	O
NMR	O
structure	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
nonstructural	O
protein	O
(	O
nsp	O
)	O
7	O
in	O
aqueous	O
solution	O
at	O
pH	O
6	O
.	O
5	O
was	O
determined	O
and	O
compared	O
with	O
the	O
results	O
of	O
previous	O
structure	O
determinations	O
of	O
nsp7	O
in	O
solution	O
at	O
pH	O
7	O
.	O
5	O
and	O
in	O
the	O
crystals	B-ANAT
of	O
a	O
hexadecameric	O
nsp7	O
/	O
nsp8	O
complex	O
obtained	O
from	O
a	O
solution	O
at	O
pH	O
7	O
.	O
5	O
.	O

ABSTRACT	O
:	O
Cimicifuga	O
rhizome	O
,	O
Meliae	O
cortex	B-ANAT
,	O
Coptidis	O
rhizome	O
and	O
Phellodendron	O
cortex	B-ANAT
have	O
been	O
previously	O
shown	O
to	O
exhibit	O
anti	O
-	O
coronavirus	O
activity	O
.	O

Acanthopanacis	O
cortex	B-ANAT
and	O
Torilis	O
fructus	O
might	O
exert	O
their	O
antiviral	O
activities	O
in	O
MHV	O
-	O
A59	O
-	O
infected	O
cells	B-ANAT
by	O
inducing	O
cyclooxygenase	O
-	O
2	O
expression	O
via	O
the	O
activation	O
of	O
extracellular	B-ANAT
signal	O
-	O
related	O
kinase	O
(	O
ERK	O
)	O
and	O
p38	O
or	O
ERK	O
alone	O
,	O
respectively	O
.	O

TITLE	O
:	O
Panton	O
-	O
Valentine	O
leukocidin	O
expressing	O
Staphylococcus	O
aureus	O
pneumonia	O
managed	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
:	O
experience	O
and	O
outcome	O
.	O

Little	O
information	O
is	O
available	O
on	O
the	O
management	O
of	O
patients	O
with	O
Panton	O
-	O
Valentine	O
leukocidin	O
expressing	O
S	O
.	O
aureus	O
pneumonia	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
support	O
.	O

Locally	O
held	O
register	O
of	O
all	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
patients	O
at	O
Glenfield	O
Hospital	O
.	O

On	O
review	O
of	O
our	O
database	O
held	O
from	O
September	O
1989	O
until	O
date	O
,	O
there	O
were	O
four	O
patients	O
with	O
sputum	B-ANAT
-	O
confirmed	O
Panton	O
-	O
Valentine	O
leukocidin	O
expressing	O
S	O
.	O
aureus	O
pneumonia	O
managed	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

RESULTS	O
:	O
Significantly	O
better	O
oxygenation	O
with	O
higher	O
PaO	O
(	O
2	O
)	O
and	O
alveolar	B-ANAT
-	O
arterial	B-ANAT
oxygen	O
difference	O
was	O
noted	O
in	O
the	O
Surf	O
and	O
Bude	O
+	O
Surf	O
groups	O
,	O
compared	O
with	O
the	O
control	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
),	O
but	O
there	O
were	O
no	O
significant	O
differences	O
between	O
the	O
Surf	O
and	O
Bude	O
+	O
Surf	O
groups	O
.	O

Patients	O
with	O
severe	O
acute	O
pancreatitis	O
and	O
abdominal	B-ANAT
compartment	I-ANAT
syndrome	O
managed	O
by	O
surgical	O
decompression	O
had	O
severe	O
multiple	O
-	O
organ	B-ANAT
dysfunction	O
syndrome	O
and	O
high	O
mortality	O
.	O

RESULTS	O
:	O
At	O
the	O
time	O
of	O
surgical	O
decompression	O
,	O
the	O
median	O
sequential	O
organ	B-ANAT
failure	O
assessment	O
score	O
among	O
patients	O
was	O
12	O
(	O
interquartile	O
range	O
,	O
10	O
-	O
15	O
),	O
and	O
the	O
median	O
intra	O
-	O
abdominal	B-ANAT
pressure	O
was	O
31	O
.	O
5	O
(	O
interquartile	O
range	O
,	O
27	O
-	O
35	O
)	O
mm	O
Hg	O
.	O

The	O
M	O
carboxy	O
-	O
terminal	O
endodomain	O
contains	O
a	O
conserved	O
domain	O
(	O
CD	O
)	O
following	O
the	O
third	O
transmembrane	B-ANAT
(	O
TM	O
)	O
domain	O
.	O

E121Q	O
and	O
E121L	O
M	O
proteins	O
were	O
capable	O
of	O
forming	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
(	O
VLPs	B-ANAT
)	O
when	O
coexpressed	O
with	O
E	O
,	O
whereas	O
E121R	O
and	O
E121K	O
proteins	O
were	O
not	O
.	O

N	O
protein	O
coexpression	O
with	O
some	O
M	O
mutants	O
increased	O
VLP	B-ANAT
production	O
.	O

The	O
results	O
overall	O
suggest	O
that	O
the	O
CD	O
is	O
important	O
for	O
formation	O
of	O
the	O
viral	B-ANAT
envelope	I-ANAT
by	O
helping	O
mediate	O
fundamental	O
M	O
-	O
M	O
interactions	O
and	O
that	O
the	O
presence	O
of	O
the	O
N	O
protein	O
may	O
help	O
stabilize	O
M	O
complexes	O
during	O
virus	O
assembly	O
.	O

RESULTS	O
:	O
Of	O
18	O
patients	O
admitted	O
,	O
6	O
were	O
treated	O
with	O
veno	O
-	O
venous	B-ANAT
and	O
3	O
with	O
veno	O
-	O
arterial	B-ANAT
ECMO	O
after	O
median	O
(	O
interquartile	O
,	O
IQR	O
)	O
duration	O
of	O
mechanical	O
ventilation	O
of	O
10	O
(	O
6	O
-	O
96	O
)	O
h	O
.	O
Six	O
ECMO	O
were	O
initiated	O
in	O
a	O
referral	O
hospital	O
by	O
a	O
mobile	O
team	O
,	O
a	O
median	O
(	O
IQR	O
)	O
of	O
3	O
(	O
2	O
-	O
4	O
)	O
h	O
after	O
phone	O
contact	O
.	O

The	O
assay	O
was	O
tested	O
in	O
75	O
bovine	O
feces	B-ANAT
samples	O
tested	O
previously	O
for	O
rotavirus	O
using	O
PAGE	O
and	O
for	O
BCoV	O
using	O
nested	O
RT	O
-	O
PCR	O
targeted	O
to	O
RdRp	O
gene	O
.	O

TITLE	O
:	O
Intra	O
-	O
abdominal	B-ANAT
vacuum	O
-	O
assisted	O
closure	O
(	O
VAC	O
)	O
after	O
necrosectomy	O
for	O
acute	O
necrotising	O
pancreatitis	O
:	O
preliminary	O
experience	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
is	O
a	O
virion	B-ANAT
structural	O
protein	O
.	O

TITLE	O
:	O
Murine	O
coronavirus	O
receptors	O
are	O
differentially	O
expressed	O
in	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
and	O
play	O
virus	O
strain	O
-	O
dependent	O
roles	O
in	O
neuronal	O
spread	O
.	O

Given	O
the	O
low	O
levels	O
of	O
neuronal	O
expression	O
of	O
ceacam1a	O
,	O
primary	O
neurons	B-ANAT
from	O
wild	O
-	O
type	O
and	O
ceacam1a	O
knockout	O
mice	O
were	O
inoculated	O
with	O
MHV	O
to	O
determine	O
the	O
extent	O
to	O
which	O
CEACAM1a	O
-	O
independent	O
infection	O
might	O
contribute	O
to	O
CNS	B-ANAT
infection	O
.	O

With	O
aggressive	O
hydration	O
her	O
renal	B-ANAT
function	O
remained	O
normal	O
throughout	O
the	O
entire	O
disease	O
course	O
,	O
and	O
she	O
steadily	O
improved	O
clinically	O
.	O

This	O
conference	O
report	O
highlights	O
selected	O
presentations	O
on	O
human	O
norovirus	O
(	O
HuNoV	O
),	O
SARS	O
coronavirus	O
and	O
Rift	O
Valley	O
fever	O
virus	O
vaccine	O
technologies	O
;	O
programmed	O
cell	B-ANAT
death	O
-	O
1	O
(	O
PD1	O
)	O
blockade	O
and	O
HyperAcute	O
alpha	O
-	O
Gal	O
platform	O
technology	O
methods	O
;	O
aerosol	O
vaccination	O
delivery	O
;	O
novel	O
technologies	O
to	O
produce	O
influenza	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
(	O
VLP	B-ANAT
)	O
in	O
mammalian	B-ANAT
cell	I-ANAT
lines	O
;	O
and	O
investigational	O
human	O
rotavirus	O
vaccines	O
.	O

TITLE	O
:	O
SARS	O
-	O
coronavirus	O
protein	O
6	O
conformations	O
required	O
to	O
impede	O
protein	O
import	O
into	O
the	O
nucleus	B-ANAT
.	O

Accessory	O
protein	O
6	O
is	O
a	O
63	O
-	O
residue	O
amphipathic	O
peptide	O
that	O
accelerates	O
coronavirus	O
infection	O
kinetics	O
in	O
cell	B-ANAT
culture	O
and	O
in	O
mice	O
.	O

Respiratory	O
symptoms	O
(	O
98	O
.	O
0	O
%),	O
including	O
cough	O
(	O
90	O
.	O
1	O
%),	O
were	O
the	O
most	O
frequently	O
reported	O
symptoms	O
,	O
followed	O
by	O
muscle	B-ANAT
aches	O
(	O
66	O
.	O
2	O
%),	O
fever	O
(	O
62	O
.	O
5	O
%),	O
headache	O
(	O
57	O
.	O
9	O
%),	O
diarrhea	O
(	O
16	O
.	O
5	O
%),	O
and	O
vomiting	O
(	O
9	O
.	O
8	O
%).	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
its	O
severe	O
form	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
are	O
the	O
most	O
common	O
complications	O
of	O
sepsis	O
,	O
and	O
the	O
mortality	O
of	O
sepsis	O
-	O
induced	O
ALI	O
remains	O
high	O
in	O
critically	O
ill	O
patients	O
.	O

We	O
thus	O
found	O
that	O
pretreatment	O
with	O
GHRP	O
-	O
2	O
markedly	O
suppressed	O
the	O
activation	O
of	O
NF	O
-	O
kappaB	O
in	O
lung	B-ANAT
tissues	I-ANAT
.	O

TITLE	O
:	O
Acute	O
lung	B-ANAT
injury	O
and	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
pathophysiology	O
and	O
treatment	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
represent	O
a	O
spectrum	O
of	O
acute	O
respiratory	O
failure	O
with	O
diffuse	O
,	O
bilateral	O
lung	B-ANAT
injury	O
and	O
severe	O
hypoxemia	O
caused	O
by	O
non	O
-	O
cardiogenic	O
pulmonary	B-ANAT
edema	O
.	O

Failure	O
may	O
be	O
initiated	O
by	O
pulmonary	B-ANAT
or	O
extrapulmonary	O
insults	O
(	O
e	O
.	O
g	O
.,	O
pneumonia	O
,	O
sepsis	O
,	O
trauma	O
,	O
aspiration	O
)	O
that	O
increase	O
alveolar	B-ANAT
epithelial	O
endothelial	B-ANAT
permeability	O
,	O
flood	O
alveoli	B-ANAT
,	O
and	O
reduce	O
lung	B-ANAT
compliance	O
.	O

The	O
only	O
treatment	O
proven	O
to	O
improve	O
survival	O
is	O
mechanical	O
ventilation	O
using	O
a	O
'	B-ANAT
lung	I-ANAT
protective	O
strategy	O
'	O
with	O
tidal	O
volume	O
=	O
6	O
mL	O
/	O
kg	O
predicted	O
body	B-ANAT
weight	O
.	O

CONCLUSIONS	O
:	O
The	O
similarity	O
between	O
the	O
clinical	O
features	O
of	O
the	O
case	O
we	O
present	O
and	O
those	O
reported	O
in	O
connection	O
to	O
abrupt	O
withdrawal	O
of	O
intrathecal	B-ANAT
baclofen	O
is	O
emphasized	O
.	O

The	O
diagnostic	O
criteria	O
include	O
:	O
acute	O
onset	O
,	O
severe	O
arterial	B-ANAT
hypoxemia	O
resistant	O
to	O
oxygen	O
therapy	O
alone	O
(	O
PaOâ	O
/	O
FIOâ	O
ratio	O
â¤	O
200	O
for	O
ARDS	O
and	O
â¤	O
300	O
for	O
ALI	O
),	O
diffuse	O
pulmonary	B-ANAT
inflammation	O
(	O
bilateral	O
infiltrates	O
on	O
chest	B-ANAT
radiograph	O
)	O
and	O
No	O
evidence	O
of	O
left	O
atrial	B-ANAT
hypertension	O
.	O

ABSTRACT	O
:	O
Several	O
important	O
viruses	O
including	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV	O
-	O
1	O
)	O
and	O
the	O
SARS	O
-	O
associated	O
Coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
employ	O
programmed	O
-	O
1	O
ribosomal	B-ANAT
frameshifting	O
(	O
PRF	O
)	O
for	O
their	O
protein	O
expression	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
the	O
extent	O
of	O
elimination	O
of	O
trimethoprim	O
(	O
TMP	O
)	O
and	O
sulfamethoxazole	O
(	O
SMX	O
)	O
via	O
continuous	O
venovenous	O
hemodiafiltration	O
(	O
CVVHDF	O
)	O
in	O
2	O
critically	O
ill	O
patients	O
with	O
renal	B-ANAT
failure	O
.	O

A	O
77	O
-	O
year	O
-	O
old	O
man	O
was	O
admitted	O
for	O
aortic	B-ANAT
root	I-ANAT
replacement	O
and	O
developed	O
septic	O
shock	O
and	O
nosocomial	O
pneumonia	O
due	O
to	O
Stenotrophomonas	O
maltophilia	O
.	O

However	O
,	O
the	O
replication	O
kinetics	O
of	O
MK	O
and	O
MK	O
-	O
p10	O
did	O
not	O
differ	O
from	O
each	O
other	O
in	O
the	O
brain	B-ANAT
and	O
in	O
cultured	B-ANAT
cells	I-ANAT
.	O

TITLE	O
:	O
[	O
Acute	O
respiratory	O
insufficiency	O
due	O
to	O
severe	O
lung	B-ANAT
injury	O
-	O
ARDS	O
and	O
ALI	O
].	O

In	O
this	O
study	O
,	O
the	O
avian	O
nucleolar	B-ANAT
proteome	O
was	O
defined	O
in	O
the	O
absence	O
and	O
presence	O
of	O
virus	O
,	O
in	O
this	O
case	O
the	O
positive	O
strand	O
RNA	O
virus	O
,	O
avian	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
.	O

TITLE	O
:	O
The	O
membrane	B-ANAT
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
acts	O
as	O
a	O
dominant	O
immunogen	O
revealed	O
by	O
a	O
clustering	O
region	O
of	O
novel	O
functionally	O
and	O
structurally	O
defined	O
cytotoxic	B-ANAT
T	I-ANAT
-	I-ANAT
lymphocyte	I-ANAT
epitopes	O
.	O

However	O
,	O
its	O
potential	O
roles	O
in	O
stimulating	O
cellular	B-ANAT
immunity	O
remain	O
elusive	O
.	O

Among	O
patients	O
who	O
developed	O
ALI	O
/	O
ARDS	O
,	O
there	O
was	O
no	O
evidence	O
to	O
support	O
a	O
difference	O
in	O
partial	O
pressure	O
of	O
oxygen	O
in	O
arterial	B-ANAT
blood	I-ANAT
to	O
fraction	O
of	O
inspired	O
oxygen	O
(	O
Pao	O
(	O
2	O
)/	O
Fio	O
(	O
2	O
))	O
(	O
P	O
=	O
.	O
33	O
),	O
lung	B-ANAT
injury	O
score	O
(	O
P	O
=	O
.	O
67	O
),	O
or	O
mortality	O
(	O
P	O
=	O
.	O
78	O
)	O
by	O
race	O
.	O

ABSTRACT	O
:	O
Antineutrophil	O
cytoplasmic	B-ANAT
antibody	O
-	O
associated	O
vasculitis	O
is	O
a	O
life	O
-	O
threatening	O
disorder	O
for	O
which	O
medical	O
therapy	O
has	O
greatly	O
improved	O
survival	O
.	O

Little	O
data	O
exists	O
on	O
the	O
utility	O
of	O
lung	B-ANAT
transplantation	O
for	O
patients	O
,	O
especially	O
with	O
an	O
acute	O
and	O
severe	O
form	O
of	O
this	O
disease	O
.	O

There	O
was	O
no	O
improvement	O
noted	O
in	O
pulmonary	B-ANAT
function	O
in	O
animals	O
that	O
received	O
a	O
higher	O
dose	O
of	O
tiotropium	O
bromide	O
.	O

Eligible	O
studies	O
were	O
published	O
between	O
1999	O
and	O
2009	O
and	O
assessed	O
quality	O
of	O
life	O
â¥	O
12	O
months	O
after	O
intensive	O
care	O
unit	O
discharge	B-ANAT
by	O
means	O
of	O
the	O
Medical	O
Outcomes	O
Study	O
36	O
-	O
Item	O
Short	O
Form	O
Health	O
Survey	O
,	O
the	O
RAND	O
36	O
-	O
Item	O
Health	O
Survey	O
,	O
EuroQol	O
-	O
5D	O
,	O
and	O
/	O
or	O
the	O
Nottingham	O
Health	O
Profile	O
in	O
adult	O
intensive	O
care	O
unit	O
patients	O
.	O

TITLE	O
:	O
Novel	O
immunodominant	O
peptide	O
presentation	O
strategy	O
:	O
a	O
featured	O
HLA	B-ANAT
-	O
A	O
*	O
2402	O
-	O
restricted	O
cytotoxic	B-ANAT
T	I-ANAT
-	I-ANAT
lymphocyte	I-ANAT
epitope	O
stabilized	O
by	O
intrachain	O
hydrogen	O
bonds	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
nucleocapsid	B-ANAT
protein	O
.	O

Here	O
,	O
a	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
-	O
derived	O
CTL	B-ANAT
epitope	O
,	O
N1	O
(	O
QFKDNVILL	O
),	O
restricted	O
by	O
HLA	B-ANAT
-	O
A	O
*	O
2402	O
was	O
identified	O
by	O
a	O
series	O
of	O
in	O
vitro	O
studies	O
,	O
including	O
a	O
computer	O
-	O
assisted	O
algorithm	O
for	O
prediction	O
,	O
stabilization	O
of	O
the	O
peptide	O
by	O
co	O
-	O
refolding	O
with	O
HLA	B-ANAT
-	O
A	O
*	O
2402	O
heavy	O
chain	O
and	O
Î²	O
(	O
2	O
)-	O
microglobulin	O
(	O
Î²	O
(	O
2	O
)	O
m	O
),	O
and	O
T2	O
-	O
A24	O
cell	B-ANAT
binding	O
.	O

This	O
may	O
contribute	O
to	O
the	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
receptor	O
(	O
TCR	B-ANAT
)	O
interaction	O
,	O
showing	O
a	O
host	O
immunodominant	O
peptide	O
presentation	O
strategy	O
.	O

Moreover	O
,	O
the	O
fusion	O
of	O
the	O
GM	O
-	O
CSF	B-ANAT
markedly	O
increased	O
spleen	B-ANAT
cell	B-ANAT
proliferation	O
and	O
IFN	O
-	O
Î³	O
production	O
while	O
mild	O
increased	O
in	O
IL	O
-	O
4	O
production	O
,	O
which	O
demonstrated	O
the	O
enhancement	O
of	O
cell	B-ANAT
-	O
mediated	O
immune	O
responses	O
.	O

We	O
identified	O
one	O
or	O
more	O
precipitating	O
factors	O
of	O
heart	B-ANAT
failure	O
decompensation	O
in	O
89	O
.	O
6	O
%	O
of	O
the	O
patients	O
.	O

The	O
variables	O
independently	O
associated	O
with	O
hospital	O
mortality	O
were	O
acute	O
renal	B-ANAT
failure	O
,	O
severe	O
hypoalbuminemia	O
,	O
systolic	O
blood	B-ANAT
pressure	O
<	O
110mmHg	O
,	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
count	O
>	O
10	O
.	O
000	O
per	O
mmÂ³	O
and	O
valvular	O
heart	B-ANAT
disease	O
.	O

TITLE	O
:	O
[	O
Expression	O
of	O
secretory	O
type	O
II	O
phospholipase	O
Aâ	O
in	O
acute	O
lung	B-ANAT
injury	O
following	O
acute	O
pancreatitis	O
and	O
interventional	O
effect	O
of	O
Qingyi	O
decoction	O
on	O
it	O
].	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
expression	O
of	O
secretory	O
type	O
II	O
phospholipase	O
A	O
(	O
2	O
)	O
(	O
sPLA	O
(	O
2	O
)-	O
II	O
)	O
in	O
lung	B-ANAT
of	O
rats	O
with	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
complicating	O
severe	O
acute	O
pancreatitis	O
(	O
SAP	O
),	O
and	O
the	O
effect	O
of	O
Qingyi	O
decoction	O
(	O
QYT	O
)	O
on	O
ALI	O
.	O

The	O
higher	O
expression	O
of	O
sPLA	O
(	O
2	O
)-	O
IIin	O
lung	B-ANAT
may	O
be	O
one	O
of	O
pathogenetic	O
factors	O
in	O
ALI	O
induced	O
by	O
SAP	O
.	O

RESULTS	O
:	O
Compared	O
with	O
SO	O
group	O
,	O
the	O
levels	O
of	O
arterial	B-ANAT
partial	O
pressure	O
of	O
oxygen	O
(	O
PaO	O
(	O
2	O
))	O
and	O
pH	O
value	O
in	O
model	O
group	O
were	O
significantly	O
decreased	O
[	O
PaO	O
(	O
2	O
)	O
(	O
mm	O
Hg	O
,	O
1	O
mm	O
Hg	O
=	O
0	O
.	O
133	O
kPa	O
):	O
79	O
.	O
24	O
Â±	O
5	O
.	O
84	O
vs	O
.	O
96	O
.	O
78	O
Â±	O
3	O
.	O
81	O
,	O
pH	O
value	O
:	O
7	O
.	O
269	O
Â±	O
0	O
.	O
054	O
vs	O
.	O
7	O
.	O
391	O
Â±	O
0	O
.	O
054	O
],	O
arterial	B-ANAT
partial	O
pressure	O
of	O
carbon	O
dioxide	O
(	O
PaCO	O
(	O
2	O
)),	O
the	O
serum	B-ANAT
levels	O
of	O
AMY	O
,	O
W	O
/	O
D	O
ratio	O
and	O
the	O
serum	B-ANAT
levels	O
of	O
sPLA	O
(	O
2	O
)	O
were	O
significantly	O
increased	O
[	O
PaCO	O
(	O
2	O
)	O
(	O
mm	O
Hg	O
):	O
47	O
.	O
57	O
Â±	O
2	O
.	O
55	O
vs	O
.	O
27	O
.	O
69	O
Â±	O
1	O
.	O
02	O
,	O
AMY	O
(	O
U	O
/	O
L	O
):	O
7	O
144	O
.	O
19	O
Â±	O
727	O
.	O
91	O
vs	O
.	O
1	O
193	O
.	O
41	O
Â±	O
192	O
.	O
54	O
,	O
W	O
/	O
D	O
ratio	O
:	O
8	O
.	O
57	O
Â±	O
2	O
.	O
45	O
vs	O
.	O
3	O
.	O
70	O
Â±	O
0	O
.	O
90	O
,	O
sPLA	O
(	O
2	O
)	O
(	O
nmol	O
Ã	O
min	O
(-	O
1	O
)	O
Ã	O
ml	O
(-	O
1	O
)):	O
45	O
.	O
13	O
Â±	O
6	O
.	O
05	O
vs	O
.	O
29	O
.	O
94	O
Â±	O
6	O
.	O
39	O
],	O
the	O
expression	O
of	O
sPLA	O
(	O
2	O
)-	O
II	O
mRNA	O
(	O
1	O
.	O
28	O
Â±	O
0	O
.	O
21	O
vs	O
.	O
0	O
.	O
80	O
Â±	O
0	O
.	O
08	O
)	O
and	O
protein	O
were	O
significantly	O
increased	O
(	O
all	O
P	O
<	O
0	O
.	O
05	O
).	O

In	O
the	O
case	O
of	O
the	O
Coronaviridae	O
this	O
family	O
is	O
now	O
recognized	O
as	O
including	O
potent	O
human	O
pathogens	O
causing	O
upper	O
and	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
as	O
well	O
as	O
nosocomial	O
ones	O
.	O

To	O
explore	O
the	O
link	O
between	O
coronavirus	O
infection	O
and	O
the	O
ubiquitin	O
system	O
,	O
we	O
asked	O
whether	O
protein	O
degradation	O
by	O
the	O
26S	B-ANAT
proteasome	I-ANAT
plays	O
a	O
role	O
in	O
severe	O
coronavirus	O
infections	O
using	O
a	O
murine	O
model	O
of	O
SARS	O
-	O
like	O
pneumonitis	O
induced	O
by	O
murine	O
hepatitis	O
virus	O
strain	O
1	O
(	O
MHV	O
-	O
1	O
).	O

TITLE	O
:	O
The	O
SARS	O
coronavirus	O
E	O
protein	O
interacts	O
with	O
PALS1	O
and	O
alters	O
tight	B-ANAT
junction	I-ANAT
formation	O
and	O
epithelial	O
morphogenesis	O
.	O

ABSTRACT	O
:	O
Intercellular	O
tight	B-ANAT
junctions	I-ANAT
define	O
epithelial	O
apicobasal	O
polarity	O
and	O
form	O
a	O
physical	O
fence	O
which	O
protects	O
underlying	O
tissues	B-ANAT
from	O
pathogen	O
invasions	O
.	O

A	O
T7	O
phage	O
display	O
cDNA	O
library	O
from	O
N2a	O
cells	B-ANAT
was	O
constructed	O
,	O
and	O
the	O
library	O
was	O
screened	O
with	O
the	O
soluble	O
PHE	O
-	O
CoV	O
S	O
glycoproteins	O
.	O

Potential	O
uses	O
in	O
respiratory	O
distress	O
syndrome	O
as	O
suggested	O
by	O
improved	O
lung	B-ANAT
function	O
in	O
primate	O
models	O
is	O
supported	O
by	O
the	O
decreased	O
time	O
on	O
mechanical	O
ventilation	O
and	O
need	O
for	O
oxygen	O
therapy	O
.	O

To	O
define	O
the	O
mechanisms	O
by	O
which	O
B7	O
-	O
H1	O
alters	O
pathogenic	O
outcome	O
,	O
virus	O
-	O
infected	O
B7	O
-	O
H1	O
-	O
deficient	O
(	O
B7	O
-	O
H1	O
(-/-))	O
mice	O
were	O
analyzed	O
for	O
altered	O
peripheral	O
and	O
CNS	B-ANAT
immune	O
responses	O
.	O

We	O
analyzed	O
,	O
in	O
ALI	O
/	O
ARDS	O
patients	O
,	O
plasma	B-ANAT
and	O
alveolar	B-ANAT
levels	O
of	O
sRAGE	O
over	O
time	O
and	O
the	O
association	O
with	O
severity	O
of	O
lung	B-ANAT
injury	O
.	O

Improvements	O
in	O
extracorporeal	O
circulation	O
devices	O
have	O
allowed	O
us	O
to	O
set	O
up	O
two	O
specialized	O
mobile	O
units	O
:	O
a	O
mobile	O
cardiac	B-ANAT
assistance	O
unit	O
(	O
MCAU	O
)	O
and	O
a	O
mobile	O
respiratory	O
assistance	O
unit	O
(	O
MRAU	O
).	O

ABSTRACT	O
:	O
The	O
immunogenicity	O
and	O
efficacy	O
of	O
Î²	O
-	O
propiolactone	O
(	O
BPL	O
)	O
inactivated	O
whole	O
virion	B-ANAT
SARS	O
-	O
CoV	O
(	O
WI	O
-	O
SARS	O
)	O
vaccine	O
was	O
evaluated	O
in	O
BALB	O
/	O
c	O
mice	O
and	O
golden	O
Syrian	O
hamsters	O
.	O

Enhanced	O
disease	O
was	O
not	O
observed	O
in	O
the	O
lungs	B-ANAT
or	O
liver	B-ANAT
of	O
hamsters	O
following	O
SARS	O
-	O
CoV	O
challenge	O
,	O
regardless	O
of	O
the	O
level	O
of	O
serum	B-ANAT
neutralizing	O
antibodies	O
.	O

Influenza	O
-	O
like	O
illness	O
(	O
fever	O
and	O
cough	O
or	O
sore	O
throat	B-ANAT
)	O
developed	O
in	O
29	O
%	O
(	O
95	O
%	O
CI	O
,	O
20	O
.	O
5	O
%-	O
36	O
.	O
7	O
%)	O
of	O
household	O
contacts	O
.	O

TITLE	O
:	O
Anti	O
-	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
activity	O
of	O
1	O
,	O
8	O
-	O
cineole	O
:	O
effect	O
on	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
.	O

Respondents	O
reported	O
use	O
of	O
noninvasive	O
positive	O
-	O
pressure	O
ventilation	O
for	O
acute	O
respiratory	O
failure	O
in	O
lower	O
airway	B-ANAT
disease	O
(	O
70	O
%),	O
asthma	O
(	O
51	O
%),	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
43	O
%),	O
and	O
upper	O
airway	B-ANAT
obstruction	O
(	O
31	O
%).	O

The	O
patient	O
group	O
had	O
a	O
period	O
of	O
standardised	O
chest	B-ANAT
physiotherapy	O
treatment	O
.	O

Five	O
main	O
issues	O
are	O
common	O
to	O
mass	O
decontamination	O
events	O
:	O
(	O
i	O
)	O
perception	O
,	O
(	O
ii	O
)	O
somatisation	O
,	O
(	O
iii	O
)	O
media	B-ANAT
role	O
and	O
communication	O
,	O
(	O
iv	O
)	O
information	O
sharing	O
,	O
(	O
v	O
)	O
behavioural	O
guidance	O
and	O
(	O
vi	O
)	O
organisational	O
issues	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	O
small	O
envelope	B-ANAT
(	O
E	O
)	O
protein	O
plays	O
a	O
crucial	O
,	O
but	O
poorly	O
defined	O
,	O
role	O
in	O
the	O
assembly	O
of	O
virions	B-ANAT
.	O

To	O
investigate	O
E	O
protein	O
function	O
,	O
we	O
previously	O
generated	O
E	O
gene	O
point	O
mutants	O
of	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
that	O
were	O
defective	O
in	O
growth	O
and	O
assembled	O
virions	B-ANAT
with	O
anomalous	O
morphologies	O
.	O

To	O
test	O
this	O
,	O
the	O
TMPRSS2	O
and	O
S	O
proteins	O
were	O
expressed	O
in	O
cells	B-ANAT
labeled	O
with	O
fluorescent	O
probes	O
of	O
different	O
colors	O
,	O
and	O
the	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
between	O
these	O
cells	B-ANAT
was	O
tested	O
.	O

Our	O
findings	O
suggest	O
that	O
the	O
TMPRSS2	O
expressed	O
in	O
lung	B-ANAT
tissues	I-ANAT
may	O
be	O
a	O
determinant	O
of	O
viral	O
tropism	O
and	O
pathogenicity	O
at	O
the	O
initial	O
site	O
of	O
SARS	O
-	O
CoV	O
infection	O
.	O

To	O
assess	O
the	O
virome	O
of	O
North	O
American	O
bats	O
,	O
we	O
collected	O
fecal	B-ANAT
,	O
oral	B-ANAT
,	O
urine	B-ANAT
,	O
and	O
tissue	B-ANAT
samples	O
from	O
individual	O
bats	O
captured	O
at	O
an	O
abandoned	O
railroad	O
tunnel	O
in	O
Maryland	O
that	O
is	O
cohabitated	O
by	O
7	O
to	O
10	O
different	O
bat	O
species	O
.	O

The	O
acute	O
physiology	O
and	O
chronic	O
health	O
evaluation	O
II	O
(	O
APACHE	O
II	O
)	O
score	O
,	O
ECMO	O
flow	O
,	O
and	O
respiratory	O
parameters	O
,	O
such	O
as	O
PaO2	O
/	O
FiO2	O
(	O
P	O
/	O
F	O
ratio	O
),	O
pulmonary	B-ANAT
compliance	O
,	O
and	O
Lung	B-ANAT
Injury	O
Score	O
(	O
LIS	O
)	O
before	O
and	O
after	O
the	O
introduction	O
of	O
ECMO	O
,	O
were	O
compared	O
among	O
patients	O
in	O
whom	O
ECMO	O
could	O
or	O
could	O
not	O
be	O
removed	O
.	O

ARDS	O
is	O
caused	O
by	O
protein	O
-	O
rich	O
pulmonary	B-ANAT
edema	O
that	O
causes	O
severe	O
hypoxemia	O
and	O
impaired	O
carbon	O
dioxide	O
excretion	O
.	O

The	O
lung	B-ANAT
injury	O
is	O
caused	O
primarily	O
by	O
neutrophil	B-ANAT
-	O
dependent	O
and	O
platelet	B-ANAT
-	O
dependent	O
damage	O
to	O
the	O
endothelial	B-ANAT
and	O
epithelial	O
barriers	O
of	O
the	O
lung	B-ANAT
.	O

However	O
,	O
there	O
is	O
no	O
effective	O
pharmacologic	O
therapy	O
,	O
although	O
cell	B-ANAT
-	O
based	O
therapy	O
and	O
other	O
therapies	O
currently	O
being	O
tested	O
in	O
clinical	O
trials	O
may	O
provide	O
novel	O
treatments	O
for	O
ARDS	O
.	O

Consecutive	O
adult	O
patients	O
(	O
n	O
=	O
502	O
)	O
who	O
underwent	O
cardiac	B-ANAT
surgery	O
with	O
cardiopulmonary	B-ANAT
bypass	O
were	O
eligible	O
;	O
analysis	O
was	O
by	O
intention	O
-	O
to	O
-	O
treat	O
.	O

Patients	O
were	O
randomly	O
assigned	O
to	O
a	O
liberal	O
strategy	O
of	O
blood	B-ANAT
transfusion	O
(	O
to	O
maintain	O
a	O
hematocrit	O
â¥	O
30	O
%)	O
or	O
to	O
a	O
restrictive	O
strategy	O
(	O
hematocrit	O
â¥	O
24	O
%).	O

A	O
total	O
of	O
198	O
of	O
253	O
patients	O
(	O
78	O
%)	O
in	O
the	O
liberal	O
-	O
strategy	O
group	O
and	O
118	O
of	O
249	O
(	O
47	O
%)	O
in	O
the	O
restrictive	O
-	O
strategy	O
group	O
received	O
a	O
blood	B-ANAT
transfusion	O
(	O
P	O
<	O
.	O
001	O
).	O

TITLE	O
:	O
Prevalence	O
of	O
antibodies	O
to	O
four	O
human	O
coronaviruses	O
is	O
lower	O
in	O
nasal	B-ANAT
secretions	B-ANAT
than	O
in	O
serum	B-ANAT
.	O

Frequent	O
high	O
titer	O
antibodies	O
were	O
detected	O
against	O
a	O
spectrum	O
of	O
autoantigens	O
including	O
potassium	O
channel	O
regulator	O
,	O
gastric	B-ANAT
ATPase	O
,	O
glutamic	O
decarboxylase	O
-	O
65	O
and	O
several	O
cytokines	O
.	O

Though	O
S	O
protein	O
was	O
not	O
solubilized	O
by	O
cold	O
non	O
-	O
ionic	O
detergents	O
,	O
this	O
behavior	O
was	O
unchanged	O
when	O
cholesterol	O
was	O
depleted	O
from	O
viral	B-ANAT
membrane	I-ANAT
by	O
methyl	O
-	O
Î²	O
-	O
cyclodextrin	O
(	O
MÎ²CD	O
)	O
and	O
the	O
protein	O
did	O
not	O
comigrate	O
with	O
cellular	B-ANAT
DRM	O
marker	O
proteins	O
in	O
flotation	O
analyses	O
.	O

The	O
recombinant	O
plasmid	O
of	O
pTRE	O
-	O
Tight	O
-	O
SARS	O
-	O
N	O
was	O
constructed	O
by	O
using	O
the	O
plasmid	O
p8S	O
as	O
the	O
PCR	O
template	O
which	O
contains	O
a	O
cDNA	O
clone	O
covering	O
the	O
nucleocapsid	B-ANAT
gene	O
of	O
SARS	O
-	O
CoV	O
HKU	O
-	O
39449	O
.	O

Restriction	O
enzymes	O
digestion	O
and	O
sequence	O
analysis	O
indicated	O
the	O
recombinant	O
plasmid	O
of	O
pTRE	O
-	O
Tight	O
-	O
SARS	O
-	O
N	O
contained	O
the	O
nucleocapsid	B-ANAT
gene	O
with	O
the	O
optimized	O
nucleotide	O
sequence	O
which	O
will	O
improve	O
the	O
translation	O
efficiency	O
.	O

TITLE	O
:	O
Cxcl16	O
interact	O
with	O
SARS	O
-	O
CoV	O
N	O
protein	O
in	O
and	O
out	O
cell	B-ANAT
.	O

The	O
eukaryotic	O
expression	O
vectors	O
pEGFP	O
-	O
N1	O
/	O
SARS	O
-	O
CoVN	O
and	O
pdsRed2	O
-	O
N1	O
/	O
CXCL16	O
were	O
constructed	O
and	O
used	O
to	O
co	O
-	O
transfect	O
HEK293FT	O
cells	B-ANAT
by	O
the	O
calcium	O
phosphate	O
method	O
.	O

Cranial	B-ANAT
CT	O
and	O
MRI	O
were	O
performed	O
for	O
8	O
patients	O
who	O
had	O
neurological	O
symptoms	O
.	O

Until	O
February	O
1	O
,	O
2010	O
,	O
a	O
total	O
of	O
47	O
cases	O
of	O
influenza	O
A	O
(	O
Inf	O
A	O
)	O
were	O
recorded	O
by	O
the	O
Spanish	O
Society	O
of	O
Nephrology	O
in	O
kidney	B-ANAT
transplant	I-ANAT
recipients	O
.	O

A	O
38	O
-	O
year	O
-	O
old	O
woman	O
with	O
chronic	O
renal	B-ANAT
failure	O
(	O
CRF	O
)	O
of	O
undetermined	O
etiology	O
received	O
a	O
kidney	B-ANAT
transplant	I-ANAT
9	O
months	O
previously	O
.	O

From	O
the	O
consideration	O
of	O
respiratory	O
and	O
renal	B-ANAT
situations	O
,	O
their	O
courses	O
were	O
satisfactory	O
.	O

Antimalarial	O
treatment	O
was	O
continued	O
for	O
a	O
total	O
of	O
7	O
days	O
followed	O
by	O
primaquine	O
for	O
14	O
days	O
once	O
the	O
blood	B-ANAT
smear	O
results	O
revealed	O
Plasmodium	O
ovale	O
infection	O
.	O

The	O
patient	O
remained	O
intubated	O
in	O
the	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
for	O
16	O
days	O
,	O
and	O
was	O
later	O
extubated	O
successfully	O
with	O
a	O
clear	O
chest	B-ANAT
x	O
-	O
ray	O
after	O
a	O
total	O
of	O
one	O
month	O
hospitalization	O
.	O

However	O
,	O
non	O
-	O
protein	O
-	O
coding	O
RNAs	O
(	O
ncRNAs	O
)	O
are	O
transcribed	O
in	O
mammalian	O
cells	B-ANAT
,	O
and	O
the	O
roles	O
of	O
many	O
of	O
these	O
ncRNAs	O
remain	O
enigmas	O
.	O

However	O
,	O
in	O
many	O
patients	O
with	O
severe	O
ARDS	O
it	O
can	O
be	O
difficult	O
to	O
achieve	O
a	O
balance	O
between	O
maintaining	O
adequate	O
tissue	B-ANAT
oxygenation	O
and	O
avoiding	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
(	O
VILI	O
).	O

A	O
potential	O
strategy	O
for	O
the	O
management	O
of	O
such	O
patients	O
involves	O
goal	O
-	O
oriented	O
manipulation	O
of	O
cardiac	B-ANAT
output	O
and	O
,	O
if	O
necessary	O
,	O
hemoglobin	O
concentration	O
,	O
to	O
compensate	O
for	O
hypoxemia	O
and	O
maintain	O
a	O
normal	O
(	O
but	O
not	O
supranormal	O
)	O
value	O
of	O
oxygen	O
delivery	O
.	O

ABSTRACT	O
:	O
Severe	O
leptospirosis	O
usually	O
associates	O
shock	O
,	O
jaundice	O
,	O
renal	B-ANAT
failure	O
,	O
and	O
thrombocytopenia	O
.	O

Massive	O
hemoptysis	O
due	O
to	O
diffuse	O
alveolar	B-ANAT
haemorrhage	O
may	O
rarely	O
occur	O
leading	O
to	O
an	O
acute	O
respiratory	O
failure	O
and	O
multiple	O
organ	B-ANAT
failure	O
.	O

ABSTRACT	O
:	O
Infection	O
of	O
mouse	O
oligodendrocytes	B-ANAT
with	O
a	O
recombinant	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
expressing	O
a	O
green	O
fluorescence	O
protein	O
facilitated	O
specific	O
selection	O
of	O
virus	O
-	O
infected	O
cells	B-ANAT
and	O
subsequent	O
establishment	O
of	O
persistence	O
.	O

TITLE	O
:	O
Significance	O
of	O
elevated	O
cardiac	B-ANAT
troponin	O
T	O
levels	O
in	O
critically	O
ill	O
patients	O
with	O
acute	O
respiratory	O
disease	O
.	O

Moreover	O
,	O
ISG20	O
demonstrated	O
cell	B-ANAT
-	O
type	O
specific	O
antiviral	O
activity	O
against	O
yellow	O
fever	O
virus	O
,	O
a	O
classical	O
flavivirus	O
.	O

Therefore	O
,	O
IHC	O
can	O
effectively	O
serve	O
as	O
a	O
competent	O
screening	O
technique	O
for	O
those	O
disease	O
surveillance	O
agencies	O
that	O
lack	O
expensive	O
RT	O
-	O
PCR	O
technology	O
while	O
promoting	O
safer	O
biohazardous	O
conditions	O
,	O
except	O
at	O
the	O
initial	O
stage	O
of	O
tissue	B-ANAT
collection	O
.	O

Unlike	O
the	O
nsp1	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
,	O
a	O
betacoronavirus	O
,	O
the	O
TGEV	O
nsp1	O
protein	O
was	O
unable	O
to	O
bind	O
40S	B-ANAT
ribosomal	I-ANAT
subunits	I-ANAT
or	O
promote	O
host	O
mRNA	O
degradation	O
.	O

The	O
mutant	O
virus	O
,	O
IBV	O
-	O
EG3	O
,	O
was	O
defective	O
in	O
release	O
of	O
infectious	O
virus	B-ANAT
particles	I-ANAT
.	O

Surprisingly	O
,	O
we	O
found	O
that	O
IBV	O
E	O
,	O
but	O
not	O
EG3	O
,	O
dramatically	O
reduced	O
the	O
delivery	O
of	O
cargo	O
to	O
the	O
plasma	B-ANAT
membrane	I-ANAT
by	O
impeding	O
movement	O
through	O
the	O
Golgi	B-ANAT
complex	I-ANAT
.	O

Furthermore	O
,	O
we	O
observed	O
that	O
overexpression	O
of	O
IBV	O
E	O
,	O
but	O
not	O
EG3	O
,	O
induced	O
the	O
disassembly	O
of	O
the	O
Golgi	B-ANAT
complex	I-ANAT
.	O

Neutrophil	B-ANAT
counts	O
were	O
less	O
than	O
0	O
.	O
5	O
Ã	O
10	O
(	O
9	O
)/	O
L	O
in	O
all	O
4	O
patients	O
.	O

Fungi	O
were	O
found	O
in	O
2	O
of	O
20	O
sputum	B-ANAT
cultures	O
in	O
2	O
patients	O
and	O
these	O
2	O
patients	O
had	O
been	O
considered	O
as	O
having	O
fungal	O
pneumonias	O
.	O

ABSTRACT	O
:	O
We	O
have	O
described	O
occurrence	O
and	O
clinical	O
manifestations	O
of	O
human	O
coronaviruses	O
(	O
HCoV	O
)	O
in	O
hospitalized	O
Norwegian	O
children	O
with	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
(	O
RTI	O
)	O
and	O
compared	O
them	O
with	O
a	O
group	O
of	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
)-	O
infected	O
children	O
.	O

PTX3	O
expression	O
is	O
increased	O
in	O
animals	O
with	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
in	O
patients	O
with	O
sepsis	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
is	O
considered	O
to	O
be	O
a	O
potential	O
biomarker	O
for	O
these	O
diseases	O
.	O

Our	O
data	O
suggest	O
that	O
the	O
endogenously	O
expressed	O
PTX3	O
plays	O
a	O
protective	O
role	O
in	O
the	O
pathogenesis	O
of	O
ALI	O
and	O
that	O
a	O
lack	O
of	O
PTX3	O
may	O
enhance	O
neutrophil	B-ANAT
recruitment	O
,	O
cell	B-ANAT
death	O
,	O
activation	O
of	O
coagulation	O
cascades	O
,	O
and	O
inflammatory	O
responses	O
in	O
the	O
lung	B-ANAT
.	O

In	O
addition	O
,	O
JHM	O
.	O
SD	O
induces	O
only	O
a	O
minimal	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
response	O
,	O
whereas	O
the	O
strong	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
response	O
and	O
the	O
concomitant	O
interferon	O
-	O
Î³	O
(	O
IFN	O
-	O
Î³	O
)	O
induced	O
by	O
the	O
less	O
neurovirulent	O
A59	O
is	O
protective	O
.	O

The	O
objective	O
of	O
this	O
study	O
,	O
therefore	O
,	O
was	O
to	O
analyze	O
perioperative	O
demographics	O
and	O
pulmonary	B-ANAT
outcomes	O
of	O
patients	O
with	O
SA	O
after	O
orthopedic	O
and	O
general	O
surgical	O
procedures	O
using	O
a	O
population	O
-	O
based	O
sample	O
.	O

CONCLUSIONS	O
:	O
SA	O
is	O
an	O
independent	O
risk	O
factor	O
for	O
perioperative	O
pulmonary	B-ANAT
complications	O
.	O

The	O
described	O
assay	O
could	O
detect	O
up	O
to	O
3	O
ng	O
/	O
ml	O
of	O
N	O
protein	O
and	O
50	O
50	O
%	O
tissue	B-ANAT
culture	O
infective	O
doses	O
/	O
ml	O
of	O
virus	O
stock	O
.	O

Oleic	O
acid	O
was	O
injected	O
into	O
the	O
pulmonary	B-ANAT
circulation	O
until	O
PaO2	O
:	O
FiO2	O
â¤	O
60	O
mm	O
Hg	O
,	O
followed	O
by	O
transition	O
to	O
a	O
protective	O
CMV	O
protocol	O
(	O
n	O
=	O
5	O
)	O
or	O
TLV	O
(	O
n	O
=	O
5	O
)	O
for	O
24	O
hours	O
.	O

Usually	O
,	O
immediate	O
diagnosis	O
of	O
such	O
a	O
condition	O
with	O
MRI	O
is	O
not	O
possible	O
in	O
hospitals	O
in	O
the	O
Coastal	O
border	B-ANAT
.	O

USA	O
,	O
nationwide	O
hospital	O
discharge	B-ANAT
data	O
.	O

In	O
2004	O
-	O
2006	O
,	O
64	O
.	O
5	O
%	O
of	O
the	O
cases	O
of	O
acute	O
myocardial	O
infarction	O
,	O
57	O
.	O
5	O
%	O
of	O
the	O
instances	O
of	O
cardiac	B-ANAT
arrest	O
/	O
ventricular	B-ANAT
fibrillation	O
,	O
27	O
.	O
8	O
%	O
of	O
in	O
-	O
hospital	O
mortality	O
and	O
26	O
.	O
0	O
%	O
of	O
the	O
cases	O
of	O
adult	O
respiratory	O
distress	O
syndrome	O
were	O
associated	O
with	O
hospitalisations	O
with	O
chronic	O
heart	B-ANAT
disease	O
.	O

The	O
blood	B-ANAT
test	O
for	O
TORCH	O
complex	O
and	O
various	O
metabolic	O
tests	O
of	O
blood	B-ANAT
and	O
urine	B-ANAT
specimens	O
yielded	O
unremarkable	O
results	O
.	O

The	O
acute	O
phase	O
of	O
Fisher	O
syndrome	O
should	O
be	O
carefully	O
observed	O
to	O
see	O
if	O
it	O
occurs	O
concomitantly	O
with	O
Guillain	O
-	O
BarrÃ©	O
syndrome	O
or	O
if	O
there	O
is	O
development	O
to	O
Bickerstaff	O
brainstem	B-ANAT
encephalitis	O
,	O
as	O
these	O
require	O
specific	O
immune	O
treatments	O
.	O

To	O
accelerate	O
the	O
start	O
of	O
recovery	O
,	O
IVIg	O
can	O
be	O
given	O
,	O
but	O
it	O
is	O
important	O
to	O
first	O
obtain	O
informed	O
consent	O
from	O
patients	O
after	O
the	O
potential	O
risks	O
of	O
blood	B-ANAT
products	O
are	O
explained	O
.	O

ABSTRACT	O
:	O
We	O
developed	O
a	O
two	O
-	O
layer	B-ANAT
,	O
four	O
-	O
channel	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)-	O
capillary	B-ANAT
electrophoresis	O
microdevice	O
that	O
integrates	O
nucleic	B-ANAT
acid	O
amplification	O
,	O
sample	O
cleanup	O
and	O
concentration	O
,	O
capillary	B-ANAT
electrophoretic	O
separation	O
,	O
and	O
detection	O
for	O
multiplex	O
analysis	O
of	O
four	O
human	O
respiratory	O
viral	O
pathogens	O
,	O
influenza	O
A	O
,	O
influenza	O
B	O
,	O
coronavirus	O
OC43	O
,	O
and	O
human	O
metapneumovirus	O
.	O

Enterococcus	O
and	O
C	O
.	O
albicans	O
were	O
the	O
main	O
isolated	O
microorganisms	O
in	O
the	O
bile	B-ANAT
.	O

In	O
this	O
experimental	O
and	O
clinical	O
study	O
of	O
ALI	O
/	O
ARDS	O
,	O
the	O
activity	O
of	O
NEP	O
was	O
significantly	O
decreased	O
in	O
plasma	B-ANAT
and	O
increased	O
in	O
the	O
alveolar	B-ANAT
air	I-ANAT
space	O
.	O

CONCLUSIONS	O
:	O
In	O
this	O
experimental	O
and	O
clinical	O
study	O
of	O
ALI	O
/	O
ARDS	O
,	O
the	O
activity	O
of	O
NEP	O
was	O
significantly	O
decreased	O
in	O
plasma	B-ANAT
and	O
increased	O
in	O
the	O
alveolar	B-ANAT
air	I-ANAT
space	O
.	O

TITLE	O
:	O
Bedside	O
lung	B-ANAT
mechanics	O
predict	O
survival	O
in	O
hypoplastic	O
lung	B-ANAT
disease	O
.	O

All	O
other	O
measures	O
of	O
lung	B-ANAT
capacity	O
or	O
blood	B-ANAT
gas	O
assessments	O
were	O
less	O
valuable	O
than	O
V	O
(	O
T	O
)	O
in	O
predicting	O
survival	O
.	O

Treatment	O
of	O
potentially	O
reversible	O
causes	O
:	O
"("""	O
4	O
Hs	O
and	O
4	O
Ts	O
""")"	O
hypoxia	O
and	O
hypovolaemia	O
,	O
hypokalaemia	O
and	O
hyperkalaemia	O
,	O
hypothermia	O
,	O
and	O
tension	O
pneumothorax	O
,	O
tamponade	O
,	O
toxic	O
/	O
therapeutic	O
disturbances	O
,	O
thrombosis	O
(	O
coronary	B-ANAT
/	O
pulmonary	B-ANAT
).	O

Prediction	O
of	O
CPR	O
outcome	O
is	O
not	O
possible	O
at	O
the	O
scene	O
,	O
determine	O
neurological	O
outcome	O
<	O
72	O
h	O
after	O
cardiac	B-ANAT
arrest	O
with	O
somatosensory	O
evoked	O
potentials	O
,	O
biochemical	O
tests	O
and	O
neurological	O
examination	O
.	O

We	O
advocate	O
careful	O
cardiac	B-ANAT
monitoring	O
of	O
myasthenia	O
gravis	O
patients	O
during	O
acute	O
emotional	O
or	O
physical	O
stress	O
,	O
as	O
there	O
is	O
potential	O
risk	O
of	O
developing	O
takotsubo	O
cardiomyopathy	O
.	O

Determination	O
of	O
vanadium	O
concentration	O
in	O
blood	B-ANAT
was	O
carried	O
out	O
by	O
means	O
of	O
mass	O
spectrometer	O
(	O
ICP	O
-	O
MS	O
)	O
using	O
rhodium	O
((	O
103	O
)	O
Rh	O
)	O
as	O
the	O
internal	O
standard	O
.	O

Particularly	O
as	O
a	O
disinfection	O
technology	O
,	O
electrical	O
discharge	B-ANAT
processes	O
do	O
not	O
produce	O
toxic	O
byproducts	O
,	O
and	O
effectively	O
inactivate	O
a	O
wide	O
spectrum	O
of	O
microorganisms	O
by	O
multiple	O
lethal	O
actions	O
generated	O
by	O
the	O
formation	O
of	O
plasma	B-ANAT
channels	O
.	O

The	O
shockwave	O
generated	O
upon	O
plasma	B-ANAT
channel	O
formation	O
appears	O
to	O
be	O
the	O
most	O
important	O
factor	O
responsible	O
for	O
MS2	O
phage	O
inactivation	O
.	O

-	O
433	O
patients	O
were	O
consulted	O
by	O
a	O
general	O
practitioner	O
and	O
reported	O
symptoms	O
of	O
an	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
,	O
128	O
(	O
30	O
%)	O
of	O
them	O
met	O
inclusion	O
criteria	O
for	O
ILI	O
and	O
were	O
tested	O
with	O
RIDT	O
:	O
31	O
children	O
younger	O
than	O
14	O
years	O
and	O
97	O
adults	O
.	O

Exposure	O
to	O
inhaled	O
toxic	O
chemicals	O
can	O
result	O
in	O
an	O
acute	O
lung	B-ANAT
injury	O
,	O
and	O
in	O
severe	O
cases	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
for	O
which	O
there	O
is	O
currently	O
no	O
specific	O
medical	O
therapy	O
,	O
treatment	O
remaining	O
largely	O
supportive	O
.	O

This	O
article	O
reviews	O
data	O
used	O
to	O
derive	O
potential	O
clinical	O
management	O
strategies	O
for	O
chemically	O
induced	O
lung	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
Despite	O
improvements	O
in	O
outcome	O
due	O
to	O
lung	B-ANAT
protective	O
ventilation	O
strategies	O
using	O
low	O
tidal	O
volumes	O
,	O
the	O
mortality	O
rate	O
from	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
remains	O
unacceptably	O
high	O
,	O
ranging	O
from	O
34	O
to	O
64	O
%.	O

Treatment	O
of	O
severely	O
hypoxemic	O
patients	O
should	O
aim	O
to	O
improve	O
oxygenation	O
while	O
limiting	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

The	O
etiologic	O
agent	O
was	O
then	O
identified	O
as	O
a	O
novel	O
H1N1	O
influenza	O
A	O
virus	O
,	O
which	O
subsequent	O
spread	O
rapidly	O
throughout	O
the	O
globe	B-ANAT
.	O

These	O
two	O
patients	O
were	O
male	O
with	O
at	O
least	O
one	O
known	O
risk	O
factor	O
for	O
severe	O
S	O
-	O
OIV	O
infection	O
(	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
COPD	O
)	O
and	O
morbid	O
obesity	O
,	O
respectively	O
);	O
the	O
COPD	O
patient	O
developed	O
an	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
nucleocapsid	B-ANAT
antibody	O
titer	O
was	O
between	O
1	O
/	O
156	O
and	O
1	O
/	O
210	O
in	O
3	O
cases	O
,	O
and	O
2	O
cases	O
were	O
normal	O
.	O

CONCLUSIONS	O
:	O
By	O
testing	O
the	O
special	O
IgG	O
,	O
IgM	O
,	O
nucleocapsid	B-ANAT
antibody	O
to	O
SARS	O
-	O
CoV	O
of	O
the	O
14	O
family	O
clustering	O
cases	O
,	O
we	O
found	O
that	O
they	O
all	O
decreased	O
in	O
the	O
7	O
(	O
th	O
)	O
year	O
,	O
and	O
most	O
of	O
them	O
disappeared	O
.	O

The	O
RBCs	B-ANAT
were	O
then	O
washed	O
before	O
being	O
readministered	O
to	O
the	O
patient	O
.	O

Furthermore	O
,	O
promising	O
results	O
on	O
the	O
prevention	O
of	O
the	O
occurrence	O
of	O
severe	O
acute	O
respiratory	O
failure	O
have	O
been	O
provided	O
by	O
clinical	O
studies	O
on	O
the	O
noninvasive	O
application	O
of	O
continuous	O
positive	O
airway	B-ANAT
pressure	O
as	O
well	O
as	O
by	O
experimental	O
investigations	O
in	O
basic	O
science	O
.	O

The	O
clinical	O
presentations	O
of	O
HCoV	O
-	O
HKU1	O
positive	O
children	O
included	O
fever	O
,	O
cough	O
,	O
sputum	B-ANAT
production	O
,	O
diarrhea	O
,	O
vomiting	O
;	O
pharynx	B-ANAT
engorgement	O
,	O
crackles	O
,	O
and	O
wheezing	O
.	O

To	O
evaluate	O
the	O
prevalence	O
and	O
clinical	O
presentations	O
of	O
HKU1	O
and	O
NL63	O
in	O
adults	O
with	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
,	O
an	O
investigation	O
of	O
HCoV	O
infections	O
in	O
Beijing	O
,	O
China	O
from	O
2005	O
to	O
2009	O
was	O
performed	O
by	O
using	O
reverse	O
transcriptase	O
PCR	O
assays	O
and	O
sequencing	O
analysis	O
.	O

Comparison	O
of	O
the	O
protein	O
profiles	O
of	O
Golgi	B-ANAT
-	O
enriched	O
fractions	O
of	O
cells	B-ANAT
that	O
were	O
either	O
mock	O
infected	O
or	O
infected	O
with	O
mouse	O
hepatitis	O
virus	O
revealed	O
the	O
significant	O
depletion	O
or	O
enrichment	O
of	O
116	O
proteins	O
.	O

In	O
ten	O
healthy	O
individuals	O
,	O
we	O
also	O
explored	O
the	O
minimal	O
cross	O
-	O
sectional	O
area	O
of	O
the	O
oropharyngeal	B-ANAT
duct	B-ANAT
with	O
the	O
acoustic	O
reflection	O
technique	O
;	O
it	O
was	O
found	O
identical	O
in	O
supine	O
and	O
PP	O
.	O

Sequence	O
analysis	O
and	O
BLAST	B-ANAT
homology	O
search	O
in	O
GenBank	O
data	O
base	O
indicate	O
that	O
two	O
of	O
the	O
farms	O
were	O
infected	O
with	O
the	O
4	O
/	O
91	O
strain	O
,	O
one	O
with	O
an	O
unidentified	O
IBV	O
and	O
five	O
were	O
infected	O
with	O
Sul	O
/	O
01	O
/	O
09	O
.	O

TITLE	O
:	O
Screening	O
and	O
identification	O
of	O
T	O
helper	O
1	O
and	O
linear	O
immunodominant	O
antibody	O
-	O
binding	O
epitopes	O
in	O
the	O
spike	O
2	O
domain	O
and	O
the	O
nucleocapsid	B-ANAT
protein	O
of	O
feline	O
infectious	O
peritonitis	O
virus	O
.	O

The	O
most	O
N	O
-	O
terminal	O
portion	O
of	O
the	O
S1	O
region	O
,	O
which	O
comprises	O
antigenic	O
sites	O
C	O
and	O
B	O
,	O
is	O
needed	O
for	O
the	O
enteric	O
tropism	O
of	O
TGEV	O
,	O
whereas	O
the	O
major	O
antigenic	O
site	O
A	O
at	O
the	O
C	O
-	O
terminal	O
moiety	O
is	O
required	O
for	O
both	O
respiratory	O
and	O
enteric	O
cell	B-ANAT
tropism	O
,	O
and	O
is	O
engaged	O
in	O
recognition	O
of	O
the	O
aminopeptidase	O
N	O
(	O
APN	O
)	O
receptor	O
.	O

Infection	O
with	O
novel	O
(	O
swine	O
origin	O
)	O
influenza	O
A	O
/	O
H1N1	O
was	O
confirmed	O
by	O
PCR	O
analysis	O
of	O
blood	B-ANAT
as	O
well	O
as	O
myocardial	B-ANAT
tissue	I-ANAT
.	O

Influenza	O
-	O
caused	O
diarrhea	O
with	O
consecutive	O
hypokalemia	O
potentially	O
contributed	O
to	O
the	O
fatal	O
outcome	O
of	O
the	O
myocarditis	O
,	O
characterized	O
by	O
ventricular	B-ANAT
fibrillation	O
.	O

Twenty	O
-	O
three	O
healthy	O
subjects	O
received	O
nasal	B-ANAT
LTB4	O
in	O
a	O
randomized	O
and	O
sham	O
-	O
controlled	O
design	O
.	O

In	O
38	O
healthy	O
individuals	O
,	O
nasal	B-ANAT
inoculation	O
with	O
human	O
rhinovirus	O
-	O
16	O
(	O
HRV	O
-	O
16	O
)	O
was	O
performed	O
.	O

Nasal	B-ANAT
LTB4	O
induces	O
a	O
selective	O
recruitment	O
/	O
activation	O
of	O
neutrophils	B-ANAT
.	O

LTB4	O
can	O
condition	O
neutrophils	B-ANAT
to	O
exert	O
virucidal	O
effects	O
in	O
vitro	O
and	O
may	O
reduce	O
virus	O
replication	O
in	O
vivo	O
.	O

They	O
further	O
show	O
that	O
IFITM	O
proteins	O
differentially	O
restrict	O
the	O
entry	O
of	O
a	O
broad	O
range	O
of	O
enveloped	O
viruses	O
,	O
and	O
modulate	O
cellular	B-ANAT
tropism	O
independently	O
of	O
viral	O
receptor	O
expression	O
.	O

ABSTRACT	O
:	O
Different	O
isoforms	O
of	O
nitric	O
oxide	O
(	O
NO	O
)	O
synthase	O
are	O
critically	O
involved	O
in	O
the	O
development	O
of	O
pulmonary	B-ANAT
failure	O
secondary	O
to	O
acute	O
lung	B-ANAT
injury	O
.	O

A	O
proteomics	O
approach	O
demonstrated	O
downregulation	O
of	O
extracellular	B-ANAT
signal	O
-	O
regulated	O
kinase	O
(	O
ERK	O
)	O
1	O
and	O
upregulation	O
of	O
ubiquitin	O
-	O
conjugating	O
enzyme	O
(	O
UBC	O
)	O
E2	O
-	O
25k	O
as	O
inhibitory	O
mechanism	O
of	O
PLpro	O
on	O
IFN	O
-	O
Î±	O
-	O
induced	O
responses	O
.	O

Serum	B-ANAT
antibodies	O
against	O
CCoV	O
were	O
detected	O
in	O
vaccinates	O
starting	O
from	O
study	O
day	O
14	O
(	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
)	O
or	O
28	O
(	O
by	O
virus	O
neutralisation	O
test	O
).	O

The	O
N	O
protein	O
of	O
HCoV	O
-	O
HKU1	O
was	O
expressed	O
in	O
E	O
.	O
Coli	O
,	O
anti	O
-	O
N	O
antibody	O
assay	O
was	O
established	O
using	O
Western	O
Blotting	O
with	O
turn	O
-	O
based	O
membrane	B-ANAT
.	O

A	O
prospective	O
cohort	O
genetic	O
association	O
study	O
of	O
lung	B-ANAT
injury	O
in	O
children	O
with	O
community	O
-	O
acquired	O
pneumonia	O
.	O

Six	O
primers	O
were	O
designed	O
to	O
amplify	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
gene	O
of	O
PEDV	O
.	O

The	O
source	O
of	O
high	O
viral	O
loads	O
in	O
saliva	B-ANAT
,	O
however	O
,	O
remains	O
elusive	O
.	O

Here	O
we	O
propose	O
a	O
strategy	O
to	O
reduce	O
model	O
bias	O
when	O
only	O
part	O
of	O
a	O
new	O
structure	O
is	O
known	O
:	O
after	O
the	O
MR	O
search	O
,	O
structure	O
determination	O
of	O
the	O
unknown	O
part	O
of	O
the	O
new	O
structure	O
can	O
be	O
facilitated	O
by	O
cross	O
-	O
crystal	B-ANAT
averaging	O
of	O
the	O
known	O
part	O
of	O
the	O
new	O
structure	O
with	O
the	O
search	O
model	O
.	O

Patients	O
were	O
divided	O
into	O
three	O
groups	O
according	O
to	O
the	O
configuration	O
:	O
veno	O
-	O
venous	B-ANAT
(	O
vv	O
;	O
n	O
=	O
11	O
),	O
venoarterial	O
(	O
va	O
;	O
n	O
=	O
8	O
)	O
or	O
veno	O
-	O
venoarterial	O
(	O
vva	O
;	O
n	O
=	O
11	O
).	O

To	O
identify	O
independent	O
risk	O
factors	O
,	O
univariate	O
analysis	O
was	O
performed	O
for	O
clinical	O
parameters	O
,	O
such	O
as	O
age	O
,	O
body	B-ANAT
mass	O
index	O
,	O
gender	O
,	O
configuration	O
,	O
low	O
-	O
pH	O
,	O
oxygenation	O
index	O
(	O
pO	O
(	O
2	O
)/	O
FiO	O
(	O
2	O
))	O
and	O
underlying	O
disease	O
.	O

Chest	B-ANAT
CT	O
(	O
16	O
-/	O
64	O
-	O
row	O
multidetector	O
CT	O
)	O
of	O
23	O
patients	O
(	O
of	O
whom	O
9	O
patients	O
died	O
)	O
were	O
retrospectively	O
reviewed	O
by	O
three	O
independent	O
blinded	O
observers	O
.	O

TITLE	O
:	O
The	O
leader	O
proteinase	O
of	O
foot	B-ANAT
-	O
and	O
-	O
mouth	B-ANAT
disease	O
virus	O
negatively	O
regulates	O
the	O
type	O
I	O
interferon	O
pathway	O
by	O
acting	O
as	O
a	O
viral	O
deubiquitinase	O
.	O

All	O
18	O
patients	O
had	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

All	O
the	O
isolates	O
formed	O
a	O
distinct	O
phylogenetic	O
group	O
with	O
very	O
short	O
branched	B-ANAT
distances	O
,	O
suggesting	O
that	O
isolates	O
had	O
a	O
similar	O
origin	O
.	O

Strikingly	O
,	O
IL	O
-	O
10	O
(+)	O
CD8	O
T	B-ANAT
cells	I-ANAT
were	O
more	O
highly	O
activated	O
and	O
cytolytic	O
than	O
IL	O
-	O
10	O
(-)	O
CD8	O
T	B-ANAT
cells	I-ANAT
,	O
expressing	O
greater	O
levels	O
of	O
proinflammatory	O
cytokines	O
and	O
chemokines	O
,	O
as	O
well	O
as	O
cytotoxic	O
proteins	O
.	O

In	O
the	O
remaining	O
five	O
experiments	O
,	O
the	O
oxygenation	O
increased	O
significantly	O
(	O
arterial	B-ANAT
oxygen	O
saturation	O
[	O
SaO2	O
]	O
from	O
79	O
Â±	O
5	O
%	O
before	O
HEXMO	O
to	O
92	O
%	O
Â±	O
11	O
%	O
after	O
4	O
hours	O
)	O
facilitated	O
by	O
a	O
mean	O
oxygen	O
transfer	O
of	O
66	O
Â±	O
29	O
ml	O
/	O
dl	O
through	O
the	O
oxygenator	O
.	O

From	O
immunofluorescence	O
microscopy	O
,	O
the	O
localization	O
of	O
c	O
-	O
myc	O
tagged	O
3CLpro	O
was	O
detected	O
both	O
in	O
the	O
cytoplasm	B-ANAT
and	O
nucleus	B-ANAT
of	O
transfected	O
A549	O
cells	B-ANAT
.	O

Furthermore	O
,	O
the	O
protein	O
levels	O
of	O
NF	O
-	O
kB	O
decreased	O
in	O
3CLpro	O
-	O
transfected	O
A549	O
cells	B-ANAT
when	O
compared	O
to	O
EGFP	O
transfected	O
cells	B-ANAT
.	O

TITLE	O
:	O
Distinct	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
pathways	O
in	O
two	O
different	O
nonhuman	O
primate	O
species	O
.	O

Inflammatory	O
cytokines	O
,	O
such	O
as	O
interleukin	O
1Î²	O
(	O
IL	O
-	O
1Î²	O
),	O
IL	O
-	O
8	O
,	O
and	O
IL	O
-	O
6	O
,	O
play	O
a	O
major	O
role	O
in	O
mediating	O
and	O
amplifying	O
ALI	O
/	O
ARDS	O
by	O
stimulating	O
chemotaxis	O
and	O
activation	O
of	O
neutrophils	B-ANAT
.	O

In	O
summary	O
,	O
we	O
show	O
that	O
TMPRSS2	O
might	O
promote	O
viral	O
spread	O
and	O
pathogenesis	O
by	O
diminishing	O
viral	O
recognition	O
by	O
neutralizing	O
antibodies	O
and	O
by	O
activating	O
SARS	O
S	O
for	O
cell	B-ANAT
-	O
cell	B-ANAT
and	O
virus	O
-	O
cell	B-ANAT
fusion	O
.	O

TITLE	O
:	O
Infection	O
with	O
human	O
coronavirus	O
NL63	O
enhances	O
streptococcal	O
adherence	O
to	O
epithelial	B-ANAT
cells	I-ANAT
.	O

The	O
result	O
showed	O
that	O
random	O
-	O
priming	O
cDNA	O
library	O
is	O
valid	O
for	O
the	O
investigation	O
of	O
transcript	O
diversity	O
in	O
the	O
virus	O
-	O
infected	O
tissue	B-ANAT
.	O

A	O
vaccination	O
-	O
challenge	O
test	O
that	O
was	O
performed	O
using	O
the	O
three	O
QX	O
-	O
like	O
strains	O
showed	O
that	O
the	O
commercially	O
available	O
H120	O
vaccine	O
did	O
not	O
provide	O
sufficient	O
protection	O
against	O
challenge	O
with	O
the	O
QX	O
-	O
like	O
isolates	O
,	O
as	O
demonstrated	O
by	O
comparison	O
of	O
the	O
clinical	O
signs	O
,	O
pathological	O
lesions	O
and	O
virus	O
recovery	O
from	O
the	O
trachea	B-ANAT
and	O
kidney	B-ANAT
of	O
unvaccinated	O
-	O
challenged	O
and	O
vaccinated	O
-	O
challenged	O
birds	O
.	O

ABSTRACT	O
:	O
Airway	B-ANAT
pressure	O
release	O
ventilation	O
(	O
APRV	O
)	O
and	O
bi	O
-	O
level	O
positive	O
airway	B-ANAT
pressure	O
(	O
BIPAP	O
)	O
are	O
proposed	O
to	O
reduce	O
patient	O
work	O
of	O
breathing	O
(	O
WOB	O
)	O
sufficiently	O
and	O
to	O
obviate	O
issues	O
related	O
to	O
patient	O
-	O
ventilator	O
synchrony	O
,	O
so	O
that	O
spontaneous	O
breathing	O
can	O
be	O
maintained	O
throughout	O
the	O
course	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
).	O

The	O
antibody	O
-	O
dependent	O
enhancement	O
(	O
ADE	O
)	O
of	O
FIPV	O
infection	O
has	O
been	O
recognised	O
in	O
experimentally	O
infected	O
cats	O
,	O
and	O
cellular	B-ANAT
immunity	O
is	O
considered	O
to	O
play	O
an	O
important	O
role	O
in	O
preventing	O
the	O
onset	O
of	O
FIP	O
.	O

In	O
all	O
tests	O
,	O
fIFN	O
-	O
Î³	O
production	O
from	O
peripheral	B-ANAT
blood	I-ANAT
mononuclear	I-ANAT
cells	I-ANAT
(	O
PBMCs	O
)	O
obtained	O
from	O
cats	O
experimentally	O
infected	O
with	O
an	O
FIPV	O
isolate	O
that	O
did	O
not	O
develop	O
the	O
disease	O
was	O
significantly	O
increased	O
by	O
heat	O
-	O
inactivated	O
FIPV	O
stimulation	O
in	O
comparison	O
with	O
medium	O
alone	O
.	O

Especially	O
,	O
CD8	O
(+)	O
fIFN	O
-	O
Î³	O
(+)	O
cells	B-ANAT
,	O
but	O
not	O
CD4	O
(+)	O
fIFN	O
-	O
Î³	O
(+)	O
cells	B-ANAT
,	O
were	O
increased	O
.	O

TITLE	O
:	O
Utilization	O
patterns	O
and	O
patient	O
outcomes	O
associated	O
with	O
use	O
of	O
rescue	O
therapies	O
in	O
acute	O
lung	B-ANAT
injury	O
.	O

One	O
hundred	O
sixty	O
-	O
six	O
of	O
2632	O
(	O
6	O
.	O
3	O
%)	O
subjects	O
received	O
rescue	O
therapy	O
,	O
defined	O
as	O
prone	O
positioning	O
(	O
97	O
of	O
166	O
[	O
58	O
%]),	O
inhaled	O
vasodilators	O
(	O
47	O
of	O
166	O
[	O
28	O
%]),	O
high	O
-	O
frequency	O
ventilation	O
(	O
12	O
of	O
166	O
[	O
7	O
%]),	O
or	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
10	O
of	O
166	O
[	O
6	O
%]).	O

Multivariate	O
predictors	O
for	O
use	O
of	O
rescue	O
therapy	O
included	O
age	O
(	O
odds	O
ratio	O
per	O
10	O
yrs	O
and	O
95	O
%	O
confidence	O
interval	O
:	O
0	O
.	O
88	O
;	O
0	O
.	O
78	O
-	O
0	O
.	O
99	O
;	O
p	O
=	O
.	O
049	O
),	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
odds	O
ratio	O
per	O
5	O
-	O
cm	O
H2O	O
increase	O
:	O
1	O
.	O
33	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
1	O
.	O
05	O
-	O
1	O
.	O
69	O
;	O
p	O
=	O
.	O
019	O
),	O
Pao2	O
/	O
Fio2	O
;	O
odds	O
ratio	O
per	O
5	O
-	O
cm	O
H2O	O
increase	O
:	O
0	O
.	O
98	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
0	O
.	O
96	O
-	O
0	O
.	O
99	O
;	O
p	O
=	O
.	O
017	O
),	O
peak	O
airway	B-ANAT
pressure	O
(	O
odds	O
ratio	O
per	O
5	O
-	O
cm	O
H2O	O
increase	O
:	O
1	O
.	O
11	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
1	O
.	O
001	O
-	O
1	O
.	O
237	O
;	O
p	O
=	O
.	O
047	O
),	O
and	O
study	O
order	O
(	O
odds	O
ratio	O
per	O
subsequent	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
Clinical	O
Trials	O
Network	O
study	O
:	O
1	O
.	O
21	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
1	O
.	O
03	O
-	O
1	O
.	O
41	O
;	O
p	O
=	O
.	O
02	O
).	O

ABSTRACT	O
:	O
Systemic	O
lupus	O
erythematosus	O
(	O
SLE	O
)	O
is	O
a	O
chronic	O
inflammatory	O
disease	O
that	O
can	O
lead	O
to	O
damage	O
to	O
several	O
vital	O
organs	B-ANAT
.	O

Nevertheless	O
,	O
the	O
patient	O
died	O
of	O
diffuse	O
alveolar	B-ANAT
hemorrhage	O
and	O
respiratory	O
failure	O
and	O
shock	O
.	O

The	O
emphasis	O
of	O
treatment	O
for	O
DIC	O
is	O
on	O
platelet	B-ANAT
and	O
fresh	B-ANAT
plasma	B-ANAT
transfusion	O
,	O
in	O
contrast	O
with	O
anti	O
-	O
coagulant	O
for	O
CAPS	O
.	O

Clinical	O
findings	O
,	O
serum	B-ANAT
protein	O
electrophoresis	O
(	O
SPE	O
),	O
analysis	O
of	O
the	O
effusions	O
(	O
AE	O
),	O
antifeline	O
coronavirus	O
serology	O
,	O
serum	B-ANAT
concentration	O
of	O
Î±1	O
-	O
acid	O
glycoprotein	O
(	O
AGP	O
)	O
and	O
histopathology	O
were	O
classified	O
as	O
consistent	O
,	O
doubtful	O
or	O
non	O
-	O
consistent	O
with	O
FIP	O
.	O

In	O
patients	O
admitted	O
to	O
ICU	O
with	O
Guillain	O
-	O
BarrÃ©	O
syndrome	O
and	O
acute	O
respiratory	O
failure	O
,	O
the	O
lack	O
of	O
foot	B-ANAT
flexion	O
ability	O
at	O
the	O
end	O
of	O
immune	O
therapy	O
predicts	O
a	O
prolonged	O
duration	O
of	O
MV	O
.	O

The	O
association	O
of	O
a	O
sciatic	B-ANAT
nerve	I-ANAT
motor	O
conduction	O
block	O
with	O
the	O
lack	O
of	O
foot	B-ANAT
flexion	O
at	O
the	O
end	O
of	O
immunotherapy	O
was	O
associated	O
with	O
prolonged	O
MV	O
with	O
a	O
100	O
%	O
positive	O
predictive	O
value	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
first	O
examined	O
the	O
efficacy	O
of	O
UDA	O
on	O
the	O
replication	O
of	O
different	O
SARS	O
-	O
CoV	O
strains	O
in	O
Vero	O
76	O
cells	B-ANAT
.	O

When	O
UDA	O
was	O
exposed	O
to	O
N	O
-	O
acetylglucosamine	O
and	O
then	O
UDA	O
was	O
added	O
to	O
cells	B-ANAT
just	O
prior	O
to	O
adsorption	O
,	O
UDA	O
did	O
not	O
inhibit	O
the	O
virus	O
infection	O
.	O

These	O
data	O
support	O
the	O
conclusion	O
that	O
UDA	O
might	O
bind	O
to	O
N	O
-	O
acetylglucosamine	O
-	O
like	O
residues	O
present	O
on	O
the	O
glycosylated	O
envelope	B-ANAT
glycoproteins	O
,	O
thereby	O
preventing	O
virus	O
attachment	O
to	O
cells	B-ANAT
.	O

Entry	O
and	O
release	O
of	O
canine	O
coronavirus	O
from	O
polarized	O
epithelial	B-ANAT
cells	I-ANAT
.	O

In	O
order	O
to	O
establish	O
the	O
polarity	O
of	O
entry	O
and	O
release	O
of	O
CCoV	O
from	O
epithelial	B-ANAT
cells	I-ANAT
,	O
the	O
interactions	O
of	O
the	O
virus	O
with	O
A72	O
and	O
CrFK	O
cells	B-ANAT
grown	O
on	O
permeable	O
supports	O
was	O
evaluated	O
,	O
and	O
the	O
amount	O
of	O
infective	O
virus	O
in	O
the	O
apical	O
and	O
in	O
the	O
basolateral	O
media	B-ANAT
was	O
determined	O
and	O
compared	O
.	O

To	O
establish	O
the	O
reciprocal	O
binding	O
of	O
CCoV	O
on	O
plasma	B-ANAT
membrane	I-ANAT
,	O
A72	O
cells	B-ANAT
on	O
a	O
permeable	O
support	O
were	O
preincubated	O
with	O
a	O
mAb	O
specific	O
for	O
CCoV	O
.	O
Infection	O
from	O
the	O
apical	O
side	O
was	O
blocked	O
by	O
mAb	O
applied	O
to	O
that	O
side	O
;	O
in	O
contrast	O
,	O
such	O
treatment	O
on	O
the	O
basolateral	O
side	O
had	O
no	O
effect	O
on	O
the	O
infectious	O
process	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
severe	O
inflammatory	O
lung	B-ANAT
diseases	O
associated	O
with	O
very	O
high	O
mortality	O
,	O
and	O
are	O
the	O
most	O
common	O
and	O
earliest	O
organ	B-ANAT
dysfunctions	O
in	O
the	O
development	O
of	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
.	O

TITLE	O
:	O
Comparative	O
anti	O
-	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
activity	O
of	O
(-)-	O
pinene	O
:	O
effect	O
on	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
.	O

With	O
some	O
improvements	O
in	O
the	O
expression	O
system	O
,	O
it	O
could	O
be	O
used	O
to	O
induce	O
a	O
targeted	O
immune	O
response	O
against	O
specific	O
mucosal	B-ANAT
pathogens	O
,	O
and	O
co	O
-	O
expression	O
of	O
several	O
antigens	O
would	O
allow	O
development	O
of	O
a	O
novel	O
multivalent	O
vaccine	O
.	O

TITLE	O
:	O
Cutting	O
edge	O
:	O
attrition	O
of	O
Plasmodium	O
-	O
specific	O
memory	O
CD8	O
T	B-ANAT
cells	I-ANAT
results	O
in	O
decreased	O
protection	O
that	O
is	O
rescued	O
by	O
booster	O
immunization	O
.	O

We	O
show	O
that	O
P	O
.	O
berghei	O
circumsporozoite	O
-	O
specific	O
memory	O
CD8	O
T	B-ANAT
cells	I-ANAT
underwent	O
significant	O
attrition	O
in	O
numbers	O
in	O
mice	O
subjected	O
to	O
unrelated	O
infections	O
.	O

Initially	O
the	O
diseases	O
present	O
with	O
unspecific	O
symptoms	O
,	O
followed	O
by	O
more	O
or	O
less	O
extensive	O
blistering	O
and	O
shedding	O
of	O
the	O
skin	B-ANAT
.	O

Thirty	O
-	O
four	O
patients	O
(	O
85	O
%)	O
survived	O
to	O
hospital	O
discharge	B-ANAT
.	O

Albeit	O
promiscuous	O
in	O
deubiquitinating	O
cellular	B-ANAT
proteins	O
,	O
PLP2	O
inactivated	O
TBK1	O
and	O
IFN	O
-	O
Î²	O
response	O
in	O
TNF	O
receptor	O
associated	O
factor	O
3	O
(	O
TRAF3	O
)	O
deficient	O
cells	B-ANAT
,	O
suggesting	O
that	O
targeting	O
TBK1	O
would	O
be	O
sufficient	O
for	O
PLP2	O
to	O
inhibit	O
IRF3	O
activation	O
.	O

The	O
average	O
optical	O
density	O
(	O
OD	O
)	O
reading	O
of	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
-	O
specific	O
antibodies	O
fell	O
dramatically	O
between	O
month	O
3	O
and	O
month	O
12	O
,	O
and	O
it	O
decreased	O
gradually	O
at	O
low	O
levels	O
that	O
were	O
a	O
little	O
higher	O
than	O
the	O
cut	O
-	O
off	O
value	O
from	O
month	O
12	O
.	O

Human	O
coronaviruses	O
(	O
HCoVs	O
)	O
have	O
only	O
recently	O
been	O
shown	O
to	O
cause	O
both	O
lower	O
and	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
.	O

Infection	O
with	O
HCoV	O
-	O
NL63	O
has	O
since	O
been	O
shown	O
to	O
be	O
a	O
common	O
worldwide	O
occurrence	O
and	O
has	O
been	O
associated	O
with	O
many	O
clinical	O
symptoms	O
and	O
diagnoses	O
,	O
including	O
severe	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
,	O
croup	O
and	O
bronchiolitis	O
.	O

The	O
ocular	B-ANAT
abnormalities	O
included	O
:	O
severe	O
myopia	O
,	O
abnormalities	O
of	O
the	O
vitreous	O
,	O
and	O
high	O
risk	O
of	O
retinal	B-ANAT
detachment	O
(	O
with	O
subsequent	O
blindness	O
).	O

By	O
analogy	O
to	O
other	O
plus	O
-	O
stranded	O
RNA	O
viruses	O
,	O
such	O
as	O
polioviruses	O
,	O
in	O
which	O
translation	O
and	O
replication	O
switch	O
involves	O
a	O
cellular	B-ANAT
factor	O
(	O
PCBP	O
)	O
and	O
a	O
viral	O
protein	O
(	O
3CD	O
)	O
it	O
is	O
conceivable	O
that	O
in	O
CoVs	O
the	O
switch	O
between	O
replication	O
and	O
transcription	O
is	O
also	O
associated	O
with	O
the	O
binding	O
of	O
proteins	O
that	O
are	O
specifically	O
recruited	O
by	O
the	O
replication	O
or	O
transcription	O
complexes	O
.	O

X	O
-	O
ray	O
study	O
revealed	O
pulmonary	B-ANAT
hemorrhages	O
and	O
edema	O
.	O

TITLE	O
:	O
Proteomic	O
analysis	O
of	O
chicken	O
embryonic	B-ANAT
trachea	B-ANAT
and	O
kidney	B-ANAT
tissues	B-ANAT
after	O
infection	O
in	O
ovo	O
by	O
avian	O
infectious	O
bronchitis	O
coronavirus	O
.	O

17	O
differentially	O
expressed	O
proteins	O
from	O
tracheal	O
tissues	B-ANAT
and	O
19	O
differentially	O
expressed	O
proteins	O
from	O
kidney	B-ANAT
tissues	B-ANAT
were	O
identified	O
.	O

Acute	O
chest	B-ANAT
syndrome	O
(	O
ACS	O
)	O
is	O
an	O
acute	O
lung	B-ANAT
injury	O
often	O
preceded	O
by	O
a	O
vaso	O
-	O
occlusive	O
crisis	O
and	O
triggered	O
by	O
different	O
factors	O
including	O
:	O
hypoventilation	O
,	O
pulmonary	B-ANAT
infectious	O
disease	O
and	O
vascular	B-ANAT
occlusions	O
.	O

These	O
occlusions	O
can	O
be	O
secondary	O
to	O
fat	O
embolism	O
,	O
thrombosis	O
or	O
sickling	B-ANAT
.	O

Exchange	O
transfusion	O
may	O
be	O
indicated	O
in	O
severe	O
forms	O
of	O
ACS	O
,	O
characterized	O
by	O
a	O
right	O
ventricular	B-ANAT
dysfunction	O
and	O
acute	O
respiratory	O
failure	O
.	O

Other	O
respiratory	O
complications	O
such	O
as	O
sleep	O
disorders	O
and	O
nocturnal	O
hypoxemia	O
,	O
infiltrative	O
lung	B-ANAT
disease	O
and	O
exertional	O
dyspnea	O
are	O
described	O
and	O
should	O
be	O
considered	O
.	O

ABSTRACT	O
:	O
Acute	O
chest	B-ANAT
syndrome	O
describes	O
new	O
respiratory	O
symptoms	O
and	O
findings	O
,	O
often	O
severe	O
and	O
progressive	O
,	O
in	O
a	O
child	O
with	O
sickle	B-ANAT
cell	I-ANAT
disease	O
and	O
a	O
new	O
pulmonary	B-ANAT
infiltrate	O
.	O

TITLE	O
:	O
The	O
polypyrimidine	O
tract	O
-	O
binding	O
protein	O
affects	O
coronavirus	O
RNA	O
accumulation	O
levels	O
and	O
relocalizes	O
viral	O
RNAs	O
to	O
novel	O
cytoplasmic	B-ANAT
domains	O
different	O
from	O
replication	O
-	O
transcription	O
sites	O
.	O

The	O
assay	O
was	O
carried	O
out	O
using	O
two	O
sets	O
of	O
primers	O
designed	O
to	O
amplify	O
highly	O
conserved	O
sequences	O
of	O
the	O
nucleocapsid	B-ANAT
gene	O
of	O
BCoV	O
and	O
the	O
internal	O
control	O
,	O
bovine	O
glyceraldehyde	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
,	O
RNA	O
.	O

Because	O
gene	O
expression	O
is	O
an	O
intermediate	O
phenotype	O
that	O
resides	O
between	O
the	O
DNA	O
sequence	O
variation	O
and	O
the	O
higher	O
level	O
cellular	B-ANAT
or	O
whole	O
-	O
body	B-ANAT
phenotypes	O
,	O
the	O
illustration	O
of	O
gene	O
expression	O
regulatory	O
networks	O
potentially	O
could	O
enhance	O
understanding	O
of	O
disease	O
susceptibility	O
and	O
the	O
development	O
of	O
inflammatory	O
lung	B-ANAT
syndromes	O
.	O

Inhaled	O
ribavirin	O
is	O
approved	O
for	O
the	O
treatment	O
of	O
hospitalized	O
infants	O
and	O
young	O
children	O
with	O
severe	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
due	O
to	O
RSV	O
.	O

Immunohistochemistry	O
demonstrated	O
that	O
in	O
birds	O
infected	O
with	O
the	O
pathogenic	O
strain	O
of	O
virus	O
,	O
IBV	O
spike	O
protein	O
is	O
detected	O
first	O
in	O
the	O
ciliated	O
cells	B-ANAT
lining	I-ANAT
the	O
air	B-ANAT
sac	I-ANAT
.	O

TITLE	O
:	O
[	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
and	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
.	O

We	O
suspected	O
severe	O
immunosuppression	O
caused	O
by	O
various	O
factors	O
,	O
such	O
as	O
predonisolone	O
administration	O
,	O
chronic	O
renal	B-ANAT
failure	O
on	O
maintenance	O
hemodialysis	O
,	O
depression	O
,	O
and	O
malnutrition	O
due	O
to	O
chronic	O
inflammation	O
and	O
granulocytopenia	O
as	O
a	O
side	O
effect	O
of	O
ganciclovir	O
.	O

ABSTRACT	O
:	O
H1N1	O
subtype	O
of	O
influenza	O
A	O
virus	O
has	O
clinical	O
presentation	O
ranging	O
from	O
mild	O
flu	O
like	O
illness	O
to	O
severe	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

We	O
have	O
adopted	O
the	O
technique	O
on	O
25	O
occasions	O
and	O
had	O
no	O
incidence	O
of	O
vascular	B-ANAT
damage	O
or	O
cardiac	B-ANAT
perforation	O
.	O

TITLE	O
:	O
Different	O
host	B-ANAT
cell	I-ANAT
proteases	O
activate	O
the	O
SARS	O
-	O
coronavirus	O
spike	O
-	O
protein	O
for	O
cell	B-ANAT
-	O
cell	B-ANAT
and	O
virus	O
-	O
cell	B-ANAT
fusion	O
.	O

Pleural	B-ANAT
effusion	I-ANAT
and	O
lymphadenopathy	O
were	O
of	O
consistent	O
rare	O
features	O
in	O
both	O
groups	O
.	O

Pleural	B-ANAT
effusion	I-ANAT
and	O
lymphadenopathy	O
were	O
of	O
consistent	O
rare	O
features	O
in	O
both	O
groups	O
.	O

Nasal	B-ANAT
specimens	O
were	O
available	O
in	O
166	O
episodes	O
,	O
92	O
of	O
which	O
were	O
diagnosed	O
as	O
asthma	O
exacerbations	O
,	O
and	O
74	O
non	O
-	O
asthma	O
related	O
episodes	O
.	O

ABSTRACT	O
:	O
Acutelunginjury	O
(	O
ALI	O
)	O
and	O
its	O
more	O
severe	O
form	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
syndromes	O
with	O
a	O
spectrum	O
of	O
increasing	O
severity	O
of	O
lung	B-ANAT
injury	O
defined	O
by	O
physiologic	O
and	O
radiographic	O
criteria	O
.	O

Although	O
the	O
envelope	B-ANAT
protein	O
(	O
E	O
)	O
makes	O
up	O
only	O
a	O
small	O
percentage	O
of	O
the	O
viral	B-ANAT
envelope	I-ANAT
,	O
it	O
plays	O
an	O
important	O
,	O
as	O
-	O
yet	O
-	O
undefined	O
role	O
in	O
virus	O
production	O
.	O

To	O
dissect	O
the	O
targeting	O
of	O
the	O
SARS	O
-	O
CoV	O
E	O
protein	O
to	O
the	O
Golgi	B-ANAT
region	O
,	O
we	O
exogenously	O
expressed	O
the	O
protein	O
and	O
various	O
mutants	O
from	O
cDNA	O
and	O
determined	O
their	O
localization	O
using	O
immunofluorescence	O
microscopy	O
and	O
biochemical	O
assays	O
.	O

We	O
show	O
that	O
the	O
cytoplasmic	B-ANAT
tail	I-ANAT
of	O
the	O
SARS	O
-	O
CoV	O
E	O
protein	O
is	O
sufficient	O
to	O
redirect	O
a	O
plasma	B-ANAT
membrane	I-ANAT
protein	O
to	O
the	O
Golgi	B-ANAT
region	O
.	O

Common	O
complications	O
of	O
influenza	O
virus	O
include	O
upper	O
and	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
,	O
otitis	O
media	B-ANAT
,	O
myocarditis	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
multi	O
-	O
organ	B-ANAT
failure	O
.	O

TITLE	O
:	O
Viral	O
infection	O
in	O
acute	O
exacerbation	O
of	O
idiopathic	O
pulmonary	B-ANAT
fibrosis	O
.	O

ABSTRACT	O
:	O
Idiopathic	O
pulmonary	B-ANAT
fibrosis	O
is	O
a	O
progressive	O
,	O
uniformly	O
fatal	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
.	O

Viral	O
infection	O
was	O
not	O
detected	O
in	O
most	O
cases	O
of	O
acute	O
exacerbation	O
of	O
idiopathic	O
pulmonary	B-ANAT
fibrosis	O
.	O

The	O
survival	O
rate	O
and	O
its	O
resulting	O
pathological	O
changes	O
were	O
observed	O
and	O
patho	O
physiological	O
indexes	O
and	O
lung	B-ANAT
fluid	O
content	O
were	O
determined	O
at	O
sequential	O
time	O
points	O
post	O
explosion	O
.	O

We	O
investigated	O
vascular	B-ANAT
endothelial	B-ANAT
growth	O
factor	O
(	O
VEGF	O
)	O
to	O
examine	O
the	O
relationship	O
between	O
VEGF	O
levels	O
and	O
the	O
amounts	O
of	O
effusion	B-ANAT
in	O
cats	O
with	O
FIP	O
.	O

In	O
FIPV	O
-	O
infected	O
monocytes	B-ANAT
/	O
macrophages	B-ANAT
,	O
the	O
production	O
of	O
VEGF	O
was	O
associated	O
with	O
proliferation	O
of	O
virus	O
.	O

Direct	O
intracranial	B-ANAT
injection	O
of	O
iBAC	O
-	O
FXN	O
-	O
lacZ	O
into	O
the	O
adult	O
mouse	B-ANAT
cerebellum	I-ANAT
resulted	O
in	O
a	O
large	O
number	O
of	O
easily	O
detectable	O
transduced	O
cells	B-ANAT
,	O
with	O
LacZ	O
expression	O
driven	O
by	O
the	O
FXN	O
genomic	O
locus	O
,	O
which	O
persisted	O
for	O
at	O
least	O
75	O
days	O
.	O

Nasal	B-ANAT
/	O
throat	B-ANAT
swabs	O
were	O
obtained	O
for	O
polymerase	O
chain	O
reaction	O
test	O
from	O
315	O
hospitalized	O
patients	O
and	O
20	O
non	O
-	O
hospitalized	O
patients	O
,	O
and	O
145	O
(	O
46	O
%)	O
and	O
15	O
(	O
75	O
%)	O
specimens	O
,	O
respectively	O
,	O
tested	O
positive	O
on	O
A	O
(	O
H1N1	O
)	O
v	O
.	O

The	O
Brazilian	O
isolates	O
branched	B-ANAT
into	O
one	O
unique	O
cluster	O
,	O
separate	O
from	O
the	O
reference	O
serotypes	O
used	O
for	O
infectious	O
bronchitis	O
control	O
in	O
other	O
countries	O
.	O

Patients	O
with	O
clinically	O
stable	O
asthma	O
and	O
healthy	O
controls	O
have	O
similar	O
detection	O
rates	O
of	O
respiratory	O
viruses	O
in	O
samples	O
from	O
nasopharynx	B-ANAT
,	O
sputum	B-ANAT
and	O
exhaled	B-ANAT
air	I-ANAT
.	O

Nasal	B-ANAT
and	O
throat	B-ANAT
swab	I-ANAT
samples	O
were	O
collected	O
in	O
843	O
children	O
with	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
.	O

These	O
results	O
demonstrate	O
that	O
CXCR3	O
ligands	O
are	O
indispensable	O
for	O
recruitment	O
of	O
activated	O
ASC	O
into	O
the	O
inflamed	O
CNS	B-ANAT
and	O
highlight	O
their	O
local	O
protective	O
role	O
during	O
persistent	O
infection	O
.	O

Within	O
the	O
study	O
period	O
,	O
12	O
patients	O
died	O
(	O
48	O
%)	O
mainly	O
of	O
multi	O
-	O
organ	B-ANAT
failure	O
.	O

Venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
was	O
used	O
temporarily	O
.	O

However	O
,	O
lung	B-ANAT
-	O
protective	O
ventilation	O
is	O
the	O
only	O
confirmed	O
option	O
in	O
ARDS	O
management	O
improving	O
survival	O
,	O
and	O
few	O
other	O
therapies	O
have	O
translated	O
into	O
improved	O
oxygenation	O
or	O
reduced	O
ventilation	O
time	O
.	O

TITLE	O
:	O
Subcellular	O
location	O
and	O
topology	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
envelope	B-ANAT
protein	O
.	O

E	O
protein	O
was	O
mainly	O
found	O
in	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
-	I-ANAT
Golgi	I-ANAT
intermediate	I-ANAT
compartment	I-ANAT
(	O
ERGIC	B-ANAT
)	O
of	O
cells	B-ANAT
transfected	O
with	O
a	O
plasmid	O
encoding	O
E	O
protein	O
or	O
infected	O
with	O
SARS	O
-	O
CoV	O
.	O
No	O
evidence	O
of	O
E	O
protein	O
presence	O
in	O
the	O
plasma	B-ANAT
membrane	I-ANAT
was	O
found	O
by	O
using	O
immunofluorescence	O
,	O
immunoelectron	O
microscopy	O
and	O
cell	B-ANAT
surface	I-ANAT
protein	O
labeling	O
.	O

ABSTRACT	O
:	O
Interleukin	O
-	O
10	O
(	O
IL	O
-	O
10	O
)	O
mRNA	O
is	O
rapidly	O
upregulated	O
in	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
following	O
infection	O
with	O
neurotropic	O
coronavirus	O
and	O
remains	O
elevated	O
during	O
persistent	O
infection	O
.	O

Secondly	O
,	O
we	O
collected	O
serum	B-ANAT
,	O
fecal	B-ANAT
,	O
nasal	B-ANAT
,	O
ophthalmic	B-ANAT
,	O
and	O
vaginal	B-ANAT
samples	O
from	O
pre	O
-	O
immune	O
mice	O
and	O
after	O
the	O
first	O
immunization	O
(	O
on	O
days	O
7	O
,	O
14	O
,	O
21	O
,	O
28	O
,	O
35	O
,	O
and	O
42	O
)	O
that	O
were	O
used	O
to	O
analyze	O
the	O
levels	O
of	O
immunoglobulins	O
G	O
and	O
A	O
against	O
TGEV	O
by	O
using	O
ELISA	O
.	O

A	O
statistically	O
significant	O
difference	O
in	O
serum	B-ANAT
tests	O
between	O
groups	O
demonstrated	O
that	O
rLppg612	O
-	O
6D	O
induced	O
better	O
immunogenicity	O
than	O
rLppg611	O
-	O
6D	O
,	O
making	O
rLppg612	O
-	O
6D	O
the	O
better	O
candidate	O
for	O
oral	B-ANAT
vaccine	O
.	O

ABSTRACT	O
:	O
The	O
criteria	O
that	O
define	O
acute	O
lung	B-ANAT
injury	O
and	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
include	O
PaOâ	O
/	O
Fioâ	O
but	O
not	O
positive	O
end	O
-	O
expiratory	O
pressure	O
or	O
Fio2	O
.	O

The	O
primary	O
purpose	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
value	O
of	O
adding	O
baseline	O
positive	O
end	O
-	O
expiratory	O
pressure	O
and	O
Fioâ	O
to	O
PaOâ	O
/	O
Fioâ	O
for	O
predicting	O
mortality	O
of	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
enrolled	O
in	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
Network	O
clinical	O
trials	O
.	O

At	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
Network	O
hospitals	O
,	O
the	O
addition	O
of	O
baseline	O
positive	O
end	O
-	O
expiratory	O
pressure	O
would	O
not	O
have	O
increased	O
the	O
value	O
of	O
PaOâ	O
/	O
Fioâ	O
for	O
predicting	O
mortality	O
of	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
is	O
used	O
in	O
the	O
treatment	O
of	O
severe	O
respiratory	O
failure	O
that	O
is	O
potentially	O
reversible	O
.	O

A	O
CT	O
scan	O
showed	O
almost	O
the	O
entire	B-ANAT
lung	I-ANAT
had	O
collapsed	O
,	O
even	O
though	O
we	O
had	O
administered	O
diuretics	O
,	O
steroids	O
,	O
nitric	O
oxide	O
,	O
sivelestat	O
,	O
and	O
surfactant	O
for	O
ARDS	O
.	O

The	O
collapsed	O
lung	B-ANAT
was	O
then	O
gradually	O
recruited	O
,	O
and	O
pulmonary	B-ANAT
oxygenation	O
improved	O
(	O
P	O
/	O
F	O
ratio	O
=	O
434	O
).	O

Although	O
HFOV	O
has	O
failed	O
to	O
show	O
a	O
mortality	O
benefit	O
in	O
ARDS	O
patients	O
,	O
the	O
unique	O
lung	B-ANAT
recruitment	O
by	O
HFOV	O
can	O
be	O
a	O
useful	O
therapeutic	O
option	O
for	O
severe	O
ARDS	O
patients	O
in	O
combination	O
with	O
sufficient	O
lung	B-ANAT
rest	O
produced	O
by	O
ECMO	O
.	O

When	O
expressed	O
in	O
Xenopus	O
oocytes	B-ANAT
the	O
protein	O
forms	O
channels	O
.	O

TITLE	O
:	O
Interference	O
of	O
ribosomal	B-ANAT
frameshifting	O
by	O
antisense	O
peptide	O
nucleic	B-ANAT
acids	O
suppresses	O
SARS	O
coronavirus	O
replication	O
.	O

Attempts	O
were	O
made	O
to	O
detect	O
viruses	O
by	O
inoculation	O
of	O
these	O
eluates	O
in	O
cell	B-ANAT
cultures	O
(	O
Vero	O
,	O
MDCK	O
,	O
and	O
RK	O
-	O
13	O
)	O
and	O
specific	O
pathogen	O
-	O
free	O
embryonated	O
chicken	O
eggs	O
.	O

Two	O
passages	O
of	O
eluates	O
in	O
cell	B-ANAT
cultures	O
or	O
these	O
eggs	O
did	O
not	O
reveal	O
the	O
presence	O
of	O
any	O
live	O
virus	O
.	O

RESULTS	O
:	O
Attempts	O
were	O
made	O
to	O
detect	O
viruses	O
by	O
inoculation	O
of	O
these	O
eluates	O
in	O
cell	B-ANAT
cultures	O
(	O
Vero	O
,	O
MDCK	O
,	O
and	O
RK	O
-	O
13	O
)	O
and	O
specific	O
pathogen	O
-	O
free	O
embryonated	O
chicken	O
eggs	O
.	O

TITLE	O
:	O
Bronchopleural	O
fistulae	O
and	O
pulmonary	B-ANAT
ossification	O
in	O
posttraumatic	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
successful	O
treatment	O
with	O
extracorporeal	O
support	O
.	O

ABSTRACT	O
:	O
Previously	O
,	O
we	O
have	O
reported	O
that	O
a	O
serial	O
passage	O
of	O
83P	O
-	O
5	O
strain	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
in	O
Vero	B-ANAT
cells	I-ANAT
resulted	O
in	O
a	O
growth	O
adaptation	O
of	O
the	O
virus	O
in	O
cultured	B-ANAT
cells	I-ANAT
at	O
the	O
22nd	O
passage	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
purified	O
recombinant	O
human	O
ADAM17	O
is	O
able	O
to	O
cleave	O
a	O
20	O
-	O
amino	O
acid	O
peptide	O
mimetic	O
corresponding	O
to	O
the	O
extracellular	B-ANAT
juxtamembrane	B-ANAT
region	O
of	O
human	O
ACE2	O
between	O
Arg	O
(	O
708	O
)	O
and	O
Ser	B-ANAT
(	O
709	O
).	O

The	O
observation	O
of	O
the	O
shedding	O
profiles	O
of	O
ACE2	O
mutants	O
expressing	O
CHO	B-ANAT
-	O
K1	O
and	O
CHO	B-ANAT
-	O
P	O
cells	B-ANAT
indicates	O
that	O
the	O
Arg	O
(	O
708	O
)	O
â	O
Glu	O
(	O
708	O
)	O
mutation	O
and	O
the	O
Arg	O
(	O
708	O
)	O
Arg	O
(	O
710	O
)	O
â	O
Glu	O
(	O
708	O
)	O
Glu	O
(	O
710	O
)	O
double	O
mutation	O
produced	O
increases	O
in	O
the	O
amount	O
of	O
ACE2	O
shed	O
when	O
stimulated	O
by	O
phorbol	O
ester	O
PMA	O
.	O

ABSTRACT	O
:	O
The	O
spectrum	O
of	O
pulmonary	B-ANAT
pathology	O
in	O
the	O
Middle	O
East	O
is	O
as	O
versatile	O
as	O
its	O
civilizations	O
and	O
cultures	O
.	O

We	O
shed	O
light	O
on	O
the	O
diverse	O
conditions	O
commonly	O
encountered	O
in	O
the	O
region	O
,	O
from	O
the	O
centuries	O
-	O
old	O
illnesses	O
of	O
tuberculosis	O
,	O
to	O
contemporary	O
problems	O
such	O
as	O
lung	B-ANAT
complications	O
from	O
chemical	O
warfare	O
.	O

TITLE	O
:	O
Macrophage	B-ANAT
-	O
mediated	O
optic	B-ANAT
neuritis	O
induced	O
by	O
retrograde	O
axonal	O
transport	O
of	O
spike	O
gene	O
recombinant	O
mouse	O
hepatitis	O
virus	O
.	O

These	O
data	O
indicate	O
that	O
MHV	O
spreads	O
by	O
retrograde	O
axonal	O
transport	O
to	O
the	O
eye	B-ANAT
and	O
that	O
targeting	O
spike	O
protein	O
interactions	O
with	O
axonal	O
transport	O
machinery	O
is	O
a	O
potential	O
therapeutic	O
strategy	O
for	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
viral	O
infections	O
and	O
associated	O
diseases	O
.	O

TITLE	O
:	O
Action	O
mechanisms	O
of	O
lithium	O
chloride	O
on	O
cell	B-ANAT
infection	O
by	O
transmissible	O
gastroenteritis	O
coronavirus	O
.	O

Moreover	O
,	O
immunofluorescence	O
(	O
IF	O
)	O
and	O
flow	O
cytometry	O
analyses	O
based	O
on	O
staining	O
of	O
Annexin	O
V	O
and	O
propidium	O
iodide	O
staining	O
of	O
nuclei	O
indicated	O
that	O
early	O
and	O
late	O
cell	B-ANAT
apoptosis	O
induced	O
by	O
TGEV	O
was	O
inhibited	O
efficiently	O
.	O

17	O
pigs	O
,	O
in	O
which	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
was	O
induced	O
by	O
saline	O
lavage	O
,	O
were	O
studied	O
.	O

Patients	O
with	O
more	O
severe	O
clinical	O
manifestations	O
seemed	O
to	O
present	O
a	O
higher	O
level	O
of	O
Ag	O
-	O
specific	O
memory	O
T	B-ANAT
cell	I-ANAT
response	O
.	O

Since	O
the	O
mammalian	B-ANAT
cell	I-ANAT
system	O
is	O
capable	O
of	O
post	O
-	O
translational	O
modification	O
,	O
thus	O
forming	O
properly	O
folded	O
and	O
glycosylated	O
proteins	O
,	O
recombinant	O
proteins	O
expressed	O
in	O
mammalian	O
cells	B-ANAT
have	O
shown	O
the	O
greatest	O
potential	O
to	O
maintain	O
high	O
antigenicity	O
and	O
immunogenicity	O
.	O

RESULTS	O
:	O
5H10	O
,	O
which	O
recognized	O
the	O
same	O
epitope	O
that	O
is	O
also	O
a	O
cleavage	O
site	O
critical	O
for	O
the	O
entry	O
of	O
SARS	O
-	O
CoV	O
into	O
host	O
cells	B-ANAT
,	O
inhibited	O
propagation	O
of	O
the	O
virus	O
and	O
pathological	O
changes	O
found	O
in	O
Rhesus	O
macaques	O
infected	O
with	O
the	O
virus	O
through	O
the	O
nasal	B-ANAT
route	O
.	O

The	O
virus	B-ANAT
particles	I-ANAT
revealed	O
the	O
characteristic	O
morphology	O
of	O
feline	O
FCoV	O
represented	O
by	O
envelope	B-ANAT
viruses	O
surrounded	O
by	O
peplomers	O
.	O

Following	O
oral	B-ANAT
and	O
nasal	B-ANAT
administration	O
to	O
chickens	O
,	O
the	O
serum	B-ANAT
and	O
mucosal	B-ANAT
samples	O
were	O
collected	O
and	O
antibodies	O
against	O
IBV	O
were	O
measured	O
.	O

ABSTRACT	O
:	O
In	O
order	O
to	O
survive	O
and	O
propagate	O
,	O
RNA	O
viruses	O
must	O
achieve	O
a	O
balance	O
between	O
the	O
capacity	O
for	O
adaptation	O
to	O
new	O
environmental	O
conditions	O
or	O
host	O
cells	B-ANAT
with	O
the	O
need	O
to	O
maintain	O
an	O
intact	O
and	O
replication	O
competent	O
genome	O
.	O

Mortality	O
,	O
(	O
multi	O
)	O
organ	B-ANAT
failure	O
during	O
admission	O
were	O
observed	O
,	O
blood	B-ANAT
samples	I-ANAT
for	O
laboratory	O
analysis	O
were	O
drawn	O
on	O
admission	O
,	O
on	O
Days	O
3	O
,	O
7	O
,	O
and	O
14	O
of	O
the	O
treatment	O
.	O

Plaque	O
formation	O
and	O
chicken	O
embryo	B-ANAT
infectivity	O
assays	O
confirmed	O
these	O
results	O
.	O

Furthermore	O
,	O
this	O
autoAb	O
disappeared	O
after	O
30	O
days	O
of	O
treatment	O
with	O
ethyl	O
pyruvate	O
,	O
along	O
with	O
a	O
substantial	O
reduction	O
in	O
serum	B-ANAT
HMGB1	O
concentration	O
.	O

TITLE	O
:	O
Soluble	O
endothelial	B-ANAT
selectin	O
in	O
acute	O
lung	B-ANAT
injury	O
complicated	O
by	O
severe	O
pneumonia	O
.	O

Complication	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
by	O
pneumonia	O
makes	O
patients	O
very	O
ill	O
due	O
to	O
severe	O
respiratory	O
failure	O
.	O

When	O
infected	O
Vero	B-ANAT
cells	I-ANAT
were	O
cultured	O
for	O
3	O
days	O
in	O
the	O
absence	O
of	O
trypsin	O
but	O
were	O
then	O
treated	O
transiently	O
with	O
trypsin	O
,	O
infectious	O
viruses	O
were	O
immediately	O
released	O
from	O
infected	O
cells	B-ANAT
.	O

TITLE	O
:	O
Characterization	O
of	O
splenic	B-ANAT
cells	B-ANAT
during	O
the	O
early	O
phase	O
of	O
infection	O
with	O
neuropathogenic	O
mouse	O
hepatitis	O
virus	O
.	O

The	O
cytospin	O
procedure	O
enabled	O
effective	O
preservation	O
of	O
the	O
cells	B-ANAT
on	O
glass	O
slides	O
.	O

ABSTRACT	O
:	O
Stepwise	O
recruitment	O
maneuvers	O
(	O
RM	O
)	O
applied	O
with	O
high	O
airway	B-ANAT
pressures	O
may	O
optimize	O
lung	B-ANAT
recruitment	O
,	O
but	O
this	O
kind	O
of	O
intervention	O
may	O
lead	O
to	O
widely	O
heterogeneous	O
responses	O
with	O
possible	O
side	O
effects	O
.	O

Starting	O
from	O
a	O
Pplat	O
/	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
of	O
40	O
/	O
25	O
,	O
we	O
sequentially	O
increased	O
airway	B-ANAT
pressure	O
in	O
5	O
cmH	O
(	O
2	O
)	O
O	O
steps	O
until	O
a	O
PaO	O
(	O
2	O
)/	O
FiO	O
(	O
2	O
)	O
of	O
350	O
mmHg	O
or	O
a	O
Pplat	O
/	O
PEEP	O
of	O
60	O
/	O
40	O
cmH	O
(	O
2	O
)	O
O	O
was	O
reached	O
.	O

The	O
medium	O
-	O
term	O
renal	B-ANAT
outcome	O
of	O
the	O
Chinese	O
population	O
appears	O
to	O
be	O
more	O
favourable	O
than	O
the	O
Caucasians	O
.	O

Intranasal	O
inoculation	O
of	O
ferrets	O
with	O
influenza	O
A	O
/	O
H5N1	O
virus	O
causes	O
lesions	O
in	O
both	O
the	O
respiratory	B-ANAT
tract	I-ANAT
and	O
extrarespiratory	O
organs	B-ANAT
(	O
primarily	O
brain	B-ANAT
).	O

In	O
the	O
present	O
study	O
,	O
we	O
characterized	O
lesions	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
and	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
of	O
ferrets	O
(	O
n	O
=	O
8	O
)	O
inoculated	O
intranasally	O
with	O
influenza	O
virus	O
A	O
/	O
Indonesia	O
/	O
5	O
/	O
2005	O
(	O
H5N1	O
).	O

Most	O
recently	O
,	O
clinical	O
trials	O
with	O
Î²2	O
agonists	O
aiding	O
alveolar	B-ANAT
fluid	O
clearance	O
and	O
immunonutrition	O
with	O
omega	O
-	O
3	O
fatty	O
acids	O
have	O
also	O
provided	O
disappointing	O
results	O
.	O

ABSTRACT	O
:	O
Delayed	O
acute	O
abdominal	B-ANAT
compartment	I-ANAT
syndrome	O
(	O
ACS	O
)	O
due	O
to	O
retroperitoneal	B-ANAT
bleeding	O
is	O
rare	O
.	O

His	O
abdomen	B-ANAT
was	O
soft	O
and	O
not	O
distended	O
.	O

The	O
abdomen	B-ANAT
was	O
closed	O
primarily	O
on	O
day	O
6	O
.	O

TITLE	O
:	O
Viral	O
-	O
bacterial	O
co	O
-	O
infection	O
in	O
Australian	O
Indigenous	O
children	O
with	O
acute	O
otitis	O
media	B-ANAT
.	O

TITLE	O
:	O
Detection	O
of	O
feline	O
herpes	O
virus	O
1	O
via	O
polymerase	O
chain	O
reaction	O
and	O
immunohistochemistry	O
in	O
cats	O
with	O
ulcerative	O
facial	B-ANAT
dermatitis	O
,	O
eosinophilic	O
granuloma	O
complex	O
reaction	O
patterns	O
and	O
mosquito	O
bite	O
hypersensitivity	O
.	O

In	O
this	O
retrospective	O
study	O
,	O
we	O
evaluated	O
the	O
presence	O
of	O
FHV	O
-	O
1	O
by	O
IHC	O
and	O
PCR	O
in	O
skin	B-ANAT
biopsies	O
and	O
compared	O
the	O
results	O
of	O
the	O
two	O
tests	O
.	O

In	O
addition	O
the	O
more	O
severe	O
complications	O
of	O
sickle	B-ANAT
cell	I-ANAT
,	O
including	O
the	O
acute	O
chest	B-ANAT
syndrome	O
and	O
stroke	O
are	O
covered	O
.	O

EPA	O
/	O
GLA	O
has	O
anti	O
-	O
inflammatory	O
benefits	O
,	O
as	O
evidenced	O
by	O
its	O
association	O
with	O
reduction	O
in	O
pulmonary	B-ANAT
inflammation	O
,	O
improvement	O
in	O
oxygenation	O
and	O
improved	O
clinical	O
outcomes	O
in	O
patients	O
with	O
severe	O
forms	O
of	O
acute	O
lung	B-ANAT
injury	O
.	O

Secondary	O
outcomes	O
included	O
the	O
development	O
of	O
individual	O
organ	B-ANAT
failure	O
,	O
increased	O
ICU	O
and	O
hospital	O
length	O
of	O
stay	O
,	O
need	O
for	O
mechanical	O
ventilation	O
and	O
28	O
-	O
day	O
all	O
-	O
cause	O
mortality	O
.	O

Data	O
suggest	O
that	O
severe	O
pulmonary	B-ANAT
involvement	O
in	O
HVS1	O
infection	O
associated	O
with	O
septicemia	O
/	O
shock	O
is	O
a	O
rare	O
but	O
often	O
fatal	O
in	O
immunocompetent	O
adult	O
as	O
well	O
.	O

ABSTRACT	O
:	O
Pericardial	B-ANAT
effusion	I-ANAT
is	O
a	O
common	O
finding	O
in	O
everyday	O
clinical	O
practice	O
.	O

In	O
the	O
middle	O
,	O
echocardiographic	O
tamponade	O
is	O
recognized	O
by	O
the	O
presence	O
of	O
cardiac	B-ANAT
chamber	I-ANAT
collapses	O
and	O
characteristic	O
alterations	O
in	O
respiratory	O
variations	O
of	O
mitral	O
and	O
tricuspid	O
flow	O
.	O

ABSTRACT	O
:	O
Porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
infection	O
in	O
Vero	B-ANAT
cells	I-ANAT
is	O
facilitated	O
by	O
trypsin	O
through	O
an	O
undefined	O
mechanism	O
.	O

Trypsin	O
treatment	O
during	O
the	O
budding	O
stage	O
of	O
virus	O
infection	O
induces	O
an	O
obvious	O
cytopathic	O
effect	O
in	O
infected	O
cells	B-ANAT
.	O

These	O
findings	O
indicate	O
that	O
trypsin	O
affects	O
only	O
cell	B-ANAT
-	O
attached	O
PEDV	O
and	O
increases	O
infectivity	O
and	O
syncytium	B-ANAT
formation	O
in	O
PEDV	O
-	O
infected	O
Vero	B-ANAT
cells	I-ANAT
by	O
cleavage	O
of	O
the	O
PEDV	O
S	O
protein	O
.	O

TITLE	O
:	O
Mineralocorticoid	O
receptor	O
antagonism	O
:	O
therapeutic	O
potential	O
in	O
acute	O
heart	B-ANAT
failure	O
syndromes	O
.	O

Dyspnoea	O
,	O
pulmonary	B-ANAT
,	O
and	O
systemic	O
congestion	O
often	O
characterize	O
AHFS	O
due	O
to	O
acutely	O
elevated	O
intracardiac	B-ANAT
filling	O
pressures	O
and	O
fluid	O
overload	O
.	O

ABSTRACT	O
:	O
Reversible	O
cerebral	B-ANAT
vasoconstriction	O
syndrome	O
(	O
RCVS	O
)	O
has	O
reversible	O
multifocal	O
narrowing	O
of	O
the	O
cerebral	B-ANAT
arteries	I-ANAT
.	O

A	O
54	O
year	O
-	O
old	O
woman	O
presented	O
with	O
a	O
1	O
-	O
week	O
of	O
throbbing	O
headache	O
around	O
her	O
forehead	B-ANAT
while	O
travelling	O
in	O
moderately	O
high	O
altitude	O
,	O
during	O
a	O
windy	O
winter	O
.	O

Another	O
issue	O
is	O
the	O
potential	O
environmental	O
resistance	O
and	O
spread	O
of	O
viral	B-ANAT
particles	I-ANAT
.	O

Macromolecular	O
synthesis	O
analysis	O
showed	O
that	O
rTGEV	O
-	O
Î7	O
virus	O
infection	O
led	O
to	O
host	O
translational	O
shut	O
-	O
off	O
and	O
increased	O
cellular	B-ANAT
RNA	O
degradation	O
compared	O
with	O
rTGEV	O
-	O
wt	O
infection	O
.	O

Overall	O
,	O
the	O
results	O
indicated	O
that	O
gene	O
7	O
counteracted	O
host	B-ANAT
cell	I-ANAT
defenses	O
,	O
and	O
modified	O
TGEV	O
persistence	O
increasing	O
TGEV	O
survival	O
.	O

TITLE	O
:	O
Establishment	O
of	O
a	O
novel	O
ovine	O
kidney	B-ANAT
cell	I-ANAT
line	O
for	O
isolation	O
and	O
propagation	O
of	O
viruses	O
infecting	O
domestic	O
cloven	O
-	O
hoofed	B-ANAT
animal	O
species	O
.	O

Whenever	O
surfactant	O
inactivation	O
is	O
suspected	O
,	O
higher	O
or	O
repetitive	O
doses	O
of	O
natural	O
surfactant	O
may	O
help	O
to	O
overcome	O
surfactant	O
inactivation	O
and	O
to	O
restore	O
lung	B-ANAT
function	O
.	O

However	O
,	O
in	O
the	O
surviving	O
mice	O
,	O
instead	O
of	O
DAD	O
,	O
glandular	B-ANAT
metaplasia	O
was	O
broadly	O
observed	O
in	O
their	O
lungs	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
role	O
of	O
airway	B-ANAT
pressure	O
release	O
ventilation	O
in	O
the	O
management	O
of	O
early	O
smoke	O
inhalation	O
injury	O
has	O
not	O
been	O
studied	O
.	O

They	O
also	O
suggest	O
two	O
mechanisms	O
by	O
which	O
TNFR1	O
mediates	O
TNF	O
-	O
Î±	O
-	O
driven	O
DC	O
maturation	O
,	O
as	O
follows	O
:	O
a	O
direct	O
effect	O
through	O
TNFR1	O
expressed	O
on	O
immature	O
DCs	O
and	O
an	O
indirect	O
effect	O
through	O
TNFR1	O
expressed	O
on	O
naive	O
T	B-ANAT
cells	I-ANAT
.	O

TITLE	O
:	O
Effects	O
of	O
hypercapnia	O
and	O
hypercapnic	O
acidosis	O
on	O
attenuation	O
of	O
ventilator	O
-	O
associated	O
lung	B-ANAT
injury	O
.	O

Arterial	B-ANAT
blood	I-ANAT
gases	O
,	O
spirometry	O
,	O
and	O
hemodynamic	O
parameters	O
were	O
repeatedly	O
obtained	O
in	O
all	O
phases	O
of	O
CMV	O
and	O
HFOV	O
at	O
different	O
settings	O
.	O

Higher	O
respiratory	B-ANAT
system	I-ANAT
compliance	O
and	O
tidal	O
volume	O
were	O
found	O
during	O
CMV	O
after	O
24	O
hours	O
of	O
HFOV	O
.	O

Viruses	O
carrying	O
the	O
(	O
131	O
)	O
ACA	B-ANAT
(	O
133	O
)	O
deletion	O
were	O
heterogeneous	O
in	O
plaque	O
size	O
.	O

Little	O
is	O
known	O
about	O
processes	O
which	O
determine	O
the	O
endothelial	B-ANAT
barrier	O
enhancement	O
or	O
protection	O
against	O
permeability	O
increase	O
.	O

ABSTRACT	O
:	O
The	O
management	O
of	O
bronchial	B-ANAT
fistula	O
associated	O
with	O
acute	O
lung	B-ANAT
injury	O
raises	O
two	O
major	O
concerns	O
:	O
(	O
1	O
)	O
high	O
ventilation	O
pressures	O
are	O
necessary	O
for	O
lung	B-ANAT
recruitment	O
but	O
detrimental	O
for	O
fistula	O
healing	O
,	O
and	O
(	O
2	O
)	O
adequate	O
lung	B-ANAT
recruitment	O
is	O
prevented	O
by	O
large	O
air	O
leak	O
.	O

This	O
enhancement	O
was	O
further	O
observed	O
by	O
the	O
reduction	O
of	O
TGEV	O
shedding	O
and	O
replication	O
,	O
and	O
the	O
expression	O
of	O
IFN	O
-	O
stimulated	O
gene	O
products	O
in	O
the	O
intestinal	B-ANAT
tract	I-ANAT
.	O

ABSTRACT	O
:	O
A	O
2	O
-	O
year	O
-	O
old	O
black	O
girl	O
was	O
diagnosed	O
with	O
Sweet	O
syndrome	O
and	O
cutis	B-ANAT
laxa	O
,	O
and	O
she	O
was	O
given	O
corticosteroid	O
therapy	O
.	O

Patients	O
with	O
septic	O
shock	O
in	O
whom	O
pulmonary	B-ANAT
artery	I-ANAT
catheter	O
(	O
PAC	O
)	O
was	O
inserted	O
were	O
included	O
in	O
the	O
study	O
.	O

If	O
their	O
'	B-ANAT
fresh	I-ANAT
'	O
host	O
had	O
no	O
defences	O
,	O
the	O
viruses	O
could	O
cause	O
a	O
serious	O
pandemic	O
,	O
as	O
seen	O
with	O
HIV	O
,	O
SARS	O
(	O
severe	O
acute	O
respiratory	O
syndrome	O
)	O
and	O
avian	O
influenza	O
virus	O
that	O
originated	O
from	O
chimpanzees	O
,	O
the	O
common	O
palm	B-ANAT
civet	O
and	O
birds	O
,	O
respectively	O
.	O

TITLE	O
:	O
Interventional	O
lung	B-ANAT
assist	O
enables	O
lung	B-ANAT
protective	O
mechanical	O
ventilation	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
meta	O
-	O
analysis	O
on	O
individual	O
data	O
of	O
these	O
three	O
studies	O
showed	O
that	O
the	O
hospital	O
mortality	O
was	O
not	O
significantly	O
different	O
between	O
the	O
two	O
groups	O
of	O
patients	O
,	O
was	O
significantly	O
lower	O
in	O
the	O
higher	O
PEEP	O
group	O
in	O
the	O
subset	O
of	O
ARDS	O
patients	O
(	O
PaO	O
(	O
2	O
)/	O
F	O
(	O
I	O
)	O
O	O
(	O
2	O
)	O
â¤	O
200	O
mm	O
Hg	O
),	O
and	O
tended	O
to	O
be	O
higher	O
in	O
the	O
higher	O
PEEP	O
group	O
in	O
the	O
subset	O
of	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
(	O
200	O
<	O
PaO	O
(	O
2	O
)/	O
F	O
(	O
I	O
)	O
O	O
(	O
2	O
)	O
â¤	O
300	O
mm	O
Hg	O
).	O

More	O
than	O
one	O
tissue	B-ANAT
sample	I-ANAT
is	O
suggested	O
to	O
screen	O
WNv	O
infection	O
using	O
IHC	O
technique	O
.	O

TITLE	O
:	O
The	O
NS1	O
glycoprotein	O
can	O
generate	O
dramatic	O
antibody	O
-	O
enhanced	O
dengue	O
viral	O
replication	O
in	O
normal	O
out	O
-	O
bred	O
mice	O
resulting	O
in	O
lethal	O
multi	O
-	O
organ	B-ANAT
disease	O
.	O

Their	O
spleens	B-ANAT
contained	O
infiltrated	O
megakaryocytes	B-ANAT
with	O
DENV	O
-	O
2	O
antigen	O
-	O
positive	O
red	O
-	O
pulp	B-ANAT
macrophages	B-ANAT
,	O
while	O
their	O
livers	B-ANAT
displayed	O
extensive	O
necrosis	O
,	O
apoptosis	O
and	O
macro	O
-	O
and	O
micro	O
-	O
steatosis	O
,	O
with	O
DENV	O
-	O
2	O
antigen	O
-	O
positive	O
Kuppfer	O
cells	B-ANAT
and	O
hepatocytes	B-ANAT
.	O

This	O
DENV	O
-	O
2	O
AER	B-ANAT
/	O
AED	O
was	O
blocked	O
by	O
high	O
concentrations	O
of	O
only	O
the	O
NG	O
-	O
C	O
NS1	O
glycoprotein	O
.	O

Predicting	O
and	O
identifying	O
super	O
-	O
spreaders	O
open	O
significant	O
medical	O
and	O
public	O
health	O
challenges	O
,	O
and	O
represent	O
important	O
facets	B-ANAT
of	O
infectious	O
disease	O
management	O
and	O
pandemic	O
preparedness	O
plans	O
.	O

ABSTRACT	O
:	O
Retroviruses	O
assemble	O
new	O
virus	B-ANAT
particles	I-ANAT
that	O
are	O
released	O
by	O
budding	O
from	O
the	O
plasma	B-ANAT
membranes	I-ANAT
of	O
infected	O
cells	B-ANAT
.	O

We	O
propose	O
that	O
association	O
of	O
the	O
viral	O
RNA	O
induces	O
a	O
conformational	O
change	O
in	O
Gag	O
that	O
reveals	O
its	O
nuclear	O
export	O
signal	O
(	O
NES	O
)	O
and	O
prepares	O
that	O
complex	O
for	O
its	O
journey	O
to	O
the	O
plasma	B-ANAT
membrane	I-ANAT
for	O
budding	O
.	O

However	O
,	O
dysfunction	O
in	O
many	O
organ	B-ANAT
systems	I-ANAT
,	O
including	O
the	O
kidneys	B-ANAT
,	O
has	O
also	O
been	O
described	O
.	O

Chest	B-ANAT
radiography	O
shows	O
diffuse	O
pulmonary	B-ANAT
opacities	O
.	O

ABSTRACT	O
:	O
Acute	O
encephalitis	O
,	O
encephalopathy	O
,	O
and	O
seizures	O
are	O
known	O
rare	O
neurologic	O
sequelae	O
of	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
with	O
seasonal	O
influenza	O
A	O
and	O
B	O
virus	O
,	O
but	O
the	O
neurological	O
complications	O
of	O
the	O
pandemic	O
2009	O
swine	O
influenza	O
A	O
(	O
H1N1	O
)	O
virus	O
,	O
particularly	O
in	O
adults	O
,	O
are	O
ill	O
-	O
defined	O
.	O

These	O
virus	O
-	O
specific	O
T	B-ANAT
reg	I-ANAT
cells	B-ANAT
may	O
be	O
especially	O
effective	O
in	O
inhibiting	O
the	O
immune	O
response	O
during	O
the	O
peak	O
of	O
infection	O
,	O
when	O
virus	O
antigen	O
is	O
maximal	O
.	O

These	O
results	O
show	O
that	O
pathogen	O
epitope	O
-	O
specific	O
Foxp3	O
(+)	O
T	B-ANAT
reg	I-ANAT
cells	B-ANAT
can	O
be	O
identified	O
on	O
the	O
basis	O
of	O
cytokine	O
production	O
.	O

Ultrasound	O
examination	O
and	O
urine	B-ANAT
test	O
was	O
inconspicuous	O
.	O

Curettage	B-ANAT
post	O
abortem	O
was	O
not	O
necessary	O
.	O

Autopsy	O
findings	O
failed	O
to	O
show	O
influenza	O
in	O
the	O
lungs	B-ANAT
or	O
lupus	O
pneumonitis	O
.	O

High	O
levels	O
of	O
PD	O
-	O
1	O
-	O
positive	O
CD4	O
(+),	O
CD8	O
(+)	O
T	O
cells	B-ANAT
,	I-ANAT
NK	I-ANAT
cells	B-ANAT
and	O
macrophages	B-ANAT
were	O
observed	O
in	O
liver	B-ANAT
,	O
spleen	B-ANAT
,	O
lymph	B-ANAT
node	I-ANAT
and	O
thymus	B-ANAT
tissues	B-ANAT
following	O
MHV	O
-	O
3	O
infection	O
.	O

These	O
data	O
imply	O
that	O
the	O
ability	O
of	O
MHV	O
to	O
replicate	O
in	O
macrophages	B-ANAT
is	O
a	O
prerequisite	O
for	O
replication	O
in	O
the	O
liver	B-ANAT
and	O
induction	O
of	O
hepatitis	O
but	O
not	O
for	O
replication	O
or	O
disease	O
in	O
the	O
CNS	B-ANAT
,	O
underscoring	O
the	O
importance	O
of	O
IFN	O
signaling	O
in	O
macrophages	B-ANAT
in	O
vivo	O
for	O
protection	O
of	O
the	O
host	O
from	O
hepatitis	O
.	O

Endotoxin	O
produced	O
a	O
severe	O
lung	B-ANAT
injury	O
compared	O
to	O
sham	O
injury	O
.	O

The	O
AAV	O
vector	O
encoding	O
EC	O
-	O
SOD	O
increased	O
lung	B-ANAT
EC	O
-	O
SOD	O
concentrations	O
,	O
and	O
enhanced	O
the	O
antioxidant	O
capacity	O
of	O
the	O
lung	B-ANAT
.	O

These	O
viruses	O
are	O
distributed	O
throughout	O
the	O
globe	B-ANAT
and	O
affect	O
people	O
of	O
all	O
ages	O
.	O

Likewise	O
,	O
the	O
SARS	O
VLP	B-ANAT
vaccine	O
,	O
containing	O
4	O
Î¼g	O
of	O
S	O
protein	O
without	O
adjuvant	O
,	O
reduced	O
lung	B-ANAT
virus	O
titer	O
to	O
below	O
detectable	O
level	O
,	O
protected	O
mice	O
from	O
weight	O
loss	O
,	O
and	O
elicited	O
a	O
high	O
level	O
of	O
neutralizing	O
antibodies	O
against	O
SARS	O
-	O
CoV	O
.	O
Sf9	B-ANAT
cell	I-ANAT
-	O
produced	O
full	O
length	O
purified	O
SARS	O
S	O
protein	O
was	O
also	O
an	O
effective	O
vaccine	O
against	O
SARS	O
-	O
CoV	O
but	O
only	O
when	O
co	O
-	O
administered	O
IM	O
with	O
aluminum	O
hydroxide	O
.	O

ABSTRACT	O
:	O
Prokaryotic	O
expression	O
plasmids	O
carrying	O
N	O
-	O
terminal	O
(	O
1	O
-	O
163aa	O
)	O
and	O
C	O
-	O
terminal	O
(	O
141	O
-	O
306aa	O
)	O
gene	O
of	O
HCoV	O
-	O
NL63	O
nucleocapsid	B-ANAT
protein	O
were	O
constructed	O
with	O
pET	O
-	O
30a	O
(+)	O
vector	O
.	O

We	O
detected	O
anti	O
-	O
HCoV	O
-	O
NL63	O
antibodies	O
among	O
50	O
sera	B-ANAT
samples	O
collected	O
from	O
adult	O
for	O
health	O
-	O
examination	O
by	O
WBLA	O
.	O

The	O
results	O
showed	O
that	O
:	O
25	O
(	O
50	O
%),	O
27	O
(	O
54	O
%),	O
36	O
(	O
72	O
%)	O
of	O
50	O
sera	B-ANAT
were	O
indentified	O
as	O
anti	O
-	O
HCoV	O
-	O
NL63	O
antibody	O
positive	O
when	O
the	O
antigen	O
was	O
from	O
Nf	O
,	O
Np	O
and	O
Cp	O
,	O
respectively	O
.	O

In	O
addition	O
,	O
the	O
display	O
of	O
detection	O
data	O
on	O
remote	O
platforms	O
such	O
as	O
cell	B-ANAT
phone	O
and	O
computer	O
was	O
also	O
successfully	O
demonstrated	O
with	O
a	O
wireless	O
module	O
.	O

TITLE	O
:	O
[	O
Detection	O
and	O
clinical	O
study	O
on	O
coronavirus	O
HKU1	O
with	O
acute	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
of	O
hospitalized	O
children	O
in	O
Changsha	O
].	O

The	O
C	O
-	O
terminal	O
domain	O
of	O
SARS	O
-	O
CoV	O
nsp2	O
was	O
cloned	O
,	O
overexpressed	O
,	O
purified	O
and	O
crystallized	O
using	O
polyethylene	O
glycol	O
5000	O
monomethyl	O
ether	O
as	O
the	O
precipitant	O
;	O
the	O
crystals	B-ANAT
diffracted	O
to	O
2	O
.	O
5	O
Ã	O
resolution	O
.	O

Serum	B-ANAT
and	O
bronchoalveolar	O
lavage	O
samples	O
were	O
obtained	O
from	O
three	O
mechanically	O
ventilated	O
patients	O
diagnosed	O
with	O
Influenza	O
A	O
(	O
H1N1	O
)	O
virus	O
pneumonia	O
by	O
bronchoscopic	O
bronchoalveolar	O
lavage	O
.	O

Our	O
results	O
showed	O
that	O
:	O
(	O
i	O
)	O
deletion	O
of	O
18aa	O
from	O
the	O
C	O
-	O
terminus	O
enhanced	O
the	O
S	O
protein	O
accumulation	O
and	O
virus	O
entry	O
,	O
which	O
might	O
be	O
due	O
to	O
the	O
deletion	O
of	O
intracellular	B-ANAT
retention	O
signals	O
;	O
(	O
ii	O
)	O
further	O
deletion	O
to	O
residue	O
29	O
also	O
enhanced	O
the	O
amount	O
of	O
S	O
protein	O
on	O
the	O
cell	B-ANAT
surface	I-ANAT
and	O
in	O
virion	B-ANAT
,	O
but	O
reduced	O
virus	O
entry	O
by	O
25	O
%,	O
suggesting	O
that	O
residues	O
19	O
-	O
29	O
contributes	O
to	O
membrane	B-ANAT
fusion	O
;	O
(	O
iii	O
)	O
a	O
29aa	O
-	O
deletion	O
mutant	O
had	O
a	O
defect	O
in	O
anchoring	O
on	O
the	O
plasma	B-ANAT
membrane	I-ANAT
,	O
which	O
led	O
to	O
a	O
dramatic	O
decrease	O
of	O
S	O
protein	O
in	O
virion	B-ANAT
and	O
virus	O
entry	O
;	O
(	O
iv	O
)	O
a	O
total	O
of	O
15	O
residues	O
(	O
Y498	O
,	O
V499	O
,	O
V531	O
,	O
G534	O
,	O
G537	O
,	O
D538	O
,	O
S540	O
,	O
G575	O
,	O
S576	O
,	O
E582	O
,	O
W585	O
,	O
Y590	O
,	O
T591	O
,	O
V593	O
and	O
G594	O
)	O
within	O
RBD	O
were	O
important	O
for	O
receptor	O
binding	O
and	O
virus	O
entry	O
.	O

ABSTRACT	O
:	O
Expression	O
of	O
matrix	O
metalloproteinases	O
(	O
MMPs	O
),	O
especially	O
MMP9	O
correlates	O
with	O
blood	B-ANAT
-	I-ANAT
brain	I-ANAT
barrier	I-ANAT
(	O
BBB	B-ANAT
)	O
disruption	O
during	O
many	O
neuroinflammatory	O
diseases	O
.	O

By	O
contrast	O
,	O
infected	O
MMP9	O
(-/-)	O
mice	O
revealed	O
no	O
differences	O
in	O
CNS	B-ANAT
leukocyte	B-ANAT
infiltration	O
,	O
composition	O
or	O
localization	O
,	O
consistent	O
with	O
BBB	B-ANAT
disruption	O
similar	O
to	O
wild	O
-	O
type	O
(	O
WT	O
)	O
mice	O
.	O

Unimpaired	O
T	B-ANAT
cell	I-ANAT
mediated	O
virus	O
control	O
supported	O
an	O
unexpectedly	O
redundant	O
role	O
of	O
MMP9	O
in	O
promoting	O
leukocyte	B-ANAT
access	O
to	O
the	O
brain	B-ANAT
parenchyma	B-ANAT
.	O

Two	O
pairs	O
of	O
primers	O
used	O
to	O
amplify	O
N	O
gene	O
and	O
B23	O
.	O
1	O
gene	O
were	O
designed	O
and	O
synthesized	O
according	O
to	O
CV777	O
N	O
gene	O
sequence	O
(	O
AF353511	O
)	O
and	O
human	O
nucleolar	B-ANAT
phosphoprotein	O
B23	O
.	O
1	O
gene	O
sequence	O
(	O
BC050628	O
.	O
1	O
),	O
respectively	O
.	O

The	O
fusion	O
proteins	O
successfully	O
expressed	O
in	O
transfected	O
Vero	O
E6	O
cells	B-ANAT
by	O
western	O
blot	O
analysis	O
,	O
and	O
the	O
PEDV	O
N	O
protein	O
and	O
the	O
B23	O
.	O
1	O
phosphoprotein	O
showed	O
co	O
-	O
localization	O
features	O
in	O
co	O
-	O
transfected	O
cells	B-ANAT
through	O
confocal	O
microscopy	O
analysis	O
.	O

RESULTS	O
:	O
The	O
fusion	O
proteins	O
successfully	O
expressed	O
in	O
transfected	O
Vero	O
E6	O
cells	B-ANAT
by	O
western	O
blot	O
analysis	O
,	O
and	O
the	O
PEDV	O
N	O
protein	O
and	O
the	O
B23	O
.	O
1	O
phosphoprotein	O
showed	O
co	O
-	O
localization	O
features	O
in	O
co	O
-	O
transfected	O
cells	B-ANAT
through	O
confocal	O
microscopy	O
analysis	O
.	O

This	O
was	O
an	O
observational	O
cohort	O
study	O
of	O
114	O
adults	O
with	O
SCD	O
who	O
completed	O
respiratory	O
symptom	O
questionnaires	O
and	O
had	O
serum	B-ANAT
IgE	O
measurements	O
.	O

Furthermore	O
,	O
ELISA	O
performed	O
using	O
these	O
peptides	O
was	O
more	O
sensitive	O
than	O
commercial	O
ELISA	O
used	O
for	O
a	O
screening	O
sera	B-ANAT
from	O
mice	O
infected	O
accidentally	O
to	O
MHV	O
maintained	O
in	O
cages	O
,	O
suggesting	O
that	O
these	O
peptides	O
are	O
useful	O
for	O
serological	O
diagnosis	O
of	O
MHV	O
infection	O
.	O

TITLE	O
:	O
Engineering	O
T	B-ANAT
cells	I-ANAT
specific	O
for	O
a	O
dominant	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
CD8	O
T	B-ANAT
cell	I-ANAT
epitope	O
.	O

TITLE	O
:	O
Difficulties	O
with	O
neurological	O
prognostication	O
in	O
a	O
young	O
woman	O
with	O
delayed	O
-	O
onset	O
generalised	O
status	O
myoclonus	O
after	O
cardiac	B-ANAT
arrest	O
due	O
to	O
acute	O
severe	O
asthma	O
.	O

In	O
conclusion	O
,	O
E2	O
treatment	O
could	O
effectively	O
attenuate	O
seawater	O
aspiration	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
in	O
rats	O
by	O
the	O
down	O
-	O
regulation	O
of	O
AQP1	O
and	O
AQP5	O
.	O

The	O
assay	O
system	O
employs	O
a	O
novel	O
dual	O
envelope	B-ANAT
strategy	O
,	O
using	O
lentiviral	O
pseudovirions	O
as	O
targets	O
whose	O
entry	O
is	O
driven	O
by	O
the	O
SARS	O
-	O
CoV	O
Spike	O
glycoprotein	O
.	O

ABSTRACT	O
:	O
Deep	O
neck	B-ANAT
infections	O
(	O
DNI	O
)	O
are	O
potentially	O
lethal	O
processes	O
and	O
are	O
susceptible	O
to	O
severe	O
complications	O
.	O

More	O
than	O
30	O
%	O
of	O
cases	O
are	O
idiopathic	O
,	O
but	O
they	O
are	O
commonly	O
related	O
to	O
a	O
dental	O
or	O
oropharyngeal	B-ANAT
infection	O
.	O

TITLE	O
:	O
Extracorporeal	O
liver	B-ANAT
support	O
with	O
multipass	O
albumin	O
dialysis	O
or	O
plasmapheresis	O
and	O
filtering	O
systems	O
in	O
acute	O
liver	B-ANAT
failure	O
.	O

Other	O
retrospective	O
studies	O
have	O
shown	O
benefits	O
in	O
improving	O
hepatic	B-ANAT
encephalopathy	O
and	O
brain	B-ANAT
oedema	O
.	O

ABSTRACT	O
:	O
Anatomic	O
and	O
physiologic	O
changes	O
of	O
pregnancy	O
predispose	O
the	O
mother	O
to	O
increased	O
morbidity	O
and	O
mortality	O
whereas	O
increasing	O
risks	O
of	O
a	O
less	O
than	O
optimal	O
outcome	O
for	O
the	O
fetus	B-ANAT
.	O

Hospitals	O
must	O
establish	O
systems	O
to	O
assure	O
timely	O
assessment	O
,	O
multidisciplinary	O
care	O
,	O
and	O
possibly	O
a	O
plan	O
for	O
transfer	O
to	O
a	O
higher	O
level	O
of	O
care	O
to	O
provide	O
highest	O
quality	O
care	O
to	O
the	O
perinatal	O
patient	O
presenting	O
with	O
a	O
severe	O
respiratory	O
condition	O
to	O
promote	O
optimal	O
outcomes	O
for	O
the	O
woman	O
and	O
the	O
fetus	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
use	O
of	O
steroids	O
is	O
not	O
required	O
in	O
myeloid	O
malignancies	O
and	O
remains	O
controversial	O
in	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Blood	B-ANAT
samples	I-ANAT
from	O
eight	O
healthy	O
volunteers	O
were	O
used	O
as	O
control	O
.	O

Isolated	O
chest	B-ANAT
injury	O
,	O
however	O
,	O
was	O
not	O
abundant	O
enough	O
to	O
cause	O
ARDS	O
,	O
so	O
a	O
second	O
hit	O
appears	O
crucial	O
.	O

Antileukocyte	O
antibodies	O
in	O
blood	B-ANAT
donors	O
plasma	B-ANAT
,	O
caused	O
TRALI	O
in	O
89	O
%	O
of	O
cases	O
;	O
also	O
it	O
has	O
been	O
found	O
antigen	O
specificity	O
against	O
leukocyte	B-ANAT
blood	B-ANAT
receptor	O
in	O
59	O
%.	O

TITLE	O
:	O
Lung	B-ANAT
function	O
and	O
organ	B-ANAT
dysfunctions	O
in	O
178	O
patients	O
requiring	O
mechanical	O
ventilation	O
during	O
the	O
2009	O
influenza	O
A	O
(	O
H1N1	O
)	O
pandemic	O
.	O

The	O
complete	O
genome	O
sequencing	O
of	O
two	O
genotype	O
C	O
and	O
D	O
strains	O
and	O
bootscan	O
analysis	O
showed	O
recombination	O
events	O
between	O
genotypes	O
B	O
and	O
C	O
in	O
the	O
generation	O
of	O
genotype	O
D	O
.	O
Of	O
the	O
29	O
strains	O
,	O
none	O
belonged	O
to	O
the	O
more	O
ancient	O
genotype	O
A	O
,	O
5	O
from	O
2004	O
belonged	O
to	O
genotype	O
B	O
,	O
15	O
from	O
2004	O
to	O
2006	O
belonged	O
to	O
genotype	O
C	O
,	O
and	O
1	O
from	O
2004	O
and	O
all	O
8	O
from	O
2008	O
to	O
2011	O
belonged	O
to	O
the	O
recombinant	O
genotype	O
D	O
.	O
Molecular	O
clock	O
analysis	O
using	O
spike	O
and	O
nucleocapsid	B-ANAT
genes	O
dated	O
the	O
most	O
recent	O
common	O
ancestor	O
of	O
all	O
genotypes	O
to	O
the	O
1950s	O
,	O
genotype	O
B	O
and	O
C	O
to	O
the	O
1980s	O
,	O
genotype	O
B	O
to	O
the	O
1990s	O
,	O
and	O
genotype	O
C	O
to	O
the	O
late	O
1990s	O
to	O
early	O
2000s	O
,	O
while	O
the	O
recombinant	O
genotype	O
D	O
strains	O
were	O
detected	O
as	O
early	O
as	O
2004	O
.	O

Modern	O
molecular	O
technology	O
has	O
now	O
made	O
it	O
possible	O
to	O
detect	O
other	O
RVIs	O
including	O
human	O
metapneumovirus	O
,	O
coronavirus	O
,	O
and	O
bocavirus	O
,	O
and	O
the	O
role	O
of	O
these	O
viruses	O
in	O
causing	O
serious	O
disease	O
in	O
transplant	B-ANAT
recipients	O
is	O
still	O
being	O
worked	O
out	O
.	O

The	O
present	O
study	O
describes	O
abdominal	B-ANAT
imaging	O
features	O
of	O
11	O
ferrets	O
with	O
FSCV	O
.	O

Abdominal	B-ANAT
survey	O
radiographs	O
were	O
available	O
for	O
eight	O
ferrets	O
and	O
ultrasound	O
examination	O
for	O
all	O
cases	O
.	O

The	O
most	O
relevant	O
long	O
-	O
term	O
sequelae	O
,	O
bronchopulmonary	O
dysplasia	O
,	O
is	O
currently	O
being	O
observed	O
in	O
about	O
15	O
%	O
of	O
preterms	O
with	O
less	O
than	O
32	O
weeks	O
of	O
gestation	O
and	O
is	O
associated	O
with	O
severe	O
pulmonary	B-ANAT
and	O
extrapulmonary	O
consequences	O
.	O

Despite	O
the	O
fact	O
that	O
removal	O
of	O
useful	O
substances	O
cannot	O
be	O
ignored	O
,	O
we	O
believe	O
that	O
an	O
appropriate	O
stage	O
or	O
timing	O
can	O
be	O
identified	O
so	O
that	O
we	O
can	O
avoid	O
a	O
vicious	O
cycle	O
and	O
use	O
blood	B-ANAT
purification	O
with	O
effective	O
diffusion	O
,	O
filtration	O
and	O
adsorption	O
.	O

HRV	O
was	O
the	O
most	O
common	O
finding	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
,	O
independent	O
of	O
season	O
.	O

After	O
separation	O
of	O
the	O
nanoparticle	O
-	O
protein	B-ANAT
complex	I-ANAT
from	O
plasma	B-ANAT
,	O
the	O
protein	O
mixture	O
was	O
digested	O
,	O
and	O
peptides	O
were	O
analyzed	O
by	O
nanoliquid	O
chromatography	O
-	O
Orbitrap	O
LTQ	O
-	O
XL	O
mass	O
spectrometry	O
.	O

It	O
occurs	O
when	O
multiple	O
serotonergic	O
medications	O
are	O
ingested	O
and	O
is	O
associated	O
with	O
rapid	O
onset	O
of	O
altered	O
mental	O
status	O
,	O
myoclonus	O
,	O
and	O
autonomic	B-ANAT
instability	O
.	O

Further	O
,	O
we	O
have	O
examined	O
if	O
the	O
structure	O
of	O
mitochondria	B-ANAT
is	O
altered	O
.	O

Similarly	O
,	O
the	O
activity	O
of	O
electron	O
transport	O
chain	O
complex	B-ANAT
III	I-ANAT
was	O
inhibited	O
by	O
35	O
and	O
52	O
%	O
respectively	O
,	O
at	O
18	O
and	O
24	O
h	O
,	O
respectively	O
.	O

Our	O
results	O
also	O
suggest	O
mitochondrial	B-ANAT
swelling	O
in	O
FHF	O
induced	O
rats	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
effects	O
of	O
different	O
tidal	O
volumes	O
with	O
associated	O
hypercapnia	O
on	O
lung	B-ANAT
injury	O
and	O
gas	O
exchange	O
in	O
a	O
model	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
reduction	O
of	O
the	O
tidal	O
volume	O
below	O
4	O
-	O
5	O
ml	O
/	O
kg	O
did	O
not	O
enhance	O
lung	B-ANAT
protection	O
.	O

Taken	O
together	O
,	O
our	O
results	O
suggest	O
that	O
,	O
in	O
addition	O
to	O
ACE2	O
,	O
HSPGs	O
are	O
essential	O
cell	B-ANAT
-	O
surface	O
molecules	O
involved	O
in	O
SARS	O
-	O
CoV	O
cell	B-ANAT
entry	O
.	O

LF	O
may	O
play	O
a	O
protective	O
role	O
in	O
host	O
defense	O
against	O
SARS	O
-	O
CoV	O
infection	O
through	O
binding	O
to	O
HSPGs	O
and	O
blocking	O
the	O
preliminary	O
interaction	O
between	O
SARS	O
-	O
CoV	O
and	O
host	O
cells	B-ANAT
.	O

All	O
12	O
patients	O
survived	O
and	O
ten	O
had	O
complete	O
neurological	O
and	O
renal	B-ANAT
function	O
recovery	O
.	O

Further	O
,	O
the	O
mitochondrial	B-ANAT
translation	O
deficiencies	O
present	O
in	O
myoblasts	B-ANAT
from	O
mitochondrial	B-ANAT
encephalomyopathy	O
,	O
lactic	O
acidosis	O
and	O
stroke	O
-	O
like	O
episode	O
and	O
MERRF	O
patients	O
,	O
which	O
are	O
associated	O
with	O
defects	O
in	O
post	O
-	O
transcriptional	O
modification	O
of	O
mitochondrial	B-ANAT
tRNAs	O
,	O
did	O
not	O
worsen	O
following	O
knockdown	O
of	O
MTU1	O
in	O
these	O
cells	B-ANAT
.	O

These	O
findings	O
suggest	O
that	O
ChPLA2	O
-	O
V	O
could	O
be	O
a	O
potential	O
biomarker	O
for	O
lung	B-ANAT
inflammation	O
.	O

This	O
is	O
the	O
first	O
reported	O
study	O
that	O
demonstrates	O
quantitatively	O
and	O
objectively	O
the	O
substantial	O
impairment	O
of	O
nasal	B-ANAT
airflow	O
in	O
terms	O
of	O
increased	O
breathing	O
resistance	O
with	O
the	O
use	O
of	O
N95	O
respirators	O
on	O
actual	O
human	O
subjects	O
.	O

Î±	O
-	O
2	O
-	O
Heremans	O
-	O
Schmid	O
Glycoprotein	O
(	O
AHSG	O
),	O
which	O
is	O
required	O
for	O
macrophage	B-ANAT
deactivation	O
by	O
endogenous	O
cations	O
,	O
is	O
associated	O
with	O
inflammatory	O
regulation	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)	O
has	O
a	O
sialic	O
acid	O
binding	O
activity	O
that	O
is	O
believed	O
to	O
be	O
important	O
for	O
enteropathogenicity	O
,	O
but	O
that	O
has	O
so	O
far	O
appeared	O
to	O
be	O
dispensable	O
for	O
infection	O
of	O
cultured	B-ANAT
cells	I-ANAT
.	O

RESULTS	O
:	O
Desialylation	O
of	O
cells	B-ANAT
only	O
had	O
a	O
minor	O
effect	O
on	O
the	O
infection	O
by	O
TGEV	O
strain	O
Purdue	O
46	O
when	O
an	O
adsorption	O
period	O
of	O
60	O
min	O
was	O
allowed	O
for	O
initiation	O
of	O
infection	O
.	O

Nasopharyngeal	B-ANAT
specimens	O
from	O
children	O
less	O
than	O
16	O
years	O
old	O
who	O
were	O
suffering	O
from	O
acute	O
respiratory	O
diseases	O
were	O
tested	O
for	O
hMPV	O
and	O
HCoV	O
-	O
NL63	O
by	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
.	O

Lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
disease	O
occurs	O
in	O
immunocompromised	O
individuals	O
and	O
those	O
with	O
underlying	O
conditions	O
.	O

ABSTRACT	O
:	O
Perturbation	O
of	O
cell	B-ANAT
cycle	O
regulation	O
is	O
a	O
characteristic	O
feature	O
of	O
infection	O
by	O
many	O
DNA	O
and	O
RNA	O
viruses	O
,	O
including	O
Coronavirus	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
).	O

The	O
results	O
suggest	O
that	O
ANXA2	O
is	O
a	O
cellular	B-ANAT
RBP	O
that	O
can	O
modulate	O
the	O
frameshifting	O
efficiency	O
of	O
viral	O
RNA	O
,	O
enabling	O
it	O
to	O
act	O
as	O
an	O
anti	O
-	O
viral	O
cellular	B-ANAT
protein	O
,	O
and	O
hinting	O
at	O
roles	O
in	O
RNA	O
metabolism	O
for	O
other	O
cellular	B-ANAT
mRNAs	O
.	O

They	O
also	O
compared	O
changes	O
in	O
oxygenation	O
,	O
airway	B-ANAT
pressures	O
,	O
chest	B-ANAT
radiograph	O
findings	O
,	O
fluid	O
administration	O
,	O
and	O
early	O
development	O
of	O
pneumonia	O
and	O
organ	B-ANAT
failure	O
,	O
by	O
severity	O
of	O
inhalation	O
injury	O
according	O
to	O
the	O
AIS	O
.	O

Death	O
occurred	O
15	O
days	O
later	O
due	O
to	O
alveolar	B-ANAT
haemorrhage	O
following	O
a	O
further	O
""""	O
bang	O
""""	O
of	O
cannabis	O
.	O

These	O
acids	O
have	O
a	O
double	O
effect	O
on	O
the	O
lungs	B-ANAT
:	O
a	O
direct	O
toxicity	O
with	O
severe	O
inflammation	O
of	O
the	O
mucosa	B-ANAT
leading	O
to	O
alveolar	B-ANAT
haemorrhage	O
and	O
subsequently	O
the	O
acid	O
anhydrides	O
may	O
lead	O
to	O
the	O
syndrome	O
of	O
intra	O
-	O
alveolar	B-ANAT
haemorrhage	O
and	O
anaemia	O
described	O
in	O
occupational	O
lung	B-ANAT
diseases	O
by	O
Herbert	O
in	O
Oxford	O
in	O
1979	O
.	O

ABSTRACT	O
:	O
We	O
aimed	O
at	O
synchronously	O
examining	O
the	O
early	O
time	O
course	O
of	O
4	O
proinflammatory	O
cytokines	O
as	O
predictive	O
factors	O
for	O
development	O
of	O
organ	B-ANAT
failure	O
in	O
patients	O
with	O
acute	O
pancreatitis	O
(	O
AP	O
).	O

Inhibition	O
of	O
glutamate	O
excitotoxicity	O
using	O
a	O
2	O
-	O
amino	O
-	O
3	O
-(	O
5	O
-	O
methyl	O
-	O
3	O
-	O
oxo	O
-	O
1	O
,	O
2	O
-	O
oxazol	O
-	O
4	O
-	O
yl	O
)	O
propranoic	O
acid	O
(	O
AMPA	O
)	O
receptor	O
antagonist	O
(	O
GYKI	O
-	O
52466	O
)	O
improved	O
clinical	O
scores	O
related	O
to	O
the	O
paralysis	O
and	O
motor	O
disabilities	O
in	O
S	O
mutant	O
virus	O
-	O
infected	O
mice	O
,	O
as	O
well	O
as	O
protected	O
the	O
CNS	B-ANAT
from	O
neuronal	O
dysfunctions	O
,	O
as	O
illustrated	O
by	O
restoration	O
of	O
the	O
phosphorylation	O
state	O
of	O
neurofilaments	B-ANAT
.	O

Expression	O
of	O
the	O
glial	B-ANAT
glutamate	O
transporter	O
GLT	O
-	O
1	O
,	O
responsible	O
for	O
glutamate	O
homeostasis	O
,	O
was	O
downregulated	O
following	O
infection	O
,	O
and	O
GYKI	O
-	O
52466	O
also	O
significantly	O
restored	O
its	O
steady	O
-	O
state	O
expression	O
level	O
.	O

Finally	O
,	O
GYKI	O
-	O
52466	O
treatment	O
of	O
S	O
mutant	O
virus	O
-	O
infected	O
mice	O
led	O
to	O
reduced	O
microglial	B-ANAT
activation	O
,	O
which	O
may	O
lead	O
to	O
improvement	O
in	O
the	O
regulation	O
of	O
CNS	B-ANAT
glutamate	O
homeostasis	O
.	O

A	O
case	O
-	O
control	O
study	O
of	O
the	O
association	O
of	O
HLA	B-ANAT
with	O
SARS	O
revealed	O
that	O
the	O
HLA	B-ANAT
-	O
Cw1502	O
and	O
DR0301	O
alleles	O
conferred	O
resistance	O
against	O
SARS	O
infection	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

TITLE	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
as	O
a	O
bridge	O
to	O
liver	B-ANAT
transplantation	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
-	O
induced	O
life	O
-	O
threatening	O
hypoxaemia	O
aggravated	O
by	O
hepatopulmonary	O
syndrome	O
.	O

Orthotopic	O
liver	B-ANAT
transplantation	O
was	O
performed	O
at	O
Day	O
13	O
.	O

ABSTRACT	O
:	O
Induction	O
of	O
pro	O
-	O
inflammatory	O
response	O
is	O
a	O
crucial	O
cellular	B-ANAT
process	O
that	O
detects	O
and	O
controls	O
the	O
invading	O
viruses	O
at	O
early	O
stages	O
of	O
the	O
infection	O
.	O

Meanwhile	O
,	O
IBV	O
has	O
developed	O
a	O
strategy	O
to	O
counteract	O
the	O
induction	O
of	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
by	O
inducing	O
the	O
expression	O
of	O
dual	O
-	O
specificity	O
phosphatase	O
1	O
(	O
DUSP1	O
),	O
a	O
negative	O
regulator	O
of	O
the	O
p38	O
MAPK	O
,	O
in	O
order	O
to	O
limit	O
the	O
production	O
of	O
an	O
excessive	O
amount	O
of	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
in	O
the	O
infected	O
cells	B-ANAT
.	O

Indeed	O
,	O
a	O
number	O
of	O
viruses	O
that	O
infect	O
lungs	B-ANAT
,	O
such	O
as	O
avian	O
influenza	O
virus	O
,	O
SARS	O
-	O
associated	O
coronavirus	O
,	O
and	O
respiratory	O
syncytial	O
virus	O
,	O
elicit	O
a	O
very	O
high	O
level	O
of	O
proinflammatory	O
cytokines	O
;	O
however	O
,	O
it	O
is	O
unclear	O
what	O
triggers	O
their	O
production	O
.	O

The	O
effect	O
of	O
circumcision	O
was	O
stronger	O
at	O
the	O
glans	O
/	O
corona	O
(	O
OR	O
,	O
0	O
.	O
47	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
37	O
-	O
0	O
.	O
60	O
)	O
and	O
urethra	B-ANAT
(	O
OR	O
,	O
0	O
.	O
35	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
12	O
-	O
1	O
.	O
05	O
)	O
compared	O
with	O
sites	O
more	O
distal	O
to	O
the	O
foreskin	B-ANAT
.	O

Antiviral	O
activity	O
of	O
antioxidants	O
such	O
as	O
NAC	B-ANAT
,	O
pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
),	O
and	O
the	O
vitamin	O
E	O
derivative	O
,	O
trolox	O
,	O
were	O
hardly	O
noticed	O
.	O

TITLE	O
:	O
The	O
value	O
of	O
pulmonary	B-ANAT
contusion	O
volume	O
measurement	O
with	O
three	O
-	O
dimensional	O
computed	O
tomography	O
in	O
predicting	O
acute	O
respiratory	O
distress	O
syndrome	O
development	O
.	O

ABSTRACT	O
:	O
We	O
have	O
recently	O
identified	O
apurinic	O
/	O
apyrimidinic	O
endonuclease	O
1	O
(	O
APE1	O
)	O
as	O
an	O
endoribonuclease	O
that	O
cleaves	O
c	O
-	O
myc	O
mRNA	O
in	O
vitro	O
and	O
regulates	O
c	O
-	O
myc	O
mRNA	O
levels	O
and	O
half	O
-	O
life	O
in	O
cells	B-ANAT
.	O

CONCLUSIONS	O
:	O
The	O
presence	O
of	O
gross	O
vulva	B-ANAT
oedema	O
in	O
pre	O
-	O
eclampsia	O
may	O
be	O
an	O
indicator	O
of	O
severity	O
of	O
disease	O
and	O
or	O
deteriorating	O
fetomaternal	O
condition	O
.	O

In	O
contrast	O
,	O
SARS	O
-	O
CoV	O
S	O
protein	O
is	O
cleaved	B-ANAT
by	O
the	O
protease	O
following	O
receptor	O
-	O
induced	O
conformational	O
changes	O
.	O

TITLE	O
:	O
A	O
case	O
of	O
toxic	O
epidermal	B-ANAT
necrolysis	O
(	O
ten	O
)	O
with	O
severe	O
chronic	O
ocular	B-ANAT
complications	O
in	O
a	O
healthy	O
46	O
-	O
year	O
-	O
old	O
woman	O
.	O

We	O
present	O
a	O
case	O
of	O
toxic	O
epidermal	B-ANAT
necrolysis	O
in	O
a	O
healthy	O
46	O
-	O
yr	O
-	O
old	O
female	O
patient	O
who	O
had	O
inhaled	O
glycophosphate	O
(	O
herbicide	O
)	O
and	O
was	O
treated	O
with	O
paracetamol	O
,	O
aspirin	O
,	O
and	O
chlorpheniramine	O
.	O

The	O
most	O
common	O
method	O
for	O
diagnosing	O
HCoV	O
-	O
HKU1	O
infection	O
is	O
RT	O
-	O
PCR	O
or	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
using	O
RNA	O
extracted	O
from	O
respiratory	B-ANAT
tract	I-ANAT
samples	O
such	O
as	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
(	O
NPA	O
).	O

Both	O
the	O
pol	O
and	O
nucleocapsid	B-ANAT
genes	O
have	O
been	O
used	O
as	O
the	O
targets	O
for	O
amplification	O
.	O

SNPs	O
and	O
deletions	O
causing	O
a	O
truncation	O
of	O
the	O
3c	O
gene	O
product	O
were	O
found	O
in	O
almost	O
all	O
isolates	O
from	O
the	O
diseased	O
tissues	B-ANAT
of	O
the	O
eight	O
cats	O
suffering	O
from	O
FIP	O
,	O
whereas	O
most	O
,	O
but	O
not	O
all	O
fecal	B-ANAT
isolates	O
from	O
these	O
same	O
cats	O
had	O
intact	O
3c	O
genes	O
.	O

Of	O
the	O
cohort	O
,	O
1	O
,	O
330	O
patients	O
(	O
91	O
%)	O
survived	O
to	O
hospital	O
discharge	B-ANAT
.	O

In	O
this	O
population	O
of	O
young	O
children	O
with	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
,	O
RV	O
/	O
EV	O
accounted	O
for	O
the	O
majority	O
of	O
the	O
additional	O
pathogens	O
detected	O
by	O
FilmArray	O
RP	O
.	O

From	O
conventional	O
molecular	O
dynamics	O
and	O
accelerated	O
molecular	O
dynamics	O
(	O
aMD	O
)	O
simulations	O
,	O
we	O
find	O
that	O
with	O
conventional	O
molecular	O
dynamics	O
simulation	O
,	O
PLpro	O
translationally	O
samples	O
the	O
open	O
and	O
closed	O
conformation	O
of	O
BL2	B-ANAT
loop	O
on	O
a	O
picosecond	O
-	O
nanosecond	O
timescale	O
but	O
does	O
not	O
reproduce	O
the	O
peptide	O
bond	O
inversion	O
between	O
loop	O
residues	O
Tyr269	O
and	O
Gln270	O
that	O
is	O
observed	O
on	O
inhibitor	O
GRL0617	O
binding	O
.	O

ABSTRACT	O
:	O
A	O
52	O
-	O
year	O
-	O
old	O
female	O
was	O
treated	O
with	O
CT	O
-	O
guided	O
stereotactic	O
aspiration	O
for	O
acute	O
spontaneous	O
pontine	B-ANAT
hemorrhage	O
.	O

Investigations	O
including	O
neurophysiological	O
studies	O
and	O
cerebral	B-ANAT
spinal	I-ANAT
fluid	I-ANAT
analysis	O
prompted	O
the	O
diagnosis	O
of	O
acute	O
motor	O
axonal	O
neuropathy	O
,	O
a	O
variant	O
of	O
Guillain	O
-	O
BarrÃ©	O
syndrome	O
.	O

Although	O
Guillain	O
-	O
BarrÃ©	O
syndrome	O
rarely	O
occurs	O
,	O
clinicians	O
should	O
be	O
alert	O
to	O
the	O
possibility	O
of	O
this	O
potentially	O
life	O
-	O
threatening	O
consequence	O
after	O
cranial	B-ANAT
surgery	O
with	O
severe	O
respiratory	O
infection	O
.	O

TITLE	O
:	O
Noninvasive	O
ventilation	O
for	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

ABSTRACT	O
:	O
Few	O
studies	O
have	O
been	O
performed	O
on	O
noninvasive	O
ventilation	O
(	O
NIV	O
)	O
to	O
treat	O
hypoxic	O
acute	O
respiratory	O
failure	O
in	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Immediately	O
before	O
the	O
transfer	O
,	O
she	O
suffered	O
two	O
cardiac	B-ANAT
arrest	O
episodes	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
proapoptotic	O
proteins	O
BAX	O
,	O
cytochrome	O
c	O
(	O
CytC	O
),	O
and	O
apoptosis	O
-	O
inducing	O
factor	O
(	O
AIF	O
)	O
were	O
relocalized	O
toward	O
the	O
mitochondria	B-ANAT
,	O
cytosol	B-ANAT
,	O
and	O
nucleus	B-ANAT
,	O
respectively	O
,	O
after	O
infection	O
by	O
both	O
virus	O
variants	O
.	O

TITLE	O
:	O
Effects	O
of	O
blood	B-ANAT
sample	I-ANAT
mishandling	O
on	O
ELISA	O
results	O
for	O
infectious	O
bronchitis	O
virus	O
,	O
avian	O
encephalomyelitis	O
virus	O
and	O
chicken	O
anaemia	O
virus	O
.	O

Moreover	O
,	O
in	O
one	O
patient	O
with	O
a	O
CT	O
diagnosis	O
of	O
pulmonary	B-ANAT
fibrosis	O
,	O
we	O
observed	O
progressive	O
regression	O
of	O
radiological	O
findings	O
over	O
4	O
months	O
of	O
follow	O
-	O
up	O
.	O

Moreover	O
,	O
in	O
one	O
patient	O
with	O
a	O
CT	O
diagnosis	O
of	O
pulmonary	B-ANAT
fibrosis	O
,	O
we	O
observed	O
progressive	O
regression	O
of	O
radiological	O
findings	O
over	O
4	O
months	O
of	O
follow	O
-	O
up	O
.	O

We	O
undertook	O
a	O
prospective	O
study	O
to	O
investigate	O
the	O
determinants	O
of	O
mortality	O
and	O
the	O
sequential	O
evolution	O
of	O
organ	B-ANAT
failures	O
in	O
HFOV	O
-	O
treated	O
adult	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
.	O

Organ	B-ANAT
failure	O
system	O
scoring	O
may	O
be	O
used	O
for	O
deciding	O
on	O
HFOV	O
initiation	O
and	O
for	O
evaluating	O
the	O
effects	O
of	O
HFOV	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
virus	O
(	O
SARS	O
-	O
CoV	O
)	O
that	O
lacks	O
the	O
envelope	B-ANAT
(	O
E	O
)	O
gene	O
(	O
rSARS	O
-	O
CoV	O
-	O
ÎE	O
)	O
is	O
attenuated	O
in	O
vivo	O
.	O

In	O
addition	O
,	O
SARS	O
-	O
CoV	O
E	O
protein	O
down	O
-	O
regulated	O
the	O
signaling	O
pathway	O
inositol	O
-	O
requiring	O
enzyme	O
1	O
(	O
IRE	O
-	O
1	O
)	O
of	O
the	O
unfolded	O
protein	O
response	O
,	O
but	O
not	O
the	O
PKR	O
-	O
like	O
ER	O
kinase	O
(	O
PERK	O
)	O
or	O
activating	O
transcription	O
factor	O
6	O
(	O
ATF	O
-	O
6	O
)	O
pathways	O
,	O
and	O
reduced	O
cell	B-ANAT
apoptosis	O
.	O

TITLE	O
:	O
Vaccination	O
against	O
pandemic	O
H1N1	O
(	O
2009	O
)	O
in	O
patients	O
after	O
allogeneic	O
hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplantation	O
:	O
a	O
retrospective	O
analysis	O
.	O

TITLE	O
:	O
Physiologic	O
effect	O
and	O
safety	O
of	O
the	O
pumpless	O
extracorporeal	O
interventional	O
lung	B-ANAT
assist	O
system	O
in	O
patients	O
with	O
acute	O
respiratory	O
failure	O
--	O
a	O
pilot	O
study	O
.	O

ABSTRACT	O
:	O
Interventional	O
lung	B-ANAT
assist	O
(	O
iLA	O
)	O
effectively	O
reduces	O
CO	O
(	O
2	O
)	O
tension	O
and	O
permits	O
protective	O
lung	B-ANAT
ventilation	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
defined	O
as	O
severe	O
hypoxemic	O
respiratory	O
failure	O
resulting	O
from	O
diffuse	O
lung	B-ANAT
injury	O
and	O
secondary	O
to	O
direct	O
and	O
indirect	O
insults	O
.	O

TITLE	O
:	O
The	O
SARS	O
-	O
coronavirus	O
-	O
host	O
interactome	O
:	O
identification	O
of	O
cyclophilins	O
as	O
target	O
for	O
pan	B-ANAT
-	O
coronavirus	O
inhibitors	O
.	O

TITLE	O
:	O
Aerosolized	O
human	O
extracellular	B-ANAT
superoxide	O
dismutase	O
prevents	O
hyperoxia	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

The	O
levels	O
of	O
oxidative	O
biomarker	O
8	O
-	O
oxo	O
-	O
dG	O
in	O
the	O
lung	B-ANAT
and	O
liver	B-ANAT
were	O
significantly	O
decreased	O
on	O
day	O
2	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
but	O
the	O
marker	O
in	O
the	O
liver	B-ANAT
increased	O
abruptly	O
after	O
day	O
3	O
of	O
hyperoxia	O
when	O
the	O
mortality	O
increased	O
.	O

ABSTRACT	O
:	O
Pulmonary	B-ANAT
arterial	B-ANAT
hypertension	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
represent	O
diseases	O
caused	O
in	O
large	O
part	O
by	O
lung	B-ANAT
endothelial	B-ANAT
injury	O
and	O
inflammation	O
.	O

We	O
also	O
demonstrate	O
that	O
in	O
vivo	O
neutralization	O
of	O
very	O
late	O
antigen	O
-	O
4	O
restricts	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
infiltration	O
of	O
CD8	O
(+)	O
T	B-ANAT
lymphocytes	I-ANAT
in	O
active	O
immunization	O
and	O
adoptive	O
transfer	O
experimental	O
autoimmune	O
encephalomyelitis	O
,	O
and	O
in	O
coronavirus	O
-	O
induced	O
encephalitis	O
.	O

The	O
information	O
in	O
this	O
review	O
,	O
which	O
summarises	O
current	O
knowledge	O
of	O
infectious	O
diseases	O
affecting	O
the	O
CNS	B-ANAT
,	O
is	O
collated	O
from	O
publications	O
on	O
the	O
infectious	O
diseases	O
comprising	O
previous	O
research	O
papers	O
,	O
review	O
articles	O
,	O
case	O
series	O
,	O
case	O
reports	O
and	O
textbooks	O
,	O
supplemented	O
by	O
the	O
clinical	O
experience	O
of	O
the	O
authors	O
.	O

TITLE	O
:	O
Prognostic	O
value	O
of	O
pulmonary	B-ANAT
dead	O
space	O
in	O
patients	O
with	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

These	O
results	O
add	O
to	O
the	O
growing	O
evidence	O
supporting	O
the	O
clinical	O
and	O
research	O
value	O
of	O
measuring	O
pulmonary	B-ANAT
dead	O
space	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
using	O
this	O
pulmonary	B-ANAT
physiologic	O
end	O
-	O
point	O
as	O
one	O
indicator	O
of	O
a	O
favorable	O
response	O
to	O
therapy	O
.	O

Chickens	O
that	O
were	O
challenged	O
by	O
LPS	O
or	O
CPM	O
had	O
a	O
lower	O
ileal	B-ANAT
CP	O
digestibility	O
than	O
that	O
of	O
the	O
control	O
group	O
(	O
P	O
<	O
0	O
.	O
01	O
).	O

In	O
total	O
,	O
ninety	O
7	O
-	O
d	O
-	O
old	O
poults	O
,	O
which	O
tested	O
negative	O
for	O
the	O
presence	O
of	O
astrovirus	O
,	O
rotavirus	O
,	O
coronavirus	O
,	O
and	O
reovirus	O
by	O
reverse	O
transcriptase	O
(	O
RT	O
)	O
PCR	O
,	O
were	O
divided	O
evenly	O
into	O
3	O
groups	O
:	O
A	O
,	O
B	O
,	O
and	O
C	O
.	O
Birds	O
in	O
group	O
A	O
were	O
inoculated	O
orally	B-ANAT
with	O
turkey	O
astrovirus	O
-	O
positive	O
intestinal	B-ANAT
contents	I-ANAT
from	O
birds	O
affected	O
with	O
PES	B-ANAT
.	O

Recombinant	O
human	O
APC	B-ANAT
(	O
continuous	O
infusion	O
24	O
Î¼g	O
/	O
kg	O
per	O
hour	O
)	O
and	O
ceftazidime	O
(	O
3	O
-	O
g	O
bolus	O
at	O
1	O
and	O
13	O
h	O
)	O
were	O
intravenously	O
administered	O
.	O

Combined	O
rhAPC	O
and	O
ceftazidime	O
significantly	O
improved	O
cardiopulmonary	B-ANAT
function	O
,	O
reduced	O
pulmonary	B-ANAT
and	O
cardiac	B-ANAT
tissue	B-ANAT
injury	O
,	O
and	O
prevented	O
the	O
onset	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
ovine	O
severe	O
sepsis	O
without	O
obvious	O
adverse	O
effects	O
.	O

Proteomic	O
analysis	O
of	O
highly	O
purified	O
transmissible	O
gastroenteritis	O
virus	O
showed	O
the	O
RdRp	O
to	O
be	O
a	O
component	O
of	O
the	O
viral	B-ANAT
particles	I-ANAT
.	O

However	O
,	O
a	O
human	O
bronchial	B-ANAT
epithelial	I-ANAT
cell	I-ANAT
line	O
(	O
16HBE	O
)	O
was	O
readily	O
infected	O
.	O

FIP	O
was	O
confirmed	O
by	O
histology	O
or	O
immunostaining	O
of	O
feline	O
coronavirus	O
(	O
FCoV	O
)	O
antigen	O
in	O
effusion	B-ANAT
or	O
tissue	B-ANAT
macrophages	B-ANAT
or	O
both	O
.	O

Epidemiological	O
studies	O
from	O
geographical	O
areas	O
,	O
where	O
incidence	O
of	O
MS	O
has	O
increased	O
in	O
recent	O
decades	O
,	O
pointed	O
out	O
a	O
high	O
frequency	O
of	O
varicella	O
and	O
zoster	O
in	O
the	O
clinical	O
antecedents	O
of	O
MS	O
patients	O
,	O
and	O
also	O
laboratory	O
investigations	O
have	O
found	O
large	O
quantities	O
of	O
DNA	O
from	O
VZV	O
in	O
leucocytes	B-ANAT
and	O
cerebrospinal	B-ANAT
fluid	I-ANAT
of	O
MS	O
patients	O
restricted	O
to	O
the	O
ephemeral	O
period	O
of	O
MS	O
relapse	O
,	O
followed	O
by	O
disappearance	O
of	O
the	O
virus	O
during	O
remission	O
.	O

In	O
one	O
patient	O
,	O
ECMO	O
was	O
introduced	O
after	O
partial	O
pulmonary	B-ANAT
resection	O
for	O
congenital	O
cystic	O
adenomatoid	O
malformation	O
because	O
of	O
respiratory	O
failure	O
.	O

Five	O
patients	O
had	O
additional	O
operative	O
procedures	O
:	O
systemic	O
-	O
pulmonary	B-ANAT
shunt	O
in	O
two	O
,	O
bidirectional	O
Glenn	O
takedown	O
with	O
right	O
modified	O
Blalock	O
-	O
Taussig	O
shunt	O
,	O
total	O
cavopulmonary	O
connection	O
takedown	O
,	O
and	O
redo	O
ECMO	O
in	O
one	O
patient	O
each	O
.	O

T	B-ANAT
cells	I-ANAT
are	O
necessary	O
for	O
viral	O
clearance	O
,	O
and	O
many	O
age	O
-	O
dependent	O
intrinsic	O
T	B-ANAT
cell	I-ANAT
defects	O
have	O
been	O
documented	O
.	O

However	O
,	O
the	O
development	O
of	O
robust	O
T	B-ANAT
cell	I-ANAT
responses	O
in	O
the	O
lung	B-ANAT
also	O
requires	O
respiratory	O
DCs	O
(	O
rDCs	O
),	O
which	O
must	O
process	O
antigen	O
and	O
migrate	O
to	O
draining	O
LNs	O
(	O
DLNs	O
),	O
and	O
little	O
is	O
known	O
about	O
age	O
-	O
related	O
defects	O
in	O
these	O
T	B-ANAT
cell	I-ANAT
-	O
extrinsic	O
functions	O
.	O

At	O
the	O
histological	O
point	O
of	O
view	O
,	O
there	O
is	O
an	O
extensive	O
interstitial	B-ANAT
and	O
intra	O
-	O
alveolar	B-ANAT
pulmonary	B-ANAT
infiltration	O
by	O
maturing	O
myeloid	O
cells	B-ANAT
,	I-ANAT
endothelial	I-ANAT
cell	B-ANAT
damage	O
,	O
intra	O
-	O
alveolar	B-ANAT
edema	O
,	O
inter	O
-	O
alveolar	B-ANAT
hemorrhage	O
,	O
and	O
fibrinous	O
exsudates	O
.	O

During	O
this	O
re	O
-	O
cloning	O
,	O
we	O
obtained	O
the	O
mutant	O
viruses	O
,	O
Mu	O
-	O
1	O
,	O
Mu	O
-	O
2	O
,	O
and	O
Br	O
-	O
1	O
which	O
was	O
isolated	O
from	O
the	O
mice	O
brain	B-ANAT
infected	O
with	O
srr7	O
(	O
Mix	O
).	O

Research	O
has	O
investigated	O
the	O
efficacy	O
of	O
intravenous	O
hyperoxygenated	O
solutions	O
(	O
HOS	O
)	O
as	O
auxiliary	O
oxygen	O
supplies	O
in	O
several	O
hypoxic	O
states	O
including	O
cardiopulmonary	B-ANAT
resuscitation	O
,	O
respiratory	O
failure	O
,	O
cerebrovascular	O
disease	O
,	O
myocardial	O
ischaemia	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
poisoning	O
,	O
neonatal	O
hypoxia	O
,	O
altitude	O
sickness	O
,	O
large	O
burns	O
and	O
traumatic	O
haemorrhagic	O
shock	O
.	O

After	O
nine	O
days	O
of	O
ECMO	O
and	O
further	O
two	O
days	O
of	O
conventional	O
ventilatory	O
treatment	O
he	O
was	O
extubated	O
,	O
and	O
four	O
months	O
later	O
the	O
child	O
presented	O
with	O
normal	O
X	O
-	O
ray	O
of	O
the	O
lungs	B-ANAT
and	O
without	O
any	O
signs	O
of	O
disease	O
.	O

ABSTRACT	O
:	O
This	O
paper	O
summarizes	O
results	O
obtained	O
by	O
multiplex	O
PCR	O
screening	O
of	O
human	O
clinical	O
samples	O
for	O
respiratory	O
viruses	O
and	O
corresponding	O
data	O
obtained	O
after	O
passaging	O
of	O
virus	O
-	O
positive	O
samples	O
in	O
MDCK	O
33016PF	O
cells	B-ANAT
.	O

Intracellular	B-ANAT
cccDNA	O
,	O
pgRNA	O
and	O
HBcAg	O
were	O
also	O
found	O
to	O
be	O
decreased	O
by	O
compound	O
1	O
in	O
a	O
concentration	O
-	O
dependent	O
manner	O
.	O

The	O
shRNAs	O
were	O
transiently	O
transfected	O
into	O
a	O
porcine	O
kidney	B-ANAT
cell	I-ANAT
line	O
,	O
PK	O
-	O
15	O
,	O
to	O
determine	O
whether	O
these	O
constructs	O
inhibited	O
PHEV	O
production	O
.	O

ABSTRACT	O
:	O
Reduced	O
total	O
body	B-ANAT
protein	O
mass	O
is	O
a	O
marker	O
of	O
protein	O
-	O
energy	O
malnutrition	O
and	O
has	O
been	O
associated	O
with	O
numerous	O
complications	O
.	O

Nutritional	O
support	O
limits	O
but	O
does	O
not	O
stop	O
the	O
loss	O
of	O
total	O
body	B-ANAT
protein	O
mass	O
occurring	O
in	O
acute	O
severe	O
illness	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
has	O
been	O
used	O
in	O
clinical	O
medicine	O
for	O
40	O
years	O
but	O
remains	O
controversial	O
therapy	O
,	O
particularly	O
in	O
adult	O
patients	O
with	O
severe	O
respiratory	O
failure	O
.	O

TITLE	O
:	O
[	O
A	O
protocol	O
for	O
the	O
cessation	O
of	O
sedation	O
in	O
brain	B-ANAT
-	O
injured	O
patients	O
].	O

An	O
agitation	O
occurred	O
5	O
hours	O
(	O
1	O
-	O
21	O
)	O
after	O
cessation	O
of	O
opioid	O
,	O
associated	O
with	O
tachycardia	O
,	O
arterial	B-ANAT
hypertension	O
,	O
and	O
tachypnea	O
.	O

The	O
cessation	O
of	O
sedation	O
in	O
severely	O
brain	B-ANAT
-	O
injured	O
patients	O
can	O
be	O
successfully	O
managed	O
with	O
the	O
use	O
of	O
clorazepate	O
,	O
associated	O
with	O
buprenorphine	O
in	O
the	O
presence	O
of	O
agitation	O
.	O

In	O
this	O
paper	O
,	O
we	O
review	O
the	O
current	O
understanding	O
of	O
the	O
pathophysiology	O
and	O
management	O
of	O
MAS	B-ANAT
.	O

One	O
of	O
these	O
,	O
NSC158362	O
,	O
potently	O
inhibited	O
SARS	O
-	O
CoV	O
replication	O
in	O
cell	B-ANAT
culture	O
without	O
toxic	O
effects	O
on	O
cells	B-ANAT
,	O
and	O
it	O
specifically	O
inhibited	O
SARS	O
-	O
CoV	O
replication	O
but	O
not	O
influenza	O
virus	O
replication	O
.	O

Another	O
suppressor	O
,	O
NSC158011	O
,	O
demonstrated	O
the	O
ability	O
to	O
inhibit	O
PLP	O
protease	O
activity	O
in	O
a	O
cell	B-ANAT
-	O
based	O
assay	O
.	O

Furthermore	O
the	O
data	O
with	O
NSC158362	O
suggest	O
a	O
novel	O
mechanism	O
for	O
inhibition	O
of	O
SARS	O
-	O
CoV	O
replication	O
that	O
may	O
involve	O
an	O
unknown	O
activity	O
of	O
PLP	O
,	O
or	O
alternatively	O
a	O
direct	O
effect	O
on	O
a	O
cellular	B-ANAT
target	O
that	O
modifies	O
or	O
bypasses	O
PLP	O
function	O
in	O
yeast	O
and	O
mammalian	O
cells	B-ANAT
.	O

BToV	O
was	O
the	O
only	O
enteric	O
pathogen	O
detected	O
in	O
these	O
outbreaks	O
,	O
as	O
determined	O
by	O
electron	O
microscopy	O
,	O
reverse	O
transcription	O
-	O
PCR	O
,	O
bacteria	O
and	O
parasite	O
tests	O
of	O
fecal	B-ANAT
samples	O
,	O
and	O
antibody	O
tests	O
with	O
paired	O
sera	B-ANAT
.	O

TITLE	O
:	O
Pulmonary	B-ANAT
blastomycosis	O
.	O

The	O
technology	O
is	O
based	O
on	O
administration	O
of	O
one	O
or	O
several	O
functionally	O
active	O
genes	O
encoding	O
for	O
antigens	O
of	O
pathogens	O
which	O
induces	O
formation	O
of	O
both	O
cellular	B-ANAT
and	O
humoral	O
immunity	O
against	O
the	O
respective	O
microorganism	O
.	O

TITLE	O
:	O
Performance	O
of	O
different	O
mono	O
-	O
and	O
multiplex	O
nucleic	B-ANAT
acid	O
amplification	O
tests	O
on	O
a	O
multipathogen	O
external	O
quality	O
assessment	O
panel	O
.	O

ABSTRACT	O
:	O
Positive	O
-	O
sense	O
RNA	O
((+)	O
RNA	O
)	O
viruses	O
such	O
as	O
hepatitis	O
C	O
virus	O
exploit	O
host	O
cells	B-ANAT
by	O
subverting	O
host	O
proteins	O
,	O
remodelling	O
subcellular	O
membranes	B-ANAT
,	O
co	O
-	O
opting	O
and	O
modulating	O
protein	O
and	O
ribonucleoprotein	B-ANAT
complexes	O
,	O
and	O
altering	O
cellular	B-ANAT
metabolic	O
pathways	O
during	O
infection	O
.	O

TITLE	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
interhospital	O
transfer	O
of	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
:	O
5	O
-	O
year	O
experience	O
.	O

Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
allows	O
safe	O
transport	O
of	O
these	O
patients	O
to	O
tertiary	O
care	O
institutions	O
.	O

TITLE	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
respiratory	O
failure	O
in	O
adults	O
.	O

ABSTRACT	O
:	O
This	O
article	O
reviews	O
case	O
series	O
and	O
trials	O
that	O
evaluated	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
for	O
respiratory	O
failure	O
and	O
describes	O
patient	O
and	O
circuit	O
management	O
in	O
the	O
modern	O
era	O
of	O
ECMO	O
support	O
.	O

The	O
frequencies	O
of	O
severe	O
HCoVs	O
infection	O
was	O
determined	O
by	O
real	O
time	O
RT	O
-	O
PCR	O
among	O
1471	O
hospitalized	O
infants	O
(<	O
2	O
-	O
years	O
old	O
)	O
with	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
disease	O
.	O

The	O
pathogenesis	O
of	O
ARDS	O
is	O
unknown	O
but	O
lung	B-ANAT
inflammation	O
and	O
lung	B-ANAT
oxidative	O
stress	O
are	O
likely	O
contributing	O
factors	O
.	O

Peripheral	O
expansion	O
of	O
virus	O
-	O
specific	O
CD8	O
T	B-ANAT
cells	I-ANAT
was	O
impaired	O
when	O
CD4	O
T	B-ANAT
cells	I-ANAT
were	O
ablated	O
prior	O
to	O
infection	O
but	O
not	O
at	O
4	O
days	O
postinfection	O
.	O

MPO	O
(-/-)	O
mice	O
also	O
suppressed	O
viral	O
load	O
in	O
the	O
lung	B-ANAT
.	O

The	O
use	O
of	O
EVLW	O
improves	O
the	O
posttest	O
OR	O
for	O
the	O
diagnosis	O
of	O
ALI	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
severe	O
lung	B-ANAT
injury	O
(	O
sLI	O
)	O
by	O
up	O
to	O
eightfold	O
.	O

The	O
use	O
of	O
EVLW	O
as	O
a	O
bedside	O
test	O
conferred	O
added	O
diagnostic	O
value	O
for	O
the	O
identification	O
of	O
patients	O
with	O
lung	B-ANAT
injury	O
.	O

Roughly	O
one	O
quarter	O
of	O
patients	O
with	O
APL	O
undergoing	O
induction	O
therapy	O
will	O
develop	O
the	O
DS	O
,	O
characterized	O
by	O
unexplained	O
fever	O
,	O
acute	O
respiratory	O
distress	O
with	O
interstitial	B-ANAT
pulmonary	B-ANAT
infiltrates	O
,	O
and	O
/	O
or	O
a	O
vascular	B-ANAT
capillary	B-ANAT
leak	O
syndrome	O
leading	O
to	O
acute	O
renal	B-ANAT
failure	O
.	O

To	O
study	O
the	O
function	O
of	O
the	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
protein	O
,	O
we	O
have	O
conducted	O
a	O
yeast	O
two	O
-	O
hybrid	O
screening	O
experiment	O
to	O
identify	O
cellular	B-ANAT
proteins	O
that	O
may	O
interact	O
with	O
the	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
protein	O
.	O

Pyruvate	O
kinase	O
(	O
liver	B-ANAT
)	O
was	O
found	O
to	O
interact	O
with	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
protein	O
in	O
this	O
experiment	O
.	O

TITLE	O
:	O
Immune	O
responses	O
to	O
mucosal	B-ANAT
vaccination	O
by	O
the	O
recombinant	O
A1	O
and	O
N	O
proteins	O
of	O
infectious	O
bronchitis	O
virus	O
.	O

TITLE	O
:	O
Characterization	O
of	O
germline	O
antibody	O
libraries	O
from	O
human	O
umbilical	B-ANAT
cord	I-ANAT
blood	I-ANAT
and	O
selection	O
of	O
monoclonal	O
antibodies	O
to	O
viral	B-ANAT
envelope	I-ANAT
glycoproteins	O
:	O
Implications	O
for	O
mechanisms	O
of	O
immune	O
evasion	O
and	O
design	O
of	O
vaccine	O
immunogens	O
.	O

They	O
were	O
panned	O
against	O
different	O
HIV	O
-	O
1	O
envelope	B-ANAT
glycoproteins	O
(	O
Envs	O
),	O
SARS	O
CoV	O
protein	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
),	O
and	O
soluble	O
Hendra	O
virus	O
G	O
protein	O
(	O
sG	O
).	O

Despite	O
a	O
high	O
sequence	O
and	O
combinatorial	O
diversity	O
observed	O
in	O
the	O
cord	B-ANAT
blood	I-ANAT
-	O
derived	O
IgM	B-ANAT
antibody	I-ANAT
repertoire	O
,	O
no	O
enrichment	O
for	O
binders	O
of	O
Envs	O
was	O
observed	O
in	O
contrast	O
to	O
considerable	O
specific	O
enrichments	O
produced	O
with	O
panning	O
against	O
RBD	O
and	O
sG	O
;	O
one	O
of	O
the	O
selected	O
monoclonal	O
antibodies	O
(	O
against	O
the	O
RBD	O
)	O
was	O
of	O
high	O
(	O
nM	O
)	O
affinity	O
with	O
only	O
few	O
somatic	O
mutations	O
.	O

TITLE	O
:	O
Spontaneous	O
breathing	O
activity	O
in	O
acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
modern	O
variants	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
are	O
not	O
only	O
rescue	O
alternatives	O
but	O
also	O
therapeutic	O
options	O
for	O
patients	O
with	O
severe	O
but	O
potentially	O
reversible	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

TITLE	O
:	O
Human	O
serum	B-ANAT
albumin	O
:	O
from	O
bench	O
to	O
bedside	O
.	O

We	O
show	O
here	O
that	O
whereas	O
antibody	O
-	O
or	O
B	B-ANAT
cell	I-ANAT
-	O
deficient	O
mice	O
failed	O
to	O
contain	O
MHV	O
CNS	B-ANAT
infection	O
and	O
developed	O
progressive	O
demyelinating	O
disease	O
,	O
germline	O
IgM	O
produced	O
in	O
activation	O
-	O
induced	O
cytidine	O
deaminase	O
-	O
deficient	O
mice	O
(	O
aicda	O
(-/-))	O
provided	O
long	O
-	O
term	O
protection	O
against	O
the	O
chronic	O
multiple	O
sclerosis	O
-	O
like	O
disease	O
.	O

Furthermore	O
,	O
we	O
found	O
that	O
appropriate	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
activation	O
within	O
the	O
CNS	B-ANAT
-	O
draining	O
lymph	B-ANAT
node	I-ANAT
and	O
subsequent	O
CXCR3	O
-	O
mediated	O
migration	O
of	O
antiviral	O
IgM	O
-	O
secreting	O
cells	B-ANAT
to	O
the	O
infected	O
CNS	B-ANAT
was	O
dependent	O
on	O
CD40	O
-	O
mediated	O
interaction	O
of	O
B	B-ANAT
cells	I-ANAT
with	O
T	B-ANAT
helper	I-ANAT
cells	I-ANAT
.	O

These	O
data	O
indicate	O
that	O
the	O
CD40	O
-	O
mediated	O
collaboration	O
of	O
T	O
and	O
B	B-ANAT
cells	I-ANAT
is	O
critical	O
to	O
secure	O
neuroprotective	O
IgM	O
responses	O
during	O
viral	O
CNS	B-ANAT
infection	O
.	O

Arterial	B-ANAT
blood	I-ANAT
gas	O
,	O
leukocyte	B-ANAT
count	O
in	O
the	O
bronchial	B-ANAT
alveolar	I-ANAT
lavage	I-ANAT
fluid	I-ANAT
and	O
blood	B-ANAT
,	O
virus	O
titers	O
,	O
and	O
cytokine	O
levels	O
in	O
the	O
lung	B-ANAT
were	O
measured	O
at	O
various	O
times	O
post	O
-	O
inoculation	O
.	O

We	O
also	O
summarise	O
existing	O
pre	O
-	O
clinical	O
evidence	O
,	O
evaluate	O
the	O
potential	O
and	O
pitfalls	O
of	O
using	O
mesenchymal	B-ANAT
stem	I-ANAT
cells	I-ANAT
for	O
treatment	O
,	O
and	O
examine	O
the	O
likely	O
future	O
directions	O
for	O
mesenchymal	B-ANAT
stem	I-ANAT
cells	I-ANAT
in	O
ARDS	O
.	O

A	O
total	O
of	O
57	O
patients	O
with	O
osteolysis	O
of	O
lymphatic	B-ANAT
origin	O
had	O
been	O
studied	O
at	O
our	O
institution	O
,	O
of	O
whom	O
three	O
died	O
,	O
two	O
from	O
sepsis	O
,	O
and	O
one	O
from	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Furthermore	O
,	O
viral	O
production	O
is	O
reduced	O
in	O
infected	O
Vero	B-ANAT
cells	I-ANAT
when	O
ORF3	O
gene	O
is	O
silenced	O
by	O
siRNA	O
.	O

TITLE	O
:	O
Pathophysiology	O
of	O
pulmonary	B-ANAT
hypertension	O
in	O
acute	O
lung	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
are	O
characterized	O
by	O
protein	O
rich	O
alveolar	B-ANAT
edema	O
,	O
reduced	O
lung	B-ANAT
compliance	O
,	O
and	O
acute	O
severe	O
hypoxemia	O
.	O

Although	O
the	O
introduction	O
of	O
lung	B-ANAT
protective	O
ventilation	O
strategies	O
has	O
probably	O
reduced	O
the	O
severity	O
of	O
PH	O
in	O
ALI	O
,	O
a	O
recent	O
invasive	O
hemodynamic	O
analysis	O
suggests	O
that	O
even	O
in	O
the	O
modern	O
era	O
,	O
its	O
presence	O
remains	O
clinically	O
important	O
.	O

Male	O
ACE2	O
(-/	O
y	O
)	O
BLM	O
injured	O
mice	O
exhibited	O
poorer	O
exercise	O
capacity	O
,	O
worse	O
lung	B-ANAT
function	O
and	O
exacerbated	O
lung	B-ANAT
fibrosis	O
and	O
collagen	B-ANAT
deposition	O
compared	O
with	O
WT	O
.	O

These	O
changes	O
were	O
associated	O
with	O
increased	O
expression	O
of	O
the	O
profibrotic	O
genes	O
Î±	O
-	O
smooth	B-ANAT
muscle	I-ANAT
actin	O
(	O
Î±	O
-	O
SMA	O
)	O
and	O
Transforming	O
Growth	O
Factor	O
Ã1	O
.	O

In	O
comparison	O
to	O
three	O
other	O
cases	O
of	O
influenza	O
pneumonia	O
in	O
the	O
same	O
outbreak	O
with	O
known	O
risk	O
factors	O
for	O
severe	O
influenza	O
,	O
such	O
as	O
pregnancy	O
and	O
diabetes	O
mellitus	O
,	O
a	O
much	O
higher	O
viral	O
load	O
was	O
detected	O
in	O
the	O
lungs	B-ANAT
of	O
this	O
patient	O
despite	O
antiviral	O
treatment	O
.	O

ABSTRACT	O
:	O
Swine	O
hemagglutinating	O
encephalomyelitis	O
virus	O
(	O
HEV	B-ANAT
)	O
has	O
been	O
shown	O
to	O
have	O
a	O
capability	O
to	O
gain	O
access	O
to	O
the	O
cell	B-ANAT
bodies	O
of	O
sensory	B-ANAT
neurons	I-ANAT
after	O
peripheral	O
inoculation	O
,	O
resulting	O
in	O
ganglionic	B-ANAT
infection	O
.	O

By	O
ultrastructurally	O
examining	O
HEV	B-ANAT
-	O
infected	O
rat	O
dorsal	B-ANAT
root	I-ANAT
ganglia	I-ANAT
,	O
we	O
found	O
that	O
HEV	B-ANAT
in	O
the	O
cell	B-ANAT
bodies	O
of	O
infected	O
neurons	B-ANAT
budded	O
from	O
endoplasmic	B-ANAT
reticulum	I-ANAT
-	O
Golgi	B-ANAT
intermediate	O
compartments	B-ANAT
,	O
and	O
were	O
assembled	O
either	O
individually	O
within	O
small	O
vesicles	B-ANAT
or	O
in	O
groups	O
within	O
large	O
vesicles	B-ANAT
.	O

Sputum	B-ANAT
culture	O
revealed	O
the	O
presence	O
of	O
MRSA	O
,	O
and	O
HSV	O
was	O
isolated	O
in	O
broncho	O
-	O
alveoler	O
lavage	O
(	O
BAL	O
)	O
fluid	O
.	O

ABSTRACT	O
:	O
Virus	O
-	O
induced	O
apoptosis	O
and	O
viral	O
mechanisms	O
that	O
regulate	O
this	O
cell	B-ANAT
death	O
program	O
are	O
key	O
issues	O
in	O
understanding	O
virus	O
-	O
host	O
interactions	O
and	O
viral	O
pathogenesis	O
.	O

ABSTRACT	O
:	O
Fecal	B-ANAT
suspensions	O
with	O
an	O
aerosol	O
route	O
of	O
transmission	O
were	O
responsible	O
for	O
a	O
cluster	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
cases	O
in	O
2003	O
in	O
Hong	O
Kong	O
.	O

UV	O
and	O
confocal	O
microscopic	O
observation	O
indicated	O
attachment	O
of	O
residual	O
labeled	O
virions	B-ANAT
to	O
the	O
lettuce	O
surface	O
after	O
the	O
elution	O
procedure	O
,	O
suggesting	O
that	O
rates	O
of	O
inactivation	O
or	O
detection	O
of	O
the	O
virus	O
may	O
be	O
underestimated	O
.	O

ABSTRACT	O
:	O
In	O
vitro	O
infection	O
of	O
Vero	O
E6	O
cells	B-ANAT
by	O
SARS	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
is	O
blocked	O
by	O
hexapeptide	O
Tyr	O
-	O
Lys	O
-	O
Tyr	O
-	O
Arg	O
-	O
Tyr	O
-	O
Leu	O
.	O

We	O
used	O
primary	O
rat	O
alveolar	B-ANAT
type	O
II	O
cells	B-ANAT
to	O
investigate	O
the	O
mechanisms	O
by	O
which	O
alcohol	O
regulates	O
alveolar	B-ANAT
Na	O
(+)	O
transport	O
.	O

Alcohol	O
induced	O
increases	O
in	O
lung	B-ANAT
adenosine	O
levels	O
may	O
be	O
responsible	O
for	O
reduction	O
in	O
alveolar	B-ANAT
fluid	O
clearance	O
and	O
associated	O
worsening	O
of	O
lung	B-ANAT
injury	O
.	O

The	O
diagnosis	O
of	O
miliary	O
TB	O
was	O
confirmed	O
by	O
a	O
thoracoscopic	O
lung	B-ANAT
biopsy	O
.	O

The	O
3c	O
genes	O
of	O
fecal	B-ANAT
isolates	O
from	O
healthy	O
cats	O
were	O
always	O
intact	O
.	O

The	O
patient	O
underwent	O
total	O
abdominal	B-ANAT
colectomy	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
from	O
palm	B-ANAT
civets	O
has	O
twice	O
evolved	O
the	O
capacity	O
to	O
infect	O
humans	O
by	O
gaining	O
binding	O
affinity	O
for	O
human	O
receptor	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
).	O

Spirometry	O
findings	O
showed	O
17	O
%	O
patients	O
had	O
early	O
small	O
airway	B-ANAT
obstruction	O
.	O

The	O
endoribonuclease	O
activity	O
of	O
the	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
A59	O
Nsp15	O
was	O
also	O
increased	O
by	O
pRb	O
in	O
vitro	O
,	O
and	O
an	O
MHV	O
with	O
mutations	O
in	O
the	O
LXCXE	O
/	O
D	O
-	O
motif	O
,	O
named	O
vLC	B-ANAT
,	O
exhibited	O
a	O
smaller	O
plaque	O
diameter	O
and	O
reduced	O
the	O
virus	O
titer	O
by	O
â¼	O
1	O
log	O
.	O

The	O
known	O
isoforms	O
of	O
PSG16	O
are	O
N	O
-	O
terminally	O
truncated	O
relative	O
to	O
other	O
PSG	B-ANAT
family	O
proteins	O
and	O
are	O
expressed	O
in	O
neurons	B-ANAT
as	O
well	O
as	O
in	O
the	O
placenta	B-ANAT
.	O

Follow	O
-	O
up	O
detected	O
partial	O
impairment	O
of	O
axonal	O
fibers	O
of	O
the	O
right	O
external	O
popliteal	B-ANAT
sciatic	B-ANAT
nerve	I-ANAT
.	O

In	O
this	O
paper	O
,	O
different	O
aspects	O
of	O
the	O
genetics	O
,	O
host	B-ANAT
cell	I-ANAT
tropism	O
,	O
and	O
pathogenesis	O
of	O
the	O
feline	O
and	O
canine	O
coronaviruses	O
(	O
FCoV	O
and	O
CCoV	O
)	O
will	O
be	O
discussed	O
,	O
with	O
a	O
view	O
to	O
illustrating	O
how	O
study	O
of	O
FCoVs	O
and	O
CCoVs	O
can	O
improve	O
our	O
general	O
understanding	O
of	O
the	O
pathobiology	O
of	O
coronaviruses	O
.	O

However	O
the	O
virus	O
is	O
also	O
detectable	O
in	O
other	O
body	B-ANAT
fluids	I-ANAT
and	O
excreta	O
.	O

The	O
dried	B-ANAT
virus	O
on	O
smooth	O
surfaces	O
retained	O
its	O
viability	O
for	O
over	O
5	O
days	O
at	O
temperatures	O
of	O
22	O
-	O
25	O
Â°	O
C	O
and	O
relative	O
humidity	O
of	O
40	O
-	O
50	O
%,	O
that	O
is	O
,	O
typical	O
air	O
-	O
conditioned	O
environments	O
.	O

We	O
found	O
that	O
expression	O
of	O
the	O
membrane	B-ANAT
anchored	O
PLP	O
domain	O
from	O
human	O
HCoV	O
-	O
NL63	O
(	O
PLP2	O
-	O
TM	O
)	O
or	O
SARS	O
-	O
CoV	O
(	O
PLpro	O
-	O
TM	O
)	O
inhibits	O
STING	O
-	O
mediated	O
activation	O
of	O
IRF	O
-	O
3	O
nuclear	O
translocation	O
and	O
induction	O
of	O
IRF	O
-	O
3	O
dependent	O
promoters	O
.	O

ABSTRACT	O
:	O
Recruitment	O
maneuvers	O
and	O
the	O
application	O
of	O
high	O
levels	O
of	O
positive	O
end	O
-	O
expiratory	O
pressure	O
combined	O
with	O
lung	B-ANAT
protective	O
mechanical	O
ventilation	O
strategies	O
have	O
been	O
proposed	O
to	O
improve	O
pulmonary	B-ANAT
function	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

In	O
6	O
cases	O
,	O
pulse	O
blood	B-ANAT
oxygen	O
saturation	O
[	O
SpO	O
(	O
2	O
)]	O
was	O
elevated	O
(	O
0	O
.	O
45	O
-	O
0	O
.	O
92	O
up	O
to	O
0	O
.	O
94	O
-	O
1	O
.	O
00	O
),	O
PEEP	O
level	O
[	O
cm	O
H	O
(	O
2	O
)	O
O	O
,	O
1	O
cm	O
H	O
(	O
2	O
)	O
O	O
=	O
0	O
.	O
098	O
kPa	O
]	O
and	O
[	O
FiO	O
(	O
2	O
)]	O
were	O
lowered	O
[	O
PEEP	O
:	O
10	O
.	O
0	O
-	O
22	O
.	O
0	O
down	O
to	O
4	O
.	O
0	O
-	O
15	O
.	O
0	O
;	O
FiO	O
(	O
2	O
):	O
1	O
.	O
00	O
down	O
to	O
0	O
.	O
30	O
-	O
0	O
.	O
60	O
]	O
after	O
treatment	O
with	O
ECMO	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
supportive	O
effects	O
on	O
cardiopulmonary	B-ANAT
failure	O
in	O
critically	O
ill	O
patients	O
treated	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
).	O

The	O
setting	O
of	O
ventilator	O
support	O
were	O
significantly	O
decreased	O
,	O
and	O
arterial	B-ANAT
oxygen	O
saturation	O
[	O
SaO	O
(	O
2	O
)],	O
arterial	B-ANAT
blood	I-ANAT
carbon	O
dioxide	O
partial	O
pressure	O
[	O
PaCO	O
(	O
2	O
)]	O
and	O
blood	B-ANAT
pH	O
value	O
were	O
improved	O
significantly	O
after	O
the	O
V	O
-	O
V	O
mode	O
ECMO	O
.	O

The	O
mean	O
amount	O
of	O
red	B-ANAT
blood	I-ANAT
cell	I-ANAT
suspension	O
administered	O
per	O
patients	O
was	O
(	O
15	O
.	O
1	O
Â±	O
9	O
.	O
9	O
)	O
U	O
,	O
and	O
length	O
of	O
ICU	O
stay	O
was	O
(	O
18	O
.	O
9	O
Â±	O
15	O
.	O
7	O
)	O
days	O
.	O

One	O
nasopharyngeal	B-ANAT
aspirate	I-ANAT
specimen	O
was	O
collected	O
from	O
each	O
patient	O
.	O

Parvovirus	O
-	O
infected	O
patients	O
also	O
showed	O
significantly	O
lower	O
leukocyte	B-ANAT
and	O
erythrocyte	B-ANAT
counts	O
as	O
well	O
as	O
hematocrit	O
,	O
total	O
protein	O
,	O
and	O
albumin	O
levels	O
compared	O
to	O
all	O
other	O
groups	O
.	O

Physiological	O
parameters	O
2	O
-	O
6	O
hours	O
prior	O
to	O
ECMO	O
use	O
were	O
:	O
(	O
53	O
Â±	O
14	O
)	O
mm	O
Hg	O
of	O
PaO2	O
/	O
FiO2	O
,	O
(	O
17	O
Â±	O
5	O
)	O
cm	O
H2O	O
of	O
positive	O
end	O
expiratory	O
pressure	O
(	O
PEEP	O
),	O
3	O
.	O
80	O
Â±	O
0	O
.	O
29	O
of	O
Murray	O
lung	B-ANAT
injury	O
score	O
,	O
(	O
7	O
.	O
38	O
Â±	O
0	O
.	O
10	O
)	O
of	O
arterial	B-ANAT
pH	O
,	O
(	O
3	O
.	O
3	O
Â±	O
2	O
.	O
3	O
)	O
mmol	O
/	O
L	O
of	O
serum	B-ANAT
lactate	O
,	O
16	O
Â±	O
8	O
of	O
APACHE	O
II	O
score	O
.	O

As	O
an	O
effective	O
measure	O
of	O
respiratory	O
supports	O
,	O
ECMO	O
may	O
provide	O
pulmonary	B-ANAT
rest	O
and	O
improve	O
gas	O
exchanges	O
in	O
severe	O
ARDS	O
induced	O
by	O
novel	O
H1N1	O
Influenza	O
.	O

Respiratory	B-ANAT
samples	I-ANAT
from	O
3	O
,	O
525	O
patients	O
with	O
respiratory	O
syndrome	O
,	O
cerebrospinal	B-ANAT
fluid	I-ANAT
(	O
CSF	B-ANAT
)	O
from	O
340	O
patients	O
with	O
neurologic	O
syndrome	O
as	O
well	O
as	O
CSF	B-ANAT
and	O
plasma	B-ANAT
samples	O
from	O
five	O
neonatal	O
patients	O
with	O
sepsis	O
-	O
like	O
illness	O
collected	O
from	O
October	O
2008	O
to	O
2010	O
were	O
tested	O
retrospectively	O
using	O
HPeV	O
-	O
specific	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
.	O

Hemodynamic	O
and	O
pulmonary	B-ANAT
function	O
data	O
were	O
measured	O
.	O

TITLE	O
:	O
Study	O
on	O
the	O
initial	O
velocity	O
distribution	O
of	O
exhaled	B-ANAT
air	I-ANAT
from	O
coughing	O
and	O
speaking	O
.	O

The	O
angle	O
of	O
the	O
exhaled	B-ANAT
air	I-ANAT
from	O
coughing	O
was	O
around	O
38	O
Â°	O
for	O
the	O
males	O
and	O
32	O
Â°	O
for	O
the	O
females	O
,	O
while	O
that	O
of	O
the	O
exhaled	B-ANAT
air	I-ANAT
from	O
speaking	O
was	O
around	O
49	O
Â°	O
and	O
78	O
Â°	O
respectively	O
.	O

Replacement	O
with	O
the	O
BCoV	O
32	O
-	O
nucleotide	O
(	O
nt	O
)	O
inter	O
-	O
stem	B-ANAT
-	O
loop	O
fourth	O
domain	O
between	O
stem	B-ANAT
-	O
loops	O
III	O
and	O
IV	O
,	O
however	O
,	O
required	O
blind	O
cell	B-ANAT
passaging	O
for	O
virus	O
recovery	O
.	O

This	O
study	O
represents	O
one	O
of	O
the	O
first	O
comprehensive	O
analyses	O
of	O
lung	B-ANAT
immunity	O
,	O
including	O
changes	O
in	O
leukocyte	B-ANAT
populations	O
,	O
lung	B-ANAT
-	O
specific	O
cytokines	O
,	O
and	O
antibody	O
responses	O
following	O
SARS	O
-	O
CoV	O
rechallenge	O
in	O
AGMs	O
.	O

We	O
previously	O
reported	O
that	O
synthetic	O
Î¸	O
-	O
defensins	O
called	O
retrocyclins	O
can	O
neutralize	O
and	O
aggregate	O
various	O
strains	O
of	O
IAV	O
and	O
increase	O
IAV	O
uptake	O
by	O
neutrophils	B-ANAT
.	O

OC	O
Cmax	O
(	O
1029	O
Â±	O
478	O
ng	O
/	O
mL	O
)	O
and	O
area	O
under	O
the	O
curve	O
(	O
9	O
.	O
00	O
Â±	O
4	O
.	O
52	O
mcg	O
Â·	O
h	O
/	O
mL	O
)	O
for	O
patients	O
on	O
ECMO	O
with	O
preserved	O
renal	B-ANAT
function	O
were	O
comparable	O
with	O
those	O
of	O
healthy	O
volunteers	O
or	O
noncritically	O
ill	O
patients	O
.	O

ABSTRACT	O
:	O
This	O
work	O
investigates	O
the	O
formulation	O
and	O
in	O
vivo	O
efficacy	O
of	O
dendritic	B-ANAT
cell	I-ANAT
(	O
DC	O
)	O
targeted	O
plasmid	O
DNA	O
loaded	O
biotinylated	O
chitosan	O
nanoparticles	O
for	O
nasal	B-ANAT
immunization	O
against	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
as	O
antigen	O
.	O

The	O
new	O
viruses	O
cause	O
respiratory	O
illnesses	O
such	O
as	O
common	O
cold	O
,	O
bronchitis	O
,	O
bronchiolitis	O
,	O
exacerbations	O
of	O
asthma	O
and	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
and	O
pneumonia	O
.	O

In	O
each	O
of	O
these	O
patients	O
,	O
a	O
PD	O
catheter	O
was	O
placed	O
for	O
severe	O
abdominal	B-ANAT
distension	O
and	O
proven	O
/	O
suspected	O
ACS	O
.	O

ABSTRACT	O
:	O
Papain	O
-	O
like	O
protease	O
(	O
PLpro	O
)	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	O
is	O
one	O
of	O
the	O
two	O
proteases	O
involved	O
in	O
the	O
proteolytic	O
processing	O
of	O
the	O
virion	B-ANAT
polyproteins	O
.	O

Antibody	O
against	O
RbCoV	O
was	O
detected	O
in	O
20	O
(	O
67	O
%)	O
of	O
30	O
rabbit	O
sera	B-ANAT
tested	O
by	O
an	O
N	O
-	O
protein	O
-	O
based	O
Western	O
blot	O
assay	O
,	O
whereas	O
neutralizing	O
antibody	O
was	O
detected	O
in	O
1	O
of	O
these	O
20	O
rabbits	O
.	O

ABSTRACT	O
:	O
In	O
2009	O
,	O
during	O
the	O
influenza	O
A	O
(	O
H1N1	O
)	O
epidemic	O
,	O
there	O
were	O
many	O
reported	O
cases	O
of	O
pulmonary	B-ANAT
infection	O
with	O
severe	O
hypoxemia	O
that	O
was	O
refractory	O
to	O
the	O
ventilatory	O
strategies	O
and	O
rescue	O
therapies	O
commonly	O
used	O
to	O
treat	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Dissection	O
of	O
the	O
underlying	O
immunopathological	O
mechanisms	O
revealed	O
the	O
elaborate	O
Treg	O
-	O
dependent	O
regulation	O
of	O
self	O
-	O
reactive	O
CD4	O
(+)	O
T	B-ANAT
cell	I-ANAT
proliferation	O
within	O
the	O
CNS	B-ANAT
-	O
draining	O
lymph	B-ANAT
node	I-ANAT
and	O
downtuning	O
of	O
CXCR3	O
expression	O
on	O
T	B-ANAT
cells	I-ANAT
.	O

This	O
girl	O
experienced	O
severe	O
heart	B-ANAT
failure	O
at	O
1	O
-	O
month	O
of	O
age	O
.	O

Echocardiography	O
diagnosed	O
dilated	O
-	O
hypokinetic	O
and	O
hypertrophic	O
cardiomyopathy	O
with	O
noncompaction	O
of	O
the	O
left	B-ANAT
ventricle	I-ANAT
.	O

A	O
preliminary	O
structure	O
-	O
activity	O
relationship	O
study	O
(	O
SARs	O
)	O
revealed	O
the	O
necessity	O
of	O
the	O
biflavonoid	O
skeleton	B-ANAT
,	O
the	O
influence	O
of	O
number	O
and	O
position	O
of	O
methoxylations	O
,	O
and	O
the	O
importance	O
of	O
a	O
free	O
rotation	O
of	O
the	O
linkage	O
between	O
the	O
two	O
apigenin	O
monomers	O
of	O
the	O
biflavonoids	O
.	O

(	O
i	O
)	O
To	O
elucidate	O
the	O
clinical	O
aspects	O
of	O
alveolar	B-ANAT
hemorrhage	O
,	O
(	O
ii	O
)	O
to	O
develop	O
a	O
simple	O
diagnostic	O
algorithm	O
in	O
order	O
to	O
separate	O
DAH	O
from	O
other	O
important	O
pulmonary	B-ANAT
diseases	O
with	O
similar	O
clinical	O
picture	O
and	O
comparably	O
high	O
mortality	O
.	O

We	O
have	O
provided	O
evidence	O
for	O
the	O
involvement	O
of	O
recruited	O
neutrophils	B-ANAT
,	O
their	O
toxic	O
enzymes	O
such	O
as	O
myeloperoxidase	O
and	O
matrix	O
metalloproteinases	O
(	O
MMPs	O
),	O
and	O
neutrophil	B-ANAT
extracellular	B-ANAT
traps	O
in	O
aggravating	O
alveolar	B-ANAT
-	O
capillary	B-ANAT
damage	O
.	O

These	O
results	O
suggest	O
that	O
multiple	O
cysteine	O
as	O
well	O
as	O
charged	O
residues	O
concurrently	O
improves	O
the	O
membrane	B-ANAT
-	O
associated	O
functions	O
of	O
S	O
protein	O
in	O
viral	O
replication	O
and	O
cytopathogenesis	O
.	O

Finally	O
,	O
they	O
were	O
either	O
monitored	O
for	O
survival	O
time	O
or	O
euthanized	O
by	O
exsanguination	O
for	O
lung	B-ANAT
tissue	I-ANAT
examination	O
24	O
hrs	O
after	O
hemorrhage	O
.	O

TITLE	O
:	O
[	O
KCTD9	O
,	O
a	O
novel	O
potassium	O
channel	O
related	O
gene	O
,	O
was	O
highly	O
expressed	O
in	O
hepatic	B-ANAT
NK	B-ANAT
cells	I-ANAT
and	O
T	B-ANAT
cells	I-ANAT
of	O
fulminant	O
hepatitis	O
mice	O
induced	O
by	O
MHV	O
-	O
3	O
].	O

In	O
contrast	O
,	O
in	O
model	O
mice	O
of	O
chronic	O
viral	O
hepatitis	O
the	O
expressions	O
of	O
KCTD9	O
mRNA	O
were	O
down	O
-	O
regulated	O
by	O
71	O
%	O
and	O
51	O
%	O
in	O
hepatic	B-ANAT
CD4	O
+	O
T	B-ANAT
cells	I-ANAT
and	O
NK	B-ANAT
cells	I-ANAT
,	O
respectively	O
.	O

Data	O
were	O
collected	O
through	O
face	B-ANAT
-	O
to	O
-	O
face	B-ANAT
interviews	O
and	O
were	O
analyzed	O
using	O
Braun	O
and	O
Clarke	O
'	O
s	O
process	O
of	O
thematic	O
analysis	O
.	O

We	O
present	O
a	O
patient	O
with	O
an	O
antenatally	O
detected	O
mediastinal	B-ANAT
mass	O
that	O
appeared	O
to	O
regress	O
during	O
foetal	O
life	O
and	O
was	O
not	O
demonstrated	O
on	O
early	O
postnatal	O
imaging	O
.	O

TITLE	O
:	O
Prolonged	O
use	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
combined	O
with	O
prone	O
positioning	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
invasive	O
Aspergillosis	O
.	O

However	O
,	O
as	O
pores	O
connecting	O
the	O
DMV	O
interior	O
with	O
the	O
cytoplasm	B-ANAT
have	O
not	O
been	O
detected	O
,	O
it	O
is	O
unclear	O
whether	O
RNA	O
synthesis	O
occurs	O
at	O
these	O
same	O
sites	O
.	O

A	O
subset	O
of	O
samples	O
was	O
screened	O
using	O
qRT	O
-	O
PCR	O
,	O
ELISA	O
and	O
a	O
commercial	O
LAT	O
dipstick	O
(	O
132	O
faecal	B-ANAT
samples	O
were	O
tested	O
for	O
coronavirus	O
and	O
122	O
samples	O
for	O
rotavirus	O
).	O

The	O
current	O
study	O
examines	O
the	O
contributions	O
of	O
the	O
transcription	O
factor	O
Olig1	O
on	O
NPC	B-ANAT
differentiation	O
and	O
remyelination	O
.	O

In	O
vivo	O
characterization	O
of	O
NPCs	O
revealed	O
that	O
Olig1	O
+/+	O
NPCs	O
preferentially	O
differentiated	O
into	O
NG2	O
-	O
positive	O
OPCs	O
and	O
formed	O
processes	O
expressing	O
myelin	B-ANAT
basic	O
protein	O
that	O
encircled	O
axons	B-ANAT
.	O

They	O
had	O
no	O
electrophysiological	O
abnormalities	O
at	O
median	O
and	O
ulnar	B-ANAT
nerves	I-ANAT
before	O
intubation	O
.	O

CONCLUSIONS	O
:	O
The	O
normal	O
RNS	O
in	O
all	O
patients	O
developing	O
early	O
respiratory	O
failure	O
suggests	O
that	O
it	O
is	O
due	O
to	O
a	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
and	O
muscarinic	O
effect	O
.	O

Results	O
demonstrated	O
that	O
some	O
proteins	O
which	O
had	O
functions	O
in	O
cytoskeleton	B-ANAT
organization	O
,	O
anti	O
-	O
oxidative	O
stress	O
,	O
and	O
stress	O
response	O
,	O
showed	O
different	O
change	O
patterns	O
in	O
abundance	O
from	O
chicken	O
infected	O
with	O
the	O
highly	O
virulent	O
ck	O
/	O
CH	O
/	O
LDL	O
/	O
97I	O
P5	O
strain	O
and	O
those	O
given	O
the	O
embryo	B-ANAT
-	O
passaged	O
,	O
attenuated	O
P115	O
stain	O
.	O

ABSTRACT	O
:	O
A	O
series	O
of	O
caudatin	O
derivatives	O
were	O
synthesized	O
,	O
and	O
their	O
anti	O
-	O
hepatitis	O
B	O
virus	O
(	O
HBV	O
)	O
activity	O
was	O
evaluated	O
in	O
HepG	O
2	O
.	O
2	O
.	O
15	O
cells	B-ANAT
.	O

Five	O
groups	O
of	O
day	O
-	O
old	O
broilers	O
of	O
15	O
birds	O
each	O
were	O
housed	O
in	O
isolators	O
and	O
were	O
inoculated	O
at	O
29	O
days	O
of	O
age	O
with	O
Infectious	O
Bronchitis	O
Virus	O
strain	O
M41	O
by	O
the	O
oculo	O
-	O
nasal	B-ANAT
and	O
IT	O
(	O
intratracheal	O
)	O
route	O
(	O
10	O
(	O
5	O
.	O
4	O
)	O
EID	O
(	O
50	O
)	O
(	O
egg	B-ANAT
infectious	O
dosis	O
50	O
)/	O
broiler	O
)	O
and	O
at	O
33	O
days	O
of	O
age	O
with	O
Escherichia	O
coli	O
strain	O
506	O
by	O
the	O
IT	O
route	O
(	O
10	O
(	O
7	O
.	O
6	O
)	O
colony	O
forming	O
units	O
/	O
broiler	O
).	O

ABSTRACT	O
:	O
Vitamin	O
D	O
deficiency	O
is	O
known	O
to	O
be	O
common	O
among	O
patients	O
with	O
sickle	B-ANAT
cell	I-ANAT
anemia	O
(	O
SCA	B-ANAT
).	O

Vitamin	O
D	O
levels	O
were	O
associated	O
with	O
pulmonary	B-ANAT
function	O
(	O
forced	O
expiratory	O
volume	O
in	O
1	O
second	O
[	O
FEV	O
(	O
1	O
)]),	O
but	O
not	O
associated	O
with	O
either	O
rates	O
of	O
acute	O
pain	O
or	O
acute	O
chest	B-ANAT
syndrome	O
episodes	O
.	O

Recent	O
studies	O
in	O
our	O
laboratory	O
and	O
others	O
have	O
revealed	O
a	O
hitherto	O
unknown	O
correlation	O
between	O
chemokine	O
CXCL10	O
/	O
CXCR3	O
,	O
Heme	O
/	O
HO	O
-	O
1	O
and	O
STAT3	O
and	O
cerebral	B-ANAT
malaria	O
severity	O
and	O
mortality	O
.	O

ABSTRACT	O
:	O
Porcine	O
aminopeptidase	O
N	O
(	O
pAPN	O
)	O
is	O
a	O
common	O
cellular	B-ANAT
receptor	O
for	O
swine	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)	O
and	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
).	O

TITLE	O
:	O
Laparostomy	O
management	O
using	O
the	O
ABThera	O
â¢	O
open	O
abdomen	B-ANAT
negative	O
pressure	O
therapy	O
system	O
in	O
a	O
grade	O
IV	O
open	O
abdomen	B-ANAT
secondary	O
to	O
acute	O
pancreatitis	O
.	O

A	O
44	O
-	O
year	O
-	O
old	O
gentleman	O
presented	O
with	O
a	O
3	O
-	O
day	O
history	O
of	O
constant	O
severe	O
epigastric	B-ANAT
pain	O
and	O
associated	O
vomiting	O
.	O

This	O
efficient	O
inhibition	O
could	O
be	O
attributed	O
to	O
the	O
dual	O
blockade	O
of	O
entry	O
from	O
the	O
cell	B-ANAT
surface	I-ANAT
and	O
through	O
the	O
endosomal	O
pathway	O
.	O

Eleven	O
patients	O
received	O
VA	O
ECMO	O
support	O
due	O
to	O
cardiac	B-ANAT
failure	O
(	O
2	O
post	O
-	O
resuscitation	O
).	O

Typical	O
complications	O
include	O
coagulation	O
disorder	O
,	O
acute	O
respiratory	O
failure	O
,	O
acute	O
renal	B-ANAT
failure	O
,	O
infections	O
,	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
symptoms	O
,	O
hepatic	B-ANAT
failure	O
and	O
bleeding	O
,	O
and	O
premature	O
ablation	O
of	O
the	O
placenta	B-ANAT
.	O

Fecal	B-ANAT
changes	O
are	O
frequent	O
and	O
can	O
be	O
signs	O
of	O
infection	O
by	O
digestive	O
pathogens	O
(	O
bacteria	O
,	O
viruses	O
,	O
parasites	O
)	O
and	O
indicators	O
of	O
nutritional	O
and	O
environmental	O
stress	O
.	O

The	O
quality	O
of	O
feces	B-ANAT
was	O
affected	O
by	O
both	O
age	O
and	O
breed	O
size	O
.	O

In	O
large	O
breeds	O
,	O
the	O
ADG	O
was	O
significantly	O
reduced	O
under	O
a	O
fecal	B-ANAT
score	O
of	O
5	O
whatever	O
the	O
age	O
of	O
the	O
puppy	O
.	O

TITLE	O
:	O
Ventilator	O
-	O
associated	O
pneumonia	O
and	O
ICU	O
mortality	O
in	O
severe	O
ARDS	O
patients	O
ventilated	O
according	O
to	O
a	O
lung	B-ANAT
-	O
protective	O
strategy	O
.	O

Tracheostomy	O
,	O
enteral	O
nutrition	O
,	O
and	O
the	O
use	O
of	O
a	O
subglottic	B-ANAT
secretion	B-ANAT
-	O
drainage	B-ANAT
device	O
were	O
protective	O
.	O

These	O
results	O
demonstrated	O
that	O
peptide	O
Kn2	O
-	O
7	O
could	O
inhibit	O
HIV	O
-	O
1	O
by	O
direct	O
interaction	O
with	O
viral	B-ANAT
particle	I-ANAT
and	O
may	O
become	O
a	O
promising	O
candidate	O
compound	O
for	O
further	O
development	O
of	O
microbicide	O
against	O
HIV	O
-	O
1	O
.	O

on	O
day	O
0	O
and	O
28	O
and	O
sacrificed	O
for	O
serum	B-ANAT
antibody	O
measurements	O
or	O
challenged	O
with	O
live	O
virus	O
on	O
day	O
56	O
.	O

On	O
day	O
58	O
,	O
challenged	O
mice	O
were	O
sacrificed	O
and	O
lungs	B-ANAT
obtained	O
for	O
virus	O
and	O
histopathology	O
.	O

RESULTS	O
:	O
All	O
vaccines	O
induced	O
serum	B-ANAT
neutralizing	O
antibody	O
with	O
increasing	O
dosages	O
and	O
/	O
or	O
alum	O
significantly	O
increasing	O
responses	O
.	O

Gross	O
lesions	O
and	O
histological	O
changes	O
were	O
mainly	O
evident	O
in	O
the	O
gut	B-ANAT
and	O
lymphoid	B-ANAT
tissues	I-ANAT
,	O
although	O
some	O
animals	O
showed	O
remarkable	O
changed	O
also	O
in	O
parenchymatous	O
organs	B-ANAT
.	O

FK506	O
(	O
an	O
immunosuppressor	O
of	O
the	O
pathway	O
that	O
binds	O
cellular	B-ANAT
FK506	O
-	O
binding	O
protein	O
(	O
FKBP	O
)	O
but	O
not	O
CyP	O
)	O
did	O
not	O
affect	O
FIPV	O
replication	O
.	O

Cardiac	B-ANAT
catheterization	O
showed	O
no	O
obstructive	O
coronary	B-ANAT
artery	I-ANAT
disease	O
,	O
pulmonary	B-ANAT
hypertension	O
,	O
or	O
elevated	O
left	O
atrial	B-ANAT
pressures	O
,	O
and	O
chest	B-ANAT
imaging	O
only	O
revealed	O
signs	O
of	O
aspiration	O
.	O

ABSTRACT	O
:	O
The	O
article	O
summarises	O
the	O
results	O
of	O
more	O
than	O
30	O
years	O
of	O
research	O
on	O
palmitoylation	O
(	O
S	O
-	O
acylation	O
)	O
of	O
viral	O
proteins	O
,	O
the	O
post	O
-	O
translational	O
attachment	O
of	O
fatty	O
acids	O
to	O
cysteine	O
residues	O
of	O
integral	O
and	O
peripheral	O
membrane	B-ANAT
proteins	O
.	O

Analysing	O
viral	O
proteins	O
is	O
not	O
only	O
important	O
to	O
characterise	O
the	O
cellular	B-ANAT
pathogens	O
but	O
also	O
instrumental	O
to	O
decipher	O
the	O
palmitoylation	O
machinery	O
of	O
cells	B-ANAT
.	O

This	O
comprehensive	O
review	O
describes	O
methods	O
to	O
identify	O
S	O
-	O
acylated	O
proteins	O
and	O
covers	O
the	O
fundamental	O
biochemistry	O
of	O
palmitoylation	O
:	O
the	O
location	O
of	O
palmitoylation	O
sites	O
in	O
viral	O
proteins	O
,	O
the	O
fatty	O
acid	O
species	O
found	O
in	O
S	O
-	O
acylated	O
proteins	O
,	O
the	O
intracellular	B-ANAT
site	O
of	O
palmitoylation	O
and	O
the	O
enzymology	O
of	O
the	O
reaction	O
.	O

Finally	O
,	O
the	O
functional	O
consequences	O
of	O
palmitoylation	O
are	O
discussed	O
regarding	O
binding	O
of	O
proteins	O
to	O
membranes	B-ANAT
or	O
membrane	B-ANAT
rafts	O
,	O
entry	O
of	O
enveloped	O
viruses	O
into	O
target	B-ANAT
cells	I-ANAT
by	O
spike	O
-	O
mediated	O
membrane	B-ANAT
fusion	O
as	O
well	O
as	O
assembly	O
and	O
release	O
of	O
virus	B-ANAT
particles	I-ANAT
from	O
infected	O
cells	B-ANAT
.	O

TITLE	O
:	O
Influenza	O
and	O
SARS	O
-	O
coronavirus	O
activating	O
proteases	O
TMPRSS2	O
and	O
HAT	O
are	O
expressed	O
at	O
multiple	O
sites	O
in	O
human	O
respiratory	O
and	O
gastrointestinal	B-ANAT
tracts	I-ANAT
.	O

Other	O
intubation	O
associated	O
procedures	O
,	O
endotracheal	O
aspiration	O
,	O
suction	O
of	O
body	B-ANAT
fluids	I-ANAT
,	O
bronchoscopy	O
,	O
nebulizer	O
treatment	O
,	O
administration	O
of	O
O2	O
,	O
high	O
flow	O
O2	O
,	O
manipulation	O
of	O
O2	O
mask	O
or	O
BiPAP	O
mask	O
,	O
defibrillation	O
,	O
chest	B-ANAT
compressions	O
,	O
insertion	O
of	O
nasogastric	B-ANAT
tube	O
,	O
and	O
collection	O
of	O
sputum	B-ANAT
were	O
not	O
significant	O
.	O

Viral	O
RNA	O
was	O
detected	O
in	O
the	O
kidney	B-ANAT
,	O
lung	B-ANAT
and	O
tracheas	B-ANAT
on	O
days	O
1	O
to	O
13	O
PI	O
,	O
in	O
the	O
oviduct	B-ANAT
between	O
,	O
days	O
3	O
and	O
13	O
,	O
in	O
testes	B-ANAT
between	O
days	O
1	O
and	O
11	O
PI	O
,	O
and	O
in	O
the	O
caecal	B-ANAT
tonsil	I-ANAT
consistently	O
up	O
to	O
day	O
20	O
PI	O
.	O

Abdominal	B-ANAT
radiography	O
showed	O
severe	O
dilation	O
of	O
the	O
colon	B-ANAT
with	O
horseshoe	O
signal	O
suggesting	O
a	O
sigmoid	B-ANAT
volvulus	O
,	O
pneumoperitoneum	O
and	O
we	O
could	O
not	O
we	O
could	O
not	O
identify	O
fetal	B-ANAT
heartbeats	O
.	O

This	O
case	O
suggests	O
that	O
severe	O
pericardial	B-ANAT
effusion	I-ANAT
and	O
pericardial	B-ANAT
tamponade	O
may	O
be	O
life	O
-	O
threatening	O
complications	O
of	O
transient	O
leukemia	O
of	O
Down	O
syndrome	O
and	O
also	O
it	O
may	O
be	O
managed	O
successfully	O
with	O
appropriate	O
treatments	O
.	O

ABSTRACT	O
:	O
For	O
antiviral	O
screenings	O
purposes	O
,	O
infection	O
of	O
cell	B-ANAT
cultures	O
with	O
the	O
virus	O
under	O
study	O
,	O
should	O
ideally	O
result	O
in	O
the	O
induction	O
,	O
within	O
just	O
a	O
few	O
days	O
,	O
of	O
(	O
nearly	O
)	O
complete	O
CPE	O
and	O
allow	O
the	O
calculation	O
of	O
acceptable	O
Z	O
'	O
factors	O
(>	O
0	O
.	O
5	O
).	O

Following	O
infection	O
of	O
Vero118	O
cells	B-ANAT
,	O
virus	O
-	O
induced	O
CPE	O
was	O
too	O
low	O
to	O
allow	O
readout	O
based	O
on	O
classical	O
colorimetric	O
methods	O
(	O
such	O
as	O
the	O
MTS	O
assay	O
),	O
even	O
following	O
prolonged	O
incubation	O
times	O
(>	O
7	O
days	O
).	O

ABSTRACT	O
:	O
A	O
19	O
-	O
year	O
-	O
old	O
man	O
affected	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
that	O
was	O
unresponsive	O
to	O
medical	O
treatment	O
was	O
successfully	O
weaned	O
without	O
anticoagulation	O
therapy	O
from	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
because	O
of	O
life	O
-	O
threatening	O
bleeding	O
.	O

PEEP	O
was	O
applied	O
and	O
adjusted	O
to	O
appropriate	O
levels	O
on	O
the	O
basis	O
of	O
information	O
obtained	O
from	O
continuous	O
monitoring	O
of	O
cerebral	B-ANAT
and	O
systemic	O
haemodynamics	O
.	O

With	O
the	O
application	O
of	O
high	O
PEEP	O
ventilation	O
,	O
the	O
patient	O
survived	O
ARDS	O
following	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
and	O
achieved	O
a	O
favourable	O
neurological	O
outcome	O
.	O

Coronavirus	O
S	O
proteins	O
acquire	O
membrane	B-ANAT
fusion	O
competence	O
by	O
receptor	O
interactions	O
,	O
proteolysis	O
,	O
and	O
acidification	O
in	O
endosomes	O
.	O

We	O
focus	O
on	O
receptors	O
and	O
proteases	O
in	O
prompting	O
entry	O
and	O
highlight	O
the	O
type	O
II	O
transmembrane	B-ANAT
serine	O
proteases	O
(	O
TTSPs	O
)	O
known	O
to	O
activate	O
several	O
virus	O
fusion	O
proteins	O
.	O

ABSTRACT	O
:	O
The	O
authors	O
present	O
the	O
case	O
of	O
a	O
72	O
-	O
year	O
-	O
old	O
patient	O
who	O
presented	O
with	O
severe	O
dyspnoea	O
,	O
scant	O
haemoptysis	O
,	O
pronounced	O
desaturation	O
and	O
bilateral	O
haematomas	O
on	O
the	O
upper	B-ANAT
limbs	I-ANAT
.	O

Endotracheal	O
intubation	O
,	O
fluid	O
boluses	O
,	O
and	O
vasopressors	O
were	O
commenced	O
,	O
followed	O
by	O
emergent	O
surgical	O
fecal	B-ANAT
disimpaction	O
.	O

Unfortunately	O
all	O
tested	O
compounds	O
exhibited	O
high	O
cellular	B-ANAT
cytotoxicity	O
in	O
cell	B-ANAT
culture	O
which	O
limited	O
their	O
applications	O
as	O
antiviral	O
agents	O
.	O

A	O
total	O
of	O
1128	O
CSF	B-ANAT
samples	O
were	O
retrospectively	O
tested	O
using	O
the	O
Parechovirus	O
-	O
Rgene	O
â¢	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
assay	O
.	O

Some	O
of	O
them	O
developed	O
shortness	O
of	O
breath	B-ANAT
or	O
severe	O
dyspnea	O
on	O
6	O
days	O
after	O
disease	O
onset	O
.	O

Within	O
this	O
genus	O
of	O
coronaviruses	O
,	O
the	O
avian	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
causes	O
a	O
highly	O
infectious	O
upper	O
-	O
respiratory	B-ANAT
tract	I-ANAT
disease	O
in	O
commercial	O
poultry	O
.	O

We	O
studied	O
the	O
influence	O
of	O
the	O
inhibitory	O
CD200	O
-	O
CD200R	O
axis	B-ANAT
on	O
clearance	O
and	O
pathology	O
in	O
two	O
different	O
virus	O
infection	O
models	O
.	O

However	O
,	O
absence	O
of	O
CD200R	O
in	O
influenza	O
A	O
virus	O
infection	O
results	O
in	O
enhanced	O
lung	B-ANAT
neutrophil	B-ANAT
influx	O
and	O
pathology	O
in	O
females	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
biochemical	O
and	O
biological	O
properties	O
of	O
nonstructural	O
protein	O
(	O
nsp	O
)	O
15	O
among	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
),	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
and	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)	O
in	O
virus	O
-	O
infected	O
and	O
ectopically	O
expressed	O
cells	B-ANAT
.	O

Moreover	O
,	O
adoptively	O
transferring	O
macrophages	B-ANAT
to	O
BTLA	O
-/-	O
mice	O
caused	O
sensitisation	O
,	O
whereas	O
blocking	O
BTLA	O
protected	O
wild	O
-	O
type	O
mice	O
from	O
virus	O
-	O
induced	O
FH	O
mortality	O
.	O

CNS	B-ANAT
inflammatory	O
conditions	O
were	O
selectively	O
manipulated	O
by	O
adoptive	O
transfer	O
of	O
virus	O
-	O
primed	O
wild	O
-	O
type	O
(	O
WT	O
)	O
or	O
IFN	O
-	O
Î³	O
deficient	O
(	O
GKO	O
)	O
memory	O
CD4	O
+	O
T	B-ANAT
cells	I-ANAT
into	O
infected	O
SCID	O
mice	O
,	O
coupled	O
with	O
antibody	O
-	O
mediated	O
neutrophil	B-ANAT
depletion	O
and	O
cytokine	O
blockade	O
.	O

Recipients	O
of	O
WT	O
CD4	O
+	O
T	B-ANAT
cells	I-ANAT
depleted	O
of	O
IFN	O
-	O
Î³	O
did	O
not	O
express	O
IL	O
-	O
17	O
and	O
were	O
spared	O
from	O
mortality	O
despite	O
abundant	O
CNS	B-ANAT
neutrophil	B-ANAT
infiltration	O
,	O
indicating	O
that	O
mortality	O
was	O
not	O
mediated	O
by	O
excessive	O
CNS	B-ANAT
neutrophil	B-ANAT
accumulation	O
.	O

Using	O
peripheral	B-ANAT
blood	I-ANAT
samples	O
from	O
drug	O
-	O
allergic	O
patients	O
,	O
the	O
drug	O
-	O
induced	O
lymphocyte	B-ANAT
stimulation	O
test	O
(	O
DLST	O
)	O
and	O
the	O
leukocyte	B-ANAT
migration	O
test	O
(	O
LMT	O
)	O
can	O
detect	O
the	O
presence	O
of	O
drug	O
-	O
sensitized	O
T	B-ANAT
cells	I-ANAT
.	O

TITLE	O
:	O
A	O
real	O
-	O
time	O
PCR	O
assay	O
for	O
bat	O
SARS	O
-	O
like	O
coronavirus	O
detection	O
and	O
its	O
application	O
to	O
Italian	O
greater	O
horseshoe	O
bat	O
faecal	B-ANAT
sample	O
surveys	O
.	O

Blood	B-ANAT
gas	O
analysis	O
(	O
BGA	O
)	O
however	O
showed	O
a	O
massive	O
increase	O
in	O
methemoglobinemia	O
from	O
0	O
.	O
5	O
%	O
just	O
prior	O
to	O
MCP	O
injection	O
to	O
53	O
.	O
1	O
%	O
after	O
MCP	O
injection	O
;	O
simultaneously	O
the	O
pO2	O
decreased	O
from	O
74	O
auf	O
54	O
mmHg	O
and	O
the	O
pCO2	O
from	O
37	O
.	O
7	O
to	O
34	O
.	O
1	O
mmHg	O
.	O

TITLE	O
:	O
Successful	O
treatment	O
of	O
a	O
case	O
of	O
extensive	O
radiation	O
burns	O
with	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
.	O

Sufficient	O
albumen	O
by	O
vein	B-ANAT
and	O
steroid	O
should	O
be	O
administered	O
for	O
treatment	O
against	O
nephropathy	O
and	O
for	O
control	O
of	O
infection	O
.	O

VIGOR	O
accurately	O
detects	O
the	O
complex	O
gene	O
features	O
like	O
ribonucleicacid	O
editing	O
,	O
stop	O
codon	O
leakage	O
and	O
ribosomal	B-ANAT
shunting	O
.	O

This	O
different	O
antigenic	O
phenotype	O
was	O
also	O
confirmed	O
by	O
a	O
neutralizing	O
test	O
with	O
clinically	O
isolated	O
human	O
sera	B-ANAT
.	O

TITLE	O
:	O
Organ	B-ANAT
tropism	O
of	O
murine	O
coronavirus	O
does	O
not	O
correlate	O
with	O
the	O
expression	O
levels	O
of	O
the	O
membrane	B-ANAT
-	O
anchored	O
or	O
secreted	O
isoforms	O
of	O
the	O
carcinoembryonic	O
antigen	O
-	O
related	O
cell	B-ANAT
adhesion	O
molecule	O
1	O
receptor	O
.	O

Patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
intact	O
alveolar	B-ANAT
fluid	O
clearance	O
demonstrate	O
lower	O
mortality	O
than	O
those	O
with	O
compromised	O
fluid	O
clearance	O
.	O

We	O
therefore	O
investigated	O
the	O
effects	O
of	O
treatment	O
with	O
nebulized	O
A77	O
-	O
1726	O
(	O
67	O
.	O
5	O
mg	O
/	O
kg	O
)	O
on	O
indices	O
of	O
cardiopulmonary	B-ANAT
function	O
relevant	O
to	O
the	O
diagnosis	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Facial	B-ANAT
pressure	O
ulcers	O
developed	O
in	O
four	O
patients	O
(	O
22	O
%).	O

During	O
the	O
2010s	O
,	O
the	O
military	O
surgeons	O
promoted	O
the	O
use	O
of	O
a	O
hemostatic	O
regimen	O
which	O
consists	O
of	O
platelets	B-ANAT
,	O
RBC	B-ANAT
,	O
and	O
FFP	O
in	O
a	O
1	O
:	O
1	O
:	O
1	O
ratio	O
.	O

This	O
syndrome	O
was	O
typically	O
seen	O
after	O
treatment	O
of	O
HS	O
and	O
was	O
associated	O
with	O
abnormal	O
bleeding	O
plus	O
respiratory	O
failure	O
and	O
renal	B-ANAT
failure	O
thought	O
to	O
be	O
caused	O
by	O
a	O
combination	O
of	O
micro	O
-	O
and	O
macrothromboses	O
.	O

During	O
the	O
influenza	O
season	O
,	O
almost	O
one	O
third	O
of	O
critical	O
patients	O
with	O
suspected	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
had	O
influenza	O
,	O
and	O
in	O
48	O
.	O
4	O
%,	O
the	O
influenza	O
was	O
unsuspected	O
.	O

Their	O
biogenesis	O
is	O
unusual	O
because	O
each	O
peptide	O
is	O
an	O
18	O
-	O
residue	O
chimera	O
formed	O
by	O
the	O
head	B-ANAT
-	O
to	O
-	O
tail	O
splicing	O
of	O
nonapeptides	O
derived	O
from	O
two	O
separate	O
precursors	O
.	O

Infectious	O
bronchitis	O
virus	O
is	O
a	O
significant	O
pathogen	O
in	O
the	O
domestic	O
chicken	O
,	O
affecting	O
the	O
respiratory	O
and	O
renal	B-ANAT
systems	O
as	O
well	O
as	O
the	O
female	B-ANAT
reproductive	I-ANAT
tract	I-ANAT
.	O

In	O
multicellular	O
eukaryotes	O
,	O
there	O
is	O
a	O
weak	O
correlation	O
between	O
the	O
complexity	O
of	O
an	O
organism	O
(	O
evaluated	O
as	O
a	O
number	O
of	O
different	O
cell	B-ANAT
types	O
)	O
and	O
its	O
overall	O
disorder	O
content	O
.	O

However	O
,	O
disorder	O
shows	O
a	O
sharp	O
increase	O
associated	O
with	O
the	O
transition	O
from	O
prokaryotic	O
to	O
eukaryotic	B-ANAT
cells	I-ANAT
.	O

Ns2	O
cleaves	O
2	O
',	O
5	O
'-	O
oligoadenylate	O
,	O
the	O
product	O
of	O
OAS	O
,	O
to	O
prevent	O
activation	O
of	O
the	O
cellular	B-ANAT
endoribonuclease	O
RNase	O
L	O
and	O
consequently	O
block	O
viral	O
RNA	O
degradation	O
.	O

Feline	O
coronaviruses	O
occur	O
as	O
2	O
pathotypes	O
:	O
nonvirulent	O
feline	O
enteric	O
coronaviruses	O
(	O
FECVs	O
),	O
which	O
replicate	O
in	O
intestinal	B-ANAT
epithelium	I-ANAT
cells	B-ANAT
,	O
and	O
lethal	O
feline	O
infectious	O
peritonitis	O
viruses	O
(	O
FIPVs	O
),	O
which	O
replicate	O
in	O
macrophages	B-ANAT
.	O

Although	O
many	O
researchers	O
have	O
explored	O
the	O
combination	O
of	O
proteins	O
with	O
organic	O
polymers	O
,	O
far	O
fewer	O
investigations	O
have	O
explored	O
nucleic	B-ANAT
acid	O
/	O
polymer	O
hybrids	O
,	O
known	O
as	O
DNA	O
block	O
copolymers	O
(	O
DBCs	O
).	O

TITLE	O
:	O
Microparticles	O
and	O
acute	O
lung	B-ANAT
injury	O
.	O

Cytokine	O
expression	O
,	O
severity	O
of	O
lung	B-ANAT
injury	O
,	O
leukocyte	B-ANAT
infiltration	O
and	O
inflammatory	O
responses	O
were	O
examined	O
in	O
vivo	O
.	O

Results	O
from	O
this	O
study	O
indicate	O
a	O
protective	O
role	O
of	O
PTX3	O
in	O
coronaviral	O
infection	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
.	O

These	O
results	O
suggest	O
that	O
SSYA10	O
-	O
001	O
specifically	O
blocks	O
nsp13	O
through	O
a	O
novel	O
mechanism	O
and	O
is	O
less	O
likely	O
to	O
interfere	O
with	O
the	O
functions	O
of	O
cellular	B-ANAT
enzymes	O
that	O
process	O
nucleic	B-ANAT
acids	O
or	O
ATP	O
.	O

The	O
systemic	O
and	O
mucosal	B-ANAT
immune	O
responses	O
were	O
confirmed	O
by	O
measuring	O
COE	O
-	O
specific	O
IgG	O
and	O
IgA	O
antibody	B-ANAT
-	I-ANAT
secreting	I-ANAT
cells	I-ANAT
in	O
the	O
lymphocytes	B-ANAT
extracted	O
from	O
the	O
spleen	B-ANAT
and	O
COE	O
-	O
specific	O
IgA	O
antibody	B-ANAT
-	I-ANAT
secreting	I-ANAT
cells	I-ANAT
in	O
the	O
Peyer	B-ANAT
'	I-ANAT
s	I-ANAT
patches	I-ANAT
from	O
immunized	O
mice	O
.	O

All	O
nine	O
patients	O
were	O
treated	O
with	O
veno	O
-	O
venous	B-ANAT
ECMO	O
via	O
percutaneous	O
access	O
.	O

Five	O
patients	O
(	O
55	O
.	O
7	O
%)	O
survived	O
to	O
hospital	O
discharge	B-ANAT
.	O

The	O
purposes	O
of	O
this	O
review	O
are	O
to	O
summarize	O
the	O
key	O
findings	O
in	O
supporting	O
the	O
post	O
-	O
transcriptional	O
control	O
of	O
type	O
I	O
interferon	O
in	O
its	O
natural	O
host	O
cells	B-ANAT
and	O
to	O
propose	O
the	O
possible	O
role	O
of	O
translational	O
control	O
in	O
the	O
regulation	O
of	O
type	O
I	O
interferon	O
induction	O
by	O
PRRSV	O
.	O

Natural	O
regulatory	B-ANAT
T	I-ANAT
cells	I-ANAT
(	O
nT	O
(	O
regs	O
))	O
are	O
a	O
distinct	O
population	O
of	O
T	B-ANAT
cells	I-ANAT
that	O
express	O
CD4	O
and	O
FoxP3	O
.	O

Macrophages	B-ANAT
are	O
antigen	B-ANAT
-	I-ANAT
presenting	I-ANAT
cells	I-ANAT
that	O
express	O
TLRs	O
and	O
have	O
a	O
key	O
role	O
in	O
the	O
innate	O
and	O
adaptive	O
immunity	O
against	O
viruses	O
.	O

We	O
assessed	O
the	O
effect	O
of	O
triggering	O
TLR2	O
,	O
TLR3	O
,	O
TLR4	O
,	O
and	O
TLR7	O
with	O
selected	O
ligands	O
on	O
the	O
susceptibility	O
of	O
the	O
J774A	O
.	O
1	O
macrophage	B-ANAT
cell	B-ANAT
line	I-ANAT
to	O
infection	O
with	O
murine	O
coronavirus	O
(	O
mouse	O
hepatitis	O
virus	O
,	O
[	O
MHV	O
]).	O

High	O
-	O
flow	O
nasal	B-ANAT
cannula	O
O	O
(	O
2	O
)	O
therapy	O
appears	O
to	O
be	O
an	O
innovative	O
and	O
effective	O
modality	O
for	O
early	O
treatment	O
of	O
adults	O
with	O
SARI	O
.	O

One	O
child	O
evolving	O
with	O
coma	O
was	O
also	O
characterized	O
,	O
but	O
no	O
parasite	O
was	O
detected	O
in	O
the	O
brain	B-ANAT
tissue	I-ANAT
.	O

In	O
one	O
patient	O
who	O
developed	O
ARDS	O
and	O
presented	O
negative	O
peripheral	O
parasitemia	O
by	O
the	O
time	O
of	O
death	O
,	O
scattered	O
parasitized	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
were	O
seen	O
inside	O
pulmonary	B-ANAT
capillaries	B-ANAT
,	O
suggesting	O
some	O
sequestration	O
in	O
the	O
lung	B-ANAT
.	O

Induction	O
of	O
autophagy	O
by	O
MG132	O
treatment	O
was	O
excluded	O
from	O
playing	O
a	O
role	O
,	O
and	O
no	O
changes	O
in	O
SARS	O
-	O
CoV	O
titers	O
were	O
observed	O
during	O
infection	O
of	O
wild	O
-	O
type	O
or	O
autophagy	O
-	O
deficient	O
ATG5	O
(-/-)	O
mouse	O
embryonic	B-ANAT
fibroblasts	B-ANAT
overexpressing	O
the	O
human	O
SARS	O
-	O
CoV	O
receptor	O
,	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
).	O

V	O
-	O
type	O
H	O
+	O
ATPase	O
inhibition	O
in	O
the	O
renal	B-ANAT
tubule	I-ANAT
has	O
been	O
demonstrated	O
.	O

TITLE	O
:	O
Protective	O
roles	O
of	O
Cordyceps	O
on	O
lung	B-ANAT
fibrosis	O
in	O
cellular	B-ANAT
and	O
rat	O
models	O
.	O

We	O
hypothesize	O
that	O
Cordyceps	O
has	O
beneficial	O
effects	O
on	O
lung	B-ANAT
fibrosis	O
and	O
the	O
objective	O
of	O
this	O
study	O
is	O
to	O
explore	O
the	O
target	O
(	O
s	O
)	O
of	O
Cordyceps	O
in	O
the	O
relief	O
of	O
lung	B-ANAT
fibrosis	O
in	O
animal	O
and	O
cell	B-ANAT
models	O
and	O
to	O
gain	O
insight	O
into	O
its	O
underlying	O
mechanisms	O
.	O

TITLE	O
:	O
[	O
Effects	O
of	O
pulmonary	B-ANAT
surfactant	O
in	O
treatment	O
of	O
acute	O
lung	B-ANAT
injury	O
after	O
cardiac	B-ANAT
surgery	O
in	O
infants	O
].	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
is	O
a	O
severe	O
complication	O
after	O
cardiac	B-ANAT
surgery	O
performed	O
with	O
cardiopulmonary	B-ANAT
bypass	O
in	O
infant	O
patients	O
.	O

Demographics	O
(	O
body	B-ANAT
weigh	O
,	O
age	O
,	O
gender	O
,	O
VSD	O
diameter	O
)	O
and	O
clinical	O
characteristics	O
(	O
CPB	O
time	O
,	O
oxygenation	O
index	O
,	O
mean	O
airway	B-ANAT
pressure	O
,	O
pH	O
and	O
PCO2	O
)	O
of	O
all	O
the	O
patients	O
were	O
collected	O
,	O
and	O
statistical	O
analysis	O
was	O
done	O
to	O
compare	O
the	O
data	O
between	O
treatment	O
and	O
control	O
group	O
.	O

TITLE	O
:	O
The	O
long	O
duration	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
in	O
a	O
child	O
with	O
acute	O
severe	O
hypoxic	O
respiratory	O
failure	O
treated	O
in	O
a	O
resource	O
-	O
limited	O
center	O
.	O

Improved	O
outcome	O
from	O
using	O
ECMO	O
for	O
respiratory	O
failure	O
has	O
been	O
reported	O
worldwide	O
,	O
ranging	O
from	O
15	O
%	O
to	O
over	O
50	O
%	O
in	O
recent	O
reviews	O
.(	O
1	O
,	O
2	O
)	O
The	O
rationale	O
of	O
this	O
therapy	O
is	O
to	O
allow	O
time	O
for	O
the	O
lungs	B-ANAT
to	O
heal	O
,	O
minimizing	O
further	O
lung	B-ANAT
injury	O
from	O
positive	O
pressure	O
ventilation	O
.(	O
3	O
,	O
4	O
)	O
We	O
describe	O
a	O
case	O
of	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
with	O
extensive	O
barotrauma	O
supported	O
by	O
VV	O
-	O
ECMO	O
for	O
96	O
days	O
in	O
a	O
resource	O
-	O
limited	O
center	O
.	O

Multivariable	O
predictors	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
after	O
trauma	O
included	O
subject	O
age	O
,	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
II	O
Score	O
,	O
injury	O
severity	O
score	O
,	O
and	O
the	O
presence	O
of	O
blunt	O
traumatic	O
injury	O
,	O
pulmonary	B-ANAT
contusion	O
,	O
massive	O
transfusion	O
,	O
and	O
flail	O
chest	B-ANAT
injury	O
(	O
area	O
under	O
the	O
receiver	O
operator	O
characteristic	O
curve	O
0	O
.	O
79	O
[	O
95	O
%	O
confidence	O
interval	O
0	O
.	O
73	O
,	O
0	O
.	O
85	O
]).	O

ABSTRACT	O
:	O
To	O
determine	O
the	O
frequency	O
of	O
enteropathogens	O
in	O
cats	O
entering	O
an	O
animal	O
shelter	O
with	O
normal	O
feces	B-ANAT
or	O
diarrhea	O
.	O

Most	O
infections	O
were	O
not	O
associated	O
with	O
diarrhea	O
or	O
any	O
specific	O
risk	O
factors	O
such	O
as	O
signalment	O
,	O
source	O
,	O
or	O
body	B-ANAT
condition	O
,	O
making	O
it	O
difficult	O
to	O
predict	O
which	O
cats	O
were	O
most	O
likely	O
to	O
be	O
infected	O
.	O

It	O
is	O
classified	O
as	O
a	O
class	O
I	O
fusion	O
protein	O
,	O
and	O
is	O
responsible	O
for	O
binding	O
to	O
the	O
receptor	O
on	O
the	O
host	B-ANAT
cell	I-ANAT
as	O
well	O
as	O
mediating	O
the	O
fusion	O
of	O
host	O
and	O
viral	O
membranes	B-ANAT
-	O
A	O
process	O
driven	O
by	O
major	O
conformational	O
changes	O
of	O
the	O
S	O
protein	O
.	O

Sixty	O
-	O
seven	O
percent	O
had	O
an	O
underlying	O
medical	O
conditions	O
,	O
including	O
diabetes	O
,	O
obesity	O
,	O
heart	B-ANAT
and	I-ANAT
lung	I-ANAT
diseases	O
,	O
and	O
pregnancy	O
.	O

However	O
,	O
ZnCl	O
(	O
2	O
)	O
and	O
ZnSO	O
(	O
4	O
)	O
markedly	O
reduced	O
viral	O
titers	O
as	O
well	O
as	O
TGEV	O
RNA	O
and	O
viral	O
protein	O
synthesis	O
when	O
applied	O
during	O
virus	O
penetration	O
and	O
at	O
different	O
time	O
points	O
after	O
viral	O
cell	B-ANAT
entry	O
.	O

To	O
further	O
analyze	O
this	O
functions	O
,	O
the	O
interaction	O
of	O
SARS	O
-	O
CoV	O
protein	O
6	O
with	O
other	O
viral	O
and	O
/	O
or	O
cellular	B-ANAT
factors	O
has	O
been	O
analyzed	O
during	O
SARS	O
-	O
CoV	O
infective	O
cycle	O
.	O

TITLE	O
:	O
The	O
effect	O
of	O
APRV	O
ventilation	O
on	O
ICP	O
and	O
cerebral	B-ANAT
hemodynamics	O
.	O

APRV	O
is	O
associated	O
with	O
a	O
higher	O
mean	O
airway	B-ANAT
pressure	O
than	O
conventional	O
ventilation	O
and	O
has	O
therefore	O
not	O
been	O
evaluated	O
in	O
patients	O
with	O
acute	O
neurological	O
injuries	O
.	O

Both	O
of	O
them	O
formed	O
a	O
voltage	O
independent	O
ion	O
conductive	O
pore	B-ANAT
with	O
symmetric	O
ion	O
transport	O
properties	O
.	O

E	O
protein	O
derived	O
channels	O
showed	O
no	O
cation	O
preference	O
in	O
non	O
-	O
charged	O
lipid	O
membranes	B-ANAT
,	O
whereas	O
they	O
behaved	O
as	O
pores	O
with	O
mild	O
cation	O
selectivity	O
in	O
negatively	O
-	O
charged	O
lipid	O
membranes	B-ANAT
.	O

To	O
explore	O
the	O
distribution	O
of	O
BtCoVs	O
in	O
the	O
Philippines	O
,	O
we	O
collected	O
179	O
bats	O
and	O
detected	O
viral	O
RNA	O
from	O
intestinal	B-ANAT
or	O
fecal	B-ANAT
samples	O
by	O
RT	O
-	O
PCR	O
.	O

TITLE	O
:	O
[	O
Clinical	O
signs	O
of	O
endothelial	B-ANAT
disorders	O
in	O
patients	O
with	O
severe	O
sepsis	O
].	O

It	O
was	O
noted	O
that	O
acute	O
respiratory	O
distress	O
syndrome	O
symptoms	O
occurred	O
earlier	O
than	O
hepatic	B-ANAT
dysfunction	O
,	O
if	O
the	O
latter	O
joints	B-ANAT
,	O
it	O
aggravates	O
the	O
patients	O
status	O
and	O
worsens	O
the	O
prognosis	O
.	O

Chickens	O
from	O
the	O
control	O
,	O
non	O
-	O
vaccinated	O
group	O
developed	O
severe	O
respiratory	O
symptoms	O
and	O
demonstrated	O
significant	O
pathological	O
changes	O
in	O
lung	B-ANAT
,	O
kidney	B-ANAT
and	O
bursa	B-ANAT
of	I-ANAT
Fabricius	I-ANAT
post	O
challenge	O
with	O
M41	O
.	O

Out	O
of	O
the	O
studied	O
172	O
infants	O
,	O
33	O
infants	O
(	O
19	O
.	O
2	O
%)	O
developed	O
ROP	O
in	O
one	O
or	O
both	O
eyes	B-ANAT
;	O
18	O
(	O
54	O
.	O
5	O
%)	O
cases	O
stage	O
1	O
,	O
9	O
(	O
27	O
.	O
3	O
%)	O
cases	O
stage	O
2	O
,	O
and	O
6	O
(	O
18	O
.	O
2	O
%)	O
cases	O
stage	O
3	O
.	O

ABSTRACT	O
:	O
Low	O
tidal	O
volume	O
(	O
V	O
(	O
T	O
)),	O
PEEP	O
,	O
and	O
low	O
plateau	O
pressure	O
(	O
P	O
(	O
PLAT	O
))	O
are	O
lung	B-ANAT
protective	O
during	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

This	O
study	O
tested	O
the	O
hypothesis	O
that	O
the	O
aspiration	O
of	O
dead	O
space	O
(	O
ASPIDS	O
)	O
together	O
with	O
computer	O
simulation	O
can	O
help	O
maintain	O
gas	O
exchange	O
at	O
these	O
settings	O
,	O
thus	O
promoting	O
protection	O
of	O
the	O
lungs	B-ANAT
.	O

Pressure	O
-	O
volume	O
curves	O
(	O
P	O
(	O
el	O
)/	O
V	O
),	O
blood	B-ANAT
gases	O
,	O
and	O
haemodynamics	O
were	O
studied	O
at	O
0	O
,	O
4	O
,	O
8	O
,	O
16	O
,	O
and	O
24	O
h	O
after	O
the	O
induction	O
of	O
ARDS	O
and	O
lung	B-ANAT
histology	O
was	O
evaluated	O
.	O

Based	O
on	O
both	O
experimental	O
and	O
clinical	O
studies	O
,	O
progress	O
has	O
been	O
made	O
in	O
understanding	O
the	O
mechanisms	O
responsible	O
for	O
the	O
pathogenesis	O
and	O
the	O
resolution	O
of	O
lung	B-ANAT
injury	O
,	O
including	O
the	O
contribution	O
of	O
environmental	O
and	O
genetic	O
factors	O
.	O

Postnatal	O
period	O
is	O
critical	O
to	O
the	O
development	O
of	O
neuro	O
--	O
hypothalamic	B-ANAT
circuits	O
involved	O
in	O
appetite	O
control	O
--	O
nutritional	O
programming	O
--	O
in	O
which	O
leptin	O
,	O
present	O
in	O
breast	B-ANAT
milk	I-ANAT
,	O
appears	O
to	O
have	O
a	O
decisive	O
role	O
.	O

RESULTS	O
:	O
Breast	B-ANAT
-	O
feeding	O
is	O
clearly	O
associated	O
with	O
benefits	O
to	O
the	O
infant	O
,	O
including	O
significant	O
protective	O
effects	O
for	O
gastrointestinal	O
infections	O
(	O
64	O
%),	O
middle	B-ANAT
ear	I-ANAT
(	O
23	O
-	O
50	O
%),	O
severe	O
respiratory	O
infections	O
(	O
73	O
%)	O
and	O
for	O
acute	O
lymphocytic	O
leukemia	O
(	O
19	O
%)	O
and	O
sudden	O
death	O
syndrome	O
in	O
infants	O
(	O
36	O
%).	O

RESULTS	O
:	O
We	O
obtained	O
four	O
hybridoma	B-ANAT
cell	B-ANAT
lines	I-ANAT
secreting	O
mAbs	O
against	O
recombinant	O
N	O
protein	O
.	O

TITLE	O
:	O
SARS	O
-	O
CoV	O
regulates	O
immune	O
function	O
-	O
related	O
gene	O
expression	O
in	O
human	O
monocytic	B-ANAT
cells	B-ANAT
.	O

Mouse	O
survival	O
,	O
body	B-ANAT
weight	O
and	O
general	O
condition	O
were	O
observed	O
for	O
up	O
to	O
20	O
days	O
after	O
inoculation	O
.	O

It	O
was	O
concluded	O
that	O
IL	O
-	O
17	O
may	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
MHV	O
-	O
3	O
-	O
induced	O
acute	O
liver	B-ANAT
failure	O
.	O

Here	O
,	O
alignments	O
of	O
transmembrane	B-ANAT
domains	O
(	O
TMDs	O
)	O
of	O
viral	O
channel	O
forming	O
proteins	O
with	O
host	O
ion	O
channels	O
and	O
toxins	O
are	O
evaluated	O
.	O

The	O
regulation	O
of	O
ERAD	O
is	O
therefore	O
crucial	O
to	O
maintain	O
cellular	B-ANAT
proteostasis	O
.	O

The	O
area	O
under	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
for	O
serum	B-ANAT
CC16	O
and	O
pneumonia	O
was	O
0	O
.	O
79	O
(	O
0	O
.	O
62	O
-	O
0	O
.	O
97	O
;	O
p	O
=	O
0	O
.	O
0011	O
).	O

CONCLUSIONS	O
:	O
Our	O
results	O
confirm	O
the	O
previously	O
described	O
association	O
between	O
initial	O
elevation	O
in	O
CC16	O
serum	B-ANAT
levels	O
and	O
severe	O
thoracic	B-ANAT
injury	O
in	O
patients	O
with	O
multiple	O
injuries	O
.	O

EPEC	O
show	O
similarities	O
to	O
enterohaemorrhagic	O
E	O
.	O
coli	O
(	O
EHEC	O
)	O
additionally	O
carrying	O
shiga	O
toxin	O
genes	O
integrated	O
into	O
the	O
chromosome	B-ANAT
by	O
lambdoid	O
phages	O
.	O

As	O
an	O
overall	O
result	O
,	O
ileal	B-ANAT
segments	O
of	O
18	O
.	O
5	O
%	O
of	O
infected	O
pigs	O
were	O
shown	O
to	O
be	O
colonised	O
by	O
EPEC	O
,	O
while	O
no	O
EPEC	O
were	O
detected	O
in	O
the	O
ilea	O
of	O
controls	O
.	O

A	O
CT	O
scan	O
revealed	O
the	O
presence	O
of	O
patchy	O
bilateral	O
lung	B-ANAT
opacities	O
at	O
the	O
level	O
of	O
superior	O
and	O
parahilar	O
zones	O
;	O
follow	O
-	O
up	O
CT	O
scans	O
three	O
days	O
later	O
and	O
10	O
days	O
later	O
are	O
also	O
reported	O
.	O

Prevalence	O
of	O
FIP	O
in	O
cats	O
with	O
effusion	B-ANAT
and	O
a	O
conclusive	O
Rivalta	O
test	O
result	O
was	O
34	O
.	O
6	O
%.	O

Major	O
technological	O
improvements	O
in	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
machines	O
and	O
the	O
positive	O
results	O
of	O
the	O
conventional	O
ventilatory	O
support	O
versus	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
severe	O
adult	O
respiratory	O
failure	O
(	O
CESAR	O
)	O
trial	O
have	O
reignited	O
interest	O
in	O
VV	O
-	O
ECMO	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
persistent	O
hypoxemia	O
or	O
hypercarbia	O
on	O
conventional	O
mechanical	O
ventilation	O
.	O

These	O
viruses	O
possess	O
3C	O
or	O
3C	O
-	O
like	O
proteases	O
(	O
3Cpro	O
or	O
3CLpro	O
,	O
respectively	O
),	O
which	O
contain	O
a	O
typical	O
chymotrypsin	O
-	O
like	O
fold	O
and	O
a	O
catalytic	O
triad	B-ANAT
(	O
or	O
dyad	O
)	O
with	O
a	O
Cys	O
residue	O
as	O
a	O
nucleophile	O
.	O

S	O
-	O
pseudovirus	O
produced	O
by	O
calnexin	O
siRNA	O
-	O
treated	O
cells	B-ANAT
contained	O
S	O
protein	O
modified	O
with	O
N	O
-	O
glycan	O
side	O
chains	O
differently	O
from	O
other	O
two	O
S	O
proteins	O
and	O
consisted	O
of	O
two	O
kinds	O
of	O
viral	B-ANAT
particles	I-ANAT
:	O
those	O
of	O
normal	O
density	O
with	O
little	O
S	O
protein	O
and	O
those	O
of	O
high	O
density	O
with	O
abundant	O
S	O
protein	O
.	O

We	O
also	O
identified	O
a	O
potential	O
cellular	B-ANAT
target	O
for	O
poly	O
(	O
I	O
Â·	O
C	O
)	O
by	O
showing	O
that	O
treatment	O
inhibited	O
virus	O
replication	O
in	O
primary	O
human	O
airway	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

Veno	O
-	O
venous	B-ANAT
ECMO	O
rescued	O
this	O
young	O
patient	O
,	O
allowing	O
for	O
full	O
recovery	O
.	O

TITLE	O
:	O
Acute	O
viral	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
in	O
Cambodian	O
children	O
:	O
clinical	O
and	O
epidemiologic	O
characteristics	O
.	O

A	O
3	O
-	O
year	O
prospective	O
descriptive	O
study	O
was	O
conducted	O
among	O
Cambodian	O
children	O
admitted	O
to	O
2	O
provincial	O
hospitals	O
for	O
acute	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
.	O

Proteomic	O
analysis	O
,	O
Western	O
blot	O
,	O
and	O
quantitative	O
real	O
-	O
time	O
PCR	O
assays	O
indicated	O
PLpro	O
upregulating	O
TGF	O
-	O
Î²1	O
-	O
associated	O
genes	O
:	O
HSP27	O
,	O
protein	O
disulfide	O
isomerase	O
A3	O
precursor	O
,	O
glial	B-ANAT
fibrillary	I-ANAT
acidic	I-ANAT
protein	I-ANAT
,	O
vimentin	B-ANAT
,	O
retinal	B-ANAT
dehydrogenase	O
2	O
,	O
and	O
glutathione	O
transferase	O
omega	O
-	O
1	O
.	O

We	O
found	O
that	O
viral	O
peak	O
titres	O
in	O
lungs	B-ANAT
of	O
dKO	O
and	O
STAT1	O
-	O
deficient	O
mice	O
were	O
similar	O
,	O
but	O
significantly	O
higher	O
than	O
in	O
wild	O
-	O
type	O
mice	O
.	O

Surprisingly	O
,	O
however	O
,	O
infected	O
dKO	O
mice	O
remained	O
healthy	O
,	O
whereas	O
infected	O
STAT1	O
-	O
deficient	O
mice	O
developed	O
liver	B-ANAT
pathology	O
and	O
eventually	O
succumbed	O
to	O
neurological	O
disease	O
.	O

The	O
presence	O
,	O
however	O
,	O
of	O
anti	O
-	O
Ro	O
/	O
SSA	O
antibodies	O
led	O
us	O
to	O
understand	O
that	O
we	O
were	O
dealing	O
here	O
with	O
a	O
more	O
severe	O
form	O
of	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
.	O

Thus	O
,	O
he	O
was	O
treated	O
with	O
infusions	O
of	O
anti	O
-	O
CD20	O
therapy	O
(	O
rituximab	O
):	O
his	O
clinical	O
conditions	O
improved	O
very	O
rapidly	O
and	O
a	O
significant	O
decrease	O
in	O
the	O
activity	O
of	O
pulmonary	B-ANAT
disease	O
was	O
detected	O
using	O
high	O
-	O
resolution	O
computerized	O
tomography	O
(	O
HRCT	O
)	O
of	O
the	O
thorax	B-ANAT
and	O
pulmonary	B-ANAT
function	O
tests	O
.	O

Characterization	O
of	O
the	O
immune	O
cell	B-ANAT
profile	O
in	O
naÃ¯ve	O
ps20	O
(-/-)	O
mice	O
revealed	O
an	O
increase	O
in	O
circulating	O
neutrophils	B-ANAT
compared	O
to	O
ps20	O
(+/+)	O
mice	O
.	O

One	O
patient	O
with	O
severe	O
nephritis	O
developed	O
pulmonary	B-ANAT
hemorrhage	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Lung	B-ANAT
infection	O
and	O
blood	B-ANAT
stream	O
infection	O
were	O
respectively	O
observed	O
in	O
1	O
and	O
4	O
patient	O
(	O
s	O
)	O
in	O
treatment	O
group	O
,	O
and	O
9	O
and	O
11	O
patients	O
in	O
control	O
group	O
from	O
PBD	O
7	O
to	O
14	O
.	O

ABSTRACT	O
:	O
Transplantation	O
of	O
syngeneic	O
neural	O
progenitor	B-ANAT
cells	I-ANAT
(	O
NPCs	O
)	O
into	O
mice	O
persistently	O
infected	O
with	O
the	O
JHM	O
strain	O
of	O
mouse	O
hepatitis	O
virus	O
(	O
JHMV	O
)	O
results	O
in	O
enhanced	O
differentiation	O
into	O
oligodendrocyte	B-ANAT
progenitor	B-ANAT
cells	I-ANAT
that	O
is	O
associated	O
with	O
remyelination	O
,	O
axonal	O
sparing	O
,	O
and	O
clinical	O
improvement	O
.	O

This	O
study	O
revealed	O
that	O
mRT	B-ANAT
-	O
PCR	O
had	O
almost	O
exactly	O
the	O
same	O
performance	O
or	O
results	O
were	O
almost	O
100	O
%	O
in	O
agreement	O
with	O
that	O
of	O
RT	O
-	O
PCR	O
and	O
RAT	O
both	O
in	O
terms	O
of	O
the	O
assay	O
sensitivity	O
and	O
specificity	O
which	O
was	O
more	O
highly	O
evident	O
in	O
detecting	O
CIV	O
,	O
CDV	O
and	O
CRCoV	O
antigens	O
present	O
in	O
canine	O
nasal	B-ANAT
swab	O
samples	O
.	O

In	O
the	O
O2	O
-	O
PS	O
group	O
,	O
the	O
breathing	O
rates	O
and	O
lung	B-ANAT
injury	O
scores	O
were	O
significantly	O
lower	O
than	O
that	O
of	O
the	O
air	O
-	O
PS	O
group	O
.	O

In	O
the	O
O2	O
-	O
PS	O
-	O
Dex	O
group	O
,	O
lung	B-ANAT
edema	O
,	O
total	O
protein	O
,	O
and	O
inflammatory	O
cytokines	O
in	O
BALF	O
were	O
significantly	O
reduced	O
in	O
comparison	O
with	O
the	O
O2	O
-	O
PS	O
group	O
.	O

This	O
method	O
can	O
also	O
be	O
used	O
to	O
deliver	O
Dex	O
and	O
other	O
therapeutic	O
agents	O
to	O
ameliorate	O
lung	B-ANAT
injury	O
.	O

all	O
sera	B-ANAT
samples	O
from	O
patients	O
with	O
SARS	O
positive	O
were	O
the	O
ELISA	O
positive	O
(	O
100	O
%	O
sensitivity	O
).	O

the	O
specificity	O
of	O
the	O
SARS	O
-	O
CoV	O
N	O
protein	O
-	O
based	O
IgG	O
ELISA	O
assay	O
for	O
the	O
detection	O
of	O
the	O
SARS	O
-	O
CoV	O
N	O
specific	O
IgG	O
in	O
plasma	B-ANAT
samples	O
from	O
IDUs	O
with	O
HIV	O
-	O
1	O
positive	O
is	O
,	O
therefore	O
,	O
questionable	O
.	O

CONCLUSIONS	O
:	O
the	O
specificity	O
of	O
the	O
SARS	O
-	O
CoV	O
N	O
protein	O
-	O
based	O
IgG	O
ELISA	O
assay	O
for	O
the	O
detection	O
of	O
the	O
SARS	O
-	O
CoV	O
N	O
specific	O
IgG	O
in	O
plasma	B-ANAT
samples	O
from	O
IDUs	O
with	O
HIV	O
-	O
1	O
positive	O
is	O
,	O
therefore	O
,	O
questionable	O
.	O

To	O
investigate	O
the	O
epidemiological	O
and	O
genetic	O
variation	O
of	O
HBoV	O
in	O
Guangzhou	O
,	O
South	O
China	O
,	O
we	O
screened	O
3460	O
throat	B-ANAT
swab	I-ANAT
samples	O
from	O
1686	O
children	O
and	O
1774	O
adults	O
with	O
acute	O
respiratory	O
infection	O
symptoms	O
for	O
HBoV	O
between	O
March	O
2010	O
and	O
February	O
2011	O
,	O
and	O
analyzed	O
the	O
complete	O
genome	O
sequence	O
of	O
2	O
HBoV	O
strains	O
.	O

15	O
.	O
5	O
%	O
of	O
them	O
developed	O
post	O
-	O
pneumonic	O
changes	O
in	O
the	O
form	O
of	O
diffuse	O
pneumosclerosis	O
,	O
pleural	O
adhesions	O
,	O
and	O
dry	O
cavities	B-ANAT
in	O
the	O
lung	B-ANAT
tissue	I-ANAT
.	O

TITLE	O
:	O
Plasma	B-ANAT
exchange	O
for	O
severe	O
hypertriglyceridemia	O
-	O
induced	O
pancreatitis	O
in	O
an	O
orthotopic	O
heart	B-ANAT
transplant	B-ANAT
recipient	O
.	O

We	O
report	O
three	O
cases	O
of	O
sigmoid	B-ANAT
perforation	O
in	O
burn	O
patients	O
appearing	O
late	O
during	O
hospitalization	O
.	O

Bone	B-ANAT
marrow	I-ANAT
chimera	O
experiments	O
demonstrated	O
that	O
hematopoietic	O
cells	B-ANAT
are	O
responsible	O
for	O
the	O
pathogenesis	O
in	O
STAT1	O
(-/-)	O
mice	O
,	O
and	O
because	O
of	O
an	O
induction	O
of	O
alternatively	O
activated	O
(	O
AA	O
)	O
macrophages	B-ANAT
after	O
infection	O
,	O
we	O
hypothesized	O
that	O
the	O
AA	O
macrophages	B-ANAT
were	O
critical	O
for	O
disease	O
severity	O
.	O

We	O
propose	O
that	O
the	O
control	O
of	O
AA	O
macrophages	B-ANAT
by	O
STAT1	O
is	O
critical	O
to	O
regulating	O
immune	O
pathologies	O
and	O
for	O
protection	O
from	O
long	O
-	O
term	O
progression	O
to	O
fibrotic	O
lung	B-ANAT
disease	O
in	O
a	O
mouse	O
model	O
of	O
SARS	O
-	O
CoV	O
infection	O
.	O

TITLE	O
:	O
Repeated	O
lung	B-ANAT
lavage	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
treating	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
due	O
to	O
nasogastric	B-ANAT
tube	O
malposition	O
for	O
enternal	O
nutrition	O
:	O
a	O
case	O
report	O
.	O

However	O
,	O
tracheal	O
mucosal	B-ANAT
thicknesses	O
of	O
intratracheally	O
challenged	O
pullets	O
were	O
not	O
statistically	O
different	O
from	O
those	O
of	O
the	O
eye	B-ANAT
drop	O
challenged	O
or	O
control	O
pullets	O
at	O
two	O
and	O
three	O
weeks	O
post	O
infection	O
.	O

We	O
identified	O
gene	O
expression	O
signatures	O
in	O
the	O
lungs	B-ANAT
of	O
ferrets	O
associated	O
with	O
primary	O
immune	O
responses	O
to	O
SARS	O
-	O
CoV	O
infection	O
and	O
in	O
ferrets	O
that	O
received	O
an	O
identical	O
second	O
inoculum	O
.	O

nsp1	O
inhibits	O
the	O
translation	O
of	O
cap	O
-	O
dependent	O
and	O
internal	O
ribosome	B-ANAT
entry	O
site	O
(	O
IRES	O
)-	O
driven	O
mRNAs	O
,	O
including	O
SARS	O
coronavirus	O
mRNAs	O
,	O
hepatitis	O
C	O
virus	O
(	O
HCV	O
),	O
and	O
cricket	O
paralysis	O
virus	O
(	O
CrPV	O
)	O
IRES	O
-	O
driven	O
mRNAs	O
that	O
are	O
resistant	O
to	O
nsp1	O
-	O
induced	O
RNA	O
cleavage	O
.	O

Fusion	O
of	O
the	O
signal	O
pepitide	O
gene	O
SPusp45	O
and	O
the	O
nine	O
-	O
peptide	O
LEISSTCDA	O
encoding	O
oligonucleotide	O
to	O
EpiC	O
increased	O
the	O
secretion	B-ANAT
of	O
EpiC	O
,	O
but	O
reduced	O
the	O
total	O
yields	O
of	O
EpiC	O
.	O
Oral	B-ANAT
immunization	O
to	O
specific	O
-	O
pathogen	O
-	O
free	O
(	O
SPF	O
)	O
chickens	O
with	O
recombinant	O
strains	O
induced	O
significantly	O
higher	O
levels	O
of	O
humoral	O
immune	O
responses	O
,	O
and	O
provided	O
protection	O
against	O
lethal	O
dose	O
challenge	O
by	O
the	O
IBV	O
SAIBk	O
strain	O
.	O

This	O
mRT	B-ANAT
-	O
PCR	O
was	O
found	O
to	O
be	O
specific	O
as	O
no	O
amplification	O
was	O
observed	O
with	O
avian	O
influenza	O
virus	O
,	O
Newcastle	O
disease	O
virus	O
,	O
turkey	O
coronavirus	O
,	O
avian	O
metapneumovirus	O
,	O
and	O
intestinal	B-ANAT
contents	I-ANAT
of	O
uninfected	O
turkey	O
poults	O
.	O

This	O
single	O
-	O
tube	O
mRT	B-ANAT
-	O
PCR	O
assay	O
has	O
the	O
potential	O
to	O
serve	O
as	O
a	O
rapid	O
diagnostic	O
method	O
for	O
the	O
simultaneous	O
detection	O
of	O
the	O
three	O
enteric	O
viruses	O
in	O
turkeys	O
.	O

TITLE	O
:	O
No	O
novel	O
coronaviruses	O
identified	O
in	O
a	O
large	O
collection	O
of	O
human	O
nasopharyngeal	B-ANAT
specimens	O
using	O
family	O
-	O
wide	O
CODEHOP	O
-	O
based	O
primers	O
.	O

In	O
this	O
study	O
,	O
we	O
screened	O
1800	O
nasopharyngeal	B-ANAT
samples	O
from	O
adult	O
outpatients	O
with	O
respiratory	O
disease	O
symptoms	O
and	O
healthy	O
individuals	O
.	O

Lobectomy	O
included	O
the	O
right	B-ANAT
upper	I-ANAT
lobe	I-ANAT
in	O
two	O
cases	O
,	O
the	O
right	B-ANAT
middle	I-ANAT
lobe	I-ANAT
in	O
three	O
,	O
the	O
right	B-ANAT
lower	I-ANAT
lobe	I-ANAT
in	O
two	O
,	O
the	O
right	O
middle	O
-	O
lower	O
lobe	B-ANAT
in	O
two	O
,	O
and	O
the	O
left	B-ANAT
lower	I-ANAT
lobe	I-ANAT
in	O
three	O
.	O

TITLE	O
:	O
Cytokine	O
responses	O
in	O
the	O
common	O
cold	O
and	O
otitis	O
media	B-ANAT
.	O

TITLE	O
:	O
Frequency	O
of	O
common	O
viruses	O
in	O
etiology	O
of	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
.	O

Î±B	O
-	O
crystallin	O
is	O
increased	O
in	O
patients	O
with	O
inflammatory	O
lung	B-ANAT
diseases	O
.	O

When	O
used	O
in	O
early	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
NMBAs	O
assist	O
to	O
establish	O
a	O
lung	B-ANAT
protective	O
strategy	O
,	O
which	O
leads	O
to	O
improved	O
oxygenation	O
,	O
decreased	O
pulmonary	B-ANAT
and	O
systemic	O
inflammation	O
,	O
and	O
potentially	O
improved	O
mortality	O
.	O

Ultimately	O
,	O
we	O
conclude	O
that	O
NMBAs	O
should	O
be	O
considered	O
a	O
lung	B-ANAT
protective	O
adjuvant	O
in	O
early	O
ARDS	O
and	O
that	O
clinicians	O
should	O
consider	O
using	O
an	O
alternative	O
NMBA	O
to	O
the	O
aminosteroids	O
in	O
septic	O
shock	O
with	O
less	O
severe	O
lung	B-ANAT
injury	O
pending	O
further	O
studies	O
.	O

TITLE	O
:	O
The	O
use	O
of	O
inhaled	O
nitric	O
oxide	O
and	O
prone	O
position	O
in	O
an	O
ARDS	O
patient	O
with	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
during	O
spine	B-ANAT
stabilization	O
.	O

ABSTRACT	O
:	O
The	O
use	O
of	O
inhaled	O
nitric	O
oxide	O
in	O
patients	O
with	O
traumatic	O
brain	B-ANAT
injury	O
,	O
intracranial	B-ANAT
hypertension	O
,	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
has	O
been	O
reported	O
in	O
an	O
intensive	O
care	O
unit	O
setting	O
only	O
in	O
a	O
few	O
case	O
reports	O
.	O

Here	O
we	O
report	O
our	O
experience	O
with	O
the	O
use	O
of	O
both	O
inhaled	O
nitric	O
oxide	O
and	O
the	O
prone	O
position	O
together	O
in	O
the	O
operating	O
room	O
in	O
a	O
patient	O
with	O
head	B-ANAT
injury	O
and	O
ARDS	O
who	O
underwent	O
column	B-ANAT
stabilization	O
.	O

TITLE	O
:	O
Structural	O
basis	O
for	O
multifunctional	O
roles	O
of	O
mammalian	O
aminopeptidase	O
N	O
.	O
ABSTRACT	O
:	O
Mammalian	O
aminopeptidase	O
N	O
(	O
APN	O
)	O
plays	O
multifunctional	O
roles	O
in	O
many	O
physiological	O
processes	O
,	O
including	O
peptide	O
metabolism	O
,	O
cell	B-ANAT
motility	O
and	O
adhesion	O
,	O
and	O
coronavirus	O
entry	O
.	O

These	O
structural	O
features	O
enable	O
APN	O
to	O
function	O
ubiquitously	O
in	O
peptide	O
metabolism	O
,	O
interact	O
with	O
other	O
proteins	O
to	O
mediate	O
cell	B-ANAT
motility	O
and	O
adhesion	O
,	O
and	O
serve	O
as	O
a	O
coronavirus	O
receptor	O
.	O

Despite	O
its	O
life	O
-	O
saving	O
potential	O
,	O
however	O
,	O
several	O
experimental	O
and	O
clinical	O
studies	O
have	O
suggested	O
that	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
can	O
adversely	O
affect	O
the	O
lungs	B-ANAT
and	O
patient	O
outcomes	O
.	O

CLINICAL	O
APPLICATIONS	O
OF	O
EXTRACORPOREAL	O
LUNG	B-ANAT
SUPPORT	O
:	O
Extracorporeal	O
lung	B-ANAT
support	O
technologies	O
[	O
i	O
.	O
e	O
.,	O
Interventional	O
Lung	B-ANAT
Assist	O
(	O
ILA	O
)	O
and	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)]	O
have	O
been	O
advocated	O
for	O
use	O
in	O
the	O
treatment	O
of	O
patients	O
with	O
respiratory	O
failure	O
.	O

As	O
a	O
bridge	O
to	O
recovery	O
after	O
LTx	O
-	O
used	O
as	O
lung	B-ANAT
support	O
for	O
patients	O
with	O
PGD	O
or	O
severe	O
hypoxemia	O
.	O

Generally	O
,	O
about	O
15	O
%	O
to	O
20	O
%	O
of	O
donor	O
lungs	B-ANAT
are	O
suitable	O
for	O
LTx	O
,	O
but	O
these	O
figures	O
may	O
increase	O
with	O
the	O
use	O
of	O
ex	O
-	O
vivo	O
lung	B-ANAT
perfusion	O
.	O

Four	O
studies	O
reported	O
the	O
means	O
and	O
standard	O
deviations	O
of	O
blood	B-ANAT
gas	O
transfer	O
and	O
arterial	B-ANAT
blood	I-ANAT
pH	O
,	O
which	O
were	O
used	O
for	O
meta	O
-	O
analysis	O
.	O

However	O
,	O
general	O
wear	O
and	O
tear	B-ANAT
over	O
time	O
may	O
compromise	O
the	O
HVAC	O
system	O
'	O
s	O
effectiveness	O
to	O
maintain	O
adequate	O
indoor	O
air	O
quality	O
.	O

In	O
-	O
room	O
air	O
cleaners	O
are	O
supplied	O
as	O
portable	O
or	O
fixed	B-ANAT
devices	O
.	O

Predominating	O
preexisting	O
condition	O
was	O
coronary	B-ANAT
heart	B-ANAT
disease	O
.	O

Upon	O
admission	O
,	O
polymerase	O
chain	O
reaction	O
was	O
performed	O
using	O
nasopharyngeal	B-ANAT
swabs	O
and	O
blood	B-ANAT
cultures	O
to	O
detect	O
respiratory	O
viruses	O
and	O
bacteria	O
,	O
respectively	O
.	O

Age	O
,	O
GCS	O
score	O
,	O
pupil	B-ANAT
dilation	O
,	O
Injury	O
Severity	O
Score	O
(	O
ISS	O
),	O
ICP	O
>	O
25	O
mmHg	O
,	O
hyperglycaemia	O
and	O
pneumonia	O
predicted	O
a	O
worse	O
outcome	O
.	O

TITLE	O
:	O
Steroid	O
modulation	O
of	O
cytokine	O
release	O
and	O
desmosine	O
levels	O
in	O
bilateral	O
total	O
knee	B-ANAT
replacement	O
:	O
a	O
prospective	O
,	O
double	O
-	O
blind	O
,	O
randomized	O
controlled	O
trial	O
.	O

Corticosteroids	O
decreased	O
the	O
prevalence	O
of	O
fever	O
,	O
lowered	O
visual	O
analog	O
pain	O
scores	O
,	O
and	O
improved	O
knee	B-ANAT
motion	O
.	O

A	O
total	O
of	O
124	O
animals	O
tested	O
positive	O
for	O
CCoV	O
,	O
with	O
33	O
of	O
them	O
displaying	O
the	O
virus	O
in	O
extraintestinal	O
tissues	B-ANAT
.	O

Many	O
clinical	O
experiences	O
of	O
the	O
extracorporeal	O
membrane	B-ANAT
oxygenator	O
(	O
ECMO	O
)	O
treatment	O
for	O
adult	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
patients	O
,	O
which	O
is	O
caused	O
by	O
the	O
H1N1	O
influenza	O
A	O
virus	O
,	O
were	O
reported	O
.	O

These	O
data	O
demonstrate	O
a	O
regulatory	O
role	O
for	O
EBI3	B-ANAT
-	O
associated	O
cytokines	O
in	O
controlling	O
host	O
responses	O
following	O
CNS	B-ANAT
viral	O
infection	O
.	O

Fecal	B-ANAT
samples	O
were	O
collected	O
from	O
sick	O
and	O
healthy	O
horses	O
for	O
the	O
PCR	O
detection	O
of	O
ECoV	O
.	O
All	O
four	O
outbreaks	O
involved	O
primarily	O
adult	O
horses	O
.	O

TITLE	O
:	O
Fine	O
level	O
epitope	O
mapping	O
and	O
conservation	O
analysis	O
of	O
two	O
novel	O
linear	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
epitopes	O
of	O
the	O
avian	O
infectious	O
bronchitis	O
coronavirus	O
nucleocapsid	B-ANAT
protein	O
.	O

Following	O
accidental	O
inhalation	O
of	O
water	O
,	O
she	O
had	O
an	O
unstaged	O
ascent	O
and	O
,	O
on	O
reaching	O
the	O
surface	O
,	O
developed	O
severe	O
acute	O
abdominal	B-ANAT
pain	O
and	O
distension	O
.	O

Failure	O
of	O
IAT	O
was	O
defined	O
as	O
a	O
rise	O
in	O
C	O
-	O
reactive	O
protein	O
(	O
CRP	O
)	O
or	O
leukocyte	B-ANAT
count	O
on	O
day	O
3	O
compared	O
with	O
the	O
values	O
on	O
admission	O
.	O

Central	O
venous	B-ANAT
lines	O
were	O
more	O
frequently	O
present	O
in	O
patients	O
with	O
failure	O
to	O
IAT	O
when	O
compared	O
with	O
those	O
with	O
response	O
(	O
51	O
vs	O
.	O
22	O
%;	O
p	O
=	O
0	O
.	O
009	O
).	O

The	O
single	O
attempt	O
placement	O
with	O
the	O
external	O
indwelling	O
cannula	O
was	O
achieved	O
in	O
85	O
.	O
2	O
%	O
of	O
patients	O
with	O
axillary	B-ANAT
brachial	B-ANAT
plexus	I-ANAT
block	O
and	O
78	O
.	O
8	O
%	O
with	O
modified	O
interscalene	O
brachial	B-ANAT
plexus	I-ANAT
block	O
.	O

CXCL10	O
may	O
not	O
be	O
a	O
bystander	O
to	O
the	O
severe	O
virus	O
infection	O
but	O
may	O
directly	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
neutrophil	B-ANAT
-	O
mediated	O
,	O
excessive	O
pulmonary	B-ANAT
inflammation	O
.	O

The	O
increased	O
levels	O
of	O
CXCL10	O
in	O
lungs	B-ANAT
with	O
ARDS	O
originate	O
to	O
a	O
large	O
extent	O
from	O
infiltrated	O
pulmonary	B-ANAT
neutrophils	B-ANAT
,	O
which	O
express	O
a	O
unique	O
CXCR3	O
receptor	O
via	O
TRIF	O
.	O

Thus	O
,	O
the	O
CXCL10	O
-	O
CXCR3	O
axis	B-ANAT
could	O
represent	O
a	O
prime	O
therapeutic	O
target	O
in	O
the	O
treatment	O
of	O
the	O
acute	O
phase	O
of	O
ARDS	O
of	O
nonviral	O
and	O
viral	O
origins	O
.	O

Ochroconis	O
gallopavum	O
is	O
a	O
neurotropic	O
dematiaceous	O
mold	O
responsible	O
for	O
life	O
-	O
threatening	O
respiratory	O
and	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
infections	O
in	O
domestic	O
poultry	O
and	O
in	O
immunologically	O
compromised	O
humans	O
.	O

No	O
brain	B-ANAT
involvement	O
was	O
observed	O
.	O

TITLE	O
:	O
Effect	O
of	O
Chaiqinchengqi	O
decoction	O
on	O
serum	B-ANAT
amyloid	O
A	O
in	O
severe	O
acute	O
pancreatitis	O
patients	O
.	O

Even	O
if	O
A	O
/	O
H1N1	O
/	O
09	O
infection	O
rate	O
in	O
hospitalized	O
patients	O
with	O
and	O
without	O
cirrhosis	O
was	O
not	O
significantly	O
different	O
,	O
cirrhosis	O
and	O
D222G	O
/	O
S183P	O
substitutions	O
were	O
significantly	O
associated	O
with	O
severe	O
disease	O
and	O
poor	O
outcome	O
,	O
also	O
suggesting	O
fungal	O
or	O
bacterial	O
superinfection	O
and	O
portal	B-ANAT
hypertension	O
as	O
risk	O
factors	O
for	O
A	O
/	O
H1N1	O
/	O
09	O
disease	O
severity	O
in	O
patients	O
with	O
cirrhosis	O
.	O

The	O
tracheal	O
,	O
cecal	B-ANAT
tonsil	I-ANAT
,	O
and	O
supracoracoid	O
muscle	B-ANAT
(	O
with	O
and	O
without	O
lesions	O
)	O
samples	O
from	O
the	O
40	O
broiler	O
flocks	O
were	O
screened	O
by	O
RT	O
-	O
PCR	O
to	O
detect	O
IBV	O
.	O

Histopathology	O
of	O
muscle	B-ANAT
and	O
tracheal	O
tissue	B-ANAT
was	O
carried	O
out	O
.	O

The	O
participants	O
self	O
-	O
collected	O
another	O
two	O
swabs	O
(	O
one	O
from	O
each	O
nostril	B-ANAT
)	O
on	O
a	O
subsequent	O
day	O
.	O

TITLE	O
:	O
Heroin	O
addict	O
with	O
gangrene	O
of	O
the	O
extremities	B-ANAT
,	O
rhabdomyolysis	O
and	O
severe	O
hyperkalemia	O
.	O

Rhabdomyolysis	O
is	O
characterized	O
by	O
injury	O
of	O
skeletal	B-ANAT
muscle	I-ANAT
with	O
subsequent	O
release	O
of	O
intracellular	B-ANAT
contents	O
,	O
such	O
as	O
myoglobin	O
,	O
potassium	O
and	O
creatine	O
phosphokinase	O
.	O

We	O
presented	O
a	O
male	O
patient	O
,	O
aged	O
50	O
,	O
hospitalized	O
in	O
the	O
Emergency	O
Center	O
Kragujevac	O
due	O
to	O
altered	O
mental	O
status	O
(	O
Glasgow	O
Coma	O
Score	O
11	O
),	O
partial	O
respiratory	O
insufficiency	O
(	O
pO2	O
7	O
.	O
5	O
kPa	O
,	O
pCO2	O
4	O
.	O
3	O
kPa	O
,	O
SpO2	O
89	O
%),	O
weakness	O
of	O
lower	B-ANAT
extremities	I-ANAT
and	O
atypical	O
electrocardiographic	O
changes	O
.	O

The	O
patient	O
refused	O
the	O
suggested	O
surgical	O
treatment	O
(	O
fasciotomy	O
,	O
foot	B-ANAT
amputation	O
).	O

TITLE	O
:	O
[	O
Emergency	O
use	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
in	O
pediatric	O
critically	O
ill	O
patients	O
].	O

Six	O
cases	O
had	O
bleeding	O
from	O
sutures	O
,	O
2	O
cases	O
with	O
severe	O
bleeding	O
underwent	O
thoracotomy	O
hemostasis	O
,	O
2	O
presented	O
with	O
acute	O
renal	B-ANAT
failure	O
.	O

None	O
of	O
the	O
3	O
cases	O
treated	O
for	O
sacrococcygeal	O
teratoma	O
,	O
operated	O
in	O
1985	O
,	O
1984	O
and	O
2006	O
,	O
have	O
ever	O
developed	O
functional	O
sequelae	O
such	O
as	O
ano	B-ANAT
-	I-ANAT
rectal	I-ANAT
and	O
/	O
or	O
bladder	B-ANAT
dysfunction	O
or	O
hypotonia	O
of	O
the	O
lower	B-ANAT
limbs	I-ANAT
.	O

Being	O
congenital	O
tumors	O
,	O
prenatal	O
diagnosis	O
by	O
US	O
scan	O
is	O
extremely	O
important	O
in	O
order	O
to	O
decide	O
either	O
for	O
an	O
anticipated	O
delivery	O
or	O
to	O
perform	O
,	O
in	O
critical	O
fetuses	B-ANAT
,	O
prenatal	O
treatment	O
within	O
highly	O
specialized	O
facilities	O
,	O
or	O
to	O
organize	O
proper	O
perinatal	O
care	O
,	O
always	O
in	O
appropriate	O
facilities	O
where	O
it	O
is	O
possible	O
to	O
define	O
the	O
diagnosis	O
and	O
carry	O
out	O
emergency	O
surgery	O
.	O

Sacrococcygeal	O
teratomas	O
are	O
commonly	O
considered	O
as	O
lesions	O
at	O
particular	O
risk	O
,	O
in	O
which	O
the	O
coccyx	B-ANAT
must	O
always	O
be	O
removed	O
together	O
with	O
the	O
mass	O
and	O
overlying	O
skin	B-ANAT
,	O
taking	O
particular	O
care	O
of	O
the	O
deep	O
pelvic	B-ANAT
fascia	I-ANAT
to	O
prevent	O
functional	O
disorders	O
of	O
the	O
bladder	B-ANAT
and	O
anal	B-ANAT
canal	I-ANAT
,	O
as	O
well	O
as	O
any	O
motor	O
alterations	O
of	O
the	O
lower	B-ANAT
limbs	I-ANAT
,	O
usually	O
due	O
to	O
iatrogenic	O
lesions	O
of	O
the	O
subfascial	O
nerve	B-ANAT
structures	I-ANAT
.	O

The	O
CK	O
/	O
CH	O
/	O
Zhejiang	O
/	O
06	O
/	O
10	O
strain	O
(	O
IBV	O
-	O
YX10	O
)	O
was	O
isolated	O
from	O
a	O
12	O
-	O
day	O
-	O
old	O
broiler	O
chicken	O
in	O
a	O
flock	O
of	O
chickens	O
with	O
swollen	O
speckled	O
kidneys	B-ANAT
and	O
distended	O
ureters	B-ANAT
filled	O
with	O
uric	O
acid	O
in	O
China	O
in	O
2010	O
.	O

Three	O
assays	O
were	O
conducted	O
:	O
inhibition	O
of	O
cancer	B-ANAT
cell	I-ANAT
proliferation	O
,	O
inhibition	O
of	O
TGEV	O
replication	O
for	O
anticoronavirus	O
activity	O
,	O
and	O
suppression	O
of	O
nitric	O
oxide	O
production	O
in	O
RAW264	O
.	O
7	O
cells	B-ANAT
(	O
a	O
measure	O
of	O
anti	O
-	O
inflammation	O
).	O

Cytoadherence	O
of	O
infected	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
to	O
the	O
vascular	B-ANAT
endothelium	I-ANAT
of	O
different	O
organs	B-ANAT
and	O
rosetting	O
are	O
unique	O
features	O
of	O
malaria	O
parasites	O
which	O
are	O
likely	O
to	O
contribute	O
to	O
the	O
vascular	B-ANAT
damage	O
and	O
the	O
consequent	O
excessive	O
inflammatory	O
/	O
immune	O
response	O
of	O
the	O
host	O
.	O

In	O
addition	O
to	O
cerebral	B-ANAT
malaria	O
or	O
severe	O
anaemia	O
,	O
which	O
are	O
quite	O
common	O
manifestation	O
of	O
severe	O
malaria	O
,	O
clinical	O
evidences	O
of	O
thrombocytopenia	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
liver	B-ANAT
and	O
kidney	B-ANAT
disease	O
,	O
are	O
reported	O
.	O

In	O
the	O
following	O
pages	O
,	O
some	O
of	O
the	O
pathogenetic	O
aspects	O
will	O
be	O
briefly	O
reviewed	O
and	O
then	O
data	O
on	O
selected	O
and	O
less	O
frequent	O
manifestation	O
of	O
severe	O
malaria	O
,	O
such	O
as	O
liver	B-ANAT
or	O
renal	B-ANAT
failure	O
or	O
ARDS	O
will	O
be	O
discussed	O
.	O

Of	O
the	O
total	O
number	O
of	O
cats	O
sampled	O
,	O
95	O
%	O
(	O
40	O
/	O
42	O
)	O
were	O
RT	O
-	O
PCR	O
positive	O
for	O
FCoV	O
.	O
Inoculation	O
of	O
clinical	O
samples	O
into	O
Crandell	O
feline	O
kidney	B-ANAT
cells	B-ANAT
(	O
CrFK	O
),	O
and	O
Feline	O
catus	O
whole	O
fetus	B-ANAT
-	O
4	O
cells	B-ANAT
(	O
Fcwf	O
-	O
4	O
),	O
show	O
cytopathic	O
effect	O
(	O
CPE	O
)	O
characterized	O
by	O
syncytial	O
cells	B-ANAT
formation	O
and	O
later	O
cell	B-ANAT
detachment	O
.	O

Using	O
the	O
purified	O
recombinant	O
NP	O
as	O
an	O
antigen	O
,	O
a	O
polyclonal	O
antibody	O
from	O
rabbit	O
serum	B-ANAT
with	O
specificity	O
for	O
HCoV	O
-	O
OC43	O
NP	O
was	O
generated	O
;	O
this	O
antibody	O
reacts	O
specifically	O
with	O
HCoV	O
-	O
OC43	O
NP	O
and	O
does	O
not	O
cross	O
-	O
react	O
with	O
other	O
human	O
CoV	O
NPs	O
(	O
including	O
those	O
of	O
SARS	O
-	O
CoV	O
and	O
HCoV	O
-	O
229E	O
)	O
by	O
Western	O
blot	O
.	O

ABSTRACT	O
:	O
Emphysematous	O
cystitis	O
(	O
EC	O
)	O
is	O
a	O
comparatively	O
rare	O
urinary	B-ANAT
tract	I-ANAT
infection	O
characterized	O
by	O
air	O
within	O
the	O
bladder	B-ANAT
wall	I-ANAT
and	O
lumen	B-ANAT
and	O
is	O
usually	O
associated	O
with	O
immunosuppression	O
or	O
poorly	O
controlled	O
diabetes	O
mellitus	O
.	O

We	O
performed	O
a	O
yeast	O
two	O
-	O
hybrid	O
screen	O
using	O
as	O
bait	O
the	O
carboxy	O
-	O
terminal	O
endodomain	O
of	O
S	O
,	O
which	O
faces	B-ANAT
the	O
cytosol	B-ANAT
during	O
and	O
after	O
opening	O
of	O
the	O
fusion	O
pore	B-ANAT
at	O
early	O
stages	O
of	O
the	O
virus	O
life	O
cycle	O
.	O

Our	O
data	O
present	O
a	O
novel	O
mechanism	O
involving	O
a	O
cellular	B-ANAT
factor	O
in	O
the	O
regulation	O
of	O
S	O
-	O
dependent	O
early	O
events	O
of	O
infection	O
.	O

We	O
hypothesized	O
that	O
monitoring	O
of	O
diaphragm	B-ANAT
electrical	O
activity	O
(	O
EAdi	O
)	O
may	O
enhance	O
asynchrony	O
assessment	O
and	O
that	O
neurally	O
adjusted	O
ventilatory	O
assist	O
(	O
NAVA	O
)	O
may	O
reduce	O
asynchrony	O
,	O
especially	O
in	O
more	O
severely	O
restricted	O
patients	O
.	O

A	O
common	O
feature	O
among	O
positive	O
-	O
strand	O
RNA	O
viruses	O
is	O
their	O
assembly	O
of	O
replication	O
-	O
transcription	O
complexes	O
in	O
association	O
with	O
cytoplasmic	B-ANAT
membranes	I-ANAT
.	O

The	O
membranes	B-ANAT
observed	O
in	O
coronavirus	O
infected	O
cells	B-ANAT
include	O
double	O
membrane	B-ANAT
vesicles	B-ANAT
.	O

ABSTRACT	O
:	O
Coronaviral	O
infection	O
is	O
associated	O
with	O
up	O
to	O
5	O
%	O
of	O
respiratory	B-ANAT
tract	I-ANAT
diseases	O
.	O

In	O
patients	O
with	O
BOS	O
,	O
we	O
identified	O
two	O
functional	O
phenotypes	O
:	O
a	O
typical	O
OLD	O
,	O
that	O
is	O
,	O
forced	O
expiratory	O
volume	O
in	O
1	O
s	O
(	O
FEV1	O
)/	O
forced	O
vital	O
capacity	O
(	O
FVC	O
)	O
ratio	O
<	O
0	O
.	O
7	O
(	O
n	O
=	O
53	O
),	O
and	O
an	O
atypical	O
OLD	O
with	O
a	O
concomitant	O
decrease	O
in	O
the	O
FEV1	O
<	O
80	O
%	O
and	O
FVC	O
<	O
80	O
%	O
predicted	O
with	O
a	O
normal	O
total	O
lung	B-ANAT
capacity	O
(	O
n	O
=	O
24	O
).	O

We	O
describe	O
a	O
case	O
of	O
acute	O
pulmonary	B-ANAT
toxicity	O
(	O
APT	O
)	O
induced	O
by	O
amiodarone	O
in	O
a	O
57	O
year	O
old	O
patient	O
submitted	O
to	O
a	O
perfusion	O
of	O
900	O
mg	O
in	O
just	O
6	O
hours	O
,	O
to	O
control	O
an	O
auricular	B-ANAT
flutter	O
with	O
rapid	O
ventricular	B-ANAT
response	O
.	O

We	O
compared	O
,	O
at	O
two	O
different	O
levels	O
of	O
pump	O
flow	O
,	O
SaO	O
(	O
2	O
)	O
and	O
the	O
oxygen	O
saturation	O
measured	O
in	O
the	O
pulmonary	B-ANAT
artery	I-ANAT
(	O
SpaO	O
(	O
2	O
))	O
with	O
the	O
predicted	O
saturation	O
using	O
the	O
formula	O
:	O
SpaO	O
(	O
2	O
)	O
=	O
(	O
EF	O
/	O
CO	O
)	O
SmO	O
(	O
2	O
)	O
+	O
(	O
1	O
-	O
EF	O
/	O
CO	O
)	O
SvO	O
(	O
2	O
)	O
+	O
10	O
(-	O
2	O
)	O
PmO	O
(	O
2	O
),	O
where	O
PF	O
is	O
pump	O
flow	O
,	O
R	O
is	O
recirculation	O
,	O
EF	O
is	O
effective	O
flow	O
[=	O
(	O
1	O
-	O
R	O
)	O
PF	O
],	O
SmO	O
(	O
2	O
)	O
is	O
saturation	O
of	O
the	O
oxygenator	O
outgoing	O
blood	B-ANAT
,	O
CO	O
is	O
cardiac	B-ANAT
output	O
,	O
SvO	O
(	O
2	O
)	O
is	O
saturation	O
of	O
mixed	B-ANAT
venous	I-ANAT
blood	I-ANAT
,	O
and	O
PmO	O
(	O
2	O
)	O
is	O
oxygen	O
partial	O
pressure	O
of	O
the	O
oxygenator	O
outgoing	O
blood	B-ANAT
.	O

Analysis	O
of	O
sequences	O
of	O
membrane	B-ANAT
(	O
M	O
)	O
and	O
spike	O
(	O
S	O
)	O
gene	O
fragments	O
revealed	O
strains	O
in	O
the	O
genus	O
Alphacoronavirus	O
,	O
including	O
three	O
distinct	O
strains	O
in	O
hyenas	O
and	O
one	O
distinct	O
strain	O
in	O
a	O
jackal	O
.	O

The	O
technique	O
relies	O
on	O
the	O
addition	O
of	O
synthetic	O
oligonucleotides	O
to	O
both	O
termini	O
of	O
RNA	O
fragments	O
in	O
a	O
sequence	O
-	O
dependent	O
manner	O
during	O
first	O
-	O
and	O
second	O
-	O
strand	O
DNA	O
synthesis	O
;	O
these	O
oligonucleotides	O
are	O
used	O
subsequently	O
for	O
amplification	O
of	O
the	O
viral	O
nucleic	B-ANAT
acids	O
of	O
interest	O
.	O

Their	O
cause	O
-	O
effect	O
relationship	O
was	O
studied	O
using	O
cells	B-ANAT
and	O
mouse	O
models	O
.	O

Pathological	O
examinations	O
showed	O
that	O
lungs	B-ANAT
were	O
the	O
predominantly	O
affected	O
organ	B-ANAT
with	O
edema	O
,	O
hemorrhage	O
,	O
microvascular	O
thrombosis	O
,	O
and	O
neutrophil	B-ANAT
congestion	O
.	O

Expedient	O
diagnosis	O
from	O
history	O
,	O
examination	O
and	O
x	O
-	O
ray	O
study	O
,	O
and	O
simple	O
treatment	O
by	O
passage	O
of	O
feeding	O
tube	O
and	O
gastric	B-ANAT
decompression	O
relieved	O
the	O
distress	O
and	O
helped	O
us	O
overcome	O
the	O
acute	O
crisis	O
.	O

Mean	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
II	O
score	O
was	O
18	O
.	O
0	O
Â±	O
8	O
.	O
1	O
,	O
and	O
mean	O
Sequential	O
Organ	B-ANAT
Failure	O
Assessment	O
score	O
was	O
6	O
.	O
5	O
Â±	O
3	O
.	O
8	O
.	O

Seven	O
hundred	O
sixty	O
-	O
five	O
patients	O
(	O
59	O
.	O
0	O
%)	O
developed	O
infections	O
,	O
followed	O
by	O
severe	O
sepsis	O
or	O
septic	O
shock	O
(	O
484	O
,	O
37	O
.	O
3	O
%),	O
acute	O
kidney	B-ANAT
injury	O
(	O
398	O
,	O
30	O
.	O
7	O
%),	O
and	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
351	O
,	O
27	O
.	O
1	O
%).	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
therapy	O
for	O
patients	O
with	O
influenza	O
A	O
(	O
H1N1	O
)-	O
related	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
has	O
been	O
described	O
once	O
all	O
other	O
therapeutic	O
options	O
have	O
been	O
exhausted	O
.	O

TITLE	O
:	O
Assays	O
for	O
laboratory	O
confirmation	O
of	O
novel	O
human	O
coronavirus	O
(	O
hCoV	O
-	O
EMC	B-ANAT
)	O
infections	O
.	O

However	O
,	O
unlike	O
the	O
earlier	O
cases	O
,	O
and	O
despite	O
underlying	O
chronic	O
disease	O
and	O
a	O
single	O
kidney	B-ANAT
,	O
he	O
survived	O
his	O
infection	O
and	O
has	O
been	O
discharged	O
home	O
.	O

As	O
human	O
CoV	O
normally	O
cannot	O
replicate	O
in	O
bat	O
cells	B-ANAT
from	O
different	O
families	O
,	O
this	O
suggests	O
that	O
hCoV	O
-	O
EMC	B-ANAT
might	O
use	O
a	O
receptor	O
molecule	O
that	O
is	O
conserved	O
in	O
bats	O
,	O
pigs	O
,	O
and	O
humans	O
,	O
implicating	O
a	O
low	O
barrier	O
against	O
cross	O
-	O
host	O
transmission	O
.	O

This	O
knowledge	O
is	O
highly	O
critical	O
,	O
because	O
the	O
SARS	O
-	O
CoV	O
receptor	O
influenced	O
pathology	O
,	O
and	O
its	O
localization	O
in	O
the	O
deep	O
respiratory	B-ANAT
tract	I-ANAT
is	O
thought	O
to	O
have	O
restricted	O
the	O
transmissibility	O
of	O
SARS	O
.	O

ADV	O
is	O
one	O
of	O
the	O
most	O
important	O
pathogens	O
of	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
in	O
children	O
in	O
Nanjing	O
area	O
,	O
and	O
adenovirus	O
type	O
3	O
was	O
the	O
most	O
prevalent	O
serotype	O
.	O

Their	O
structure	O
was	O
proved	O
by	O
determining	O
the	O
X	O
-	O
ray	O
single	O
crystal	B-ANAT
structure	O
of	O
one	O
hydrolytic	O
elaboration	O
product	O
.	O

TITLE	O
:	O
The	O
new	O
definition	O
for	O
acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
is	O
there	O
room	O
for	O
improvement	O
?	O

In	O
this	O
review	O
,	O
we	O
propose	O
that	O
both	O
the	O
use	O
of	O
P	O
/	O
F	O
ratio	O
after	O
some	O
stabilization	O
(	O
first	O
24	O
h	O
)	O
and	O
the	O
use	O
of	O
compliance	O
stratified	O
at	O
0	O
.	O
4	O
ml	O
/	O
cm	O
H	O
(	O
2	O
)	O
O	O
/	O
kg	O
ideal	O
body	B-ANAT
weight	O
might	O
improve	O
the	O
stratification	O
of	O
patients	O
.	O

Three	O
-	O
dimensional	O
reconstructions	O
identify	O
DMVs	O
as	O
protrusions	O
from	O
the	O
ER	B-ANAT
membrane	I-ANAT
into	O
the	O
cytosol	B-ANAT
,	O
frequently	O
connected	O
to	O
the	O
ER	B-ANAT
membrane	I-ANAT
via	O
a	O
neck	B-ANAT
-	O
like	O
structure	O
.	O

By	O
contrast	O
,	O
the	O
absence	O
of	O
B7	O
-	O
H1	O
enhances	O
CD8	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
function	O
and	O
accelerates	O
viral	O
control	O
,	O
but	O
increases	O
morbidity	O
.	O

CD4	O
depletion	O
in	O
B7	O
-	O
H1	O
-/-	O
mice	O
also	O
decreased	O
inducible	O
nitric	O
oxide	O
synthase	O
expression	O
by	O
microglia	B-ANAT
and	O
macrophages	B-ANAT
,	O
consistent	O
with	O
decreased	O
microglia	B-ANAT
/	O
macrophage	B-ANAT
activation	O
and	O
reduced	O
interferon	O
(	O
IFN	O
)-	O
Î³	O
.	O

The	O
wide	O
spectrum	O
of	O
initial	O
target	B-ANAT
cells	I-ANAT
following	O
MK	O
-	O
p10	O
infection	O
,	O
as	O
well	O
as	O
its	O
faster	O
spread	O
in	O
the	O
brain	B-ANAT
,	O
may	O
be	O
evidence	O
of	O
enhanced	O
virulence	O
in	O
suckling	O
mice	O
.	O

TITLE	O
:	O
Rapid	O
NK	B-ANAT
-	I-ANAT
cell	I-ANAT
activation	O
in	O
chicken	O
after	O
infection	O
with	O
infectious	O
bronchitis	O
virus	O
M41	O
.	O

Based	O
on	O
surface	O
expression	O
of	O
CD107	O
+,	O
enhanced	O
activation	O
of	O
lung	B-ANAT
NK	B-ANAT
cells	I-ANAT
was	O
observed	O
at	O
1	O
dpi	O
,	O
whereas	O
in	O
blood	B-ANAT
prolonged	O
NK	B-ANAT
-	I-ANAT
cell	I-ANAT
activation	O
was	O
found	O
.	O

Collectively	O
,	O
infection	O
with	O
IBV	O
-	O
M41	O
resulted	O
in	O
activation	O
of	O
NK	B-ANAT
cells	I-ANAT
in	O
the	O
lung	B-ANAT
and	O
blood	B-ANAT
and	O
rapid	O
production	O
of	O
IFN	O
-	O
Î³	O
and	O
not	O
IFN	O
-	O
Î±	O
and	O
IFN	O
-	O
Î²	O
compared	O
to	O
uninfected	O
birds	O
.	O

Forty	O
-	O
one	O
percent	O
were	O
viral	O
coinfections	O
,	O
which	O
were	O
significantly	O
younger	O
than	O
virus	O
negative	O
patients	O
,	O
had	O
a	O
higher	O
leukocyte	B-ANAT
count	O
and	O
were	O
hospitalized	O
for	O
a	O
longer	O
time	O
.	O

TITLE	O
:	O
Respiratory	O
and	O
hemodynamic	O
effects	O
of	O
a	O
stepwise	O
lung	B-ANAT
recruitment	O
maneuver	O
in	O
pediatric	O
ARDS	O
:	O
a	O
feasibility	O
study	O
.	O

Efficacy	O
was	O
evaluated	O
as	O
changes	O
in	O
lung	B-ANAT
compliance	O
(	O
Cdyn	O
)	O
and	O
gas	O
exchange	O
1	O
,	O
12	O
,	O
and	O
24	O
hr	O
after	O
the	O
RM	O
.	O

Intra	O
-	O
abdominal	B-ANAT
hypertension	O
has	O
a	O
serious	O
impact	O
on	O
the	O
function	O
of	O
respiratory	O
as	O
well	O
as	O
peripheral	O
organs	B-ANAT
.	O

First	O
line	O
hypoxaemic	O
rescue	O
therapies	O
include	O
inhaled	O
nitric	O
oxide	O
,	O
prone	O
positioning	O
,	O
alveolar	B-ANAT
recruitment	O
manoeuvres	O
and	O
high	O
frequency	O
oscillatory	O
ventilation	O
,	O
which	O
have	O
all	O
been	O
shown	O
to	O
be	O
effective	O
in	O
improving	O
oxygenation	O
.	O

Here	O
,	O
we	O
focus	O
on	O
the	O
role	O
of	O
CD4	O
CD8	O
double	O
negative	O
T	O
(	O
DN	O
T	O
)	O
cells	B-ANAT
involved	O
in	O
the	O
mechanisms	O
of	O
viral	O
persistence	O
in	O
hepatitis	O
.	O

Adoptive	O
transfer	O
of	O
DN	O
T	B-ANAT
cells	I-ANAT
from	O
MHV	O
-	O
3	O
infected	O
mice	O
led	O
to	O
a	O
significant	O
increase	O
in	O
mice	O
survival	O
.	O

In	O
short	O
,	O
our	O
study	O
identified	O
DN	O
T	B-ANAT
cells	I-ANAT
contributing	O
to	O
viral	O
persistence	O
in	O
MHV	O
-	O
3	O
induced	O
hepatitis	O
in	O
C3H	O
/	O
HeJ	O
mice	O
,	O
which	O
provides	O
a	O
rationale	O
for	O
modulating	O
DN	O
T	B-ANAT
cells	I-ANAT
for	O
the	O
management	O
of	O
viral	O
hepatitis	O
.	O

Secondly	O
,	O
we	O
describe	O
permissive	O
hypoxemia	O
:	O
the	O
acceptance	O
of	O
levels	O
of	O
arterial	B-ANAT
oxygenation	O
lower	O
than	O
is	O
conventionally	O
tolerated	O
in	O
patients	O
.	O

We	O
searched	O
PubMed	O
for	O
references	O
to	O
""""	O
permissive	O
hypoxemia	O
/	O
hypoxaemia	O
""""	O
and	O
""""	O
precise	O
control	O
of	O
arterial	B-ANAT
oxygenation	O
""""	O
as	O
well	O
as	O
reference	O
to	O
""""	O
profound	O
hypoxemia	O
/	O
hypoxaemia	O
/	O
hypoxia	O
","""	O
""""	O
severe	O
hypoxemia	O
/	O
hypoxaemia	O
/	O
hypoxia	O
.	O

The	O
two	O
virus	O
infection	O
groups	O
both	O
exhibited	O
obvious	O
pathologies	O
in	O
the	O
liver	B-ANAT
characteristic	O
of	O
chronic	O
viral	O
hepatitis	O
with	O
increased	O
lipid	O
accumulation	O
in	O
the	O
hepatocytes	B-ANAT
.	O

Severe	O
hypoxemia	O
in	O
acute	O
lung	B-ANAT
injury	O
and	O
ARDS	O
can	O
be	O
improved	O
by	O
ventilation	O
with	O
PEEP	O
,	O
and	O
also	O
in	O
many	O
patients	O
by	O
various	O
adjunctive	O
techniques	O
and	O
alternative	O
support	O
strategies	O
.	O

TITLE	O
:	O
Detection	O
of	O
feline	O
coronavirus	O
in	O
cheetah	O
(	O
Acinonyx	O
jubatus	O
)	O
feces	B-ANAT
by	O
reverse	O
transcription	O
-	O
nested	O
polymerase	O
chain	O
reaction	O
in	O
cheetahs	O
with	O
variable	O
frequency	O
of	O
viral	O
shedding	O
.	O

Forty	O
-	O
four	O
percent	O
(	O
7	O
/	O
16	O
)	O
of	O
cheetahs	O
had	O
detectable	O
FCoV	O
in	O
feces	B-ANAT
,	O
and	O
the	O
proportion	O
of	O
positive	O
samples	O
for	O
individual	O
animals	O
ranged	O
from	O
13	O
to	O
93	O
%.	O

Demographic	O
and	O
management	O
risk	O
factors	O
were	O
not	O
significantly	O
associated	O
(	O
P	O
<	O
or	O
=	O
0	O
.	O
05	O
)	O
with	O
fecal	B-ANAT
viral	O
shedding	O
.	O

The	O
retrospective	O
observational	O
study	O
included	O
all	O
mechanically	O
ventilated	O
adult	O
patients	O
of	O
three	O
university	O
-	O
affiliated	O
hospitals	O
between	O
November	O
1	O
,	O
2009	O
and	O
March	O
1	O
2010	O
who	O
had	O
2009	O
H1N1	O
influenza	O
infection	O
confirmed	O
by	O
real	O
-	O
time	O
reverse	O
transcriptase	O
-	O
polymerase	O
-	O
chain	O
-	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
from	O
nasopharyngeal	B-ANAT
swab	I-ANAT
specimens	O
and	O
respiratory	O
secretions	B-ANAT
.	O

Sixteen	O
patients	O
(	O
30	O
%)	O
presented	O
with	O
one	O
or	O
more	O
chronic	O
medical	O
condition	O
:	O
8	O
(	O
16	O
%)	O
with	O
chronic	O
lung	B-ANAT
disease	O
,	O
5	O
(	O
10	O
%)	O
with	O
chronic	O
heart	B-ANAT
failure	O
,	O
and	O
3	O
(	O
6	O
%)	O
with	O
diabetes	O
mellitus	O
.	O

The	O
conserved	O
existence	O
of	O
a	O
third	O
stem	B-ANAT
-	O
loop	O
suggested	O
an	O
important	O
hitherto	O
unknown	O
function	O
.	O

We	O
uncovered	O
RNA	O
dimerization	O
through	O
a	O
palindromic	O
sequence	O
embedded	O
in	O
the	O
SARS	O
-	O
CoV	O
Stem	B-ANAT
3	O
.	O

The	O
successful	O
re	O
-	O
isolation	O
of	O
CRCoV	O
from	O
a	O
wide	O
range	O
of	O
respiratory	O
and	O
mucosal	B-ANAT
associated	O
lymphoid	B-ANAT
tissues	I-ANAT
,	O
and	O
lung	B-ANAT
lavage	I-ANAT
fluids	I-ANAT
demonstrates	O
a	O
clear	O
tropism	O
of	O
CRCoV	O
for	O
respiratory	O
tissues	B-ANAT
and	O
fulfils	O
the	O
final	O
requirement	O
for	O
Koch	O
'	O
s	O
postulates	O
.	O

In	O
a	O
multi	O
-	O
variate	O
Cox	O
regression	O
model	O
,	O
pre	O
-	O
ECMO	O
factors	O
including	O
lower	O
PaO2	O
/	O
FiO2	O
and	O
increasing	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
count	O
were	O
associated	O
with	O
increased	O
risks	O
of	O
death	O
(	O
RR	O
was	O
0	O
.	O
733	O
,	O
1	O
.	O
701	O
respectively	O
,	O
both	O
P	O
values	O
<	O
0	O
.	O
05	O
).	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
value	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
for	O
adult	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

The	O
APACHEIIscore	O
(	O
13	O
.	O
3	O
Â±	O
1	O
.	O
0	O
vs	O
14	O
.	O
1	O
Â±	O
1	O
.	O
2	O
)	O
and	O
the	O
level	O
of	O
TBil	O
[(	O
20	O
.	O
4	O
Â±	O
11	O
.	O
3	O
)	O
Âµmol	O
/	O
L	O
vs	O
(	O
28	O
.	O
1	O
Â±	O
10	O
.	O
9	O
)	O
Âµmol	O
/	O
L	O
],	O
creatinine	O
[(	O
178	O
.	O
7	O
Â±	O
71	O
.	O
8	O
)	O
Âµmol	O
/	O
L	O
vs	O
(	O
215	O
.	O
6	O
Â±	O
51	O
.	O
3	O
)	O
Âµmol	O
/	O
L	O
],	O
blood	B-ANAT
urea	O
nitrogen	O
[(	O
10	O
.	O
1	O
Â±	O
5	O
.	O
6	O
)	O
mmol	O
/	O
L	O
vs	O
(	O
13	O
.	O
2	O
Â±	O
3	O
.	O
8	O
)	O
mmol	O
/	O
L	O
]	O
and	O
ALT	O
[(	O
51	O
.	O
3	O
Â±	O
13	O
.	O
2	O
)	O
U	O
/	O
L	O
vs	O
(	O
62	O
.	O
5	O
Â±	O
14	O
.	O
3	O
)	O
U	O
/	O
L	O
]	O
were	O
decreased	O
compared	O
to	O
those	O
in	O
the	O
control	O
group	O
(	O
all	O
P	O
values	O
<	O
0	O
.	O
05	O
).	O

Mean	O
artery	B-ANAT
pressure	O
(	O
mAP	O
)	O
increased	O
gradually	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
in	O
the	O
hemofiltration	O
group	O
than	O
in	O
the	O
control	O
group	O
.	O

Indeed	O
,	O
some	O
authors	O
have	O
described	O
the	O
clinical	O
features	O
associated	O
with	O
blood	B-ANAT
and	O
urine	B-ANAT
concentrations	O
following	O
intoxication	O
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
to	O
describe	O
the	O
clinical	O
feature	O
and	O
determinate	O
the	O
utility	O
of	O
the	O
glyphosate	O
concentration	O
in	O
blood	B-ANAT
and	O
urine	B-ANAT
and	O
the	O
dose	O
taken	O
for	O
predicting	O
clinical	O
outcomes	O
.	O

In	O
13	O
glyphosate	O
poisoning	O
cases	O
treated	O
in	O
our	O
laboratory	O
within	O
7	O
years	O
period	O
from	O
2002	O
to	O
2009	O
,	O
we	O
registered	O
clinical	O
observations	O
and	O
collected	O
blood	B-ANAT
and	O
urine	B-ANAT
samples	O
to	O
HPLC	O
-	O
MS	O
-	O
MS	O
analysis	O
.	O

In	O
three	O
additional	O
patients	O
evaluated	O
before	O
and	O
after	O
red	B-ANAT
blood	I-ANAT
cell	I-ANAT
transfusion	O
,	O
O2	O
delivery	O
increased	O
after	O
transfusion	O
,	O
allowing	O
lower	O
ECMO	O
flows	O
to	O
reach	O
adequate	O
SaO2	O
.	O

TITLE	O
:	O
Astrocyte	B-ANAT
-	O
derived	O
CXCL10	O
drives	O
accumulation	O
of	O
antibody	B-ANAT
-	I-ANAT
secreting	I-ANAT
cells	I-ANAT
in	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
during	O
viral	O
encephalomyelitis	O
.	O

ABSTRACT	O
:	O
Microbial	O
infections	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
are	O
often	O
associated	O
with	O
local	O
accumulation	O
of	O
antibody	O
(	O
Ab	O
)-	O
secreting	O
cells	B-ANAT
(	O
ASC	O
).	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
is	O
characterized	O
by	O
damage	O
to	O
the	O
lung	B-ANAT
caused	O
by	O
various	O
insults	O
,	O
including	O
ventilation	O
itself	O
,	O
and	O
tidal	O
hyperinflation	O
can	O
lead	O
to	O
ventilator	O
induced	O
lung	B-ANAT
injury	O
(	O
VILI	O
).	O

We	O
investigated	O
the	O
effects	O
of	O
a	O
low	O
tidal	O
volume	O
(	O
V	O
(	O
T	O
))	O
strategy	O
(	O
V	O
(	O
T	O
)	O
â	O
3	O
ml	O
/	O
kg	O
/	O
predicted	O
body	B-ANAT
weight	O
[	O
PBW	O
])	O
using	O
pumpless	O
extracorporeal	O
lung	B-ANAT
assist	O
in	O
established	O
ARDS	O
.	O

Three	O
bovine	O
nasal	B-ANAT
samples	O
infected	O
with	O
bovine	O
coronavirus	O
were	O
used	O
to	O
infect	O
human	O
and	O
bovine	O
macrophage	B-ANAT
and	O
lung	B-ANAT
cell	B-ANAT
lines	I-ANAT
.	O

ABSTRACT	O
:	O
By	O
using	O
a	O
fragment	O
-	O
assembly	O
strategy	O
and	O
bioisosteric	O
-	O
replacement	O
principle	O
,	O
a	O
series	O
of	O
novel	O
piperazine	O
derivatives	O
were	O
designed	O
,	O
synthesized	O
,	O
and	O
evaluated	O
for	O
their	O
cellular	B-ANAT
target	O
-	O
effector	O
fusion	O
activities	O
and	O
in	O
vitro	O
antiviral	O
activities	O
against	O
HIV	O
-	O
1	O
.	O

ABSTRACT	O
:	O
Refeeding	O
syndrome	O
is	O
a	O
potentially	O
life	O
-	O
threatening	O
condition	O
characterised	O
by	O
severe	O
intracellular	B-ANAT
electrolyte	O
shifts	O
,	O
acute	O
circulatory	O
fluid	O
overload	O
and	O
organ	B-ANAT
failure	O
.	O

Death	O
of	O
these	O
participants	O
was	O
due	O
to	O
cerebrovascular	O
accident	O
,	O
traumatic	O
injury	O
,	O
respiratory	O
failure	O
,	O
organ	B-ANAT
failure	O
or	O
end	O
-	O
of	O
-	O
life	O
causes	O
.	O

Independent	O
predictors	O
for	O
refeeding	O
syndrome	O
were	O
starvation	O
and	O
baseline	O
low	O
-	O
serum	B-ANAT
magnesium	O
concentration	O
.	O

The	O
need	O
for	O
ICU	O
admission	O
(	O
P	O
=	O
0	O
.	O
000	O
;	O
OR	O
,	O
6	O
.	O
1	O
)	O
and	O
lung	B-ANAT
consolidation	O
(	O
P	O
=	O
0	O
.	O
008	O
,	O
OR	O
,	O
2	O
.	O
46	O
)	O
were	O
independent	O
risk	O
factors	O
associated	O
with	O
PLOS	O
.	O

We	O
found	O
no	O
correlation	O
between	O
individual	O
maximal	O
plasma	B-ANAT
HBP	O
levels	O
at	O
admission	O
and	O
ISS	O
,	O
admission	O
SOFA	O
or	O
APACHE	O
II	O
.	O

Further	O
research	O
is	O
required	O
to	O
confirm	O
a	O
casual	O
relationship	O
between	O
plasma	B-ANAT
HBP	O
and	O
the	O
development	O
of	O
ARDS	O
.	O

TITLE	O
:	O
Activation	O
of	O
the	O
heat	O
shock	O
response	O
attenuates	O
the	O
interleukin	O
1Î²	O
-	O
mediated	O
inhibition	O
of	O
the	O
amiloride	O
-	O
sensitive	O
alveolar	B-ANAT
epithelial	O
ion	O
transport	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
is	O
a	O
clinical	O
syndrome	O
characterized	O
by	O
hypoxia	O
,	O
which	O
is	O
caused	O
by	O
the	O
breakdown	O
of	O
the	O
alveolar	B-ANAT
capillary	B-ANAT
barrier	O
.	O

Loss	O
of	O
ACE2	O
can	O
be	O
detrimental	O
,	O
as	O
it	O
leads	O
to	O
functional	O
deterioration	O
of	O
the	O
heart	B-ANAT
and	O
progression	O
of	O
cardiac	B-ANAT
,	O
renal	B-ANAT
,	O
and	O
vascular	B-ANAT
pathologies	O
.	O

ACE2	O
is	O
a	O
multifunctional	O
enzyme	O
and	O
thus	O
potentially	O
acts	O
on	O
other	O
vasoactive	O
peptides	O
,	O
such	O
as	O
Apelin	O
,	O
a	O
vital	O
regulator	O
of	O
blood	B-ANAT
pressure	O
and	O
myocardium	B-ANAT
contractility	O
.	O

This	O
may	O
suggest	O
that	O
IBV	O
can	O
inhibit	O
or	O
control	O
autophagy	O
in	O
avian	O
cells	B-ANAT
,	O
although	O
IBV	O
did	O
not	O
appear	O
to	O
inhibit	O
autophagy	O
induced	O
by	O
starvation	O
or	O
rapamycin	O
treatment	O
.	O

The	O
ND	O
,	O
IB	O
and	O
AI	O
antibody	O
titers	O
and	O
the	O
lymphocyte	B-ANAT
proliferation	O
were	O
enhanced	O
at	O
30	O
mg	O
/	O
mL	O
SPP	O
.	O

During	O
the	O
2003	O
pandemic	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
the	O
use	O
of	O
quarantine	O
,	O
border	B-ANAT
controls	O
,	O
contact	O
tracing	O
,	O
and	O
surveillance	O
proved	O
effective	O
in	O
containing	O
the	O
global	O
threat	O
in	O
just	O
over	O
3	O
months	O
.	O

TITLE	O
:	O
Identification	O
of	O
viral	O
pathogen	O
diversity	O
in	O
sewage	O
sludge	B-ANAT
by	O
metagenome	O
analysis	O
.	O

In	O
the	O
U	O
.	O
S	O
.,	O
the	O
primary	O
fate	O
of	O
processed	O
sewage	O
sludge	B-ANAT
(	O
class	O
B	O
biosolids	O
)	O
is	O
application	O
to	O
agricultural	O
land	B-ANAT
as	O
a	O
soil	O
amendment	O
.	O

To	O
characterize	O
and	O
understand	O
infectious	O
risks	O
associated	O
with	O
land	B-ANAT
application	O
,	O
and	O
to	O
describe	O
the	O
diversity	O
of	O
viruses	O
in	O
human	O
populations	O
,	O
shotgun	O
viral	O
metagenomics	O
was	O
applied	O
to	O
10	O
sewage	O
sludge	B-ANAT
samples	O
from	O
5	O
wastewater	O
treatment	O
plants	O
throughout	O
the	O
continental	O
U	O
.	O
S	O
,	O
each	O
serving	O
between	O
100	O
,	O
000	O
and	O
1	O
,	O
000	O
,	O
000	O
people	O
.	O

Compared	O
with	O
WT	O
mice	O
,	O
ADORA2A	O
(-/-)	O
mice	O
exposed	O
to	O
IT	O
LPS	O
and	O
60	O
%	O
oxygen	O
demonstrated	O
significantly	O
more	O
histologic	O
lung	B-ANAT
injury	O
,	O
alveolar	B-ANAT
neutrophils	B-ANAT
,	O
and	O
protein	O
.	O

CGS	O
-	O
21680	O
prevented	O
the	O
oxygen	O
-	O
induced	O
augmentation	O
of	O
lung	B-ANAT
injury	O
after	O
LPS	O
only	O
in	O
WT	O
mice	O
.	O

ADORA2A	O
is	O
protective	O
against	O
lung	B-ANAT
injury	O
after	O
LPS	O
and	O
oxygen	O
.	O

TITLE	O
:	O
Analysis	O
of	O
a	O
QX	O
-	O
like	O
avian	O
infectious	O
bronchitis	O
virus	O
genome	O
identified	O
recombination	O
in	O
the	O
region	O
containing	O
the	O
ORF	O
5a	O
,	O
ORF	O
5b	O
,	O
and	O
nucleocapsid	B-ANAT
protein	O
gene	O
sequences	O
.	O

A	O
blood	B-ANAT
sample	I-ANAT
was	O
drawn	O
on	O
the	O
first	O
day	O
of	O
ICU	O
admission	O
,	O
and	O
DNA	O
was	O
extracted	O
.	O

Variables	O
included	O
in	O
the	O
maximal	O
multivariate	O
model	O
were	O
male	O
sex	O
,	O
chronic	O
alcoholism	O
,	O
use	O
of	O
ACE	O
inhibitors	O
or	O
angiotensin	O
-	O
receptor	O
blockers	O
,	O
Simplified	O
Acute	O
Physiology	O
Score	O
II	O
score	O
,	O
serum	B-ANAT
glucose	O
concentration	O
at	O
ICU	O
admission	O
,	O
and	O
the	O
presence	O
of	O
the	O
allele	O
D	O
of	O
the	O
ACE	O
gene	O
.	O

Results	O
were	O
confirmed	O
by	O
proteomic	O
and	O
chromatin	B-ANAT
immunoprecipitation	O
assay	O
analyses	O
and	O
in	O
parallel	O
microarray	O
studies	O
using	O
infected	O
primary	O
human	O
airway	B-ANAT
epithelial	B-ANAT
cell	I-ANAT
cultures	O
.	O

There	O
is	O
consistent	O
evidence	O
that	O
downregulation	O
of	O
systemic	O
inflammation	O
with	O
prolonged	O
low	O
-	O
dose	O
glucocorticoid	O
treatment	O
in	O
patients	O
with	O
severe	O
sepsis	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
improves	O
cardiovascular	B-ANAT
and	O
pulmonary	B-ANAT
organ	B-ANAT
physiology	O
.	O

In	O
patients	O
with	O
AGE	O
,	O
HCoVs	O
were	O
present	O
in	O
NP	O
samples	O
more	O
often	O
than	O
in	O
stools	B-ANAT
(	O
22	O
/	O
256	O
,	O
8	O
.	O
6	O
%,	O
versus	O
6	O
/	O
260	O
,	O
2	O
.	O
3	O
%;	O
P	O
=	O
0	O
.	O
0004	O
).	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
its	O
most	O
severe	O
form	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
are	O
characterised	O
by	O
high	O
-	O
protein	O
pulmonary	B-ANAT
edema	O
and	O
severe	O
hypoxaemic	O
respiratory	O
failure	O
due	O
to	O
increased	O
permeability	O
of	O
pulmonary	B-ANAT
microvascular	O
endothelial	B-ANAT
cells	I-ANAT
(	O
PMVEC	O
).	O

PMVEC	O
isolated	O
from	O
human	O
lung	B-ANAT
were	O
treated	O
in	O
vitro	O
with	O
septic	O
stimulation	O
(	O
lipopolysaccharide	O
[	O
LPS	O
],	O
a	O
mixture	O
of	O
clinically	O
-	O
relevant	O
cytokines	O
[	O
cytomix	O
],	O
or	O
plasma	B-ANAT
from	O
patients	O
with	O
severe	O
sepsis	O
),	O
and	O
the	O
trans	O
-	O
PMVEC	O
leak	O
of	O
Evans	O
Blue	O
dye	O
-	O
labeled	O
albumin	O
assessed	O
.	O

Septic	O
stimulation	O
with	O
LPS	O
,	O
cytomix	O
,	O
or	O
septic	O
plasma	B-ANAT
induced	O
marked	O
PMVEC	O
hyper	O
-	O
permeability	O
(	O
10	O
.	O
2	O
Â±	O
1	O
.	O
8	O
,	O
8	O
.	O
9	O
Â±	O
2	O
.	O
2	O
,	O
and	O
3	O
.	O
7	O
Â±	O
0	O
.	O
2	O
fold	O
-	O
increase	O
vs	O
.	O
control	O
,	O
respectively	O
,	O
p	O
<	O
0	O
.	O
01	O
for	O
all	O
).	O

The	O
serum	B-ANAT
levels	O
of	O
angiogenic	O
factors	O
were	O
measured	O
at	O
the	O
time	O
of	O
admission	O
(	O
day	O
1	O
),	O
as	O
well	O
as	O
day	O
3	O
and	O
day	O
5	O
and	O
then	O
were	O
compared	O
among	O
the	O
ALI	O
,	O
ARDS	O
and	O
non	O
-	O
ALI	O
/	O
ARDS	O
groups	O
.	O

Plasma	B-ANAT
kallistatin	O
,	O
kallikrein	O
,	O
and	O
other	O
biomarkers	O
of	O
inflammation	O
(	O
tumor	O
necrosis	O
factor	O
-	O
Î±	O
(	O
TNF	O
-	O
Î±	O
),	O
interleukin	O
(	O
IL	O
)-	O
1Î²	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
C	O
-	O
reactive	O
protein	O
(	O
CRP	O
)),	O
and	O
anti	O
-	O
coagulation	O
(	O
protein	O
C	O
,	O
anti	O
-	O
thrombin	O
III	O
)	O
were	O
measured	O
on	O
days	O
1	O
and	O
4	O
of	O
ICU	O
admission	O
.	O

Plasma	B-ANAT
kallistatin	O
levels	O
on	O
day	O
1	O
of	O
ICU	O
admission	O
were	O
significantly	O
decreased	O
in	O
patients	O
who	O
developed	O
septic	O
shock	O
(	O
P	O
=	O
0	O
.	O
017	O
)	O
and	O
who	O
had	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
P	O
=	O
0	O
.	O
044	O
).	O

TITLE	O
:	O
Italian	O
field	O
survey	O
reveals	O
a	O
high	O
diffusion	O
of	O
avian	O
metapneumovirus	O
subtype	O
B	O
in	O
layers	B-ANAT
and	O
weaknesses	O
in	O
the	O
vaccination	O
strategy	O
applied	O
.	O

Occurrences	O
of	O
respiratory	O
signs	O
and	O
a	O
drop	O
in	O
egg	B-ANAT
production	O
were	O
recorded	O
.	O

Possible	O
involvement	O
of	O
infectious	O
bronchitis	O
(	O
IB	O
)	O
and	O
egg	B-ANAT
drop	O
syndrome	O
(	O
EDS	O
)	O
viruses	O
that	O
could	O
have	O
caused	O
loss	O
of	O
egg	B-ANAT
production	O
we	O
ruled	O
out	O
for	O
IB	O
virus	O
by	O
RT	O
-	O
PCR	O
,	O
and	O
EDS	O
virus	O
was	O
ruled	O
out	O
by	O
hemagglutination	O
-	O
inhibition	O
(	O
HI	O
).	O

Arteriviruses	O
are	O
economically	O
important	O
positive	O
-	O
stranded	O
RNA	O
viruses	O
that	O
encode	O
an	O
ovarian	B-ANAT
tumor	O
(	O
OTU	O
)	O
domain	O
DUB	O
known	O
as	O
papain	O
-	O
like	O
protease	O
2	O
(	O
PLP2	O
).	O

PaCO2	O
and	O
CBF	O
increased	O
significantly	O
in	O
the	O
SF	O
-	O
bolus	O
group	O
during	O
the	O
first	O
15	O
-	O
30	O
min	O
,	O
without	O
concomitant	O
changes	O
in	O
cardiovascular	B-ANAT
parameters	O
,	O
whereas	O
in	O
the	O
SF	O
-	O
aero	O
group	O
,	O
PaCO2	O
and	O
CBF	O
decreased	O
gradually	O
.	O

When	O
OSA	O
is	O
diagnosed	O
preoperatively	O
,	O
the	O
rate	O
of	O
postoperative	O
pulmonary	B-ANAT
complications	O
is	O
low	O
and	O
not	O
associated	O
with	O
OSA	O
severity	O
.	O

A	O
48	O
-	O
year	O
-	O
old	O
Chinese	O
woman	O
was	O
referred	O
to	O
our	O
hospital	O
,	O
complaining	O
of	O
occasional	O
pain	O
in	O
the	O
right	O
lower	B-ANAT
back	I-ANAT
for	O
one	O
month	O
.	O

During	O
the	O
7	O
years	O
of	O
follow	O
-	O
up	O
,	O
66	O
hips	B-ANAT
progressed	O
to	O
symptoms	O
,	O
50	O
hips	B-ANAT
collapsed	O
and	O
10	O
hips	B-ANAT
showed	O
complete	O
regression	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
coronavirus	O
(	O
CoV	O
)	O
produces	O
a	O
devastating	O
primary	O
viral	O
pneumonia	O
with	O
diffuse	O
alveolar	B-ANAT
damage	O
and	O
a	O
marked	O
increase	O
in	O
circulating	O
cytokines	O
.	O

Our	O
objectives	O
included	O
developing	O
a	O
culture	O
system	O
permissive	O
for	O
SARS	O
-	O
CoV	O
infection	O
in	O
primary	O
human	O
type	O
II	O
cells	B-ANAT
and	O
defining	O
their	O
innate	O
immune	O
response	O
.	O

RESULTS	O
:	O
Of	O
173	O
patients	O
,	O
100	O
(	O
57	O
.	O
8	O
%),	O
73	O
(	O
42	O
.	O
2	O
%)	O
and	O
23	O
(	O
13	O
.	O
3	O
%)	O
had	O
body	B-ANAT
mass	O
index	O
(	O
BMI	O
)	O
<	O
30	O
kg	O
/	O
m	O
(	O
2	O
),	O
â¥	O
30	O
kg	O
/	O
m	O
(	O
2	O
)	O
(	O
obese	O
)	O
and	O
â¥	O
40	O
kg	O
/	O
m	O
(	O
2	O
)	O
(	O
morbidly	O
obese	O
)	O
respectively	O
.	O

More	O
than	O
one	O
-	O
half	O
of	O
patients	O
experience	O
severe	O
pain	O
,	O
and	O
about	O
two	O
-	O
thirds	O
have	O
autonomic	B-ANAT
symptoms	O
,	O
such	O
as	O
cardiac	B-ANAT
arrhythmias	O
,	O
blood	B-ANAT
pressure	O
instability	O
,	O
or	O
urinary	O
retention	O
.	O

Nine	O
H1N1	O
-	O
infected	O
adult	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
were	O
admitted	O
into	O
an	O
intensive	O
care	O
unit	O
of	O
a	O
large	O
urban	O
hospital	O
for	O
rescue	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
therapy	O
.	O

For	O
future	O
pandemics	O
,	O
this	O
study	O
identified	O
the	O
need	O
for	O
all	O
staff	O
to	O
have	O
a	O
basic	O
understanding	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
;	O
strengthen	O
inter	O
-	O
professional	O
collaboration	O
and	O
communication	O
;	O
provision	O
for	O
more	O
support	O
and	O
recognition	O
of	O
these	O
highly	O
specialized	O
nurses	O
,	O
along	O
with	O
providing	O
regular	O
pandemic	O
updates	O
and	O
offering	O
counselling	O
services	O
.	O

TITLE	O
:	O
Hemagglutination	O
mediated	O
by	O
the	O
spike	O
protein	O
of	O
cell	B-ANAT
-	O
adapted	O
bovine	O
torovirus	O
.	O

Like	O
SARS	O
-	O
CoV	O
,	O
HCoV	O
-	O
EMC	B-ANAT
is	O
of	O
zoonotic	O
origin	O
and	O
closely	O
related	O
to	O
bat	O
coronaviruses	O
.	O

AKI	O
was	O
associated	O
with	O
oliguria	O
/	O
anuria	O
(	O
48	O
%),	O
anaemia	O
(	O
70	O
%),	O
thrombocytopenia	O
(	O
84	O
%),	O
hepatic	B-ANAT
dysfunction	O
(	O
48	O
%),	O
gastrointestinal	O
manifestations	O
(	O
33	O
%),	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
(	O
14	O
%),	O
cerebral	B-ANAT
malaria	O
(	O
6	O
%),	O
disseminated	O
intravascular	O
coagulation	O
(	O
8	O
%)	O
and	O
shock	O
(	O
11	O
%).	O

Recently	O
,	O
we	O
demonstrated	O
that	O
Calu	O
-	O
3	O
cells	B-ANAT
are	O
susceptible	O
to	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
)	O
infection	O
in	O
a	O
manner	O
consistent	O
with	O
NHBE	O
.	O

Calu	O
-	O
3	O
monolayer	O
cultures	O
should	O
remain	O
below	O
90	O
%	O
confluence	O
,	O
should	O
be	O
subcultured	O
fewer	O
than	O
10	O
times	O
from	O
frozen	O
stock	O
,	O
and	O
should	O
regularly	O
be	O
supplied	O
with	O
fresh	B-ANAT
medium	O
.	O

Polarization	O
is	O
monitored	O
by	O
evaluating	O
trans	O
-	O
epithelial	O
electrical	O
resistance	O
(	O
TEER	O
)	O
and	O
is	O
verified	O
by	O
evaluating	O
the	O
passive	O
equilibration	O
of	O
sodium	O
fluorescein	O
between	O
the	O
apical	O
and	O
basolateral	O
compartments	B-ANAT
.	O

Once	O
TEER	O
plateaus	O
at	O
or	O
above	O
1	O
,	O
000	O
Î©	O
Ã	O
cm	O
(	O
2	O
),	O
Calu	O
-	O
3	O
LCC	O
are	O
ready	O
to	O
use	O
to	O
examine	O
cellular	B-ANAT
responses	O
to	O
respiratory	O
pathogens	O
.	O

To	O
expand	O
the	O
knowledge	O
on	O
fundamental	O
virus	O
-	O
host	O
interactions	O
for	O
all	O
four	O
HCoVs	O
at	O
the	O
site	O
of	O
primary	O
infection	O
,	O
we	O
used	O
pseudostratified	O
HAE	O
cell	B-ANAT
cultures	O
to	O
isolate	O
and	O
characterize	O
representative	O
clinical	O
HCoV	O
strains	O
directly	O
from	O
nasopharyngeal	B-ANAT
material	O
.	O

Collectively	O
,	O
the	O
data	O
demonstrate	O
that	O
HAE	O
cell	B-ANAT
cultures	O
,	O
which	O
morphologically	O
and	O
functionally	O
resemble	O
human	O
airways	O
in	O
vivo	O
,	O
represent	O
a	O
robust	O
universal	O
culture	O
system	O
for	O
isolating	O
and	O
comparing	O
all	O
contemporary	O
HCoV	O
strains	O
.	O

TITLE	O
:	O
High	O
-	O
frequency	O
oscillatory	O
ventilation	O
for	O
cardiac	B-ANAT
surgery	O
children	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Because	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
(	O
HFOV	O
)	O
had	O
been	O
used	O
successfully	O
with	O
pediatric	O
patients	O
who	O
had	O
no	O
congenital	O
heart	B-ANAT
defects	O
,	O
this	O
therapy	O
was	O
used	O
in	O
our	O
unit	O
.	O

Pulmonary	B-ANAT
hypertension	O
and	O
RRTIs	O
before	O
surgery	O
were	O
risk	O
factors	O
for	O
in	O
-	O
hospital	O
mortality	O
.	O

In	O
addition	O
,	O
other	O
regulatory	O
lymphocytes	B-ANAT
(	O
CD4	O
+	O
CD25	O
-	O
Foxp3	O
+	O
and	O
CD3	O
+	O
CD8	O
+	O
Foxp3	O
+)	O
were	O
found	O
to	O
be	O
depleted	O
from	O
blood	B-ANAT
and	O
LN	O
as	O
well	O
.	O

Phenotypic	O
analysis	O
of	O
blood	B-ANAT
-	O
derived	O
NK	B-ANAT
cells	I-ANAT
in	O
FIP	O
cats	O
revealed	O
an	O
upregulation	O
of	O
activation	O
markers	O
(	O
CD16	O
and	O
CD25	O
)	O
and	O
migration	O
markers	O
(	O
CD11b	O
and	O
CD62L	O
)	O
while	O
LN	O
-	O
derived	O
NK	B-ANAT
cells	I-ANAT
showed	O
upregulation	O
of	O
only	O
CD16	O
and	O
CD62L	O
.	O

LN	O
-	O
derived	O
NK	B-ANAT
cells	I-ANAT
from	O
FIPV	O
-	O
infected	O
cats	O
were	O
also	O
significantly	O
less	O
cytotoxic	O
when	O
compared	O
with	O
healthy	O
cats	O
.	O

This	O
will	O
un	O
-	O
doubtfully	O
lead	O
to	O
a	O
reduced	O
capacity	O
of	O
the	O
innate	O
immune	B-ANAT
system	I-ANAT
(	O
NK	B-ANAT
cells	I-ANAT
)	O
to	O
battle	O
FIPV	O
infection	O
and	O
a	O
decreased	O
capacity	O
(	O
Tregs	O
)	O
to	O
suppress	O
the	O
immunopathology	O
typical	O
for	O
FIP	O
.	O

After	O
reintubation	O
,	O
the	O
patient	O
presented	O
a	O
worsening	O
in	O
oxygen	O
saturation	O
and	O
a	O
chest	B-ANAT
radiography	O
(	O
CXR	O
)	O
revealed	O
a	O
large	O
pneumothorax	O
.	O

A	O
repeat	O
CXR	O
confirmed	O
correct	O
positioning	O
of	O
the	O
chest	B-ANAT
tube	O
and	O
reexpansion	O
of	O
the	O
right	B-ANAT
lung	I-ANAT
.	O

We	O
estimated	O
this	O
negative	O
binomial	O
dispersion	O
parameter	O
for	O
TB	O
in	O
the	O
Netherlands	O
,	O
using	O
the	O
genotypic	O
cluster	O
size	O
distribution	O
for	O
all	O
8330	O
cases	O
of	O
culture	O
confirmed	O
,	O
pulmonary	B-ANAT
TB	O
diagnosed	O
between	O
1993	O
and	O
2007	O
in	O
the	O
Netherlands	O
.	O

The	O
patient	O
was	O
prescribed	O
oral	B-ANAT
tranexamic	O
acid	O
(	O
1000	O
mg	O
every	O
8	O
hours	O
),	O
with	O
partial	O
resolution	O
of	O
symptoms	O
.	O

Exposure	O
to	O
mixtures	O
of	O
ethenone	O
and	O
crotonaldehyde	O
can	O
cause	O
severe	O
pulmonary	B-ANAT
injury	O
leading	O
to	O
delayed	O
ARDS	O
.	O

Eighty	O
-	O
five	O
contacts	O
provided	O
blood	B-ANAT
for	O
a	O
serological	O
test	O
using	O
a	O
two	O
-	O
stage	O
approach	O
with	O
an	O
initial	O
immunofluorescence	O
assay	O
as	O
screening	O
test	O
,	O
followed	O
by	O
recombinant	O
immunofluorescence	O
assays	O
and	O
a	O
NCoV	O
-	O
specific	O
serum	B-ANAT
neutralisation	O
test	O
.	O

Further	O
76	O
hospital	O
contacts	O
also	O
tested	O
negative	O
,	O
including	O
two	O
sera	B-ANAT
initially	O
reactive	O
in	O
the	O
screening	O
test	O
.	O

Endocan	O
,	O
specifically	O
secreted	O
by	O
activated	O
-	O
pulmonary	B-ANAT
vascular	B-ANAT
endothelial	I-ANAT
cells	I-ANAT
,	O
is	O
thought	O
to	O
play	O
a	O
key	O
role	O
in	O
the	O
control	O
of	O
the	O
lung	B-ANAT
inflammatory	O
reaction	O
.	O

A	O
recent	O
clinical	O
investigation	O
found	O
that	O
a	O
low	O
plasma	B-ANAT
endocan	O
level	O
was	O
predictive	O
of	O
respiratory	O
failure	O
.	O

We	O
demonstrate	O
that	O
cathepsin	O
G	O
(	O
CG	O
),	O
neutrophil	B-ANAT
elastase	O
(	O
NE	O
),	O
and	O
to	O
a	O
lesser	O
extent	O
proteinase	O
3	O
(	O
PR3	O
),	O
degrade	O
endocan	O
.	O

A	O
pan	B-ANAT
-	O
coronavirus	O
RT	O
-	O
PCR	O
screening	O
assay	O
was	O
performed	O
,	O
followed	O
by	O
species	O
-	O
specific	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
monoplex	O
assays	O
.	O

In	O
this	O
review	O
,	O
we	O
describe	O
the	O
anatomical	O
proximity	O
and	O
cellular	B-ANAT
receptor	O
distribution	O
between	O
ocular	B-ANAT
and	O
respiratory	O
tissues	B-ANAT
.	O

An	O
increase	O
in	O
lymphocyte	B-ANAT
percentage	O
coincided	O
with	O
a	O
decreased	O
heterophil	B-ANAT
percentage	O
and	O
heterophil	B-ANAT
to	O
lymphocyte	B-ANAT
ratio	O
(	O
d	O
14	O
)	O
in	O
the	O
HYPER	O
group	O
.	O

ABSTRACT	O
:	O
A	O
27	O
-	O
year	O
-	O
old	O
man	O
presented	O
with	O
acute	O
dyspnea	O
and	O
a	O
previous	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
with	O
progressive	O
dyspnoea	O
and	O
chest	B-ANAT
pain	O
over	O
2	O
weeks	O
.	O

The	O
immediate	O
initiation	O
of	O
a	O
mechanical	O
circulatory	O
support	O
by	O
an	O
Extracorporal	O
Membrane	B-ANAT
Oxygenator	O
(	O
ECMO	O
)	O
facilitated	O
rapid	O
hemodynamic	O
stabilization	O
and	O
recovery	O
of	O
organ	B-ANAT
function	O
.	O

Cerebral	B-ANAT
malaria	O
and	O
acute	O
kidney	B-ANAT
injury	O
occurred	O
earlier	O
(	O
median	O
day	O
1	O
)	O
than	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
median	O
day	O
3	O
).	O

TITLE	O
:	O
Crystal	B-ANAT
structure	O
-	O
based	O
exploration	O
of	O
the	O
important	O
role	O
of	O
Arg106	O
in	O
the	O
RNA	O
-	O
binding	O
domain	O
of	O
human	O
coronavirus	O
OC43	O
nucleocapsid	B-ANAT
protein	O
.	O

After	O
emergency	O
treatment	O
and	O
CVVH	O
therapy	O
,	O
the	O
values	O
of	O
CPK	O
,	O
Mb	O
,	O
and	O
LDH	O
in	O
the	O
blood	B-ANAT
plasma	I-ANAT
of	O
the	O
patients	O
decreased	O
significantly	O
.	O

ABSTRACT	O
:	O
The	O
lung	B-ANAT
-	O
protective	O
mechanical	O
ventilation	O
strategy	O
has	O
been	O
standard	O
practice	O
for	O
management	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
for	O
more	O
than	O
a	O
decade	O
.	O

Most	O
patients	O
tolerate	O
lung	B-ANAT
protective	O
mechanical	O
ventilation	O
well	O
without	O
the	O
need	O
for	O
excessive	O
sedation	O
.	O

TITLE	O
:	O
Do	O
parameters	O
used	O
to	O
clear	O
noncritically	O
injured	O
polytrauma	O
patients	O
for	O
extremity	B-ANAT
surgery	O
predict	O
complications	O
?	O

We	O
therefore	O
asked	O
whether	O
(	O
1	O
)	O
any	O
preoperative	O
indicators	O
predict	O
major	O
complications	O
after	O
major	O
extremity	B-ANAT
surgery	O
;	O
(	O
2	O
)	O
perioperative	O
routine	O
parameters	O
other	O
than	O
those	O
indicative	O
of	O
hemorrhagic	O
shock	O
predict	O
postoperative	O
complications	O
;	O
and	O
(	O
3	O
)	O
any	O
postoperative	O
clinical	O
findings	O
can	O
predict	O
major	O
complications	O
in	O
the	O
further	O
course	O
of	O
the	O
patient	O
.	O

(	O
3	O
)	O
The	O
presence	O
of	O
a	O
lung	B-ANAT
contusion	O
and	O
ventilation	O
>	O
48	O
hours	O
were	O
associated	O
with	O
complications	O
in	O
the	O
further	O
course	O
.	O

The	O
incidences	O
of	O
pancreatic	B-ANAT
sepsis	O
,	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
and	O
mortality	O
were	O
lower	O
in	O
the	O
somatostatin	O
,	O
somatostatin	O
+	O
ulinastatin	O
,	O
somatostatin	O
+	O
S	O
miltiorrhiza	O
and	O
somatostatin	O
+	O
ulinastatin	O
+	O
S	O
miltiorrhiza	O
subgroups	O
compared	O
with	O
the	O
basic	O
treatment	O
subgroup	O
.	O

For	O
refractory	O
APCPF	O
,	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
is	O
one	O
of	O
the	O
last	O
resorts	O
.	O

No	O
other	O
severe	O
cases	O
were	O
identified	O
or	O
nCoV	O
detected	O
in	O
respiratory	B-ANAT
samples	I-ANAT
among	O
135	O
contacts	O
followed	O
for	O
10	O
days	O
.	O

Historically	O
,	O
the	O
development	O
of	O
severe	O
fibroproliferative	O
lung	B-ANAT
disease	O
has	O
been	O
associated	O
with	O
a	O
poor	O
prognosis	O
with	O
high	O
mortality	O
and	O
/	O
or	O
prolonged	O
ventilator	O
dependence	O
.	O

TITLE	O
:	O
Identification	O
of	O
the	O
first	O
synthetic	O
inhibitors	O
of	O
the	O
type	O
II	O
transmembrane	B-ANAT
serine	O
protease	O
TMPRSS2	O
suitable	O
for	O
inhibition	O
of	O
influenza	O
virus	O
activation	O
.	O

ABSTRACT	O
:	O
TMPRSS2	O
(	O
transmembrane	B-ANAT
serine	O
proteinase	O
2	O
)	O
is	O
a	O
multidomain	O
type	O
II	O
transmembrane	B-ANAT
serine	O
protease	O
that	O
cleaves	O
the	O
surface	O
glycoprotein	O
HA	O
(	O
haemagglutinin	O
)	O
of	O
influenza	O
viruses	O
with	O
a	O
monobasic	O
cleavage	O
site	O
,	O
which	O
is	O
a	O
prerequisite	O
for	O
virus	O
fusion	O
and	O
propagation	O
.	O

We	O
sought	O
to	O
determine	O
whether	O
validated	O
scores	O
on	O
the	O
Alcohol	O
Use	O
Disorders	O
Identification	O
Test	O
that	O
correspond	O
to	O
past	O
-	O
year	O
abstinence	O
(	O
zone	B-ANAT
1	I-ANAT
),	O
low	O
-	O
risk	O
drinking	O
(	O
zone	B-ANAT
2	I-ANAT
),	O
mild	O
to	O
moderate	O
alcohol	O
misuse	O
(	O
zone	B-ANAT
3	I-ANAT
),	O
and	O
severe	O
alcohol	O
misuse	O
(	O
zone	O
4	O
)	O
are	O
associated	O
with	O
poor	O
outcomes	O
in	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
.	O

Alcohol	O
misuse	O
was	O
common	O
with	O
70	O
(	O
7	O
%)	O
of	O
patients	O
having	O
Alcohol	O
Use	O
Disorders	O
Identification	O
Test	O
scores	O
in	O
zone	B-ANAT
3	I-ANAT
and	O
129	O
(	O
12	O
%)	O
patients	O
in	O
zone	O
4	O
.	O

Severe	O
but	O
not	O
mild	O
to	O
moderate	O
alcohol	O
misuse	O
is	O
independently	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
death	O
or	O
persistent	O
hospitalization	O
at	O
90	O
days	O
in	O
acute	O
lung	B-ANAT
injury	O
patients	O
.	O

PMX	O
-	O
DHP	O
was	O
then	O
started	O
,	O
and	O
severe	O
respiratory	O
failure	O
improved	O
with	O
reduction	O
of	O
serum	B-ANAT
levels	O
of	O
amiodarone	O
and	O
its	O
metabolite	O
monodesethylamiodarone	O
.	O

Ultrasonography	O
revealed	O
gallbladder	B-ANAT
with	O
wall	O
thickening	O
in	O
all	O
patients	O
,	O
plus	O
other	O
(	O
s	O
)	O
major	O
criteria	O
.	O

Of	O
note	O
are	O
SARS	O
-	O
like	O
-	O
CoVs	O
and	O
novel	O
HCoV	O
-	O
EMC	B-ANAT
identified	O
in	O
2012	O
.	O

ABSTRACT	O
:	O
Chronic	O
Obstructive	O
Pulmonary	B-ANAT
Disease	O
(	O
COPD	O
)	O
is	O
often	O
associated	O
with	O
comorbidities	O
,	O
especially	O
cardiovascular	B-ANAT
,	O
that	O
have	O
a	O
heavy	O
burden	O
in	O
terms	O
of	O
hospitalization	O
and	O
mortality	O
.	O

ABSTRACT	O
:	O
Since	O
April	O
2012	O
,	O
there	O
have	O
been	O
17	O
laboratory	O
-	O
confirmed	O
human	O
cases	O
of	O
respiratory	O
disease	O
associated	O
with	O
newly	O
recognized	O
human	O
betacoronavirus	O
lineage	O
C	O
virus	O
EMC	B-ANAT
(	O
HCoV	O
-	O
EMC	B-ANAT
),	O
and	O
7	O
of	O
them	O
were	O
fatal	O
.	O

We	O
utilized	O
ex	O
vivo	O
cultures	O
of	O
human	O
bronchial	B-ANAT
and	O
lung	B-ANAT
tissue	I-ANAT
specimens	O
to	O
investigate	O
the	O
tissue	B-ANAT
tropism	O
and	O
virus	O
replication	O
kinetics	O
following	O
experimental	O
infection	O
with	O
HCoV	O
-	O
EMC	B-ANAT
compared	O
with	O
those	O
following	O
infection	O
with	O
human	O
coronavirus	O
229E	O
(	O
HCoV	O
-	O
229E	O
)	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
).	O

TIM1	O
has	O
been	O
proposed	O
to	O
serve	O
as	O
a	O
cellular	B-ANAT
receptor	O
for	O
hepatitis	O
A	O
virus	O
and	O
Ebola	O
virus	O
and	O
as	O
an	O
entry	O
factor	O
for	O
dengue	O
virus	O
.	O

ABSTRACT	O
:	O
Progress	O
in	O
intensive	O
care	O
(	O
ICU	O
)	O
treatment	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
over	O
the	O
last	O
20	O
years	O
includes	O
the	O
introduction	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
for	O
CO2	O
removal	O
and	O
the	O
widespread	O
use	O
of	O
evidence	O
-	O
based	O
lung	B-ANAT
-	O
protective	O
ventilatory	O
strategies	O
.	O

Long	O
-	O
term	O
outcome	O
was	O
evaluated	O
on	O
average	O
5	O
.	O
0	O
Â±	O
3	O
.	O
1	O
years	O
after	O
discharge	B-ANAT
from	O
the	O
ICU	O
.	O

The	O
present	O
study	O
for	O
the	O
first	O
time	O
has	O
documented	O
significantly	O
increased	O
MCs	B-ANAT
in	O
CPV	O
-	O
2	O
-	O
associated	O
ECA	O
as	O
was	O
previously	O
reported	O
for	O
IBD	O
,	O
showing	O
that	O
MCs	B-ANAT
may	O
also	O
play	O
an	O
important	O
role	O
in	O
CPV	O
-	O
2	O
-	O
associated	O
ECA	O
.	O

TITLE	O
:	O
Diffusion	O
tensor	O
MRI	O
evaluation	O
of	O
the	O
corona	B-ANAT
radiata	I-ANAT
,	O
cingulate	O
gyri	O
,	O
and	O
corpus	B-ANAT
callosum	I-ANAT
in	O
HIV	O
patients	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
white	B-ANAT
matter	I-ANAT
integrity	O
of	O
the	O
corona	B-ANAT
radiata	I-ANAT
,	O
cingulate	O
gyri	O
,	O
and	O
corpus	B-ANAT
callosum	I-ANAT
in	O
patients	O
with	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
infection	O
through	O
diffusion	O
tensor	O
imaging	O
(	O
DTI	O
).	O

We	O
found	O
that	O
in	O
the	O
body	B-ANAT
of	I-ANAT
corpus	I-ANAT
callosum	I-ANAT
the	O
fractional	O
anisotropy	O
(	O
FA	O
)	O
was	O
significantly	O
reduced	O
,	O
whereas	O
mean	O
diffusivity	O
(	O
MD	O
)	O
and	O
radial	O
diffusivity	O
(	O
RD	O
)	O
were	O
increased	O
in	O
HIV	O
patients	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
associated	O
with	O
a	O
high	O
mortality	O
linked	O
primarily	O
to	O
co	O
-	O
morbidities	O
(	O
sepsis	O
,	O
cardiac	B-ANAT
failure	O
,	O
multiple	O
organ	B-ANAT
failure	O
,	O
etc	O
.).	O

The	O
expected	O
benefits	O
would	O
be	O
to	O
prevent	O
acquired	O
diaphragmatic	B-ANAT
weakness	O
,	O
accumulation	O
of	O
sedation	O
,	O
cognitive	O
dysfunction	O
,	O
and	O
presumably	O
improved	O
outcome	O
.	O

We	O
also	O
investigate	O
the	O
subcellular	O
localization	O
and	O
function	O
of	O
PEDV	O
N	O
protein	O
by	O
examining	O
its	O
effects	O
on	O
cell	B-ANAT
growth	O
,	O
cycle	O
progression	O
,	O
interleukin	O
-	O
8	O
(	O
IL	O
-	O
8	O
)	O
expression	O
,	O
and	O
survival	O
.	O

This	O
is	O
the	O
first	O
report	O
to	O
demonstrate	O
that	O
PEDV	O
N	O
protein	O
can	O
induce	O
cell	B-ANAT
cycle	O
prolongation	O
at	O
the	O
S	O
-	O
phase	O
,	O
ER	O
stress	O
and	O
up	O
-	O
regulation	O
interleukin	O
-	O
8	O
expression	O
.	O

The	O
association	O
between	O
breast	B-ANAT
milk	I-ANAT
-	O
transmitted	O
CMV	O
and	O
development	O
of	O
cystic	O
lung	B-ANAT
disease	O
and	O
Wilson	O
-	O
Mikity	O
syndrome	O
has	O
also	O
been	O
reported	O
.	O

He	O
then	O
developed	O
ascending	O
areflexic	O
weakness	O
of	O
all	O
four	O
limbs	B-ANAT
and	O
bifacial	O
weakness	O
.	O

ABSTRACT	O
:	O
Ventricular	B-ANAT
assist	O
devices	O
(	O
VADs	O
)	O
are	O
used	O
in	O
children	O
with	O
severe	O
heart	B-ANAT
failure	O
as	O
a	O
bridge	O
to	O
heart	B-ANAT
transplantation	O
or	O
recovery	O
.	O

An	O
oxygenator	O
used	O
in	O
conjunction	O
with	O
a	O
VAD	O
may	O
be	O
a	O
life	O
-	O
saving	O
therapy	O
,	O
allowing	O
adequate	O
oxygenation	O
and	O
ventilation	O
in	O
severe	O
respiratory	O
and	O
cardiac	B-ANAT
failure	O
.	O

Extended	O
use	O
may	O
facilitate	O
the	O
prevention	O
of	O
ventilator	O
-	O
associated	O
lung	B-ANAT
injury	O
and	O
organ	B-ANAT
dysfunction	O
.	O

However	O
,	O
in	O
the	O
last	O
decade	O
novel	O
potent	O
mAbs	O
have	O
been	O
discovered	O
and	O
characterized	O
with	O
potential	O
as	O
therapeutics	O
against	O
viruses	O
of	O
major	O
importance	O
for	O
public	O
health	O
and	O
biosecurity	O
including	O
Hendra	O
virus	O
(	O
HeV	B-ANAT
),	O
Nipah	O
virus	O
(	O
NiV	O
),	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
),	O
Ebola	O
virus	O
(	O
EBOV	O
),	O
West	O
Nile	O
virus	O
(	O
WNV	O
),	O
influenza	O
virus	O
(	O
IFV	O
)	O
and	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV	O
-	O
1	O
).	O

TITLE	O
:	O
Acute	O
-	O
phase	O
concentrations	O
of	O
soluble	O
fibrinogen	B-ANAT
inhibit	O
neutrophil	B-ANAT
adhesion	O
under	O
flow	O
conditions	O
in	O
vitro	O
through	O
interactions	O
with	O
ICAM	O
-	O
1	O
and	O
MAC	B-ANAT
-	O
1	O
(	O
CD11b	O
/	O
CD18	O
).	O

To	O
study	O
the	O
effect	O
of	O
soluble	O
fibrinogen	B-ANAT
in	O
concentrations	O
found	O
in	O
severe	O
acute	O
inflammation	O
on	O
leukocyte	B-ANAT
adhesion	O
.	O

The	O
histopathological	O
findings	O
in	O
the	O
affected	O
lungs	B-ANAT
were	O
characterized	O
by	O
a	O
granulomatous	O
pneumonia	O
.	O

Surprisingly	O
,	O
17	O
/	O
28	O
(	O
60	O
.	O
7	O
%)	O
of	O
SARS	O
patients	O
had	O
significant	O
IF	O
antibody	O
titers	O
with	O
7	O
/	O
28	O
(	O
25	O
%)	O
having	O
anti	O
-	O
HCoV	O
-	O
EMC	B-ANAT
neutralizing	O
antibodies	O
at	O
low	O
titers	O
which	O
significantly	O
correlated	O
with	O
that	O
of	O
HCoV	O
-	O
OC43	O
.	O

Bioinformatics	O
analysis	O
demonstrated	O
a	O
significant	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
epitope	O
overlapping	O
the	O
heptad	O
repeat	O
-	O
2	O
region	O
of	O
Spike	O
protein	O
.	O

The	O
chest	B-ANAT
radiograph	O
showed	O
that	O
interstitial	B-ANAT
disease	O
predominates	O
at	O
the	O
lung	B-ANAT
bases	O
in	O
all	O
cases	O
with	O
a	O
large	O
aspect	O
of	O
the	O
pulmonary	B-ANAT
arteries	I-ANAT
in	O
two	O
cases	O
.	O

Subsequently	O
,	O
either	O
S1	O
or	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
genes	O
of	O
IBV	O
were	O
positioned	O
between	O
AMPV	O
M	O
and	O
F	O
genes	O
,	O
while	O
later	O
a	O
bivalent	O
recombinant	O
was	O
prepared	O
by	O
inserting	O
S1	O
and	O
N	O
at	O
AMPV	O
MF	O
and	O
GL	O
junctions	O
respectively	O
.	O

CONCLUSIONS	O
:	O
Plasminogen	O
activator	O
inhibitor	O
-	O
1	O
is	O
sensitive	O
blood	B-ANAT
symbol	O
for	O
screening	O
high	O
-	O
risk	O
susceptible	O
population	O
;	O
4G	O
/	O
4G	O
PAI	O
-	O
1	O
genotype	O
may	O
be	O
an	O
etiological	O
factor	O
in	O
osteonecrosis	O
.	O

ECMO	O
provides	O
support	O
that	O
prevents	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
while	O
the	O
lungs	B-ANAT
heal	O
.	O

The	O
mutant	O
virus	O
had	O
similar	O
growth	O
kinetics	O
to	O
MHV	O
-	O
A59	O
wild	O
-	O
type	O
virus	O
in	O
17CI	O
-	O
1	O
cells	B-ANAT
,	O
but	O
was	O
highly	O
attenuated	O
in	O
vivo	O
.	O

Shortly	O
after	O
our	O
patient	O
was	O
born	O
,	O
we	O
were	O
consulted	O
for	O
airway	B-ANAT
management	O
,	O
as	O
the	O
parents	O
'	O
goal	O
was	O
to	O
bring	O
their	O
child	O
home	O
.	O

TITLE	O
:	O
Monoclonal	O
antibody	O
against	O
membrane	B-ANAT
protein	O
of	O
transmissible	O
gastroenteritis	O
virus	O
.	O

TGEV	O
membrane	B-ANAT
(	O
M	O
)	O
protein	O
not	O
only	O
plays	O
a	O
vital	O
role	O
in	O
the	O
process	O
of	O
virus	O
assembly	O
and	O
budding	O
,	O
but	O
also	O
induces	O
the	O
production	O
of	O
interferon	O
-	O
Î±	O
during	O
infection	O
.	O

Immunofluorescence	O
assays	O
indicated	O
that	O
MAb	O
7G7	O
was	O
capable	O
of	O
detecting	O
cell	B-ANAT
infection	O
by	O
TGEV	O
.	O

TITLE	O
:	O
Expression	O
and	O
Purification	O
of	O
the	O
scFv	O
from	O
hybridoma	B-ANAT
cells	B-ANAT
secreting	O
a	O
monoclonal	O
antibody	O
against	O
S	O
PROTEIN	O
of	O
PEDV	O
.	O

As	O
TCoV	O
does	O
not	O
grow	O
in	O
cell	B-ANAT
culture	O
,	O
the	O
presence	O
of	O
residual	O
infectious	O
TCoV	O
in	O
the	O
stored	O
samples	O
was	O
tested	O
by	O
inoculating	O
embryonated	O
specific	O
pathogen	O
free	O
turkey	O
eggs	O
.	O

T	O
regulatory	O
(	O
T	O
(	O
reg	O
))	O
cells	B-ANAT
in	O
the	O
lungs	B-ANAT
are	O
reported	O
to	O
modify	O
innate	O
immune	O
responses	O
during	O
resolution	O
of	O
acute	O
lung	B-ANAT
injury	O
.	O

HMGB1	O
levels	O
in	O
the	O
lungs	B-ANAT
increased	O
to	O
a	O
higher	O
level	O
in	O
ARDS	O
mice	O
compared	O
to	O
those	O
in	O
mice	O
treated	O
with	O
LPS	O
alone	O
.	O

CONCLUSIONS	O
:	O
Operative	O
fractures	O
of	O
the	O
thoracolumbar	B-ANAT
spine	I-ANAT
,	O
pelvis	B-ANAT
,	O
acetabulum	B-ANAT
and	O
femur	B-ANAT
increase	O
the	O
risk	O
of	O
developing	O
systemic	O
complications	O
in	O
patients	O
with	O
blunt	O
abdominal	B-ANAT
injury	O
.	O

The	O
spectrum	O
of	O
pulmonary	B-ANAT
complications	O
may	O
range	O
from	O
atelectasis	O
and	O
pneumonia	O
to	O
acute	O
lung	B-ANAT
injury	O
,	O
with	O
the	O
most	O
severe	O
form	O
being	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

In	O
this	O
study	O
,	O
we	O
characterized	O
MERS	O
-	O
CoV	O
replication	O
and	O
cytotoxicity	O
in	O
human	O
and	O
monkey	O
cell	B-ANAT
lines	I-ANAT
.	O

The	O
finding	O
of	O
oligoclonal	O
protein	O
electrophoresis	O
(>	O
80	O
%)	O
and	O
antibodies	O
in	O
serum	B-ANAT
and	O
cerebrospinal	B-ANAT
fluid	I-ANAT
directed	O
against	O
the	O
NR1	O
subunit	O
of	O
the	O
NMDA	O
receptor	O
confirms	O
the	O
diagnosis	O
.	O

TITLE	O
:	O
Human	O
betacoronavirus	O
2c	O
EMC	B-ANAT
/	O
2012	O
-	O
related	O
viruses	O
in	O
bats	O
,	O
Ghana	O
and	O
Europe	O
.	O

Conditional	O
ablation	O
of	O
lymphotoxin	O
-	O
Î²	O
receptor	O
(	O
LTÎ²R	O
)	O
expression	O
in	O
LN	O
FRCs	O
and	O
their	O
mesenchymal	O
progenitors	O
in	O
developing	O
LNs	O
revealed	O
that	O
LTÎ²R	O
-	O
signaling	O
in	O
these	O
cells	B-ANAT
was	O
not	O
essential	O
for	O
the	O
formation	O
of	O
LNs	O
.	O

HCoV	O
-	O
NL63	O
is	O
an	O
important	O
pathogen	O
of	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
in	O
children	O
in	O
Lanzhou	O
city	O
.	O

ABSTRACT	O
:	O
Coronavirus	O
spike	O
(	O
S	O
)	O
protein	O
assembles	O
into	O
virions	B-ANAT
via	O
its	O
carboxy	O
-	O
terminus	O
,	O
which	O
is	O
composed	O
of	O
a	O
transmembrane	B-ANAT
domain	O
and	O
an	O
endodomain	O
.	O

HCoV	O
-	O
EMC	B-ANAT
was	O
able	O
to	O
replicate	O
as	O
efficiently	O
as	O
SARS	O
-	O
CoV	O
in	O
Calu	O
-	O
3	O
cells	B-ANAT
and	O
similarly	O
induced	O
minimal	O
transcriptomic	O
changes	O
before	O
12	O
h	O
postinfection	O
.	O

ABSTRACT	O
:	O
The	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
main	O
protease	O
(	O
M	O
(	O
pro	O
))	O
cleaves	O
two	O
virion	B-ANAT
polyproteins	O
(	O
pp1a	O
and	O
pp1ab	O
);	O
this	O
essential	O
process	O
represents	O
an	O
attractive	O
target	O
for	O
the	O
development	O
of	O
anti	O
-	O
SARS	O
drugs	O
.	O

TITLE	O
:	O
Regulation	O
of	O
programmed	O
ribosomal	B-ANAT
frameshifting	O
by	O
co	O
-	O
translational	O
refolding	O
RNA	O
hairpins	O
.	O

Since	O
the	O
upstream	O
hairpin	O
is	O
unwound	O
(	O
by	O
a	O
marching	O
ribosome	B-ANAT
)	O
before	O
the	O
downstream	O
stimulator	O
,	O
this	O
study	O
'	O
s	O
findings	O
suggest	O
a	O
new	O
mode	O
of	O
translational	O
regulation	O
that	O
is	O
mediated	O
by	O
the	O
reformed	O
stem	B-ANAT
of	O
a	O
ribosomal	B-ANAT
unwound	O
RNA	O
hairpin	O
during	O
elongation	O
.	O

In	O
this	O
study	O
,	O
we	O
established	O
an	O
in	O
vitro	O
model	O
to	O
compare	O
the	O
responses	O
of	O
type	O
I	O
(	O
ATI	O
)	O
and	O
type	O
II	O
(	O
ATII	O
)	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
to	O
infection	O
by	O
respiratory	O
viruses	O
used	O
in	O
murine	O
models	O
:	O
mouse	O
-	O
adapted	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
,	O
v2163	O
),	O
murine	O
coronavirus	O
MHV	O
-	O
1	O
,	O
and	O
influenza	O
A	O
(	O
H1N1	O
)	O
virus	O
,	O
strain	O
PR8	O
.	O

Histological	O
lesions	O
revealed	O
that	O
the	O
trachea	B-ANAT
and	O
bronchial	B-ANAT
epithelium	I-ANAT
were	O
hyperplastic	O
and	O
infiltrated	O
by	O
neutrophil	B-ANAT
granulocytes	B-ANAT
.	O

All	O
paired	O
sera	B-ANAT
(	O
9	O
/	O
9	O
)	O
collected	O
from	O
febrile	O
horses	O
showed	O
seroconversion	O
by	O
neutralization	O
test	O
.	O

DSS	O
complicated	O
with	O
severe	O
bleeding	O
,	O
multi	O
-	O
organ	B-ANAT
failure	O
and	O
coagulopathy	O
were	O
the	O
primary	O
causes	O
of	O
deaths	O
.	O

The	O
changes	O
of	O
brain	B-ANAT
metabolism	O
in	O
PTSD	O
are	O
caused	O
by	O
SARS	O
.	O

SARS	O
may	O
also	O
lead	O
to	O
the	O
changes	O
of	O
brain	B-ANAT
metabolism	O
.	O

In	O
this	O
study	O
,	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
gene	O
of	O
a	O
Chinese	O
PEDV	O
isolate	O
designated	O
HLJBY	O
was	O
cloned	O
.	O

During	O
the	O
hospitalization	O
,	O
she	O
required	O
emergency	O
transfer	O
to	O
the	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
because	O
of	O
progressive	O
deterioration	O
of	O
respiratory	B-ANAT
muscle	I-ANAT
function	O
,	O
severe	O
respiratory	O
acidosis	O
,	O
obtundation	O
and	O
hypotension	O
.	O

HFRS	O
is	O
considered	O
to	O
be	O
distinct	O
from	O
hantavirus	O
(	O
cardio	O
-)	O
pulmonary	B-ANAT
syndrome	O
(	O
HPS	O
or	O
HCPS	O
),	O
described	O
in	O
the	O
New	O
World	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
a	O
potentially	O
devastating	O
form	O
of	O
acute	O
inflammatory	O
lung	B-ANAT
injury	O
with	O
a	O
high	O
short	O
-	O
term	O
mortality	O
rate	O
and	O
significant	O
long	O
-	O
term	O
consequences	O
among	O
survivors	O
.	O

Key	O
components	O
of	O
such	O
a	O
strategy	O
include	O
avoiding	O
lung	B-ANAT
overdistension	O
by	O
limiting	O
tidal	O
volumes	O
and	O
airway	B-ANAT
pressures	O
,	O
and	O
the	O
use	O
of	O
positive	O
end	O
-	O
expiratory	O
pressure	O
with	O
or	O
without	O
lung	B-ANAT
recruitment	O
manoeuvres	O
in	O
patients	O
with	O
severe	O
ARDS	O
.	O

TITLE	O
:	O
Prevalence	O
and	O
prognosis	O
of	O
cor	B-ANAT
pulmonale	O
during	O
protective	O
ventilation	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Cor	B-ANAT
pulmonale	O
was	O
defined	O
as	O
a	O
dilated	O
right	B-ANAT
ventricle	I-ANAT
associated	O
with	O
septal	O
dyskinesia	O
.	O

Multivariate	O
logistic	O
regression	O
identified	O
McCabe	O
and	O
Jackson	O
class	O
,	O
lung	B-ANAT
injury	O
not	O
related	O
to	O
pneumonia	O
,	O
aspiration	O
,	O
or	O
sepsis	O
,	O
lactic	O
acidosis	O
,	O
driving	O
pressure	O
,	O
and	O
cor	B-ANAT
pulmonale	O
as	O
independent	O
risk	O
factors	O
for	O
28	O
-	O
day	O
mortality	O
.	O

CONCLUSIONS	O
:	O
Cor	B-ANAT
pulmonale	O
occurrence	O
is	O
not	O
negligible	O
in	O
ARDS	O
patients	O
ventilated	O
with	O
airway	B-ANAT
pressure	O
limitation	O
.	O

The	O
dynamics	O
of	O
the	O
serum	B-ANAT
antibodies	O
of	O
SARS	O
patients	O
were	O
observed	O
from	O
3	O
to	O
360	O
days	O
after	O
onset	O
of	O
symptoms	O
.	O

90	O
%	O
of	O
257	O
patient	O
serum	B-ANAT
specimens	O
after	O
20	O
days	O
of	O
disease	O
onset	O
showed	O
positive	O
SARS	O
-	O
CoV	O
IgG	O
either	O
using	O
ELISA	O
or	O
IFA	O
.	O

Serum	B-ANAT
IgG	O
antibodies	O
has	O
diagnostic	O
value	O
for	O
SARS	O
in	O
the	O
late	O
course	O
of	O
disease	O
and	O
the	O
antibodies	O
present	O
more	O
than	O
48	O
months	O
.	O

Our	O
previous	O
studies	O
demonstrated	O
that	O
TGEV	O
could	O
activate	O
FasL	O
-	O
and	O
mitochondria	B-ANAT
-	O
mediated	O
pathways	O
to	O
induce	O
apoptosis	O
in	O
PK	O
-	O
15	O
cells	B-ANAT
.	O

Some	O
patients	O
treated	O
with	O
blinatumomab	O
and	O
other	O
T	B-ANAT
cell	I-ANAT
-	O
activating	O
therapies	O
develop	O
cytokine	O
release	O
syndrome	O
(	O
CRS	O
).	O

Patients	O
treated	O
with	O
T	B-ANAT
cell	I-ANAT
-	O
activating	O
therapies	O
,	O
including	O
blinatumomab	O
,	O
should	O
be	O
monitored	O
for	O
HLH	O
,	O
and	O
cytokine	O
-	O
directed	O
therapy	O
may	O
be	O
considered	O
in	O
cases	O
of	O
life	O
-	O
threatening	O
CRS	O
.	O

Studies	O
on	O
their	O
mechanisms	O
of	O
action	O
revealed	O
that	O
the	O
compounds	O
act	O
by	O
three	O
distinct	O
mechanisms	O
:	O
(	O
i	O
)	O
SSAA09E2	O
{	O
N	O
-[[	O
4	O
-(	O
4	O
-	O
methylpiperazin	O
-	O
1	O
-	O
yl	O
)	O
phenyl	O
]	O
methyl	O
]-	O
1	O
,	O
2	O
-	O
oxazole	O
-	O
5	O
-	O
carboxamide	O
}	O
acts	O
through	O
a	O
novel	O
mechanism	O
of	O
action	O
,	O
by	O
blocking	O
early	O
interactions	O
of	O
SARS	O
-	O
S	O
with	O
the	O
receptor	O
for	O
SARS	O
-	O
CoV	O
,	O
angiotensin	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
);	O
(	O
ii	O
)	O
SSAA09E1	O
{[(	O
Z	O
)-	O
1	O
-	O
thiophen	O
-	O
2	O
-	O
ylethylideneamino	O
]	O
thiourea	O
}	O
acts	O
later	O
,	O
by	O
blocking	O
cathepsin	O
L	O
,	O
a	O
host	O
protease	O
required	O
for	O
processing	O
of	O
SARS	O
-	O
S	O
during	O
viral	O
entry	O
;	O
and	O
(	O
iii	O
)	O
SSAA09E3	O
[	O
N	O
-(	O
9	O
,	O
10	O
-	O
dioxo	O
-	O
9	O
,	O
10	O
-	O
dihydroanthracen	O
-	O
2	O
-	O
yl	O
)	O
benzamide	O
]	O
also	O
acts	O
later	O
and	O
does	O
not	O
affect	O
interactions	O
of	O
SARS	O
-	O
S	O
with	O
ACE2	O
or	O
the	O
enzymatic	O
functions	O
of	O
cathepsin	O
L	O
but	O
prevents	O
fusion	O
of	O
the	O
viral	B-ANAT
membrane	I-ANAT
with	O
the	O
host	O
cellular	B-ANAT
membrane	I-ANAT
.	O

In	O
GADD153	O
-	O
knockdown	O
cells	B-ANAT
,	O
IBV	O
-	O
induced	O
apoptosis	O
was	O
suppressed	O
and	O
virus	O
replication	O
inhibited	O
,	O
revealing	O
a	O
key	O
role	O
of	O
GADD153	O
in	O
IBV	O
-	O
induced	O
cell	B-ANAT
death	O
and	O
virus	O
replication	O
.	O

TITLE	O
:	O
Survival	O
of	O
Respiratory	O
Viruses	O
on	O
Fresh	B-ANAT
Produce	O
.	O

Following	O
post	O
mortem	O
of	O
one	O
case	O
,	O
histology	O
of	O
the	O
trapezius	B-ANAT
muscle	I-ANAT
demonstrated	O
an	O
acute	O
,	O
severe	O
myofibre	O
degeneration	O
.	O

TITLE	O
:	O
The	O
lung	B-ANAT
microvascular	O
endothelium	B-ANAT
as	O
a	O
therapeutic	O
target	O
in	O
severe	O
influenza	O
.	O

Recent	O
data	O
suggest	O
that	O
influenza	O
virus	O
can	O
exert	O
both	O
direct	O
and	O
indirect	O
effects	O
on	O
the	O
lung	B-ANAT
endothelium	B-ANAT
,	O
activating	O
it	O
and	O
inducing	O
microvascular	O
leak	O
.	O

Overall	O
,	O
the	O
whole	O
set	O
of	O
experiments	O
supports	O
the	O
proteolipidic	O
structure	O
of	O
SARS	O
-	O
CoV	O
E	O
channels	O
and	O
explains	O
the	O
large	O
difference	O
in	O
channel	O
conductance	O
observed	O
between	O
neutral	O
and	O
charged	O
membranes	B-ANAT
.	O

Compared	O
to	O
controls	O
,	O
ARDS	O
demonstrates	O
increased	O
serum	B-ANAT
endotoxin	O
and	O
IL	O
-	O
6	O
levels	O
,	O
and	O
decreased	O
HDL	O
,	O
apoA	O
-	O
I	O
and	O
activity	O
of	O
anti	O
-	O
oxidant	O
HDL	O
-	O
associated	O
paraoxanase	O
-	O
1	O
.	O

TITLE	O
:	O
Concentrated	O
ascites	O
reinfusion	O
therapy	O
for	O
sinusoidal	O
obstructive	O
syndrome	O
after	O
hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplantation	O
.	O

ABSTRACT	O
:	O
Although	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
was	O
used	O
in	O
many	O
patients	O
following	O
its	O
introduction	O
in	O
1972	O
,	O
most	O
hospitals	O
had	O
abandoned	O
this	O
experimental	O
treatment	O
for	O
adult	O
patients	O
.	O

We	O
searched	O
Pubmed	O
,	O
Toxnet	O
,	O
Cochrane	O
database	O
and	O
Embase	O
from	O
1966	O
to	O
September	O
2012	O
using	O
the	O
search	O
terms	O
(''	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
'',	O
'	O
extracorporeal	O
life	O
support	O
',	O
'	O
ECMO	O
',	O
'	O
ECLS	O
',	O
'	O
assist	O
-	O
device	O
',	O
and	O
'	O
intox	O
*'	O
or	O
'	O
poison	O
*').	O

The	O
replication	O
of	O
wild	O
-	O
type	O
MHV	O
strain	O
A59	O
(	O
A59	O
)	O
and	O
a	O
mutant	O
with	O
an	O
inactive	O
phosphodiesterase	O
(	O
ns2	O
-	O
H126R	O
)	O
was	O
assessed	O
in	O
primary	O
hepatocytes	B-ANAT
and	O
primary	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
cell	B-ANAT
types	O
-	O
neurons	B-ANAT
,	O
astrocytes	B-ANAT
,	O
and	O
oligodendrocytes	B-ANAT
.	O

Activation	O
of	O
RNase	O
L	O
correlated	O
with	O
the	O
induction	O
of	O
type	O
I	O
interferon	O
and	O
the	O
consequent	O
high	O
levels	O
of	O
OAS	O
mRNA	O
induced	O
in	O
these	O
cell	B-ANAT
types	O
.	O

CsA	O
is	O
a	O
well	O
-	O
known	O
immunosuppressive	O
drug	O
that	O
binds	O
to	O
cellular	B-ANAT
cyclophilins	O
to	O
inhibit	O
calcineurin	O
,	O
a	O
calcium	O
-	O
calmodulin	O
-	O
activated	O
serine	O
/	O
threonine	O
-	O
specific	O
phosphatase	O
.	O

Results	O
from	O
cross	O
-	O
linking	O
VLP	B-ANAT
analyses	O
suggest	O
that	O
the	O
cysteine	O
residues	O
63	O
,	O
85	O
and	O
158	O
are	O
not	O
in	O
close	O
proximity	O
to	O
the	O
M	O
dimer	O
interface	O
.	O

Interview	O
by	O
Hannah	O
Branch	B-ANAT
.	O

Subsequent	O
to	O
the	O
first	O
report	O
in	O
France	O
in	O
2005	O
,	O
there	O
have	O
been	O
17	O
facial	B-ANAT
allograft	O
transplantations	O
performed	O
worldwide	O
.	O

The	O
management	O
of	O
patients	O
with	O
neurofibromatosis	O
or	O
burns	O
involving	O
the	O
whole	O
face	B-ANAT
was	O
more	O
difficult	O
and	O
haemorrhagic	O
than	O
the	O
patients	O
with	O
lower	O
face	B-ANAT
transplantation	O
.	O

The	O
virus	O
was	O
also	O
detected	O
in	O
the	O
kidneys	B-ANAT
from	O
days	O
4	O
-	O
10	O
PI	O
and	O
in	O
the	O
bursa	B-ANAT
of	I-ANAT
Fabricius	I-ANAT
from	O
days	O
4	O
-	O
12	O
PI	O
.	O

Clinically	O
the	O
cat	O
was	O
obese	O
,	O
pyrexic	O
(	O
39	O
.	O
8	O
Â°	O
C	O
),	O
had	O
acute	O
abdominal	B-ANAT
pain	O
and	O
severe	O
bilirubinuria	O
.	O

Immunohistochemical	O
staining	O
for	O
Toxoplasma	O
gondii	O
was	O
strongly	O
positive	O
,	O
with	O
scattered	O
cysts	O
and	O
tachyzoites	O
in	O
the	O
liver	B-ANAT
,	O
lymph	B-ANAT
nodes	I-ANAT
,	O
spleen	B-ANAT
,	O
lungs	B-ANAT
,	O
brain	B-ANAT
,	O
salivary	B-ANAT
glands	I-ANAT
and	O
intracellularly	O
in	O
round	B-ANAT
cells	I-ANAT
in	O
occasional	O
blood	B-ANAT
vessels	I-ANAT
.	O

The	O
flow	O
cytometric	O
method	O
provided	O
repeatable	O
results	O
for	O
neutrophils	B-ANAT
(	O
coefficients	O
of	O
variations	O
,	O
CVs	O
<	O
15	O
%)	O
but	O
not	O
for	O
monocytes	B-ANAT
(	O
CVs	O
>	O
20	O
%)	O
which	O
had	O
also	O
a	O
high	O
individual	O
variability	O
.	O

Both	O
patients	O
developed	O
acute	O
renal	B-ANAT
failure	O
.	O

MERS	O
-	O
CoV	O
was	O
detected	O
in	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
specimens	O
with	O
high	O
viral	O
load	O
(	O
eg	O
,	O
cycle	O
threshold	O
[	O
Ct	O
]	O
values	O
of	O
22	O
Â·	O
9	O
for	O
upE	O
and	O
24	O
for	O
Orf1a	O
for	O
a	O
bronchoalveolar	O
lavage	O
sample	O
from	O
patient	O
1	O
;	O
Ct	O
values	O
of	O
22	O
Â·	O
5	O
for	O
upE	O
and	O
23	O
Â·	O
9	O
for	O
Orf1a	O
for	O
an	O
induced	B-ANAT
sputum	I-ANAT
sample	O
from	O
patient	O
2	O
),	O
whereas	O
nasopharyngeal	B-ANAT
specimens	O
were	O
weakly	O
positive	O
or	O
inconclusive	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
its	O
more	O
severe	O
form	O
of	O
clinical	O
manifestation	O
,	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
is	O
associated	O
with	O
significant	O
dysfunction	O
in	O
air	O
exchange	O
due	O
to	O
inflammation	O
of	O
the	O
lung	B-ANAT
parenchyma	I-ANAT
.	O

Haematology	O
and	O
serum	B-ANAT
biochemistry	O
demonstrated	O
a	O
moderate	O
,	O
poorly	O
regenerative	O
anaemia	O
,	O
hypoalbuminaemia	O
and	O
hyperglobulinaemia	O
with	O
a	O
low	O
albumin	O
:	O
globulin	O
ratio	O
.	O

Immunocytochemistry	O
for	O
feline	O
coronavirus	O
was	O
performed	O
on	O
the	O
CSF	B-ANAT
,	O
with	O
positive	O
staining	O
observed	O
inside	O
macrophages	B-ANAT
.	O

It	O
is	O
important	O
to	O
note	O
that	O
the	O
clinical	O
presentation	O
ofmyositis	O
syndrome	O
may	O
overlap	O
with	O
symptoms	O
of	O
other	O
connective	B-ANAT
tissue	I-ANAT
disease	O
in	O
overlap	O
syndromes	O
(	O
SLE	O
,	O
SSCL	O
,	O
RA	O
,	O
SSjÃ¶	O
).	O

Common	O
manifestations	O
of	O
the	O
disease	O
are	O
weakness	O
and	O
muscle	B-ANAT
fatigue	O
,	O
which	O
is	O
the	O
result	O
of	O
skeletal	B-ANAT
muscles	I-ANAT
inflammation	O
(	O
usually	O
the	O
proximal	O
group	O
of	O
muscles	B-ANAT
,	O
bilaterally	O
and	O
symmetrical	O
).	O

The	O
basis	O
for	O
myositis	O
treatment	O
are	O
glucocorticoids	O
,	O
which	O
are	O
applied	O
orally	B-ANAT
in	O
a	O
daily	O
dosage	O
regimen	O
of	O
0	O
.	O
75	O
to	O
1	O
mg	O
/	O
kg	O
/	O
day	O
,	O
and	O
in	O
severe	O
forms	O
of	O
the	O
disease	O
in	O
the	O
i	O
.	O
v	O
.	O

A	O
prompt	O
treatment	O
of	O
infections	O
and	O
heart	B-ANAT
failure	O
is	O
sometimes	O
life	O
-	O
saving	O
in	O
patients	O
with	O
myositis	O
.	O

ABSTRACT	O
:	O
The	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
)	O
protein	O
of	O
HCoV	O
-	O
NL63	O
is	O
a	O
major	O
target	O
in	O
the	O
development	O
of	O
diagnostic	O
assay	O
and	O
vaccine	O
,	O
it	O
has	O
a	O
pivotal	O
role	O
in	O
receptor	O
attachment	O
,	O
viral	O
entry	O
and	O
membrane	B-ANAT
fusion	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
characterized	O
by	O
the	O
formation	O
of	O
a	O
protein	O
-	O
rich	O
alveolar	B-ANAT
edema	O
caused	O
by	O
increased	O
permeability	O
of	O
the	O
alveolocapillary	B-ANAT
membrane	I-ANAT
.	O

The	O
key	O
clinical	O
feature	O
is	O
refractory	O
arterial	B-ANAT
hypoxemia	O
,	O
which	O
in	O
severe	O
cases	O
necessitates	O
the	O
application	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

Consecutive	O
inpatients	O
admitted	O
from	O
the	O
emergency	O
department	O
were	O
included	O
if	O
they	O
were	O
â¥	O
18	O
years	O
of	O
age	O
,	O
underwent	O
a	O
screening	O
tool	O
assessment	O
at	O
presentation	O
and	O
had	O
a	O
most	O
responsible	O
diagnosis	O
that	O
was	O
cardiac	B-ANAT
,	O
respiratory	O
or	O
infectious	O
.	O

Moreover	O
,	O
the	O
tripeptide	O
pan	B-ANAT
-	O
ICE	O
(	O
caspase	O
)	O
inhibitor	O
Z	O
-	O
VAD	O
-	O
FMK	O
blocked	O
PHEV	O
-	O
induced	O
apoptosis	O
but	O
did	O
not	O
have	O
an	O
effect	O
on	O
virus	O
production	O
by	O
96h	O
post	O
-	O
infection	O
.	O

ABSTRACT	O
:	O
The	O
definition	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
by	O
American	O
-	O
European	O
Consensus	O
Conference	O
(	O
AECC	O
)	O
in	O
1994	O
has	O
promoted	O
clinical	O
and	O
epidemiological	O
research	O
leading	O
to	O
improved	O
survival	O
outcome	O
of	O
the	O
ARDS	O
patients	O
by	O
establishing	O
lung	B-ANAT
protective	O
ventilation	O
.	O

Based	O
on	O
experimental	O
and	O
clinical	O
studies	O
,	O
progress	O
has	O
been	O
made	O
in	O
understanding	O
the	O
mechanisms	O
responsible	O
for	O
the	O
pathogenesis	O
and	O
the	O
resolution	O
of	O
lung	B-ANAT
injury	O
.	O

Future	O
progress	O
will	O
depend	O
on	O
developing	O
novel	O
therapeutics	O
that	O
can	O
ameliorate	O
lung	B-ANAT
injury	O
and	O
systemic	O
derangements	O
and	O
facilitate	O
lung	B-ANAT
repair	O
.	O

Morbidity	O
odds	O
ratios	O
(	O
95	O
%	O
confidence	O
interval	O
)	O
for	O
complications	O
were	O
not	O
significant	O
for	O
HRR	O
but	O
were	O
for	O
crystalloids	O
:	O
bacteremia	O
,	O
1	O
.	O
05	O
(	O
1	O
.	O
0	O
-	O
1	O
.	O
1	O
);	O
adult	O
respiratory	O
distress	O
syndrome	O
,	O
1	O
.	O
13	O
(	O
1	O
.	O
0	O
-	O
1	O
.	O
2	O
),	O
and	O
acute	O
renal	B-ANAT
failure	O
,	O
1	O
.	O
05	O
(	O
1	O
.	O
0	O
-	O
1	O
.	O
1	O
).	O

Caution	O
in	O
overzealous	O
use	O
of	O
crystalloid	B-ANAT
during	O
HRR	O
is	O
warranted	O
.	O

During	O
late	O
resuscitation	O
,	O
age	O
(	O
OR	O
,	O
1	O
.	O
02	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
00	O
-	O
1	O
.	O
04	O
),	O
chest	B-ANAT
AIS	O
score	O
(	O
OR	O
,	O
1	O
.	O
33	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
11	O
-	O
1	O
.	O
59	O
),	O
and	O
crystalloids	O
given	O
during	O
this	O
period	O
(	O
OR	O
,	O
1	O
.	O
05	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
01	O
-	O
1	O
.	O
10	O
)	O
were	O
also	O
predictive	O
of	O
moderate	O
-	O
to	O
-	O
severe	O
hypoxemia	O
.	O

Red	B-ANAT
blood	I-ANAT
cell	I-ANAT
,	O
plasma	B-ANAT
,	O
and	O
platelet	B-ANAT
transfusions	O
(	O
whether	O
received	O
during	O
early	O
or	O
late	O
resuscitation	O
)	O
failed	O
to	O
demonstrate	O
an	O
increased	O
risk	O
of	O
developing	O
moderate	O
/	O
severe	O
hypoxemia	O
.	O

TITLE	O
:	O
Vitamin	O
D	O
deficiency	O
and	O
acute	O
lung	B-ANAT
injury	O
.	O

From	O
time	O
of	O
diagnosis	O
,	O
respiratory	O
,	O
faecal	B-ANAT
,	O
and	O
urine	B-ANAT
samples	O
were	O
obtained	O
for	O
virus	O
quantification	O
.	O

Viral	O
loads	O
were	O
highest	O
in	O
samples	O
from	O
the	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
(	O
up	O
to	O
1	O
Â·	O
2	O
Ã	O
10	O
(	O
6	O
)	O
copies	O
per	O
mL	O
).	O

We	O
have	O
utilized	O
solution	O
-	O
state	O
nuclear	O
magnetic	O
resonance	O
spectroscopy	O
to	O
investigate	O
DC	O
-	O
SIGNR	O
binding	O
and	O
herein	O
report	O
the	O
first	O
backbone	B-ANAT
assignment	O
of	O
its	O
active	O
,	O
calcium	O
-	O
bound	O
carbohydrate	O
recognition	O
domain	O
.	O

ABSTRACT	O
:	O
Severe	O
pulmonary	B-ANAT
involvement	O
in	O
malaria	O
has	O
been	O
frequently	O
reported	O
in	O
cases	O
of	O
Plasmodium	O
falciparum	O
infection	O
but	O
rarely	O
in	O
vivax	O
malaria	O
.	O

Both	O
cholesterol	O
-	O
and	O
cholesterol	O
-	O
PEG3	O
-	O
tagged	O
peptides	O
were	O
able	O
to	O
protect	O
chicken	O
embryos	B-ANAT
from	O
infection	O
with	O
different	O
serotypes	O
of	O
NDV	O
and	O
IBV	O
when	O
administered	O
12	O
h	O
prior	O
to	O
virus	O
inoculation	O
.	O

Within	O
twelve	O
hrs	O
after	O
cell	B-ANAT
cultures	O
were	O
initiated	O
,	O
cytoplasmic	B-ANAT
vacuoles	B-ANAT
appeared	O
in	O
many	O
of	O
the	O
RPTEC	O
.	O

Human	O
coronavirus	O
NL63	O
was	O
isolated	O
and	O
identified	O
by	O
RT	O
-	O
PCR	O
and	O
sequencing	O
,	O
and	O
its	O
replication	O
in	O
a	O
fresh	B-ANAT
batch	O
of	O
RPTEC	O
and	O
another	O
type	O
of	O
primary	O
human	O
kidney	B-ANAT
cells	B-ANAT
was	O
confirmed	O
.	O

In	O
this	O
study	O
,	O
by	O
screening	O
a	O
collection	O
of	O
256	O
dog	O
fecal	B-ANAT
samples	O
either	O
from	O
diarrhoeic	O
or	O
asymptomatic	O
animals	O
,	O
CaKV	O
was	O
identified	O
in	O
six	O
specimens	O
with	O
an	O
overall	O
prevalence	O
of	O
2	O
.	O
34	O
%	O
(	O
6	O
/	O
256	O
).	O

The	O
diagnostic	O
accuracy	O
in	O
predetermined	O
subgroups	O
(	O
those	O
with	O
diffuse	O
alveolar	B-ANAT
damage	O
,	O
with	O
â¥	O
3	O
affected	O
chest	B-ANAT
x	O
-	O
ray	O
quadrants	O
,	O
with	O
diagnosis	O
â¥	O
3	O
days	O
,	O
with	O
pulmonary	B-ANAT
vs	O
extrapulmonary	O
cause	O
)	O
was	O
also	O
examined	O
.	O

A	O
novel	O
assay	O
,	O
using	O
reverse	O
transcription	O
recombinase	O
polymerase	O
amplification	O
(	O
RT	O
-	O
RPA	B-ANAT
),	O
for	O
the	O
detection	O
of	O
BCoV	O
is	O
developed	O
.	O

HPIV	O
-	O
3	O
infection	O
was	O
diagnosed	O
on	O
the	O
rhinopharyngeal	B-ANAT
fluid	O
and	O
immunological	O
examinations	O
revealed	O
a	O
hypogammaglobulinemia	O
.	O

TITLE	O
:	O
Malaria	O
,	O
clinical	O
features	O
and	O
acute	O
crisis	O
in	O
children	O
suffering	O
from	O
sickle	B-ANAT
cell	I-ANAT
disease	O
in	O
resource	O
-	O
limited	O
settings	O
:	O
a	O
retrospective	O
description	O
of	O
90	O
cases	O
.	O

TITLE	O
:	O
[	O
A	O
case	O
of	O
severe	O
Legionella	O
pneumonia	O
in	O
which	O
survival	O
was	O
achieved	O
without	O
sequelae	O
with	O
the	O
use	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)].	O

An	O
increase	O
in	O
macrophage	B-ANAT
recruitment	O
and	O
activation	O
in	O
lung	B-ANAT
tissues	I-ANAT
infected	O
with	O
rTGEV	O
-	O
Î7	O
virus	O
was	O
observed	O
compared	O
to	O
cells	B-ANAT
infected	O
with	O
the	O
parental	O
virus	O
.	O

Here	O
we	O
showed	O
that	O
residues	O
377	O
to	O
662	O
in	O
the	O
S	O
protein	O
of	O
MERS	O
-	O
CoV	O
specifically	O
bound	O
to	O
DPP4	O
-	O
expressing	O
cells	B-ANAT
and	O
soluble	O
DPP4	O
protein	O
and	O
induced	O
significant	O
neutralizing	O
antibody	O
responses	O
,	O
suggesting	O
that	O
this	O
region	O
contains	O
the	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
),	O
which	O
has	O
a	O
potential	O
to	O
be	O
developed	O
as	O
a	O
MERS	O
-	O
CoV	O
vaccine	O
.	O

ABSTRACT	O
:	O
Foreign	O
body	B-ANAT
(	O
FB	O
)	O
ingestion	O
,	O
a	O
common	O
and	O
serious	O
problem	O
in	O
children	O
can	O
present	O
with	O
a	O
wide	O
variety	O
of	O
symptoms	O
.	O

ABSTRACT	O
:	O
In	O
Panama	O
,	O
hantavirus	O
pulmonary	B-ANAT
syndrome	O
(	O
HPS	O
)	O
is	O
caused	O
by	O
Choclo	O
virus	O
,	O
a	O
species	O
phylogenetically	O
related	O
to	O
Andes	O
and	O
Maporal	O
viruses	O
.	O

From	O
2006	O
to	O
2009	O
,	O
at	O
least	O
21	O
%	O
of	O
117	O
patients	O
diagnosed	O
with	O
HV	O
infection	O
had	O
HV	O
Fever	O
(	O
HF	O
)	O
with	O
no	O
evidence	O
of	O
pulmonary	B-ANAT
edema	O
(	O
no	O
respiratory	O
distress	O
or	O
radiographic	O
lung	B-ANAT
infiltrates	O
),	O
and	O
44	O
%	O
of	O
patients	O
had	O
very	O
mild	O
HPS	O
(	O
radiographic	O
pulmonary	B-ANAT
edema	O
but	O
no	O
respiratory	O
insufficiency	O
).	O

The	O
recent	O
human	O
infections	O
with	O
H7N9	O
virus	O
,	O
totalling	O
over	O
130	O
cases	O
with	O
39	O
fatalities	O
to	O
date	O
,	O
have	O
been	O
characterized	O
by	O
severe	O
pulmonary	B-ANAT
disease	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
relationship	O
between	O
extravascular	O
lung	B-ANAT
water	O
,	O
pulmonary	B-ANAT
vascular	B-ANAT
permeability	O
,	O
and	O
the	O
severity	O
categories	O
as	O
defined	O
by	O
the	O
Berlin	O
definition	O
,	O
and	O
to	O
confirm	O
the	O
associated	O
predictive	O
validity	O
for	O
severity	O
.	O

The	O
authors	O
analyzed	O
the	O
pulmonary	B-ANAT
distribution	O
of	O
radiolabeled	O
microspheres	O
in	O
normal	O
(	O
n	O
=	O
6	O
)	O
and	O
injured	O
(	O
n	O
=	O
12	O
)	O
anesthetized	O
rat	O
lungs	B-ANAT
using	O
positron	O
emission	B-ANAT
tomography	O
,	O
computed	O
tomography	O
,	O
and	O
histological	O
examination	O
.	O

After	O
acid	O
aspiration	O
,	O
computed	O
tomography	O
scans	O
revealed	O
that	O
lung	B-ANAT
density	O
had	O
increased	O
in	O
the	O
injured	O
regions	O
and	O
that	O
these	O
regions	O
colocalized	O
with	O
areas	O
of	O
increased	O
blood	B-ANAT
flow	O
.	O

The	O
acid	O
was	O
instilled	O
into	O
the	O
middle	O
and	O
basal	O
regions	O
of	O
the	O
lungs	B-ANAT
.	O

The	O
blood	B-ANAT
flow	O
was	O
significantly	O
increased	O
to	O
these	O
regions	O
compared	O
with	O
the	O
blood	B-ANAT
flow	O
to	O
uninjured	O
lungs	B-ANAT
in	O
the	O
control	O
animals	O
(	O
middle	O
region	O
:	O
1	O
.	O
23	O
[	O
1	O
.	O
1	O
;	O
1	O
.	O
4	O
]	O
(	O
median	O
[	O
25	O
%;	O
75	O
%])	O
vs	O
.	O
1	O
.	O
04	O
[	O
1	O
.	O
0	O
;	O
1	O
.	O
1	O
]	O
and	O
basal	O
region	O
:	O
1	O
.	O
25	O
[	O
1	O
.	O
2	O
;	O
1	O
.	O
3	O
]	O
vs	O
.	O
1	O
.	O
02	O
[	O
1	O
.	O
0	O
;	O
1	O
.	O
05	O
],	O
respectively	O
).	O

The	O
increase	O
in	O
blood	B-ANAT
flow	O
did	O
not	O
seem	O
to	O
be	O
due	O
to	O
vascular	B-ANAT
leakage	O
into	O
these	O
injured	O
areas	O
.	O

This	O
study	O
reveals	O
a	O
cellular	B-ANAT
kinase	O
responsible	O
for	O
phosphorylation	O
of	O
a	O
coronavirus	O
N	O
protein	O
at	O
two	O
positions	O
and	O
the	O
functional	O
consequence	O
of	O
this	O
modification	O
on	O
coronavirus	O
replication	O
.	O

ABSTRACT	O
:	O
The	O
most	O
severe	O
complication	O
of	O
ischemia	O
-	O
reperfusion	O
injury	O
following	O
lower	B-ANAT
limb	I-ANAT
arterial	B-ANAT
surgery	O
is	O
reperfusion	O
syndrome	O
.	O

Thorough	O
postmortem	O
examination	O
confirmed	O
the	O
presence	O
of	O
remote	O
organ	B-ANAT
damage	O
.	O

By	O
using	O
special	O
staining	O
techniques	O
,	O
the	O
presence	O
of	O
myoglobin	O
and	O
lipofuscin	O
deposits	O
was	O
confirmed	O
in	O
the	O
kidney	B-ANAT
samples	O
.	O

TITLE	O
:	O
Control	O
of	O
ventilation	O
in	O
COPD	O
and	O
lung	B-ANAT
injury	O
.	O

The	O
objective	O
of	O
this	O
review	O
,	O
is	O
to	O
illustrate	O
functional	O
changes	O
and	O
compensatory	O
mechanisms	O
which	O
occur	O
with	O
the	O
onset	O
and	O
progression	O
of	O
acute	O
and	O
chronic	O
lung	B-ANAT
disease	O
.	O

Taken	O
together	O
,	O
these	O
disease	O
models	O
highlight	O
the	O
plasticity	O
of	O
the	O
respiratory	O
control	O
system	O
in	O
response	O
to	O
the	O
development	O
and	O
progression	O
of	O
lung	B-ANAT
disease	O
.	O

We	O
hypothesize	O
that	O
ASA	O
in	O
a	O
high	O
dose	O
is	O
superior	O
to	O
low	O
-	O
dose	O
ASA	O
in	O
preventing	O
lung	B-ANAT
injury	O
.	O

Also	O
,	O
the	O
effect	O
on	O
lung	B-ANAT
injury	O
of	O
inhibiting	O
platelet	B-ANAT
activation	O
by	O
clopidogrel	O
was	O
investigated	O
.	O

Acute	O
lung	B-ANAT
injury	O
was	O
induced	O
by	O
intranasal	O
instillation	O
of	O
10	O
Î¼g	O
lipopolysaccharide	O
(	O
LPS	O
).	O

A	O
total	O
of	O
twelve	O
patients	O
with	O
a	O
diagnosis	O
of	O
Legionella	O
pneumonia	O
were	O
treated	O
with	O
veno	O
-	O
venous	B-ANAT
(	O
VV	O
)	O
ECLS	O
over	O
this	O
time	O
period	O
.	O

Lung	B-ANAT
injury	O
was	O
established	O
by	O
intravenous	O
infusion	O
of	O
oleic	O
acid	O
.	O

Furthermore	O
,	O
the	O
expression	O
of	O
CD34	O
,	O
KDR	O
,	O
and	O
CD133	O
messenger	O
RNA	O
in	O
lung	B-ANAT
tissue	I-ANAT
was	O
correlated	O
with	O
stromal	B-ANAT
cell	I-ANAT
-	O
derived	O
factor	O
-	O
1	O
in	O
the	O
lung	B-ANAT
.	O

XILP	O
inhibited	O
proliferation	O
of	O
various	O
cancer	B-ANAT
cell	I-ANAT
lines	O
but	O
did	O
not	O
do	O
so	O
in	O
human	O
embryonic	B-ANAT
liver	B-ANAT
(	O
WRL	O
68	O
)	O
cells	B-ANAT
.	O

Ages	O
greater	O
than	O
55	O
years	O
,	O
severity	O
at	O
admission	O
(	O
p	O
<	O
0	O
.	O
001	O
),	O
injured	O
cranial	B-ANAT
nerves	I-ANAT
(	O
p	O
=	O
0	O
.	O
008	O
)	O
and	O
the	O
needing	O
of	O
ventilator	O
support	O
(	O
p	O
=	O
0	O
.	O
003	O
)	O
were	O
associated	O
with	O
greater	O
sequels	O
at	O
the	O
discharge	B-ANAT
and	O
at	O
the	O
posterior	O
reviews	O
in	O
the	O
following	O
months	O
.	O

Acute	O
renal	B-ANAT
failure	O
(	O
ARF	O
)	O
secondary	O
to	O
obstructive	O
uropathy	O
is	O
rare	O
.	O

The	O
primary	O
objective	O
of	O
this	O
review	O
was	O
to	O
assess	O
whether	O
PLV	O
reduced	O
mortality	O
(	O
at	O
28	O
d	O
,	O
at	O
discharge	B-ANAT
from	O
the	O
intensive	O
care	O
unit	O
(	O
ICU	O
),	O
at	O
discharge	B-ANAT
from	O
hospital	O
and	O
at	O
one	O
,	O
two	O
and	O
five	O
years	O
)	O
in	O
adults	O
with	O
ALI	O
or	O
ARDS	O
when	O
compared	O
with	O
conventional	O
ventilatory	O
support	O
.	O

ABSTRACT	O
:	O
A	O
novel	O
lineage	O
C	O
betacoronavirus	O
,	O
originally	O
named	O
human	O
coronavirus	O
EMC	B-ANAT
/	O
2012	O
(	O
HCoV	O
-	O
EMC	B-ANAT
)	O
and	O
recently	O
renamed	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
),	O
that	O
is	O
phylogenetically	O
closely	O
related	O
to	O
Tylonycteris	O
bat	O
coronavirus	O
HKU4	O
and	O
Pipistrellus	O
bat	O
coronavirus	O
HKU5	O
,	O
which	O
we	O
discovered	O
in	O
2007	O
from	O
bats	O
in	O
Hong	O
Kong	O
,	O
has	O
recently	O
emerged	O
in	O
the	O
Middle	O
East	O
to	O
cause	O
a	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
like	O
infection	O
in	O
humans	O
.	O

The	O
first	O
laboratory	O
-	O
confirmed	O
case	O
,	O
which	O
involved	O
a	O
60	O
-	O
year	O
-	O
old	O
man	O
from	O
Bisha	O
,	O
the	O
Kingdom	O
of	O
Saudi	O
Arabia	O
(	O
KSA	O
),	O
who	O
died	O
of	O
rapidly	O
progressive	O
community	O
-	O
acquired	O
pneumonia	O
and	O
acute	O
renal	B-ANAT
failure	O
,	O
was	O
announced	O
by	O
the	O
World	O
Health	O
Organization	O
(	O
WHO	O
)	O
on	O
September	O
23	O
,	O
2012	O
.	O

More	O
than	O
a	O
half	O
of	O
the	O
fecal	B-ANAT
samples	O
from	O
the	O
diarrheic	O
calves	O
had	O
multiple	O
pathogens	O
.	O

ABSTRACT	O
:	O
Total	O
internal	O
reflection	O
microscopy	O
combined	O
with	O
microfluidics	O
and	O
supported	O
bilayers	O
is	O
a	O
powerful	O
,	O
single	O
particle	O
tracking	O
(	O
SPT	O
)	O
platform	O
for	O
host	O
-	O
pathogen	O
membrane	B-ANAT
fusion	O
studies	O
.	O

To	O
assess	O
pulmonary	B-ANAT
co	O
-	O
morbidities	O
,	O
we	O
used	O
infant	O
pulmonary	B-ANAT
function	O
testing	O
through	O
the	O
raised	O
volume	O
rapid	O
thoracoabdominal	O
compression	O
technique	O
as	O
both	O
an	O
established	O
study	O
of	O
early	O
cystic	O
fibrosis	O
and	O
also	O
as	O
a	O
newer	O
study	O
of	O
mechanism	O
for	O
early	O
sickle	B-ANAT
cell	I-ANAT
lung	B-ANAT
disease	O
.	O

This	O
further	O
serves	O
as	O
the	O
first	O
report	O
of	O
the	O
raised	O
volume	O
rapid	O
thoracoabdominal	O
compression	O
technique	O
to	O
determine	O
raised	O
volume	O
forced	O
expiratory	O
flows	O
and	O
fractional	O
lung	B-ANAT
volumes	O
in	O
a	O
patient	O
with	O
a	O
hemoglobinopathy	O
.	O

Gastrointestinal	O
symptoms	O
were	O
also	O
frequent	O
,	O
including	O
diarrhoea	O
(	O
12	O
[	O
26	O
%]),	O
vomiting	O
(	O
ten	O
[	O
21	O
%]),	O
and	O
abdominal	B-ANAT
pain	O
(	O
eight	O
[	O
17	O
%]).	O

ABSTRACT	O
:	O
Because	O
they	O
are	O
the	O
natural	O
target	O
for	O
respiratory	O
pathogens	O
,	O
primary	O
human	O
respiratory	O
epithelial	B-ANAT
cells	I-ANAT
provide	O
the	O
ideal	O
in	O
vitro	O
system	O
for	O
isolation	O
and	O
study	O
of	O
human	O
respiratory	O
viruses	O
,	O
which	O
display	O
a	O
high	O
degree	O
of	O
cell	B-ANAT
,	O
tissue	B-ANAT
,	O
and	O
host	O
specificity	O
.	O

iatrogenic	O
sigmoid	B-ANAT
perforation	O
and	O
Crohn	O
'	O
s	O
disease	O
,	O
and	O
4	O
.	O

RESULTS	O
:	O
Four	O
children	O
with	O
different	O
clinical	O
presentations	O
(	O
1	O
.	O
neonatal	O
abdominal	B-ANAT
distension	O
,	O
2	O
.	O

Structured	O
scoping	O
review	O
methods	O
were	O
used	O
to	O
identify	O
,	O
characterize	O
,	O
and	O
evaluate	O
all	O
published	O
primary	O
research	O
,	O
expert	O
review	O
,	O
and	O
commentary	O
articles	O
regarding	O
the	O
use	O
of	O
social	O
media	B-ANAT
in	O
surveillance	O
of	O
infectious	O
diseases	O
from	O
2002	O
-	O
2011	O
.	O

The	O
most	O
commonly	O
reported	O
strengths	O
of	O
social	O
media	B-ANAT
surveillance	O
programs	O
included	O
their	O
effectiveness	O
(	O
21	O
/	O
32	O
,	O
66	O
%)	O
and	O
rapid	O
detection	O
of	O
disease	O
(	O
21	O
/	O
32	O
,	O
66	O
%).	O

The	O
present	O
study	O
demonstrates	O
that	O
among	O
major	O
complications	O
,	O
low	O
output	O
syndrome	O
,	O
renal	B-ANAT
failure	O
requiring	O
renal	B-ANAT
replacement	O
therapy	O
and	O
sepsis	O
,	O
dramatically	O
impaired	O
the	O
postoperative	O
course	O
patients	O
aged	O
over	O
80	O
years	O
undergoing	O
CABG	O
,	O
AVR	O
or	O
combined	O
CABG	O
and	O
AVR	O
.	O

Pro	O
-	O
inflammatory	O
cytokines	O
(	O
IL	O
-	O
9	O
,	O
IFN	O
-	O
Î³	O
and	O
TNF	O
-	O
Î±	O
)	O
were	O
also	O
examined	O
by	O
using	O
intracellular	B-ANAT
staining	O
.	O

Meanwhile	O
,	O
the	O
CD69	O
expression	O
in	O
hepatic	B-ANAT
NK	B-ANAT
cells	I-ANAT
was	O
highly	O
correlated	O
with	O
the	O
serum	B-ANAT
level	O
of	O
ALT	O
and	O
AST	O
.	O

In	O
contrast	O
,	O
the	O
NKG2A	O
expression	O
was	O
increased	O
in	O
hepatic	B-ANAT
CD69	O
-	O
NK	B-ANAT
cells	I-ANAT
but	O
not	O
in	O
CD69	B-ANAT
+	I-ANAT
NK	I-ANAT
cells	I-ANAT
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
diagnostic	O
utility	O
of	O
aqueous	B-ANAT
humor	I-ANAT
analysis	O
in	O
animals	O
with	O
anterior	O
uveitis	O
.	O

Cytologically	O
assessed	O
plasma	B-ANAT
cell	I-ANAT
number	O
was	O
correlated	O
with	O
keratic	O
precipitates	O
and	O
disease	O
duration	O
.	O

Aqueous	B-ANAT
humor	I-ANAT
cytology	O
permitted	O
diagnosis	O
of	O
neoplasia	O
in	O
dogs	O
with	O
anterior	O
uveitis	O
but	O
was	O
generally	O
not	O
helpful	O
in	O
cats	O
.	O

Poor	O
correlation	O
between	O
clinical	O
and	O
cytologic	O
assessment	O
of	O
cell	B-ANAT
numbers	O
and	O
type	O
within	O
the	O
anterior	B-ANAT
chamber	I-ANAT
dictates	O
that	O
clinical	O
grading	O
should	O
not	O
be	O
the	O
sole	B-ANAT
criterion	O
for	O
electing	O
to	O
perform	O
aqueocentesis	O
.	O

In	O
addition	O
,	O
the	O
expression	O
of	O
the	O
Î±4	O
subunit	O
(	O
CD49d	O
)	O
of	O
the	O
Î²1	O
integrin	O
very	O
late	O
antigen	O
(	O
VLA	O
)-	O
4	O
was	O
elevated	O
on	O
B	B-ANAT
-	I-ANAT
lymphocytes	I-ANAT
from	O
FIP	O
patients	O
.	O

The	O
expression	O
of	O
CD11b	O
and	O
CD18	O
,	O
that	O
combine	O
to	O
form	O
the	O
Î²2	O
integrin	O
macrophage	B-ANAT
-	O
1	O
antigen	O
(	O
Mac	B-ANAT
-	O
1	O
),	O
was	O
elevated	O
on	O
monocytes	B-ANAT
,	O
whereas	O
the	O
density	O
of	O
CD49d	O
was	O
reduced	O
on	O
this	O
population	O
in	O
FIP	O
.	O

Plasma	B-ANAT
levels	O
of	O
activated	O
protein	O
C	O
(	O
aPC	B-ANAT
)	O
are	O
lower	O
than	O
normal	O
in	O
acute	O
inflammation	O
in	O
humans	O
,	O
except	O
early	O
after	O
severe	O
trauma	O
when	O
high	O
plasma	B-ANAT
levels	O
of	O
aPC	B-ANAT
may	O
play	O
a	O
mechanistic	O
role	O
in	O
the	O
development	O
of	O
posttraumatic	O
coagulopathy	O
.	O

Since	O
up	O
to	O
75	O
%	O
of	O
sepsis	O
originates	O
from	O
the	O
lung	B-ANAT
,	O
aPC	B-ANAT
treatment	O
may	O
not	O
have	O
added	O
enough	O
to	O
the	O
beneficial	O
effect	O
of	O
lung	B-ANAT
-	O
protective	O
ventilation	O
to	O
show	O
lower	O
mortality	O
.	O

Because	O
recombinant	O
human	O
aPC	B-ANAT
has	O
been	O
withdrawn	O
from	O
the	O
market	O
,	O
a	O
better	O
understanding	O
of	O
the	O
complex	O
interactions	O
between	O
coagulation	O
and	O
inflammation	O
is	O
needed	O
before	O
considering	O
the	O
development	O
of	O
new	O
drugs	O
that	O
modulate	O
both	O
coagulation	O
and	O
acute	O
inflammation	O
in	O
humans	O
.	O

However	O
,	O
established	O
mouse	O
cell	B-ANAT
lines	I-ANAT
highly	O
susceptible	O
to	O
mouse	O
-	O
adapted	O
SARS	O
-	O
CoV	O
infection	O
are	O
not	O
available	O
.	O

In	O
addition	O
,	O
in	O
these	O
cell	B-ANAT
lines	I-ANAT
,	O
SARS	O
-	O
CoV	O
-	O
MA15	O
induced	O
the	O
expression	O
of	O
proinflammatory	O
cytokines	O
and	O
IFN	O
-	O
Î²	O
,	O
mimicking	O
what	O
has	O
been	O
observed	O
in	O
experimental	O
animal	O
models	O
infected	O
with	O
SARS	O
-	O
CoV	O
and	O
SARS	O
patients	O
.	O

Using	O
computed	O
tomography	O
,	O
single	O
,	O
basal	O
slices	O
of	O
the	O
lung	B-ANAT
were	O
obtained	O
during	O
inspiratory	O
and	O
expiratory	O
pauses	O
at	O
a	O
tidal	O
volume	O
of	O
6	O
ml	O
/	O
kg	O
and	O
a	O
positive	O
end	O
-	O
expiratory	O
pressure	O
of	O
5	O
,	O
10	O
,	O
15	O
and	O
20	O
cmH2O	O
.	O

In	O
addition	O
,	O
increasing	O
levels	O
of	O
positive	O
end	O
-	O
expiratory	O
pressure	O
systematically	O
increased	O
strain	O
along	O
the	O
sternovertebral	O
axis	B-ANAT
.	O

This	O
review	O
explains	O
the	O
viral	O
metagenomics	O
strategy	O
for	O
virus	O
discovery	O
and	O
describes	O
viruses	O
discovered	O
in	O
human	O
feces	B-ANAT
in	O
the	O
past	O
10	O
years	O
using	O
this	O
approach	O
.	O

Femoral	B-ANAT
venous	B-ANAT
blood	I-ANAT
and	O
urine	B-ANAT
had	O
MDPV	O
concentrations	O
of	O
130	O
ng	O
/	O
mL	O
and	O
3800	O
ng	O
/	O
mL	O
.	O
The	O
blood	B-ANAT
and	O
urine	B-ANAT
MDPV	O
concentrations	O
are	O
within	O
the	O
reported	O
recreational	O
concentration	O
ranges	O
(	O
blood	B-ANAT
24	O
-	O
241	O
ng	O
/	O
mL	O
and	O
urine	B-ANAT
34	O
-	O
3900	O
ng	O
/	O
mL	O
).	O

ABSTRACT	O
:	O
The	O
incidence	O
and	O
clinical	O
impact	O
of	O
coronavirus	O
(	O
CoV	O
)	O
infection	O
in	O
elderly	O
persons	O
and	O
those	O
with	O
underlying	O
cardiopulmonary	B-ANAT
disease	O
over	O
a	O
long	O
duration	O
is	O
not	O
well	O
described	O
.	O

ABSTRACT	O
:	O
In	O
patients	O
with	O
A	O
(	O
H1N1	O
)	O
pdm09	O
infection	O
,	O
severe	O
lung	B-ANAT
involvement	O
requiring	O
admission	O
to	O
intensive	O
care	O
units	O
(	O
ICU	O
)	O
has	O
been	O
reported	O
.	O

D222G	O
and	O
D222N	O
mutants	O
were	O
identified	O
in	O
upper	O
and	O
lower	O
respiratory	B-ANAT
samples	I-ANAT
.	O

D222G	O
and	O
D222N	O
mutants	O
were	O
identified	O
in	O
upper	O
and	O
lower	O
respiratory	B-ANAT
samples	I-ANAT
.	O

Reverse	O
transcription	O
(	O
RT	O
)	O
PCRs	O
were	O
performed	O
to	O
detect	O
common	O
respiratory	B-ANAT
tract	I-ANAT
viruses	O
including	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
),	O
human	O
rhinovirus	O
(	O
HRV	O
),	O
influenza	O
virus	O
(	O
IFV	O
),	O
parainfluenza	O
virus	O
(	O
PIV	O
)	O
type	O
1	O
-	O
4	O
,	O
adenovirus	O
(	O
ADV	O
),	O
enterovirus	O
(	O
EV	O
),	O
human	O
coronavirus	O
(	O
HCOV	O
),	O
human	O
metapneumonia	O
virus	O
(	O
HMPV	O
)	O
and	O
human	O
bocavirus	O
(	O
HBOV	O
).	O

Reverse	O
transcription	O
(	O
RT	O
)	O
PCRs	O
were	O
performed	O
to	O
detect	O
common	O
respiratory	B-ANAT
tract	I-ANAT
viruses	O
including	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
),	O
human	O
rhinovirus	O
(	O
HRV	O
),	O
influenza	O
virus	O
(	O
IFV	O
),	O
parainfluenza	O
virus	O
(	O
PIV	O
)	O
type	O
1	O
-	O
4	O
,	O
adenovirus	O
(	O
ADV	O
),	O
enterovirus	O
(	O
EV	O
),	O
human	O
coronavirus	O
(	O
HCOV	O
),	O
human	O
metapneumonia	O
virus	O
(	O
HMPV	O
)	O
and	O
human	O
bocavirus	O
(	O
HBOV	O
).	O

We	O
investigated	O
possible	O
animal	O
reservoirs	O
of	O
MERS	O
-	O
CoV	O
by	O
assessing	O
specific	O
serum	B-ANAT
antibodies	O
in	O
livestock	O
.	O

Cattle	O
(	O
n	O
=	O
80	O
),	O
sheep	O
(	O
n	O
=	O
40	O
),	O
goats	O
(	O
n	O
=	O
40	O
),	O
dromedary	O
camels	O
(	O
n	O
=	O
155	O
),	O
and	O
various	O
other	O
camelid	O
species	O
(	O
n	O
=	O
34	O
)	O
were	O
tested	O
for	O
specific	O
serum	B-ANAT
IgG	O
by	O
protein	O
microarray	O
using	O
the	O
receptor	O
-	O
binding	O
S1	O
subunits	O
of	O
spike	O
proteins	O
of	O
MERS	O
-	O
CoV	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
,	O
and	O
human	O
coronavirus	O
OC43	O
.	O

ABSTRACT	O
:	O
Acute	O
viral	O
pneumonia	O
is	O
an	O
important	O
cause	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
),	O
although	O
not	O
enough	O
is	O
known	O
about	O
the	O
exact	O
incidence	O
of	O
viral	O
infection	O
in	O
ALI	O
.	O

The	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
epidemic	O
and	O
the	O
2009	O
H1N1	O
influenza	O
pandemic	O
provided	O
a	O
better	O
understanding	O
of	O
how	O
viral	O
pathogens	O
mediate	O
lung	B-ANAT
injury	O
.	O

Here	O
we	O
implement	O
an	O
integrated	O
network	O
interrogation	O
approach	O
,	O
in	O
which	O
proteome	O
and	O
transcriptome	O
datasets	O
from	O
infection	O
of	O
both	O
viruses	O
in	O
human	O
lung	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
are	O
utilized	O
to	O
predict	O
regulatory	O
genes	O
involved	O
in	O
the	O
host	O
response	O
.	O

TITLE	O
:	O
Influenza	O
-	O
B	O
associated	O
rhabdomyolysis	O
and	O
acute	O
renal	B-ANAT
failure	O
.	O

Although	O
these	O
double	O
-	O
membrane	B-ANAT
vesicles	B-ANAT
have	O
been	O
well	O
characterized	O
,	O
the	O
mechanism	O
behind	O
their	O
formation	O
remains	O
unclear	O
,	O
including	O
which	O
viral	O
proteins	O
are	O
responsible	O
.	O

Here	O
,	O
we	O
use	O
transfection	O
of	O
plasmid	O
constructs	O
encoding	O
full	O
-	O
length	O
versions	O
of	O
the	O
three	O
transmembrane	B-ANAT
-	O
containing	O
nonstructural	O
proteins	O
(	O
nsps	O
)	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	O
to	O
examine	O
the	O
ability	O
of	O
each	O
to	O
induce	O
double	O
-	O
membrane	B-ANAT
vesicles	B-ANAT
in	O
tissue	B-ANAT
culture	O
.	O

nsp6	O
has	O
membrane	B-ANAT
proliferation	O
ability	O
as	O
well	O
,	O
inducing	O
perinuclear	O
vesicles	B-ANAT
localized	O
around	O
the	O
microtubule	B-ANAT
organizing	I-ANAT
center	I-ANAT
.	O

TITLE	O
:	O
[	O
Multiple	O
organ	B-ANAT
failure	O
complicating	O
a	O
severe	O
acute	O
necrotising	O
pancreatitis	O
secondary	O
of	O
a	O
severe	O
hypertriglyceridemia	O
:	O
a	O
case	O
report	O
].	O

A	O
multi	O
-	O
organ	B-ANAT
failure	O
complicating	O
a	O
severe	O
acute	O
pancreatitis	O
secondary	O
of	O
a	O
major	O
hypertriglyceridemia	O
was	O
mentioned	O
.	O

Thus	O
,	O
an	O
Ark	O
-	O
type	O
IBV	O
ocular	B-ANAT
vaccine	O
induces	O
a	O
central	O
memory	O
IFN	O
-	O
Î³	O
response	O
in	O
the	O
spleen	B-ANAT
while	O
the	O
cytotoxic	O
effector	O
memory	O
response	O
,	O
as	O
measured	O
by	O
GZMA	O
and	O
perforin	O
mRNA	O
expression	O
,	O
remains	O
associated	O
with	O
CALT	O
after	O
boosting	O
.	O

The	O
complications	O
of	O
hypotension	O
(	O
5	O
.	O
7	O
%),	O
septic	O
shock	O
(	O
3	O
.	O
4	O
%),	O
pneumonia	O
(	O
10	O
.	O
9	O
%),	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
(	O
11	O
.	O
5	O
%),	O
meningoencephalitis	O
(	O
6	O
.	O
9	O
%),	O
encephalopathy	O
(	O
5	O
.	O
2	O
%),	O
gastrointestinal	O
bleed	O
(	O
1	O
.	O
3	O
%),	O
myocarditis	O
(	O
3	O
.	O
4	O
%),	O
disseminated	O
intravascular	O
coagulation	O
(	O
2	O
.	O
9	O
%)	O
and	O
multi	O
organ	B-ANAT
failure	O
(	O
MOF	O
)	O
(	O
10	O
.	O
3	O
%)	O
developed	O
during	O
course	O
of	O
hospitalization	O
in	O
these	O
patients	O
.	O

Age	O
,	O
a	O
shorter	O
hospital	O
stay	O
,	O
severities	O
of	O
leukocytosis	O
,	O
thrombocytopenia	O
,	O
azotemia	O
,	O
hypoalbuminemia	O
,	O
hepatic	B-ANAT
dysfunction	O
and	O
the	O
complications	O
of	O
ARDS	O
,	O
encephalopathy	O
,	O
MOF	O
and	O
need	O
for	O
ICU	O
support	O
are	O
the	O
factors	O
associated	O
with	O
mortality	O
.	O

Extracorporeal	O
membrane	B-ANAT
oxygenation	O
benefit	O
on	O
hospital	O
mortality	O
is	O
unclear	O
.	O

Histology	O
revealed	O
severe	O
atrophy	O
of	O
villi	O
in	O
all	O
segments	O
of	O
the	O
small	B-ANAT
intestines	I-ANAT
with	O
occasional	O
villus	B-ANAT
-	O
epithelial	O
syncytial	O
cells	B-ANAT
,	O
but	O
testing	O
for	O
rotaviruses	O
and	O
Transmissible	O
gastroenteritis	O
virus	O
(	O
Alphacoronavirus	O
1	O
)	O
were	O
negative	O
.	O

Negative	O
-	O
staining	O
electron	O
microscopy	O
of	O
feces	B-ANAT
revealed	O
coronavirus	O
-	O
like	O
particles	O
and	O
a	O
pan	B-ANAT
-	O
coronavirus	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
designed	O
to	O
amplify	O
a	O
conserved	O
region	O
of	O
the	O
polymerase	O
gene	O
for	O
all	O
members	O
in	O
the	O
family	O
Coronaviridae	O
produced	O
expected	O
251	O
-	O
bp	O
amplicons	O
.	O

Toxin	O
-	O
induced	O
endothelial	B-ANAT
hyperpermeability	O
can	O
involve	O
myosin	O
light	O
chain	O
phosphorylation	O
and	O
/	O
or	O
microtubule	B-ANAT
rearrangement	O
.	O

The	O
enzyme	O
arginase	O
,	O
the	O
activity	O
of	O
which	O
can	O
be	O
regulated	O
by	O
the	O
redox	O
status	O
of	O
the	O
cell	B-ANAT
,	O
exists	O
in	O
two	O
isoforms	O
-	O
arginase	O
1	O
(	O
cytosolic	B-ANAT
)	O
and	O
arginase	O
2	O
(	O
mitochondrial	B-ANAT
)	O
-	O
both	O
of	O
which	O
can	O
be	O
expressed	O
in	O
lung	B-ANAT
microvascular	O
endothelial	B-ANAT
cells	I-ANAT
.	O

The	O
gene	O
product	O
,	O
pVHL	O
,	O
regulates	O
the	O
level	O
of	O
proteins	O
that	O
play	O
a	O
central	O
role	O
in	O
protecting	O
cells	B-ANAT
against	O
hypoxia	O
.	O

After	O
consolidation	O
therapy	O
patient	O
developed	O
bone	B-ANAT
marrow	I-ANAT
aplasia	O
and	O
severe	O
pneumonia	O
.	O

No	O
evidence	O
of	O
relationship	O
between	O
VHL	O
disease	O
and	O
blood	B-ANAT
cancers	O
has	O
been	O
demonstrated	O
so	O
far	O
.	O

Immunization	O
with	O
C	O
vaccine	O
allowed	O
to	O
harvest	O
eggs	O
with	O
satisfactory	O
levels	O
of	O
E	O
.	O
coli	O
,	O
rotavirus	O
and	O
coronavirus	O
IgY	O
antibodies	O
which	O
may	O
be	O
used	O
to	O
evaluate	O
their	O
protective	O
effect	O
by	O
oral	B-ANAT
administration	O
in	O
calves	O
.	O

In	O
this	O
study	O
,	O
we	O
produced	O
a	O
pseudovirus	O
bearing	O
the	O
full	O
-	O
length	O
spike	O
(	O
S	O
)	O
protein	O
of	O
MERS	O
-	O
CoV	O
in	O
the	O
Env	O
-	O
defective	O
,	O
luciferase	O
-	O
expressing	O
HIV	O
-	O
1	O
backbone	B-ANAT
.	O

With	O
the	O
rapid	O
advancement	O
in	O
the	O
field	O
of	O
microglia	B-ANAT
and	O
astrocytic	B-ANAT
neurobiology	O
,	O
the	O
term	O
neuroinflammation	O
progressively	O
started	O
to	O
denote	O
chronic	O
CNS	B-ANAT
cell	B-ANAT
-	O
specific	O
inflammation	O
in	O
MS	O
.	O

The	O
mean	O
of	O
the	O
highest	O
plasma	B-ANAT
-	O
free	O
haemoglobin	O
during	O
MCS	B-ANAT
was	O
21	O
.	O
0	O
(Â±	O
42	O
.	O
9	O
)	O
mg	O
/	O
dl	O
.	O

In	O
this	O
commentary	O
,	O
the	O
authors	O
discuss	O
the	O
rationale	O
,	O
based	O
on	O
the	O
physiologic	O
principle	O
of	O
targeting	O
both	O
vital	O
organs	B-ANAT
,	O
of	O
applying	O
high	O
-	O
frequency	O
oscillation	O
and	O
tracheal	O
gas	O
insufflation	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
with	O
traumatic	O
brain	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
Positioning	O
therapy	O
may	O
improve	O
lung	B-ANAT
recruitment	O
and	O
oxygenation	O
and	O
is	O
part	O
of	O
the	O
standard	O
care	O
in	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

ABSTRACT	O
:	O
Stevens	O
-	O
Johnson	O
syndrome	O
and	O
toxic	O
epidermal	B-ANAT
necrolysis	O
are	O
severe	O
adverse	O
cutaneous	O
drug	O
reactions	O
characterized	O
by	O
widespread	O
skin	B-ANAT
and	O
mucous	B-ANAT
membrane	I-ANAT
detachments	O
,	O
including	O
bronchial	B-ANAT
mucosa	I-ANAT
,	O
which	O
may	O
be	O
associated	O
with	O
respiratory	O
failure	O
requiring	O
mechanical	O
ventilation	O
.	O

The	O
presentation	O
and	O
outcome	O
of	O
patients	O
requiring	O
mechanical	O
ventilation	O
and	O
the	O
characteristics	O
of	O
bronchial	B-ANAT
epithelial	O
lesions	O
among	O
ventilated	O
patients	O
are	O
reported	O
.	O

Among	O
patients	O
receiving	O
mechanical	O
ventilation	O
,	O
57	O
%	O
of	O
the	O
patients	O
died	O
;	O
those	O
having	O
bronchial	B-ANAT
epithelial	O
lesions	O
(	O
22	O
of	O
56	O
)	O
required	O
intubation	O
earlier	O
than	O
others	O
(	O
1	O
[	O
1	O
-	O
4	O
]	O
vs	O
4	O
[	O
1	O
-	O
6	O
]	O
d	O
after	O
hospital	O
admission	O
;	O
p	O
=	O
0	O
.	O
027	O
).	O

ABSTRACT	O
:	O
Lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
(	O
LRTI	O
)	O
caused	O
by	O
adenovirus	O
can	O
be	O
severe	O
with	O
resultant	O
chronic	O
pulmonary	B-ANAT
sequelae	O
.	O

To	O
better	O
understand	O
the	O
genomic	O
changes	O
associated	O
with	O
viral	O
adaptation	O
,	O
we	O
sequenced	O
the	O
complete	O
genomes	O
of	O
FIPV	O
WSU	O
79	O
-	O
1146	O
at	O
different	O
tissue	B-ANAT
passage	O
levels	O
:	O
passage	O
1	O
,	O
passage	O
8	O
,	O
and	O
passage	O
50	O
tissue	B-ANAT
culture	O
.	O

Only	O
one	O
residue	O
change	O
was	O
observed	O
in	O
the	O
spike	O
glycoprotein	O
,	O
which	O
reverted	O
back	B-ANAT
on	O
subsequent	O
passages	O
,	O
four	O
changes	O
were	O
observed	O
in	O
the	O
3c	O
protein	O
,	O
and	O
one	O
change	O
was	O
observed	O
in	O
each	O
3a	O
,	O
small	O
membrane	B-ANAT
,	O
nucleocapsid	B-ANAT
and	O
7a	O
proteins	O
.	O

The	O
mutation	O
rate	O
was	O
calculated	O
to	O
be	O
5	O
.	O
08	O
-	O
6	O
.	O
3	O
Ã	O
10	O
(-	O
6	O
)	O
nucleotides	O
/	O
site	O
/	O
passage	O
in	O
tissue	B-ANAT
culture	O
suggesting	O
a	O
relatively	O
stable	O
virus	O
.	O

The	O
mutant	O
viruses	O
presented	O
growth	O
kinetics	O
similar	O
to	O
those	O
of	O
the	O
wild	O
-	O
type	O
virus	O
,	O
indicating	O
that	O
accessory	O
genes	O
were	O
not	O
essential	O
for	O
MERS	O
-	O
CoV	O
replication	O
in	O
cell	B-ANAT
cultures	O
.	O

None	O
of	O
the	O
cells	B-ANAT
were	O
sensitive	O
to	O
infection	O
by	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
),	O
a	O
porcine	O
coronavirus	O
,	O
or	O
to	O
infection	O
mediated	O
by	O
the	O
Spike	O
(	O
S	O
)	O
protein	O
of	O
SARS	O
-	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
incorporated	O
into	O
pseudotypes	O
based	O
on	O
vesicular	O
stomatitis	O
virus	O
(	O
VSV	O
).	O

Furthermore	O
,	O
these	O
results	O
show	O
a	O
receptor	O
-	O
dependent	O
restriction	O
of	O
the	O
infection	O
of	O
bat	O
cells	B-ANAT
by	O
CoV	O
.	O
The	O
implications	O
for	O
the	O
isolation	O
of	O
coronaviruses	O
from	O
bats	O
are	O
discussed	O
.	O

Infections	O
were	O
associated	O
with	O
transient	O
lung	B-ANAT
function	O
loss	O
and	O
high	O
calcineurin	O
inhibitor	O
blood	B-ANAT
levels	O
.	O

In	O
1991	O
we	O
published	O
a	O
report	O
showing	O
that	O
,	O
in	O
ARDS	O
patients	O
,	O
shifting	O
from	O
supine	O
to	O
prone	O
position	O
led	O
immediately	O
to	O
the	O
inversion	O
of	O
the	O
inflation	O
gradient	O
and	O
to	O
a	O
redistribution	O
of	O
densities	O
from	O
dorsal	O
to	O
ventral	O
lung	B-ANAT
regions	O
.	O

The	O
more	O
homogeneous	O
distribution	O
of	O
inflation	O
(	O
i	O
.	O
e	O
.	O
of	O
stress	O
and	O
strain	O
)	O
decreases	O
/	O
prevents	O
the	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
,	O
as	O
consistently	O
shown	O
in	O
animal	O
experiments	O
.	O

We	O
previously	O
showed	O
that	O
MERS	O
-	O
CoV	O
counteracts	O
parts	O
of	O
the	O
innate	O
immune	O
response	O
in	O
human	O
bronchiolar	B-ANAT
cells	B-ANAT
.	O

These	O
results	O
suggest	O
that	O
a	O
single	O
treatment	O
with	O
camostat	O
is	O
sufficient	O
to	O
block	O
MERS	O
-	O
CoV	O
entry	O
into	O
a	O
well	O
-	O
differentiated	O
lung	B-ANAT
-	O
derived	O
cell	B-ANAT
line	I-ANAT
.	O

Our	O
results	O
also	O
provide	O
evidence	O
that	O
chimeric	O
viruses	O
within	O
coronavirus	O
genogroups	O
can	O
be	O
used	O
to	O
test	O
nsp5	O
determinants	O
of	O
function	O
and	O
inhibition	O
in	O
common	O
isogenic	O
backgrounds	O
and	O
cell	B-ANAT
types	O
.	O

This	O
study	O
aims	O
to	O
examine	O
the	O
effects	O
of	O
vaporized	O
PFC	O
on	O
gas	O
exchange	O
and	O
lung	B-ANAT
mechanics	O
in	O
a	O
piglet	O
model	O
with	O
ARDS	O
.	O

Plasma	B-ANAT
SP	O
-	O
D	O
levels	O
are	O
usually	O
low	O
,	O
but	O
may	O
increase	O
when	O
the	O
lung	B-ANAT
-	O
blood	B-ANAT
barrier	O
is	O
impaired	O
.	O

In	O
this	O
study	O
,	O
we	O
analyzed	O
whether	O
plasma	B-ANAT
SP	O
-	O
D	O
concentrations	O
reflect	O
rejection	O
or	O
infection	O
of	O
the	O
lung	B-ANAT
allograft	O
.	O

We	O
additionally	O
determined	O
aquaporin	O
-	O
1	O
expression	O
upon	O
lipopolysaccharide	O
(	O
LPS	O
)	O
exposure	O
and	O
explored	O
functional	O
effects	O
of	O
aquaporin	O
-	O
1	O
induction	O
in	O
polymorphonuclear	O
granulocytes	B-ANAT
(	O
PMNs	O
).	O

Leukocyte	B-ANAT
aquaporin	O
-	O
1	O
expression	O
was	O
induced	O
at	O
the	O
onset	O
of	O
sepsis	O
(	O
median	O
1	O
.	O
71	O
-	O
fold	O
increase	O
;	O
interquartile	O
range	O
:	O
0	O
.	O
99	O
to	O
2	O
.	O
42	O
,	O
P	O
=	O
0	O
.	O
012	O
from	O
baseline	O
)	O
and	O
was	O
further	O
increased	O
upon	O
septic	O
shock	O
(	O
median	O
3	O
.	O
00	O
-	O
fold	O
increase	O
;	O
interquartile	O
range	O
:	O
1	O
.	O
20	O
to	O
5	O
.	O
40	O
,	O
P	O
=	O
0	O
.	O
023	O
from	O
sepsis	O
,	O
Wilcoxon	O
signed	O
-	O
rank	O
test	O
);	O
no	O
difference	O
was	O
observed	O
between	O
baseline	O
and	O
discharge	B-ANAT
in	O
patients	O
who	O
did	O
not	O
develop	O
sepsis	O
.	O

During	O
the	O
period	O
April	O
2011	O
to	O
April	O
2012	O
,	O
689	O
stool	B-ANAT
samples	O
from	O
as	O
many	O
patients	O
hospitalized	O
at	O
the	O
Fondazione	O
IRCCS	O
Policlinico	O
San	O
Matteo	O
of	O
Pavia	O
exhibiting	O
gastrointestinal	O
syndromes	O
were	O
examined	O
for	O
the	O
presence	O
of	O
rotavirus	O
,	O
norovirus	O
,	O
astrovirus	O
,	O
adenovirus	O
,	O
rhinovirus	O
,	O
enterovirus	O
,	O
parechovirus	O
,	O
bocavirus	O
,	O
coronavirus	O
,	O
sapovirus	O
,	O
cosavirus	O
,	O
and	O
aichi	O
virus	O
using	O
polymerase	O
chain	O
reaction	O
assays	O
.	O

Previously	O
,	O
we	O
have	O
described	O
a	O
role	O
of	O
actin	O
binding	O
protein	O
cofilin	O
in	O
mediating	O
cytoskeletal	B-ANAT
alterations	O
essential	O
for	O
NF	O
-	O
ÎºB	O
activation	O
and	O
EC	O
inflammation	O
.	O

Our	O
data	O
show	O
that	O
knockdown	O
of	O
LIMK1	O
destabilizes	O
whereas	O
knockdown	O
of	O
SSH	O
-	O
1L	O
stabilizes	O
the	O
actin	B-ANAT
filaments	I-ANAT
through	O
modulation	O
of	O
cofilin	O
phosphorylation	O
;	O
however	O
,	O
in	O
either	O
case	O
thrombin	O
-	O
induced	O
NF	O
-	O
ÎºB	O
activity	O
and	O
expression	O
of	O
its	O
target	O
genes	O
(	O
ICAM	O
-	O
1	O
and	O
VCAM	O
-	O
1	O
)	O
is	O
inhibited	O
.	O

To	O
measure	O
antibodies	O
to	O
the	O
spike	O
(	O
S	O
)	O
protein	O
of	O
the	O
four	O
common	O
non	O
-	O
SARS	O
HCoVs	O
,	O
recombinant	O
S	O
proteins	O
of	O
the	O
four	O
HCoVs	O
were	O
expressed	O
and	O
characterised	O
in	O
293	O
T	B-ANAT
cell	I-ANAT
.	O

While	O
the	O
M41	O
spike	O
ectodomain	O
showed	O
increased	O
attachment	O
to	O
both	O
CAM	B-ANAT
and	O
chicken	O
trachea	B-ANAT
,	O
no	O
binding	O
to	O
mammalian	O
cells	B-ANAT
was	O
observed	O
.	O

In	O
contrast	O
,	O
Beaudette	O
spike	O
ectodomain	O
had	O
relatively	O
weak	O
ability	O
to	O
bind	O
to	O
chicken	O
trachea	B-ANAT
,	O
but	O
displayed	O
marked	O
extended	O
host	O
range	O
to	O
mammalian	O
cells	B-ANAT
.	O

The	O
following	O
characteristics	O
(	O
or	O
predictors	O
)	O
were	O
compared	O
between	O
the	O
groups	O
:	O
age	O
,	O
sex	O
,	O
calculated	O
amount	O
of	O
glufosinate	O
(	O
volume	O
of	O
ingested	O
poison	O
(	O
glufosinate	O
-	O
containing	O
herbicide	O
)	O
Ã	O
glufosinate	O
concentration	O
of	O
the	O
product	O
),	O
time	O
duration	O
from	O
poison	O
ingestion	O
to	O
arrival	O
at	O
our	O
hospital	O
,	O
use	O
of	O
gastric	B-ANAT
lavage	O
,	O
use	O
of	O
whole	O
bowel	B-ANAT
irrigation	O
,	O
Glasgow	O
Coma	O
Scale	O
,	O
laboratory	O
parameters	O
,	O
PaOâ	O
/	O
FiOâ	O
ratio	O
(	O
P	O
/	O
F	O
ratio	O
),	O
shock	O
index	O
,	O
and	O
presence	O
or	O
absence	O
of	O
systemic	O
inflammatory	O
response	O
syndrome	O
(	O
SIRS	O
)	O
on	O
arrival	O
.	O

It	O
is	O
apparent	O
from	O
the	O
recent	O
experiences	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
pandemic	O
(	O
H1N1	O
)	O
2009	O
influenza	O
that	O
healthcare	O
workers	O
may	O
have	O
difficulty	O
in	O
choosing	O
the	O
correct	O
type	O
of	O
facial	B-ANAT
and	O
respiratory	O
protection	O
in	O
any	O
given	O
clinical	O
situation	O
.	O

TITLE	O
:	O
Pathogenic	O
mouse	O
hepatitis	O
virus	O
or	O
poly	O
(	O
I	O
:	O
C	O
)	O
induce	O
IL	O
-	O
33	O
in	O
hepatocytes	B-ANAT
in	O
murine	O
models	O
of	O
hepatitis	O
.	O

Here	O
,	O
we	O
detail	O
the	O
genes	O
and	O
pathways	O
associated	O
with	O
MHV	O
-	O
induced	O
demyelinating	O
disease	O
in	O
the	O
spinal	B-ANAT
cord	I-ANAT
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
causes	O
transient	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
in	O
rhesus	O
macaques	O
.	O

Clinical	O
signs	O
,	O
virus	O
shedding	O
,	O
virus	O
replication	O
in	O
respiratory	O
tissues	B-ANAT
,	O
gene	O
expression	O
,	O
and	O
cytokine	O
and	O
chemokine	O
profiles	O
peaked	O
early	O
in	O
infection	O
and	O
decreased	O
over	O
time	O
.	O

RESULTS	O
:	O
The	O
low	O
vitamin	O
A	O
diet	O
reduced	O
serum	B-ANAT
retinol	O
concentrations	O
between	O
days	O
112	O
and	O
140	O
.	O

TITLE	O
:	O
A	O
rare	O
cause	O
of	O
dyspnea	O
in	O
emergency	O
medicine	O
:	O
transfusion	O
-	O
related	O
acute	O
lung	B-ANAT
injury	O
.	O

A	O
78	O
year	O
old	O
female	O
patient	O
with	O
history	O
of	O
myelodysplastic	O
syndrome	O
,	O
coronary	B-ANAT
artey	O
disease	O
and	O
hypertansion	O
,	O
was	O
admitted	O
to	O
the	O
hospital	O
because	O
of	O
dyspnea	O
after	O
the	O
blood	B-ANAT
transfusion	O
.	O

Immunohistochemical	O
testing	O
of	O
biopsy	O
specimens	O
and	O
postmortem	O
examination	O
are	O
the	O
standard	O
diagnostic	O
methods	O
,	O
although	O
direct	O
immunofluorescence	O
(	O
DIF	O
)	O
testing	O
to	O
detect	O
feline	O
coronavirus	O
in	O
macrophages	B-ANAT
in	O
effusion	B-ANAT
specimens	O
has	O
been	O
reported	O
to	O
have	O
100	O
%	O
specificity	O
and	O
has	O
been	O
recommended	O
as	O
an	O
antemortem	O
confirmatory	O
test	O
.	O

The	O
cat	O
had	O
tracheal	O
resection	O
and	O
subsequently	O
developed	O
laryngeal	B-ANAT
paralysis	O
.	O

ABSTRACT	O
:	O
Multiple	O
sclerosis	O
(	O
MS	O
)	O
is	O
an	O
inflammatory	O
demyelinating	O
disease	O
of	O
the	O
human	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
).	O

Infiltrating	O
cells	B-ANAT
were	O
phenotypically	O
CD11b	O
(	O
hi	O
),	O
F4	O
/	O
80	O
(	O
lo	O
).	O

Inflammation	O
was	O
primarily	O
restricted	O
to	O
the	O
bronchioles	B-ANAT
and	O
perivascular	O
interstitium	B-ANAT
with	O
minimal	O
spread	O
to	O
alveoli	B-ANAT
.	O

This	O
study	O
evaluates	O
the	O
feasibility	O
of	O
intrapleural	B-ANAT
steroid	O
instillation	O
(	O
IPSI	O
)	O
in	O
patients	O
with	O
ARDS	O
and	O
MODS	O
unresponsive	O
to	O
conventional	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
).	O

TITLE	O
:	O
Inhaled	O
nitric	O
oxide	O
for	O
the	O
treatment	O
of	O
pulmonary	B-ANAT
arterial	B-ANAT
hypertension	O
.	O

In	O
this	O
study	O
we	O
investigated	O
the	O
effects	O
of	O
TGEV	O
infection	O
on	O
the	O
cell	B-ANAT
cycle	O
of	O
host	O
cells	B-ANAT
and	O
the	O
roles	O
of	O
p53	O
activation	O
in	O
this	O
process	O
.	O

Pharyngeal	B-ANAT
swabs	O
were	O
performed	O
at	O
the	O
first	O
visit	O
and	O
if	O
new	O
symptoms	O
were	O
present	O
.	O

Here	O
we	O
report	O
that	O
transfection	O
of	O
Sf9	O
cells	B-ANAT
with	O
a	O
single	O
recombinant	O
baculovirus	O
encoding	O
M	O
and	O
S	O
proteins	O
resulted	O
in	O
the	O
assembly	O
of	O
IBV	O
VLPs	B-ANAT
;	O
this	O
is	O
the	O
first	O
report	O
that	O
S	O
protein	O
plus	O
M	O
protein	O
alone	O
were	O
able	O
to	O
be	O
assembled	O
into	O
VLPs	B-ANAT
for	O
coronaviruses	O
.	O

We	O
further	O
showed	O
that	O
the	O
generated	O
IBV	O
VLPs	B-ANAT
could	O
induce	O
humoral	O
immune	O
responses	O
in	O
a	O
level	O
comparable	O
to	O
that	O
of	O
inactivated	O
IBV	O
vaccine	O
,	O
and	O
more	O
importantly	O
the	O
IBV	O
VLPs	B-ANAT
could	O
elicit	O
significantly	O
higher	O
cellular	B-ANAT
immune	O
responses	O
than	O
the	O
inactivated	O
IBV	O
vaccine	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
frequency	O
of	O
respiratory	O
viruses	O
responsible	O
for	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
in	O
Turkish	O
children	O
during	O
the	O
2011	O
-	O
2012	O
influenza	O
season	O
.	O

ABSTRACT	O
:	O
Dedicator	O
of	O
cytokinesis	O
8	O
(	O
DOCK8	O
)	O
deficiency	O
is	O
an	O
autosomal	B-ANAT
recessive	O
type	O
of	O
combined	O
immunodeficiency	O
with	O
elevated	O
IgE	O
.	O
In	O
this	O
report	O
,	O
we	O
describe	O
a	O
Japanese	O
girl	O
of	O
non	O
-	O
consanguineous	O
family	O
suffering	O
from	O
acute	O
eosinophilic	O
pneumonia	O
(	O
AEP	O
)	O
as	O
a	O
presenting	O
feature	O
of	O
DOCK8	O
deficiency	O
.	O

TITLE	O
:	O
Development	O
of	O
an	O
infection	O
screening	O
system	O
for	O
entry	O
inspection	O
at	O
airport	O
quarantine	O
stations	O
using	O
ear	B-ANAT
temperature	O
,	O
heart	B-ANAT
and	O
respiration	O
rates	O
.	O

Then	O
,	O
female	O
BALB	O
/	O
c	O
mice	O
were	O
immunized	O
with	O
the	O
purified	O
recombinant	O
S1	O
protein	O
(	O
rS1	O
),	O
and	O
a	O
monoclonal	O
antibody	O
(	O
MAb	O
designated	O
as	O
5E12	O
)	O
against	O
the	O
rS1	O
protein	O
was	O
achieved	O
by	O
hybridoma	B-ANAT
technique	O
.	O

Only	O
little	O
information	O
on	O
the	O
influence	O
of	O
sample	O
storage	B-ANAT
and	O
reaction	O
conditions	O
on	O
test	O
results	O
is	O
available	O
,	O
and	O
diagnostic	O
sensitivity	O
and	O
specificity	O
to	O
diagnose	O
FIP	O
vary	O
considerably	O
between	O
few	O
available	O
studies	O
.	O

This	O
study	O
determined	O
the	O
influence	O
of	O
storage	B-ANAT
of	O
effusion	B-ANAT
,	O
modifications	O
on	O
reaction	O
conditions	O
,	O
and	O
inter	O
-	O
observer	O
variation	O
.	O

Even	O
after	O
storage	B-ANAT
for	O
21	O
days	O
,	O
test	O
results	O
were	O
comparable	O
.	O

The	O
Rivalta	O
'	O
s	O
test	O
seems	O
to	O
be	O
a	O
very	O
robust	O
test	O
concerning	O
storage	B-ANAT
conditions	O
.	O

Two	O
patients	O
survived	O
to	O
hospital	O
-	O
discharge	B-ANAT
(	O
duration	O
of	O
ECMO	O
support	O
:	O
8	O
.	O
5	O
days	O
)	O
and	O
one	O
patient	O
died	O
from	O
nosocomial	O
sepsis	O
and	O
multi	O
-	O
organ	B-ANAT
failure	O
after	O
40	O
days	O
of	O
ECMO	O
support	O
.	O

ECMO	O
support	O
allowed	O
adequate	O
oxygenation	O
and	O
correction	O
of	O
hypercapnia	O
under	O
lung	B-ANAT
protective	O
ventilation	O
,	O
therefore	O
reducing	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

Histological	O
lesions	O
in	O
small	B-ANAT
intestine	I-ANAT
sections	O
of	O
affected	O
pigs	O
and	O
the	O
complete	O
genomic	O
sequences	O
of	O
three	O
emergent	O
strains	O
of	O
PEDV	O
isolated	O
from	O
outbreaks	O
in	O
Minnesota	O
and	O
Iowa	O
were	O
characterized	O
.	O

TITLE	O
:	O
Brain	B-ANAT
stem	I-ANAT
serotonin	O
protects	O
blood	B-ANAT
pressure	O
in	O
neonatal	O
rats	O
exposed	O
to	O
episodic	O
anoxia	O
.	O

We	O
analyzed	O
BALF	O
samples	O
from	O
preterm	O
babies	O
,	O
born	O
at	O
different	O
stages	O
of	O
lung	B-ANAT
development	O
.	O

Pulmonary	B-ANAT
biomarkers	O
are	O
needed	O
to	O
predict	O
the	O
clinical	O
course	O
of	O
lung	B-ANAT
disease	O
,	O
status	O
,	O
progression	O
and	O
response	O
to	O
treatment	O
.	O

ABSTRACT	O
:	O
Although	O
intra	O
-	O
abdominal	B-ANAT
hypertension	O
(	O
IAH	O
)	O
and	O
abdominal	B-ANAT
compartment	I-ANAT
syndrome	O
(	O
ACS	O
)	O
are	O
associated	O
with	O
substantial	O
morbidity	O
and	O
mortality	O
among	O
critically	O
ill	O
adults	O
,	O
it	O
remains	O
unknown	O
if	O
prevention	O
or	O
treatment	O
of	O
these	O
conditions	O
improves	O
patient	O
outcomes	O
.	O

GRFT	O
displays	O
no	O
human	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
mitogenic	O
activity	O
and	O
does	O
not	O
induce	O
production	O
of	O
proinflammatory	O
cytokines	O
in	O
treated	O
human	O
cell	B-ANAT
lines	I-ANAT
.	O

Here	O
we	O
describe	O
a	O
detailed	O
study	O
of	O
the	O
membrane	B-ANAT
rearrangements	O
induced	O
by	O
the	O
avian	O
gammacoronavirus	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
in	O
a	O
mammalian	B-ANAT
cell	I-ANAT
line	O
but	O
also	O
in	O
primary	O
avian	O
cells	B-ANAT
and	O
in	O
epithelial	B-ANAT
cells	I-ANAT
of	O
ex	O
vivo	O
tracheal	O
organ	B-ANAT
cultures	O
.	O

Absence	O
of	O
left	O
atrial	B-ANAT
pressure	O
elevation	O
was	O
based	O
on	O
combined	O
hemodynamic	O
and	O
echocardiographic	O
assessment	O
.	O

CD4	O
âº	O
and	O
CD8	O
âº	O
T	B-ANAT
cells	I-ANAT
are	O
essential	O
to	O
control	O
infectious	O
virus	O
but	O
at	O
the	O
cost	O
of	O
tissue	B-ANAT
damage	O
.	O

An	O
enigma	O
in	O
understanding	O
the	O
contribution	O
of	O
T	B-ANAT
cell	I-ANAT
subsets	I-ANAT
in	O
pathogenesis	O
resides	O
in	O
their	O
distinct	O
migration	O
pattern	O
across	O
the	O
BBB	B-ANAT
(	O
blood	B-ANAT
brain	I-ANAT
barrier	I-ANAT
).	O

Whereas	O
virus	O
control	O
was	O
not	O
affected	O
by	O
perivascular	O
retention	O
of	O
CD4	O
âº	O
T	B-ANAT
cells	I-ANAT
,	O
disease	O
severity	O
was	O
decreased	O
and	O
associated	O
with	O
reduced	O
IFNÎ³	O
(	O
interferon	O
Î³	O
)	O
production	O
.	O

A	O
panel	O
that	O
included	O
11	O
biomarkers	O
of	O
inflammation	O
,	O
fibroblast	B-ANAT
activation	O
,	O
proteolytic	O
injury	O
,	O
endothelial	B-ANAT
injury	O
,	O
and	O
lung	B-ANAT
epithelial	O
injury	O
was	O
measured	O
in	O
plasma	B-ANAT
from	O
the	O
morning	O
of	O
ICU	O
day	O
two	O
.	O

Using	O
the	O
five	O
best	O
-	O
performing	O
biomarkers	O
(	O
surfactant	O
protein	O
-	O
D	O
(	O
SP	O
-	O
D	O
),	O
receptor	O
for	O
advanced	O
glycation	O
end	O
-	O
products	O
(	O
RAGE	O
),	O
interleukin	O
-	O
8	O
(	O
IL	O
-	O
8	O
),	O
club	O
cell	B-ANAT
secretory	O
protein	O
(	O
CC	O
-	O
16	O
),	O
and	O
interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
))	O
the	O
area	O
under	O
the	O
receiver	O
operator	O
characteristic	O
curve	O
(	O
AUC	O
)	O
was	O
0	O
.	O
75	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
7	O
to	O
0	O
.	O
84	O
)	O
for	O
the	O
diagnosis	O
of	O
ARDS	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
whether	O
BNP	O
and	O
RVEDVI	O
are	O
clinically	O
valuable	O
parameters	O
that	O
can	O
distinguish	O
among	O
hypovolemia	O
,	O
euvolemia	O
,	O
and	O
hypervolemia	O
,	O
as	O
measured	O
by	O
blood	B-ANAT
volume	O
(	O
BV	O
)	O
analysis	O
in	O
critically	O
ill	O
surgical	O
subjects	O
.	O

Twenty	O
-	O
seven	O
hospitalised	O
patients	O
with	O
PUUV	O
-	O
infection	O
were	O
examined	O
with	O
lung	B-ANAT
function	O
tests	O
,	O
chest	B-ANAT
high	O
-	O
resolution	O
CT	O
(	O
HRCT	O
),	O
echocardiography	O
including	O
speckle	O
tracking	O
strain	O
rate	O
analysis	O
,	O
ECG	O
and	O
measurements	O
of	O
cardiac	B-ANAT
biomarkers	O
N	O
-	O
terminal	O
pro	O
-	O
B	O
-	O
type	O
natriuretic	O
peptide	O
(	O
NT	O
-	O
ProBNP	O
)	O
and	O
troponin	O
T	O
.	O
Patients	O
were	O
re	O
-	O
evaluated	O
after	O
3	O
months	O
.	O

HRCT	O
showed	O
thoracic	B-ANAT
effusions	O
or	O
pulmonary	B-ANAT
oedema	O
in	O
46	O
%	O
of	O
the	O
patients	O
.	O

Because	O
bronchiolar	B-ANAT
obstruction	O
from	O
inflammatory	O
,	O
mucous	B-ANAT
,	O
and	O
airway	B-ANAT
epithelial	O
debris	O
can	O
be	O
seen	O
in	O
severe	O
pertussis	O
,	O
a	O
regimen	O
of	O
repeated	O
therapeutic	O
bronchoscopy	O
was	O
initiated	O
,	O
and	O
thick	O
,	O
inspissated	O
secretions	B-ANAT
were	O
retrieved	O
.	O

TITLE	O
:	O
Transcriptome	O
analysis	O
of	O
chicken	O
kidney	B-ANAT
tissues	B-ANAT
following	O
coronavirus	O
avian	O
infectious	O
bronchitis	O
virus	O
infection	O
.	O

The	O
lung	B-ANAT
may	O
have	O
unexpected	O
regenerative	O
capacity	O
with	O
native	O
lung	B-ANAT
recovery	O
after	O
prolonged	O
mechanical	O
support	O
,	O
similar	O
to	O
acute	O
kidney	B-ANAT
injury	O
and	O
native	O
renal	B-ANAT
recovery	O
.	O

Diverse	O
SARS	O
-	O
like	O
coronaviruses	O
(	O
SL	O
-	O
CoVs	O
)	O
have	O
now	O
been	O
reported	O
from	O
bats	O
in	O
China	O
,	O
Europe	O
and	O
Africa	O
,	O
but	O
none	O
is	O
considered	O
a	O
direct	O
progenitor	O
of	O
SARS	O
-	O
CoV	O
because	O
of	O
their	O
phylogenetic	O
disparity	O
from	O
this	O
virus	O
and	O
the	O
inability	O
of	O
their	O
spike	O
proteins	O
to	O
use	O
the	O
SARS	O
-	O
CoV	O
cellular	B-ANAT
receptor	O
molecule	O
,	O
the	O
human	O
angiotensin	O
converting	O
enzyme	O
II	O
(	O
ACE2	O
).	O

Both	O
,	O
viral	O
and	O
cellular	B-ANAT
factors	O
cooperatively	O
generate	O
distinct	O
organelle	B-ANAT
-	O
like	O
structures	O
,	O
designated	O
viral	O
replication	O
factories	O
.	O

This	O
compartmentalization	O
allows	O
coordination	O
of	O
the	O
different	O
steps	O
of	O
the	O
viral	O
replication	O
cycle	O
,	O
highly	O
efficient	O
genome	O
replication	O
and	O
protection	O
of	O
the	O
viral	O
RNA	O
from	O
cellular	B-ANAT
defense	O
mechanisms	O
.	O

CSF	B-ANAT
acidosis	O
also	O
develops	O
during	O
respiratory	O
failure	O
due	O
to	O
brainstem	B-ANAT
or	O
high	O
cervical	B-ANAT
spinal	I-ANAT
cord	I-ANAT
lesions	O
,	O
the	O
most	O
common	O
cause	O
of	O
death	O
in	O
NMO	O
.	O

We	O
aimed	O
to	O
determine	O
which	O
bedside	O
method	O
would	O
provide	O
positive	O
end	O
-	O
expiratory	O
pressure	O
better	O
related	O
to	O
lung	B-ANAT
recruitability	O
.	O

When	O
patients	O
were	O
classified	O
according	O
to	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
Berlin	O
definition	O
,	O
the	O
lung	B-ANAT
open	O
ventilation	O
method	O
was	O
the	O
only	O
one	O
which	O
gave	O
lower	O
positive	O
end	O
-	O
expiratory	O
pressure	O
levels	O
in	O
mild	O
and	O
moderate	O
acute	O
respiratory	O
distress	O
syndrome	O
compared	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
8	O
Â±	O
2	O
and	O
11	O
Â±	O
3	O
cm	O
H2O	O
vs	O
15	O
Â±	O
3	O
cm	O
H2O	O
;	O
p	O
<	O
0	O
.	O
05	O
),	O
whereas	O
ExPress	O
,	O
stress	O
index	O
,	O
and	O
esophageal	O
pressure	O
methods	O
gave	O
similar	O
positive	O
end	O
-	O
expiratory	O
pressure	O
values	O
in	O
mild	O
,	O
moderate	O
,	O
and	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
patient	O
was	O
in	O
a	O
fair	O
condition	O
during	O
30	O
hours	O
of	O
hospitalization	O
until	O
he	O
suddenly	O
developed	O
respiratory	O
distress	O
and	O
unfortunately	O
died	O
with	O
cardiopulmonary	B-ANAT
arrest	O
.	O

The	O
deceased	O
body	B-ANAT
referred	O
to	O
our	O
legal	O
medicine	O
center	O
for	O
determining	O
cause	O
of	O
death	O
and	O
investigating	O
possible	O
medical	O
staff	O
malpractices	O
.	O

The	O
committee	O
determined	O
the	O
most	O
probable	O
cause	O
of	O
death	O
as	O
acute	O
cardiopulmonary	B-ANAT
complications	O
induced	O
by	O
colchicine	O
poisoning	O
and	O
the	O
manner	O
of	O
death	O
as	O
accidental	O
.	O

Here	O
we	O
describe	O
two	O
PEDV	O
isolates	O
(	O
ISU13	O
-	O
19338E	O
and	O
ISU13	O
-	O
22038	O
)	O
successfully	O
obtained	O
from	O
the	O
small	B-ANAT
intestines	I-ANAT
of	O
piglets	O
from	O
sow	O
farms	O
in	O
Indiana	O
and	O
Iowa	O
,	O
respectively	O
.	O

Here	O
,	O
we	O
show	O
that	O
absence	O
of	O
the	O
E	O
protein	O
resulted	O
in	O
reduced	O
expression	O
of	O
proinflammatory	O
cytokines	O
,	O
decreased	O
numbers	O
of	O
neutrophils	B-ANAT
in	O
lung	B-ANAT
infiltrates	O
,	O
diminished	O
lung	B-ANAT
pathology	O
,	O
and	O
increased	O
mouse	O
survival	O
,	O
suggesting	O
that	O
lung	B-ANAT
inflammation	O
contributed	O
to	O
SARS	O
-	O
CoV	O
virulence	O
.	O

Multivariable	O
logistic	O
regression	O
analysis	O
was	O
performed	O
to	O
examine	O
the	O
relationship	O
between	O
maternal	O
age	O
,	O
race	O
,	O
and	O
relevant	O
clinical	O
variables	O
and	O
the	O
risk	O
of	O
massive	O
blood	B-ANAT
transfusion	O
defined	O
as	O
10	O
or	O
more	O
units	O
of	O
blood	B-ANAT
recorded	O
.	O

The	O
most	O
common	O
etiologies	O
of	O
massive	O
blood	B-ANAT
transfusion	O
were	O
abnormal	O
placentation	O
(	O
26	O
.	O
6	O
%	O
of	O
cases	O
),	O
uterine	B-ANAT
atony	O
(	O
21	O
.	O
2	O
%),	O
placental	B-ANAT
abruption	O
(	O
16	O
.	O
7	O
%),	O
and	O
postpartum	O
hemorrhage	O
associated	O
with	O
coagulopathy	O
(	O
15	O
.	O
0	O
%).	O

The	O
majority	O
of	O
the	O
genes	O
that	O
were	O
significantly	O
regulated	O
,	O
were	O
those	O
associated	O
with	O
monocytes	B-ANAT
-	O
macrophage	B-ANAT
and	O
Th1	B-ANAT
cell	I-ANAT
functions	O
,	O
and	O
the	O
regulation	O
of	O
apoptosis	O
.	O

TITLE	O
:	O
Role	O
of	O
CD25	O
(+)	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
in	O
acute	O
and	O
persistent	O
coronavirus	O
infection	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
.	O

Treg	O
in	O
the	O
CNS	B-ANAT
were	O
highest	O
during	O
initial	O
T	B-ANAT
cell	I-ANAT
mediated	O
virus	O
control	O
,	O
decreased	O
and	O
then	O
remained	O
relatively	O
stable	O
during	O
persistence	O
.	O

Many	O
patients	O
also	O
receive	O
invasive	O
mechanical	O
ventilation	O
for	O
support	O
for	O
oxygenation	O
,	O
while	O
in	O
resource	O
-	O
poor	O
settings	O
,	O
supplemental	O
oxygen	O
via	O
face	B-ANAT
mask	O
may	O
be	O
the	O
only	O
available	O
intervention	O
.	O

Recent	O
studies	O
have	O
provided	O
encouraging	O
results	O
in	O
treating	O
respiratory	O
syncytial	O
virus	O
infections	O
in	O
lung	B-ANAT
transplant	B-ANAT
recipients	O
,	O
serious	O
parainfluenza	O
virus	O
and	O
adenovirus	O
infections	O
in	O
immunocompromised	O
hosts	O
,	O
and	O
rhinovirus	O
colds	O
in	O
outpatient	O
asthmatics	O
.	O

It	O
usually	O
causes	O
acute	O
and	O
occasionally	O
chronic	O
pneumonias	O
with	O
disseminated	O
infection	O
,	O
particularly	O
skin	B-ANAT
lesion	O
,	O
as	O
an	O
extrapulmonary	O
manifestation	O
.	O

To	O
our	O
knowledge	O
,	O
there	O
are	O
only	O
four	O
reported	O
cases	O
of	O
cardiac	B-ANAT
blastomycosis	O
in	O
the	O
literature	O
.	O

In	O
our	O
patient	O
,	O
it	O
was	O
practically	O
impossible	O
to	O
establish	O
a	O
diagnosis	O
of	O
cardiac	B-ANAT
blastomycosis	O
antemortem	O
because	O
of	O
his	O
previous	O
cardiac	B-ANAT
history	O
related	O
to	O
alcoholic	O
cardiomyopathy	O
,	O
which	O
confounded	O
the	O
cardiac	B-ANAT
findings	O
.	O

Their	O
genome	O
size	O
is	O
about	O
32	O
,	O
000	O
nucleotides	O
,	O
the	O
largest	O
among	O
all	O
CoVs	O
,	O
as	O
a	O
result	O
of	O
multiple	O
unique	O
open	O
reading	O
frames	O
(	O
NS5a	O
,	O
NS5b	O
,	O
NS5c	O
,	O
NS6	O
,	O
NS7	O
,	O
NS8	O
,	O
NS9	O
,	O
and	O
NS10	O
)	O
between	O
their	O
membrane	B-ANAT
(	O
M	O
)	O
and	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
genes	O
.	O

TITLE	O
:	O
Acute	O
onset	O
Lance	O
-	O
Adams	O
syndrome	O
following	O
brief	O
exposure	O
to	O
severe	O
hypoxia	O
without	O
cardiac	B-ANAT
arrest	O
-	O
a	O
case	O
report	O
-.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
a	O
severe	O
form	O
of	O
lung	B-ANAT
injury	O
that	O
frequently	O
occurs	O
during	O
pneumonia	O
and	O
sepsis	O
.	O

All	O
of	O
these	O
effects	O
were	O
associated	O
with	O
strong	O
expression	O
of	O
PARP	O
and	O
NF	O
-	O
ÎºB	O
.	O
Treatment	O
with	O
3	O
-	O
AB	O
prevented	O
the	O
LPS	O
-	O
induced	O
metabolic	O
acidosis	O
and	O
hypotension	O
,	O
reduced	O
the	O
plasma	B-ANAT
levels	O
of	O
lactate	O
,	O
creatinine	O
and	O
potassium	O
,	O
reduced	O
the	O
cytokine	O
mRNA	O
expressions	O
,	O
reduced	O
the	O
expression	O
of	O
PARP	O
and	O
NF	O
-	O
ÎºB	O
,	O
improved	O
pulmonary	B-ANAT
edema	O
and	O
oxygenation	O
and	O
preserved	O
renal	B-ANAT
function	O
.	O

All	O
of	O
these	O
effects	O
were	O
associated	O
with	O
strong	O
expression	O
of	O
PARP	O
and	O
NF	O
-	O
ÎºB	O
.	O
Treatment	O
with	O
3	O
-	O
AB	O
prevented	O
the	O
LPS	O
-	O
induced	O
metabolic	O
acidosis	O
and	O
hypotension	O
,	O
reduced	O
the	O
plasma	B-ANAT
levels	O
of	O
lactate	O
,	O
creatinine	O
and	O
potassium	O
,	O
reduced	O
the	O
cytokine	O
mRNA	O
expressions	O
,	O
reduced	O
the	O
expression	O
of	O
PARP	O
and	O
NF	O
-	O
ÎºB	O
,	O
improved	O
pulmonary	B-ANAT
edema	O
and	O
oxygenation	O
and	O
preserved	O
renal	B-ANAT
function	O
.	O

TITLE	O
:	O
Apnea	O
testing	O
for	O
brain	B-ANAT
death	O
in	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
a	O
possible	O
solution	O
.	O

ABSTRACT	O
:	O
A	O
42	O
-	O
year	O
-	O
old	O
man	O
with	O
a	O
subarachnoid	O
hemorrhage	O
complicated	O
by	O
anoxic	O
brain	B-ANAT
injury	O
,	O
respiratory	O
failure	O
requiring	O
mechanical	O
ventilation	O
,	O
and	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
presented	O
a	O
clinical	O
conundrum	O
for	O
safe	O
apnea	O
testing	O
in	O
brain	B-ANAT
death	O
determination	O
due	O
to	O
profound	O
hypoxemia	O
.	O

ABSTRACT	O
:	O
AlphaCoV	O
and	O
lineage	O
C	O
betaCoV	O
,	O
genetically	O
similar	O
to	O
those	O
identified	O
in	O
Spanish	O
related	O
bat	O
species	O
,	O
have	O
been	O
detected	O
in	O
Italian	O
Myotis	O
blithii	O
and	O
Eptesicus	O
serotinus	O
,	O
respectively	O
,	O
out	O
of	O
75	O
anal	B-ANAT
swabs	O
collected	O
from	O
Vespertilionidae	O
between	O
2009	O
and	O
2012	O
.	O

TITLE	O
:	O
Prone	O
positioning	O
during	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
adults	O
.	O

TITLE	O
:	O
Lung	B-ANAT
inhomogeneity	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

We	O
defined	O
as	O
the	O
extent	O
of	O
lung	B-ANAT
inhomogeneities	O
the	O
fraction	O
of	O
the	O
lung	B-ANAT
showing	O
an	O
inflation	O
ratio	O
greater	O
than	O
95th	O
percentile	O
of	O
the	O
control	O
group	O
(	O
1	O
.	O
61	O
).	O

TITLE	O
:	O
[	O
The	O
Proteus	O
syndrome	O
:	O
a	O
rare	O
cause	O
of	O
pulmonary	B-ANAT
emphysema	O
].	O

Prominent	O
among	O
them	O
is	O
the	O
effect	O
that	O
the	O
disease	O
has	O
on	O
lung	B-ANAT
growth	O
and	O
function	O
.	O

The	O
following	O
article	O
reviews	O
the	O
current	O
knowledge	O
on	O
the	O
effects	O
of	O
SCD	O
on	O
lung	B-ANAT
growth	O
and	O
function	O
.	O

TITLE	O
:	O
Cell	B-ANAT
-	O
based	O
antiviral	O
screening	O
against	O
coronaviruses	O
:	O
developing	O
virus	O
-	O
specific	O
and	O
broad	O
-	O
spectrum	O
inhibitors	O
.	O

An	O
important	O
step	O
in	O
antiviral	O
drug	O
development	O
is	O
the	O
screening	O
of	O
potential	O
inhibitors	O
in	O
cell	B-ANAT
-	O
based	O
systems	O
.	O

Using	O
this	O
model	O
,	O
MERS	O
-	O
CoV	O
is	O
placed	O
into	O
disorder	O
group	O
C	O
,	O
which	O
consists	O
of	O
coronaviruses	O
that	O
have	O
relatively	O
hard	O
inner	O
and	O
outer	O
shells	B-ANAT
.	O

Clinical	O
presentation	O
ranges	O
from	O
asymptomatic	O
to	O
severe	O
pneumonia	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
multi	O
-	O
organ	B-ANAT
failure	O
.	O

Furthermore	O
,	O
miR	O
-	O
146a	O
delivery	O
or	O
Akt2	O
silencing	O
in	O
WT	O
mice	O
exposed	O
to	O
acid	O
resulted	O
in	O
suppression	O
of	O
iNOS	O
in	O
alveolar	B-ANAT
macrophages	I-ANAT
.	O

TITLE	O
:	O
Pulmonary	B-ANAT
sequelae	O
of	O
severe	O
H1N1	O
infection	O
treated	O
with	O
high	O
frequency	O
oscillatory	O
ventilation	O
.	O

Post	O
-	O
inflammatory	O
changes	O
on	O
CT	O
thorax	B-ANAT
at	O
6	O
months	O
were	O
seen	O
in	O
all	O
4	O
cases	O
.	O

Chickens	O
immunized	O
with	O
the	O
IBV	O
K40	O
/	O
09	O
strain	O
showed	O
significantly	O
high	O
levels	O
of	O
protection	O
against	O
all	O
challenge	O
viruses	O
at	O
the	O
trachea	B-ANAT
and	O
kidney	B-ANAT
levels	O
.	O

Furthermore	O
,	O
we	O
show	O
that	O
strategies	O
aimed	O
at	O
either	O
enhancing	O
ATP	O
catabolism	O
(	O
ip	O
ecto	O
-	O
5	O
'-	O
nucleotidase	O
administration	O
)	O
or	O
inhibiting	O
glycolytic	O
ATP	O
production	O
(	O
ip	O
2	O
-	O
deoxy	O
-	O
d	O
-	O
glucose	O
treatment	O
)	O
reduce	O
extracellular	B-ANAT
ATP	O
accumulation	O
,	O
limit	O
vascular	B-ANAT
leakage	O
,	O
and	O
effectively	O
block	O
the	O
late	O
,	O
but	O
not	O
the	O
early	O
,	O
stages	O
of	O
neutrophil	B-ANAT
recruitment	O
to	O
the	O
lung	B-ANAT
after	O
LPS	O
instillation	O
.	O

Protection	O
studies	O
showed	O
that	O
vaccination	O
with	O
rBeau	O
-	O
H120	O
(	O
S1e	O
)	O
at	O
7	O
-	O
day	O
after	O
hatch	O
provided	O
80	O
%	O
rate	O
of	O
immune	O
protection	O
against	O
challenge	O
with	O
10	O
(	O
3	O
)	O
50	O
%	O
embryos	B-ANAT
infection	O
dose	O
of	O
the	O
virulent	O
IBV	O
M41	O
strain	O
.	O

ABSTRACT	O
:	O
Trafficking	O
of	O
proteins	O
and	O
RNA	O
into	O
and	O
out	O
of	O
the	O
nucleus	B-ANAT
occurs	O
through	O
the	O
nuclear	B-ANAT
pore	I-ANAT
complex	O
(	O
NPC	B-ANAT
).	O

Because	O
of	O
its	O
critical	O
function	O
in	O
many	O
cellular	B-ANAT
processes	O
,	O
the	O
NPC	B-ANAT
and	O
transport	O
factors	O
are	O
common	O
targets	O
of	O
several	O
viruses	O
that	O
disrupt	O
key	O
constituents	O
of	O
the	O
machinery	O
to	O
facilitate	O
viral	O
replication	O
.	O

While	O
the	O
criteria	O
for	O
diagnosis	O
have	O
evolved	O
since	O
the	O
first	O
description	O
in	O
1967	O
,	O
the	O
characteristics	O
of	O
hypoxemia	O
,	O
tachypnea	O
,	O
rapidly	O
progressing	O
acute	O
respiratory	O
failure	O
,	O
and	O
poor	O
lung	B-ANAT
compliance	O
continue	O
.	O

Sepsis	O
-	O
related	O
ARDS	O
has	O
a	O
generally	O
higher	O
disease	O
severity	O
and	O
poorer	O
recovery	O
period	O
from	O
lung	B-ANAT
injury	O
with	O
an	O
increased	O
mortality	O
rate	O
.	O

RESULTS	O
:	O
Of	O
6069	O
patients	O
who	O
underwent	O
cardiac	B-ANAT
surgery	O
during	O
the	O
study	O
period	O
,	O
37	O
patients	O
developed	O
ARDS	O
during	O
the	O
postoperative	O
period	O
.	O

The	O
serum	B-ANAT
MMP	O
-	O
9	O
was	O
positively	O
correlated	O
with	O
the	O
APACHE	O
II	O
score	O
on	O
the	O
1st	O
day	O
(	O
r	O
=	O
0	O
.	O
430	O
,	O
P	O
=	O
0	O
.	O
01	O
).	O

Moreover	O
,	O
Flt3L	O
vectors	O
more	O
efficiently	O
induced	O
tumor	O
-	O
specific	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
,	O
expanded	O
the	O
epitope	O
repertoire	O
,	O
and	O
provided	O
both	O
prophylactic	O
and	O
therapeutic	O
tumor	O
immunity	O
.	O

The	O
new	O
definition	O
of	O
ARDS	O
(	O
Berlin	O
definition	O
)	O
addresses	O
clinicians	O
to	O
the	O
best	O
treatment	O
options	O
in	O
respect	O
of	O
the	O
severity	O
of	O
illness	O
and	O
allocates	O
ECMO	O
as	O
a	O
potential	O
therapeutic	O
option	O
for	O
patients	O
with	O
severe	O
ARDS	O
and	O
a	O
P	O
/	O
F	O
ratio	O
lower	O
than	O
100	O
and	O
proposed	O
that	O
the	O
indication	O
of	O
ECMO	O
may	O
be	O
shifted	O
from	O
the	O
treatment	O
of	O
choice	O
for	O
refractory	O
hypoxemia	O
to	O
the	O
treatment	O
of	O
choice	O
to	O
minimize	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

TITLE	O
:	O
Interferon	O
-	O
Î²	O
and	O
mycophenolic	O
acid	O
are	O
potent	O
inhibitors	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
in	O
cell	B-ANAT
-	O
based	O
assays	O
.	O

TITLE	O
:	O
Neutrophils	B-ANAT
are	O
needed	O
for	O
an	O
effective	O
immune	O
response	O
against	O
pulmonary	B-ANAT
rat	O
coronavirus	O
infection	O
,	O
but	O
also	O
contribute	O
to	O
pathology	O
.	O

PMN	B-ANAT
-	O
depleted	O
animals	O
had	O
fewer	O
macrophages	B-ANAT
and	O
lymphocytes	B-ANAT
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
,	O
corresponding	O
to	O
lower	O
chemokine	O
levels	O
.	O

TITLE	O
:	O
A	O
case	O
of	O
vivax	O
malaria	O
complicated	O
by	O
adult	O
respiratory	O
distress	O
syndrome	O
and	O
successful	O
management	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

IFN	O
-	O
Î»	O
is	O
expressed	O
at	O
higher	O
levels	O
in	O
organs	B-ANAT
with	O
high	O
epithelial	B-ANAT
cell	I-ANAT
content	O
such	O
as	O
the	O
respiratory	O
and	O
gastrointestinal	B-ANAT
tracts	I-ANAT
.	O

No	O
dislocations	O
of	O
intravascular	O
catheters	O
/	O
cannulae	O
,	O
endotracheal	O
tubes	O
or	O
chest	B-ANAT
tubes	O
were	O
observed	O
.	O

68	O
patients	O
with	O
severe	O
inhomogeneous	O
lung	B-ANAT
injure	O
(	O
severe	O
concomitant	O
trauma	O
,	O
pneumonia	O
,	O
and	O
pancreonecrosis	O
)	O
were	O
involved	O
in	O
the	O
study	O
.	O

To	O
achieve	O
this	O
,	O
eleven	O
fecal	B-ANAT
samples	O
from	O
dairy	O
cows	O
with	O
winter	O
dysentery	O
,	O
three	O
from	O
calves	O
,	O
and	O
two	O
from	O
horses	O
,	O
all	O
from	O
Brazil	O
,	O
were	O
analysed	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
causes	O
severe	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
in	O
people	O
.	O

However	O
,	O
little	O
is	O
known	O
about	O
persistent	O
or	O
long	O
-	O
term	O
organ	B-ANAT
dysfunction	O
in	O
this	O
patient	O
population	O
.	O

We	O
performed	O
a	O
systematic	O
review	O
of	O
studies	O
reporting	O
organ	B-ANAT
-	O
specific	O
outcomes	O
at	O
28	O
days	O
or	O
greater	O
in	O
survivors	O
of	O
severe	O
sepsis	O
.	O

The	O
most	O
recent	O
study	O
had	O
the	O
highest	O
rates	O
of	O
dysfunction	O
(>	O
47	O
%)	O
across	O
all	O
organ	B-ANAT
systems	I-ANAT
.	O

The	O
disease	O
was	O
characterized	O
by	O
increased	O
mortality	O
,	O
kidney	B-ANAT
lesions	O
and	O
proventriculitis	O
.	O

The	O
production	O
of	O
mature	O
pro	O
-	O
inflammatory	O
cytokines	O
was	O
also	O
suppressed	O
by	O
pretreatment	O
with	O
FJU	O
-	O
C4	O
in	O
either	O
cell	B-ANAT
culture	O
medium	O
or	O
mice	O
serum	B-ANAT
when	O
stimulated	O
by	O
LPS	O
.	O

Finally	O
,	O
the	O
chimeric	O
VLPs	B-ANAT
induced	O
significantly	O
higher	O
IL	O
-	O
4	O
production	O
in	O
mice	O
.	O

The	O
patient	O
was	O
treated	O
with	O
hemodialysis	O
,	O
high	O
-	O
dose	O
glucocorticoids	O
,	O
plasma	B-ANAT
exchange	O
,	O
intravenous	O
cyclophosphamide	O
,	O
and	O
rituximab	O
.	O

Otherwise	O
,	O
patients	O
are	O
at	O
risk	O
of	O
severe	O
hypooxygenation	O
with	O
consecutive	O
overloading	O
and	O
dilatation	O
of	O
the	O
right	O
cardiac	B-ANAT
ventricle	I-ANAT
with	O
subsequent	O
failure	O
.	O

The	O
observed	O
decrease	O
in	O
metabolic	O
syndrome	O
was	O
mediated	O
by	O
significant	O
improvements	O
in	O
exercise	O
efficiency	O
for	O
the	O
AER	B-ANAT
and	O
AER	B-ANAT
+	O
RES	O
training	O
groups	O
(	O
P	O
<	O
0	O
.	O
05	O
),	O
which	O
was	O
more	O
strongly	O
related	O
to	O
TTE	O
(	O
25	O
%-	O
30	O
%;	O
r	O
=	O
-	O
0	O
.	O
38	O
,	O
95	O
%	O
CI	O
=	O
-	O
0	O
.	O
55	O
to	O
-	O
0	O
.	O
19	O
)	O
than	O
VO2peak	O
(	O
5	O
%-	O
6	O
%;	O
r	O
=	O
-	O
0	O
.	O
24	O
,	O
95	O
%	O
CI	O
=	O
-	O
0	O
.	O
45	O
to	O
-	O
0	O
.	O
01	O
).	O

Thirty	O
cc	O
of	O
heparinized	O
blood	B-ANAT
were	O
drawn	O
from	O
each	O
individual	O
within	O
a	O
few	O
hours	O
after	O
the	O
injury	O
.	O

NPPV	O
may	O
be	O
an	O
effective	O
option	O
for	O
the	O
treatment	O
of	O
ARDS	O
/	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
following	O
esophagectomy	O
for	O
esophageal	O
cancer	O
.	O

Both	O
S	O
proteins	O
were	O
found	O
in	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
.	O

Total	O
RNA	O
was	O
isolated	O
from	O
the	O
infected	O
cells	B-ANAT
and	O
cDNA	O
was	O
synthesized	O
.	O

The	O
virus	O
load	O
decreased	O
when	O
any	O
of	O
the	O
Ah	O
,	O
Ns	O
or	O
Cs	O
extracts	O
was	O
added	O
to	O
the	O
CoV	O
infected	O
cells	B-ANAT
with	O
Ah	O
extract	O
treatment	O
leading	O
to	O
undetectable	O
virus	O
load	O
for	O
both	O
6	O
and	O
8	O
hpi	O
.	O

It	O
was	O
also	O
demonstrated	O
that	O
N	O
-	O
protein	O
binds	O
to	O
nucleic	B-ANAT
acid	O
at	O
multiple	O
sites	O
with	O
a	O
coupled	O
-	O
allostery	O
manner	O
.	O

We	O
propose	O
a	O
SARS	O
-	O
CoV	O
RNP	B-ANAT
model	O
that	O
conforms	O
to	O
existing	O
data	O
and	O
bears	O
resemblance	O
to	O
the	O
existing	O
RNP	B-ANAT
structures	O
of	O
RNA	O
viruses	O
.	O

This	O
strain	O
formed	O
a	O
separate	O
branch	B-ANAT
in	O
subgroup	O
II	O
,	O
clearly	O
different	O
from	O
the	O
current	O
Scandinavian	O
sequences	O
.	O

Virus	O
titers	O
from	O
infected	O
cells	B-ANAT
treated	O
with	O
R	O
.	O
rosea	O
and	O
N	O
.	O
sativa	O
extracts	O
were	O
not	O
substantially	O
different	O
from	O
infected	O
cells	B-ANAT
treated	O
with	O
solvent	O
alone	O
.	O

TITLE	O
:	O
Systemic	O
oxygen	O
delivery	O
by	O
peritoneal	B-ANAT
perfusion	O
of	O
oxygen	O
microbubbles	O
.	O

Peritoneal	B-ANAT
oxygenation	O
with	O
OMBs	O
was	O
therefore	O
shown	O
to	O
be	O
safe	O
and	O
effective	O
,	O
and	O
the	O
method	O
requires	O
less	O
equipment	O
and	O
technical	O
expertise	O
than	O
initiating	O
and	O
maintaining	O
an	O
extracorporeal	O
circuit	O
.	O

Further	O
translation	O
of	O
peritoneal	B-ANAT
oxygenation	O
with	O
OMBs	O
may	O
provide	O
therapy	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
arising	O
from	O
trauma	O
,	O
sepsis	O
,	O
pneumonia	O
,	O
aspiration	O
,	O
burns	O
and	O
other	O
pulmonary	B-ANAT
diseases	O
.	O

TITLE	O
:	O
Loss	O
of	O
caveolin	O
-	O
1	O
and	O
adiponectin	O
induces	O
severe	O
inflammatory	O
lung	B-ANAT
injury	O
following	O
LPS	O
challenge	O
through	O
excessive	O
oxidative	O
/	O
nitrative	O
stress	O
.	O

TITLE	O
:	O
The	O
ORF4b	O
-	O
encoded	O
accessory	O
proteins	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
and	O
two	O
related	O
bat	O
coronaviruses	O
localize	O
to	O
the	O
nucleus	B-ANAT
and	O
inhibit	O
innate	O
immune	O
signalling	O
.	O

ABSTRACT	O
:	O
Programmed	O
-	O
1	O
ribosomal	B-ANAT
frameshifting	O
(-	O
1	O
PRF	O
)	O
stimulated	O
by	O
mRNA	O
pseudoknots	O
regulates	O
gene	O
expression	O
in	O
many	O
viruses	O
,	O
making	O
pseudoknots	O
potential	O
targets	O
for	O
anti	O
-	O
viral	O
drugs	O
.	O

TITLE	O
:	O
Mutant	O
murine	O
hepatitis	O
virus	O
-	O
induced	O
apoptosis	O
in	O
the	O
hippocampus	B-ANAT
.	O

The	O
apoptotic	O
cells	B-ANAT
,	O
indicated	O
by	O
caspase	O
3	O
-	O
activation	O
,	O
were	O
a	O
mixed	O
population	O
of	O
infected	O
and	O
a	O
higher	O
number	O
of	O
uninfected	O
cells	B-ANAT
.	O

Thus	O
,	O
induction	O
of	O
the	O
cellular	B-ANAT
immune	O
response	O
is	O
essential	O
in	O
vaccines	O
against	O
FIP	O
virus	O
(	O
FIPV	O
)	O
infection	O
.	O

The	O
National	O
Trauma	O
Data	O
Bank	O
was	O
used	O
for	O
a	O
retrospective	O
analysis	O
of	O
the	O
injury	O
patterns	O
,	O
management	O
,	O
and	O
clinical	O
outcomes	O
associated	O
with	O
flail	O
chest	B-ANAT
injuries	O
.	O

Patients	O
with	O
a	O
flail	O
chest	B-ANAT
injury	O
admitted	O
from	O
2007	O
to	O
2009	O
were	O
included	O
in	O
the	O
analysis	O
.	O

Treatment	O
practices	O
included	O
epidural	B-ANAT
catheters	O
in	O
8	O
%	O
and	O
surgical	O
fixation	O
of	O
the	O
chest	B-ANAT
wall	I-ANAT
in	O
0	O
.	O
7	O
%	O
of	O
the	O
patients	O
.	O

Chest	B-ANAT
tubes	O
were	O
used	O
in	O
44	O
%,	O
and	O
21	O
%	O
required	O
a	O
tracheostomy	O
.	O

Given	O
the	O
high	O
rates	O
of	O
morbidity	O
and	O
mortality	O
in	O
patients	O
with	O
a	O
flail	O
chest	B-ANAT
injury	O
,	O
alternate	O
methods	O
of	O
treatment	O
including	O
more	O
consistent	O
use	O
of	O
epidural	B-ANAT
catheters	O
for	O
pain	O
or	O
surgical	O
fixation	O
need	O
to	O
be	O
investigated	O
with	O
large	O
randomized	O
controlled	O
trials	O
.	O

ABSTRACT	O
:	O
Benign	O
prostatic	B-ANAT
hyperplasia	O
(	O
BPH	O
)	O
and	O
lower	B-ANAT
urinary	I-ANAT
tract	I-ANAT
symptoms	O
(	O
LUTS	O
)	O
are	O
conditions	O
extremely	O
prevalent	O
in	O
the	O
aging	O
male	O
.	O

We	O
present	O
a	O
42	O
-	O
year	O
-	O
old	O
male	O
admitted	O
after	O
heroin	O
use	O
with	O
heroin	O
-	O
related	O
peripheral	B-ANAT
nervous	I-ANAT
system	I-ANAT
complication	O
preceded	O
by	O
an	O
acute	O
gluteal	B-ANAT
compartment	I-ANAT
syndrome	O
and	O
severe	O
rhabdomyolysis	O
.	O

TITLE	O
:	O
Ocular	B-ANAT
manifestations	O
of	O
feline	O
viral	O
diseases	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
influence	O
of	O
the	O
variation	O
of	O
the	O
original	O
skeletons	B-ANAT
of	O
natural	O
phenanthroindo	O
/	O
quinolizidine	O
alkaloids	O
on	O
antiviral	O
activities	O
,	O
two	O
types	O
of	O
structurally	O
totally	O
novel	O
analogues	O
7a	O
,	O
7b	O
,	O
16a	O
,	O
and	O
16b	O
were	O
designed	O
,	O
synthesized	O
,	O
and	O
evaluated	O
against	O
tobacco	O
mosaic	O
virus	O
(	O
TMV	O
)	O
for	O
the	O
first	O
time	O
.	O

TITLE	O
:	O
Fulminant	O
systemic	B-ANAT
capillary	I-ANAT
leak	O
syndrome	O
due	O
to	O
C1	O
inhibitor	O
deficiency	O
complicating	O
acute	O
dermatomyositis	O
:	O
a	O
case	O
report	O
.	O

Furthermore	O
,	O
the	O
pigs	O
infected	O
with	O
HP	O
-	O
PRRSV	O
showed	O
the	O
higher	O
levels	O
of	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)-	O
Î±	O
,	O
interleukin	O
(	O
IL	O
)-	O
1Î²	O
,	O
interleukin	O
(	O
IL	O
)-	O
8	O
and	O
histamine	O
,	O
leukotriene	O
B4	O
(	O
LTB4	O
),	O
platelet	B-ANAT
activation	O
factor	O
(	O
PAF	O
)	O
in	O
sera	B-ANAT
than	O
those	O
inoculated	O
with	O
LP	O
-	O
PRRSV	O
.	O

These	O
associated	O
pathological	O
changes	O
of	O
lung	B-ANAT
are	O
in	O
part	O
responsible	O
for	O
the	O
additional	O
morbidity	O
and	O
mortality	O
observed	O
in	O
HP	O
-	O
PRRSV	O
infection	O
.	O

TITLE	O
:	O
A	O
cluster	O
of	O
lung	B-ANAT
injury	O
associated	O
with	O
home	O
humidifier	O
use	O
:	O
clinical	O
,	O
radiological	O
and	O
pathological	O
description	O
of	O
a	O
new	O
syndrome	O
.	O

Pathological	O
specimens	O
(	O
11	O
/	O
17	O
)	O
showed	O
a	O
bronchiolocentric	O
,	O
temporally	O
homogenous	O
,	O
acute	O
lung	B-ANAT
injury	O
pattern	O
with	O
sparing	O
of	O
the	O
subpleural	O
and	O
peripheral	O
alveolar	B-ANAT
areas	O
.	O

Other	O
viruses	O
have	O
developed	O
'	O
cap	O
-	O
mimicking	O
'	O
mechanisms	O
by	O
attaching	O
a	O
peptide	O
to	O
the	O
5	O
'	O
end	O
of	O
viral	O
RNA	O
(	O
e	O
.	O
g	O
.	O
picornavirus	O
and	O
calicivirus	O
)	O
or	O
by	O
having	O
a	O
complex	O
5	O
'	O
RNA	O
structure	O
(	O
internal	O
ribosome	B-ANAT
entry	O
site	O
)	O
for	O
translation	O
initiation	O
(	O
e	O
.	O
g	O
.	O
picornavirus	O
,	O
pestivirus	O
and	O
hepacivirus	O
).	O

MSCs	O
have	O
been	O
demonstrated	O
to	O
decrease	O
injury	O
and	O
/	O
or	O
restore	O
function	O
in	O
other	O
organs	B-ANAT
,	O
including	O
the	O
kidney	B-ANAT
,	O
liver	B-ANAT
and	O
heart	B-ANAT
.	O

This	O
work	O
describes	O
the	O
interactions	O
of	O
the	O
two	O
RNA	O
-	O
binding	O
domains	O
of	O
the	O
nucleocapsid	B-ANAT
protein	O
of	O
a	O
model	O
coronavirus	O
,	O
mouse	O
hepatitis	O
virus	O
.	O

We	O
found	O
that	O
expression	O
of	O
MERS	O
-	O
CoV	O
PLpro	O
reduces	O
the	O
levels	O
of	O
ubiquitinated	O
and	O
ISGylated	O
host	B-ANAT
cell	I-ANAT
proteins	O
;	O
consistent	O
with	O
multifunctional	O
PLpro	O
activity	O
.	O

This	O
initial	O
down	O
-	O
regulation	O
followed	O
by	O
the	O
induction	O
of	O
innate	O
immune	O
response	O
to	O
IBV	O
infection	O
appears	O
to	O
be	O
inadequate	O
for	O
the	O
control	O
of	O
IBV	O
genome	O
accumulation	O
and	O
consequent	O
histopathological	O
changes	O
in	O
these	O
tissues	B-ANAT
.	O

Additionally	O
,	O
we	O
discuss	O
controversies	O
and	O
future	O
directions	O
,	O
such	O
as	O
novel	O
technologies	O
and	O
indications	O
,	O
mechanical	O
ventilation	O
of	O
the	O
native	O
lung	B-ANAT
during	O
ECLS	O
,	O
and	O
ethics	O
considerations	O
.	O

The	O
transmission	O
of	O
hantavirus	O
to	O
man	O
occurs	O
by	O
contact	O
with	O
or	O
through	O
aerosols	O
of	O
excreta	O
and	O
secretions	B-ANAT
of	O
infected	O
rodents	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
the	O
IFN	O
-	O
antagonizing	O
activity	O
is	O
specific	O
to	O
SARS	O
coronavirus	O
M	O
protein	O
and	O
is	O
mediated	O
through	O
its	O
first	O
transmembrane	B-ANAT
domain	O
(	O
TM1	O
)	O
located	O
at	O
the	O
N	O
terminus	O
.	O

TITLE	O
:	O
Isolation	O
of	O
bovine	O
coronavirus	O
(	O
bcoV	O
)	O
in	O
vero	O
cell	B-ANAT
line	I-ANAT
and	O
its	O
confirmation	O
by	O
direct	O
FAT	O
and	O
RT	O
-	O
PCR	O
.	O

The	O
virus	O
is	O
one	O
of	O
the	O
largest	O
RNA	O
virus	O
and	O
has	O
specific	O
tropism	O
for	O
intestinal	B-ANAT
and	O
pulmonary	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
the	O
SARS	O
coronavirus	O
in	O
2002	O
/	O
2003	O
and	O
the	O
recent	O
disease	O
cases	O
with	O
a	O
new	O
human	O
coronavirus	O
(	O
originally	O
designated	O
EMC	B-ANAT
-	O
CoV	O
,	O
recently	O
renamed	O
MERS	O
-	O
CoV	O
)	O
have	O
put	O
the	O
focus	O
onto	O
the	O
virus	O
family	O
Coronaviridae	O
.	O

All	O
three	O
ICA	O
kits	O
were	O
capable	O
of	O
detecting	O
anti	O
-	O
FCoV	O
antibodies	O
;	O
however	O
,	O
non	O
-	O
specific	O
positive	O
reactions	O
of	O
anti	O
-	O
FCoV	O
antibody	O
-	O
negative	O
plasma	B-ANAT
samples	O
with	O
the	O
test	O
line	O
were	O
observed	O
in	O
2	O
ICA	O
kits	O
(	O
CJIgG	O
/	O
TNP	O
and	O
CJNP	O
/	O
TNP	O
),	O
in	O
which	O
rNP	B-ANAT
was	O
used	O
as	O
the	O
test	O
line	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
specific	O
detection	O
of	O
anti	O
-	O
FCoV	O
antibodies	O
was	O
possible	O
in	O
all	O
plasma	B-ANAT
,	O
serum	B-ANAT
,	O
whole	B-ANAT
blood	I-ANAT
,	O
and	O
ascitic	B-ANAT
fluid	I-ANAT
samples	O
using	O
the	O
ICA	O
kit	O
with	O
protein	O
A	O
blotted	O
as	O
the	O
test	O
line	O
(	O
CJNP	O
/	O
TPA	O
).	O

ABSTRACT	O
:	O
Monocytes	B-ANAT
infected	O
with	O
feline	O
infectious	O
peritonitis	O
virus	O
,	O
a	O
coronavirus	O
,	O
express	O
viral	O
proteins	O
in	O
their	O
plasma	B-ANAT
membranes	I-ANAT
.	O

TITLE	O
:	O
Transient	O
cardiac	B-ANAT
effects	O
in	O
a	O
child	O
with	O
acute	O
cholinergic	O
syndrome	O
due	O
to	O
rivastigmine	O
poisoning	O
.	O

The	O
main	O
factors	O
predisposing	O
to	O
the	O
development	O
of	O
such	O
complications	O
are	O
autonomic	B-ANAT
disorder	O
,	O
hypoxemia	O
,	O
acidosis	O
,	O
and	O
electrolyte	O
imbalance	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
relationship	O
between	O
extravascular	O
lung	B-ANAT
water	O
index	O
(	O
EVLWI	O
),	O
pulmonary	B-ANAT
vascular	B-ANAT
permeability	O
index	O
(	O
PVPI	O
)	O
and	O
the	O
severity	O
categories	O
defined	O
by	O
the	O
Berlin	O
definition	O
,	O
and	O
investigate	O
the	O
prognostic	O
value	O
of	O
EVLWI	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Fifty	O
-	O
four	O
patients	O
with	O
ARDS	O
who	O
received	O
pulse	O
index	O
continuous	O
cardiac	B-ANAT
output	O
(	O
PiCCO	O
)	O
monitoring	O
were	O
analyzed	O
retrospectively	O
.	O

Under	O
non	O
-	O
toxic	O
concentrations	O
,	O
Ag	O
NPs	O
and	O
silver	O
nanowires	O
significantly	O
diminished	O
the	O
infectivity	O
of	O
TGEV	O
in	O
ST	O
cells	B-ANAT
.	O

TITLE	O
:	O
Cell	B-ANAT
adhesion	O
as	O
a	O
novel	O
approach	O
to	O
determining	O
the	O
cellular	B-ANAT
binding	O
motif	O
on	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
spike	O
protein	O
.	O

The	O
structure	O
also	O
revealed	O
an	O
N	O
-	O
cyclohexyl	O
-	O
2	O
-	O
aminethanesulfonic	O
acid	O
molecule	O
near	O
the	O
catalytic	O
triad	B-ANAT
,	O
and	O
kinetic	O
studies	O
suggest	O
that	O
this	O
binding	O
site	O
is	O
also	O
used	O
by	O
other	O
PLpro	O
inhibitors	O
.	O

In	O
conclusion	O
,	O
our	O
results	O
suggest	O
that	O
serum	B-ANAT
IgG	O
Fc	O
glycosylation	O
in	O
GBS	O
is	O
related	O
to	O
disease	O
severity	O
and	O
clinical	O
recovery	O
after	O
IVIg	O
and	O
may	O
help	O
to	O
develop	O
new	O
measures	O
to	O
monitor	O
the	O
efficacy	O
of	O
treatment	O
.	O

ABSTRACT	O
:	O
Our	O
previous	O
studies	O
showed	O
that	O
TGEV	O
infection	O
could	O
induce	O
cell	B-ANAT
cycle	O
arrest	O
and	O
apoptosis	O
via	O
activation	O
of	O
p53	O
signaling	O
in	O
cultured	O
host	O
cells	B-ANAT
.	O

Predictors	O
for	O
the	O
development	O
of	O
moderate	O
or	O
severe	O
ARDS	O
were	O
inhalation	O
injury	O
(	O
odds	O
ratio	O
[	O
OR	O
],	O
1	O
.	O
90	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
],	O
1	O
.	O
01	O
-	O
3	O
.	O
54	O
;	O
p	O
=	O
0	O
.	O
046	O
),	O
Injury	O
Severity	O
Score	O
(	O
ISS	O
)	O
(	O
OR	O
,	O
1	O
.	O
04	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
01	O
-	O
1	O
.	O
07	O
;	O
p	O
=	O
0	O
.	O
0021	O
),	O
pneumonia	O
(	O
OR	O
,	O
198	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
07	O
-	O
3	O
.	O
66	O
;	O
p	O
=	O
0	O
.	O
03	O
),	O
and	O
transfusion	O
of	O
fresh	B-ANAT
frozen	I-ANAT
plasma	I-ANAT
(	O
OR	O
,	O
1	O
.	O
32	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
01	O
-	O
1	O
.	O
72	O
;	O
p	O
=	O
0	O
.	O
04	O
).	O

We	O
compared	O
the	O
receptors	O
of	O
humans	O
and	O
Middle	O
Eastern	O
animals	O
and	O
found	O
that	O
human	O
,	O
camel	O
,	O
and	O
horse	O
receptors	O
sensitized	O
cells	B-ANAT
to	O
MERS	O
-	O
CoV	O
infection	O
more	O
robustly	O
than	O
goat	O
and	O
bat	O
receptors	O
.	O

Assay	O
specificity	O
was	O
tested	O
using	O
sera	B-ANAT
from	O
pigs	O
seropositive	O
for	O
other	O
pathogens	O
(	O
2	O
different	O
pigs	O
seropositive	O
for	O
each	O
pathogen	O
).	O

TITLE	O
:	O
Diabetic	O
muscle	B-ANAT
infarction	O
:	O
a	O
rare	O
cause	O
of	O
acute	O
limb	B-ANAT
pain	O
in	O
dialysis	O
patients	O
.	O

The	O
presenting	O
symptom	O
is	O
a	O
localized	O
painful	O
swelling	O
of	O
the	O
affected	O
limb	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
a	O
severe	O
inflammatory	O
disease	O
manifested	O
as	O
a	O
result	O
of	O
pulmonary	B-ANAT
and	O
systemic	O
responses	O
to	O
several	O
insults	O
.	O

Thus	O
,	O
key	O
events	O
in	O
the	O
pathogenesis	O
of	O
FIP	O
are	O
systemic	O
infection	O
with	O
FIPV	O
,	O
effective	O
and	O
sustainable	O
viral	O
replication	O
in	O
monocytes	B-ANAT
,	O
and	O
activation	O
of	O
infected	O
monocytes	B-ANAT
.	O

The	O
host	O
'	O
s	O
genetics	O
and	O
immune	B-ANAT
system	I-ANAT
also	O
play	O
important	O
roles	O
.	O

Our	O
institutional	O
experience	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenator	O
support	O
for	O
cardiac	B-ANAT
indications	O
in	O
adult	O
patients	O
indicates	O
poor	O
survival	O
.	O

The	O
expression	O
of	O
CD31	O
,	O
CD61	O
,	O
CD	O
62p	O
,	O
CD63	O
and	O
PAC	O
-	O
1	O
on	O
platelet	B-ANAT
membrane	B-ANAT
in	O
26	O
patients	O
was	O
all	O
lower	O
than	O
that	O
in	O
17	O
healthy	O
subjects	O
(	O
P	O
<	O
0	O
.	O
01	O
).	O

Central	B-ANAT
nervous	I-ANAT
system	I-ANAT
involvement	O
in	O
leptospirosis	O
most	O
commonly	O
occurs	O
as	O
aseptic	O
meningitis	O
,	O
often	O
asymptomatic	O
,	O
only	O
with	O
abnormal	O
cerebrospinal	B-ANAT
fluid	I-ANAT
findings	O
.	O

Direct	O
sequencing	O
was	O
performed	O
on	O
the	O
endotracheal	B-ANAT
aspirate	I-ANAT
collected	O
from	O
a	O
36	O
-	O
year	O
-	O
old	O
female	O
with	O
history	O
of	O
poultry	O
contact	O
.	O

Infections	O
caused	O
by	O
HCoV	O
-	O
OC43	O
and	O
HCoV	O
-	O
NL63	O
are	O
common	O
and	O
include	O
some	O
with	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
involvement	O
and	O
severe	O
disease	O
,	O
especially	O
in	O
children	O
with	O
underlying	O
medical	O
conditions	O
.	O

TITLE	O
:	O
Genetic	O
variability	O
and	O
phylogeny	O
of	O
current	O
Chinese	O
porcine	O
epidemic	O
diarrhea	O
virus	O
strains	O
based	O
on	O
spike	O
,	O
ORF3	O
,	O
and	O
membrane	B-ANAT
genes	O
.	O

In	O
this	O
study	O
,	O
partial	O
spike	O
(	O
S	O
),	O
ORF3	O
,	O
and	O
membrane	B-ANAT
(	O
M	O
)	O
genes	O
amplified	O
from	O
these	O
variants	O
were	O
sequenced	O
and	O
analyzed	O
.	O

aMPV	O
and	O
THEV	O
diagnostic	O
swabs	O
and	O
blood	B-ANAT
samples	I-ANAT
were	O
made	O
once	O
a	O
week	O
up	O
to	O
14	O
weeks	O
of	O
age	O
.	O

Using	O
reverse	O
genetic	O
approaches	O
our	O
study	O
is	O
the	O
first	O
experimental	O
proof	O
that	O
ORF3abc	O
is	O
indeed	O
responsible	O
for	O
the	O
restriction	O
of	O
FECV	O
replication	O
to	O
the	O
intestine	B-ANAT
in	O
vivo	O
.	O

The	O
type	O
II	O
transmembrane	B-ANAT
serine	O
protease	O
TMPRSS2	O
is	O
expressed	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
and	O
is	O
capable	O
of	O
activating	O
a	O
variety	O
of	O
respiratory	O
viruses	O
,	O
including	O
low	O
-	O
pathogenic	O
(	O
LP	O
)	O
IAVs	O
possessing	O
a	O
single	O
arginine	O
residue	O
at	O
the	O
cleavage	O
site	O
.	O

Airway	B-ANAT
collapse	O
and	O
the	O
two	O
episodes	O
of	O
respiratory	O
failures	O
while	O
under	O
general	O
anesthesia	O
were	O
attributed	O
to	O
post	O
-	O
tracheotomy	O
tracheomalacia	O
.	O

TITLE	O
:	O
Advances	O
in	O
ventilator	O
-	O
associated	O
lung	B-ANAT
injury	O
:	O
prevention	O
is	O
the	O
target	O
.	O

In	O
vitro	O
C5a	O
administration	O
accelerates	O
MHV	O
-	O
3	O
-	O
induced	O
Fgl2	O
secretion	B-ANAT
by	O
macrophages	B-ANAT
.	O

Also	O
mitochondria	B-ANAT
are	O
affected	O
;	O
a	O
subunit	O
of	O
respiratory	O
complex	B-ANAT
III	I-ANAT
is	O
dysregulated	O
,	O
the	O
inner	B-ANAT
mitochondrial	I-ANAT
membrane	I-ANAT
is	O
leaking	O
protons	O
,	O
and	O
brain	B-ANAT
ATP	O
levels	O
seem	O
reduced	O
.	O

Since	O
several	O
ion	O
-	O
channels	O
and	O
neurotransmitter	O
receptors	O
are	O
redox	O
modulated	O
,	O
the	O
mitochondrial	B-ANAT
alterations	O
and	O
the	O
associated	O
oxidative	O
burden	O
may	O
contribute	O
to	O
the	O
neuronal	O
dysfunction	O
in	O
RS	O
.	O

Transduction	O
of	O
the	O
N	O
gene	O
in	O
the	O
insect	O
Sf9	O
cells	B-ANAT
revealed	O
a	O
high	O
level	O
of	O
protein	O
expression	O
.	O

Here	O
we	O
evaluated	O
the	O
role	O
of	O
alveolar	B-ANAT
macrophages	I-ANAT
(	O
AM	O
)	O
in	O
modulating	O
the	O
adaptive	O
immune	O
response	O
and	O
subsequent	O
disease	O
.	O

We	O
hypothesized	O
that	O
distinct	O
immune	O
responses	O
in	O
the	O
lung	B-ANAT
and	O
gut	B-ANAT
during	O
the	O
primary	O
and	O
chronic	O
stages	O
of	O
viral	O
infection	O
contribute	O
to	O
these	O
differences	O
.	O

Our	O
findings	O
showed	O
that	O
both	O
mucosal	B-ANAT
compartments	B-ANAT
harbor	O
similar	O
percentages	O
of	O
memory	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
and	O
displayed	O
comparable	O
cytokine	O
(	O
IL	O
-	O
2	O
,	O
IFN	O
-	O
Î³	O
,	O
and	O
TNF	O
-	O
Î±	O
)	O
responses	O
to	O
mitogenic	O
stimulations	O
prior	O
to	O
infection	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
whether	O
severe	O
cancer	O
cachexia	O
disrupts	O
the	O
acute	O
contraction	O
-	O
induced	O
response	O
to	O
low	O
-	O
frequency	O
muscle	B-ANAT
contraction	O
[	O
low	O
-	O
frequency	O
stimulation	O
(	O
LoFS	O
)].	O

LoFS	O
increased	O
muscle	B-ANAT
phosphorylated	O
-	O
AMP	O
-	O
activated	O
protein	O
kinase	O
and	O
p38	O
in	O
BL	O
-	O
6	O
and	O
Min	O
mice	O
.	O

The	O
expression	O
of	O
IL	O
-	O
6	O
receptor	O
,	O
but	O
not	O
IL	O
-	O
1Î²	O
receptor	O
,	O
was	O
identified	O
in	O
the	O
tubular	O
gland	B-ANAT
cells	B-ANAT
in	O
the	O
isthmus	O
and	O
uterus	B-ANAT
.	O

This	O
review	O
discusses	O
the	O
effects	O
of	O
ITSN	O
-	O
1s	O
deficiency	O
on	O
pulmonary	B-ANAT
endothelium	B-ANAT
and	O
its	O
significance	O
in	O
the	O
pathology	O
of	O
ALI	O
/	O
ARDS	O
.	O

In	O
addition	O
,	O
for	O
almost	O
three	O
decades	O
now	O
,	O
the	O
scientific	O
literature	O
has	O
also	O
demonstrated	O
that	O
HCoV	O
are	O
neuroinvasive	O
and	O
neurotropic	O
and	O
could	O
induce	O
an	O
overactivation	O
of	O
the	O
immune	B-ANAT
system	I-ANAT
,	O
in	O
part	O
by	O
participating	O
in	O
the	O
activation	O
of	O
autoreactive	O
immune	O
cells	B-ANAT
that	O
could	O
be	O
associated	O
with	O
autoimmunity	O
in	O
susceptible	O
individuals	O
.	O

METHODS	O
:	O
Nasopharyngeal	B-ANAT
samples	O
were	O
collected	O
from	O
5235	O
adult	O
pilgrims	O
from	O
22	O
countries	O
and	O
screened	O
for	O
MERS	O
-	O
CoV	O
using	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
.	O

TITLE	O
:	O
Oxidative	O
tissue	B-ANAT
injury	O
in	O
multiple	O
sclerosis	O
is	O
only	O
partly	O
reflected	O
in	O
experimental	O
disease	O
models	O
.	O

In	O
both	O
,	O
MS	O
and	O
coronavirus	O
-	O
induced	O
encephalomyelitis	O
,	O
this	O
was	O
associated	O
with	O
massive	O
microglial	B-ANAT
and	O
macrophage	B-ANAT
activation	O
,	O
accompanied	O
by	O
the	O
expression	O
of	O
the	O
NADPH	O
oxidase	O
subunit	O
p22phox	O
but	O
only	O
sparse	O
expression	O
of	O
inducible	O
nitric	O
oxide	O
synthase	O
(	O
iNOS	O
).	O

Our	O
study	O
shows	O
that	O
oxidative	O
injury	O
and	O
its	O
triggering	O
mechanisms	O
diverge	O
in	O
different	O
models	O
of	O
rodent	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
inflammation	O
.	O

Current	O
use	O
of	O
ECMO	O
extends	O
beyond	O
its	O
most	O
familiar	O
role	O
in	O
the	O
support	O
of	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
to	O
treat	O
patients	O
with	O
various	O
forms	O
of	O
severe	O
hypoxemic	O
or	O
hypercapnic	O
respiratory	O
failure	O
,	O
ranging	O
from	O
bridging	O
patients	O
to	O
lung	B-ANAT
transplantation	O
to	O
managing	O
pulmonary	B-ANAT
hypertensive	O
crises	O
.	O

Immature	O
immune	B-ANAT
system	I-ANAT
and	O
lack	O
of	O
fully	O
established	O
microbiota	O
at	O
birth	O
predispose	O
neonatal	O
piglets	O
to	O
infection	O
with	O
enteric	O
pathogens	O
.	O

Bacteriological	O
samples	O
isolated	O
M	O
.	O
pneumoniae	O
in	O
nasopharyngeal	B-ANAT
secretions	B-ANAT
with	O
a	O
positive	O
serology	O
.	O

Finally	O
,	O
the	O
activity	O
of	O
this	O
nuclear	O
export	O
signal	O
(	O
NES	O
)	O
was	O
inhibited	O
by	O
the	O
antibiotic	O
Lepomycin	O
B	O
,	O
suggesting	O
that	O
N	O
is	O
exported	O
by	O
a	O
chromosome	B-ANAT
region	O
maintenance	O
1	O
-	O
related	O
export	O
pathway	O
.	O

We	O
found	O
that	O
for	O
each	O
reported	O
new	O
SARS	O
case	O
there	O
is	O
an	O
immediate	O
loss	O
of	O
about	O
1200	O
underground	O
ridership	O
(	O
the	O
fresh	B-ANAT
fear	O
).	O

Instead	O
,	O
delayed	O
MHV	O
-	O
3	O
replication	O
coincided	O
with	O
high	O
levels	O
of	O
cellular	B-ANAT
ISGylation	O
.	O

TITLE	O
:	O
Avoiding	O
ECMO	O
in	O
a	O
patient	O
with	O
""""	O
pump	O
""""	O
lung	B-ANAT
post	O
-	O
cardiopulmonary	B-ANAT
bypass	O
.	O

MMP	O
-	O
8	O
and	O
TIMP	O
-	O
1	O
levels	O
were	O
analyzed	O
from	O
blood	B-ANAT
samples	I-ANAT
taken	O
on	O
enrollment	O
in	O
the	O
study	O
and	O
48	O
hours	O
later	O
.	O

Most	O
(	O
632	O
/	O
651	O
,	O
97	O
.	O
1	O
%)	O
camels	O
had	O
antibodies	O
against	O
MERS	O
-	O
CoV	O
.	O
This	O
result	O
included	O
all	O
151	O
serum	B-ANAT
samples	O
obtained	O
in	O
2003	O
.	O

Most	O
(	O
389	O
/	O
651	O
,	O
59	O
.	O
8	O
%)	O
serum	B-ANAT
samples	O
had	O
MERS	O
-	O
CoV	O
-	O
neutralizing	O
antibody	O
titers	O
>	O
1	O
,	O
280	O
.	O

ABSTRACT	O
:	O
In	O
2013	O
,	O
a	O
novel	O
betacoronavirus	O
was	O
identified	O
in	O
fecal	B-ANAT
samples	O
from	O
dromedaries	O
in	O
Dubai	O
,	O
United	O
Arab	O
Emirates	O
.	O

Nucleic	B-ANAT
acids	O
collected	O
using	O
FTA	O
Cards	O
without	O
the	O
need	O
for	O
a	O
cold	O
-	O
chain	O
or	O
special	O
liquid	O
media	B-ANAT
handling	O
provided	O
realtime	O
PCR	O
results	O
consistent	O
(	O
96	O
.	O
8	O
%	O
agreement	O
,	O
kappa	O
0	O
.	O
923	O
[	O
95	O
%	O
CI	O
=	O
0	O
.	O
89	O
-	O
0	O
.	O
96	O
])	O
with	O
the	O
same	O
specimens	O
collected	O
using	O
traditional	O
viral	O
transport	O
media	B-ANAT
and	O
shipped	O
on	O
ice	O
using	O
the	O
U	O
.	O
S	O
.	O
Department	O
of	O
Transportation	O
mandated	O
liquid	O
handling	O
requirements	O
.	O

Rarer	O
still	O
is	O
the	O
transport	O
of	O
such	O
a	O
patient	O
using	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
to	O
a	O
specialized	O
ECMO	O
center	O
for	O
definitive	O
repair	O
.	O

Notably	O
,	O
ectopically	O
expressed	O
Î¼1	O
and	O
Ï1	O
induced	O
similar	O
pathological	O
apoptosis	O
,	O
independent	O
of	O
BYD1	O
infection	O
,	O
in	O
host	O
cells	B-ANAT
in	O
which	O
they	O
were	O
expressed	O
,	O
which	O
suggests	O
that	O
Î¼1	O
and	O
Ï1	O
are	O
both	O
apoptotic	O
virulence	O
factors	O
.	O

Collectively	O
,	O
our	O
data	O
suggest	O
that	O
BYD1	O
Î¼1	O
-	O
and	O
Ï1	O
-	O
induced	O
apoptosis	O
is	O
involved	O
in	O
the	O
multi	O
-	O
organ	B-ANAT
lesions	O
in	O
a	O
suckling	O
mouse	O
BYD1	O
infection	O
model	O
.	O

TITLE	O
:	O
Role	O
of	O
alveolar	B-ANAT
macrophages	I-ANAT
in	O
the	O
inflammatory	O
response	O
after	O
trauma	O
.	O

Because	O
no	O
small	O
animal	O
model	O
exists	O
to	O
evaluate	O
MERS	O
-	O
CoV	O
pathogenesis	O
or	O
to	O
test	O
vaccines	O
,	O
we	O
constructed	O
a	O
recombinant	O
BtCoV	O
HKU5	O
that	O
expressed	O
a	O
region	O
of	O
the	O
SARS	O
-	O
CoV	O
spike	O
(	O
S	O
)	O
glycoprotein	O
,	O
thereby	O
allowing	O
the	O
recombinant	O
virus	O
to	O
grow	O
in	O
cell	B-ANAT
culture	O
and	O
in	O
mice	O
.	O

We	O
show	O
that	O
this	O
recombinant	O
virus	O
targets	O
airway	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
and	O
causes	O
disease	O
in	O
aged	O
mice	O
.	O

Clinical	O
examination	O
and	O
chest	B-ANAT
radiography	O
may	O
be	O
misleading	O
in	O
these	O
patients	O
as	O
tracheobronchomegaly	O
is	O
easily	O
overlooked	O
on	O
radiographs	O
.	O

We	O
present	O
an	O
interesting	O
report	O
of	O
our	O
patient	O
who	O
presented	O
with	O
acute	O
shortness	O
of	O
breath	B-ANAT
.	O

Others	O
and	O
we	O
have	O
previously	O
shown	O
the	O
beneficial	O
effect	O
of	O
infusion	O
of	O
exogenous	O
adult	O
stem	B-ANAT
cells	I-ANAT
in	O
different	O
pre	O
-	O
clinical	O
models	O
of	O
ARDS	O
.	O

We	O
highlight	O
challenges	O
and	O
potential	O
pitfalls	O
that	O
occur	O
when	O
dealing	O
with	O
a	O
novel	O
emerging	O
coronavirus	O
like	O
MERS	O
-	O
CoV	O
.	O
In	O
addition	O
we	O
describe	O
problems	O
that	O
might	O
occur	O
when	O
animal	O
sera	B-ANAT
are	O
tested	O
in	O
serological	O
assays	O
for	O
the	O
identification	O
of	O
putative	O
reservoirs	O
.	O

ABSTRACT	O
:	O
The	O
relationships	O
between	O
tonsillar	B-ANAT
immune	O
responses	O
,	O
and	O
viral	O
infection	O
and	O
allergy	O
are	O
incompletely	O
known	O
.	O

RESULTS	O
:	O
Fifty	O
percentage	O
of	O
subjects	O
reported	O
allergy	O
,	O
59	O
%	O
had	O
â¥	O
1	O
nasopharyngeal	B-ANAT
viruses	O
,	O
and	O
24	O
%	O
had	O
â¥	O
1	O
intratonsillar	O
viruses	O
.	O

We	O
integrated	O
a	O
pediatric	O
oxygenator	O
in	O
a	O
continuous	O
veno	O
-	O
venous	B-ANAT
hemofiltration	O
circuit	O
.	O

Hair	B-ANAT
under	O
light	O
microscopy	O
showed	O
evenly	O
distributed	O
,	O
large	O
melanin	O
granules	O
,	O
suggestive	O
of	O
Chediak	O
-	O
Higashi	O
syndrome	O
(	O
CHS	O
).	O

Blood	B-ANAT
smear	O
shows	O
monocytosis	O
(>	O
1	O
Ã	O
10	O
(	O
9	O
)/	O
L	O
)	O
presence	O
of	O
myeloid	O
progenitors	O
and	O
abnormal	O
basophils	B-ANAT
.	O

TITLE	O
:	O
Competitive	O
fitness	O
in	O
coronaviruses	O
is	O
not	O
correlated	O
with	O
size	O
or	O
number	O
of	O
double	O
-	O
membrane	B-ANAT
vesicles	B-ANAT
under	O
reduced	O
-	O
temperature	O
growth	O
conditions	O
.	O

For	O
coronaviruses	O
,	O
these	O
organelles	B-ANAT
take	O
the	O
form	O
of	O
double	O
-	O
membrane	B-ANAT
vesicles	B-ANAT
(	O
DMVs	O
)	O
interconnected	O
by	O
a	O
convoluted	O
membrane	B-ANAT
network	O
.	O

Certain	O
laboratory	O
parameters	O
such	O
as	O
plasma	B-ANAT
CRP	O
,	O
PCT	O
,	O
PTA	O
and	O
virus	O
positive	O
days	O
predicted	O
mortality	O
of	O
H7N9	O
infection	O
and	O
plasma	B-ANAT
CRP	O
is	O
an	O
independent	O
predictor	O
of	O
mortality	O
in	O
these	O
patients	O
.	O

TITLE	O
:	O
Successful	O
slide	O
tracheoplasty	O
and	O
partial	O
atrioventricular	O
septal	O
defect	O
repair	O
following	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
support	O
.	O

Analysis	O
of	O
shorebird	O
fecal	B-ANAT
samples	O
indicated	O
the	O
presence	O
of	O
a	O
novel	O
astrovirus	O
and	O
coronavirus	O
.	O

Examples	O
are	O
calcitonin	O
-	O
producing	O
tumors	O
,	O
medullary	B-ANAT
C	B-ANAT
-	I-ANAT
cell	I-ANAT
thyroid	B-ANAT
carcinoma	O
,	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

TITLE	O
:	O
Pulmonary	B-ANAT
retention	O
of	O
primed	O
neutrophils	B-ANAT
:	O
a	O
novel	O
protective	O
host	O
response	O
,	O
which	O
is	O
impaired	O
in	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Flow	O
cytometry	O
of	O
whole	O
blood	B-ANAT
samples	I-ANAT
was	O
used	O
to	O
assess	O
transpulmonary	O
neutrophil	B-ANAT
priming	O
gradients	O
in	O
patients	O
with	O
ARDS	O
,	O
sepsis	O
and	O
perioperative	O
controls	O
.	O

TITLE	O
:	O
Dramatic	O
differences	O
in	O
the	O
response	O
of	O
macrophages	B-ANAT
from	O
B2	O
and	O
B19	O
MHC	B-ANAT
-	O
defined	O
haplotypes	O
to	O
interferon	O
gamma	O
and	O
polyinosinic	O
:	O
polycytidylic	O
acid	O
stimulation	O
.	O

Not	O
only	O
did	O
B2	O
-	O
derived	O
peripheral	O
monocytes	B-ANAT
differentiate	O
into	O
macrophages	B-ANAT
more	O
readily	O
than	O
the	O
B19	O
monocytes	B-ANAT
,	O
but	O
as	O
determined	O
by	O
NO	O
production	O
,	O
macrophages	B-ANAT
from	O
B2	O
and	O
B2	O
on	O
B19	O
genetic	O
background	O
chicks	O
were	O
also	O
significantly	O
more	O
responsive	O
to	O
either	O
stimulant	O
.	O

Based	O
on	O
the	O
theory	O
of	O
traditional	O
Chinese	O
medicine	O
,	O
mix	O
-	O
using	O
herbs	O
provide	O
a	O
synergistic	O
benefit	O
on	O
preventing	O
and	O
healing	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
.	O

In	O
this	O
study	O
,	O
more	O
than	O
200	O
extracts	O
from	O
Chinese	O
medicinal	O
herbs	O
were	O
evaluated	O
for	O
anti	O
-	O
SARS	O
-	O
CoV	O
activities	O
using	O
a	O
cell	B-ANAT
-	O
based	O
assay	O
that	O
measured	O
SARS	O
-	O
CoV	O
-	O
induced	O
cytopathogenic	O
effect	O
(	O
CPE	O
)	O
in	O
vitro	O
on	O
Vero	O
E6	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
We	O
present	O
a	O
case	O
of	O
a	O
48	O
year	O
old	O
female	O
,	O
with	O
a	O
medical	O
history	O
significant	O
for	O
paraplegia	O
due	O
to	O
a	O
cervical	B-ANAT
cord	B-ANAT
injury	O
and	O
a	O
history	O
of	O
transitional	B-ANAT
cell	I-ANAT
carcinoma	O
,	O
which	O
necessitated	O
a	O
urinary	B-ANAT
bladder	I-ANAT
ileal	B-ANAT
reconstruction	O
.	O

ABSTRACT	O
:	O
Veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
vvECMO	O
)	O
can	O
be	O
a	O
life	O
-	O
saving	O
therapy	O
in	O
patients	O
with	O
severe	O
acute	O
lung	B-ANAT
failure	O
refractory	O
to	O
conventional	O
therapy	O
.	O

The	O
15	O
distinct	O
mammalian	O
viruses	O
identified	O
in	O
the	O
pooled	O
diarrhoeic	O
sample	O
were	O
,	O
in	O
order	O
of	O
abundance	O
of	O
nucleic	B-ANAT
acid	O
sequence	O
,	O
Porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
),	O
sapovirus	O
,	O
porcine	O
bocavirus	O
-	O
4	O
(	O
PBoV	O
-	O
4	O
),	O
sapelovirus	O
,	O
torovirus	O
,	O
coronavirus	O
,	O
PBoV	O
-	O
2	O
,	O
stool	B-ANAT
-	O
associated	O
single	O
-	O
stranded	O
DNA	O
virus	O
(	O
poSCV	O
),	O
astrovirus	O
(	O
AstV	O
),	O
kobuvirus	O
,	O
posavirus	O
-	O
1	O
,	O
porcine	O
enterovirus	O
-	O
9	O
(	O
PEV	O
-	O
9	O
),	O
porcine	O
circovirus	O
-	O
like	O
(	O
po	O
-	O
circo	O
-	O
like	O
)	O
virus	O
,	O
picobirnavirus	O
(	O
PBV	O
)	O
and	O
Torque	O
teno	O
sus	O
virus	O
2	O
(	O
TTSuV	O
-	O
2	O
).	O

There	O
are	O
also	O
documented	O
case	O
reports	O
of	O
the	O
development	O
of	O
non	O
-	O
cardiogenic	O
pulmonary	B-ANAT
oedema	O
after	O
verapamil	O
overdose	O
.	O

However	O
,	O
the	O
exact	O
mechanisms	O
responsible	O
for	O
pulmonary	B-ANAT
oedema	O
remain	O
unclear	O
.	O

Using	O
monocyte	B-ANAT
-	O
derived	O
-	O
dendritic	B-ANAT
cells	I-ANAT
(	O
Mo	O
-	O
DCs	O
),	O
we	O
discovered	O
fundamental	O
discrepancies	O
in	O
the	O
outcome	O
of	O
MERS	O
-	O
CoV	O
-	O
and	O
SARS	O
-	O
CoV	O
-	O
infection	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
terms	O
of	O
mean	O
age	O
,	O
immune	O
status	O
,	O
leukocyte	B-ANAT
count	O
,	O
C	O
-	O
reactive	O
protein	O
(	O
CRP	O
)	O
values	O
,	O
hospitalization	O
duration	O
and	O
CURB	O
-	O
65	O
score	O
between	O
bacterial	O
and	O
mixed	O
viral	O
-	O
bacterial	O
detections	O
.	O

TITLE	O
:	O
Neutrophil	B-ANAT
elastase	O
inhibitor	O
reduces	O
ventilation	O
-	O
induced	O
lung	B-ANAT
injury	O
via	O
nuclear	O
factor	O
-	O
ÎºB	O
and	O
NF	O
-	O
ÎºB	O
repressing	O
factor	O
in	O
mice	O
.	O

ABSTRACT	O
:	O
Mechanical	O
ventilation	O
used	O
in	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
can	O
damage	O
pulmonary	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
through	O
production	O
of	O
inflammatory	O
cytokines	O
,	O
oxygen	O
radicals	O
,	O
and	O
neutrophil	B-ANAT
infiltration	O
,	O
termed	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

Neutrophil	B-ANAT
elastase	O
inhibitor	O
ameliorated	O
high	O
-	O
tidal	O
-	O
volume	O
ventilation	O
-	O
induced	O
lung	B-ANAT
injury	O
,	O
neutrophil	B-ANAT
influx	O
,	O
production	O
of	O
MIP	O
-	O
2	O
and	O
malondialdehyde	O
,	O
activation	O
of	O
NF	O
-	O
ÎºB	O
and	O
NRF	O
,	O
apoptotic	O
epithelial	B-ANAT
cell	I-ANAT
death	O
,	O
and	O
disruption	O
of	O
bronchial	B-ANAT
microstructure	O
in	O
mice	O
.	O

TITLE	O
:	O
Mechanical	O
ventilation	O
drives	O
pneumococcal	O
pneumonia	O
into	O
lung	B-ANAT
injury	O
and	O
sepsis	O
in	O
mice	O
:	O
protection	O
by	O
adrenomedullin	O
.	O

In	O
a	O
previous	O
study	O
,	O
the	O
endogenous	O
peptide	O
adrenomedullin	O
(	O
AM	O
)	O
protected	O
murine	O
lungs	B-ANAT
from	O
VILI	O
.	O

MV	O
induced	O
systemic	O
leukocytopenia	O
and	O
liver	B-ANAT
,	O
gut	B-ANAT
and	O
kidney	B-ANAT
injury	O
in	O
mice	O
with	O
pneumonia	O
.	O

Infusion	O
of	O
AM	O
protected	O
against	O
MV	O
-	O
induced	O
lung	B-ANAT
injury	O
(	O
66	O
%	O
reduction	O
of	O
pulmonary	B-ANAT
permeability	O
p	O
<	O
0	O
.	O
01	O
;	O
prevention	O
of	O
pulmonary	B-ANAT
restriction	O
)	O
and	O
against	O
VILI	O
-	O
induced	O
liver	B-ANAT
and	O
gut	B-ANAT
injury	O
in	O
pneumonia	O
(	O
91	O
%	O
reduction	O
of	O
AST	O
levels	O
p	O
<	O
0	O
.	O
05	O
,	O
96	O
%	O
reduction	O
of	O
alanine	O
aminotransaminase	O
(	O
ALT	O
)	O
levels	O
p	O
<	O
0	O
.	O
05	O
,	O
abrogation	O
of	O
histopathological	O
changes	O
and	O
parenchymal	O
apoptosis	O
in	O
liver	B-ANAT
and	O
gut	B-ANAT
).	O

MV	O
paved	O
the	O
way	O
for	O
the	O
progression	O
of	O
pneumonia	O
towards	O
ARDS	O
and	O
sepsis	O
by	O
aggravating	O
lung	B-ANAT
injury	O
and	O
systemic	O
hyperinflammation	O
leading	O
to	O
liver	B-ANAT
,	O
kidney	B-ANAT
and	O
gut	B-ANAT
injury	O
.	O

We	O
analyzed	O
the	O
incidence	O
,	O
risk	O
factors	O
,	O
and	O
prognosis	O
of	O
VRIs	O
in	O
a	O
cohort	O
of	O
transplanted	B-ANAT
patients	O
.	O

Methods	O
:	O
Thirty	O
patients	O
with	O
nasal	B-ANAT
polyps	O
and	O
a	O
group	O
of	O
20	O
healthy	O
patients	O
(	O
control	O
group	O
)	O
were	O
included	O
in	O
this	O
study	O
.	O

The	O
spike	O
glycoproteins	O
of	O
coronaviruses	O
reside	O
on	O
the	O
surface	O
of	O
the	O
virion	B-ANAT
and	O
are	O
responsible	O
for	O
virus	O
entry	O
.	O

Vaccination	O
strategies	O
for	O
coronaviruses	O
have	O
involved	O
live	O
attenuated	O
virus	O
,	O
recombinant	O
viruses	O
,	O
non	O
-	O
replicative	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
expressing	O
coronavirus	O
proteins	O
or	O
DNA	O
plasmids	O
expressing	O
coronavirus	O
genes	O
.	O

TITLE	O
:	O
Coronavirus	O
entry	O
and	O
release	O
in	O
polarized	O
epithelial	B-ANAT
cells	I-ANAT
:	O
a	O
review	O
.	O

Our	O
results	O
showed	O
that	O
immature	O
and	O
mature	O
monocyte	B-ANAT
-	O
derived	O
dendritic	B-ANAT
cells	I-ANAT
(	O
Mo	O
-	O
DCs	O
)	O
were	O
susceptible	O
to	O
infection	O
with	O
SHXB	O
and	O
STC3	O
.	O

In	O
contrast	O
,	O
these	O
abilities	O
of	O
intestinal	B-ANAT
DCs	O
were	O
enhanced	O
in	O
STC3	O
-	O
infected	O
piglets	O
.	O

To	O
provide	O
information	O
regarding	O
the	O
health	O
status	O
of	O
the	O
canine	O
population	O
in	O
Vila	O
do	O
Maio	O
,	O
Maio	O
Island	O
,	O
Cape	O
Verde	O
,	O
53	O
rectal	O
swabs	O
were	O
collected	O
from	O
53	O
stray	O
dogs	O
during	O
2010	O
and	O
93	O
rectal	O
swabs	O
and	O
88	O
blood	B-ANAT
samples	I-ANAT
were	O
collected	O
from	O
125	O
stray	O
dogs	O
in	O
2011	O
.	O

All	O
rectal	O
swabs	O
(	O
2010	O
n	O
=	O
53	O
;	O
2011	O
n	O
=	O
93	O
)	O
were	O
analysed	O
for	O
the	O
presence	O
of	O
canine	O
parvovirus	O
,	O
canine	O
distemper	O
virus	O
and	O
canine	O
coronavirus	O
nucleic	B-ANAT
acids	O
by	O
quantitative	O
PCR	O
methods	O
.	O

Chickens	O
vaccinated	O
with	O
vaccine	O
B	O
had	O
significantly	O
higher	O
viral	O
loads	O
in	O
tears	B-ANAT
at	O
5	O
days	O
postvaccination	O
(	O
DPV	O
)	O
than	O
those	O
vaccinated	O
with	O
vaccine	O
A	O
.	O
Vaccine	O
B	O
also	O
induced	O
a	O
significantly	O
higher	O
lachrymal	O
immunoglobulin	O
M	O
response	O
at	O
11	O
DPV	O
,	O
an	O
earlier	O
peak	O
of	O
IBV	O
-	O
specific	O
lachrymal	O
immunoglobulin	O
A	O
,	O
and	O
higher	O
serum	B-ANAT
antibodies	O
than	O
vaccine	O
A	O
.	O
In	O
addition	O
,	O
a	O
significantly	O
higher	O
proportion	O
of	O
birds	O
vaccinated	O
with	O
vaccine	O
B	O
had	O
vaccine	O
virus	O
detected	O
in	O
the	O
trachea	B-ANAT
at	O
20	O
DPV	O
than	O
those	O
vaccinated	O
with	O
vaccine	O
A	O
.	O
Furthermore	O
,	O
the	O
virus	O
detected	O
at	O
20	O
DPV	O
in	O
most	O
of	O
the	O
chickens	O
vaccinated	O
with	O
vaccine	O
B	O
was	O
a	O
single	O
specific	O
subpopulation	O
(	O
subpopulation	O
4	O
)	O
selected	O
from	O
multiple	O
vaccine	O
subpopulations	O
detected	O
earlier	O
at	O
5	O
and	O
7	O
DPV	O
in	O
the	O
same	O
chickens	O
.	O

On	O
the	O
other	O
hand	O
,	O
a	O
higher	O
proportion	O
of	O
chickens	O
vaccinated	O
with	O
vaccine	O
A	O
had	O
virus	O
detected	O
in	O
cloacal	B-ANAT
swabs	O
at	O
20	O
DPV	O
.	O

The	O
subcellular	O
distribution	O
of	O
the	O
3a	O
protein	O
was	O
studied	O
by	O
immunofluorescence	O
staining	O
of	O
cells	B-ANAT
transfected	O
with	O
wild	O
type	O
and	O
mutant	O
constructs	O
along	O
with	O
markers	O
for	O
different	O
intracellular	B-ANAT
compartments	B-ANAT
.	O

The	O
diagnosis	O
of	O
patients	O
was	O
based	O
on	O
positive	O
nasopharyngeal	B-ANAT
swabs	O
on	O
10	O
patients	O
.	O

The	O
diagnosis	O
of	O
patients	O
was	O
based	O
on	O
positive	O
nasopharyngeal	B-ANAT
swabs	O
on	O
10	O
patients	O
.	O

The	O
exhaled	O
breath	B-ANAT
profile	O
from	O
patients	O
with	O
cardiopulmonary	B-ANAT
edema	O
and	O
pneumonia	O
was	O
different	O
from	O
that	O
of	O
patients	O
with	O
moderate	O
/	O
severe	O
ARDS	O
.	O

An	O
electronic	O
nose	B-ANAT
can	O
rapidly	O
and	O
non	O
-	O
invasively	O
discriminate	O
between	O
patients	O
with	O
and	O
without	O
ARDS	O
with	O
modest	O
accuracy	O
.	O

In	O
patients	O
with	O
severe	O
ARDS	O
in	O
prone	O
position	O
,	O
gravitational	O
pressure	O
transmits	O
through	O
abdominal	B-ANAT
support	O
,	O
resulting	O
in	O
better	O
chest	B-ANAT
wall	I-ANAT
expansion	O
and	O
leading	O
to	O
more	O
oxygenation	O
and	O
opening	O
of	O
the	O
alveoli	B-ANAT
in	O
ventral	O
lung	B-ANAT
along	O
with	O
the	O
dorsal	O
lung	B-ANAT
portion	O
that	O
is	O
usually	O
better	O
ventilated	O
in	O
prone	O
position	O
.	O

We	O
here	O
present	O
an	O
integrated	O
""""	O
DÃ¼sseldorf	O
hands	B-ANAT
-	O
on	O
translation	O
""""	O
in	O
the	O
form	O
of	O
a	O
""""	O
one	O
-	O
page	O
""""	O
standard	O
operating	O
procedure	O
in	O
order	O
to	O
fasten	O
and	O
standardize	O
both	O
diagnosis	O
and	O
therapeutic	O
algorithms	O
on	O
an	O
intensive	O
care	O
unit	O
.	O

ABSTRACT	O
:	O
Most	O
patients	O
infected	O
with	O
avian	O
H7N9	O
influenza	O
virus	O
develop	O
severe	O
disease	O
,	O
including	O
respiratory	O
failure	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
and	O
multi	O
-	O
organ	B-ANAT
failure	O
.	O

Interestingly	O
,	O
the	O
degree	O
of	O
liver	B-ANAT
damage	O
in	O
these	O
patients	O
significantly	O
correlated	O
with	O
their	O
serum	B-ANAT
levels	O
of	O
Th2	O
cytokines	O
,	O
interleukin	O
(	O
IL	O
)-	O
4	O
,	O
and	O
IL	O
-	O
9	O
.	O

Entry	O
of	O
MERS	O
-	O
CoV	O
into	O
target	B-ANAT
cells	I-ANAT
depends	O
on	O
binding	O
of	O
the	O
receptor	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
the	O
viral	B-ANAT
envelope	I-ANAT
spike	O
glycoprotein	O
to	O
the	O
cellular	B-ANAT
receptor	O
dipeptidyl	O
peptidase	O
4	O
(	O
DPP4	O
).	O

TITLE	O
:	O
[	O
Influenza	O
infection	O
in	O
intensive	O
cardiac	B-ANAT
care	O
unit	O
patients	O
].	O

Also	O
infection	O
with	O
influenza	O
type	O
AH1N1	O
may	O
contribute	O
to	O
aggravation	O
of	O
cardiac	B-ANAT
disorders	O
,	O
i	O
.	O
e	O
.	O
acute	O
coronary	B-ANAT
syndrome	O
,	O
heart	B-ANAT
failure	O
,	O
cardiogenic	O
shock	O
,	O
severe	O
ventricular	B-ANAT
arrythmias	O
.	O

Antibodies	O
to	O
and	O
viral	O
nucleic	B-ANAT
acids	O
of	O
MERS	O
-	O
CoV	O
have	O
been	O
found	O
in	O
dromedaries	O
,	O
suggesting	O
the	O
possibility	O
that	O
they	O
may	O
serve	O
as	O
a	O
reservoir	O
or	O
vector	O
for	O
human	O
infection	O
.	O

Sputum	B-ANAT
is	O
representative	O
of	O
the	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
but	O
is	O
used	O
rarely	O
for	O
viral	O
testing	O
.	O

The	O
detection	O
rates	O
of	O
respiratory	O
viruses	O
from	O
sputum	B-ANAT
samples	O
were	O
significantly	O
higher	O
than	O
those	O
from	O
nasopharyngeal	B-ANAT
swabs	O
in	O
adults	O
using	O
real	O
-	O
time	O
multiplex	O
RT	O
-	O
PCR	O
.	O

These	O
findings	O
suggest	O
that	O
sputum	B-ANAT
would	O
benefit	O
for	O
the	O
detection	O
of	O
respiratory	O
viruses	O
by	O
nucleic	B-ANAT
acid	O
amplification	O
tests	O
(	O
NAATs	O
)	O
in	O
patients	O
who	O
produce	O
sputum	B-ANAT
.	O

This	O
may	O
relate	O
to	O
the	O
confinement	O
of	O
PEDV	O
natural	O
infection	O
to	O
the	O
protease	O
-	O
rich	O
small	B-ANAT
intestine	I-ANAT
of	O
pigs	O
.	O

TITLE	O
:	O
[	O
The	O
influence	O
of	O
positive	O
end	O
-	O
expiratory	O
pressure	O
on	O
cerebral	B-ANAT
blood	B-ANAT
flow	O
and	O
cerebrovascular	O
autoregulation	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
].	O

Arterial	B-ANAT
blood	I-ANAT
lactate	O
at	O
pre	O
-	O
ECMO	O
support	O
(	O
0	O
h	O
)	O
and	O
at	O
post	O
-	O
ECMO	O
6	O
hours	O
(	O
6	O
h	O
)	O
were	O
measured	O
and	O
then	O
6	O
h	O
lactate	O
clearance	O
rate	O
was	O
calculated	O
.	O

The	O
value	O
of	O
0	O
h	O
blood	B-ANAT
lactate	O
,	O
6	O
h	O
lactate	O
clearance	O
rate	O
and	O
APACHE	O
II	O
score	O
for	O
predicting	O
death	O
was	O
evaluated	O
by	O
receiver	O
operating	O
characteristic	O
(	O
ROC	O
)	O
curves	O
.	O

(	O
4	O
)	O
Multivariate	O
logistic	O
regression	O
analysis	O
showed	O
that	O
0	O
h	O
blood	B-ANAT
lactate	O
(	O
OR	O
=	O
1	O
.	O
318	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
159	O
â¼	O
6	O
.	O
882	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
6	O
h	O
lactate	O
clearance	O
rate	O
(	O
OR	O
=	O
6	O
.	O
921	O
,	O
95	O
%	O
CI	O
:	O
4	O
.	O
469	O
â¼	O
15	O
.	O
036	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
APACHEII	O
score	O
(	O
OR	O
=	O
4	O
.	O
417	O
,	O
95	O
%	O
CI	O
:	O
3	O
.	O
058	O
â¼	O
10	O
.	O
356	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
were	O
independent	O
risk	O
factors	O
associated	O
with	O
mortality	O
of	O
patients	O
on	O
ECMO	O
.	O

ABSTRACT	O
:	O
Pulmonary	B-ANAT
aspiration	O
is	O
an	O
important	O
recognized	O
cause	O
of	O
ARDS	O
.	O

We	O
conducted	O
a	O
secondary	O
analysis	O
of	O
the	O
Lung	B-ANAT
Injury	O
Prediction	O
Score	O
cohort	O
to	O
better	O
characterize	O
patients	O
with	O
aspiration	O
,	O
including	O
their	O
potential	O
risk	O
factors	O
and	O
related	O
outcomes	O
.	O

The	O
patient	O
developed	O
as	O
an	O
early	O
complication	O
ischemic	O
lesions	O
of	O
both	O
arms	B-ANAT
and	O
feet	B-ANAT
.	O

Later	O
complications	O
included	O
repeated	O
candidemia	O
and	O
bacteraemia	O
despite	O
appropriate	O
therapy	O
;	O
the	O
origin	O
appeared	O
to	O
be	O
diffuse	O
ischemic	O
injury	O
of	O
the	O
gastrointestinal	B-ANAT
tract	I-ANAT
.	O

Vergadi	O
et	O
al	O
.	O
are	O
the	O
first	O
to	O
demonstrate	O
that	O
depletion	O
of	O
Akt2	O
kinase	O
and	O
microRNA	O
-	O
146a	O
induction	O
in	O
mice	O
resulted	O
in	O
polarization	O
of	O
alveolar	B-ANAT
macrophages	I-ANAT
towards	O
an	O
M2	O
activation	O
phenotype	O
and	O
resulted	O
in	O
less	O
severe	O
injury	O
following	O
acid	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
Twenty	O
-	O
two	O
flocks	O
of	O
turkeys	O
affected	O
by	O
enteric	O
problems	O
,	O
with	O
ages	O
between	O
10	O
and	O
104	O
days	O
and	O
located	O
in	O
the	O
Southern	O
region	O
of	O
Brazil	O
,	O
were	O
surveyed	O
for	O
turkey	O
by	O
PCR	O
for	O
turkey	O
astrovirus	O
type	O
2	O
(	O
TAstV	O
-	O
2	O
),	O
turkey	O
coronavirus	O
(	O
TCoV	O
),	O
hemorrhagic	O
enteritis	O
virus	O
(	O
HEV	B-ANAT
),	O
rotavirus	O
,	O
reovirus	O
,	O
Salmonella	O
spp	O
.,	O
and	O
Lawsonia	O
intracellularis	O
(	O
Li	O
)	O
infections	O
.	O

The	O
most	O
common	O
complaints	O
of	O
patients	O
on	O
admission	O
were	O
cough	O
(	O
100	O
%),	O
runny	O
nose	B-ANAT
(	O
82	O
.	O
3	O
%)	O
and	O
respiratory	O
difficulty	O
(	O
71	O
%),	O
whereas	O
fever	O
was	O
present	O
in	O
21	O
(	O
33	O
.	O
9	O
%)	O
patients	O
.	O

ABSTRACT	O
:	O
Sickle	B-ANAT
cell	I-ANAT
disease	O
(	O
or	O
drepanocytosis	O
)	O
is	O
a	O
hemoglobinopathy	O
characterized	O
by	O
an	O
increase	O
in	O
viscosity	O
and	O
adhesivity	O
of	O
the	O
typically	O
sickle	O
-	O
shaped	O
erythrocytes	B-ANAT
.	O

Epidemiologic	O
and	O
clinical	O
characteristics	O
of	O
selected	O
potential	O
cases	O
were	O
assessed	O
through	O
serum	B-ANAT
blood	B-ANAT
specimens	O
,	O
medical	O
record	O
reviews	O
,	O
and	O
interviews	O
with	O
surviving	O
outbreak	O
members	O
,	O
household	O
contacts	O
,	O
and	O
healthcare	O
personnel	O
.	O

Accordingly	O
,	O
extensive	O
mononuclear	O
infiltration	O
and	O
alveolar	B-ANAT
destruction	O
were	O
present	O
in	O
the	O
lungs	B-ANAT
of	O
infected	O
WT	O
mice	O
,	O
followed	O
by	O
100	O
%	O
lethality	O
.	O

Conversely	O
,	O
in	O
Î±7	O
(-/-)	O
mice	O
,	O
virus	O
replication	O
was	O
restricted	O
mostly	O
to	O
the	O
bronchial	B-ANAT
epithelium	I-ANAT
with	O
marginal	O
alveolar	B-ANAT
infection	O
,	O
resulting	O
in	O
significantly	O
reduced	O
lung	B-ANAT
damage	O
and	O
enhanced	O
animal	O
survival	O
.	O

To	O
investigate	O
the	O
host	O
immune	O
response	O
during	O
alveolar	B-ANAT
virus	O
replication	O
,	O
we	O
studied	O
the	O
role	O
of	O
primary	O
macrophages	B-ANAT
in	O
virus	O
propagation	O
and	O
clearance	O
.	O

SIRS	O
independently	O
and	O
adversely	O
affects	O
the	O
in	O
-	O
hospital	O
outcome	O
in	O
patients	O
with	O
liver	B-ANAT
cirrhosis	O
.	O

We	O
describe	O
a	O
case	O
of	O
TEN	O
presenting	O
with	O
stage	O
III	O
acute	O
kidney	B-ANAT
injury	O
,	O
rhabdomyolysis	O
,	O
and	O
acute	O
respiratory	O
failure	O
likely	O
triggered	O
by	O
allopurinol	O
for	O
recently	O
diagnosed	O
gout	O
.	O

Using	O
two	O
-	O
photon	O
imaging	O
of	O
a	O
newly	O
developed	O
ventral	O
spinal	B-ANAT
cord	I-ANAT
preparation	O
and	O
a	O
viral	O
model	O
of	O
demyelination	O
,	O
we	O
describe	O
the	O
motility	O
and	O
intercellular	O
interactions	O
of	O
transplanted	B-ANAT
mouse	O
NPCs	O
expressing	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
)	O
with	O
damaged	O
axons	B-ANAT
expressing	O
yellow	O
fluorescent	O
protein	O
(	O
YFP	O
).	O

A	O
tidal	O
volume	O
of	O
6	O
mL	O
/	O
kg	O
predicted	O
body	B-ANAT
weight	O
is	O
recommended	O
,	O
either	O
in	O
pressure	O
or	O
volume	O
control	O
ventilation	O
.	O

The	O
use	O
of	O
vv	O
-	O
ECMO	O
was	O
performed	O
without	O
anticoagulation	O
because	O
of	O
his	O
traumatic	O
brain	B-ANAT
injury	O
and	O
severe	O
spinal	B-ANAT
cord	I-ANAT
injury	O
.	O

TITLE	O
:	O
Effects	O
of	O
Toll	O
-	O
like	O
receptor	O
stimulation	O
on	O
eosinophilic	O
infiltration	O
in	O
lungs	B-ANAT
of	O
BALB	O
/	O
c	O
mice	O
immunized	O
with	O
UV	O
-	O
inactivated	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
related	O
coronavirus	O
vaccine	O
.	O

In	O
contrast	O
,	O
TLR	O
agonists	O
added	O
to	O
UV	O
-	O
V	O
vaccine	O
,	O
including	O
lipopolysaccharide	O
,	O
poly	O
(	O
U	O
),	O
and	O
poly	O
(	O
I	O
Â·	O
C	O
)	O
(	O
UV	O
-	O
V	O
+	O
TLR	O
),	O
strikingly	O
reduced	O
excess	O
eosinophilic	O
infiltration	O
in	O
the	O
lungs	B-ANAT
and	O
induced	O
lower	O
levels	O
of	O
interleukin	O
-	O
4	O
and	O
-	O
13	O
and	O
eotaxin	O
in	O
the	O
lungs	B-ANAT
than	O
UV	O
-	O
V	O
-	O
immunization	O
alone	O
.	O

We	O
report	O
a	O
case	O
in	O
which	O
PLUS	O
was	O
used	O
to	O
clinically	O
monitor	O
a	O
complex	O
lung	B-ANAT
lesion	O
during	O
treatment	O
of	O
a	O
child	O
with	O
congenital	O
heart	B-ANAT
disease	O
suffering	O
from	O
severe	O
lung	B-ANAT
injury	O
.	O

PLUS	O
was	O
performed	O
daily	O
to	O
monitor	O
the	O
disease	O
'	O
s	O
progression	O
and	O
response	O
to	O
treatment	O
during	O
lung	B-ANAT
rest	O
.	O

A	O
decade	O
later	O
,	O
One	O
Health	O
advocates	O
face	B-ANAT
increasing	O
pressure	O
to	O
translate	O
the	O
approach	O
from	O
theory	O
into	O
action	O
.	O

In	O
both	O
cohorts	O
,	O
we	O
identified	O
a	O
hyperinflammatory	O
subphenotype	O
(	O
phenotype	O
2	O
)	O
that	O
was	O
characterised	O
by	O
higher	O
plasma	B-ANAT
concentrations	O
of	O
inflammatory	O
biomarkers	O
,	O
a	O
higher	O
prevalence	O
of	O
vasopressor	O
use	O
,	O
lower	O
serum	B-ANAT
bicarbonate	O
concentrations	O
,	O
and	O
a	O
higher	O
prevalence	O
of	O
sepsis	O
than	O
phenotype	O
1	O
.	O

We	O
propose	O
that	O
PLpro	O
'	O
s	O
higher	O
affinity	O
for	O
K48	O
-	O
linked	O
ubiquitin	O
chains	O
and	O
ISG15	O
stems	B-ANAT
from	O
a	O
bivalent	O
mechanism	O
of	O
binding	O
,	O
where	O
two	O
ubiquitin	O
-	O
like	O
domains	O
prefer	O
to	O
bind	O
in	O
the	O
palm	B-ANAT
domain	O
of	O
PLpro	O
with	O
the	O
most	O
distal	O
ubiquitin	O
domain	O
interacting	O
with	O
a	O
""""	O
ridge	O
""""	O
region	O
of	O
the	O
thumb	B-ANAT
domain	O
.	O

In	O
the	O
novel	O
environment	O
test	O
,	O
calves	O
with	O
physical	O
contact	O
(	O
T	O
,	O
P	O
,	O
and	O
VP	O
)	O
had	O
a	O
lower	O
heart	B-ANAT
rate	O
,	O
and	O
more	O
of	O
these	O
calves	O
vocalized	O
during	O
the	O
test	O
compared	O
with	O
calves	O
without	O
physical	O
contact	O
(	O
I	O
and	O
V	O
).	O

We	O
tested	O
this	O
array	O
on	O
155	O
febrile	O
and	O
afebrile	O
patients	O
(	O
35	O
.	O
4	O
Â°	O
C	O
â¤	O
axillary	B-ANAT
temperature	O
â¤	O
39	O
.	O
3	O
Â°	O
C	O
)	O
with	O
seasonal	O
influenza	O
at	O
the	O
Japan	O
Self	O
-	O
Defense	O
Forces	O
Central	O
Hospital	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	O
,	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
),	O
JHM	O
strain	O
induces	O
a	O
biphasic	O
disease	O
in	O
BALB	O
/	O
c	O
mice	O
that	O
consists	O
of	O
an	O
acute	O
retinitis	O
followed	O
by	O
progression	O
to	O
a	O
chronic	O
retinal	B-ANAT
degeneration	O
with	O
autoimmune	O
reactivity	O
.	O

The	O
phase	O
of	O
T	B-ANAT
cell	I-ANAT
-	O
dependent	O
,	O
antibody	O
-	O
independent	O
control	O
of	O
infectious	O
virus	O
was	O
associated	O
with	O
a	O
similar	O
recruitment	O
of	O
naive	O
/	O
early	O
-	O
activated	O
IgD	O
(+)	O
IgM	O
(+)	O
B	B-ANAT
cells	I-ANAT
into	O
both	O
the	O
brain	B-ANAT
and	I-ANAT
spinal	I-ANAT
cord	I-ANAT
.	O

TITLE	O
:	O
Targeting	O
membrane	B-ANAT
-	O
bound	O
viral	O
RNA	O
synthesis	O
reveals	O
potent	O
inhibition	O
of	O
diverse	O
coronaviruses	O
including	O
the	O
middle	O
East	O
respiratory	O
syndrome	O
virus	O
.	O

Here	O
we	O
screened	O
a	O
collection	O
of	O
16671	O
diverse	O
compounds	O
for	O
anti	O
-	O
human	O
coronavirus	O
229E	O
activity	O
and	O
identified	O
an	O
inhibitor	O
,	O
designated	O
K22	O
,	O
that	O
specifically	O
targets	O
membrane	B-ANAT
-	O
bound	O
coronaviral	O
RNA	O
synthesis	O
.	O

TITLE	O
:	O
Severe	O
nocturnal	O
and	O
postexercise	O
hypoxia	O
in	O
children	O
and	O
adolescents	O
with	O
sickle	B-ANAT
cell	I-ANAT
disease	O
.	O

TITLE	O
:	O
The	O
first	O
reported	O
case	O
of	O
ureteral	O
perforation	O
in	O
a	O
patient	O
with	O
severe	O
toxic	O
epidermal	B-ANAT
necrolysis	O
syndrome	O
.	O

There	O
have	O
been	O
descriptions	O
of	O
gastrointestinal	O
,	O
respiratory	O
,	O
vaginal	B-ANAT
,	O
and	O
ocular	B-ANAT
mucosal	B-ANAT
involvement	O
,	O
including	O
cases	O
of	O
corneal	O
and	O
colonic	B-ANAT
perforation	O
.	O

ABSTRACT	O
:	O
Prone	O
positioning	O
has	O
been	O
used	O
for	O
many	O
years	O
in	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
with	O
no	O
clear	O
benefit	O
for	O
patient	O
outcome	O
.	O

Whereas	O
resolution	O
of	O
alveolar	B-ANAT
edema	O
in	O
cardiogenic	O
pulmonary	B-ANAT
edema	O
can	O
be	O
rapid	O
,	O
the	O
rate	O
of	O
edema	O
resolution	O
in	O
most	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
markedly	O
impaired	O
,	O
a	O
finding	O
that	O
correlates	O
with	O
higher	O
mortality	O
.	O

Several	O
mechanisms	O
impair	O
the	O
resolution	O
of	O
alveolar	B-ANAT
edema	O
in	O
ARDS	O
,	O
including	O
cell	B-ANAT
injury	O
from	O
unfavorable	O
ventilator	O
strategies	O
or	O
pathogens	O
,	O
hypoxia	O
,	O
cytokines	O
,	O
and	O
oxidative	O
stress	O
.	O

TITLE	O
:	O
Serum	B-ANAT
activin	O
A	O
and	O
B	O
,	O
and	O
follistatin	O
in	O
critically	O
ill	O
patients	O
with	O
influenza	O
A	O
(	O
H1N1	O
)	O
infection	O
.	O

Clinical	O
information	O
was	O
recorded	O
during	O
ICU	O
treatment	O
,	O
and	O
serum	B-ANAT
activin	O
A	O
,	O
activin	O
B	O
,	O
FS	O
,	O
IL	O
-	O
6	O
and	O
IL	O
-	O
10	O
were	O
measured	O
at	O
admission	O
to	O
ICU	O
and	O
on	O
days	O
2	O
and	O
7	O
.	O

TITLE	O
:	O
Antibody	O
-	O
dependent	O
infection	O
of	O
human	O
macrophages	B-ANAT
by	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
.	O

Furthermore	O
,	O
only	O
FcÎ³RII	O
with	O
intact	O
cytoplasmic	B-ANAT
signaling	O
domains	O
were	O
competent	O
to	O
sustain	O
ADE	O
of	O
SARS	O
-	O
CoVpp	O
infection	O
,	O
thus	O
providing	O
additional	O
information	O
on	O
the	O
role	O
of	O
downstream	O
signaling	O
by	O
FcÎ³RII	O
.	O

Since	O
cellular	B-ANAT
immunity	O
is	O
thought	O
to	O
be	O
critical	O
in	O
preventing	O
FIP	O
and	O
because	O
diseased	O
cats	O
often	O
show	O
a	O
significant	O
decrease	O
in	O
interferon	O
-	O
Î³	O
(	O
IFN	O
-	O
Î³	O
)	O
production	O
,	O
we	O
investigated	O
whether	O
single	O
nucleotide	O
polymorphisms	O
(	O
SNP	O
)	O
in	O
the	O
feline	O
IFN	O
-	O
Î³	O
gene	O
(	O
fIFNG	O
)	O
are	O
associated	O
with	O
the	O
outcome	O
of	O
infection	O
.	O

The	O
initial	O
patient	O
presentation	O
was	O
of	O
uncomplicated	O
P	O
.	O
vivax	O
(	O
0	O
.	O
5	O
%	O
parasitaemia	O
)	O
in	O
a	O
term	O
,	O
multigravida	O
woman	O
who	O
responded	O
rapidly	O
to	O
oral	B-ANAT
artesunate	O
and	O
mefloquine	O
treatment	O
,	O
clearing	O
her	O
blood	B-ANAT
stage	O
parasites	O
within	O
48	O
hours	O
.	O

Despite	O
induction	O
and	O
delivery	O
of	O
a	O
stillborn	O
foetus	B-ANAT
,	O
ventilatory	O
requirements	O
increased	O
and	O
the	O
patient	O
died	O
on	O
day	O
7	O
.	O

The	O
results	O
of	O
this	O
systematic	O
review	O
will	O
comprehensively	O
summarize	O
the	O
safety	O
and	O
efficacy	O
of	O
MSC	O
therapy	O
in	O
preclinical	O
models	O
of	O
acute	O
lung	B-ANAT
injury	O
.	O

Western	O
blots	O
demonstrated	O
that	O
peptide	O
H	O
interacted	O
with	O
PEDV	O
spike	O
protein	O
and	O
that	O
pre	O
-	O
treatment	O
of	O
PEDV	O
with	O
peptide	O
H	O
led	O
to	O
a	O
higher	O
inhibition	O
than	O
synchronous	O
incubation	O
with	O
cells	B-ANAT
.	O

Rather	O
,	O
it	O
limits	O
CNS	B-ANAT
inflammation	O
and	O
impairs	O
control	O
of	O
CNS	B-ANAT
virus	O
replication	O
via	O
induction	O
of	O
IL	O
-	O
10	O
in	O
virus	O
-	O
specific	O
CD4	O
+	O
T	B-ANAT
cells	I-ANAT
.	O

Human	O
MSCs	O
were	O
well	O
tolerated	O
and	O
improved	O
oxygenation	O
and	O
decreased	O
pulmonary	B-ANAT
oedema	O
in	O
a	O
sheep	O
model	O
of	O
severe	O
ARDS	O
.	O

ABSTRACT	O
:	O
Transfusion	O
-	O
related	O
acute	O
lung	B-ANAT
injury	O
(	O
TRALI	O
)	O
is	O
defined	O
as	O
the	O
onset	O
or	O
the	O
worsening	O
of	O
respiratory	O
distress	O
within	O
6	O
h	O
of	O
the	O
transfusion	O
of	O
a	O
plasma	B-ANAT
-	O
containing	O
blood	B-ANAT
component	I-ANAT
.	O

Cultured	O
NPCs	O
derived	O
from	O
C57BL	O
/	O
6	O
(	O
H	O
-	O
2	O
(	O
b	O
)	O
)	O
mice	O
express	O
the	O
NKG2D	O
ligand	O
retinoic	O
acid	O
early	O
precursor	O
transcript	O
(	O
RAE	O
)-	O
1	O
but	O
expression	O
was	O
dramatically	O
reduced	O
upon	O
differentiation	O
into	O
either	O
glia	B-ANAT
or	O
neurons	B-ANAT
.	O

ABSTRACT	O
:	O
Little	O
attention	O
has	O
been	O
given	O
to	O
ARDS	O
in	O
cancer	O
patients	O
,	O
despite	O
their	O
high	O
risk	O
for	O
pulmonary	B-ANAT
complications	O
.	O

Risk	O
factors	O
for	O
higher	O
mortality	O
were	O
allogeneic	O
bone	B-ANAT
-	O
marrow	O
transplantation	O
,	O
modified	O
SOFA	O
,	O
NIV	O
failure	O
,	O
severe	O
ARDS	O
,	O
and	O
invasive	O
fungal	O
infection	O
.	O

Gene	O
transcription	O
is	O
dynamic	O
and	O
condition	O
-	O
specific	O
;	O
therefore	O
,	O
to	O
better	O
understand	O
the	O
mouse	O
transcriptional	O
response	O
to	O
respiratory	O
virus	O
infection	O
,	O
we	O
infected	O
the	O
eight	O
founder	O
strains	O
of	O
the	O
Collaborative	O
Cross	O
with	O
either	O
influenza	O
A	O
virus	O
or	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
and	O
sequenced	O
lung	B-ANAT
RNA	O
samples	O
at	O
2	O
and	O
4	O
days	O
after	O
infection	O
.	O

After	O
the	O
development	O
of	O
a	O
severe	O
headache	O
,	O
nausea	O
,	O
diplopia	O
,	O
and	O
attacks	O
of	O
hypertension	O
in	O
the	O
early	O
postoperative	O
period	O
,	O
a	O
computer	O
tomography	O
of	O
the	O
brain	B-ANAT
was	O
normal	O
.	O

ABSTRACT	O
:	O
An	O
essential	O
function	O
of	O
innate	O
immunity	O
is	O
to	O
distinguish	O
self	O
from	O
non	O
-	O
self	O
and	O
receptors	O
have	O
evolved	O
to	O
specifically	O
recognize	O
viral	B-ANAT
components	I-ANAT
and	O
initiate	O
the	O
expression	O
of	O
antiviral	O
proteins	O
to	O
restrict	O
viral	O
replication	O
.	O

Replacing	O
proline	O
939	O
with	O
the	O
corresponding	O
HCoV	O
-	O
OC43	O
residue	O
,	O
leucine	O
,	O
decreased	O
the	O
ability	O
MHV	O
to	O
induce	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
,	O
providing	O
experimental	O
support	O
for	O
an	O
earlier	O
proposal	O
that	O
residues	O
929	O
-	O
944	O
make	O
up	O
the	O
fusion	O
peptide	O
of	O
the	O
MHV	O
S	O
protein	O
.	O

ABSTRACT	O
:	O
The	O
World	O
Health	O
Organization	O
(	O
WHO	O
)	O
ranks	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
(	O
RTI	O
)	O
as	O
the	O
second	O
leading	O
cause	O
of	O
death	O
worldwide	O
for	O
children	O
under	O
5	O
years	O
of	O
age	O
.	O

TITLE	O
:	O
Membrane	B-ANAT
rearrangements	O
mediated	O
by	O
coronavirus	O
nonstructural	O
proteins	O
3	O
and	O
4	O
.	O

We	O
now	O
show	O
that	O
these	O
foci	O
correspond	O
to	O
areas	O
of	O
rearranged	O
ER	O
-	O
derived	O
membranes	B-ANAT
,	O
which	O
display	O
increased	O
membrane	B-ANAT
curvature	O
.	O

Binding	O
tests	O
with	O
isolated	O
primary	O
oviduct	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
and	O
soluble	O
S1	O
proteins	O
revealed	O
that	O
S1	O
proteins	O
of	O
two	O
IBV	O
strains	O
bound	O
with	O
the	O
same	O
efficiency	O
to	O
oviduct	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

Two	O
patients	O
were	O
alive	O
,	O
with	O
a	O
good	O
immunovirological	O
profile	O
and	O
they	O
went	O
back	B-ANAT
to	O
their	O
previous	O
quality	O
of	O
life	O
.	O

In	O
this	O
study	O
,	O
the	O
SARS	O
coronavirus	O
small	O
envelope	B-ANAT
protein	O
(	O
SCVE	O
)	O
was	O
expressed	O
in	O
E	O
.	O
coli	O
cells	B-ANAT
previously	O
engineered	O
for	O
periplasmic	B-ANAT
expression	O
of	O
carbonic	O
anhydrase	O
(	O
CA	O
)	O
activity	O
.	O

Feline	O
enteric	O
coronavirus	O
(	O
88	O
%),	O
Giardia	O
(	O
56	O
%),	O
Clostridium	O
perfringens	O
(	O
49	O
%),	O
and	O
Tritrichomonas	O
foetus	B-ANAT
(	O
39	O
%)	O
were	O
most	O
common	O
in	O
cats	O
with	O
diarrhea	O
.	O

Our	O
results	O
showed	O
that	O
the	O
SOCS3	O
expression	O
was	O
significantly	O
elevated	O
in	O
both	O
the	O
liver	B-ANAT
tissue	I-ANAT
and	O
PBMCs	O
from	O
patients	O
with	O
HBV	O
-	O
ACLF	O
compared	O
to	O
mild	O
chronic	O
hepatitis	O
B	O
(	O
CHB	O
).	O

These	O
data	O
suggested	O
that	O
SOCS3	O
may	O
play	O
a	O
pivotal	O
role	O
in	O
the	O
pathogenesis	O
of	O
MHV	O
-	O
3	O
-	O
induced	O
acute	O
liver	B-ANAT
failure	O
and	O
HBV	O
-	O
ACLF	O
.	O

ABSTRACT	O
:	O
We	O
examined	O
the	O
role	O
of	O
wild	O
birds	O
in	O
the	O
epidemiology	O
of	O
avian	O
coronaviruses	O
by	O
studying	O
oropharyngeal	B-ANAT
swabs	O
from	O
32	O
wild	O
bird	O
species	O
.	O

Here	O
,	O
we	O
identified	O
the	O
steps	O
that	O
govern	O
-	O
1PRF	O
by	O
following	O
the	O
stepwise	O
movement	O
of	O
the	O
ribosome	B-ANAT
through	O
the	O
frameshifting	O
site	O
of	O
a	O
model	O
mRNA	O
derived	O
from	O
the	O
IBV	O
1a	O
/	O
1b	O
gene	O
in	O
a	O
reconstituted	O
in	O
vitro	O
translation	O
system	O
from	O
Escherichia	O
coli	O
.	O

The	O
potential	O
for	O
antiviral	O
development	O
is	O
currently	O
hindered	O
by	O
a	O
poor	O
understanding	O
of	O
RNA	O
-	O
driven	O
molecular	O
mechanisms	O
,	O
resulting	O
from	O
a	O
lack	O
of	O
structural	O
information	O
on	O
large	O
RNAs	O
and	O
ribonucleoprotein	B-ANAT
complexes	O
.	O

Monitoring	O
included	O
standard	O
respiratory	O
,	O
arterial	B-ANAT
blood	I-ANAT
gas	O
analysis	O
and	O
electrical	O
impedance	O
tomography	O
(	O
EIT	O
)	O
images	O
.	O

The	O
most	O
common	O
clinical	O
presentations	O
were	O
nonspecific	O
influenza	O
symptoms	O
(	O
43	O
.	O
7	O
%),	O
pneumonia	O
(	O
29	O
.	O
2	O
%)	O
and	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
exacerbation	O
(	O
8	O
.	O
3	O
%).	O

All	O
tests	O
worked	O
with	O
effusions	O
,	O
even	O
when	O
only	O
blood	B-ANAT
products	O
were	O
stipulated	O
in	O
the	O
instruction	O
manual	O
.	O

Here	O
,	O
we	O
investigate	O
whether	O
plasma	B-ANAT
proteins	O
raise	O
T	O
in	O
situ	O
in	O
the	O
isolated	O
rat	B-ANAT
lung	I-ANAT
under	O
physiologic	O
conditions	O
.	O

We	O
flood	O
alveoli	B-ANAT
with	O
liquid	O
that	O
omits	O
/	O
includes	O
plasma	B-ANAT
proteins	O
.	O

Little	O
is	O
known	O
about	O
the	O
molecular	O
mechanisms	O
of	O
brain	B-ANAT
injury	O
caused	O
by	O
PHEV	O
.	O

Significantly	O
downregulated	O
genes	O
were	O
mainly	O
involved	O
in	O
nervous	O
-	O
system	O
development	O
,	O
synaptic	O
transmission	O
,	O
neuron	B-ANAT
-	O
projection	O
development	O
,	O
the	O
transmission	O
of	O
nerve	B-ANAT
impulses	O
and	O
negative	O
regulation	O
of	O
glial	B-ANAT
cell	I-ANAT
differentiation	O
.	O

TITLE	O
:	O
Detection	O
of	O
respiratory	O
viruses	O
and	O
Bordetella	O
bronchiseptica	O
in	O
dogs	O
with	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
.	O

ABSTRACT	O
:	O
In	O
chronic	O
persistent	O
asthma	O
and	O
severe	O
acute	O
exacerbations	O
of	O
bronchial	B-ANAT
asthma	O
,	O
infectious	O
agents	O
are	O
the	O
predominant	O
triggers	O
that	O
drive	O
disease	O
and	O
airway	B-ANAT
pathobiology	O
.	O

Primers	O
were	O
designed	O
based	O
on	O
multiple	O
alignment	O
of	O
reference	O
sequences	O
,	O
targeting	O
the	O
conserved	O
regions	O
of	O
each	O
species	O
of	O
HcoV	O
.	O
Virus	O
strains	O
and	O
nucleic	B-ANAT
acid	O
preserved	O
in	O
our	O
lab	O
were	O
used	O
as	O
template	O
in	O
developing	O
this	O
automatic	O
-	O
electrophoresis	O
-	O
based	O
one	O
-	O
tube	O
multiplex	O
RT	O
-	O
PCR	O
assay	O
.	O

ABSTRACT	O
:	O
Innate	O
immunity	O
has	O
a	O
primary	O
role	O
in	O
lung	B-ANAT
antimicrobial	O
defenses	O
.	O

ABSTRACT	O
:	O
Viral	O
2	O
',	O
5	O
'-	O
phosphodiesterases	O
(	O
2	O
',	O
5	O
'-	O
PDEs	O
)	O
help	O
disparate	O
RNA	O
viruses	O
evade	O
the	O
antiviral	O
activity	O
of	O
interferon	O
(	O
IFN	O
)	O
by	O
degrading	O
2	O
',	O
5	O
'-	O
oligoadenylate	O
(	O
2	O
-	O
5A	O
)	O
activators	O
of	O
RNase	O
L	O
.	O
A	O
kinase	O
anchoring	O
proteins	O
(	O
AKAPs	O
)	O
bind	O
the	O
regulatory	O
subunits	O
of	O
protein	O
kinase	O
A	O
(	O
PKA	B-ANAT
)	O
to	O
localize	O
and	O
organize	O
cyclic	O
AMP	O
(	O
cAMP	O
)	O
signaling	O
during	O
diverse	O
physiological	O
processes	O
.	O

The	O
AKAP7	O
PDE	O
domain	O
or	O
N	O
-	O
terminally	O
truncated	O
AKAP7	O
(	O
both	O
lacking	O
a	O
nuclear	O
localization	O
motif	O
),	O
but	O
not	O
full	O
-	O
length	O
AKAP7	O
or	O
a	O
mutant	O
,	O
AKAP7	O
(	O
H185R	O
),	O
PDE	O
domain	O
restored	O
the	O
infectivity	O
of	O
ns2	O
mutant	O
MHV	O
in	O
bone	B-ANAT
marrow	I-ANAT
macrophages	B-ANAT
and	O
in	O
livers	B-ANAT
of	O
infected	O
mice	O
.	O

The	O
proviral	O
effect	O
requires	O
cytoplasmic	B-ANAT
localization	O
of	O
the	O
AKAP7	O
PDE	O
domain	O
.	O

Coronavirus	O
infection	O
of	O
cultured	B-ANAT
cells	I-ANAT
was	O
previously	O
shown	O
to	O
cause	O
ER	O
stress	O
and	O
induce	O
the	O
unfolded	O
protein	O
response	O
(	O
UPR	O
),	O
a	O
process	O
that	O
aims	O
to	O
restore	O
the	O
ER	O
homeostasis	O
by	O
global	O
translation	O
shutdown	O
and	O
increasing	O
the	O
ER	O
folding	O
capacity	O
.	O

ABSTRACT	O
:	O
Autophagy	O
is	O
a	O
cellular	B-ANAT
response	O
to	O
starvation	O
that	O
generates	O
autophagosomes	O
to	O
carry	O
long	O
-	O
lived	O
proteins	O
and	O
cellular	B-ANAT
organelles	B-ANAT
to	O
lysosomes	B-ANAT
for	O
degradation	O
.	O

Pre	O
-	O
and	O
post	O
-	O
treatment	O
lymphopenia	O
and	O
pre	O
-	O
treatment	O
serum	B-ANAT
albumin	O
should	O
be	O
considered	O
in	O
order	O
to	O
minimize	O
the	O
risk	O
of	O
FN	O
when	O
selecting	O
patients	O
with	O
prostate	B-ANAT
cancer	O
for	O
docetaxel	O
therapy	O
,	O
and	O
when	O
considering	O
dose	O
modifications	O
,	O
and	O
the	O
prophylactic	O
use	O
of	O
granulocyte	B-ANAT
colony	O
-	O
stimulating	O
factor	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
are	O
positive	O
stranded	O
RNA	O
viruses	O
that	O
cause	O
respiratory	O
,	O
enteric	O
and	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
diseases	O
in	O
many	O
species	O
,	O
including	O
humans	O
.	O

The	O
first	O
serum	B-ANAT
sample	I-ANAT
taken	O
on	O
day	O
6	O
tested	O
negative	O
for	O
leptospira	O
,	O
while	O
PCR	O
showed	O
positive	O
results	O
for	O
leptospiral	O
DNA	O
.	O

We	O
found	O
that	O
up	O
-	O
regulation	O
of	O
miR	O
-	O
125b	O
expression	O
maintained	O
the	O
body	B-ANAT
weight	O
and	O
survival	O
of	O
ALI	O
mice	O
,	O
and	O
significantly	O
reduced	O
LPS	O
-	O
induced	O
pulmonary	B-ANAT
inflammation	O
as	O
reflected	O
by	O
reductions	O
in	O
total	O
cell	B-ANAT
and	O
neutrophil	B-ANAT
counts	O
,	O
proinflammatory	O
cytokines	O
,	O
as	O
well	O
as	O
chemokines	O
in	O
BAL	O
fluid	O
.	O

At	O
the	O
time	O
of	O
discharge	B-ANAT
,	O
he	O
had	O
residual	O
opacities	O
in	O
the	O
chest	B-ANAT
radiograph	O
and	O
resting	B-ANAT
oxygen	O
saturation	O
was	O
94	O
%	O
on	O
room	O
air	O
.	O

Assessment	O
of	O
micturition	O
patterns	O
by	O
filter	O
paper	O
assay	O
determined	O
an	O
increase	O
in	O
the	O
number	O
of	O
small	O
and	O
large	O
urine	B-ANAT
spots	O
in	O
CIE	O
mice	O
starting	O
from	O
the	O
second	O
week	O
after	O
inoculation	O
.	O

The	O
spike	O
(	O
S	O
)	O
protein	O
of	O
PEDV	O
is	O
a	O
type	O
1	O
transmembrane	B-ANAT
envelope	B-ANAT
glycoprotein	O
and	O
consists	O
of	O
the	O
S1	O
and	O
S2	O
domains	O
,	O
which	O
are	O
responsible	O
for	O
virus	O
binding	O
and	O
fusion	O
,	O
respectively	O
.	O

Title	O
compounds	O
were	O
tested	O
in	O
cell	B-ANAT
-	O
based	O
assays	O
for	O
cytotoxicity	O
and	O
antiviral	O
activity	O
against	O
representatives	O
of	O
two	O
DNA	O
virus	O
families	O
as	O
wells	O
as	O
against	O
representatives	O
of	O
RNA	O
virus	O
families	O
containing	O
single	O
-	O
stranded	O
,	O
either	O
positive	O
-	O
sense	O
(	O
ssRNA	O
(+))	O
or	O
negative	O
-	O
sense	O
(	O
ssRNA	O
(-)),	O
and	O
double	O
-	O
stranded	O
genomes	O
(	O
dsRNA	O
).	O

Respiratory	O
viruses	O
were	O
investigated	O
from	O
nasopharyngeal	B-ANAT
swabs	O
of	O
76	O
patients	O
diagnosed	O
with	O
atypical	O
pneumonia	O
and	O
64	O
healthy	O
controls	O
using	O
the	O
CLART	O
Pneumovir	O
(	O
Genomica	O
,	O
Spain	O
)	O
kit	O
and	O
from	O
10	O
mL	O
blood	B-ANAT
samples	I-ANAT
of	O
the	O
same	O
subjects	O
.	O

TITLE	O
:	O
Sensitivity	O
of	O
SARS	O
/	O
MERS	O
CoV	O
to	O
interferons	O
and	O
other	O
drugs	O
based	O
on	O
achievable	O
serum	B-ANAT
concentrations	O
in	O
humans	O
.	O

The	O
most	O
active	O
drugs	O
against	O
SARS	O
/	O
MERS	O
CoV	O
at	O
clinically	O
achievable	O
serum	B-ANAT
levels	O
were	O
type	O
I	O
interferons	O
and	O
a	O
TLR3	O
agonist	O
,	O
interferon	O
inducer	O
/	O
activator	O
.	O

The	O
bacterial	O
co	O
-	O
detection	O
rate	O
was	O
26	O
.	O
5	O
%,	O
and	O
those	O
cases	O
were	O
more	O
likely	O
to	O
have	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
involvement	O
(	O
P	O
=	O
0	O
.	O
001	O
),	O
longer	O
hospital	O
stay	O
(	O
P	O
=	O
0	O
.	O
001	O
),	O
and	O
higher	O
mortality	O
(	O
P	O
=	O
0	O
.	O
001	O
).	O

These	O
rescue	O
therapies	O
allowed	O
the	O
patients	O
to	O
overcome	O
the	O
critical	O
situation	O
without	O
associated	O
complications	O
and	O
with	O
no	O
detrimental	O
effects	O
on	O
the	O
intracranial	B-ANAT
and	O
cerebral	B-ANAT
perfusion	O
pressures	O
.	O

ABSTRACT	O
:	O
Administration	O
of	O
convalescent	O
plasma	B-ANAT
,	O
serum	B-ANAT
,	O
or	O
hyperimmune	O
immunoglobulin	O
may	O
be	O
of	O
clinical	O
benefit	O
for	O
treatment	O
of	O
severe	O
acute	O
respiratory	O
infections	O
(	O
SARIs	O
)	O
of	O
viral	O
etiology	O
.	O

The	O
presence	O
of	O
a	O
genetically	O
divergent	O
S1	O
subunit	O
within	O
the	O
NeoCoV	O
spike	O
gene	O
indicated	O
that	O
intraspike	O
recombination	O
events	O
may	O
have	O
been	O
involved	O
in	O
the	O
emergence	O
of	O
MERS	O
-	O
CoV	O
.	O
NeoCoV	O
constitutes	O
a	O
sister	O
taxon	O
of	O
MERS	O
-	O
CoV	O
,	O
placing	O
the	O
MERS	O
-	O
CoV	O
root	B-ANAT
between	O
a	O
recently	O
described	O
virus	O
from	O
African	O
camels	O
and	O
all	O
other	O
viruses	O
.	O

These	O
exchanges	O
may	O
have	O
taken	O
place	O
either	O
in	O
bat	O
ancestors	O
or	O
in	O
camels	O
acting	O
as	O
mixing	O
vessels	B-ANAT
for	O
viruses	O
from	O
different	O
hosts	O
.	O

Organ	B-ANAT
failure	O
-	O
free	O
days	O
or	O
ICU	O
stay	O
have	O
not	O
been	O
shown	O
to	O
decrease	O
with	O
ECCOvR	O
.	O
Carbon	O
dioxide	O
removal	O
was	O
widely	O
demonstrated	O
as	O
feasible	O
,	O
facilitating	O
the	O
use	O
of	O
lower	O
tidal	O
volume	O
ventilation	O
.	O

The	O
results	O
suggest	O
that	O
the	O
regulation	O
of	O
coronaviral	O
poly	O
(	O
A	O
)	O
tail	O
length	O
during	O
infection	O
may	O
be	O
a	O
common	O
feature	O
among	O
coronaviruses	O
and	O
can	O
occur	O
in	O
a	O
noncancerous	O
cell	B-ANAT
line	I-ANAT
(	O
BHK	O
-	O
21	O
cells	B-ANAT
),	O
primary	O
cell	B-ANAT
culture	O
(	O
CEK	O
cells	B-ANAT
),	O
and	O
living	O
system	O
(	O
chickens	O
),	O
further	O
reinforcing	O
the	O
biological	O
significance	O
of	O
this	O
regulation	O
during	O
coronavirus	O
infection	O
.	O

The	O
vector	O
can	O
be	O
used	O
at	O
biosafety	O
level	O
1	O
,	O
has	O
intrinsic	O
adjuvant	O
capacities	O
and	O
induces	O
humoral	O
and	O
cellular	B-ANAT
immune	O
responses	O
.	O

TITLE	O
:	O
Application	O
of	O
damage	O
control	O
resuscitation	O
strategies	O
to	O
patients	O
with	O
severe	O
traumatic	O
hemorrhage	O
:	O
review	O
of	O
plasma	B-ANAT
to	O
packed	O
red	B-ANAT
blood	I-ANAT
cell	I-ANAT
ratios	O
at	O
a	O
single	O
institution	O
.	O

TITLE	O
:	O
Effects	O
of	O
therapeutic	O
approach	O
on	O
the	O
neonatal	O
evolution	O
of	O
very	O
low	O
birth	O
weight	O
infants	O
with	O
patent	O
ductus	B-ANAT
arteriosus	I-ANAT
.	O

Patients	O
underwent	O
whole	O
-	O
lung	B-ANAT
computed	O
tomography	O
(	O
CT	O
)	O
scan	O
at	O
5	O
and	O
45	O
cm	O
H2O	O
.	O

Interestingly	O
,	O
the	O
peak	O
IgA	O
SFC	O
response	O
occurred	O
2	O
days	O
earlier	O
in	O
spleen	B-ANAT
than	O
in	O
the	O
head	B-ANAT
-	O
associated	O
lymphoid	B-ANAT
tissues	I-ANAT
despite	O
ocular	B-ANAT
vaccination	O
.	O

Furthermore	O
,	O
IgA	O
IBV	O
-	O
specific	O
antibody	O
levels	O
significantly	O
increased	O
over	O
controls	O
3	O
days	O
earlier	O
in	O
tears	B-ANAT
and	O
4	O
days	O
earlier	O
in	O
plasma	B-ANAT
than	O
did	O
IgG	O
antibodies	O
.	O

TITLE	O
:	O
Detection	O
of	O
respiratory	O
viruses	O
in	O
sputum	B-ANAT
from	O
adults	O
by	O
use	O
of	O
automated	O
multiplex	O
PCR	O
.	O

A	O
sterile	O
cotton	O
-	O
tip	O
swab	O
was	O
dunked	O
in	O
sputum	B-ANAT
,	O
swirled	O
in	O
700	O
Î¼L	O
of	O
sterile	O
water	O
(	O
dunk	O
and	O
swirl	O
method	O
)	O
and	O
tested	O
by	O
the	O
FilmArray	O
assay	O
.	O

Of	O
108	O
sputum	B-ANAT
samples	O
evaluated	O
by	O
the	O
FilmArray	O
assay	O
using	O
the	O
dunk	O
and	O
swirl	O
method	O
,	O
99	O
(	O
92	O
%)	O
were	O
positive	O
.	O

Overall	O
,	O
our	O
results	O
show	O
that	O
SARS	O
-	O
CoV	O
-	O
specific	O
memory	O
CD8	O
T	B-ANAT
cells	I-ANAT
protect	O
susceptible	O
hosts	O
from	O
lethal	O
SARS	O
-	O
CoV	O
infection	O
,	O
but	O
they	O
also	O
suggest	O
that	O
SARS	O
-	O
CoV	O
-	O
specific	O
CD4	O
T	B-ANAT
cell	I-ANAT
and	O
antibody	O
responses	O
are	O
necessary	O
for	O
complete	O
protection	O
.	O

Histological	O
examination	O
of	O
the	O
lung	B-ANAT
showed	O
alveolar	B-ANAT
damage	O
,	O
microvascular	O
congestion	O
,	O
microvascular	O
injury	O
,	O
infiltration	O
of	O
inflammatory	B-ANAT
cells	I-ANAT
,	O
pulmonary	B-ANAT
edema	O
and	O
necrosis	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

TITLE	O
:	O
Position	O
paper	O
for	O
the	O
organization	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
programs	O
for	O
acute	O
respiratory	O
failure	O
in	O
adult	O
patients	O
.	O

ABSTRACT	O
:	O
The	O
use	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
for	O
severe	O
acute	O
respiratory	O
failure	O
(	O
ARF	O
)	O
in	O
adults	O
is	O
growing	O
rapidly	O
given	O
recent	O
advances	O
in	O
technology	O
,	O
even	O
though	O
there	O
is	O
controversy	O
regarding	O
the	O
evidence	O
justifying	O
its	O
use	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
developed	O
a	O
chimeric	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particle	I-ANAT
(	O
VLP	B-ANAT
)	O
vaccine	O
candidate	O
for	O
porcine	O
reproductive	O
and	O
respiratory	O
syndrome	O
virus	O
(	O
PRRSV	O
)	O
and	O
H3N2	O
influenza	O
virus	O
and	O
investigated	O
its	O
immunogenicity	O
in	O
mice	O
.	O

Local	O
and	O
systemic	O
reactions	O
were	O
similarly	O
frequent	O
in	O
the	O
patients	O
and	O
controls	O
,	O
and	O
there	O
were	O
no	O
significant	O
changes	O
in	O
27	O
-	O
joint	B-ANAT
juvenile	O
arthritis	O
disease	O
activity	O
score	O
or	O
laboratory	O
tests	O
.	O

The	O
primary	O
outcome	O
measure	O
was	O
the	O
prevalence	O
of	O
respiratory	O
viruses	O
(	O
adenovirus	O
,	O
bocavirus	O
,	O
coronavirus	O
,	O
EBV	O
,	O
hMPV	O
,	O
influenza	O
,	O
parainfluenza	O
,	O
rhino	O
-/	O
enterovirus	O
,	O
RSV	O
)	O
in	O
respiratory	O
secretions	B-ANAT
of	O
patients	O
during	O
an	O
AECOPD	O
.	O

Seven	O
of	O
the	O
eight	O
analyzed	O
viruses	O
had	O
a	O
higher	O
prevalence	O
in	O
LRT	B-ANAT
samples	O
.	O

This	O
is	O
a	O
considerable	O
problem	O
for	O
patients	O
where	O
the	O
time	O
interval	O
for	O
lung	B-ANAT
recovery	O
and	O
the	O
bridge	O
to	O
the	O
transplantation	O
is	O
prolonged	O
.	O

These	O
cases	O
were	O
mostly	O
conjoined	O
to	O
the	O
implantation	O
phase	O
or	O
the	O
early	O
postoperative	O
phase	O
and	O
vary	O
between	O
right	B-ANAT
heart	I-ANAT
perforation	O
to	O
migration	O
of	O
the	O
cannula	O
.	O

Lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
excretion	O
of	O
MERS	O
-	O
CoV	O
could	O
be	O
observed	O
for	O
more	O
than	O
one	O
month	O
.	O

TITLE	O
:	O
Case	O
Report	O
:	O
Severe	O
form	O
of	O
hemolytic	O
-	O
uremic	O
syndrome	O
with	O
multiple	O
organ	B-ANAT
failure	O
in	O
a	O
child	O
:	O
a	O
case	O
report	O
.	O

She	O
was	O
successfully	O
treated	O
in	O
the	O
intensive	O
care	O
unit	O
and	O
significant	O
improvement	O
was	O
noticed	O
after	O
plasmapheresis	O
and	O
continuous	O
veno	O
-	O
venous	B-ANAT
hemodialysis	O
.	O

Early	O
start	O
of	O
plasmapheresis	O
and	O
meticulous	O
supportive	O
treatment	O
in	O
the	O
intensive	O
care	O
unit	O
,	O
including	O
renal	B-ANAT
placement	O
therapy	O
,	O
may	O
be	O
the	O
therapy	O
of	O
choice	O
in	O
severe	O
cases	O
of	O
HUS	O
presented	O
by	O
MOF	O
.	O

TITLE	O
:	O
Placement	O
of	O
a	O
caudal	B-ANAT
vena	B-ANAT
cava	I-ANAT
stent	O
for	O
treatment	O
of	O
Budd	O
-	O
Chiari	O
-	O
like	O
syndrome	O
in	O
a	O
4	O
-	O
month	O
-	O
old	O
Ragdoll	O
cat	O
.	O

Physical	O
examination	O
findings	O
included	O
a	O
markedly	O
distended	O
abdomen	B-ANAT
and	O
panting	O
.	O

TITLE	O
:	O
Faecal	B-ANAT
virome	O
of	O
cats	O
in	O
an	O
animal	O
shelter	O
.	O

Microarray	O
profiles	O
of	O
host	O
responses	O
to	O
IAPV	O
infection	O
revealed	O
that	O
mitochondrial	B-ANAT
function	O
is	O
the	O
most	O
significantly	O
affected	O
biological	O
process	O
,	O
suggesting	O
that	O
viral	O
infection	O
causes	O
significant	O
disturbance	O
in	O
energy	O
-	O
related	O
host	O
processes	O
.	O

Compared	O
with	O
control	O
subjects	O
,	O
infections	O
with	O
HCoV	O
-	O
229E	O
(	O
OR	O
=	O
5	O
.	O
15	O
,	O
95	O
%	O
CI	O
=	O
2	O
.	O
24	O
-	O
11	O
.	O
78	O
),	O
HCoV	O
-	O
OC43	O
(	O
OR	O
=	O
6	O
.	O
16	O
,	O
95	O
%	O
CI	O
=	O
1	O
.	O
77	O
-	O
21	O
.	O
65	O
)	O
and	O
combine	O
HCoVs	O
(	O
OR	O
=	O
2	O
.	O
36	O
,	O
95	O
%	O
CI	O
=	O
1	O
.	O
5	O
=	O
3	O
.	O
72	O
)	O
were	O
associated	O
with	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
.	O

HCoVs	O
could	O
play	O
significant	O
role	O
in	O
causing	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
among	O
adults	O
and	O
older	O
children	O
in	O
rural	O
areas	O
of	O
Ghana	O
.	O

Imaging	O
enabled	O
us	O
to	O
examine	O
the	O
cranium	B-ANAT
,	O
as	O
the	O
family	O
refused	O
cerebral	B-ANAT
dissection	O
.	O

We	O
observed	O
some	O
structural	O
changes	O
in	O
tissue	B-ANAT
secondary	O
to	O
contrast	O
agent	O
injection	O
,	O
affecting	O
the	O
vascular	B-ANAT
system	I-ANAT
and	O
renal	B-ANAT
parenchyma	I-ANAT
in	O
particular	O
.	O

Our	O
data	O
confirmed	O
that	O
PEDV	O
entry	O
followed	O
clathrin	O
-	O
mediated	O
endocytosis	O
independence	O
of	O
caveolae	B-ANAT
-	O
coated	B-ANAT
pit	I-ANAT
assembly	O
.	O

Clinical	O
signs	O
of	O
PEDV	O
infection	O
(	O
vomiting	O
and	O
diarrhea	O
)	O
and	O
viral	O
shedding	O
were	O
observed	O
in	O
both	O
the	O
Positive	O
control	O
and	O
Treatment	O
group	O
'	O
post	O
-	O
consumption	O
with	O
virus	O
and	O
microscopic	O
lesions	O
detected	O
in	O
intestinal	B-ANAT
samples	O
No	O
evidence	O
of	O
infection	O
was	O
observed	O
in	O
the	O
Negative	O
controls	O
.	O

ABSTRACT	O
:	O
HIV	O
-	O
1	O
reverse	O
transcriptase	O
(	O
RT	O
)-	O
associated	O
RNase	O
H	O
activity	O
is	O
an	O
essential	O
function	O
in	O
viral	B-ANAT
genome	I-ANAT
retrotranscription	O
.	O

Overall	O
,	O
we	O
provide	O
the	O
first	O
demonstration	O
that	O
RNase	O
H	O
inhibition	O
by	O
DKAs	O
is	O
due	O
not	O
only	O
to	O
their	O
chelating	O
properties	O
but	O
also	O
to	O
specific	O
interactions	O
with	O
highly	O
conserved	O
amino	O
acid	O
residues	O
in	O
the	O
RNase	O
H	O
domain	O
,	O
leading	O
to	O
effective	O
targeting	O
of	O
HIV	O
retrotranscription	O
in	O
cells	B-ANAT
and	O
hence	O
offering	O
important	O
insights	O
for	O
the	O
rational	O
design	O
of	O
RNase	O
H	O
inhibitors	O
.	O

In	O
fact	O
,	O
after	O
infection	O
with	O
viruses	O
in	O
which	O
this	O
protein	O
has	O
been	O
deleted	O
,	O
increased	O
cellular	B-ANAT
stress	O
and	O
unfolded	O
protein	O
responses	O
,	O
apoptosis	O
,	O
and	O
augmented	O
host	O
immune	O
responses	O
were	O
observed	O
.	O

In	O
fact	O
,	O
E	O
protein	O
is	O
responsible	O
in	O
a	O
significant	O
proportion	O
of	O
the	O
inflammasome	O
activation	O
and	O
the	O
associated	O
inflammation	O
elicited	O
by	O
SARS	O
-	O
CoV	O
in	O
the	O
lung	B-ANAT
parenchyma	I-ANAT
.	O

TITLE	O
:	O
Amlodipine	O
poisoning	O
revisited	O
:	O
Acidosis	O
,	O
acute	O
kidney	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

ABSTRACT	O
:	O
No	O
coronavirus	O
was	O
detected	O
by	O
PCR	O
in	O
lung	B-ANAT
and	O
intestine	B-ANAT
samples	O
of	O
100	O
bats	O
,	O
mostly	O
common	O
pipistrelles	O
(	O
Pipistrellus	O
pipistrellus	O
),	O
collected	O
dead	O
between	O
2008	O
and	O
2013	O
for	O
rabies	O
surveillance	O
in	O
Belgium	O
.	O

The	O
negative	O
results	O
contrast	O
with	O
the	O
high	O
prevalence	O
of	O
coronaviruses	O
detected	O
in	O
fecal	B-ANAT
pellets	O
from	O
live	O
-	O
captured	O
bats	O
in	O
some	O
European	O
countries	O
.	O

The	O
human	O
CCR5	O
gene	O
encodes	O
a	O
cytokine	O
receptor	O
important	O
for	O
cell	B-ANAT
-	O
mediated	O
immune	O
response	O
against	O
H1N1pdm09	O
.	O

Clonal	B-ANAT
sequencing	O
identified	O
single	O
or	O
double	O
mutations	O
within	O
the	O
3CLpro	O
coding	O
sequence	O
of	O
inhibitor	O
-	O
resistant	O
virus	O
.	O

He	O
was	O
treated	O
with	O
antibiotics	O
,	O
intravenous	O
immunoglobulin	O
,	O
and	O
oxygen	O
by	O
nasal	B-ANAT
cannula	O
.	O

In	O
addition	O
,	O
M133	O
Tregs	O
diminished	O
microglia	B-ANAT
activation	O
and	O
decreased	O
the	O
number	O
and	O
function	O
of	O
Tconv	O
in	O
the	O
infected	O
brain	B-ANAT
.	O

ABSTRACT	O
:	O
Noma	O
is	O
a	O
poorly	O
studied	O
disease	O
that	O
leads	O
to	O
severe	O
facial	B-ANAT
tissue	B-ANAT
destruction	O
in	O
children	O
in	O
developing	O
countries	O
,	O
but	O
the	O
cause	O
remains	O
unknown	O
.	O

TITLE	O
:	O
Inflammatory	O
and	O
cell	B-ANAT
-	O
mediated	O
immune	O
responses	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
of	O
chickens	O
to	O
infection	O
with	O
avian	O
infectious	O
bronchitis	O
virus	O
.	O

After	O
serial	O
passage	O
in	O
tissue	B-ANAT
cultures	O
,	O
stable	O
expression	O
of	O
small	O
PRRSV	O
protein	O
antigenic	O
domains	O
was	O
achieved	O
.	O

Immunization	O
of	O
piglets	O
with	O
these	O
TGEV	O
vectors	O
led	O
to	O
partial	O
protection	O
against	O
a	O
challenge	O
with	O
a	O
virulent	O
PRRSV	O
strain	O
,	O
as	O
immunized	O
animals	O
showed	O
reduced	O
clinical	O
signs	O
and	O
lung	B-ANAT
damage	O
.	O

A	O
CVP	O
>	O
8	O
mmHg	O
has	O
been	O
demonstrated	O
to	O
decrease	O
microcirculatory	O
flow	O
,	O
as	O
well	O
as	O
renal	B-ANAT
blood	B-ANAT
flow	O
and	O
is	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
renal	B-ANAT
failure	O
and	O
death	O
.	O

The	O
objectives	O
of	O
this	O
article	O
are	O
to	O
review	O
current	O
concepts	O
of	O
extracorporeal	O
life	O
support	O
techniques	O
(	O
ECMO	O
and	O
ECCO	O
(	O
2	O
)	O
R	O
systems	O
)	O
and	O
provide	O
the	O
rationale	O
for	O
their	O
application	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
chronic	O
obstruction	O
pulmonary	B-ANAT
disease	O
,	O
and	O
as	O
adjunctive	O
therapy	O
for	O
bridging	O
patients	O
to	O
lung	B-ANAT
transplantation	O
.	O

Second	O
,	O
in	O
the	O
absence	O
of	O
exogenous	O
proteases	O
,	O
both	O
MERS	O
-	O
CoV	O
and	O
HKU4	O
spikes	O
mediate	O
pseudovirus	O
entry	O
into	O
bat	O
cells	B-ANAT
,	O
whereas	O
only	O
MERS	O
-	O
CoV	O
spike	O
,	O
but	O
not	O
HKU4	O
spike	O
,	O
mediates	O
pseudovirus	O
entry	O
into	O
human	O
cells	B-ANAT
.	O

Thus	O
,	O
MERS	O
-	O
CoV	O
,	O
but	O
not	O
HKU4	O
,	O
has	O
adapted	O
to	O
use	O
human	O
DPP4	O
and	O
human	O
cellular	B-ANAT
proteases	O
for	O
efficient	O
human	O
cell	B-ANAT
entry	O
,	O
contributing	O
to	O
the	O
enhanced	O
pathogenesis	O
of	O
MERS	O
-	O
CoV	O
in	O
humans	O
.	O

ABSTRACT	O
:	O
Porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
is	O
a	O
causative	O
agent	O
of	O
porcine	O
epidemic	O
diarrhea	O
;	O
consequently	O
,	O
the	O
small	B-ANAT
intestine	I-ANAT
was	O
believed	O
to	O
be	O
its	O
only	O
target	O
organ	B-ANAT
.	O

Furthermore	O
,	O
under	O
the	O
study	O
conditions	O
SDPP	O
or	O
egg	B-ANAT
-	O
derived	O
liquid	O
PEDV	O
globulin	O
addition	O
did	O
not	O
significantly	O
alter	O
PEDV	O
-	O
shedding	O
or	O
overall	O
disease	O
course	O
after	O
experimental	O
challenge	O
.	O

TITLE	O
:	O
The	O
PDZ	O
-	O
binding	O
motif	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
envelope	B-ANAT
protein	O
is	O
a	O
determinant	O
of	O
viral	O
pathogenesis	O
.	O

Silencing	O
of	O
syntenin	O
using	O
siRNAs	O
led	O
to	O
a	O
decrease	O
in	O
p38	O
MAPK	O
activation	O
in	O
SARS	O
-	O
CoV	O
infected	O
cells	B-ANAT
,	O
further	O
reinforcing	O
their	O
functional	O
relationship	O
.	O

TITLE	O
:	O
DESC1	O
and	O
MSPL	O
activate	O
influenza	O
A	O
viruses	O
and	O
emerging	O
coronaviruses	O
for	O
host	B-ANAT
cell	I-ANAT
entry	O
.	O

In	O
sum	O
,	O
we	O
identified	O
two	O
host	B-ANAT
cell	I-ANAT
proteases	O
that	O
could	O
promote	O
the	O
amplification	O
of	O
influenza	O
viruses	O
and	O
emerging	O
coronaviruses	O
in	O
humans	O
and	O
might	O
constitute	O
targets	O
for	O
antiviral	O
intervention	O
.	O

An	O
immunofluorescence	O
assay	O
based	O
on	O
cells	B-ANAT
infected	O
with	O
the	O
recombinant	O
viruses	O
that	O
was	O
capable	O
of	O
distinguishing	O
between	O
the	O
two	O
types	O
of	O
viral	O
infection	O
was	O
established	O
.	O

Cardiac	B-ANAT
output	O
(	O
CO	O
)	O
gradually	O
lowered	O
,	O
and	O
the	O
differences	O
at	O
20	O
,	O
40	O
,	O
60	O
cmHâO	O
were	O
logistically	O
significant	O
(	O
11	O
.	O
14	O
Â±	O
2	O
.	O
65	O
L	O
/	O
min	O
,	O
9	O
.	O
56	O
Â±	O
2	O
.	O
17	O
L	O
/	O
min	O
,	O
6	O
.	O
01	O
Â±	O
1	O
.	O
39	O
L	O
/	O
min	O
,	O
P	O
<	O
0	O
.	O
05	O
or	O
P	O
<	O
0	O
.	O
01	O
).	O

With	O
an	O
increase	O
in	O
RM	O
pressure	O
,	O
the	O
difference	O
in	O
HR	O
,	O
MAP	O
,	O
CO	O
in	O
independent	O
lung	B-ANAT
ventilation	O
group	O
were	O
not	O
significant	O
,	O
and	O
the	O
HR	O
at	O
60	O
cmHâO	O
was	O
significantly	O
lower	O
than	O
that	O
of	O
the	O
control	O
group	O
(	O
178	O
.	O
20	O
Â±	O
18	O
.	O
26	O
bpm	O
vs	O
.	O
192	O
.	O
65	O
Â±	O
22	O
.	O
99	O
bpm	O
,	O
P	O
<	O
0	O
.	O
05	O
),	O
and	O
MAP	O
and	O
CO	O
were	O
significantly	O
higher	O
than	O
those	O
of	O
the	O
control	O
group	O
(	O
MAP	O
:	O
110	O
.	O
80	O
Â±	O
11	O
.	O
60	O
mmHg	O
vs	O
.	O
78	O
.	O
55	O
Â±	O
25	O
.	O
77	O
mmHg	O
,	O
CO	O
:	O
9	O
.	O
68	O
Â±	O
2	O
.	O
08	O
L	O
/	O
min	O
vs	O
.	O
6	O
.	O
01	O
Â±	O
1	O
.	O
39	O
L	O
/	O
min	O
,	O
both	O
P	O
<	O
0	O
.	O
01	O
).	O

Our	O
data	O
provide	O
a	O
structural	O
basis	O
for	O
how	O
the	O
glutathione	O
modification	O
alters	O
recognition	O
by	O
virus	O
-	O
specific	O
T	B-ANAT
cells	I-ANAT
.	O

Sepsis	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
involve	O
the	O
release	O
of	O
inflammatory	O
mediators	O
to	O
the	O
systemic	O
circulation	O
,	O
propagating	O
the	O
cellular	B-ANAT
and	O
molecular	O
response	O
and	O
affecting	O
distal	O
organs	B-ANAT
,	O
including	O
the	O
brain	B-ANAT
.	O

These	O
results	O
support	O
a	O
brain	B-ANAT
-	O
lung	B-ANAT
crosstalk	O
during	O
sepsis	O
and	O
sepsis	O
-	O
induced	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

TITLE	O
:	O
Effects	O
of	O
a	O
pragmatic	O
lifestyle	O
intervention	O
for	O
reducing	O
body	B-ANAT
mass	O
in	O
obese	O
adults	O
with	O
obstructive	O
sleep	O
apnoea	O
:	O
a	O
randomised	O
controlled	O
trial	O
.	O

Reduced	O
neuroinflammation	O
in	O
FTY720	O
-	O
treated	O
mice	O
correlated	O
with	O
increased	O
retention	O
of	O
T	B-ANAT
lymphocytes	I-ANAT
within	O
draining	O
cervical	B-ANAT
lymph	I-ANAT
nodes	I-ANAT
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Treatment	O
with	O
FTY720	O
did	O
not	O
affect	O
virus	O
-	O
specific	O
T	B-ANAT
cell	I-ANAT
proliferation	O
,	O
expression	O
of	O
IFN	O
-	O
Î³	O
,	O
TNF	O
-	O
Î±	O
or	O
cytolytic	O
activity	O
.	O

All	O
horses	O
excreted	O
a	O
large	O
amount	O
of	O
virus	O
into	O
their	O
feces	B-ANAT
for	O
more	O
than	O
9	O
days	O
after	O
inoculation	O
regardless	O
of	O
the	O
presence	O
or	O
absence	O
of	O
clinical	O
signs	O
,	O
which	O
suggests	O
that	O
feces	B-ANAT
are	O
an	O
important	O
source	O
of	O
ECoV	O
infection	O
.	O

ABSTRACT	O
:	O
The	O
unfolded	O
-	O
protein	O
response	O
(	O
UPR	O
)	O
is	O
a	O
signal	O
transduction	O
cascade	O
triggered	O
by	O
perturbation	O
of	O
the	O
homeostasis	O
of	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
).	O

UPR	O
resolves	O
ER	O
stress	O
by	O
activating	O
a	O
cascade	O
of	O
cellular	B-ANAT
responses	O
,	O
including	O
the	O
induction	O
of	O
molecular	O
chaperones	O
,	O
translational	O
attenuation	O
,	O
ER	O
-	O
associated	O
degradation	O
,	O
and	O
other	O
mechanisms	O
.	O

Taken	O
together	O
,	O
the	O
data	O
indicate	O
that	O
the	O
ER	O
stress	O
sensor	O
IRE1Î±	O
is	O
activated	O
in	O
IBV	O
-	O
infected	O
cells	B-ANAT
and	O
serves	O
as	O
a	O
survival	O
factor	O
during	O
coronavirus	O
infection	O
.	O

Extensive	O
lesions	O
were	O
evident	O
in	O
the	O
lungs	B-ANAT
of	O
all	O
animals	O
necropsied	O
at	O
different	O
time	O
points	O
post	O
inoculation	O
.	O

The	O
aim	O
of	O
the	O
current	O
study	O
was	O
to	O
compare	O
the	O
diagnostic	O
accuracy	O
of	O
LUS	O
and	O
an	O
integrative	O
cardiopulmonary	B-ANAT
ultrasound	O
approach	O
(	O
thoracic	B-ANAT
ultrasonography	O
[	O
TUS	O
])	O
in	O
patients	O
with	O
ARF	O
.	O

The	O
plateau	O
pressure	O
and	O
static	O
compliance	O
of	O
the	O
respiratory	B-ANAT
system	I-ANAT
were	O
similar	O
in	O
the	O
two	O
groups	O
.	O

ABSTRACT	O
:	O
Reduced	O
levels	O
of	O
brain	B-ANAT
-	O
derived	O
neurotrophic	O
factor	O
(	O
BDNF	O
)	O
are	O
thought	O
to	O
contribute	O
to	O
the	O
pathophysiology	O
of	O
Rett	O
syndrome	O
(	O
RTT	O
),	O
a	O
severe	O
neurodevelopmental	O
disorder	O
caused	O
by	O
loss	O
-	O
of	O
-	O
function	O
mutations	O
in	O
the	O
gene	O
encoding	O
methyl	O
-	O
CpG	O
-	O
binding	O
protein	O
2	O
(	O
MeCP2	O
).	O

Traditional	O
management	O
of	O
aHUS	O
includes	O
plasma	B-ANAT
infusion	O
/	O
exchange	O
,	O
but	O
in	O
small	O
or	O
unstable	O
infants	O
,	O
plasma	B-ANAT
exchange	O
can	O
be	O
challenging	O
because	O
of	O
high	O
extracorporeal	O
volume	O
and	O
difficulty	O
to	O
obtain	O
an	O
adequate	O
venous	B-ANAT
access	O
.	O

We	O
report	O
on	O
an	O
11	O
-	O
day	O
-	O
old	O
neonate	O
with	O
severe	O
aHUS	O
(	O
myocardial	O
impairment	O
,	O
respiratory	O
failure	O
,	O
acute	O
kidney	B-ANAT
disease	O
requiring	O
hemodiafiltration	O
)	O
due	O
to	O
homozygous	O
factor	O
-	O
H	O
deficiency	O
.	O

For	O
this	O
faeces	B-ANAT
and	O
/	O
or	O
ascites	O
samples	O
from	O
19	O
cats	O
suffering	O
from	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
)	O
as	O
well	O
as	O
from	O
20	O
FECV	O
-	O
infected	O
healthy	O
cats	O
were	O
used	O
.	O

For	O
each	O
test	O
condition	O
,	O
assessments	O
included	O
relative	O
quantification	O
of	O
the	O
inhibition	O
of	O
intracellular	B-ANAT
viral	O
genomic	O
RNA	O
synthesis	O
by	O
means	O
of	O
real	O
-	O
time	O
,	O
reverse	O
-	O
transcription	O
PCR	O
analysis	O
;	O
flow	O
cytometric	O
evaluation	O
of	O
the	O
reduction	O
of	O
viral	O
protein	O
expression	O
in	O
infected	O
cells	B-ANAT
;	O
and	O
assessment	O
of	O
virus	O
replication	O
inhibition	O
via	O
titration	O
of	O
extracellular	B-ANAT
virus	O
with	O
a	O
TCIDââ	O
infectivity	O
assay	O
.	O

Survival	O
to	O
hospital	O
discharge	B-ANAT
was	O
83	O
%	O
in	O
those	O
managed	O
with	O
ECMO	O
.	O

Probable	O
cases	O
of	O
secondary	O
transmission	O
were	O
identified	O
on	O
the	O
basis	O
of	O
reactivity	O
in	O
two	O
reverse	O
-	O
transcriptase	O
-	O
polymerase	O
-	O
chain	O
-	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
assays	O
with	O
independent	O
RNA	O
extraction	O
from	O
throat	B-ANAT
swabs	O
or	O
reactivity	O
on	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
against	O
MERS	O
-	O
CoV	O
S1	O
antigen	O
,	O
supported	O
by	O
reactivity	O
on	O
recombinant	O
S	O
-	O
protein	O
immunofluorescence	O
and	O
demonstration	O
of	O
neutralization	O
of	O
more	O
than	O
50	O
%	O
of	O
the	O
infectious	O
virus	O
seed	O
dose	O
on	O
plaque	O
-	O
reduction	O
neutralization	O
testing	O
.	O

Six	O
months	O
after	O
diagnosis	O
and	O
first	O
line	O
of	O
treatment	O
,	O
he	O
presented	O
acute	O
dyspnea	O
with	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
.	O

Computed	O
tomography	O
showed	O
severe	O
bullous	O
emphysema	O
and	O
diffuse	O
,	O
patchy	O
,	O
multifocal	O
infiltrations	O
bilaterally	O
with	O
nodular	O
character	O
,	O
small	O
bilateral	O
pleural	O
effusions	O
,	O
mediastinal	B-ANAT
lymphadenopathy	O
,	O
and	O
a	O
known	O
lytic	O
lesion	O
of	O
the	O
12th	O
vertebra	B-ANAT
.	O

Postmortem	O
analysis	O
revealed	O
diffuse	O
and	O
nodular	O
infracentimetric	O
infiltration	O
of	O
the	O
lung	B-ANAT
parenchyma	I-ANAT
by	O
neoplastic	O
plasma	B-ANAT
cells	I-ANAT
.	O

ABSTRACT	O
:	O
After	O
surgery	O
,	O
hypoxemia	O
and	O
/	O
or	O
acute	O
respiratory	O
failure	O
(	O
ARF	O
)	O
mainly	O
develop	O
following	O
abdominal	B-ANAT
and	O
/	O
or	O
thoracic	B-ANAT
surgery	O
.	O

Although	O
invasive	O
endotracheal	O
mechanical	O
ventilation	O
has	O
remained	O
the	O
cornerstone	O
of	O
ventilatory	O
strategy	O
for	O
many	O
years	O
for	O
severe	O
acute	O
respiratory	O
failure	O
,	O
several	O
studies	O
have	O
shown	O
that	O
mortality	O
associated	O
with	O
pulmonary	B-ANAT
disease	O
is	O
largely	O
related	O
to	O
complications	O
of	O
postoperative	O
reintubation	O
and	O
mechanical	O
ventilation	O
.	O

A	O
linear	O
correlation	O
was	O
obtained	O
between	O
predicted	O
antibody	O
titres	O
at	O
a	O
single	O
working	O
dilution	O
of	O
1	O
:	O
100	O
and	O
the	O
corresponding	O
serum	B-ANAT
titres	O
observed	O
as	O
determined	O
by	O
the	O
standard	O
serial	O
dilution	O
method	O
.	O

And	O
TGEV	O
could	O
impair	O
the	O
barrier	O
integrity	O
of	O
IPEC	O
-	O
J2	O
cells	B-ANAT
at	O
early	O
stages	O
of	O
infection	O
through	O
down	O
-	O
regulating	O
some	O
proteins	O
of	O
tight	O
and	O
adherens	B-ANAT
junctions	I-ANAT
,	O
while	O
PEDV	O
cloud	O
cause	O
a	O
slight	O
of	O
damage	O
in	O
the	O
integrity	O
of	O
epithelial	O
barrier	O
.	O

These	O
studies	O
provide	O
a	O
new	O
insight	O
from	O
the	O
perspective	O
of	O
the	O
epithelial	O
barrier	O
and	O
microfilaments	B-ANAT
into	O
the	O
pathogenesis	O
of	O
PEDV	O
and	O
TGEV	O
.	O

We	O
aimed	O
to	O
compare	O
MERS	O
-	O
CoV	O
isolates	O
from	O
dromedaries	O
in	O
Saudi	O
Arabia	O
and	O
Egypt	O
with	O
a	O
prototype	O
human	O
MERS	O
-	O
CoV	O
to	O
assess	O
virus	O
replication	O
competence	O
and	O
cell	B-ANAT
tropism	O
in	O
ex	O
-	O
vivo	O
cultures	O
of	O
human	O
bronchus	B-ANAT
and	I-ANAT
lung	I-ANAT
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygen	O
(	O
ECMO	O
)	O
has	O
been	O
used	O
for	O
many	O
years	O
in	O
patients	O
with	O
life	O
-	O
threatening	O
hypoxaemia	O
and	O
/	O
or	O
hypercarbia	O
.	O

Swab	O
samples	O
were	O
tested	O
by	O
cell	B-ANAT
culture	O
and	O
/	O
or	O
nucleic	B-ANAT
amplification	O
tests	O
.	O

This	O
contrasts	O
against	O
previous	O
investigations	O
demonstrating	O
an	O
influence	O
of	O
nonpulmonary	O
organ	B-ANAT
dysfunction	O
on	O
outcome	O
in	O
ARDS	O
.	O

The	O
peptide	O
sequence	O
could	O
interact	O
with	O
as	O
many	O
as	O
16	O
human	O
leukocyte	B-ANAT
antigens	O
(	O
HLAs	O
)	O
and	O
showed	O
high	O
cumulative	O
population	O
coverage	O
,	O
ranging	O
from	O
75	O
.	O
68	O
%	O
to	O
90	O
.	O
73	O
%.	O

TITLE	O
:	O
Emerging	O
novel	O
and	O
antimicrobial	O
-	O
resistant	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
:	O
new	O
drug	O
development	O
and	O
therapeutic	O
options	O
.	O

New	O
viral	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
with	O
epidemic	O
potential	O
,	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
swine	O
-	O
origin	O
influenza	O
A	O
H1N1	O
,	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
infection	O
,	O
require	O
development	O
of	O
new	O
antiviral	O
agents	O
.	O

Successful	O
treatment	O
outcomes	O
for	O
patients	O
with	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
across	O
all	O
health	O
-	O
care	O
settings	O
will	O
necessitate	O
rapid	O
,	O
precise	O
diagnosis	O
and	O
more	O
effective	O
and	O
pathogen	O
-	O
specific	O
therapies	O
.	O

This	O
Series	O
paper	O
describes	O
the	O
development	O
and	O
use	O
of	O
new	O
antimicrobial	O
agents	O
and	O
immune	O
-	O
based	O
and	O
host	O
-	O
directed	O
therapies	O
for	O
a	O
range	O
of	O
conventional	O
and	O
emerging	O
viral	O
,	O
bacterial	O
,	O
and	O
fungal	O
causes	O
of	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
.	O

ABSTRACT	O
:	O
Panton	O
-	O
Valentine	O
leukocidin	O
(	O
PVL	O
)	O
is	O
a	O
cytotoxin	O
that	O
causes	O
leukocyte	B-ANAT
destruction	O
and	O
lung	B-ANAT
necrosis	O
.	O

In	O
this	O
case	O
report	O
we	O
present	O
an	O
end	O
stage	O
patient	O
with	O
adenocarcinoma	O
of	O
ampulla	B-ANAT
of	I-ANAT
Vater	I-ANAT
with	O
involvement	O
of	O
both	O
abdomen	B-ANAT
and	O
thorax	B-ANAT
who	O
presented	O
with	O
severe	O
intractable	O
abdominal	B-ANAT
pain	O
.	O

We	O
discuss	O
the	O
rare	O
complications	O
of	O
celiac	B-ANAT
plexus	I-ANAT
block	O
as	O
well	O
.	O

TITLE	O
:	O
Genomic	O
characteristics	O
and	O
changes	O
of	O
avian	O
infectious	O
bronchitis	O
virus	O
strain	O
CK	O
/	O
CH	O
/	O
LDL	O
/	O
97I	O
after	O
serial	O
passages	O
in	O
chicken	O
embryos	B-ANAT
.	O

Our	O
computational	O
data	O
are	O
in	O
line	O
with	O
available	O
experimental	O
results	O
,	O
such	O
as	O
X	O
-	O
ray	O
geometries	O
,	O
measured	O
pKa	B-ANAT
values	O
,	O
mutagenesis	O
experiments	O
,	O
and	O
the	O
measured	O
differences	O
between	O
the	O
kinetic	O
parameters	O
of	O
substrates	O
and	O
inhibitors	O
.	O

TITLE	O
:	O
One	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
protein	B-ANAT
complex	I-ANAT
integrates	O
processive	O
RNA	O
polymerase	O
and	O
exonuclease	O
activities	O
.	O

Sorted	O
liver	B-ANAT
sinusoidal	O
endothelial	B-ANAT
cells	I-ANAT
(	O
LSECs	O
)	O
or	O
myeloid	O
-	O
derived	O
(	O
CD11b	O
(+))	O
cells	B-ANAT
were	O
stimulated	O
with	O
C5a	O
,	O
TNF	O
-	O
Î±	O
or	O
MHV	O
-	O
3	O
in	O
vitro	O
.	O

The	O
MHV	O
-	O
3	O
infected	O
C5aR	O
(-/-)	O
mice	O
exhibited	O
reduced	O
numbers	O
of	O
infiltrated	O
inflammatory	O
CD11b	O
(+)	O
cells	B-ANAT
and	O
a	O
reduced	O
expression	O
of	O
TNF	O
-	O
Î±	O
and	O
FGL2	O
.	O

Influenza	O
might	O
cause	O
severe	O
pulmonary	B-ANAT
infection	O
and	O
death	O
.	O

In	O
addition	O
to	O
diffuse	O
alveolar	B-ANAT
damage	O
,	O
sub	O
-	O
pleural	O
and	O
intrapulmonary	O
air	O
cysts	O
might	O
occur	O
in	O
influenza	O
-	O
related	O
ARDS	O
and	O
may	O
lead	O
to	O
spontaneous	O
pneumothorax	O
.	O

Agents	O
given	O
the	O
highest	O
priority	O
due	O
to	O
a	O
known	O
transfusion	O
-	O
transmission	O
threat	O
and	O
severe	O
/	O
fatal	O
disease	O
in	O
recipients	O
were	O
the	O
vCJD	O
prion	O
,	O
dengue	O
viruses	O
and	O
the	O
obligate	O
red	O
-	O
cell	B-ANAT
parasite	O
that	O
causes	O
babesiosis	O
(	O
Since	O
the	O
publication	O
of	O
the	O
Supplement	O
,	O
six	O
new	O
FSs	O
(	O
yellow	O
fever	O
viruses	O
-	O
including	O
vaccine	O
breakthrough	O
infections	O
,	O
miscellaneous	O
arboviruses	O
,	O
XMRV	O
,	O
human	O
parvoviruses	O
/	O
bocaviruses	O
other	O
than	O
B19	O
,	O
and	O
most	O
recently	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
,	O
MERS	O
-	O
CoV	O
)	O
were	O
added	O
and	O
14	O
existing	O
FSs	O
updated	O
(	O
Anaplasma	O
,	O
Babesia	O
,	O
Bartonella	O
,	O
Erhlichia	O
,	O
chronic	O
wasting	O
disease	O
-	O
CWD	O
,	O
human	O
prions	O
other	O
than	O
vCJD	O
,	O
vCJD	O
,	O
The	O
process	O
and	O
final	O
product	O
(	O
toolkit	O
)	O
including	O
methods	O
to	O
monitor	O
EID	O
agent	O
emergence	O
,	O
identification	O
/	O
recognition	O
of	O
a	O
transfusion	O
-	O
transmission	O
threat	O
,	O
methods	O
for	O
quantitative	O
risk	O
assessments	O
,	O
and	O
the	O
appropriate	O
management	O
of	O
such	O
threats	O
should	O
be	O
considered	O
for	O
implementation	O
by	O
all	O
blood	B-ANAT
systems	O
.	O

A	O
total	O
of	O
63	O
patients	O
were	O
divided	O
into	O
a	O
severe	O
pulmonary	B-ANAT
contusion	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
group	O
and	O
a	O
non	O
-	O
ARDS	O
group	O
,	O
or	O
a	O
survivor	O
group	O
and	O
a	O
non	O
-	O
survivor	O
group	O
,	O
or	O
an	O
injury	O
severity	O
score	O
(	O
ISS	O
)	O
<	O
20	O
group	O
and	O
an	O
ISS	O
â¥	O
20	O
group	O
.	O

The	O
concentration	O
of	O
serum	B-ANAT
IL	O
-	O
8	O
showed	O
a	O
similar	O
expression	O
pattern	O
in	O
both	O
groups	O
,	O
but	O
the	O
expression	O
increased	O
more	O
significantly	O
in	O
the	O
ARDS	O
group	O
than	O
in	O
the	O
non	O
-	O
ARDS	O
group	O
.	O

CONCLUSIONS	O
:	O
The	O
elevated	O
levels	O
of	O
plasma	B-ANAT
vWF	O
and	O
serum	B-ANAT
IL	O
-	O
8	O
in	O
severe	O
pulmonary	B-ANAT
contusion	O
patients	O
reflect	O
the	O
severity	O
of	O
pulmonary	B-ANAT
injury	O
and	O
patients	O
outcomes	O
,	O
suggesting	O
that	O
the	O
plasma	B-ANAT
vWF	O
and	O
serum	B-ANAT
IL	O
-	O
8	O
are	O
sensitive	O
markers	O
for	O
clinical	O
evaluation	O
of	O
the	O
severity	O
of	O
pulmonary	B-ANAT
injury	O
and	O
predication	O
of	O
patient	O
prognosis	O
.	O

The	O
paper	O
ends	O
with	O
the	O
notion	O
of	O
panorama	O
,	O
as	O
defined	O
by	O
Bruno	O
Latour	O
:	O
a	O
suggestion	O
to	O
describe	O
the	O
common	O
denominator	O
of	O
the	O
aforementioned	O
operators	O
,	O
and	O
a	O
means	O
to	O
foresee	O
the	O
development	O
of	O
global	O
scales	B-ANAT
for	O
certain	O
health	O
alerts	O
.	O

However	O
,	O
extremely	O
little	O
is	O
known	O
about	O
the	O
use	O
of	O
CAM	B-ANAT
by	O
SARS	O
survivors	O
in	O
the	O
post	O
-	O
SARS	O
period	O
and	O
even	O
less	O
is	O
known	O
about	O
how	O
the	O
use	O
of	O
CAM	B-ANAT
is	O
related	O
to	O
the	O
unpleasant	O
social	O
and	O
medical	O
-	O
treatment	O
experiences	O
of	O
SARS	O
survivors	O
,	O
their	O
eagerness	O
to	O
re	O
-	O
establish	O
social	O
networks	O
,	O
and	O
their	O
awareness	O
to	O
prepare	O
for	O
future	O
epidemics	O
.	O

The	O
present	O
study	O
aimed	O
to	O
investigate	O
the	O
effects	O
of	O
various	O
combined	O
non	O
-	O
biological	O
artificial	O
liver	B-ANAT
treatments	O
for	O
patients	O
with	O
acute	O
liver	B-ANAT
failure	O
(	O
ALF	O
)	O
complicated	O
by	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
(	O
MODS	O
).	O

Mesenchymal	B-ANAT
stem	I-ANAT
cells	I-ANAT
(	O
MSCs	O
)	O
are	O
promising	O
therapeutic	O
cells	B-ANAT
for	O
preventing	O
apoptosis	O
and	O
eliminating	O
cellular	B-ANAT
injury	O
.	O

Prior	O
experience	O
of	O
face	B-ANAT
-	O
mask	O
usage	O
also	O
results	O
in	O
increased	O
support	O
for	O
future	O
usage	O
,	O
as	O
well	O
as	O
other	O
NPIs	O
.	O

Myeloid	B-ANAT
cells	I-ANAT
,	O
including	O
monocytes	B-ANAT
and	O
macrophages	B-ANAT
,	O
play	O
an	O
important	O
role	O
in	O
this	O
balance	O
,	O
particularly	O
through	O
the	O
activities	O
of	O
the	O
arginine	O
-	O
hydrolyzing	O
enzymes	O
nitric	O
oxide	O
synthase	O
2	O
(	O
Nos2	O
;	O
iNOS	O
)	O
and	O
arginase	O
1	O
(	O
Arg1	O
).	O

Nitric	O
oxide	O
(	O
NO	O
)	O
production	O
by	O
iNOS	O
is	O
an	O
important	O
proinflammatory	O
mediator	O
,	O
whereas	O
Arg1	O
-	O
expressing	O
macrophages	B-ANAT
contribute	O
to	O
the	O
resolution	O
of	O
inflammation	O
and	O
wound	O
repair	O
.	O

Both	O
RAGE	O
isoforms	O
were	O
transiently	O
increased	O
in	O
plasma	B-ANAT
within	O
24	O
hours	O
after	O
trauma	O
,	O
while	O
cytokeratin	O
18	O
levels	O
were	O
unchanged	O
.	O

Furthermore	O
,	O
TRIM56	O
was	O
revealed	O
to	O
impair	O
YFV	O
and	O
DENV2	O
propagation	O
by	O
suppressing	O
intracellular	B-ANAT
viral	O
RNA	O
accumulation	O
but	O
to	O
compromise	O
HCoV	O
-	O
OC43	O
infection	O
at	O
a	O
later	O
step	O
in	O
the	O
viral	O
life	O
cycle	O
,	O
suggesting	O
that	O
distinct	O
TRIM56	O
domains	O
accommodate	O
differing	O
antiviral	O
mechanisms	O
.	O

One	O
of	O
the	O
CCoV	O
-	O
IIa	O
variants	O
was	O
isolated	O
in	O
cell	B-ANAT
culture	O
.	O

Infection	O
with	O
CCoV	O
alone	O
was	O
found	O
in	O
five	O
puppies	O
,	O
of	O
which	O
two	O
also	O
had	O
small	B-ANAT
intestinal	I-ANAT
intussusception	O
.	O

In	O
293T	O
cells	B-ANAT
,	O
IFITM	O
-	O
mediated	O
inhibition	O
of	O
cellular	B-ANAT
entry	O
of	O
the	O
emerging	O
MERS	O
-	O
and	O
SARS	O
-	O
CoV	O
was	O
less	O
efficient	O
than	O
blockade	O
of	O
entry	O
of	O
the	O
globally	O
circulating	O
human	O
coronaviruses	O
229E	O
and	O
NL63	O
.	O

Similar	O
differences	O
were	O
not	O
observed	O
in	O
A549	O
cells	B-ANAT
,	O
suggesting	O
that	O
cellular	B-ANAT
context	O
and	O
/	O
or	O
IFITM	O
expression	O
levels	O
can	O
impact	O
inhibition	O
efficiency	O
.	O

The	O
optimal	O
serum	B-ANAT
SP	O
-	O
A	O
cut	O
-	O
off	O
value	O
to	O
discriminate	O
SAP	O
-	O
induced	O
ARDS	O
and	O
other	O
groups	O
(	O
SO	O
group	O
and	O
non	O
-	O
ARDS	O
group	O
)	O
is	O
around	O
150	O
ug	O
/	O
ml	O
.	O

The	O
mechanical	O
forces	O
are	O
considered	O
to	O
regulate	O
pulmonary	B-ANAT
fibrosis	O
via	O
activation	O
of	O
lung	B-ANAT
fibroblasts	B-ANAT
.	O

Molecular	O
docking	O
study	O
was	O
also	O
employed	O
to	O
check	O
the	O
affinity	O
of	O
the	O
potential	O
epitope	O
towards	O
the	O
binding	O
cleft	O
of	O
the	O
specific	O
HLA	B-ANAT
allele	O
.	O

ABSTRACT	O
:	O
In	O
recent	O
years	O
a	O
rapid	O
expansion	O
of	O
extracorporeal	O
devices	O
for	O
support	O
of	O
severe	O
lung	B-ANAT
failure	O
has	O
been	O
witnessed	O
.	O

TITLE	O
:	O
Hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplantation	O
for	O
patients	O
with	O
acute	O
lymphoblastic	B-ANAT
leukemia	O
and	O
Down	O
syndrome	O
.	O

TITLE	O
:	O
Efficacy	O
of	O
continuous	O
renal	B-ANAT
replacement	O
therapy	O
in	O
the	O
treatment	O
of	O
severe	O
acute	O
pancreatitis	O
associated	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

While	O
these	O
viruses	O
are	O
susceptible	O
to	O
interferon	O
treatment	O
in	O
vitro	O
,	O
they	O
both	O
encode	O
numerous	O
genes	O
that	O
allow	O
for	O
successful	O
evasion	O
of	O
the	O
host	O
immune	B-ANAT
system	I-ANAT
until	O
after	O
high	O
virus	O
titres	O
have	O
been	O
achieved	O
.	O

This	O
illustrates	O
that	O
M	O
-	O
protein	O
perturbs	O
the	O
PDK1	O
and	O
PKB	O
/	O
Akt	O
cell	B-ANAT
survival	O
signalling	O
pathway	O
.	O

Twenty	O
-	O
six	O
(	O
5	O
.	O
38	O
%)	O
of	O
all	O
cases	O
were	O
co	O
-	O
infected	O
with	O
two	O
or	O
more	O
viruses	O
,	O
most	O
commonly	O
HEV	B-ANAT
/	O
HRV	O
with	O
other	O
viruses	O
.	O

TITLE	O
:	O
Spred	O
-	O
2	O
deficiency	O
exacerbates	O
lipopolysaccharide	O
-	O
induced	O
acute	O
lung	B-ANAT
inflammation	O
in	O
mice	O
.	O

PEDV	O
-	O
specific	O
antigen	O
was	O
detected	O
in	O
villous	O
enterocytes	B-ANAT
of	O
challenged	O
pigs	O
by	O
immunohistochemistry	O
(	O
IHC	O
)	O
on	O
dpi	O
1	O
,	O
2	O
,	O
3	O
,	O
4	O
,	O
7	O
,	O
and	O
14	O
.	O

ABSTRACT	O
:	O
In	O
the	O
United	O
States	O
,	O
lung	B-ANAT
infections	O
consistently	O
rank	O
in	O
the	O
top	O
10	O
leading	O
causes	O
of	O
death	O
,	O
accounting	O
for	O
>	O
50	O
,	O
000	O
deaths	O
annually	O
.	O

Neuroinvasive	O
coronaviruses	O
could	O
damage	O
the	O
CNS	B-ANAT
as	O
a	O
result	O
of	O
misdirected	O
host	O
immune	O
responses	O
that	O
could	O
be	O
associated	O
with	O
autoimmunity	O
in	O
susceptible	O
individuals	O
(	O
virus	O
-	O
induced	O
neuroimmunopathology	O
)	O
and	O
/	O
or	O
viral	O
replication	O
,	O
which	O
directly	O
induces	O
damage	O
to	O
CNS	B-ANAT
cells	B-ANAT
(	O
virus	O
-	O
induced	O
neuropathology	O
).	O

Although	O
MERS	O
-	O
CoV	O
remained	O
detectable	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
secretions	B-ANAT
of	O
the	O
patient	O
until	O
the	O
fourth	O
week	O
of	O
illness	O
,	O
viraemia	O
was	O
last	O
detected	O
2	O
days	O
after	O
initiation	O
of	O
triple	O
combination	O
therapy	O
with	O
pegylated	O
interferon	O
,	O
ribavirin	O
and	O
lopinavir	O
/	O
ritonavir	O
,	O
administered	O
from	O
Day	O
13	O
of	O
illness	O
.	O

Most	O
importantly	O
,	O
chest	B-ANAT
radiographs	O
and	O
imaging	O
results	O
of	O
patients	O
with	O
MERS	O
show	O
features	O
that	O
resemble	O
the	O
findings	O
of	O
organizing	O
pneumonia	O
,	O
different	O
from	O
the	O
lesions	O
in	O
SARS	O
patients	O
,	O
which	O
show	O
fibrocellular	O
intra	O
-	O
alveolar	B-ANAT
organization	O
with	O
a	O
bronchiolitis	O
obliterans	O
organizing	O
pneumonia	O
-	O
like	O
pattern	O
.	O

CONCLUSIONS	O
:	O
The	O
cost	O
-	O
utility	O
ratio	O
associated	O
with	O
the	O
use	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
in	O
Brazil	O
is	O
potentially	O
acceptable	O
according	O
to	O
this	O
hypothetical	O
study	O
.	O

TITLE	O
:	O
Nucleocapsid	B-ANAT
phosphorylation	O
and	O
RNA	O
helicase	O
DDX1	O
recruitment	O
enables	O
coronavirus	O
transition	O
from	O
discontinuous	O
to	O
continuous	O
transcription	O
.	O

The	O
possible	O
mechanism	O
of	O
the	O
inhibitory	O
action	O
on	O
the	O
male	O
immunity	O
was	O
associated	O
with	O
the	O
protein	O
kinase	O
cascade	O
,	O
including	O
protein	O
kinase	O
C	O
,	O
activated	O
by	O
phorbolmyristate	O
in	O
the	O
cells	B-ANAT
of	O
the	O
immune	B-ANAT
system	I-ANAT
.	O

TITLE	O
:	O
ECMO	O
support	O
for	O
right	O
main	O
bronchial	B-ANAT
disruption	O
in	O
multiple	O
trauma	O
patient	O
with	O
brain	B-ANAT
injury	O
--	O
a	O
case	O
report	O
and	O
literature	O
review	O
.	O

Overall	O
,	O
this	O
research	O
revealed	O
that	O
polysaccharide	O
could	O
inhibit	O
PEDV	O
infection	O
,	O
and	O
that	O
polysaccharide	O
may	O
be	O
involved	O
in	O
PEDV	O
-	O
Vero	B-ANAT
cell	I-ANAT
interactions	O
,	O
as	O
the	O
virus	O
attachment	O
and	O
entry	O
to	O
the	O
Vero	B-ANAT
cells	I-ANAT
was	O
hindered	O
by	O
the	O
polysaccharide	O
.	O

The	O
low	O
mortality	O
is	O
associated	O
with	O
the	O
maintenance	O
of	O
the	O
lower	O
airway	B-ANAT
obstructive	O
pattern	O
during	O
the	O
period	O
on	O
mechanical	O
ventilation	O
.	O

ABSTRACT	O
:	O
Coronavirus	O
replication	O
is	O
structurally	O
and	O
functionally	O
associated	O
with	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
),	O
a	O
major	O
site	O
of	O
protein	O
synthesis	O
,	O
folding	O
,	O
modification	O
and	O
sorting	O
in	O
the	O
eukaryotic	B-ANAT
cells	I-ANAT
.	O

In	O
cells	B-ANAT
under	O
prolonged	O
and	O
irremediable	O
ER	O
stress	O
,	O
UPR	O
can	O
also	O
trigger	O
apoptotic	O
cell	B-ANAT
death	O
.	O

These	O
facts	O
suggest	O
an	O
evasion	O
of	O
the	O
immune	B-ANAT
system	I-ANAT
by	O
virulent	O
TGEV	O
.	O

Moreover	O
,	O
SHXB	O
-	O
infected	O
immature	O
Mo	O
-	O
DCs	O
showed	O
low	O
expression	O
of	O
IL	O
-	O
12	O
and	O
IFN	O
-	O
Î³	O
,	O
and	O
also	O
lost	O
the	O
ability	O
to	O
stimulate	O
T	B-ANAT
cell	I-ANAT
proliferation	O
.	O

He	O
developed	O
multiple	O
organ	B-ANAT
dysfunction	O
syndromes	O
(	O
pulmonary	B-ANAT
,	O
renal	B-ANAT
,	O
coagulation	O
,	O
cardiovascular	B-ANAT
and	O
metabolic	O
).	O

Treatment	O
and	O
invasive	O
hemodynamic	O
monitoring	O
with	O
pulmonary	B-ANAT
artery	I-ANAT
catheter	O
was	O
early	O
instituted	O
.	O

Nevertheless	O
,	O
he	O
developed	O
persistent	O
pulmonary	B-ANAT
hypertension	O
and	O
shock	O
.	O

However	O
,	O
in	O
this	O
case	O
,	O
it	O
contributed	O
to	O
the	O
recovery	O
of	O
the	O
organ	B-ANAT
dysfunctions	O
presented	O
by	O
the	O
patient	O
.	O

Diagnosis	O
may	O
be	O
established	O
through	O
sputum	B-ANAT
and	O
stool	B-ANAT
examination	O
for	O
Strongyloides	O
stercoralis	O
worms	O
.	O

From	O
the	O
criteria	O
described	O
in	O
medical	O
literature	O
to	O
define	O
critical	O
malaria	O
,	O
the	O
patient	O
fulfilled	O
the	O
following	O
:	O
acute	O
renal	B-ANAT
failure	O
,	O
ARDS	O
,	O
metabolic	O
acidosis	O
,	O
altered	O
level	O
of	O
consciousness	O
,	O
macroscopic	O
hemoglobinuria	O
,	O
hyperparasitism	O
and	O
hyperbilirubinemia	O
,	O
related	O
to	O
a	O
lethality	O
rate	O
of	O
over	O
10	O
%,	O
depending	O
on	O
early	O
treatment	O
and	O
available	O
resources	O
.	O

A	O
total	O
of	O
850	O
fecal	B-ANAT
samples	O
were	O
collected	O
from	O
67	O
calves	O
.	O

ABSTRACT	O
:	O
Acute	O
chest	B-ANAT
syndrome	O
(	O
ACS	O
)	O
is	O
the	O
leading	O
cause	O
of	O
ICU	O
admission	O
in	O
patients	O
with	O
sickle	B-ANAT
cell	I-ANAT
disease	O
and	O
is	O
characterized	O
by	O
golden	O
sputum	B-ANAT
,	O
which	O
is	O
commonly	O
attributed	O
to	O
the	O
presence	O
of	O
bilirubin	O
.	O

Virus	O
isolates	O
representing	O
outbreaks	O
in	O
Jeddah	O
and	O
Riyadh	O
were	O
not	O
different	O
from	O
MERS	O
-	O
CoV	O
EMC	B-ANAT
/	O
2012	O
in	O
replication	O
,	O
escape	O
of	O
interferon	O
response	O
,	O
or	O
serum	B-ANAT
neutralization	O
.	O

Second	O
,	O
it	O
highlights	O
the	O
importance	O
of	O
a	O
closely	O
monitoring	O
of	O
clotting	O
parameters	O
during	O
ECMO	O
therapy	O
and	O
third	O
,	O
if	O
severe	O
respiratory	O
failure	O
is	O
complicated	O
by	O
cardiogenic	O
shock	O
,	O
veno	O
-	O
atrial	B-ANAT
ECMO	O
support	O
via	O
median	O
sternotomy	O
should	O
be	O
considered	O
as	O
a	O
viable	O
treatment	O
option	O
without	O
further	O
delay	O
.	O

ABSTRACT	O
:	O
Red	B-ANAT
blood	I-ANAT
cell	I-ANAT
(	O
RBC	B-ANAT
)	O
transfusions	O
are	O
associated	O
with	O
increased	O
risk	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
the	O
critically	O
ill	O
,	O
yet	O
the	O
mechanisms	O
for	O
enhanced	O
susceptibility	O
to	O
ARDS	O
conferred	O
by	O
RBC	B-ANAT
transfusions	O
remain	O
unknown	O
.	O

To	O
determine	O
the	O
mechanisms	O
of	O
lung	B-ANAT
endothelial	B-ANAT
cell	I-ANAT
(	O
EC	O
)	O
High	O
Mobility	O
Group	O
Box	O
1	O
(	O
HMGB1	O
)	O
release	O
following	O
exposure	O
to	O
RBCs	B-ANAT
and	O
to	O
determine	O
whether	O
RBC	B-ANAT
transfusion	O
increases	O
susceptibility	O
to	O
lung	B-ANAT
inflammation	O
in	O
vivo	O
through	O
release	O
of	O
the	O
danger	O
signal	O
HMGB1	O
.	O

The	O
plasma	B-ANAT
from	O
transfused	O
and	O
nontransfused	O
patients	O
with	O
severe	O
sepsis	O
was	O
examined	O
for	O
markers	O
of	O
cellular	B-ANAT
injury	O
.	O

Then	O
based	O
on	O
the	O
gene	O
expression	O
,	O
PPI	O
and	O
signalling	O
pathways	O
data	O
,	O
we	O
investigate	O
the	O
comorbidity	O
association	O
of	O
these	O
2	O
infective	O
pathologies	O
with	O
other	O
7	O
diseases	O
(	O
heart	B-ANAT
failure	O
,	O
kidney	B-ANAT
disorder	O
,	O
breast	B-ANAT
cancer	O
,	O
neurodegenerative	O
disorders	O
,	O
bone	B-ANAT
diseases	O
,	O
Type	O
1	O
and	O
Type	O
2	O
diabetes	O
).	O

The	O
differential	O
gene	O
expression	O
profiling	O
strongly	O
suggests	O
that	O
the	O
response	O
of	O
SARS	O
affected	O
patients	O
seems	O
to	O
be	O
mainly	O
an	O
innate	O
inflammatory	O
response	O
and	O
statistically	O
dysregulates	O
a	O
large	O
number	O
of	O
genes	O
,	O
pathways	O
and	O
PPIs	O
subnetworks	O
in	O
different	O
pathologies	O
such	O
as	O
chronic	O
heart	B-ANAT
failure	O
(	O
21	O
genes	O
),	O
breast	B-ANAT
cancer	O
(	O
16	O
genes	O
)	O
and	O
bone	B-ANAT
diseases	O
(	O
11	O
genes	O
).	O

It	O
can	O
be	O
defined	O
as	O
adverse	O
physiologic	O
consequences	O
that	O
occur	O
as	O
a	O
result	O
of	O
an	O
acute	O
increase	O
in	O
the	O
intra	O
-	O
abdominal	B-ANAT
pressure	O
.	O

Hence	O
,	O
in	O
addition	O
to	O
reducing	O
the	O
production	O
of	O
infectious	O
virions	B-ANAT
,	O
inhibition	O
of	O
ER	O
glucosidases	O
also	O
impairs	O
the	O
entry	O
of	O
selected	O
viruses	O
via	O
a	O
post	O
-	O
receptor	O
-	O
binding	O
mechanism	O
.	O

However	O
,	O
data	O
of	O
patients	O
with	O
low	O
and	O
high	O
RecV	O
showed	O
less	O
severe	O
lung	B-ANAT
disease	O
in	O
high	O
'	O
recruiters	O
',	O
indicating	O
that	O
RecV	O
may	O
not	O
equal	O
the	O
'	O
potentially	O
recruitable	O
lung	B-ANAT
tissue	I-ANAT
'	O
seen	O
in	O
computed	O
tomography	O
scans	O
.	O

ABSTRACT	O
:	O
Procalcitonin	O
(	O
PCT	O
)	O
is	O
activated	O
during	O
cardiopulmonary	B-ANAT
bypass	O
(	O
CPB	O
)	O
and	O
may	O
be	O
a	O
predictor	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Lung	B-ANAT
tissues	I-ANAT
were	O
negative	O
for	O
influenza	O
A	O
virus	O
,	O
canine	O
distemper	O
virus	O
,	O
canine	O
parainfluenza	O
virus	O
,	O
canine	O
respiratory	O
coronavirus	O
,	O
and	O
canine	O
adenovirus	O
2	O
.	O

TITLE	O
:	O
Ultrasound	O
-	O
guided	O
lung	B-ANAT
recruitment	O
in	O
a	O
3	O
-	O
month	O
-	O
old	O
infant	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

We	O
report	O
a	O
case	O
of	O
US	O
-	O
guided	O
lung	B-ANAT
recruitment	O
procedure	O
applied	O
in	O
an	O
infant	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
advocate	O
that	O
the	O
lung	B-ANAT
US	O
-	O
guided	O
RM	O
in	O
infants	O
is	O
a	O
feasible	O
and	O
safe	O
procedure	O
.	O

TITLE	O
:	O
Use	O
of	O
High	O
-	O
Flow	O
Nasal	B-ANAT
Cannula	O
Oxygen	O
Therapy	O
in	O
Subjects	O
With	O
ARDS	O
:	O
A	O
1	O
-	O
Year	O
Observational	O
Study	O
.	O

During	O
infusion	O
of	O
vancomycin	O
,	O
he	O
became	O
diaphoretic	O
,	O
hypotensive	O
,	O
and	O
unresponsive	O
,	O
and	O
exhibited	O
respiratory	O
distress	O
and	O
a	O
disseminated	O
red	O
skin	B-ANAT
rash	O
consistent	O
with	O
a	O
severe	O
allergic	O
reaction	O
referred	O
to	O
as	O
the	O
red	O
man	O
syndrome	O
.	O

CONCLUSIONS	O
:	O
Retinal	B-ANAT
artery	I-ANAT
occlusion	O
is	O
a	O
rare	O
but	O
potentially	O
devastating	O
complication	O
of	O
sickle	B-ANAT
cell	I-ANAT
disease	O
.	O

Our	O
results	O
indicate	O
that	O
entry	O
of	O
MHV	O
depends	O
on	O
proteolytic	O
processing	O
of	O
its	O
fusion	O
protein	O
S	O
by	O
lysosomal	B-ANAT
proteases	O
.	O

All	O
of	O
the	O
antibodies	O
raised	O
by	O
S	O
-	O
peptide	O
immunisation	O
were	O
specific	O
and	O
sensitive	O
for	O
S	O
protein	O
expressed	O
in	O
transfected	O
cells	B-ANAT
in	O
the	O
indirect	O
immunofluorescence	O
assay	O
or	O
Western	O
blotting	O
.	O

TITLE	O
:	O
Septic	O
thrombosis	O
of	O
the	O
internal	B-ANAT
jugular	I-ANAT
vein	I-ANAT
:	O
Lemierre	O
'	O
s	O
syndrome	O
revisited	O
.	O

We	O
analyzed	O
the	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
bacterial	O
content	O
of	O
57	O
healthy	O
asymptomatic	O
people	O
(	O
17	O
health	O
-	O
care	O
workers	O
and	O
40	O
community	O
people	O
)	O
and	O
59	O
patients	O
acutely	O
infected	O
with	O
influenza	O
,	O
parainfluenza	O
,	O
rhino	O
,	O
respiratory	O
syncytial	O
,	O
corona	O
,	O
adeno	O
,	O
or	O
metapneumo	O
viruses	O
using	O
culture	O
-	O
independent	O
pyrosequencing	O
.	O

Quantifying	O
the	O
similarities	O
between	O
bacterial	O
populations	O
by	O
using	O
Fast	O
UniFrac	O
analysis	O
indicated	O
that	O
bacterial	O
profiles	O
were	O
apparently	O
divisible	O
into	O
6	O
oropharyngeal	B-ANAT
types	O
in	O
the	O
tested	O
subjects	O
.	O

This	O
study	O
identified	O
6	O
oropharyngeal	B-ANAT
microbiome	O
types	O
.	O

We	O
describe	O
how	O
land	B-ANAT
-	O
use	O
changes	O
may	O
affect	O
co	O
-	O
occurrence	O
and	O
contact	O
between	O
bats	O
and	O
recipient	O
hosts	O
.	O

Depending	O
on	O
the	O
disease	O
condition	O
,	O
additional	O
mechanisms	O
that	O
can	O
contribute	O
to	O
an	O
elevated	O
physiological	O
dead	O
space	O
measurement	O
include	O
shunt	O
,	O
a	O
substantial	O
increase	O
in	O
overall	O
V	O
'	O
A	O
/	O
Q	O
'	O
ratio	O
,	O
diffusion	O
impairment	O
,	O
and	O
ventilation	O
delivered	O
to	O
unperfused	O
alveolar	B-ANAT
spaces	O
.	O

ABSTRACT	O
:	O
To	O
compare	O
inter	O
-	O
hospital	O
transport	O
and	O
clinical	O
outcome	O
in	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
patients	O
whom	O
were	O
transported	O
either	O
on	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
or	O
on	O
conventional	O
ventilation	O
,	O
and	O
to	O
investigate	O
the	O
optimal	O
means	O
of	O
inter	O
-	O
hospital	O
transport	O
.	O

The	O
acute	O
physiology	O
and	O
chronic	O
health	O
evaluation	O
II	O
(	O
APACHEII	O
)	O
score	O
,	O
sequential	O
organ	B-ANAT
failure	O
assessment	O
(	O
SOFA	O
)	O
score	O
,	O
oxygenation	O
index	O
(	O
PaOâ	O
/	O
FiOâ	O
),	O
lung	B-ANAT
injury	O
score	O
(	O
LIS	O
)	O
were	O
recorded	O
within	O
24	O
hours	O
after	O
admission	O
.	O

ABSTRACT	O
:	O
Ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
(	O
VILI	O
)	O
contributes	O
to	O
mortality	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
the	O
most	O
severe	O
form	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
).	O

TITLE	O
:	O
CD26	O
/	O
DPP4	O
cell	B-ANAT
-	O
surface	O
expression	O
in	O
bat	O
cells	B-ANAT
correlates	O
with	O
bat	O
cell	B-ANAT
susceptibility	O
to	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
and	O
evolution	O
of	O
persistent	O
infection	O
.	O

We	O
found	O
that	O
the	O
susceptibility	O
or	O
resistance	O
of	O
these	O
bat	O
cell	B-ANAT
lines	I-ANAT
directly	O
correlates	O
with	O
the	O
presence	O
or	O
absence	O
of	O
cell	B-ANAT
surface	I-ANAT
-	O
expressed	O
CD26	O
/	O
DPP4	O
,	O
the	O
functional	O
human	O
receptor	O
for	O
MERS	O
-	O
CoV	O
.	O
Human	O
anti	O
-	O
CD26	O
/	O
DPP4	O
antibodies	O
inhibited	O
infection	O
of	O
susceptible	O
bat	O
cells	B-ANAT
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

Together	O
,	O
these	O
results	O
imply	O
that	O
bats	O
indeed	O
could	O
be	O
among	O
the	O
MERS	O
-	O
CoV	O
host	O
spectrum	O
,	O
and	O
that	O
cellular	B-ANAT
restriction	O
of	O
MERS	O
-	O
CoV	O
is	O
determined	O
by	O
CD26	O
/	O
DPP4	O
expression	O
rather	O
than	O
by	O
downstream	O
restriction	O
factors	O
.	O

Administration	O
of	O
carrageenan	O
nasal	B-ANAT
spray	O
in	O
children	O
as	O
well	O
as	O
in	O
adults	O
suffering	O
from	O
virus	O
-	O
confirmed	O
common	O
cold	O
reduced	O
duration	O
of	O
disease	O
,	O
increased	O
viral	O
clearance	O
and	O
reduced	O
relapses	O
of	O
symptoms	O
.	O

TITLE	O
:	O
Is	O
there	O
still	O
room	O
for	O
novel	O
viral	O
pathogens	O
in	O
pediatric	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
?	O

This	O
case	O
showed	O
a	O
critical	O
onset	O
with	O
respiratory	O
failure	O
and	O
kidney	B-ANAT
functional	O
impairment	O
due	O
to	O
L	O
.	O
pneumophila	O
,	O
subsequently	O
disclosing	O
Guillain	O
-	O
BarrÃ©	O
syndrome	O
.	O

Only	O
few	O
cases	O
of	O
respiratory	O
failure	O
caused	O
by	O
liver	B-ANAT
abscess	O
and	O
treated	O
with	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
have	O
been	O
reported	O
.	O

We	O
hypothesized	O
that	O
recipients	O
of	O
lungs	B-ANAT
from	O
heavy	O
drinkers	O
would	O
be	O
more	O
susceptible	O
to	O
lung	B-ANAT
injury	O
following	O
transplantation	O
.	O

ABSTRACT	O
:	O
The	O
usual	O
duration	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
is	O
7	O
-	O
10	O
days	O
.	O

EL	O
and	O
the	O
ratio	O
between	O
EL	O
and	O
respiratory	B-ANAT
system	I-ANAT
elastance	O
(	O
ERS	O
)	O
calculated	O
with	O
the	O
two	O
methods	O
were	O
compared	O
.	O

133	O
kPa	O
),	O
lung	B-ANAT
recruitment	O
maneuver	O
was	O
performed	O
combining	O
incremental	O
positive	O
end	O
-	O
expiratory	O
pressure	O
.	O

Before	O
combining	O
lung	B-ANAT
recruitment	O
maneuver	O
,	O
24	O
h	O
after	O
combining	O
lung	B-ANAT
recruitment	O
maneuver	O
,	O
and	O
at	O
the	O
end	O
of	O
combining	O
lung	B-ANAT
recruitment	O
maneuver	O
,	O
the	O
EVLWI	O
values	O
of	O
4	O
patients	O
who	O
received	O
PiCCO	O
monitoring	O
were	O
respectively	O
(	O
13	O
.	O
5	O
Â±	O
1	O
.	O
3	O
),	O
(	O
10	O
.	O
2	O
Â±	O
1	O
.	O
0	O
),	O
(	O
7	O
.	O
0	O
Â±	O
0	O
.	O
8	O
)	O
mL	O
/	O
kg	O
(	O
F	O
=	O
117	O
.	O
00	O
,	O
P	O
<	O
0	O
.	O
01	O
).	O

Lung	B-ANAT
protective	O
ventilation	O
strategy	O
combining	O
lung	B-ANAT
recruitment	O
maneuver	O
can	O
significantly	O
improve	O
the	O
oxygenation	O
in	O
patients	O
with	O
severe	O
burn	O
complicated	O
with	O
ARDS	O
and	O
may	O
therefore	O
improve	O
the	O
prognosis	O
.	O

During	O
7	O
days	O
of	O
ECMO	O
use	O
,	O
organ	B-ANAT
dysfunction	O
scores	O
were	O
significantly	O
lower	O
for	O
survivors	O
than	O
nonsurvivors	O
.	O

Autopsy	O
lung	B-ANAT
tissue	I-ANAT
was	O
assigned	O
scores	O
for	O
histologic	O
abnormalities	O
in	O
9	O
categories	O
,	O
including	O
alveolar	B-ANAT
and	O
interstitial	B-ANAT
fibrosis	O
,	O
hyaline	B-ANAT
membranes	B-ANAT
,	O
and	O
type	O
II	O
epithelial	B-ANAT
cell	I-ANAT
proliferation	O
.	O

Type	O
II	O
epithelial	B-ANAT
cell	I-ANAT
proliferation	O
was	O
significantly	O
more	O
common	O
in	O
cases	O
with	O
a	O
longer	O
time	O
between	O
burn	O
and	O
admission	O
(	O
p	O
<	O
0	O
.	O
02	O
).	O

Interstitial	B-ANAT
fibrosis	O
was	O
significantly	O
more	O
severe	O
in	O
cases	O
with	O
longer	O
survival	O
after	O
burn	O
(	O
p	O
<	O
0	O
.	O
01	O
).	O

RESULTS	O
:	O
Type	O
II	O
epithelial	B-ANAT
cell	I-ANAT
proliferation	O
was	O
significantly	O
more	O
common	O
in	O
cases	O
with	O
a	O
longer	O
time	O
between	O
burn	O
and	O
admission	O
(	O
p	O
<	O
0	O
.	O
02	O
).	O

While	O
coronavirus	O
cell	B-ANAT
and	O
tissue	B-ANAT
tropism	O
,	O
host	O
range	O
,	O
and	O
pathogenesis	O
are	O
initially	O
controlled	O
by	O
interactions	O
between	O
the	O
spike	O
envelope	B-ANAT
glycoprotein	O
and	O
host	B-ANAT
cell	I-ANAT
receptor	O
,	O
it	O
is	O
becoming	O
increasingly	O
apparent	O
that	O
proteolytic	O
activation	O
of	O
spike	O
by	O
host	B-ANAT
cell	I-ANAT
proteases	O
also	O
plays	O
a	O
critical	O
role	O
.	O

This	O
review	O
focuses	O
on	O
the	O
diversity	O
of	O
strategies	O
coronaviruses	O
have	O
evolved	O
to	O
proteolytically	O
activate	O
their	O
fusion	O
protein	O
during	O
spike	O
protein	O
biosynthesis	O
and	O
the	O
critical	O
entry	O
step	O
of	O
their	O
life	O
cycle	O
,	O
and	O
highlights	O
important	O
findings	O
on	O
how	O
proteolytic	O
activation	O
of	O
coronavirus	O
spike	O
influences	O
tissue	B-ANAT
and	O
cell	B-ANAT
tropism	O
,	O
host	O
range	O
and	O
pathogenicity	O
.	O

Various	O
models	O
have	O
successfully	O
been	O
developed	O
to	O
elucidate	O
the	O
contribution	O
of	O
the	O
spike	O
in	O
binding	O
of	O
the	O
virus	O
to	O
cells	B-ANAT
,	O
entry	O
of	O
cell	B-ANAT
culture	O
cells	B-ANAT
and	O
organ	B-ANAT
explants	O
,	O
and	O
the	O
in	O
vivo	O
tropism	O
and	O
pathogenesis	O
.	O

In	O
an	O
effort	O
to	O
assist	O
rapid	O
development	O
of	O
anti	O
-	O
coronavirus	O
drugs	O
,	O
here	O
we	O
screened	O
the	O
NIH	O
Clinical	O
Collection	O
in	O
cell	B-ANAT
culture	O
using	O
a	O
luciferase	O
reporter	O
-	O
expressing	O
recombinant	O
murine	O
coronavirus	O
.	O

Differential	O
diagnoses	O
of	O
AE	O
COPD	O
include	O
infectious	O
pneumonia	O
,	O
pneumothorax	O
,	O
acute	O
heart	B-ANAT
failure	O
and	O
pulmonary	B-ANAT
embolism	O
.	O

Virus	O
yields	O
were	O
higher	O
from	O
macaque	O
cells	B-ANAT
than	O
from	O
baboon	O
cells	B-ANAT
.	O

Fluid	O
resuscitation	O
with	O
crystalloids	O
and	O
continuous	O
norepinephrine	O
infusion	O
was	O
needed	O
because	O
of	O
arterial	B-ANAT
hypotension	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
infects	O
host	O
cells	B-ANAT
through	O
binding	O
the	O
receptor	O
binding	O
domain	O
(	O
RBD	O
)	O
on	O
its	O
spike	O
glycoprotein	O
to	O
human	O
receptor	O
dipeptidyl	O
peptidase	O
4	O
(	O
hDPP4	O
).	O

TITLE	O
:	O
Metagenomic	O
analysis	O
of	O
viromes	O
of	O
dromedary	O
camel	O
fecal	B-ANAT
samples	O
reveals	O
large	O
number	O
and	O
high	O
diversity	O
of	O
circoviruses	O
and	O
picobirnaviruses	O
.	O

The	O
pattern	O
of	O
SHAPE	O
reactivity	O
of	O
in	O
virio	O
genomic	O
RNA	O
,	O
ex	O
virio	O
genomic	O
RNA	O
,	O
and	O
in	O
vitro	O
synthesized	O
RNA	O
was	O
similar	O
,	O
suggesting	O
that	O
binding	O
of	O
N	O
protein	O
or	O
other	O
proteins	O
to	O
virion	B-ANAT
RNA	O
fails	O
to	O
protect	O
the	O
RNA	O
from	O
reaction	O
with	O
lipid	O
permeable	O
SHAPE	O
reagent	O
.	O

To	O
assess	O
the	O
feasibility	O
and	O
patient	O
acceptability	O
of	O
self	O
-	O
collected	O
foam	O
nasal	B-ANAT
swabs	O
for	O
detection	O
of	O
respiratory	O
viruses	O
in	O
SOT	O
recipients	O
and	O
to	O
define	O
the	O
virologic	O
and	O
clinical	O
course	O
.	O

One	O
hundred	O
four	O
weekly	O
self	O
-	O
collected	O
nasal	B-ANAT
swabs	O
were	O
obtained	O
,	O
with	O
a	O
median	O
of	O
4	O
samples	O
per	O
patient	O
(	O
range	O
1	O
-	O
17	O
).	O

HCoVs	O
were	O
present	O
in	O
the	O
stools	B-ANAT
of	O
eight	O
(	O
4	O
.	O
7	O
%)	O
of	O
the	O
172	O
children	O
with	O
AGE	O
;	O
in	O
six	O
of	O
these	O
cases	O
,	O
the	O
nasal	B-ANAT
swab	O
sample	O
was	O
also	O
positive	O
for	O
the	O
respective	O
HCoV	O
.	O
Additionally	O
,	O
in	O
six	O
of	O
the	O
eight	O
cases	O
,	O
the	O
stool	B-ANAT
sample	I-ANAT
contained	O
either	O
rotavirus	O
or	O
calicivirus	O
.	O

ABSTRACT	O
:	O
Respiratory	B-ANAT
tract	I-ANAT
infections	O
(	O
RTIs	O
)	O
are	O
common	O
during	O
the	O
Hajj	O
season	O
and	O
are	O
caused	O
by	O
a	O
variety	O
of	O
organisms	O
,	O
which	O
can	O
be	O
transmitted	O
via	O
the	O
air	O
or	O
contaminated	O
surfaces	O
.	O

Using	O
a	O
laboratory	O
scale	O
drier	O
,	O
inoculated	O
plasma	B-ANAT
was	O
spray	O
dried	B-ANAT
at	O
200	O
Â°	O
C	O
inlet	O
temperature	O
and	O
either	O
70	O
or	O
80	O
Â°	O
C	O
throughout	O
substance	O
.	O

Both	O
liquid	O
and	O
dried	B-ANAT
samples	O
were	O
subjected	O
to	O
three	O
passages	O
on	O
VERO	B-ANAT
cell	I-ANAT
monolayers	O
to	O
determine	O
PEDV	O
infectivity	O
.	O

In	O
summary	O
,	O
PEDV	O
was	O
not	O
infectious	O
on	O
cell	B-ANAT
culture	O
within	O
7	O
days	O
when	O
stored	O
at	O
room	O
temperature	O
and	O
within	O
21	O
days	O
when	O
stored	O
at	O
refrigerated	O
temperature	O
.	O

Clinically	O
,	O
ALI	O
/	O
ARDS	O
is	O
manifested	O
by	O
decreased	O
lung	B-ANAT
compliance	O
,	O
severe	O
hypoxemia	O
,	O
and	O
bilateral	O
pulmonary	B-ANAT
infiltrates	O
.	O

Here	O
,	O
we	O
show	O
proof	O
-	O
of	O
-	O
concept	O
of	O
a	O
microfluidic	O
system	O
capable	O
of	O
being	O
fully	O
automated	O
and	O
handling	O
samples	O
in	O
a	O
parallel	O
format	O
with	O
a	O
miniature	O
physical	O
footprint	O
where	O
the	O
affinity	O
beads	O
are	O
retained	O
in	O
a	O
non	O
-	O
contact	O
levitated	O
mode	O
in	O
a	O
glass	O
capillary	B-ANAT
throughout	O
the	O
assay	O
protocol	O
.	O

The	O
flow	O
rates	O
applied	O
to	O
the	O
capillary	B-ANAT
during	O
the	O
initial	O
trapping	O
event	O
and	O
the	O
wash	O
steps	O
were	O
optimised	O
for	O
maximum	O
bead	O
recovery	O
,	O
resulting	O
in	O
a	O
bead	O
recovery	O
of	O
75	O
%	O
for	O
the	O
complete	O
assay	O
.	O

Coronaviruses	O
induce	O
double	O
-	O
membrane	B-ANAT
vesicles	B-ANAT
(	O
DMVs	B-ANAT
),	O
but	O
the	O
role	O
of	O
DMVs	B-ANAT
in	O
replication	O
and	O
virus	O
fitness	O
remains	O
unclear	O
.	O

The	O
N	O
-	O
terminal	O
fusion	O
peptide	O
(	O
FP	O
,	O
residues	O
770	O
-	O
788	O
),	O
an	O
internal	O
fusion	O
peptide	O
(	O
IFP	O
,	O
residues	O
873	O
-	O
888	O
)	O
and	O
the	O
pre	O
-	O
transmembrane	B-ANAT
region	O
(	O
PTM	O
,	O
residues	O
1185	O
-	O
1202	O
)	O
demonstrated	O
interactions	O
with	O
model	O
lipid	O
membranes	B-ANAT
and	O
potentially	O
involved	O
in	O
the	O
fusion	O
process	O
.	O

ABSTRACT	O
:	O
Calf	B-ANAT
diarrhoea	O
causes	O
substantial	O
economic	O
losses	O
in	O
cattle	O
herds	O
worldwide	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
clinical	O
value	O
of	O
the	O
pulse	O
indicator	O
continuous	O
cardiac	B-ANAT
output	O
(	O
PiCCO	O
)	O
system	O
in	O
patients	O
with	O
severe	O
acute	O
pancreatitis	O
(	O
SAP	O
)	O
complicated	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

PiCCO	O
monitoring	O
can	O
provide	O
real	O
-	O
time	O
surveillance	O
of	O
cardiac	B-ANAT
function	O
,	O
cardiac	B-ANAT
preload	O
and	O
afterload	O
,	O
and	O
extravascular	O
lung	B-ANAT
water	O
in	O
pediatric	O
patients	O
with	O
SAP	O
combined	O
with	O
ARDS	O
.	O

To	O
find	O
out	O
whether	O
the	O
S	O
protein	O
interacts	O
with	O
cellular	B-ANAT
proteins	O
via	O
this	O
sorting	O
signal	O
,	O
a	O
pulldown	O
assay	O
with	O
GST	O
fusion	O
proteins	O
was	O
performed	O
.	O

Infected	O
cells	B-ANAT
were	O
observed	O
for	O
all	O
three	O
samples	O
.	O

CONCLUSIONS	O
:	O
We	O
present	O
here	O
a	O
new	O
method	O
for	O
virus	O
discovery	O
that	O
requires	O
a	O
virus	O
culture	O
on	O
primary	O
cells	B-ANAT
and	O
an	O
antibody	O
detection	O
.	O

Compared	O
with	O
pressure	O
support	O
,	O
neurally	O
adjusted	O
ventilatory	O
assist	O
has	O
been	O
shown	O
to	O
improve	O
patient	O
-	O
ventilator	O
interaction	O
and	O
synchrony	O
in	O
patients	O
with	O
the	O
most	O
challenging	O
respiratory	B-ANAT
system	I-ANAT
mechanics	O
,	O
such	O
as	O
very	O
low	O
compliance	O
consequent	O
to	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
high	O
resistance	O
and	O
air	O
trapping	O
due	O
to	O
chronic	O
airflow	O
obstruction	O
;	O
enhance	O
redistribution	O
of	O
the	O
ventilation	O
in	O
the	O
dependent	O
lung	B-ANAT
regions	O
;	O
avert	O
the	O
risk	O
of	O
patient	O
-	O
ventilator	O
asynchrony	O
due	O
to	O
sedation	O
;	O
avoid	O
central	O
apneas	O
;	O
limit	O
the	O
risk	O
of	O
high	O
(	O
injurious	O
)	O
tidal	O
volumes	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
of	O
varied	O
severity	O
;	O
and	O
improve	O
patient	O
-	O
ventilator	O
interaction	O
and	O
synchrony	O
during	O
noninvasive	O
ventilation	O
,	O
irrespective	O
of	O
the	O
interface	O
utilized	O
.	O

Although	O
the	O
damage	O
-	O
control	O
surgery	O
principles	O
are	O
applicable	O
to	O
thoracic	B-ANAT
trauma	O
,	O
there	O
is	O
a	O
dearth	O
of	O
data	O
on	O
damage	O
-	O
control	O
thoracic	B-ANAT
surgery	O
.	O

When	O
comparing	O
physiologic	O
parameters	O
at	O
initial	O
operation	O
and	O
chest	B-ANAT
closure	O
,	O
temperature	O
was	O
34	O
.	O
4	O
Â°	O
C	O
(	O
1	O
.	O
3	O
Â°	O
C	O
)	O
versus	O
37	O
.	O
4	O
Â°	O
C	O
(	O
0	O
.	O
8	O
Â°	O
C	O
),	O
pH	O
was	O
7	O
.	O
13	O
(	O
0	O
.	O
14	O
)	O
versus	O
7	O
.	O
38	O
(	O
0	O
.	O
6	O
),	O
and	O
international	O
normalized	O
ratio	O
was	O
1	O
.	O
8	O
(	O
0	O
.	O
9	O
)	O
versus	O
1	O
.	O
2	O
(	O
0	O
.	O
3	O
),	O
respectively	O
,	O
all	O
statistically	O
significantly	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

This	O
explains	O
their	O
participation	O
in	O
virtually	O
every	O
metabolic	O
process	O
that	O
involves	O
nucleic	B-ANAT
acids	O
,	O
including	O
DNA	O
replication	O
,	O
recombination	O
and	O
repair	O
,	O
transcription	O
,	O
translation	O
,	O
as	O
well	O
as	O
RNA	O
processing	O
.	O

The	O
physiologic	O
effects	O
of	O
hypercapnia	O
are	O
increasingly	O
well	O
understood	O
,	O
and	O
important	O
recent	O
insights	O
have	O
emerged	O
regarding	O
the	O
cellular	B-ANAT
and	O
molecular	O
mechanisms	O
of	O
action	O
of	O
hypercapnia	O
and	O
acidosis	O
.	O

The	O
investigators	O
revealed	O
mutations	O
in	O
the	O
strain	O
isolated	O
from	O
the	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
of	O
a	O
patient	O
with	O
severe	O
pneumonia	O
complicated	O
by	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

One	O
hundred	O
forty	O
-	O
eight	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
according	O
to	O
the	O
American	O
-	O
European	O
Consensus	O
Conference	O
criteria	O
.	O

Whole	O
-	O
lung	B-ANAT
CT	O
scans	O
were	O
obtained	O
at	O
5	O
and	O
45	O
cm	O
H2O	O
airway	B-ANAT
pressure	O
.	O

In	O
these	O
patients	O
,	O
lung	B-ANAT
recruitability	O
and	O
clinical	O
positive	O
end	O
-	O
expiratory	O
pressure	O
were	O
higher	O
than	O
in	O
patients	O
who	O
remained	O
in	O
the	O
mild	O
subgroup	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

RESULTS	O
:	O
A	O
total	O
of	O
447	O
fecal	B-ANAT
samples	O
,	O
representing	O
24	O
European	O
bat	O
species	O
were	O
tested	O
.	O

ABSTRACT	O
:	O
Aspirin	O
-	O
exacerbated	O
respiratory	O
disease	O
(	O
AERD	O
),	O
also	O
known	O
as	O
Samter	O
'	O
s	O
triad	B-ANAT
,	O
is	O
a	O
clinical	O
syndrome	O
which	O
consists	O
of	O
aspirin	O
(	O
ASA	O
)	O
intolerance	O
,	O
chronic	O
rhinosinusitis	O
with	O
nasal	B-ANAT
polyposis	O
,	O
and	O
intrinsic	O
bronchial	B-ANAT
asthma	O
(	O
Press	O
Med	O
119	O
:	O
48	O
-	O
51	O
,	O
1922	O
).	O

Recently	O
,	O
dipeptidyle	O
peptidase	O
(	O
CD26	O
,	O
DPP4	O
)	O
was	O
identified	O
as	O
the	O
host	B-ANAT
cell	I-ANAT
receptor	O
for	O
MERS	O
-	O
CoV	O
.	O
Interestingly	O
,	O
despite	O
of	O
common	O
presence	O
of	O
DPP4	O
receptors	O
the	O
binding	O
and	O
infection	O
of	O
various	O
cells	B-ANAT
shows	O
imminent	O
variability	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
vaccines	O
formulated	O
with	O
delta	O
inulin	O
adjuvants	O
provide	O
enhanced	O
protection	O
while	O
ameliorating	O
lung	B-ANAT
eosinophilic	O
immunopathology	O
.	O

This	O
study	O
shows	O
that	O
formulation	O
of	O
SARS	O
-	O
CoV	O
spike	O
protein	O
or	O
inactivated	O
whole	O
-	O
virus	O
vaccines	O
with	O
novel	O
delta	O
inulin	O
-	O
based	O
polysaccharide	O
adjuvants	O
enhances	O
neutralizing	O
-	O
antibody	O
titers	O
and	O
protection	O
against	O
clinical	O
disease	O
but	O
at	O
the	O
same	O
time	O
also	O
protects	O
against	O
development	O
of	O
lung	B-ANAT
eosinophilic	O
immunopathology	O
.	O

Human	O
plasma	B-ANAT
-	O
derived	O
C1	O
-	O
INH	O
(	O
pdC1	O
-	O
INH	O
)	O
concentrate	O
is	O
indicated	O
for	O
the	O
treatment	O
of	O
both	O
acute	O
HAE	O
attacks	O
and	O
pre	O
-	O
procedure	O
prevention	O
of	O
HAE	O
episodes	O
in	O
patients	O
undergoing	O
medical	O
,	O
dental	O
,	O
or	O
surgical	O
procedures	O
.	O

The	O
nasal	B-ANAT
and	O
seroprevalence	O
of	O
BoHV	O
-	O
1	O
,	O
BRSV	O
,	O
BVDV	O
-	O
1	O
,	O
and	O
BPIV	O
-	O
3	O
was	O
1	O
.	O
0	O
%	O
and	O
39	O
%,	O
1	O
.	O
2	O
%	O
and	O
46	O
%,	O
3	O
.	O
0	O
%	O
and	O
56	O
%,	O
and	O
1	O
.	O
4	O
%	O
and	O
87	O
%,	O
respectively	O
.	O

The	O
data	O
of	O
investigated	O
children	O
'	O
s	O
contingent	O
with	O
intestinal	B-ANAT
colic	O
prevailed	O
by	O
following	O
comorbidities	O
:	O
SARS	O
--	O
12	O
(	O
18	O
.	O
18	O
%	O
Â±	O
4	O
.	O
78	O
%),	O
protein	O
-	O
energy	O
malnutrition	O
--	O
9	O
(	O
12	O
.	O
85	O
%	O
Â±	O
3	O
.	O
82	O
%),	O
pneumonia	O
--	O
6	O
(	O
8	O
.	O
57	O
%	O
Â±	O
3	O
.	O
57	O
%),	O
atopic	O
dermatitis	O
--	O
7	O
(	O
10	O
.	O
00	O
%	O
Â±.	O
3	O
.	O
57	O
%).	O

TITLE	O
:	O
Mesenchymal	O
stem	B-ANAT
(	O
stromal	O
)	O
cells	B-ANAT
for	O
treatment	O
of	O
ARDS	O
:	O
a	O
phase	O
1	O
clinical	O
trial	O
.	O

Preclinical	O
studies	O
support	O
the	O
efficacy	O
of	O
mesenchymal	O
stem	B-ANAT
(	O
stromal	O
)	O
cells	B-ANAT
(	O
MSCs	O
)	O
in	O
the	O
treatment	O
of	O
lung	B-ANAT
injury	O
.	O

Recombination	O
was	O
analyzed	O
based	O
on	O
full	O
-	O
length	O
viral	B-ANAT
genome	I-ANAT
sequences	O
.	O

TITLE	O
:	O
Levels	O
of	O
feline	O
infectious	O
peritonitis	O
virus	O
in	O
blood	B-ANAT
,	O
effusions	O
,	O
and	O
various	O
tissues	B-ANAT
and	O
the	O
role	O
of	O
lymphopenia	O
in	O
disease	O
outcome	O
following	O
experimental	O
infection	O
.	O

Analysis	O
of	O
interacting	O
proteins	O
by	O
mass	O
spectrometry	O
allowed	O
identification	O
of	O
15	O
cellular	B-ANAT
protein	O
bands	O
representative	O
of	O
12	O
cellular	B-ANAT
proteins	O
including	O
vimentin	B-ANAT
that	O
bound	O
to	O
N	O
protein	O
.	O

Predicted	O
activation	O
for	O
STAT3	O
mediating	O
gene	O
expression	O
relevant	O
for	O
epithelial	B-ANAT
cell	I-ANAT
-	O
to	O
-	O
cell	B-ANAT
adherens	O
and	O
junction	O
signaling	O
in	O
MERS	O
-	O
CoV	O
Eng	O
1	O
infection	O
suggest	O
that	O
these	O
transcriptional	O
differences	O
may	O
be	O
the	O
result	O
of	O
amino	O
acid	O
differences	O
in	O
viral	O
proteins	O
known	O
to	O
modulate	O
innate	O
immunity	O
during	O
MERS	O
-	O
CoV	O
infection	O
.	O

In	O
two	O
cases	O
the	O
T	B-ANAT
lymphocytes	I-ANAT
decreased	O
,	O
and	O
the	O
NK	B-ANAT
cell	I-ANAT
activity	O
decreased	O
significantly	O
in	O
one	O
.	O

Flexible	O
bronchoscopy	O
and	O
bronchial	B-ANAT
lavage	I-ANAT
were	O
performed	O
and	O
bronchial	B-ANAT
cast	B-ANAT
was	O
found	O
in	O
two	O
cases	O
.	O

Blood	B-ANAT
samples	I-ANAT
and	O
nasal	B-ANAT
swabs	O
were	O
collected	O
from	O
153	O
and	O
77	O
children	O
with	O
and	O
without	O
symptoms	O
of	O
respiratory	O
infections	O
,	O
respectively	O
.	O

Finally	O
,	O
the	O
positive	O
end	O
-	O
expiratory	O
pressure	O
adequate	O
for	O
full	O
lung	B-ANAT
opening	O
may	O
be	O
computed	O
combining	O
the	O
computed	O
tomography	O
scan	O
variables	O
and	O
the	O
chest	B-ANAT
wall	I-ANAT
elastance	O
.	O

This	O
pathological	O
manifestation	O
is	O
associated	O
with	O
dramatical	O
elevation	O
of	O
tissue	B-ANAT
IP	O
-	O
10	O
and	O
IFN	O
-	O
Î³	O
and	O
moderate	O
increase	O
of	O
TNF	O
-	O
Î±	O
and	O
IL	O
-	O
1Î²	O
,	O
but	O
inability	O
of	O
anti	O
-	O
viral	O
type	O
I	O
interferon	O
response	O
.	O

ABSTRACT	O
:	O
Supplemental	O
oxygen	O
inhalation	O
is	O
frequently	O
used	O
to	O
treat	O
severe	O
respiratory	O
failure	O
;	O
however	O
,	O
prolonged	O
exposure	O
to	O
hyperoxia	O
causes	O
hyperoxic	O
acute	O
lung	B-ANAT
injury	O
(	O
HALI	O
),	O
which	O
induces	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
leads	O
to	O
high	O
mortality	O
rates	O
.	O

TITLE	O
:	O
No	O
redistribution	O
of	O
lung	B-ANAT
blood	B-ANAT
flow	O
by	O
inhaled	O
nitric	O
oxide	O
in	O
endotoxemic	O
piglets	O
pretreated	O
with	O
an	O
endothelin	O
receptor	O
antagonist	O
.	O

The	O
clinical	O
picture	O
in	O
this	O
scorpion	O
envenoming	O
is	O
mainly	O
characterized	O
by	O
an	O
acute	O
dysfunction	O
of	O
cerebellar	B-ANAT
activities	O
and	O
abnormal	O
neuromuscular	O
manifestations	O
and	O
in	O
some	O
cases	O
muscle	B-ANAT
injury	O
which	O
are	O
not	O
described	O
in	O
any	O
other	O
region	O
of	O
the	O
world	O
.	O

This	O
review	O
provides	O
an	O
up	O
-	O
to	O
-	O
date	O
discussion	O
on	O
the	O
SARS	O
-	O
CoV	O
papain	O
-	O
like	O
protease	O
including	O
a	O
brief	O
overview	O
of	O
the	O
SARS	O
-	O
CoV	O
genome	O
and	O
replication	O
followed	O
by	O
a	O
more	O
in	O
-	O
depth	O
discussion	O
on	O
the	O
structure	O
and	O
catalytic	O
mechanism	O
of	O
SARS	O
-	O
CoV	O
PLpro	O
,	O
the	O
multiple	O
cellular	B-ANAT
functions	O
of	O
SARS	O
-	O
CoV	O
PLpro	O
,	O
the	O
inhibition	O
of	O
SARS	O
-	O
CoV	O
PLpro	O
by	O
small	O
molecule	O
inhibitors	O
,	O
and	O
the	O
prospect	O
of	O
inhibiting	O
papain	O
-	O
like	O
protease	O
from	O
other	O
coronaviruses	O
.	O

Lung	B-ANAT
HRCT	O
analysis	O
on	O
the	O
sixth	O
month	O
indicated	O
that	O
the	O
degree	O
of	O
involvement	O
of	O
the	O
ventral	O
region	O
was	O
greater	O
than	O
that	O
of	O
the	O
dorsal	O
area	O
.	O

CONCLUSIONS	O
:	O
Lung	B-ANAT
HRCT	O
of	O
severe	O
ARDS	O
survivors	O
after	O
ECMO	O
treatment	O
showed	O
various	O
degrees	O
of	O
morphological	O
changes	O
in	O
the	O
lung	B-ANAT
parenchyma	I-ANAT
.	O

MARC	O
-	O
145	O
cells	B-ANAT
were	O
treated	O
with	O
LiCl	O
at	O
various	O
stages	O
of	O
PRRSV	O
life	O
cycle	O
.	O

Further	O
prospective	O
trials	O
on	O
the	O
optimal	O
mechanical	O
ventilation	O
strategy	O
during	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
support	O
are	O
warranted	O
.	O

With	O
the	O
accumulating	O
evidences	O
of	O
survival	O
benefit	O
,	O
the	O
long	O
-	O
term	O
outcome	O
such	O
as	O
pulmonary	B-ANAT
function	O
and	O
quality	O
of	O
life	O
are	O
in	O
concern	O
.	O

Moreover	O
,	O
infected	O
mice	O
treated	O
with	O
MT	O
did	O
express	O
anti	O
-	O
FAH	O
autoAb	O
and	O
high	O
levels	O
of	O
serum	B-ANAT
HMGB1	O
.	O

The	O
neural	B-ANAT
circuits	I-ANAT
involved	O
in	O
this	O
behavior	O
remain	O
largely	O
unknown	O
.	O

These	O
findings	O
reveal	O
a	O
novel	O
function	O
played	O
by	O
the	O
vomeronasal	B-ANAT
system	I-ANAT
.	O

Biologically	O
,	O
PEDV	O
strain	O
CV777	O
induced	O
greater	O
cell	B-ANAT
fusion	O
in	O
Vero	B-ANAT
cells	I-ANAT
than	O
did	O
U	O
.	O
S	O
.	O
PEDV	O
strains	O
.	O

By	O
further	O
mapping	O
,	O
we	O
found	O
that	O
polymorphisms	O
in	O
JHM	O
.	O
WU	O
structural	O
protein	O
M	O
and	O
nonstructural	O
replicase	O
proteins	O
nsp1	O
and	O
nsp13	O
are	O
essential	O
for	O
liver	B-ANAT
pathogenesis	O
.	O

In	O
contrast	O
,	O
an	O
inconsistent	O
mild	O
perivascular	O
cuffing	O
was	O
the	O
only	O
pathological	O
change	O
associated	O
with	O
the	O
infected	O
brains	B-ANAT
.	O

There	O
is	O
significant	O
difference	O
between	O
west	O
and	O
east	O
of	O
Guilan	O
in	O
relation	O
to	O
referred	O
patients	O
(	O
12	O
.	O
9	O
%	O
vs	O
78	O
.	O
5	O
%	O
respectively	O
).	O
Of	O
course	O
this	O
may	O
be	O
due	O
to	O
referral	O
issues	O
of	O
patients	O
and	O
medical	O
teamwork	O
connections	O
METHODS	O
:	O
This	O
retrospective	O
study	O
was	O
done	O
by	O
reviewing	O
sarcoidosis	O
patient	O
'	O
s	O
records	O
containing	O
demographic	O
,	O
sign	O
and	O
symptom	O
and	O
clinical	O
data	O
in	O
a	O
pulmonary	B-ANAT
clinic	O
in	O
Rasht	O
from	O
2001	O
-	O
09	O
.	O

TITLE	O
:	O
Design	O
and	O
implementation	O
of	O
the	O
START	O
(	O
STem	B-ANAT
cells	I-ANAT
for	O
ARDS	O
Treatment	O
)	O
trial	O
,	O
a	O
phase	O
1	O
/	O
2	O
trial	O
of	O
human	O
mesenchymal	O
stem	B-ANAT
/	O
stromal	B-ANAT
cells	I-ANAT
for	O
the	O
treatment	O
of	O
moderate	O
-	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

We	O
previously	O
reported	O
the	O
successful	O
in	O
vitro	O
inhibition	O
of	O
FIPV	O
replication	O
by	O
synthetic	O
siRNA	O
mediated	O
RNA	O
interference	O
(	O
RNAi	O
)	O
in	O
an	O
immortalised	O
cell	B-ANAT
line	I-ANAT
(	O
McDonagh	O
et	O
al	O
.,	O
2011	O
).	O

Furthermore	O
,	O
the	O
involvement	O
of	O
tachykinin	O
NK1	O
receptors	O
expressed	O
on	O
mast	O
cell	B-ANAT
membranes	I-ANAT
was	O
elucidated	O
by	O
their	O
blocking	O
with	O
an	O
antagonist	O
.	O

Particularly	O
,	O
we	O
analyzed	O
secretion	B-ANAT
of	O
type	O
I	O
and	O
type	O
III	O
interferons	O
(	O
IFNs	O
)	O
by	O
APCs	O
,	O
i	O
.	O
e	O
.,	O
B	B-ANAT
cells	I-ANAT
,	O
macrophages	B-ANAT
,	I-ANAT
monocyte	I-ANAT
-	I-ANAT
derived	I-ANAT
/	O
myeloid	O
dendritic	B-ANAT
cells	I-ANAT
(	O
MDDCs	O
/	O
mDCs	O
),	O
and	O
by	O
plasmacytoid	B-ANAT
dendritic	I-ANAT
cells	I-ANAT
(	O
pDCs	O
)	O
of	O
human	O
and	O
murine	O
origin	O
after	O
inoculation	O
with	O
MERS	O
-	O
CoV	O
.	O
Production	O
of	O
large	O
amounts	O
of	O
type	O
I	O
and	O
III	O
IFNs	O
was	O
induced	O
exclusively	O
in	O
human	O
pDCs	O
,	O
which	O
were	O
significantly	O
higher	O
than	O
IFN	O
induction	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
CoV	O
.	O
Of	O
note	O
,	O
IFNs	O
were	O
secreted	O
in	O
the	O
absence	O
of	O
productive	O
replication	O
.	O

We	O
computationally	O
predicted	O
potential	O
13	O
cellular	B-ANAT
miRNAs	O
from	O
11	O
potential	O
hairpin	O
sequences	O
of	O
MERS	O
-	O
CoV	O
genome	O
.	O

Two	O
reviewers	O
scored	O
chest	B-ANAT
radiographs	O
and	O
CT	O
examinations	O
for	O
segmental	O
involvement	O
,	O
ground	O
-	O
glass	O
opacities	O
,	O
consolidation	O
,	O
and	O
interstitial	B-ANAT
thickening	O
.	O

CT	O
of	O
patients	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
predominantly	O
showed	O
ground	O
-	O
glass	O
opacities	O
,	O
with	O
peripheral	O
lower	O
lobe	B-ANAT
preference	O
.	O

There	O
have	O
been	O
no	O
previous	O
studies	O
focusing	O
on	O
the	O
effects	O
of	O
exchange	O
transfusion	O
(	O
ExT	O
)	O
on	O
WBC	B-ANAT
count	O
,	O
respiratory	O
status	O
,	O
and	O
other	O
parameters	O
in	O
TL	O
patients	O
with	O
hyperleukocytosis	O
.	O

All	O
patients	O
required	O
respiratory	O
support	O
before	O
ExT	O
.	O
After	O
ExT	O
,	O
respiration	O
status	O
improved	O
in	O
all	O
five	O
patients	O
:	O
WBC	B-ANAT
count	O
(	O
mean	O
)	O
decreased	O
by	O
85	O
%	O
from	O
143	O
Ã	O
10	O
(	O
9	O
)	O
/	O
L	O
to	O
21	O
Ã	O
10	O
(	O
9	O
)	O
/	O
L	O
.	O

Two	O
of	O
the	O
three	O
surviving	O
neonates	O
developed	O
acute	O
megakaryocytic	B-ANAT
leukemia	O
at	O
age	O
90	O
days	O
and	O
222	O
days	O
.	O

Twenty	O
-	O
two	O
calves	O
had	O
clinical	O
BRD	O
and	O
49	O
had	O
ultrasonographic	O
evidence	O
of	O
lung	B-ANAT
consolidation	O
.	O

Moreover	O
,	O
border	B-ANAT
screening	O
has	O
high	O
opportunity	O
costs	O
,	O
financially	O
and	O
in	O
terms	O
of	O
the	O
use	O
of	O
scarce	O
public	O
health	O
staff	O
resources	O
during	O
a	O
time	O
of	O
high	O
need	O
.	O

We	O
suspected	O
that	O
his	O
symptoms	O
were	O
associated	O
with	O
a	O
pulmonary	B-ANAT
lipiodol	O
embolism	O
after	O
TACE	O
,	O
and	O
we	O
began	O
intensive	O
treatment	O
.	O

These	O
values	O
peaked	O
at	O
the	O
same	O
time	O
as	O
mortality	O
,	O
which	O
was	O
1	O
yr	O
after	O
the	O
WBC	B-ANAT
peak	O
.	O

Vacuolar	B-ANAT
degeneration	O
and	O
diffuse	O
fatty	O
change	O
were	O
observed	O
in	O
the	O
liver	B-ANAT
.	O

Only	O
CAdV	O
type	O
1	O
(	O
CAdV	O
-	O
1	O
)	O
was	O
detected	O
in	O
several	O
organs	B-ANAT
(	O
liver	B-ANAT
,	O
lung	B-ANAT
,	O
brain	B-ANAT
,	O
kidney	B-ANAT
,	O
spleen	B-ANAT
,	O
and	O
heart	B-ANAT
),	O
and	O
other	O
viruses	O
were	O
not	O
found	O
.	O

ABSTRACT	O
:	O
Classical	O
swine	O
fever	O
(	O
CSF	B-ANAT
)	O
is	O
an	O
OIE	O
-	O
listed	O
disease	O
that	O
can	O
have	O
a	O
severe	O
impact	O
on	O
the	O
swine	O
industry	O
.	O

The	O
iiRT	O
-	O
PCR	O
assay	O
accurately	O
detected	O
CSFV	O
as	O
early	O
as	O
2	O
days	O
post	O
-	O
inoculation	O
in	O
RNA	O
extracted	O
from	O
serum	B-ANAT
samples	O
of	O
experimentally	O
infected	O
pigs	O
,	O
before	O
appearance	O
of	O
clinical	O
signs	O
.	O

To	O
determine	O
the	O
effectiveness	O
and	O
safety	O
of	O
transfusing	O
patients	O
with	O
severe	O
trauma	O
and	O
major	O
bleeding	O
using	O
plasma	B-ANAT
,	O
platelets	B-ANAT
,	O
and	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
in	O
a	O
1	O
:	O
1	O
:	O
1	O
ratio	O
compared	O
with	O
a	O
1	O
:	O
1	O
:	O
2	O
ratio	O
.	O

Prespecified	O
ancillary	O
outcomes	O
included	O
time	O
to	O
hemostasis	O
,	O
blood	B-ANAT
product	O
volumes	O
transfused	O
,	O
complications	O
,	O
incidence	O
of	O
surgical	O
procedures	O
,	O
and	O
functional	O
status	O
.	O

Despite	O
the	O
1	O
:	O
1	O
:	O
1	O
group	O
receiving	O
more	O
plasma	B-ANAT
(	O
median	O
of	O
7	O
U	O
vs	O
5	O
U	O
,	O
P	O
<	O
.	O
001	O
)	O
and	O
platelets	B-ANAT
(	O
12	O
U	O
vs	O
6	O
U	O
,	O
P	O
<	O
.	O
001	O
)	O
and	O
similar	O
amounts	O
of	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
(	O
9	O
U	O
)	O
over	O
the	O
first	O
24	O
hours	O
,	O
no	O
differences	O
between	O
the	O
2	O
groups	O
were	O
found	O
for	O
the	O
23	O
prespecified	O
complications	O
,	O
including	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
multiple	O
organ	B-ANAT
failure	O
,	O
venous	B-ANAT
thromboembolism	O
,	O
sepsis	O
,	O
and	O
transfusion	O
-	O
related	O
complications	O
.	O

Despite	O
the	O
1	O
:	O
1	O
:	O
1	O
group	O
receiving	O
more	O
plasma	B-ANAT
(	O
median	O
of	O
7	O
U	O
vs	O
5	O
U	O
,	O
P	O
<	O
.	O
001	O
)	O
and	O
platelets	B-ANAT
(	O
12	O
U	O
vs	O
6	O
U	O
,	O
P	O
<	O
.	O
001	O
)	O
and	O
similar	O
amounts	O
of	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
(	O
9	O
U	O
)	O
over	O
the	O
first	O
24	O
hours	O
,	O
no	O
differences	O
between	O
the	O
2	O
groups	O
were	O
found	O
for	O
the	O
23	O
prespecified	O
complications	O
,	O
including	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
multiple	O
organ	B-ANAT
failure	O
,	O
venous	B-ANAT
thromboembolism	O
,	O
sepsis	O
,	O
and	O
transfusion	O
-	O
related	O
complications	O
.	O

ECoV	O
was	O
detected	O
by	O
quantitative	O
polymerase	O
chain	O
reaction	O
in	O
small	B-ANAT
intestinal	I-ANAT
tissue	B-ANAT
,	O
contents	O
,	O
and	O
/	O
or	O
feces	B-ANAT
,	O
and	O
coronavirus	O
antigen	O
was	O
detected	O
by	O
immunohistochemistry	O
in	O
the	O
small	B-ANAT
intestine	I-ANAT
in	O
all	O
cases	O
.	O

Individuals	O
(	O
n	O
=	O
4	O
)	O
from	O
four	O
different	O
species	O
of	O
frugivorous	O
(	O
Artibeus	O
jamaicensis	O
,	O
Carollia	O
perspicillata	O
and	O
Carollia	O
castanea	O
)	O
and	O
nectivorous	O
(	O
Glossophaga	O
soricina	O
)	O
bats	O
were	O
positive	O
for	O
coronavirus	O
-	O
derived	O
nucleic	B-ANAT
acids	O
.	O

TITLE	O
:	O
Plasma	B-ANAT
levels	O
of	O
soluble	O
receptor	O
for	O
advanced	O
glycation	O
end	O
products	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Plasma	B-ANAT
samples	O
were	O
collected	O
within	O
24	O
hours	O
and	O
levels	O
of	O
sRAGE	O
were	O
determined	O
using	O
a	O
commercially	O
available	O
sandwich	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
kit	O
.	O

In	O
canine	O
cells	B-ANAT
,	O
all	O
proteins	O
are	O
expressed	O
with	O
similar	O
level	O
whereas	O
in	O
feline	O
cells	B-ANAT
,	O
the	O
expression	O
of	O
gp3	O
-	O
Î1	O
is	O
higher	O
than	O
the	O
two	O
other	O
forms	O
of	O
gp3	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
explore	O
the	O
effects	O
of	O
different	O
tidal	O
volume	O
(	O
VT	O
)	O
ventilation	O
on	O
paraquat	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ALI	O
/	O
ARDS	O
)	O
in	O
piglets	O
.	O

The	O
hemodynamics	O
were	O
monitored	O
by	O
pulse	O
-	O
indicated	O
continuous	O
cardiac	B-ANAT
output	O
(	O
PiCCO	O
)	O
and	O
the	O
airway	B-ANAT
pressure	O
changes	O
and	O
blood	B-ANAT
gas	O
analysis	O
indexes	O
were	O
recorded	O
at	O
different	O
time	O
points	O
.	O

The	O
lung	B-ANAT
histopathology	O
showed	O
that	O
the	O
large	O
VT	O
group	O
had	O
the	O
most	O
severe	O
damage	O
and	O
the	O
small	O
VT	O
group	O
had	O
only	O
minimal	O
damage	O
.	O

Kallistatin	O
is	O
a	O
protective	O
hormokine	O
released	O
during	O
monocyte	B-ANAT
activation	O
and	O
low	O
levels	O
in	O
the	O
setting	O
of	O
septic	O
shock	O
can	O
predict	O
adverse	O
outcomes	O
.	O

ABSTRACT	O
:	O
Gut	B-ANAT
health	O
is	O
very	O
important	O
to	O
get	O
maximum	O
returns	O
in	O
terms	O
of	O
weight	O
gain	O
and	O
egg	B-ANAT
production	O
.	O

Health	O
-	O
related	O
quality	O
of	O
life	O
of	O
Australasian	O
survivors	O
of	O
severe	O
H1N1	O
influenza	O
was	O
comparable	O
to	O
the	O
healthy	O
population	O
1	O
year	O
after	O
ICU	O
discharge	B-ANAT
.	O

In	O
this	O
study	O
,	O
nine	O
alkylated	O
chalcones	O
(	O
1	O
-	O
9	O
)	O
and	O
four	O
coumarins	O
(	O
10	O
-	O
13	O
)	O
were	O
isolated	O
from	O
Angelica	O
keiskei	O
,	O
and	O
the	O
inhibitory	O
activities	O
of	O
these	O
constituents	O
against	O
SARS	O
-	O
CoV	O
proteases	O
(	O
3CL	O
(	O
pro	O
)	O
and	O
PL	O
(	O
pro	O
))	O
were	O
determined	O
(	O
cell	B-ANAT
-	O
free	O
/	O
based	O
).	O

Adjustment	O
of	O
PEEP	O
and	O
inspiratory	O
driving	O
pressures	O
did	O
not	O
worsen	O
oxygenation	O
and	O
did	O
not	O
affect	O
cardiac	B-ANAT
output	O
significantly	O
.	O

The	O
main	O
phenotypes	O
of	O
SP	O
are	O
distinguished	O
according	O
the	O
leading	O
resuscitation	O
syndrome	O
(	O
SP	O
with	O
sepsis	O
without	O
multiple	O
organ	B-ANAT
failure	O
(	O
6	O
.	O
9	O
%)	O
including	O
SP	O
with	O
clinical	O
manifestations	O
of	O
acute	O
respiratory	O
failure	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
4	O
.	O
0	O
%),	O
SP	O
with	O
severe	O
sepsis	O
(	O
93	O
.	O
1	O
%)	O
including	O
SP	O
with	O
septic	O
shock	O
(	O
26	O
.	O
7	O
%).	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
characterize	O
the	O
HCoV	O
-	O
NL63	O
nucleocapsid	B-ANAT
protein	O
.	O

Biochemical	O
analyses	O
revealed	O
that	O
the	O
protein	O
shares	O
characteristics	O
with	O
homologous	O
proteins	O
encoded	O
in	O
other	O
coronaviral	O
genomes	O
,	O
with	O
the	O
N	O
-	O
terminal	O
domain	O
responsible	O
for	O
nucleic	B-ANAT
acid	O
binding	O
and	O
the	O
C	O
-	O
terminal	O
domain	O
involved	O
in	O
protein	O
oligomerization	O
.	O

Pre	O
-	O
and	O
post	O
-	O
Hajj	O
nasal	B-ANAT
specimens	O
were	O
prospectively	O
obtained	O
from	O
a	O
paired	O
cohort	O
(	O
692	O
pilgrims	O
)	O
and	O
from	O
nonpaired	O
cohorts	O
(	O
514	O
arriving	O
and	O
470	O
departing	O
pilgrims	O
)	O
from	O
13	O
countries	O
.	O

Nasal	B-ANAT
specimens	O
were	O
tested	O
for	O
34	O
respiratory	O
pathogens	O
using	O
RT	O
-	O
PCR	O
.	O

Influenza	O
and	O
pneumococcal	O
vaccination	O
,	O
face	B-ANAT
mask	O
use	O
and	O
hand	O
hygiene	O
should	O
be	O
considered	O
in	O
the	O
context	O
of	O
the	O
Hajj	O
.	O

TITLE	O
:	O
Limitations	O
of	O
global	O
end	O
-	O
diastolic	O
volume	O
index	O
as	O
a	O
parameter	O
of	O
cardiac	B-ANAT
preload	O
in	O
the	O
early	O
phase	O
of	O
severe	O
sepsis	O
:	O
a	O
subgroup	O
analysis	O
of	O
a	O
multicenter	O
,	O
prospective	O
observational	O
study	O
.	O

SVV	O
â¤	O
13	O
%	O
implies	O
the	O
attainment	O
of	O
cardiac	B-ANAT
preload	O
optimization	O
.	O

GEDI	O
should	O
be	O
used	O
as	O
a	O
cardiac	B-ANAT
preload	O
parameter	O
with	O
awareness	O
of	O
its	O
limitations	O
.	O

On	O
day	O
6	O
,	O
the	O
patient	O
was	O
diagnosed	O
with	O
severe	O
sepsis	O
,	O
and	O
E	O
.	O
coli	O
was	O
isolated	O
by	O
blood	B-ANAT
culture	O
.	O

The	O
patient	O
expired	O
on	O
day	O
13	O
due	O
to	O
multiple	O
organ	B-ANAT
failure	O
.	O

TITLE	O
:	O
Analysis	O
of	O
cathepsin	O
and	O
furin	O
proteolytic	O
enzymes	O
involved	O
in	O
viral	O
fusion	O
protein	O
activation	O
in	O
cells	B-ANAT
of	O
the	O
bat	O
reservoir	O
host	O
.	O

However	O
,	O
kinetic	O
analysis	O
suggests	O
that	O
differences	O
may	O
exist	O
in	O
the	O
cellular	B-ANAT
localization	O
of	O
furin	O
between	O
different	O
species	O
.	O

Data	O
on	O
the	O
clinical	O
presentation	O
in	O
solid	O
organ	B-ANAT
transplant	I-ANAT
recipients	O
are	O
lacking	O
.	O

This	O
is	O
a	O
rare	O
report	O
of	O
MERS	O
CoV	O
infection	O
in	O
renal	B-ANAT
transplant	B-ANAT
recipients	O
.	O

TITLE	O
:	O
Protein	O
histochemistry	O
using	O
coronaviral	O
spike	O
proteins	O
:	O
studying	O
binding	O
profiles	O
and	O
sialic	O
acid	O
requirements	O
for	O
attachment	O
to	O
tissues	B-ANAT
.	O

TITLE	O
:	O
Single	O
particle	O
tracking	O
assay	O
to	O
study	O
coronavirus	O
membrane	B-ANAT
fusion	O
.	O

In	O
particular	O
,	O
this	O
sequence	O
-	O
specific	O
and	O
powerful	O
loss	O
-	O
of	O
-	O
function	O
approach	O
has	O
greatly	O
simplified	O
the	O
study	O
of	O
the	O
role	O
of	O
host	B-ANAT
cell	I-ANAT
factors	O
implicated	O
in	O
the	O
life	O
cycle	O
of	O
viruses	O
.	O

TITLE	O
:	O
Quantification	O
of	O
interferon	O
signaling	O
in	O
avian	O
cells	B-ANAT
.	O

RESULTS	O
:	O
Over	O
60	O
months	O
,	O
a	O
total	O
of	O
19	O
patients	O
with	O
severe	O
traumatic	O
lung	B-ANAT
injury	O
who	O
received	O
ECMO	O
management	O
were	O
retrospectively	O
reviewed	O
.	O

ABSTRACT	O
:	O
The	O
N	O
gene	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
was	O
amplified	O
by	O
RT	O
-	O
PCR	O
using	O
specific	O
primers	O
,	O
and	O
inserted	O
into	O
the	O
expression	O
vector	O
pCold	O
-	O
I	O
to	O
construct	O
a	O
recombinant	O
plasmid	O
pCold	O
-	O
I	O
-	O
N	O
.	O
The	O
recombinant	O
plasmid	O
was	O
expressed	O
in	O
Escherichia	O
coli	O
BL21	B-ANAT
(	O
DE3	O
)	O
under	O
IPTG	O
induction	O
.	O

Correlative	O
light	O
electron	O
microscopy	O
(	O
CLEM	O
)	O
confirmed	O
the	O
presence	O
of	O
E	O
in	O
Golgi	B-ANAT
cisternae	I-ANAT
.	O

Patients	O
with	O
severe	O
hypoxemia	O
and	O
cardiopulmonary	B-ANAT
failure	O
(	O
n	O
=	O
139	O
)	O
at	O
referring	O
hospitals	O
in	O
whom	O
conventional	O
therapy	O
was	O
unsuccessful	O
were	O
treated	O
with	O
iNO	O
in	O
the	O
intensive	O
care	O
units	O
in	O
anticipation	O
of	O
transfer	O
to	O
a	O
tertiary	O
center	O
.	O

Arterial	B-ANAT
blood	I-ANAT
gas	O
analysis	O
was	O
done	O
before	O
and	O
after	O
iNO	O
treatment	O
.	O

Nasal	B-ANAT
swabs	O
from	O
RT	O
-	O
PCR	O
positive	O
camels	O
(	O
Ct	O
values	O
12	O
.	O
9	O
-	O
32	O
.	O
2	O
)	O
yielded	O
reliable	O
sequence	O
information	O
in	O
14	O
samples	O
.	O

Here	O
,	O
we	O
retrospectively	O
analysed	O
the	O
characteristics	O
and	O
outcomes	O
of	O
patients	O
commenced	O
on	O
either	O
veno	O
-	O
venous	B-ANAT
or	O
veno	O
-	O
arterial	B-ANAT
ECMO	O
due	O
to	O
respiratory	O
failure	O
,	O
and	O
then	O
switched	O
to	O
v	O
-	O
v	O
-	O
a	O
ECMO	O
.	O

The	O
underlying	O
conditions	O
were	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
n	O
=	O
3	O
),	O
end	O
-	O
stage	O
pulmonary	B-ANAT
fibrosis	O
(	O
n	O
=	O
5	O
)	O
and	O
respiratory	O
failure	O
after	O
major	O
thoracic	B-ANAT
surgery	O
(	O
n	O
=	O
1	O
)	O
and	O
Caesarean	O
section	O
(	O
n	O
=	O
1	O
).	O

Five	O
patients	O
survived	O
until	O
hospital	O
discharge	B-ANAT
and	O
all	O
of	O
them	O
were	O
alive	O
at	O
the	O
end	O
of	O
the	O
follow	O
-	O
up	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
sensitivity	O
and	O
specificity	O
of	O
a	O
real	O
-	O
time	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
)	O
detecting	O
feline	O
coronavirus	O
(	O
FCoV	O
)	O
RNA	O
in	O
cerebrospinal	B-ANAT
fluid	I-ANAT
(	O
CSF	B-ANAT
)	O
of	O
cats	O
with	O
and	O
without	O
neurological	O
and	O
/	O
or	O
ocular	B-ANAT
signs	O
for	O
the	O
diagnosis	O
of	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
).	O

If	O
only	O
cats	O
with	O
neurological	O
involvement	O
are	O
evaluated	O
,	O
the	O
sensitivity	O
of	O
this	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
in	O
CSF	B-ANAT
is	O
also	O
high	O
.	O

ABSTRACT	O
:	O
p	O
-	O
Hydroxyacetophenone	O
(	O
p	O
-	O
HAP	O
),	O
as	O
a	O
main	O
hepatoprotective	O
and	O
choleretic	O
constituent	O
of	O
Artemisia	O
capillaris	B-ANAT
,	O
was	O
revealed	O
with	O
anti	O
-	O
hepatitis	O
B	O
virus	O
(	O
HBV	O
)	O
effects	O
in	O
recent	O
investigation	O
.	O

Cell	B-ANAT
culture	O
isolation	O
and	O
propagation	O
were	O
optimized	O
,	O
and	O
the	O
isolates	O
were	O
serially	O
propagated	O
in	O
cell	B-ANAT
culture	O
for	O
>	O
20	O
passages	O
.	O

ABSTRACT	O
:	O
To	O
retrospectively	O
evaluate	O
the	O
efficacy	O
and	O
safety	O
of	O
rituximab	O
(	O
Rtx	O
)	O
treatment	O
in	O
patients	O
with	O
anti	O
-	O
synthetase	O
syndrome	O
(	O
ASS	O
)	O
and	O
severe	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
(	O
ILD	O
).	O

Clinical	O
data	O
,	O
including	O
pulmonary	B-ANAT
function	O
tests	O
(	O
PFTs	O
),	O
were	O
retrospectively	O
collected	O
from	O
medical	O
reports	O
.	O

TITLE	O
:	O
CD107a	O
as	O
a	O
marker	O
of	O
activation	O
in	O
chicken	O
cytotoxic	B-ANAT
T	I-ANAT
cells	I-ANAT
.	O

We	O
present	O
3	O
cases	O
of	O
respiratory	O
failure	O
and	O
severe	O
pulmonary	B-ANAT
disease	O
managed	O
with	O
airway	B-ANAT
pressure	O
release	O
ventilation	O
,	O
among	O
other	O
ventilatory	O
modes	O
,	O
with	O
improved	O
ventilation	O
.	O

ABSTRACT	O
:	O
Nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
gene	O
of	O
turkey	O
coronavirus	O
(	O
TCoV	O
)	O
was	O
expressed	O
in	O
a	O
prokaryotic	O
system	O
and	O
used	O
to	O
develop	O
an	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
for	O
detection	O
of	O
antibody	O
to	O
TCoV	O
.	O
Anti	O
-	O
TCoV	O
hyperimmune	O
turkey	O
serum	B-ANAT
and	O
normal	O
turkey	O
serum	B-ANAT
were	O
used	O
as	O
positive	O
or	O
negative	O
controls	O
for	O
optimization	O
of	O
the	O
ELISA	O
.	O

The	O
established	O
ELISA	O
was	O
also	O
examined	O
with	O
serum	B-ANAT
samples	O
obtained	O
from	O
turkeys	O
experimentally	O
infected	O
with	O
TCoV	O
.	O
Those	O
serum	B-ANAT
samples	O
were	O
collected	O
at	O
various	O
time	O
intervals	O
from	O
1	O
to	O
63	O
days	O
post	O
-	O
infection	O
.	O

The	O
present	O
findings	O
suggest	O
that	O
the	O
poorly	O
aerated	O
lung	B-ANAT
tissue	I-ANAT
is	O
an	O
important	O
target	O
of	O
the	O
perpetuation	O
of	O
the	O
inflammatory	O
process	O
occurring	O
during	O
ventilation	O
according	O
to	O
the	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
Network	O
strategy	O
.	O

Other	O
common	O
symptoms	O
were	O
vomiting	O
(	O
56	O
%),	O
facial	B-ANAT
swelling	O
(	O
52	O
%),	O
cough	O
(	O
35	O
%),	O
abdominal	B-ANAT
pain	O
(	O
33	O
%),	O
breathlessness	O
(	O
29	O
%)	O
and	O
decreased	O
urine	B-ANAT
output	O
(	O
29	O
%).	O

Meningoencephalitis	O
(	O
30	O
.	O
3	O
%),	O
severe	O
thrombocytopenia	O
(	O
27	O
.	O
2	O
%),	O
shock	O
(	O
25	O
.	O
8	O
%),	O
acute	O
kidney	B-ANAT
injury	O
(	O
16	O
.	O
7	O
%)	O
and	O
hepatitis	O
(	O
13	O
.	O
6	O
%)	O
were	O
the	O
most	O
common	O
complications	O
observed	O
in	O
these	O
children	O
.	O

Causes	O
of	O
death	O
were	O
refractory	O
shock	O
,	O
meningoencephalitis	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
bronchopneumonia	O
,	O
acute	O
kidney	B-ANAT
injury	O
and	O
myocarditis	O
.	O

Mild	O
interstitial	B-ANAT
pneumonia	O
was	O
identified	O
in	O
the	O
lungs	B-ANAT
of	O
PdCV	O
-	O
infected	O
piglets	O
.	O

Her	O
liver	B-ANAT
function	O
,	O
clinical	O
signs	O
and	O
symptoms	O
improved	O
significantly	O
.	O

TITLE	O
:	O
Highly	O
PEGylated	O
DNA	O
Nanoparticles	O
Provide	O
Uniform	O
and	O
Widespread	O
Gene	O
Transfer	O
in	O
the	O
Brain	B-ANAT
.	O

Following	O
convection	O
enhanced	O
delivery	O
(	O
CED	O
),	O
conventional	O
gene	O
vectors	O
are	O
confined	O
to	O
the	O
injection	O
site	O
,	O
presumably	O
by	O
adhesive	O
interactions	O
with	O
the	O
brain	B-ANAT
ECM	B-ANAT
and	O
do	O
not	O
provide	O
gene	O
expression	O
beyond	O
the	O
point	O
of	O
administration	O
.	O

ABSTRACT	O
:	O
An	O
ideal	O
vaccine	O
against	O
mucosal	B-ANAT
pathogens	O
such	O
as	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
should	O
confer	O
sustained	O
,	O
protective	O
immunity	O
at	O
both	O
systemic	O
and	O
mucosal	B-ANAT
levels	O
.	O

Intragastric	O
administration	O
of	O
either	O
Ad5	O
-	O
S	O
or	O
Ad41	O
-	O
S	O
induced	O
antigen	O
-	O
specific	O
IgG	O
and	O
neutralizing	O
antibody	O
in	O
serum	B-ANAT
;	O
however	O
,	O
antigen	O
-	O
specific	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
responses	O
were	O
not	O
detected	O
.	O

RESULTS	O
:	O
In	O
February	O
2008	O
,	O
on	O
board	O
a	O
bulk	O
carrier	O
with	O
a	O
cargo	O
of	O
peas	O
,	O
a	O
56	O
-	O
year	O
-	O
old	O
seafarer	O
with	O
intense	O
abdominal	B-ANAT
and	O
chest	B-ANAT
pains	O
,	O
associated	O
with	O
dizziness	O
,	O
was	O
rescued	O
by	O
helicopter	O
80	O
miles	O
away	O
from	O
the	O
coast	O
.	O

TITLE	O
:	O
Emerging	O
respiratory	B-ANAT
tract	I-ANAT
viral	O
infections	O
.	O

A	O
total	O
of	O
500	O
samples	O
,	O
including	O
tracheal	O
and	O
cloacal	B-ANAT
swabs	O
collected	O
from	O
312	O
wild	O
birds	O
belonging	O
to	O
42	O
species	O
,	O
were	O
analysed	O
using	O
molecular	O
assays	O
.	O

ABSTRACT	O
:	O
Hepatitis	O
E	O
virus	O
(	O
HEV	B-ANAT
)	O
is	O
the	O
most	O
common	O
cause	O
of	O
acute	O
viral	O
hepatitis	O
worldwide	O
.	O

Immunocompromised	O
patients	O
can	O
be	O
infected	O
with	O
multiple	O
viruses	O
and	O
shed	O
viruses	O
in	O
their	O
stools	B-ANAT
for	O
prolonged	O
periods	O
.	O

ABSTRACT	O
:	O
Severe	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
)	O
disease	O
is	O
a	O
frequent	O
cause	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
young	O
children	O
,	O
and	O
is	O
associated	O
with	O
marked	O
lung	B-ANAT
epithelial	O
injury	O
and	O
neutrophilic	O
inflammation	O
.	O

Here	O
,	O
we	O
report	O
a	O
comprehensive	O
analysis	O
of	O
host	O
miRNA	O
expression	O
in	O
TGEV	O
-	O
infected	O
swine	O
testis	B-ANAT
(	O
ST	O
)	O
cells	B-ANAT
.	O

TITLE	O
:	O
Passive	O
immunotherapy	O
with	O
dromedary	O
immune	O
serum	B-ANAT
in	O
an	O
experimental	O
animal	O
model	O
for	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
infection	O
.	O

One	O
promising	O
approach	O
is	O
passive	O
administration	O
of	O
sera	B-ANAT
from	O
convalescent	O
human	O
MERS	O
patients	O
or	O
other	O
animals	O
to	O
exposed	O
or	O
infected	O
patients	O
.	O

Whether	O
sRAGE	O
could	O
inform	O
on	O
the	O
response	O
to	O
ventilator	O
settings	O
has	O
been	O
poorly	O
investigated	O
,	O
and	O
whether	O
a	O
recruitment	O
maneuver	O
(	O
RM	O
)	O
may	O
influence	O
plasma	B-ANAT
sRAGE	O
remains	O
unknown	O
.	O

Most	O
of	O
these	O
viruses	O
are	O
genetically	O
simple	O
and	O
rely	O
heavily	O
on	O
co	O
-	O
opting	O
cellular	B-ANAT
proteins	O
,	O
particularly	O
cellular	B-ANAT
RNA	O
-	O
binding	O
proteins	O
,	O
into	O
new	O
roles	O
for	O
support	O
of	O
virus	O
infection	O
at	O
the	O
level	O
of	O
virus	O
-	O
specific	O
translation	O
,	O
and	O
building	O
RNA	O
replication	O
complexes	O
.	O

Canine	O
parainfluenza	O
virus	O
(	O
CPIV	O
),	O
canine	O
adenovirus	O
,	O
canine	O
herpes	O
virus	O
,	O
canine	O
influenzavirus	O
,	O
canine	O
distemper	O
virus	O
,	O
canine	O
respiratory	O
coronavirus	O
(	O
CRCoV	O
)	O
and	O
canine	O
pneumovirus	O
,	O
as	O
well	O
as	O
B	O
.	O
bronchiseptica	O
and	O
Mycoplasma	O
spp	O
.	O
were	O
analyzed	O
in	O
respiratory	B-ANAT
samples	I-ANAT
using	O
PCR	O
assays	O
.	O

Since	O
the	O
proposal	O
did	O
not	O
mandate	O
PaOâ	O
/	O
FiOâ	O
calculation	O
under	O
standardised	O
ventilator	O
settings	O
(	O
SVS	O
),	O
we	O
hypothesised	O
that	O
a	O
stratification	O
based	O
on	O
baseline	O
PaOâ	O
/	O
FiOv	O
would	O
not	O
provide	O
accurate	O
assessment	O
of	O
lung	B-ANAT
injury	O
severity	O
.	O

Furthermore	O
,	O
all	O
the	O
4	O
case	O
-	O
control	O
studies	O
demonstrated	O
a	O
cumulative	O
effect	O
on	O
risk	O
of	O
SARS	O
-	O
CoV	O
infection	O
for	O
the	O
combination	O
of	O
polymorphisms	O
(	O
joint	B-ANAT
P	O
=	O
1	O
.	O
3	O
Ã	O
10	O
(-	O
10	O
)).	O

An	O
effective	O
recruitment	O
maneuver	O
is	O
expected	O
to	O
reinflate	O
nonaerated	O
lung	B-ANAT
units	O
.	O

End	O
-	O
expiratory	O
lung	B-ANAT
volume	O
,	O
compliance	O
,	O
dead	O
space	O
,	O
volumetric	O
capnography	O
,	O
and	O
bedside	O
imaging	O
techniques	O
such	O
as	O
lung	B-ANAT
ultrasound	O
and	O
electrical	O
impedance	O
tomography	O
have	O
all	O
different	O
strengths	O
and	O
weaknesses	O
.	O

In	O
addition	O
,	O
the	O
percutaneous	O
arterial	B-ANAT
oxygen	O
saturation	O
decreased	O
to	O
95	O
.	O
7	O
%Â±	O
3	O
.	O
8	O
%,	O
although	O
it	O
was	O
never	O
lower	O
than	O
90	O
.	O
0	O
%	O
during	O
the	O
procedure	O
,	O
and	O
no	O
patients	O
required	O
intubation	O
.	O

Furthermore	O
,	O
the	O
arterial	B-ANAT
blood	I-ANAT
pressure	O
significantly	O
but	O
transiently	O
decreased	O
due	O
to	O
sedation	O
,	O
and	O
the	O
procedure	O
yielded	O
diagnostic	O
information	O
in	O
all	O
nine	O
patients	O
.	O

Similarly	O
,	O
cells	B-ANAT
with	O
reduced	O
levels	O
of	O
the	O
tetraspanin	O
CD9	O
resisted	O
CoV	O
pseudoparticle	O
transductions	O
but	O
were	O
made	O
susceptible	O
by	O
overproducing	O
TEM	O
-	O
associated	O
proteases	O
.	O

Enveloped	O
viruses	O
use	O
their	O
surface	O
glycoproteins	O
to	O
catalyze	O
membrane	B-ANAT
fusion	O
,	O
an	O
essential	O
cell	B-ANAT
entry	O
step	O
.	O

A	O
QX	O
-	O
like	O
strain	O
was	O
analysed	O
by	O
high	O
-	O
throughput	O
Illumina	O
sequencing	O
and	O
genetic	O
variation	O
across	O
the	O
entire	O
viral	B-ANAT
genome	I-ANAT
was	O
explored	O
at	O
the	O
sub	O
-	O
consensus	O
level	O
by	O
single	O
nucleotide	O
polymorphism	O
(	O
SNP	O
)	O
analysis	O
.	O

It	O
is	O
maintained	O
mainly	O
by	O
tight	B-ANAT
junctions	I-ANAT
(	O
TJs	O
)	O
and	O
adherens	B-ANAT
junctions	I-ANAT
(	O
AJs	O
).	O

TITLE	O
:	O
High	O
diagnostic	O
accuracy	O
of	O
the	O
Sysmex	O
XT	O
-	O
2000iV	O
delta	O
total	O
nucleated	O
cells	B-ANAT
on	O
effusions	O
for	O
feline	O
infectious	O
peritonitis	O
.	O

ABSTRACT	O
:	O
A	O
series	O
of	O
phenylpropanoid	O
derivatives	O
were	O
synthesized	O
,	O
and	O
their	O
anti	O
-	O
hepatitis	O
B	O
virus	O
(	O
HBV	O
)	O
activity	O
was	O
evaluated	O
in	O
HepG	O
2	O
.	O
2	O
.	O
15	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
management	O
of	O
respiratory	O
virus	O
infections	O
prior	O
to	O
hematopoietic	B-ANAT
cell	I-ANAT
transplant	B-ANAT
(	O
HCT	O
)	O
is	O
difficult	O
.	O

Lung	B-ANAT
mechanics	O
,	O
(	O
respiratory	B-ANAT
system	I-ANAT
elastance	O
,	O
tissue	B-ANAT
damping	O
and	O
airway	B-ANAT
resistance	O
),	O
were	O
evaluated	O
by	O
forced	O
oscillation	O
technique	O
,	O
while	O
respiratory	B-ANAT
system	I-ANAT
compliance	O
was	O
measured	O
with	O
quasi	O
-	O
static	O
pressure	O
-	O
volume	O
curves	O
.	O

For	O
the	O
systemic	O
response	O
,	O
we	O
obtained	O
plasma	B-ANAT
levels	O
of	O
Tumor	O
Necrosis	O
Factor	O
-	O
Î±	O
,	O
Interleukin	O
-	O
6	O
and	O
Matrix	O
-	O
Metalloprotease	O
-	O
9	O
by	O
ELISA	O
.	O

There	O
was	O
a	O
3	O
-	O
fold	O
increase	O
in	O
plasma	B-ANAT
Tumor	O
Necrosis	O
Factor	O
-	O
Î±	O
,	O
a	O
7	O
-	O
fold	O
increase	O
in	O
plasma	B-ANAT
Interleukin	O
-	O
6	O
and	O
a	O
20	O
-	O
fold	O
increase	O
in	O
lavage	O
fluid	O
Matrix	O
-	O
Metalloprotease	O
-	O
9	O
by	O
HVt	O
but	O
simvastatin	O
reduced	O
these	O
levels	O
to	O
control	O
.	O

Despite	O
lung	B-ANAT
protective	O
ventilation	O
strategies	O
with	O
maximal	O
F	O
i	O
O2	O
(	O
patients	O
A	O
-	O
D	O
),	O
neuromuscular	O
blockade	O
(	O
patients	O
A	O
-	O
D	O
),	O
inhaled	O
nitric	O
oxide	O
(	O
patients	O
A	O
and	O
D	O
),	O
and	O
prone	O
positioning	O
(	O
patient	O
D	O
),	O
progressive	O
hypoxemia	O
resulted	O
in	O
initiation	O
of	O
venovenous	O
ECMO	O
by	O
hours	O
24	O
-	O
90	O
of	O
mechanical	O
ventilation	O
with	O
subsequent	O
de	O
-	O
escalation	O
of	O
ventilatory	O
support	O
.	O

Unlike	O
other	O
enveloped	O
viruses	O
,	O
CoVs	O
bud	B-ANAT
and	O
assemble	O
at	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
)-	O
Golgi	B-ANAT
intermediate	O
compartment	B-ANAT
(	O
ERGIC	B-ANAT
).	O

For	O
that	O
reason	O
,	O
it	O
is	O
recommended	O
to	O
collect	O
a	O
urine	B-ANAT
sample	I-ANAT
from	O
these	O
patients	O
to	O
allow	O
an	O
early	O
diagnosis	O
of	O
SIADH	O
,	O
and	O
thus	O
early	O
treatment	O
of	O
fluid	O
and	O
electrolyte	O
abnormalities	O
.	O

Being	O
able	O
to	O
incorporate	O
the	O
key	O
features	O
of	O
these	O
proteins	O
that	O
enable	O
cell	B-ANAT
entry	O
into	O
simpler	O
scaffolds	O
opens	O
up	O
a	O
wide	O
range	O
of	O
opportunities	O
for	O
the	O
development	O
of	O
new	O
delivery	O
reagents	O
with	O
improved	O
performance	O
.	O

Patients	O
with	O
intra	O
-	O
cardiac	B-ANAT
shunt	O
through	O
patent	O
foramen	B-ANAT
ovale	I-ANAT
were	O
excluded	O
.	O

Patients	O
with	O
moderate	O
-	O
to	O
-	O
large	O
TPBT	O
had	O
higher	O
values	O
of	O
cardiac	B-ANAT
index	O
and	O
heart	B-ANAT
rate	O
as	O
compared	O
to	O
those	O
without	O
TPBT	O
.	O

This	O
patient	O
was	O
successfully	O
managed	O
by	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
high	O
frequency	O
oscillator	O
ventilation	O
,	O
proning	O
position	O
and	O
tube	O
thoracostomy	O
.	O

We	O
used	O
two	O
-	O
tailed	B-ANAT
Mann	O
Whitney	O
U	O
exact	O
tests	O
,	O
Ï	O
(	O
2	O
),	O
and	O
Fisher	O
'	O
s	O
exact	O
tests	O
to	O
analyse	O
the	O
data	O
.	O

To	O
investigate	O
the	O
genotypes	O
of	O
prevailing	O
PEDVs	O
,	O
intestinal	B-ANAT
and	O
fecal	B-ANAT
samples	O
from	O
piglets	O
from	O
central	O
and	O
northern	O
Vietnam	O
were	O
collected	O
and	O
analyzed	O
.	O

Then	O
,	O
the	O
transcription	O
product	O
was	O
transfected	O
into	O
Vero	B-ANAT
cells	I-ANAT
by	O
electroporation	O
.	O

Western	O
blot	O
analysis	O
of	O
rBeau	O
-	O
H120	O
(	O
S1	O
)-	O
infected	O
Vero	B-ANAT
cell	I-ANAT
lysates	O
demonstrated	O
that	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
was	O
expressed	O
,	O
which	O
implied	O
that	O
rBeau	O
-	O
H120	O
(	O
S1	O
)	O
could	O
propagate	O
in	O
Vero	B-ANAT
cells	I-ANAT
.	O

Our	O
results	O
showed	O
that	O
S377	O
-	O
588	O
-	O
Fc	O
at	O
1	O
Î¼g	O
was	O
able	O
to	O
induce	O
in	O
the	O
immunized	O
mice	O
potent	O
humoral	O
and	O
cellular	B-ANAT
immune	O
responses	O
.	O

The	O
survived	O
10	O
patients	O
were	O
followed	O
up	O
for	O
1	O
year	O
,	O
1	O
patient	O
with	O
localized	O
pneumothorax	O
,	O
bronchopleural	O
fistula	O
,	O
1	O
case	O
of	O
mild	O
pulmonary	B-ANAT
fibrosis	O
,	O
1	O
case	O
of	O
acute	O
laryngitis	O
with	O
persistent	O
hoarseness	O
,	O
and	O
mild	O
inspiratory	O
dyspnea	O
were	O
found	O
.	O

TITLE	O
:	O
Plasma	B-ANAT
level	O
of	O
soluble	O
receptor	O
for	O
advanced	O
glycation	O
end	O
-	O
products	O
and	O
aquaporin	O
5	O
in	O
preterm	O
infants	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Collected	O
the	O
plasma	B-ANAT
of	O
all	O
53	O
newborns	O
at	O
24	O
,	O
48	O
and	O
72	O
hours	O
after	O
birth	O
,	O
detected	O
the	O
plasma	B-ANAT
level	O
of	O
sRAGE	O
and	O
AQP5	O
by	O
enzyme	O
linked	O
immunosorbent	O
assay	O
.	O

The	O
plasma	B-ANAT
level	O
of	O
sRAGE	O
and	O
AQP5	O
might	O
be	O
associated	O
with	O
the	O
severity	O
of	O
RDS	O
in	O
preterm	O
infants	O
.	O

The	O
clinical	O
feature	O
like	O
dyspnoea	O
,	O
cough	O
,	O
low	O
blood	B-ANAT
pressure	O
(	O
MAP	O
<	O
65	O
mmHg	O
),	O
IVC	O
collapsibility	O
(	O
by	O
ultrasound	O
)	O
and	O
laboratory	O
parameters	O
like	O
decreased	O
Hemoglobin	O
,	O
Hematocrit	O
,	O
Serum	B-ANAT
albumin	O
,	O
and	O
increased	O
serum	B-ANAT
creatinine	O
,	O
serum	B-ANAT
total	O
bilirubin	O
,	O
SGOT	O
,	O
SGPT	O
,	O
LDH	O
,	O
CPK	O
,	O
and	O
serum	B-ANAT
lactate	O
were	O
statistically	O
significant	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
in	O
scrub	O
typhus	O
patients	O
group	O
with	O
ARDS	O
.	O

Nerve	B-ANAT
conduction	O
studies	O
demonstrated	O
acute	O
motor	O
-	O
sensory	O
axonal	O
neuropathy	O
including	O
both	O
phrenic	B-ANAT
nerves	I-ANAT
.	O

Lung	B-ANAT
tissue	I-ANAT
biopsy	O
revealed	O
chronic	O
reparative	O
and	O
resorptive	O
reaction	O
with	O
organizing	O
vasculitis	O
.	O

CONCLUSIONS	O
:	O
We	O
conclude	O
that	O
a	O
diagnosis	O
of	O
GATA	O
-	O
2	O
deficiency	O
should	O
be	O
considered	O
in	O
all	O
patients	O
with	O
diffuse	O
parenchymal	O
lung	B-ANAT
disease	O
presenting	O
together	O
with	O
leukocytopenia	O
,	O
namely	O
monocyto	O
-,	O
dendritic	B-ANAT
cell	I-ANAT
-	O
and	O
B	O
-	O
lymphopenia	O
,	O
irrespective	O
of	O
severity	O
of	O
the	O
clinical	O
phenotype	O
.	O

In	O
an	O
additional	O
group	O
,	O
HS	O
and	O
standardized	O
lung	B-ANAT
injury	O
induced	O
by	O
OA	O
were	O
combined	O
(	O
group	O
lung	B-ANAT
injury	O
[	O
HS	O
+	O
OA	O
]).	O

After	O
the	O
shock	O
period	O
,	O
both	O
groups	O
were	O
resuscitated	O
over	O
15	O
min	O
by	O
transfusion	O
of	O
the	O
removed	O
blood	B-ANAT
and	O
an	O
equal	O
volume	O
of	O
lactate	O
Ringer	O
solution	O
.	O

The	O
end	O
point	O
was	O
6	O
h	O
.	O
Plasma	B-ANAT
interleukin	O
(	O
IL	O
)-	O
6	O
,	O
keratinocyte	B-ANAT
chemoattractant	O
(	O
KC	O
),	O
IL	O
-	O
10	O
,	O
monocyte	B-ANAT
chemoattractant	O
protein	O
-	O
1	O
(	O
MCP	O
-	O
1	O
),	O
and	O
lung	B-ANAT
histology	O
were	O
carried	O
out	O
.	O

Histologic	O
analysis	O
confirmed	O
diffuse	O
alveolar	B-ANAT
congestion	O
and	O
moderate	O
-	O
to	O
-	O
severe	O
lung	B-ANAT
edema	O
in	O
animals	O
with	O
HS	O
+	O
OA	O
.	O

TITLE	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
in	O
a	O
child	O
with	O
severe	O
epileptic	O
disorder	O
treated	O
successfully	O
by	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
:	O
a	O
case	O
report	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
is	O
now	O
a	O
candidate	O
therapy	O
for	O
children	O
with	O
acute	O
respiratory	O
failure	O
.	O

CONCLUSIONS	O
:	O
The	O
successful	O
outcome	O
in	O
this	O
case	O
resulted	O
from	O
the	O
central	O
ECMO	O
,	O
which	O
enabled	O
""""	O
lung	B-ANAT
rest	O
""""	O
and	O
adequate	O
cerebral	B-ANAT
blood	B-ANAT
flow	O
.	O

Th17	O
/	O
Treg	O
ratio	O
was	O
positively	O
correlated	O
with	O
APACHE	O
II	O
score	O
,	O
SOFA	O
score	O
,	O
and	O
Lung	B-ANAT
Injury	O
Score	O
,	O
while	O
negatively	O
correlated	O
with	O
PaOâ	O
/	O
FiOâ	O
.	O
The	O
areas	O
under	O
the	O
receiver	O
operating	O
characteristic	O
(	O
AUC	O
)	O
curves	O
of	O
Th17	O
/	O
Treg	O
ratio	O
for	O
predicting	O
28	O
-	O
day	O
mortality	O
in	O
ARDS	O
patients	O
was	O
higher	O
than	O
that	O
of	O
APACHE	O
II	O
score	O
,	O
SOFA	O
score	O
,	O
Lung	B-ANAT
injury	O
score	O
,	O
as	O
well	O
as	O
PaO2	O
/	O
FiO2	O
.	O

RESULTS	O
:	O
Within	O
24	O
hours	O
after	O
the	O
onset	O
of	O
ARDS	O
,	O
the	O
changes	O
of	O
peripheral	O
circulating	O
Th17	O
and	O
Treg	B-ANAT
cell	I-ANAT
frequencies	O
gradually	O
increased	O
from	O
mild	O
to	O
severe	O
ARDS	O
.	O

Compared	O
with	O
single	O
viral	O
infections	O
,	O
those	O
with	O
co	O
-	O
detections	O
less	O
frequently	O
reported	O
sore	O
throat	B-ANAT
(	O
P	O
=	O
0	O
.	O
01	O
),	O
missed	O
fewer	O
days	O
of	O
school	O
(	O
1	O
.	O
1	O
vs	O
.	O
2	O
days	O
;	O
P	O
=	O
0	O
.	O
04	O
),	O
or	O
work	O
(	O
2	O
vs	O
.	O
3	O
days	O
;	O
P	O
=	O
0	O
.	O
03	O
);	O
other	O
measures	O
of	O
illness	O
severity	O
did	O
not	O
vary	O
.	O

We	O
analyzed	O
fecal	B-ANAT
and	O
throat	B-ANAT
swabs	O
to	O
detect	O
the	O
presence	O
of	O
virus	O
through	O
amplification	O
of	O
the	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
(	O
RdRp	O
)	O
gene	O
,	O
which	O
is	O
highly	O
conserved	O
in	O
all	O
known	O
coronaviruses	O
.	O

PCR	O
was	O
used	O
to	O
identify	O
the	O
pathogen	O
and	O
we	O
tested	O
for	O
eight	O
viruses	O
(	O
HEV	B-ANAT
,	O
Porcine	O
reproductive	O
and	O
respiratory	O
syndrome	O
virus	O
,	O
PCV2	O
,	O
Classical	O
swine	O
fever	O
virus	O
,	O
Porcine	O
epidemic	O
diarrhea	O
virus	O
,	O
Transmissible	O
gastroenteritis	O
coronavirus	O
,	O
Porcine	O
parvovirus	O
and	O
Pseudorabies	O
virus	O
)	O
that	O
are	O
prevalent	O
in	O
Chinese	O
pig	O
farms	O
.	O

Immunohistochemical	O
staining	O
showed	O
HEV	B-ANAT
-	O
and	O
PCV2	O
-	O
antigen	O
-	O
positive	O
signals	O
in	O
the	O
livers	B-ANAT
,	O
kidneys	B-ANAT
,	O
lungs	B-ANAT
,	O
lymph	B-ANAT
nodes	I-ANAT
,	O
and	O
intestine	B-ANAT
.	O

HEV	B-ANAT
and	O
PCV2	O
co	O
-	O
infection	O
in	O
piglets	O
was	O
detected	O
in	O
four	O
out	O
of	O
seven	O
dead	O
pigs	O
from	O
two	O
pig	O
farms	O
in	O
Hebei	O
,	O
China	O
,	O
producing	O
severe	O
pathological	O
changes	O
.	O

We	O
speculate	O
that	O
co	O
-	O
infection	O
with	O
PCV2	O
and	O
HEV	B-ANAT
may	O
bring	O
some	O
negative	O
effect	O
on	O
pig	O
production	O
and	O
recommend	O
that	O
more	O
attention	O
should	O
be	O
paid	O
to	O
this	O
phenomenon	O
.	O

TITLE	O
:	O
Anti	O
-	O
inflammatory	O
effects	O
of	O
novel	O
curcumin	O
analogs	O
in	O
experimental	O
acute	O
lung	B-ANAT
injury	O
.	O

Nasal	B-ANAT
and	O
throat	B-ANAT
swabs	O
were	O
collected	O
from	O
all	O
adult	O
patients	O
with	O
influenza	O
-	O
like	O
illness	O
(	O
ILI	O
),	O
acute	O
respiratory	O
infection	O
(	O
ARI	O
),	O
or	O
severe	O
ARI	O
(	O
SARI	O
)	O
admitted	O
to	O
a	O
tertiary	O
hospital	O
in	O
Surakarta	O
,	O
Indonesia	O
,	O
between	O
March	O
2010	O
and	O
April	O
2011	O
and	O
analyzed	O
for	O
19	O
respiratory	O
viruses	O
and	O
for	O
torque	O
teno	O
virus	O
(	O
TTV	O
)	O
and	O
human	O
gyrovirus	O
(	O
HGyV	O
).	O

Patients	O
with	O
hypoxemia	O
were	O
significantly	O
less	O
likely	O
to	O
have	O
a	O
severe	O
head	B-ANAT
injury	O
(	O
GCS	O
<	O
9	O
),	O
p	O
<	O
0	O
.	O
05	O
.	O

TITLE	O
:	O
Porcine	O
epidemic	O
diarrhea	O
virus	O
uses	O
cell	B-ANAT
-	O
surface	O
heparan	O
sulfate	O
as	O
an	O
attachment	O
factor	O
.	O

In	O
summary	O
,	O
our	O
studies	O
revealed	O
that	O
heparan	O
sulfate	O
acts	O
as	O
the	O
attachment	O
factor	O
of	O
PEDV	O
in	O
Vero	B-ANAT
cells	I-ANAT
.	O

Plasma	B-ANAT
MERS	O
-	O
CoV	O
RT	O
-	O
PCR	O
was	O
performed	O
at	O
the	O
time	O
of	O
diagnosis	O
for	O
19	O
patients	O
.	O

At	O
35	O
days	O
of	O
age	O
,	O
birds	O
were	O
slaughtered	O
and	O
blood	B-ANAT
was	O
collected	O
for	O
investigating	O
the	O
antibody	O
titre	O
against	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
and	O
clinical	O
chemical	O
parameters	O
.	O

The	O
results	O
showed	O
that	O
DON	O
reduced	O
(	O
p	O
=	O
0	O
.	O
032	O
)	O
the	O
titre	O
against	O
IBV	O
,	O
decreased	O
(	O
p	O
=	O
0	O
.	O
005	O
)	O
the	O
level	O
of	O
alanine	O
transaminase	O
(	O
ALT	O
)	O
(	O
4	O
.	O
2	O
Â±	O
0	O
.	O
5	O
U	O
/	O
l	O
)	O
compared	O
with	O
control	O
birds	O
(	O
6	O
.	O
4	O
Â±	O
0	O
.	O
5	O
U	O
/	O
l	O
),	O
increased	O
(	O
p	O
=	O
0	O
.	O
002	O
)	O
the	O
serum	B-ANAT
cholesterol	O
concentration	O
(	O
144	O
Â±	O
6	O
mg	O
/	O
dl	O
)	O
compared	O
with	O
their	O
control	O
counterparts	O
(	O
123	O
Â±	O
5	O
mg	O
/	O
dl	O
)	O
and	O
increased	O
(	O
p	O
=	O
0	O
.	O
074	O
)	O
the	O
amount	O
of	O
circulating	O
triglycerides	O
(	O
62	O
.	O
25	O
Â±	O
7	O
.	O
50	O
mg	O
/	O
dl	O
)	O
compared	O
with	O
controls	O
(	O
39	O
.	O
55	O
Â±	O
4	O
.	O
74	O
).	O

Recent	O
observations	O
indicated	O
that	O
chicks	O
may	O
have	O
an	O
immature	O
immune	B-ANAT
system	I-ANAT
immediately	O
after	O
hatching	O
when	O
vaccinated	O
for	O
IBV	O
.	O

We	O
conducted	O
a	O
cross	O
-	O
sectional	O
national	O
survey	O
of	O
302	O
adult	O
critical	O
care	O
training	O
programs	O
in	O
the	O
United	O
States	O
to	O
understand	O
the	O
current	O
preferences	O
of	O
intensivists	O
regarding	O
the	O
use	O
of	O
different	O
therapies	O
for	O
severe	O
ARDS	O
,	O
including	O
the	O
use	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
).	O

We	O
describe	O
a	O
child	O
with	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
acute	O
lymphoblastic	B-ANAT
leukemia	O
,	O
who	O
developed	O
an	O
unusually	O
dramatic	O
tumor	O
lysis	O
syndrome	O
,	O
after	O
administration	O
of	O
the	O
first	O
low	O
doses	O
of	O
steroid	O
,	O
that	O
was	O
rapidly	O
associated	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Serum	B-ANAT
specimens	O
were	O
also	O
collected	O
and	O
serological	O
test	O
were	O
performed	O
.	O

Our	O
initial	O
inconclusive	O
rRT	O
-	O
PCR	O
results	O
highlight	O
the	O
importance	O
of	O
collecting	O
multiple	O
specimens	O
from	O
suspect	O
MERS	O
-	O
CoV	O
cases	O
and	O
particularly	O
specimens	O
from	O
the	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
.	O

ABSTRACT	O
:	O
Cost	O
-	O
effective	O
interventions	O
are	O
needed	O
to	O
control	O
the	O
transmission	O
of	O
viral	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
(	O
RTIs	O
)	O
in	O
mass	O
gatherings	O
.	O

Our	O
objective	O
was	O
to	O
predict	O
the	O
outcome	O
of	O
COPD	O
patients	O
associated	O
with	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
(	O
MODS	O
)	O
by	O
scoring	O
models	O
.	O

The	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
(	O
APACHE	O
)	O
II	O
,	O
APACHE	O
III	O
,	O
Multiple	O
Organ	B-ANAT
Dysfunction	O
Score	O
(	O
MODS	O
),	O
Simplified	O
Acute	O
Physiology	O
Score	O
II	O
(	O
SAPS	O
II	O
),	O
and	O
Sepsis	O
-	O
related	O
Organ	B-ANAT
Failure	O
Assessment	O
(	O
SOFA	O
)	O
scores	O
were	O
calculated	O
for	O
patients	O
.	O

We	O
evaluated	O
effects	O
of	O
prone	O
position	O
duration	O
and	O
protective	O
lung	B-ANAT
strategies	O
on	O
mortality	O
rates	O
in	O
ARDS	O
.	O

Prone	O
positioning	O
tends	O
to	O
reduce	O
the	O
mortality	O
rates	O
in	O
ARDS	O
patients	O
,	O
especially	O
when	O
used	O
in	O
conjunction	O
with	O
a	O
lung	B-ANAT
protective	O
strategy	O
and	O
longer	O
prone	O
position	O
durations	O
.	O

One	O
such	O
approach	O
(	O
the	O
Buxco	O
platform	O
)	O
performs	O
unrestrained	O
whole	B-ANAT
body	I-ANAT
plethysmography	O
on	O
mice	O
which	O
infers	O
thoracic	B-ANAT
movements	O
from	O
pressure	O
differences	O
from	O
the	O
act	O
of	O
inhalation	O
and	O
exhalation	O
.	O

ABSTRACT	O
:	O
Human	O
coronavirus	O
(	O
hCoV	O
)	O
HKU1	O
is	O
one	O
of	O
six	O
hCoVs	O
identified	O
to	O
date	O
and	O
the	O
only	O
one	O
with	O
an	O
unidentified	O
cellular	B-ANAT
receptor	O
.	O

Severe	O
watery	O
diarrhea	O
and	O
atrophic	O
enteritis	O
with	O
moderate	O
to	O
high	O
PEDV	O
RNA	O
titers	O
in	O
feces	B-ANAT
(	O
7	O
.	O
5	O
-	O
12	O
.	O
2	O
log10	O
GE	O
/	O
ml	O
)	O
and	O
low	O
viral	O
RNA	O
titers	O
in	O
serum	B-ANAT
(	O
5	O
.	O
6	O
-	O
8	O
.	O
6	O
log10	O
GE	O
/	O
ml	O
)	O
were	O
observed	O
in	O
all	O
inoculated	O
nursing	O
piglets	O
at	O
PIDs	O
1	O
-	O
5	O
.	O

Pigs	O
exhibited	O
high	O
fecal	B-ANAT
shedding	O
titers	O
at	O
PIDs	O
2	O
-	O
5	O
and	O
mild	O
to	O
severe	O
atrophic	O
enteritis	O
at	O
PIDs	O
3	O
-	O
5	O
,	O
indicating	O
a	O
longer	O
incubation	O
for	O
PEDV	O
infection	O
.	O

Biologic	O
mediators	O
that	O
promote	O
crypt	B-ANAT
stem	B-ANAT
cell	I-ANAT
regeneration	O
would	O
be	O
targets	O
to	O
improve	O
the	O
intestinal	B-ANAT
epithelium	I-ANAT
renewal	O
during	O
PEDV	O
infection	O
.	O

Altogether	O
23	O
patients	O
were	O
treated	O
on	O
the	O
ward	O
for	O
postoperative	O
care	O
after	O
kidney	B-ANAT
transplantation	O
during	O
the	O
outbreak	O
.	O

After	O
the	O
first	O
positive	O
case	O
,	O
all	O
patients	O
were	O
tested	O
with	O
nasopharyngeal	B-ANAT
swab	I-ANAT
tests	O
and	O
7	O
patients	O
were	O
diagnosed	O
with	O
influenza	O
A	O
(	O
H1N1	O
).	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
highly	O
pathogenic	O
virus	O
that	O
causes	O
severe	O
respiratory	O
illness	O
accompanied	O
by	O
multi	O
-	O
organ	B-ANAT
dysfunction	O
,	O
resulting	O
in	O
a	O
case	O
fatality	O
rate	O
of	O
approximately	O
40	O
%.	O

Furthermore	O
,	O
the	O
initial	O
respiratory	B-ANAT
system	I-ANAT
compliance	O
(	O
C	O
rs	O
)	O
decreased	O
by	O
29	O
.	O
6	O
%	O
and	O
28	O
.	O
5	O
%	O
at	O
1	O
min	O
and	O
10	O
min	O
,	O
respectively	O
.	O

For	O
years	O
,	O
the	O
diagnosis	O
of	O
viral	O
pneumonia	O
was	O
based	O
on	O
cell	B-ANAT
culture	O
and	O
antigen	O
detection	O
,	O
but	O
since	O
the	O
introduction	O
of	O
polymerase	O
chain	O
reaction	O
techniques	O
in	O
the	O
clinical	O
setting	O
,	O
identification	O
of	O
these	O
pathogens	O
has	O
increased	O
and	O
new	O
microorganisms	O
such	O
as	O
human	O
bocavirus	O
have	O
been	O
discovered	O
.	O

However	O
,	O
in	O
recent	O
years	O
,	O
outbreaks	O
of	O
deadly	O
coronavirus	O
and	O
zoonotic	O
influenza	O
virus	O
have	O
demonstrated	O
the	O
need	O
for	O
constant	O
alert	O
in	O
the	O
face	B-ANAT
of	O
new	O
emerging	O
pathogens	O
.	O

However	O
,	O
his	O
postoperative	O
lung	B-ANAT
infection	O
led	O
to	O
a	O
significantly	O
prolonged	O
and	O
expensive	O
hospital	O
stay	O
.	O

This	O
condition	O
is	O
frequently	O
misdiagnosed	O
as	O
pulmonary	B-ANAT
tuberculosis	O
,	O
lymphoma	O
,	O
schistosomiasis	O
,	O
Wegener	O
'	O
s	O
granuloma	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
or	O
severe	O
community	O
-	O
acquired	O
pneumonia	O
.	O

A	O
roundworm	O
identified	O
in	O
the	O
patient	O
'	O
s	O
stool	B-ANAT
confirmed	O
the	O
precise	O
diagnosis	O
to	O
be	O
parasitic	O
EP	O
.	O

Necropsy	O
revealed	O
diffuse	O
congestion	O
of	O
internal	O
organs	B-ANAT
like	O
lungs	B-ANAT
and	O
liver	B-ANAT
,	O
epicardial	O
petechial	O
hemorrhages	O
,	O
and	O
gastric	B-ANAT
hemorrhages	O
.	O

Early	O
and	O
aggressive	O
management	O
may	O
be	O
conducive	O
to	O
a	O
favorable	O
outcome	O
with	O
minimal	O
residual	O
pulmonary	B-ANAT
sequelae	O
.	O

TITLE	O
:	O
Polytetrafluoroethylene	O
fume	O
-	O
induced	O
pulmonary	B-ANAT
edema	O
:	O
a	O
case	O
report	O
and	O
review	O
of	O
the	O
literature	O
.	O

He	O
was	O
treated	O
with	O
non	O
-	O
invasive	O
positive	O
pressure	O
ventilation	O
and	O
a	O
neutrophil	B-ANAT
elastase	O
inhibitor	O
,	O
which	O
dramatically	O
alleviated	O
his	O
symptoms	O
and	O
improved	O
his	O
oxygenation	O
.	O

A	O
literature	O
review	O
was	O
performed	O
to	O
survey	O
all	O
reported	O
cases	O
of	O
polytetrafluoroethylene	O
fume	O
-	O
induced	O
pulmonary	B-ANAT
edema	O
.	O

Likewise	O
,	O
an	O
attenuated	O
response	O
was	O
observed	O
in	O
PVK	O
cells	B-ANAT
infected	O
with	O
recombinant	O
NDVs	O
expressing	O
the	O
NiV	O
IFN	O
antagonist	O
proteins	O
V	O
and	O
W	O
.	O
This	O
study	O
provides	O
the	O
first	O
global	O
profile	O
of	O
a	O
robust	O
virus	O
-	O
induced	O
innate	O
immune	O
response	O
in	O
bats	O
and	O
indicates	O
that	O
henipavirus	O
IFN	O
antagonist	O
mechanisms	O
are	O
likely	O
active	O
in	O
bat	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
Chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
COPD	O
)	O
and	O
idiopathic	O
interstitial	B-ANAT
pneumonias	O
(	O
IIP	O
),	O
with	O
different	O
radiological	O
,	O
pathological	O
,	O
functional	O
and	O
prognostic	O
characteristics	O
,	O
have	O
been	O
regarded	O
as	O
separate	O
entities	O
for	O
a	O
long	O
time	O
.	O

However	O
,	O
there	O
is	O
an	O
increasing	O
recognition	O
of	O
the	O
coexistence	O
of	O
emphysema	O
and	O
pulmonary	B-ANAT
fibrosis	O
in	O
individuals	O
.	O

CPFE	O
is	O
frequently	O
complicated	O
by	O
pulmonary	B-ANAT
hypertension	O
,	O
acute	O
lung	B-ANAT
injury	O
and	O
lung	B-ANAT
cancer	O
and	O
prognosis	O
of	O
it	O
is	O
poor	O
.	O

Treatments	O
for	O
CPFE	O
patients	O
with	O
severe	O
pulmonary	B-ANAT
hypertension	O
are	O
less	O
effective	O
other	O
than	O
lung	B-ANAT
transplantation	O
.	O

TITLE	O
:	O
Broken	O
lung	B-ANAT
.	O

Generally	O
,	O
a	O
BPF	O
of	O
more	O
than	O
6	O
mm	O
in	O
size	O
is	O
considered	O
as	O
large	O
.(	O
1	O
)	O
Small	O
BPFs	O
can	O
be	O
easily	O
missed	O
on	O
CT	O
scan	O
chest	B-ANAT
,	O
but	O
a	O
persistent	O
air	O
-	O
leak	O
through	O
an	O
adequately	O
placed	O
chest	B-ANAT
tube	O
should	O
raise	O
suspicion	O
for	O
a	O
BPF	O
.	O

ABSTRACT	O
:	O
Diffuse	O
alveolar	B-ANAT
damage	O
(	O
DAD	O
)	O
is	O
the	O
pathological	O
hallmark	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
however	O
,	O
the	O
presence	O
of	O
DAD	O
in	O
the	O
clinical	O
criteria	O
of	O
ARDS	O
patients	O
by	O
Berlin	O
definition	O
is	O
little	O
known	O
.	O

This	O
is	O
a	O
case	O
report	O
of	O
acute	O
severe	O
phenol	O
dermal	O
burn	O
after	O
accidental	O
splash	O
of	O
94	O
%	O
phenol	O
on	O
35	O
-	O
year	O
-	O
old	O
patient	O
'	O
s	O
body	B-ANAT
who	O
was	O
brought	O
to	O
hospital	O
after	O
90	O
min	O
of	O
exposure	O
.	O

It	O
is	O
possible	O
that	O
extracellular	B-ANAT
histones	O
were	O
derived	O
from	O
formation	O
of	O
neutrophil	B-ANAT
extracellular	B-ANAT
traps	O
(	O
NETs	O
)	O
in	O
lung	B-ANAT
after	O
PMN	B-ANAT
contact	O
with	O
C5a	O
.	O

ABSTRACT	O
:	O
Virus	O
-	O
host	B-ANAT
cell	I-ANAT
interactions	O
are	O
most	O
commonly	O
analyzed	O
in	O
cells	B-ANAT
maintained	O
in	O
vitro	O
as	O
two	O
-	O
dimensional	O
tissue	B-ANAT
cultures	O
.	O

ABSTRACT	O
:	O
In	O
patients	O
presenting	O
with	O
severe	O
dyspnea	O
,	O
several	O
diagnostic	O
challenges	O
arise	O
in	O
distinguishing	O
the	O
diagnosis	O
of	O
pneumothorax	O
versus	O
several	O
other	O
pulmonary	B-ANAT
etiologies	O
like	O
bullous	O
lung	B-ANAT
disease	O
,	O
pneumonia	O
,	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
,	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

We	O
studied	O
>	O
800	O
dromedaries	O
of	O
all	O
ages	O
and	O
15	O
mother	O
-	O
calf	B-ANAT
pairs	O
.	O

Intratracheal	O
administration	O
of	O
recombinant	O
mouse	O
complement	O
component	O
(	O
C5a	O
)	O
caused	O
alveolar	B-ANAT
inflammation	O
with	O
abundant	O
recruitment	O
of	O
Ly6	O
-	O
G	O
(+)	O
CD11b	O
(+)	O
leukocytes	B-ANAT
to	O
the	O
alveolar	B-ANAT
spaces	O
and	O
severe	O
alveolar	B-ANAT
-	O
capillary	B-ANAT
barrier	O
dysfunction	O
(	O
C5a	O
-	O
ALI	O
;	O
EC	O
(	O
50	O
[	O
C5a	O
])	O
=	O
20	O
ng	O
/	O
g	O
body	B-ANAT
weight	O
).	O

The	O
thoracic	B-ANAT
epidural	B-ANAT
catheter	O
which	O
was	O
placed	O
pre	O
-	O
operatively	O
,	O
had	O
developed	O
blockage	O
during	O
the	O
hospital	O
stay	O
.	O

Despite	O
the	O
hypothesis	O
of	O
its	O
usefulness	O
in	O
causing	O
anaesthesia	O
of	O
the	O
hemithorax	B-ANAT
,	O
there	O
are	O
no	O
available	O
reports	O
of	O
clinical	O
use	O
for	O
pain	O
relief	O
following	O
thoracotomy	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
that	O
causes	O
a	O
severe	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
in	O
humans	O
is	O
now	O
considered	O
a	O
pandemic	O
threat	O
to	O
the	O
Gulf	O
region	O
.	O

Distinct	O
alterations	O
in	O
inflammation	O
were	O
present	O
in	O
TRIF	O
(-/-)	O
mice	O
infected	O
with	O
SARS	O
-	O
CoV	O
,	O
including	O
excess	O
infiltration	O
of	O
neutrophils	B-ANAT
and	O
inflammatory	B-ANAT
cell	I-ANAT
types	O
that	O
correlate	O
with	O
increased	O
pathology	O
of	O
other	O
known	O
causes	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
including	O
influenza	O
virus	O
infections	O
.	O

Toll	O
-	O
like	O
receptors	O
are	O
a	O
family	O
of	O
sensor	O
proteins	O
that	O
enable	O
the	O
immune	B-ANAT
system	I-ANAT
to	O
differentiate	O
between	O
""""	O
self	O
""""	O
and	O
""""	O
non	O
-	O
self	O
.	O

On	O
a	O
repeat	O
head	B-ANAT
imaging	O
,	O
vasogenic	O
edema	O
(	O
P	O
=	O
0	O
.	O
023	O
)	O
and	O
subcortical	B-ANAT
white	B-ANAT
matter	I-ANAT
lesions	O
(	O
P	O
=	O
0	O
.	O
011	O
)	O
were	O
significantly	O
higher	O
in	O
patients	O
with	O
SE	O
than	O
those	O
without	O
SE	O
,	O
while	O
hematoma	O
growth	O
(	O
P	O
=	O
0	O
.	O
000	O
),	O
infarction	O
progress	O
(	O
P	O
=	O
0	O
.	O
003	O
),	O
and	O
recurrent	O
subarachnoid	O
hemorrhage	O
(	O
SAH	O
)	O
(	O
P	O
=	O
0	O
.	O
011	O
)	O
were	O
significantly	O
lower	O
in	O
patients	O
with	O
SE	O
than	O
those	O
without	O
SE	O
.	O

ABSTRACT	O
:	O
Based	O
on	O
findings	O
in	O
small	O
RNA	O
-	O
sequencing	O
(	O
Seq	O
)	O
data	O
analysis	O
,	O
we	O
developed	O
highly	O
sensitive	O
and	O
specific	O
real	O
-	O
time	O
reverse	O
transcription	O
(	O
RT	O
)-	O
PCR	O
assays	O
with	O
locked	O
nucleic	B-ANAT
acid	O
probes	O
targeting	O
the	O
abundantly	O
expressed	O
leader	O
sequences	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
and	O
other	O
human	O
coronaviruses	O
.	O

ABSTRACT	O
:	O
Tissue	B-ANAT
factor	O
(	O
TF	O
)	O
and	O
tissue	B-ANAT
factor	O
pathway	O
inhibitor	O
(	O
TFPI	O
)	O
play	O
a	O
central	O
role	O
in	O
the	O
endothelial	B-ANAT
permeability	O
regulation	O
and	O
dysfunction	O
,	O
which	O
is	O
associated	O
with	O
the	O
development	O
of	O
sepsis	O
and	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ALI	O
/	O
ARDS	O
).	O

Plasma	B-ANAT
TF	O
levels	O
in	O
the	O
non	O
-	O
survivors	O
of	O
severe	O
sepsis	O
were	O
significantly	O
higher	O
than	O
those	O
of	O
survivors	O
(	O
1618	O
.	O
6	O
(	O
1017	O
.	O
1	O
to	O
2900	O
.	O
8	O
)	O
pg	O
/	O
ml	O
vs	O
.	O
979	O
.	O
9	O
(	O
757	O
.	O
2	O
to	O
1645	O
.	O
5	O
)	O
pg	O
/	O
ml	O
,	O
P	O
<	O
0	O
.	O
001	O
),	O
and	O
multivariate	O
logistic	O
regression	O
showed	O
the	O
plasma	B-ANAT
value	O
of	O
TF	O
was	O
the	O
independent	O
predictor	O
for	O
30	O
-	O
day	O
mortality	O
in	O
patients	O
with	O
severe	O
sepsis	O
(	O
P	O
=	O
0	O
.	O
0022	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=	O
1	O
.	O
41	O
,	O
95	O
%	O
CI	O
1	O
.	O
24	O
-	O
1	O
.	O
69	O
).	O

TITLE	O
:	O
The	O
Serum	B-ANAT
Profile	O
of	O
Hypercytokinemia	O
Factors	O
Identified	O
in	O
H7N9	O
-	O
Infected	O
Patients	O
can	O
Predict	O
Fatal	O
Outcomes	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
a	O
severe	O
inflammatory	O
disorder	O
characterized	O
by	O
acute	O
respiratory	O
failure	O
,	O
resulting	O
from	O
severe	O
,	O
destructive	O
lung	B-ANAT
inflammation	O
and	O
irreversible	O
lung	B-ANAT
fibrosis	O
.	O

SHED	O
-	O
CM	O
contained	O
multiple	O
therapeutic	O
factors	O
involved	O
in	O
lung	B-ANAT
-	O
regenerative	O
mechanisms	O
.	O

Furthermore	O
,	O
SHED	O
-	O
CM	O
promoted	O
the	O
in	O
vitro	O
differentiation	O
of	O
bone	B-ANAT
marrow	I-ANAT
-	I-ANAT
derived	I-ANAT
macrophages	I-ANAT
into	O
M2	O
-	O
like	O
cells	B-ANAT
,	O
which	O
expressed	O
high	O
levels	O
of	O
Arginase1	O
,	O
CD206	O
and	O
Ym	O
-	O
1	O
.	O

TITLE	O
:	O
Influenza	O
induces	O
IL	O
-	O
8	O
and	O
GM	O
-	O
CSF	B-ANAT
secretion	B-ANAT
by	O
human	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
through	O
HGF	O
/	O
c	O
-	O
Met	O
and	O
TGF	O
-	O
Î±	O
/	O
EGFR	O
signaling	O
.	O

Infected	O
epithelial	B-ANAT
cells	I-ANAT
produce	O
cytokines	O
that	O
attract	O
and	O
activate	O
neutrophils	B-ANAT
and	O
macrophages	B-ANAT
,	O
which	O
in	O
turn	O
induce	O
damage	O
to	O
the	O
epithelial	O
-	O
endothelial	B-ANAT
barrier	O
.	O

TITLE	O
:	O
Noninvasive	O
support	O
and	O
ventilation	O
for	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
proceedings	O
from	O
the	O
Pediatric	O
Acute	O
Lung	B-ANAT
Injury	O
Consensus	O
Conference	O
.	O

TITLE	O
:	O
Ventilatory	O
support	O
in	O
children	O
with	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
proceedings	O
from	O
the	O
Pediatric	O
Acute	O
Lung	B-ANAT
Injury	O
Consensus	O
Conference	O
.	O

Using	O
positive	O
end	O
-	O
expiratory	O
pressure	O
levels	O
greater	O
than	O
15	O
cm	O
H2O	O
in	O
severe	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
under	O
the	O
condition	O
that	O
the	O
markers	O
of	O
oxygen	O
delivery	O
,	O
respiratory	B-ANAT
system	I-ANAT
compliance	O
,	O
and	O
hemodynamics	O
are	O
closely	O
monitored	O
as	O
positive	O
end	O
-	O
expiratory	O
pressure	O
is	O
increased	O
,	O
is	O
strongly	O
recommended	O
.	O

Overall	O
,	O
the	O
routine	O
use	O
of	O
surfactant	O
,	O
inhaled	O
nitric	O
oxide	O
,	O
glucocorticoids	O
,	O
prone	O
positioning	O
,	O
endotracheal	O
suctioning	O
,	O
and	O
chest	B-ANAT
physiotherapy	O
cannot	O
be	O
recommended	O
.	O

The	O
previously	O
believed	O
chicken	O
-	O
specific	O
coronavirus	O
(	O
CoV	O
)	O
M41	O
spike	O
(	O
S1	O
)	O
protein	O
displayed	O
a	O
broad	O
attachment	O
pattern	O
to	O
respiratory	O
tissues	B-ANAT
of	O
various	O
avian	O
species	O
,	O
albeit	O
with	O
lower	O
affinity	O
than	O
hemagglutinin	O
,	O
suggesting	O
that	O
other	O
avian	O
species	O
might	O
be	O
susceptible	O
for	O
chicken	O
CoV	O
.	O
When	O
comparing	O
tissue	B-ANAT
-	O
specific	O
binding	O
patterns	O
of	O
various	O
avian	O
coronaviral	O
S1	O
proteins	O
on	O
the	O
single	O
-	O
species	O
TMAs	O
,	O
chicken	O
and	O
partridge	O
CoV	O
S1	O
had	O
predominant	O
affinity	O
for	O
the	O
trachea	B-ANAT
,	O
while	O
pigeon	O
CoV	O
S1	O
showed	O
marked	O
preference	O
for	O
lung	B-ANAT
of	O
their	O
respective	O
hosts	O
.	O

The	O
virus	O
has	O
4	O
clusters	O
,	O
grouped	O
into	O
7	O
serotypes	O
and	O
the	O
most	O
important	O
strains	O
are	O
Massachusetts	O
,	O
Connecticut	O
,	O
Arkansas	O
,	O
Gray	O
,	O
Holte	O
and	O
Florida	O
along	O
with	O
numerous	O
others	O
,	O
distributed	O
round	O
the	O
globe	B-ANAT
.	O

The	O
patient	O
then	O
developed	O
respiratory	O
distress	O
syndrome	O
secondary	O
to	O
acute	O
pulmonary	B-ANAT
oedema	O
.	O

Reversal	O
of	O
symptoms	O
and	O
successful	O
reweaning	O
was	O
achieved	O
by	O
restarting	O
a	O
low	O
-	O
dose	O
clonidine	O
infusion	O
followed	O
by	O
slow	O
downward	O
titration	O
and	O
use	O
of	O
oral	B-ANAT
clonidine	O
as	O
a	O
step	O
-	O
down	O
measure	O
.	O

Comparison	O
of	O
the	O
seven	O
conserved	O
replicase	O
domains	O
for	O
species	O
demarcation	O
shows	O
that	O
HCoV	O
-	O
EMC	B-ANAT
is	O
a	O
novel	O
CoV	O
species	O
.	O

Recombinant	O
plasmid	O
pcDNA3	O
.	O
1	O
expressing	O
SPA	O
,	O
SPB	B-ANAT
and	O
SPC	O
was	O
constructed	O
and	O
introduced	O
into	O
Madin	O
-	O
Darby	O
canine	O
kidney	B-ANAT
(	O
MDCK	O
)	O
cells	B-ANAT
by	O
transfection	O
.	O

TITLE	O
:	O
Cerebral	B-ANAT
pyogranuloma	O
associated	O
with	O
systemic	O
coronavirus	O
infection	O
in	O
a	O
ferret	O
.	O

Histopathology	O
of	O
the	O
excised	O
mass	O
showed	O
multiple	O
meningeal	O
nodular	O
lesions	O
with	O
infiltrates	O
of	O
epithelioid	O
macrophages	B-ANAT
,	O
occasionally	O
centred	O
on	O
degenerated	O
neutrophils	B-ANAT
and	O
surrounded	O
by	O
a	O
broad	O
rim	O
of	O
plasma	B-ANAT
cells	I-ANAT
,	O
features	O
consistent	O
with	O
pyogranulomatous	O
meningitis	O
.	O

Ventilation	O
impairment	O
may	O
be	O
due	O
to	O
either	O
neurologic	O
compromise	O
such	O
as	O
cervical	B-ANAT
intervertebral	B-ANAT
disk	I-ANAT
disease	O
or	O
severe	O
parenchymal	O
disease	O
,	O
while	O
oxygenation	O
failure	O
may	O
result	O
from	O
either	O
the	O
underlying	O
disease	O
or	O
severe	O
complications	O
such	O
as	O
aspiration	O
pneumonia	O
,	O
volume	O
overload	O
,	O
pulmonary	B-ANAT
thromboembolism	O
,	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

There	O
is	O
accumulating	O
evidence	O
in	O
rodents	O
and	O
humans	O
suggesting	O
that	O
extracellular	B-ANAT
histones	O
are	O
strong	O
drivers	O
of	O
inflammation	O
and	O
tissue	B-ANAT
damage	O
.	O

The	O
viral	B-ANAT
genome	I-ANAT
harbors	O
a	O
tandem	O
repeat	O
which	O
is	O
rare	O
in	O
vertebrate	O
RNA	O
viruses	O
.	O

In	O
addition	O
,	O
searches	O
for	O
protein	O
-	O
protein	O
interactions	O
using	O
yeast	O
-	O
two	O
hybrid	O
techniques	O
have	O
shed	O
light	O
on	O
possible	O
functional	O
roles	O
for	O
their	O
exposed	O
cytoplasmic	B-ANAT
domains	O
.	O

ABSTRACT	O
:	O
Anthrax	O
is	O
associated	O
with	O
severe	O
vascular	B-ANAT
leak	O
,	O
which	O
is	O
caused	O
by	O
the	O
bacterial	O
lethal	O
toxin	O
(	O
LeTx	O
).	O

We	O
have	O
now	O
designed	O
a	O
peptide	O
that	O
directly	O
and	O
specifically	O
activates	O
MK2	O
,	O
causing	O
HSP27	O
phosphorylation	O
in	O
cells	B-ANAT
and	O
in	O
vivo	O
.	O

ABSTRACT	O
:	O
Microvesicles	O
(	O
MVs	O
)	O
are	O
anuclear	O
fragments	O
of	O
cells	B-ANAT
released	O
from	O
the	O
endosomal	O
compartment	B-ANAT
or	O
shed	O
from	O
surface	O
membranes	B-ANAT
.	O

Vascular	B-ANAT
cell	B-ANAT
adhesion	O
molecule	O
-	O
1	O
(	O
VCAM	O
-	O
1	O
)	O
is	O
one	O
kind	O
of	O
adhesion	O
molecules	O
participating	O
in	O
the	O
process	O
of	O
polymorphonuclear	B-ANAT
leukocyte	I-ANAT
transmigration	O
and	O
regulating	O
the	O
occurrence	O
and	O
amplification	O
of	O
tissue	B-ANAT
inflammation	O
.	O

Post	O
-	O
treatment	O
surface	O
swabs	O
of	O
the	O
coupons	O
tested	O
RT	O
-	O
PCR	O
positive	O
but	O
were	O
not	O
infectious	O
to	O
cultured	B-ANAT
cells	I-ANAT
or	O
naÃ¯ve	O
pigs	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
has	O
recently	O
attracted	O
interest	O
as	O
a	O
treatment	O
for	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

ABSTRACT	O
:	O
Sickle	B-ANAT
cell	I-ANAT
disease	O
,	O
the	O
most	O
common	O
inherited	O
hemoglobinopathy	O
in	O
the	O
United	O
States	O
,	O
is	O
a	O
group	O
of	O
autosomal	B-ANAT
recessive	O
red	B-ANAT
cell	I-ANAT
disorders	O
resulting	O
from	O
hemoglobin	O
S	O
.	O
Hemoglobin	O
S	O
forms	O
rigid	O
polymers	O
when	O
deoxygenated	O
that	O
give	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
their	O
sickle	O
crescent	O
shape	O
.	O

Hydroxyurea	O
decreases	O
sickling	B-ANAT
,	O
improves	O
red	B-ANAT
cell	I-ANAT
survival	O
,	O
and	O
reduces	O
the	O
frequency	O
of	O
vasoocclusive	O
crises	O
.	O

We	O
identified	O
a	O
novel	O
VSR	O
from	O
coronaviruses	O
,	O
a	O
group	O
of	O
medically	O
important	O
mammalian	O
viruses	O
including	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
),	O
and	O
showed	O
that	O
the	O
nucleocapsid	B-ANAT
protein	O
(	O
N	O
protein	O
)	O
of	O
coronaviruses	O
suppresses	O
RNAi	O
triggered	O
by	O
either	O
short	O
hairpin	O
RNAs	O
or	O
small	O
interfering	O
RNAs	O
in	O
mammalian	O
cells	B-ANAT
.	O

We	O
treated	O
human	O
lung	B-ANAT
fibroblasts	B-ANAT
(	O
HLF	O
)	O
with	O
PDGF	O
,	O
or	O
TGFÎ²1	O
,	O
or	O
combined	O
,	O
and	O
examined	O
the	O
activation	O
of	O
p38	O
MAPK	O
,	O
p42	O
/	O
p44	O
MAPK	O
and	O
SMAD3	O
.	O

Treatments	O
with	O
both	O
PDGF	O
and	O
TGFÎ²1	O
antagonists	O
may	O
result	O
in	O
a	O
better	O
anti	O
-	O
fibrotic	O
outcome	O
for	O
ALI	O
-	O
induced	O
lung	B-ANAT
fibrosis	O
.	O

Activation	O
of	O
SMAD3	O
by	O
TGFÎ²1	O
did	O
not	O
affect	O
either	O
collagen	B-ANAT
I	O
or	O
Î±	O
-	O
SMA	O
in	O
HLF	O
cells	B-ANAT
.	O

CONCLUSIONS	O
:	O
PDGF	O
and	O
TGFÎ²1	O
regulate	O
ARDS	O
-	O
associated	O
lung	B-ANAT
fibrosis	O
through	O
distinct	O
signaling	O
pathway	O
-	O
mediated	O
activation	O
of	O
fibrosis	O
-	O
related	O
proteins	O
.	O

Both	O
cases	O
were	O
similar	O
in	O
terms	O
of	O
starting	O
symptoms	O
,	O
the	O
rapid	O
progression	O
to	O
ARDS	O
,	O
and	O
the	O
treatment	O
strategy	O
,	O
direct	O
hemoperfusion	O
with	O
a	O
polymyxin	O
-	O
B	O
-	O
immobilized	O
fiber	B-ANAT
column	B-ANAT
(	O
PMX	O
-	O
DHP	O
)	O
and	O
oseltamivir	O
.	O

Despite	O
multimodal	O
therapy	O
,	O
including	O
noninvasive	O
positive	O
pressure	O
ventilation	O
,	O
polymyxin	O
B	O
-	O
immobilized	O
fiber	B-ANAT
column	B-ANAT
hemoperfusion	O
,	O
and	O
methylprednisolone	O
infusion	O
,	O
his	O
general	O
condition	O
gradually	O
deteriorated	O
.	O

Hantavirus	O
pulmonary	B-ANAT
syndrome	O
is	O
a	O
severe	O
acute	O
disease	O
that	O
is	O
associated	O
with	O
respiratory	O
failure	O
,	O
pulmonary	B-ANAT
edema	O
and	O
cardiogenic	O
shock	O
.	O

In	O
this	O
study	O
,	O
PEDV	O
strain	O
HN1303	O
was	O
isolated	O
successfully	O
on	O
Vero	B-ANAT
cells	I-ANAT
with	O
supplemental	O
trypsin	O
,	O
and	O
the	O
isolate	O
has	O
been	O
serially	O
propagated	O
in	O
cell	B-ANAT
culture	O
for	O
over	O
95	O
passages	O
.	O

The	O
infectious	O
titers	O
of	O
the	O
virus	O
during	O
the	O
first	O
10	O
passages	O
ranged	O
from	O
10	O
(	O
2	O
.	O
6	O
)	O
to	O
10	O
(	O
5	O
.	O
8	O
)	O
50	O
%	O
tissue	B-ANAT
culture	O
infective	O
doses	O
(	O
TCID50	O
)/	O
ml	O
,	O
and	O
the	O
titers	O
of	O
20	O
-	O
95	O
passages	O
ranged	O
from	O
10	O
(	O
6	O
.	O
2	O
)	O
to	O
10	O
(	O
8	O
.	O
0	O
)	O
TCID50	O
/	O
ml	O
.	O

In	O
preclinical	O
models	O
,	O
p38	O
inhibitors	O
reduce	O
lung	B-ANAT
injury	O
following	O
pancreatitis	O
and	O
burn	O
injury	O
.	O

We	O
conducted	O
a	O
phase	O
IIa	O
,	O
randomized	O
,	O
double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
,	O
parallel	O
-	O
group	O
study	O
to	O
evaluate	O
the	O
safety	O
and	O
tolerability	O
of	O
dilmapimod	O
,	O
a	O
novel	O
p38	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
inhibitor	O
,	O
in	O
patients	O
at	O
risk	O
for	O
developing	O
acute	O
respiratory	O
distress	O
syndrome	O
admitted	O
with	O
an	O
Injury	O
Severity	O
Score	O
more	O
than	O
16	O
,	O
excluding	O
head	B-ANAT
trauma	O
.	O

Ground	O
-	O
glass	O
opacity	O
in	O
a	O
peripheral	O
location	O
was	O
the	O
most	O
common	O
abnormality	O
noted	O
on	O
chest	B-ANAT
radiographs	O
.	O

TITLE	O
:	O
Functional	O
characterization	O
and	O
proteomic	O
analysis	O
of	O
the	O
nucleocapsid	B-ANAT
protein	O
of	O
porcine	O
deltacoronavirus	O
.	O

Therefore	O
,	O
as	O
the	O
first	O
step	O
toward	O
understanding	O
the	O
biology	O
of	O
PDCoV	O
,	O
the	O
present	O
study	O
investigated	O
functional	O
characteristics	O
and	O
expression	O
dynamics	O
of	O
host	O
proteins	O
in	O
a	O
stable	O
porcine	O
cell	B-ANAT
line	I-ANAT
constitutively	O
expressing	O
the	O
PDCoV	O
N	O
protein	O
.	O

Notably	O
,	O
two	O
members	O
of	O
the	O
heat	O
shock	O
protein	O
70	O
family	O
were	O
found	O
to	O
be	O
up	O
-	O
regulated	O
in	O
PK	O
-	O
PDCoV	O
-	O
N	O
cells	B-ANAT
.	O

In	O
a	O
small	O
-	O
molecule	O
screen	O
to	O
identify	O
host	O
mediators	O
of	O
reovirus	O
infection	O
,	O
we	O
found	O
that	O
treatment	O
of	O
cells	B-ANAT
with	O
5	O
-	O
nonyloxytryptamine	O
(	O
5	O
-	O
NT	O
),	O
a	O
prototype	O
serotonin	O
receptor	O
agonist	O
,	O
diminished	O
reovirus	O
cytotoxicity	O
.	O

In	O
contrast	O
,	O
treatment	O
of	O
cells	B-ANAT
with	O
methiothepin	O
mesylate	O
,	O
a	O
serotonin	O
antagonist	O
,	O
enhanced	O
infection	O
by	O
reovirus	O
.	O

5	O
-	O
NT	O
did	O
not	O
alter	O
cell	B-ANAT
surface	I-ANAT
expression	O
of	O
JAM	O
-	O
A	O
or	O
attachment	O
of	O
reovirus	O
to	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
After	O
suffering	O
from	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
several	O
patients	O
show	O
generalized	O
brain	B-ANAT
alterations	O
and	O
atrophy	O
.	O

A	O
distinctive	O
morphologic	O
pattern	O
of	O
cerebral	B-ANAT
injury	O
,	O
however	O
,	O
has	O
not	O
been	O
found	O
so	O
far	O
.	O

Viral	O
antigen	O
was	O
detected	O
in	O
enterocytes	B-ANAT
by	O
immunohistochemistry	O
in	O
the	O
duodenum	B-ANAT
and	O
ileum	B-ANAT
of	O
piglets	O
euthanized	O
at	O
12	O
hpi	O
and	O
was	O
apparent	O
throughout	O
the	O
small	B-ANAT
intestine	I-ANAT
of	O
all	O
piglets	O
thereafter	O
,	O
with	O
villus	B-ANAT
height	O
:	O
crypt	B-ANAT
depth	O
ratios	O
consistently	O
below	O
4	O
:	O
1	O
.	O

TITLE	O
:	O
Extracellular	B-ANAT
signal	O
-	O
regulated	O
kinase	O
(	O
ERK	O
)	O
activation	O
is	O
required	O
for	O
porcine	O
epidemic	O
diarrhea	O
virus	O
replication	O
.	O

ABSTRACT	O
:	O
To	O
assess	O
relationships	O
between	O
xanthine	O
oxidase	O
(	O
XOD	O
)	O
and	O
nephropathogenic	O
infectious	O
bronchitis	O
virus	O
(	O
NIBV	O
)	O
infection	O
,	O
240	O
growing	O
layers	B-ANAT
(	O
35	O
days	O
old	O
)	O
were	O
randomly	O
divided	O
into	O
two	O
groups	O
(	O
infected	O
and	O
control	O
)	O
of	O
120	O
chickens	O
each	O
.	O

The	O
serum	B-ANAT
uric	O
acid	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
control	O
group	O
at	O
15	O
dpi	O
(	O
p	O
<	O
0	O
.	O
01	O
).	O

Our	O
results	O
suggest	O
that	O
reduced	O
cellular	B-ANAT
immune	O
function	O
during	O
the	O
winter	O
may	O
have	O
increased	O
honey	O
bee	O
'	O
s	O
susceptibility	O
to	O
DWV	O
.	O

Splenic	B-ANAT
rupture	O
has	O
been	O
generally	O
described	O
as	O
a	O
complication	O
of	O
severe	O
illness	O
secondary	O
to	O
babesiosis	O
.	O

The	O
results	O
showed	O
that	O
the	O
rapid	O
growth	O
period	O
of	O
the	O
virus	O
load	O
of	O
all	O
the	O
3	O
generations	O
was	O
approximately	O
12	O
-	O
36	O
h	O
post	O
-	O
infection	O
;	O
the	O
peak	O
of	O
the	O
virus	O
load	O
appeared	O
at	O
36	O
h	O
post	O
-	O
infection	O
and	O
then	O
decreased	O
gradually	O
in	O
the	O
order	O
of	O
20th	O
>	O
54th	O
>	O
87th	O
for	O
the	O
3	O
generations	O
of	O
CEK	O
-	O
adapted	O
strains	O
;	O
the	O
dynamic	O
change	O
curve	O
of	O
the	O
IBV	O
load	O
in	O
the	O
supernatant	O
of	O
primary	O
CEK	O
cells	B-ANAT
showed	O
a	O
single	O
peak	O
.	O

Veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
VV	O
-	O
ECMO	O
)	O
has	O
been	O
used	O
successfully	O
in	O
acutely	O
reversible	O
respiratory	O
failure	O
when	O
conventional	O
mechanical	O
ventilation	O
has	O
been	O
unable	O
to	O
adequately	O
oxygenate	O
and	O
ventilate	O
in	O
a	O
lung	B-ANAT
-	O
protective	O
fashion	O
.	O

Nevertheless	O
,	O
lesions	O
exhibited	O
sustained	O
expansion	O
providing	O
a	O
model	O
of	O
dysregulated	O
white	B-ANAT
matter	I-ANAT
injury	O
temporally	O
remote	O
from	O
the	O
acute	O
CNS	B-ANAT
insult	O
.	O

We	O
hypothesize	O
that	O
this	O
conceptual	O
model	O
will	O
aid	O
in	O
the	O
design	O
of	O
future	O
mechanistic	O
and	O
clinical	O
investigations	O
of	O
the	O
skeletal	B-ANAT
muscle	I-ANAT
system	I-ANAT
in	O
ARDS	O
and	O
other	O
critical	O
illnesses	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
(	O
CoVs	O
)	O
assemble	O
by	O
budding	O
into	O
the	O
lumen	B-ANAT
of	O
the	O
early	O
Golgi	B-ANAT
complex	I-ANAT
prior	O
to	O
exocytosis	O
.	O

By	O
controlling	O
both	O
early	O
innate	O
immune	O
responses	O
and	O
CD4	O
T	B-ANAT
cell	I-ANAT
-	O
mediated	O
antiviral	O
IFN	O
-	O
Î³	O
,	O
Myd88	O
signaling	O
limits	O
the	O
initial	O
viral	O
dissemination	O
and	O
is	O
vital	O
for	O
T	B-ANAT
cell	I-ANAT
-	O
mediated	O
control	O
of	O
viral	O
loads	O
.	O

The	O
risk	O
factors	O
of	O
the	O
two	O
groups	O
were	O
analyzed	O
by	O
variable	O
analysis	O
,	O
and	O
it	O
was	O
shown	O
that	O
compared	O
with	O
those	O
in	O
survival	O
group	O
,	O
the	O
age	O
(	O
years	O
:	O
57	O
.	O
26	O
Â±	O
16	O
.	O
23	O
vs	O
.	O
48	O
.	O
07	O
Â±	O
13	O
.	O
48	O
,	O
t	O
=	O
3	O
.	O
544	O
,	O
P	O
=	O
0	O
.	O
000	O
),	O
APACHEII	O
score	O
(	O
20	O
.	O
83	O
Â±	O
9	O
.	O
73	O
vs	O
.	O
12	O
.	O
61	O
Â±	O
6	O
.	O
63	O
,	O
t	O
=	O
4	O
.	O
777	O
,	O
P	O
=	O
0	O
.	O
000	O
),	O
the	O
length	O
of	O
invasive	O
mechanical	O
ventilation	O
(	O
days	O
:	O
10	O
.	O
97	O
Â±	O
7	O
.	O
71	O
vs	O
.	O
6	O
.	O
91	O
Â±	O
2	O
.	O
48	O
,	O
t	O
=	O
2	O
.	O
555	O
,	O
P	O
=	O
0	O
.	O
015	O
)	O
and	O
the	O
number	O
of	O
dysfunction	O
organs	B-ANAT
(	O
3	O
.	O
11	O
Â±	O
1	O
.	O
21	O
vs	O
.	O
1	O
.	O
60	O
Â±	O
1	O
.	O
34	O
,	O
t	O
=	O
6	O
.	O
222	O
,	O
P	O
=	O
0	O
.	O
000	O
)	O
in	O
death	O
group	O
were	O
significantly	O
higher	O
.	O

Another	O
observer	O
of	O
recording	O
was	O
responsible	O
for	O
the	O
results	O
of	O
lung	B-ANAT
ultrasound	O
,	O
LUS	O
,	O
and	O
echocardiogram	O
.	O

LUS	O
in	O
the	O
pulmonary	B-ANAT
ARDS	O
group	O
had	O
a	O
positive	O
correlation	O
with	O
CPIS	O
(	O
r	O
=	O
0	O
.	O
399	O
,	O
P	O
<	O
0	O
.	O
05	O
),	O
and	O
a	O
positive	O
correlation	O
was	O
found	O
in	O
non	O
-	O
pulmonary	B-ANAT
ARDS	O
group	O
(	O
r	O
=	O
0	O
.	O
350	O
,	O
P	O
<	O
0	O
.	O
05	O
),	O
which	O
indicated	O
that	O
the	O
correlation	O
in	O
pulmonary	B-ANAT
ARDS	O
was	O
more	O
satisfactory	O
than	O
that	O
in	O
non	O
-	O
pulmonary	B-ANAT
ARDS	O
.	O

TITLE	O
:	O
Risk	O
factors	O
and	O
outcomes	O
associated	O
with	O
new	O
-	O
onset	O
atrial	B-ANAT
fibrillation	O
during	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

ABSTRACT	O
:	O
Outcomes	O
and	O
risk	O
factors	O
associated	O
with	O
new	O
-	O
onset	O
atrial	B-ANAT
fibrillation	O
(	O
AF	O
)	O
during	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
unclear	O
.	O

Serious	O
maternal	O
complications	O
were	O
defined	O
as	O
:	O
hemorrhage	O
(	O
blood	B-ANAT
loss	O
â¥	O
1500	O
mL	O
,	O
blood	B-ANAT
transfusion	O
,	O
or	O
hysterectomy	O
for	O
hemorrhage	O
),	O
infection	O
(	O
endometritis	O
,	O
wound	O
dehiscence	O
,	O
or	O
wound	O
infection	O
requiring	O
antibiotics	O
,	O
reopening	O
,	O
or	O
unexpected	O
procedure	O
),	O
intensive	O
care	O
unit	O
admission	O
,	O
or	O
death	O
.	O

Delivery	O
route	O
was	O
categorized	O
as	O
classic	O
cesarean	O
delivery	O
(	O
CCD	O
),	O
low	O
transverse	O
cesarean	O
delivery	O
(	O
LTCD	O
),	O
low	O
vertical	O
cesarean	O
delivery	O
(	O
LVCD	O
),	O
and	O
vaginal	B-ANAT
delivery	O
.	O

This	O
is	O
in	O
accordance	O
with	O
a	O
highly	O
physiological	O
cell	B-ANAT
culture	O
system	O
consisting	O
of	O
differentiated	O
primary	O
human	O
bronchial	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
which	O
are	O
little	O
susceptible	O
for	O
apical	O
HAdV	O
-	O
C5	O
infections	O
.	O

Therefore	O
,	O
the	O
apical	O
infection	O
of	O
differentiated	O
primary	O
human	O
bronchial	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
with	O
the	O
pneumotropic	O
and	O
virulent	O
type	O
HAdV	O
-	O
B14p1	O
was	O
investigated	O
in	O
comparison	O
to	O
the	O
less	O
pneumotropic	O
HAdV	O
-	O
C5	O
as	O
a	O
control	O
.	O

TITLE	O
:	O
[	O
Value	O
of	O
lung	B-ANAT
ultrasound	O
examination	O
in	O
making	O
decision	O
of	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
receiving	O
prone	O
ventilation	O
].	O

CONCLUSIONS	O
:	O
In	O
patients	O
with	O
severe	O
ARDS	O
,	O
applicating	O
2	O
-	O
4	O
hours	O
validity	O
of	O
prone	O
position	O
ventilation	O
significantly	O
improves	O
the	O
pulmonary	B-ANAT
ventilation	O
,	O
more	O
than	O
4	O
h	O
PPV	O
do	O
not	O
better	O
for	O
patients	O
probably	O
.	O

TITLE	O
:	O
[	O
Correlation	O
of	O
severity	O
classification	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
by	O
the	O
Berlin	O
definition	O
with	O
extra	B-ANAT
vascular	I-ANAT
lung	I-ANAT
water	I-ANAT
index	O
and	O
pulmonary	B-ANAT
vascular	B-ANAT
permeability	O
index	O
].	O

ABSTRACT	O
:	O
To	O
explore	O
the	O
correlation	O
of	O
severity	O
classification	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
by	O
the	O
Berlin	O
definition	O
with	O
extra	B-ANAT
vascular	I-ANAT
lung	I-ANAT
water	I-ANAT
index	O
(	O
EVLWI	O
)	O
and	O
pulmonary	B-ANAT
vascular	B-ANAT
permeability	O
index	O
(	O
PVPI	O
).	O

Meanwhile	O
blood	B-ANAT
gas	O
was	O
analyzed	O
and	O
oxygenation	O
index	O
(	O
OI	O
)	O
calculated	O
.	O

Ulinastatin	O
plus	O
octreotide	O
can	O
significantly	O
improve	O
the	O
serum	B-ANAT
and	O
clinical	O
parameters	O
and	O
reduce	O
the	O
incidence	O
of	O
complications	O
in	O
SAP	O
patients	O
.	O

CONCLUSIONS	O
:	O
Ulinastatin	O
plus	O
octreotide	O
can	O
significantly	O
improve	O
the	O
serum	B-ANAT
and	O
clinical	O
parameters	O
and	O
reduce	O
the	O
incidence	O
of	O
complications	O
in	O
SAP	O
patients	O
.	O

Hyperbilirubinaemia	O
also	O
occurred	O
significantly	O
more	O
often	O
in	O
cats	O
with	O
vs	O
without	O
effusion	B-ANAT
.	O

The	O
RT	O
-	O
iiPCR	O
method	O
was	O
applied	O
in	O
a	O
point	O
-	O
of	O
-	O
need	O
PCR	O
detection	O
platform	O
--	O
a	O
field	O
-	O
deployable	O
device	O
capable	O
of	O
generating	O
automatically	O
interpreted	O
RT	O
-	O
iiPCR	O
results	O
from	O
nucleic	B-ANAT
acids	O
within	O
1	O
hr	O
.	O

Based	O
on	O
analysis	O
of	O
76	O
clinical	O
samples	O
(	O
including	O
blood	B-ANAT
and	O
bone	B-ANAT
marrow	I-ANAT
)	O
with	O
the	O
FIV	O
RT	O
-	O
iiPCR	O
,	O
test	O
sensitivity	O
was	O
97	O
.	O
78	O
%	O
(	O
44	O
/	O
45	O
),	O
specificity	O
was	O
100	O
.	O
00	O
%	O
(	O
31	O
/	O
31	O
),	O
and	O
agreement	O
was	O
98	O
.	O
65	O
%	O
(	O
75	O
/	O
76	O
),	O
determined	O
against	O
a	O
reference	O
nested	O
-	O
PCR	O
assay	O
.	O

Endothelial	B-ANAT
'	O
rheostats	O
'	O
(	O
e	O
.	O
g	O
.	O
inhibitors	O
of	O
NF	O
-	O
ÎºB	O
,	O
A20	O
protein	O
,	O
CRADD	O
/	O
RAIDD	O
protein	O
and	O
microRNAs	O
)	O
regulate	O
endothelial	B-ANAT
signaling	O
.	O

As	O
sepsis	O
cases	O
rose	O
from	O
387	O
330	O
in	O
1996	O
to	O
1	O
.	O
1	O
million	O
in	O
2011	O
,	O
and	O
are	O
estimated	O
to	O
reach	O
2	O
million	O
by	O
2020	O
in	O
the	O
US	O
,	O
mortality	O
due	O
to	O
sepsis	O
approaches	O
that	O
of	O
heart	B-ANAT
attacks	O
and	O
exceeds	O
deaths	O
from	O
stroke	O
.	O

ABSTRACT	O
:	O
Since	O
1996	O
a	O
new	O
Infectious	O
Bronchitis	O
virus	O
(	O
IBV	O
)	O
genotype	O
,	O
referred	O
to	O
as	O
Q1	O
,	O
circulated	O
in	O
China	O
and	O
was	O
reported	O
for	O
the	O
first	O
time	O
in	O
Italy	O
in	O
2011	O
,	O
associated	O
with	O
an	O
increase	O
of	O
mortality	O
,	O
kidney	B-ANAT
lesions	O
and	O
proventriculitis	O
.	O

At	O
the	O
same	O
time	O
,	O
emergency	O
phase	O
I	O
simple	O
debridement	O
plus	O
external	O
fixator	O
or	O
bundled	O
with	O
fixed	B-ANAT
pelvic	B-ANAT
was	O
done	O
,	O
and	O
the	O
chest	B-ANAT
or	O
abdomen	B-ANAT
combined	O
injury	O
was	O
treated	O
at	O
first	O
.	O

In	O
addition	O
,	O
the	O
entire	O
genomes	O
or	O
complete	O
S	O
genes	O
of	O
KNU	O
-	O
141112	O
viruses	O
at	O
selected	O
cell	B-ANAT
culture	O
passages	O
were	O
sequenced	O
to	O
assess	O
the	O
genetic	O
stability	O
and	O
relatedness	O
.	O

The	O
lopinavir	O
/	O
ritonavir	O
-	O
treated	O
and	O
interferon	O
-	O
Î²1b	O
-	O
treated	O
animals	O
had	O
better	O
outcome	O
than	O
the	O
untreated	O
animals	O
,	O
with	O
improved	O
clinical	O
(	O
mean	O
clinical	O
scores	O
â	O
50	O
.	O
9	O
%-	O
95	O
.	O
0	O
%	O
and	O
â	O
weight	O
loss	O
than	O
the	O
untreated	O
animals	O
),	O
radiological	O
(	O
minimal	O
pulmonary	B-ANAT
infiltrates	O
),	O
and	O
pathological	O
(	O
mild	O
bronchointerstitial	O
pneumonia	O
)	O
findings	O
,	O
and	O
lower	O
mean	O
viral	O
loads	O
in	O
necropsied	O
lung	B-ANAT
(â	O
0	O
.	O
59	O
-	O
1	O
.	O
06	O
log10	O
copies	O
/	O
glyceraldehyde	O
3	O
-	O
phosphate	O
dehydrogenase	O
[	O
GAPDH	O
];	O
P	O
<	O
.	O
050	O
)	O
and	O
extrapulmonary	O
(â	O
0	O
.	O
11	O
-	O
1	O
.	O
29	O
log10	O
copies	O
/	O
GAPDH	O
;	O
P	O
<	O
.	O
050	O
in	O
kidney	B-ANAT
)	O
tissues	B-ANAT
.	O

ABSTRACT	O
:	O
Prone	O
position	O
ventilation	O
is	O
an	O
important	O
treatment	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
but	O
chest	B-ANAT
wall	I-ANAT
elastance	O
increases	O
in	O
prone	O
position	O
ventilation	O
,	O
and	O
stress	O
index	O
may	O
not	O
reflect	O
the	O
changes	O
in	O
lung	B-ANAT
mechanics	O
.	O

Similarly	O
,	O
there	O
was	O
no	O
significant	O
difference	O
between	O
open	O
-	O
lung	B-ANAT
and	O
stress	O
-	O
index	O
guided	O
PEEPs	O
in	O
terms	O
of	O
oxygenation	O
index	O
(	O
P	O
=	O
0	O
.	O
95	O
)	O
and	O
PaCO2	O
(	O
P	O
=	O
0	O
.	O
42	O
).	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
its	O
most	O
severe	O
manifestation	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
is	O
a	O
clinical	O
syndrome	O
defined	O
by	O
acute	O
hypoxemic	O
respiratory	O
failure	O
and	O
bilateral	O
pulmonary	B-ANAT
infiltrates	O
consistent	O
with	O
edema	O
.	O

Our	O
findings	O
highlight	O
the	O
importance	O
of	O
IFN	O
-	O
Î²	O
production	O
by	O
infected	O
BMECs	O
in	O
preserving	O
BBB	B-ANAT
function	O
and	O
preventing	O
access	O
of	O
blood	B-ANAT
-	O
borne	O
infectious	O
viruses	O
to	O
the	O
brain	B-ANAT
.	O

BBB	B-ANAT
invasion	O
by	O
CoVs	O
correlates	O
with	O
virus	O
-	O
induced	O
disruption	O
of	O
tight	B-ANAT
junctions	I-ANAT
on	O
BMECs	O
,	O
leading	O
to	O
BBB	B-ANAT
dysfunction	O
and	O
enhanced	O
permeability	O
.	O

Importantly	O
,	O
our	O
results	O
suggested	O
that	O
MERS	O
-	O
CoV	O
efficiently	O
infected	O
T	B-ANAT
cells	I-ANAT
from	O
the	O
peripheral	B-ANAT
blood	I-ANAT
and	O
from	O
human	O
lymphoid	B-ANAT
organs	I-ANAT
,	O
including	O
the	O
spleen	B-ANAT
and	O
the	O
tonsil	B-ANAT
.	O

Remarkably	O
,	O
immunostaining	O
of	O
spleen	B-ANAT
sections	O
from	O
MERS	O
-	O
CoV	O
-	O
infected	O
common	O
marmosets	O
demonstrated	O
the	O
presence	O
of	O
viral	O
nucleoprotein	O
in	O
their	O
CD3	O
(+)	O
T	B-ANAT
cells	I-ANAT
.	O

In	O
addition	O
,	O
the	O
S	O
protein	O
needs	O
to	O
be	O
cleaved	B-ANAT
by	O
host	O
proteases	O
before	O
executing	O
fusion	O
,	O
making	O
these	O
proteases	O
a	O
second	O
determinant	O
of	O
coronavirus	O
interspecies	O
infection	O
.	O

A	O
lung	B-ANAT
computed	O
tomography	O
(	O
CT	O
)	O
scan	O
was	O
performed	O
in	O
the	O
two	O
positions	O
to	O
compute	O
gas	O
content	O
(	O
i	O
.	O
e	O
.	O
functional	O
residual	O
capacity	O
(	O
FRC	O
))	O
and	O
the	O
distribution	O
of	O
aeration	O
.	O

Recruitment	O
was	O
defined	O
as	O
a	O
percentage	O
change	O
in	O
non	O
-	O
aerated	O
lung	B-ANAT
tissue	I-ANAT
compared	O
to	O
the	O
total	O
lung	B-ANAT
weight	O
.	O

Lung	B-ANAT
recruitment	O
was	O
low	O
(	O
3	O
Â±	O
2	O
%)	O
and	O
was	O
not	O
correlated	O
to	O
increases	O
in	O
functional	O
residual	O
capacity	O
(	O
R	O
(	O
2	O
)	O
0	O
.	O
2	O
,	O
p	O
=	O
0	O
.	O
19	O
).	O

A	O
higher	O
amount	O
of	O
well	O
-	O
aerated	O
and	O
a	O
lower	O
amount	O
of	O
poorly	O
aerated	O
lung	B-ANAT
tissue	I-ANAT
were	O
found	O
in	O
prone	O
position	O
.	O

ABSTRACT	O
:	O
Septic	O
shock	O
is	O
a	O
syndrome	O
with	O
severe	O
hypotension	O
and	O
multiple	O
organ	B-ANAT
dysfunction	O
caused	O
by	O
an	O
imbalance	O
between	O
pro	O
-	O
inflammatory	O
and	O
anti	O
-	O
inflammatory	O
response	O
.	O

Thus	O
,	O
we	O
investigated	O
the	O
major	O
components	O
of	O
Wnt3a	O
and	O
Wnt5a	O
signaling	O
pathway	O
in	O
the	O
lung	B-ANAT
of	O
endotoxemic	O
rats	O
.	O

The	O
lung	B-ANAT
from	O
rats	O
with	O
endotoxic	O
shock	O
exhibited	O
significant	O
decreases	O
in	O
the	O
levels	O
of	O
Wnt3a	O
,	O
Fzd1	O
,	O
Dsh1	O
,	O
phosphorylated	O
GSK	O
-	O
3Î²	O
at	O
Ser9	O
,	O
and	O
Î²	O
-	O
catenin	O
.	O

Even	O
when	O
Mass	O
and	O
Ark	O
vaccines	O
were	O
inoculated	O
into	O
separate	O
eyes	B-ANAT
,	O
Mass	O
vaccine	O
virus	O
was	O
able	O
to	O
outcompete	O
Ark	O
vaccine	O
virus	O
.	O

Only	O
Mass	O
vaccine	O
was	O
detected	O
in	O
tears	B-ANAT
of	O
sentinel	O
birds	O
introduced	O
into	O
groups	O
receiving	O
both	O
vaccines	O
.	O

Furthermore	O
,	O
Ark	O
vaccine	O
virus	O
RNA	O
was	O
not	O
detectable	O
until	O
10	O
DPV	O
in	O
most	O
tear	B-ANAT
samples	O
from	O
chickens	O
vaccinated	O
with	O
both	O
Ark	O
and	O
Mass	O
vaccines	O
at	O
varying	O
Ark	O
vaccine	O
doses	O
,	O
while	O
high	O
concentrations	O
of	O
Mass	O
virus	O
RNA	O
were	O
detectable	O
at	O
3	O
-	O
7	O
DPV	O
.	O

Some	O
serological	O
assays	O
for	O
PEDV	O
have	O
been	O
previously	O
described	O
,	O
but	O
few	O
were	O
readily	O
available	O
in	O
the	O
U	O
.	O
S	O
.	O
Several	O
U	O
.	O
S	O
.	O
laboratories	O
quickly	O
developed	O
indirect	O
fluorescent	O
antibody	O
(	O
IFA	O
)	O
assays	O
for	O
the	O
detection	O
of	O
antibodies	O
to	O
PEDV	O
in	O
swine	O
serum	B-ANAT
,	O
indicating	O
prior	O
exposure	O
.	O

Regarding	O
complications	O
non	O
-	O
survivors	O
had	O
significantly	O
prolonged	O
bleeding	O
and	O
higher	O
rate	O
of	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
(	O
p	O
=	O
0	O
.	O
0001	O
;	O
p	O
=	O
0	O
.	O
0001	O
),	O
while	O
survivors	O
had	O
significantly	O
higher	O
rate	O
of	O
pleural	B-ANAT
effusion	I-ANAT
(	O
p	O
=	O
0	O
.	O
0001	O
).	O

CONCLUSIONS	O
:	O
All	O
efforts	O
in	O
the	O
treatment	O
of	O
severe	O
liver	B-ANAT
injuries	O
should	O
be	O
directed	O
to	O
the	O
rapid	O
and	O
effective	O
control	O
of	O
bleeding	O
,	O
because	O
uncontrollable	O
hemorrhage	O
is	O
the	O
cause	O
of	O
early	O
death	O
and	O
it	O
requires	O
massive	O
blood	B-ANAT
transfusion	O
,	O
all	O
of	O
which	O
contributes	O
to	O
the	O
late	O
fatal	O
complication	O
.	O

Minocycline	O
is	O
commonly	O
used	O
for	O
pneumonia	O
,	O
acute	O
bronchitis	O
,	O
urinary	B-ANAT
tract	I-ANAT
infections	O
,	O
and	O
acne	O
and	O
is	O
likely	O
the	O
cause	O
of	O
AEP	O
in	O
our	O
patient	O
.	O

An	O
immunoadhesin	O
based	O
on	O
the	O
receptor	O
for	O
human	O
rhinovirus	O
,	O
ICAM	O
-	O
1	O
,	O
potently	O
blocks	O
infection	O
of	O
human	O
cells	B-ANAT
by	O
one	O
of	O
the	O
major	O
causes	O
of	O
the	O
common	O
cold	O
.	O

ABSTRACT	O
:	O
The	O
N	O
-	O
terminal	O
domain	O
of	O
the	O
nucleocapsid	B-ANAT
protein	O
from	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
NP	O
-	O
NTD	O
)	O
contains	O
many	O
positively	O
charged	O
residues	O
and	O
has	O
been	O
identified	O
to	O
be	O
responsible	O
for	O
RNA	O
binding	O
during	O
ribonucleocapsid	O
formation	O
by	O
the	O
virus	O
.	O

To	O
detect	O
PEDV	O
antibodies	O
in	O
eight	O
herds	O
,	O
382	O
serum	B-ANAT
samples	O
were	O
collected	O
from	O
sows	O
that	O
had	O
been	O
immunized	O
with	O
a	O
PED	O
vaccine	O
,	O
and	O
screened	O
using	O
the	O
developed	O
ELISA	O
in	O
parallel	O
with	O
a	O
serum	B-ANAT
neutralization	O
(	O
SN	O
)	O
assay	O
.	O

The	O
conserved	O
motifs	O
,	O
including	O
two	O
cleavage	O
recognition	O
sequences	O
of	O
the	O
S	O
protein	O
,	O
two	O
heptad	O
repeats	O
,	O
the	O
transmembrane	B-ANAT
domain	O
,	O
and	O
the	O
Golgi	B-ANAT
retention	O
signal	O
were	O
identified	O
in	O
all	O
TCoV	O
isolates	O
.	O

At	O
the	O
same	O
time	O
symptomatic	O
treatment	O
such	O
as	O
methimazole	O
and	O
liver	B-ANAT
protection	O
therapy	O
were	O
given	O
.	O

There	O
was	O
no	O
sputum	B-ANAT
at	O
first	O
,	O
then	O
a	O
small	O
amount	O
of	O
sputum	B-ANAT
with	O
a	O
little	O
blood	B-ANAT
appeared	O
after	O
the	O
admission	O
.	O

Mild	O
shortness	O
of	O
breath	B-ANAT
and	O
diarrhea	O
after	O
exertion	O
were	O
noticed	O
.	O

He	O
had	O
a	O
sustaining	O
fever	O
for	O
1	O
week	O
with	O
the	O
maximum	O
temperature	O
of	O
39	O
.	O
5	O
centigrade	O
,	O
then	O
the	O
body	B-ANAT
temperature	O
returned	O
to	O
normal	O
.	O

Negative	O
test	O
for	O
virus	O
in	O
sputum	B-ANAT
was	O
late	O
,	O
indicating	O
that	O
clearance	O
of	O
virus	O
was	O
slow	O
from	O
the	O
lungs	B-ANAT
.	O

To	O
trace	O
the	O
evolution	O
of	O
CaKV	O
strains	O
,	O
a	O
total	O
of	O
201	O
fecal	B-ANAT
samples	O
from	O
rectal	O
swabs	O
of	O
diarrheic	O
dogs	O
,	O
which	O
were	O
obtained	O
from	O
May	O
2014	O
to	O
April	O
2015	O
in	O
northeast	O
China	O
,	O
were	O
detected	O
by	O
reverse	O
transcription	O
-	O
PCR	O
targeting	O
a	O
partial	O
(	O
504	O
bp	O
)	O
fragment	O
of	O
the	O
3D	O
gene	O
.	O

The	O
results	O
indicated	O
that	O
36	O
fecal	B-ANAT
samples	O
(	O
17	O
.	O
91	O
%,	O
36	O
/	O
201	O
)	O
were	O
positive	O
for	O
CaKV	O
,	O
in	O
which	O
the	O
co	O
-	O
infection	O
rates	O
of	O
canine	O
coronavirus	O
,	O
canine	O
parvovirus	O
-	O
2	O
and	O
canine	O
bocavirus	O
were	O
58	O
.	O
33	O
%,	O
41	O
.	O
67	O
%,	O
and	O
11	O
.	O
11	O
%,	O
respectively	O
.	O

In	O
eight	O
pigs	O
(	O
median	O
weight	O
34	O
[	O
29	O
,	O
36	O
]	O
kg	O
),	O
ARDS	O
was	O
induced	O
by	O
pulmonary	B-ANAT
lavage	O
and	O
injurious	O
ventilation	O
.	O

After	O
lung	B-ANAT
injury	O
,	O
the	O
PaO2	O
/	O
FiO2	O
(	O
P	O
/	O
F	O
)	O
ratio	O
was	O
92	O
[	O
63	O
,	O
118	O
]	O
mmHg	O
,	O
pulmonary	B-ANAT
shunt	O
26	O
[	O
17	O
,	O
31	O
]%,	O
and	O
static	O
compliance	O
11	O
[	O
8	O
,	O
14	O
]	O
mL	O
/	O
cmH2O	O
.	O

Mean	O
airway	B-ANAT
pressure	O
was	O
maintained	O
constant	O
and	O
was	O
increased	O
only	O
during	O
HFOV	O
.	O

Despite	O
a	O
changed	O
diagnostic	O
distribution	O
in	O
the	O
direction	O
of	O
congenital	O
pulmonary	B-ANAT
disease	O
,	O
the	O
survival	O
rate	O
of	O
ECMO	O
in	O
the	O
neonates	O
has	O
remained	O
well	O
above	O
70	O
%.	O

Although	O
studied	O
separately	O
,	O
their	O
joint	B-ANAT
occurrence	O
and	O
the	O
molecular	O
diversity	O
in	O
cattle	O
in	O
Croatia	O
have	O
not	O
been	O
investigated	O
.	O

A	O
survey	O
is	O
carried	O
out	O
on	O
101	O
fecal	B-ANAT
samples	O
from	O
diarrheic	O
young	O
and	O
adult	O
cattle	O
during	O
the	O
3	O
-	O
year	O
period	O
from	O
i	O
)	O
one	O
large	O
dairy	O
herd	O
,	O
ii	O
)	O
four	O
small	O
herds	O
and	O
iii	O
)	O
three	O
nasal	B-ANAT
and	O
paired	O
fecal	B-ANAT
samples	O
from	O
calves	O
with	O
symptoms	O
of	O
respiratory	O
disease	O
.	O

The	O
genome	O
sequences	O
of	O
Tokachi09	O
,	O
Obihiro12	O
-	O
1	O
and	O
Obihiro12	O
-	O
2	O
were	O
30	O
,	O
782	O
,	O
30	O
,	O
916	O
and	O
30	O
,	O
916	O
nucleotides	O
in	O
length	O
,	O
respectively	O
,	O
excluding	O
the	O
3	O
'-	O
poly	O
(	O
A	O
)	O
tails	B-ANAT
.	O

ABSTRACT	O
:	O
Hemodynamic	O
monitoring	O
is	O
frequently	O
needed	O
in	O
ventilated	O
patients	O
with	O
unstable	O
hemodynamics	O
after	O
open	O
-	O
heart	B-ANAT
surgery	O
.	O

Taken	O
together	O
,	O
we	O
show	O
that	O
isotope	O
-	O
edited	O
FTIR	O
is	O
a	O
powerful	O
tool	O
to	O
analyze	O
small	O
membrane	B-ANAT
proteins	O
in	O
their	O
native	O
environment	O
,	O
enabling	O
us	O
to	O
relate	O
the	O
unusual	O
structure	O
of	O
the	O
SARS	O
E	O
protein	O
to	O
its	O
function	O
.	O

Here	O
we	O
determined	O
the	O
crystal	B-ANAT
structure	O
of	O
MERS	O
-	O
CoV	O
RBD	O
bound	O
to	O
the	O
Fab	O
fragment	O
of	O
MERS	O
-	O
27	O
antibody	O
at	O
3	O
.	O
20	O
Ã	O
resolution	O
.	O

Taken	O
together	O
,	O
our	O
data	O
demonstrated	O
for	O
the	O
first	O
time	O
that	O
PEDV	O
infection	O
of	O
its	O
target	B-ANAT
cell	I-ANAT
line	O
,	O
IECs	O
,	O
inhibited	O
dsRNA	O
-	O
mediated	O
IFN	O
-	O
Î²	O
production	O
by	O
blocking	O
the	O
activation	O
of	O
IPS	O
-	O
1	O
in	O
RIG	O
-	O
I	O
-	O
mediated	O
pathway	O
.	O

The	O
findings	O
also	O
suggest	O
,	O
but	O
do	O
not	O
prove	O
,	O
a	O
beneficial	O
effect	O
of	O
lung	B-ANAT
protective	O
strategies	O
using	O
adoptively	O
transferred	O
MSCs	O
in	O
ARDS	O
.	O

Unlike	O
acute	O
forms	O
of	O
ARDS	O
(	O
such	O
in	O
the	O
current	O
NIH	O
-	O
sponsored	O
study	O
of	O
mesenchymal	O
stromal	B-ANAT
cells	I-ANAT
in	O
ARDS	O
),	O
recovery	O
does	O
not	O
generally	O
occur	O
in	O
such	O
patients	O
.	O

TITLE	O
:	O
Effects	O
of	O
Adaptation	O
of	O
Infectious	O
Bronchitis	O
Virus	O
Arkansas	O
Attenuated	O
Vaccine	O
to	O
Embryonic	B-ANAT
Kidney	B-ANAT
Cells	B-ANAT
.	O

From	O
an	O
applied	O
perspective	O
,	O
the	O
fact	O
that	O
CEK	O
adaptation	O
of	O
embryo	B-ANAT
-	O
attenuated	O
Ark	O
vaccines	O
reduces	O
population	O
heterogeneity	O
,	O
and	O
that	O
changes	O
do	O
not	O
revert	O
after	O
one	O
replication	O
cycle	O
in	O
ECE	O
or	O
in	O
chickens	O
,	O
provides	O
an	O
opportunity	O
to	O
improve	O
commercial	O
ArkDPI	O
-	O
derived	O
vaccines	O
.	O

ABSTRACT	O
:	O
studies	O
in	O
our	O
laboratory	O
showed	O
that	O
the	O
Arkansas	O
-	O
Delmarva	O
Poultry	O
Industry	O
(	O
Ark	O
-	O
DPI	O
)	O
vaccine	O
given	O
to	O
1	O
-	O
day	O
-	O
old	O
chickens	O
by	O
hatchery	O
spray	O
cabinet	O
replicated	O
poorly	O
and	O
failed	O
to	O
adequately	O
protect	O
broilers	O
against	O
homologous	O
virus	O
challenge	O
,	O
whereas	O
the	O
same	O
vaccine	O
given	O
by	O
eye	B-ANAT
-	O
drop	O
did	O
replicate	O
and	O
the	O
birds	O
were	O
protected	O
following	O
homologous	O
virus	O
challenge	O
.	O

No	O
obvious	O
differences	O
were	O
observed	O
in	O
virus	O
morphology	O
and	O
no	O
consistent	O
trend	O
in	O
the	O
number	O
of	O
spikes	O
per	O
virion	B-ANAT
was	O
found	O
in	O
before	O
-	O
and	O
after	O
-	O
spray	O
samples	O
.	O

This	O
study	O
also	O
used	O
the	O
corresponding	O
monoclonal	O
antibodies	O
that	O
were	O
produced	O
with	O
the	O
use	O
of	O
hybridoma	B-ANAT
technology	O
,	O
which	O
were	O
fixed	B-ANAT
on	O
the	O
chip	O
after	O
purification	O
,	O
for	O
further	O
serum	B-ANAT
detection	O
.	O

The	O
most	O
beneficial	O
effects	O
of	O
iEPO	O
have	O
been	O
seen	O
in	O
adult	O
patients	O
with	O
secondary	O
ARDS	O
as	O
compared	O
with	O
primary	O
ARDS	O
,	O
most	O
likely	O
due	O
to	O
the	O
difference	O
in	O
etiology	O
of	O
the	O
two	O
disease	O
states	O
,	O
and	O
in	O
patients	O
suffering	O
from	O
baseline	O
right	O
ventricular	B-ANAT
heart	B-ANAT
failure	O
.	O

Murine	O
ARDS	O
models	O
typically	O
are	O
defined	O
by	O
such	O
features	O
as	O
pulmonary	B-ANAT
edema	O
and	O
leukocyte	B-ANAT
infiltration	O
in	O
cytological	O
preparations	O
of	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
and	O
/	O
or	O
lung	B-ANAT
sections	O
.	O

Results	O
confirmed	O
that	O
the	O
recombinant	O
vaccine	O
increased	O
the	O
proliferation	O
of	O
peripheral	O
T	B-ANAT
lymphocyte	I-ANAT
.	O

Multiplexing	O
would	O
allow	O
their	O
cost	O
to	O
be	O
spread	O
over	O
multiple	O
targets	O
,	O
but	O
often	O
only	O
with	O
lower	O
sensitivity	O
and	O
accuracy	O
,	O
noise	O
,	O
false	O
positives	O
,	O
and	O
false	O
negatives	O
;	O
these	O
arise	O
by	O
interactions	O
between	O
the	O
multiple	O
nucleic	B-ANAT
acid	O
primers	O
and	O
probes	O
in	O
a	O
multiplexed	O
kit	O
.	O

Two	O
patients	O
required	O
surgical	O
exploration	O
of	O
the	O
femoral	B-ANAT
artery	I-ANAT
.	O

However	O
,	O
upregulation	O
of	O
proteins	O
was	O
found	O
,	O
usually	O
incoherent	O
of	O
exerting	O
effects	O
in	O
blunt	O
thoracic	B-ANAT
trauma	O
(	O
pendrin	O
,	O
resistin	O
,	O
metallothionein	O
and	O
glucocorticoid	O
-	O
induced	O
leucine	O
zipper	O
).	O

Brain	B-ANAT
tissue	I-ANAT
oxygen	O
pressure	O
and	O
oxygen	O
saturation	O
increased	O
significantly	O
with	O
increasing	O
positive	O
end	O
-	O
expiratory	O
pressure	O
from	O
5	O
to	O
10	O
and	O
from	O
10	O
to	O
15	O
cm	O
H2O	O
(	O
P	O
=.	O
0001	O
and	O
P	O
=.	O
0001	O
respectively	O
).	O

Further	O
studies	O
should	O
focus	O
on	O
the	O
relationship	O
between	O
OD	O
values	O
of	O
sera	B-ANAT
and	O
its	O
virus	O
neutralization	O
.	O

Using	O
genome	O
-	O
wide	O
siRNA	O
screening	O
,	O
we	O
identified	O
novel	O
genes	O
supporting	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
replication	O
in	O
human	O
cells	B-ANAT
.	O

Injured	O
lungs	B-ANAT
can	O
be	O
partially	O
protected	O
by	O
optimal	O
settings	O
and	O
ventilation	O
modes	O
,	O
using	O
low	O
tidal	O
volume	O
(	O
VT	O
)	O
values	O
and	O
high	O
positive	O
-	O
end	O
expiratory	O
pressure	O
(	O
PEEP	O
).	O

The	O
tracheal	B-ANAT
aspirate	I-ANAT
sample	O
obtained	O
before	O
he	O
died	O
was	O
sent	O
to	O
Virology	O
Unit	O
of	O
Reference	O
Laboratories	O
of	O
the	O
Turkish	O
Public	O
Health	O
Institution	O
.	O

Detection	O
of	O
viral	O
RNA	O
was	O
performed	O
by	O
using	O
a	O
commercial	O
real	O
-	O
time	O
PCR	O
kit	O
(	O
hCoV	O
-	O
EMC	B-ANAT
Real	O
-	O
Time	O
RT	O
-	O
PCR	O
,	O
Fast	O
Track	O
Diagnostics	O
,	O
Luxembourg	O
)	O
targeting	O
the	O
MERS	O
-	O
CoV	O
E	O
protein	O
(	O
upE	O
),	O
ORF1a	O
and	O
ORF1b	O
gene	O
regions	O
.	O

Additionally	O
,	O
there	O
were	O
no	O
significant	O
differences	O
in	O
the	O
mean	O
values	O
for	O
arterial	B-ANAT
pressure	O
(	O
MAP	O
),	O
cardiac	B-ANAT
index	O
(	O
CI	O
),	O
central	O
venous	B-ANAT
pressure	O
(	O
CVP	O
),	O
heart	B-ANAT
rate	O
(	O
HR	O
),	O
lactic	O
acid	O
(	O
LAC	O
)	O
levels	O
or	O
the	O
doses	O
of	O
norepinephrine	O
(	O
NE	O
)	O
administered	O
when	O
compared	O
pre	O
-	O
PPV	O
,	O
post	O
-	O
PPV	O
,	O
and	O
post	O
-	O
SPV	O
.	O

Although	O
there	O
was	O
no	O
difference	O
between	O
groups	O
regarding	O
the	O
primary	O
outcome	O
,	O
a	O
restrictive	O
transfusion	O
strategy	O
may	O
result	O
in	O
an	O
increased	O
rate	O
of	O
cardiogenic	O
shock	O
in	O
elderly	O
patients	O
undergoing	O
cardiac	B-ANAT
surgery	O
compared	O
with	O
a	O
more	O
liberal	O
strategy	O
.	O

At	O
autopsy	O
,	O
the	O
liver	B-ANAT
,	O
spleen	B-ANAT
,	O
and	O
mesenteric	B-ANAT
lymph	I-ANAT
node	I-ANAT
were	O
enlarged	O
,	O
and	O
white	O
foci	O
were	O
observed	O
on	O
the	O
outer	O
surface	O
of	O
the	O
liver	B-ANAT
.	O

This	O
study	O
identified	O
SARS	O
-	O
CoV	O
ORF6	O
-	O
interacting	O
proteins	O
using	O
the	O
phage	O
displayed	O
human	O
lung	B-ANAT
cDNA	O
libraries	O
,	O
and	O
examined	O
the	O
association	O
of	O
ORF6	O
-	O
host	O
factor	O
interaction	O
with	O
Type	O
I	O
IFN	O
antagonism	O
.	O

In	O
addition	O
,	O
confocal	O
imaging	O
and	O
Western	O
blotting	O
assays	O
revealed	O
that	O
the	O
increases	O
in	O
STAT	O
-	O
1	O
nuclear	O
translocation	O
and	O
phosphorylation	O
occurred	O
in	O
the	O
transfected	O
cells	B-ANAT
expressing	O
both	O
genes	O
of	O
ORF6	O
and	O
NPIPB3	O
,	O
but	O
not	O
in	O
the	O
ORF6	O
-	O
expressing	O
cells	B-ANAT
in	O
response	O
to	O
IFN	O
-	O
Î²	O
.	O

Pv	O
infection	O
is	O
associated	O
with	O
ARDS	O
and	O
other	O
complications	O
such	O
as	O
sepsis	O
and	O
multi	O
-	O
organ	B-ANAT
dysfunction	O
syndrome	O
;	O
this	O
enhanced	O
severity	O
of	O
Pv	O
infection	O
,	O
if	O
unrecognized	O
,	O
can	O
lead	O
to	O
more	O
deaths	O
in	O
malaria	O
-	O
endemic	O
areas	O
.	O

However	O
,	O
at	O
present	O
specific	O
preventive	O
or	O
curative	O
strategies	O
for	O
the	O
treatment	O
of	O
lung	B-ANAT
failure	O
in	O
pneumonia	O
in	O
addition	O
to	O
antibiotics	O
are	O
still	O
missing	O
.	O

A	O
real	O
-	O
time	O
quantitative	O
RT	O
-	O
PCR	O
further	O
confirmed	O
that	O
the	O
amounts	O
of	O
viral	O
RNAs	O
in	O
cell	B-ANAT
cultures	O
pre	O
-	O
transfected	O
with	O
these	O
two	O
plasmids	O
were	O
reduced	O
by	O
95	O
.	O
0	O
%.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
envelope	B-ANAT
(	O
E	O
)	O
protein	O
is	O
a	O
viroporin	O
involved	O
in	O
virulence	O
.	O

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
SARS	O
-	O
CoV	O
E	O
protein	O
forms	O
protein	O
-	O
lipid	O
channels	O
in	O
ERGIC	B-ANAT
/	O
Golgi	B-ANAT
membranes	B-ANAT
that	O
are	O
permeable	O
to	O
calcium	O
ions	O
,	O
a	O
highly	O
relevant	O
feature	O
never	O
reported	O
before	O
.	O

A	O
total	O
of	O
204	O
and	O
97	O
nasopharyngeal	B-ANAT
samples	O
were	O
collected	O
in	O
the	O
GENDRES	O
and	O
UK	O
cohorts	O
,	O
respectively	O
.	O

The	O
nanoparticles	O
were	O
also	O
therapeutically	O
beneficial	O
in	O
vivo	O
in	O
both	O
systemic	O
and	O
pulmonary	B-ANAT
murine	O
models	O
replicating	O
inflammatory	O
features	O
of	O
sepsis	O
and	O
ARDS	O
.	O

One	O
hundred	O
fifty	O
-	O
seven	O
samples	O
were	O
throat	B-ANAT
swabs	O
and	O
45	O
were	O
bronchoalveolar	O
lavages	O
.	O

In	O
rare	O
cases	O
,	O
ventilator	O
therapy	O
proves	O
insufficient	O
,	O
and	O
only	O
the	O
option	O
of	O
employing	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
V	O
-	O
V	O
)	O
remains	O
.	O

He	O
was	O
initially	O
diagnosed	O
as	O
having	O
nasopharyngeal	B-ANAT
carcinoma	O
(	O
cT2N0M0	O
),	O
and	O
concurrent	O
chemoradiotherapy	O
was	O
used	O
as	O
a	O
primary	O
treatment	O
.	O

The	O
patient	O
developed	O
a	O
high	O
fever	O
with	O
a	O
decreased	O
neutrophil	B-ANAT
count	O
on	O
day	O
8	O
,	O
and	O
went	O
into	O
a	O
state	O
of	O
shock	O
on	O
day	O
9	O
.	O

The	O
autopsy	O
findings	O
suggested	O
that	O
the	O
main	O
cause	O
of	O
death	O
was	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
but	O
cytomegalovirus	O
(	O
CMV	O
)	O
infection	O
was	O
also	O
noted	O
in	O
multiple	O
organs	B-ANAT
.	O
.	O

Furthermore	O
,	O
mice	O
infected	O
with	O
HCoV	O
-	O
OC43	O
-	O
Îns12	O
.	O
9	O
exhibited	O
reduced	O
inflammation	O
and	O
virulence	O
accompanied	O
by	O
a	O
lower	O
titer	O
in	O
the	O
brain	B-ANAT
than	O
that	O
of	O
wild	O
-	O
type	O
-	O
infected	O
mice	O
,	O
suggesting	O
the	O
ns12	O
.	O
9	O
viroporin	O
influences	O
virus	O
pathogenesis	O
.	O

Blood	B-ANAT
type	O
A	O
again	O
conferred	O
higher	O
AKI	O
risk	O
relative	O
to	O
type	O
O	O
among	O
patients	O
of	O
European	O
descent	O
(	O
n	O
=	O
437	O
;	O
adjusted	O
risk	O
,	O
0	O
.	O
53	O
versus	O
0	O
.	O
40	O
;	O
risk	O
difference	O
,	O
0	O
.	O
14	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
0	O
.	O
04	O
to	O
0	O
.	O
23	O
;	O
P	O
=	O
0	O
.	O
01	O
).	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
causes	O
a	O
severe	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
with	O
a	O
high	O
fatality	O
rate	O
in	O
humans	O
.	O

ABSTRACT	O
:	O
We	O
investigated	O
bovine	O
coronavirus	O
(	O
BCoV	O
)	O
as	O
an	O
etiological	O
agent	O
in	O
cattle	O
with	O
clinical	O
respiratory	O
and	O
digestive	O
signs	O
using	O
147	O
feces	B-ANAT
and	O
199	O
nasal	B-ANAT
swab	O
samples	O
.	O

The	O
main	O
areas	O
during	O
mechanical	O
ventilation	O
of	O
lungs	B-ANAT
in	O
patients	O
with	O
a	O
sharp	O
decline	O
in	O
restrictive	O
lung	B-ANAT
function	O
(	O
ARDS	O
,	O
pneumonia	O
),	O
regardless	O
of	O
the	O
reason	O
it	O
was	O
summoned	O
,	O
optimal	O
value	O
is	O
the	O
observance	O
of	O
the	O
positive	O
end	O
-	O
expiratory	O
pressure	O
,	O
the	O
ratio	O
of	O
inhale	O
/	O
exhale	O
(	O
depending	O
on	O
the	O
degree	O
of	O
hypoxemia	O
),	O
to	O
maintain	O
sufficient	O
blood	B-ANAT
oxygen	O
saturation	O
and	O
partial	O
pressure	O
of	O
oxygen	O
in	O
the	O
blood	B-ANAT
plasma	I-ANAT
.	O

This	O
report	O
raises	O
concern	O
regarding	O
the	O
potential	O
severity	O
of	O
pulmonary	B-ANAT
Burkholderia	O
cepacia	O
complex	O
infection	O
and	O
the	O
need	O
to	O
broaden	O
clinicians	O
'	O
suspicion	O
for	O
Cepacia	O
syndrome	O
.	O

All	O
blunt	O
thoracic	B-ANAT
trauma	O
patients	O
admitted	O
consecutively	O
to	O
our	O
trauma	O
centre	O
between	O
January	O
2005	O
and	O
December	O
2009	O
were	O
retrospectively	O
included	O
if	O
they	O
presented	O
a	O
pulmonary	B-ANAT
contusion	O
on	O
the	O
admission	O
chest	B-ANAT
computed	O
tomography	O
scan	O
.	O

TITLE	O
:	O
Assessment	O
of	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
using	O
B	O
-	O
type	O
brain	B-ANAT
natriuretic	O
peptide	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
clinical	O
value	O
of	O
B	O
-	O
type	O
natriuretic	O
peptide	O
(	O
BNP	O
)	O
in	O
the	O
assessment	O
of	O
severity	O
and	O
prognosis	O
in	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ALI	O
/	O
ARDS	O
).	O

Plasma	B-ANAT
BNP	O
level	O
,	O
arterial	B-ANAT
blood	I-ANAT
gases	O
,	O
serum	B-ANAT
C	O
-	O
reactive	O
protein	O
level	O
,	O
alveolar	B-ANAT
-	O
arterial	B-ANAT
oxygen	O
tension	O
difference	O
and	O
oxygenation	O
index	O
were	O
measured	O
in	O
patients	O
with	O
and	O
without	O
ALI	O
/	O
ARDS	O
within	O
24	O
h	O
of	O
admission	O
to	O
an	O
intensive	O
care	O
unit	O
.	O

Comprehensive	O
studies	O
have	O
revealed	O
that	O
the	O
PEDV	O
virulent	O
strain	O
suppressed	O
protein	O
synthesis	O
of	O
Vero	B-ANAT
cells	I-ANAT
through	O
down	O
-	O
regulating	O
mTOR	O
as	O
well	O
as	O
its	O
downstream	O
targets	O
4EBP1	O
and	O
p70S6K	O
activities	O
,	O
which	O
were	O
validated	O
by	O
immunoblotting	O
.	O

Fortunately	O
,	O
the	O
condition	O
of	O
this	O
woman	O
was	O
stabilized	O
and	O
she	O
achieved	O
complete	O
physical	O
recovery	O
,	O
despite	O
minor	O
neurological	O
deficit	O
in	O
the	O
fingers	B-ANAT
of	O
her	O
right	B-ANAT
hand	I-ANAT
.	O

We	O
included	O
278	O
preschool	O
children	O
hospitalized	O
because	O
of	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
.	O

TITLE	O
:	O
TMPRSS2	O
Isoform	O
1	O
Activates	O
Respiratory	O
Viruses	O
and	O
Is	O
Expressed	O
in	O
Viral	O
Target	B-ANAT
Cells	I-ANAT
.	O

TITLE	O
:	O
Clinical	O
Effects	O
of	O
a	O
Longer	O
Duration	O
of	O
Polymyxin	O
B	O
-	O
Immobilized	O
Fiber	B-ANAT
Column	B-ANAT
Direct	O
Hemoperfusion	O
Therapy	O
for	O
Severe	O
Sepsis	O
and	O
Septic	O
Shock	O
.	O

Then	O
,	O
next	O
generation	O
sequencing	O
was	O
performed	O
on	O
9	O
hpi	O
and	O
control	O
uninfected	O
cells	B-ANAT
by	O
Illumina	O
analyzer	O
.	O

RESULTS	O
:	O
The	O
signs	O
of	O
leukostases	O
were	O
detected	O
in	O
more	O
than	O
half	O
of	O
the	O
18	O
patients	O
with	O
higher	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
counts	O
:	O
13	O
(	O
72	O
%)	O
with	O
lung	B-ANAT
injury	O
,	O
including	O
5	O
of	O
them	O
with	O
signs	O
of	O
respiratory	O
distress	O
syndrome	O
,	O
6	O
(	O
27	O
.	O
8	O
%)	O
with	O
neurological	O
symptomatology	O
,	O
7	O
(	O
38	O
.	O
9	O
%)	O
with	O
disseminated	O
intravascular	O
coagulation	O
syndrome	O
,	O
including	O
1	O
with	O
intracranial	B-ANAT
hemorrhage	O
.	O

To	O
maintain	O
lung	B-ANAT
homeostasis	O
,	O
chronic	O
inflammation	O
is	O
countered	O
by	O
enhanced	O
expression	O
of	O
proresolving	O
/	O
antiinflammatory	O
factors	O
.	O

New	O
ventilatory	O
approaches	O
are	O
needed	O
to	O
safely	O
treat	O
patients	O
with	O
ARDS	O
,	O
and	O
recent	O
studies	O
have	O
suggested	O
the	O
potential	O
utility	O
of	O
open	O
-	O
lung	B-ANAT
strategies	O
.	O

ABSTRACT	O
:	O
Veno	O
-	O
arterial	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
VA	O
-	O
ECMO	O
(	O
1	O
))	O
systems	O
are	O
a	O
life	O
-	O
saving	O
option	O
in	O
the	O
treatment	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
(	O
2	O
)),	O
but	O
may	O
be	O
encumbered	O
by	O
severe	O
vascular	B-ANAT
complications	O
in	O
the	O
groin	B-ANAT
.	O

Evolution	O
was	O
further	O
bad	O
with	O
wound	O
infection	O
(	O
Pseudomonas	O
,	O
Proteus	O
),	O
which	O
imposed	O
large	O
debridement	O
,	O
replacing	O
the	O
PTFE	O
patch	O
with	O
2	O
parallel	O
venous	B-ANAT
patches	O
and	O
wound	O
reconstruction	O
through	O
sartorius	B-ANAT
muscle	I-ANAT
rotation	O
.	O

CONCLUSIONS	O
:	O
Although	O
ischemic	O
complications	O
associated	O
with	O
VA	O
-	O
ECMO	O
are	O
accepted	O
by	O
intensivists	O
under	O
the	O
slogan	O
""""	O
leg	B-ANAT
for	O
life	O
""","	O
for	O
the	O
repair	O
of	O
the	O
femoral	B-ANAT
artery	I-ANAT
in	O
the	O
presence	O
of	O
groin	B-ANAT
infection	O
the	O
sartorius	B-ANAT
muscle	I-ANAT
remains	O
an	O
efficient	O
solution	O
for	O
limb	B-ANAT
salvage	O
.	O

CONCLUSIONS	O
:	O
These	O
data	O
indicate	O
that	O
PVP	O
-	O
I	O
-	O
based	O
hand	O
wash	O
products	O
for	O
potentially	O
contaminated	O
skin	B-ANAT
,	O
and	O
PVP	O
-	O
I	O
gargle	O
/	O
mouthwash	O
for	O
reduction	O
of	O
viral	O
load	O
in	O
the	O
oral	B-ANAT
cavity	I-ANAT
and	O
the	O
oropharynx	B-ANAT
,	O
may	O
help	O
to	O
support	O
hygiene	O
measures	O
to	O
prevent	O
transmission	O
of	O
MERS	O
-	O
CoV	O
.	O

Neurological	O
analysis	O
revealed	O
cranial	B-ANAT
nerve	I-ANAT
involvement	O
in	O
407	O
(	O
34	O
.	O
90	O
%)	O
patients	O
,	O
facial	B-ANAT
palsy	O
in	O
401	O
(	O
34	O
.	O
39	O
%)	O
and	O
ataxia	O
in	O
88	O
(	O
7	O
.	O
54	O
%)	O
patients	O
.	O

For	O
the	O
two	O
simulated	O
MERS	O
-	O
CoV	O
-	O
positive	O
NPAs	O
with	O
serial	O
dilutions	O
of	O
live	O
MERS	O
-	O
CoV	O
,	O
all	O
samples	O
with	O
â¥	O
10	O
50	O
%	O
tissue	B-ANAT
culture	O
infective	O
dose	O
(	O
TCID50	O
)/	O
0	O
.	O
1	O
mL	O
showed	O
positive	O
results	O
.	O

The	O
natural	O
killer	O
(	O
NK	O
)	O
cell	B-ANAT
frequencies	O
,	O
NK	B-ANAT
cell	I-ANAT
activities	O
(	O
lysis	O
of	O
target	O
K562	B-ANAT
tumor	B-ANAT
cells	I-ANAT
in	O
vitro	O
),	O
CD3	O
+	O
CD4	O
+	O
T	B-ANAT
cell	I-ANAT
and	O
CD3	O
+	O
CD8	O
+	O
T	B-ANAT
cell	I-ANAT
frequencies	O
were	O
measured	O
in	O
blood	B-ANAT
and	O
ileum	B-ANAT
at	O
PIDs	O
1	O
and	O
5	O
.	O

Our	O
results	O
revealed	O
that	O
the	O
PEDV	O
M	O
protein	O
is	O
localized	O
throughout	O
the	O
cytoplasm	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
oral	B-ANAT
drug	O
FTY720	O
affects	O
sphingosine	O
-	O
1	O
-	O
phosphate	O
(	O
S1P	O
)	O
signaling	O
on	O
targeted	O
cells	B-ANAT
that	O
bear	O
the	O
S1P	O
receptors	O
S1P1	O
,	O
S1P3	O
,	O
S1P4	O
,	O
and	O
S1P5	O
.	O

Formalin	O
-	O
fixed	B-ANAT
and	O
paraffin	O
embedded	O
skin	B-ANAT
biopsies	O
were	O
prepared	O
according	O
to	O
standard	O
protocols	O
for	O
H	O
&	O
E	O
and	O
immunohistochemistry	O
.	O

The	O
clinical	O
presentation	O
and	O
biopsy	O
findings	O
were	O
held	O
to	O
be	O
indicative	O
of	O
Degos	O
disease	O
/	O
malignant	O
atrophic	O
papulosis	O
(	O
MAP	O
)	O
but	O
with	O
unusual	O
clinical	O
features	O
including	O
renal	B-ANAT
failure	O
and	O
severe	O
respiratory	O
insufficiency	O
.	O

ABSTRACT	O
:	O
Both	O
HIV	O
disease	O
and	O
advanced	O
age	O
have	O
been	O
associated	O
with	O
alterations	O
to	O
cerebral	B-ANAT
white	I-ANAT
matter	I-ANAT
,	O
as	O
measured	O
with	O
white	B-ANAT
matter	I-ANAT
hyperintensities	O
(	O
WMH	O
)	O
on	O
fluid	O
-	O
attenuated	O
inversion	O
recovery	O
(	O
FLAIR	O
)	O
magnetic	O
resonance	O
imaging	O
(	O
MRI	O
),	O
and	O
more	O
recently	O
with	O
diffusion	O
tensor	O
imaging	O
(	O
DTI	O
).	O

The	O
interactive	O
effects	O
of	O
HIV	O
and	O
age	O
were	O
stronger	O
with	O
respect	O
to	O
whole	O
-	O
brain	B-ANAT
WMH	O
than	O
for	O
any	O
of	O
the	O
FA	O
measures	O
.	O

Among	O
HIV	O
+	O
participants	O
,	O
greater	O
WMH	O
and	O
lower	O
anterior	O
corona	B-ANAT
radiata	I-ANAT
FA	O
were	O
associated	O
with	O
active	O
hepatitis	O
C	O
virus	O
infection	O
,	O
a	O
history	O
of	O
AIDS	O
,	O
and	O
higher	O
current	O
CD4	B-ANAT
cell	I-ANAT
count	O
.	O

Impedance	O
distribution	O
in	O
ventral	O
,	O
mid	O
-	O
ventral	O
,	O
mid	O
-	O
dorsal	O
,	O
and	O
dorsal	O
layers	B-ANAT
before	O
and	O
20	O
min	O
after	O
the	O
start	O
of	O
prone	O
positioning	O
was	O
9	O
,	O
48	O
,	O
44	O
,	O
and	O
0	O
%,	O
and	O
10	O
,	O
25	O
,	O
48	O
,	O
and	O
16	O
%,	O
respectively	O
.	O

Lung	B-ANAT
recruitment	O
monitored	O
by	O
EIT	O
paralleled	O
the	O
improvement	O
of	O
PaO2	O
/	O
FIO2	O
from	O
123	O
to	O
239	O
mmHg	O
.	O

TITLE	O
:	O
Genetic	O
Predisposition	O
to	O
Stevens	O
-	O
Johnson	O
Syndrome	O
With	O
Severe	O
Ocular	B-ANAT
Surface	O
Complications	O
.	O

In	O
patients	O
with	O
extensive	O
skin	B-ANAT
detachment	O
and	O
a	O
poor	O
prognosis	O
,	O
the	O
condition	O
is	O
termed	O
toxic	O
epidermal	B-ANAT
necrolysis	O
(	O
TEN	O
).	O

Lung	B-ANAT
pathology	O
and	O
transcriptomic	O
data	O
from	O
mice	O
genetically	O
deficient	O
in	O
Trim55	O
were	O
used	O
to	O
validate	O
its	O
role	O
in	O
SARS	O
-	O
CoV	O
-	O
induced	O
vascular	B-ANAT
cuffing	O
and	O
inflammation	O
.	O

The	O
ubiquitously	O
available	O
social	O
media	B-ANAT
have	O
facilitated	O
communication	O
and	O
networking	O
amongst	O
healthcare	O
professionals	O
and	O
eventually	O
proved	O
to	O
be	O
important	O
channels	O
for	O
presenting	O
the	O
public	O
with	O
factual	O
material	O
,	O
timely	O
updates	O
and	O
relevant	O
advice	O
.	O

The	O
HAdV	O
genotype	O
was	O
determined	O
by	O
sequencing	O
the	O
partial	O
hexon	O
and	O
fiber	B-ANAT
genes	O
.	O

Patients	O
with	O
underlying	O
neurologic	O
diseases	O
(	O
OR	O
76	O
.	O
8	O
;	O
p	O
<	O
0	O
.	O
001	O
),	O
airway	B-ANAT
anomaly	O
(	O
OR	O
15	O
.	O
1	O
;	O
p	O
=	O
0	O
.	O
033	O
),	O
chronic	O
lung	B-ANAT
diseases	O
(	O
OR	O
12	O
.	O
5	O
;	O
p	O
=	O
0	O
.	O
047	O
),	O
weight	O
<	O
3	O
CONCLUSIONS	O
:	O
HAdV	O
infections	O
circulate	O
all	O
year	O
-	O
round	O
.	O

TITLE	O
:	O
The	O
use	O
of	O
convalescent	O
plasma	B-ANAT
to	O
treat	O
emerging	O
infectious	O
diseases	O
:	O
focus	O
on	O
Ebola	O
virus	O
disease	O
.	O

The	O
purpose	O
of	O
this	O
review	O
is	O
to	O
discuss	O
the	O
use	O
of	O
convalescent	O
plasma	B-ANAT
for	O
the	O
treatment	O
of	O
emerging	O
infectious	O
diseases	O
,	O
focusing	O
on	O
the	O
recent	O
use	O
for	O
the	O
treatment	O
of	O
Ebola	O
virus	O
disease	O
(	O
EVD	O
).	O

Even	O
more	O
recently	O
,	O
convalescent	O
plasma	B-ANAT
has	O
been	O
used	O
for	O
treatment	O
of	O
individuals	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
.	O

In	O
addition	O
,	O
the	O
immunogenicity	O
of	O
IBV	O
VLPs	B-ANAT
had	O
been	O
investigated	O
.	O

TITLE	O
:	O
Complications	O
of	O
Prone	O
Positioning	O
During	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
for	O
Respiratory	O
Failure	O
:	O
A	O
Systematic	O
Review	O
.	O

The	O
addition	O
of	O
prone	O
positioning	O
therapy	O
used	O
concurrently	O
with	O
ECMO	O
can	O
further	O
aid	O
in	O
optimizing	O
alveolar	B-ANAT
recruitment	O
and	O
reducing	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
,	O
ultimately	O
resulting	O
in	O
fewer	O
ICU	O
admission	O
days	O
and	O
improved	O
overall	O
survival	O
.	O

From	O
cloacal	B-ANAT
swabs	O
and	O
intestines	B-ANAT
,	O
TCoV	O
was	O
consistently	O
detected	O
by	O
reverse	O
transcriptase	O
-	O
PCR	O
throughout	O
the	O
experimental	O
period	O
(	O
1	O
-	O
21	O
days	O
postinoculation	O
[	O
DPI	O
])	O
from	O
all	O
age	O
groups	O
.	O

Little	O
is	O
known	O
about	O
the	O
reservoir	O
in	O
the	O
Horn	B-ANAT
of	O
Africa	O
.	O

TITLE	O
:	O
Feline	O
coronavirus	O
quantitative	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
on	O
effusion	B-ANAT
samples	O
in	O
cats	O
with	O
and	O
without	O
feline	O
infectious	O
peritonitis	O
.	O

Title	O
compounds	O
were	O
tested	O
in	O
cell	B-ANAT
-	O
based	O
assays	O
for	O
cytotoxicity	O
and	O
antiviral	O
activity	O
against	O
RNA	O
virus	O
families	O
containing	O
single	O
-	O
stranded	O
(	O
either	O
positive	O
-	O
sense	O
(	O
ssRNA	O
+)	O
or	O
negative	O
-	O
sense	O
(	O
ssRNA	O
-)),	O
and	O
double	O
-	O
stranded	O
genomes	O
(	O
dsRNA	O
),	O
and	O
against	O
two	O
representatives	O
of	O
DNA	O
virus	O
families	O
.	O

Echocardiography	O
was	O
used	O
to	O
identify	O
pulmonary	B-ANAT
hypertension	O
in	O
21	O
patients	O
with	O
refractory	O
ARDS	O
just	O
before	O
ECMO	O
implantation	O
.	O

MERS	O
-	O
CoV	O
-	O
infected	O
lungs	B-ANAT
revealed	O
mononuclear	B-ANAT
cell	I-ANAT
infiltration	O
,	O
alveolar	B-ANAT
edema	O
,	O
and	O
microvascular	O
thrombosis	O
,	O
with	O
airways	O
generally	O
unaffected	O
.	O

We	O
evaluated	O
whether	O
cycle	O
threshold	O
(	O
Ct	O
)	O
values	O
(	O
which	O
are	O
inversely	O
related	O
to	O
virus	O
load	O
)	O
were	O
associated	O
with	O
clinical	O
severity	O
in	O
patients	O
from	O
Saudi	O
Arabia	O
whose	O
nasopharyngeal	B-ANAT
specimens	O
tested	O
positive	O
for	O
this	O
virus	O
by	O
real	O
-	O
time	O
reverse	O
transcription	O
PCR	O
.	O

ABSTRACT	O
:	O
Pathogenic	O
viral	O
infections	O
pose	O
major	O
health	O
risks	O
to	O
humans	O
and	O
livestock	O
due	O
to	O
viral	O
infection	O
-	O
associated	O
illnesses	O
such	O
as	O
chronic	O
or	O
acute	O
inflammation	O
in	O
crucial	O
organs	B-ANAT
and	O
systems	O
,	O
malignant	O
and	O
benign	O
lesions	O
.	O

ABSTRACT	O
:	O
The	O
incidence	O
of	O
adult	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
(	O
TBI	O
)	O
is	O
poorly	O
reported	O
.	O

One	O
patient	O
showed	O
a	O
diffuse	O
comet	O
tail	O
sign	O
or	O
consolidation	O
area	O
in	O
four	O
lung	B-ANAT
areas	O
,	O
with	O
an	O
ultrasound	O
score	O
of	O
14	O
.	O

ABSTRACT	O
:	O
The	O
study	O
aimed	O
at	O
exploring	O
bereavement	O
and	O
complicated	O
grief	O
(	O
CG	O
)	O
symptoms	O
among	O
subjects	O
without	O
a	O
history	O
of	O
coronary	B-ANAT
heart	B-ANAT
disease	O
(	O
CHD	O
)	O
at	O
the	O
time	O
of	O
a	O
first	O
acute	O
coronary	B-ANAT
syndrome	O
(	O
ACS	O
)	O
and	O
to	O
evaluate	O
the	O
relationship	O
of	O
CG	O
symptoms	O
and	O
ACS	O
.	O

Our	O
data	O
corroborate	O
previous	O
data	O
indicating	O
a	O
strong	O
relationship	O
between	O
CG	O
symptoms	O
and	O
severe	O
cardiac	B-ANAT
problems	O
.	O

History	O
of	O
intestinal	B-ANAT
infection	O
was	O
present	O
in	O
40	O
%	O
of	O
patients	O
,	O
and	O
respiratory	O
infection	O
in	O
24	O
.	O
4	O
%.	O

If	O
the	O
patient	O
is	O
not	O
diagnosed	O
early	O
,	O
ascites	O
,	O
pleural	O
and	O
more	O
rarely	O
pericardial	B-ANAT
effusions	O
,	O
severe	O
respiratory	O
failure	O
and	O
ARDS	O
,	O
hypercoagulability	O
with	O
tromboembolism	O
and	O
multiple	O
organ	B-ANAT
system	I-ANAT
failure	O
can	O
occur	O
.	O

Due	O
to	O
the	O
increased	O
use	O
of	O
therapeutic	O
strategies	O
for	O
infertility	O
(	O
particularly	O
those	O
using	O
human	O
chorionic	B-ANAT
gonadotropin	O
),	O
the	O
systemic	O
,	O
particularly	O
the	O
pulmonary	B-ANAT
,	O
complications	O
of	O
this	O
syndrome	O
must	O
be	O
identified	O
early	O
to	O
allow	O
appropriate	O
diagnosis	O
and	O
management	O
.	O

Pulmonary	B-ANAT
intensive	O
care	O
may	O
involve	O
thoracentesis	O
,	O
oxygen	O
supplementation	O
and	O
in	O
more	O
severe	O
cases	O
assisted	O
ventilation	O
.	O

TITLE	O
:	O
Severe	O
Blunt	O
Hepatic	B-ANAT
Trauma	O
in	O
Polytrauma	O
Patient	O
-	O
Management	O
and	O
Outcome	O
.	O

Liver	B-ANAT
related	O
mortality	O
was	O
17	O
.	O
1	O
%.	O

Patients	O
with	O
high	O
-	O
grade	O
liver	B-ANAT
trauma	O
who	O
present	O
with	O
hemorrhagic	O
shock	O
and	O
associated	O
severe	O
injury	O
should	O
be	O
managed	O
operatively	O
.	O

Mortality	O
from	O
liver	B-ANAT
trauma	O
is	O
high	O
for	O
patients	O
with	O
higher	O
AAST	O
grade	O
of	O
injury	O
,	O
associated	O
brain	B-ANAT
injury	O
and	O
massive	O
transfusion	O
score	O
.	O

Liposuction	O
surgery	O
,	O
in	O
which	O
adipocytes	B-ANAT
are	O
mechanically	O
disrupted	O
,	O
is	O
one	O
cause	O
of	O
FES	O
.	O

Among	O
83	O
university	O
students	O
with	O
acute	O
pharyngitis	O
,	O
we	O
detected	O
respiratory	O
viruses	O
with	O
molecular	O
assays	O
on	O
two	O
samples	O
collected	O
per	O
student	O
:	O
with	O
a	O
flocked	O
nasal	B-ANAT
mid	O
-	O
turbinate	B-ANAT
swab	O
and	O
a	O
rayon	O
throat	B-ANAT
swab	I-ANAT
.	O

For	O
patients	O
with	O
a	O
severe	O
pneumothorax	O
,	O
and	O
especially	O
those	O
with	O
severe	O
mediastinal	B-ANAT
emphysema	O
,	O
timely	O
,	O
continuous	O
,	O
retrosternal	O
,	O
closed	O
thoracic	B-ANAT
drainage	B-ANAT
can	O
effectively	O
relieve	O
compression	O
.	O

Respiratory	O
mechanics	O
,	O
blood	B-ANAT
gases	O
,	O
hemodynamic	O
data	O
,	O
and	O
whole	O
-	O
lung	B-ANAT
computed	O
tomography	O
scans	O
were	O
recorded	O
at	O
each	O
PEEP	O
level	O
.	O

OL	O
-	O
PEEP	O
was	O
higher	O
than	O
Pes	B-ANAT
-	O
PEEP	O
,	O
which	O
induced	O
a	O
higher	O
PL	O
-	O
exp	O
at	O
OL	O
-	O
PEEP	O
than	O
at	O
Pes	B-ANAT
-	O
PEEP	O
(	O
4	O
.	O
6	O
[	O
1	O
.	O
6	O
]	O
cm	O
H2O	O
vs	O
.	O
1	O
.	O
2	O
[	O
0	O
.	O
6	O
]	O
cm	O
H2O	O
,	O
p	O
<	O
0	O
.	O
001	O
).	O

The	O
SP	O
correlated	O
with	O
PL	O
-	O
exp	O
at	O
the	O
dorsal	O
level	O
and	O
the	O
nonaerated	O
lung	B-ANAT
region	O
.	O

TITLE	O
:	O
Extracorporeal	O
decarboxylation	O
in	O
patients	O
with	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
and	O
ARDS	O
enables	O
effective	O
control	O
of	O
intracranial	B-ANAT
pressure	O
.	O

A	O
retrospective	O
analysis	O
of	O
ARDS	O
renal	B-ANAT
recipients	O
with	O
ESKAPE	O
/	O
rESKAPE	O
pneumonia	O
was	O
reviewed	O
.	O

The	O
independent	O
determinants	O
of	O
mortality	O
were	O
associated	O
with	O
ARDS	O
renal	B-ANAT
recipients	O
with	O
rESKAPE	O
pneumonia	O
were	O
serum	B-ANAT
creatinine	O
level	O
>	O
1	O
.	O
5	O
mg	O
/	O
dL	O
(	O
OR	O
13	O
.	O
7	O
,	O
95	O
%	O
CI	O
1	O
.	O
3	O
-	O
142	O
.	O
1	O
,	O
P	O
=	O
.	O
028	O
)	O
and	O
body	B-ANAT
temperature	O
less	O
than	O
38	O
Â°	O
C	O
(	O
OR	O
5	O
.	O
5	O
(	O
95	O
%	O
CI	O
1	O
.	O
1	O
-	O
26	O
.	O
6	O
)	O
at	O
ARDS	O
onset	O
,	O
P	O
=	O
.	O
035	O
).	O

ABSTRACT	O
:	O
Bovine	O
coronavirus	O
(	O
BCoV	O
)	O
is	O
an	O
important	O
viral	O
pathogen	O
associated	O
with	O
neonatal	O
calf	B-ANAT
diarrhea	O
.	O

These	O
targeted	O
liposomes	O
showed	O
binding	O
to	O
alphavbeta5	O
integrin	O
receptors	O
expressed	O
on	O
alveolar	B-ANAT
cells	B-ANAT
.	O

The	O
respiratory	O
virus	O
examination	O
was	O
determined	O
by	O
a	O
liquid	O
bead	O
array	O
xTAG	O
Respiratory	O
Virus	O
Panel	O
in	O
pharyngeal	B-ANAT
swabs	O
,	O
while	O
bacterial	O
infection	O
was	O
studied	O
by	O
conventional	O
sputum	B-ANAT
culture	O
.	O

In	O
this	O
particular	O
case	O
,	O
the	O
cardiac	B-ANAT
electrical	O
instability	O
was	O
definitely	O
maintained	O
by	O
several	O
causes	O
,	O
including	O
severe	O
hypokalemia	O
,	O
which	O
has	O
not	O
been	O
previously	O
reported	O
as	O
related	O
to	O
Taxus	O
poisoning	O
.	O

TITLE	O
:	O
Ruptured	O
spinal	O
arteriovenous	O
malformation	O
:	O
Presenting	O
as	O
stunned	O
myocardium	B-ANAT
and	O
neurogenic	O
shock	O
.	O

Using	O
the	O
SARS	O
-	O
CoV	O
reverse	O
genetics	O
system	O
,	O
we	O
generated	O
and	O
characterized	O
a	O
chimeric	O
virus	O
expressing	O
the	O
spike	O
of	O
bat	O
coronavirus	O
SHC014	O
in	O
a	O
mouse	O
-	O
adapted	O
SARS	O
-	O
CoV	O
backbone	B-ANAT
.	O

Exposure	O
to	O
copper	O
destroyed	O
the	O
viral	O
genomes	O
and	O
irreversibly	O
affected	O
virus	O
morphology	O
,	O
including	O
disintegration	O
of	O
envelope	B-ANAT
and	O
dispersal	O
of	O
surface	O
spikes	O
.	O

We	O
show	O
here	O
that	O
a	O
closely	O
related	O
human	O
coronavirus	O
,	O
229E	O
,	O
which	O
causes	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
in	O
healthy	O
individuals	O
and	O
serious	O
disease	O
in	O
patients	O
with	O
comorbidities	O
,	O
remained	O
infectious	O
on	O
surface	O
materials	O
common	O
to	O
public	O
and	O
domestic	O
areas	O
for	O
several	O
days	O
.	O

The	O
most	O
common	O
cause	O
is	O
Gullian	O
-	O
Barre	O
syndrome	O
,	O
but	O
infections	O
,	O
spinal	B-ANAT
cord	I-ANAT
diseases	O
,	O
neuromuscular	O
diseases	O
such	O
as	O
myasthenia	O
gravis	O
,	O
drugs	O
and	O
toxins	O
,	O
periodic	O
hypokalemic	O
paralysis	O
,	O
electrolyte	O
disturbances	O
,	O
and	O
botulism	O
should	O
be	O
considered	O
as	O
in	O
the	O
differential	O
diagnosis	O
.	O

Pulmonary	B-ANAT
embolism	O
,	O
pneumothorax	O
and	O
deep	O
venous	B-ANAT
thrombosis	O
were	O
identified	O
based	O
on	O
imaging	O
results	O
.	O

Cardiac	B-ANAT
arrhythmias	O
and	O
renal	B-ANAT
failure	O
were	O
extracted	O
from	O
the	O
clinical	O
documentation	O
.	O

acute	O
respiratory	O
distress	O
syndrome	O
and	O
acute	O
lung	B-ANAT
injury	O
were	O
determined	O
based	O
on	O
chest	B-ANAT
imaging	O
and	O
arterial	B-ANAT
blood	I-ANAT
gas	O
results	O
.	O

Method	O
of	O
injury	O
included	O
motor	O
vehicle	O
accident	O
(	O
n	O
=	O
29	O
),	O
motor	O
cycle	O
crash	O
(	O
n	O
=	O
220	O
),	O
blunt	O
head	B-ANAT
trauma	O
(	O
n	O
=	O
212	O
),	O
fall	O
(	O
n	O
=	O
229	O
),	O
pedestrian	O
hit	O
by	O
car	B-ANAT
(	O
n	O
=	O
216	O
),	O
and	O
gunshot	O
wound	O
to	O
the	O
head	B-ANAT
(	O
n	O
=	O
27	O
).	O

We	O
aimed	O
to	O
describe	O
the	O
consequences	O
of	O
bronchoscopy	O
during	O
lung	B-ANAT
-	O
protective	O
ventilation	O
in	O
a	O
bench	O
study	O
,	O
and	O
thereby	O
to	O
determine	O
the	O
optimal	O
diameter	O
of	O
the	O
bronchoscope	O
for	O
avoiding	O
disruption	O
of	O
the	O
protective	O
-	O
ventilation	O
strategy	O
during	O
the	O
procedure	O
.	O

Antibodies	O
and	O
serum	B-ANAT
neutralizing	O
activities	O
were	O
determined	O
over	O
the	O
course	O
of	O
disease	O
.	O

We	O
herein	O
present	O
a	O
case	O
of	O
severe	O
leptospirosis	O
complicated	O
by	O
massive	O
pulmonary	B-ANAT
hemorrhage	O
,	O
which	O
was	O
successfully	O
managed	O
by	O
extra	O
corporeal	O
membrane	B-ANAT
oxygenation	O
.	O

An	O
analysis	O
restricted	O
to	O
the	O
changes	O
in	O
normally	O
aerated	O
lung	B-ANAT
yielded	O
similar	O
results	O
.	O

Although	O
the	O
fundus	B-ANAT
was	O
invisible	O
due	O
to	O
cataract	O
,	O
right	O
endophthalmitis	O
of	O
unknown	O
origin	O
was	O
suggested	O
by	O
pus	B-ANAT
in	O
the	O
anterior	B-ANAT
chamber	I-ANAT
and	O
brain	B-ANAT
computed	O
tomography	O
(	O
CT	O
)	O
findings	O
showing	O
nasal	B-ANAT
scleral	O
rupture	O
and	O
orbital	O
cellulitis	O
.	O

CONCLUSIONS	O
:	O
Severe	O
bacterial	O
endophthalmitis	O
may	O
cause	O
intracranial	B-ANAT
infection	O
via	O
the	O
optic	B-ANAT
nerve	I-ANAT
.	O

Five	O
necropsied	O
cats	O
that	O
were	O
naturally	O
infected	O
with	O
FIP	O
virus	O
,	O
confirmed	O
by	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
and	O
immunohistochemistry	O
,	O
with	O
different	O
intensities	O
of	O
CNS	B-ANAT
lesions	O
,	O
were	O
studied	O
.	O

Noninvasive	O
ventilation	O
was	O
uniformly	O
delivered	O
using	O
a	O
simple	O
algorithm	O
targeting	O
the	O
expired	O
tidal	O
volume	O
between	O
6	O
and	O
8	O
mL	O
/	O
kg	O
of	O
predicted	O
body	B-ANAT
weight	O
.	O

The	O
median	O
(	O
interquartile	O
range	O
)	O
expired	O
tidal	O
volume	O
averaged	O
over	O
all	O
noninvasive	O
ventilation	O
sessions	O
(	O
mean	O
expired	O
tidal	O
volume	O
)	O
was	O
9	O
.	O
8	O
mL	O
/	O
kg	O
predicted	O
body	B-ANAT
weight	O
(	O
8	O
.	O
1	O
-	O
11	O
.	O
1	O
mL	O
/	O
kg	O
predicted	O
body	B-ANAT
weight	O
).	O

The	O
mean	O
expired	O
tidal	O
volume	O
was	O
significantly	O
higher	O
in	O
patients	O
who	O
failed	O
noninvasive	O
ventilation	O
as	O
compared	O
with	O
those	O
who	O
succeeded	O
(	O
10	O
.	O
6	O
mL	O
/	O
kg	O
predicted	O
body	B-ANAT
weight	O
[	O
9	O
.	O
6	O
-	O
12	O
.	O
0	O
]	O
vs	O
8	O
.	O
5	O
mL	O
/	O
kg	O
predicted	O
body	B-ANAT
weight	O
[	O
7	O
.	O
6	O
-	O
10	O
.	O
2	O
];	O
p	O
=	O
0	O
.	O
001	O
),	O
and	O
expired	O
tidal	O
volume	O
was	O
independently	O
associated	O
with	O
noninvasive	O
ventilation	O
failure	O
in	O
multivariate	O
analysis	O
.	O

TITLE	O
:	O
Interleukin	O
-	O
1	O
Receptor	O
Blockade	O
Is	O
Associated	O
With	O
Reduced	O
Mortality	O
in	O
Sepsis	O
Patients	O
With	O
Features	O
of	O
Macrophage	B-ANAT
Activation	O
Syndrome	O
:	O
Reanalysis	O
of	O
a	O
Prior	O
Phase	O
III	O
Trial	O
.	O

The	O
non	O
-	O
hepatobiliary	B-ANAT
dysfunction	O
/	O
disseminated	O
intravascular	O
coagulation	O
group	O
included	O
patients	O
with	O
only	O
hepatobiliary	B-ANAT
dysfunction	O
,	O
only	O
disseminated	O
intravascular	O
coagulation	O
,	O
or	O
neither	O
.	O

Treatment	O
with	O
anakinra	O
was	O
associated	O
with	O
significant	O
improvement	O
in	O
the	O
28	O
-	O
day	O
survival	O
rate	O
in	O
hepatobiliary	B-ANAT
dysfunction	O
/	O
disseminated	O
intravascular	O
coagulation	O
patients	O
(	O
65	O
.	O
4	O
%	O
anakinra	O
vs	O
35	O
.	O
3	O
%	O
placebo	O
),	O
with	O
hazard	O
ratio	O
for	O
death	O
0	O
.	O
28	O
(	O
0	O
.	O
11	O
-	O
0	O
.	O
71	O
;	O
p	O
=	O
0	O
.	O
0071	O
)	O
for	O
the	O
treatment	O
group	O
in	O
Cox	O
regression	O
.	O

Nucleic	B-ANAT
acid	O
biomarkers	O
for	O
these	O
diseases	O
can	O
be	O
amplified	O
and	O
quantified	O
via	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
).	O

This	O
simple	O
,	O
ultrafast	O
,	O
precise	O
,	O
robust	O
,	O
and	O
low	O
-	O
cost	O
optofluidic	O
cavity	B-ANAT
PCR	O
is	O
favorable	O
for	O
advanced	O
molecular	O
diagnostics	O
and	O
precision	O
medicine	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
assess	O
whether	O
the	O
grade	O
of	O
mucosal	B-ANAT
INH	O
severity	O
was	O
associated	O
with	O
various	O
outcomes	O
among	O
adult	O
burn	O
patients	O
.	O

ABSTRACT	O
:	O
Groundbreaking	O
research	O
into	O
the	O
pathophysiology	O
of	O
the	O
adult	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
the	O
prevention	O
of	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
has	O
led	O
to	O
dramatic	O
improvements	O
in	O
survival	O
.	O

Among	O
174	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
,	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
)	O
was	O
detected	O
in	O
39	O
samples	O
(	O
22	O
.	O
41	O
%),	O
influenza	O
A	O
virus	O
in	O
34	O
(	O
19	O
.	O
54	O
%),	O
metapneumovirus	O
(	O
MPV	O
)	O
in	O
19	O
(	O
10	O
.	O
92	O
%),	O
coronaviruses	O
in	O
14	O
(	O
8	O
.	O
05	O
%),	O
and	O
parainfluenza	O
viruses	O
(	O
PIVs	O
)	O
in	O
11	O
(	O
6	O
.	O
32	O
%).	O

At	O
one	O
month	O
from	O
seizure	O
onset	O
,	O
mild	O
to	O
moderate	O
cerebral	B-ANAT
atrophy	O
and	O
hippocampal	B-ANAT
sclerosis	O
was	O
appreciated	O
that	O
continued	O
to	O
progress	O
over	O
the	O
next	O
year	O
.	O

After	O
six	O
to	O
twelve	O
months	O
,	O
most	O
of	O
the	O
patients	O
showed	O
moderate	O
to	O
severe	O
cerebral	B-ANAT
atrophy	O
and	O
by	O
one	O
year	O
,	O
cerebellar	B-ANAT
atrophy	O
was	O
also	O
appreciated	O
.	O

We	O
speculate	O
that	O
the	O
preferential	O
spatial	O
localization	O
of	O
DPP4	O
in	O
alveolar	B-ANAT
regions	O
may	O
explain	O
why	O
MERS	O
is	O
characterized	O
by	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
disease	O
.	O

In	O
this	O
context	O
,	O
serum	B-ANAT
biomarkers	O
and	O
lung	B-ANAT
injury	O
prediction	O
scores	O
could	O
be	O
useful	O
.	O

As	O
cardiovascular	B-ANAT
surgery	O
patients	O
are	O
of	O
greater	O
risk	O
to	O
develop	O
ARDS	O
,	O
preventive	O
interventions	O
should	O
be	O
implemented	O
early	O
on	O
.	O

ELISA	O
and	O
Western	O
blot	O
assays	O
showed	O
clear	O
production	O
of	O
CXCL10	O
and	O
MxA	O
in	O
MERS	O
-	O
CoV	O
-	O
infected	O
macrophages	B-ANAT
and	O
MDDCs	O
.	O

Diagnosis	O
of	O
silicone	O
embolism	O
syndrome	O
was	O
made	O
,	O
a	O
few	O
years	O
later	O
,	O
thanks	O
to	O
the	O
histopathology	O
study	O
of	O
a	O
persistent	O
penis	B-ANAT
ulcer	O
with	O
genital	B-ANAT
lymphedema	O
.	O

Cell	B-ANAT
culture	O
medium	O
and	O
porcine	O
plasma	B-ANAT
at	O
different	O
pH	O
(	O
7	O
.	O
2	O
,	O
9	O
.	O
2	O
,	O
10	O
.	O
2	O
)	O
and	O
temperature	O
conditions	O
(	O
4	O
Â°	O
C	O
,	O
40	O
Â°	O
C	O
,	O
44	O
Â°	O
C	O
,	O
48	O
Â°	O
C	O
)	O
were	O
inoculated	O
to	O
a	O
final	O
titer	O
of	O
5	O
.	O
5	O
log10	O
TCID50	O
PEDV	O
/	O
ml	O
,	O
incubated	O
for	O
up	O
to	O
120	O
min	O
and	O
the	O
residual	O
infectivity	O
was	O
determined	O
by	O
endpoint	O
dilution	O
assay	O
.	O

At	O
moderate	O
temperatures	O
(â¥	O
40	O
Â°	O
C	O
),	O
both	O
alkaline	O
pH	O
and	O
presence	O
of	O
plasma	B-ANAT
potentiated	O
thermal	O
inactivation	O
.	O

Here	O
we	O
propose	O
heat	O
-	O
alkalinity	O
-	O
time	O
(	O
HAT	O
)	O
pasteurization	O
as	O
a	O
highly	O
efficient	O
method	O
to	O
inactivate	O
PEDV	O
during	O
industrial	O
processing	O
of	O
porcine	O
plasma	B-ANAT
.	O

However	O
,	O
recent	O
studies	O
have	O
shown	O
that	O
histones	O
,	O
also	O
known	O
as	O
chromatin	B-ANAT
-	O
basic	O
structure	O
proteins	O
,	O
could	O
be	O
released	O
into	O
the	O
extracellular	B-ANAT
space	I-ANAT
during	O
severe	O
stress	O
and	O
physical	O
challenges	O
to	O
the	O
body	B-ANAT
(	O
e	O
.	O
g	O
.,	O
sepsis	O
and	O
ARDS	O
).	O

Approximately	O
,	O
7	O
%	O
of	O
the	O
case	O
IDs	O
submitted	O
from	O
the	O
US	O
were	O
positive	O
for	O
PDCoV	O
.	O
Specimens	O
were	O
categorized	O
into	O
eight	O
groups	O
,	O
and	O
the	O
univariate	O
analysis	O
indicated	O
that	O
oral	B-ANAT
fluids	B-ANAT
had	O
1	O
.	O
89	O
times	O
higher	O
odds	O
of	O
detecting	O
PDCoV	O
compared	O
to	O
feces	B-ANAT
.	O

Our	O
results	O
indicate	O
that	O
oral	B-ANAT
fluids	B-ANAT
continue	O
to	O
be	O
a	O
valuable	O
specimen	O
to	O
monitor	O
swineherd	O
health	O
,	O
and	O
PDCoV	O
has	O
been	O
circulating	O
in	O
the	O
US	O
prior	O
to	O
2014	O
.	O

TITLE	O
:	O
A	O
multicenter	O
prospective	O
cohort	O
study	O
of	O
volume	O
management	O
after	O
subarachnoid	O
hemorrhage	O
:	O
circulatory	O
characteristics	O
of	O
pulmonary	B-ANAT
edema	O
after	O
subarachnoid	O
hemorrhage	O
.	O

Extracellular	B-ANAT
vesicles	B-ANAT
from	O
PBMCs	O
demonstrated	O
anti	O
-	O
inflammatory	O
capacity	O
in	O
a	O
TNF	O
-	O
Î±	O
-	O
mediated	O
nuclear	O
factor	O
-	O
x03BA	O
;	O
B	O
in	O
vitro	O
assay	O
.	O

RESULTS	O
:	O
We	O
found	O
that	O
after	O
2	O
days	O
of	O
initial	O
PBMC	O
/	O
EPO	O
application	O
,	O
lung	B-ANAT
function	O
improved	O
and	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
support	O
was	O
reduced	O
.	O

Subjects	O
with	O
anti	O
-	O
MERS	O
-	O
CoV	O
IFA	O
titer	O
of	O
â¥	O
1	O
:	O
160	O
and	O
no	O
clinical	O
or	O
laboratory	O
evidence	O
of	O
MERS	O
-	O
CoV	O
infection	O
will	O
be	O
screened	O
for	O
eligibility	O
for	O
plasma	B-ANAT
donation	O
according	O
to	O
standard	O
donation	O
criteria	O
.	O

However	O
,	O
pretreatment	O
of	O
mice	O
with	O
imatinib	O
increased	O
lung	B-ANAT
catalase	O
activity	O
and	O
decreased	O
intravenous	O
LPS	O
-	O
induced	O
lung	B-ANAT
oxidant	O
injury	O
as	O
measured	O
by	O
Î³	O
-	O
H2AX	O
,	O
a	O
marker	O
of	O
oxidant	O
-	O
induced	O
DNA	O
damage	O
,	O
lung	B-ANAT
apoptosis	O
,	O
and	O
pulmonary	B-ANAT
edema	O
.	O

IFN	O
-	O
Î³	O
secretion	B-ANAT
and	O
CD8	O
(+)	O
T	B-ANAT
cell	I-ANAT
proliferation	O
in	O
chickens	O
were	O
tested	O
by	O
ELISpot	O
array	O
and	O
flow	O
cytometry	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
The	O
study	O
aimed	O
to	O
evaluate	O
the	O
influence	O
of	O
repeated	O
recruitment	O
manoeuvres	O
(	O
RRMs	O
)	O
on	O
lung	B-ANAT
injury	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Recruitment	O
manoeuvres	O
(	O
RMs	O
)	O
were	O
conducted	O
with	O
continuous	O
positive	O
airway	B-ANAT
pressure	O
(	O
CPAP	O
;	O
30	O
cm	O
H2O	O
for	O
40	O
seconds	O
).	O

Changes	O
in	O
haemodynamics	O
,	O
pulmonary	B-ANAT
compliance	O
,	O
gas	O
exchange	O
and	O
extravascular	O
lung	B-ANAT
water	O
index	O
(	O
EVLWI	O
)	O
were	O
monitored	O
before	O
RM	O
(	O
pre	O
-	O
RM	O
),	O
10	O
minutes	O
after	O
each	O
RM	O
,	O
and	O
four	O
hours	O
after	O
RM3	O
(	O
4	O
hours	O
post	O
-	O
RRM	O
).	O

Extravascular	O
lung	B-ANAT
water	O
index	O
decreased	O
significantly	O
in	O
RM1	O
compared	O
with	O
that	O
in	O
RM3	O
and	O
4	O
hours	O
post	O
-	O
RRM	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

Repeated	O
recruitment	O
manoeuvres	O
during	O
lung	B-ANAT
-	O
protected	O
ventilation	O
can	O
improve	O
pulmonary	B-ANAT
compliance	O
and	O
oxygenation	O
and	O
significantly	O
decrease	O
extravascular	O
lung	B-ANAT
water	O
in	O
ARDS	O
patients	O
.	O

RESULTS	O
:	O
Compared	O
with	O
those	O
in	O
pre	O
-	O
RM	O
,	O
pulmonary	B-ANAT
compliance	O
,	O
oxygenation	O
index	O
(	O
ratio	O
of	O
partial	O
pressure	O
of	O
arterial	B-ANAT
oxygen	O
to	O
fraction	O
of	O
inspired	O
oxygen	O
[	O
PaO2	O
/	O
FiO2	O
])	O
and	O
EVLWI	O
remarkably	O
improved	O
in	O
RM1	O
,	O
RM2	O
,	O
RM3	O
and	O
4	O
hours	O
post	O
-	O
RRM	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

CONCLUSIONS	O
:	O
Repeated	O
recruitment	O
manoeuvres	O
during	O
lung	B-ANAT
-	O
protected	O
ventilation	O
can	O
improve	O
pulmonary	B-ANAT
compliance	O
and	O
oxygenation	O
and	O
significantly	O
decrease	O
extravascular	O
lung	B-ANAT
water	O
in	O
ARDS	O
patients	O
.	O

Monkeys	O
were	O
euthanized	O
3	O
days	O
after	O
challenge	O
and	O
multiple	O
specimens	O
from	O
tissues	B-ANAT
were	O
collected	O
for	O
pathological	O
,	O
virological	O
and	O
immunological	O
tests	O
.	O

Furthermore	O
,	O
the	O
rRBD	O
vaccine	O
decreased	O
viral	O
load	O
of	O
lung	B-ANAT
,	O
trachea	B-ANAT
and	O
oropharyngeal	B-ANAT
swabs	O
of	O
monkeys	O
.	O

Genetically	O
engineered	O
immunoadhesin	O
(	O
DPP4	O
-	O
Fc	O
)	O
produced	O
in	O
green	O
plants	O
has	O
been	O
shown	O
to	O
be	O
able	O
to	O
bind	O
to	O
MERS	O
-	O
CoV	O
(	O
Middle	O
East	O
Respiratory	O
Syndrome	O
),	O
preventing	O
the	O
virus	O
from	O
infecting	O
lung	B-ANAT
cells	B-ANAT
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
is	O
used	O
for	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Acute	O
lung	B-ANAT
injury	O
was	O
induced	O
with	O
repeated	O
pulmonary	B-ANAT
saline	O
lavage	O
in	O
14	O
pigs	O
until	O
PaO2	O
/	O
FiO2	O
-	O
ratio	O
was	O
<	O
100	O
mm	O
Hg	O
with	O
a	O
positive	O
-	O
end	O
-	O
expiratory	O
-	O
pressure	O
of	O
5	O
mbar	O
.	O

Further	O
development	O
and	O
design	O
modifications	O
(	O
optimized	O
rotation	O
speed	O
and	O
surface	O
coating	O
of	O
rotor	O
)	O
are	O
already	O
done	O
and	O
another	O
experiment	O
is	O
projected	O
to	O
reduce	O
hemolysis	O
and	O
platelet	B-ANAT
consumption	O
for	O
clinical	O
application	O
.	O

TITLE	O
:	O
Effect	O
of	O
extracorporeal	O
CO2	O
removal	O
on	O
right	O
ventricular	B-ANAT
and	O
hemodynamic	O
parameters	O
in	O
a	O
patient	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
impact	O
of	O
different	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
systems	O
on	O
blood	B-ANAT
hemostasis	O
in	O
adults	O
during	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
therapy	O
.	O

Over	O
time	O
,	O
miniaturized	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
therapy	O
increasingly	O
activates	O
coagulation	O
.	O

The	O
different	O
types	O
of	O
membrane	B-ANAT
oxygenators	O
and	O
pumps	O
did	O
not	O
significantly	O
alter	O
hemostasis	O
.	O

TITLE	O
:	O
Spatiotemporal	O
interplay	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
and	O
respiratory	O
mucosal	B-ANAT
cells	B-ANAT
drives	O
viral	O
dissemination	O
in	O
rhesus	O
macaques	O
.	O

Here	O
we	O
show	O
in	O
Chinese	O
macaques	O
that	O
SARS	O
-	O
CoV	O
traversed	O
the	O
mucosa	B-ANAT
through	O
the	O
respiratory	B-ANAT
tract	I-ANAT
within	O
2	O
days	O
,	O
resulting	O
in	O
extensive	O
mucosal	B-ANAT
infiltration	O
by	O
T	B-ANAT
cells	I-ANAT
,	O
MAC387	O
(+),	O
and	O
CD163	O
(+)	O
monocytes	B-ANAT
/	O
macrophages	B-ANAT
followed	O
by	O
limited	O
viral	O
replication	O
in	O
the	O
lung	B-ANAT
but	O
persistent	O
viral	O
shedding	O
into	O
the	O
upper	O
airway	B-ANAT
.	O

Mucosal	B-ANAT
monocytes	B-ANAT
/	O
macrophages	B-ANAT
sequestered	O
virions	B-ANAT
in	O
intracellular	B-ANAT
vesicles	B-ANAT
together	O
with	O
infected	O
Langerhans	B-ANAT
cells	I-ANAT
and	O
migrated	O
into	O
the	O
tonsils	B-ANAT
and	O
/	O
or	O
draining	O
lymph	B-ANAT
nodes	I-ANAT
within	O
2	O
days	O
.	O

Here	O
,	O
we	O
report	O
the	O
crystal	B-ANAT
structure	O
of	O
FIPV	O
M	O
(	O
pro	O
)	O
in	O
complex	O
with	O
dual	O
inhibitors	O
,	O
a	O
zinc	O
ion	O
and	O
a	O
Michael	O
acceptor	O
.	O

NEMO	O
is	O
cleaved	B-ANAT
at	O
glutamine	O
231	O
(	O
Q231	O
)	O
by	O
PEDV	O
,	O
and	O
this	O
cleavage	O
impaired	O
the	O
ability	O
of	O
NEMO	O
to	O
activate	O
downstream	O
IFN	O
production	O
and	O
to	O
act	O
as	O
a	O
signaling	O
adaptor	O
of	O
the	O
RIG	O
-	O
I	O
/	O
MDA5	O
pathway	O
.	O

Mechanistically	O
,	O
the	O
cysteine	O
protease	O
activity	O
of	O
PEDV	O
nsp5	O
mediates	O
proteolysis	O
of	O
NEMO	O
,	O
the	O
key	O
adaptor	O
for	O
IFN	O
synthesis	O
,	O
and	O
NEMO	O
is	O
cleaved	B-ANAT
at	O
glutamine	O
231	O
(	O
Q231	O
).	O

ABSTRACT	O
:	O
Stable	O
isotope	O
labeling	O
is	O
central	O
to	O
NMR	O
studies	O
of	O
nucleic	B-ANAT
acids	O
.	O

The	O
crystal	B-ANAT
structure	O
of	O
MERS	O
-	O
CoV	O
Mpro	O
indicates	O
that	O
it	O
shares	O
a	O
similar	O
scaffold	O
to	O
that	O
of	O
other	O
coronaviral	O
Mpro	O
and	O
consists	O
of	O
chymotrypsin	O
-	O
like	O
domains	O
I	O
and	O
II	O
and	O
a	O
helical	O
domain	O
III	O
of	O
five	O
helices	O
.	O

We	O
evaluated	O
three	O
different	O
strategies	O
for	O
managing	O
the	O
trade	O
-	O
off	O
between	O
increasing	O
respiratory	O
rate	O
and	O
reducing	O
tidal	O
volume	O
while	O
attempting	O
to	O
maintain	O
the	O
partial	O
pressure	O
of	O
carbon	O
dioxide	O
in	O
arterial	B-ANAT
blood	I-ANAT
(	O
PaCO2	O
)	O
constant	O
on	O
a	O
computational	O
simulator	O
configured	O
with	O
ARDS	O
patient	O
datasets	O
.	O

TITLE	O
:	O
Venovenous	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
for	O
Negative	O
Pressure	O
Pulmonary	B-ANAT
Hemorrhage	O
in	O
an	O
Elderly	O
Patient	O
.	O

Our	O
data	O
indicated	O
that	O
evaluation	O
of	O
both	O
PEDV	O
specific	O
IgA	O
and	O
IgG	B-ANAT
antibody	I-ANAT
levels	O
in	O
the	O
plasma	B-ANAT
and	O
oral	B-ANAT
fluid	O
(	O
but	O
not	O
feces	B-ANAT
)	O
samples	O
is	O
beneficial	O
in	O
disease	O
diagnosis	O
.	O

PEDV	O
specific	O
B	B-ANAT
cell	I-ANAT
response	O
in	O
the	O
intestine	B-ANAT
and	O
spleen	B-ANAT
of	O
infected	O
sows	O
decline	O
by	O
6	O
months	O
,	O
and	O
this	O
associates	O
with	O
specific	O
antibody	O
levels	O
in	O
the	O
plasma	B-ANAT
and	O
oral	B-ANAT
fluid	O
samples	O
;	O
but	O
the	O
virus	O
neutralization	O
titers	O
in	O
plasma	B-ANAT
remains	O
high	O
beyond	O
6	O
months	O
post	O
-	O
infection	O
.	O

In	O
patients	O
with	O
established	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
open	O
lung	B-ANAT
approach	O
improved	O
oxygenation	O
and	O
driving	O
pressure	O
,	O
without	O
detrimental	O
effects	O
on	O
mortality	O
,	O
ventilator	O
-	O
free	O
days	O
,	O
or	O
barotrauma	O
.	O

This	O
was	O
investigated	O
by	O
exposing	O
wild	O
â	O
type	O
(	O
WT	O
)	O
and	O
VDR	O
knockout	O
C57BL	O
/	O
6J	O
mice	O
to	O
LPS	O
,	O
then	O
comparing	O
the	O
healthy	O
and	O
LPS	O
â	O
treated	O
mice	O
lungs	B-ANAT
and	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
BALF	O
).	O

MERS	O
-	O
CoV	O
RNA	O
was	O
detected	O
in	O
14	O
(	O
11	O
%)	O
of	O
132	O
nasal	B-ANAT
swabs	O
and	O
antibody	O
in	O
126	O
(	O
96	O
%)	O
of	O
131	O
serum	B-ANAT
samples	O
.	O

We	O
found	O
that	O
MHV	O
infection	O
leads	O
to	O
the	O
downregulation	O
of	O
Cx43	O
in	O
vivo	O
in	O
the	O
CNS	B-ANAT
.	O

In	O
addition	O
,	O
results	O
show	O
that	O
MHV	O
infection	O
impairs	O
Cx43	O
expression	O
in	O
addition	O
to	O
gap	B-ANAT
junction	I-ANAT
communication	O
in	O
primary	O
astrocytes	B-ANAT
.	O

This	O
may	O
provide	O
a	O
basis	O
for	O
understanding	O
how	O
structural	O
alterations	O
of	O
astrocytic	B-ANAT
gap	B-ANAT
junctions	I-ANAT
can	O
disrupt	O
gap	B-ANAT
junction	I-ANAT
communication	O
between	O
other	O
CNS	B-ANAT
cells	B-ANAT
in	O
altered	O
CNS	B-ANAT
environments	O
due	O
to	O
infection	O
and	O
inflammation	O
.	O

Most	O
of	O
touchable	O
surfaces	O
in	O
MERS	O
units	O
were	O
contaminated	O
by	O
patients	O
and	O
health	O
care	O
workers	O
and	O
the	O
viable	O
virus	O
could	O
shed	O
through	O
respiratory	B-ANAT
secretion	I-ANAT
from	O
clinically	O
fully	O
recovered	O
patients	O
.	O

Excretion	O
of	O
PEDV	O
in	O
the	O
feces	B-ANAT
of	O
S	O
INDEL	O
strain	O
-	O
inoculated	O
pigs	O
occurred	O
later	O
than	O
in	O
NA	O
prototype	O
strain	O
-	O
inoculated	O
pigs	O
.	O

TITLE	O
:	O
Biodegradable	O
DNA	O
Nanoparticles	O
that	O
Provide	O
Widespread	O
Gene	O
Delivery	O
in	O
the	O
Brain	B-ANAT
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
infection	O
:	O
virus	O
-	O
host	B-ANAT
cell	I-ANAT
interactions	O
and	O
implications	O
on	O
pathogenesis	O
.	O

ABSTRACT	O
:	O
WU	O
polyomavirus	O
(	O
WUPyV	O
)	O
was	O
detected	O
in	O
a	O
bone	B-ANAT
marrow	I-ANAT
transplant	B-ANAT
recipient	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
who	O
died	O
in	O
2001	O
.	O

Recent	O
studies	O
suggest	O
that	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
proteins	O
from	O
coronaviruses	O
and	O
other	O
viruses	O
can	O
be	O
useful	O
antiviral	O
drug	O
targets	O
against	O
viral	O
infections	O
.	O

Viral	O
RNA	O
was	O
amplified	O
from	O
acute	O
-	O
phase	O
serum	B-ANAT
specimens	O
of	O
15	O
patients	O
,	O
and	O
full	O
spike	O
gene	O
-	O
coding	O
sequencing	O
was	O
obtained	O
from	O
10	O
patients	O
who	O
formed	O
a	O
discrete	O
cluster	O
;	O
sequences	O
from	O
specimens	O
of	O
9	O
patients	O
were	O
closely	O
related	O
.	O

The	O
HSCARG	O
protein	O
,	O
a	O
nicotinamide	O
adenine	O
dinucleotide	O
phosphate	O
(	O
NADPH	O
)	O
sensor	O
and	O
negative	O
regulator	O
of	O
NF	O
-	O
ÎºB	O
,	O
was	O
upregulated	O
in	O
G6PD	O
-	O
knockdown	O
cells	B-ANAT
with	O
decreased	O
NADPH	O
/	O
NADP	O
âº	O
ratio	O
.	O

Subjects	O
had	O
a	O
critical	O
ICU	O
course	O
and	O
required	O
neuromuscular	O
blockade	O
(	O
n	O
=	O
11	O
;	O
79	O
%),	O
required	O
rescue	O
therapy	O
for	O
respiratory	O
failure	O
(	O
n	O
=	O
8	O
;	O
57	O
%),	O
developed	O
shock	O
(	O
n	O
=	O
10	O
;	O
71	O
%),	O
and	O
required	O
renal	B-ANAT
replacement	O
therapy	O
(	O
n	O
=	O
8	O
;	O
57	O
%).	O

Serum	B-ANAT
/	O
plasma	B-ANAT
and	O
/	O
or	O
effusion	B-ANAT
samples	O
of	O
these	O
cats	O
were	O
examined	O
for	O
feline	O
coronavirus	O
(	O
FCoV	O
)	O
RNA	O
by	O
RT	O
-	O
nPCR	O
and	O
,	O
if	O
positive	O
,	O
PCR	O
products	O
were	O
sequenced	O
for	O
nucleotide	O
transitions	O
within	O
the	O
S	O
gene	O
.	O

Sensitivity	O
of	O
the	O
'	O
combined	O
RT	O
-	O
nPCR	O
and	O
sequencing	O
approach	O
'	O
was	O
6	O
.	O
5	O
%	O
(	O
95	O
%	O
CI	O
0	O
.	O
8	O
-	O
21	O
.	O
4	O
)	O
in	O
serum	B-ANAT
/	O
plasma	B-ANAT
and	O
65	O
.	O
3	O
%	O
(	O
95	O
%	O
CI	O
50	O
.	O
4	O
-	O
78	O
.	O
3	O
)	O
in	O
effusion	B-ANAT
.	O

Total	O
lung	B-ANAT
volume	O
,	O
residual	O
capacity	O
,	O
vital	O
capacity	O
,	O
forced	O
vital	O
capacity	O
(	O
FVC	O
),	O
FEV1	O
,	O
FEV1	O
/	O
FVC	O
and	O
lung	B-ANAT
carbon	O
monoxide	O
diffusion	O
(	O
DLCO	O
)	O
were	O
measured	O
,	O
and	O
compared	O
with	O
the	O
values	O
obtained	O
immediately	O
after	O
recovery	O
in	O
2003	O
.	O

The	O
pulmonary	B-ANAT
functions	O
of	O
SARS	O
patents	O
largely	O
returned	O
to	O
normal	O
after	O
10	O
years	O
of	O
convalescence	O
,	O
and	O
the	O
lung	B-ANAT
function	O
damage	O
was	O
characterized	O
by	O
diffusing	O
and	O
restrictive	O
ventilatory	O
dysfunctions	O
.	O

Upregulation	O
of	O
IL	O
-	O
17	O
resulted	O
in	O
increased	O
severity	O
of	O
ALI	O
as	O
evidenced	O
by	O
decreased	O
body	B-ANAT
weight	O
and	O
survival	O
rate	O
,	O
elevated	O
level	O
of	O
total	O
protein	O
and	O
albumin	O
in	O
BAL	O
fluid	O
,	O
as	O
well	O
as	O
more	O
apparent	O
histopathology	O
changes	O
of	O
lung	B-ANAT
.	O

Most	O
of	O
the	O
specimens	O
were	O
sputum	B-ANAT
(	O
73	O
.	O
5	O
%).	O

Laboratory	O
biosafety	O
preparedness	O
included	O
class	O
II	O
biosafety	O
cabinets	O
(	O
100	O
%);	O
separated	O
pre	O
-	O
PCR	O
,	O
PCR	O
,	O
and	O
post	O
-	O
PCR	O
rooms	O
(	O
88	O
.	O
6	O
%);	O
negative	O
pressure	O
pretreatment	O
rooms	O
(	O
48	O
.	O
6	O
%);	O
and	O
negative	O
pressure	O
sputum	B-ANAT
collection	O
rooms	O
(	O
20	O
.	O
0	O
%).	O

We	O
conducted	O
histologic	O
analysis	O
and	O
immunofluorescence	O
(	O
IF	O
)	O
staining	O
for	O
the	O
detection	O
of	O
PDCoV	O
antigens	O
,	O
and	O
TUNEL	O
assay	O
in	O
singly	O
or	O
serially	O
cut	O
tissue	B-ANAT
sections	O
from	O
the	O
small	O
and	O
large	O
intestines	B-ANAT
of	O
four	O
,	O
11	O
-	O
to	O
14	O
-	O
day	O
-	O
old	O
gnotobiotic	O
pigs	O
,	O
inoculated	O
orally	B-ANAT
with	O
8	O
.	O
8	O
-	O
11	O
.	O
0log10	O
genomic	O
equivalents	O
(	O
GE	O
)	O
of	O
US	O
PDCoV	O
strains	O
OH	O
-	O
FD22	O
or	O
OH	O
-	O
FD100	O
(	O
n	O
=	O
3	O
),	O
or	O
mock	O
(	O
n	O
=	O
1	O
).	O

In	O
contrast	O
,	O
by	O
double	O
IF	O
and	O
TUNEL	O
staining	O
,	O
most	O
of	O
the	O
TUNEL	O
-	O
positive	O
signals	O
(	O
apoptotic	O
nuclear	O
fragmentation	O
)	O
were	O
found	O
in	O
PDCoV	O
antigen	O
-	O
positive	O
LLC	B-ANAT
-	O
PK	O
and	O
ST	O
cells	B-ANAT
that	O
also	O
showed	O
cytopathic	O
effects	O
,	O
such	O
as	O
cell	B-ANAT
rounding	O
,	O
detachment	O
and	O
clumping	O
in	O
clusters	O
.	O

Secondary	O
annexin	O
V	O
/	O
propidium	O
iodide	O
(	O
PI	O
)	O
staining	O
revealed	O
increased	O
numbers	O
of	O
annexin	O
V	O
-	O
or	O
PI	O
-	O
positive	O
LLC	B-ANAT
-	O
PK	O
and	O
ST	O
cells	B-ANAT
at	O
21h	O
after	O
inoculation	O
,	O
compared	O
to	O
the	O
negative	O
controls	O
.	O

The	O
BCoV	O
N	O
gene	O
was	O
identified	O
in	O
42	O
.	O
9	O
%	O
(	O
6	O
/	O
14	O
)	O
of	O
the	O
diarrheic	O
fecal	B-ANAT
samples	O
evaluated	O
by	O
semi	O
-	O
nested	O
polymerase	O
chain	O
reaction	O
(	O
SN	O
-	O
PCR	O
)	O
technique	O
.	O

To	O
the	O
best	O
knowledge	O
of	O
the	O
authors	O
,	O
this	O
is	O
the	O
first	O
description	O
of	O
the	O
BCoV	O
diagnosis	O
in	O
fecal	B-ANAT
samples	O
collected	O
in	O
a	O
diarrhea	O
outbreak	O
in	O
adult	O
beef	O
cattle	O
grazing	O
in	O
the	O
grass	O
in	O
a	O
tropical	O
country	O
.	O

ABSTRACT	O
:	O
Some	O
cases	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
-	O
Coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
presented	O
renal	B-ANAT
function	O
impairment	O
after	O
the	O
first	O
MERS	O
-	O
CoV	O
patient	O
died	O
of	O
progressive	O
respiratory	O
and	O
renal	B-ANAT
failure	O
.	O

We	O
conducted	O
a	O
retrospective	O
analysis	O
of	O
the	O
serum	B-ANAT
creatinine	O
(	O
SCr	O
),	O
estimated	O
glomerular	B-ANAT
filtration	O
rate	O
(	O
eGFR	O
),	O
urine	B-ANAT
dipstick	O
tests	O
,	O
urinary	O
protein	O
quantitation	O
(	O
ACR	O
or	O
PCR	O
),	O
and	O
other	O
clinical	O
parameters	O
in	O
all	O
patients	O
.	O

Eight	O
(	O
26	O
.	O
7	O
%)	O
patients	O
showed	O
acute	O
kidney	B-ANAT
injury	O
(	O
AKI	O
),	O
and	O
the	O
mean	O
and	O
median	O
durations	O
to	O
the	O
occurrence	O
of	O
AKI	O
from	O
symptom	O
onset	O
were	O
18	O
and	O
16	O
days	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
both	O
the	O
gray	B-ANAT
matter	I-ANAT
(	O
GM	O
)	O
and	O
whiter	O
matter	O
(	O
WM	O
)	O
alterations	O
in	O
a	O
homogeneous	O
cohort	O
of	O
early	O
HIV	O
-	O
infected	O
patients	O
by	O
combining	O
voxel	O
-	O
based	O
morphometry	O
(	O
VBM	O
)	O
and	O
tract	O
-	O
based	O
spatial	O
statistics	O
(	O
TBSS	O
).	O

Areas	O
of	O
increased	O
MD	O
,	O
RD	O
,	O
and	O
AD	O
in	O
HIV	O
patients	O
were	O
more	O
extensive	O
and	O
observed	O
in	O
most	O
skeleton	B-ANAT
locations	O
(	O
P	O
<	O
0	O
.	O
05	O
,	O
FEW	O
-	O
corrected	O
).	O

Our	O
results	O
indicate	O
that	O
structural	O
brain	B-ANAT
alterations	O
occurred	O
early	O
in	O
HIV	O
-	O
infected	O
patients	O
.	O

The	O
current	O
study	O
may	O
shed	O
further	O
light	O
on	O
the	O
potential	O
brain	B-ANAT
effects	O
of	O
HIV	O
.	O

Our	O
goal	O
was	O
to	O
elucidate	O
the	O
prevalence	O
of	O
AHR	O
,	O
as	O
measured	O
by	O
a	O
methacholine	O
challenge	O
test	O
(	O
MCT	O
),	O
in	O
children	O
with	O
SCD	O
who	O
did	O
not	O
have	O
concomitant	O
asthma	O
or	O
any	O
recent	O
history	O
of	O
acute	O
chest	B-ANAT
syndrome	O
(	O
ACS	O
).	O

Cell	B-ANAT
entry	O
and	O
susceptibility	O
studies	O
indicated	O
that	O
this	O
virus	O
can	O
use	O
ACE2	O
as	O
a	O
receptor	O
and	O
infect	O
animal	O
and	O
human	O
cell	B-ANAT
lines	I-ANAT
.	O

In	O
this	O
study	O
,	O
11	O
neonatal	O
(	O
mean	O
age	O
9	O
days	O
)	O
calf	B-ANAT
BCoV	O
strains	O
from	O
the	O
south	O
of	O
Ireland	O
were	O
collected	O
over	O
a	O
one	O
year	O
period	O
and	O
characterized	O
using	O
molecular	O
methods	O
.	O

Finally	O
,	O
we	O
demonstrate	O
in	O
hock	B-ANAT
immunization	O
studies	O
in	O
mice	O
that	O
GM3	O
-	O
decorated	O
membrane	B-ANAT
-	O
wrapped	O
nanoparticles	O
achieve	O
a	O
selective	O
enrichment	O
in	O
the	O
peripheral	O
regions	O
of	O
popliteal	B-ANAT
lymph	I-ANAT
nodes	I-ANAT
that	O
contain	O
high	O
concentrations	O
of	O
CD169	O
-	O
expressing	O
antigen	B-ANAT
-	I-ANAT
presenting	I-ANAT
cells	I-ANAT
.	O

His	O
course	O
was	O
complicated	O
at	O
our	O
hospital	O
by	O
subarachnoid	O
hemorrhage	O
,	O
right	O
ventricular	B-ANAT
failure	O
,	O
multiple	O
pneumothoraces	O
,	O
and	O
significant	O
deconditioning	O
.	O

One	O
patient	O
required	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
to	O
treat	O
refractory	O
hypoxemia	O
,	O
and	O
one	O
patient	O
died	O
of	O
shock	O
with	O
multiorgan	O
failure	O
.	O

TITLE	O
:	O
Time	O
-	O
and	O
dose	O
-	O
dependent	O
severity	O
of	O
lung	B-ANAT
injury	O
in	O
a	O
rat	O
model	O
of	O
sepsis	O
.	O

There	O
was	O
no	O
increase	O
in	O
mortality	O
after	O
hospital	O
discharge	B-ANAT
.	O

TITLE	O
:	O
Incidence	O
,	O
risk	O
factors	O
and	O
outcome	O
of	O
acute	O
kidney	B-ANAT
injury	O
in	O
critically	O
ill	O
children	O
-	O
a	O
developing	O
country	O
perspective	O
.	O

This	O
study	O
was	O
based	O
on	O
in	O
vitro	O
microfluidic	O
assays	O
using	O
patient	O
sera	B-ANAT
.	O

Cellular	B-ANAT
adhesiveness	O
to	O
human	O
umbilical	B-ANAT
vein	I-ANAT
endothelial	B-ANAT
cells	I-ANAT
was	O
examined	O
using	O
the	O
laminar	O
flow	O
chamber	B-ANAT
method	O
.	O

Strong	O
stiffening	O
was	O
induced	O
by	O
IL	O
-	O
1Î²	O
,	O
IL	O
-	O
8	O
,	O
and	O
TNF	O
-	O
Î±	O
but	O
not	O
by	O
IL	O
-	O
10	O
,	O
and	O
incubations	O
with	O
sera	B-ANAT
and	O
blocking	O
antibodies	O
against	O
IL	O
-	O
1Î²	O
,	O
IL	O
-	O
8	O
,	O
or	O
TNF	O
-	O
Î±	O
significantly	O
diminished	O
the	O
stiffening	O
effect	O
of	O
serum	B-ANAT
.	O

TITLE	O
:	O
[	O
Detection	O
and	O
clinical	O
analysis	O
of	O
acute	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
with	O
human	O
coronaviruses	O
in	O
children	O
in	O
Beijing	O
area	O
2007	O
-	O
2015	O
].	O

(	O
6	O
)	O
There	O
were	O
no	O
significant	O
differences	O
in	O
the	O
incidence	O
of	O
clinical	O
manifestations	O
(	O
including	O
cough	O
,	O
gasping	O
,	O
dyspnea	O
,	O
fever	O
and	O
abnormality	O
on	O
chest	B-ANAT
X	O
-	O
ray	O
),	O
complications	O
(	O
including	O
respiratory	O
failure	O
,	O
myocardial	O
damage	O
,	O
and	O
acute	O
bronchial	B-ANAT
asthma	O
attack	O
)	O
and	O
mechanical	O
ventilation	O
between	O
hospitalized	O
ALRTI	O
patients	O
with	O
single	O
HCoV	O
infection	O
and	O
193	O
patients	O
with	O
single	O
RSV	O
infection	O
in	O
the	O
same	O
period	O
.	O

Mice	O
in	O
which	O
expression	O
of	O
CXCL1	O
is	O
under	O
the	O
control	O
of	O
a	O
tetracycline	O
-	O
inducible	O
promoter	O
active	O
within	O
glial	B-ANAT
fibrillary	I-ANAT
acidic	I-ANAT
protein	I-ANAT
-	O
positive	O
cells	B-ANAT
were	O
generated	O
and	O
this	O
allowed	O
for	O
selectively	O
increasing	O
CNS	B-ANAT
expression	O
of	O
CXCL1	O
in	O
response	O
to	O
JHMV	O
infection	O
and	O
evaluating	O
the	O
effects	O
on	O
neuroinflammation	O
,	O
control	O
of	O
viral	O
replication	O
,	O
and	O
demyelination	O
.	O

Elevated	O
levels	O
of	O
CXCL1	O
did	O
not	O
influence	O
the	O
generation	O
of	O
virus	O
-	O
specific	O
T	B-ANAT
cells	I-ANAT
,	O
and	O
there	O
was	O
no	O
difference	O
in	O
control	O
of	O
JHMV	O
replication	O
compared	O
with	O
control	O
mice	O
,	O
indicating	O
that	O
T	B-ANAT
cell	I-ANAT
infiltration	O
into	O
the	O
CNS	B-ANAT
is	O
CXCL1	O
-	O
independent	O
.	O

In	O
conclusion	O
,	O
in	O
patients	O
with	O
ACSs	O
,	O
earlier	O
administration	O
of	O
oral	B-ANAT
Î²	O
â	O
blocker	O
therapy	O
should	O
be	O
a	O
priority	O
with	O
a	O
greater	O
probability	O
of	O
improving	O
LV	O
function	O
and	O
in	O
-	O
hospital	O
survival	O
rate	O
.	O

We	O
included	O
subjects	O
with	O
respiratory	O
failure	O
,	O
admitted	O
to	O
a	O
respiratory	O
intermediate	O
care	O
unit	O
,	O
who	O
required	O
arterial	B-ANAT
blood	I-ANAT
gas	O
analysis	O
.	O

TITLE	O
:	O
A	O
molecular	O
arms	B-ANAT
race	O
between	O
host	O
innate	O
antiviral	O
response	O
and	O
emerging	O
human	O
coronaviruses	O
.	O

We	O
evaluated	O
the	O
effect	O
of	O
treatment	O
with	O
VIS410	O
,	O
a	O
human	O
monoclonal	O
antibody	O
targeting	O
the	O
HA	O
stem	B-ANAT
region	O
,	O
on	O
the	O
development	O
of	O
ARDS	O
in	O
BALB	O
/	O
c	O
mice	O
after	O
infection	O
with	O
influenza	O
A	O
(	O
H7N9	O
)	O
viruses	O
.	O

In	O
this	O
context	O
,	O
this	O
present	O
review	O
summarizes	O
a	O
large	O
body	B-ANAT
of	O
evidence	O
implicating	O
miRNAs	O
and	O
their	O
target	O
molecules	O
in	O
ALI	O
/	O
ARDS	O
originating	O
largely	O
from	O
studies	O
using	O
animal	O
and	O
cell	B-ANAT
culture	O
model	O
systems	O
of	O
ALI	O
/	O
ARDS	O
.	O

Material	O
/	O
Methods	O
:	O
The	O
prospective	O
study	O
included	O
92	O
patients	O
were	O
performed	O
with	O
severe	O
burns	O
on	O
35	O
-	O
67	O
%	O
body	B-ANAT
surface	O
large	O
area	O
,	O
aiming	O
to	O
establish	O
a	O
cut	O
-	O
off	O
score	O
for	O
each	O
studied	O
and	O
statistically	O
significant	O
prognostic	O
parameter	O
for	O
assessing	O
the	O
risk	O
of	O
mortality	O
.	O

ABSTRACT	O
:	O
Elevated	O
CXCL13	O
within	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
correlates	O
with	O
humoral	O
responses	O
in	O
several	O
neuroinflammatory	O
diseases	O
,	O
yet	O
its	O
role	O
is	O
controversial	O
.	O

The	O
diagnostic	O
criteria	O
of	O
organ	B-ANAT
failure	O
are	O
different	O
between	O
the	O
new	O
and	O
old	O
Atlanta	O
classification	O
.	O

ABSTRACT	O
:	O
The	O
DNA	O
polymerase	O
and	O
ribonuclease	O
H	O
(	O
RNase	O
H	O
)	O
activities	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV	O
-	O
1	O
)	O
are	O
needed	O
for	O
the	O
replication	O
of	O
the	O
viral	B-ANAT
genome	I-ANAT
and	O
are	O
validated	O
drug	O
targets	O
.	O

Substitutions	O
were	O
also	O
detected	O
in	O
the	O
2C10	O
epitope	O
region	O
(	O
GPRLQPY	O
to	O
GPRFQPY	O
)	O
in	O
the	O
cytoplasmic	B-ANAT
domain	I-ANAT
.	O

The	O
latter	O
was	O
assessed	O
for	O
at	O
least	O
12	O
hours	O
6	O
different	O
ultrasonography	O
windows	O
were	O
performed	O
on	O
each	O
hemithorax	B-ANAT
before	O
prone	O
(	O
H0	O
,	O
H2	O
,	O
H12	O
before	O
return	O
to	O
supine	O
and	O
at	O
H14	B-ANAT
(	O
2	O
hours	O
after	O
return	O
to	O
supine	O
).	O

Patients	O
at	O
the	O
severe	O
end	O
of	O
this	O
spectrum	O
may	O
present	O
with	O
hypoxemic	O
respiratory	O
failure	O
and	O
pulmonary	B-ANAT
infiltrates	O
,	O
meeting	O
criteria	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Compared	O
with	O
baseline	O
,	O
lung	B-ANAT
compliance	O
(	O
CL	O
)	O
(	O
48	O
.	O
1	O
Â±	O
10	O
.	O
3	O
)	O
cmH2O	O
vs	O
(	O
25	O
.	O
7	O
Â±	O
6	O
.	O
4	O
)	O
cmH2O	O
and	O
oxygenation	O
index	O
(	O
PaO2	O
/	O
FiO2	O
)	O
(	O
235	O
Â±	O
48	O
)	O
mmHg	O
vs	O
(	O
160	O
Â±	O
35	O
)	O
mmHg	O
improved	O
obviously	O
(	O
P	O
<	O
0	O
.	O
05	O
),	O
dead	O
space	O
fraction	O
(	O
VD	O
/	O
VT	O
)	O
(	O
0	O
.	O
48	O
Â±	O
0	O
.	O
07	O
)	O
vs	O
(	O
0	O
.	O
59	O
Â±	O
0	O
.	O
06	O
)	O
decreased	O
(	O
P	O
<	O
0	O
.	O
05	O
),	O
but	O
Ccw	O
and	O
respiratory	O
compliance	O
(	O
Cr	O
)	O
didn	O
'	O
t	O
improve	O
(	O
P	O
>	O
0	O
.	O
05	O
).	O

All	O
cases	O
had	O
chest	B-ANAT
CT	O
performed	O
within	O
24	O
h	O
of	O
admission	O
with	O
reported	O
findings	O
consistent	O
with	O
pulmonary	B-ANAT
contusions	O
.	O

TITLE	O
:	O
PECULIARITIES	O
OF	O
THE	O
COURSE	O
OF	O
THE	O
UPPER	O
ALIMENTARY	B-ANAT
TRACT	I-ANAT
DISEASES	O
IN	O
CHILDREN	O
WITH	O
BRONCHOOBSTRUCTIVE	O
SYNDROME	O
.	O

Diseases	O
of	O
the	O
respiratory	O
organs	B-ANAT
with	O
BOS	O
in	O
the	O
groups	O
of	O
the	O
patients	O
under	O
investigation	O
in	O
43	O
.	O
9	O
%	O
of	O
cases	O
on	O
an	O
average	O
associated	O
with	O
GERD	O
.	O

In	O
a	O
severe	O
course	O
of	O
bronchial	B-ANAT
asthma	O
GERD	O
was	O
detected	O
3	O
,	O
4	O
times	O
more	O
frequently	O
in	O
the	O
boys	O
,	O
while	O
in	O
a	O
lengthy	O
course	O
of	O
pneumonia	O
with	O
BOS	O
--	O
1	O
,	O
9	O
times	O
more	O
frequently	O
in	O
the	O
girls	O
.	O

The	O
designed	O
individual	O
anti	O
-	O
reflux	O
programs	O
in	O
complex	O
therapy	O
of	O
respiratory	O
organs	B-ANAT
'	O
diseases	O
with	O
BOS	O
associated	O
with	O
GERD	O
reduce	O
the	O
frequency	O
of	O
exacerbations	O
and	O
hospitalizations	O
of	O
patients	O
with	O
BA	O
,	O
improve	O
their	O
life	O
quality	O
.	O

Functional	O
analysis	O
was	O
performed	O
using	O
Gene	O
Ontology	O
(	O
GO	O
)	O
Immune	B-ANAT
System	I-ANAT
Process	O
terms	O
specific	O
for	O
Gallus	O
gallus	O
.	O

Healthy	O
birds	O
from	O
the	O
two	O
lines	O
showed	O
significant	O
differences	O
in	O
expression	O
profiles	O
for	O
subsets	O
of	O
adaptive	O
and	O
innate	O
immunity	O
-	O
related	O
genes	O
,	O
whereas	O
comparison	O
of	O
the	O
IBV	O
-	O
infected	O
birds	O
from	O
the	O
two	O
lines	O
showed	O
differences	O
in	O
expression	O
of	O
immunity	O
-	O
related	O
genes	O
involved	O
in	O
T	B-ANAT
cell	I-ANAT
activation	O
and	O
proliferation	O
.	O

When	O
comparing	O
IBV	O
-	O
infected	O
birds	O
between	O
the	O
two	O
lines	O
,	O
the	O
most	O
enriched	O
GO	O
terms	O
were	O
""""	O
Alpha	O
-	O
beta	O
T	B-ANAT
cell	I-ANAT
activation	O
""""	O
and	O
""""	O
Positive	O
regulation	O
of	O
leukocyte	B-ANAT
activation	O
""""	O
at	O
weeks	O
1	O
and	O
3	O
,	O
respectively	O
.	O

In	O
the	O
ICU	O
,	O
patients	O
with	O
sepsis	O
,	O
ARDS	O
,	O
community	O
-	O
acquired	O
pneumonia	O
,	O
exacerbation	O
of	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
,	O
severe	O
asthma	O
,	O
or	O
trauma	O
may	O
receive	O
corticosteroids	O
.	O

A	O
comprehensive	O
literature	O
search	O
was	O
obtained	O
from	O
MEDLINE	O
via	O
PubMed	O
.	O
gov	O
and	O
from	O
ScienceDirect	O
.	O
com	O
using	O
the	O
following	O
search	O
queries	O
:	O
ECLS	O
and	O
pregnancy	O
,	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
and	O
pregnancy	O
,	O
ECMO	O
and	O
H1N1	O
influenza	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
pregnancy	O
,	O
pregnancy	O
and	O
H1N1	O
influenza	O
,	O
and	O
Extracorporeal	O
Life	O
Support	O
Organization	O
registry	O
.	O

Indications	O
for	O
ECLS	O
were	O
severe	O
H1N1	O
influenza	O
with	O
ARDS	O
(	O
n	O
=	O
33	O
),	O
other	O
ARDS	O
(	O
n	O
=	O
8	O
),	O
cardiogenic	O
shock	O
(	O
n	O
=	O
3	O
),	O
and	O
cardiac	B-ANAT
arrest	O
(	O
n	O
=	O
1	O
).	O

When	O
treated	O
with	O
dihydro	O
-	O
resveratrol	O
,	O
pulmonary	B-ANAT
architectural	O
distortion	O
,	O
hemorrhage	O
,	O
interstitial	B-ANAT
edema	O
,	O
and	O
alveolar	B-ANAT
thickening	O
were	O
significantly	O
reduced	O
in	O
rats	O
with	O
acute	O
pancreatitis	O
.	O

In	O
addition	O
,	O
the	O
production	O
of	O
pro	O
-	O
inflammatory	O
cytokines	O
and	O
the	O
activity	O
of	O
myeloperoxidase	O
in	O
pulmonary	B-ANAT
tissues	B-ANAT
were	O
notably	O
repressed	O
.	O

ABSTRACT	O
:	O
Attenuated	O
Salmonella	O
typhimurium	O
(	O
S	O
.	O
typhimurium	O
)	O
was	O
selected	O
as	O
a	O
transgenic	O
vehicle	O
for	O
the	O
development	O
of	O
live	O
mucosal	B-ANAT
vaccines	O
against	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)	O
based	O
on	O
the	O
M	O
gene	O
.	O

The	O
bacterium	O
was	O
safe	O
to	O
mice	O
at	O
a	O
dosage	O
of	O
2	O
Ã	O
10	O
(	O
9	O
)	O
CFU	O
,	O
almost	O
eliminated	O
from	O
the	O
spleen	B-ANAT
and	O
liver	B-ANAT
at	O
week	O
4	O
post	O
-	O
immunization	O
and	O
eventually	O
cleared	O
at	O
week	O
6	O
.	O

Cytopathic	O
effects	O
showing	O
detachment	O
and	O
rounding	O
of	O
cells	B-ANAT
were	O
observed	O
in	O
Vero	B-ANAT
cell	I-ANAT
cultures	O
3	O
days	O
after	O
inoculation	O
of	O
the	O
sample	O
.	O

ABSTRACT	O
:	O
In	O
patients	O
who	O
developed	O
a	O
combined	O
situation	O
of	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
with	O
refractory	O
hypoxemia	O
and	O
acute	O
cardiac	B-ANAT
failure	O
with	O
circulatory	O
collapse	O
,	O
traditional	O
veno	O
-	O
venous	B-ANAT
or	O
veno	O
-	O
arterial	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
approach	O
alone	O
may	O
not	O
be	O
sufficient	O
enough	O
to	O
maintain	O
both	O
an	O
acceptable	O
range	O
of	O
gas	O
exchange	O
and	O
a	O
hemodynamic	O
stability	O
.	O

The	O
distribution	O
of	O
reinfusion	O
flow	O
was	O
adjusted	O
depending	O
on	O
the	O
patient	O
'	O
s	O
cardiopulmonary	B-ANAT
status	O
.	O

Although	O
there	O
is	O
no	O
consensus	O
about	O
the	O
veno	O
-	O
veno	O
-	O
arterial	B-ANAT
mode	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
this	O
combined	O
mode	O
can	O
be	O
helpful	O
in	O
patients	O
with	O
acute	O
refractory	O
respiratory	O
and	O
cardiac	B-ANAT
failure	O
,	O
as	O
shown	O
in	O
the	O
present	O
case	O
.	O

The	O
""""	O
SmartECLA	O
""""	O
system	O
was	O
tested	O
in	O
six	O
animal	O
experiments	O
with	O
increasing	O
pulmonary	B-ANAT
hypoventilation	O
and	O
hypoxic	O
inspiratory	O
gas	O
mixture	O
to	O
simulate	O
progressive	O
acute	O
respiratory	O
failure	O
.	O

Plasma	B-ANAT
alpha1	O
-	O
glycoprotein	O
and	O
vascular	B-ANAT
endothelial	B-ANAT
growth	O
factor	O
levels	O
were	O
improved	O
by	O
the	O
administration	O
of	O
mAb	O
2	O
-	O
4	O
,	O
and	O
the	O
peripheral	O
lymphocyte	B-ANAT
count	O
also	O
recovered	O
.	O

The	O
mice	O
fed	O
with	O
the	O
EA	O
fraction	O
up	O
to	O
2000	O
mg	O
/	O
kg	O
did	O
not	O
induce	O
any	O
signs	O
of	O
acute	O
toxicity	O
,	O
with	O
normal	O
histological	O
features	O
of	O
major	O
organs	B-ANAT
.	O

TITLE	O
:	O
Coronaviruses	O
and	O
the	O
human	O
airway	B-ANAT
:	O
a	O
universal	O
system	O
for	O
virus	O
-	O
host	O
interaction	O
studies	O
.	O

ABSTRACT	O
:	O
Human	O
coronaviruses	O
(	O
HCoVs	O
)	O
are	O
large	O
RNA	O
viruses	O
that	O
infect	O
the	O
human	O
respiratory	B-ANAT
tract	I-ANAT
.	O

Currently	O
,	O
different	O
cell	B-ANAT
culture	O
systems	O
are	O
available	O
to	O
recapitulate	O
the	O
human	O
airways	O
,	O
including	O
the	O
Air	O
-	O
Liquid	O
Interface	O
(	O
ALI	O
)	O
human	O
airway	B-ANAT
epithelium	B-ANAT
(	O
HAE	O
)	O
model	O
.	O

These	O
morphological	O
airway	B-ANAT
cultures	O
are	O
also	O
well	O
suited	O
for	O
the	O
identification	O
of	O
antivirals	O
,	O
evaluation	O
of	O
compound	O
toxicity	O
and	O
viral	O
inhibition	O
.	O

Despite	O
immediate	O
initiation	O
of	O
treatment	O
and	O
elimination	O
of	O
virus	O
in	O
subsequent	O
tests	O
,	O
the	O
progressive	O
lung	B-ANAT
failure	O
led	O
to	O
death	O
7	O
d	O
after	O
onset	O
of	O
fever	O
with	O
massive	O
lung	B-ANAT
bleeding	O
as	O
a	O
consequence	O
of	O
diffuse	O
alveolar	B-ANAT
hemorrhage	O
.	O

Entry	O
of	O
coronaviruses	O
into	O
cells	B-ANAT
is	O
mediated	O
by	O
the	O
transmembrane	B-ANAT
spike	O
glycoprotein	O
S	O
,	O
which	O
forms	O
a	O
trimer	O
carrying	O
receptor	O
-	O
binding	O
and	O
membrane	B-ANAT
fusion	O
functions	O
.	O

Continuing	O
nosological	O
confusion	O
on	O
M	O
.	O
pneumoniae	O
-	O
induced	O
mucositis	O
(	O
without	O
skin	B-ANAT
lesions	O
),	O
which	O
may	O
be	O
called	O
M	O
.	O
pneumoniae	O
-	O
associated	O
mucositis	O
or	O
M	O
.	O
pneumoniae	O
-	O
induced	O
rash	O
and	O
mucositis	O
separately	O
from	O
Stevens	O
-	O
Johnson	O
syndrome	O
,	O
is	O
argued	O
in	O
the	O
dermatological	O
manifestations	O
.	O

Blocking	O
the	O
secretion	B-ANAT
of	O
M	O
protein	O
by	O
brefeldin	O
A	O
(	O
BFA	O
)	O
failed	O
to	O
reverse	O
the	O
M	O
-	O
mediated	O
IFN	O
-	O
Î²	O
induction	O
.	O

Overall	O
,	O
our	O
study	O
indicates	O
for	O
the	O
first	O
time	O
that	O
a	O
pathogen	O
-	O
derived	O
protein	O
is	O
able	O
to	O
function	O
as	O
a	O
cytosolic	B-ANAT
PAMP	O
to	O
stimulate	O
type	O
I	O
interferon	O
production	O
by	O
activating	O
a	O
noncanonical	O
TLR	O
signaling	O
cascade	O
in	O
a	O
TRAF3	O
-	O
independent	O
manner	O
.	O

This	O
lineage	O
C	O
betacoronavirus	O
has	O
been	O
reported	O
to	O
cause	O
a	O
wide	O
range	O
of	O
disease	O
severity	O
in	O
humans	O
,	O
ranging	O
from	O
asymptomatic	O
to	O
progressive	O
fatal	O
pneumonia	O
that	O
may	O
be	O
accompanied	O
by	O
renal	B-ANAT
or	O
multiorgan	O
failure	O
.	O

Flow	O
cytometric	O
results	O
show	O
that	O
CD8	O
(+)	O
T	B-ANAT
lymphocytes	I-ANAT
reproduce	O
stimulated	O
by	O
the	O
Sp6	B-ANAT
and	O
the	O
nonrelated	O
peptide	O
proliferate	O
by	O
34	O
.	O
8	O
%	O
and	O
2	O
.	O
6	O
%,	O
respectively	O
.	O

Severe	O
falciparum	O
malaria	O
,	O
or	O
infections	O
complicated	O
by	O
a	O
relatively	O
high	O
parasite	O
count	O
(	O
more	O
than	O
2	O
%	O
of	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
parasitized	O
)	O
should	O
be	O
treated	O
with	O
intravenous	O
therapy	O
until	O
the	O
patient	O
is	O
well	O
enough	O
to	O
continue	O
with	O
oral	B-ANAT
treatment	O
.	O

CONCLUSIONS	O
:	O
In	O
the	O
era	O
of	O
balanced	O
hemostatic	O
resuscitation	O
practices	O
,	O
severity	O
of	O
head	B-ANAT
injury	O
,	O
male	O
sex	O
,	O
early	O
crystalloids	O
,	O
and	O
early	O
transfusion	O
of	O
platelets	B-ANAT
are	O
associated	O
with	O
a	O
higher	O
risk	O
of	O
ARDS	O
after	O
severe	O
isolated	O
TBI	O
.	O

ABSTRACT	O
:	O
Ligands	O
of	O
the	O
endothelial	B-ANAT
-	O
enriched	O
tunica	B-ANAT
interna	O
endothelial	B-ANAT
cell	I-ANAT
kinase	O
2	O
(	O
Tie2	O
)	O
are	O
markedly	O
imbalanced	O
in	O
severe	O
infections	O
associated	O
with	O
vascular	B-ANAT
leakage	O
,	O
yet	O
regulation	O
of	O
the	O
receptor	O
itself	O
has	O
been	O
understudied	O
in	O
this	O
context	O
.	O

At	O
least	O
one	O
respiratory	B-ANAT
tract	I-ANAT
pathogen	O
was	O
detected	O
by	O
polymerase	O
chain	O
reaction	O
in	O
78	O
.	O
6	O
%	O
(	O
n	O
=	O
140	O
)	O
of	O
the	O
patients	O
:	O
influenza	O
A	O
33	O
.	O
5	O
%,	O
influenza	O
B	O
16	O
.	O
4	O
%,	O
respiratory	O
syncytial	O
virus	O
9	O
.	O
2	O
%,	O
adenovirus	O
7	O
.	O
8	O
%,	O
rhinovirus	O
7	O
.	O
1	O
%,	O
coronavirus	O
7	O
.	O
1	O
%,	O
human	O
metapneumovirus	O
5	O
.	O
7	O
%,	O
human	O
bocavirus	O
5	O
.	O
7	O
%,	O
parainfluenza	O
virus	O
3	O
.	O
5	O
%,	O
coinfection	O
2	O
.	O
8	O
%.	O

TITLE	O
:	O
Melatonin	O
alleviates	O
acute	O
lung	B-ANAT
injury	O
through	O
inhibiting	O
the	O
NLRP3	O
inflammasome	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	O
membrane	B-ANAT
(	O
M	O
)	O
protein	O
is	O
the	O
central	O
actor	O
in	O
virion	B-ANAT
morphogenesis	O
.	O

Moreover	O
,	O
virions	B-ANAT
of	O
the	O
M	O
chimera	O
were	O
markedly	O
deficient	O
in	O
spike	O
(	O
S	O
)	O
protein	O
incorporation	O
.	O

The	O
assembly	O
of	O
coronavirus	O
virions	B-ANAT
entails	O
concerted	O
interactions	O
among	O
the	O
viral	O
structural	O
proteins	O
and	O
the	O
RNA	O
genome	O
.	O

The	O
results	O
clarify	O
our	O
understanding	O
of	O
the	O
interaction	O
between	O
the	O
coronavirus	O
M	O
protein	O
and	O
the	O
nucleocapsid	B-ANAT
protein	O
.	O

ABSTRACT	O
:	O
Type	O
II	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
have	O
potential	O
for	O
lung	B-ANAT
growth	O
and	O
reparation	O
.	O

Type	O
II	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
from	O
neonatal	O
male	O
piglet	O
lungs	B-ANAT
were	O
isolated	O
,	O
purified	O
,	O
cultured	O
,	O
and	O
labeled	O
with	O
chemical	O
stain	O
PKH26	O
.	O

TITLE	O
:	O
[	O
Pulmonary	B-ANAT
complications	O
of	O
malaria	O
:	O
An	O
update	O
].	O

Therefore	O
,	O
it	O
was	O
the	O
aim	O
of	O
this	O
study	O
to	O
evaluate	O
the	O
diagnostic	O
potential	O
of	O
an	O
immunocytochemical	O
(	O
ICC	O
)	O
assay	O
using	O
body	B-ANAT
cavity	I-ANAT
effusion	B-ANAT
.	O

These	O
data	O
indicate	O
that	O
the	O
Le	O
(	O
x	O
)	O
structure	O
could	O
play	O
a	O
role	O
in	O
syncytial	B-ANAT
formation	I-ANAT
and	O
cell	B-ANAT
-	O
to	O
-	O
cell	B-ANAT
infection	O
during	O
the	O
late	O
phase	O
of	O
infection	O
.	O

The	O
availability	O
of	O
recombinant	O
N	O
and	O
M	O
proteins	O
from	O
plants	O
opens	O
the	O
way	O
to	O
further	O
evaluation	O
of	O
their	O
potential	O
utility	O
for	O
the	O
development	O
of	O
diagnostic	O
and	O
protection	O
/	O
therapy	O
tools	O
to	O
be	O
quickly	O
manufactured	O
,	O
at	O
low	O
cost	O
and	O
with	O
minimal	O
risk	O
,	O
to	O
face	B-ANAT
potential	O
new	O
highly	O
infectious	O
SARS	O
-	O
CoV	O
outbreaks	O
.	O

Furthermore	O
,	O
the	O
cell	B-ANAT
tropisms	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
and	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)	O
have	O
been	O
characterized	O
by	O
live	O
and	O
pseudotyped	O
viruses	O
.	O

In	O
this	O
experimental	O
extrapulmonary	O
mild	O
ALI	O
model	O
,	O
prone	O
position	O
ventilation	O
for	O
1	O
h	O
,	O
when	O
compared	O
with	O
supine	O
position	O
ventilation	O
,	O
was	O
associated	O
with	O
lower	O
lung	B-ANAT
inflammation	O
and	O
injury	O
.	O

One	O
patient	O
died	O
of	O
heart	B-ANAT
failure	O
during	O
the	O
treatment	O
,	O
the	O
other	O
6	O
patients	O
were	O
alive	O
and	O
the	O
pulmonary	B-ANAT
function	O
parameters	O
including	O
FEV1	O
,	O
FEV1	O
/	O
FVC	O
,	O
PaO2	O
and	O
AaDO2	O
were	O
significantly	O
improved	O
after	O
6	O
months	O
as	O
compared	O
with	O
the	O
baseline	O
parameters	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

After	O
this	O
new	O
definition	O
of	O
ARDS	O
,	O
each	O
treatment	O
to	O
the	O
patients	O
with	O
ARDS	O
should	O
be	O
considered	O
,	O
depending	O
on	O
the	O
severity	O
of	O
lung	B-ANAT
injury	O
,	O
such	O
as	O
prone	O
position	O
to	O
the	O
patients	O
with	O
severe	O
ARDS	O
,	O
muscle	B-ANAT
paralysis	O
to	O
the	O
patients	O
with	O
severe	O
ARDS	O
.	O

Ribosome	B-ANAT
profiling	O
is	O
a	O
technique	O
which	O
exploits	O
the	O
capacity	O
of	O
the	O
translating	O
ribosome	B-ANAT
to	O
protect	O
around	O
30	O
nucleotides	O
of	O
mRNA	O
from	O
ribonuclease	O
digestion	O
.	O

Ribosome	B-ANAT
-	O
protected	O
mRNA	O
fragments	O
are	O
purified	O
,	O
subjected	O
to	O
deep	O
sequencing	O
and	O
mapped	O
back	B-ANAT
to	O
the	O
transcriptome	O
to	O
give	O
a	O
global	O
""""	O
snap	O
-	O
shot	O
""""	O
of	O
translation	O
.	O

Here	O
we	O
apply	O
ribosome	B-ANAT
profiling	O
to	O
cells	B-ANAT
infected	O
with	O
Murine	O
coronavirus	O
,	O
mouse	O
hepatitis	O
virus	O
,	O
strain	O
A59	O
(	O
MHV	O
-	O
A59	O
),	O
a	O
model	O
coronavirus	O
in	O
the	O
same	O
genus	O
as	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
.	O
The	O
data	O
obtained	O
allowed	O
us	O
to	O
study	O
the	O
kinetics	O
of	O
virus	O
transcription	O
and	O
translation	O
with	O
exquisite	O
precision	O
.	O

To	O
our	O
knowledge	O
this	O
is	O
the	O
first	O
application	O
of	O
ribosome	B-ANAT
profiling	O
to	O
an	O
RNA	O
virus	O
.	O

Our	O
findings	O
add	O
to	O
the	O
growing	O
evidence	O
supporting	O
the	O
concept	O
that	O
endothelial	B-ANAT
activation	O
plays	O
an	O
important	O
mechanistic	O
role	O
in	O
the	O
pathogenesis	O
of	O
ARDS	O
.	O

RESULTS	O
:	O
Patients	O
with	O
ARDS	O
had	O
significantly	O
higher	O
median	O
sVCAM	O
-	O
1	O
concentrations	O
in	O
the	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
compared	O
with	O
healthy	O
volunteers	O
(	O
985	O
vs	O
119	O
pg	O
/	O
mL	O
,	O
p	O
=	O
0	O
.	O
03	O
).	O

TITLE	O
:	O
Carotid	B-ANAT
body	I-ANAT
chemoreceptors	B-ANAT
,	O
sympathetic	O
neural	O
activation	O
,	O
and	O
cardiometabolic	O
disease	O
.	O

Severe	O
histopathological	O
lesions	O
were	O
observed	O
in	O
the	O
tracheal	B-ANAT
mucosa	I-ANAT
at	O
3	O
-	O
5	O
days	O
post	O
inoculation	O
(	O
dpi	O
)	O
and	O
in	O
the	O
kidney	B-ANAT
at	O
8	O
dpi	O
,	O
with	O
heavy	O
viral	O
loads	O
at	O
1	O
-	O
11	O
and	O
1	O
-	O
28	O
dpi	O
,	O
respectively	O
.	O

Inhaled	O
RBV	O
was	O
used	O
more	O
than	O
oral	B-ANAT
,	O
and	O
in	O
the	O
post	O
-	O
stem	O
cell	B-ANAT
transplant	I-ANAT
population	O
,	O
patients	O
with	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
(	O
LRTI	O
),	O
graft	B-ANAT
-	O
versus	O
-	O
host	O
disease	O
,	O
and	O
more	O
recent	O
transplantation	O
were	O
treated	O
at	O
higher	O
rates	O
.	O

In	O
terms	O
of	O
clinical	O
period	O
,	O
the	O
days	O
from	O
onset	O
to	O
death	O
[	O
13	O
(	O
4	O
~	O
17	O
)	O
vs	O
14	O
.	O
5	O
(	O
0	O
~	O
52	O
),	O
p	O
=	O
0	O
.	O
045	O
]	O
and	O
to	O
discharge	B-ANAT
[	O
11	O
(	O
5	O
~	O
24	O
)	O
vs	O
24	O
(	O
0	O
~	O
74	O
),	O
p	O
=	O
0	O
.	O
010	O
]	O
and	O
be	O
hospitalized	O
days	O
[	O
9	O
.	O
5	O
(	O
3	O
~	O
22	O
)	O
vs	O
22	O
(	O
0	O
~	O
69	O
),	O
p	O
=	O
0	O
.	O
040	O
]	O
were	O
much	O
shorter	O
in	O
MERS	O
-	O
HCP	O
than	O
SARS	O
-	O
HCP	O
.	O

ABSTRACT	O
:	O
Sarcoidosis	O
is	O
a	O
common	O
disease	O
that	O
involve	O
almost	O
constantly	O
the	O
lung	B-ANAT
.	O

Patients	O
infected	O
by	O
HCoV	O
-	O
NL63	O
are	O
typically	O
young	O
children	O
with	O
upper	O
and	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
,	O
presenting	O
with	O
symptoms	O
including	O
croup	O
,	O
bronchiolitis	O
,	O
and	O
pneumonia	O
.	O

An	O
absence	O
of	O
cross	O
-	O
reactivity	O
of	O
these	O
CD8	O
(+)	O
T	B-ANAT
cell	I-ANAT
responses	O
against	O
the	O
newly	O
-	O
emerged	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
was	O
also	O
demonstrated	O
.	O

These	O
patients	O
were	O
planned	O
to	O
ventilate	O
in	O
prone	O
for	O
16	O
h	O
and	O
in	O
supine	O
for	O
8	O
h	O
daily	O
until	O
P	O
/	O
F	O
ratio	O
>	O
150	O
with	O
FiO2	O
of	O
0	O
.	O
6	O
or	O
less	O
and	O
positive	O
end	O
-	O
expiratory	O
pressure	O
<	O
10	O
cm	O
of	O
H2	O
O	O
.	O
At	O
admission	O
,	O
among	O
these	O
six	O
patients	O
the	O
mean	O
tidal	O
volume	O
generated	O
was	O
about	O
376	O
.	O
6	O
ml	O
which	O
was	O
in	O
the	O
range	O
of	O
6	O
-	O
8	O
ml	O
/	O
kg	O
predicted	O
body	B-ANAT
weight	O
.	O

We	O
discuss	O
biochemical	O
determinants	O
mediating	O
MERS	O
-	O
CoV	O
host	B-ANAT
cell	I-ANAT
permissivity	O
,	O
including	O
virus	O
spike	O
interactions	O
with	O
the	O
MERS	O
-	O
CoV	O
cell	B-ANAT
surface	I-ANAT
receptor	O
dipeptidyl	O
peptidase	O
4	O
(	O
DPP4	O
),	O
and	O
evolutionary	O
mechanisms	O
that	O
may	O
facilitate	O
host	O
range	O
expansion	O
,	O
including	O
recombination	O
,	O
mutator	O
alleles	O
,	O
and	O
mutational	O
robustness	O
.	O

Donor	O
-	O
free	O
blood	B-ANAT
products	O
such	O
as	O
ex	O
vivo	O
generated	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
offer	O
a	O
theoretical	O
way	O
to	O
avoid	O
transmission	O
-	O
transmitted	O
infection	O
risk	O
,	O
although	O
biological	O
,	O
engineering	O
,	O
and	O
manufacturing	O
challenges	O
must	O
be	O
overcome	O
before	O
this	O
approach	O
becomes	O
practical	O
.	O

The	O
child	O
presented	O
with	O
cough	O
,	O
loose	O
stools	B-ANAT
,	O
breathing	O
difficulty	O
,	O
and	O
listlessness	O
.	O

Although	O
an	O
effective	O
immune	O
response	O
to	O
eliminate	O
viral	O
pathogens	O
is	O
essential	O
,	O
a	O
prolonged	O
or	O
exaggerated	O
response	O
can	O
damage	O
the	O
respiratory	B-ANAT
tract	I-ANAT
.	O

Immune	O
-	O
mediated	O
pulmonary	B-ANAT
damage	O
is	O
manifested	O
clinically	O
in	O
a	O
variety	O
of	O
ways	O
depending	O
on	O
location	O
and	O
extent	O
of	O
injury	O
.	O

However	O
,	O
the	O
patient	O
developed	O
pyrexia	O
and	O
presented	O
diffuse	O
ground	O
-	O
glass	O
attenuation	O
in	O
the	O
lungs	B-ANAT
bilaterally	O
.	O

Animal	O
studies	O
have	O
shown	O
that	O
endothelial	B-ANAT
injury	O
appears	O
within	O
minutes	O
to	O
hours	O
after	O
Acute	O
Lung	B-ANAT
Injury	O
(	O
ALI	O
)	O
initiation	O
with	O
resulting	O
intercellular	O
gaps	O
of	O
the	O
endothelial	B-ANAT
cells	I-ANAT
.	O

However	O
,	O
little	O
is	O
known	O
about	O
how	O
the	O
maternal	O
IgG	O
transport	O
across	O
the	O
intestinal	B-ANAT
barrier	O
and	O
how	O
IgG	O
enter	O
the	O
lumen	B-ANAT
of	O
intestinal	B-ANAT
tract	I-ANAT
.	O

At	O
present	O
,	O
it	O
is	O
unclear	O
whether	O
circulating	O
adiponectin	O
is	O
involved	O
in	O
the	O
pathogenesis	O
of	O
ARDS	O
or	O
simply	O
represents	O
an	O
epiphenomenon	O
of	O
other	O
unknown	O
functions	O
of	O
adipose	B-ANAT
tissue	I-ANAT
or	O
metabolic	O
alterations	O
in	O
sepsis	O
.	O

TITLE	O
:	O
Host	O
-	O
directed	O
therapies	O
for	O
antimicrobial	O
resistant	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
.	O

ABSTRACT	O
:	O
Endothelial	B-ANAT
Specific	O
Molecule	O
-	O
1	O
or	O
endocan	O
is	O
a	O
novel	O
biomarker	O
associated	O
with	O
the	O
development	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
in	O
response	O
to	O
a	O
systemic	O
inflammatory	O
state	O
such	O
as	O
trauma	O
.	O

Some	O
techniques	O
to	O
prevent	O
pulmonary	B-ANAT
aspiration	O
entered	O
medical	O
practice	O
on	O
a	O
limited	O
evidence	O
base	O
,	O
but	O
with	O
common	O
sense	O
supporting	O
its	O
use	O
.	O

Pulmonary	B-ANAT
aspiration	O
should	O
be	O
prevented	O
using	O
multidisciplinary	O
techniques	O
and	O
considerations	O
that	O
have	O
been	O
shown	O
to	O
improve	O
effectiveness	O
of	O
prophylaxes	O
.	O

TITLE	O
:	O
[	O
Prone	O
positioning	O
of	O
patients	O
during	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
is	O
safe	O
and	O
feasible	O
].	O

A	O
specific	O
mutation	O
within	O
zinc	O
finger	B-ANAT
1	O
(	O
ZF	O
-	O
C	O
)	O
led	O
to	O
production	O
of	O
a	O
viable	O
virus	O
with	O
growth	O
and	O
viral	O
RNA	O
synthesis	O
kinetics	O
similar	O
to	O
that	O
of	O
the	O
parental	O
virus	O
.	O

The	O
expression	O
of	O
beta	O
interferon	O
(	O
IFN	O
-	O
Î²	O
),	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
),	O
and	O
interferon	O
-	O
stimulated	O
genes	O
in	O
cells	B-ANAT
infected	O
with	O
mutant	O
rTGEV	O
-	O
ZF	O
-	O
C	O
was	O
reduced	O
compared	O
to	O
the	O
levels	O
seen	O
with	O
the	O
parental	O
virus	O
.	O

TITLE	O
:	O
Early	O
blood	B-ANAT
purification	O
therapy	O
of	O
severe	O
acute	O
pancreatitis	O
complicated	O
by	O
acute	O
lung	B-ANAT
injury	O
.	O

Early	O
blood	B-ANAT
purification	O
clears	O
inflammatory	O
cytokines	O
and	O
promotes	O
immune	O
function	O
recovery	O
.	O

Differential	O
diagnoses	O
considered	O
included	O
gastric	B-ANAT
dilatation	O
volvulus	O
(	O
GDV	O
),	O
severe	O
gastric	B-ANAT
distention	O
of	O
unknown	O
origin	O
,	O
and	O
gastric	B-ANAT
outflow	O
obstruction	O
.	O

Most	O
patients	O
without	O
any	O
underlying	O
diseases	O
remain	O
asymptomatic	O
or	O
develop	O
mild	O
clinical	O
disease	O
,	O
but	O
some	O
patients	O
require	O
critical	O
care	O
for	O
mechanical	O
ventilation	O
,	O
dialysis	O
and	O
other	O
organ	B-ANAT
support	O
.	O

Malarial	O
hepatopathy	O
was	O
associated	O
with	O
a	O
higher	O
incidence	O
of	O
cerebral	B-ANAT
malaria	O
,	O
shock	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
acute	O
kidney	B-ANAT
injury	O
in	O
both	O
overall	O
(	O
p	O
<	O
0	O
.	O
05	O
each	O
)	O
and	O
falciparum	O
malaria	O
(	O
p	O
<	O
0	O
.	O
05	O
each	O
)	O
and	O
hyponatremia	O
and	O
disseminated	O
intravascular	O
coagulation	O
only	O
in	O
overall	O
malaria	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

The	O
systemic	O
humoral	O
immune	O
response	O
was	O
stronger	O
than	O
the	O
cellular	B-ANAT
immune	O
response	O
after	O
TGEV	O
infection	O
.	O

Replication	O
organelles	B-ANAT
(	O
ROs	O
)	O
are	O
membranous	B-ANAT
structures	O
that	O
not	O
only	O
harbor	O
viral	O
proteins	O
but	O
also	O
contain	O
a	O
specific	O
array	O
of	O
hijacked	O
host	O
factors	O
that	O
create	O
a	O
unique	O
lipid	O
microenvironment	O
optimal	O
for	O
genome	O
replication	O
.	O

Selective	O
autophagy	O
of	O
mitochondria	B-ANAT
(	O
mitophagy	O
)	O
plays	O
an	O
important	O
role	O
in	O
the	O
quality	O
control	O
of	O
mitochondria	B-ANAT
and	O
maintenance	O
of	O
cell	B-ANAT
homeostasis	O
.	O

Here	O
,	O
we	O
report	O
that	O
TGEV	O
induces	O
mitophagy	O
to	O
suppress	O
oxidative	O
stress	O
and	O
apoptosis	O
induced	O
by	O
viral	O
infection	O
in	O
porcine	O
epithelial	B-ANAT
cells	I-ANAT
(	O
IPEC	O
-	O
J2	O
).	O

ABSTRACT	O
:	O
Sepsis	O
is	O
a	O
leading	O
cause	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
);	O
however	O
,	O
the	O
characteristics	O
and	O
outcome	O
of	O
sepsis	O
-	O
associated	O
ALI	O
are	O
poorly	O
understood	O
.	O

Among	O
the	O
other	O
sepsis	O
sites	O
,	O
urinary	B-ANAT
tract	I-ANAT
,	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
,	O
catheter	O
-	O
related	O
and	O
undetermined	O
foci	O
of	O
infection	O
had	O
worse	O
outcomes	O
when	O
associated	O
with	O
ALI	O
.	O

In	O
addition	O
,	O
virus	O
replication	O
was	O
required	O
for	O
the	O
increased	O
amount	O
of	O
the	O
autophagosome	B-ANAT
marker	O
protein	O
LC3	O
-	O
II	O
.	O

Within	O
the	O
class	O
I	O
viral	O
fusion	O
proteins	O
of	O
many	O
enveloped	O
viruses	O
,	O
the	O
FP	O
is	O
the	O
critical	O
mediator	O
of	O
fusion	O
of	O
the	O
viral	B-ANAT
envelope	I-ANAT
with	O
host	O
cell	B-ANAT
membranes	I-ANAT
leading	O
to	O
virus	O
infection	O
.	O

The	O
patient	O
initially	O
developed	O
symptoms	O
of	O
sore	O
throat	B-ANAT
and	O
coughing	O
on	O
27	O
January	O
2015	O
.	O

Moreover	O
,	O
populations	O
of	O
IgA	O
-	O
secreting	O
cells	B-ANAT
,	O
CD3	O
+	O
T	B-ANAT
lymphocytes	I-ANAT
and	O
intraepithelial	O
lymphocytes	B-ANAT
(	O
IELs	O
),	O
in	O
the	O
intestine	B-ANAT
increased	O
significantly	O
after	O
immunization	O
with	O
ITGEV	O
plus	O
CpG	O
DNA	O
(	O
P	O
â¤	O
0	O
.	O
05	O
).	O

Respiratory	O
clinical	O
signs	O
and	O
gross	O
lesions	O
consisting	O
of	O
tracheal	O
caseous	O
exudate	B-ANAT
and	O
plugs	O
,	O
and	O
swollen	O
kidneys	B-ANAT
(	O
with	O
or	O
without	O
)	O
urate	O
deposits	O
were	O
observed	O
in	O
SPF	O
and	O
broiler	O
chicks	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
a	O
severe	O
respiratory	O
failure	O
caused	O
by	O
acute	O
lung	B-ANAT
inflammation	O
.	O

On	O
the	O
day	O
of	O
the	O
donation	O
(	O
Day	O
-	O
2	O
),	O
her	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
count	O
was	O
5	O
.	O
83	O
Ã	O
10	O
The	O
isolates	O
from	O
the	O
donor	O
'	O
s	O
blood	B-ANAT
cultures	O
,	O
the	O
APC	B-ANAT
bag	O
,	O
the	O
attached	O
tube	O
,	O
and	O
the	O
donor	O
'	O
s	O
nasal	B-ANAT
sample	O
all	O
gave	O
identical	O
profiles	O
;	O
they	O
were	O
thus	O
identified	O
as	O
the	O
same	O
strain	O
and	O
the	O
TTBI	O
was	O
confirmed	O
.	O

TITLE	O
:	O
Outcome	O
and	O
Predicting	O
Factor	O
Following	O
Severe	O
Traumatic	O
Brain	B-ANAT
Injury	O
:	O
A	O
Retrospective	O
Cross	O
-	O
Sectional	O
Study	O
.	O

ABSTRACT	O
:	O
Severe	O
traumatic	O
brain	B-ANAT
injury	O
(	O
TBI	O
)	O
is	O
a	O
major	O
and	O
challenging	O
problem	O
in	O
critical	O
care	O
medicine	O
.	O

The	O
objectives	O
of	O
this	O
study	O
were	O
:	O
1	O
)	O
isolate	O
the	O
U	O
.	O
S	O
.	O
PEDV	O
S	O
-	O
INDEL	O
-	O
variant	O
strain	O
in	O
cell	B-ANAT
culture	O
;	O
2	O
)	O
generate	O
antisera	O
against	O
the	O
U	O
.	O
S	O
.	O
PEDV	O
prototype	O
and	O
S	O
-	O
INDEL	O
-	O
variant	O
strains	O
by	O
experimentally	O
infecting	O
weaned	O
pigs	O
;	O
3	O
)	O
determine	O
if	O
the	O
various	O
PEDV	O
serological	O
assays	O
could	O
detect	O
antibodies	O
against	O
the	O
U	O
.	O
S	O
.	O
PEDV	O
S	O
-	O
INDEL	O
-	O
variant	O
strain	O
and	O
vice	O
versa	O
.	O

Serum	B-ANAT
samples	O
collected	O
at	O
0	O
,	O
7	O
,	O
14	O
,	O
21	O
and	O
28	O
days	O
post	O
inoculation	O
were	O
evaluated	O
by	O
the	O
following	O
PEDV	O
serological	O
assays	O
:	O
1	O
)	O
indirect	O
fluorescent	O
antibody	O
(	O
IFA	O
)	O
assays	O
using	O
the	O
prototype	O
and	O
S	O
-	O
INDEL	O
-	O
variant	O
strains	O
as	O
indicator	O
viruses	O
;	O
2	O
)	O
virus	O
neutralization	O
(	O
VN	O
)	O
tests	O
against	O
the	O
prototype	O
and	O
S	O
-	O
INDEL	O
-	O
variant	O
viruses	O
;	O
3	O
)	O
PEDV	O
prototype	O
strain	O
whole	O
virus	O
based	O
ELISA	O
;	O
4	O
)	O
PEDV	O
prototype	O
strain	O
S1	O
-	O
based	O
ELISA	O
;	O
and	O
5	O
)	O
PEDV	O
S	O
-	O
INDEL	O
-	O
variant	O
strain	O
S1	O
-	O
based	O
ELISA	O
.	O

ABSTRACT	O
:	O
The	O
Berlin	O
definition	O
criteria	O
applied	O
at	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
5	O
cm	O
H2O	O
reasonably	O
predict	O
lung	B-ANAT
edema	O
and	O
recruitabilty	O
.	O

In	O
this	O
study	O
,	O
48	O
fecal	B-ANAT
specimens	O
were	O
collected	O
from	O
piglets	O
from	O
four	O
intensive	O
swine	O
farms	O
located	O
in	O
the	O
Gansu	O
Province	O
of	O
China	O
.	O

ABSTRACT	O
:	O
The	O
right	B-ANAT
ventricle	I-ANAT
(	O
RV	O
)	O
plays	O
a	O
pivotal	O
role	O
during	O
respiratory	O
failure	O
because	O
of	O
its	O
high	O
sensitivity	O
to	O
small	O
loading	O
changes	O
during	O
inspiration	O
.	O

Pulse	O
pressure	O
variations	O
,	O
central	O
venous	B-ANAT
pressure	O
and	O
especially	O
echocardiography	O
may	O
monitor	O
RV	O
function	O
in	O
abnormal	O
clinical	O
situations	O
.	O

The	O
pulmonary	B-ANAT
artery	I-ANAT
catheter	O
was	O
also	O
proposed	O
although	O
now	O
less	O
used	O
.	O

TITLE	O
:	O
Roles	O
of	O
neurally	O
adjusted	O
ventilatory	O
assist	O
in	O
improving	O
gas	O
exchange	O
in	O
a	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
patient	O
after	O
weaning	O
from	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
:	O
a	O
case	O
report	O
.	O

He	O
was	O
treated	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
7	O
days	O
and	O
survived	O
.	O

TITLE	O
:	O
Alcohol	O
Intoxication	O
Reduces	O
Systemic	O
Interleukin	O
-	O
6	O
Levels	O
and	O
Leukocyte	B-ANAT
Counts	O
After	O
Severe	O
TBI	O
Compared	O
With	O
Not	O
Intoxicated	O
TBI	O
Patients	O
.	O

We	O
analyzed	O
the	O
influence	O
of	O
positive	O
blood	B-ANAT
alcohol	O
concentration	O
(	O
BAC	O
)	O
on	O
inflammatory	O
changes	O
,	O
inhospital	O
complications	O
,	O
and	O
mortality	O
in	O
traumatic	O
brain	B-ANAT
injury	O
(	O
TBI	O
)	O
patients	O
.	O

Systemic	O
IL	O
-	O
6	O
levels	O
and	O
leukocyte	B-ANAT
counts	O
(	O
IL	O
-	O
6	O
:	O
65	O
.	O
0	O
Â±	O
8	O
.	O
0	O
vs	O
.	O
151	O
.	O
8	O
Â±	O
22	O
.	O
3	O
;	O
leukocytes	B-ANAT
:	O
10	O
.	O
2	O
Â±	O
0	O
.	O
9	O
vs	O
.	O
13	O
.	O
2	O
Â±	O
0	O
.	O
8	O
,	O
both	O
P	O
<	O
0	O
.	O
05	O
)	O
were	O
significantly	O
lower	O
in	O
BAC	O
-	O
positive	O
patients	O
.	O

However	O
,	O
lowered	O
systemic	O
IL	O
-	O
6	O
levels	O
and	O
leukocyte	B-ANAT
counts	O
in	O
the	O
BAC	O
group	O
were	O
also	O
detected	O
after	O
matching	O
,	O
indicating	O
that	O
this	O
effect	O
is	O
ISS	O
-	O
independent	O
.	O

According	O
to	O
sequences	O
obtained	O
,	O
54	O
.	O
3	O
%	O
belonged	O
to	O
B2	O
,	O
17	O
.	O
4	O
%	O
to	O
B1	O
,	O
4	O
.	O
3	O
%	O
to	O
A1	O
,	O
4	O
.	O
3	O
%	O
to	O
A2a	B-ANAT
,	O
and	O
20	O
%	O
to	O
A2b	B-ANAT
.	O

Performance	O
of	O
each	O
PCR	O
assay	O
was	O
further	O
evaluated	O
using	O
170	O
clinical	O
samples	O
(	O
86	O
fecal	B-ANAT
swabs	O
,	O
24	O
feces	B-ANAT
,	O
19	O
intestines	B-ANAT
,	O
and	O
41	O
oral	B-ANAT
fluids	B-ANAT
).	O

In	O
the	O
multivariate	O
analysis	O
,	O
age	O
â¥	O
65	O
years	O
,	O
CAP	O
resulting	O
from	O
P	O
aeruginosa	O
,	O
chronic	O
liver	B-ANAT
disease	O
,	O
neurologic	O
disease	O
,	O
nursing	O
home	O
,	O
criteria	O
of	O
ARDS	O
,	O
acute	O
renal	B-ANAT
failure	O
,	O
ICU	O
admission	O
,	O
and	O
inappropriate	O
empiric	O
treatment	O
were	O
the	O
factors	O
associated	O
with	O
30	O
-	O
day	O
mortality	O
.	O

The	O
patient	O
developed	O
tachypnea	O
and	O
dyspnea	O
,	O
and	O
had	O
diffuse	O
crackles	O
on	O
auscultation	O
of	O
all	O
lung	B-ANAT
fields	O
,	O
and	O
hypoxemia	O
6	O
hours	O
following	O
completion	O
of	O
the	O
fourth	O
cytarabine	O
infusion	O
(	O
300	O
mg	O
/	O
m	O
Drug	O
-	O
induced	O
ILD	O
is	O
rarely	O
reported	O
in	O
the	O
veterinary	O
literature	O
,	O
and	O
has	O
not	O
previously	O
been	O
reported	O
in	O
dogs	O
receiving	O
cytarabine	O
.	O

ABSTRACT	O
:	O
Essentials	O
Role	O
of	O
platelets	B-ANAT
in	O
immunological	O
transfusion	O
-	O
related	O
acute	O
lung	B-ANAT
injury	O
(	O
TRALI	O
)	O
is	O
debated	O
.	O

Immunological	O
TRALI	O
was	O
tested	O
in	O
mice	O
exhibiting	O
severe	O
thrombocytopenia	O
or	O
platelet	B-ANAT
dysfunction	O
.	O

Platelets	B-ANAT
are	O
required	O
to	O
prevent	O
lung	B-ANAT
hemorrhage	O
but	O
not	O
edema	O
formation	O
and	O
respiratory	O
distress	O
.	O

Furthermore	O
,	O
when	O
platelet	B-ANAT
functions	O
were	O
defective	O
because	O
of	O
administration	O
of	O
aspirin	O
or	O
clopidogrel	O
,	O
or	O
because	O
of	O
glycoprotein	O
(	O
GP	O
)	O
IIbIIIa	O
deficiency	O
,	O
TRALI	O
still	O
developed	O
but	O
no	O
lung	B-ANAT
hemorrhages	O
were	O
observed	O
.	O

To	O
search	O
for	O
evidence	O
of	O
autochthonous	O
MERS	O
-	O
CoV	O
infection	O
in	O
humans	O
,	O
we	O
tested	O
archived	O
serum	B-ANAT
from	O
livestock	O
handlers	O
in	O
Kenya	O
for	O
MERS	O
-	O
CoV	O
antibodies	O
.	O

Their	O
mean	O
age	O
was	O
47	O
.	O
7	O
Â±	O
61	O
.	O
2	O
(	O
m	O
)	O
and	O
body	B-ANAT
weight	O
was	O
25	O
.	O
3	O
Â±	O
27	O
.	O
1	O
(	O
kg	O
).	O

Retinoic	O
acid	O
(	O
RA	O
)	O
plays	O
an	O
important	O
role	O
in	O
the	O
induction	O
of	O
cells	B-ANAT
that	O
imprint	O
gut	B-ANAT
-	O
homing	O
molecules	O
.	O

Intestinal	B-ANAT
mucosal	B-ANAT
immunity	O
(	O
IgA	O
titre	O
)	O
and	O
systemic	O
immunity	O
(	O
serum	B-ANAT
IgG	O
titre	O
)	O
were	O
enhanced	O
by	O
RA	O
.	O

TITLE	O
:	O
Relative	O
frequency	O
,	O
Possible	O
Risk	O
Factors	O
,	O
Viral	O
Codetection	O
Rates	O
,	O
and	O
Seasonality	O
of	O
Respiratory	O
Syncytial	O
Virus	O
Among	O
Children	O
With	O
Lower	B-ANAT
Respiratory	I-ANAT
Tract	I-ANAT
Infection	O
in	O
Northeastern	O
Brazil	O
.	O

From	O
April	O
2012	O
to	O
March	O
2013	O
,	O
507	O
children	O
,	O
aged	O
up	O
to	O
24	O
months	O
and	O
hospitalized	O
with	O
LRTI	O
in	O
one	O
of	O
the	O
participating	O
centers	O
at	O
AracajÃº	O
,	O
Salvador	O
,	O
Recife	O
,	O
and	O
MaceiÃ³	O
,	O
had	O
a	O
sample	O
of	O
nasopharyngeal	B-ANAT
aspirate	I-ANAT
collected	O
and	O
analyzed	O
for	O
the	O
following	O
viruses	O
by	O
reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
followed	O
by	O
hybridization	O
on	O
low	O
-	O
density	O
microarrays	O
:	O
RSV	O
,	O
influenza	O
,	O
parainfluenza	O
,	O
adenovirus	O
,	O
rhinovirus	O
,	O
metapneumovirus	O
,	O
bocavirus	O
,	O
and	O
coronavirus	O
.	O

ABSTRACT	O
:	O
Hypoxic	O
lung	B-ANAT
failure	O
is	O
among	O
the	O
major	O
indications	O
for	O
patients	O
'	O
referral	O
to	O
intensive	O
care	O
units	O
either	O
for	O
surveillance	O
or	O
if	O
necessary	O
therapy	O
.	O

So	O
-	O
called	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
represents	O
a	O
very	O
severe	O
manifestation	O
of	O
hypoxemic	O
lung	B-ANAT
failure	O
that	O
is	O
of	O
particular	O
relevance	O
for	O
intensivists	O
and	O
is	O
therefore	O
the	O
focus	O
of	O
this	O
review	O
.	O

About	O
15	O
or	O
52	O
cytokines	O
showed	O
significant	O
difference	O
between	O
SP	O
and	O
SP	O
-	O
ARDS	O
patients	O
with	O
controls	O
or	O
13	O
between	O
SP	O
-	O
ARDS	O
with	O
SP	O
alone	O
and	O
controls	O
,	O
including	O
bone	B-ANAT
morphogenetic	O
protein	O
-	O
15	O
(	O
BMP	O
-	O
15	O
),	O
chemokine	O
(	O
C	O
-	O
X	O
-	O
C	O
motif	O
)	O
ligand	O
16	O
(	O
CXCL16	O
),	O
chemokine	O
(	O
C	O
-	O
X	O
-	O
C	O
motif	O
)	O
receptor	O
3	O
(	O
CXCR3	O
),	O
interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
),	O
protein	O
NOV	O
homolog	O
(	O
NOV	O
/	O
CCN3	O
),	O
glypican	O
3	O
,	O
insulin	O
-	O
like	O
growth	O
factor	O
binding	O
protein	O
4	O
(	O
IGFBP	O
-	O
4	O
),	O
IL	O
-	O
5	O
,	O
IL	O
-	O
5	O
R	O
alpha	O
,	O
IL	O
-	O
22	O
BP	O
,	O
leptin	O
,	O
MIP	O
-	O
1d	O
,	O
and	O
orexin	O
B	O
with	O
a	O
significant	O
correlation	O
with	O
Digital	B-ANAT
Evaluation	O
Score	O
System	O
(	O
DESS	O
)	O
scores	O
.	O

ICC	O
staining	O
of	O
CSF	B-ANAT
macrophages	B-ANAT
was	O
performed	O
in	O
all	O
cats	O
.	O

In	O
cats	O
with	O
diseases	O
other	O
than	O
FIP	O
and	O
without	O
neurological	O
disorders	O
,	O
2	O
/	O
3	O
revealed	O
macrophages	B-ANAT
,	O
with	O
one	O
cat	O
showing	O
positive	O
ICC	O
staining	O
.	O

Conclusions	O
and	O
relevance	O
CSF	B-ANAT
ICC	O
is	O
a	O
highly	O
sensitive	O
test	O
for	O
ante	O
-	O
mortem	O
diagnosis	O
of	O
FIP	O
manifesting	O
in	O
the	O
CNS	B-ANAT
.	O

It	O
was	O
hypothesized	O
that	O
Mmp3	O
deficient	O
(	O
Mmp3	O
(-/-))	O
mice	O
would	O
be	O
protected	O
against	O
lung	B-ANAT
dysfunction	O
associated	O
with	O
ARDS	O
and	O
maintain	O
a	O
functional	O
pulmonary	B-ANAT
surfactant	O
system	O
.	O

Blood	B-ANAT
cultures	O
were	O
collected	O
from	O
febrile	O
participants	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
is	O
used	O
in	O
refractory	O
hypoxemia	O
in	O
many	O
clinical	O
settings	O
.	O

Thoracic	B-ANAT
trauma	O
patients	O
usually	O
develop	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Survival	O
was	O
reduced	O
in	O
the	O
presence	O
of	O
coronary	B-ANAT
artery	I-ANAT
disease	O
,	O
hypotension	O
,	O
hypoxemia	O
,	O
CXR	O
(	O
chest	B-ANAT
X	O
-	O
ray	O
)	O
abnormalities	O
,	O
leukocytosis	O
,	O
creatinine	O
>	O
1	O
Â·	O
5	O
mg	O
/	O
dL	O
,	O
thrombocytopenia	O
,	O
anemia	O
,	O
and	O
renal	B-ANAT
failure	O
.	O

In	O
the	O
immune	O
protective	O
efficiency	O
tests	O
,	O
the	O
neutralizing	O
antibody	O
titers	O
in	O
sera	B-ANAT
,	O
the	O
colostrum	B-ANAT
and	O
the	O
milk	O
on	O
7th	O
day	O
after	O
farrowing	O
of	O
the	O
inactivated	O
YC2014	O
PEDV	O
strain	O
immunized	O
group	O
were	O
significantly	O
higher	O
than	O
the	O
inactivated	O
CV777	O
immunized	O
group	O
and	O
the	O
inactivated	O
DR13	O
immunized	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

To	O
investigate	O
the	O
antiviral	O
activity	O
of	O
graphene	O
oxide	O
(	O
GO	O
)	O
sheets	O
and	O
GO	O
sheets	O
with	O
silver	O
particles	O
(	O
GO	O
-	O
Ag	O
)	O
against	O
enveloped	O
and	O
non	O
-	O
enveloped	O
viruses	O
,	O
feline	O
coronavirus	O
(	O
FCoV	O
)	O
with	O
an	O
envelope	B-ANAT
and	O
infectious	O
bursal	O
disease	O
virus	O
(	O
IBDV	O
)	O
without	O
an	O
envelope	B-ANAT
were	O
chosen	O
.	O

In	O
G	O
-	O
NL	O
lesions	O
,	O
there	O
was	O
a	O
central	O
area	O
dominated	O
by	O
neutrophils	B-ANAT
with	O
low	O
numbers	O
of	O
macrophages	B-ANAT
,	O
plasma	B-ANAT
cells	I-ANAT
,	O
and	O
lymphocytes	B-ANAT
.	O

DG	O
presented	O
similar	O
cell	B-ANAT
proportions	O
,	O
but	O
distributed	O
evenly	O
throughout	O
the	O
lesions	O
.	O

Swabs	O
and	O
tissue	B-ANAT
homogenates	O
were	O
tested	O
by	O
gel	O
based	O
PCR	O
(	O
G	O
-	O
PCR	O
),	O
quantitative	O
-	O
PCR	O
(	O
qPCR	O
)	O
and	O
quantitative	O
real	O
time	O
reverse	O
transcriptase	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O
and	O
viral	O
culture	O
.	O

This	O
study	O
investigated	O
the	O
influence	O
of	O
acute	O
hypovolemia	O
on	O
the	O
respiratory	B-ANAT
system	I-ANAT
.	O

The	O
construct	O
of	O
the	O
fibers	O
mimics	O
the	O
reticular	O
fibers	O
of	O
the	O
fibroblastic	O
reticular	O
network	O
,	O
which	O
comprises	O
a	O
conduit	O
system	O
in	O
the	O
lymphoid	B-ANAT
organs	I-ANAT
.	O

Adult	O
respiratory	O
distress	O
syndrome	O
;	O
Extracorporeal	O
life	O
support	O
;	O
Multiple	O
trauma	O
;	O
Thoracic	B-ANAT
injury	O
;	O
Traumatic	O
brain	B-ANAT
injury	O
.	O

While	O
the	O
majority	O
of	O
respondents	O
used	O
low	O
-	O
Vt	O
ventilation	O
(	O
81	O
%),	O
high	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
86	O
%),	O
recruitment	O
maneuvers	O
(	O
89	O
%),	O
and	O
either	O
bolus	O
or	O
infusion	O
neuromuscular	O
blockade	O
(	O
94	O
%),	O
there	O
was	O
marked	O
variability	O
in	O
the	O
use	O
of	O
specific	O
rescue	O
strategies	O
as	O
tier	O
1	O
or	O
2	O
interventions	O
:	O
prone	O
position	O
(	O
27	O
.	O
8	O
%	O
vs	O
.	O
47	O
.	O
8	O
%,	O
respectively	O
),	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
2	O
.	O
3	O
%	O
vs	O
.	O
51	O
.	O
2	O
%,	O
respectively	O
),	O
airway	B-ANAT
pressure	O
release	O
ventilation	O
(	O
49	O
%	O
vs	O
.	O
34	O
.	O
5	O
%,	O
respectively	O
),	O
inhaled	O
vasodilators	O
(	O
30	O
.	O
1	O
%	O
vs	O
.	O
40	O
%,	O
respectively	O
),	O
and	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
(	O
7	O
.	O
8	O
%	O
vs	O
.	O
40	O
%,	O
respectively	O
).	O

Results	O
of	O
additional	O
tests	O
finally	O
excluded	O
pulmonary	B-ANAT
thromboembolism	O
and	O
acute	O
coronary	B-ANAT
syndrome	O
.	O

TITLE	O
:	O
Effect	O
of	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
Use	O
on	O
Sedative	O
Requirements	O
in	O
Patients	O
with	O
Severe	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
.	O

After	O
admission	O
,	O
ribavirin	O
was	O
given	O
orally	B-ANAT
for	O
12	O
days	O
and	O
Î±	O
-	O
interferon	O
was	O
administered	O
once	O
on	O
the	O
first	O
day	O
.	O

The	O
patients	O
in	O
early	O
group	O
were	O
not	O
treated	O
according	O
to	O
EGDT	O
guidance	O
,	O
so	O
only	O
age	O
,	O
the	O
case	O
history	O
of	O
chronic	O
disease	O
,	O
the	O
main	O
site	O
of	O
infection	O
,	O
organ	B-ANAT
dysfunction	O
,	O
vital	O
signs	O
,	O
urine	B-ANAT
output	O
,	O
the	O
amount	O
of	O
fluid	O
for	O
resuscitation	O
,	O
blood	B-ANAT
routine	O
,	O
blood	B-ANAT
gas	O
analysis	O
,	O
time	O
for	O
starting	O
antibiotics	O
treatment	O
,	O
the	O
use	O
of	O
vasoactive	O
drugs	O
and	O
hormone	O
,	O
etc	O
.	O
were	O
recorded	O
.	O

Two	O
hundred	O
sixty	O
-	O
one	O
patients	O
(	O
60	O
.	O
3	O
%)	O
received	O
lung	B-ANAT
protective	O
ventilation	O
,	O
but	O
most	O
patients	O
were	O
ventilated	O
with	O
a	O
low	O
positive	O
end	O
-	O
expiratory	O
pressure	O
,	O
high	O
fraction	O
of	O
inspired	O
oxygen	O
strategy	O
.	O

Nearly	O
40	O
%	O
of	O
ED	O
patients	O
were	O
ventilated	O
with	O
non	O
-	O
lung	B-ANAT
protective	O
ventilation	O
as	O
well	O
as	O
with	O
low	O
positive	O
end	O
-	O
expiratory	O
pressure	O
and	O
high	O
fraction	O
of	O
inspired	O
oxygen	O
.	O

Purified	O
proteins	O
were	O
detected	O
by	O
western	O
blot	O
using	O
mouse	O
anti	O
-	O
GST	O
mAb	O
and	O
pig	O
anti	O
-	O
PEDV	O
immune	O
sera	B-ANAT
.	O

In	O
an	O
indirect	O
ELISA	O
,	O
purified	O
proteins	O
showed	O
immune	O
reactivity	O
with	O
pig	O
anti	O
-	O
PEDV	O
immune	O
sera	B-ANAT
.	O

Comparative	O
and	O
kinetic	O
analyses	O
revealed	O
that	O
high	O
viral	O
loads	O
,	O
weak	O
antibody	O
responses	O
,	O
and	O
lymphopenia	O
accompanying	O
thrombocytopenia	O
were	O
associated	O
with	O
disease	O
mortality	O
,	O
whereas	O
persistent	O
and	O
gradual	O
increases	O
in	O
lymphocyte	B-ANAT
responses	O
might	O
be	O
required	O
for	O
effective	O
immunity	O
against	O
MERS	O
-	O
CoV	O
infection	O
.	O

It	O
is	O
associated	O
with	O
a	O
number	O
of	O
conditions	O
including	O
diabetes	O
,	O
Parkinson	O
'	O
s	O
disease	O
,	O
multiple	O
sclerosis	O
,	O
previous	O
abdominal	B-ANAT
surgeries	O
and	O
connective	B-ANAT
tissue	I-ANAT
disorders	O
,	O
including	O
scleroderma	O
and	O
Ehlers	O
-	O
Danlos	O
syndrome	O
.	O

Drugs	O
known	O
to	O
prolong	O
gastric	B-ANAT
transit	O
time	O
,	O
such	O
as	O
opiates	O
,	O
have	O
been	O
shown	O
to	O
exacerbate	O
symptoms	O
.	O

However	O
,	O
since	O
the	O
end	O
of	O
2015	O
,	O
an	O
increase	O
in	O
the	O
number	O
of	O
GBS	O
associated	O
cases	O
and	O
an	O
astonishing	O
number	O
of	O
microcephaly	O
in	O
fetus	B-ANAT
and	O
new	O
-	O
borns	O
in	O
Brazil	O
have	O
been	O
related	O
to	O
ZIKV	O
infection	O
,	O
raising	O
serious	O
worldwide	O
public	O
health	O
concerns	O
.	O

TITLE	O
:	O
Development	O
of	O
Monoclonal	O
Antibody	O
and	O
Diagnostic	O
Test	O
for	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	O
Using	O
Cell	B-ANAT
-	O
Free	O
Synthesized	O
Nucleocapsid	B-ANAT
Antigen	O
.	O

The	O
preparation	O
and	O
purification	O
of	O
native	O
viral	O
antigens	O
in	O
conventional	O
cell	B-ANAT
-	O
based	O
protein	O
expression	O
systems	O
are	O
often	O
accompanied	O
by	O
technical	O
hardships	O
.	O

Using	O
a	O
wheat	O
germ	B-ANAT
cell	I-ANAT
-	O
free	O
protein	O
synthesis	O
system	O
,	O
we	O
successfully	O
prepared	O
large	O
amounts	O
of	O
MERS	O
-	O
CoV	O
NP	O
antigen	O
in	O
a	O
state	O
that	O
was	O
highly	O
soluble	O
and	O
intact	O
for	O
immunization	O
.	O

Following	O
mouse	O
immunization	O
and	O
hybridoma	B-ANAT
generation	O
,	O
we	O
selected	O
seven	O
hybridoma	B-ANAT
clones	O
that	O
produced	O
mAbs	O
with	O
exclusive	O
reactivity	O
against	O
MERS	O
-	O
CoV	O
NP	O
.	O

Of	O
interest	O
were	O
the	O
serum	B-ANAT
titers	O
to	O
the	O
following	O
common	O
agents	O
found	O
in	O
vaccines	O
,	O
canine	O
parainfluenza	O
virus	O
(	O
CPIV	O
),	O
canine	O
parvovirus	O
(	O
CPV	O
),	O
canine	O
distemper	O
virus	O
(	O
CDV	O
),	O
canine	O
respiratory	O
coronavirus	O
(	O
CRCoV	O
),	O
and	O
Bordetella	O
bronchiseptica	O
.	O

Current	O
evidence	O
strongly	O
supports	O
that	O
prone	O
positioning	O
has	O
beneficial	O
effects	O
on	O
gas	O
exchange	O
,	O
respiratory	O
mechanics	O
,	O
lung	B-ANAT
protection	O
and	O
hemodynamics	O
as	O
it	O
redistributes	O
transpulmonary	O
pressure	O
,	O
stress	O
and	O
strain	O
throughout	O
the	O
lung	B-ANAT
and	O
unloads	O
the	O
right	B-ANAT
ventricle	I-ANAT
.	O

Although	O
patients	O
'	O
response	O
to	O
prone	O
positioning	O
is	O
quite	O
variable	O
and	O
hard	O
to	O
predict	O
,	O
large	O
randomized	O
trials	O
and	O
recent	O
meta	O
-	O
analyses	O
show	O
that	O
prone	O
position	O
in	O
conjunction	O
with	O
a	O
lung	B-ANAT
-	O
protective	O
strategy	O
,	O
when	O
performed	O
early	O
and	O
in	O
sufficient	O
duration	O
,	O
may	O
improve	O
survival	O
in	O
patients	O
with	O
ARDS	O
.	O

PEDV	O
RNA	O
was	O
detected	O
throughout	O
the	O
intestine	B-ANAT
in	O
euthanized	O
animals	O
at	O
4	O
days	O
post	O
-	O
inoculation	O
.	O

Western	O
blot	O
analysis	O
with	O
anti	O
-	O
Lys48	O
and	O
anti	O
-	O
Lys63	O
ubiquitin	O
antibodies	O
indicated	O
the	O
SARS	O
-	O
CoV	O
PLPro	O
removed	O
Lys63	O
-	O
linked	O
ubiquitin	O
chains	O
of	O
TRAF3	O
and	O
TRAF6	O
,	O
but	O
not	O
Lys48	O
-	O
linked	O
ubiquitin	O
chains	O
in	O
un	O
-	O
treated	O
and	O
treated	O
cells	B-ANAT
.	O

The	O
results	O
showed	O
that	O
the	O
ducks	O
were	O
infected	O
with	O
IBV	O
due	O
to	O
the	O
emergence	O
of	O
a	O
dwarfing	O
phenotype	O
and	O
the	O
death	O
of	O
embryos	B-ANAT
between	O
48	O
and	O
144	O
h	O
post	O
-	O
inoculation	O
.	O

The	O
predominant	O
comorbidities	O
included	O
hypertension	O
(	O
31	O
%),	O
diabetes	O
(	O
26	O
%),	O
respiratory	O
(	O
23	O
%),	O
and	O
renal	B-ANAT
disease	O
(	O
18	O
%).	O

In	O
relation	O
to	O
the	O
predicted	O
body	B-ANAT
weight	O
(	O
pbw	O
),	O
no	O
significant	O
change	O
in	O
EELV	O
/	O
kg	O
pbw	O
over	O
time	O
could	O
be	O
detected	O
either	O
at	O
any	O
PEEP	O
level	O
or	O
over	O
time	O
[	O
PEEP	O
20	O
36	O
ml	O
/	O
kg	O
pbw	O
at	O
day	O
1	O
vs	O
.	O
33	O
ml	O
/	O
kg	O
pbw	O
at	O
day	O
7	O
(	O
p	O
=	O
0	O
.	O
66	O
);	O
PEEP	O
15	O
33	O
vs	O
.	O
29	O
ml	O
/	O
kg	O
pbw	O
(	O
p	O
=	O
0	O
.	O
32	O
);	O
PEEP	O
10	O
27	O
vs	O
.	O
27	O
ml	O
/	O
kg	O
pbw	O
(	O
p	O
=	O
0	O
.	O
70	O
)	O
and	O
PEEP	O
5	O
22	O
vs	O
.	O
24	O
ml	O
/	O
kg	O
pbw	O
(	O
p	O
=	O
0	O
.	O
70	O
)].	O

In	O
healthy	O
control	O
children	O
HCoVs	O
were	O
detected	O
in	O
3	O
/	O
156	O
(	O
1	O
.	O
9	O
%,	O
95	O
%	O
CI	O
:	O
0	O
.	O
4	O
-	O
5	O
.	O
5	O
%)	O
NP	O
swabs	O
and	O
1	O
/	O
150	O
(	O
0	O
.	O
7	O
%,	O
95	O
%	O
CI	O
:	O
0	O
.	O
02	O
-	O
3	O
.	O
3	O
%)	O
stool	B-ANAT
samples	O
.	O

ABSTRACT	O
:	O
Acute	O
-	O
on	O
-	O
chronic	O
liver	B-ANAT
failure	O
(	O
ACLF	O
)	O
is	O
a	O
recently	O
recognized	O
syndrome	O
in	O
cirrhosis	O
characterized	O
by	O
acute	O
decompensation	O
(	O
AD	O
),	O
organ	B-ANAT
failure	O
(	O
s	O
),	O
and	O
high	O
short	O
-	O
term	O
mortality	O
.	O

SARS	O
-	O
CoV	O
PLpro	O
dose	O
-	O
and	O
time	O
-	O
dependently	O
up	O
-	O
regulates	O
TGF	O
-	O
Î²1	O
and	O
vimentin	B-ANAT
in	O
A549	O
cells	B-ANAT
.	O

LPS	O
-	O
induced	O
airway	B-ANAT
inflammatory	B-ANAT
cell	I-ANAT
recruitment	O
and	O
lung	B-ANAT
histological	O
alterations	O
were	O
significantly	O
ameliorated	O
by	O
andrographolide	O
sulfonate	O
.	O

Protein	O
levels	O
of	O
pro	O
-	O
inflammatory	O
cytokines	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
BALF	O
)	O
and	O
serum	B-ANAT
were	O
reduced	O
by	O
andrographolide	O
sulfonate	O
administration	O
.	O

The	O
results	O
showed	O
that	O
pretreatment	O
with	O
QF	O
significantly	O
inhibits	O
the	O
release	O
of	O
cytokines	O
(	O
TNF	O
-	O
Î±	O
and	O
IL	O
-	O
6	O
)	O
and	O
chemokines	O
(	O
IL	O
-	O
8	O
and	O
RANTES	O
),	O
reduces	O
leukocytes	B-ANAT
recruitment	O
into	O
inflamed	O
tissues	B-ANAT
and	O
ameliorates	O
pulmonary	B-ANAT
edema	O
and	O
necrosis	O
.	O

In	O
addition	O
,	O
pre	O
â	O
treatment	O
with	O
PTX	O
attenuated	O
CLP	O
â	O
induced	O
increases	O
in	O
the	O
number	O
of	O
T	O
â	O
regulatory	O
cells	B-ANAT
(	O
Tregs	O
)	O
and	O
interleukin	O
(	O
IL	O
)â	O
17	O
â	O
producing	O
T	O
â	O
helper	O
lymphocytes	B-ANAT
(	O
Th17	B-ANAT
)	O
among	O
spleen	B-ANAT
lymphocytes	B-ANAT
,	O
while	O
partially	O
restoring	O
the	O
Treg	O
/	O
Th17	B-ANAT
ratio	O
.	O

While	O
there	O
is	O
no	O
specific	O
therapy	O
,	O
we	O
decided	O
to	O
support	O
the	O
patient	O
with	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
V	O
-	O
V	O
ECMO	O
)	O
to	O
allow	O
the	O
ARDS	O
to	O
resolve	O
.	O

The	O
remaining	O
13	O
articles	O
are	O
original	O
contributions	O
mainly	O
covering	O
(	O
i	O
)	O
drug	O
resistance	O
;	O
(	O
ii	O
)	O
innovation	O
and	O
validation	O
in	O
the	O
field	O
of	O
mathematical	O
modelling	O
;	O
(	O
iii	O
)	O
elimination	O
of	O
infectious	O
diseases	O
;	O
and	O
(	O
iv	O
)	O
social	O
media	B-ANAT
reports	O
on	O
disease	O
outbreak	O
notifications	O
released	O
by	O
national	O
health	O
authorities	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
an	O
affinity	O
purification	O
/	O
mass	O
spectrometry	O
approach	O
to	O
demonstrate	O
that	O
a	O
bat	O
MHC	B-ANAT
class	O
I	O
molecule	O
,	O
Ptal	O
-	O
N	O
*	O
01	O
:	O
01	O
,	O
binds	O
antigenic	O
peptides	O
and	O
associates	O
with	O
peptide	O
-	O
loading	O
complex	O
components	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
risk	O
factors	O
related	O
to	O
hospital	O
mortality	O
due	O
to	O
infection	O
in	O
kidney	B-ANAT
recipients	O
with	O
ARDS	O
meeting	O
the	O
Berlin	O
definition	O
.	O

The	O
independent	O
predictors	O
of	O
infection	O
-	O
related	O
mortality	O
were	O
serum	B-ANAT
creatinine	O
level	O
>	O
1	O
.	O
5	O
mg	O
/	O
dL	O
at	O
ARDS	O
onset	O
(	O
OR	O
3	O
.	O
5	O
(	O
95	O
%	O
CI	O
1	O
.	O
2	O
-	O
10	O
.	O
1	O
),	O
p	O
=	O
0	O
.	O
018	O
)	O
and	O
severe	O
ARDS	O
(	O
OR	O
3	O
.	O
6	O
(	O
95	O
%	O
CI	O
1	O
.	O
4	O
-	O
9	O
.	O
7	O
),	O
p	O
=	O
0	O
.	O
009	O
)	O
in	O
the	O
multivariate	O
analysis	O
.	O

ABSTRACT	O
:	O
Respiratory	O
viruses	O
are	O
well	O
-	O
known	O
causes	O
of	O
acute	O
exacerbation	O
of	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
AE	O
-	O
COPD	O
)	O
and	O
also	O
important	O
pathogens	O
for	O
concomitant	O
pneumonia	O
in	O
COPD	O
(	O
CP	O
-	O
COPD	O
).	O

A	O
cross	O
-	O
sectional	O
study	O
was	O
conducted	O
at	O
a	O
tertiary	O
care	O
hospital	O
,	O
and	O
assessed	O
inpatients	O
under	O
investigation	O
for	O
SARI	O
by	O
the	O
hospital	O
epidemiology	O
department	O
,	O
and	O
all	O
patients	O
who	O
had	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
collected	O
from	O
January	O
2012	O
to	O
December	O
2013	O
to	O
detect	O
respiratory	O
viruses	O
(	O
RVs	O
).	O

Transcranial	O
Doppler	O
(	O
TCD	O
)	O
ultrasound	O
showed	O
appropriate	O
blood	B-ANAT
flow	O
to	O
the	O
brain	B-ANAT
.	O

This	O
case	O
demonstrates	O
the	O
importance	O
of	O
performing	O
a	O
proper	O
brain	B-ANAT
death	O
examination	O
,	O
which	O
includes	O
evaluation	O
for	O
irreversible	O
cerebral	B-ANAT
injury	O
,	O
exclusion	O
of	O
any	O
confounding	O
conditions	O
,	O
and	O
performance	O
of	O
tests	O
such	O
as	O
electroencephalography	O
and	O
TCDs	O
when	O
uncertainty	O
exists	O
about	O
the	O
reliability	O
of	O
the	O
clinical	O
exam	O
.	O

ABSTRACT	O
:	O
Acute	O
chest	B-ANAT
syndrome	O
(	O
ACS	O
)	O
is	O
the	O
most	O
common	O
cause	O
of	O
death	O
among	O
sickle	B-ANAT
cell	I-ANAT
disease	O
(	O
SCD	O
)	O
adult	O
patients	O
.	O

Pulmonary	B-ANAT
function	O
tests	O
performed	O
at	O
six	O
months	O
were	O
normal	O
and	O
the	O
CT	O
scan	O
showed	O
complete	O
regression	O
of	O
pulmonary	B-ANAT
injuries	O
.	O

Identifying	O
factors	O
that	O
influence	O
lactogenic	O
immunity	O
and	O
the	O
gut	B-ANAT
-	O
mammary	B-ANAT
-	O
sIgA	O
axis	B-ANAT
may	O
lead	O
to	O
improved	O
vaccine	O
regimens	O
for	O
PEDV	O
and	O
other	O
enteric	O
pathogens	O
in	O
gestating	O
swine	O
and	O
improved	O
overall	O
herd	O
immunity	O
,	O
swine	O
health	O
and	O
industry	O
productivity	O
.	O

Contacts	O
were	O
defined	O
as	O
HCWs	O
who	O
worked	O
in	O
the	O
patient	O
'	O
s	O
room	O
or	O
with	O
the	O
patient	O
'	O
s	O
body	B-ANAT
fluids	I-ANAT
.	O

To	O
investigate	O
the	O
pathogenicity	O
of	O
this	O
variant	O
,	O
TTR	O
-	O
2	O
/	O
JPN	O
/	O
2014	O
,	O
we	O
performed	O
experimental	O
infection	O
using	O
colostrum	B-ANAT
-	O
deprived	O
piglets	O
and	O
compared	O
the	O
results	O
with	O
those	O
from	O
the	O
North	O
American	O
type	O
PEDV	O
,	O
OKN	O
-	O
1	O
/	O
JPN	O
/	O
2013	O
.	O

TITLE	O
:	O
Effects	O
of	O
inactivated	O
porcine	O
epidemic	O
diarrhea	O
virus	O
on	O
porcine	O
monocyte	B-ANAT
-	O
derived	O
dendritic	B-ANAT
cells	I-ANAT
and	O
intestinal	B-ANAT
dendritic	B-ANAT
cells	I-ANAT
.	O

Thus	O
,	O
indole	O
-	O
based	O
agents	O
capable	O
to	O
modulate	O
the	O
microtubule	B-ANAT
assembly	O
have	O
gained	O
considerable	O
interest	O
among	O
scientists	O
.	O

The	O
clinical	O
course	O
of	O
the	O
disease	O
ranges	O
from	O
asymptomatic	O
infection	O
to	O
severe	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
illness	O
with	O
multiorgan	O
involvement	O
and	O
death	O
.	O

The	O
first	O
patient	O
had	O
an	O
intracerebral	O
hemorrhage	O
as	O
a	O
result	O
of	O
thrombocytopenia	O
,	O
disseminated	O
intravascular	O
coagulation	O
,	O
and	O
platelet	B-ANAT
dysfunction	O
.	O

TITLE	O
:	O
Experimental	O
and	O
numerical	O
analysis	O
of	O
B1	O
(+)	O
field	O
and	O
SAR	O
with	O
a	O
new	O
transmit	O
array	O
design	O
for	O
7T	O
breast	B-ANAT
MRI	O
.	O

The	O
proposed	O
RF	O
array	O
;	O
which	O
can	O
operate	O
in	O
a	O
single	O
or	O
multi	O
transmit	O
modes	O
,	O
demonstrates	O
homogeneous	O
RF	O
field	O
excitation	O
with	O
acceptable	O
local	O
/	O
average	O
SAR	O
levels	O
for	O
breast	B-ANAT
MRI	O
at	O
7T	O
.	O

ABSTRACT	O
:	O
Recently	O
,	O
several	O
prognostic	O
scoring	O
systems	O
for	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
requiring	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
have	O
been	O
published	O
.	O

CONCLUSIONS	O
:	O
Severe	O
ARDS	O
patients	O
should	O
receive	O
a	O
holistic	O
framework	O
of	O
respiratory	O
and	O
hemodynamic	O
support	O
aimed	O
to	O
ensure	O
adequate	O
gas	O
exchange	O
while	O
minimizing	O
the	O
risk	O
of	O
VILI	O
,	O
by	O
promoting	O
lung	B-ANAT
recruitment	O
and	O
setting	O
protective	O
mechanical	O
ventilation	O
.	O

We	O
report	O
the	O
case	O
of	O
one	O
patient	O
with	O
severe	O
ARDS	O
without	O
other	O
organ	B-ANAT
failure	O
.	O

RESULTS	O
:	O
The	O
nucleoprotein	O
of	O
PDCoV	O
was	O
expressed	O
as	O
a	O
recombinant	O
protein	O
and	O
purified	O
for	O
use	O
as	O
an	O
antigen	O
to	O
immunize	O
mice	O
for	O
polyclonal	O
,	O
hyperimmune	O
sera	B-ANAT
and	O
monoclonal	O
antibody	O
(	O
mAb	O
)	O
production	O
.	O

TITLE	O
:	O
Influence	O
of	O
Breed	O
Size	O
,	O
Age	O
,	O
Fecal	B-ANAT
Quality	O
,	O
and	O
Enteropathogen	O
Shedding	O
on	O
Fecal	B-ANAT
Calprotectin	O
and	O
Immunoglobulin	O
A	O
Concentrations	O
in	O
Puppies	O
During	O
the	O
Weaning	O
Period	O
.	O

Fecal	B-ANAT
calprotectin	O
and	O
IgA	O
concentrations	O
in	O
puppies	O
are	O
not	O
influenced	O
by	O
fecal	B-ANAT
moisture	O
in	O
puppies	O
but	O
by	O
enteropathogen	O
shedding	O
.	O

Fecal	B-ANAT
consistency	O
was	O
assessed	O
by	O
gross	O
examination	O
.	O

ABSTRACT	O
:	O
During	O
infection	O
of	O
their	O
host	O
cells	B-ANAT
,	O
viruses	O
often	O
inhibit	O
the	O
production	O
of	O
host	O
proteins	O
,	O
a	O
process	O
that	O
is	O
referred	O
to	O
as	O
host	O
shutoff	O
.	O

Many	O
viruses	O
inhibit	O
protein	O
synthesis	O
by	O
their	O
host	B-ANAT
cell	I-ANAT
to	O
enhance	O
virus	O
replication	O
and	O
to	O
antagonize	O
antiviral	O
defense	O
mechanisms	O
.	O

On	O
Site	O
One	O
,	O
pen	O
samples	O
(	O
feces	B-ANAT
and	O
oral	B-ANAT
fluids	B-ANAT
)	O
and	O
pig	O
samples	O
(	O
rectal	O
swabs	O
and	O
sera	B-ANAT
)	O
were	O
collected	O
both	O
before	O
and	O
after	O
the	O
population	O
was	O
exposed	O
to	O
PEDV	O
.	O

On	O
Site	O
Two	O
,	O
pen	O
oral	B-ANAT
fluid	O
samples	O
and	O
individual	O
pig	O
serum	B-ANAT
samples	O
were	O
negative	O
for	O
both	O
PEDV	O
antibody	O
and	O
nucleic	B-ANAT
acid	O
.	O

Analysis	O
of	O
the	O
PEDV	O
serum	B-ANAT
IgG	O
WV	O
ELISA	O
data	O
showed	O
that	O
a	O
sample	O
-	O
to	O
-	O
positive	O
(	O
S	O
/	O
P	O
)	O
cutoff	O
of	O
â¥	O
0	O
.	O
80	O
provided	O
a	O
diagnostic	O
sensitivity	O
of	O
0	O
.	O
87	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
82	O
,	O
0	O
.	O
91	O
)	O
and	O
specificity	O
of	O
0	O
.	O
99	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
98	O
,	O
1	O
.	O
00	O
).	O

Analysis	O
of	O
the	O
PEDV	O
oral	B-ANAT
fluid	O
IgA	O
WV	O
ELISA	O
found	O
that	O
a	O
cutoff	O
of	O
S	O
/	O
P	O
â¥	O
0	O
.	O
80	O
provided	O
a	O
diagnostic	O
sensitivity	O
of	O
1	O
.	O
00	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
92	O
,	O
1	O
.	O
00	O
)	O
and	O
a	O
diagnostic	O
specificity	O
of	O
1	O
.	O
00	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
99	O
,	O
1	O
.	O
00	O
).	O

RESULTS	O
:	O
On	O
Site	O
Two	O
,	O
pen	O
oral	B-ANAT
fluid	O
samples	O
and	O
individual	O
pig	O
serum	B-ANAT
samples	O
were	O
negative	O
for	O
both	O
PEDV	O
antibody	O
and	O
nucleic	B-ANAT
acid	O
.	O

Anti	O
-	O
PEDV	O
NA	O
was	O
present	O
in	O
colostrum	B-ANAT
,	O
milk	O
and	O
serum	B-ANAT
from	O
PEDV	O
-	O
infected	O
sows	O
as	O
determined	O
both	O
by	O
immunofluorescence	O
and	O
ELISA	O
-	O
based	O
neutralizing	O
assays	O
,	O
with	O
neutralization	O
levels	O
higher	O
in	O
colostrum	B-ANAT
and	O
milk	O
than	O
in	O
serum	B-ANAT
.	O

The	O
highest	O
NA	O
was	O
observed	O
in	O
colostrum	B-ANAT
on	O
day	O
1	O
,	O
and	O
decreased	O
rapidly	O
in	O
milk	O
at	O
day	O
3	O
,	O
then	O
gradually	O
declined	O
from	O
day	O
3	O
to	O
day	O
19	O
post	O
-	O
farrowing	O
.	O

Neutralizing	O
activity	O
significantly	O
correlated	O
with	O
specific	O
IgA	O
primarily	O
to	O
spike	O
domain	O
1	O
(	O
S1	O
)	O
and	O
domain	O
2	O
(	O
S2	O
)	O
proteins	O
of	O
PEDV	O
rather	O
than	O
to	O
specific	O
IgG	O
in	O
colostrum	B-ANAT
.	O

ABSTRACT	O
:	O
Infection	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
by	O
neurotropic	O
viruses	O
represents	O
an	O
increasing	O
worldwide	O
problem	O
in	O
terms	O
of	O
morbidity	O
and	O
mortality	O
for	O
people	O
of	O
all	O
ages	O
.	O

Female	O
BALB	O
/	O
C	O
mice	O
were	O
immunized	O
with	O
individual	O
polypeptide	O
-	O
KLH	O
,	O
and	O
the	O
total	O
IgG	O
was	O
detected	O
by	O
ELISA	O
as	O
well	O
as	O
the	O
cellular	B-ANAT
mediated	O
immunity	O
(	O
CMI	O
)	O
was	O
analyzed	O
using	O
ELIs	O
-	O
pot	O
assay	O
.	O

The	O
aims	O
of	O
the	O
study	O
were	O
to	O
investigate	O
the	O
duration	O
and	O
quantity	O
of	O
BCoV	O
shedding	O
in	O
feces	B-ANAT
and	O
nasal	B-ANAT
secretions	B-ANAT
related	O
to	O
clinical	O
signs	O
,	O
the	O
presence	O
of	O
virus	O
in	O
blood	B-ANAT
and	O
tissues	B-ANAT
and	O
to	O
test	O
the	O
hypothesis	O
that	O
seropositive	O
calves	O
are	O
not	O
infectious	O
to	O
naÃ¯ve	O
in	O
-	O
contact	O
calves	O
three	O
weeks	O
after	O
BCoV	O
infection	O
.	O

In	O
the	O
present	O
article	O
we	O
have	O
reviewed	O
the	O
literature	O
on	O
the	O
several	O
facets	B-ANAT
like	O
transmission	O
,	O
precautions	O
and	O
effectiveness	O
of	O
treatments	O
used	O
in	O
patients	O
with	O
MERS	O
-	O
CoV	O
and	O
SARS	O
infections	O
.	O

ABSTRACT	O
:	O
We	O
previously	O
demonstrated	O
that	O
adaptation	O
of	O
an	O
embryo	B-ANAT
-	O
attenuated	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
Arkansas	O
Delmarva	O
Poultry	O
Industry	O
(	O
ArkDPI	O
)-	O
derived	O
vaccine	O
to	O
chicken	O
embryo	B-ANAT
kidney	B-ANAT
(	O
CEK	O
)	O
cells	B-ANAT
shifted	O
the	O
virus	O
population	O
towards	O
homogeneity	O
in	O
spike	O
(	O
S	O
)	O
and	O
nonstructural	O
protein	O
genes	O
.	O

Histopathology	O
of	O
the	O
intestines	B-ANAT
revealed	O
increased	O
cellularity	O
of	O
the	O
lamina	B-ANAT
propria	I-ANAT
,	O
blunting	O
of	O
villi	O
,	O
and	O
cystic	O
changes	O
in	O
the	O
crypts	O
.	O

Transmission	O
electron	O
microscopy	O
of	O
the	O
intestine	B-ANAT
confirmed	O
coronavirus	O
in	O
the	O
cytoplasm	B-ANAT
of	O
enterocytes	B-ANAT
.	O

There	O
were	O
no	O
lesions	O
in	O
the	O
respiratory	B-ANAT
system	I-ANAT
,	O
and	O
no	O
IBV	O
antigen	O
was	O
detected	O
in	O
trachea	B-ANAT
,	O
lung	B-ANAT
,	O
air	B-ANAT
sac	I-ANAT
,	O
conjunctiva	B-ANAT
,	O
and	O
cecal	B-ANAT
tonsils	B-ANAT
.	O

Dampened	O
neuroinflammation	O
and	O
remyelination	O
was	O
correlated	O
with	O
a	O
transient	O
increase	O
in	O
CD4	O
+	O
FOXP3	O
+	O
regulatory	B-ANAT
T	I-ANAT
cells	I-ANAT
(	O
Tregs	O
)	O
concentrated	O
within	O
the	O
peripheral	O
lymphatics	B-ANAT
.	O

TITLE	O
:	O
Role	O
of	O
Nrf2	O
and	O
Autophagy	O
in	O
Acute	O
Lung	B-ANAT
Injury	O
.	O

We	O
propose	O
a	O
simple	O
sampling	O
strategy	O
to	O
enrich	O
in	O
especially	O
dangerous	O
pathogens	O
with	O
a	O
low	O
background	O
for	O
molecular	O
diagnostics	O
by	O
targeting	O
blood	B-ANAT
-	O
borne	O
pathogens	O
in	O
the	O
healthiest	O
age	O
groups	O
.	O

LUS	O
data	O
were	O
collected	O
at	O
four	O
time	O
points	O
:	O
1	O
h	O
before	O
(	O
baseline	O
)	O
and	O
1	O
h	O
after	O
turning	O
the	O
patient	O
to	O
PP	O
,	O
1	O
h	O
before	O
and	O
1	O
h	O
after	O
turning	O
the	O
patient	O
back	B-ANAT
to	O
the	O
supine	O
position	O
.	O

Serum	B-ANAT
samples	O
(	O
median	O
,	O
32	O
per	O
patient	O
)	O
were	O
taken	O
on	O
four	O
consecutive	O
days	O
,	O
and	O
total	O
linezolid	O
concentrations	O
were	O
quantified	O
.	O

We	O
described	O
a	O
case	O
of	O
DDS	O
resulting	O
in	O
irreversible	O
brain	B-ANAT
injury	O
and	O
death	O
following	O
acute	O
haemodialysis	O
.	O

CT	O
Brain	B-ANAT
showed	O
generalised	O
cerebral	B-ANAT
oedema	O
consistent	O
with	O
global	O
hypoxic	O
changes	O
involving	O
the	O
brainstem	B-ANAT
.	O

Children	O
who	O
are	O
exposed	O
to	O
secondhand	O
smoke	O
are	O
at	O
increased	O
risk	O
for	O
sudden	O
infant	O
death	O
syndrome	O
,	O
acute	O
respiratory	O
infections	O
,	O
middle	B-ANAT
ear	I-ANAT
disease	O
,	O
more	O
severe	O
asthma	O
,	O
respiratory	O
symptoms	O
,	O
and	O
slowed	O
lung	B-ANAT
growth	O
(	O
1	O
,	O
2	O
).	O

Previous	O
case	O
studies	O
have	O
demonstrated	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
as	O
a	O
life	O
-	O
saving	O
measure	O
for	O
pregnant	O
women	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
as	O
well	O
as	O
non	O
-	O
pregnant	O
patients	O
with	O
status	O
asthmaticus	O
.	O

We	O
hypothesized	O
that	O
obesity	O
-	O
associated	O
hyperleptinemia	O
,	O
and	O
not	O
body	B-ANAT
mass	O
per	O
se	O
,	O
drives	O
attenuation	O
of	O
the	O
pulmonary	B-ANAT
inflammatory	O
response	O
and	O
that	O
this	O
e_ect	O
could	O
also	O
impair	O
the	O
host	O
response	O
to	O
pneumonia	O
.	O

Viral	O
isolation	O
was	O
performed	O
in	O
Vero	B-ANAT
cells	I-ANAT
with	O
trypsin	O
.	O

ABSTRACT	O
:	O
Off	O
-	O
pump	O
Coronary	B-ANAT
Artery	I-ANAT
Bypass	O
(	O
OPCAB	O
)	O
has	O
become	O
the	O
standard	O
surgical	O
treatment	O
of	O
Coronary	B-ANAT
Artery	I-ANAT
Disease	O
in	O
most	O
centres	O
in	O
India	O
.	O

The	O
European	O
system	O
for	O
cardiac	B-ANAT
operative	O
risk	O
evaluation	O
(	O
euroSCORE	O
)	O
was	O
used	O
in	O
all	O
patients	O
.	O

The	O
occurrence	O
of	O
retinal	B-ANAT
vasculitis	O
and	O
a	O
high	O
rate	O
of	O
severe	O
complications	O
draw	O
attention	O
to	O
the	O
need	O
for	O
early	O
diagnosis	O
and	O
management	O
of	O
these	O
infections	O
.	O

Specificity	O
was	O
estimated	O
by	O
using	O
28	O
nasopharyngeal	B-ANAT
swabs	O
that	O
were	O
positive	O
for	O
other	O
respiratory	O
viruses	O
.	O

TITLE	O
:	O
Comparative	O
Evaluation	O
of	O
Three	O
Homogenization	O
Methods	O
for	O
Isolating	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	O
Nucleic	B-ANAT
Acids	O
From	O
Sputum	B-ANAT
Samples	O
for	O
Real	O
-	O
Time	O
Reverse	O
Transcription	O
PCR	O
.	O

We	O
determined	O
optimal	O
homogenization	O
methods	O
for	O
isolating	O
viral	O
nucleic	B-ANAT
acids	O
from	O
sputum	B-ANAT
.	O

Sputum	B-ANAT
samples	O
were	O
spiked	O
with	O
inactivated	O
MERS	O
-	O
CoV	O
culture	O
isolates	O
.	O

RESULTS	O
:	O
While	O
analyzing	O
15	O
spiked	O
sputum	B-ANAT
samples	O
prepared	O
in	O
technical	O
duplicate	O
,	O
false	O
-	O
negative	O
results	O
were	O
obtained	O
with	O
five	O
(	O
16	O
.	O
7	O
%)	O
and	O
four	O
samples	O
(	O
13	O
.	O
3	O
%),	O
respectively	O
,	O
by	O
using	O
the	O
PBS	O
and	O
NALC	O
methods	O
.	O

Disruption	O
of	O
the	O
hypothalamic	B-ANAT
-	I-ANAT
pituitary	I-ANAT
-	I-ANAT
adrenal	I-ANAT
axis	I-ANAT
may	O
translate	O
in	O
patients	O
with	O
sepsis	O
into	O
cardiovascular	B-ANAT
and	O
other	O
organ	B-ANAT
dysfunction	O
,	O
and	O
eventually	O
an	O
increase	O
in	O
the	O
risk	O
of	O
death	O
.	O

Except	O
for	O
increased	O
blood	B-ANAT
glucose	O
and	O
sodium	O
levels	O
,	O
treatment	O
with	O
corticosteroids	O
was	O
rather	O
well	O
tolerated	O
in	O
the	O
context	O
of	O
clinical	O
trials	O
.	O

Additionally	O
,	O
this	O
recombinant	O
virus	O
remained	O
stable	O
for	O
at	O
least	O
10	O
passages	O
in	O
BHK	O
-	O
21	O
cells	B-ANAT
.	O

We	O
have	O
classified	O
three	O
phases	O
,	O
ranging	O
from	O
sepsis	O
to	O
organ	B-ANAT
dysfunction	O
,	O
characterizing	O
the	O
interaction	O
between	O
neutrophils	B-ANAT
and	O
platelets	B-ANAT
.	O

In	O
order	O
to	O
prevent	O
ALI	O
/	O
ARDS	O
in	O
patients	O
with	O
sepsis	O
,	O
countermeasures	O
for	O
NET	O
and	O
platelet	B-ANAT
aggregation	O
should	O
be	O
pre	O
-	O
emptively	O
employed	O
and	O
confirmed	O
by	O
several	O
trials	O
.	O

However	O
,	O
exaggerated	O
,	O
excessive	O
synthesis	O
of	O
IL	O
-	O
6	O
while	O
fighting	O
environmental	O
stress	O
leads	O
to	O
an	O
acute	O
severe	O
systemic	O
inflammatory	O
response	O
known	O
as	O
'	O
cytokine	O
storm	O
',	O
since	O
high	O
levels	O
of	O
IL	O
-	O
6	O
can	O
activate	O
the	O
coagulation	O
pathway	O
and	O
vascular	B-ANAT
endothelial	I-ANAT
cells	I-ANAT
but	O
inhibit	O
myocardial	O
function	O
.	O

TITLE	O
:	O
Clinical	O
research	O
about	O
airway	B-ANAT
pressure	O
release	O
ventilation	O
for	O
moderate	O
to	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Molecular	O
analyses	O
made	O
on	O
a	O
sample	O
of	O
hepatic	B-ANAT
tissue	I-ANAT
revealed	O
the	O
presence	O
of	O
a	O
rickettsial	O
species	O
never	O
found	O
before	O
in	O
human	O
liver	B-ANAT
.	O

On	O
day	O
48	O
,	O
he	O
suddenly	O
developed	O
severe	O
abdominal	B-ANAT
pain	O
with	O
free	O
air	O
,	O
observable	O
on	O
an	O
abdominal	B-ANAT
X	O
-	O
ray	O
,	O
and	O
underwent	O
emergency	O
ileocecal	O
resection	O
.	O

Pathological	O
examination	O
of	O
the	O
resected	O
ileocecal	O
intestines	B-ANAT
revealed	O
multiple	O
ulcers	O
and	O
perforations	O
.	O

The	O
patients	O
with	O
severe	O
acidosis	O
also	O
exhibited	O
worse	O
arterial	B-ANAT
blood	I-ANAT
gas	O
parameters	O
:	O
the	O
PaCO2	O
levels	O
were	O
87	O
Â±	O
22	O
and	O
70	O
Â±	O
15	O
in	O
the	O
ACPE	O
patients	O
(	O
p	O
<	O
0	O
.	O
001	O
),	O
87	O
Â±	O
21	O
and	O
76	O
Â±	O
14	O
in	O
the	O
COPD	O
patients	O
,	O
and	O
83	O
Â±	O
17	O
and	O
74	O
Â±	O
14	O
in	O
the	O
OHS	O
patients	O
(	O
NS	O
).,	O
respectively	O
Further	O
,	O
the	O
patients	O
with	O
severe	O
acidosis	O
required	O
a	O
longer	O
duration	O
to	O
achieve	O
pH	O
normalization	O
than	O
those	O
with	O
non	O
-	O
severe	O
acidosis	O
(	O
patients	O
with	O
a	O
normalized	O
pH	O
after	O
the	O
first	O
hour	O
:	O
ACPE	O
,	O
8	O
%	O
vs	O
.	O
43	O
%,	O
p	O
<	O
0	O
.	O
001	O
;	O
COPD	O
,	O
11	O
%	O
vs	O
.	O
43	O
%,	O
p	O
<	O
0	O
.	O
001	O
;	O
and	O
OHS	O
,	O
13	O
%	O
vs	O
.	O
51	O
%,	O
p	O
<	O
0	O
.	O
001	O
),	O
and	O
they	O
had	O
longer	O
RICU	O
stays	O
,	O
particularly	O
those	O
in	O
the	O
COPD	O
group	O
(	O
ACPE	O
,	O
4	O
Â±	O
3	O
.	O
1	O
vs	O
.	O
3	O
.	O
6	O
Â±	O
2	O
.	O
5	O
,	O
NS	O
;	O
COPD	O
,	O
5	O
.	O
1	O
Â±	O
3	O
vs	O
.	O
3	O
.	O
6	O
Â±	O
2	O
.	O
1	O
,	O
p	O
<	O
0	O
.	O
001	O
;	O
and	O
OHS	O
,	O
4	O
.	O
3	O
Â±	O
2	O
.	O
6	O
vs	O
.	O
3	O
.	O
7	O
Â±	O
3	O
.	O
2	O
,	O
NS	O
).	O

Positioning	O
a	O
patient	O
in	O
a	O
prone	O
position	O
increases	O
the	O
risk	O
of	O
medical	O
device	O
-	O
related	O
pressure	O
ulcers	O
in	O
the	O
facial	B-ANAT
area	O
.	O

The	O
swelling	O
and	O
congestive	O
ovary	B-ANAT
was	O
visible	O
after	O
autopsy	O
.	O

This	O
review	O
is	O
focused	O
in	O
the	O
host	B-ANAT
cell	I-ANAT
responses	O
to	O
enteric	O
porcine	O
CoV	O
infection	O
and	O
the	O
viral	O
proteins	O
involved	O
in	O
pathogenesis	O
.	O

Veno	O
-	O
venous	B-ANAT
ECMO	O
was	O
started	O
at	O
the	O
end	O
of	O
lung	B-ANAT
injury	O
induction	O
with	O
a	O
flow	O
>	O
60	O
ml	O
/	O
kg	O
/	O
min	O
resulting	O
in	O
rapid	O
reversal	O
of	O
hypoxemia	O
and	O
pulmonary	B-ANAT
hypertension	O
.	O

TITLE	O
:	O
Pulmonary	B-ANAT
complications	O
of	O
chemical	O
pneumonÃ­a	O
:	O
a	O
case	O
report	O
.	O

Different	O
respiratory	B-ANAT
system	I-ANAT
pathologies	O
that	O
result	O
in	O
acute	O
respiratory	O
failure	O
(	O
such	O
as	O
increased	O
interstitial	B-ANAT
fluid	I-ANAT
,	O
alveolar	B-ANAT
consolidation	O
,	O
pleural	B-ANAT
effusion	I-ANAT
)	O
cause	O
characteristic	O
ultrasonographic	O
findings	O
;	O
diaphragmatic	B-ANAT
assessment	O
may	O
also	O
add	O
information	O
.	O

Intracardiac	B-ANAT
shunting	O
can	O
cause	O
severe	O
hypoxemia	O
.	O

Etiology	O
of	O
acute	O
respiratory	O
failure	O
was	O
acute	O
exacerbation	O
of	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
COPD	O
)	O
in	O
29	O
patients	O
,	O
adult	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
4	O
patients	O
,	O
severe	O
kyphoscoliosis	O
in	O
2	O
patients	O
,	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
(	O
ILD	O
)	O
in	O
4	O
patients	O
,	O
lung	B-ANAT
contusion	O
with	O
pneumonia	O
in	O
1	O
patient	O
,	O
thoracoplasty	O
in	O
1	O
patient	O
and	O
difficult	O
weaning	O
in	O
4	O
patients	O
.	O

9	O
patients	O
died	O
out	O
of	O
which	O
4	O
patients	O
had	O
advanced	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
.	O

NIPPV	O
has	O
been	O
found	O
useful	O
in	O
acute	O
respiratory	O
failure	O
due	O
to	O
acute	O
exacerbations	O
of	O
COPD	O
,	O
thoracic	B-ANAT
wall	I-ANAT
abnormalities	O
and	O
ARDS	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
causes	O
respiratory	O
failure	O
,	O
which	O
is	O
associated	O
with	O
severe	O
inflammation	O
and	O
lung	B-ANAT
damage	O
and	O
has	O
a	O
high	O
mortality	O
and	O
for	O
which	O
there	O
is	O
no	O
therapy	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
can	O
be	O
a	O
lifesaving	O
therapy	O
in	O
patients	O
with	O
refractory	O
severe	O
respiratory	O
failure	O
or	O
cardiac	B-ANAT
failure	O
.	O

TITLE	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
due	O
to	O
severe	O
pulmonary	B-ANAT
tuberculosis	O
treated	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
:	O
A	O
case	O
report	O
and	O
review	O
of	O
the	O
literature	O
.	O

There	O
has	O
been	O
no	O
external	O
validation	O
of	O
survival	O
prediction	O
models	O
for	O
severe	O
adult	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
therapy	O
in	O
China	O
.	O

In	O
M41	O
inoculated	O
animals	O
,	O
10	O
(	O
2	O
.	O
6	O
-	O
7	O
.	O
0	O
)	O
viral	O
RNA	O
copies	O
/	O
100	O
mg	O
were	O
detected	O
in	O
tracheal	O
secretions	B-ANAT
at	O
2	O
,	O
4	O
,	O
6	O
,	O
8	O
and	O
10	O
dpi	O
,	O
but	O
viral	O
RNA	O
was	O
not	O
demonstrated	O
in	O
plasma	B-ANAT
and	O
mononuclear	B-ANAT
cells	I-ANAT
(	O
except	O
in	O
one	O
chicken	O
at	O
6	O
dpi	O
).	O

A	O
total	O
of	O
47	O
patients	O
were	O
selected	O
,	O
27	O
male	O
(	O
57	O
%)	O
and	O
20	O
female	O
(	O
43	O
%),	O
aged	O
0	O
.	O
8	O
(	O
0	O
.	O
3	O
,	O
4	O
.	O
0	O
)	O
years	O
,	O
9	O
with	O
mechanical	O
or	O
chemical	O
damage	O
to	O
the	O
esophagus	B-ANAT
,	O
7	O
with	O
inflammatory	O
bowel	B-ANAT
disease	O
(	O
including	O
ulcerative	O
colitis	O
and	O
Crohn	O
'	O
s	O
disease	O
),	O
6	O
with	O
chronic	O
diarrhea	O
,	O
5	O
with	O
acute	O
pancreatitis	O
,	O
3	O
with	O
acute	O
diarrhea	O
and	O
severe	O
malnutrition	O
,	O
3	O
with	O
short	O
bowel	B-ANAT
syndrome	O
,	O
3	O
with	O
improper	O
feeding	O
,	O
3	O
with	O
feeding	O
difficulties	O
,	O
3	O
with	O
protein	O
losing	O
enteropathy	O
,	O
2	O
with	O
post	O
-	O
enterostomy	O
,	O
2	O
with	O
enterocolitis	O
,	O
1	O
with	O
gastroesophageal	B-ANAT
reflux	O
,	O
were	O
diagnosed	O
.	O

Of	O
47	O
cases	O
,	O
22	O
were	O
given	O
oral	B-ANAT
nutrition	O
,	O
28	O
were	O
fed	O
with	O
nasogastric	B-ANAT
tube	O
and	O
4	O
with	O
nasojejunal	O
tube	O
feeding	O
,	O
2	O
with	O
percutaneous	O
endoscopic	O
gastrojejunostomy	O
tube	O
feeding	O
for	O
each	O
.	O

In	O
this	O
article	O
,	O
the	O
characteristic	O
HRCT	O
findings	O
of	O
these	O
entities	O
,	O
including	O
acute	O
interstitial	B-ANAT
pneumonia	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
eosinophilic	O
pneumonia	O
,	O
non	O
-	O
cardiogenic	O
capillary	B-ANAT
leak	O
syndrome	O
,	O
diffuse	O
alveolar	B-ANAT
haemorrhage	O
,	O
transfusion	O
-	O
related	O
acute	O
lung	B-ANAT
injury	O
,	O
organising	O
pneumonia	O
,	O
and	O
bronchiolitis	O
obliterans	O
syndrome	O
,	O
are	O
shown	O
.	O

Coronaviruses	O
are	O
enveloped	O
viruses	O
,	O
with	O
the	O
spike	O
proteins	O
present	O
on	O
their	O
surface	O
responsible	O
for	O
virus	O
entry	O
into	O
the	O
target	B-ANAT
cell	I-ANAT
.	O

In	O
this	O
review	O
we	O
highlight	O
how	O
modulation	O
of	O
TRPV4	O
opening	O
is	O
a	O
vital	O
signalling	O
component	O
in	O
a	O
range	O
of	O
tissues	B-ANAT
and	O
why	O
understanding	O
of	O
TRPV4	O
regulation	O
in	O
the	O
body	B-ANAT
may	O
lead	O
to	O
novel	O
therapeutic	O
approaches	O
to	O
treating	O
a	O
range	O
of	O
disease	O
states	O
.	O

ABSTRACT	O
:	O
The	O
structural	O
maintenance	O
of	O
chromosomes	B-ANAT
(	O
SMC	B-ANAT
)	O
family	O
of	O
proteins	O
supports	O
mitotic	O
proliferation	O
,	O
meiosis	O
,	O
and	O
DNA	O
repair	O
to	O
control	O
genomic	O
stability	O
.	O

This	O
work	O
associates	O
missense	O
mutations	O
in	O
NSMCE3	O
with	O
an	O
autosomal	B-ANAT
recessive	O
chromosome	B-ANAT
breakage	O
syndrome	O
that	O
leads	O
to	O
defective	O
T	O
and	O
B	B-ANAT
cell	I-ANAT
function	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
early	O
childhood	O
.	O

Neutropenic	O
sepsis	O
is	O
associated	O
with	O
a	O
higher	O
AKI	O
risk	O
and	O
concentrations	O
of	O
inflammatory	O
mediators	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
and	O
G	O
-	O
CSF	B-ANAT
relative	O
to	O
non	O
-	O
neutropenic	O
patients	O
.	O

Methods	O
Cats	O
with	O
pleural	O
,	O
abdominal	B-ANAT
or	O
pericardial	B-ANAT
effusion	I-ANAT
were	O
prospectively	O
enrolled	O
.	O

In	O
conclusion	O
,	O
supplementation	O
of	O
diet	O
with	O
SNB	O
improved	O
humoral	O
immunity	O
by	O
increasing	O
IgG	O
concentration	O
in	O
serum	B-ANAT
,	O
and	O
modulated	O
the	O
adaptive	O
antibody	O
-	O
mediated	O
immune	O
response	O
against	O
IBV	O
.	O

Mechanical	O
ventilation	O
,	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
and	O
convalescent	O
serum	B-ANAT
were	O
employed	O
for	O
24	O
.	O
5	O
%,	O
7	O
.	O
1	O
%,	O
and	O
3	O
.	O
8	O
%	O
of	O
patients	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
Severe	O
blunt	O
chest	B-ANAT
trauma	O
is	O
associated	O
with	O
high	O
mortality	O
.	O

Activation	O
of	O
caspase	O
-	O
3	O
in	O
lung	B-ANAT
tissue	I-ANAT
after	O
DH	O
was	O
C5	O
-	O
dependent	O
whereas	O
local	O
inflammation	O
in	O
lung	B-ANAT
tissue	I-ANAT
was	O
C5	O
-	O
independent	O
.	O

ARDS	O
was	O
associated	O
with	O
more	O
non	O
-	O
respiratory	B-ANAT
organ	I-ANAT
failure	O
(	O
early	O
44	O
.	O
1	O
%,	O
late	O
75	O
.	O
0	O
%,	O
no	O
ARDS	O
27	O
.	O
6	O
%	O
P	O
<	O
0	O
.	O
001	O
),	O
longer	O
ICU	O
stay	O
(	O
mean	O
early	O
12	O
.	O
1	O
,	O
late	O
20	O
.	O
2	O
,	O
no	O
ARDS	O
7	O
.	O
3	O
days	O
P	O
<	O
0	O
.	O
001	O
)	O
and	O
longer	O
hospital	O
stay	O
(	O
mean	O
early	O
18	O
.	O
1	O
,	O
late	O
24	O
.	O
5	O
,	O
no	O
ARDS	O
14	O
.	O
2	O
days	O
P	O
<	O
0	O
.	O
001	O
)	O
but	O
no	O
difference	O
in	O
mortality	O
or	O
quality	O
of	O
life	O
.	O

The	O
presence	O
of	O
the	O
HEV	B-ANAT
helicase	O
in	O
cis	O
dramatically	O
increases	O
the	O
binding	O
of	O
the	O
macro	O
domain	O
to	O
poly	O
(	O
ADP	O
-	O
ribose	O
)	O
and	O
stimulates	O
the	O
de	O
-	O
PARylation	O
activity	O
.	O

The	O
de	O
-	O
MARylation	O
activity	O
is	O
present	O
in	O
all	O
three	O
pathogenic	O
positive	O
-	O
sense	O
,	O
single	O
-	O
stranded	O
RNA	O
[(+)	O
ssRNA	O
]	O
virus	O
families	O
which	O
carry	O
a	O
macro	O
domain	O
:	O
Coronaviridae	O
(	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
and	O
human	O
coronavirus	O
229E	O
),	O
Togaviridae	O
(	O
Venezuelan	O
equine	O
encephalitis	O
virus	O
),	O
and	O
Hepeviridae	O
(	O
HEV	B-ANAT
),	O
indicating	O
that	O
it	O
might	O
be	O
a	O
significant	O
tropism	O
and	O
/	O
or	O
pathogenic	O
determinant	O
.	O

TITLE	O
:	O
Severe	O
Thrombocytopenia	O
in	O
Adults	O
with	O
Severe	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
:	O
Impact	O
of	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
Use	O
.	O

Although	O
the	O
APACHE	O
II	O
score	O
(	O
p	O
=	O
0	O
.	O
01	O
),	O
presence	O
of	O
liver	B-ANAT
failure	O
(	O
p	O
=	O
0	O
.	O
08	O
),	O
and	O
platelet	B-ANAT
transfusion	O
(	O
p	O
=	O
0	O
.	O
0009	O
)	O
were	O
different	O
between	O
the	O
severe	O
T	O
(	O
18	O
/	O
85	O
[	O
21	O
%])	O
and	O
non	O
-	O
severe	O
T	O
groups	O
(	O
67	O
/	O
85	O
[	O
79	O
%]),	O
the	O
incidence	O
of	O
septic	O
shock	O
(	O
p	O
=	O
0	O
.	O
64	O
),	O
heparin	O
infusion	O
use	O
(	O
p	O
=	O
0	O
.	O
41	O
),	O
exposure	O
to	O
non	O
-	O
heparin	O
T	O
-	O
causing	O
medications	O
(	O
p	O
=	O
0	O
.	O
77	O
)	O
and	O
ECMO	O
use	O
(	O
p	O
=	O
0	O
.	O
5	O
)	O
were	O
not	O
.	O

In	O
conclusion	O
,	O
a	O
reasonable	O
understanding	O
of	O
the	O
indications	O
and	O
contraindications	O
of	O
VATS	O
,	O
combined	O
with	O
early	O
mechanical	O
treatment	O
significantly	O
improved	O
the	O
success	O
rate	O
of	O
the	O
treatment	O
of	O
ARDS	O
patients	O
secondary	O
to	O
severe	O
chest	B-ANAT
trauma	O
and	O
reduced	O
the	O
complications	O
.	O

ABSTRACT	O
:	O
Objective	O
To	O
estimate	O
the	O
association	O
between	O
maternal	O
super	O
obesity	O
(	O
body	B-ANAT
mass	O
index	O
[	O
BMI	O
]	O
â¥	O
50	O
kg	O
/	O
m	O
(	O
2	O
))	O
and	O
neonatal	O
morbidity	O
among	O
neonates	O
born	O
via	O
cesarean	O
delivery	O
(	O
CD	O
).	O

Treatment	O
of	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
infection	O
is	O
limited	O
to	O
providing	O
supportive	O
therapy	O
consistent	O
with	O
any	O
serious	O
lung	B-ANAT
disease	O
,	O
as	O
no	O
specific	O
drugs	O
have	O
been	O
approved	O
as	O
therapeutics	O
.	O

The	O
phylogenetic	O
analysis	O
based	O
on	O
the	O
genomic	O
sequences	O
indicated	O
that	O
poIFN	O
-	O
Î»3	O
is	O
located	O
in	O
the	O
same	O
branch	B-ANAT
as	O
B	O
.	O
taurus	O
and	O
O	O
.	O
aries	O
IFN	O
-	O
Î»3	O
.	O

In	O
addition	O
,	O
poIFN	O
-	O
Î»3	O
was	O
able	O
to	O
induce	O
the	O
expression	O
of	O
IFN	O
-	O
stimulated	O
genes	O
,	O
including	O
ISG15	O
,	O
OAS1	O
,	O
and	O
Mx1	O
in	O
Vero	O
E6	O
cells	B-ANAT
.	O

TITLE	O
:	O
Tubulins	O
interact	O
with	O
porcine	O
and	O
human	O
S	O
proteins	O
of	O
the	O
genus	O
Alphacoronavirus	O
and	O
support	O
successful	O
assembly	O
and	O
release	O
of	O
infectious	O
viral	B-ANAT
particles	I-ANAT
.	O

In	O
addition	O
,	O
a	O
partial	O
co	O
-	O
localization	O
of	O
TGEV	O
spike	O
proteins	O
with	O
authentic	O
host	B-ANAT
cell	I-ANAT
Î²	O
-	O
tubulin	B-ANAT
was	O
observed	O
.	O

ABSTRACT	O
:	O
We	O
evaluated	O
the	O
diagnostic	O
and	O
clinical	O
usefulness	O
of	O
blood	B-ANAT
specimens	O
to	O
detect	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
infection	O
in	O
21	O
patients	O
from	O
the	O
2015	O
outbreak	O
in	O
South	O
Korea	O
.	O

ABSTRACT	O
:	O
The	O
spike	O
glycoprotein	O
of	O
the	O
Middle	O
East	O
respiratory	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
facilitates	O
receptor	O
binding	O
and	O
cell	B-ANAT
entry	O
.	O

ABSTRACT	O
:	O
Human	O
rhinovirus	O
(	O
HRV	O
)	O
and	O
coronavirus	O
(	O
HCoV	O
)	O
infections	O
are	O
associated	O
with	O
both	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
illness	O
"("""	O
the	O
common	O
cold	O
""")"	O
and	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
illness	O
(	O
pneumonia	O
).	O

Key	O
areas	O
of	O
interest	O
are	O
surveillance	O
programs	O
,	O
political	O
limitations	O
on	O
our	O
ability	O
to	O
respond	O
quickly	O
enough	O
to	O
emerging	O
threats	O
,	O
media	B-ANAT
management	O
,	O
public	O
information	O
dissemination	O
,	O
infection	O
control	O
,	O
prophylaxis	O
,	O
and	O
individual	O
patient	O
management	O
.	O

Studies	O
showed	O
that	O
immunoglobulin	O
of	O
egg	B-ANAT
yolk	B-ANAT
(	O
IgY	O
)	O
from	O
immunized	O
hens	O
has	O
been	O
identified	O
to	O
be	O
a	O
convenient	O
source	O
for	O
specific	O
antibodies	O
for	O
using	O
in	O
immunotherapy	O
and	O
immunodiagnostic	O
to	O
limit	O
the	O
infections	O
.	O

TITLE	O
:	O
Mouse	O
Hepatitis	O
Virus	O
Infection	O
Induces	O
a	O
Toll	O
-	O
Like	O
Receptor	O
2	O
-	O
Dependent	O
Activation	O
of	O
Inflammatory	O
Functions	O
in	O
Liver	B-ANAT
Sinusoidal	O
Endothelial	B-ANAT
Cells	I-ANAT
during	O
Acute	O
Hepatitis	O
.	O

We	O
next	O
showed	O
in	O
vitro	O
that	O
infection	O
of	O
LSECs	O
by	O
the	O
virulent	O
MHV3	O
strain	O
altered	O
their	O
production	O
of	O
anti	O
-	O
inflammatory	O
cytokines	O
and	O
promoted	O
higher	O
release	O
of	O
proinflammatory	O
and	O
procoagulant	O
factors	O
and	O
earlier	O
cell	B-ANAT
damage	O
than	O
infection	O
by	O
attenuated	O
strains	O
.	O

Previous	O
reports	O
have	O
demonstrated	O
that	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
predominantly	O
utilizes	O
dipeptidyl	O
peptidase	O
4	O
(	O
DPP4	O
)	O
for	O
cell	B-ANAT
entry	O
.	O

Taken	O
together	O
,	O
the	O
results	O
of	O
our	O
study	O
identified	O
CEACAM5	O
as	O
a	O
novel	O
cell	B-ANAT
surface	I-ANAT
binding	O
target	O
of	O
MERS	O
-	O
CoV	O
that	O
facilitates	O
MERS	O
-	O
CoV	O
infection	O
by	O
augmenting	O
the	O
attachment	O
of	O
the	O
virus	O
to	O
the	O
host	B-ANAT
cell	I-ANAT
surface	I-ANAT
.	O

ABSTRACT	O
:	O
Coronary	B-ANAT
artery	I-ANAT
disease	O
(	O
CAD	O
)	O
is	O
a	O
leading	O
cause	O
of	O
death	O
and	O
identification	O
of	O
risk	O
factors	O
for	O
CAD	O
is	O
crucial	O
.	O

SDB	O
severity	O
did	O
not	O
vary	O
significantly	O
in	O
patients	O
with	O
stable	O
CAD	O
or	O
on	O
the	O
basis	O
of	O
left	O
ventricular	B-ANAT
ejection	O
fraction	O
.	O

Multivariate	O
logistic	O
regression	O
identified	O
age	O
,	O
sex	O
,	O
body	B-ANAT
mass	O
index	O
,	O
and	O
CABG	O
as	O
independent	O
risk	O
factors	O
for	O
severe	O
SDB	O
.	O

Furthermore	O
,	O
neutrophils	B-ANAT
isolated	O
from	O
the	O
blood	B-ANAT
or	O
BAL	O
fluid	O
differentially	O
regulated	O
the	O
cell	B-ANAT
surface	I-ANAT
expression	O
of	O
chemokine	O
(	O
C	O
-	O
X	O
-	O
C	O
motif	O
)	O
receptor	O
1	O
and	O
C	O
-	O
C	O
chemokine	O
receptor	O
type	O
2	O
during	O
ARDS	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
is	O
a	O
disease	O
of	O
the	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
and	O
is	O
characterized	O
by	O
high	O
mortality	O
.	O

TITLE	O
:	O
Eosinophilic	O
Lung	B-ANAT
Diseases	O
.	O

RESULTS	O
:	O
Based	O
on	O
our	O
results	O
,	O
in	O
the	O
second	O
group	O
,	O
IBV	O
vaccine	O
strain	O
(	O
4	O
/	O
91	O
)	O
at	O
all	O
titration	O
and	O
M41	O
in	O
10	O
(-	O
2	O
)	O
and	O
10	O
(-	O
3	O
)	O
titration	O
and	O
in	O
the	O
third	O
group	O
both	O
variants	O
of	O
virus	O
the	O
embryonic	B-ANAT
Index	O
(	O
EI	O
)	O
was	O
significantly	O
increased	O
.	O

From	O
January	O
to	O
June	O
2010	O
,	O
63	O
cow	O
-	O
calf	B-ANAT
-	O
pairs	O
from	O
20	O
different	O
farms	O
near	O
ZÃ¼rich	O
,	O
Switzerland	O
have	O
been	O
investigated	O
.	O

We	O
included	O
162	O
subjects	O
[	O
24	O
%	O
female	O
,	O
age	O
48	O
(	O
35	O
-	O
60	O
),	O
%	O
total	B-ANAT
body	I-ANAT
surface	I-ANAT
area	O
(	O
TBSA	O
)	O
burn	O
28	O
(	O
19	O
-	O
40	O
),	O
%	O
body	B-ANAT
surface	O
area	O
(	O
BSA	O
)	O
full	O
thickness	O
(	O
FT	O
)	O
burn	O
13	O
(	O
0	O
-	O
30	O
),	O
and	O
62	O
%	O
with	O
inhalation	O
injury	O
].	O

TITLE	O
:	O
Rational	O
design	O
of	O
a	O
synthetic	O
mammalian	O
riboswitch	O
as	O
a	O
ligand	O
-	O
responsive	O
-	O
1	O
ribosomal	B-ANAT
frame	O
-	O
shifting	O
stimulator	O
.	O

Conformational	O
and	O
functional	O
analyses	O
indicate	O
that	O
the	O
engineered	O
theophylline	O
-	O
responsive	O
RNA	O
functions	O
as	O
a	O
mammalian	O
riboswitch	O
with	O
robust	O
theophylline	O
-	O
dependent	O
-	O
1	O
PRF	O
stimulation	O
activity	O
in	O
a	O
stable	O
human	O
293T	O
cell	B-ANAT
-	O
line	O
.	O

Interestingly	O
,	O
Hx	O
-	O
XO	O
-	O
derived	O
ROS	O
induced	O
the	O
same	O
biphasic	O
effect	O
on	O
the	O
phosphorylation	O
of	O
the	O
focal	B-ANAT
adhesion	I-ANAT
kinase	O
(	O
FAK	O
),	O
a	O
nonreceptor	O
tyrosine	O
kinase	O
critical	O
for	O
cell	B-ANAT
adhesion	O
,	O
but	O
not	O
on	O
ERK1	O
/	O
2	O
phosphorylation	O
.	O

Finally	O
,	O
adhesion	O
assays	O
revealed	O
an	O
increased	O
adhesion	O
of	O
naive	O
monocytes	B-ANAT
to	O
ECs	O
treated	O
with	O
supernatant	O
from	O
FIPV	O
-	O
infected	O
monocytes	B-ANAT
.	O

TITLE	O
:	O
Plasma	B-ANAT
syndecan	O
-	O
1	O
levels	O
identify	O
a	O
cohort	O
of	O
patients	O
with	O
severe	O
sepsis	O
at	O
high	O
risk	O
for	O
intubation	O
after	O
large	O
-	O
volume	O
intravenous	O
fluid	O
resuscitation	O
.	O

Twenty	O
-	O
two	O
percent	O
met	O
the	O
primary	O
outcome	O
,	O
21	O
%	O
died	O
,	O
and	O
57	O
%	O
developed	O
kidney	B-ANAT
injury	O
.	O

Dromedary	O
camels	O
are	O
the	O
reservoir	O
for	O
the	O
virus	O
,	O
although	O
,	O
other	O
than	O
nasal	B-ANAT
discharge	B-ANAT
,	O
these	O
animals	O
do	O
not	O
display	O
any	O
overt	O
clinical	O
disease	O
.	O

MERS	O
-	O
CoV	O
is	O
an	O
enveloped	O
virus	O
,	O
and	O
its	O
envelope	B-ANAT
protein	O
(	O
S	O
protein	O
)	O
mediates	O
membrane	B-ANAT
fusion	O
at	O
the	O
plasma	B-ANAT
membrane	I-ANAT
or	O
endosomal	O
membrane	B-ANAT
.	O

ABSTRACT	O
:	O
Objectives	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
whether	O
the	O
frequency	O
of	O
electrophoretic	O
changes	O
in	O
serum	B-ANAT
of	O
cats	O
with	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
)	O
changed	O
in	O
recent	O
years	O
vs	O
past	O
years	O
.	O

ABSTRACT	O
:	O
In	O
cells	B-ANAT
,	O
positive	O
strand	O
RNA	O
viruses	O
,	O
such	O
as	O
Retroviridae	O
,	O
must	O
selectively	O
recognize	O
their	O
full	O
-	O
length	O
RNA	O
genome	O
among	O
abundant	O
cellular	B-ANAT
RNAs	O
to	O
assemble	O
and	O
release	O
particles	O
.	O

H120	O
,	O
one	O
of	O
the	O
safest	O
vaccine	O
strains	O
,	O
which	O
has	O
been	O
used	O
worldwide	O
as	O
a	O
primary	O
vaccine	O
,	O
cannot	O
adapt	O
to	O
passaged	O
cells	B-ANAT
,	O
which	O
severely	O
restricts	O
the	O
quality	O
of	O
the	O
vaccine	O
.	O

The	O
results	O
showed	O
that	O
biological	O
characteristics	O
of	O
R	O
-	O
H120	O
-	O
Beaudette	O
-	O
p65	O
(	O
S	O
),	O
such	O
as	O
replication	O
kinetics	O
in	O
embryonated	O
chicken	O
eggs	O
(	O
ECEs	O
)	O
and	O
embryo	B-ANAT
virulence	O
,	O
were	O
similar	O
to	O
those	O
of	O
H120	O
.	O

TITLE	O
:	O
Deleted	O
in	O
malignant	O
brain	B-ANAT
tumors	O
1	O
protein	O
is	O
a	O
potential	O
biomarker	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
induced	O
by	O
pneumonia	O
.	O

The	O
bundles	O
include	O
early	O
guideline	O
-	O
concordant	O
antibiotics	O
including	O
macrolides	O
,	O
early	O
haemodynamic	O
support	O
(	O
lactate	O
measurement	O
,	O
intravenous	O
fluids	B-ANAT
,	O
and	O
vasopressors	O
),	O
and	O
early	O
respiratory	O
support	O
(	O
high	O
-	O
flow	O
nasal	B-ANAT
cannulae	O
,	O
lung	B-ANAT
-	O
protective	O
ventilation	O
,	O
prone	O
positioning	O
,	O
and	O
neuromuscular	O
blockade	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
).	O
While	O
the	O
proposed	O
interventions	O
appear	O
straightforward	O
,	O
multiple	O
barriers	O
to	O
their	O
implementation	O
exist	O
.	O

High	O
-	O
throughput	O
analysis	O
revealed	O
that	O
the	O
cellular	B-ANAT
genes	O
most	O
significantly	O
perturbed	O
by	O
MERS	O
-	O
CoV	O
have	O
previously	O
been	O
implicated	O
in	O
renal	B-ANAT
diseases	O
.	O

The	O
transition	O
from	O
prefusion	O
to	O
postfusion	O
conformation	O
of	O
the	O
spike	O
protein	O
must	O
be	O
triggered	O
,	O
leading	O
to	O
membrane	B-ANAT
fusion	O
.	O

At	O
this	O
time	O
,	O
serum	B-ANAT
components	O
of	O
IgA	O
-	O
Î»	O
and	O
IgM	O
-	O
Î»	O
were	O
biclonally	O
positive	O
.	O

Current	O
treatment	O
options	O
for	O
MERS	O
can	O
be	O
categorized	O
as	O
:	O
immunotherapy	O
with	O
virus	O
-	O
specific	O
antibodies	O
in	O
convalescent	O
plasma	B-ANAT
;	O
polyclonal	O
and	O
monoclonal	O
antibodies	O
produced	O
in	O
vitro	O
or	O
in	O
genetically	O
modified	O
animals	O
;	O
and	O
antiviral	O
agents	O
.	O

A	O
sequential	O
organ	B-ANAT
failure	O
assessment	O
score	O
of	O
>	O
5	O
on	O
admission	O
and	O
delay	O
in	O
treatment	O
resulted	O
in	O
multi	O
-	O
organ	B-ANAT
failure	O
and	O
worsening	O
outcome	O
.	O

The	O
common	O
indications	O
for	O
mechanical	O
ventilation	O
were	O
pulmonary	B-ANAT
oedema	O
,	O
ARDS	O
and	O
acute	O
lung	B-ANAT
injury	O
.	O

RESULTS	O
:	O
These	O
droplets	O
or	O
droplet	O
nuclei	O
are	O
transported	O
by	O
expired	O
airflows	O
,	O
which	O
are	O
sometimes	O
affected	O
by	O
the	O
human	B-ANAT
body	I-ANAT
plume	O
and	O
use	O
of	O
a	O
face	B-ANAT
mask	O
,	O
as	O
well	O
as	O
room	O
airflow	O
.	O

We	O
collected	O
the	O
number	O
of	O
daily	O
laboratory	O
-	O
confirmed	O
MERS	O
cases	O
and	O
quarantined	O
cases	O
from	O
May	O
11	O
,	O
2015	O
to	O
June	O
26	O
,	O
2015	O
using	O
the	O
Korean	O
government	O
MERS	O
portal	B-ANAT
.	O

(	O
5	O
)	O
The	O
differences	O
of	O
occurrence	O
rates	O
of	O
myocardial	O
damage	O
,	O
liver	B-ANAT
injury	O
,	O
kidney	B-ANAT
injury	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
intracranial	B-ANAT
hypertension	O
syndrome	O
,	O
stress	O
ulcer	O
,	O
coagulation	O
disorders	O
,	O
circulatory	O
dysfunction	O
,	O
severe	O
sepsis	O
,	O
multiple	O
organ	B-ANAT
dysfunction	O
(	O
MODS	O
)	O
among	O
the	O
three	O
groups	O
were	O
statistically	O
significant	O
(	O
Ï	O
(	O
2	O
)=	O
8	O
.	O
826	O
,	O
17	O
.	O
864	O
,	O
49	O
.	O
061	O
,	O
96	O
.	O
221	O
,	O
106	O
.	O
918	O
,	O
80	O
.	O
559	O
,	O
30	O
.	O
355	O
,	O
99	O
.	O
183	O
,	O
196	O
.	O
412	O
,	O
133	O
.	O
887	O
,	O
154	O
.	O
239	O
,	O
9	O
.	O
206	O
,	O
P	O
all	O
<	O
0	O
.	O
01	O
).	O

Triggering	O
,	O
cycling	O
,	O
and	O
flow	O
dyssynchronies	O
were	O
identified	O
by	O
inspection	O
of	O
airway	B-ANAT
flow	O
and	O
pressure	O
tracings	O
.	O

Under	O
APC	B-ANAT
mode	O
,	O
compared	O
with	O
VC	O
,	O
DIs	O
were	O
lower	O
at	O
set	O
Vt	O
of	O
6	O
and	O
7	O
.	O
5	O
ml	O
/	O
kg	O
(	O
P	O
=	O
0	O
.	O
004	O
for	O
both	O
).	O

TITLE	O
:	O
Orally	B-ANAT
Administrated	O
Whole	O
Yeast	O
Vaccine	O
Against	O
Porcine	O
Epidemic	O
Diarrhea	O
Virus	O

The	O
pathological	O
damage	O
to	O
the	O
cystic	O
oviducts	B-ANAT
were	O
observed	O
throughout	O
the	O
surveillance	O
period	O
.	O

TITLE	O
:	O
MicroRNA	O
-	O
155	O
enhances	O
T	B-ANAT
cell	I-ANAT
trafficking	O
and	O
antiviral	O
effector	O
function	O
in	O
a	O
model	O
of	O
coronavirus	O
-	O
induced	O
neurologic	O
disease	O
.	O

Morbidity	O
and	O
mortality	O
,	O
viral	O
load	O
and	O
immune	O
cell	B-ANAT
accumulation	O
in	O
the	O
CNS	B-ANAT
,	O
and	O
spinal	B-ANAT
cord	I-ANAT
demyelination	O
were	O
assessed	O
at	O
defined	O
points	O
post	O
-	O
infection	O
.	O

For	O
patients	O
with	O
a	O
respiratory	B-ANAT
system	I-ANAT
compliance	O
above	O
40	O
mL	O
/	O
cm	O
H2O	O
or	O
patients	O
with	O
a	O
BMI	O
above	O
35	O
kg	O
/	O
m	O
(	O
2	O
),	O
we	O
found	O
a	O
trend	O
towards	O
reduced	O
mortality	O
with	O
higher	O
PEEP	O
,	O
but	O
there	O
is	O
very	O
weak	O
statistical	O
confidence	O
in	O
these	O
findings	O
.	O

TITLE	O
:	O
Phylogeny	O
and	O
S1	O
Gene	O
Variation	O
of	O
Infectious	O
Bronchitis	O
Virus	O
Detected	O
in	O
Broilers	O
and	O
Layers	B-ANAT
in	O
Turkey	O
.	O

ABSTRACT	O
:	O
Sevoflurane	O
improves	O
gas	O
exchange	O
,	O
and	O
reduces	O
alveolar	B-ANAT
edema	O
and	O
inflammation	O
in	O
preclinical	O
studies	O
of	O
lung	B-ANAT
injury	O
,	O
but	O
its	O
therapeutic	O
effects	O
have	O
never	O
been	O
investigated	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

We	O
have	O
isolated	O
and	O
passaged	O
the	O
PDCoV	O
strain	O
OH	O
-	O
FD22	O
in	O
an	O
LLC	B-ANAT
porcine	O
kidney	B-ANAT
(	O
LLC	B-ANAT
-	O
PK	O
)	O
cell	B-ANAT
line	I-ANAT
.	O

Histologic	O
lesions	O
were	O
limited	O
to	O
the	O
villous	O
epithelium	B-ANAT
of	O
the	O
jejunum	B-ANAT
and	O
ileum	B-ANAT
at	O
PID	O
3	O
.	O

Using	O
recombinant	O
ArkDPI	O
S1	O
proteins	O
,	O
we	O
conducted	O
binding	O
assays	O
on	O
chicken	O
tracheas	B-ANAT
and	O
embryonic	B-ANAT
chorioallantoic	B-ANAT
membrane	I-ANAT
(	O
CAM	B-ANAT
).	O

Protein	O
histochemistry	O
showed	O
that	O
the	O
Y43H	O
change	O
allows	O
for	O
enhanced	O
binding	O
to	O
trachea	B-ANAT
,	O
whereas	O
the	O
ArkDPI	O
S1	O
spike	O
with	O
H43	O
alone	O
was	O
able	O
to	O
bind	O
CAM	B-ANAT
.	O

TITLE	O
:	O
Rare	O
central	O
venous	B-ANAT
catheter	O
malposition	O
-	O
an	O
ultrasound	O
-	O
guided	O
approach	O
would	O
be	O
helpful	O
:	O
a	O
case	O
report	O
.	O

A	O
right	O
central	O
venous	B-ANAT
catheter	O
was	O
inserted	O
using	O
a	O
landmark	O
technique	O
to	O
monitor	O
central	O
venous	B-ANAT
pressure	O
and	O
administer	O
medications	O
.	O

Her	O
right	B-ANAT
internal	I-ANAT
mammary	I-ANAT
artery	I-ANAT
was	O
embolized	O
using	O
two	O
interlocking	O
detachable	O
coils	O
,	O
and	O
the	O
central	O
venous	B-ANAT
catheter	O
was	O
removed	O
from	O
her	O
internal	B-ANAT
mammary	I-ANAT
artery	I-ANAT
without	O
further	O
complications	O
.	O

Internal	B-ANAT
mammary	I-ANAT
artery	I-ANAT
malposition	O
is	O
a	O
rare	O
but	O
potentially	O
lethal	O
complication	O
of	O
central	O
venous	B-ANAT
catheter	O
catheterization	O
;	O
however	O
,	O
caution	O
should	O
be	O
taken	O
regarding	O
the	O
assessment	O
of	O
risk	O
factors	O
and	O
management	O
of	O
a	O
severe	O
complication	O
.	O

We	O
report	O
4	O
cases	O
of	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
from	O
influenza	O
in	O
need	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
evaluation	O
at	O
a	O
tertiary	O
care	O
center	O
,	O
transported	O
by	O
ground	O
.	O

To	O
determine	O
the	O
prevalence	O
of	O
human	O
coronavirus	O
(	O
HCoV	O
)	O
infection	O
among	O
patients	O
with	O
influenza	O
-	O
like	O
illness	O
,	O
5833	O
clinical	O
samples	O
from	O
nasopharyngeal	B-ANAT
swabs	O
and	O
aspirates	B-ANAT
collected	O
between	O
January	O
2012	O
and	O
December	O
2013	O
were	O
examined	O
.	O

We	O
present	O
a	O
case	O
of	O
acute	O
chest	B-ANAT
pain	O
in	O
a	O
58	O
-	O
year	O
-	O
old	O
male	O
with	O
severe	O
asthma	O
,	O
which	O
regressed	O
after	O
sublingual	B-ANAT
administration	O
of	O
nitroglycerine	O
.	O

During	O
the	O
next	O
days	O
,	O
there	O
was	O
increasing	O
pain	O
and	O
reduced	O
strength	O
in	O
both	O
feet	B-ANAT
.	O

Blood	B-ANAT
eosinophils	I-ANAT
were	O
elevated	O
(	O
12	O
.	O
7	O
Ã	O
10	O
(	O
9	O
)/	O
L	O
),	O
and	O
an	O
acute	O
HRCT	O
scan	O
showed	O
bilateral	O
peribronchial	O
infiltrates	O
with	O
ground	O
glass	O
opacification	O
and	O
small	O
noduli	O
.	O

This	O
peptide	O
exhibited	O
a	O
high	O
level	O
of	O
serological	O
reactivity	O
(	O
64	O
%),	O
which	O
resulted	O
from	O
the	O
additive	O
responses	O
of	O
two	O
tandem	O
epitopes	O
(	O
S597	O
-	O
603	O
and	O
S604	O
-	O
625	O
)	O
and	O
a	O
long	O
-	O
term	O
human	O
B	O
-	O
cell	B-ANAT
memory	I-ANAT
response	O
with	O
antisera	O
from	O
convalescent	O
SARS	O
patients	O
.	O

Therefore	O
,	O
the	O
developed	O
multiplex	O
PCR	O
modalities	O
were	O
able	O
to	O
simultaneously	O
diagnose	O
a	O
panel	O
of	O
CIRDC	O
viruses	O
and	O
facilitated	O
specimen	O
collection	O
through	O
being	O
suitable	O
for	O
use	O
of	O
nasal	B-ANAT
or	O
oral	B-ANAT
samples	O
.	O

TITLE	O
:	O
Plasma	B-ANAT
cytokines	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
and	O
IL	O
-	O
10	O
are	O
associated	O
with	O
the	O
development	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
patients	O
with	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
.	O

Plasma	B-ANAT
proinflammatory	O
markers	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
and	O
anti	O
-	O
inflammatory	O
marker	O
IL	O
-	O
10	O
were	O
associated	O
with	O
the	O
development	O
of	O
ARDS	O
(	O
adjusted	O
hazard	O
ratio	O
(	O
HR	O
)	O
=	O
1	O
.	O
55	O
,	O
confidence	O
interval	O
(	O
CI	O
)	O
=	O
1	O
.	O
14	O
,	O
2	O
.	O
11	O
,	O
P	O
=	O
0	O
.	O
005	O
for	O
IL	O
-	O
6	O
;	O
adjusted	O
HR	O
=	O
1	O
.	O
32	O
,	O
CI	O
=	O
1	O
.	O
10	O
,	O
1	O
.	O
59	O
,	O
P	O
=	O
0	O
.	O
003	O
for	O
IL	O
-	O
8	O
).	O

Thirteen	O
subjects	O
with	O
cardiovascular	B-ANAT
dysfunction	O
were	O
treated	O
with	O
the	O
interleukin	O
-	O
6	O
receptor	O
antibody	O
tocilizumab	O
.	O

Eighteen	O
subjects	O
(	O
46	O
%)	O
developed	O
grade	O
3	O
-	O
4	O
cytokine	O
release	O
syndrome	O
,	O
with	O
prolonged	O
fever	O
(	O
median	O
,	O
6	O
.	O
5	O
d	O
),	O
hyperferritinemia	O
(	O
median	O
peak	O
ferritin	O
,	O
60	O
,	O
214	O
ng	O
/	O
mL	O
),	O
and	O
organ	B-ANAT
dysfunction	O
.	O

The	O
cell	B-ANAT
line	I-ANAT
has	O
the	O
potential	O
to	O
be	O
used	O
for	O
isolation	O
of	O
bat	O
viruses	O
and	O
for	O
studying	O
virus	O
-	O
bat	O
interactions	O
in	O
culture	O
.	O

Bipolar	O
disorder	O
patients	O
show	O
an	O
increase	O
of	O
blood	B-ANAT
anti	O
gliadin	O
deamidated	O
antibodies	O
(	O
IgG	O
).	O

ABSTRACT	O
:	O
Tuberculosis	O
(	O
TB	O
)	O
is	O
a	O
serpent	O
disease	O
with	O
various	O
pulmonary	B-ANAT
manifestations	O
,	O
and	O
timely	O
diagnosis	O
of	O
the	O
disease	O
is	O
paramount	O
,	O
since	O
delayed	O
treatment	O
is	O
associated	O
with	O
severe	O
morbidity	O
,	O
particularly	O
in	O
intensive	O
care	O
units	O
(	O
ICU	O
).	O

TITLE	O
:	O
Activated	O
GL7	O
ABSTRACT	O
:	O
Central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
inflammation	O
associated	O
with	O
viral	O
infection	O
and	O
autoimmune	O
disease	O
results	O
in	O
the	O
accumulation	O
of	O
B	B-ANAT
cells	I-ANAT
in	O
various	O
differentiation	O
stages	O
.	O

However	O
,	O
the	O
contribution	O
between	O
peripheral	O
and	O
CNS	B-ANAT
activation	O
remains	O
unclear	O
.	O

Blood	B-ANAT
samples	I-ANAT
from	O
all	O
lions	O
were	O
negative	O
for	O
Trypanosoma	O
,	O
Anaplasma	O
,	O
Theileria	O
,	O
and	O
Ehrlichia	O
spp	O
.	O

ABSTRACT	O
:	O
Conventional	O
treatment	O
of	O
respiratory	O
failure	O
involves	O
positive	O
pressure	O
ventilation	O
that	O
can	O
worsen	O
lung	B-ANAT
damage	O
.	O

Histopathologic	O
examinations	O
of	O
the	O
dead	O
piglets	O
showed	O
characteristics	O
of	O
non	O
-	O
suppurative	O
encephalitis	O
,	O
and	O
some	O
neurons	B-ANAT
in	O
the	O
cerebral	B-ANAT
cortex	I-ANAT
were	O
degenerated	O
and	O
necrotic	O
,	O
and	O
neuronophagia	O
.	O

Similarly	O
,	O
mice	O
inoculated	O
with	O
PHEV	O
-	O
CC14	O
were	O
found	O
to	O
have	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
dysfunction	O
,	O
with	O
symptoms	O
of	O
depression	O
,	O
arched	O
waists	O
,	O
standing	O
and	O
vellicating	O
front	O
claws	B-ANAT
.	O

We	O
sought	O
to	O
test	O
the	O
external	O
validity	O
and	O
potential	O
impact	O
of	O
the	O
Pediatric	O
Acute	O
Lung	B-ANAT
Injury	O
Consensus	O
Conference	O
definition	O
by	O
comparing	O
the	O
number	O
of	O
cases	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
mortality	O
rates	O
among	O
children	O
admitted	O
to	O
a	O
multidisciplinary	O
PICU	O
when	O
classified	O
by	O
Pediatric	O
Acute	O
Lung	B-ANAT
Injury	O
Consensus	O
Conference	O
,	O
Berlin	O
,	O
and	O
American	O
European	O
Consensus	O
Conference	O
criteria	O
.	O

The	O
137	O
patients	O
who	O
met	O
Pediatric	O
Acute	O
Lung	B-ANAT
Injury	O
Consensus	O
Conference	O
but	O
not	O
Berlin	O
criteria	O
had	O
an	O
overall	O
mortality	O
rate	O
of	O
13	O
.	O
1	O
%,	O
but	O
29	O
had	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
with	O
31	O
.	O
0	O
%	O
mortality	O
.	O

Fecal	B-ANAT
samples	O
were	O
collected	O
from	O
25	O
diarrheic	O
calves	O
.	O

SCLS	O
is	O
an	O
extremely	O
rare	O
disorder	O
characterized	O
by	O
unexplained	O
episodic	O
capillary	B-ANAT
hyperpermeability	O
,	O
which	O
causes	O
shift	O
of	O
volume	O
and	O
protein	O
from	O
the	O
intravascular	O
space	O
to	O
the	O
interstitial	B-ANAT
space	I-ANAT
.	O

ABSTRACT	O
:	O
The	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
plays	O
important	O
roles	O
in	O
the	O
replication	O
and	O
translation	O
of	O
viral	O
RNA	O
.	O

The	O
virions	B-ANAT
entered	O
porcine	O
IECs	O
by	O
membrane	B-ANAT
fusion	O
and	O
the	O
mature	O
viruses	O
in	O
the	O
vacuoles	B-ANAT
were	O
transported	O
to	O
the	O
cell	B-ANAT
membrane	I-ANAT
before	O
release	O
.	O

Although	O
neutrophils	B-ANAT
have	O
traditionally	O
been	O
considered	O
mediators	O
of	O
epithelial	O
damage	O
,	O
recent	O
studies	O
suggest	O
they	O
promote	O
type	B-ANAT
II	I-ANAT
pneumocyte	I-ANAT
(	O
AT2	O
)	O
proliferation	O
,	O
which	O
is	O
essential	O
for	O
regenerating	O
alveolar	B-ANAT
epithelium	I-ANAT
.	O

We	O
found	O
that	O
the	O
loss	O
of	O
G	O
-	O
CSF	B-ANAT
recapitulated	O
the	O
neutrophil	B-ANAT
response	O
of	O
Ly6G	O
-	O
treated	O
mice	O
and	O
was	O
associated	O
with	O
defective	O
alveolar	B-ANAT
epithelial	O
repair	O
,	O
similar	O
to	O
neutrophil	B-ANAT
-	O
depleted	O
mice	O
,	O
and	O
was	O
reversed	O
by	O
administration	O
of	O
exogenous	O
G	O
-	O
CSF	B-ANAT
.	O

TITLE	O
:	O
Tissue	B-ANAT
localization	O
,	O
shedding	O
,	O
virus	O
carriage	O
,	O
antibody	O
response	O
,	O
and	O
aerosol	O
transmission	O
of	O
Porcine	O
epidemic	O
diarrhea	O
virus	O
following	O
inoculation	O
of	O
4	O
-	O
week	O
-	O
old	O
feeder	O
pigs	O
.	O

ABSTRACT	O
:	O
We	O
determined	O
tissue	B-ANAT
localization	O
,	O
shedding	O
patterns	O
,	O
virus	O
carriage	O
,	O
antibody	O
response	O
,	O
and	O
aerosol	O
transmission	O
of	O
Porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
following	O
inoculation	O
of	O
4	O
-	O
week	O
-	O
old	O
feeder	O
pigs	O
.	O

Only	O
1	O
patient	O
succumbed	O
,	O
with	O
DIC	O
and	O
multi	O
-	O
organ	B-ANAT
failure	O
.	O

Their	O
properties	O
may	O
be	O
advantageous	O
in	O
preservation	O
of	O
tissue	B-ANAT
viability	O
in	O
oxygen	O
-	O
deprived	O
states	O
,	O
such	O
as	O
in	O
acute	O
lung	B-ANAT
injury	O
.	O

TITLE	O
:	O
Constitutively	O
Expressed	O
IFITM3	O
Protein	O
in	O
Human	O
Endothelial	B-ANAT
Cells	I-ANAT
Poses	O
an	O
Early	O
Infection	O
Block	O
to	O
Human	O
Influenza	O
Viruses	O
.	O

We	O
show	O
that	O
human	O
influenza	O
virus	O
infection	O
is	O
blocked	O
during	O
the	O
early	O
stages	O
of	O
virus	O
entry	O
,	O
which	O
is	O
likely	O
due	O
to	O
the	O
relatively	O
high	O
expression	O
of	O
the	O
host	O
antiviral	O
factors	O
IFITMs	O
(	O
interferon	O
-	O
induced	O
transmembrane	B-ANAT
proteins	O
)	O
located	O
in	O
membrane	B-ANAT
-	O
bound	O
compartments	B-ANAT
inside	O
cells	B-ANAT
.	O

Epitope	O
spreading	O
,	O
molecular	O
mimicry	O
,	O
cryptic	O
antigen	O
,	O
and	O
bystander	O
activation	O
have	O
been	O
implicated	O
as	O
mechanisms	O
responsible	O
for	O
activating	O
self	O
-	O
reactive	O
(	O
SR	O
)	O
immune	O
cells	B-ANAT
,	O
ultimately	O
leading	O
to	O
organ	B-ANAT
-	O
specific	O
autoimmune	O
disease	O
.	O

Our	O
data	O
shows	O
that	O
clinical	O
condition	O
may	O
suddenly	O
deteriorate	O
around	O
7	O
days	O
of	O
illness	O
and	O
the	O
serum	B-ANAT
levels	O
of	O
IL	O
-	O
6	O
and	O
CXCL	O
-	O
10	O
was	O
significantly	O
elevated	O
in	O
MERS	O
-	O
CoV	O
patients	O
who	O
developed	O
severe	O
diseases	O
.	O

Also	O
,	O
there	O
is	O
increasing	O
evidence	O
to	O
suggest	O
that	O
individual	O
cis	O
-	O
acting	O
elements	O
may	O
be	O
part	O
of	O
higher	O
-	O
order	O
RNA	O
structures	O
involving	O
long	O
-	O
range	O
and	O
dynamic	O
RNA	O
-	O
RNA	O
interactions	O
between	O
RNA	O
structural	O
elements	O
separated	O
by	O
thousands	O
of	O
nucleotides	O
in	O
the	O
viral	B-ANAT
genome	I-ANAT
.	O

Trimers	O
of	O
the	O
S	O
glycoproteins	O
on	O
the	O
virion	B-ANAT
surface	O
accommodate	O
binding	O
to	O
a	O
cell	B-ANAT
surface	I-ANAT
receptor	O
and	O
fusion	O
of	O
the	O
viral	O
and	O
cellular	B-ANAT
membrane	I-ANAT
.	O

ABSTRACT	O
:	O
Ovarian	B-ANAT
hyperstimulation	O
syndrome	O
(	O
OHSS	O
)	O
was	O
first	O
described	O
in	O
1960	O
.	O

A	O
26	O
-	O
year	O
-	O
old	O
female	O
patient	O
with	O
polycystic	O
ovarian	B-ANAT
syndrome	O
and	O
primary	O
infertility	O
was	O
treated	O
to	O
conceive	O
.	O

She	O
was	O
found	O
to	O
have	O
edema	O
,	O
ascites	O
,	O
effusion	B-ANAT
and	O
acute	O
kidney	B-ANAT
injury	O
(	O
AKI	O
).	O

Adenoids	B-ANAT
had	O
an	O
average	O
of	O
2	O
.	O
4	O
viruses	O
compared	O
to	O
0	O
.	O
92	O
for	O
tonsils	B-ANAT
,	O
p	O
<	O
0	O
.	O
001	O
.	O

Coronavirus	O
spike	O
proteins	O
mediate	O
virus	O
entry	O
into	O
cells	B-ANAT
,	O
a	O
process	O
that	O
requires	O
the	O
spike	O
proteins	O
to	O
be	O
proteolytically	O
activated	O
.	O

We	O
found	O
that	O
the	O
PEDV	O
spike	O
is	O
activated	O
by	O
lysosomal	B-ANAT
cysteine	O
proteases	O
but	O
not	O
proprotein	O
convertases	O
or	O
cell	B-ANAT
surface	I-ANAT
serine	O
proteases	O
.	O

In	O
the	O
latter	O
,	O
domain	O
VII	O
was	O
linked	O
to	O
the	O
transmembrane	B-ANAT
segment	O
through	O
domain	O
III	O
.	O

After	O
20	O
passages	O
in	O
HeLa	B-ANAT
cells	I-ANAT
,	O
the	O
ability	O
of	O
the	O
isolate	O
to	O
use	O
cathepsin	O
increased	O
so	O
that	O
it	O
was	O
equal	O
to	O
that	O
of	O
the	O
laboratory	O
strain	O
;	O
this	O
increase	O
was	O
caused	O
by	O
an	O
amino	O
acid	O
substitution	O
(	O
I577S	O
)	O
in	O
the	O
S	O
protein	O
.	O

HCoVs	O
have	O
large	O
genomes	O
that	O
encode	O
a	O
fixed	B-ANAT
array	O
of	O
structural	O
and	O
nonstructural	O
components	O
,	O
as	O
well	O
as	O
a	O
variety	O
of	O
accessory	O
proteins	O
that	O
differ	O
in	O
number	O
and	O
sequence	O
even	O
among	O
closely	O
related	O
CoVs	O
.	O

In	O
the	O
current	O
study	O
,	O
in	O
vitro	O
T	B-ANAT
lymphocyte	I-ANAT
activation	O
measured	O
by	O
IFNÎ³	O
release	O
was	O
significantly	O
higher	O
in	O
B2	O
versus	O
B19	O
haplotypes	O
.	O

In	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
,	O
viral	O
infections	O
were	O
detected	O
in	O
12	O
(	O
66	O
.	O
7	O
%)	O
episodes	O
,	O
bacterial	O
infections	O
in	O
17	O
(	O
94	O
.	O
4	O
%)	O
episodes	O
and	O
mixed	O
bacterial	O
-	O
viral	O
infections	O
in	O
8	O
(	O
44	O
.	O
4	O
%)	O
episodes	O
.	O

The	O
large	O
observational	O
study	O
to	O
understand	O
the	O
global	O
impact	O
of	O
severe	O
acute	O
respiratory	O
failure	O
(	O
LUNG	B-ANAT
SAFE	O
)	O
was	O
an	O
international	O
,	O
multicenter	O
,	O
prospective	O
cohort	O
study	O
of	O
patients	O
with	O
severe	O
respiratory	O
failure	O
,	O
conducted	O
in	O
the	O
winter	O
of	O
2014	O
in	O
a	O
convenience	O
sample	O
of	O
459	O
ICUs	O
from	O
50	O
countries	O
across	O
five	O
continents	O
.	O

Overexpression	O
of	O
Nur77	O
markedly	O
decreased	O
basal	O
and	O
LPS	O
-	O
induced	O
ET	O
-	O
1	O
expression	O
in	O
A549	O
cells	B-ANAT
,	O
whereas	O
knockdown	O
of	O
Nur77	O
increased	O
the	O
ET	O
-	O
1	O
expression	O
.	O

Daily	O
chest	B-ANAT
x	O
-	O
rays	O
showed	O
worsening	O
of	O
bilateral	O
interstitial	B-ANAT
infiltrates	O
and	O
pleural	O
effusions	O
.	O

TITLE	O
:	O
Concise	O
SAR	O
Exploration	O
Based	O
on	O
the	O
""""	O
Head	B-ANAT
-	O
to	O
-	O
Tail	O
""""	O
Approach	O
:	O
Discovery	O
of	O
PI4KIIIÎ±	O
Inhibitors	O
Bearing	O
Diverse	O
Scaffolds	O
.	O

ABSTRACT	O
:	O
Neuromuscular	O
blockade	O
(	O
NMB	O
)	O
has	O
been	O
shown	O
to	O
improve	O
outcome	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
adults	O
,	O
challenging	O
maintaining	O
spontaneous	O
breathing	O
when	O
there	O
is	O
severe	O
lung	B-ANAT
injury	O
.	O

It	O
is	O
unknown	O
whether	O
cellular	B-ANAT
infection	O
by	O
MERS	O
-	O
CoV	O
activates	O
the	O
stress	O
response	O
pathway	O
or	O
whether	O
the	O
virus	O
has	O
evolved	O
strategies	O
to	O
suppress	O
this	O
infection	O
-	O
limiting	O
pathway	O
.	O

Of	O
the	O
811	O
enrolled	O
patients	O
,	O
291	O
had	O
acceptable	O
sputum	B-ANAT
specimens	O
that	O
were	O
included	O
for	O
analysis	O
of	O
the	O
etiologic	O
distribution	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
infects	O
humans	O
from	O
zoonotic	O
sources	O
and	O
causes	O
severe	O
pulmonary	B-ANAT
disease	O
.	O

Virions	B-ANAT
require	O
spike	O
(	O
S	O
)	O
glycoproteins	O
for	O
binding	O
to	O
cell	B-ANAT
receptors	O
and	O
for	O
catalyzing	O
virus	O
-	O
cell	B-ANAT
membrane	I-ANAT
fusion	O
.	O

Thus	O
,	O
by	O
sensitizing	O
viruses	O
to	O
receptor	O
-	O
induced	O
conformational	O
changes	O
,	O
the	O
first	O
S	O
cleavages	O
expand	O
virus	O
tropism	O
to	O
cell	B-ANAT
types	O
that	O
are	O
relevant	O
to	O
lung	B-ANAT
infection	O
,	O
and	O
therefore	O
may	O
be	O
significant	O
determinants	O
of	O
MERS	O
-	O
CoV	O
virulence	O
.	O

Nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
is	O
the	O
RNA	O
-	O
binding	O
protein	O
of	O
PEDV	O
,	O
which	O
plays	O
an	O
important	O
role	O
for	O
virus	O
life	O
cycle	O
.	O

Several	O
strategies	O
focusing	O
on	O
the	O
binding	O
grooves	B-ANAT
of	O
the	O
NHR	O
trimer	O
have	O
been	O
adopted	O
to	O
increase	O
the	O
antiviral	O
activity	O
of	O
the	O
CHR	O
peptides	O
.	O

As	O
necroptosis	O
disrupts	O
cellular	B-ANAT
membranes	B-ANAT
and	O
allows	O
the	O
release	O
of	O
damage	O
-	O
associated	O
molecular	O
patterns	O
(	O
DAMP	O
)	O
and	O
possibly	O
induces	O
the	O
production	O
of	O
proinflammatory	O
cytokines	O
,	O
it	O
may	O
represent	O
a	O
proinflammatory	O
cell	B-ANAT
death	O
mechanism	O
that	O
contributes	O
to	O
excessive	O
neuroinflammation	O
and	O
neurodegeneration	O
and	O
eventually	O
to	O
neurological	O
disorders	O
after	O
a	O
coronavirus	O
infection	O
.	O

Data	O
regarding	O
demographic	O
,	O
underlying	O
conditions	O
,	O
arterial	B-ANAT
blood	I-ANAT
gases	O
and	O
clinical	O
outcomes	O
were	O
collected	O
and	O
analyzed	O
.	O

TITLE	O
:	O
Neutrophil	B-ANAT
expression	O
of	O
glucocorticoid	O
-	O
induced	O
leucine	O
zipper	O
(	O
GILZ	O
)	O
anti	O
-	O
inflammatory	O
protein	O
is	O
associated	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
severity	O
.	O

In	O
this	O
pilot	O
study	O
,	O
we	O
show	O
for	O
the	O
first	O
time	O
that	O
blood	B-ANAT
neutrophils	I-ANAT
from	O
patients	O
with	O
ARDS	O
can	O
express	O
GILZ	O
,	O
in	O
keeping	O
with	O
an	O
anti	O
-	O
inflammatory	O
and	O
regulatory	O
endogenous	O
role	O
of	O
GILZ	O
in	O
humans	O
.	O

RESULTS	O
:	O
Neutrophil	B-ANAT
GILZ	O
expression	O
was	O
detected	O
at	O
the	O
transcriptional	O
and	O
/	O
or	O
translational	O
level	O
in	O
9	O
/	O
17	O
ARDS	O
patients	O
(	O
in	O
particular	O
7	O
/	O
10	O
severe	O
ARDS	O
)	O
and	O
in	O
2	O
/	O
14	O
ventilated	O
controls	O
.	O

Postweaning	O
body	B-ANAT
weight	O
measurements	O
were	O
collected	O
from	O
the	O
heifers	O
at	O
approximately	O
8mo	O
of	O
age	O
.	O

Postweaning	O
body	B-ANAT
weight	O
and	O
carcass	O
grading	O
information	O
was	O
collected	O
from	O
the	O
veal	O
calves	O
at	O
slaughter	O
once	O
a	O
live	O
weight	O
between	O
300	O
and	O
350kg	O
had	O
been	O
achieved	O
.	O

The	O
metabolite	O
,	O
protein	O
,	O
and	O
lipid	O
extraction	O
(	O
MPLEx	O
)	O
protocol	O
proved	O
to	O
be	O
robust	O
and	O
applicable	O
to	O
a	O
diverse	O
set	O
of	O
sample	O
types	O
,	O
including	O
cell	B-ANAT
cultures	O
,	O
microbial	O
communities	O
,	O
and	O
tissues	B-ANAT
.	O

Variables	O
associated	O
with	O
mortality	O
included	O
immunosuppression	O
,	O
shock	O
at	O
time	O
of	O
admission	O
,	O
acute	O
renal	B-ANAT
failure	O
,	O
occurrence	O
of	O
heparin	O
-	O
induced	O
thrombocytopenia	O
antibodies	O
,	O
nosocomial	O
sepsis	O
and	O
duration	O
of	O
ECMO	O
.	O

Patients	O
>	O
18	O
years	O
with	O
IE	O
and	O
available	O
serum	B-ANAT
sodium	O
levels	O
were	O
included	O
in	O
the	O
study	O
.	O

Neutrophils	B-ANAT
play	O
key	O
roles	O
in	O
the	O
pathogenesis	O
of	O
ALI	O
/	O
ARDS	O
by	O
promoting	O
the	O
inflammation	O
and	O
injury	O
of	O
the	O
alveolar	B-ANAT
microenvironment	O
.	O

Additionally	O
,	O
we	O
used	O
this	O
model	O
to	O
assess	O
pneumonia	O
-	O
induced	O
neutrophil	B-ANAT
recruitment	O
by	O
microinjecting	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
from	O
patients	O
into	O
swim	O
bladders	B-ANAT
;	O
this	O
injection	O
enhanced	O
neutrophil	B-ANAT
aggregation	O
relative	O
to	O
the	O
control	O
.	O

In	O
conclusion	O
,	O
our	O
findings	O
highlight	O
the	O
swim	O
bladder	B-ANAT
as	O
a	O
promising	O
and	O
powerful	O
model	O
for	O
mechanistic	O
and	O
drug	O
screening	O
studies	O
of	O
alveolar	B-ANAT
injuries	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
remains	O
a	O
common	O
organ	B-ANAT
dysfunction	O
in	O
the	O
critically	O
ill	O
patient	O
.	O

sPD	O
-	O
1	O
levels	O
in	O
murine	O
blood	B-ANAT
(	O
AUC	O
=	O
1	O
(	O
1	O
-	O
1	O
),	O
p	O
=	O
0	O
.	O
006	O
),	O
murine	O
BAL	O
fluid	O
(	O
AUC	O
=	O
0	O
.	O
905	O
(	O
0	O
.	O
717	O
-	O
1	O
.	O
093	O
),	O
p	O
=	O
0	O
.	O
015	O
),	O
and	O
human	O
BAL	O
(	O
AUC	O
=	O
1	O
(	O
1	O
-	O
1	O
),	O
p	O
=	O
0	O
.	O
001	O
)	O
fluid	O
predicted	O
ARDS	O
.	O

Front	O
-	O
loading	O
gilts	O
in	O
combination	O
with	O
herd	O
closure	O
is	O
more	O
cost	O
-	O
effective	O
than	O
back	B-ANAT
-	O
loading	O
.	O

TITLE	O
:	O
[	O
Extracorporeal	O
CO	O
ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injuries	O
are	O
usually	O
found	O
in	O
intensive	O
care	O
unit	O
.	O

ECCO	O
CONCLUSIONS	O
:	O
This	O
observation	O
presents	O
the	O
diagnostic	O
and	O
therapeutic	O
difficulties	O
of	O
the	O
lung	B-ANAT
parenchymental	O
disease	O
in	O
intensive	O
care	O
.	O

ECMO	O
is	O
a	O
complex	O
network	O
that	O
provides	O
oxygenation	O
and	O
ventilation	O
and	O
allows	O
the	O
lungs	B-ANAT
to	O
rest	O
and	O
recover	O
from	O
respiratory	O
failure	O
while	O
minimizing	O
iatrogenic	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

TITLE	O
:	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
immunity	O
of	O
SARS	O
-	O
CoV	O
:	O
Implications	O
for	O
vaccine	O
development	O
against	O
MERS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
Over	O
12	O
years	O
have	O
elapsed	O
since	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
triggered	O
the	O
first	O
global	O
alert	O
for	O
coronavirus	O
infections	O
.	O

To	O
detect	O
genes	O
of	O
CCoV	O
,	O
fecal	B-ANAT
samples	O
collected	O
from	O
30	O
diarrheic	O
and	O
50	O
healthy	O
dogs	O
were	O
examinated	O
by	O
RT	O
-	O
PCR	O
,	O
confirming	O
that	O
2	O
diarrheic	O
dogs	O
and	O
5	O
healthy	O
dogs	O
were	O
positive	O
for	O
CCoV	O
.	O
Nucleotide	O
sequences	O
of	O
N	O
-	O
terminal	O
region	O
of	O
spike	O
(	O
S	O
)	O
gene	O
indicated	O
that	O
CCoV	O
strains	O
were	O
divided	O
into	O
two	O
subgenotypes	O
,	O
CCoV	O
-	O
IIa	O
and	O
-	O
IIb	O
,	O
respectively	O
.	O

GP	O
IIb	O
/	O
IIIa	O
inhibitors	O
improve	O
outcome	O
in	O
patients	O
undergoing	O
percutaneous	O
coronary	B-ANAT
intervention	O
for	O
acute	O
coronary	B-ANAT
syndrome	O
.	O

The	O
authors	O
describe	O
a	O
patient	O
who	O
developed	O
acute	O
profound	O
thrombocytopenia	O
after	O
receiving	O
eptifibatide	O
before	O
emergent	O
coronary	B-ANAT
artery	I-ANAT
bypass	O
graft	B-ANAT
surgery	O
.	O

Celastrol	O
is	O
a	O
quinone	O
methide	O
triterpene	O
and	O
the	O
most	O
abundant	O
bioactive	O
constituent	O
isolated	O
from	O
the	O
root	B-ANAT
extracts	O
of	O
T	O
.	O
wilfordii	O
.	O

The	O
analysis	O
of	O
cytopathic	O
effects	O
demonstrated	O
that	O
pRNAT	O
-	O
2	O
and	O
pRNAT	O
-	O
3	O
could	O
protect	O
PK	O
-	O
15	O
cells	B-ANAT
against	O
pathological	O
changes	O
specifically	O
and	O
efficiently	O
.	O

Additionally	O
,	O
indirect	O
immunofluorescence	O
and	O
50	O
%	O
tissue	B-ANAT
culture	O
infectious	O
dose	O
(	O
TCID	O

We	O
aimed	O
to	O
evaluate	O
the	O
effect	O
of	O
PEEP	O
on	O
ICP	O
and	O
CPP	O
in	O
a	O
large	O
population	O
of	O
patients	O
with	O
acute	O
brain	B-ANAT
injury	O
and	O
varying	O
categories	O
of	O
acute	O
lung	B-ANAT
injury	O
,	O
defined	O
by	O
PaO	O
Retrospective	O
data	O
were	O
collected	O
from	O
341	O
patients	O
with	O
severe	O
acute	O
brain	B-ANAT
injury	O
admitted	O
to	O
the	O
ICU	O
between	O
2008	O
and	O
2015	O
.	O

TITLE	O
:	O
Effects	O
of	O
increased	O
positive	O
end	O
-	O
expiratory	O
pressure	O
on	O
intracranial	B-ANAT
pressure	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
a	O
protocol	O
of	O
a	O
prospective	O
physiological	O
study	O
.	O

Elastance	O
of	O
the	O
chest	B-ANAT
wall	I-ANAT
,	O
the	O
lungs	B-ANAT
and	O
the	O
respiratory	B-ANAT
system	I-ANAT
will	O
be	O
calculated	O
at	O
PEEP	O
levels	O
of	O
5	O
,	O
10	O
and	O
15	O
cm	O
H	O
The	O
study	O
protocol	O
and	O
consent	O
forms	O
were	O
approved	O
by	O
the	O
Institutional	O
Review	O
Board	O
of	O
Fujian	O
Provincial	O
Hospital	O
.	O

Swallowing	O
disorders	O
and	O
respiratory	O
muscular	B-ANAT
weakness	O
quickly	O
required	O
invasive	O
ventilation	O
.	O

Isolated	O
peripheral	B-ANAT
blood	I-ANAT
mononuclear	I-ANAT
cells	I-ANAT
from	O
all	O
time	O
points	O
were	O
negative	O
for	O
PCV	O
(	O
Type	O
2	O
),	O
PLHV	O
,	O
PRRSV	O
,	O
PCMV	O
,	O
and	O
PERV	O
-	O
A	O
,	O
PERV	O
-	O
B	O
,	O
and	O
PERV	O
-	O
C	O
by	O
PCR	O
analysis	O
in	O
all	O
six	O
recipient	O
animals	O
.	O

In	O
this	O
study	O
,	O
a	O
simple	O
way	O
to	O
conjugate	O
antigens	O
to	O
the	O
S	O
.	O
aureus	O
nanobioparticles	O
was	O
developed	O
by	O
utilizing	O
a	O
cell	B-ANAT
wall	I-ANAT
binding	O
domain	O
(	O
CBD	O
)	O
from	O
a	O
bacteriophage	O
lysin	O
PlyV12	O
.	O

TITLE	O
:	O
Severe	O
ARDS	O
caused	O
by	O
adenovirus	O
:	O
early	O
initiation	O
of	O
ECMO	O
plus	O
continuous	O
renal	B-ANAT
replacement	O
therapy	O
.	O

Levels	O
of	O
serum	B-ANAT
amylase	O
and	O
lipase	O
were	O
elevated	O
to	O
663	O
U	O
/	O
L	O
and	O
3	O
,	O
232	O
U	O
/	O
L	O
.	O
Contrast	O
-	O
enhanced	O
abdominal	B-ANAT
CT	O
showed	O
pancreatic	B-ANAT
swelling	O
,	O
peri	O
-	O
pancreatic	B-ANAT
fat	O
infiltration	O
and	O
fluid	O
collection	O
.	O

The	O
PaO	O
This	O
study	O
investigated	O
the	O
usefulness	O
of	O
the	O
PiCCO	O
system	O
in	O
improving	O
outcomes	O
for	O
patient	O
with	O
severe	O
thoracic	B-ANAT
trauma	O
and	O
ARDS	O
and	O
provided	O
new	O
evidence	O
for	O
fluid	O
management	O
in	O
critical	O
care	O
settings	O
.	O

A	O
6	O
-	O
month	O
-	O
old	O
girl	O
with	O
right	B-ANAT
lung	I-ANAT
agenesis	O
,	O
congenital	O
heart	B-ANAT
defects	O
,	O
and	O
ear	B-ANAT
anomalies	O
developed	O
repeated	O
and	O
serious	O
respiratory	O
infection	O
for	O
a	O
short	O
period	O
.	O

Dysfunction	O
of	O
the	O
upper	O
airway	B-ANAT
muscles	B-ANAT
controlling	O
airway	B-ANAT
calibre	O
and	O
collapsibility	O
is	O
implicated	O
in	O
the	O
pathophysiology	O
of	O
OSAS	O
,	O
and	O
sex	O
differences	O
in	O
the	O
neuro	O
-	O
mechanical	O
control	O
of	O
upper	O
airway	B-ANAT
patency	O
are	O
described	O
.	O

Intriguingly	O
,	O
female	O
advantage	O
intrinsic	O
to	O
upper	O
airway	B-ANAT
muscle	B-ANAT
exists	O
with	O
evidence	O
of	O
substantially	O
greater	O
loss	O
of	O
performance	O
in	O
male	O
muscle	B-ANAT
during	O
acute	O
exposure	O
to	O
severe	O
hypoxic	O
stress	O
.	O

Here	O
we	O
employed	O
differential	O
scanning	O
calorimetry	O
(	O
DSC	O
)	O
and	O
electron	O
spin	O
resonance	O
(	O
ESR	O
)	O
to	O
gather	O
information	O
on	O
the	O
membrane	B-ANAT
fusion	O
mechanism	O
promoted	O
by	O
two	O
putative	O
SARS	O
FPs	O
.	O

We	O
confirmed	O
the	O
clinical	O
utility	O
of	O
the	O
iROAD	O
assay	O
by	O
detecting	O
viral	O
RNAs	O
obtained	O
from	O
63	O
human	O
respiratory	B-ANAT
samples	I-ANAT
.	O

He	O
was	O
treated	O
with	O
non	O
-	O
rebreather	O
mask	O
and	O
intravenous	O
infusion	O
of	O
naloxone	O
with	O
gradual	O
improvement	O
of	O
consciousness	O
and	O
arterial	B-ANAT
blood	I-ANAT
gasses	O
.	O

CONCLUSIONS	O
:	O
Heroin	O
inhalation	O
may	O
cause	O
severe	O
complications	O
,	O
such	O
as	O
non	O
-	O
cardiogenic	O
pulmonary	B-ANAT
edema	O
,	O
rhabdomyolysis	O
or	O
myocardial	O
injury	O
.	O

In	O
ICU	O
case	O
studies	O
,	O
the	O
expected	O
odds	O
ratios	O
(	O
OR	O
)	O
of	O
death	O
among	O
patients	O
with	O
underlying	O
heart	B-ANAT
disease	O
or	O
renal	B-ANAT
disease	O
to	O
patients	O
without	O
such	O
comorbidities	O
were	O
0	O
.	O
6	O
(	O
95	O
%	O
Confidence	O
Interval	O
(	O
CI	O
):	O
0	O
.	O
1	O
,	O
4	O
.	O
3	O
)	O
and	O
0	O
.	O
6	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
0	O
,	O
2	O
.	O
1	O
),	O
respectively	O
,	O
while	O
the	O
ORs	O
were	O
3	O
.	O
8	O
(	O
95	O
%	O
CI	O
:	O
3	O
.	O
4	O
,	O
4	O
.	O
2	O
)	O
and	O
2	O
.	O
4	O
(	O
95	O
%	O
CI	O
:	O
2	O
.	O
0	O
,	O
2	O
.	O
9	O
),	O
respectively	O
,	O
in	O
studies	O
with	O
other	O
types	O
of	O
designs	O
.	O

TITLE	O
:	O
Lung	B-ANAT
ultrasound	O
can	O
be	O
used	O
to	O
predict	O
the	O
potential	O
of	O
prone	O
positioning	O
and	O
assess	O
prognosis	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

TITLE	O
:	O
Differential	O
Cell	B-ANAT
Count	O
and	O
CRP	O
Level	O
in	O
Blood	B-ANAT
as	O
Predictors	O
for	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	O
Infection	O
in	O
Acute	O
Febrile	O
Patients	O
during	O
Nosocomial	O
Outbreak	O
.	O

All	O
of	O
these	O
involved	O
interferon	O
-	O
stimulated	O
genes	O
(	O
ISGs	O
)	O
which	O
were	O
up	O
-	O
regulated	O
in	O
jejunums	B-ANAT
by	O
both	O
of	O
the	O
PEDV	O
-	O
infected	O
groups	O
.	O

Following	O
vaccination	O
,	O
swabs	O
and	O
tissues	B-ANAT
collected	O
at	O
intervals	O
were	O
pooled	O
and	O
RNA	O
was	O
extracted	O
for	O
detection	O
of	O
IBV	O
by	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
.	O

ABSTRACT	O
:	O
The	O
occurrence	O
of	O
a	O
noninfectious	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
is	O
a	O
rare	O
but	O
life	O
-	O
threatening	O
side	O
effect	O
of	O
infliximab	O
,	O
an	O
antitumor	O
necrosis	O
factor	O
alpha	O
antibody	O
.	O

This	O
review	O
emphasises	O
the	O
role	O
of	O
the	O
tight	B-ANAT
junction	I-ANAT
of	O
the	O
airway	B-ANAT
epithelium	B-ANAT
as	O
the	O
predominating	O
structure	O
conferring	O
epithelial	O
tightness	O
and	O
preventing	O
exudate	B-ANAT
formation	O
and	O
the	O
impact	O
of	O
inflammatory	O
perturbations	O
on	O
their	O
function	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
is	O
widely	O
used	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
myocarditis	O
.	O

Survival	O
to	O
decannulation	O
was	O
83	O
%	O
and	O
to	O
discharge	B-ANAT
was	O
66	O
%.	O

TITLE	O
:	O
Antiviral	O
Innate	O
Immune	O
Response	O
Interferes	O
with	O
the	O
Formation	O
of	O
Replication	O
-	O
Associated	O
Membrane	B-ANAT
Structures	O
Induced	O
by	O
a	O
Positive	O
-	O
Strand	O
RNA	O
Virus	O
.	O

We	O
hypothesized	O
that	O
the	O
innate	O
immune	O
response	O
has	O
tools	O
to	O
counteract	O
the	O
formation	O
of	O
these	O
virus	O
-	O
induced	O
replication	O
organelles	B-ANAT
in	O
order	O
to	O
inhibit	O
virus	O
replication	O
.	O

Thus	O
,	O
this	O
setup	O
can	O
be	O
used	O
to	O
identify	O
immune	O
effectors	O
that	O
specifically	O
target	O
the	O
(	O
formation	O
of	O
)	O
virus	O
-	O
induced	O
membrane	B-ANAT
structures	O
.	O

The	O
members	O
of	O
the	O
Respiratory	O
Therapists	O
Committee	O
of	O
the	O
Sociedad	O
Argentina	O
de	O
Terapia	O
Intensiva	O
performed	O
a	O
narrative	O
review	O
with	O
the	O
objective	O
of	O
discovering	O
the	O
available	O
evidence	O
related	O
to	O
the	O
implementation	O
of	O
prone	O
position	O
,	O
changes	O
produced	O
in	O
the	O
respiratory	B-ANAT
system	I-ANAT
due	O
to	O
the	O
application	O
of	O
this	O
maneuver	O
,	O
and	O
its	O
impact	O
on	O
mortality	O
.	O

We	O
have	O
previously	O
shown	O
that	O
a	O
proportion	O
of	O
DBA	O
/	O
2	O
mice	O
infected	O
with	O
Plasmodium	O
berghei	O
ANKA	O
(	O
PbA	O
)	O
develop	O
ALI	O
/	O
ARDS	O
and	O
that	O
these	O
mice	O
recapitulate	O
various	O
aspects	O
of	O
the	O
human	O
syndrome	O
,	O
such	O
as	O
pulmonary	B-ANAT
edema	O
,	O
hemorrhaging	O
,	O
pleural	B-ANAT
effusion	I-ANAT
and	O
hypoxemia	O
.	O

The	O
depletion	O
of	O
neutrophils	B-ANAT
,	O
treatment	O
with	O
AMD3100	O
(	O
a	O
CXCR4	O
antagonist	O
),	O
Pulmozyme	O
(	O
human	O
recombinant	O
DNase	O
)	O
or	O
Sivelestat	O
(	O
inhibitor	O
of	O
neutrophil	B-ANAT
elastase	O
)	O
decreased	O
the	O
development	O
of	O
malaria	O
-	O
associated	O
ALI	O
/	O
ARDS	O
and	O
significantly	O
increased	O
mouse	O
survival	O
.	O

Sera	B-ANAT
,	O
fecal	B-ANAT
swabs	O
,	O
and	O
different	O
tissue	B-ANAT
samples	O
were	O
collected	O
on	O
different	O
days	O
post	O
infection	O
.	O

Most	O
outpatients	O
with	O
community	O
-	O
acquired	O
pneumonia	O
do	O
not	O
require	O
microbiologic	O
testing	O
of	O
sputum	B-ANAT
or	O
blood	B-ANAT
and	O
can	O
be	O
treated	O
empirically	O
with	O
a	O
macrolide	O
,	O
doxycycline	O
,	O
or	O
a	O
respiratory	O
fluoroquinolone	O
.	O

The	O
envenomed	O
victims	O
may	O
present	O
in	O
organ	B-ANAT
and	O
/	O
or	O
system	O
failure	O
with	O
muscle	B-ANAT
paralysis	O
,	O
respiratory	O
failure	O
,	O
circulatory	O
instability	O
,	O
acute	O
kidney	B-ANAT
injury	O
,	O
severe	O
coagulation	O
disorder	O
,	O
and	O
local	O
disability	O
-	O
compartment	B-ANAT
syndrome	O
and	O
necrosis	O
.	O

After	O
a	O
median	O
follow	O
-	O
up	O
of	O
25	O
(	O
11	O
-	O
29	O
)	O
months	O
,	O
only	O
one	O
cardiovascular	B-ANAT
event	O
occurred	O
:	O
one	O
of	O
the	O
LGE	O
-	O
positive	O
patients	O
with	O
a	O
high	O
cardiovascular	B-ANAT
risk	O
profile	O
suffered	O
an	O
acute	O
coronary	B-ANAT
syndrome	O
.	O

After	O
recording	O
clinical	O
and	O
demographic	O
data	O
,	O
twin	O
swabs	O
(	O
nasopharyngeal	B-ANAT
and	O
throat	B-ANAT
)	O
were	O
collected	O
from	O
each	O
participant	O
,	O
pooled	O
in	O
viral	O
transport	O
media	B-ANAT
and	O
tested	O
by	O
real	O
-	O
time	O
RT	O
PCR	O
for	O
MERS	O
-	O
CoV	O
and	O
influenza	O
A	O
and	O
B	O
viruses	O
and	O
their	O
subtypes	O
.	O

However	O
,	O
the	O
lack	O
of	O
professional	O
immune	O
cells	B-ANAT
such	O
as	O
dendritic	B-ANAT
cells	I-ANAT
(	O
DC	O
)	O
and	O
macrophages	B-ANAT
has	O
greatly	O
limited	O
the	O
significance	O
of	O
current	O
investigations	O
.	O

MERS	O
-	O
CoV	O
S	O
protein	O
represents	O
a	O
key	O
target	O
for	O
developing	O
therapeutics	O
to	O
block	O
viral	O
entry	O
and	O
inhibit	O
membrane	B-ANAT
fusion	O
.	O

To	O
assess	O
the	O
properties	O
of	O
various	O
diagnostic	O
assays	O
for	O
the	O
detection	O
of	O
PEDV	O
infection	O
,	O
multiple	O
panels	O
of	O
porcine	O
sera	B-ANAT
have	O
been	O
shared	O
and	O
tested	O
for	O
the	O
presence	O
of	O
antibodies	O
against	O
PEDV	O
in	O
an	O
inter	O
-	O
laboratory	O
ring	O
trial	O
.	O

Median	O
plasma	B-ANAT
concentrations	O
of	O
TF	O
and	O
PAI	O
-	O
1	O
were	O
significantly	O
higher	O
at	O
CONCLUSIONS	O
:	O
This	O
pilot	O
study	O
showed	O
that	O
increased	O
plasma	B-ANAT
concentrations	O
of	O
TF	O
and	O
PAI	O
-	O
1	O
might	O
support	O
ARDS	O
diagnoses	O
in	O
mechanically	O
ventilated	O
patients	O
after	O
7	O
days	O
in	O
ICU	O
.	O

After	O
5	O
days	O
of	O
treatment	O
,	O
the	O
low	O
-	O
and	O
high	O
-	O
dose	O
groups	O
had	O
significant	O
reductions	O
in	O
serum	B-ANAT
levels	O
of	O
tumor	O
necrosis	O
factor	O
-	O
Î±	O
,	O
interleukin	O
-	O
6	O
,	O
and	O
C	O
-	O
reactive	O
protein	O
,	O
and	O
there	O
were	O
no	O
significant	O
differences	O
in	O
the	O
reductions	O
of	O
these	O
markers	O
between	O
the	O
two	O
groups	O
.	O

RESULTS	O
:	O
After	O
5	O
days	O
of	O
treatment	O
,	O
the	O
low	O
-	O
and	O
high	O
-	O
dose	O
groups	O
had	O
significant	O
reductions	O
in	O
serum	B-ANAT
levels	O
of	O
tumor	O
necrosis	O
factor	O
-	O
Î±	O
,	O
interleukin	O
-	O
6	O
,	O
and	O
C	O
-	O
reactive	O
protein	O
,	O
and	O
there	O
were	O
no	O
significant	O
differences	O
in	O
the	O
reductions	O
of	O
these	O
markers	O
between	O
the	O
two	O
groups	O
.	O

We	O
hypothesized	O
that	O
endothelial	B-ANAT
injuries	O
are	O
an	O
important	O
aspect	O
of	O
pathogenesis	O
in	O
severe	O
DLI	O
.	O

Genotyping	O
confirmed	O
HEV	B-ANAT
in	O
a	O
transfused	O
platelet	B-ANAT
pool	O
and	O
the	O
donor	O
.	O

1	O
h	O
after	O
the	O
first	O
administration	O
of	O
G	O
-	O
CSF	B-ANAT
,	O
the	O
donor	O
suddenly	O
presented	O
with	O
dry	O
cough	O
and	O
dyspnea	O
.	O

Developing	O
therapies	O
to	O
protect	O
endothelial	B-ANAT
barrier	O
integrity	O
and	O
stabilizing	O
gas	O
exchange	O
is	O
getting	O
more	O
and	O
more	O
attention	O
.	O

TITLE	O
:	O
[	O
Risk	O
factors	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
following	O
surgeries	O
for	O
pediatric	O
critical	O
and	O
complex	O
congenital	O
heart	B-ANAT
disease	O
].	O

Logistic	O
regression	O
analyses	O
showed	O
that	O
intraoperative	O
ACC	O
time	O
,	O
CPB	O
time	O
,	O
the	O
maximum	O
increasing	O
rate	O
of	O
lactic	O
acid	O
within	O
24	O
h	O
after	O
operation	O
,	O
serum	B-ANAT
procalcitonin	O
24	O
h	O
after	O
operation	O
and	O
intraoperative	O
blood	B-ANAT
loss	O
were	O
independent	O
risk	O
factors	O
for	O
postoperative	O
ARDS	O
.	O

Here	O
,	O
Sprague	O
Dawley	O
rats	O
were	O
administered	O
a	O
single	O
dose	O
of	O
GRFT	O
at	O
10	O
or	O
20	O
mg	O
/	O
kg	O
by	O
intravenous	O
,	O
oral	B-ANAT
,	O
and	O
subcutaneous	O
routes	O
,	O
respectively	O
,	O
and	O
serum	B-ANAT
GRFT	O
levels	O
were	O
measured	O
at	O
select	O
time	O
points	O
.	O

Strain	O
D998	O
/	O
15	O
had	O
a	O
distinct	O
phylogenetic	O
position	O
within	O
clade	O
A	O
,	O
being	O
more	O
closely	O
related	O
to	O
the	O
dromedary	O
isolate	O
NRCE	O
-	O
HKU205	O
from	O
Egypt	O
than	O
to	O
the	O
human	O
isolates	O
EMC	B-ANAT
/	O
2012	O
and	O
Jordan	O
-	O
N3	O
/	O
2012	O
.	O

Cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
and	O
pseudotyped	O
virus	O
infectivity	O
assays	O
demonstrated	O
that	O
the	O
S2	O
'	O
substitutions	O
decreased	O
spike	O
-	O
mediated	O
fusion	O
and	O
viral	O
entry	O
.	O

Viruses	O
,	O
bacteria	O
and	O
pathogen	O
-	O
related	O
molecules	O
interact	O
with	O
cells	B-ANAT
present	O
in	O
the	O
human	O
alveolus	B-ANAT
by	O
numerous	O
,	O
yet	O
poorly	O
understood	O
ways	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
,	O
PaOâ	O
/	O
FiOâ	O
<	O
100	O
on	O
PEEP	O
â¥	O
5	O
cm	O
HâO	O
)	O
is	O
treated	O
using	O
controlled	O
mechanical	O
ventilation	O
(	O
CMV	O
),	O
recently	O
combined	O
with	O
muscle	B-ANAT
relaxation	O
for	O
48	O
h	O
and	O
prone	O
positioning	O
.	O

However	O
,	O
conditionalities	O
are	O
stringent	O
:	O
upfront	O
circulatory	O
optimization	O
,	O
upright	O
positioning	O
,	O
lowered	O
VOâ	O
,	O
lowered	O
acidotic	O
and	O
hypercapnic	O
drives	O
,	O
sedation	O
without	O
ventilatory	O
depression	O
and	O
without	O
lowered	O
muscular	B-ANAT
tone	O
.	O

Lung	B-ANAT
function	O
and	O
the	O
percentages	O
of	O
eosinophils	B-ANAT
in	O
induced	B-ANAT
sputum	I-ANAT
samples	O
were	O
determined	O
,	O
and	O
the	O
frequencies	O
of	O
severe	O
asthma	O
exacerbations	O
during	O
the	O
previous	O
year	O
were	O
evaluated	O
in	O
the	O
group	O
of	O
patients	O
with	O
asthma	O
.	O

The	O
sequence	O
was	O
analysed	O
for	O
the	O
presence	O
of	O
coding	O
and	O
non	O
-	O
coding	O
features	O
,	O
its	O
similarity	O
with	O
reported	O
isolates	O
and	O
epitope	O
analysis	O
of	O
capsid	B-ANAT
structural	O
protein	O
.	O

The	O
genome	O
was	O
comprised	O
of	O
13	O
bp	O
5	O
'-	O
UTR	O
,	O
three	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
including	O
ORF1a	O
encoding	O
serine	O
protease	O
,	O
ORF1b	O
encoding	O
RNA	O
dependent	O
RNA	O
polymerase	O
(	O
RdRp	O
)	O
and	O
ORF2	O
encoding	O
capsid	B-ANAT
protein	O
,	O
and	O
298	O
bp	O
of	O
3	O
'-	O
UTR	O
which	O
harboured	O
two	O
corona	O
virus	O
stem	B-ANAT
loop	O
II	O
like	O
""""	O
s2m	O
""""	O
motifs	O
and	O
a	O
poly	O
A	O
stretch	O
of	O
19	O
nucleotides	O
.	O

These	O
can	O
be	O
engineered	O
to	O
contain	O
reporter	O
genes	O
such	O
as	O
luciferase	O
,	O
enabling	O
quantification	O
of	O
virus	O
entry	O
events	O
upon	O
pseudotyped	O
particle	O
infection	O
with	O
susceptible	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
Acute	O
exacerbation	O
(	O
AE	O
)	O
is	O
a	O
severe	O
complication	O
of	O
idiopathic	O
pulmonary	B-ANAT
fibrosis	O
(	O
IPF	O
),	O
which	O
shares	O
some	O
common	O
pathological	O
features	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

sVLP	O
retained	O
certain	O
parvovirus	O
characteristics	O
,	O
such	O
as	O
the	O
ability	O
to	O
agglutinate	O
pig	O
erythrocytes	B-ANAT
,	O
and	O
structural	O
morphology	O
similar	O
to	O
CPV	O
virions	B-ANAT
.	O

Immunization	O
with	O
sVLP	O
induced	O
RBD	O
-	O
specific	O
humoral	O
and	O
cellular	B-ANAT
immune	O
responses	O
in	O
mice	O
.	O

Taken	O
together	O
,	O
our	O
studies	O
demonstrate	O
a	O
specific	O
interaction	O
of	O
the	O
N	O
protein	O
with	O
the	O
host	B-ANAT
cell	I-ANAT
protein	O
NPM1	O
in	O
the	O
nucleolus	B-ANAT
.	O

A	O
59	O
-	O
year	O
old	O
man	O
staying	O
near	O
the	O
Belum	O
-	O
Temengor	O
rainforest	O
at	O
the	O
Malaysia	O
-	O
Thailand	O
border	B-ANAT
was	O
admitted	O
with	O
fever	O
for	O
6	O
days	O
,	O
with	O
respiratory	O
distress	O
.	O

Through	O
systematic	O
surveillance	O
in	O
Egypt	O
,	O
nasal	B-ANAT
,	O
rectal	O
,	O
milk	O
,	O
urine	B-ANAT
and	O
serum	B-ANAT
samples	O
were	O
collected	O
from	O
camels	O
between	O
June	O
2014	O
and	O
February	O
2016	O
.	O

This	O
paper	O
focuses	O
on	O
the	O
mechanisms	O
of	O
the	O
military	O
-	O
cooperative	O
emergency	O
response	O
to	O
infectious	O
diseases	O
--	O
the	O
joint	B-ANAT
working	O
mechanism	O
,	O
the	O
information	O
-	O
sharing	O
mechanism	O
,	O
the	O
research	O
collaboration	O
mechanism	O
,	O
and	O
the	O
joint	B-ANAT
disposal	O
mechanism	O
--	O
and	O
presents	O
a	O
sorted	O
summary	O
of	O
the	O
practices	O
and	O
experiences	O
of	O
cooperative	O
emergency	O
responses	O
to	O
infectious	O
diseases	O
.	O

In	O
the	O
future	O
,	O
the	O
Chinese	O
military	O
and	O
the	O
civilian	O
sector	O
will	O
further	O
strengthen	O
the	O
cooperative	O
joint	B-ANAT
command	O
system	O
and	O
emergency	O
rescue	O
force	O
and	O
will	O
reinforce	O
their	O
collaborative	O
information	O
-	O
sharing	O
platform	O
and	O
technical	O
equipment	O
system	O
to	O
further	O
improve	O
military	O
-	O
civilian	O
collaborative	O
emergency	O
infectious	O
diseases	O
disposal	O
,	O
advance	O
the	O
level	O
of	O
infectious	O
disease	O
prevention	O
and	O
control	O
,	O
and	O
maintain	O
public	O
health	O
.	O

The	O
most	O
important	O
imaging	O
techniques	O
include	O
chest	B-ANAT
X	O
â	O
ray	O
and	O
computed	O
tomography	O
(	O
CT	O
)	O
of	O
the	O
chest	B-ANAT
.	O

Although	O
a	O
definite	O
diagnosis	O
is	O
sometimes	O
difficult	O
or	O
even	O
impossible	O
to	O
establish	O
using	O
chest	B-ANAT
X	O
â	O
ray	O
or	O
CT	O
,	O
there	O
are	O
several	O
findings	O
indicative	O
of	O
intrapulmonary	O
or	O
extrapulmonary	O
complications	O
of	O
pneumonia	O
.	O

Furthermore	O
,	O
fever	O
with	O
cough	O
and	O
shortness	O
of	O
breath	B-ANAT
(	O
SOB	B-ANAT
)	O
(	O
n	O
=	O
39	O
;	O
20	O
.	O
5	O
%),	O
fever	O
with	O
cough	O
(	O
n	O
=	O
29	O
;	O
15	O
.	O
3	O
%),	O
fever	O
(	O
n	O
=	O
18	O
;	O
9	O
.	O
5	O
%),	O
and	O
fever	O
with	O
SOB	B-ANAT
(	O
n	O
=	O
13	O
;	O
6	O
.	O
8	O
%),	O
were	O
the	O
most	O
common	O
clinical	O
manifestations	O
associated	O
with	O
confirmed	O
MERS	O
-	O
CoV	O
cases	O
.	O

ck	O
/	O
CH	O
/	O
LGX	O
/	O
111119	O
is	O
a	O
nephropathogenic	O
strain	O
,	O
although	O
it	O
had	O
broader	O
tissue	B-ANAT
tropism	O
(	O
respiratory	O
,	O
digestive	O
,	O
urinary	O
,	O
and	O
reproductive	O
tracts	B-ANAT
)	O
among	O
chickens	O
challenged	O
at	O
one	O
day	O
old	O
.	O

Infection	O
of	O
the	O
oviducts	B-ANAT
with	O
ck	O
/	O
CH	O
/	O
LGX	O
/	O
111119	O
found	O
in	O
this	O
study	O
may	O
have	O
severe	O
implications	O
because	O
the	O
virus	O
will	O
likely	O
induce	O
the	O
occurrence	O
of	O
false	O
layers	B-ANAT
.	O

Conventional	O
intratracheal	O
inoculation	O
of	O
a	O
liquid	O
suspension	O
of	O
H5N1	O
influenza	O
virus	O
in	O
nonhuman	O
primates	O
likely	O
results	O
in	O
efficient	O
clearance	O
of	O
virus	O
within	O
the	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
and	O
rarely	O
produces	O
severe	O
disease	O
.	O

Here	O
,	O
we	O
report	O
for	O
the	O
first	O
time	O
,	O
the	O
monitoring	O
of	O
barometric	O
whole	B-ANAT
body	I-ANAT
plethysmography	O
for	O
pulmonary	B-ANAT
function	O
tests	O
in	O
non	O
-	O
anesthetized	O
ricin	O
-	O
treated	O
pigs	O
.	O

The	O
establishment	O
of	O
this	O
animal	O
model	O
of	O
pulmonary	B-ANAT
ricinosis	O
should	O
help	O
in	O
the	O
pursuit	O
of	O
efficient	O
medical	O
countermeasures	O
specifically	O
tailored	O
to	O
deal	O
with	O
the	O
respiratory	O
deficiencies	O
stemming	O
from	O
ricin	O
-	O
induced	O
ARDS	O
.	O

TITLE	O
:	O
Electrostatic	O
layer	B-ANAT
-	O
by	O
-	O
layer	B-ANAT
construction	O
of	O
fibrous	O
TMV	O
biofilms	O
.	O

Healthy	O
adults	O
(	O
18	O
-	O
45	O
years	O
of	O
age	O
)	O
were	O
randomized	O
into	O
ARMS	B-ANAT
-	O
I	O
or	O
placebo	O
group	O
(	O
50	O
subjects	O
each	O
).	O

The	O
primary	O
objectives	O
were	O
to	O
establish	O
whether	O
ARMS	B-ANAT
-	O
I	O
decreased	O
the	O
frequency	O
,	O
severity	O
or	O
duration	O
of	O
URIs	O
.	O

RESULTS	O
:	O
Of	O
the	O
94	O
individuals	O
who	O
completed	O
the	O
study	O
(	O
placebo	O
:	O
n	O
=	O
44	O
,	O
ARMS	B-ANAT
-	O
I	O
:	O
n	O
=	O
50	O
),	O
six	O
presented	O
with	O
confirmed	O
URI	O
(	O
placebo	O
:	O
4	O
,	O
ARMS	B-ANAT
-	O
I	O
:	O
2	O
),	O
representing	O
a	O
55	O
%	O
relative	O
reduction	O
,	O
albeit	O
this	O
was	O
statistically	O
not	O
significant	O
).	O

Treatment	O
was	O
started	O
once	O
the	O
diagnosis	O
of	O
disseminated	O
adenovirus	O
infection	O
was	O
made	O
;	O
however	O
,	O
at	O
that	O
time	O
patient	O
was	O
suffering	O
from	O
refractory	O
hypoxaemia	O
,	O
respiratory	O
acidosis	O
,	O
right	B-ANAT
heart	I-ANAT
failure	O
and	O
septic	O
shock	O
.	O

ABSTRACT	O
:	O
Optimal	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
is	O
unknown	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
on	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
receiving	O
mechanical	O
ventilation	O
with	O
very	O
low	O
tidal	O
volume	O
.	O

TITLE	O
:	O
Clinical	O
validation	O
of	O
3	O
commercial	O
real	O
-	O
time	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
assays	O
for	O
the	O
detection	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
from	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
specimens	O
.	O

The	O
infected	O
group	O
exhibited	O
significantly	O
higher	O
plasma	B-ANAT
uric	O
acid	O
,	O
blood	B-ANAT
urea	O
nitrogen	O
,	O
and	O
creatinine	O
levels	O
than	O
the	O
control	O
group	O
at	O
3	O
dpi	O
.	O

Our	O
results	O
indicated	O
that	O
NIBV	O
infection	O
caused	O
liver	B-ANAT
and	O
kidney	B-ANAT
damage	O
in	O
the	O
embryonic	B-ANAT
chickens	O
,	O
and	O
the	O
results	O
also	O
demonstrated	O
that	O
the	O
liver	B-ANAT
and	O
kidney	B-ANAT
damage	O
was	O
strongly	O
related	O
to	O
the	O
tissue	B-ANAT
viral	O
load	O
following	O
NIBV	O
infection	O
in	O
embryonic	B-ANAT
chickens	O
.	O

RNA	O
extraction	O
and	O
RT	O
-	O
nPCR	O
for	O
FCoV	O
were	O
performed	O
on	O
thirty	O
-	O
two	O
samples	O
(	O
11	O
faeces	B-ANAT
,	O
9	O
blood	B-ANAT
,	O
8	O
effusions	O
,	O
and	O
4	O
lymph	B-ANAT
nodes	I-ANAT
)	O
collected	O
from	O
27	O
cats	O
.	O

Although	O
IPEC	O
-	O
J2	O
cells	B-ANAT
responded	O
to	O
both	O
IFN	O
-	O
alpha	O
and	O
lambda	O
,	O
transcriptional	O
profiling	O
of	O
ISGs	O
(	O
specifically	O
ISG15	O
,	O
OASL	O
,	O
MxA	O
,	O
and	O
IFITMs	O
)	O
differed	O
when	O
induced	O
by	O
either	O
IFN	O
-	O
alpha	O
or	O
rpIFN	O
-	O
L	O
.	O
Therefore	O
,	O
our	O
data	O
provide	O
the	O
experimental	O
evidence	O
that	O
porcine	O
IFN	O
-	O
L	O
suppresses	O
PEDV	O
infection	O
of	O
IPEC	O
-	O
J2	O
cells	B-ANAT
,	O
which	O
may	O
offer	O
a	O
promising	O
therapeutic	O
for	O
combating	O
PED	O
in	O
piglets	O
.	O

FmoPV	O
RNA	O
-	O
positive	O
cats	O
had	O
lower	O
median	O
red	B-ANAT
blood	I-ANAT
cell	I-ANAT
count	O
,	O
haemoglobin	O
,	O
albumin	O
,	O
albumin	O
/	O
globulin	O
and	O
urobilinogen	O
and	O
higher	O
alanine	O
transaminase	O
,	O
alkaline	O
phosphatase	O
and	O
bilirubin	O
compared	O
with	O
non	O
-	O
infected	O
cats	O
.	O

TITLE	O
:	O
Novel	O
Approach	O
for	O
Isolation	O
and	O
Identification	O
of	O
Porcine	O
Epidemic	O
Diarrhea	O
Virus	O
(	O
PEDV	O
)	O
Strain	O
NJ	O
Using	O
Porcine	O
Intestinal	B-ANAT
Epithelial	B-ANAT
Cells	I-ANAT
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Corona	O
Virus	O
(	O
MERS	O
-	O
CoV	O
)	O
is	O
transmitted	O
via	O
the	O
respiratory	B-ANAT
tract	I-ANAT
and	O
causes	O
severe	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
by	O
infecting	O
lung	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
and	O
macrophages	B-ANAT
.	O

Macrophages	B-ANAT
can	O
readily	O
recognize	O
the	O
virus	O
and	O
eliminate	O
it	O
.	O

Respiratory	B-ANAT
samples	I-ANAT
from	O
35	O
cases	O
were	O
tested	O
for	O
up	O
to	O
20	O
respiratory	O
pathogens	O
.	O

TITLE	O
:	O
Dynamic	O
driving	O
pressure	O
associated	O
mortality	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

To	O
examine	O
this	O
question	O
,	O
we	O
used	O
4	O
cell	B-ANAT
types	O
:	O
human	O
immature	O
dendritic	B-ANAT
cells	I-ANAT
and	O
NIH3T3	O
cells	B-ANAT
expressing	O
either	O
wild	O
-	O
type	O
DC	O
-	O
SIGN	O
or	O
2	O
internalization	O
-	O
deficient	O
DC	O
-	O
SIGN	O
mutants	O
,	O
in	O
which	O
either	O
the	O
3	O
cytoplasmic	B-ANAT
internalization	O
motifs	O
are	O
silenced	O
by	O
alanine	O
substitutions	O
or	O
the	O
cytoplasmic	B-ANAT
region	I-ANAT
is	O
truncated	O
.	O

Moreover	O
,	O
all	O
3	O
DC	O
-	O
SIGN	O
molecules	O
on	O
NIH3T3	O
cells	B-ANAT
supported	O
cell	B-ANAT
infection	O
.	O

ABSTRACT	O
:	O
The	O
prevailing	O
morbidity	O
and	O
mortality	O
in	O
sepsis	O
are	O
largely	O
due	O
to	O
multiple	O
organ	B-ANAT
dysfunction	O
(	O
MOD	O
),	O
most	O
commonly	O
lung	B-ANAT
injury	O
,	O
as	O
well	O
as	O
renal	B-ANAT
and	O
cardiac	B-ANAT
dysfunction	O
.	O

Human	O
and	O
animal	O
studies	O
have	O
shown	O
that	O
pulmonary	B-ANAT
thrombosis	O
is	O
common	O
in	O
sepsis	O
-	O
induced	O
ARDS	O
,	O
and	O
preclinical	O
studies	O
have	O
shown	O
that	O
anticoagulation	O
may	O
improve	O
outcome	O
following	O
sepsis	O
challenge	O
.	O

Utilizing	O
this	O
knowledge	O
,	O
we	O
constructed	O
an	O
internal	O
hemagglutinin	O
(	O
HA	O
)	O
tag	O
that	O
replaced	O
the	O
P	O
/	O
S	O
.	O
We	O
found	O
that	O
nsp15	O
-	O
HA	O
was	O
localized	O
to	O
discrete	O
perinuclear	O
puncta	O
and	O
strongly	O
colocalized	O
with	O
nsp8	O
and	O
nsp12	O
,	O
both	O
well	O
-	O
defined	O
members	O
of	O
the	O
RTC	O
,	O
but	O
not	O
the	O
membrane	B-ANAT
(	O
M	O
)	O
protein	O
,	O
involved	O
in	O
virus	O
assembly	O
.	O

TITLE	O
:	O
Neurovirulent	O
Murine	O
Coronavirus	O
JHM	O
.	O
SD	O
Uses	O
Cellular	B-ANAT
Zinc	O
Metalloproteases	O
for	O
Virus	O
Entry	O
and	O
Cell	B-ANAT
-	O
Cell	B-ANAT
Fusion	O
.	O

However	O
,	O
TMPRSS2	O
overexpression	O
decreased	O
MHV	O
structural	O
protein	O
expression	O
,	O
release	O
of	O
infectious	O
particles	O
,	O
and	O
syncytium	B-ANAT
formation	O
,	O
and	O
endogenous	O
serine	O
protease	O
activity	O
did	O
not	O
contribute	O
greatly	O
to	O
infection	O
.	O

ABSTRACT	O
:	O
Since	O
the	O
first	O
case	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
in	O
South	O
Korea	O
was	O
reported	O
on	O
20	O
Data	O
were	O
obtained	O
through	O
the	O
MERS	O
portal	B-ANAT
by	O
the	O
Ministry	O
for	O
Health	O
and	O
Welfare	O
(	O
MOHW	O
)	O
and	O
Korea	O
Centres	O
for	O
Disease	O
Control	O
and	O
Prevention	O
,	O
press	O
releases	O
by	O
MOHW	O
,	O
and	O
reports	O
by	O
the	O
MERS	O
Policy	O
Committee	O
of	O
the	O
Korean	O
Medical	O
Association	O
.	O

Compounds	O
2	O
and	O
17	O
significantly	O
reduced	O
PEDV	O
nucleocapsid	B-ANAT
and	O
spike	O
protein	O
synthesis	O
compared	O
with	O
azauridin	O
as	O
a	O
positive	O
control	O
.	O

Replication	O
of	O
EndoU	O
-	O
deficient	O
coronaviruses	O
is	O
greatly	O
attenuated	O
in	O
vivo	O
and	O
severely	O
restricted	O
in	O
primary	O
cells	B-ANAT
even	O
during	O
the	O
early	O
phase	O
of	O
the	O
infection	O
.	O

Primary	O
duodenal	B-ANAT
ulcers	O
are	O
rare	O
in	O
children	O
but	O
stress	O
induced	O
ulceration	O
in	O
stomach	B-ANAT
occurs	O
more	O
often	O
in	O
neonatal	O
period	O
due	O
to	O
birth	O
asphyxia	O
,	O
prolonged	O
labour	O
,	O
cesarean	O
deliveries	O
,	O
instrumentations	O
,	O
respiratory	O
distress	O
syndrome	O
and	O
sepsis	O
.	O

To	O
bridge	O
this	O
gap	O
,	O
14	O
commercially	O
available	O
primary	O
antibodies	O
were	O
tested	O
for	O
their	O
suitability	O
to	O
demonstrate	O
immune	O
cell	B-ANAT
populations	O
on	O
formalin	O
fixed	B-ANAT
paraffin	O
-	O
embedded	O
(	O
FFPE	O
)	O
tissue	B-ANAT
sections	O
of	O
dromedaries	O
,	O
Bactrian	O
camels	O
,	O
llamas	O
,	O
and	O
alpacas	O
in	O
the	O
present	O
study	O
.	O

Out	O
of	O
these	O
,	O
9	O
antibodies	O
directed	O
against	O
CD3	O
,	O
CD20	O
,	O
CD79Î±	O
,	O
HLA	B-ANAT
-	O
DR	O
,	O
Iba	O
-	O
1	O
,	O
myeloid	O
/	O
histiocyte	B-ANAT
antigen	O
,	O
CD204	O
,	O
CD208	O
,	O
and	O
CD68	O
antigen	O
exhibited	O
distinct	O
immunoreaction	O
patterns	O
to	O
certain	O
camelid	O
immune	O
cell	B-ANAT
subsets	O
.	O

TITLE	O
:	O
Pediatric	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
in	O
Pediatric	O
Allogeneic	O
Hematopoietic	B-ANAT
Stem	I-ANAT
Cell	I-ANAT
Transplants	B-ANAT
:	O
A	O
Multicenter	O
Study	O
.	O

Our	O
results	O
also	O
indicate	O
that	O
a	O
higher	O
than	O
normal	O
initial	O
cardiac	B-ANAT
output	O
may	O
provide	O
protection	O
against	O
the	O
potentially	O
negative	O
effects	O
of	O
high	O
intrathoracic	O
pressures	O
associated	O
with	O
RMs	O
on	O
cardiac	B-ANAT
function	O
.	O

Eight	O
patients	O
who	O
had	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
showed	O
recovery	O
of	O
heart	B-ANAT
and	I-ANAT
lung	I-ANAT
function	O
after	O
ECMO	O
therapy	O
.	O

TITLE	O
:	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
Outcomes	O
in	O
Acute	O
Respiratory	O
Distress	O
Treatment	O
:	O
Case	O
Study	O
in	O
a	O
Chinese	O
Referral	O
Center	O
.	O

APACHE	O
II	O
score	O
on	O
admission	O
,	O
onset	O
of	O
acute	O
kidney	B-ANAT
injury	O
,	O
and	O
membrane	B-ANAT
oxygenator	O
replacement	O
,	O
and	O
the	O
evolution	O
of	O
levels	O
of	O
urea	O
nitrogen	O
,	O
platelet	B-ANAT
,	O
and	O
fibrinogen	B-ANAT
during	O
hospitalization	O
may	O
help	O
to	O
determine	O
the	O
in	O
-	O
hospital	O
patient	O
prognosis	O
.	O

TITLE	O
:	O
Inflammation	O
-	O
induced	O
caveolin	O
-	O
1	O
and	O
BMPRII	O
depletion	O
promotes	O
endothelial	B-ANAT
dysfunction	O
and	O
TGF	O
-	O
Î²	O
-	O
driven	O
pulmonary	B-ANAT
vascular	B-ANAT
remodeling	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
if	O
the	O
lung	B-ANAT
inflammatory	O
response	O
to	O

CONCLUSIONS	O
:	O
The	O
interesting	O
features	O
of	O
this	O
case	O
report	O
consist	O
of	O
:	O
1	O
)	O
the	O
presentation	O
of	O
the	O
SLS	O
as	O
an	O
alveolar	B-ANAT
hypoventilation	O
with	O
a	O
fatal	O
outcome	O
,	O
2	O
)	O
the	O
presentation	O
of	O
systemic	O
lupus	O
as	O
SLS	O
.	O

Rapid	O
nucleocapsid	B-ANAT
antigen	O
detection	O
using	O
a	O
lateral	O
flow	O
platform	O
allows	O
efficient	O
screening	O
of	O
dromedaries	O
carrying	O
MERS	O
-	O
CoV	O
.	O
In	O
addition	O
to	O
MERS	O
-	O
CoV	O
,	O
which	O
is	O
a	O
lineage	O
C	O
virus	O
in	O
the	O
Betacoronavirus	O
(	O
betaCoV	O
)	O
genus	O
,	O
a	O
lineage	O
B	O
betaCoV	O
and	O
a	O
virus	O
in	O
the	O
Alphacoronavirus	O
(	O
alphaCoV	O
)	O
genus	O
have	O
been	O
detected	O
in	O
dromedaries	O
.	O

Survival	O
to	O
discharge	B-ANAT
was	O
58	O
%	O
for	O
VV	O
ECMO	O
in	O
contrast	O
to	O
43	O
%	O
for	O
VA	O
ECMO	O
(	O
p	O
=	O
0	O
.	O
002	O
).	O

A	O
computerized	O
tomography	O
(	O
CT	O
)	O
scan	O
confirmed	O
necrotizing	O
pancreatitis	O
with	O
multiple	O
abscesses	O
spreading	O
bilaterally	O
in	O
the	O
pelvic	B-ANAT
cavity	I-ANAT
.	O

The	O
patient	O
'	O
s	O
condition	O
was	O
complicated	O
by	O
pleural	B-ANAT
effusion	I-ANAT
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
colocutaneous	O
and	O
scrotal	B-ANAT
fistulas	O
,	O
and	O
incisional	O
hernia	O
.	O

TITLE	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
avian	O
influenza	O
A	O
(	O
H7N9	O
)	O
patient	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
a	O
case	O
report	O
and	O
short	O
literature	O
review	O
.	O

A	O
44	O
years	O
-	O
old	O
female	O
with	O
H7N9	O
-	O
induced	O
ARDS	O
was	O
admitted	O
to	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
and	O
was	O
treated	O
with	O
veno	O
-	O
venous	B-ANAT
ECMO	O
for	O
six	O
days	O
,	O
antiviral	O
therapy	O
,	O
prolonged	O
corticosteroid	O
infusion	O
and	O
other	O
therapies	O
.	O

Significant	O
increases	O
in	O
mtDNA	B-ANAT
and	O
inflammatory	O
mediator	O
plasma	B-ANAT
concentrations	O
were	O
seen	O
in	O
the	O
thermal	O
injury	O
and	O
EGCG	O
groups	O
when	O
compared	O
with	O
controls	O
(	O
P	O
<	O
.	O
05	O
).	O

EGCG	O
possesses	O
anti	O
-	O
inflammatory	O
and	O
lung	B-ANAT
-	O
protective	O
properties	O
,	O
and	O
might	O
act	O
by	O
limiting	O
mtDNA	B-ANAT
release	O
after	O
thermal	O
injury	O
.	O

Poor	O
prognosis	O
of	O
severe	O
adenovirus	O
pneumonia	O
in	O
children	O
is	O
associated	O
with	O
anemia	O
,	O
low	O
serum	B-ANAT
albumin	O
,	O
inflammatory	O
response	O
,	O
concurrent	O
multiple	O
complications	O
and	O
underlying	O
lung	B-ANAT
diseases	O
.	O

Supernatants	O
of	O
frozen	O
effusions	O
from	O
FIP	O
cats	O
retain	O
the	O
ability	O
to	O
induce	O
cell	B-ANAT
clumping	O
,	O
thus	O
the	O
modified	O
ÎTNC	O
measurement	O
is	O
a	O
reliable	O
tool	O
to	O
diagnose	O
FIP	O
on	O
samples	O
that	O
cannot	O
be	O
analyzed	O
immediately	O
.	O

Although	O
the	O
serum	B-ANAT
vitamin	O
B12	O
level	O
was	O
normal	O
,	O
the	O
patient	O
was	O
treated	O
with	O
cyanocobalamin	O
,	O
with	O
no	O
improvement	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
development	O
of	O
an	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
program	O
for	O
the	O
treatment	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
adults	O
.	O

In	O
addition	O
,	O
this	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
system	O
was	O
able	O
to	O
detect	O
the	O
target	O
viruses	O
SARS	O
-	O
like	O
bat	O
CoV	O
and	O
MERS	O
-	O
CoV	O
in	O
bat	O
fecal	B-ANAT
samples	O
and	O
sputum	B-ANAT
of	O
MERS	O
patients	O
,	O
respectively	O
.	O

During	O
the	O
treatment	O
process	O
,	O
the	O
variations	O
in	O
dynamic	O
lung	B-ANAT
compliance	O
,	O
oxygenation	O
index	O
,	O
hemodynamics	O
,	O
and	O
urine	B-ANAT
volume	O
per	O
hour	O
at	O
different	O
times	O
(	O
Baseline	O
,	O
0	O
,	O
2	O
,	O
4	O
,	O
and	O
6	O
h	O
)	O
were	O
recorded	O
.	O

TITLE	O
:	O
The	O
pathogens	O
profile	O
in	O
children	O
with	O
otitis	O
media	B-ANAT
with	O
effusion	B-ANAT
and	O
adenoid	B-ANAT
hypertrophy	O
.	O

RESULTS	O
:	O
37	O
OME	O
and	O
14	O
cochlear	B-ANAT
implant	O
children	O
were	O
included	O
in	O
the	O
study	O
.	O

TITLE	O
:	O
Prone	O
positioning	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
after	O
abdominal	B-ANAT
surgery	O
:	O
a	O
multicenter	O
retrospective	O
study	O
:	O
SAPRONADONF	O
(	O
Study	O
of	O
Ards	O
and	O
PRONe	O
position	O
After	O
abDOmiNal	B-ANAT
surgery	O
in	O
France	O
).	O

Interestingly	O
,	O
nsp5	O
cleaved	B-ANAT
STAT2	O
at	O
two	O
sites	O
,	O
glutamine	O
685	O
(	O
Q685	O
)	O
and	O
Q758	O
,	O
and	O
similar	O
cleavage	O
was	O
observed	O
in	O
PDCoV	O
-	O
infected	O
cells	B-ANAT
.	O

We	O
also	O
discussed	O
the	O
substrate	O
selection	O
and	O
binding	O
mode	O
of	O
PDCoV	O
nsp5	O
by	O
homologous	O
modeling	O
of	O
PDCoV	O
nsp5	O
with	O
the	O
two	O
cleaved	B-ANAT
peptide	O
substrates	O
.	O

Sagittal	B-ANAT
-	O
lung	B-ANAT
CT	O
measurements	O
in	O
terms	O
of	O
bilateral	O
lung	B-ANAT
height	O
(	O
LH	O
),	O
anterior	O
-	O
posterior	O
lung	B-ANAT
diameter	O
(	O
APLD	O
),	O
diaphragm	B-ANAT
height	O
(	O
DH	O
),	O
and	O
anterior	O
sterno	O
-	O
diaphragmatic	B-ANAT
angle	O
(	O
ASDA	O
),	O
as	O
well	O
as	O
inter	O
-	O
pulmonary	B-ANAT
septum	B-ANAT
length	O
(	O
IPSL	O
)	O
on	O
axial	O
images	O
were	O
measured	O
both	O
before	O
and	O
after	O
bronchodilator	O
(	O
BD	O
)	O
administration	O
.	O

Besides	O
,	O
variations	O
of	O
all	O
sagittal	B-ANAT
-	O
lung	B-ANAT
CT	O
measurements	O
were	O
significantly	O
larger	O
in	O
patients	O
with	O
ACOS	O
than	O
in	O
patients	O
with	O
pure	O
COPD	O
(	O
P	O
values	O
all	O
<	O
0	O
.	O
001	O
)	O
and	O
showed	O
high	O
performance	O
in	O
differentiating	O
these	O
two	O
kinds	O
of	O
patient	O
,	O
with	O
diagnostic	O
sensitivities	O
ranging	O
from	O
76	O
.	O
4	O
to	O
97	O
.	O
2	O
%,	O
specificities	O
ranging	O
from	O
86	O
.	O
2	O
to	O
100	O
.	O
0	O
%,	O
and	O
accuracies	O
ranging	O
from	O
80	O
.	O
9	O
to	O
90	O
.	O
7	O
%.	O

The	O
ACOS	O
patients	O
had	O
larger	O
post	O
-	O
BD	O
variations	O
of	O
sagittal	B-ANAT
-	O
lung	B-ANAT
CT	O
measurements	O
than	O
patients	O
with	O
pure	O
COPD	O
.	O

N	O
-	O
Acetylcysteine	O
(	O
NAC	B-ANAT
)	O
has	O
been	O
shown	O
to	O
reduce	O
endotoxin	O
-	O
induced	O
intestinal	B-ANAT
dysfunction	O
.	O

Thirty	O
-	O
two	O
7	O
-	O
day	O
-	O
old	O
piglets	O
were	O
randomly	O
allocated	O
to	O
one	O
of	O
four	O
treatments	O
in	O
a	O
2	O
Ã	O
2	O
factorial	O
design	O
consisting	O
of	O
two	O
liquid	O
diets	O
(	O
0	O
or	O
50	O
mg	O
/	O
kg	O
BW	O
NAC	B-ANAT
supplementation	O
)	O
and	O
oral	B-ANAT
administration	O
of	O
0	O
or	O
10	O

ABSTRACT	O
:	O
PTA	O
is	O
a	O
collection	O
of	O
pus	B-ANAT
located	O
between	O
the	O
tonsillar	B-ANAT
capsule	I-ANAT
and	O
the	O
pharyngeal	B-ANAT
constrictor	I-ANAT
muscle	I-ANAT
.	O

They	O
include	O
parapharyngeal	O
abscess	O
(	O
PPA	O
),	O
upper	O
airway	B-ANAT
obstruction	O
,	O
Lemierre	O
Â´	O
s	O
syndrome	O
,	O
necrotizing	O
fasciitis	O
,	O
mediastinitis	O
,	O
erosion	O
of	O
the	O
internal	B-ANAT
carotid	I-ANAT
artery	I-ANAT
,	O
brain	B-ANAT
abscess	O
,	O
and	O
streptococcal	O
toxic	O
shock	O
syndrome	O
.	O

Furthermore	O
,	O
identification	O
of	O
pathogens	O
other	O
than	O
GAS	O
,	O
may	O
lead	O
the	O
way	O
for	O
earlier	O
bacterial	O
diagnosis	O
and	O
timely	O
intervention	O
before	O
abscess	O
formation	O
in	O
sore	O
throat	B-ANAT
patients	O
.	O

In	O
a	O
retrospective	O
study	O
on	O
all	O
847	O
PTA	O
patients	O
admitted	O
to	O
the	O
ENT	B-ANAT
department	O
at	O
Aarhus	O
University	O
Hospital	O
(	O
AUH	O
)	O
from	O
2001	O
to	O
2006	O
,	O
we	O
found	O
that	O
FN	O
was	O
the	O
most	O
prevalent	O
(	O
23	O
%)	O
bacterial	O
strain	O
in	O
pus	B-ANAT
specimens	O
.	O

FN	O
-	O
positive	O
patients	O
displayed	O
significantly	O
higher	O
infection	O
markers	O
(	O
CRP	O
and	O
neutrophil	B-ANAT
counts	O
)	O
than	O
patients	O
infected	O
with	O
other	O
bacteria	O
(	O
P	O
=	O
0	O
.	O
01	O
and	O
P	O
<	O
0	O
.	O
001	O
,	O
respectively	O
).	O

Using	O
PCR	O
analysis	O
for	O
the	O
presence	O
of	O
herpes	O
simplex	B-ANAT
1	O
and	O
2	O
,	O
adenovirus	O
,	O
influenza	O
A	O
and	O
B	O
,	O
Epstein	O
-	O
Barr	O
virus	O
(	O
EBV	O
),	O
and	O
respiratory	O
syncytial	O
virus	O
A	O
and	O
B	O
,	O
we	O
explored	O
a	O
possible	O
role	O
of	O
viruses	O
in	O
PTA	O
.	O

Furthermore	O
,	O
cultures	O
made	O
from	O
PTA	O
aspirates	B-ANAT
should	O
include	O
a	O
selective	O
FN	O
-	O
agar	O
plate	O
in	O
order	O
to	O
identify	O
growth	O
of	O
this	O
bacterium	O
.	O

Comparative	O
microbiology	O
between	O
PTA	O
patients	O
and	O
""""	O
normal	O
tonsils	B-ANAT
"""."	O

At	O
post	O
-	O
mortem	O
examination	O
no	O
skin	B-ANAT
lesions	O
were	O
observed	O
,	O
all	O
organs	B-ANAT
appeared	O
normal	O
on	O
gross	O
evaluation	O
and	O
only	O
head	B-ANAT
and	O
blood	B-ANAT
samples	I-ANAT
were	O
further	O
investigated	O
.	O

No	O
fecal	B-ANAT
shedding	O
was	O
detected	O
following	O
the	O
double	O
infection	O
.	O

Overexpression	O
of	O
occludin	O
in	O
target	B-ANAT
cells	I-ANAT
makes	O
them	O
more	O
susceptible	O
to	O
PEDV	O
infection	O
,	O
whereas	O
ablation	O
of	O
occludin	O
expression	O
by	O
use	O
of	O
small	O
interfering	O
RNA	O
(	O
siRNA	O
)	O
in	O
target	B-ANAT
cells	I-ANAT
significantly	O
reduces	O
their	O
susceptibility	O
to	O
virus	O
infection	O
.	O

Notably	O
,	O
RBD	O
protein	O
at	O
the	O
optimal	O
dosage	O
and	O
interval	O
protected	O
hDPP4	O
-	O
Tg	O
mice	O
against	O
lethal	O
MERS	O
-	O
CoV	O
challenge	O
,	O
and	O
the	O
protection	O
was	O
positively	O
correlated	O
with	O
serum	B-ANAT
neutralizing	O
antibodies	O
.	O

A	O
temporary	O
pacemaker	O
wire	O
was	O
placed	O
to	O
stabilize	O
the	O
heart	B-ANAT
rate	O
but	O
hypotension	O
persisted	O
.	O

We	O
aim	O
to	O
assess	O
how	O
much	O
of	O
the	O
lung	B-ANAT
is	O
opened	O
and	O
kept	O
open	O
within	O
the	O
limits	O
of	O
mechanical	O
ventilation	O
considered	O
safe	O
(	O
i	O
.	O
e	O
.,	O
plateau	O
pressure	O
30	O
cmH	O
Prospective	O
study	O
from	O
two	O
university	O
hospitals	O
.	O

RESULTS	O
:	O
The	O
lung	B-ANAT
tissue	I-ANAT
which	O
is	O
opened	O
between	O
30	O
and	O
45	O
cmH	O

TITLE	O
:	O
Attenuation	O
of	O
an	O
original	O
US	O
porcine	O
epidemic	O
diarrhea	O
virus	O
strain	O
PC22A	O
via	O
serial	O
cell	B-ANAT
culture	O
passage	O
.	O

The	O
virus	O
growth	O
kinetics	O
in	O
cell	B-ANAT
culture	O
,	O
virulence	O
in	O
neonatal	O
pigs	O
and	O
the	O
whole	O
genomic	O
sequences	O
of	O
selected	O
passages	O
were	O
examined	O
.	O

ABSTRACT	O
:	O
An	O
approximately	O
22	O
mo	O
old	O
male	O
neutered	O
English	O
bulldog	O
was	O
evaluated	O
for	O
acute	O
onset	O
of	O
dyspnea	O
with	O
suspected	O
brachycephalic	O
obstructive	O
airway	B-ANAT
syndrome	O
(	O
BOAS	O
).	O

ABSTRACT	O
:	O
Four	O
sampling	O
techniques	O
commonly	O
are	O
used	O
for	O
antemortem	O
identification	O
of	O
pathogens	O
from	O
cattle	O
with	O
bovine	O
respiratory	O
disease	O
(	O
BRD	O
):	O
the	O
nasal	B-ANAT
swab	O
(	O
NS	O
),	O
guarded	O
nasopharyngeal	B-ANAT
swab	I-ANAT
(	O
NPS	O
),	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
),	O
and	O
transtracheal	O
wash	O
(	O
TTW	O
).	O

We	O
carried	O
out	O
RT	O
-	O
PCR	O
on	O
306	O
nasal	B-ANAT
and	O
315	O
rectal	O
swabs	O
and	O
tested	O
243	O
sera	B-ANAT
for	O
antibodies	O
to	O
detect	O
coronavirus	O
infections	O
in	O
apparently	O
healthy	O
horses	O
in	O
Saudi	O
Arabia	O
and	O
Oman	O
.	O

Mechanistically	O
,	O
neuraminidase	O
inhibition	O
assay	O
and	O
hemagglutination	O
inhibition	O
assay	O
suggested	O
that	O
N30	O
did	O
not	O
directly	O
target	O
the	O
two	O
envelope	B-ANAT
glycoproteins	O
required	O
for	O
viral	O
adsorption	O
or	O
release	O
.	O

By	O
concentrating	O
drugs	O
in	O
inflamed	O
alveoli	B-ANAT
,	O
PELs	O
solve	O
pharmacological	O
challenge	O
(	O
1	O
)	O
above	O
.	O

In	O
keeping	O
with	O
persistence	O
of	O
respiratory	O
DNA	O
viruses	O
in	O
human	O
tonsils	B-ANAT
,	O
tonsillectomy	O
significantly	O
reduces	O
asymptomatic	O
shedding	O
of	O
HAdV	O
and	O
HBoV	O
in	O
NPWs	O
.	O

Then	O
,	O
cl	O
-	O
2	O
invades	O
the	O
ventricle	B-ANAT
and	O
ventricular	B-ANAT
wall	I-ANAT
along	O
the	O
newly	O
assembled	O
ERfibs	O
after	O
infection	O
,	O
using	O
them	O
as	O
a	O
pathway	O
from	O
the	O
meninges	B-ANAT
,	O
the	O
initial	O
site	O
of	O
infection	O
.	O

The	O
pattern	O
of	O
ECM	B-ANAT
production	O
in	O
vitro	O
indicated	O
the	O
process	O
of	O
forming	O
mature	O
ERfibs	O
in	O
the	O
brain	B-ANAT
,	O
that	O
is	O
,	O
fibers	O
made	O
of	O
collagen	B-ANAT
fibers	O
and	O
ERag	O
are	O
wrapped	O
by	O
laminin	O
prepared	O
as	O
a	O
sheet	O
structure	O
.	O

ABSTRACT	O
:	O
Interleukin	O
-	O
22	O
(	O
IL	O
-	O
22	O
),	O
a	O
member	O
of	O
the	O
IL	O
-	O
10	O
superfamily	O
,	O
plays	O
essential	O
roles	O
in	O
fighting	O
against	O
mucosal	B-ANAT
microbial	O
infection	O
and	O
maintaining	O
mucosal	B-ANAT
barrier	O
integrity	O
within	O
the	O
intestine	B-ANAT
.	O

Nine	O
hundred	O
and	O
seventy	O
seven	O
(	O
977	O
)	O
fecal	B-ANAT
samples	O
were	O
screened	O
for	O
RNA	O
viruses	O
including	O
:	O
influenza	O
A	O
virus	O
(	O
IAV	O
),	O
avian	O
paramyxovirus	O
1	O
,	O
avian	O
coronavirus	O
(	O
CoV	O
),	O
and	O
avian	O
astrovirus	O
(	O
AstroV	O
).	O

To	O
evaluate	O
whether	O
tailored	O
ventilator	O
regimens	O
may	O
impact	O
ARDS	O
outcomes	O
,	O
our	O
group	O
has	O
designed	O
a	O
randomised	O
-	O
clinical	O
-	O
trial	O
of	O
ventilator	O
settings	O
according	O
to	O
lung	B-ANAT
morphology	O
in	O
moderate	O
-	O
to	O
-	O
severe	O
ARDS	O
(	O
LIVE	O
study	O
).	O

The	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
,	O
the	O
major	O
structural	O
component	O
of	O
the	O
capsid	B-ANAT
,	O
facilitates	O
RNA	O
packing	O
,	O
links	O
the	O
capsid	B-ANAT
to	O
the	O
envelope	B-ANAT
,	O
and	O
is	O
also	O
involved	O
in	O
multiple	O
other	O
processes	O
,	O
including	O
viral	O
replication	O
and	O
evasion	O
of	O
the	O
immune	B-ANAT
system	I-ANAT
.	O

It	O
is	O
ingested	O
as	O
an	O
oral	B-ANAT
prodrug	O
that	O
is	O
rapidly	O
metabolized	O
by	O
carboxylesterase	O
1	O
(	O
CES1	O
)	O
to	O
its	O
active	O
form	O
,	O
oseltamivir	O
carboxylate	O
.	O

Serial	O
blood	B-ANAT
and	O
urine	B-ANAT
samples	O
were	O
collected	O
for	O
PK	O
analysis	O
of	O
oseltamivir	O
and	O
oseltamivir	O
carboxylate	O
on	O
Day	O
1	O
and	O
Day	O
8	O
.	O

The	O
hypothesis	O
is	O
that	O
serum	B-ANAT
IP	O
-	O
10	O
concentrations	O
correlate	O
with	O
ARI	O
severity	O
and	O
detection	O
of	O
viral	O
pathogens	O
.	O

Serum	B-ANAT
IP	O
-	O
10	O
concentration	O
correlates	O
with	O
ARI	O
global	O
severity	O
.	O

A	O
sensitive	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
assay	O
targeting	O
the	O
IBV	O
nucleocapsid	B-ANAT
gene	O
(	O
N	O
)	O
was	O
developed	O
to	O
screen	O
clinical	O
samples	O
for	O
presence	O
of	O
IBV	O
.	O

We	O
present	O
2	O
cases	O
where	O
TH	O
was	O
successfully	O
used	O
to	O
manage	O
refractory	O
ARDS	O
on	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
and	O
a	O
review	O
of	O
the	O
literature	O
around	O
TH	O
and	O
acute	O
respiratory	O
failure	O
.	O

TITLE	O
:	O
Neglected	O
dorsolateral	O
dislocation	O
of	O
the	O
first	B-ANAT
metatarsophalangeal	I-ANAT
joint	I-ANAT
:	O
A	O
case	O
report	O
.	O

TITLE	O
:	O
Mouse	O
-	O
adapted	O
MERS	O
coronavirus	O
causes	O
lethal	O
lung	B-ANAT
disease	O
in	O
human	O
DPP4	O
knockin	O
mice	O
.	O

Nasal	B-ANAT
swabs	O
were	O
collected	O
from	O
182	O
patients	O
and	O
screened	O
for	O
MERS	O
-	O
CoV	O
as	O
well	O
as	O
other	O
respiratory	O
viruses	O
using	O
RT	O
-	O
PCR	O
and	O
multiplex	O
microarray	O
.	O

GM	O
-	O
CSF	B-ANAT
-	O
treated	O
patients	O
reported	O
more	O
severe	O
posttraumatic	O
stress	O
and	O
depression	O
symptoms	O
than	O
patients	O
in	O
the	O
placebo	O
group	O
.	O

6	O
months	O
after	O
ARDS	O
,	O
age	O
,	O
sex	O
,	O
illness	O
severity	O
,	O
steroids	O
,	O
and	O
GM	O
-	O
CSF	B-ANAT
treatment	O
were	O
associated	O
with	O
psychiatric	O
symptom	O
scores	O
.	O

In	O
multiple	O
regression	O
analyses	O
,	O
younger	O
age	O
,	O
female	O
sex	O
,	O
higher	O
severity	O
of	O
illness	O
,	O
fewer	O
steroid	O
treatment	O
days	O
,	O
and	O
GM	O
-	O
CSF	B-ANAT
treatment	O
were	O
all	O
independently	O
associated	O
with	O
more	O
severe	O
psychiatric	O
symptoms	O
on	O
at	O
least	O
one	O
scale	O
.	O

Moreover	O
,	O
preincubation	O
of	O
these	O
viruses	O
with	O
soluble	O
APN	O
or	O
pretreatment	O
of	O
APN	O
expressing	O
ST	O
cells	B-ANAT
with	O
soluble	O
TGEV	O
-	O
S1	O
blocked	O
TGEV	O
infection	O
,	O
but	O
had	O
no	O
effect	O
on	O
infection	O
by	O
PEDV	O
.	O

Two	O
types	O
of	O
core	O
poly	O
(	O
lactic	O
-	O
co	O
-	O
glycolic	O
acid	O
)	O
nanoparticles	O
(	O
NL	O
and	O
NP	O
)	O
were	O
prepared	O
with	O
a	O
phospholipid	O
shell	B-ANAT
as	O
an	O
optional	O
feature	O
and	O
covered	O
with	O
polydopamine	O
that	O
enabled	O
the	O
conjugation	O
of	O
TAT	O
peptide	O
on	O
the	O
surface	O
.	O

In	O
LS174T	O
tumor	O
-	O
bearing	O
nude	O
mice	O
,	O
NPpT	O
-	O
CA	O
showed	O
less	O
accumulation	O
in	O
the	O
lung	B-ANAT
than	O
NPpT	O
,	O
reflecting	O
the	O
shielding	O
effect	O
of	O
amidation	O
,	O
but	O
tumor	O
accumulation	O
of	O
NPpT	O
and	O
NPpT	O
-	O
CA	O
was	O
equally	O
minimal	O
.	O

Going	O
forward	O
,	O
the	O
knowledge	O
gained	O
over	O
the	O
past	O
decade	O
will	O
undoubtedly	O
continue	O
to	O
inform	O
future	O
responses	O
and	O
will	O
serve	O
to	O
optimize	O
the	O
education	O
and	O
care	O
given	O
to	O
pregnant	O
women	O
in	O
the	O
face	B-ANAT
of	O
current	O
and	O
future	O
emerging	O
infectious	O
disease	O
outbreaks	O
.	O

This	O
study	O
has	O
identified	O
various	O
pro	O
-	O
inflammatory	O
cytokines	O
and	O
interferon	O
-	O
related	O
genes	O
such	O
as	O
MX1	O
,	O
viperin	O
,	O
CXCL10	O
,	O
CCL8	O
,	O
RANTES	O
,	O
KC	O
,	O
MCP1	O
,	O
IL8	O
,	O
GM	O
-	O
CSF	B-ANAT
and	O
IFNÎ³	O
in	O
FCoV	O
-	O
positive	O
cats	O
.	O

As	O
expected	O
,	O
the	O
secretion	B-ANAT
of	O
IL1Î²	O
,	O
IL6	O
and	O
TNFÎ±	O
was	O
readily	O
detected	O
in	O
the	O
supernatant	O
of	O
peritoneal	B-ANAT
effusions	I-ANAT
of	O
the	O
FCoV	O
-	O
positive	O
cats	O
.	O

ABSTRACT	O
:	O
Cases	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
continue	O
to	O
be	O
identified	O
and	O
with	O
a	O
lack	O
of	O
effective	O
clinical	O
treatment	O
and	O
no	O
preventative	O
strategies	O
,	O
treatment	O
using	O
convalescent	O
plasma	B-ANAT
or	O
monoclonal	O
antibodies	O
(	O
mAbs	O
)	O
is	O
a	O
potential	O
quick	O
route	O
to	O
an	O
intervention	O
.	O

TITLE	O
:	O
The	O
role	O
of	O
epidermal	B-ANAT
growth	O
factor	O
receptor	O
(	O
EGFR	O
)	O
signaling	O
in	O
SARS	O
coronavirus	O
-	O
induced	O
pulmonary	B-ANAT
fibrosis	O
.	O

APN	O
is	O
also	O
a	O
major	O
cell	B-ANAT
entry	O
receptor	O
for	O
coronavirus	O
,	O
which	O
binds	O
to	O
a	O
region	O
distant	O
from	O
the	O
active	O
site	O
.	O

We	O
conclude	O
that	O
allosteric	O
inhibition	O
of	O
APN	O
functions	O
occurs	O
by	O
ligand	O
suppression	O
of	O
ectodomain	O
motions	O
necessary	O
for	O
catalysis	O
and	O
virus	O
cell	B-ANAT
entry	O
,	O
as	O
validated	O
by	O
locking	O
APN	O
with	O
disulfides	O
.	O

TITLE	O
:	O
Thoracic	B-ANAT
trauma	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
polytraumatized	O
patients	O
:	O
a	O
retrospective	O
analysis	O
.	O

Of	O
those	O
patients	O
suffering	O
from	O
ARDS	O
,	O
ventilation	O
time	O
and	O
length	O
of	O
stay	O
at	O
the	O
ICU	O
were	O
longer	O
if	O
a	O
concomitant	O
thoracic	B-ANAT
injury	O
was	O
present	O
(	O
P	O
<	O
0	O
.	O
001	O
).	O

Many	O
survivors	O
of	O
SARS	O
-	O
CoV	O
infection	O
develop	O
pulmonary	B-ANAT
fibrosis	O
(	O
PF	O
),	O
with	O
higher	O
prevalence	O
in	O
older	O
patients	O
.	O

Importantly	O
,	O
we	O
show	O
that	O
during	O
infection	O
,	O
the	O
EGFR	O
ligands	O
amphiregulin	O
and	O
heparin	O
-	O
binding	O
EGF	O
-	O
like	O
growth	O
factor	O
(	O
HB	O
-	O
EGF	O
)	O
are	O
upregulated	O
,	O
and	O
exogenous	O
addition	O
of	O
these	O
ligands	O
during	O
infection	O
leads	O
to	O
enhanced	O
lung	B-ANAT
disease	O
and	O
altered	O
wound	O
healing	O
dynamics	O
.	O

Doubling	O
the	O
concentration	O
of	O
the	O
additives	O
reduced	O
the	O
delta	O
value	O
to	O
â¤	O
0	O
.	O
28	O
days	O
(	O
Commercial	O
feed	O
additives	O
(	O
acidifiers	O
and	O
salt	O
)	O
may	O
be	O
utilized	O
as	O
a	O
strategy	O
to	O
decrease	O
risk	O
of	O
PDCoV	O
in	O
feed	O
,	O
specially	O
,	O
commercial	O
feed	O
acidifiers	O
at	O
double	O
the	O
recommended	O
concentrations	O
reduced	O
PDCoV	O
survival	O
in	O
complete	O
feed	O
during	O
storage	B-ANAT
at	O
room	O
temperature	O
.	O

Hypoxemia	O
is	O
mainly	O
due	O
to	O
intrapulmonary	O
shunt	O
,	O
whereas	O
increased	O
alveolar	B-ANAT
dead	O
space	O
explains	O
the	O
alteration	O
of	O
CO	O

TITLE	O
:	O
Three	O
Hypothetical	O
Inflammation	O
Pathobiology	O
Phenotypes	O
and	O
Pediatric	O
Sepsis	O
-	O
Induced	O
Multiple	O
Organ	B-ANAT
Failure	O
Outcome	O
.	O

Multiple	O
organ	B-ANAT
failure	O
cases	O
with	O
any	O
of	O
the	O
three	O
inflammation	O
phenotypes	O
(	O
n	O
=	O
37	O
)	O
had	O
higher	O
inflammation	O
(	O
C	O
-	O
reactive	O
protein	O
,	O
p	O
=	O
0	O
.	O
009	O
and	O
ferritin	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
than	O
multiple	O
organ	B-ANAT
failure	O
cases	O
without	O
any	O
of	O
these	O
phenotypes	O
(	O
n	O
=	O
38	O
)	O
or	O
cases	O
with	O
only	O
single	O
organ	B-ANAT
failure	O
(	O
n	O
=	O
25	O
).	O

All	O
allogeneic	O
hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplantation	O
recipients	O
treated	O
with	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
between	O
2010	O
and	O
2015	O
.	O

ICU	O
admission	O
occurred	O
at	O
a	O
median	O
of	O
146	O
(	O
interquartile	O
range	O
,	O
27	O
-	O
321	O
)	O
days	O
after	O
allogeneic	O
hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplantation	O
.	O

Only	O
one	O
of	O
24	O
patients	O
(	O
4	O
%)	O
initiated	O
on	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
within	O
240	O
days	O
after	O
allogeneic	O
hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplantation	O
survived	O
compared	O
to	O
six	O
of	O
13	O
(	O
46	O
%)	O
of	O
those	O
treated	O
thereafter	O
(	O
p	O
<	O
0	O
.	O
01	O
).	O

This	O
study	O
investigated	O
the	O
correlation	O
of	O
PLpro	O
-	O
induced	O
TGF	O
-	O
Î²1	O
with	O
the	O
expression	O
of	O
Type	O
I	O
collagen	B-ANAT
in	O
human	O
lung	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
and	O
mouse	O
pulmonary	B-ANAT
tissues	B-ANAT
.	O

Subcellular	O
localization	O
analysis	O
of	O
SMAD3	O
and	O
SMAD7	O
indicated	O
that	O
non	O
-	O
SMAD	O
pathways	O
in	O
TGF	O
-	O
Î²1	O
signaling	O
involved	O
in	O
the	O
production	O
of	O
Type	O
I	O
collagen	B-ANAT
in	O
transfected	O
cells	B-ANAT
with	O
pSARS	O
-	O
PLpro	O
.	O

Moreover	O
,	O
selective	O
inhibitors	O
TGF	O
-	O
Î²RI	O
and	O
STAT6	O
(	O
AS1517499	O
)	O
ascertained	O
that	O
STAT6	O
activation	O
was	O
required	O
for	O
PLpro	O
-	O
induced	O
TGF	O
-	O
Î²1	O
-	O
dependent	O
up	O
-	O
regulation	O
of	O
Type	O
I	O
collagen	B-ANAT
in	O
human	O
lung	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

The	O
main	O
indications	O
for	O
ECMO	O
are	O
refractory	O
respiratory	O
failure	O
(	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
status	O
asthmaticus	O
,	O
severe	O
pneumonia	O
,	O
meconium	B-ANAT
aspiration	O
syndrome	O
,	O
pulmonary	B-ANAT
hypertension	O
)	O
and	O
refractory	O
circulatory	O
failure	O
(	O
cardiogenic	O
shock	O
,	O
septic	O
shock	O
,	O
refractory	O
cardiac	B-ANAT
arrest	O
).	O

Faecal	B-ANAT
and	O
urine	B-ANAT
samples	O
were	O
screened	O
for	O
the	O
presence	O
of	O
RNA	O
from	O
paramyxoviruses	O
,	O
coronaviruses	O
and	O
filoviruses	O
.	O

Live	O
virus	O
vaccines	O
can	O
be	O
improved	O
by	O
adding	O
adjuvants	O
to	O
boost	O
mucosal	B-ANAT
innate	O
and	O
adaptive	O
responses	O
.	O

It	O
also	O
did	O
not	O
affect	O
the	O
frequency	O
of	O
CD4	O
+	O
T	B-ANAT
cells	I-ANAT
,	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
and	O
monocytes	B-ANAT
/	O
macrophages	B-ANAT
in	O
the	O
blood	B-ANAT
and	O
the	O
spleen	B-ANAT
determined	O
by	O
flow	O
cytometry	O
.	O

In	O
other	O
experiments	O
,	O
right	O
ventricular	B-ANAT
systolic	O
pressure	O
was	O
recorded	O
during	O
hypoxic	O
challenges	O
in	O
uninjured	O
WT	O
mice	O
pretreated	O
with	O
rHuIL	O
-	O
6	O
or	O
rHuIL	O
-	O
6	O
+	O
non	O
-	O
selective	O
nitric	O
oxide	O
synthase	O
inhibitor	O
L	O
-	O
NAME	O
or	O
vehicle	O
.	O

IL	O
-	O
6KO	O
In	O
a	O
double	O
-	O
hit	O
murine	O
model	O
of	O
ARDS	O
,	O
IL	O
-	O
6	O
deficient	O
mice	O
experienced	O
more	O
severe	O
bronchoalveolar	O
cellular	B-ANAT
inflammation	O
as	O
compared	O
to	O
wild	O
-	O
type	O
littermates	O
.	O

Furthermore	O
,	O
IL	O
-	O
6	O
deficiency	O
caused	O
marked	O
acute	O
pulmonary	B-ANAT
hypertension	O
,	O
which	O
may	O
be	O
,	O
at	O
least	O
partially	O
,	O
due	O
to	O
vasoactive	O
mechanisms	O
.	O

We	O
analyzed	O
40	O
clinical	O
specimens	O
from	O
hospitalized	O
children	O
diagnosed	O
with	O
acute	O
bronchiolitis	O
,	O
croup	O
,	O
or	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
in	O
which	O
virus	O
identification	O
by	O
viral	O
culture	O
or	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
was	O
unsuccessful	O
.	O

Methods	O
The	O
study	O
was	O
performed	O
on	O
buffy	O
-	O
coat	B-ANAT
samples	O
from	O
EDTA	O
-	O
anticoagulated	O
whole	O
blood	B-ANAT
samples	I-ANAT
of	O
205	O
healthy	O
shelter	O
cats	O
.	O

Evidence	O
for	O
FCoV	O
replication	O
in	O
peripheral	B-ANAT
blood	I-ANAT
and	O
feces	B-ANAT
was	O
obtained	O
by	O
M	O
gene	O
mRNA	O
qRT	O
-	O
PCR	O
.	O

TITLE	O
:	O
Ex	O
Vivo	O
Lung	B-ANAT
Perfusion	O
Rehabilitates	O
Sepsis	O
-	O
Induced	O
Lung	B-ANAT
Injury	O
.	O

ABSTRACT	O
:	O
Sepsis	O
is	O
the	O
number	O
one	O
cause	O
of	O
lung	B-ANAT
injury	O
in	O
adults	O
.	O

We	O
used	O
intravenous	O
lipopolysaccharide	O
(	O
LPS	O
)	O
to	O
induce	O
a	O
systemic	O
inflammatory	O
response	O
in	O
a	O
porcine	O
model	O
of	O
lung	B-ANAT
injury	O
.	O

Lungs	B-ANAT
were	O
then	O
randomized	O
to	O
treatment	O
with	O
4	O
hours	O
of	O
normothermic	O
EVLP	O
with	O
STEEN	O
Solution	O
(	O
XVIVO	O
Perfusion	O
Inc	O
,	O
Englewood	O
,	O
CO	O
)	O
or	O
4	O
additional	O
hours	O
of	O
in	O
vivo	O
perfusion	O
(	O
control	O
).	O

The	O
latter	O
function	O
involves	O
reversing	O
the	O
post	O
-	O
translational	O
modification	O
of	O
cellular	B-ANAT
proteins	O
conjugated	O
with	O
either	O
ubiquitin	O
(	O
Ub	O
)	O
or	O
Ub	O
-	O
like	O
interferon	O
-	O
stimulated	O
gene	O
product	O
15	O
(	O
ISG15	O
).	O

Despite	O
these	O
complications	O
,	O
some	O
studies	O
have	O
shown	O
a	O
decrease	O
in	O
the	O
rates	O
of	O
orotracheal	O
intubation	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
with	O
low	O
severity	O
scores	O
,	O
hemodynamic	O
stability	O
,	O
and	O
the	O
absence	O
of	O
other	O
organ	B-ANAT
dysfunctions	O
.	O

The	O
distribution	O
of	O
DPP4	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
tissues	B-ANAT
of	O
humans	O
and	O
camels	O
reflects	O
MERS	O
-	O
CoV	O
tropism	O
.	O

The	O
preferential	O
expression	O
of	O
DPP4	O
in	O
the	O
intestinal	B-ANAT
tract	I-ANAT
of	O
insectivorous	O
bats	O
,	O
suggests	O
that	O
transmission	O
of	O
MERS	O
-	O
like	O
-	O
CoVs	O
mainly	O
occurs	O
via	O
the	O
fecal	B-ANAT
-	O
oral	B-ANAT
route	O
.	O

Bacterial	O
concentration	O
in	O
tracheal	B-ANAT
aspirate	I-ANAT
(	O
mean	O
log	O
10	O
cfu	O
/	O
mL	O
Â±	O
SD	O
on	O
days	O
2	O
-	O
5	O
:	O
1	O
.	O
2	O
Â±	O
1	O
.	O
3	O
vs	O
.	O
5	O
.	O
0	O
Â±	O
2	O
.	O
3	O
,	O
P	O
<	O
0	O
.	O
01	O
)	O
decreased	O
more	O
rapidly	O
and	O
markedly	O
in	O
the	O
TIS	O
group	O
compared	O
with	O
the	O
control	O
group	O
.	O

Bacterial	O
concentration	O
in	O
tracheal	B-ANAT
aspirate	I-ANAT
(	O
mean	O
log	O
10	O
cfu	O
/	O
mL	O
Â±	O
SD	O
on	O
days	O
2	O
-	O
5	O
:	O
1	O
.	O
2	O
Â±	O
1	O
.	O
3	O
vs	O
.	O
5	O
.	O
0	O
Â±	O
2	O
.	O
3	O
,	O
P	O
<	O
0	O
.	O
01	O
)	O
decreased	O
more	O
rapidly	O
and	O
markedly	O
in	O
the	O
TIS	O
group	O
compared	O
with	O
the	O
control	O
group	O
.	O

TITLE	O
:	O
The	O
Use	O
of	O
GMP	O
-	O
Produced	O
Bone	B-ANAT
Marrow	I-ANAT
-	O
Derived	O
Stem	B-ANAT
Cells	I-ANAT
in	O
Combination	O
with	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
in	O
ARDS	O
:	O
An	O
Animal	O
Model	O
.	O

In	O
group	O
3	O
,	O
3	O
sheep	O
received	O
a	O
dose	O
of	O
clinical	O
grade	O
good	O
manufacturing	O
practice	O
(	O
GMP	O
)-	O
produced	O
MultiPotent	O
Adult	O
Progenitor	B-ANAT
cells	I-ANAT
(	O
MAPC	O
)	O
intratracheally	O
after	O
the	O
end	O
of	O
the	O
infusion	O
of	O
E	O
.	O
coli	O
endotoxin	O
,	O
followed	O
by	O
ECMO	O
support	O
.	O

The	O
respiratory	O
parameters	O
by	O
means	O
of	O
blood	B-ANAT
gas	O
results	O
,	O
measurements	O
of	O
lung	B-ANAT
injury	O
,	O
inflammatory	O
responses	O
,	O
and	O
integrity	O
of	O
the	O
alveolar	B-ANAT
capillary	B-ANAT
barrier	O
after	O
the	O
infusion	O
of	O
these	O
cells	B-ANAT
were	O
analyzed	O
.	O

A	O
higher	O
requirement	O
of	O
PRBC	O
transfusions	O
was	O
associated	O
with	O
pre	O
-	O
ECMO	O
hematocrit	O
,	O
and	O
with	O
the	O
following	O
conditions	O
during	O
ECMO	O
:	O
platelet	B-ANAT
nadir	O
,	O
antithrombin	O
III	O
(	O
ATIII	O
),	O
and	O
stage	O
3	O
of	O
acute	O
kidney	B-ANAT
injury	O
(	O
all	O
Implementation	O
of	O
a	O
comprehensive	O
protocol	O
for	O
anticoagulation	O
and	O
transfusions	O
in	O
VV	O
-	O
ECMO	O
for	O
ARDS	O
resulted	O
in	O
a	O
low	O
PRBC	O
requirement	O
,	O
and	O
an	O
ECMO	O
survival	O
comparable	O
to	O
data	O
in	O
the	O
literature	O
.	O

Additionally	O
,	O
ileum	B-ANAT
gas	O
was	O
detected	O
for	O
ten	O
of	O
the	O
sixteen	O
cases	O
in	O
the	O
upper	B-ANAT
abdomen	I-ANAT
during	O
assessment	O
with	O
chest	B-ANAT
X	O
-	O
ray	O
.	O

Severe	O
pneumonia	O
caused	O
by	O
pathogenic	O
hCoVs	O
is	O
often	O
associated	O
with	O
rapid	O
virus	O
replication	O
,	O
massive	O
inflammatory	B-ANAT
cell	I-ANAT
infiltration	O
and	O
elevated	O
pro	O
-	O
inflammatory	O
cytokine	O
/	O
chemokine	O
responses	O
resulting	O
in	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
),	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Here	O
we	O
review	O
the	O
current	O
understanding	O
of	O
how	O
a	O
dysregulated	O
immune	O
response	O
may	O
cause	O
lung	B-ANAT
immunopathology	O
leading	O
to	O
deleterious	O
clinical	O
manifestations	O
after	O
pathogenic	O
hCoV	O
infections	O
.	O

TITLE	O
:	O
The	O
ICM	B-ANAT
research	O
agenda	O
on	O
extracorporeal	O
life	O
support	O
.	O

However	O
,	O
since	O
the	O
production	O
of	O
interferon	O
in	O
these	O
cells	B-ANAT
is	O
defective	O
,	O
Vero	B-ANAT
cells	I-ANAT
are	O
not	O
the	O
ideal	O
cell	B-ANAT
type	I-ANAT
to	O
study	O
the	O
molecular	O
mechanisms	O
of	O
PEDV	O
infection	O
and	O
the	O
host	O
antiviral	O
innate	O
immune	O
response	O
.	O

In	O
a	O
mouse	O
LPS	O
-	O
induced	O
model	O
of	O
lung	B-ANAT
injury	O
,	O
miR	O
-	O
19	O
-	O
deficient	O
murine	O
lung	B-ANAT
tissue	I-ANAT
was	O
more	O
susceptible	O
to	O
inflammatory	O
responses	O
and	O
exhibited	O
a	O
higher	O
infiltration	O
rate	O
,	O
a	O
higher	O
number	O
of	O
inflammatory	B-ANAT
cells	I-ANAT
in	O
the	O
lungs	B-ANAT
,	O
a	O
higher	O
level	O
of	O
inflammatory	O
cytokines	O
in	O
the	O
Bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
BALF	O
),	O
and	O
more	O
severe	O
pathological	O
damage	O
in	O
lung	B-ANAT
tissues	I-ANAT
.	O

The	O
RT	O
-	O
PCR	O
assay	O
detected	O
HCoV	O
229E	O
,	O
HKU1	O
,	O
NL63	O
,	O
and	O
OC43	O
in	O
nasal	B-ANAT
swabs	O
from	O
symptomatic	O
children	O
â¤	O
18	O
years	O
.	O

Age	O
<	O
2	O
years	O
(	O
odds	O
ratio	O
[	O
OR	O
]	O
=	O
5	O
.	O
0	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
],	O
1	O
.	O
9	O
-	O
13	O
.	O
1	O
)	O
and	O
cardiovascular	B-ANAT
(	O
OR	O
=	O
3	O
.	O
9	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
6	O
-	O
9	O
.	O
5	O
),	O
genetic	O
/	O
congenital	O
(	O
OR	O
=	O
2	O
.	O
8	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
1	O
-	O
7	O
.	O
0	O
),	O
and	O
respiratory	O
chronic	O
complex	O
conditions	O
([	O
CCCs	O
]	O
OR	O
=	O
4	O
.	O
5	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
7	O
-	O
12	O
.	O
0	O
)	O
were	O
associated	O
with	O
receiving	O
respiratory	O
support	O
.	O

Brain	B-ANAT
magnetic	O
resonance	O
imaging	O
(	O
MRI	O
)	O
showed	O
a	O
heart	B-ANAT
-	O
shaped	O
region	O
of	O
diffusion	O
abnormality	O
,	O
characteristic	O
of	O
BMP	O
infarction	O
.	O

A	O
43	O
-	O
year	O
-	O
old	O
woman	O
presented	O
to	O
the	O
emergency	O
department	O
with	O
acute	O
onset	O
of	O
lower	O
-	O
extremity	B-ANAT
paresthesia	O
and	O
history	O
of	O
upper	O
respiratory	O
infection	O
2	O
weeks	O
prior	O
.	O

Compared	O
with	O
the	O
general	O
population	O
,	O
ARDS	O
survivors	O
showed	O
reduced	O
HRQoL	O
.	O
Pulmonary	B-ANAT
function	O
and	O
lung	B-ANAT
morphology	O
revealed	O
sufficient	O
recovery	O
with	O
minor	O
lung	B-ANAT
impairment	O
.	O

Severe	O
lung	B-ANAT
injury	O
in	O
the	O
SS	O
group	O
was	O
confirmed	O
by	O
the	O
histopathology	O
evaluations	O
.	O

RESULTS	O
:	O
Blood	B-ANAT
cultures	O
from	O
6	O
of	O
9	O
animals	O
in	O
the	O
SS	O
group	O
were	O
positive	O
for	O
MRSA	O
.	O

Blood	B-ANAT
G	O
tests	O
presented	O
the	O
better	O
predicting	O
value	O
for	O
anastomotic	O
leak	O
.	O

Blood	B-ANAT
G	O
tests	O
and	O
PCT	O
should	O
be	O
tested	O
after	O
esophagectomy	O
.	O

We	O
orally	B-ANAT
inoculated	O
neonatal	O
,	O
conventional	O
suckling	O
piglets	O
with	O
TC	O
-	O
PC177	O
or	O
PC21A	O
to	O
compare	O
their	O
pathogenicities	O
.	O

ABSTRACT	O
:	O
In	O
cats	O
suffering	O
from	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
)	O
without	O
effusion	B-ANAT
,	O
antemortem	O
diagnosis	O
is	O
challenging	O
.	O

It	O
was	O
the	O
aim	O
of	O
this	O
study	O
to	O
evaluate	O
sensitivity	O
and	O
specificity	O
of	O
an	O
immunocytochemical	O
assay	O
(	O
ICC	O
)	O
in	O
aqueous	B-ANAT
humor	I-ANAT
of	O
cats	O
suspected	O
of	O
having	O
FIP	O
.	O

Previous	O
studies	O
have	O
suggested	O
that	O
an	O
increase	O
in	O
FGL2	O
is	O
diagnostic	O
of	O
FH	O
and	O
liver	B-ANAT
necrosis	O
,	O
and	O
animals	O
with	O
no	O
FGL2	O
had	O
better	O
survivorship	O
during	O
FH	O
.	O

TITLE	O
:	O
An	O
optimized	O
method	O
for	O
enumerating	O
CNS	B-ANAT
derived	O
memory	O
B	B-ANAT
cells	I-ANAT
during	O
viral	O
-	O
induced	O
inflammation	O
.	O

Using	O
a	O
viral	O
encephalomyelitis	O
model	O
we	O
developed	O
a	O
modified	O
limiting	O
dilution	O
in	O
vitro	O
stimulation	O
assay	O
to	O
convert	O
CNS	B-ANAT
-	O
derived	O
virus	O
specific	O
Bmem	O
into	O
ASC	O
.	O

Using	O
the	O
PRISMA	O
guidelines	O
for	O
systematic	O
reviews	O
and	O
meta	O
-	O
analysis	O
,	O
MEDLINE	O
and	O
EMBASE	O
were	O
systematically	O
searched	O
for	O
studies	O
reporting	O
complications	O
and	O
hospital	O
mortality	O
of	O
adult	O
patients	O
receiving	O
veno	O
-	O
venous	B-ANAT
ECMO	O
for	O
severe	O
and	O
refractory	O
ARDS	O
.	O

TITLE	O
:	O
Differential	O
Protein	O
Analysis	O
of	O
IPEC	O
-	O
J2	O
Cells	B-ANAT
Infected	O
with	O
Porcine	O
Epidemic	O
Diarrhea	O
Virus	O
Pandemic	O
and	O
Classical	O
Strains	O
Elucidates	O
the	O
Pathogenesis	O
of	O
Infection	O
.	O

However	O
orf1ab	O
,	O
membrane	B-ANAT
(	O
M	O
)	O
and	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
genes	O
were	O
more	O
related	O
to	O
Bovine	O
coronavirus	O
(	O
BCoV	O
)	O
than	O
CRCoV	O
-	O
B232	O
.	O

During	O
11	O
weeks	O
of	O
the	O
influenza	O
epidemic	O
period	O
in	O
January	O
-	O
March	O
2012	O
,	O
consecutive	O
adult	O
patients	O
suspected	O
to	O
be	O
septic	O
(	O
n	O
=	O
432	O
)	O
were	O
analyzed	O
with	O
cultures	O
from	O
blood	B-ANAT
and	O
nasopharynx	B-ANAT
plus	O
multiplex	O
PCR	O
for	O
respiratory	O
viruses	O
on	O
the	O
nasopharyngeal	B-ANAT
specimen	O
.	O

In	O
this	O
randomised	O
,	O
open	O
-	O
label	O
,	O
multicentre	O
,	O
phase	O
2	O
trial	O
,	O
29	O
academic	O
medical	O
centres	O
in	O
the	O
USA	O
assessed	O
the	O
safety	O
and	O
efficacy	O
of	O
anti	O
-	O
influenza	O
plasma	B-ANAT
with	O
haemagglutination	O
inhibition	O
antibody	O
titres	O
of	O
1	O
:	O
80	O
or	O
more	O
to	O
the	O
infecting	O
strain	O
.	O

Of	O
the	O
participants	O
with	O
confirmed	O
influenza	O
(	O
by	O
PCR	O
),	O
28	O
(	O
67	O
%)	O
of	O
42	O
in	O
the	O
plasma	B-ANAT
plus	O
standard	O
care	O
group	O
normalised	O
their	O
respiratory	O
status	O
by	O
day	O
28	O
compared	O
with	O
24	O
(	O
53	O
%)	O
of	O
45	O
participants	O
on	O
standard	O
care	O
alone	O
(	O
p	O
=	O
0	O
Â·	O
069	O
).	O

Six	O
participants	O
died	O
,	O
one	O
(	O
2	O
%)	O
from	O
the	O
plasma	B-ANAT
plus	O
standard	O
care	O
group	O
and	O
five	O
(	O
10	O
%)	O
from	O
the	O
standard	O
care	O
group	O
(	O
HR	O
0	O
Â·	O
19	O
[	O
95	O
%	O
CI	O
0	O
Â·	O
02	O
-	O
1	O
Â·	O
65	O
],	O
p	O
=	O
0	O
Â·	O
093	O
).	O

Although	O
there	O
was	O
no	O
significant	O
effect	O
of	O
plasma	B-ANAT
treatment	O
on	O
the	O
primary	O
endpoint	O
,	O
the	O
treatment	O
seemed	O
safe	O
and	O
well	O
tolerated	O
.	O

Virus	O
replication	O
of	O
the	O
challenged	O
virus	O
in	O
H120	O
-	O
1	O
/	O
96	O
group	O
compared	O
with	O
H120	O
-	O
H120	O
group	O
showed	O
a	O
significant	O
reduction	O
of	O
viral	O
load	O
in	O
trachea	B-ANAT
(	O
1	O
.	O
5	O
Ã	O
103	O
compared	O
to	O
503	O
)	O
and	O
kidneys	B-ANAT
.	O

Moreover	O
,	O
the	O
use	O
of	O
Vero	B-ANAT
cells	I-ANAT
expressing	O
TMPRSS2	O
and	O
MSPL	O
facilitated	O
PEDV	O
replication	O
in	O
the	O
absence	O
of	O
exogenous	O
trypsin	O
.	O

TITLE	O
:	O
Keratinocyte	B-ANAT
growth	O
factor	O
for	O
the	O
treatment	O
of	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
KARE	O
):	O
a	O
randomised	O
,	O
double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
phase	O
2	O
trial	O
.	O

The	O
characteristics	O
and	O
outcomes	O
of	O
mothers	O
and	O
fetuses	B-ANAT
were	O
determined	O
through	O
a	O
retrospective	O
chart	O
review	O
and	O
evaluated	O
using	O
Student	O
'	O
s	O
t	O
test	O
,	O
chi	O
-	O
square	O
test	O
,	O
and	O
Fisher	O
'	O
s	O
exact	O
test	O
.	O

The	O
non	O
-	O
obstetric	O
causes	O
group	O
exhibited	O
a	O
higher	O
incidence	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
renal	B-ANAT
replacement	O
therapy	O
as	O
well	O
as	O
requiring	O
more	O
ventilator	O
days	O
.	O

PEDVPT	O
-	O
P5	O
-	O
inoculation	O
induced	O
typical	O
diarrhea	O
during	O
1	O
-	O
9	O
days	O
post	O
inoculation	O
with	O
fecal	B-ANAT
viral	O
shedding	O
persisting	O
for	O
26	O
days	O
.	O

Severity	O
criteria	O
often	O
depend	O
on	O
arterial	B-ANAT
blood	I-ANAT
gas	O
results	O
.	O

The	O
mean	O
duration	O
of	O
arrival	O
at	O
hospital	O
was	O
3	O
.	O
4	O
Â±	O
3	O
.	O
7	O
d	O
with	O
a	O
range	O
of	O
1	O
to	O
30	O
d	O
.	O
Eighty	O
percent	O
had	O
oliguria	O
and	O
55	O
%	O
had	O
history	O
of	O
having	O
passed	O
red	O
or	O
brown	O
colored	O
urine	B-ANAT
.	O

As	O
compared	O
to	O
the	O
survival	O
group	O
,	O
the	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
count	O
(	O
AKI	O
due	O
to	O
snake	O
bite	O
is	O
severe	O
and	O
a	O
high	O
proportion	O
requires	O
renal	B-ANAT
replacement	O
therapy	O
.	O

Samples	O
of	O
complete	O
feed	O
,	O
spray	O
dried	B-ANAT
porcine	O
plasma	B-ANAT
,	O
meat	O
meal	O
,	O
meat	O
and	O
bone	B-ANAT
meal	O
,	O
blood	B-ANAT
meal	O
,	O
corn	O
,	O
soybean	O
meal	O
,	O
and	O
corn	O
dried	B-ANAT
distillers	O
grains	O
with	O
solubles	O
were	O
weighed	O
(	O
5	O
g	O
/	O
sample	O
)	O
into	O
scintillation	O
vials	O
and	O
inoculated	O
with	O
1	O
mL	O
of	O
PEDV	O
,	O
PDCoV	O
,	O
or	O
TGEV	O
.	O

They	O
bind	O
and	O
remove	O
ubiquitin	O
(	O
Ub	O
)	O
and	O
interferon	O
stimulated	O
gene	O
15	O
(	O
ISG15	O
)	O
from	O
cellular	B-ANAT
proteins	O
to	O
suppress	O
host	O
antiviral	O
innate	O
immune	O
responses	O
.	O

Phosphine	O
is	O
a	O
respiratory	O
toxin	O
that	O
inhibits	O
cytochrome	O
C	O
oxidase	O
system	O
resulting	O
in	O
renal	B-ANAT
failure	O
and	O
liver	B-ANAT
failure	O
.	O

The	O
late	O
deaths	O
(	O
beyond	O
24	O
h	O
)	O
had	O
been	O
commonly	O
due	O
to	O
adult	O
respiratory	O
distress	O
syndrome	O
,	O
liver	B-ANAT
and	O
renal	B-ANAT
failure	O
.	O

In	O
our	O
patient	O
,	O
Zinc	O
phosphide	O
poisoning	O
caused	O
severe	O
acute	O
kidney	B-ANAT
injury	O
,	O
abnormal	O
liver	B-ANAT
profile	O
,	O
pancreatitis	O
and	O
possible	O
myocarditis	O
.	O

The	O
differences	O
in	O
serum	B-ANAT
CC16	O
and	O
other	O
laboratory	O
indicators	O
between	O
two	O
groups	O
were	O
analyzed	O
.	O

The	O
correlation	O
between	O
serum	B-ANAT
CC16	O
levels	O
and	O
the	O
severity	O
of	O
ARDS	O
as	O
quantified	O
by	O
PaO	O
The	O
serum	B-ANAT
CC16	O
levels	O
in	O
ARDS	O
patients	O
were	O
significantly	O
higher	O
than	O
that	O
in	O
non	O
-	O
ARDS	O
patients	O
(	O
54	O
.	O
44	O
Â±	O
19	O
.	O
62	O
vs	O
24	O
.	O
13	O
Â±	O
12	O
.	O
32	O
ng	O
/	O
mL	O
,	O
P	O
=.	O
001	O
).	O

The	O
serum	B-ANAT
CC16	O
levels	O
were	O
significantly	O
greater	O
in	O
non	O
-	O
survivors	O
than	O
in	O
survivors	O
from	O
the	O
ARDS	O
group	O
.	O

Seventy	O
-	O
nine	O
patients	O
less	O
than	O
18	O
years	O
old	O
treated	O
for	O
severe	O
sepsis	O
/	O
septic	O
shock	O
in	O
2012	O
-	O
2013	O
who	O
died	O
prior	O
to	O
hospital	O
discharge	B-ANAT
.	O

The	O
most	O
common	O
cause	O
of	O
death	O
was	O
refractory	O
shock	O
(	O
34	O
%),	O
then	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
after	O
shock	O
recovery	O
(	O
27	O
%),	O
neurologic	O
injury	O
(	O
19	O
%),	O
single	O
-	O
organ	B-ANAT
respiratory	O
failure	O
(	O
9	O
%),	O
and	O
nonseptic	O
comorbidity	O
(	O
6	O
%).	O

Early	O
deaths	O
(â¤	O
3	O
d	O
)	O
were	O
mostly	O
due	O
to	O
refractory	O
shock	O
in	O
young	O
,	O
previously	O
healthy	O
patients	O
while	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
predominated	O
after	O
3	O
days	O
.	O

TITLE	O
:	O
[	O
EXTRACORPOREAL	O
MEMBRANE	B-ANAT
OXYGENATION	O
IN	O
ISRAEL	O
:	O
6	O
.	O
5	O
YEARS	O
OF	O
EXPERIENCE	O
AT	O
THE	O
LARGEST	O
ECMO	O
TREATMENT	O
CENTER	O
IN	O
ISRAEL	O
].	O

The	O
most	O
significant	O
increase	O
in	O
the	O
use	O
of	O
ECMO	O
as	O
a	O
replacement	O
lung	B-ANAT
function	O
began	O
after	O
the	O
publication	O
of	O
the	O
CESAR	O
study	O
in	O
2009	O
,	O
which	O
demonstrated	O
a	O
decrease	O
in	O
mortality	O
of	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
treated	O
with	O
ECMO	O
,	O
compared	O
with	O
conservative	O
treatment	O
.	O

Herein	O
,	O
we	O
review	O
the	O
contribution	O
of	O
neutrophils	B-ANAT
to	O
IAV	O
disease	O
pathogenesis	O
and	O
to	O
other	O
respiratory	O
virus	O
infections	O
.	O

No	O
significant	O
cellular	B-ANAT
toxicity	O
was	O
observed	O
at	O
the	O
effective	O
concentrations	O
.	O

Future	O
research	O
should	O
examine	O
whether	O
any	O
additional	O
improvements	O
in	O
neurocognition	O
and	O
white	B-ANAT
matter	I-ANAT
integrity	O
among	O
SVRs	O
occur	O
with	O
longer	O
follow	O
-	O
up	O
periods	O
.	O

During	O
course	O
of	O
therapy	O
with	O
drainage	B-ANAT
of	O
intraventricular	B-ANAT
intracerebral	O
hemorrhage	O
,	O
the	O
patient	O
developed	O
pneumonia	O
followed	O
by	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
with	O
critically	O
raised	O
ICP	O
.	O

An	O
endotracheal	O
wash	O
was	O
performed	O
,	O
which	O
confirmed	O
a	O
diagnosis	O
of	O
pulmonary	B-ANAT
toxoplasmosis	O
.	O

Necropsy	O
was	O
performed	O
and	O
histopathology	O
revealed	O
protozoal	O
organisms	O
disseminated	O
throughout	O
the	O
heart	B-ANAT
,	O
lungs	B-ANAT
,	O
liver	B-ANAT
,	O
and	O
brain	B-ANAT
.	O

Although	O
the	O
pathogenesis	O
of	O
HFRS	O
and	O
HPS	O
remains	O
largely	O
unknown	O
,	O
postmortem	B-ANAT
tissue	I-ANAT
studies	O
have	O
identified	O
endothelial	B-ANAT
cells	I-ANAT
as	O
the	O
primary	O
target	O
of	O
infection	O
.	O

Importantly	O
,	O
cell	B-ANAT
damage	O
due	O
to	O
virus	O
replication	O
,	O
or	O
subsequent	O
tissue	B-ANAT
repair	O
,	O
has	O
not	O
been	O
documented	O
.	O

Overall	O
,	O
serum	B-ANAT
cytokine	O
profiles	O
associated	O
with	O
HPS	O
revealed	O
a	O
more	O
pro	O
-	O
inflammatory	O
milieu	O
as	O
compared	O
to	O
HFRS	O
.	O

Finally	O
,	O
the	O
results	O
of	O
our	O
analysis	O
suggest	O
that	O
serum	B-ANAT
cytokines	O
profiles	O
of	O
HPS	O
and	O
HFRS	O
cases	O
are	O
consistent	O
with	O
the	O
presence	O
of	O
extracellular	B-ANAT
matrix	I-ANAT
degradation	O
,	O
increased	O
mononuclear	B-ANAT
leukocyte	I-ANAT
proliferation	O
,	O
and	O
transendothelial	O
migration	O
.	O

In	O
conclusion	O
,	O
using	O
bioinformatics	O
methods	O
,	O
we	O
analyzed	O
the	O
genome	O
sequence	O
of	O
MERS	O
-	O
CoV	O
and	O
identified	O
a	O
potential	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
epitope	O
of	O
the	O
E	O
protein	O
,	O
which	O
might	O
significantly	O
improve	O
our	O
current	O
MERS	O
vaccine	O
development	O
strategies	O
.	O

CONCLUSIONS	O
:	O
The	O
multiplex	O
kindred	O
reported	O
herein	O
expands	O
the	O
genotypic	O
and	O
phenotypic	O
spectrum	O
of	O
this	O
recently	O
described	O
clinical	O
syndrome	O
due	O
to	O
autosomal	B-ANAT
recessive	O
NBAS	O
deficiency	O
.	O

The	O
duration	O
of	O
viral	O
RNA	O
detection	O
(	O
but	O
not	O
viral	O
load	O
)	O
in	O
sputum	B-ANAT
significantly	O
correlated	O
with	O
the	O
antibody	O
response	O
magnitude	O
.	O

Obtaining	O
convalescent	O
-	O
phase	O
plasma	B-ANAT
with	O
high	O
antibody	O
titers	O
to	O
treat	O
MERS	O
will	O
be	O
challenging	O
.	O

ABSTRACT	O
:	O
Objectives	O
Feline	O
leukaemia	O
virus	O
(	O
FeLV	O
),	O
a	O
gamma	O
retrovirus	O
,	O
causes	O
diseases	O
of	O
the	O
feline	O
haematopoietic	B-ANAT
system	I-ANAT
that	O
are	O
invariably	O
fatal	O
.	O

A	O
retrospective	O
study	O
including	O
116	O
clinical	O
plasma	B-ANAT
and	O
serum	B-ANAT
samples	O
that	O
had	O
been	O
tested	O
with	O
virus	O
isolation	O
,	O
real	O
-	O
time	O
PCR	O
and	O
ELISA	O
,	O
and	O
a	O
prospective	O
study	O
including	O
150	O
clinical	O
plasma	B-ANAT
and	O
serum	B-ANAT
samples	O
were	O
implemented	O
to	O
evaluate	O
the	O
clinical	O
performances	O
of	O
the	O
iiPCR	O
-	O
based	O
methods	O
for	O
FeLV	O
detection	O
.	O

Further	O
studies	O
showed	O
that	O
both	O
MHV	O
and	O
SARS	O
-	O
CoV	O
N	O
proteins	O
directly	O
interacted	O
with	O
protein	O
activator	O
of	O
protein	O
kinase	O
R	O
(	O
PACT	O
),	O
a	O
cellular	B-ANAT
dsRNA	O
-	O
binding	O
protein	O
that	O
can	O
bind	O
to	O
RIG	O
-	O
I	O
and	O
MDA5	O
to	O
activate	O
IFN	O
production	O
.	O

Half	O
the	O
patients	O
received	O
mechanical	O
ventilation	O
within	O
1	O
(	O
1	O
-	O
2	O
)	O
day	O
following	O
ICU	O
admission	O
(	O
the	O
ratio	O
of	O
arterial	B-ANAT
oxygen	O
partial	O
pressure	O
to	O
fractional	O
inspired	O
oxygen	O
(	O
PaO	O

We	O
generated	O
264	O
F2	O
mice	O
between	O
these	O
strains	O
,	O
and	O
infected	O
them	O
with	O
SARS	O
-	O
CoV	O
.	O
Weight	O
loss	O
,	O
pulmonary	B-ANAT
hemorrhage	O
,	O
and	O
viral	O
load	O
were	O
all	O
highly	O
correlated	O
disease	O
phenotypes	O
.	O

Major	O
advances	O
in	O
the	O
study	O
of	O
the	O
molecular	O
biology	O
of	O
IBV	O
have	O
resulted	O
from	O
the	O
development	O
of	O
reverse	O
genetics	O
systems	O
for	O
the	O
highly	O
attenuated	O
,	O
cell	B-ANAT
culture	O
-	O
adapted	O
,	O
IBV	O
strain	O
Beaudette	O
.	O

First	O
,	O
a	O
genomic	O
and	O
a	O
chimeric	O
synthetic	O
,	O
modified	O
IBV	O
RNA	O
were	O
co	O
-	O
transfected	O
into	O
non	O
-	O
susceptible	O
cells	B-ANAT
to	O
generate	O
a	O
recombinant	O
chimeric	O
murinized	O
(	O
m	O
)	O
IBV	O
intermediate	O
(	O
mIBV	O
).	O

ABSTRACT	O
:	O
In	O
ARDS	O
,	O
elevated	O
pulmonary	B-ANAT
dead	O
-	O
space	O
fraction	O
(	O
V	O
This	O
single	O
-	O
center	O
,	O
retrospective	O
,	O
observational	O
study	O
(	O
2010	O
-	O
2016	O
)	O
measured	O
V	O
V	O
V	O

Extracorporeal	O
membrane	B-ANAT
oxygenation	O
patients	O
experienced	O
more	O
clinically	O
significant	O
iatrogenic	O
withdrawal	O
than	O
moderate	O
/	O
severe	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
managed	O
without	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
support	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

To	O
assess	O
potential	O
drug	O
-	O
induced	O
liver	B-ANAT
injury	O
,	O
we	O
also	O
analyzed	O
biomarkers	O
of	O
liver	B-ANAT
cell	I-ANAT
integrity	O
.	O

Chickens	O
were	O
sacrificed	O
at	O
three	O
days	O
post	O
inoculation	O
,	O
and	O
the	O
lung	B-ANAT
,	O
trachea	B-ANAT
,	O
and	O
air	B-ANAT
sac	I-ANAT
samples	O
were	O
taken	O
to	O
determine	O
histological	O
changes	O
and	O
expression	O
levels	O
of	O
cSP	O
-	O
A	O
mRNA	O
and	O
cSP	O
-	O
A	O
protein	O
.	O

Medical	O
history	O
included	O
type	O
2	O
diabetes	O
,	O
recurrent	O
pulmonary	B-ANAT
embolisms	O
and	O
pre	O
-	O
existing	O
diaphragmatic	B-ANAT
hernia	O
containing	O
part	O
of	O
the	O
liver	B-ANAT
.	O

ATP	O
measurements	O
and	O
HE	O
staining	O
revealed	O
living	O
tissue	B-ANAT
in	O
culture	O
for	O
up	O
to	O
24h	O
.	O

Finally	O
,	O
TGEV	O
GFP	O
is	O
a	O
recombinant	O
strain	O
that	O
obtained	O
its	O
main	O
body	B-ANAT
from	O
TGEV	O
PUR	O
46	O
-	O
MAD	O
,	O
but	O
its	O
spike	O
protein	O
from	O
TGEV	O
PUR	O
-	O
C11	O
that	O
showed	O
high	O
mortality	O
in	O
piglets	O
in	O
vivo	O
.	O

TITLE	O
:	O
A	O
spike	O
-	O
specific	O
whole	O
-	O
porcine	O
antibody	O
isolated	O
from	O
a	O
porcine	O
B	B-ANAT
cell	I-ANAT
that	O
neutralizes	O
both	O
genogroup	O
1	O
and	O
2	O
PEDV	O
strains	O
.	O

The	O
antibody	O
,	O
named	O
PC10	O
,	O
was	O
demonstrated	O
to	O
target	O
the	O
conformational	O
epitope	O
of	O
PEDV	O
spike	O
protein	O
,	O
specifically	O
bind	O
to	O
the	O
infected	O
cells	B-ANAT
of	O
PEDV	O
genogroup	O
1	O
and	O
2	O
strains	O
,	O
and	O
potently	O
neutralize	O
PEDV	O
infection	O
.	O

TITLE	O
:	O
Geo	O
-	O
economic	O
variations	O
in	O
epidemiology	O
,	O
patterns	O
of	O
care	O
,	O
and	O
outcomes	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
insights	O
from	O
the	O
LUNG	B-ANAT
SAFE	O
prospective	O
cohort	O
study	O
.	O

This	O
cements	B-ANAT
bats	O
as	O
the	O
major	O
evolutionary	O
reservoirs	O
and	O
ecological	O
drivers	O
of	O
CoV	O
diversity	O
.	O

73	O
anaesthetised	O
rats	O
(	O
acid	O
aspiration	O
model	O
)	O
were	O
ventilated	O
(	O
protective	O
or	O
non	O
-	O
protective	O
)	O
for	O
up	O
to	O
4	O
hours	O
to	O
generate	O
a	O
spectrum	O
of	O
lung	B-ANAT
injury	O
.	O

Phylogenetic	O
analysis	O
showed	O
that	O
the	O
two	O
nasopharyngeal	B-ANAT
strains	O
in	O
the	O
present	O
study	O
were	O
most	O
closely	O
related	O
to	O
the	O
strains	O
PDCoV	O
/	O
CHJXNI2	O
/	O
2015	O
from	O
Jiangxi	O
,	O
China	O
,	O
and	O
CH	O
/	O
Sichuan	O
/	O
S27	O
/	O
2012	O
from	O
Sichuan	O
,	O
China	O
.	O

The	O
presence	O
of	O
the	O
virus	O
in	O
respiratory	B-ANAT
samples	I-ANAT
provides	O
an	O
alternative	O
clinical	O
sample	O
to	O
confirm	O
the	O
diagnosis	O
of	O
Coronavirus	O
HKU15	O
infection	O
.	O

ABSTRACT	O
:	O
Two	O
herds	O
of	O
dromedary	O
camels	O
were	O
longitudinally	O
sampled	O
with	O
nasal	B-ANAT
and	O
rectal	O
swabs	O
and	O
serum	B-ANAT
,	O
between	O
September	O
2014	O
and	O
May	O
2015	O
,	O
and	O
the	O
samples	O
were	O
tested	O
for	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
coronavirus	O
RNA	O
and	O
antibodies	O
.	O

TITLE	O
:	O
Argatroban	O
for	O
Heparin	O
-	O
Induced	O
Thrombocytopenia	O
during	O
Venovenous	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
with	O
Continuous	O
Venovenous	O
Hemofiltration	O
.	O

This	O
review	O
summarizes	O
our	O
current	O
understanding	O
of	O
coronavirus	O
-	O
host	O
interactions	O
at	O
the	O
level	O
of	O
the	O
infected	O
cell	B-ANAT
,	O
with	O
special	O
attention	O
for	O
the	O
assembly	O
and	O
function	O
of	O
the	O
viral	O
RNA	O
-	O
synthesising	O
machinery	O
and	O
the	O
evasion	O
of	O
cellular	B-ANAT
innate	O
immune	O
responses	O
.	O

V	O
-	O
V	O
ECMO	O
does	O
not	O
provide	O
treatment	O
for	O
acutely	O
and	O
severely	O
diseased	O
lungs	B-ANAT
,	O
but	O
it	O
enables	O
patient	O
to	O
survive	O
the	O
critical	O
phase	O
of	O
severe	O
ARDS	O
until	O
recovery	O
of	O
lung	B-ANAT
function	O
.	O

TITLE	O
:	O
Aortic	B-ANAT
stenosis	O
concomitant	O
with	O
microscopic	O
polyangiitis	O
:	O
a	O
challenge	O
in	O
medical	O
reasoning	O
and	O
thinking	O
.	O

A	O
renal	B-ANAT
biopsy	O
was	O
undertaken	O
but	O
the	O
specimen	O
was	O
exiguous	O
,	O
showing	O
4	O
sclerotic	O
glomeruli	O
and	O
1	O
glomerulus	B-ANAT
with	O
crescentic	O
glomerulonephritis	O
.	O

Severe	O
acute	O
respiratory	O
syndrome	O
CoV	O
(	O
SARS	O
-	O
CoV	O
)	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
CoV	O
(	O
MERS	O
-	O
CoV	O
)	O
successively	O
emerged	O
,	O
causing	O
severe	O
epidemic	O
respiratory	O
disease	O
in	O
immunologically	O
naÃ¯ve	O
human	O
populations	O
throughout	O
the	O
globe	B-ANAT
.	O

The	O
experiments	O
also	O
included	O
comparing	O
the	O
ability	O
of	O
six	O
vaccination	O
programmes	O
to	O
induce	O
virus	O
neutralizing	O
antibodies	O
(	O
VNA	O
)	O
in	O
layers	B-ANAT
against	O
four	O
selected	O
Chilean	O
strains	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
frequency	O
of	O
respiratory	O
viral	O
infections	O
in	O
a	O
young	O
child	O
and	O
to	O
examine	O
the	O
duration	O
of	O
viral	B-ANAT
genome	I-ANAT
detection	O
in	O
clinical	O
specimens	O
.	O

We	O
report	O
the	O
first	O
case	O
of	O
CHS	O
as	O
a	O
complication	O
of	O
lateral	O
medullary	B-ANAT
infarction	O
after	O
endovascular	B-ANAT
treatment	O
.	O

TITLE	O
:	O
Kidney	B-ANAT
Cell	I-ANAT
-	O
Adapted	O
Infectious	O
Bronchitis	O
ArkDPI	O
Vaccine	O
is	O
Stable	O
and	O
Protective	O
.	O

Using	O
the	O
recombinant	O
S	O
proteins	O
as	O
probes	O
to	O
perform	O
S	O
protein	O
affinity	O
histochemistry	O
in	O
paraffin	O
-	O
embedded	O
tissues	B-ANAT
,	O
although	O
no	O
tissue	B-ANAT
or	O
enteric	O
binding	O
of	O
FECV	O
UU7	O
S	O
protein	O
was	O
detected	O
,	O
it	O
was	O
found	O
that	O
by	O
immunohistochemistry	O
that	O
the	O
tissue	B-ANAT
distribution	O
of	O
FIPV	O
UU4	O
S	O
protein	O
-	O
bound	O
cells	B-ANAT
correlated	O
with	O
that	O
of	O
FIPV	O
antigen	O
-	O
positive	O
cells	B-ANAT
and	O
lesions	O
associated	O
with	O
FIP	O
and	O
that	O
the	O
affinity	O
binding	O
of	O
FIPV	O
UU4	O
S	O
protein	O
on	O
macrophages	B-ANAT
was	O
not	O
affected	O
by	O
enzymatic	O
removal	O
of	O
host	B-ANAT
cell	I-ANAT
-	O
surface	O
sialic	O
acid	O
with	O
neuraminidase	O
.	O

These	O
findings	O
suggest	O
that	O
a	O
factor	O
(	O
s	O
)	O
other	O
than	O
sialic	O
acid	O
contribute	O
(	O
s	O
)	O
to	O
the	O
macrophage	B-ANAT
tropism	O
of	O
FIPV	O
strain	O
UU4	O
.	O

Adults	O
with	O
severe	O
injury	O
who	O
underwent	O
definitive	O
fixation	O
of	O
a	O
femoral	B-ANAT
shaft	I-ANAT
fracture	O
at	O
a	O
level	O
I	O
or	O
II	O
trauma	O
center	O
participating	O
in	O
ACS	O
TQIP	O
(	O
2012	O
-	O
2015	O
)	O
were	O
included	O
.	O

Here	O
,	O
we	O
present	O
2	O
cases	O
with	O
both	O
MERS	O
-	O
CoV	O
and	O
pulmonary	B-ANAT
TB	O
.	O

Interestingly	O
,	O
hemorrhage	O
and	O
atrophy	O
were	O
observed	O
in	O
thymus	B-ANAT
gland	I-ANAT
of	O
birds	O
challenged	O
with	O
single	O
AIV	O
-	O
H9N2	O
or	O
mixed	O
AIV	O
-	O
H9N2	O
/	O
IBV	O
.	O

To	O
evaluate	O
performance	O
according	O
to	O
serum	B-ANAT
collection	O
time	O
,	O
we	O
used	O
'	O
days	O
post	O
onset	O
of	O
illness	O
(	O
dpoi	O
)'	O
and	O
'	O
days	O
post	O
exposure	O
(	O
dpex	O
)'	O
assessing	O
neutralization	O
activity	O
and	O
infection	O
diagnosis	O
,	O
respectively	O
.	O

Mitochondrial	B-ANAT
DNA	I-ANAT
analyses	O
revealed	O
that	O
both	O
the	O
bat	O
flies	O
and	O
their	O
bat	O
hosts	O
belong	O
to	O
putative	O
new	O
species	O
.	O

In	O
these	O
patients	O
,	O
ECCO	O
Optimized	O
use	O
of	O
NIV	O
and	O
lung	B-ANAT
-	O
protective	O
ventilation	O
remains	O
standard	O
of	O
care	O
in	O
the	O
management	O
of	O
hypercapnic	O
respiratory	O
failure	O
.	O

The	O
complete	O
genome	O
sequence	O
obtained	O
from	O
a	O
sputum	B-ANAT
sample	I-ANAT
(	O
taken	O
on	O
day	O
11	O
)	O
showed	O
the	O
highest	O
sequence	O
similarity	O
(	O
99	O
.	O
59	O
%)	O
with	O
the	O
virus	O
from	O
an	O
outbreak	O
in	O
Riyadh	O
,	O
Saudi	O
Arabia	O
,	O
in	O
February	O
2015	O
.	O

Tough	O
quick	O
cesarean	O
section	O
was	O
performed	O
as	O
symptoms	O
got	O
worse	O
with	O
onset	O
of	O
multiorgan	O
failure	O
requiring	O
mechanical	O
ventilation	O
for	O
acute	O
respiratory	O
distress	O
,	O
continuous	O
renal	B-ANAT
replacement	O
,	O
and	O
vasopressors	O
.	O

Asthma	O
is	O
characterized	O
by	O
variable	O
airway	B-ANAT
obstruction	O
,	O
airway	B-ANAT
hyperresponsiveness	O
,	O
and	O
airway	B-ANAT
inflammation	O
.	O

TITLE	O
:	O
Coronavirus	O
nucleocapsid	B-ANAT
proteins	O
assemble	O
constitutively	O
in	O
high	O
molecular	O
oligomers	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
(	O
CoV	O
)	O
are	O
enveloped	O
viruses	O
and	O
rely	O
on	O
their	O
nucleocapsid	B-ANAT
N	O
protein	O
to	O
incorporate	O
the	O
positive	O
-	O
stranded	O
genomic	O
RNA	O
into	O
the	O
virions	B-ANAT
.	O

Labs	O
showed	O
severe	O
hyponatremia	O
,	O
acute	O
kidney	B-ANAT
injury	O
,	O
rhabdomyolysis	O
,	O
hyperkalemia	O
,	O
and	O
elevated	O
liver	B-ANAT
enzymes	O
.	O

TITLE	O
:	O
Vero	B-ANAT
cell	I-ANAT
technology	O
for	O
rapid	O
development	O
of	O
inactivated	O
whole	O
virus	O
vaccines	O
for	O
emerging	O
viral	O
diseases	O
.	O

Moreover	O
,	O
mRNA	O
levels	O
of	O
inflammatory	O
cytokines	O
(	O
TNF	O
-	O
Î±	O
,	O
IL	O
-	O
1Î²	O
,	O
and	O
IL	O
-	O
6	O
)	O
significantly	O
increased	O
with	O
ADE	O
of	O
FIPV	O
79	O
-	O
1146	O
infection	O
in	O
primary	O
feline	O
monocytes	B-ANAT
,	O
but	O
FECV	O
79	O
-	O
1683	O
did	O
not	O
demonstrate	O
an	O
increase	O
in	O
these	O
levels	O
.	O

In	O
conclusion	O
,	O
infection	O
of	O
monocytes	B-ANAT
by	O
FECV	O
was	O
enhanced	O
by	O
antibodies	O
,	O
but	O
the	O
efficiency	O
of	O
infection	O
was	O
lower	O
than	O
that	O
of	O
FIPV	O
.	O

The	O
dysregulation	O
of	O
EPCR	O
and	O
TM	O
in	O
the	O
lung	B-ANAT
,	O
especially	O
in	O
those	O
with	O
increased	O
levels	O
of	O
hemozoin	O
,	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
malaria	O
-	O
associated	O
ARDS	O
through	O
an	O
apoptotic	O
pathway	O
.	O

TITLE	O
:	O
Outbreak	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
-	O
Coronavirus	O
Causes	O
High	O
Fatality	O
After	O
Cardiac	B-ANAT
Operations	O
.	O

Because	O
there	O
are	O
not	O
enough	O
lung	B-ANAT
donors	O
,	O
it	O
is	O
important	O
to	O
determine	O
their	O
optimal	O
use	O
.	O

RESULTS	O
:	O
Of	O
the	O
194	O
patients	O
who	O
underwent	O
respiratory	O
ECMO	O
over	O
a	O
4	O
-	O
year	O
period	O
,	O
a	O
BTT	O
strategy	O
was	O
used	O
for	O
19	O
patients	O
(	O
median	O
age	O
,	O
58	O
years	O
)	O
on	O
our	O
institution	O
'	O
s	O
lung	B-ANAT
transplantation	O
waiting	O
list	O
(	O
15	O
veno	O
-	O
venous	B-ANAT
,	O
3	O
veno	O
-	O
veno	O
-	O
arterial	B-ANAT
,	O
1	O
veno	O
-	O
arterial	B-ANAT
).	O

RESULTS	O
:	O
There	O
was	O
no	O
difference	O
in	O
baseline	O
characteristics	O
between	O
the	O
two	O
groups	O
except	O
for	O
higher	O
driving	O
pressure	O
and	O
more	O
diastolic	O
dysfunction	O
in	O
ILD	O
group	O
than	O
severe	O
ARDS	O
group	O
Compared	O
with	O
pre	O
-	O
PPV	O
,	O
cardiac	B-ANAT
index	O
and	O
driving	O
pressure	O
remained	O
unchanged	O
post	O
-	O
PPV	O
in	O
both	O
groups	O
.	O

Through	O
cell	B-ANAT
culture	O
adaptation	O
,	O
we	O
obtained	O
four	O
distinct	O
deletion	O
(	O
DEL	O
)	O
mutants	O
by	O
plaque	O
purification	O
followed	O
by	O
nucleotide	O
sequencing	O
of	O
the	O
spike	O
(	O
S	O
)/	O
ORF3	O
gene	O
-	O
coding	O
region	O
,	O
which	O
were	O
designated	O
KNU	O
-	O
141112	O
-	O
S	O
DEL2	O
,	O
-	O
S	O
DEL5	O
,	O
-	O
S	O
DEL2	O
/	O
ORF3	O
,	O
and	O
-	O
S	O
DEL5	O
/	O
ORF3	O
.	O

TITLE	O
:	O
Identification	O
and	O
characterization	O
of	O
a	O
Golgi	B-ANAT
retention	O
signal	O
in	O
feline	O
coronavirus	O
accessory	O
protein	O
7b	O
.	O

ABSTRACT	O
:	O
Infection	O
by	O
enveloped	O
coronaviruses	O
(	O
CoVs	O
)	O
initiates	O
with	O
viral	O
spike	O
(	O
S	O
)	O
proteins	O
binding	O
to	O
cellular	B-ANAT
receptors	O
,	O
and	O
is	O
followed	O
by	O
proteolytic	O
cleavage	O
of	O
receptor	O
-	O
bound	O
S	O
proteins	O
,	O
which	O
prompts	O
S	O
protein	O
-	O
mediated	O
virus	O
-	O
cell	B-ANAT
membrane	I-ANAT
fusion	O
.	O

Using	O
a	O
double	O
immunofluorescent	O
technique	O
,	O
we	O
observed	O
that	O
both	O
IBV	O
Massachusetts	O
-	O
type	O
41	O
(	O
M41	O
)	O
and	O
Connecticut	O
A5968	O
(	O
Conn	O
A5968	O
)	O
strains	O
replicate	O
in	O
avian	O
macrophages	B-ANAT
at	O
a	O
low	O
level	O
in	O
vivo	O
.	O

During	O
the	O
replication	O
of	O
IBV	O
in	O
macrophages	B-ANAT
,	O
their	O
ability	O
to	O
produce	O
NO	O
can	O
be	O
affected	O
without	O
affecting	O
the	O
ability	O
to	O
induce	O
type	O
1	O
IFN	O
activity	O
.	O

Effusion	B-ANAT
and	O
/	O
or	O
serum	B-ANAT
/	O
plasma	B-ANAT
samples	O
were	O
examined	O
by	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
targeting	O
the	O
two	O
FCoV	O
spike	O
gene	O
fusion	O
peptide	O
mutations	O
M1058	O
L	O
and	O
S1060A	O
using	O
an	O
allelic	O
discrimination	O
approach	O
.	O

FIPV	O
was	O
detected	O
in	O
the	O
effusion	B-ANAT
of	O
25	O
/	O
59	O
cats	O
,	O
one	O
of	O
them	O
being	O
a	O
control	O
cat	O
with	O
chronic	O
kidney	B-ANAT
disease	O
.	O

A	O
mixed	O
population	O
of	O
FIPV	O
/	O
FECV	O
was	O
detected	O
in	O
the	O
effusion	B-ANAT
of	O
2	O
/	O
59	O
cats	O
;	O
all	O
of	O
them	O
had	O
FIP	O
.	O

RT	O
-	O
PCR	O
was	O
negative	O
or	O
the	O
pathotype	O
could	O
not	O
be	O
determined	O
in	O
34	O
/	O
59	O
effusion	B-ANAT
samples	O
.	O

In	O
effusion	B-ANAT
,	O
sensitivity	O
was	O
68	O
.	O
6	O
%	O
(	O
95	O
%	O
CI	O
50	O
.	O
7	O
-	O
83	O
.	O
2	O
),	O
specificity	O
was	O
95	O
.	O
8	O
%	O
(	O
95	O
%	O
CI	O
78	O
.	O
9	O
-	O
99	O
.	O
9	O
).	O

RESULTS	O
:	O
FIPV	O
was	O
detected	O
in	O
the	O
effusion	B-ANAT
of	O
25	O
/	O
59	O
cats	O
,	O
one	O
of	O
them	O
being	O
a	O
control	O
cat	O
with	O
chronic	O
kidney	B-ANAT
disease	O
.	O

The	O
best	O
examples	O
are	O
the	O
recurring	O
outbreaks	O
of	O
dengue	O
and	O
chikungunya	O
fever	O
in	O
tropical	O
and	O
sub	O
-	O
tropical	O
regions	O
,	O
the	O
recent	O
epidemic	O
of	O
Zika	O
in	O
the	O
Americas	O
and	O
the	O
Caribbean	O
,	O
and	O
the	O
SARS	O
,	O
MERS	O
,	O
and	O
influenza	O
A	O
outbreaks	O
across	O
the	O
globe	B-ANAT
.	O

CONCLUSIONS	O
:	O
DAD	O
due	O
to	O
viral	O
A	O
(	O
H1N1	O
)	O
pdm09	O
is	O
associated	O
with	O
a	O
cytotoxic	O
inflammatory	O
phenotype	O
,	O
with	O
partially	O
divergent	O
responses	O
in	O
the	O
parenchyma	B-ANAT
relative	O
to	O
the	O
small	O
airways	O
.	O

Twenty	O
-	O
six	O
patients	O
(	O
51	O
.	O
0	O
%)	O
had	O
clinically	O
relevant	O
lung	B-ANAT
damage	O
caused	O
by	O
VGS	O
BSI	O
(	O
i	O
.	O
e	O
.,	O
acute	O
lung	B-ANAT
injury	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
).	O

ABSTRACT	O
:	O
Postoperative	O
pulmonary	B-ANAT
complications	O
(	O
PPCs	O
)	O
are	O
the	O
most	O
common	O
causes	O
of	O
serious	O
morbidity	O
after	O
esophagectomy	O
,	O
which	O
involves	O
both	O
thoracic	B-ANAT
and	O
abdominal	B-ANAT
incisions	O
.	O

JCOG0502	O
is	O
a	O
four	O
-	O
arm	B-ANAT
prospective	O
study	O
comparing	O
esophagectomy	O
with	O
definitive	O
chemo	O
-	O
radiotherapy	O
.	O

TITLE	O
:	O
Effect	O
of	O
Booster	O
Vaccination	O
with	O
Inactivated	O
Porcine	O
Epidemic	O
Diarrhea	O
Virus	O
on	O
Neutralizing	O
Antibody	O
Response	O
in	O
Mammary	B-ANAT
Secretions	B-ANAT
.	O

ABSTRACT	O
:	O
Idiopathic	O
pulmonary	B-ANAT
hemosiderosis	O
(	O
IPH	O
)	O
is	O
an	O
extremely	O
rare	O
cause	O
of	O
massive	O
pulmonary	B-ANAT
hemorrhage	O
in	O
children	O
.	O

TITLE	O
:	O
Rapid	O
onset	O
of	O
amiodarone	O
induced	O
pulmonary	B-ANAT
toxicity	O
after	O
lung	B-ANAT
lobe	I-ANAT
resection	O
-	O
A	O
case	O
report	O
and	O
review	O
of	O
recent	O
literature	O
.	O

Laboratory	O
results	O
show	O
increased	O
serum	B-ANAT
creatinine	O
kinase	O
and	O
AST	O
.	O

The	O
patient	O
'	O
s	O
respiratory	O
status	O
continued	O
to	O
decline	O
postpartum	O
,	O
and	O
she	O
ultimately	O
required	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

TITLE	O
:	O
Propagation	O
of	O
respiratory	O
viruses	O
in	O
human	O
airway	B-ANAT
epithelia	O
reveals	O
persistent	O
virus	O
-	O
specific	O
signatures	O
.	O

RNA	O
sequencing	O
highlighted	O
perturbation	O
of	O
tissue	B-ANAT
metabolism	O
and	O
induction	O
of	O
a	O
transient	O
but	O
important	O
immune	O
response	O
at	O
4	O
days	O
after	O
infection	O
.	O

Bulbar	B-ANAT
and	O
respiratory	B-ANAT
muscle	I-ANAT
weakness	O
may	O
or	O
may	O
not	O
be	O
present	O
.	O

The	O
animals	O
showed	O
clinical	O
signs	O
of	O
acute	O
respiratory	O
disease	O
with	O
frothy	O
nasal	B-ANAT
discharge	B-ANAT
(	O
1	O
-	O
2	O
days	O
)	O
and	O
mortality	O
of	O
twenty	O
animals	O
(	O
80	O
%)	O
within	O
48	O
hr	O
.	O

Swabs	O
from	O
trachea	B-ANAT
and	O
nasal	B-ANAT
tract	O
along	O
with	O
tissue	B-ANAT
samples	O
of	O
spleen	B-ANAT
and	O
lung	B-ANAT
from	O
dead	O
animals	O
were	O
found	O
positive	O
for	O
PPR	O
virus	O
based	O
on	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
using	O
H	O
gene	O
and	O
partial	O
N	O
gene	O
-	O
specific	O
primers	O
.	O

As	O
in	O
other	O
coronaviruses	O
,	O
the	O
spike	O
(	O
S	O
)	O
glycoprotein	O
of	O
MERS	O
-	O
CoV	O
mediates	O
receptor	O
recognition	O
and	O
membrane	B-ANAT
fusion	O
and	O
is	O
the	O
primary	O
target	O
of	O
the	O
humoral	O
immune	O
response	O
during	O
infection	O
.	O

A	O
real	O
-	O
time	O
reverse	O
transcription	O
RPA	B-ANAT
(	O
RT	O
-	O
RPA	B-ANAT
)	O
assay	O
for	O
the	O
detection	O
of	O
canine	O
distemper	O
virus	O
(	O
CDV	O
)	O
using	O
primers	O
and	O
exo	O
probe	O
targeting	O
the	O
CDV	O
nucleocapsid	B-ANAT
protein	O
gene	O
was	O
developed	O
.	O

The	O
results	O
indicated	O
an	O
excellent	O
correlation	O
between	O
RT	O
-	O
RPA	B-ANAT
and	O
a	O
reference	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
method	O
.	O

Anaesthetized	O
,	O
mechanically	O
ventilated	O
animals	O
underwent	O
right	B-ANAT
lung	I-ANAT
ischaemia	O
(	O
series	O
1	O
,	O
30	O
minutes	O
;	O
series	O
2	O
,	O
60	O
minutes	O
)	O
followed	O
by	O
reperfusion	O
for	O
300	O
minutes	O
.	O

In	O
fact	O
,	O
reinfection	O
resulted	O
in	O
enhanced	O
pulmonary	B-ANAT
inflammation	O
,	O
without	O
an	O
associated	O
increase	O
in	O
viral	O
RNA	O
titers	O
.	O

Approximately	O
half	O
the	O
SAD	O
mice	O
that	O
survived	O
to	O
adulthood	O
had	O
an	O
identifiable	O
respiratory	O
phenotype	O
including	O
baseline	O
tachypnea	O
at	O
7	O
-	O
8	O
months	O
of	O
age	O
,	O
restrictive	O
lung	B-ANAT
disease	O
,	O
pulmonary	B-ANAT
hypertension	O
,	O
cardiac	B-ANAT
enlargement	O
,	O
lower	O
total	O
lung	B-ANAT
capacity	O
,	O
and	O
pulmonary	B-ANAT
vascular	B-ANAT
congestion	O
.	O

ABSTRACT	O
:	O
The	O
present	O
study	O
examines	O
the	O
susceptibility	O
of	O
mouse	O
induced	O
pluripotent	B-ANAT
stem	I-ANAT
cell	I-ANAT
-	O
derived	O
neural	O
precursor	O
cells	B-ANAT
(	O
iPSC	O
-	O
NPCs	O
)	O
to	O
infection	O
with	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	O
hepatitis	O
virus	O
(	O
JHMV	O
).	O

Similar	O
to	O
NPCs	O
derived	O
from	O
striatum	B-ANAT
of	O
day	O
1	O
postnatal	O
GFP	O
-	O
transgenic	O
mice	O
(	O
GFP	O
-	O
NPCs	O
),	O
iPSC	O
-	O
derived	O
NPCs	O
(	O
iPSC	O
-	O
NPCs	O
)	O
are	O
able	O
to	O
differentiate	O
into	O
terminal	O
neural	B-ANAT
cell	I-ANAT
types	O
and	O
express	O
MHC	B-ANAT
class	O
I	O
and	O
II	O
in	O
response	O
to	O
IFN	O
-	O
Î³	O
treatment	O
.	O

At	O
14	O
,	O
28	O
,	O
and	O
42	O
days	O
after	O
the	O
first	O
vaccination	O
,	O
serum	B-ANAT
anti	O
-	O
IBV	O
antibody	O
titers	O
;	O
peripheral	O
lymphocyte	B-ANAT
proliferation	O
;	O
and	O
the	O
mRNA	O
expression	O
of	O
IL	O
-	O
1Î²	O
,	O
IL	O
-	O
2	O
,	O
IL	O
-	O
8	O
,	O
and	O
TNF	O
-	O
Î±	O
in	O
the	O
spleen	B-ANAT
were	O
assessed	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
),	O
the	O
cell	B-ANAT
counting	O
kit	O
-	O
8	O
(	O
CCK	O
-	O
8	O
),	O
and	O
real	O
time	O
quantitative	O
RT	O
-	O
PCR	O
(	O
qRT	O
-	O
PCR	O
),	O
respectively	O
.	O

After	O
having	O
demonstrated	O
its	O
capability	O
to	O
significantly	O
improve	O
oxygenation	O
in	O
a	O
large	O
number	O
of	O
patients	O
,	O
sometimes	O
dramatically	O
,	O
this	O
procedure	O
has	O
been	O
found	O
to	O
prevent	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
,	O
the	O
primary	O
concern	O
for	O
the	O
intensivists	O
managing	O
ARDS	O
patients	O
.	O

TITLE	O
:	O
Right	B-ANAT
heart	I-ANAT
function	O
during	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Clinical	O
questionnaire	O
responses	O
and	O
examination	O
findings	O
indicated	O
that	O
the	O
patients	O
had	O
experienced	O
various	O
diseases	O
,	O
including	O
lung	B-ANAT
susceptibility	O
to	O
infections	O
,	O
tumors	O
,	O
cardiovascular	B-ANAT
disorders	O
,	O
and	O
abnormal	O
glucose	O
metabolism	O
.	O

For	O
the	O
first	O
time	O
,	O
a	O
natural	O
recombination	O
strain	O
of	O
a	O
TGEV	O
Anhui	O
Hefei	O
(	O
AHHF	O
)	O
virus	O
between	O
the	O
Purdue	O
and	O
the	O
Miller	O
clusters	O
was	O
isolated	O
from	O
the	O
small	B-ANAT
intestine	I-ANAT
content	O
of	O
piglets	O
in	O
China	O
.	O

ABSTRACT	O
:	O
Feline	O
infectious	O
peritonitis	O
(	O
FIP	O
)	O
is	O
the	O
most	O
common	O
infectious	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
disease	O
in	O
the	O
cat	O
and	O
is	O
invariably	O
fatal	O
.	O

Archived	O
records	O
from	O
5	O
institutions	O
were	O
retrospectively	O
reviewed	O
to	O
identify	O
cases	O
with	O
confirmed	O
neurologic	O
FIP	O
that	O
had	O
undergone	O
antemortem	O
MRI	O
of	O
the	O
CNS	B-ANAT
.	O

Histopathologic	O
analysis	O
identified	O
perivascular	O
pyogranulomatous	O
infiltrates	O
,	O
lymphoplasmacytic	O
infiltrates	O
,	O
or	O
both	O
affecting	O
the	O
leptomeninges	B-ANAT
(	O
16	O
),	O
choroid	B-ANAT
plexuses	O
(	O
16	O
),	O
and	O
periventricular	O
parenchyma	B-ANAT
(	O
13	O
).	O

TITLE	O
:	O
Acute	O
hypopituitarism	O
associated	O
with	O
periorbital	B-ANAT
swelling	O
and	O
cardiac	B-ANAT
dysfunction	O
in	O
a	O
patient	O
with	O
pituitary	B-ANAT
tumor	O
apoplexy	O
:	O
a	O
case	O
report	O
.	O

ABSTRACT	O
:	O
Pituitary	B-ANAT
tumor	O
apoplexy	O
is	O
a	O
rare	O
clinical	O
syndrome	O
caused	O
by	O
acute	O
hemorrhage	O
or	O
infarction	O
in	O
a	O
preexisting	O
pituitary	B-ANAT
adenoma	O
.	O

It	O
typically	O
manifests	O
as	O
an	O
acute	O
episode	O
of	O
headache	O
,	O
visual	O
disturbance	O
,	O
mental	O
status	O
changes	O
,	O
cranial	B-ANAT
nerve	I-ANAT
palsy	O
,	O
and	O
endocrine	O
pituitary	B-ANAT
dysfunction	O
.	O

Magnetic	O
resonance	O
imaging	O
showed	O
a	O
2	O
.	O
5	O
-	O
cm	O
pituitary	B-ANAT
tumor	O
containing	O
a	O
mixed	O
pattern	O
of	O
solid	O
and	O
liquid	O
components	O
indicating	O
pituitary	B-ANAT
tumor	O
apoplexy	O
due	O
to	O
hemorrhage	O
in	O
a	O
preexisting	O
pituitary	B-ANAT
adenoma	O
.	O

Replacement	O
therapy	O
with	O
oral	B-ANAT
hydrocortisone	O
and	O
levothyroxine	O
relieved	O
his	O
symptoms	O
of	O
central	O
adrenal	O
insufficiency	O
,	O
central	O
hypothyroidism	O
,	O
periorbital	B-ANAT
edema	O
,	O
and	O
cardiac	B-ANAT
dysfunction	O
.	O

Common	O
causes	O
of	O
periorbital	B-ANAT
edema	O
include	O
infections	O
,	O
inflammation	O
,	O
trauma	O
,	O
allergy	O
,	O
kidney	B-ANAT
or	O
cardiac	B-ANAT
dysfunction	O
,	O
and	O
endocrine	O
disorders	O
such	O
as	O
primary	O
hypothyroidism	O
.	O

ABSTRACT	O
:	O
OBJECTIVE	O
To	O
evaluate	O
the	O
effect	O
of	O
serum	B-ANAT
antibody	O
abundance	O
against	O
bovine	O
coronavirus	O
(	O
BCV	O
)	O
on	O
BCV	O
shedding	O
and	O
risk	O
of	O
bovine	O
respiratory	O
disease	O
(	O
BRD	O
)	O
in	O
beef	O
calves	O
from	O
birth	O
through	O
the	O
first	O
5	O
weeks	O
in	O
a	O
feedlot	O
.	O

To	O
reduce	O
the	O
risk	O
of	O
TTI	O
,	O
sensitive	O
tests	O
are	O
needed	O
and	O
the	O
choice	O
of	O
the	O
best	O
protocol	O
is	O
a	O
critical	O
step	O
in	O
improving	O
blood	B-ANAT
safety	O
.	O

The	O
patient	O
was	O
immediately	O
moved	O
back	B-ANAT
into	O
the	O
NPU	O
and	O
then	O
transferred	O
to	O
Bamrasnaradura	O
Infectious	O
Disease	O
Institute	O
.	O

During	O
2015	O
-	O
2016	O
,	O
a	O
total	O
of	O
104	O
diarrheic	O
fecal	B-ANAT
samples	O
were	O
collected	O
from	O
puppies	O
and	O
adult	O
dogs	O
,	O
with	O
or	O
without	O
hemorrhagic	O
gastroenteritis	O
,	O
on	O
the	O
Caribbean	O
island	O
of	O
St	O
.	O
Kitts	O
(	O
KNA	O
).	O

TITLE	O
:	O
Cellular	B-ANAT
RNA	O
Helicase	O
DDX1	O
Is	O
Involved	O
in	O
Transmissible	O
Gastroenteritis	O
Virus	O
nsp14	O
-	O
Induced	O
Interferon	O
-	O
Beta	O
Production	O
.	O

RT	O
-	O
PCR	O
assays	O
were	O
performed	O
for	O
the	O
detection	O
of	O
aichivirus	O
B	O
RdRP	O
and	O
VP1	O
genes	O
and	O
for	O
rotavirus	O
A	O
VP7	O
and	O
VP4	O
genes	O
in	O
fecal	B-ANAT
samples	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
severe	O
inflammatory	O
lung	B-ANAT
diseases	O
.	O

In	O
addition	O
,	O
nasal	B-ANAT
swab	O
samples	O
were	O
taken	O
from	O
20	O
pigs	O
and	O
three	O
pigs	O
per	O
case	O
herd	O
were	O
necropsied	O
during	O
the	O
first	O
visit	O
.	O

Serology	O
was	O
used	O
to	O
detect	O
According	O
to	O
the	O
pathology	O
and	O
bacteriology	O
of	O
the	O
lung	B-ANAT
samples	O
,	O
APP	O
and	O
APP	O
was	O
the	O
most	O
common	O
cause	O
for	O
acute	O
respiratory	O
outbreaks	O
in	O
our	O
study	O
.	O

These	O
include	O
viral	O
S	O
protein	O
targeting	O
;	O
inhibitors	O
of	O
host	O
proteases	O
,	O
including	O
TMPRSS2	O
,	O
cathepsin	O
L	O
and	O
furin	O
protease	O
,	O
and	O
of	O
viral	O
M	O
(	O
pro	O
)	O
and	O
the	O
PL	O
(	O
pro	O
)	O
proteases	O
;	O
convalescent	O
plasma	B-ANAT
;	O
and	O
vaccine	O
candidates	O
.	O

The	O
high	O
rates	O
of	O
infection	O
,	O
presence	O
of	O
extrapulmonary	O
end	O
organ	B-ANAT
damage	O
,	O
intensive	O
care	O
unit	O
-	O
acquired	O
weakness	O
,	O
and	O
high	O
short	O
-	O
term	O
mortality	O
associated	O
with	O
ARDS	O
are	O
all	O
significant	O
hurdles	O
that	O
make	O
lung	B-ANAT
transplantation	O
a	O
difficult	O
prospect	O
to	O
consider	O
.	O

However	O
,	O
ECMO	O
support	O
has	O
been	O
used	O
as	O
a	O
bridge	O
to	O
transplant	B-ANAT
in	O
patients	O
with	O
other	O
underlying	O
chronic	O
lung	B-ANAT
diseases	O
.	O

Our	O
case	O
illustrates	O
the	O
successful	O
use	O
of	O
lung	B-ANAT
transplantation	O
for	O
a	O
patient	O
with	O
no	O
previous	O
lung	B-ANAT
disease	O
who	O
developed	O
refractory	O
ARDS	O
requiring	O
protracted	O
ECMO	O
support	O
.	O

RESULTS	O
:	O
The	O
protective	O
group	O
displayed	O
lower	O
numbers	O
of	O
Pseudomonas	O
aeruginosa	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
the	O
lung	B-ANAT
tissue	I-ANAT
,	O
and	O
a	O
lower	O
wet	O
-	O
to	O
-	O
dry	O
ratio	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
than	O
the	O
control	O
group	O
.	O

Three	O
-	O
hundred	O
ninety	O
-	O
four	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
centers	O
registered	O
with	O
the	O
Extracorporeal	O
Life	O
Support	O
Organization	O
.	O

The	O
most	O
frequently	O
perceived	O
barriers	O
to	O
mobilization	O
were	O
hemodynamic	O
instability	O
,	O
hypoxemia	O
,	O
and	O
dependency	O
on	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
support	O
.	O

There	O
is	O
considerable	O
variability	O
surrounding	O
early	O
physical	O
therapy	O
and	O
mobilization	O
goals	O
for	O
patients	O
with	O
acute	O
respiratory	O
failure	O
supported	O
by	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

TITLE	O
:	O
Neurologic	O
Injury	O
With	O
Severe	O
Adult	O
Respiratory	O
Distress	O
Syndrome	O
in	O
Patients	O
Undergoing	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
:	O
A	O
Single	O
-	O
Center	O
Retrospective	O
Analysis	O
.	O

TITLE	O
:	O
Veno	O
-	O
veno	O
-	O
arterial	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
with	O
septic	O
-	O
induced	O
cardiomyopathy	O
due	O
to	O
severe	O
pulmonary	B-ANAT
tuberculosis	O
.	O

ABSTRACT	O
:	O
We	O
describe	O
the	O
rare	O
experience	O
of	O
veno	O
-	O
veno	O
-	O
arterial	B-ANAT
(	O
VVA	O
)	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
in	O
a	O
patient	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
septic	O
-	O
induced	O
cardiomyopathy	O
due	O
to	O
pulmonary	B-ANAT
tuberculosis	O
(	O
TB	O
).	O

Patients	O
with	O
SCA	B-ANAT
were	O
less	O
likely	O
to	O
have	O
risk	O
factors	O
for	O
coronary	B-ANAT
artery	I-ANAT
disease	O
than	O
those	O
without	O
SCA	B-ANAT
.	O

The	O
essential	O
skills	O
that	O
were	O
included	O
were	O
the	O
use	O
of	O
Personal	O
Protective	O
Equipment	O
(	O
PPE	O
)	O
including	O
gown	O
,	O
gloves	O
,	O
head	B-ANAT
cover	O
and	O
N95	O
mask	O
,	O
hand	O
hygiene	O
,	O
the	O
practice	O
of	O
donning	O
and	O
doffing	O
and	O
the	O
collection	O
of	O
MERS	O
-	O
CoV	O
nasopharyngeal	B-ANAT
specimens	O
.	O

TITLE	O
:	O
Unexplained	O
Dyspnea	O
in	O
a	O
Young	O
Adult	O
with	O
Epstein	O
-	O
Barr	O
Virus	O
Infectious	O
Mononucleosis	O
:	O
Pulmonary	B-ANAT
Involvement	O
or	O
Co	O
-	O
Infection	O
with	O
Mycoplasma	O
pneumoniae	O
Pneumonia	O
?	O

Under	O
an	O
impression	O
of	O
placenta	B-ANAT
abruption	O
,	O
an	O
emergent	O
cesarean	O
section	O
was	O
performed	O
.	O

ABSTRACT	O
:	O
Respiratory	O
complications	O
are	O
a	O
major	O
factor	O
contributing	O
to	O
postoperative	O
morbidity	O
and	O
mortality	O
,	O
especially	O
in	O
patients	O
with	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
COPD	O
).	O

Our	O
objective	O
was	O
to	O
compare	O
the	O
rate	O
of	O
respiratory	O
complications	O
in	O
patients	O
with	O
COPD	O
with	O
severe	O
aortic	B-ANAT
stenosis	O
who	O
underwent	O
transcatheter	O
aortic	B-ANAT
valve	I-ANAT
implantation	O
(	O
TAVI	O
)	O
versus	O
surgical	O
aortic	B-ANAT
valve	I-ANAT
replacement	O
(	O
SAVR	O
).	O

Among	O
patients	O
with	O
moderate	O
or	O
severe	O
COPD	O
at	O
low	O
-	O
to	O
-	O
intermediate	O
surgical	O
risk	O
,	O
TAVI	O
patients	O
had	O
a	O
similar	O
rate	O
of	O
30	O
-	O
day	O
major	O
pulmonary	B-ANAT
complications	O
compared	O
with	O
SAVR	O
patients	O
despite	O
a	O
higher	O
baseline	O
risk	O
profile	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
support	O
for	O
severe	O
acute	O
respiratory	O
failure	O
has	O
been	O
increasing	O
.	O

Interestingly	O
,	O
an	O
increased	O
transcription	O
of	O
type	O
I	O
interferon	O
including	O
interferon	O
-	O
Î±	O
and	O
Î²	O
was	O
observed	O
in	O
infected	O
cells	B-ANAT
compared	O
to	O
mock	O
infected	O
cells	B-ANAT
.	O

A	O
slight	O
increase	O
in	O
interferon	O
-	O
Î±	O
protein	O
production	O
in	O
the	O
supernatants	O
of	O
PEDV	O
-	O
infected	O
cells	B-ANAT
was	O
observed	O
compared	O
to	O
mock	O
infected	O
cells	B-ANAT
.	O

Subsequently	O
,	O
he	O
developed	O
multi	O
-	O
organ	B-ANAT
failure	O
despite	O
the	O
ongoing	O
full	O
supportive	O
care	O
and	O
empiric	O
broad	O
spectrum	O
antibiotics	O
.	O

The	O
levels	O
of	O
serum	B-ANAT
vitamin	O
A	O
in	O
the	O
two	O
affected	O
calves	O
were	O
0	O
.	O
317	O
Âµg	O
/	O
dl	O
and	O
0	O
.	O
481	O
Âµg	O
/	O
dl	O
,	O
respectively	O
.	O

Examination	O
also	O
revealed	O
enlarged	O
multiple	O
cervical	B-ANAT
lymph	I-ANAT
nodes	I-ANAT
on	O
the	O
same	O
side	B-ANAT
of	I-ANAT
neck	I-ANAT
.	O

At	O
eight	O
weeks	O
follow	O
up	O
,	O
complete	O
resolution	O
of	O
microscopic	O
haematuria	O
with	O
normal	O
C3	B-ANAT
levels	I-ANAT
was	O
observed	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
murine	O
coronavirus	O
,	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
),	O
infection	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
and	O
liver	B-ANAT
to	O
assess	O
of	O
the	O
role	O
of	O
the	O
inflammasome	O
and	O
its	O
related	O
cytokines	O
on	O
pathogenesis	O
and	O
host	O
defense	O
during	O
viral	O
infection	O
.	O

There	O
was	O
retarded	O
development	O
and	O
abnormal	O
eruption	O
of	O
permanent	B-ANAT
teeth	I-ANAT
in	O
cats	O
treated	O
before	O
16	O
-	O
18	O
weeks	O
of	O
age	O
.	O

ABSTRACT	O
:	O
The	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
(	O
CDC	O
)	O
algorithm	O
for	O
detecting	O
presence	O
of	O
serum	B-ANAT
antibodies	O
against	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
in	O
subjects	O
with	O
potential	O
infections	O
with	O
the	O
virus	O
has	O
included	O
screening	O
by	O
indirect	O
ELISA	O
against	O
recombinant	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
and	O
confirmation	O
by	O
immunofluorescent	O
staining	O
of	O
infected	O
monolayers	O
and	O
/	O
or	O
microneutralization	O
titration	O
.	O

On	O
Study	O
Day	O
1	O
,	O
mean	O
Vt	O
was	O
7	O
.	O
5	O
(	O
SD	O
=	O
2	O
.	O
1	O
)	O
ml	O
/	O
kg	O
predicted	O
body	B-ANAT
weight	O
(	O
n	O
=	O
625	O
);	O
80	O
%	O
(	O
n	O
=	O
501	O
)	O
received	O
Vt	O
greater	O
than	O
6	O
ml	O
/	O
kg	O
.	O

Paradoxically	O
,	O
therapies	O
with	O
less	O
evidence	O
supporting	O
their	O
use	O
(	O
e	O
.	O
g	O
.,	O
pulmonary	B-ANAT
vasodilators	O
)	O
were	O
over	O
-	O
used	O
,	O
whereas	O
those	O
with	O
more	O
evidence	O
(	O
e	O
.	O
g	O
.,	O
prone	O
positioning	O
,	O
neuromuscular	O
blockade	O
)	O
were	O
under	O
-	O
used	O
.	O

However	O
,	O
the	O
cell	B-ANAT
types	O
responsible	O
for	O
IL	O
-	O
17A	O
production	O
during	O
the	O
early	O
stage	O
of	O
severe	O
influenza	O
A	O
(	O
H1N1	O
)	O
pdm09	O
infection	O
remained	O
unknown	O
.	O

Older	O
trials	O
are	O
not	O
relevant	O
anymore	O
since	O
the	O
ECMO	O
circuitry	O
was	O
not	O
heparin	O
-	O
coated	O
leading	O
to	O
severe	O
hemorrhagic	O
complications	O
due	O
to	O
high	O
levels	O
of	O
anticoagulation	O
,	O
and	O
because	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
and	O
control	O
group	O
patients	O
did	O
not	O
receive	O
lung	B-ANAT
-	O
protective	O
ventilation	O
.	O

Serology	O
testing	O
for	O
the	O
presence	O
of	O
virus	O
-	O
elicited	O
antibodies	O
in	O
blood	B-ANAT
is	O
one	O
of	O
the	O
methods	O
used	O
commonly	O
for	O
clinical	O
diagnosis	O
of	O
viral	O
infections	O
.	O

TITLE	O
:	O
A	O
novel	O
Coltivirus	O
-	O
related	O
virus	O
isolated	O
from	O
free	O
-	O
tailed	B-ANAT
bats	O
from	O
CÃ´te	O
d	O
'	O
Ivoire	O
is	O
able	O
to	O
infect	O
human	O
cells	B-ANAT
in	O
vitro	O
.	O

We	O
carried	O
out	O
a	O
retrospective	O
study	O
enrolling	O
all	O
patients	O
with	O
ARDS	O
by	O
influence	O
A	O
H1N1	O
treated	O
with	O
veno	O
-	O
venous	B-ANAT
ECMO	O
.	O

N	O
-	O
acetylcysteine	O
(	O
NAC	B-ANAT
)	O
is	O
the	O
most	O
commonly	O
used	O
anti	O
-	O
oxidant	O
.	O

In	O
the	O
present	O
study	O
,	O
a	O
meta	O
-	O
analysis	O
was	O
performed	O
to	O
evaluate	O
the	O
effects	O
of	O
NAC	B-ANAT
for	O
adult	O
patients	O
with	O
ARDS	O
.	O

As	O
the	O
number	O
of	O
included	O
trials	O
and	O
patients	O
was	O
small	O
,	O
additional	O
trials	O
are	O
required	O
to	O
provide	O
sufficient	O
evidence	O
for	O
the	O
efficacy	O
of	O
NAC	B-ANAT
in	O
ARDS	O
.	O

The	O
current	O
study	O
demonstrates	O
that	O
the	O
replication	O
intermediates	O
of	O
minus	O
strand	O
of	O
subgenomic	O
RNA	O
(	O
sgRNA	O
)	O
can	O
be	O
readily	O
recovered	O
from	O
SARS	O
-	O
CoV	O
infected	O
cells	B-ANAT
.	O

We	O
also	O
discuss	O
various	O
cellular	B-ANAT
processes	O
,	O
such	O
as	O
apoptosis	O
,	O
innate	O
immunity	O
,	O
ER	O
stress	O
response	O
,	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
(	O
MAPK	O
)	O
pathway	O
and	O
nuclear	O
factor	O
kappa	O
B	O
(	O
NF	O
-	O
ÎºB	O
)	O
pathway	O
that	O
may	O
be	O
modulated	O
by	O
HCoVs	O
.	O

In	O
this	O
study	O
,	O
chicken	O
macrophage	B-ANAT
HD11	O
cells	B-ANAT
were	O
established	O
as	O
a	O
cellular	B-ANAT
model	O
that	O
is	O
permissive	O
to	O
IBV	O
infection	O
.	O

Then	O
,	O
IBV	O
-	O
induced	O
apoptosis	O
was	O
observed	O
through	O
a	O
cell	B-ANAT
viability	O
assay	O
,	O
morphological	O
changes	O
,	O
and	O
flow	O
cytometry	O
.	O

ABSTRACT	O
:	O
Maternal	O
hemorrhage	O
,	O
defined	O
as	O
a	O
cumulative	O
blood	B-ANAT
loss	O
of	O
greater	O
than	O
or	O
equal	O
to	O
1	O
,	O
000	O
mL	O
or	O
blood	B-ANAT
loss	O
accompanied	O
by	O
signs	O
or	O
symptoms	O
of	O
hypovolemia	O
within	O
24	O
hours	O
after	O
the	O
birth	O
process	O
,	O
remains	O
the	O
leading	O
cause	O
of	O
maternal	O
mortality	O
worldwide	O
(	O
1	O
).	O

We	O
suggest	O
against	O
using	O
plasma	B-ANAT
-	O
free	O
cortisol	O
or	O
salivary	O
cortisol	O
level	O
over	O
plasma	B-ANAT
total	O
cortisol	O
(	O
conditional	O
,	O
very	O
low	O
quality	O
of	O
evidence	O
).	O

This	O
work	O
performs	O
selection	O
of	O
synthetic	O
polymers	O
as	O
novel	O
broadly	O
active	O
agents	O
and	O
demonstrates	O
activity	O
of	O
these	O
polymers	O
against	O
Zika	O
,	O
Ebola	O
,	O
Lassa	O
,	O
Lyssa	O
,	O
Rabies	O
,	O
Marburg	O
,	O
Ebola	O
,	O
influenza	O
,	O
herpes	O
simplex	B-ANAT
,	O
and	O
human	O
immunodeficiency	O
viruses	O
.	O

In	O
a	O
Saudi	O
Gentleman	O
after	O
Cardiac	B-ANAT
Bypass	O
Surgery	O
.	O

ABSTRACT	O
:	O
Outcomes	O
for	O
invasive	O
mechanical	O
ventilation	O
and	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
to	O
treat	O
acute	O
respiratory	O
failure	O
in	O
patients	O
with	O
mild	O
cystic	O
fibrosis	O
(	O
CF	O
)	O
lung	B-ANAT
disease	O
are	O
not	O
known	O
.	O

ABSTRACT	O
:	O
Hexachloroethane	O
(	O
HC	O
)/	O
zinc	O
chloride	O
(	O
ZnCl	O
,	O
smoke	O
bomb	O
)	O
exposure	O
in	O
the	O
military	O
setting	O
results	O
in	O
lung	B-ANAT
injury	O
which	O
is	O
uncommon	O
and	O
has	O
been	O
rarely	O
described	O
in	O
previous	O
studies	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
the	O
correlation	O
between	O
the	O
serum	B-ANAT
zinc	O
in	O
patients	O
with	O
HC	O
/	O
ZnCl	O
smoke	O
inhalation	O
lung	B-ANAT
injury	O
and	O
disease	O
severity	O
.	O

With	O
the	O
development	O
of	O
severe	O
acute	O
kidney	B-ANAT
injury	O
and	O
nephrotic	O
-	O
range	O
proteinuria	O
(	O
creatininemia	O
2	O
.	O
6	O
from	O
1	O
.	O
9	O
mg	O
/	O
dL	O
with	O
overt	O
proteinuria	O
34	O
from	O
2	O
.	O
1	O
g	O
/	O
g	O
creat	O
),	O
a	O
kidney	B-ANAT
-	O
lung	B-ANAT
syndrome	O
was	O
evoked	O
.	O

Those	O
findings	O
were	O
consistent	O
with	O
a	O
rare	O
form	O
of	O
IgA	O
vasculitis	O
(	O
formerly	O
Henoch	O
-	O
SchÃ¶nlein	O
syndrome	O
),	O
the	O
originality	O
of	O
the	O
case	O
lying	O
in	O
the	O
occurrence	O
of	O
a	O
kidney	B-ANAT
-	O
lung	B-ANAT
syndrome	O
in	O
an	O
elderly	O
patient	O
.	O

Recently	O
,	O
reverse	O
genetics	O
techniques	O
including	O
targeted	O
RNA	O
recombination	O
,	O
bacteria	O
artificial	O
chromosome	B-ANAT
system	O
and	O
in	O
vitro	O
ligation	O
have	O
been	O
successfully	O
used	O
to	O
manipulate	O
the	O
genome	O
of	O
PEDV	O
,	O
which	O
providing	O
new	O
strategies	O
for	O
the	O
clear	O
delineation	O
of	O
the	O
functions	O
of	O
the	O
viral	O
proteins	O
,	O
the	O
mechanisms	O
behind	O
PEDV	O
pathogenesis	O
and	O
the	O
design	O
of	O
novel	O
vaccines	O
against	O
PEDV	O
.	O

To	O
verify	O
the	O
roles	O
of	O
distinct	O
endocytic	O
pathways	O
,	O
systematic	O
approaches	O
were	O
used	O
,	O
including	O
pharmacological	O
inhibition	O
,	O
RNA	O
interference	O
,	O
confocal	O
microscopy	O
analysis	O
,	O
use	O
of	O
fluorescently	O
labeled	O
virus	B-ANAT
particles	I-ANAT
,	O
and	O
overexpression	O
of	O
a	O
dominant	O
negative	O
(	O
DN	O
)	O
mutant	O
.	O

Our	O
findings	O
demonstrate	O
that	O
PHEV	O
hijacks	O
the	O
CME	O
and	O
endosomal	O
system	O
of	O
the	O
host	O
to	O
enter	O
and	O
traffic	O
within	O
neural	O
cells	B-ANAT
,	O
providing	O
new	O
insights	O
into	O
PHEV	O
pathogenesis	O
and	O
guidance	O
for	O
antiviral	O
drug	O
design	O
.	O

Our	O
goal	O
was	O
to	O
determine	O
resistance	O
and	O
susceptibility	O
of	O
MHC	B-ANAT
B	O
haplotype	O
in	O
congenic	O
and	O
inbred	O
chicken	O
lines	O
in	O
order	O
to	O
establish	O
a	O
resistant	O
-	O
susceptible	O
model	O
.	O

Eight	O
congenic	O
lines	O
(	O
253	O
/	O
B18	O
,	O
254	O
/	O
B15	O
,	O
330	O
/	O
B21	O
,	O
312	O
/	O
B24	O
,	O
331	O
/	O
B2	O
,	O
335	O
/	O
B19	O
,	O
336	O
/	O
B21	O
,	O
and	O
342	O
/	O
BO	O
),	O
two	O
inbred	O
lines	O
(	O
003	O
/	O
B17	O
and	O
077	O
/	O
B19	O
),	O
and	O
three	O
commercial	O
lines	O
(	O
white	O
leghorn	O
,	O
brown	O
layers	B-ANAT
,	O
and	O
broilers	O
)	O
were	O
used	O
in	O
two	O
experiments	O
.	O

These	O
two	O
lines	O
will	O
be	O
used	O
as	O
an	O
animal	O
model	O
in	O
subsequent	O
experiments	O
to	O
understand	O
the	O
mechanisms	O
by	O
which	O
the	O
immune	B-ANAT
system	I-ANAT
in	O
chickens	O
generates	O
resistance	O
to	O
infectious	O
bronchitis	O
virus	O
.	O

Thirty	O
-	O
four	O
isolates	O
were	O
collected	O
,	O
and	O
egg	B-ANAT
propagation	O
revealed	O
their	O
ability	O
to	O
induce	O
typical	O
IBV	O
lesions	O
after	O
three	O
to	O
five	O
successive	O
passages	O
.	O

TITLE	O
:	O
ABSTRACT	O
:	O
Multiple	O
sclerosis	O
(	O
MS	O
)	O
is	O
the	O
most	O
common	O
autoimmune	O
disease	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
).	O

RESULTS	O
:	O
The	O
step	O
with	O
RR	O
of	O
60	O
after	O
lung	B-ANAT
recruitment	O
had	O
the	O
highest	O
PEEP	O
when	O
compared	O
with	O
all	O
other	O
steps	O
(	O
17	O
[	O
16	O
,	O
19	O
]	O
vs	O
14	O
[	O
10	O
,	O
17	O
]	O
cmH2O	O
),	O
but	O
had	O
lower	O
driving	O
pressures	O
(	O
13	O
[	O
13	O
,	O
11	O
]	O
vs	O
16	O
[	O
14	O
,	O
17	O
]	O
cmH2O	O
),	O
higher	O
P	O
/	O
F	O
ratios	O
(	O
212	O
[	O
191	O
,	O
243	O
]	O
vs	O
141	O
[	O
105	O
,	O
184	O
]	O
mmHg	O
),	O
lower	O
shunt	O
(	O
23	O
[	O
20	O
,	O
23	O
]	O
vs	O
32	O
[	O
27	O
,	O
49	O
]%),	O
lower	O
dead	O
space	O
ventilation	O
(	O
10	O
[	O
0	O
,	O
15	O
]	O
vs	O
30	O
[	O
20	O
,	O
37	O
]%),	O
and	O
a	O
more	O
homogeneous	O
alveolar	B-ANAT
ventilation	O
distribution	O
.	O

The	O
multivariate	O
analysis	O
identified	O
brain	B-ANAT
tumour	O
(	O
OR	O
14	O
.	O
54	O
;	O
95	O
%	O
CI	O
3	O
.	O
86	O
-	O
54	O
.	O
77	O
;	O
p	O
<	O
0	O
.	O
0001	O
),	O
stage	O
IV	O
cancer	O
(	O
OR	O
3	O
.	O
47	O
;	O
95	O
%	O
CI	O
1	O
.	O
26	O
-	O
9	O
.	O
54	O
;	O
p	O
=	O
0	O
.	O
016	O
),	O
sepsis	O
upon	O
admission	O
(	O
OR	O
2	O
.	O
28	O
;	O
95	O
%	O
CI	O
1	O
.	O
14	O
-	O
4	O
.	O
56	O
;	O
p	O
=	O
0	O
.	O
020	O
)	O
and	O
an	O
APACHE	O
II	O
score	O
â¥	O
20	O
points	O
(	O
OR	O
5	O
.	O
38	O
;	O
95	O
%	O
CI	O
1	O
.	O
92	O
-	O
15	O
.	O
05	O
;	O
p	O
=	O
0	O
.	O
001	O
)	O
as	O
being	O
independently	O
associated	O
to	O
SARF	O
-	O
MV	O
.	O

Moreover	O
,	O
the	O
association	O
between	O
driving	O
airway	B-ANAT
pressure	O
and	O
mortality	O
in	O
ARDS	O
patients	O
potentially	O
underlines	O
the	O
importance	O
of	O
sizing	O
tidal	O
volume	O
on	O
respiratory	B-ANAT
system	I-ANAT
compliance	O
rather	O
than	O
on	O
predicted	O
body	B-ANAT
weight	O
.	O

HELLP	O
syndrome	O
is	O
a	O
life	O
-	O
threatening	O
condition	O
frequently	O
associated	O
with	O
severe	O
preeclampsia	O
-	O
eclampsia	O
and	O
is	O
characterized	O
by	O
three	O
hallmark	O
features	O
of	O
hemolysis	O
,	O
elevated	O
liver	B-ANAT
enzymes	O
and	O
low	O
platelets	B-ANAT
.	O

TITLE	O
:	O
Treatments	O
for	O
Pulmonary	B-ANAT
Ricin	O
Intoxication	O
:	O
Current	O
Aspects	O
and	O
Future	O
Prospects	O
.	O

The	O
clinical	O
manifestation	O
of	O
pulmonary	B-ANAT
ricin	O
intoxication	O
in	O
animal	O
models	O
is	O
closely	O
related	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
which	O
involves	O
pulmonary	B-ANAT
proinflammatory	O
cytokine	O
upregulation	O
,	O
massive	O
neutrophil	B-ANAT
infiltration	O
and	O
severe	O
edema	O
.	O

Currently	O
,	O
the	O
only	O
post	O
-	O
exposure	O
measure	O
that	O
is	O
effective	O
against	O
pulmonary	B-ANAT
ricinosis	O
at	O
clinically	O
relevant	O
time	O
-	O
points	O
following	O
intoxication	O
in	O
pre	O
-	O
clinical	O
studies	O
is	O
passive	O
immunization	O
with	O
anti	O
-	O
ricin	O
neutralizing	O
antibodies	O
.	O

To	O
evaluate	O
whether	O
an	O
individualized	O
blood	B-ANAT
pressure	O
management	O
strategy	O
tailored	O
to	O
individual	O
patient	O
physiology	O
could	O
reduce	O
postoperative	O
organ	B-ANAT
dysfunction	O
.	O

Individualized	O
management	O
strategy	O
aimed	O
at	O
achieving	O
a	O
systolic	O
blood	B-ANAT
pressure	O
(	O
SBP	O
)	O
within	O
10	O
%	O
of	O
the	O
reference	O
value	O
(	O
ie	O
,	O
patient	O
'	O
s	O
resting	B-ANAT
SBP	O
)	O
or	O
standard	O
management	O
strategy	O
of	O
treating	O
SBP	O
less	O
than	O
80	O
mm	O
Hg	O
or	O
lower	O
than	O
40	O
%	O
from	O
the	O
reference	O
value	O
during	O
and	O
for	O
4	O
hours	O
following	O
surgery	O
.	O

TITLE	O
:	O
Effect	O
of	O
Lung	B-ANAT
Recruitment	O
and	O
Titrated	O
Positive	O
End	O
-	O
Expiratory	O
Pressure	O
(	O
PEEP	O
)	O
vs	O
Low	O
PEEP	O
on	O
Mortality	O
in	O
Patients	O
With	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
:	O
A	O
Randomized	O
Clinical	O
Trial	O
.	O

Compared	O
with	O
the	O
control	O
group	O
,	O
the	O
experimental	O
group	O
strategy	O
increased	O
6	O
-	O
month	O
mortality	O
(	O
65	O
.	O
3	O
%	O
vs	O
59	O
.	O
9	O
%;	O
HR	O
,	O
1	O
.	O
18	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
01	O
to	O
1	O
.	O
38	O
;	O
P	O
=	O
.	O
04	O
),	O
decreased	O
the	O
number	O
of	O
mean	O
ventilator	O
-	O
free	O
days	O
(	O
5	O
.	O
3	O
vs	O
6	O
.	O
4	O
;	O
difference	O
,	O
-	O
1	O
.	O
1	O
;	O
95	O
%	O
CI	O
,	O
-	O
2	O
.	O
1	O
to	O
-	O
0	O
.	O
1	O
;	O
P	O
=	O
.	O
03	O
),	O
increased	O
the	O
risk	O
of	O
pneumothorax	O
requiring	O
drainage	B-ANAT
(	O
3	O
.	O
2	O
%	O
vs	O
1	O
.	O
2	O
%;	O
difference	O
,	O
2	O
.	O
0	O
%;	O
95	O
%	O
CI	O
,	O
0	O
.	O
0	O
%	O
to	O
4	O
.	O
0	O
%;	O
P	O
=	O
.	O
03	O
),	O
and	O
the	O
risk	O
of	O
barotrauma	O
(	O
5	O
.	O
6	O
%	O
vs	O
1	O
.	O
6	O
%;	O
difference	O
,	O
4	O
.	O
0	O
%;	O
95	O
%	O
CI	O
,	O
1	O
.	O
5	O
%	O
to	O
6	O
.	O
5	O
%;	O
P	O
=	O
.	O
001	O
).	O

In	O
patients	O
with	O
moderate	O
to	O
severe	O
ARDS	O
,	O
a	O
strategy	O
with	O
lung	B-ANAT
recruitment	O
and	O
titrated	O
PEEP	O
compared	O
with	O
low	O
PEEP	O
increased	O
28	O
-	O
day	O
all	O
-	O
cause	O
mortality	O
.	O

These	O
findings	O
do	O
not	O
support	O
the	O
routine	O
use	O
of	O
lung	B-ANAT
recruitment	O
maneuver	O
and	O
PEEP	O
titration	O
in	O
these	O
patients	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
changes	O
in	O
the	O
microcirculation	O
in	O
musculature	B-ANAT
over	O
time	O
during	O
shock	O
and	O
subsequent	O
resuscitation	O
in	O
a	O
porcine	O
model	O
of	O
haemorrhagic	O
shock	O
and	O
polytrauma	O
.	O

Microcirculation	O
data	O
were	O
measured	O
from	O
the	O
vastus	B-ANAT
lateralis	I-ANAT
muscle	I-ANAT
using	O
a	O
combined	O
white	O
light	O
spectrometry	O
and	O
laser	O
spectroscopy	O
system	O
every	O
15	O
min	O
during	O
the	O
shock	O
and	O
resuscitation	O
period	O
,	O
and	O
at	O
24	O
,	O
48	O
,	O
and	O
72	O
h	O
.	O
Oxygen	O
delivery	O
and	O
oxygen	O
consumption	O
were	O
calculated	O
and	O
compared	O
to	O
baseline	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
man	O
who	O
presented	O
after	O
with	O
a	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
including	O
intracranial	B-ANAT
and	O
extradural	O
haemorrhage	O
.	O

Mutations	O
in	O
the	O
viral	O
spike	O
(	O
S	O
)	O
gene	O
have	O
been	O
associated	O
with	O
FCoVs	O
found	O
in	O
tissues	B-ANAT
from	O
cats	O
with	O
FIP	O
,	O
but	O
not	O
FCoVs	O
found	O
in	O
faeces	B-ANAT
from	O
healthy	O
cats	O
,	O
and	O
are	O
implicated	O
in	O
monocyte	B-ANAT
/	O
macrophage	B-ANAT
tropism	O
and	O
systemic	O
spread	O
.	O

Tissue	B-ANAT
,	O
fluid	O
,	O
and	O
faecal	B-ANAT
samples	O
from	O
cats	O
with	O
FIP	O
were	O
more	O
likely	O
to	O
be	O
FCoV	O
RT	O
-	O
qPCR	O
-	O
positive	O
(	O
90	O
.	O
4	O
,	O
78	O
.	O
4	O
and	O
64	O
.	O
6	O
%	O
respectively	O
)	O
than	O
those	O
from	O
cats	O
without	O
FIP	O
(	O
7	O
.	O
8	O
,	O
2	O
.	O
1	O
and	O
20	O
%	O
respectively	O
).	O

The	O
S	O
-	O
INDEL	O
-	O
inoculated	O
pigs	O
had	O
lower	O
ileal	B-ANAT
IgA	O
antibody	B-ANAT
secreting	I-ANAT
cells	I-ANAT
,	O
serum	B-ANAT
IgA	O
and	O
neutralizing	O
antibody	O
titers	O
compared	O
with	O
PC21A	O
-	O
inoculated	O
pigs	O
.	O

To	O
study	O
glycocalyx	B-ANAT
degradation	O
in	O
sepsis	O
-	O
induced	O
ARDS	O
,	O
we	O
measured	O
plasma	B-ANAT
levels	O
of	O
syndecan	O
-	O
1	O
,	O
a	O
marker	O
for	O
glycocalyx	B-ANAT
degradation	O
.	O

Competitive	O
ELISA	O
(	O
cELISA	O
),	O
in	O
which	O
a	O
labeled	O
monoclonal	O
antibody	O
(	O
MAb	O
)	O
competes	O
with	O
test	O
serum	B-ANAT
antibodies	O
for	O
target	O
epitopes	O
,	O
may	O
be	O
a	O
suitable	O
alternative	O
because	O
it	O
detects	O
antibodies	O
in	O
a	O
species	O
-	O
independent	O
manner	O
.	O

Nasal	B-ANAT
samples	O
from	O
camels	O
,	O
sheep	O
,	O
goats	O
,	O
and	O
cattle	O
were	O
examined	O
by	O
real	O
-	O
time	O
reverse	O
-	O
transcription	O
PCR	O
(	O
RT	O
-	O
PCR	O
)	O
to	O
detect	O
MERS	O
-	O
CoV	O
RNA	O
,	O
and	O
the	O
Anti	O
-	O
MERS	O
ELISA	O
assay	O
was	O
performed	O
to	O
detect	O
camel	O
humeral	O
immune	O
response	O
(	O
IgG	O
)	O
to	O
MERS	O
-	O
CoV	O
S1	O
antigen	O
infection	O
.	O

Management	O
can	O
require	O
exceptional	O
therapies	O
,	O
such	O
as	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

Only	O
3	O
OI	O
patients	O
developed	O
the	O
criteria	O
for	O
ARDS	O
,	O
and	O
only	O
3	O
patients	O
with	O
orthopaedic	O
injuries	O
died	O
,	O
2	O
died	O
within	O
24	O
hours	O
of	O
presentation	O
and	O
1	O
within	O
48	O
hours	O
,	O
all	O
had	O
severe	O
brain	B-ANAT
trauma	O
.	O

During	O
2013	O
-	O
2016	O
,	O
a	O
total	O
of	O
42351	O
throat	B-ANAT
swabs	O
were	O
examined	O
for	O
presence	O
of	O
influenza	O
viruses	O
and	O
MERS	O
-	O
CoV	O
in	O
Iranian	O
general	O
population	O
and	O
pilgrims	O
returning	O
from	O
Mecca	O
and	O
Karbala	O
with	O
SARI	O
by	O
using	O
one	O
step	O
RT	O
-	O
PCR	O
kit	O
.	O

The	O
vascular	B-ANAT
endothelial	B-ANAT
growth	O
factor	O
-	O
A	O
(	O
VEGF	O
-	O
A	O
)	O
and	O
the	O
placental	B-ANAT
growth	O
factor	O
(	O
PlGF	O
)	O
are	O
vascular	B-ANAT
permeability	O
factors	O
and	O
may	O
be	O
involved	O
in	O
the	O
disruption	O
of	O
the	O
alveolar	B-ANAT
-	O
capillary	B-ANAT
membrane	B-ANAT
,	O
leading	O
to	O
alveolar	B-ANAT
edema	O
.	O

After	O
severe	O
blunt	O
trauma	O
,	O
a	O
history	O
of	O
smoking	O
is	O
related	O
to	O
lung	B-ANAT
microbiota	O
composition	O
,	O
both	O
at	O
the	O
time	O
of	O
ICU	O
admission	O
and	O
at	O
48	O
hours	O
.	O

We	O
discuss	O
the	O
origins	O
of	O
ROS	O
within	O
the	O
cell	B-ANAT
,	O
cellular	B-ANAT
defense	O
mechanisms	O
against	O
oxidative	O
damage	O
,	O
the	O
role	O
of	O
ROS	O
in	O
the	O
development	O
of	O
endothelial	B-ANAT
permeability	O
,	O
and	O
potential	O
therapies	O
targeted	O
at	O
oxidative	O
stress	O
.	O

IBV	O
titres	O
in	O
the	O
supernatant	O
were	O
significantly	O
increased	O
when	O
CD59	O
proteins	O
were	O
overexpressed	O
in	O
cells	B-ANAT
followed	O
by	O
IBV	O
infection	O
,	O
and	O
this	O
observation	O
was	O
further	O
supported	O
by	O
knockdown	O
or	O
cleavage	O
of	O
CD59	O
.	O

TITLE	O
:	O
Prevalence	O
of	O
respiratory	O
viruses	O
in	O
Iranian	O
patients	O
with	O
idiopathic	O
pulmonary	B-ANAT
fibrosis	O
.	O

Furthermore	O
,	O
dendritic	B-ANAT
cells	I-ANAT
(	O
DCs	O
),	O
professional	O
antigen	B-ANAT
-	I-ANAT
presenting	I-ANAT
cells	I-ANAT
,	O
link	O
humoral	O
and	O
cellular	B-ANAT
immune	O
responses	O
for	O
homeostasis	O
of	O
the	O
intestinal	B-ANAT
immune	O
environment	O
.	O

Visual	O
acuity	O
was	O
20	O
/	O
40	O
with	O
an	O
intraocular	B-ANAT
pressure	O
(	O
IOP	O
)	O
of	O
30	O
mmHg	O
in	O
the	O
affected	O
eye	B-ANAT
despite	O
maximal	O
tolerated	O
medical	O
therapy	O
.	O

The	O
patient	O
'	O
s	O
IOP	O
on	O
the	O
first	O
post	O
-	O
operative	O
day	O
was	O
13	O
mmHg	O
,	O
and	O
anterior	B-ANAT
chamber	I-ANAT
inflammation	O
was	O
noted	O
to	O
be	O
significantly	O
reduced	O
at	O
post	O
-	O
operative	O
week	O
2	O
.	O

TITLE	O
:	O
Cryo	O
-	O
Electron	O
Microscopy	O
Structure	O
of	O
Porcine	O
Deltacoronavirus	O
Spike	O
Protein	O
in	O
the	O
Prefusion	O
State	O
ABSTRACT	O
:	O
Coronavirus	O
spike	O
proteins	O
from	O
different	O
genera	O
are	O
divergent	O
,	O
although	O
they	O
all	O
mediate	O
coronavirus	O
entry	O
into	O
cells	B-ANAT
by	O
binding	O
to	O
host	O
receptors	O
and	O
fusing	O
viral	O
and	O
cell	B-ANAT
membranes	I-ANAT
.	O

PdCoV	O
S1	O
-	O
CTD	O
binds	O
to	O
an	O
unidentified	O
receptor	O
on	O
host	B-ANAT
cell	I-ANAT
surfaces	O
.	O

The	O
two	O
most	O
and	O
least	O
stable	O
reference	O
genes	O
obtained	O
in	O
the	O
study	O
,	O
were	O
further	O
used	O
for	O
candidate	O
target	O
gene	O
expression	O
data	O
normalisation	O
of	O
the	O
shell	B-ANAT
gland	I-ANAT
and	O
spleen	B-ANAT
under	O
an	O
IBV	O
infection	O
model	O
.	O

Chimpanzee	O
adenoviral	O
(	O
ChAd	O
)	O
vectors	O
have	O
been	O
developed	O
as	O
vaccine	O
candidates	O
for	O
multiple	O
infectious	O
diseases	O
and	O
prostate	B-ANAT
cancer	O
.	O

TITLE	O
:	O
The	O
impact	O
of	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
on	O
cytokine	O
levels	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
a	O
prospective	O
,	O
observational	O
study	O
.	O

Their	O
median	O
Sequential	O
Organ	B-ANAT
Failure	O
Assessment	O
score	O
was	O
12	O
,	O
PaO	O
CONCLUSIONS	O
:	O
Cytokine	O
levels	O
,	O
on	O
average	O
,	O
fall	O
rapidly	O
after	O
initiation	O
of	O
VV	O
ECMO	O
,	O
which	O
may	O
be	O
related	O
to	O
the	O
reduction	O
of	O
invasiveness	O
of	O
mechanical	O
ventilation	O
.	O

The	O
demonstration	O
of	O
pathogen	O
targeting	O
and	O
isolation	O
by	O
RBC	B-ANAT
-	O
mNPs	O
highlights	O
a	O
biologically	O
inspired	O
approach	O
toward	O
improved	O
treatment	O
and	O
diagnosis	O
against	O
infectious	O
disease	O
threats	O
.	O

Patient	O
demographics	O
,	O
length	O
of	O
ventilations	O
days	O
,	O
number	O
of	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
admission	O
days	O
,	O
chest	B-ANAT
radiographic	O
score	O
,	O
chest	B-ANAT
radiographic	O
deterioration	O
pattern	O
(	O
Types	O
1	O
-	O
4	O
)	O
and	O
peak	O
lactate	O
dehydrogenase	O
level	O
were	O
compared	O
between	O
the	O
two	O
groups	O
using	O
the	O
student	O
Follow	O
-	O
up	O
chest	B-ANAT
radiographs	O
were	O
normal	O
in	O
23	O
out	O
of	O
36	O
(	O
64	O
%)	O
patients	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
long	O
-	O
term	O
efficacy	O
of	O
a	O
combination	O
treatment	O
of	O
alendronate	O
,	O
extracorporeal	O
shock	O
and	O
hyperbaric	O
oxygen	O
for	O
osteonecrosis	O
of	O
the	O
femoral	B-ANAT
head	I-ANAT
(	O
ONFH	O
)	O
of	O
post	O
-	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
patients	O
.	O

In	O
order	O
to	O
evaluate	O
piglet	O
diarrhea	O
caused	O
TGEV	O
and	O
ETEC	O
K88	O
,	O
the	O
authors	O
examin	O
the	O
effects	O
of	O
coinfection	O
in	O
IPEC	O
-	O
J2	O
cells	B-ANAT
.	O

RESULTS	O
:	O
77	O
,	O
89	O
,	O
and	O
136	O
differentially	O
expressed	O
proteins	O
are	O
identified	O
in	O
TGEV	O
infected	O
,	O
ETEC	O
K88	O
infected	O
,	O
and	O
coinfected	O
cells	B-ANAT
,	O
respectively	O
.	O

ABSTRACT	O
:	O
Despite	O
advancements	O
in	O
ventilator	O
technologies	O
,	O
lung	B-ANAT
supportive	O
and	O
rescue	O
therapies	O
,	O
the	O
outcome	O
and	O
prognostication	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
remains	O
incremental	O
and	O
ambiguous	O
.	O

In	O
our	O
study	O
patients	O
diagnosed	O
with	O
mild	O
and	O
moderate	O
/	O
severe	O
ARDS	O
clinically	O
governed	O
by	O
hypoxemic	O
P	O
/	O
F	O
ratio	O
between	O
100	O
-	O
300	O
but	O
with	O
indistinct	O
molecular	O
phenotype	O
were	O
discriminated	O
employing	O
nuclear	O
magnetic	O
resonance	O
(	O
NMR	O
)	O
based	O
metabolomics	O
of	O
mini	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
mBALF	O
).	O

Moreover	O
,	O
the	O
capability	O
to	O
activate	O
dendritic	B-ANAT
cells	I-ANAT
(	O
DCs	O
)	O
of	O
this	O
isolate	O
was	O
identified	O
.	O

ABSTRACT	O
:	O
The	O
pig	O
intestinal	B-ANAT
epithelium	I-ANAT
can	O
be	O
compromised	O
by	O
pathogens	O
leading	O
to	O
reduced	O
integrity	O
and	O
function	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
longitudinal	O
impact	O
of	O
PEDV	O
on	O
nursery	O
pig	O
intestinal	B-ANAT
function	O
and	O
integrity	O
.	O

PEDV	O
-	O
infected	O
pigs	O
had	O
reduced	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
villus	B-ANAT
height	O
and	O
decreased	O
transepithelial	O
resistance	O
compared	O
with	O
controls	O
.	O

In	O
addition	O
,	O
PEDV	O
pigs	O
had	O
increased	O
stem	B-ANAT
cell	I-ANAT
proliferation	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
a	O
numerical	O
increase	O
in	O
DNA	O
fragmentation	O
compared	O
with	O
controls	O
through	O
dpi	O
7	O
which	O
coincided	O
with	O
an	O
observed	O
return	O
of	O
digestive	O
function	O
to	O
that	O
of	O
controls	O
.	O

PCR	O
or	O
RT	O
-	O
PCR	O
assays	O
did	O
not	O
identify	O
P	O
.	O
multocida	O
,	O
M	O
.	O
bovis	O
,	O
BoHV	O
-	O
1	O
,	O
BVDV	O
,	O
or	O
BPIV	O
-	O
3	O
from	O
the	O
nasopharyngeal	B-ANAT
swabs	O
.	O

Notably	O
,	O
data	O
collected	O
from	O
the	O
mRNA	O
â	O
seq	O
analysis	O
revealed	O
similar	O
mechanisms	O
between	O
NRDS	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
a	O
clinical	O
phenotype	O
precipitated	O
by	O
the	O
manifestation	O
of	O
a	O
severe	O
form	O
of	O
lung	B-ANAT
injury	O
due	O
to	O
numerous	O
lung	B-ANAT
insults	O
,	O
implying	O
that	O
similar	O
therapies	O
may	O
be	O
applied	O
to	O
treat	O
these	O
two	O
diseases	O
.	O

Of	O
the	O
7	O
maternal	O
deaths	O
analyzed	O
by	O
the	O
expert	O
committee	O
,	O
anesthetic	O
complications	O
were	O
in	O
5	O
cases	O
the	O
main	O
cause	O
of	O
death	O
:	O
4	O
attributed	O
to	O
direct	O
causes	O
related	O
to	O
anesthetic	O
procedures	O
during	O
childbirth	O
and	O
1	O
to	O
indirect	O
cause	O
in	O
connection	O
with	O
an	O
ENT	B-ANAT
complication	O
during	O
pregnancy	O
.	O

TITLE	O
:	O
Refractory	O
status	O
epilepticus	O
,	O
circulatory	O
collapse	O
after	O
cardiac	B-ANAT
arrest	O
,	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
caused	O
by	O
severe	O
isolated	O
fluvoxamine	O
poisoning	O
:	O
a	O
case	O
report	O
.	O

During	O
the	O
CPR	O
which	O
lasted	O
for	O
an	O
hour	O
,	O
a	O
large	O
amount	O
of	O
body	B-ANAT
fluid	I-ANAT
was	O
splashed	O
.	O

The	O
possible	O
routes	O
of	O
infection	O
may	O
include	O
the	O
following	O
:	O
respiratory	O
invasion	O
of	O
aerosols	O
contaminated	O
with	O
MERS	O
-	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
through	O
a	O
gap	O
between	O
the	O
face	B-ANAT
and	O
mask	O
;	O
mucosal	B-ANAT
exposure	O
to	O
sweat	B-ANAT
contaminated	O
with	O
MERS	O
-	O
CoV	O
;	O
and	O
contamination	O
during	O
doffing	O
of	O
personal	O
protective	O
equipment	O
.	O

This	O
report	O
details	O
an	O
E	O
.	O
coli	O
based	O
expression	O
and	O
purification	O
process	O
of	O
multiple	O
vaccine	O
candidates	O
for	O
PEDV	O
using	O
Hepatitis	O
B	O
Core	O
Antigen	O
(	O
HBcAg	O
)	O
as	O
a	O
backbone	B-ANAT
protein	O
.	O

Common	O
concurrent	O
injuries	O
included	O
fractures	O
to	O
the	O
rib	B-ANAT
/	O
sternum	B-ANAT
/	O
larynx	B-ANAT
/	O
trachea	B-ANAT
(	O
19	O
.	O
6	O
%).	O

Regression	O
analyses	O
were	O
used	O
to	O
assess	O
the	O
relationship	O
between	O
(	O
1	O
)	O
platelet	B-ANAT
aggregation	O
and	O
ARDS	O
and	O
(	O
2	O
)	O
cigarette	O
smoke	O
exposure	O
and	O
platelet	B-ANAT
aggregation	O
.	O

At	O
both	O
0	O
hour	O
and	O
24	O
hours	O
,	O
impaired	O
platelet	B-ANAT
aggregation	O
was	O
associated	O
with	O
increased	O
odds	O
of	O
developing	O
ARDS	O
.	O

Impaired	O
platelet	B-ANAT
aggregation	O
at	O
0	O
hour	O
and	O
24	O
hours	O
is	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
developing	O
ARDS	O
after	O
severe	O
blunt	O
trauma	O
.	O

Cigarette	O
smoke	O
-	O
exposed	O
patients	O
are	O
more	O
likely	O
to	O
develop	O
impaired	O
platelet	B-ANAT
aggregation	O
over	O
the	O
first	O
24	O
hours	O
of	O
admission	O
,	O
which	O
may	O
contribute	O
to	O
their	O
increased	O
risk	O
of	O
ARDS	O
.	O

The	O
virus	O
binds	O
to	O
target	B-ANAT
cells	I-ANAT
by	O
use	O
of	O
heparan	O
sulfate	O
proteoglycans	O
and	O
interacts	O
with	O
the	O
ACE2	O
protein	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrated	O
that	O
miR	O
-	O
223	O
limits	O
the	O
number	O
of	O
Ly6G	O
+	O
neutrophils	B-ANAT
and	O
inhibits	O
the	O
activity	O
of	O
the	O
NLRP3	O
inflammasome	O
to	O
alleviate	O
ALI	O
induced	O
by	O
mitochondrial	B-ANAT
damage	O
-	O
associated	O
molecular	O
patterns	O
(	O
DAMPs	O
)	O
(	O
MTDs	O
).	O

miR	O
-	O
223	O
expression	O
is	O
increased	O
in	O
the	O
lungs	B-ANAT
of	O
MTD	O
-	O
induced	O
mice	O
or	O
ARDS	O
patients	O
following	O
trauma	O
/	O
transfusion	O
or	O
following	O
the	O
physiological	O
remission	O
of	O
ALI	O
/	O
ARDS	O
.	O

For	O
the	O
subgroup	O
analyses	O
including	O
age	O
,	O
gender	O
,	O
extent	O
of	O
CAD	O
,	O
severe	O
chronic	O
kidney	B-ANAT
disease	O
and	O
heart	B-ANAT
failure	O
,	O
there	O
was	O
no	O
significant	O
interaction	O
between	O
the	O
subgroup	O
factors	O
and	O
the	O
effect	O
of	O
the	O
single	O
-	O
session	O
strategy	O
relative	O
to	O
the	O
staged	O
strategy	O
for	O
the	O
primary	O
outcome	O
measure	O
.	O

This	O
study	O
confirms	O
the	O
high	O
incidence	O
of	O
respiratory	O
viruses	O
in	O
children	O
hospitalized	O
for	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
in	O
the	O
Sousse	O
area	O
,	O
Tunisia	O
.	O

We	O
describe	O
the	O
unusual	O
case	O
of	O
a	O
one	O
-	O
year	O
-	O
old	O
child	O
affected	O
by	O
short	O
bowel	B-ANAT
syndrome	O
and	O
history	O
of	O
severe	O
cow	O
'	O
s	O
milk	O
allergy	O
(	O
CMA	O
)	O
and	O
anaphylactic	O
reaction	O
due	O
to	O
intravenous	O
administration	O
of	O
methyl	O
-	O
prednisolone	O
sodium	O
succinate	O
(	O
Solu	O
-	O
Medrol	O
40	O
mg	O
,	O
Pfizer	O
).	O

The	O
clinical	O
data	O
of	O
17	O
patients	O
who	O
were	O
diagnosed	O
as	O
ARDS	O
caused	O
by	O
severe	O
pneumonia	O
after	O
kidney	B-ANAT
transplantation	O
and	O
treated	O
with	O
NIV	O
in	O
Sichuan	O
Provincial	O
People	O
'	O
s	O
Hospital	O
from	O
January	O
1st	O
,	O
2014	O
to	O
June	O
1st	O
,	O
2016	O
were	O
collected	O
and	O
retrospectively	O
analyzed	O
.	O

TITLE	O
:	O
[	O
Research	O
progress	O
of	O
mesenchymal	B-ANAT
stem	I-ANAT
cells	I-ANAT
in	O
the	O
treatment	O
of	O
ALI	O
].	O

Median	O
pulmonary	B-ANAT
vital	O
capacity	O
was	O
9	O
.	O
0	O
%	O
(	O
6	O
.	O
0	O
;	O
15	O
.	O
0	O
)	O
of	O
predicted	O
value	O
.	O

ABSTRACT	O
:	O
The	O
macrophage	B-ANAT
scavenger	O
receptor	O
1	O
(	O
Msr1	O
,	O
also	O
called	O
SRA	O
)	O
is	O
a	O
pattern	O
recognition	O
receptor	O
primarily	O
expressed	O
on	O
myeloid	B-ANAT
cells	I-ANAT
,	O
which	O
plays	O
an	O
important	O
role	O
in	O
the	O
maintenance	O
of	O
immune	O
homeostasis	O
.	O

Respiratory	O
virus	O
in	O
upper	O
and	O
/	O
or	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
(	O
URT	O
and	O
LRT	B-ANAT
)	O
specimens	O
were	O
tested	O
using	O
Luminex	O
xTAG	O
RVP	O
Fast	O
v1	O
assay	O
.	O

CoV	O
RVIs	O
are	O
common	O
after	O
allo	O
-	O
HSCT	O
,	O
and	O
in	O
a	O
significant	O
proportion	O
of	O
cases	O
CoV	O
progressed	O
to	O
LRT	B-ANAT
and	O
showed	O
moderate	O
to	O
severe	O
clinical	O
features	O
.	O

Murine	O
acute	O
lung	B-ANAT
infection	O
models	O
mirror	O
human	O
pathologies	O
in	O
many	O
aspects	O
and	O
contribute	O
to	O
our	O
understanding	O
of	O
the	O
disease	O
and	O
the	O
development	O
of	O
novel	O
treatment	O
strategies	O
.	O

Despite	O
progress	O
in	O
other	O
fields	O
of	O
tissue	B-ANAT
imaging	O
,	O
histopathology	O
remains	O
the	O
most	O
conclusive	O
and	O
practical	O
read	O
out	O
tool	O
for	O
the	O
descriptive	O
and	O
semiquantitative	O
evaluation	O
of	O
mouse	O
pneumonia	O
and	O
therapeutic	O
interventions	O
.	O

There	O
was	O
no	O
other	O
organ	B-ANAT
failure	O
.	O

TITLE	O
:	O
A	O
Morphological	O
and	O
Quantitative	O
Analysis	O
of	O
Lung	B-ANAT
CT	O
Scan	O
in	O
Patients	O
With	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
and	O
in	O
Cardiogenic	O
Pulmonary	B-ANAT
Edema	O
.	O

Coronavirus	O
RNA	O
synthesis	O
is	O
thought	O
to	O
be	O
associated	O
with	O
replication	O
organelles	B-ANAT
(	O
ROs	O
)	O
consisting	O
of	O
modified	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
)	O
membranes	B-ANAT
.	O

The	O
intratracheal	O
administration	O
of	O
flagellated	O
cytotoxic	O
P	O
.	O
aeruginosa	O
(	O
ATCC	O
19660	O
)	O
upregulated	O
IL	O
-	O
36Î±	O
and	O
IL	O
-	O
36Î³	O
,	O
but	O
not	O
IL	O
-	O
36Î²	O
,	O
in	O
the	O
lungs	B-ANAT
.	O

Finally	O
,	O
we	O
observed	O
an	O
increase	O
in	O
IL	O
-	O
36Î³	O
,	O
but	O
not	O
IL	O
-	O
36Î±	O
,	O
in	O
the	O
airspace	O
and	O
plasma	B-ANAT
of	O
patients	O
with	O
P	O
.	O
aeruginosa	O
-	O
induced	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

A	O
total	O
of	O
3298	O
nasopharyngeal	B-ANAT
swabs	O
samples	O
were	O
collected	O
from	O
cross	O
-	O
border	B-ANAT
children	O
(<	O
6	O
years	O
,	O
crossing	O
border	B-ANAT
between	O
Southern	O
China	O
and	O
Hong	O
Kong	O
SAR	O
)	O
showing	O
symptoms	O
of	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
,	O
such	O
as	O
fever	O
(	O
body	B-ANAT
temperature	O
>	O
37	O
.	O
5	O
Â°	O
C	O
),	O
from	O
2014	O
May	O
to	O
2015	O
Dec	O
.	O
Viral	O
nucleic	B-ANAT
acids	O
were	O
analyzed	O
and	O
sequenced	O
to	O
study	O
the	O
prevalence	O
and	O
genetic	O
diversity	O
of	O
the	O
four	O
human	O
coronaviruses	O
.	O

ABSTRACT	O
:	O
ARDS	O
is	O
a	O
severe	O
pulmonary	B-ANAT
disease	O
characterized	O
by	O
inflammation	O
.	O

After	O
34	O
days	O
,	O
the	O
patient	O
was	O
weaned	O
from	O
mechanical	O
ventilation	O
and	O
was	O
discharged	O
to	O
the	O
pulmonary	B-ANAT
ward	O
,	O
followed	O
by	O
complete	O
recovery	O
.	O

CONCLUSIONS	O
:	O
This	O
case	O
offers	O
a	O
guideline	O
for	O
the	O
clinical	O
management	O
towards	O
survival	O
of	O
GITB	O
in	O
transplant	B-ANAT
patients	O
,	O
complicated	O
by	O
septic	O
shock	O
and	O
multiple	O
organ	B-ANAT
failure	O
,	O
including	O
acute	O
renal	B-ANAT
injury	O
and	O
ARDS	O
.	O

ABSTRACT	O
:	O
Mice	O
infected	O
with	O
mouse	O
hepatitis	O
virus	O
A59	O
(	O
MHV	O
-	O
A59	O
)	O
develop	O
hepatitis	O
and	O
autoantibodies	O
(	O
autoAb	O
)	O
to	O
liver	B-ANAT
and	O
kidney	B-ANAT
fumarylacetoacetate	O
hydrolase	O
(	O
FAH	O
),	O
a	O
fact	O
closely	O
related	O
to	O
the	O
release	O
of	O
alarmins	O
such	O
as	O
uric	O
acid	O
and	O
/	O
or	O
high	O
-	O
mobility	O
group	O
box	O
protein	O
1	O
(	O
HMGB1	O
).	O

TITLE	O
:	O
Evaluation	O
of	O
an	O
accelerated	O
hydrogen	O
peroxide	O
disinfectant	O
to	O
inactivate	O
porcine	O
epidemic	O
diarrhea	O
virus	O
in	O
swine	O
feces	B-ANAT
on	O
aluminum	O
surfaces	O
under	O
freezing	O
conditions	O
.	O

Most	O
ECMO	O
patients	O
have	O
good	O
physical	O
and	O
social	O
functioning	O
after	O
hospital	O
discharge	B-ANAT
.	O

ABSTRACT	O
:	O
A	O
complex	O
community	O
of	O
bacteria	O
,	O
viruses	O
,	O
fungi	O
,	O
protists	O
,	O
and	O
other	O
microorganisms	O
inhabit	O
the	O
gastrointestinal	B-ANAT
tract	I-ANAT
of	O
calves	O
and	O
play	O
important	O
roles	O
in	O
gut	B-ANAT
health	O
and	O
disease	O
.	O

However	O
,	O
determining	O
the	O
contribution	O
of	O
these	O
viruses	O
to	O
calf	B-ANAT
diarrhea	O
has	O
been	O
challenging	O
and	O
much	O
uncertainty	O
remains	O
concerning	O
their	O
roles	O
as	O
primary	O
pathogens	O
,	O
co	O
-	O
infection	O
agents	O
,	O
or	O
commensals	O
.	O

We	O
collected	O
11	O
,	O
399	O
throat	B-ANAT
swabs	O
from	O
hospitalized	O
children	O
with	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
from	O
July	O
2009	O
to	O
June	O
2016	O
in	O
Guangzhou	O
,	O
China	O
.	O

Patients	O
infected	O
with	O
a	O
single	O
strain	O
of	O
HCoV	O
infection	O
were	O
less	O
likely	O
to	O
present	O
fever	O
(â¥	O
38	O
Â°	O
C	O
)	O
(	O
p	O
=	O
0	O
.	O
014	O
)	O
and	O
more	O
likely	O
to	O
present	O
pulmonary	B-ANAT
rales	O
(	O
p	O
=	O
0	O
.	O
043	O
)	O
than	O
those	O
co	O
-	O
infected	O
with	O
more	O
than	O
one	O
HCoV	O
strain	O
or	O
other	O
respiratory	O
pathogens	O
.	O

The	O
areas	O
under	O
the	O
curve	O
of	O
the	O
receiver	O
operating	O
characteristic	O
(	O
ROC	O
)	O
curves	O
for	O
discriminating	O
between	O
IPS	O
and	O
unaffected	O
controls	O
at	O
day	O
7	O
post	O
-	O
HCT	O
were	O
.	O
8	O
for	O
ST2	B-ANAT
,	O
.	O
75	O
for	O
IL	O
-	O
6	O
,	O
and	O
.	O
68	O
for	O
TNFR1	O
.	O

This	O
study	O
aims	O
to	O
explore	O
the	O
significance	O
of	O
platelet	B-ANAT
concentration	O
during	O
the	O
course	O
of	O
the	O
disease	O
in	O
victims	O
of	O
a	O
mass	O
burn	O
casualty	O
.	O

The	O
examined	O
data	O
included	O
age	O
,	O
gender	O
,	O
total	O
burn	O
area	O
(%	O
TBSA	O
),	O
third	O
-	O
degree	O
burn	O
area	O
(%	O
TBSA	O
),	O
and	O
platelet	B-ANAT
concentration	O
within	O
the	O
first	O
5	O
days	O
after	O
the	O
burn	O
injury	O
.	O

ABSTRACT	O
:	O
Lung	B-ANAT
inflammation	O
is	O
one	O
of	O
the	O
main	O
consequences	O
of	O
intestinal	B-ANAT
ischemia	O
reperfusion	O
(	O
intestinal	B-ANAT
IR	O
)	O
and	O
,	O
in	O
severe	O
cases	O
,	O
can	O
lead	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
death	O
.	O

We	O
observed	O
a	O
significant	O
increase	O
in	O
serum	B-ANAT
levels	O
of	O
IL	O
-	O
10	O
,	O
CINC	O
-	O
1	O
,	O
uric	O
acid	O
and	O
circulating	O
,	O
but	O
not	O
bone	B-ANAT
marrow	I-ANAT
,	O
leukocyte	B-ANAT
numbers	O
.	O

In	O
addition	O
,	O
17Î²	O
-	O
estradiol	O
significantly	O
prevented	O
the	O
ex	O
-	O
vivo	O
release	O
of	O
IL	O
-	O
1Î²	O
and	O
VEGF	O
from	O
lung	B-ANAT
tissue	I-ANAT
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
characterized	O
by	O
excess	O
production	O
of	O
inflammatory	O
factors	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
test	O
the	O
anti	O
-	O
inflammatory	O
and	O
reparative	O
effects	O
of	O
ATII	O
cells	B-ANAT
in	O
an	O
experimental	O
model	O
of	O
ALI	O
.	O

The	O
lack	O
of	O
a	O
protein	O
corona	O
on	O
CPMV	O
and	O
eVLP	O
surfaces	O
in	O
GI	O
fluids	B-ANAT
would	O
imply	O
that	O
,	O
if	O
orally	B-ANAT
administered	O
,	O
these	O
nanoparticles	O
could	O
maintain	O
their	O
native	O
surface	O
characteristics	O
;	O
thus	O
,	O
their	O
biological	O
interactions	O
would	O
remain	O
predictable	O
and	O
unchanged	O
.	O

In	O
this	O
study	O
,	O
we	O
sequenced	O
whole	O
MERS	O
-	O
CoV	O
genomes	O
directly	O
from	O
respiratory	B-ANAT
samples	I-ANAT
collected	O
from	O
23	O
confirmed	O
MERS	O
cases	O
in	O
the	O
United	O
Arab	O
Emirates	O
(	O
UAE	O
).	O

Knockdown	O
of	O
clathrin	O
expression	O
by	O
siRNA	O
drastically	O
abrogated	O
the	O
infection	O
of	O
VSVÎG	O
-	O
MERS	O
in	O
Vero	B-ANAT
cells	I-ANAT
.	O

ABSTRACT	O
:	O
Mobile	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
retrieval	O
teams	O
(	O
MERTs	O
)	O
assure	O
ECMO	O
implantation	O
and	O
under	O
-	O
ECMO	O
retrieval	O
of	O
patients	O
with	O
most	O
severe	O
acute	O
respiratory	O
failure	O
(	O
ARF	O
)	O
to	O
experienced	O
ECMO	O
centers	O
.	O

TITLE	O
:	O
Coronaviruses	O
and	O
arteriviruses	O
display	O
striking	O
differences	O
in	O
their	O
cyclophilin	O
A	O
-	O
dependence	O
during	O
replication	O
in	O
cell	B-ANAT
culture	O
.	O

Here	O
,	O
we	O
investigated	O
the	O
CypA	O
dependence	O
of	O
three	O
distantly	O
related	O
nidoviruses	O
that	O
can	O
all	O
replicate	O
in	O
Huh7	O
cells	B-ANAT
:	O
the	O
arterivirus	O
equine	O
arteritis	O
virus	O
(	O
EAV	O
),	O
the	O
alphacoronavirus	O
human	O
coronavirus	O
229E	O
(	O
HCoV	O
-	O
229E	O
),	O
and	O
the	O
betacoronavirus	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
).	O

ABSTRACT	O
:	O
To	O
report	O
a	O
case	O
of	O
bilateral	O
central	B-ANAT
retinal	I-ANAT
artery	I-ANAT
occlusion	O
with	O
both	O
anterior	O
and	O
posterior	O
ischemic	O
optic	B-ANAT
neuropathy	O
.	O

TITLE	O
:	O
Investigating	O
the	O
Effects	O
of	O
Mass	O
Media	B-ANAT
Exposure	O
on	O
the	O
Uptake	O
of	O
Preventive	O
Measures	O
by	O
Hong	O
Kong	O
Residents	O
during	O
the	O
2015	O
MERS	O
Outbreak	O
:	O
The	O
Mediating	O
Role	O
of	O
Interpersonal	O
Communication	O
and	O
the	O
Perception	O
of	O
Concern	O
.	O

TITLE	O
:	O
Oxygen	O
Exposure	O
Resulting	O
in	O
Arterial	B-ANAT
Oxygen	O
Tensions	O
Above	O
the	O
Protocol	O
Goal	O

We	O
sought	O
to	O
determine	O
if	O
oxygen	O
exposure	O
that	O
resulted	O
in	O
a	O
partial	O
pressure	O
of	O
oxygen	O
in	O
arterial	B-ANAT
blood	I-ANAT
above	O
goal	O
(>	O
80	O
mm	O
Hg	O
)	O
was	O
associated	O
with	O
worse	O
outcomes	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Oxygen	O
exposure	O
resulting	O
in	O
arterial	B-ANAT
oxygen	O
tensions	O
above	O
the	O
protocol	O
goal	O
occurred	O
frequently	O
and	O
was	O
associated	O
with	O
worse	O
clinical	O
outcomes	O
at	O
all	O
levels	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
severity	O
.	O

ABSTRACT	O
:	O
Interferon	O
-	O
induced	O
transmembrane	B-ANAT
proteins	O
(	O
IFITMs	O
)	O
are	O
restriction	O
factors	O
that	O
inhibit	O
the	O
infectious	O
entry	O
of	O
many	O
enveloped	O
RNA	O
viruses	O
.	O

These	O
findings	O
suggest	O
that	O
these	O
residues	O
and	O
structural	O
motifs	O
of	O
IFITM	O
proteins	O
are	O
key	O
determinants	O
for	O
modulating	O
the	O
entry	O
of	O
HCoVs	O
,	O
most	O
likely	O
through	O
interaction	O
with	O
viral	O
and	O
/	O
or	O
host	O
cellular	B-ANAT
components	O
at	O
the	O
site	O
of	O
viral	O
entry	O
to	O
modulate	O
the	O
fusion	O
of	O
viral	B-ANAT
envelope	I-ANAT
and	O
cellular	B-ANAT
membranes	B-ANAT
.	O

The	O
remarkable	O
and	O
selective	O
regeneration	O
of	O
ABCA3	O
-	O
sufficient	O
AT2	O
progenitor	B-ANAT
cells	I-ANAT
provides	O
plausible	O
approaches	O
for	O
future	O
correction	O
of	O
ABCA3	O
and	O
other	O
genetic	O
disorders	O
associated	O
with	O
surfactant	O
deficiency	O
and	O
acute	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
.	O

Iterative	O
sequencing	O
and	O
RT	O
-	O
PCR	O
confirmation	O
of	O
four	O
respiratory	B-ANAT
samples	I-ANAT
over	O
the	O
4	O
-	O
week	O
peritransplant	O
period	O
revealed	O
that	O
the	O
pre	O
-	O
conditioning	O
strain	O
contained	O
an	O
intact	O
ORF4	O
gene	O
,	O
while	O
the	O
deletion	O
strain	O
appeared	O
just	O
after	O
conditioning	O
and	O
persisted	O
over	O
a	O
2	O
.	O
5	O
-	O
week	O
period	O
.	O

MBL	O
was	O
assayed	O
from	O
blood	B-ANAT
drawn	O
at	O
influenza	O
diagnosis	O
within	O
24	O
-	O
48	O
h	O
following	O
the	O
ICU	O
admission	O
.	O

ABSTRACT	O
:	O
During	O
viral	O
entry	O
,	O
enveloped	O
viruses	O
require	O
the	O
fusion	O
of	O
their	O
lipid	O
envelope	B-ANAT
with	O
host	O
cell	B-ANAT
membranes	I-ANAT
.	O

We	O
analyzed	O
the	O
environment	O
and	O
land	B-ANAT
use	O
using	O
remote	O
spatial	O
data	O
around	O
the	O
sampling	O
locations	O
of	O
bats	O
positive	O
for	O
coronavirus	O
(	O
21	O
sites	O
)	O
and	O
astrovirus	O
(	O
11	O
sites	O
)	O
collected	O
in	O
43	O
sites	O
.	O

This	O
Account	O
will	O
build	O
toward	O
examples	O
of	O
in	O
vivo	O
studies	O
in	O
cardiovascular	B-ANAT
disease	O
and	O
cancer	O
models	O
,	O
including	O
diagnostic	O
studies	O
by	O
magnetic	O
resonance	O
imaging	O
(	O
MRI	O
),	O
computed	O
tomography	O
(	O
CT	O
),	O
and	O
positron	O
emission	B-ANAT
tomography	O
(	O
PET	O
).	O

The	O
symptoms	O
typically	O
present	O
with	O
fever	O
and	O
skin	B-ANAT
rash	O
,	O
and	O
rapidly	O
progress	O
to	O
multiple	O
organ	B-ANAT
failures	O
.	O

We	O
described	O
a	O
case	O
of	O
a	O
39	O
year	O
-	O
old	O
man	O
who	O
was	O
treated	O
with	O
vancomycin	O
for	O
osteomyelitis	O
of	O
the	O
foot	B-ANAT
.	O

ABSTRACT	O
:	O
Pulmonary	B-ANAT
disorders	O
and	O
respiratory	O
failure	O
represent	O
one	O
of	O
the	O
most	O
common	O
morbidities	O
of	O
preterm	O
newborns	O
admitted	O
to	O
neonatal	O
intensive	O
care	O
units	O
(	O
NICUs	O
).	O

Individual	O
characteristics	O
:	O
PaO2	O
/	O
FiO2	O
=	O
110	O
Â±	O
60	O
mmHg	O
,	O
alveolar	B-ANAT
-	O
arterial	B-ANAT
oxygen	O
gradient	O
(	O
A	O
-	O
aO2	O
)	O
=	O
549	O
Â±	O
148	O
.	O
9	O
mmHg	O
,	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
=	O
8	O
.	O
7	O
Â±	O
3	O
.	O
5	O
cmH	O

AFI	O
TAC	O
detected	O
nucleic	B-ANAT
acid	O
for	O
one	O
or	O
more	O
of	O
seven	O
microbial	O
agents	O
in	O
49	O
%	O
of	O
AFI	O
blood	B-ANAT
samples	I-ANAT
,	O
including	O
:	O
Plasmodium	O
(	O
47	O
%),	O
Leptospira	O
(	O
3	O
%),	O
Bartonella	O
(	O
1	O
%),	O
Salmonella	O
enterica	O
(	O
1	O
%),	O
Coxiella	O
burnetii	O
(	O
1	O
%),	O
Rickettsia	O
(	O
1	O
%),	O
and	O
West	O
Nile	O
virus	O
(	O
1	O
%).	O

In	O
this	O
study	O
,	O
we	O
described	O
the	O
development	O
of	O
lateral	O
-	O
flow	O
dipstick	O
isothermal	O
recombinase	O
polymerase	O
amplification	O
(	O
LFD	O
-	O
RPA	B-ANAT
)	O
assays	O
for	O
detection	O
of	O
BEFV	O
.	O

Positive	O
hybridoma	B-ANAT
cells	B-ANAT
are	O
stained	O
using	O
a	O
fluorescently	O
labeled	O
anti	O
-	O
mouse	O
IgG	O
-	O
Fc	O
antibody	O
.	O

The	O
tissue	B-ANAT
distribution	O
of	O
the	O
two	O
virus	O
strains	O
was	O
tested	O
by	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
.	O

To	O
assess	O
long	O
-	O
term	O
renal	B-ANAT
recovery	O
in	O
patients	O
with	O
acute	O
kidney	B-ANAT
injury	O
and	O
severe	O
ARDS	O
due	O
to	O
pH1N1	O
.	O

Baseline	O
characteristics	O
,	O
acute	O
kidney	B-ANAT
injury	O
stage	O
,	O
continuous	O
renal	B-ANAT
replacement	O
therapy	O
(	O
CRRT	O
),	O
intermittent	O
hemodialysis	O
,	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
survival	O
,	O
and	O
renal	B-ANAT
recovery	O
(	O
defined	O
as	O
dialysis	O
independence	O
)	O
were	O
evaluated	O
.	O

Extracorporeal	O
membrane	B-ANAT
oxygenation	O
was	O
instituted	O
in	O
17	O
patients	O
;	O
15	O
of	O
these	O
patients	O
required	O
CRRT	O
.	O

TITLE	O
:	O
Memory	O
CD8	O
T	B-ANAT
cells	I-ANAT
mediate	O
severe	O
immunopathology	O
following	O
respiratory	O
syncytial	O
virus	O
infection	O
.	O

Memory	O
CD8	O
T	B-ANAT
cells	I-ANAT
rapidly	O
produced	O
IFN	O
-	O
Î³	O
following	O
RSV	O
infection	O
resulting	O
in	O
elevated	O
protein	O
levels	O
in	O
the	O
lung	B-ANAT
and	O
periphery	O
.	O

For	O
any	O
given	O
airway	B-ANAT
pressure	O
generated	O
by	O
the	O
ventilator	O
,	O
the	O
pressure	O
acting	O
directly	O
on	O
the	O
lung	B-ANAT
(	O
i	O
.	O
e	O
.,	O
the	O
transpulmonary	O
pressure	O
or	O
lung	B-ANAT
stress	O
)	O
is	O
determined	O
by	O
two	O
main	O
factors	O
:	O
1	O
)	O
the	O
ratio	O
between	O
lung	B-ANAT
elastance	O
and	O
the	O
total	O
elastance	O
of	O
the	O
respiratory	B-ANAT
system	I-ANAT
(	O
which	O
has	O
been	O
shown	O
to	O
vary	O
widely	O
in	O
ARDS	O
patients	O
,	O
between	O
0	O
.	O
2	O
and	O
0	O
.	O
8	O
);	O
and	O
2	O
)	O
the	O
lung	B-ANAT
size	O
.	O

In	O
the	O
end	O
,	O
decreasing	O
mechanical	O
power	O
,	O
increasing	O
lung	B-ANAT
homogeneity	O
,	O
and	O
avoiding	O
reaching	O
the	O
anatomical	O
limits	O
of	O
the	O
'	O
baby	O
lung	B-ANAT
'	O
should	O
be	O
the	O
goals	O
for	O
safe	O
ventilation	O
in	O
ARDS	O
.	O

ABSTRACT	O
:	O
To	O
report	O
outcomes	O
of	O
immunocompromised	O
patients	O
treated	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
for	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
to	O
identify	O
their	O
pre	O
-	O
ECMO	O
predictors	O
of	O
6	O
-	O
month	O
mortality	O
and	O
main	O
ECMO	O
-	O
related	O
complications	O
.	O

Immunocompromised	O
patients	O
,	O
defined	O
as	O
having	O
hematological	O
malignancies	O
,	O
active	O
solid	O
tumor	O
,	O
solid	O
-	O
organ	B-ANAT
transplant	I-ANAT
,	O
acquired	O
immunodeficiency	O
syndrome	O
,	O
or	O
long	O
-	O
term	O
or	O
high	O
-	O
dose	O
corticosteroid	O
or	O
immunosuppressant	O
use	O
,	O
and	O
severe	O
ECMO	O
-	O
treated	O
ARDS	O
from	O
2008	O
to	O
2015	O
were	O
included	O
Measurements	O
and	O
Main	O
Results	O
:	O
We	O
collected	O
demographics	O
,	O
clinical	O
,	O
ECMO	O
-	O
related	O
complications	O
,	O
ICU	O
-	O
and	O
6	O
-	O
month	O
-	O
outcome	O
data	O
for	O
203	O
patients	O
(	O
median	O
APACHE	O
II	O
28	O
[	O
25th	O
;	O
75th	O
percentile	O
,	O
20	O
;	O
33	O
];	O
age	O
51	O
[	O
38	O
;	O
59	O
]	O
years	O
,	O
PaO2	O
/	O
FiO2	O
60	O
[	O
50	O
;	O
82	O
]	O
mmHg	O
before	O
ECMO	O
)	O
who	O
fulfilled	O
our	O
inclusion	O
criteria	O
.	O

The	O
suckling	O
piglets	O
in	O
the	O
DC	O
-	O
targeted	O
vaccine	O
group	O
showed	O
increased	O
gross	O
pathological	O
lesions	O
in	O
the	O
small	B-ANAT
intestine	I-ANAT
.	O

ABSTRACT	O
:	O
To	O
determine	O
rates	O
of	O
both	O
symptomatic	O
and	O
asymptomatic	O
infection	O
among	O
ambulatory	O
adults	O
,	O
we	O
collected	O
nasopharyngeal	B-ANAT
swab	I-ANAT
specimens	O
,	O
demographic	O
characteristics	O
,	O
and	O
survey	O
information	O
from	O
1477	O
adult	O
visitors	O
to	O
a	O
New	O
York	O
City	O
tourist	O
attraction	O
during	O
April	O
-	O
July	O
2016	O
.	O

TITLE	O
:	O
Impact	O
of	O
Sex	O
on	O
Comparative	O
Outcomes	O
of	O
Radial	O
Versus	O
Femoral	B-ANAT
Access	O
in	O
Patients	O
With	O
Acute	O
Coronary	B-ANAT
Syndromes	O
Undergoing	O
Invasive	O
Management	O
:	O

The	O
30	O
-	O
day	O
coprimary	O
outcomes	O
were	O
major	O
adverse	O
cardiovascular	B-ANAT
and	O
cerebrovascular	O
events	O
(	O
MACCE	O
),	O
defined	O
as	O
death	O
,	O
myocardial	O
infarction	O
,	O
or	O
stroke	O
,	O
and	O
net	O
adverse	O
clinical	O
events	O
(	O
NACE	O
),	O
defined	O
as	O
MACCE	O
or	O
major	O
bleeding	O
.	O

Elevated	O
numbers	O
of	O
apoptotic	O
cells	B-ANAT
were	O
observed	O
at	O
24	O
,	O
48	O
and	O
72	O
h	O
post	O
-	O
infection	O
(	O
p	O
.	O
i	O
.).	O

Viral	O
infection	O
was	O
associated	O
with	O
mitochondrial	B-ANAT
membrane	I-ANAT
depolarization	O
and	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
production	O
at	O
all	O
of	O
the	O
examined	O
timepoints	O
p	O
.	O
i	O
.	O

TITLE	O
:	O
[	O
Establishment	O
of	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
early	O
warning	O
score	O
in	O
patients	O
with	O
severe	O
trauma	O
and	O
its	O
clinical	O
significance	O
:	O
a	O
multicenter	O
study	O
].	O

As	O
a	O
strong	O
stressor	O
during	O
sepsis	O
,	O
the	O
severe	O
infectious	O
state	O
of	O
the	O
body	B-ANAT
triggers	O
serious	O
stress	O
reaction	O
.	O

The	O
hypothalamus	B-ANAT
-	O
pituitary	B-ANAT
-	O
adrenal	O
cortical	B-ANAT
(	O
HPA	B-ANAT
)	O
axis	B-ANAT
and	O
sympathetic	O
-	O
adrenal	B-ANAT
medulla	I-ANAT
axis	B-ANAT
were	O
activated	O
and	O
participated	O
the	O
initiation	O
and	O
progression	O
of	O
the	O
stress	O
response	O
through	O
the	O
production	O
of	O
adrenocorticotropic	O
hormone	O
(	O
ACTH	O
),	O
glucocorticoid	O
(	O
GC	O
),	O
epinephrine	O
and	O
norepinephrine	O
(	O
NE	O
).	O

TITLE	O
:	O
Decreased	O
expression	O
of	O
megalin	O
and	O
cubilin	O
and	O
altered	O
mitochondrial	B-ANAT
activity	O
in	O
tenofovir	O
nephrotoxicity	O
.	O

Hepatic	B-ANAT
enzymes	O
,	O
antioxidant	O
defenses	O
and	O
lipids	O
content	O
and	O
composition	O
were	O
also	O
evaluated	O
.	O

In	O
the	O
present	O
report	O
,	O
three	O
cases	O
of	O
AIP	O
complicated	O
by	O
refractory	O
respiratory	O
failure	O
supported	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
are	O
presented	O
.	O

Despite	O
lung	B-ANAT
protective	O
ventilation	O
,	O
prone	O
position	O
and	O
neuromuscular	O
blockade	O
,	O
refractory	O
respiratory	O
failure	O
of	O
unknown	O
etiology	O
supervened	O
(	O
ratio	O
of	O
arterial	B-ANAT
oxygen	O
partial	O
pressure	O
to	O
fractional	O
inspired	O
oxygen	O
46	O
-	O
130	O
)	O
and	O
ECMO	O
was	O
initiated	O
after	O
3	O
-	O
7	O
days	O
of	O
mechanical	O
ventilation	O
.	O

Histological	O
changes	O
of	O
lung	B-ANAT
tissues	I-ANAT
were	O
evaluated	O
by	O
H	O
&	O
E	O
staining	O
and	O
Masson	O
'	O
s	O
trichrome	O
staining	O
.	O

In	O
PSV	O
,	O
PEEP	O
=	O
5	O
cmH2O	O
compared	O
with	O
PEEP	O
=	O
2	O
cmH2O	O
was	O
associated	O
with	O
significantly	O
reduced	O
diffuse	O
alveolar	B-ANAT
damage	O
score	O
[	O
median	O
(	O
interquartile	O
range	O
),	O
11	O
(	O
8	O
.	O
5	O
to	O
13	O
.	O
5	O
)	O
vs	O
.	O
23	O
(	O
19	O
to	O
26	O
),	O
P	O
=	O
0	O
.	O
005	O
]	O
and	O
expressions	O
of	O
IL	O
-	O
6	O
and	O
CINC	O
-	O
1	O
(	O
P	O
=	O
0	O
.	O
02	O
for	O
both	O
),	O
whereas	O
surfactant	O
protein	O
-	O
B	O
mRNA	O
expression	O
increased	O
(	O
P	O
=	O
0	O
.	O
03	O
).	O

Human	O
lung	B-ANAT
epithelial	O
(	O
BEAS	O
-	O
2B	O
)	O
cells	B-ANAT
were	O
incubated	O
with	O
LPS	O
in	O
the	O
presence	O
or	O
absence	O
of	O
UTI	O
.	O

We	O
found	O
that	O
patients	O
with	O
severe	O
influenza	O
showed	O
elevated	O
plasma	B-ANAT
NET	O
level	O
on	O
the	O
day	O
of	O
admission	O
.	O

Neutrophils	B-ANAT
from	O
these	O
patients	O
showed	O
higher	O
capacity	O
to	O
release	O
MPO	O
-	O
DNA	O
complex	O
in	O
response	O
to	O
interleukin	O
-	O
8	O
or	O
lipopolysaccharide	O
stimulation	O
.	O

These	O
data	O
indicate	O
that	O
high	O
level	O
of	O
NETs	O
contributes	O
to	O
lung	B-ANAT
injury	O
and	O
is	O
correlated	O
with	O
severity	O
of	O
disease	O
.	O

We	O
also	O
examined	O
the	O
prevalence	O
of	O
viral	O
infection	O
stratified	O
by	O
age	O
,	O
geographic	O
region	O
,	O
type	O
of	O
respiratory	B-ANAT
secretion	I-ANAT
,	O
and	O
detection	O
method	O
.	O

Out	O
of	O
1234	O
ARDS	O
patients	O
,	O
431	O
(	O
34	O
.	O
9	O
%)	O
were	O
transported	O
,	O
and	O
52	O
of	O
these	O
(	O
12	O
.	O
1	O
%)	O
treated	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

TITLE	O
:	O
Acute	O
kidney	B-ANAT
injury	O
due	O
to	O
multiple	O
Hymenoptera	O
stings	O
-	O
a	O
clinicopathological	O
study	O
.	O

The	O
main	O
complications	O
included	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
encephalopathy	O
in	O
four	O
(	O
11	O
.	O
4	O
%)	O
patients	O
each	O
;	O
gastrointestinal	O
bleeding	O
,	O
hypertension	O
and	O
panniculitis	O
in	O
two	O
(	O
5	O
.	O
7	O
%)	O
patients	O
each	O
and	O
one	O
(	O
2	O
.	O
9	O
%)	O
patient	O
each	O
developed	O
intra	O
-	O
abdominal	B-ANAT
bleeding	O
,	O
stroke	O
and	O
polyserositis	O
.	O

In	O
four	O
(	O
30	O
.	O
8	O
%)	O
patients	O
,	O
the	O
kidney	B-ANAT
biopsy	O
showed	O
severe	O
ATN	O
and	O
in	O
the	O
other	O
six	O
(	O
46	O
.	O
2	O
%),	O
the	O
kidney	B-ANAT
biopsy	O
showed	O
features	O
of	O
ATN	O
associated	O
with	O
mild	O
to	O
moderate	O
acute	O
interstitial	B-ANAT
nephritis	O
(	O
AIN	O
).	O

Consistent	O
with	O
a	O
proinflammatory	O
phenotype	O
,	O
immunofluorescence	O
revealed	O
increased	O
phosphorylated	O
signal	O
transduction	O
and	O
activation	O
of	O
transcription	O
3	O
(	O
pSTAT3	O
),	O
suggesting	O
enhanced	O
Janus	O
kinase	O
(	O
JAK	O
)/	O
STAT	O
activation	O
in	O
inflammatory	O
and	O
AT2	O
cells	B-ANAT
of	O
SPC	O
-	O
TK	O
/	O
SPC	O
-	O
KO	O
mice	O
.	O

Renal	B-ANAT
function	O
recovery	O
occurred	O
earlier	O
with	O
the	O
delayed	O
RRT	O
strategy	O
in	O
patients	O
with	O
septic	O
shock	O
or	O
ARDS	O
(	O
P	O
<	O
0	O
.	O
001	O
and	O
P	O
=	O
0	O
.	O
003	O
,	O
respectively	O
).	O

The	O
aims	O
of	O
the	O
study	O
were	O
to	O
determine	O
the	O
duration	O
of	O
viral	O
RNA	O
carriage	O
and	O
the	O
infectivity	O
of	O
viral	B-ANAT
particles	I-ANAT
on	O
fomites	O
and	O
human	O
nasal	B-ANAT
mucosa	I-ANAT
after	O
exposure	O
to	O
BCoV	O
and	O
BRSV	O
.	O

For	O
BCoV	O
,	O
46	O
%	O
(	O
n	O
=	O
80	O
)	O
of	O
the	O
swabs	O
from	O
human	O
nasal	B-ANAT
mucosa	I-ANAT
collected	O
30	O
min	O
after	O
exposure	O
were	O
positive	O
by	O
RT	O
-	O
qPCR	O
.	O

RESULTS	O
:	O
For	O
BCoV	O
,	O
46	O
%	O
(	O
n	O
=	O
80	O
)	O
of	O
the	O
swabs	O
from	O
human	O
nasal	B-ANAT
mucosa	I-ANAT
collected	O
30	O
min	O
after	O
exposure	O
were	O
positive	O
by	O
RT	O
-	O
qPCR	O
.	O

Survival	O
outcomes	O
remain	O
unclear	O
in	O
those	O
who	O
develop	O
acute	O
kidney	B-ANAT
injury	O
(	O
AKI	O
)	O
requiring	O
continuous	O
renal	B-ANAT
replacement	O
therapy	O
(	O
CRRT	O
)	O
during	O
VV	O
ECMO	O
for	O
isolated	O
severe	O
respiratory	O
failure	O
in	O
adult	O
populations	O
.	O

A	O
PDCoV	O
strain	O
named	O
HB	O
-	O
BD	O
was	O
successfully	O
isolated	O
from	O
the	O
intestinal	B-ANAT
contents	I-ANAT
of	O
a	O
diarrhoeic	O
piglet	O
and	O
serially	O
propagated	O
in	O
swine	O
testicular	O
(	O
ST	O
)	O
cells	B-ANAT
for	O
>	O
40	O
passages	O
.	O

TITLE	O
:	O
Galectin	O
-	O
3	O
Enhances	O
Avian	O
H5N1	O
Influenza	O
A	O
Virus	O
-	O
Induced	O
Pulmonary	B-ANAT
Inflammation	O
by	O
Promoting	O
NLRP3	O
Inflammasome	O
Activation	O
.	O

ABSTRACT	O
:	O
This	O
review	O
describes	O
the	O
current	O
understanding	O
of	O
the	O
lungs	B-ANAT
'	O
response	O
to	O
deforming	O
stress	O
under	O
conditions	O
of	O
both	O
normal	O
physiology	O
and	O
acute	O
lung	B-ANAT
injury	O
.	O

The	O
implications	O
issuing	O
from	O
these	O
3	O
topics	O
inform	O
a	O
safer	O
approach	O
to	O
setting	O
and	O
adjusting	O
the	O
ventilator	O
to	O
minimize	O
the	O
risk	O
of	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

Thereby	O
we	O
propose	O
a	O
model	O
where	O
4b	O
outcompetes	O
NF	O
-	O
ÎºB	O
for	O
KPNA4	O
binding	O
and	O
translocation	O
into	O
the	O
nucleus	B-ANAT
as	O
a	O
mechanism	O
of	O
interference	O
with	O
the	O
NF	O
-	O
ÎºB	O
-	O
mediated	O
innate	O
immune	O
response	O
.	O

In	O
seven	O
cases	O
,	O
CNVs	O
in	O
various	O
causative	O
genes	O
of	O
inherited	O
kidney	B-ANAT
diseases	O
were	O
detected	O
by	O
pair	O
analysis	O
.	O

High	O
-	O
flow	O
nasal	B-ANAT
cannula	O
oxygen	O
therapy	O
is	O
another	O
supportive	O
strategy	O
which	O
serves	O
to	O
improve	O
the	O
symptoms	O
of	O
hypoxic	O
respiratory	O
failure	O
.	O

TITLE	O
:	O
Does	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
Improve	O
Survival	O
in	O
Pediatric	O
Acute	O
Respiratory	O
Failure	O
?	O

Microglia	B-ANAT
are	O
not	O
only	O
vital	O
cells	B-ANAT
in	O
maintaining	O
CNS	B-ANAT
homeostasis	O
,	O
but	O
also	O
respond	O
to	O
injury	O
,	O
infection	O
,	O
and	O
disease	O
by	O
undergoing	O
proliferation	O
and	O
changes	O
in	O
transcription	O
and	O
morphology	O
.	O

A	O
better	O
understanding	O
of	O
the	O
specific	O
role	O
of	O
microglia	B-ANAT
in	O
responding	O
to	O
viral	O
infection	O
is	O
complicated	O
by	O
the	O
presence	O
of	O
nonmicroglial	O
myeloid	B-ANAT
cells	I-ANAT
with	O
potentially	O
overlapping	O
function	O
in	O
the	O
healthy	O
brain	B-ANAT
and	O
by	O
the	O
rapid	O
infiltration	O
of	O
hematopoietic	O
myeloid	B-ANAT
cells	I-ANAT
into	O
the	O
brain	B-ANAT
in	O
diseased	O
states	O
.	O

Liver	B-ANAT
and	O
jejunum	B-ANAT
gluconeogenic	O
enzyme	O
activities	O
were	O
not	O
different	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
between	O
treatments	O
within	O
dpi	O
.	O

Although	O
all	O
nasopharyngeal	B-ANAT
samples	O
were	O
negative	O
,	O
MERS	O
CoV	O
infection	O
was	O
confirmed	O
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
of	O
the	O
E	O
gene	O
(	O
UpE	O
)	O
and	O
open	O
reading	O
frame	O
(	O
ORF1b	O
)	O
on	O
sputum	B-ANAT
samples	O
.	O

PEDV	O
-	O
specific	O
immune	O
responses	O
in	O
serum	B-ANAT
and	O
milk	O
of	O
the	O
sows	O
were	O
assayed	O
by	O
virus	O
neutralization	O
assay	O
.	O

TITLE	O
:	O
Bilateral	O
acute	O
iris	B-ANAT
transillumination	O
syndrome	O
.	O

BAIT	O
syndrome	O
is	O
a	O
new	O
clinical	O
condition	O
characterised	O
by	O
severe	O
transillumination	O
of	O
the	O
iris	B-ANAT
,	O
acute	O
onset	O
of	O
pigment	O
dispersion	O
in	O
the	O
anterior	B-ANAT
chamber	I-ANAT
,	O
and	O
a	O
medial	O
mydriatic	O
pupil	B-ANAT
that	O
is	O
unresponsive	O
or	O
poorly	O
responsive	O
to	O
light	O
,	O
due	O
to	O
a	O
sphincter	B-ANAT
paralysis	O
.	O

Study	O
participants	O
were	O
asked	O
to	O
score	O
each	O
of	O
these	O
12	O
attributes	O
on	O
a	O
scale	O
of	O
0	O
-	O
3	O
:	O
Infectivity	O
,	O
Infection	O
-	O
to	O
-	O
Disease	O
Ratio	O
(	O
Reliability	O
),	O
Predictability	O
(&	O
Incubation	O
Period	O
),	O
Morbidity	O
&	O
Mortality	O
(	O
Virulence	O
),	O
Ease	O
of	O
Large	O
-	O
Scale	O
Production	O
&	O
Storage	B-ANAT
,	O
Aerosol	O
Stability	O
,	O
Atmospheric	O
Stability	O
,	O
Ease	O
of	O
Dispersal	O
,	O
Communicability	O
,	O
Prophylactic	O
Countermeasure	O
Availability	O
,	O
Therapeutic	O
Countermeasure	O
Availability	O
,	O
and	O
Ease	O
of	O
Detection	O
.	O

TITLE	O
:	O
Detection	O
of	O
Zika	O
virus	O
using	O
reverse	O
-	O
transcription	O
LAMP	O
coupled	O
with	O
reverse	O
dot	O
blot	O
analysis	O
in	O
saliva	B-ANAT
.	O

Although	O
,	O
PEDV	O
RNA	O
was	O
found	O
in	O
fecal	B-ANAT
samples	O
of	O
all	O
piglets	O
,	O
13	O
piglets	O
did	O
not	O
demonstrate	O
antibodies	O
at	O
any	O
sampling	O
day	O
.	O

We	O
found	O
that	O
229E	O
-	O
HR1P	O
and	O
229E	O
-	O
HR2P	O
could	O
interact	O
to	O
form	O
a	O
stable	O
six	O
-	O
helix	O
bundle	O
and	O
inhibit	O
HCoV	O
-	O
229E	O
spike	O
protein	O
-	O
mediated	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
with	O
IC	O

Importantly	O
,	O
we	O
discovered	O
that	O
the	O
lipoxin	O
pathway	O
could	O
be	O
a	O
potent	O
modulator	O
of	O
NET	O
formation	O
,	O
and	O
that	O
mice	O
deficient	O
in	O
the	O
lipoxin	O
receptor	O
(	O
Fpr2	O
-/-)	O
produced	O
excess	O
NETs	O
leading	O
to	O
increased	O
lung	B-ANAT
injury	O
and	O
mortality	O
.	O

Lastly	O
,	O
we	O
observed	O
in	O
humans	O
that	O
increased	O
plasma	B-ANAT
NETs	O
were	O
associated	O
with	O
ARDS	O
severity	O
and	O
mortality	O
,	O
and	O
lower	O
plasma	B-ANAT
DNase	O
I	O
levels	O
were	O
associated	O
with	O
the	O
development	O
of	O
sepsis	O
-	O
induced	O
ARDS	O
.	O

It	O
would	O
be	O
challenging	O
to	O
prove	O
that	O
specific	O
lung	B-ANAT
-	O
directed	O
therapies	O
have	O
an	O
effect	O
on	O
overall	O
survival	O
.	O

ABSTRACT	O
:	O
The	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
(	O
ARDS	O
)	O
is	O
defined	O
by	O
hypoxemic	O
respiratory	O
failure	O
caused	O
by	O
inflammatory	O
response	O
within	O
the	O
lung	B-ANAT
usually	O
requiring	O
invasive	O
mechanical	O
ventilation	O
.	O

The	O
immunogenicity	O
of	O
the	O
orally	B-ANAT
administered	O
recombinant	O
strains	O
was	O
evaluated	O
.	O

Following	O
experimental	O
IBV	O
infection	O
in	O
6	O
days	O
old	O
chickens	O
,	O
we	O
found	O
increased	O
production	O
of	O
IL	O
-	O
1Î²	O
and	O
increased	O
recruitment	O
of	O
macrophages	B-ANAT
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
.	O

TITLE	O
:	O
Heart	B-ANAT
-	O
lung	B-ANAT
interactions	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
pathophysiology	O
,	O
detection	O
and	O
management	O
strategies	O
.	O

The	O
injured	O
lungs	B-ANAT
may	O
recover	O
completely	O
with	O
effective	O
ECMO	O
therapy	O
.	O

TITLE	O
:	O
Predictors	O
of	O
long	O
-	O
term	O
adherence	O
to	O
continuous	O
positive	O
airway	B-ANAT
pressure	O
in	O
patients	O
with	O
obstructive	O
sleep	O
apnoea	O
and	O
acute	O
coronary	B-ANAT
syndrome	O
.	O

Additionally	O
,	O
the	O
composition	O
of	O
the	O
small	B-ANAT
intestinal	I-ANAT
microbiota	O
of	O
sucking	O
piglets	O
infected	O
with	O
PEDV	O
showed	O
marked	O
differences	O
from	O
that	O
of	O
the	O
uninfected	O
piglets	O
.	O

Therefore	O
,	O
adjusting	O
the	O
intestinal	B-ANAT
microbiota	O
might	O
be	O
a	O
promising	O
method	O
for	O
the	O
prevention	O
or	O
treatment	O
of	O
PEDV	O
.	O

ABSTRACT	O
:	O
Venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
VV	O
-	O
ECMO	O
)	O
has	O
been	O
gaining	O
use	O
to	O
bridge	O
the	O
recovery	O
from	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
refractory	O
to	O
conventional	O
treatment	O
.	O

The	O
abdomen	B-ANAT
was	O
left	O
open	O
for	O
subsequent	O
washouts	O
and	O
ongoing	O
resuscitation	O
.	O

Increased	O
angiopoietin	O
-	O
2	O
serum	B-ANAT
levels	O
predicted	O
mortality	O
and	O
length	O
of	O
hospital	O
stay	O
,	O
and	O
angiopoietin	O
-	O
1	O
may	O
provide	O
a	O
therapeutic	O
target	O
for	O
severe	O
pneumonia	O
.	O

We	O
present	O
an	O
unusual	O
observation	O
of	O
platypnoea	O
-	O
orthodeoxia	O
syndrome	O
in	O
a	O
young	O
woman	O
with	O
acute	O
atelectasis	O
due	O
to	O
post	O
-	O
tuberculosis	O
bronchial	B-ANAT
stricture	O
.	O

Imaging	O
revealed	O
complete	O
middle	O
and	O
right	B-ANAT
lower	I-ANAT
lobe	I-ANAT
atelectasis	O
with	O
a	O
partially	O
aerated	O
right	B-ANAT
upper	I-ANAT
lobe	I-ANAT
.	O

In	O
contrast	O
,	O
the	O
ts	O
-	O
11	O
vaccine	O
had	O
a	O
more	O
pronounced	O
reductive	O
effect	O
on	O
replication	O
in	O
tracheas	B-ANAT
,	O
air	B-ANAT
sacs	I-ANAT
,	O
bursae	B-ANAT
and	O
heart	B-ANAT
at	O
days	O
28	O
and	O
31	O
,	O
yet	O
increased	O
replication	O
in	O
lungs	B-ANAT
.	O

One	O
of	O
the	O
limitations	O
in	O
using	O
traditional	O
culture	O
systems	O
from	O
non	O
-	O
reservoir	O
species	O
is	O
that	O
cell	B-ANAT
types	O
and	O
culture	O
conditions	O
may	O
not	O
be	O
compatible	O
for	O
isolation	O
of	O
bat	O
-	O
borne	O
viruses	O
.	O

There	O
is	O
,	O
therefore	O
,	O
a	O
need	O
to	O
develop	O
additional	O
bat	O
cell	B-ANAT
lines	I-ANAT
that	O
correspond	O
to	O
different	O
cell	B-ANAT
types	O
,	O
including	O
less	O
represented	O
cell	B-ANAT
types	O
such	O
as	O
immune	O
cells	B-ANAT
,	O
and	O
culture	O
them	O
under	O
more	O
physiologically	O
relevant	O
conditions	O
to	O
study	O
virus	O
host	O
interactions	O
and	O
for	O
virus	O
isolation	O
.	O

We	O
collected	O
demographic	O
data	O
and	O
physiologic	O
data	O
for	O
CPP	O
,	O
intracranial	B-ANAT
pressure	O
,	O
mechanical	O
ventilation	O
,	O
cumulative	O
fluid	O
balance	O
and	O
delta	O
/	O
driving	O
pressure	O
(	O
ÎP	O
).	O

Patients	O
with	O
ARDS	O
had	O
higher	O
ÎP	O
and	O
lower	O
lung	B-ANAT
compliance	O
.	O

Patients	O
who	O
developed	O
ARDS	O
had	O
a	O
higher	O
ÎP	O
(	O
15	O
mmHg	O
[	O
5	O
]	O
vs	O
.	O
12	O
mmHg	O
[	O
4	O
],	O
p	O
=	O
0	O
.	O
016	O
)	O
and	O
lower	O
lung	B-ANAT
compliance	O
(	O
35	O
ml	O
/	O
cmH2O	O
[	O
10	O
]	O
vs	O
.	O
49	O
ml	O
/	O
cmH2O	O
[	O
18	O
],	O
p	O
=	O
0	O
.	O
024	O
)	O
versus	O
those	O
who	O
did	O
not	O
.	O

A	O
23	O
-	O
year	O
-	O
old	O
male	O
patient	O
with	O
recurrent	O
tongue	B-ANAT
cancer	O
was	O
scheduled	O
to	O
undergo	O
partial	O
glossectomy	O
and	O
neck	B-ANAT
dissection	O
.	O

ABSTRACT	O
:	O
HCoV	O
-	O
229E	O
spike	O
(	O
S	O
)	O
protein	O
mediates	O
virion	B-ANAT
attachment	O
to	O
cells	B-ANAT
and	O
subsequent	O
fusion	O
of	O
the	O
viral	O
and	O
cellular	B-ANAT
membranes	B-ANAT
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
is	O
an	O
inï¬ammatory	O
disease	O
characterized	O
by	O
dysfunction	O
of	O
pulmonary	B-ANAT
epithelial	O
and	O
capillary	B-ANAT
endothelial	I-ANAT
cells	I-ANAT
,	O
infiltration	O
of	O
alveolar	B-ANAT
macrophages	I-ANAT
and	O
neutrophils	B-ANAT
,	O
cell	B-ANAT
apoptosis	O
,	O
necroptosis	O
,	O
NETosis	O
,	O
and	O
fibrosis	O
.	O

Of	O
total	O
rectal	B-ANAT
swab	I-ANAT
positives	O
(	O
68	O
/	O
367	O
,	O
18	O
.	O
5	O
%),	O
ratio	O
was	O
higher	O
in	O
bats	O
captured	O
at	O
S1	O
(	O
11	O
/	O
44	O
,	O
25	O
.	O
0	O
%)	O
and	O
S2	O
(	O
35	O
/	O
99	O
,	O
35	O
.	O
4	O
%)	O
foraging	O
sites	O
than	O
at	O
roost	O
(	O
S3	O
)	O
(	O
22	O
/	O
224	O
,	O
9	O
.	O
8	O
%).	O

The	O
cornerstone	O
of	O
management	O
remains	O
mechanical	O
ventilation	O
,	O
with	O
a	O
goal	O
to	O
minimize	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
(	O
VILI	O
).	O

ABSTRACT	O
:	O
To	O
report	O
a	O
case	O
of	O
labour	O
induction	O
during	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
support	O
in	O
a	O
patient	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
caused	O
by	O
influenza	O
and	O
review	O
of	O
the	O
literature	O
.	O

Biopsy	O
specimens	O
showed	O
diffuse	O
alveolar	B-ANAT
injury	O
with	O
a	O
striking	O
paucity	O
of	O
alveolar	B-ANAT
epithelial	O
regeneration	O
,	O
rare	O
hyaline	B-ANAT
membranes	B-ANAT
,	O
and	O
diffuse	O
contiguous	O
airspace	O
lining	O
by	O
macrophages	B-ANAT
.	O

Immunosuppressed	O
macaques	O
supported	O
significantly	O
higher	O
levels	O
of	O
MERS	O
-	O
CoV	O
replication	O
in	O
respiratory	O
tissues	B-ANAT
and	O
shed	O
more	O
virus	O
,	O
and	O
virus	O
disseminated	O
to	O
tissues	B-ANAT
outside	O
of	O
the	O
respiratory	B-ANAT
tract	I-ANAT
,	O
whereas	O
viral	O
RNA	O
was	O
confined	O
to	O
respiratory	O
tissues	B-ANAT
in	O
non	O
-	O
immunosuppressed	O
animals	O
.	O

Despite	O
increased	O
viral	O
replication	O
,	O
pathology	O
in	O
the	O
lungs	B-ANAT
was	O
significantly	O
lower	O
in	O
immunosuppressed	O
animals	O
.	O

Although	O
astrocytes	B-ANAT
poorly	O
induced	O

The	O
method	O
was	O
able	O
to	O
rapidly	O
identify	O
the	O
Mass	O
genotype	O
among	O
IBV	O
field	O
isolates	O
,	O
vaccine	O
attenuated	O
strains	O
and	O
reference	O
M41	O
strain	O
in	O
allantoic	O
liquid	O
and	O
also	O
directly	O
in	O
tissues	B-ANAT
.	O

The	O
RT	O
-	O
qPCR	O
developed	O
detected	O
the	O
virus	O
in	O
both	O
tracheal	O
and	O
pulmonary	B-ANAT
samples	O
from	O
M41	O
-	O
infected	O
or	O
H120	O
-	O
infected	O
birds	O
,	O
in	O
a	O
larger	O
post	O
-	O
infection	O
period	O
compared	O
to	O
detection	O
by	O
standard	O
method	O
of	O
virus	O
isolation	O
.	O

Accordingly	O
,	O
we	O
developed	O
a	O
dual	O
signal	O
firefly	O
and	O
Renilla	O
luciferase	O
cell	B-ANAT
-	O
based	O
drug	O
screening	O
assay	O
able	O
to	O
quantify	O
IFN	O
-	O
mediated	O
induction	O
of	O
Interferon	O
Stimulated	O
Genes	O
(	O
ISGs	O
)	O
and	O
its	O
inhibition	O
by	O
VP24	O
.	O

Stimulation	O
of	O
cells	B-ANAT
with	O
IFN	O
-	O
Î±	O
activated	O
the	O
IFN	O
cascade	O
leading	O
to	O
the	O
expression	O
of	O
ISRE	O
.	O

Before	O
surgery	O
gastric	B-ANAT
emptying	O
with	O
a	O
nasogastric	B-ANAT
tube	O
is	O
mandatory	O
in	O
patients	O
with	O
ileus	O
and	O
passage	O
or	O
defecation	O
disorders	O
.	O

In	O
testing	O
too	O
many	O
facets	B-ANAT
of	O
emergency	O
response	O
,	O
the	O
public	O
health	O
response	O
could	O
be	O
deprioritised	O
.	O
o	O
The	O
practical	O
implementation	O
of	O
communication	O
protocols	O
in	O
a	O
real	O
-	O
time	O
exercise	O
of	O
this	O
scope	O
proved	O
challenging	O
.	O

TITLE	O
:	O
Identification	O
of	O
H209	O
as	O
Essential	O
for	O
pH	O
8	O
-	O
Triggered	O
Receptor	O
-	O
Independent	O
Syncytium	B-ANAT
Formation	O
by	O
S	O
Protein	O
of	O
Mouse	O
Hepatitis	O
Virus	O
A59	O
.	O

Replacement	O
of	O
H209	O
with	O
Ala	O
had	O
no	O
effect	O
on	O
receptor	O
binding	O
,	O
but	O
in	O
murine	O
17Cl	O
.	O
1	O
cells	B-ANAT
mutant	O
H209A	O
MHV	O
-	O
A59	O
showed	O
delayed	O
growth	O
kinetics	O
and	O
was	O
readily	O
outcompeted	O
by	O
wild	O
-	O
type	O
virus	O
when	O
mixed	O
together	O
,	O
indicating	O
that	O
the	O
H209A	O
mutation	O
caused	O
a	O
defect	O
in	O
virus	O
fitness	O
.	O

TITLE	O
:	O
[	O
Application	O
of	O
mesenchymal	B-ANAT
stem	I-ANAT
cell	I-ANAT
in	O
the	O
treatment	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
].	O

TITLE	O
:	O
A	O
highly	O
pathogenic	O
porcine	O
reproductive	O
and	O
respiratory	O
syndrome	O
virus	O
type	O
1	O
(	O
PRRSV	O
-	O
1	O
)	O
strongly	O
modulates	O
cellular	B-ANAT
innate	O
and	O
adaptive	O
immune	O
subsets	O
upon	O
experimental	O
infection	O
.	O

PR40	O
infected	O
animals	O
showed	O
an	O
early	O
and	O
marked	O
reduction	O
of	O
pro	O
-	O
inflammatory	O
CD172Î±	O
+	O
CD14	O
+	O
CD16	O
+	O
and	O
CD14	O
+	O
CD163	O
+	O
monocytes	B-ANAT
and	O
TCRÎ³Î´	O
+	O
CD8Î±	O
+/	O
CD8Î±	O
-	O
lymphocytes	B-ANAT
when	O
pigs	O
were	O
most	O
infected	O
,	O
possibly	O
due	O
to	O
a	O
recruitment	O
sustaining	O
an	O
acute	O
inflammatory	O
response	O
in	O
target	O
tissues	B-ANAT
.	O

NBM	O
is	O
associated	O
with	O
decreased	O
biomarkers	O
of	O
epithelial	O
and	O
endothelial	B-ANAT
lung	B-ANAT
injury	O
and	O
systemic	O
inflammation	O
in	O
ARDS	O
patients	O
receiving	O
low	O
tidal	O
volume	O
ventilation	O
and	O
those	O
with	O
a	O
P	O
/	O
F	O
ratio	O
less	O
than	O
or	O
equal	O
to	O
120	O
.	O

ABSTRACT	O
:	O
Fever	O
accompanying	O
vaso	O
-	O
occlusive	O
crisis	O
is	O
a	O
common	O
presentation	O
in	O
patients	O
with	O
sickle	B-ANAT
cell	I-ANAT
disease	O
(	O
SCD	O
)	O
and	O
carries	O
a	O
broad	O
differential	O
diagnosis	O
.	O

Previous	O
studies	O
exploring	O
CAM	B-ANAT
use	O
among	O
cancer	O
patients	O
in	O
the	O
Middle	O
East	O
region	O
have	O
shown	O
discrepant	O
results	O
.	O

It	O
also	O
discusses	O
the	O
possible	O
benefits	O
and	O
harm	O
related	O
to	O
CAM	B-ANAT
use	O
by	O
cancer	O
patients	O
,	O
and	O
it	O
explores	O
the	O
beliefs	O
patients	O
hold	O
and	O
their	O
transparency	O
with	O
health	O
care	O
providers	O
regarding	O
their	O
CAM	B-ANAT
use	O
.	O

Drinking	O
camel	O
milk	O
was	O
reported	O
by	O
24	O
.	O
1	O
%	O
of	O
CAM	B-ANAT
users	O
,	O
whereas	O
camel	O
urine	B-ANAT
was	O
consumed	O
by	O
15	O
.	O
7	O
%.	O

Doctor	O
-	O
patient	O
communication	O
regarding	O
CAM	B-ANAT
use	O
is	O
of	O
paramount	O
importance	O
in	O
cancer	O
care	O
.	O

Ischaemic	O
heart	B-ANAT
disease	O
increased	O
the	O
risk	O
of	O
problem	O
behaviours	O
approximately	O
threefold	O
(	O
OR	O
:	O
3	O
.	O
29	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
02	O
-	O
10	O
.	O
60	O
).	O

ABSTRACT	O
:	O
The	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
is	O
a	O
major	O
structural	O
component	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
),	O
which	O
is	O
predicted	O
to	O
be	O
a	O
multifunctional	O
protein	O
in	O
viral	O
replication	O
.	O

In	O
this	O
review	O
,	O
we	O
discuss	O
the	O
utility	O
of	O
different	O
biochemical	O
and	O
cell	B-ANAT
-	O
based	O
assays	O
and	O
provide	O
recommendations	O
for	O
assessing	O
toxicity	O
liability	O
before	O
entering	O
animal	O
toxicity	O
studies	O
.	O

Charts	O
were	O
reviewed	O
for	O
RVI	O
events	O
associated	O
with	O
hospitalization	O
within	O
1	O
year	O
after	O
the	O
transplant	B-ANAT
.	O

In	O
this	O
study	O
,	O
hospital	O
-	O
associated	O
RVI	O
was	O
common	O
in	O
the	O
first	O
year	O
after	O
pediatric	O
SOT	O
and	O
associated	O
with	O
younger	O
age	O
at	O
transplant	B-ANAT
.	O

Arterial	B-ANAT
blood	I-ANAT
gas	O
analysis	O
confirmed	O
a	O
severe	O
respiratory	O
failure	O
(	O
type	O
I	O
).	O

In	O
patients	O
with	O
confirmed	O
influenza	O
A	O
H7N9	O
infection	O
whose	O
condition	O
worsens	O
again	O
,	O
especially	O
with	O
new	O
infiltration	O
or	O
lung	B-ANAT
ground	O
-	O
glass	O
infiltration	O
,	O
one	O
should	O
suspect	O
infection	O
by	O
other	O
pathogens	O
such	O
as	O
Mycoplasma	O
pneumoniae	O
.	O

However	O
,	O
when	O
mice	O
were	O
treated	O
with	O
antibiotics	O
after	O
infection	O
to	O
improve	O
clinical	O
relevance	O
,	O
the	O
survival	O
benefit	O
was	O
lost	O
,	O
and	O
CS	O
-	O
exposed	O
mice	O
had	O
more	O
pulmonary	B-ANAT
edema	O
,	O
increased	O
numbers	O
of	O
BAL	O
monocytes	B-ANAT
,	O
and	O
elevated	O
monocyte	B-ANAT
and	O
lymphocyte	B-ANAT
chemokines	O
.	O

CS	O
-	O
exposed	O
antibiotic	O
-	O
treated	O
mice	O
also	O
had	O
higher	O
serum	B-ANAT
surfactant	O
protein	O
D	O
and	O
angiopoietin	O
-	O
2	O
,	O
consistent	O
with	O
more	O
severe	O
lung	B-ANAT
epithelial	O
and	O
endothelial	B-ANAT
injury	O
.	O

RESULTS	O
:	O
Among	O
3	O
,	O
603	O
patients	O
assigned	O
to	O
receive	O
UFH	O
,	O
781	O
(	O
21	O
.	O
7	O
%)	O
underwent	O
planned	O
treatment	O
with	O
GPI	O
before	O
coronary	B-ANAT
intervention	O
.	O

The	O
coordinated	O
activities	O
of	O
immune	O
resistance	O
and	O
tissue	B-ANAT
resilience	O
then	O
dictate	O
whether	O
and	O
how	O
pneumonia	O
progresses	O
or	O
resolves	O
.	O

TITLE	O
:	O
The	O
impact	O
of	O
organ	B-ANAT
dysfunctions	O
on	O
mortality	O
in	O
patients	O
with	O
severe	O
sepsis	O
:	O
A	O
multicenter	O
prospective	O
observational	O
study	O
.	O

TITLE	O
:	O
Rapid	O
detection	O
of	O
transmissible	O
gastroenteritis	O
virus	O
in	O
swine	O
small	B-ANAT
intestine	I-ANAT
samples	O
using	O
real	O
-	O
time	O
reverse	O
transcription	O
recombinase	O
polymerase	O
amplification	O
.	O

Fourteen	O
samples	O
were	O
TGEV	O
RNA	O
positive	O
in	O
RT	O
-	O
RPA	B-ANAT
(	O
18	O
.	O
4	O
%,	O
14	O
/	O
76	O
),	O
which	O
were	O
also	O
positive	O
in	O
the	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
.	O

ABSTRACT	O
:	O
Enveloped	O
viruses	O
gain	O
entry	O
into	O
host	O
cells	B-ANAT
by	O
fusing	O
with	O
cellular	B-ANAT
membranes	B-ANAT
,	O
a	O
step	O
that	O
is	O
required	O
for	O
virus	O
replication	O
.	O

Coronaviruses	O
,	O
including	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
),	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
and	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
),	O
fuse	O
at	O
the	O
plasma	B-ANAT
membrane	I-ANAT
or	O
use	O
receptor	O
-	O
mediated	O
endocytosis	O
and	O
fuse	O
with	O
endosomes	O
,	O
depending	O
on	O
the	O
cell	B-ANAT
or	O
tissue	B-ANAT
type	I-ANAT
.	O

SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
are	O
classified	O
as	O
BSL	O
-	O
3	O
viruses	O
,	O
which	O
makes	O
experimentation	O
into	O
the	O
cellular	B-ANAT
mechanisms	O
involved	O
in	O
infection	O
more	O
challenging	O
.	O

Additionally	O
,	O
complement	O
factor	O
H	O
(	O
CFH	O
)	O
and	O
complement	O
C3	B-ANAT
levels	I-ANAT
were	O
decreased	O
.	O

He	O
required	O
continued	O
renal	B-ANAT
replacement	O
treatment	O
(	O
CRRT	O
)	O
and	O
plasma	B-ANAT
exchange	O
due	O
to	O
thrombotic	O
microangiopathy	O
(	O
TMA	O
).	O

Blood	B-ANAT
samples	I-ANAT
were	O
collected	O
between	O
1	O
and	O
5	O
days	O
of	O
age	O
from	O
each	O
calf	B-ANAT
included	O
in	O
the	O
study	O
,	O
and	O
disease	O
and	O
mortality	O
occurrence	O
was	O
monitored	O
throughout	O
the	O
first	O
month	O
of	O
life	O
.	O

Even	O
if	O
not	O
significantly	O
(	O
P	O
=	O
.	O
127	O
),	O
lower	O
serum	B-ANAT
Ig	O
concentrations	O
were	O
observed	O
in	O
sick	O
calves	O
that	O
had	O
been	O
treated	O
with	O
antibiotics	O
compared	O
to	O
those	O
that	O
had	O
not	O
been	O
treated	O
.	O

Patients	O
with	O
H7N9	O
had	O
higher	O
rates	O
of	O
invasive	O
mechanical	O
ventilation	O
;	O
serious	O
complications	O
,	O
including	O
alimentary	B-ANAT
tract	I-ANAT
hemorrhage	O
,	O
pneumothorax	O
or	O
septum	B-ANAT
emphysema	O
,	O
hospital	O
-	O
acquired	O
pneumonia	O
(	O
HAP	O
)	O
and	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
(	O
MODS	O
);	O
and	O
hospital	O
mortality	O
(	O
P	O
<	O
.	O
05	O
).	O

EV	O
-	O
D68	O
proteases	O
cleave	O
a	O
major	O
autophagic	O
cargo	O
adaptor	O
and	O
the	O
autophagic	O
SNARE	O
SNAP29	O
,	O
which	O
reportedly	O
regulates	O
fusion	O
between	O
autophagosome	B-ANAT
to	O
amphisome	O
/	O
autolysosome	B-ANAT
.	O

TITLE	O
:	O
MERS	O
-	O
CoV	O
pathogenesis	O
and	O
antiviral	O
efficacy	O
of	O
licensed	O
drugs	O
in	O
human	O
monocyte	B-ANAT
-	O
derived	O
antigen	B-ANAT
-	I-ANAT
presenting	I-ANAT
cells	I-ANAT
.	O

While	O
chloroquine	O
was	O
not	O
active	O
in	O
these	O
primary	O
cells	B-ANAT
,	O
chlorpromazine	O
showed	O
strong	O
anti	O
-	O
MERS	O
-	O
CoV	O
activity	O
,	O
but	O
it	O
was	O
associated	O
with	O
high	O
cytotoxicity	O
narrowing	O
the	O
potential	O
window	O
for	O
drug	O
utilization	O
.	O

ABSTRACT	O
:	O
Idiopathic	O
pulmonary	B-ANAT
fibrosis	O
(	O
IPF	O
)	O
is	O
a	O
fibrotic	O
lung	B-ANAT
disease	O
characterized	O
by	O
progressive	O
loss	O
of	O
lung	B-ANAT
function	O
and	O
poor	O
prognosis	O
.	O

The	O
beneficial	O
effect	O
of	O
high	O
levels	O
of	O
positive	O
end	O
-	O
expiratory	O
pressure	O
and	O
prone	O
positioning	O
has	O
still	O
to	O
be	O
elucidated	O
in	O
AE	O
-	O
IPF	O
patients	O
,	O
as	O
well	O
as	O
the	O
precise	O
role	O
of	O
other	O
types	O
of	O
respiratory	O
assistance	O
(	O
e	O
.	O
g	O
.,	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
)	O
or	O
innovative	O
therapies	O
(	O
e	O
.	O
g	O
.,	O
polymyxin	O
-	O
B	O
direct	O
hemoperfusion	O
).	O

Splenic	B-ANAT
rupture	O
(	O
SR	O
)	O
is	O
a	O
very	O
rare	O
but	O
life	O
-	O
threatening	O
complication	O
of	O
severe	O
B	O
.	O
microti	O
infection	O
.	O

She	O
responded	O
favorably	O
to	O
10	O
days	O
of	O
azithromycin	O
and	O
atovaquone	O
and	O
21	O
days	O
of	O
oral	B-ANAT
doxycycline	O
.	O

PDCoV	O
CHN	O
-	O
GD	O
-	O
2016	O
could	O
be	O
identified	O
by	O
immunofluorescence	O
with	O
PDCoV	O
specific	O
rabbit	O
antisera	O
,	O
and	O
typical	O
crown	B-ANAT
-	O
shaped	O
particles	O
with	O
spiky	O
surface	O
projections	O
of	O
this	O
PDCoV	O
were	O
observed	O
with	O
electron	O
microscopy	O
.	O

Immune	O
reconstitution	O
inflammatory	O
syndrome	O
(	O
IRIS	B-ANAT
)	O
involves	O
excessive	O
inflammatory	O
response	O
to	O
a	O
pathogen	O
with	O
paradoxical	O
clinical	O
deterioration	O
following	O
HAART	O
initiation	O
and	O
may	O
present	O
as	O
severe	O
respiratory	O
failure	O
.	O

Bilevel	O
NIV	O
was	O
applied	O
mostly	O
through	O
an	O
oronasal	O
mask	O
(	O
44	O
.	O
4	O
%),	O
and	O
continuous	O
positive	O
airway	B-ANAT
pressure	O
through	O
nasal	B-ANAT
cannulae	O
(	O
39	O
.	O
8	O
%).	O

In	O
the	O
control	O
group	O
,	O
intraoperative	O
fluids	B-ANAT
were	O
given	O
based	O
on	O
traditional	O
principles	O
.	O

There	O
were	O
also	O
fewer	O
complications	O
(	O
acute	O
kidney	B-ANAT
disease	O
,	O
pulmonary	B-ANAT
oedema	O
,	O
respiratory	O
distress	O
syndrome	O
,	O
wound	O
infections	O
,	O
etc	O
.),	O
and	O
length	O
of	O
hospital	O
stay	O
was	O
shorter	O
in	O
the	O
GDHT	O
group	O
.	O

As	O
the	O
number	O
of	O
vaccinations	O
increased	O
,	O
the	O
amounts	O
of	O
antibody	O
in	O
serum	B-ANAT
and	O
colostrum	B-ANAT
,	O
and	O
neutralizing	O
activities	O
increased	O
.	O

From	O
the	O
patient	O
'	O
s	O
medical	O
history	O
it	O
was	O
revealed	O
that	O
several	O
hours	O
before	O
the	O
admission	O
in	O
the	O
clinic	O
the	O
following	O
symptoms	O
were	O
present	O
:	O
shortness	O
of	O
breath	B-ANAT
,	O
fever	O
,	O
hypotonia	O
,	O
consciousness	O
inhibition	O
,	O
because	O
of	O
which	O
emergency	O
brigade	O
was	O
called	O
and	O
was	O
brought	O
by	O
the	O
Emergency	O
Brigade	O
.	O

This	O
study	O
aimed	O
to	O
ascertain	O
the	O
gastrointestinal	O
virome	O
of	O
these	O
bats	O
,	O
as	O
viruses	O
excreted	O
in	O
fecal	B-ANAT
material	O
or	O
which	O
may	O
be	O
replicating	O
in	O
rectal	O
or	O
intestinal	B-ANAT
tissues	B-ANAT
have	O
the	O
greatest	O
opportunities	O
of	O
coming	O
into	O
contact	O
with	O
other	O
hosts	O
.	O

ABSTRACT	O
:	O
Coronavirus	O
infection	O
delays	O
the	O
development	O
of	O
the	O
cortico	O
-	O
medullary	B-ANAT
(	O
CM	O
)	O
capillary	B-ANAT
network	I-ANAT
which	O
results	O
in	O
retarded	O
development	O
of	O
bursal	O
follicles	B-ANAT
.	O

TITLE	O
:	O
Exogenous	O
surfactant	O
as	O
a	O
bridge	O
to	O
prolonged	O
""""	O
total	O
lung	B-ANAT
rest	O
""""	O
in	O
severely	O
injured	O
patient	O
during	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

Positive	O
pressure	O
mechanical	O
ventilation	O
induced	O
pressure	O
-	O
dependent	O
massive	O
air	O
leak	O
from	O
disrupted	O
pulmonary	B-ANAT
tissue	B-ANAT
.	O

ABSTRACT	O
:	O
Dipeptidyl	O
peptidase	O
4	O
(	O
DPP4	O
)	O
is	O
a	O
receptor	O
for	O
MERS	O
-	O
CoV	O
.	O
The	O
soluble	O
form	O
of	O
DPP4	O
(	O
sDPP4	O
)	O
circulates	O
systematically	O
and	O
can	O
competitively	O
inhibit	O
MERS	O
-	O
CoV	O
entry	O
into	O
host	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
Nucleated	B-ANAT
red	I-ANAT
blood	I-ANAT
cells	I-ANAT
(	O
NRBCs	O
)	O
in	O
critically	O
ill	O
patients	O
are	O
associated	O
with	O
increased	O
mortality	O
and	O
poor	O
outcome	O
.	O

The	O
presence	O
of	O
NRBCs	O
in	O
the	O
blood	B-ANAT
might	O
be	O
regarded	O
as	O
a	O
marker	O
of	O
disease	O
severity	O
indicating	O
a	O
higher	O
risk	O
of	O
ICU	O
death	O
.	O

Lung	B-ANAT
protective	O
strategies	O
with	O
low	O
tidal	O
volume	O
(	O
VT	O
)	O
and	O
lung	B-ANAT
recruitment	O
should	O
consider	O
the	O
physiology	O
of	O
ARDS	O
because	O
ARDS	O
presents	O
lung	B-ANAT
inhomogeneity	O
;	O
the	O
same	O
low	O
VT	O
might	O
increase	O
local	O
stress	O
and	O
strain	O
in	O
some	O
patients	O
with	O
low	O
compliance	O
,	O
and	O
lung	B-ANAT
recruitment	O
could	O
injure	O
lungs	B-ANAT
in	O
ARDS	O
patients	O
with	O
low	O
recruitability	O
and	O
hemodynamic	O
instability	O
.	O

Traditionally	O
the	O
plant	O
is	O
used	O
for	O
its	O
various	O
beneficial	O
properties	O
against	O
inflammation	O
,	O
pneumonia	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
muscular	B-ANAT
sprain	O
,	O
stomach	B-ANAT
ulcer	O
etc	O
.	O

TITLE	O
:	O
Extravascular	O
lung	B-ANAT
water	O
measurements	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
why	O
,	O
how	O
,	O
and	O
when	O
?	O

Intravenous	O
artesunate	O
and	O
oral	B-ANAT
doxycycline	O
were	O
started	O
and	O
he	O
made	O
a	O
full	O
recovery	O
.	O

Interestingly	O
,	O
the	O
presence	O
of	O
both	O
MG	O
and	O
MGC	O
appeared	O
to	O
enhance	O
IBV	O
replication	O
in	O
the	O
tracheas	B-ANAT
of	O
infected	O
chickens	O
,	O
whereas	O
the	O
presence	O
of	O
IBV	O
suppressed	O
MG	O
and	O
MGC	O
proliferation	O
in	O
the	O
trachea	B-ANAT
.	O

In	O
the	O
present	O
study	O
,	O
the	O
full	O
-	O
length	O
open	O
reading	O
frames	O
of	O
the	O
spike	O
(	O
S	O
)	O
and	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
genes	O
of	O
the	O
virus	O
were	O
sequenced	O
and	O
analyzed	O
.	O

In	O
the	O
PDCoV	O
-	O
inoculated	O
group	O
,	O
viruses	O
were	O
mainly	O
detected	O
from	O
jejunums	B-ANAT
to	O
colons	B-ANAT
by	O
a	O
quantitative	O
PDCoV	O
-	O
specific	O
PCR	O
and	O
microscopic	O
observation	O
.	O

Two	O
different	O
models	O
were	O
developed	O
(	O
with	O
and	O
without	O
acute	O
-	O
illness	O
severity	O
scores	O
)	O
and	O
factors	O
independently	O
associated	O
with	O
5	O
-	O
year	O
mortality	O
were	O
[	O
adjusted	O
odds	O
ratio	O
(	O
95	O
%	O
confidence	O
interval	O
)]:	O
age	O
=	O
1	O
.	O
03	O
per	O
year	O
(	O
1	O
.	O
02	O
-	O
1	O
.	O
04	O
),	O
cancer	O
=	O
4	O
.	O
36	O
(	O
1	O
.	O
65	O
-	O
11	O
.	O
53	O
),	O
no	O
comorbidities	O
=	O
0	O
.	O
4	O
(	O
0	O
.	O
26	O
-	O
0	O
.	O
62	O
),	O
Karnovsky	O
Index	O
<	O
70	O
=	O
2	O
.	O
25	O
(	O
1	O
.	O
48	O
-	O
3	O
.	O
40	O
),	O
SAPS	O
(	O
Simplified	O
Acute	O
Physiology	O
Score	O
)	O
II	O
=	O
1	O
.	O
05	O
per	O
point	O
(	O
1	O
.	O
03	O
-	O
1	O
.	O
07	O
),	O
positive	O
blood	B-ANAT
cultures	O
=	O
1	O
.	O
57	O
(	O
1	O
.	O
01	O
-	O
2	O
.	O
44	O
)	O
and	O
infection	O
by	O
an	O
ESKAPE	O
pathogen	O
(	O
Enterococcus	O
faecium	O
,	O
Staphylococcus	O
aureus	O
,	O
Klebsiella	O
pneumoniae	O
,	O
Acinetobacter	O
baumannii	O
,	O
Pseudomonas	O
aeroginosa	O
and	O
Enterobacter	O
species	O
)	O
=	O
1	O
.	O
61	O
(	O
1	O
.	O
00	O
-	O
2	O
.	O
60	O
);	O
and	O
in	O
the	O
second	O
model	O
[	O
without	O
SAPS	O
II	O
and	O
SOFA	O
(	O
Sequential	O
Organ	B-ANAT
Failure	O
Assessment	O
)	O
scores	O
]:	O
age	O
=	O
1	O
.	O
04	O
per	O
year	O
(	O
1	O
.	O
03	O
-	O
1	O
.	O
05	O
),	O
cancer	O
=	O
5	O
.	O
93	O
(	O
2	O
.	O
26	O
-	O
15	O
.	O
51	O
),	O
chronic	O
haematologic	O
disease	O
=	O
2	O
.	O
37	O
(	O
1	O
.	O
14	O
-	O
4	O
.	O
93	O
),	O
no	O
comorbidities	O
=	O
0	O
.	O
45	O
(	O
0	O
.	O
29	O
-	O
0	O
.	O
69	O
),	O
Karnovsky	O
Index	O
<	O
70	O
=	O
2	O
.	O
32	O
(	O
1	O
.	O
54	O
-	O
3	O
.	O
50	O
),	O
septic	O
shock	O
[	O
reference	O
is	O
infection	O
without	O
SIRS	O
(	O
Systemic	O
Inflammatory	O
Response	O
Syndrome	O
)]	O
=	O
3	O
.	O
77	O
(	O
1	O
.	O
80	O
-	O
7	O
.	O
89	O
)	O
and	O
infection	O
by	O
an	O
ESKAPE	O
pathogen	O
=	O
1	O
.	O
61	O
(	O
1	O
.	O
00	O
-	O
2	O
.	O
60	O
).	O

Karnovsky	O
Index	O
<	O
70	O
=	O
2	O
.	O
50	O
(	O
1	O
.	O
63	O
-	O
3	O
.	O
83	O
)	O
and	O
positive	O
blood	B-ANAT
cultures	O
=	O
1	O
.	O
66	O
(	O
1	O
.	O
04	O
-	O
2	O
.	O
64	O
)	O
with	O
an	O
AU	O
-	O
ROC	O
curve	O
of	O
0	O
.	O
77	O
(	O
0	O
.	O
73	O
-	O
0	O
.	O
81	O
).	O

The	O
three	O
other	O
patients	O
(	O
43	O
%)	O
were	O
asymptomatic	O
and	O
were	O
in	O
contact	O
with	O
patients	O
with	O
confirmed	O
diagnosis	O
of	O
MERS	O
-	O
CoV	O
.	O
The	O
most	O
common	O
presenting	O
symptoms	O
were	O
fever	O
(	O
57	O
%),	O
cough	O
(	O
14	O
%),	O
shortness	O
of	O
breath	B-ANAT
(	O
14	O
%),	O
vomiting	O
(	O
28	O
%),	O
and	O
diarrhea	O
(	O
28	O
%).	O

In	O
this	O
test	O
,	O
the	O
recombinant	O
nucleocapsid	B-ANAT
protein	O
of	O
PEDV	O
was	O
expressed	O
in	O
soluble	O
form	O
and	O
purified	O
by	O
using	O
Ni	O
-	O
NTA	O
resin	O
and	O
gel	O
filtration	O
chromatography	O
.	O

TITLE	O
:	O
In	O
Vitro	O
Bactericidal	O
and	O
Virucidal	O
Efficacy	O
of	O
Povidone	O
-	O
Iodine	O
Gargle	O
/	O
Mouthwash	O
Against	O
Respiratory	O
and	O
Oral	B-ANAT
Tract	O
Pathogens	O
.	O

CONCLUSIONS	O
:	O
PVP	O
-	O
I	O
7	O
%	O
gargle	O
/	O
mouthwash	O
showed	O
rapid	O
bactericidal	O
activity	O
and	O
virucidal	O
efficacy	O
in	O
vitro	O
at	O
a	O
concentration	O
of	O
0	O
.	O
23	O
%	O
PVP	O
-	O
I	O
and	O
may	O
provide	O
a	O
protective	O
oropharyngeal	B-ANAT
hygiene	O
measure	O
for	O
individuals	O
at	O
high	O
risk	O
of	O
exposure	O
to	O
oral	B-ANAT
and	O
respiratory	O
pathogens	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
has	O
emerged	O
as	O
a	O
treatment	O
of	O
choice	O
for	O
refractory	O
hypoxemia	O
in	O
the	O
intensive	O
care	O
unit	O
.	O

ABSTRACT	O
:	O
Adjuvant	O
enhancing	O
mucosal	B-ANAT
immune	O
response	O
is	O
preferred	O
in	O
controlling	O
many	O
pathogens	O
at	O
the	O
portal	B-ANAT
of	O
entry	O
.	O

R	O
-	O
848	O
enhanced	O
the	O
antigen	O
specific	O
humoral	O
and	O
cellular	B-ANAT
immune	O
responses	O
when	O
co	O
-	O
administered	O
with	O
the	O
vaccines	O
as	O
evidenced	O
by	O
an	O
increase	O
in	O
the	O
antibody	O
titre	O
in	O
ELISA	O
and	O
stimulation	O
index	O
in	O
lymphocyte	B-ANAT
transformation	O
test	O
(	O
LTT	O
)	O
till	O
35	O
dpi	O
and	O
increased	O
proportion	O
of	O
CD4	O

ABSTRACT	O
:	O
It	O
is	O
unknown	O
if	O
the	O
plasma	B-ANAT
lipidome	O
is	O
a	O
useful	O
tool	O
for	O
improving	O
our	O
understanding	O
of	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

We	O
hypothesized	O
that	O
both	O
the	O
absolute	O
concentration	O
and	O
change	O
in	O
concentration	O
over	O
time	O
of	O
plasma	B-ANAT
lipids	O
are	O
associated	O
with	O
28	O
-	O
day	O
mortality	O
in	O
this	O
population	O
.	O

Ectopic	O
expression	O
of	O
pAPN	O
in	O
non	O
-	O
susceptible	O
BHK	O
-	O
21	O
cells	B-ANAT
rendered	O
them	O
susceptible	O
to	O
PDCoV	O
.	O
These	O
results	O
indicate	O
that	O
pAPN	O
may	O
be	O
a	O
functional	O
receptor	O
for	O
PDCoV	O
infection	O
.	O

Polarization	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
macrophages	B-ANAT
was	O
studied	O
by	O
flow	O
cytometry	O
and	O
quantitative	O
polymerase	O
chain	O
reaction	O
.	O

Previously	O
reported	O
cases	O
of	O
multiple	O
mitochondrial	B-ANAT
dysfunctions	O
syndrome	O
2	O
(	O
MMDS2	O
)	O
with	O
hyperglycinaemia	O
caused	O
by	O
BOLA3	O
mutations	O
have	O
leukodystrophy	O
with	O
severe	O
,	O
progressive	O
neurological	O
and	O
multisystem	O
disease	O
.	O

The	O
various	O
factors	O
associated	O
with	O
the	O
need	O
for	O
mechanical	O
ventilation	O
were	O
partial	O
pressure	O
of	O
oxygen	O
:	O
fraction	O
of	O
inspired	O
oxygen	O
ratio	O
<	O
150	O
,	O
quick	O
sequential	O
(	O
sepsis	O
-	O
related	O
)	O
organ	B-ANAT
failure	O
assessment	O
(	O
qSOFA	O
)	O
>	O
2	O
,	O
and	O
early	O
bacterial	O
coinfection	O
.	O

ABSTRACT	O
:	O
Pulmonary	B-ANAT
microvascular	O
endothelial	B-ANAT
cells	I-ANAT
(	O
ECs	O
)	O
are	O
integral	O
to	O
the	O
alveoli	B-ANAT
-	O
capillary	B-ANAT
barrier	O
of	O
the	O
lung	B-ANAT
.	O

A	O
primary	O
sero	O
-	O
prevalence	O
study	O
of	O
MERS	O
-	O
CoV	O
preexisting	O
neutralizing	O
antibodies	O
in	O
Dromedary	O
camel	O
serum	B-ANAT
was	O
conducted	O
in	O
Tabuk	O
,	O
western	O
north	O
region	O
of	O
KSA	O
,	O
in	O
order	O
to	O
assess	O
the	O
seopositivity	O
of	O
these	O
animals	O
and	O
to	O
explain	O
their	O
possible	O
role	O
in	O
the	O
transmission	O
of	O
the	O
infection	O
to	O
Human	O
.	O

One	O
hundred	O
seventy	O
one	O
(	O
171	O
)	O
serum	B-ANAT
samples	O
were	O
collected	O
from	O
healthy	O
dromedary	O
camels	O
with	O
different	O
ages	O
and	O
genders	O
in	O
Tabuk	O
city	O
and	O
tested	O
for	O
specific	O
serum	B-ANAT
IgG	O
by	O
ELISA	O
using	O
the	O
receptor	O
-	O
binding	O
S1	O
subunits	O
of	O
spike	O
proteins	O
of	O
MERS	O
-	O
CoV	O
.	O
144	O
(	O
84	O
,	O
21	O
%)	O
of	O
the	O
total	O
camel	O
sera	B-ANAT
shown	O
the	O
presence	O
of	O
protein	O
-	O
specific	O
antibodies	O
against	O
MERS	O
-	O
CoV	O
.	O
These	O
results	O
may	O
provide	O
evidence	O
that	O
MERS	O
-	O
CoV	O
has	O
previously	O
infected	O
dromedary	O
camels	O
in	O
Tabuk	O
and	O
may	O
support	O
the	O
possible	O
role	O
of	O
camels	O
in	O
the	O
human	O
infection	O
.	O

TITLE	O
:	O
Effect	O
of	O
selected	O
gastrointestinal	O
parasites	O
and	O
viral	O
agents	O
on	O
fecal	B-ANAT
S100A12	O
concentrations	O
in	O
puppies	O
as	O
a	O
potential	O
comparative	O
model	O
.	O

ABSTRACT	O
:	O
Previous	O
data	O
suggest	O
that	O
fecal	B-ANAT
S100A12	O
has	O
clinical	O
utility	O
as	O
a	O
biomarker	O
of	O
chronic	O
gastrointestinal	O
inflammation	O
(	O
idiopathic	O
inflammatory	O
bowel	B-ANAT
disease	O
)	O
in	O
both	O
people	O
and	O
dogs	O
,	O
but	O
the	O
effect	O
of	O
gastrointestinal	O
pathogens	O
on	O
fecal	B-ANAT
S100A12	O
concentrations	O
is	O
largely	O
unknown	O
.	O

Thus	O
,	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
fecal	B-ANAT
S100A12	O
concentrations	O
in	O
a	O
cohort	O
of	O
puppies	O
with	O
intestinal	B-ANAT
parasites	O
(	O
Cystoisospora	O
spp	O
.,	O
Toxocara	O
canis	O
,	O
Giardia	O
sp	O
.)	O
and	O
viral	O
agents	O
that	O
are	O
frequently	O
encountered	O
and	O
known	O
to	O
cause	O
gastrointestinal	O
signs	O
in	O
dogs	O
(	O
coronavirus	O
,	O
parvovirus	O
)	O
as	O
a	O
comparative	O
model	O
.	O

Fecal	B-ANAT
S100A12	O
concentrations	O
ranged	O
from	O
<	O
24	O
-	O
14	O
,	O
363	O
ng	O
/	O
g	O
.	O

The	O
results	O
of	O
logistic	O
regression	O
analyses	O
showed	O
that	O
age	O
,	O
urolithiasis	O
,	O
hyperuricemia	O
,	O
coronary	B-ANAT
artery	I-ANAT
disease	O
,	O
thiazide	O
drugs	O
intake	O
,	O
family	O
history	O
of	O
diabetes	O
and	O
hypertension	O
were	O
all	O
significantly	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
metabolic	O
syndrome	O
(	O
OR	O
>	O
1	O
).	O

These	O
unusual	O
epidemiological	O
characteristics	O
observed	O
in	O
this	O
BCoV	O
diarrhea	O
outbreak	O
raise	O
awareness	O
of	O
the	O
health	O
threat	O
present	O
in	O
calf	B-ANAT
rearing	O
units	O
as	O
well	O
as	O
of	O
the	O
easy	O
and	O
rapid	O
viral	O
spread	O
in	O
a	O
population	O
of	O
young	O
animals	O
from	O
different	O
dairy	O
herds	O
and	O
,	O
therefore	O
,	O
with	O
very	O
distinct	O
immunological	O
status	O
.	O

ABSTRACT	O
:	O
Obstructive	O
sleep	O
apnea	O
(	O
OSA	O
)	O
might	O
influence	O
disease	O
severity	O
in	O
acute	O
pulmonary	B-ANAT
embolism	O
(	O
PE	O
).	O

The	O
trimeric	O
IBV	O
spike	O
ectodomain	O
contains	O
three	O
receptor	O
-	O
binding	O
S1	O
heads	B-ANAT
and	O
a	O
trimeric	O
membrane	B-ANAT
-	O
fusion	O
S2	O
stalk	B-ANAT
.	O

The	O
objective	O
of	O
the	O
study	O
was	O
to	O
report	O
the	O
feasibility	O
and	O
results	O
of	O
superior	B-ANAT
mesenteric	I-ANAT
artery	I-ANAT
(	O
SMA	O
)	O
stenting	O
using	O
embolic	O
protection	O
devices	O
(	O
EPDs	O
)	O
to	O
treat	O
acute	O
mesenteric	B-ANAT
ischemia	O
(	O
AMI	O
)	O
and	O
chronic	O
mesenteric	B-ANAT
ischemia	O
(	O
CMI	O
).	O

Therefore	O
,	O
the	O
combined	O
induction	O
of	O
virus	O
-	O
specific	O
CD8	O
T	B-ANAT
cells	I-ANAT
and	O
antibodies	O
may	O
provide	O
optimal	O
protective	O
immunity	O
.	O

Since	O
excessive	O
complement	O
activation	O
is	O
an	O
important	O
factor	O
that	O
contributes	O
to	O
acute	O
lung	B-ANAT
injury	O
after	O
viral	O
infection	O
,	O
in	O
this	O
study	O
,	O
we	O
investigated	O
the	O
role	O
of	O
complement	O
in	O
MERS	O
-	O
CoV	O
-	O
induced	O
lung	B-ANAT
damage	O
.	O

Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
(	O
ECMO	O
)	O
can	O
be	O
used	O
as	O
a	O
""""	O
bridge	O
to	O
recovery	O
"""."	O

The	O
total	O
time	O
,	O
by	O
definition	O
,	O
means	O
the	O
time	O
from	O
the	O
first	O
contact	O
with	O
the	O
mannequin	O
to	O
the	O
cannulation	O
of	O
artificial	O
vessels	B-ANAT
and	O
starting	O
VV	O
perfusion	O
on	O
ECMO	O
,	O
did	O
not	O
exceed	O
3	O
h	O
-	O
including	O
75	O
min	O
of	O
transport	O
(	O
the	O
total	O
time	O
of	O
simulation	O
with	O
first	O
call	O
from	O
provincial	O
hospital	O
to	O
admission	O
to	O
the	O
Clinical	O
Intensive	O
Care	O
department	O
was	O
5	O
h	O
).	O

TITLE	O
:	O
Preventing	O
the	O
spread	O
of	O
norovirus	O
-	O
like	O
infections	O
by	O
the	O
airborne	O
route	O
using	O
plasma	B-ANAT
assisted	O
catalytic	O
technology	O
(	O
PACT	O
).	O

TITLE	O
:	O
Evaluation	O
of	O
full	O
S1	O
gene	O
sequencing	O
of	O
classical	O
and	O
variant	O
infectious	O
bronchitis	O
viruses	O
extracted	O
from	O
allantoic	B-ANAT
fluid	I-ANAT
and	O
FTA	O
cards	O
.	O

Antibody	O
responses	O
were	O
assessed	O
in	O
serum	B-ANAT
,	O
colostrum	B-ANAT
and	O
milk	O
of	O
immunized	O
gilts	O
,	O
and	O
passive	O
transfer	O
of	O
antibodies	O
was	O
evaluated	O
in	O
piglet	O
sera	B-ANAT
.	O

Vascular	B-ANAT
alterations	O
,	O
hypoxia	O
,	O
hypercapnia	O
and	O
effects	O
of	O
mechanical	O
ventilation	O
may	O
play	O
a	O
role	O
.	O

Once	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
is	O
indicated	O
in	O
these	O
patients	O
,	O
the	O
right	O
ECMO	O
modus	O
needs	O
to	O
be	O
chosen	O
.	O

This	O
study	O
investigated	O
the	O
efficacy	O
of	O
the	O
THERAFLEX	O
UV	O
-	O
Platelets	B-ANAT
and	O
THERAFLEX	O
MB	O
-	O
Plasma	B-ANAT
pathogen	O
inactivation	O
systems	O
to	O
inactivate	O
EBOV	O
and	O
MERS	O
-	O
CoV	O
in	O
platelet	B-ANAT
concentrates	O
(	O
PCs	O
)	O
and	O
plasma	B-ANAT
,	O
respectively	O
.	O

UVC	O
reduced	O
EBOV	O
(â¥	O
4	O
.	O
5	O
log	O
)	O
and	O
MERS	O
-	O
CoV	O
(â¥	O
3	O
.	O
7	O
log	O
)	O
infectivity	O
in	O
PCs	O
to	O
the	O
limit	O
of	O
detection	O
,	O
and	O
MB	O
/	O
light	O
decreased	O
EBOV	O
(â¥	O
4	O
.	O
6	O
log	O
)	O
and	O
MERS	O
-	O
CoV	O
(â¥	O
3	O
.	O
3	O
log	O
)	O
titers	O
in	O
plasma	B-ANAT
to	O
nondetectable	O
levels	O
.	O

The	O
number	O
of	O
monthly	O
antibiotic	O
prescriptions	O
and	O
the	O
incidence	O
of	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
between	O
2010	O
and	O
2015	O
at	O
all	O
primary	O
care	O
clinics	O
were	O
obtained	O
from	O
the	O
Korean	O
Health	O
Insurance	O
Review	O
and	O
Assessment	O
Service	O
.	O

Interestingly	O
,	O
Th1	B-ANAT
cell	I-ANAT
activation	O
was	O
induced	O
by	O
immunization	O
schedules	O
including	O
Ad5	O
/	O
MERS	O
,	O
but	O
not	O
by	O
those	O
including	O
only	O
spike	O
protein	O
nanoparticles	O
.	O

TITLE	O
:	O
Early	O
events	O
during	O
human	O
coronavirus	O
OC43	O
entry	O
to	O
the	O
cell	B-ANAT
.	O

Furthermore	O
,	O
the	O
vesicle	B-ANAT
internalization	O
process	O
requires	O
actin	B-ANAT
cytoskeleton	I-ANAT
rearrangements	O
.	O

DTI	O
parameters	O
were	O
correlated	O
with	O
clinical	O
variables	O
(	O
age	O
,	O
CD4	O
DTI	O
quantified	O
diffusion	O
alterations	O
in	O
the	O
corpus	B-ANAT
callosum	I-ANAT
and	O
corona	B-ANAT
radiata	I-ANAT
(	O
MD	O
increased	O
significantly	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
chronic	O
axonal	O
injury	O
in	O
the	O
corpus	B-ANAT
callosum	I-ANAT
,	O
corona	B-ANAT
radiata	I-ANAT
,	O
internal	B-ANAT
capsule	I-ANAT
,	O
external	B-ANAT
capsule	I-ANAT
,	O
posterior	B-ANAT
thalamic	I-ANAT
radiation	I-ANAT
,	O
sagittal	B-ANAT
stratum	O
,	O
and	O
superior	B-ANAT
longitudinal	I-ANAT
fasciculus	I-ANAT
(	O
AD	O
increased	O
significantly	O
,	O
P	O
<	O
0	O
.	O
05	O
).	O

Two	O
primer	O
sets	O
(	O
targeting	O
nucleocapsid	B-ANAT
and	O
ORF1a	O
sequences	O
)	O
were	O
constructed	O
to	O
confirm	O
MERS	O
cases	O
by	O
RT	O
-	O
LAMP	O
assay	O
only	O
.	O

Among	O
11	O
biomarkers	O
,	O
the	O
combination	O
of	O
the	O
endothelial	B-ANAT
injury	O
marker	O
angiopoietin	O
-	O
2	O
(	O
Ang	O
-	O
2	O
)	O
and	O
the	O
lung	B-ANAT
epithelial	O
injury	O
marker	O
receptor	O
for	O
advanced	O
glycation	O
endproducts	O
(	O
RAGE	O
)	O
provided	O
good	O
discrimination	O
for	O
ARDS	O
in	O
the	O
derivation	O
cohort	O
(	O
area	O
under	O
the	O
curve	O
(	O
AUC	O
)=	O
0	O
.	O
74	O
(	O
95	O
%	O
CI	O
0	O
.	O
67	O
to	O
0	O
.	O
80	O
).	O

FalCoV	O
UAE	O
-	O
HKU27	O
,	O
HouCoV	O
UAE	O
-	O
HKU28	O
,	O
and	O
PiCoV	O
UAE	O
-	O
HKU29	O
originated	O
from	O
recombination	O
between	O
white	O
-	O
eye	B-ANAT
coronavirus	O
HKU16	O
(	O
WECoV	O
HKU16	O
)	O
and	O
magpie	O
robin	O
coronavirus	O
HKU18	O
(	O
MRCoV	O
HKU18	O
),	O
QuaCoV	O
UAE	O
-	O
HKU30	O
from	O
recombination	O
between	O
PorCoV	O
HKU15	O
/	O
SpCoV	O
HKU17	O
and	O
munia	O
coronavirus	O
HKU13	O
(	O
MunCoV	O
HKU13	O
),	O
and	O
PorCoV	O
HKU15	O
from	O
recombination	O
between	O
SpCoV	O
HKU17	O
and	O
bulbul	O
coronavirus	O
HKU11	O
(	O
BuCoV	O
HKU11	O
).	O

Our	O
results	O
indicated	O
that	O
approximately	O
95	O
%	O
FCoVs	O
in	O
faeces	B-ANAT
did	O
not	O
carry	O
mutations	O
in	O
the	O
two	O
genes	O
.	O

The	O
role	O
of	O
CD26	O
in	O
immune	O
regulation	O
has	O
been	O
extensively	O
characterized	O
,	O
with	O
recent	O
findings	O
elucidating	O
its	O
linkage	O
with	O
signaling	O
pathways	O
and	O
structures	O
involved	O
in	O
T	B-ANAT
-	I-ANAT
lymphocyte	I-ANAT
activation	O
as	O
well	O
as	O
antigen	B-ANAT
presenting	I-ANAT
cell	I-ANAT
-	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
interaction	O
.	O

TITLE	O
:	O
Pancreatitis	O
and	O
Systemic	O
Coronavirus	O
Infection	O
in	O
a	O
Ferret	O
(	O
ABSTRACT	O
:	O
A	O
1	O
-	O
y	O
-	O
old	O
spayed	O
female	O
ferret	O
(	O
Mustela	O
putorius	O
furo	O
)	O
was	O
referred	O
for	O
additional	O
diagnostic	O
evaluation	O
after	O
physical	O
examination	O
by	O
the	O
referring	O
veterinarian	O
revealed	O
a	O
cranial	B-ANAT
abdominal	B-ANAT
mass	O
.	O

Fine	O
-	O
needle	O
aspirates	B-ANAT
of	O
the	O
mass	O
were	O
nondiagnostic	O
.	O

Total	O
health	O
score	O
,	O
diarrhea	O
days	O
,	O
average	O
respiratory	O
score	O
,	O
packed	O
cell	B-ANAT
volume	O
,	O
and	O
serum	B-ANAT
total	O
protein	O
were	O
not	O
affected	O
by	O
feeding	O
anti	O
-	O
IL	O
-	O
10	O
egg	B-ANAT
antibodies	O
.	O

Like	O
other	O
coronaviruses	O
,	O
HCoV	O
-	O
229E	O
exploits	O
cellular	B-ANAT
proteases	O
to	O
activate	O
fusion	O
mediated	O
by	O
the	O
spike	O
protein	O
.	O

Additionally	O
,	O
proteins	O
3a	O
and	O
E	O
have	O
a	O
PDZ	O
-	O
binding	O
motif	O
(	O
PBM	O
),	O
which	O
can	O
potentially	O
bind	O
over	O
400	O
cellular	B-ANAT
proteins	O
which	O
contain	O
a	O
PDZ	O
domain	O
,	O
making	O
them	O
potentially	O
important	O
for	O
the	O
control	O
of	O
cell	B-ANAT
function	O
.	O

Using	O
the	O
VLP	B-ANAT
system	O
,	O
a	O
258	O
-	O
nucleotide	O
RNA	O
fragment	O
,	O
which	O
spans	O
nucleotides	O
19	O
,	O
712	O
to	O
19	O
,	O
969	O
of	O
the	O
MERS	O
-	O
CoV	O
genome	O
(	O
designated	O
PS258	O
(	O
19712	O
-	O
19969	O
)	O
A	O
MERS	O
-	O
oV	O
RNA	O
packaging	O
signal	O
was	O
identified	O
by	O
the	O
detection	O
of	O
GFP	O
expression	O
following	O
an	O
incubation	O
of	O
MERS	O
VLPs	B-ANAT
carrying	O
the	O
heterologous	O
mRNA	O
GFP	O
-	O
PS258	O
(	O
19712	O
-	O
19969	O
)	O

p53	O
protein	O
exists	O
in	O
a	O
wide	O
variety	O
of	O
animal	O
cells	B-ANAT
,	O
which	O
is	O
involved	O
in	O
cell	B-ANAT
cycle	O
regulation	O
,	O
apoptosis	O
,	O
cell	B-ANAT
differentiation	O
and	O
other	O
biological	O
functions	O
.	O

TITLE	O
:	O
Metagenomic	O
analysis	O
of	O
the	O
RNA	O
fraction	O
of	O
the	O
fecal	B-ANAT
virome	O
indicates	O
high	O
diversity	O
in	O
pigs	O
infected	O
by	O
porcine	O
endemic	O
diarrhea	O
virus	O
in	O
the	O
United	O
States	O
.	O

Against	O
human	O
coronavirus	O
229E	O
,	O
0	O
.	O
5	O
%	O
sodium	O
hypochlorite	O
alone	O
failed	O
disinfection	O
success	O
criteria	O
,	O
whereas	O
0	O
.	O
5	O
%	O
sodium	O
hypochlorite	O
with	O
color	O
additive	O
achieved	O
full	O
viral	O
inactivation	O
(â¥	O
4	O
.	O
50	O
log	O
This	O
color	O
additive	O
can	O
be	O
combined	O
with	O
chlorine	O
disinfectants	O
without	O
adversely	O
affecting	O
antimicrobial	O
efficacy	O
or	O
skin	B-ANAT
safety	O
.	O

ABSTRACT	O
:	O
Chimeric	O
antigen	O
receptor	O
(	O
CAR	B-ANAT
)	O
therapy	O
targeting	O
CD19	O
is	O
an	O
effective	O
treatment	O
for	O
refractory	O
B	B-ANAT
cell	I-ANAT
malignancies	O
,	O
especially	O
acute	O
lymphoblastic	B-ANAT
leukemia	O
(	O
ALL	O
)	O

We	O
collected	O
107	O
faecal	B-ANAT
samples	O
from	O
domestic	O
dogs	O
with	O
obvious	O
diarrhoea	O
.	O

Sivelestat	O
sodium	O
hydrate	O
reportedly	O
improves	O
the	O
pulmonary	B-ANAT
outcome	O
in	O
the	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
).	O

Respiratory	B-ANAT
tract	I-ANAT
infection	O
was	O
diagnosed	O
,	O
and	O
empirical	O
antibiotics	O
were	O
started	O
.	O

Within	O
two	O
days	O
,	O
she	O
developed	O
bilateral	O
pleural	O
effusions	O
,	O
diffuse	O
consolidations	O
,	O
and	O
ground	O
glass	O
opacities	O
involving	O
all	O
lung	B-ANAT
fields	O
.	O

In	O
this	O
observational	O
study	O
,	O
we	O
retrospectively	O
analyzed	O
the	O
results	O
of	O
all	O
the	O
respiratory	B-ANAT
samples	I-ANAT
,	O
which	O
had	O
been	O
processed	O
during	O
1	O
year	O
-	O
period	O
(	O
November	O
2015	O
to	O
November	O
2016	O
)	O
with	O
the	O
FA	O
-	O
RP	O
,	O
in	O
the	O
Central	O
Laboratories	O
of	O
Hygeia	O
&	O
Mitera	O
General	O
Hospitals	O
of	O
Athens	O
,	O
Greece	O
.	O

TITLE	O
:	O
Permissive	O
Hypercapnia	O
,	O
Alveolar	B-ANAT
Recruitment	O
and	O
Low	O
Airway	B-ANAT
Pressure	O
(	O
PHARLAP	O
):	O
a	O
protocol	O
for	O
a	O
phase	O
2	O
trial	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

MERS	O
-	O
CoV	O
-	O
specific	O
antibodies	O
have	O
been	O
detected	O
in	O
the	O
serum	B-ANAT
of	O
dromedary	O
camels	O
across	O
Northern	O
Africa	O
and	O
across	O
the	O
Arabian	O
Peninsula	O
.	O

The	O
prevalence	O
of	O
MERS	O
-	O
CoV	O
antibodies	O
in	O
Israeli	O
camels	O
was	O
examined	O
in	O
71	O
camel	O
sera	B-ANAT
collected	O
from	O
four	O
farms	O
across	O
Israel	O
by	O
MERS	O
-	O
CoV	O
-	O
specific	O
microneutralization	O
(	O
Mnt	O
)	O
assay	O
and	O
confirmed	O
by	O
MERS	O
-	O
CoV	O
-	O
specific	O
immunofluorescence	O
assay	O
(	O
IFA	O
).	O

MERS	O
-	O
CoV	O
neutralizing	O
antibodies	O
were	O
detectable	O
in	O
51	O
(	O
71	O
.	O
8	O
%)	O
camel	O
sera	B-ANAT
,	O
and	O
no	O
association	O
was	O
observed	O
between	O
the	O
presence	O
of	O
neutralizing	O
antibodies	O
and	O
camel	O
age	O
or	O
gender	O
.	O

TITLE	O
:	O
Life	O
span	O
of	O
different	O
extracorporeal	O
membrane	B-ANAT
systems	O
for	O
severe	O
respiratory	O
failure	O
in	O
the	O
clinical	O
practice	O
.	O

TITLE	O
:	O
Preparation	O
and	O
protective	O
efficacy	O
of	O
a	O
chicken	O
embryo	B-ANAT
kidney	B-ANAT
cell	I-ANAT
-	O
attenuation	O
GI	O
-	O
19	O
/	O
QX	O
-	O
like	O
avian	O
infectious	O
bronchitis	O
virus	O
vaccine	O
.	O

Following	O
physical	O
examination	O
,	O
laboratory	O
investigations	O
and	O
thoracic	B-ANAT
radiography	O
,	O
we	O
established	O
the	O
diagnosis	O
of	O
aspiration	O
pneumonia	O
with	O
acute	O
respiratory	O
failure	O
.	O

During	O
the	O
entire	O
hospitalization	O
,	O
the	O
patient	O
showed	O
nocturnal	O
respiratory	O
rhythm	O
disorders	O
,	O
with	O
sleep	O
apnea	O
crisis	O
of	O
approximately	O
20	O
seconds	O
and	O
desaturation	O
,	O
followed	O
by	O
severe	O
hypercapnic	O
respiratory	O
acidosis	O
,	O
manifestations	O
that	O
persisted	O
even	O
after	O
the	O
remission	O
of	O
pulmonary	B-ANAT
infection	O
,	O
raising	O
the	O
suspicion	O
of	O
an	O
apnea	O
syndrome	O
.	O

After	O
excluding	O
the	O
causes	O
of	O
obstructive	O
apnea	O
,	O
a	O
cerebral	B-ANAT
CT	O
scan	O
was	O
performed	O
,	O
revealing	O
isolated	O
fourth	B-ANAT
ventricle	I-ANAT
compressing	O
the	O
brainstem	B-ANAT
.	O

TITLE	O
:	O
Interactions	O
Between	O
Plant	O
Viral	O
Nanoparticles	O
(	O
VNPs	O
)	O
and	O
Blood	B-ANAT
Plasma	I-ANAT
Proteins	O
,	O
and	O
Their	O
Impact	O
on	O
the	O
VNP	O
In	O
Vivo	O
Fates	O
.	O

Biomolecules	O
present	O
in	O
plasma	B-ANAT
are	O
known	O
to	O
adsorb	O
onto	O
the	O
surface	O
of	O
nanomaterials	O
(	O
including	O
VNPs	O
),	O
forming	O
a	O
biointerface	O
called	O
the	O
protein	O
corona	O
,	O
which	O
is	O
capable	O
of	O
reprogramming	O
the	O
properties	O
of	O
VNPs	O
.	O

TITLE	O
:	O
Ulk1	O
Governs	O
Nerve	B-ANAT
Growth	O
Factor	O
/	O
TrkA	O
Signaling	O
by	O
Mediating	O
Rab5	O
GTPase	O
Activation	O
in	O
Porcine	O
Hemagglutinating	O
Encephalomyelitis	O
Virus	O
-	O
Induced	O
Neurodegenerative	O
Disorders	O
.	O

ABSTRACT	O
:	O
Porcine	O
hemagglutinating	O
encephalomyelitis	O
virus	O
(	O
PHEV	O
)	O
is	O
a	O
highly	O
neurovirulent	O
coronavirus	O
and	O
causes	O
neurological	O
dysfunction	O
in	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
),	O
but	O
the	O
neuropathological	O
mechanism	O
of	O
PHEV	O
remains	O
poorly	O
understood	O
.	O

Together	O
,	O
the	O
data	O
indicate	O
that	O
the	O
nose	B-ANAT
and	O
upper	O
airway	B-ANAT
remotely	O
prime	O
the	O
lung	B-ANAT
immunity	O
to	O
protect	O
the	O
lungs	B-ANAT
from	O
direct	O
viral	O
infections	O
.	O

TITLE	O
:	O
Metagenomics	O
detection	O
and	O
characterisation	O
of	O
viruses	O
in	O
faecal	B-ANAT
samples	O
from	O
Australian	O
wild	O
birds	O
.	O

TGEV	O
entry	O
is	O
via	O
clathrin	O
and	O
caveolin	O
mediated	O
endocytosis	O
in	O
IPEC	O
-	O
J2	O
cells	B-ANAT
.	O

Mortality	O
was	O
independently	O
associated	O
with	O
P	O
Half	O
the	O
patients	O
with	O
ARDS	O
had	O
major	O
comorbidities	O
,	O
which	O
were	O
associated	O
with	O
severe	O
ARDS	O
,	O
multiple	O
organ	B-ANAT
dysfunction	O
,	O
and	O
day	O
-	O
28	O
mortality	O
.	O

A	O
bronchoscopy	O
with	O
BAL	O
and	O
transbronchial	O
biopsies	O
did	O
not	O
show	O
acute	O
cellular	B-ANAT
rejection	O
,	O
but	O
the	O
BAL	O
fluid	O
was	O
positive	O
for	O
coronavirus	O
.	O

When	O
animals	O
were	O
treated	O
with	O
mAbs	O
one	O
day	O
before	O
challenge	O
,	O
respiratory	O
disease	O
was	O
less	O
severe	O
and	O
,	O
in	O
animals	O
treated	O
with	O
both	O
REGN3048	O
and	O
REGN3051	O
,	O
viral	O
loads	O
in	O
the	O
lungs	B-ANAT
were	O
reduced	O
.	O

Demographics	O
,	O
total	B-ANAT
body	I-ANAT
surface	I-ANAT
area	O
(	O
TBSA	O
)	O
burn	O
,	O
the	O
presence	O
of	O
mouth	B-ANAT
and	O
nose	B-ANAT
burn	O
,	O
ABSI	O
,	O
inhalation	O
injury	O
,	O
and	O
clinical	O
outcomes	O
for	O
each	O
patient	O
were	O
analysed	O
for	O
association	O
with	O
inpatient	O
ARDS	O
based	O
on	O
the	O
Berlin	O
definition	O
.	O

TITLE	O
:	O
Insight	O
into	O
the	O
evolution	O
of	O
nidovirus	O
endoribonuclease	O
based	O
on	O
the	O
finding	O
that	O
nsp15	O
from	O
porcine	O
ABSTRACT	O
:	O
Nidovirus	O
endoribonucleases	O
(	O
NendoUs	O
)	O
include	O
nonstructural	O
protein	O
15	O
(	O
nsp15	O
)	O
from	O
coronaviruses	O
and	O
nsp11	O
from	O
arteriviruses	O
,	O
both	O
of	O
which	O
have	O
been	O
reported	O
to	O
participate	O
in	O
the	O
viral	O
replication	O
process	O
and	O
in	O
the	O
evasion	O
of	O
the	O
host	O
immune	B-ANAT
system	I-ANAT
.	O

Moreover	O
,	O
coronavirus	O
spikes	O
can	O
recognize	O
a	O
broad	O
range	O
of	O
cell	B-ANAT
-	O
surface	O
molecules	O
in	O
addition	O
to	O
the	O
receptors	O
and	O
thereby	O
can	O
augment	O
coronavirus	O
attachment	O
or	O
entry	O
.	O

In	O
this	O
study	O
,	O
we	O
identified	O
membrane	B-ANAT
-	O
associated	O
78	O
-	O
kDa	O
glucose	O
-	O
regulated	O
protein	O
(	O
GRP78	O
)	O
as	O
an	O
additional	O
binding	O
target	O
of	O
the	O
MERS	O
-	O
CoV	O
spike	O
.	O

Further	O
analyses	O
indicated	O
that	O
GRP78	O
could	O
not	O
independently	O
render	O
nonpermissive	O
cells	B-ANAT
susceptible	O
to	O
MERS	O
-	O
CoV	O
infection	O
but	O
could	O
facilitate	O
MERS	O
-	O
CoV	O
entry	O
into	O
permissive	O
cells	B-ANAT
by	O
augmenting	O
virus	O
attachment	O
.	O

Leaves	O
of	O
the	O
medicinal	O
herb	O
Microcos	O
paniculata	O
have	O
been	O
traditionally	O
used	O
for	O
treating	O
upper	O
airway	B-ANAT
infections	O
,	O
by	O
virtue	O
of	O
its	O
content	O
of	O
flavonoids	O
such	O
as	O
apigenin	O
C	O
-	O
glycosides	O
(	O
ACGs	O
).	O

The	O
vaccination	O
not	O
only	O
enhanced	O
the	O
antibody	O
responses	O
of	O
serum	B-ANAT
IgG	O
/	O
IgA	O
,	O
mucosal	B-ANAT
IgA	O
and	O
serum	B-ANAT
neutralizing	O
antibody	O
,	O
but	O
also	O
improved	O
the	O
production	O
of	O
IFN	O
-	O
Î³	O
and	O
IL	O
-	O
4	O
.	O

ABSTRACT	O
:	O
This	O
nationwide	O
,	O
prospective	O
cohort	O
study	O
evaluated	O
pulmonary	B-ANAT
function	O
and	O
radiological	O
sequelae	O
according	O
to	O
infection	O
severity	O
in	O
73	O
survivors	O
from	O
the	O
2015	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
outbreak	O
in	O
Korea	O
.	O

Patients	O
with	O
severe	O
pneumonia	O
in	O
MERS	O
-	O
coronavirus	O
infection	O
had	O
more	O
impaired	O
pulmonary	B-ANAT
function	O
than	O
those	O
with	O
no	O
or	O
mild	O
pneumonia	O
at	O
the	O
1	O
-	O
year	O
follow	O
-	O
up	O
,	O
which	O
was	O
compatible	O
with	O
the	O
radiological	O
sequelae	O
.	O

Renal	B-ANAT
failure	O
,	O
metabolic	O
acidosis	O
appeared	O
to	O
be	O
good	O
predictors	O
of	O
mortality	O
.	O

TITLE	O
:	O
Transmissible	O
gastroenteritis	O
virus	O
N	O
protein	O
causes	O
endoplasmic	B-ANAT
reticulum	I-ANAT
stress	O
,	O
up	O
-	O
regulates	O
interleukin	O
-	O
8	O
expression	O
and	O
its	O
subcellular	O
localization	O
in	O
the	O
porcine	O
intestinal	B-ANAT
epithelial	B-ANAT
cell	I-ANAT
.	O

ABSTRACT	O
:	O
Serotonin	O
is	O
a	O
critical	O
monoamine	O
neurotransmitter	O
molecule	O
stored	O
and	O
released	O
from	O
enterochromaffin	O
(	O
EC	O
)	O
cells	B-ANAT
into	O
the	O
gut	B-ANAT
submucosa	B-ANAT
,	O
transmitting	O
the	O
vomiting	O
signal	O
to	O
the	O
brain	B-ANAT
.	O

Compared	O
with	O
the	O
younger	O
group	O
,	O
the	O
incidences	O
of	O
ARDS	O
and	O
cardiac	B-ANAT
insufficiency	O
were	O
higher	O
in	O
the	O
senior	O
group	O
[	O
85	O
.	O
9	O
ï¼	O
(	O
176	O
/	O
205	O
)	O
vs	O
.	O
77	O
.	O
5	O
ï¼	O
(	O
238	O
/	O
307	O
),	O
82	O
.	O
9	O
ï¼(	O
170	O
/	O
205	O
)	O
vs	O
.	O
32	O
.	O
9	O
ï¼	O
(	O
147	O
/	O
307	O
),	O
both	O
P	O
ï¼	O
0	O
.	O
05	O
],	O
so	O
were	O
the	O
time	O
of	O
vasopressor	O
usage	O
during	O
EGDT	O
(	O
hours	O
:	O
5	O
.	O
81	O
Â±	O
0	O
.	O
28vs	O
.	O
5	O
.	O
68	O
Â±	O
0	O
.	O
52	O
,	O
P	O
ï¼	O
0	O
.	O
05	O
)	O
was	O
prolonged	O
markedly	O
and	O
the	O
28	O
-	O
day	O
mortality	O
[	O
42	O
.	O
9	O
ï¼	O
(	O
88	O
/	O
205	O
)	O
vs	O
.	O
21	O
.	O
8	O
ï¼	O
(	O
67	O
/	O
307	O
),	O
P	O
ï¼	O
0	O
.	O
05	O
]	O
was	O
increased	O
significantly	O
.	O

In	O
this	O
study	O
,	O
we	O
present	O
a	O
previously	O
healthy	O
14	O
-	O
year	O
-	O
old	O
male	O
hospitalized	O
with	O
2009	O
H1N1	O
influenza	O
and	O
methicillin	O
-	O
resistant	O
Staphylococcus	O
aureus	O
coinfection	O
complicated	O
by	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
multifocal	O
necrotizing	O
pneumonia	O
,	O
with	O
significant	O
lung	B-ANAT
tissue	I-ANAT
damage	O
requiring	O
prolonged	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
support	O
.	O

The	O
development	O
of	O
multiple	O
BPFs	O
precluded	O
lung	B-ANAT
recruitment	O
necessary	O
to	O
wean	O
from	O
ECMO	O
.	O

Treatment	O
options	O
were	O
very	O
limited	O
and	O
endobronchial	O
valves	B-ANAT
were	O
considered	O
.	O

Donor	O
plasma	B-ANAT
and	O
one	O
or	O
two	O
recipient	O
'	O
s	O
serum	B-ANAT
samples	O
per	O
week	O
of	O
illness	O
including	O
one	O
taken	O
the	O
day	O
after	O
each	O
CP	O
infusion	O
were	O
evaluated	O
.	O

ABSTRACT	O
:	O
We	O
reviewed	O
the	O
use	O
of	O
noninvasive	O
ventilation	O
(	O
NIV	O
)	O
versus	O
high	O
flow	O
nasal	B-ANAT
cannula	O
(	O
HFNC	O
)	O
oxygen	O
in	O
adult	O
acute	O
respiratory	O
failure	O
(	O
ARF	O
).	O

METHODS	O
Coagulated	O
blood	B-ANAT
samples	I-ANAT
for	O
serology	O
and	O
oropharyngeal	B-ANAT
swabs	O
for	O
virology	O
were	O
collected	O
from	O
healthy	O
dogs	O
(	O
n	O
=	O
47	O
)	O
and	O
from	O
dogs	O
with	O
acute	O
respiratory	O
disease	O
(	O
n	O
=	O
49	O
).	O

Sera	B-ANAT
were	O
tested	O
for	O
CRCoV	O
antibody	O
using	O
competitive	O
ELISA	O
and	O
results	O
expressed	O
as	O
percent	O
of	O
inhibition	O
(	O
POI	O
).	O

Our	O
data	O
demonstrate	O
that	O
both	O
passive	O
diffusion	O
of	O
released	O
viral	B-ANAT
particles	I-ANAT
and	O
axonal	O
transport	O
are	O
valid	O
propagation	O
strategies	O
used	O
by	O
the	O
virus	O
.	O

TITLE	O
:	O
Breakthrough	O
infection	O
of	O
Geotrichum	O
capitatum	O
during	O
empirical	O
caspofungin	O
therapy	O
after	O
umbilical	B-ANAT
cord	I-ANAT
blood	I-ANAT
transplantation	O
.	O

ABSTRACT	O
:	O
Respiratory	B-ANAT
tract	I-ANAT
infections	O
(	O
RTIs	O
)	O
are	O
responsible	O
for	O
over	O
2	O
.	O
8	O
million	O
deaths	O
per	O
year	O
worldwide	O
with	O
pathobiont	O
carriage	O
a	O
required	O
precursor	O
to	O
infection	O
.	O

ACTB	O
-	O
actin	O
beta	O
;	O
ATG13	O
-	O
autophagy	O
related	O
13	O
;	O
ATG14	O
-	O
autophagy	O
related	O
14	O
;	O
ATG101	O
-	O
autophagy	O
related	O
101	O
;	O
BECN1	O
-	O
beclin	O
1	O
;	O
CVB3	O
-	O
coxsackievirus	O
B3	O
;	O
DMV	O
-	O
double	O
-	O
membraned	O
vesicles	B-ANAT
;	O
EM	O
-	O
electron	O
microscopy	O
;	O
EMCV	O
-	O
encephalomyocarditis	O
virus	O
;	O
EV	O
-	O
71	O
-	O
enterovirus	O
71	O
;	O
FMDV	O
-	O
foot	B-ANAT
and	O
mouth	B-ANAT
disease	O
virus	O
;	O
GFP	O
-	O
green	O
fluorescent	O
protein	O
;	O
MAP1LC3B	O
/	O
LC3B	O
-	O
microtubule	B-ANAT
associated	O
protein	O
1	O
light	O
chain	O
3	O
beta	O
;	O
MOI	O
-	O
multiplicity	O
of	O
infection	O
;	O
MTOR	O
-	O
mechanistic	O
target	O
of	O
rapamycin	O
kinase	O
;	O
PIK3C3	O
-	O
phosphatidylinositol	O
3	O
-	O
kinase	O
catalytic	O
subunit	O
type	O
3	O
;	O
PRKAA2	O
-	O
protein	O
kinase	O
AMP	O
-	O
activated	O
catalytic	O
subunit	O
alpha	O
2	O
;	O
PSMG1	O
-	O
proteasome	O
assembly	O
chaperone	O
1	O
;	O
PSMG2	O
-	O
proteasome	O
assembly	O
chaperone	O
2PV	O
-	O
poliovirus	O
;	O
RB1CC1	O
-	O
RB1	O
inducible	O
coiled	O
-	O
coil	O
1	O
;	O
SQSTM1	O
-	O
sequestosome	O
1	O
;	O
ULK1	O
-	O
unc	O
-	O
51	O
like	O
autophagy	O
activating	O
kinase	O
1	O
;	O
ULK2	O
-	O
unc	O
-	O
51	O
like	O
autophagy	O
activating	O
kinase	O
2	O
;	O
WIPI1	O
-	O
WD	O
repeat	O
domain	O
,	O
phosphoinositide	O
interacting	O
1	O
.	O

TITLE	O
:	O
Differential	O
susceptibility	O
of	O
macrophages	B-ANAT
to	O
serotype	O
II	O
feline	O
coronaviruses	O
correlates	O
with	O
differences	O
in	O
the	O
viral	O
spike	O
protein	O
.	O

Furthermore	O
,	O
PDCoV	O
infection	O
necessitated	O
the	O
activation	O
of	O
the	O
initiator	O
caspase	O
-	O
9	O
responsible	O
for	O
the	O
intrinsic	O
mitochondrial	B-ANAT
apoptosis	O
pathway	O
.	O

As	O
a	O
result	O
this	O
important	O
innate	O
primary	O
defense	O
mechanism	O
,	O
which	O
protects	O
the	O
lungs	B-ANAT
from	O
the	O
deleterious	O
effects	O
of	O
different	O
pollutants	O
,	O
allergens	O
and	O
pathogens	O
,	O
is	O
weakened	O
.	O

It	O
is	O
difficult	O
to	O
establish	O
a	O
causal	O
link	O
between	O
alcohol	O
and	O
lung	B-ANAT
cancer	O
as	O
the	O
lung	B-ANAT
cancer	O
risk	O
is	O
likely	O
confounded	O
by	O
the	O
effect	O
of	O
smoking	O
.	O

Furthermore	O
,	O
while	O
BMDM	O
exhibited	O
a	O
mixed	O
phenotype	O
of	O
M1	O
and	O
M2	O
markers	O
,	O
microglia	B-ANAT
repressed	O
the	O
vast	O
majority	O
of	O
M2	O
-	O
markers	O
.	O

ABSTRACT	O
:	O
Tonsils	B-ANAT
provide	O
an	O
innovative	O
in	O
vivo	O
model	O
for	O
investigating	O
immune	O
response	O
to	O
infections	O
and	O
allergens	O
.	O

Tonsils	B-ANAT
of	O
89	O
surgical	O
patients	O
with	O
tonsillar	B-ANAT
hypertrophy	O
(	O
n	O
=	O
47	O
)	O
or	O
recurrent	O
tonsillitis	O
(	O
n	O
=	O
42	O
)	O
were	O
analysed	O
.	O

Polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
was	O
used	O
to	O
analyze	O
the	O
Variable	O
Number	O
of	O
Tandem	O
Repeats	O
(	O
VNTRs	O
)	O
of	O
IL1RA	O
gene	O
polymorphism	O
and	O
ELISA	O
test	O
to	O
detect	O
serum	B-ANAT
levels	O
of	O
IL1RA	O
.	O

Serum	B-ANAT
IL1RA	O
(	O
ng	O
/	O
mL	O
)	O
was	O
statistically	O
significantly	O
elevated	O
in	O
CAP	O
with	O
AO	O
(	O
2	O
.	O
55	O
Â±	O
1	O
.	O
44	O
)	O
versus	O
uncomplicated	O
(	O
0	O
.	O
87	O
Â±	O
0	O
.	O
52	O
)	O
(	O
P	O
<	O
0	O
.	O
0001	O
).	O

Additionally	O
,	O
statistically	O
significant	O
clusters	O
were	O
mapped	O
and	O
layered	B-ANAT
on	O
a	O
hot	O
-	O
spot	O
analysis	O
of	O
commercial	O
poultry	O
farm	O
density	O
in	O
order	O
to	O
qualitatively	O
assess	O
the	O
relationship	O
between	O
farm	O
density	O
and	O
clusters	O
of	O
IBV	O
.	O

TITLE	O
:	O
Experimental	O
infection	O
of	O
dromedaries	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
Coronavirus	O
is	O
accompanied	O
by	O
massive	O
ciliary	O
loss	O
and	O
depletion	O
of	O
the	O
cell	B-ANAT
surface	I-ANAT
receptor	O
dipeptidyl	O
peptidase	O
4	O
.	O

Recent	O
data	O
indicate	O
that	O
dromedaries	O
represent	O
an	O
important	O
source	O
of	O
infection	O
,	O
although	O
information	O
regarding	O
viral	O
cell	B-ANAT
tropism	O
and	O
pathogenesis	O
is	O
sparse	O
.	O

Tissues	B-ANAT
were	O
analyzed	O
by	O
histology	O
,	O
immunohistochemistry	O
,	O
immunofluorescence	O
,	O
and	O
scanning	O
electron	O
microscopy	O
.	O

DPP4	O
was	O
mainly	O
expressed	O
by	O
human	O
lymphocytes	B-ANAT
and	O
dromedary	O
monocytes	B-ANAT
,	O
but	O
overall	O
the	O
expression	O
level	O
was	O
lower	O
in	O
dromedaries	O
.	O

TITLE	O
:	O
Organelle	B-ANAT
dynamics	O
and	O
viral	O
infections	O
:	O
at	O
cross	O
roads	O
.	O

In	O
this	O
review	O
,	O
we	O
aim	O
to	O
summarize	O
and	O
highlight	O
modulations	O
caused	O
to	O
various	O
organelles	B-ANAT
upon	O
viral	O
infection	O
or	O
expression	O
of	O
its	O
proteins	O
.	O

The	O
IBV	O
-	O
specific	O
antibody	O
levels	O
,	O
as	O
well	O
as	O
the	O
percentages	O
of	O
CD4	O
+	O
and	O
CD8	O
+	O
T	B-ANAT
lymphocytes	I-ANAT
,	O
were	O
detected	O
within	O
28	O
days	O
post	O
-	O
vaccination	O
(	O
dpv	O
).	O

The	O
results	O
showed	O
that	O
the	O
IBV	O
-	O
specific	O
antibody	O
levels	O
and	O
the	O
percentages	O
of	O
CD4	O
+	O
and	O
CD8	O
+	O
T	B-ANAT
lymphocytes	I-ANAT
were	O
higher	O
in	O
the	O
rHBM	O
-	O
S1	O
-	O
N	O
vaccinated	O
birds	O
compared	O
to	O
birds	O
vaccinated	O
with	O
the	O
rHBM	O
-	O
S1	O
and	O
rHBM	O
-	O
N	O
vaccines	O
.	O

TITLE	O
:	O
Splenic	B-ANAT
rupture	O
from	O
babesiosis	O
,	O
an	O
emerging	O
concern	O
?	O

Patients	O
with	O
splenic	B-ANAT
rupture	O
due	O
to	O
human	O
babesiosis	O
were	O
successfully	O
treated	O
by	O
various	O
management	O
strategies	O
,	O
such	O
as	O
conservative	O
non	O
-	O
operative	O
approach	O
,	O
splenic	B-ANAT
artery	I-ANAT
embolization	O
,	O
and	O
splenectomy	O
.	O

Undoubtedly	O
,	O
more	O
research	O
on	O
the	O
gut	B-ANAT
-	O
lung	B-ANAT
crosstalk	O
in	O
critically	O
ill	O
patients	O
is	O
needed	O
to	O
identify	O
causal	O
relationships	O
between	O
the	O
altered	O
microbiome	O
,	O
infections	O
,	O
inflammation	O
,	O
and	O
acute	O
lung	B-ANAT
injury	O
.	O

Their	O
clinical	O
phenotypes	O
including	O
laboratory	O
test	O
results	O
,	O
high	O
-	O
resolution	O
lung	B-ANAT
computed	O
tomography	O
data	O
,	O
response	O
to	O
therapy	O
,	O
and	O
prognosis	O
were	O
compared	O
between	O
those	O
who	O
were	O
positive	O
and	O
negative	O
for	O
MAAs	O
,	O
such	O
as	O
antinuclear	O
antibody	O
(	O
ANA	O
),	O
anti	O
-	O
cyclic	O
citrullinated	O
peptide	O
(	O
CCP	O
),	O
anti	O
-	O
SSA	O
,	O
and	O
anti	O
-	O
SSB	B-ANAT
antibodies	O
.	O

Among	O
24	O
patients	O
,	O
9	O
(	O
37	O
.	O
5	O
%)	O
additionally	O
had	O
at	O
least	O
one	O
of	O
the	O
MAAs	O
examined	O
in	O
this	O
study	O
:	O
1	O
patient	O
was	O
positive	O
for	O
ANA	O
,	O
5	O
for	O
anti	O
-	O
CCP	O
,	O
5	O
for	O
either	O
anti	O
-	O
SSA	O
or	O
anti	O
-	O
SSB	B-ANAT
,	O
1	O
for	O
anti	O
-	O
cardiolipin	O
,	O
and	O
1	O
for	O
anti	O
-	O
Scl	O
-	O
70	O
.	O

Endocan	O
blood	B-ANAT
values	O
at	O
inclusion	O
were	O
significantly	O
lower	O
in	O
patients	O
who	O
developed	O
an	O
ARDS	O
at	O
72	O
h	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

A	O
chest	B-ANAT
X	O
-	O
ray	O
showed	O
bilateral	O
infiltration	O
.	O

This	O
report	O
covers	O
an	O
ARDS	O
case	O
occurring	O
post	O
left	O
pneumonectomy	O
,	O
with	O
a	O
favorable	O
outcome	O
,	O
despite	O
association	O
with	O
an	O
acute	O
colonic	B-ANAT
pseudo	O
-	O
obstruction	O
syndrome	O
(	O
Ogilvie	O
syndrome	O
)	O
that	O
required	O
abdominal	B-ANAT
surgery	O
for	O
decompression	O
.	O

The	O
present	O
study	O
aimed	O
to	O
investigate	O
the	O
effects	O
of	O
Flammulina	O
velutipes	O
mushroom	O
waste	O
(	O
FVW	O
)	O
on	O
performance	O
,	O
immune	O
response	O
and	O
serum	B-ANAT
immunity	O
in	O
growing	O
layer	B-ANAT
hens	O
.	O

TITLE	O
:	O
Nucleocapsid	B-ANAT
protein	O
from	O
porcine	O
epidemic	O
diarrhea	O
virus	O
isolates	O
can	O
antagonize	O
interferon	O
-	O
Î»	O
production	O
by	O
blocking	O
the	O
nuclear	O
factor	O
-	O
ÎºB	O
nuclear	O
translocation	O
.	O

Community	O
-	O
acquired	O
pneumonia	O
(	O
n	O
=	O
6	O
),	O
aspiration	O
pneumonia	O
(	O
n	O
=	O
4	O
)	O
and	O
liver	B-ANAT
abscess	O
(	O
n	O
=	O
2	O
)	O
represented	O
initial	O
sites	O
and	O
mode	O
of	O
infection	O
.	O

Compared	O
to	O
non	O
-	O
hvKp	O
infections	O
,	O
patients	O
with	O
hvKp	O
infections	O
displayed	O
higher	O
rates	O
of	O
multi	O
-	O
organ	B-ANAT
failure	O
(	O
83	O
.	O
3	O
%	O
vs	O
35	O
.	O
7	O
%;	O
P	O
=	O
0	O
.	O
04	O
),	O
but	O
mortality	O
rates	O
were	O
not	O
different	O
(	O
50	O
%	O
vs	O
35	O
%;	O
P	O
=	O
0	O
.	O
71	O
).	O

Based	O
on	O
a	O
documentary	O
review	O
,	O
followed	O
by	O
five	O
week	O
-	O
long	O
country	O
visits	O
involving	O
a	O
total	O
of	O
61	O
interviews	O
and	O
group	O
discussions	O
with	O
experts	O
from	O
both	O
the	O
health	O
and	O
non	O
-	O
health	O
sectors	O
,	O
this	O
qualitative	O
case	O
study	O
has	O
investigated	O
six	O
issues	O
related	O
to	O
preparedness	O
and	O
response	O
to	O
MERS	O
and	O
poliomyelitis	O
:	O
national	O
plans	O
and	O
overall	O
preparedness	O
capacity	O
;	O
training	O
and	O
exercises	O
;	O
risk	O
communication	O
;	O
linking	O
policy	O
and	O
implementation	O
;	O
interoperability	O
between	O
the	O
health	O
and	O
non	O
-	O
health	O
sectors	O
;	O
and	O
cross	O
-	O
border	B-ANAT
collaboration	O
.	O

Moreover	O
,	O
we	O
demonstrate	O
that	O
TMPRSS11A	O
is	O
expressed	O
in	O
murine	O
tracheal	B-ANAT
epithelium	I-ANAT
,	O
which	O
is	O
a	O
target	O
of	O
FLUAV	O
infection	O
,	O
and	O
in	O
human	O
trachea	B-ANAT
,	O
suggesting	O
that	O
the	O
protease	O
could	O
support	O
FLUAV	O
spread	O
in	O
patients	O
.	O

Our	O
patient	O
'	O
s	O
hypoxemia	O
improved	O
with	O
inhaled	O
nitric	O
oxide	O
as	O
an	O
adjunct	O
to	O
mechanical	O
ventilation	O
without	O
requiring	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
and	O
eventually	O
a	O
percutaneous	O
closure	O
with	O
a	O
30	O
mm	O
CardioSeal	O
patent	O
foramen	B-ANAT
ovale	I-ANAT
closure	O
device	O
was	O
accomplished	O
.	O

In	O
order	O
to	O
investigate	O
the	O
codon	O
usage	O
characteristics	O
and	O
influence	O
factors	O
,	O
codon	O
preference	O
and	O
multivariate	O
statistical	O
analysis	O
of	O
MERS	O
-	O
Co	O
V	O
9	O
gene	O
sequences	O
were	O
performed	O
by	O
using	O
Codon	O
W	O
,	O
CUSP	B-ANAT
and	O
SPSS	O
software	O
,	O
getting	O
the	O
content	O
of	O
GC	O
at	O
three	O
positions	O
of	O
codons	O
,	O
ENC	O
(	O
Effective	O
number	O
of	O
codon	O
)	O
and	O
RSCU	O
(	O
Relative	O
synonymous	O
codon	O
usage	O
)	O
of	O
all	O
genes	O
.	O

Worsening	O
severity	O
of	O
disease	O
is	O
associated	O
with	O
severe	O
chest	B-ANAT
trauma	O
and	O
volume	O
of	O
plasma	B-ANAT
transfusion	O
.	O

In	O
total	O
,	O
838	O
blood	B-ANAT
samples	I-ANAT
from	O
sows	O
from	O
267	O
farms	O
and	O
101	O
samples	O
from	O
wild	O
boars	O
were	O
collected	O
from	O
May	O
till	O
November	O
2014	O
and	O
tested	O
for	O
antibodies	O
against	O
PEDV	O
by	O
ELISA	O
.	O

There	O
was	O
increased	O
interleukin	O
-	O
6	O
in	O
PDCoV	O
-	O
infected	O
IPEC	O
-	O
J2	O
cell	B-ANAT
culture	O
supernatants	O
at	O
post	O
-	O
inoculation	O
hour	O
(	O
PIH	O
)	O
48	O
-	O
96	O
,	O
as	O
evaluated	O
by	O
ELISA	O
,	O
concurrent	O
with	O
increased	O
titers	O
of	O
PDCoV	O
at	O
PIH	O
24	O
-	O
72	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
clinical	O
outcomes	O
of	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
subjected	O
to	O
prone	O
positioning	O
before	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
).	O

He	O
was	O
diagnosed	O
with	O
pulmonary	B-ANAT
blastomycosis	O
and	O
started	O
therapy	O
with	O
liposomal	O
amphotericin	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
a	O
life	O
threatening	O
condition	O
characterized	O
by	O
severe	O
hypoxemia	O
due	O
to	O
pulmonary	B-ANAT
gas	O
exchange	O
failure	O
and	O
was	O
first	O
recognized	O
in	O
1960s	O
.	O

TITLE	O
:	O
Mouse	O
Models	O
of	O
Acute	O
Lung	B-ANAT
Injury	O
and	O
ARDS	O
.	O

Methods	O
for	O
growth	O
and	O
preparation	O
of	O
Streptococcus	O
pneumoniae	O
are	O
provided	O
as	O
methods	O
to	O
assess	O
lung	B-ANAT
inflammation	O
and	O
injury	O
.	O

Whether	O
the	O
gut	B-ANAT
microbiota	O
plays	O
any	O
role	O
in	O
the	O
development	O
of	O
TRALI	O
is	O
currently	O
unknown	O
.	O

The	O
prevention	O
of	O
TRALI	O
in	O
the	O
SPF	O
mice	O
and	O
gut	B-ANAT
flora	O
-	O
depleted	O
BF	O
mice	O
was	O
associated	O
with	O
decreased	O
plasma	B-ANAT
macrophage	B-ANAT
inflammatory	O
protein	O
-	O
2	O
levels	O
as	O
well	O
as	O
decreased	O
pulmonary	B-ANAT
neutrophil	B-ANAT
accumulation	O
.	O

DNA	O
sequencing	O
of	O
amplicons	O
of	O
the	O
16S	O
ribosomal	B-ANAT
RNA	I-ANAT
gene	O
revealed	O
a	O
varying	O
gastrointestinal	O
bacterial	O
composition	O
between	O
BF	O
and	O
SPF	O
mice	O
.	O

Assessment	O
of	O
gut	B-ANAT
microbial	O
composition	O
may	O
help	O
in	O
TRALI	O
risk	O
assessment	O
before	O
transfusion	O
.	O

Neurologic	O
signs	O
,	O
petechial	O
hemorrhages	O
and	O
acute	O
respiratory	O
failure	O
constitute	O
the	O
characteristic	O
presenting	O
triad	B-ANAT
.	O

A	O
total	O
of	O
6	O
.	O
2	O
%	O
of	O
samples	O
(	O
168	O
individuals	O
)	O
tested	O
positive	O
for	O
at	O
least	O
one	O
virus	O
,	O
with	O
5	O
.	O
6	O
%	O
testing	O
positive	O
in	O
the	O
summer	O
arm	B-ANAT
and	O
7	O
.	O
0	O
%	O
testing	O
positive	O
in	O
the	O
winter	O
arm	B-ANAT
.	O

There	O
have	O
been	O
many	O
advances	O
in	O
the	O
management	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
a	O
condition	O
which	O
Bellani	O
et	O
al	O
,	O
in	O
the	O
LUNG	B-ANAT
SAFE	O
trial	O
(	O
Large	O
Observational	O
Study	O
to	O
Understand	O
the	O
Global	O
Impact	O
of	O
Severe	O
Acute	O
Respiratory	O
Failure	O
),	O
found	O
represents	O
up	O
to	O
10	O
.	O
4	O
%	O
of	O
intensive	O
care	O
unit	O
admissions	O
and	O
23	O
.	O
4	O
%	O
of	O
patients	O
requiring	O
mechanical	O
ventilation	O
,	O
with	O
an	O
unadjusted	O
intensive	O
care	O
unit	O
and	O
hospital	O
mortality	O
of	O
35	O
.	O
3	O
%	O
and	O
40	O
%,	O
respectively	O
.	O

ABSTRACT	O
:	O
Since	O
the	O
2009	O
pandemic	O
influenza	O
,	O
we	O
have	O
nationally	O
established	O
a	O
committee	O
of	O
the	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
project	O
.	O

Therefore	O
,	O
it	O
is	O
used	O
as	O
the	O
active	O
component	O
in	O
the	O
antiviral	O
nasal	B-ANAT
spray	O
Coldamaris	O
prophylactic	O
(	O
1	O
.	O
2	O
mg	O
/	O
mL	O
iota	O
-	O
carrageenan	O
in	O
0	O
.	O
5	O
%	O
NaCl	O
)	O
and	O
other	O
medical	O
device	O
nasal	B-ANAT
sprays	O
that	O
are	O
approved	O
and	O
marketed	O
in	O
the	O
EU	O
.	O

Permeation	O
experiments	O
using	O
bovine	O
nasal	B-ANAT
mucosa	I-ANAT
showed	O
that	O
iota	O
-	O
carrageenan	O
had	O
no	O
significant	O
influence	O
on	O
the	O
permeation	O
of	O
xylometazoline	O
HCl	O
.	O

TITLE	O
:	O
Heme	O
Oxygenase	O
-	O
1	O
Reduces	O
Sepsis	O
-	O
Induced	O
Endoplasmic	B-ANAT
Reticulum	I-ANAT
Stress	O
and	O
Acute	O
Lung	B-ANAT
Injury	O
.	O

The	O
effects	O
of	O
HO	O
-	O
1	O
on	O
ER	O
stress	O
during	O
septic	O
ALI	O
were	O
investigated	O
Compared	O
with	O
the	O
sham	O
group	O
,	O
ER	O
stress	O
in	O
septic	O
lung	B-ANAT
increased	O
significantly	O
18	O
hours	O
after	O
CLP	O
,	O
which	O
was	O
significantly	O
reduced	O
by	O
pretreatment	O
with	O
the	O
ER	O
inhibitor	O
4	O
-	O
phenylbutyrate	O
(	O
4	O
-	O
PBA	O
).	O

In	O
this	O
study	O
,	O
we	O
reexamined	O
furin	O
usage	O
by	O
MERS	O
-	O
CoV	O
using	O
a	O
real	O
-	O
time	O
PCR	O
-	O
based	O
virus	O
cell	B-ANAT
entry	O
assay	O
after	O
inhibition	O
of	O
cellular	B-ANAT
proteases	O
.	O

ABSTRACT	O
:	O
Complications	O
after	O
injury	O
,	O
such	O
as	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
are	O
common	O
after	O
traumatic	O
brain	B-ANAT
injury	O
(	O
TBI	O
)	O
and	O
associated	O
with	O
poor	O
clinical	O
outcomes	O
.	O

Tissue	B-ANAT
inhibitor	O
of	O
matrix	O
metalloproteinase	O
-	O
3	O
(	O
TIMP	O
-	O
3	O
)	O
is	O
a	O
regulator	O
of	O
matrix	O
metalloproteinase	O
activity	O
,	O
inflammation	O
,	O
and	O
vascular	B-ANAT
permeability	O
,	O
and	O
hence	O
has	O
plausibility	O
as	O
a	O
biomarker	O
for	O
the	O
systemic	O
response	O
to	O
TBI	O
.	O

Along	O
with	O
clinical	O
and	O
demographic	O
data	O
,	O
early	O
measurements	O
of	O
plasma	B-ANAT
biomarkers	O
such	O
as	O
TIMP	O
-	O
3	O
may	O
help	O
identify	O
patients	O
at	O
higher	O
risk	O
of	O
ARDS	O
and	O
death	O
after	O
severe	O
isolated	O
TBI	O
.	O

We	O
suggest	O
that	O
vinorelbine	O
-	O
induced	O
lung	B-ANAT
toxicity	O
is	O
driven	O
by	O
a	O
primarily	O
immune	O
-	O
mediated	O
mechanism	O
and	O
that	O
it	O
can	O
respond	O
favourably	O
to	O
immunosuppressive	O
therapy	O
.	O

TITLE	O
:	O
Moderate	O
and	O
Severe	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
:	O
Hemodynamic	O
and	O
Cardiac	B-ANAT
Effects	O
of	O
an	O
Open	O
Lung	B-ANAT
Strategy	O
With	O
Recruitment	O
Maneuver	O
Analyzed	O
Using	O
Echocardiography	O
.	O

Both	O
left	O
and	O
right	O
ventricular	B-ANAT
global	O
longitudinal	O
strain	O
were	O
impaired	O
(-	O
15	O
.	O
8	O
%	O
Â±	O
4	O
.	O
5	O
%	O
to	O
-	O
11	O
%	O
Â±	O
4	O
.	O
7	O
%	O
and	O
-	O
19	O
%	O
Â±	O
5	O
%	O
to	O
-	O
14	O
%	O
Â±	O
6	O
%	O
[	O
p	O
=	O
0	O
.	O
05	O
]	O
respectively	O
).	O

CONCLUSIONS	O
:	O
Both	O
structural	O
and	O
accessory	O
HCoV	O
-	O
OC43	O
proteins	O
are	O
able	O
to	O
inhibit	O
antiviral	O
response	O
elements	O
in	O
HEK	O
-	O
293	O
cells	B-ANAT
,	O
and	O
to	O
block	O
the	O
activation	O
of	O
different	O
antiviral	O
signaling	O
pathways	O
.	O

Recently	O
,	O
antiviral	O
effects	O
have	O
been	O
described	O
as	O
a	O
novel	O
feature	O
of	O
Na	O
,	O
K	O
-	O
ATPase	O
inhibition	O
with	O
the	O
use	O
of	O
cardiac	B-ANAT
glycosides	O
.	O

Global	O
pandemic	O
concerns	O
stem	B-ANAT
from	O
their	O
high	O
mortality	O
rates	O
,	O
capacity	O
for	O
human	O
-	O
to	O
-	O
human	O
spread	O
by	O
respiratory	O
transmission	O
,	O
and	O
complete	O
lack	O
of	O
approved	O
therapeutic	O
countermeasures	O
.	O

We	O
detected	O
HRV	O
,	O
coronavirus	O
,	O
paramyxovirus	O
,	O
influenza	O
and	O
bocavirus	O
with	O
the	O
FilmArray	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
platform	O
(	O
BioFire	O
Diagnostics	O
,	O
LLC	B-ANAT
).	O

During	O
the	O
reporting	O
period	O
,	O
22	O
deaths	O
in	O
intensive	O
care	O
units	O
(	O
55	O
%)	O
were	O
reported	O
,	O
the	O
median	O
age	O
was	O
53	O
years	O
(	O
IQR	O
37	O
-	O
61	O
),	O
24	O
(	O
61	O
%)	O
were	O
male	O
,	O
The	O
median	O
scores	O
SAPS	O
II	O
and	O
SOFA	O
were	O
respectively	O
29	O
(	O
IQR	O
23	O
-	O
36	O
)	O
and	O
6	O
(	O
IQR	O
3	O
-	O
10	O
),	O
27	O
%	O
had	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
COPD	O
),	O
33	O
.	O
3	O
%	O
diabetic	O
and	O
no	O
patients	O
were	O
vaccinated	O
against	O
influenza	O
A	O
.	O
The	O
cause	O
of	O
admission	O
was	O
in	O
72	O
.	O
5	O
%	O
of	O
the	O
cases	O
was	O
hypoxemic	O
pneumonae	O
.	O

Pig	O
feces	B-ANAT
,	O
pig	O
oral	B-ANAT
secretions	I-ANAT
,	O
bioaerosols	O
,	O
and	O
worker	O
nasal	B-ANAT
wash	O
samples	O
were	O
collected	O
and	O
analyzed	O
via	O
rPCR	O
and	O
rRT	O
-	O
PCR	O
for	O
respiratory	O
and	O
diarrheal	O
viruses	O
.	O

PCV2	O
was	O
detected	O
in	O
21	O
pig	O
fecal	B-ANAT
,	O
43	O
pig	O
oral	B-ANAT
or	O
water	O
,	O
3	O
bioaerosol	O
,	O
and	O
4	O
worker	O
nasal	B-ANAT
wash	O
samples	O
.	O

However	O
,	O
one	O
10	O
%	O
MCFA	O
rice	O
hull	O
sample	O
collected	O
from	O
the	O
bucket	O
elevator	O
discharge	B-ANAT
spout	O
had	O
detectible	O
PEDV	O
RNA	O
.	O

We	O
present	O
an	O
extremely	O
rare	O
case	O
of	O
a	O
patient	O
with	O
rapid	O
malignant	O
brain	B-ANAT
swelling	O
subacutely	O
after	O
acute	O
ischemic	O
stroke	O
.	O

Urosepsis	O
was	O
diagnosed	O
,	O
and	O
computed	O
tomography	O
revealed	O
massive	O
hemorrhagic	O
infarction	O
in	O
the	O
left	B-ANAT
frontal	I-ANAT
lobe	I-ANAT
and	O
diffuse	O
subarachnoid	O
hemorrhage	O
.	O

In	O
this	O
review	O
,	O
we	O
illustrate	O
the	O
structure	O
and	O
function	O
of	O
S	O
protein	O
as	O
a	O
vaccine	O
target	O
,	O
describe	O
available	O
animal	O
models	O
for	O
evaluating	O
MERS	O
vaccines	O
,	O
and	O
summarize	O
recent	O
progress	O
on	O
MERS	O
-	O
CoV	O
S	O
-	O
based	O
vaccines	O
,	O
focusing	O
on	O
their	O
ability	O
to	O
elicit	O
antibody	O
and	O
/	O
or	O
cellular	B-ANAT
immune	O
responses	O
,	O
neutralizing	O
antibodies	O
,	O
and	O
protection	O
against	O
MERS	O
-	O
CoV	O
infection	O
in	O
different	O
models	O
.	O

Embryo	B-ANAT
mortality	O
after	O
the	O
inoculation	O
of	O
8	O
-	O
day	O
-	O
old	O
embryonated	O
chicken	O
eggs	O
with	O
recombinant	O
and	O
wild	O
-	O
type	O
viruses	O
showed	O
that	O
rIBV	O
-	O
Î3b	O
,	O
rIBV	O
-	O
Î5a	O
and	O
rIBV	O
-	O
Î5b	O
had	O
an	O
attenuated	O
phenotype	O
in	O
ovo	O
,	O
with	O
reduced	O
titres	O
at	O
6	O
h	O
p	O
.	O
i	O
.	O

ABSTRACT	O
:	O
Multiple	O
sclerosis	O
(	O
MS	O
)	O
is	O
a	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
disease	O
characterized	O
by	O
chronic	O
neuroinflammation	O
,	O
demyelination	O
,	O
and	O
axonal	O
damage	O
.	O

Infiltration	O
of	O
activated	O
lymphocytes	B-ANAT
and	O
myeloid	B-ANAT
cells	I-ANAT
are	O
thought	O
to	O
be	O
primarily	O
responsible	O
for	O
white	B-ANAT
matter	I-ANAT
damage	O
and	O
axonopathy	O
.	O

Intracranial	B-ANAT
infection	O
of	O
mice	O
with	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	O
hepatitis	O
virus	O
(	O
JHMV	O
)	O
results	O
in	O
immune	O
-	O
mediated	O
demyelination	O
and	O
axonopathy	O
,	O
making	O
this	O
an	O
excellent	O
model	O
to	O
interrogate	O
the	O
therapeutic	O
potential	O
of	O
stem	B-ANAT
cell	I-ANAT
derivatives	O
in	O
evoking	O
remyelination	O
.	O

This	O
review	O
provides	O
a	O
succinct	O
overview	O
of	O
our	O
recent	O
findings	O
using	O
intraspinal	O
injection	O
of	O
mouse	O
CNS	B-ANAT
neural	O
progenitor	B-ANAT
cells	I-ANAT
and	O
human	O
neural	O
precursors	O
into	O
JHMV	O
-	O
infected	O
mice	O
.	O

TITLE	O
:	O
Surfactin	O
Inhibits	O
Membrane	B-ANAT
Fusion	O
during	O
Invasion	O
of	O
Epithelial	B-ANAT
Cells	I-ANAT
by	O
Enveloped	O
Viruses	O
.	O

The	O
age	O
-	O
allied	O
prevalence	O
of	O
MERS	O
-	O
CoV	O
was	O
highest	O
amongst	O
elderly	O
people	O
with	O
chronic	O
debilitating	O
diseases	O
such	O
as	O
pulmonary	B-ANAT
diseases	O
,	O
end	O
-	O
stage	O
renal	B-ANAT
illness	O
,	O
diabetes	O
mellitus	O
and	O
malignancy	O
.	O

Two	O
doses	O
of	O
the	O
nasal	B-ANAT
spray	O
H7N9	O
vaccine	O
induced	O
higher	O
titers	O
of	O
HI	O
(	O
6	O
.	O
7	O
Â±	O
0	O
.	O
67	O
vs	O
.	O
5	O
.	O
3	O
Â±	O
1	O
.	O
16	O
,	O
P	O
=	O
0	O
.	O
004	O
)	O
and	O
anti	O
-	O
HA	O
IgG	O
in	O
sera	B-ANAT
(	O
19	O
.	O
26	O
Â±	O
0	O
.	O
67	O
vs	O
.	O
13	O
.	O
97	O
Â±	O
0	O
.	O
82	O
,	O
P	O
<	O
0	O
.	O
0001	O
)	O
and	O
of	O
anti	O
-	O
HA	O
sIgA	O
(	O
7	O
.	O
13	O
Â±	O
2	O
.	O
54	O
vs	O
.	O
0	O
,	O
P	O
=	O
0	O
.	O
0000	O
)	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
BALF	O
)	O
than	O
one	O
dose	O
of	O
intramuscular	O
H7N9	O
vaccine	O
3	O
weeks	O
after	O
the	O
last	O
immunization	O
.	O

However	O
,	O
when	O
we	O
immunized	O
the	O
mice	O
with	O
two	O
doses	O
of	O
both	O
vaccines	O
separately	O
,	O
the	O
nasal	B-ANAT
spray	O
H7N9	O
vaccine	O
induced	O
higher	O
titers	O
of	O
anti	O
-	O
HA	O
IgG	O
(	O
19	O
.	O
26	O
Â±	O
0	O
.	O
67	O
vs	O
.	O
17	O
.	O
56	O
Â±	O
0	O
.	O
57	O
,	O
P	O
<	O
0	O
.	O
0001	O
)	O
and	O
anti	O
-	O
HA	O
sIgA	O
(	O
7	O
.	O
13	O
Â±	O
2	O
.	O
54	O
vs	O
.	O
4	O
.	O
02	O
Â±	O
0	O
.	O
33	O
,	O
P	O
=	O
0	O
.	O
0026	O
)	O
than	O
did	O
the	O
intramuscular	O
H7N9	O
vaccine	O
,	O
and	O
there	O
was	O
no	O
difference	O
in	O
HI	O
titer	O
between	O
the	O
two	O
groups	O
(	O
P	O
=	O
0	O
.	O
3745	O
).	O

This	O
finding	O
indicates	O
that	O
the	O
JY	O
-	O
adjuvanted	O
nasal	B-ANAT
spray	O
H7N9	O
vaccine	O
induced	O
not	O
only	O
the	O
systemic	O
immune	O
response	O
but	O
also	O
a	O
local	O
mucosal	B-ANAT
response	O
,	O
which	O
may	O
improve	O
the	O
efficacy	O
of	O
H7N9	O
influenza	O
prevention	O
through	O
respiratory	B-ANAT
tract	I-ANAT
transmission	O
.	O

Virulence	O
of	O
the	O
attenuated	O
viruses	O
was	O
then	O
tested	O
via	O
the	O
ocular	B-ANAT
route	O
inoculation	O
and	O
the	O
in	O
vivo	O
back	B-ANAT
passage	O
in	O
day	O
-	O
old	O
SPF	O
chickens	O
.	O

TITLE	O
:	O
Characterization	O
of	O
peritoneal	B-ANAT
cells	B-ANAT
from	O
cats	O
with	O
experimentally	O
-	O
induced	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
)	O
using	O
RNA	O
-	O
seq	O
.	O

TITLE	O
:	O
Different	O
intestinal	B-ANAT
tropism	O
of	O
the	O
G2b	O
Taiwan	O
porcine	O
epidemic	O
diarrhea	O
virus	O
-	O
Pintung	O
52	O
strain	O
in	O
conventional	O
7	O
-	O
day	O
-	O
old	O
piglets	O
.	O

With	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
select	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
can	O
be	O
managed	O
without	O
mechanical	O
ventilation	O
,	O
sedation	O
,	O
or	O
neuromuscular	O
blockade	O
.	O

The	O
primary	O
outcome	O
was	O
survival	O
to	O
hospital	O
discharge	B-ANAT
and	O
at	O
90	O
days	O
.	O

A	O
statistically	O
significant	O
difference	O
in	O
lung	B-ANAT
compliance	O
[	O
Îµ	O
=	O
0	O
.	O
150	O
,	O
F	O
(	O
1	O
.	O
053	O
,	O
3	O
.	O
158	O
)=	O
31	O
.	O
098	O
,	O
p	O
=	O
0	O
.	O
010	O
]	O
and	O
driving	O
pressure	O
[	O
Îµ	O
=	O
0	O
.	O
263	O
,	O
F	O
(	O
1	O
.	O
844	O
,	O
5	O
.	O
532	O
)=	O
7	O
.	O
042	O
,	O
p	O
=	O
0	O
.	O
031	O
]	O
was	O
observed	O
with	O
time	O
,	O
while	O
plateau	O
pressure	O
did	O
not	O
changed	O
significantly	O
during	O
surgery	O
[	O
Îµ	O
=	O
0	O
.	O
322	O
,	O
F	O
(	O
2	O
.	O
256	O
,	O
6	O
.	O
769	O
)=	O
1	O
.	O
920	O
,	O
p	O
=	O
0	O
.	O
219	O
].	O

ABSTRACT	O
:	O
1	O
,	O
3	O
-	O
oxazine	O
nucleus	B-ANAT
and	O
thiazolyl	O
group	O
features	O
prominently	O
in	O
many	O
biologically	O
important	O
natural	O
products	O
as	O
well	O
as	O
bioactive	O
molecules	O
.	O

Through	O
direct	O
cloning	O
and	O
expression	O
of	O
the	O
variable	O
heavy	O
chains	O
(	O
VHHs	O
)	O
of	O
HCAbs	O
from	O
the	O
bone	B-ANAT
marrow	I-ANAT
of	O
MERS	O
-	O
CoV	O
-	O
infected	O
dromedaries	O
,	O
we	O
identified	O
several	O
MERS	O
-	O
CoV	O
-	O
specific	O
VHHs	O
or	O
nanobodies	O
.	O

Among	O
these	O
seven	O
synthesized	O
compounds	O
,	O
linear	O
reniochalistatin	O
B	O
was	O
found	O
to	O
have	O
potent	O
activity	O
against	O
several	O
cancer	B-ANAT
cell	I-ANAT
lines	O
not	O
shown	O
by	O
the	O
cyclic	O
reniochalistatin	O
B	O
counterpart	O
.	O

Viral	O
RNA	O
was	O
detected	O
in	O
faeces	B-ANAT
and	O
various	O
tissues	B-ANAT
of	O
the	O
infected	O
piglets	O
.	O

Moreover	O
,	O
macroscopic	O
and	O
microscopic	O
lesions	O
in	O
whole	O
intestinal	B-ANAT
tract	I-ANAT
were	O
observed	O
,	O
and	O
viral	O
antigen	O
could	O
be	O
detected	O
in	O
the	O
small	B-ANAT
intestines	I-ANAT
by	O
immunohistochemical	O
staining	O
and	O
electron	O
microscopy	O
.	O

Following	O
microbial	O
infection	O
,	O
there	O
is	O
often	O
robust	O
chemokine	O
signaling	O
elicited	O
from	O
infected	O
cells	B-ANAT
,	O
which	O
contributes	O
to	O
both	O
innate	O
and	O
adaptive	O
immune	O
responses	O
that	O
control	O
growth	O
of	O
the	O
invading	O
pathogen	O
.	O

Intracranial	B-ANAT
inoculation	O
of	O
the	O
CNS	B-ANAT
of	O
susceptible	O
mice	O
with	O
JHMV	O
results	O
in	O
an	O
acute	O
encephalomyelitis	O
characterized	O
by	O
widespread	O
dissemination	O
of	O
virus	O
throughout	O
the	O
parenchyma	B-ANAT
.	O

We	O
used	O
latent	O
class	O
analysis	O
to	O
identify	O
patients	O
with	O
distinct	O
MMP	O
profiles	O
and	O
then	O
associated	O
those	O
profiles	O
with	O
markers	O
of	O
inflammation	O
(	O
IL	O
-	O
1RA	O
,	O
-	O
6	O
,	O
-	O
8	O
,	O
-	O
10	O
,	O
and	O
-	O
18	O
;	O
macrophage	B-ANAT
inflammatory	O
protein	O
-	O
1Î±	O
and	O
-	O
1Î²	O
;	O
tumor	O
necrosis	O
factor	O
-	O
Î±	O
and	O
-	O
R2	O
),	O
endothelial	B-ANAT
injury	O
(	O
angiopoietin	O
-	O
2	O
,	O
von	O
Willebrand	O
factor	O
,	O
soluble	O
thrombomodulin	O
),	O
impaired	O
oxygenation	O
(	O
Pa	O
In	O
geographically	O
distinct	O
derivation	O
and	O
validation	O
cohorts	O
,	O
approximately	O
one	O
-	O
third	O
of	O
patients	O
demonstrated	O
an	O
MMP	O
profile	O
characterized	O
by	O
elevated	O
MMP	O
-	O
1	O
,	O
-	O
2	O
,	O
-	O
3	O
,	O
-	O
7	O
,	O
and	O
-	O
8	O
and	O
tissue	B-ANAT
inhibitor	O
of	O
metalloproteinase	O
-	O
1	O
and	O
-	O
2	O
;	O
and	O
depressed	O
active	O
and	O
total	O
MMP	O
-	O
9	O
.	O

TITLE	O
:	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
in	O
Predominantly	O
Leuco	O
-	O
and	O
Thrombocytopenic	O
Haematologic	O
/	O
Oncologic	O
Patients	O
with	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
-	O
a	O
Single	O
-	O
Centre	O
Experience	O
.	O

25	O
patients	O
,	O
11	O
of	O
whom	O
underwent	O
haematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplantation	O
(	O
SCT	O
),	O
were	O
analysed	O
.	O

TITLE	O
:	O
Oral	B-ANAT
administration	O
of	O
inactivated	O
porcine	O
epidemic	O
diarrhea	O
virus	O
activate	O
DCs	O
in	O
porcine	O
Peyer	B-ANAT
'	I-ANAT
s	I-ANAT
patches	I-ANAT
.	O

Firstly	O
,	O
a	O
method	O
to	O
isolate	O
DCs	O
from	O
porcine	O
PPs	O
was	O
established	O
,	O
in	O
which	O
the	O
purity	O
of	O
SWC3a	O
Our	O
findings	O
indicate	O
that	O
oral	B-ANAT
administration	O
of	O
inactivated	O
PEDV	O
activate	O
DCs	O
in	O
porcine	O
Peyer	B-ANAT
'	I-ANAT
s	I-ANAT
patches	I-ANAT
and	O
inactivated	O
PEDV	O
may	O
be	O
a	O
useful	O
and	O
safe	O
vaccine	O
to	O
trigger	O
adaptive	O
immunity	O
.	O

As	O
an	O
enveloped	O
virus	O
,	O
translocation	O
through	O
the	O
endolysosomal	O
system	O
provides	O
one	O
pathway	O
for	O
cellular	B-ANAT
entry	O
of	O
MERS	O
-	O
CoV	O
.	O
In	O
this	O
context	O
,	O
Ca	O

TITLE	O
:	O
Î³Î´	O
T	B-ANAT
Cells	I-ANAT
Contribute	O
to	O
the	O
Outcome	O
of	O
Murine	O
Fulminant	O
Viral	O
Hepatitis	O
via	O
Effector	O
Cytokines	O
TNF	O
-	O
Î±	O
and	O
IFN	O
-	O
Î³	O
.	O

The	O
proportions	O
of	O
Î³Î´	O
T	B-ANAT
cells	I-ANAT
in	O
blood	B-ANAT
,	O
spleen	B-ANAT
and	O
liver	B-ANAT
were	O
significantly	O
increased	O
post	O
MHV	O
-	O
3	O
infection	O
,	O
while	O
those	O
of	O
the	O
early	O
activating	O
molecule	O
CD69	O
-	O
expressing	O
Î³Î´	O
T	B-ANAT
cells	I-ANAT
and	O
productions	O
of	O
cytokines	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
(	O
TNF	O
-	O
Î±	O
)	O
and	O
interferon	O
-	O
Î³	O
(	O
IFN	O
-	O
Î³	O
)	O
increased	O
remarkably	O
in	O
the	O
liver	B-ANAT
.	O

These	O
highly	O
activated	O
liver	B-ANAT
Î³Î´	O
T	B-ANAT
cells	I-ANAT
were	O
cytotoxic	O
to	O
MHV	O
-	O
3	O
-	O
infected	O
hepatocytes	B-ANAT
in	O
vitro	O
and	O
this	O
effect	O
of	O
liver	B-ANAT
Î³Î´	O
T	B-ANAT
cells	I-ANAT
against	O
hepatocytes	B-ANAT
might	O
involve	O
the	O
TNF	O
-	O
Î±	O
and	O
IFN	O
-	O
Î³	O
pathway	O
.	O

In	O
addition	O
,	O
uncontrolled	O
secretion	B-ANAT
of	O
interferon	O
É£	O
-	O
induced	O
protein	O
10	O
and	O
monocyte	B-ANAT
chemoattractant	O
protein	O
-	O
1	O
can	O
suppress	O
proliferation	O
of	O
human	O
myeloid	B-ANAT
progenitor	I-ANAT
cells	I-ANAT
.	O

Fifteen	O
pilgrims	O
had	O
fever	O
(>	O
38	O
Â°	O
C	O
)	O
accompanied	O
by	O
respiratory	O
symptoms	O
;	O
of	O
these	O
,	O
12	O
patients	O
were	O
diagnosed	O
with	O
upper	O
and	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
and	O
three	O
patients	O
with	O
pneumonia	O
.	O

B	O
cell	B-ANAT
hybridoma	I-ANAT
technique	O
was	O
used	O
to	O
generate	O
hybridoma	B-ANAT
cells	B-ANAT
that	O
secrete	O
specific	O
antibodies	O
.	O

We	O
obtained	O
samples	O
with	O
nylon	O
swabs	O
from	O
the	O
glans	B-ANAT
penis	I-ANAT
,	O
corona	O
,	O
inner	O
layer	B-ANAT
of	O
the	O
prepuce	B-ANAT
and	O
penile	B-ANAT
body	I-ANAT
and	O
detected	O
different	O
types	O
of	O
HPV	O
infection	O
using	O
the	O
Hybribio	O
HPV	O
typing	O
kit	O
,	O
PCR	O
and	O
membrane	B-ANAT
hybridization	O
.	O

Both	O
strains	O
caused	O
respiratory	O
and	O
kidney	B-ANAT
infections	O
based	O
on	O
immunohistochemistry	O
(	O
IHC	O
),	O
real	O
-	O
time	O
quantitative	O
polymerase	O
chain	O
reaction	O
(	O
qPCR	O
)	O
and	O
a	O
ciliostasis	O
study	O
;	O
however	O
,	O
the	O
results	O
showed	O
that	O
the	O
QX	O
-	O
like	O
strain	O
was	O
more	O
pathogenic	O
,	O
caused	O
higher	O
mortality	O
and	O
showed	O
higher	O
tissue	B-ANAT
tropism	O
for	O
the	O
kidney	B-ANAT
than	O
the	O
variant	O
strain	O
.	O

In	O
contrast	O
,	O
despite	O
causing	O
low	O
or	O
no	O
mortality	O
depending	O
on	O
the	O
age	O
of	O
the	O
infected	O
chickens	O
,	O
the	O
Malaysian	O
variant	O
strain	O
showed	O
high	O
tissue	B-ANAT
tropism	O
for	O
the	O
respiratory	B-ANAT
tract	I-ANAT
compared	O
with	O
the	O
QX	O
-	O
like	O
strain	O
.	O

A	O
descriptive	O
study	O
was	O
carried	O
out	O
on	O
159	O
adult	O
burn	O
patients	O
with	O
burn	O
extent	O
â¥	O
20	O
%	O
total	B-ANAT
body	I-ANAT
surface	I-ANAT
area	O
,	O
treated	O
at	O
the	O
Burn	O
Intensive	O
Care	O
Unit	O
,	O
National	O
Institute	O
of	O
Burns	O
.	O

However	O
,	O
the	O
details	O
of	O
how	O
sialic	O
acid	O
and	O
low	O
pH	O
affect	O
virus	O
binding	O
to	O
the	O
host	B-ANAT
cell	I-ANAT
are	O
not	O
determined	O
,	O
and	O
the	O
functions	O
of	O
the	O
proteases	O
are	O
unknown	O
.	O

TITLE	O
:	O
SARS	O
-	O
Coronavirus	O
Open	O
Reading	O
Frame	O
-	O
3a	O
drives	O
multimodal	O
necrotic	O
cell	B-ANAT
death	O
.	O

Consequently	O
,	O
Transcription	O
Factor	O
EB	O
(	O
TFEB	O
)	O
translocates	O
to	O
the	O
nucleus	B-ANAT
increasing	O
the	O
transcription	O
of	O
autophagy	O
-	O
and	O
lysosome	B-ANAT
-	O
related	O
genes	O
.	O

LPS	O
decreased	O
the	O
expression	O
levels	O
of	O
CD26	O
/	O
DPP4	O
on	O
pulmonary	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
and	O
PVECs	O
isolated	O
from	O
mouse	O
lungs	B-ANAT
,	O
and	O
the	O
effect	O
was	O
partially	O
reversed	O
by	O
sitagliptin	O
.	O

In	O
vitro	O
,	O
human	O
lung	B-ANAT
microvascular	O
ECs	O
(	O
HLMVECs	O
)	O
expressed	O
higher	O
levels	O
of	O
CD26	O
/	O
DPP4	O
than	O
human	O
pulmonary	B-ANAT
arterial	B-ANAT
ECs	O
.	O

In	O
summary	O
,	O
sitagliptin	O
attenuates	O
LPS	O
-	O
induced	O
lung	B-ANAT
injury	O
in	O
mice	O
and	O
exerts	O
anti	O
-	O
inflammatory	O
effects	O
on	O
HLMVECs	O
.	O

Chest	B-ANAT
computed	O
tomography	O
(	O
CT	O
)	O
on	O
arrival	O
showed	O
ground	O
glass	O
opacity	O
(	O
GGO	O
)	O
in	O
the	O
bilateral	O
lungs	B-ANAT
with	O
emphysematous	O
change	O
.	O

Moreover	O
,	O
HRG	O
suppressed	O
tumor	O
necrosis	O
factor	O
Î±	O
,	O
inducible	O
nitric	O
oxide	O
synthase	O
,	O
interleukin	O
6	O
,	O
and	O
neutrophil	B-ANAT
elastase	O
mRNA	O
expression	O
and	O
myeloperoxidase	O
activity	O
in	O
the	O
lung	B-ANAT
.	O

Further	O
attenuation	O
of	O
the	O
Ark99	O
vaccine	O
was	O
achieved	O
by	O
passage	O
in	O
embryonated	O
eggs	O
but	O
ArkGA	O
P1	O
,	O
P20	O
,	O
and	O
P40	B-ANAT
(	O
designated	O
ArkGA	O
after	O
P1	O
)	O
were	O
still	O
too	O
reactive	O
to	O
be	O
suitable	O
vaccine	O
candidates	O
.	O

The	O
patients	O
with	O
ultrasound	O
integrated	O
management	O
received	O
a	O
more	O
appropriate	O
pharmacological	O
therapy	O
(	O
p	O
0	O
.	O
01	O
),	O
as	O
well	O
as	O
non	O
-	O
invasive	O
ventilation	O
(	O
CPAP	O
)	O
was	O
used	O
more	O
frequently	O
in	O
those	O
with	O
an	O
acute	O
exacerbation	O
of	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
p	O
0	O
.	O
011	O
).	O

RESULTS	O
:	O
Pre	O
-	O
hospital	O
lung	B-ANAT
ultrasound	O
had	O
a	O
high	O
specificity	O
(	O
94	O
.	O
4	O
%)	O
and	O
sensitivity	O
(	O
100	O
%)	O
for	O
the	O
correct	O
identification	O
of	O
alveolar	B-ANAT
interstitial	B-ANAT
syndrome	O
using	O
B	O
lines	O
,	O
whereas	O
the	O
percentages	O
obtained	O
with	O
pleural	B-ANAT
effusion	I-ANAT
were	O
lower	O
(	O
83	O
.	O
3	O
,	O
53	O
.	O
3	O
%,	O
respectively	O
).	O

The	O
most	O
recent	O
common	O
ancestor	O
of	O
HBV	O
/	O
C	O
was	O
traced	O
back	B-ANAT
to	O
the	O
early	O
1900s	O
in	O
China	O
,	O
where	O
it	O
eventually	O
diverged	O
into	O
two	O
major	O
lineages	O
during	O
the	O
1930s	O
-	O
1960s	O
that	O
gave	O
rise	O
to	O
distinct	O
epidemic	O
waves	O
spreading	O
exponentially	O
to	O
other	O
East	O
Asian	O
countries	O
and	O
the	O
USA	O
.	O

This	O
could	O
be	O
explained	O
by	O
an	O
HFO	O
-	O
induced	O
right	O
ventricular	B-ANAT
(	O
RV	O
)	O
dysfunction	O
/	O
failure	O
due	O
to	O
high	O
intrathoracic	O
pressures	O
and	O
hypercapnia	O
.	O

TITLE	O
:	O
Clinical	O
features	O
and	O
outcome	O
of	O
patients	O
with	O
acute	O
respiratory	O
failure	O
revealing	O
anti	O
-	O
synthetase	O
or	O
anti	O
-	O
MDA	O
-	O
5	O
dermato	O
-	O
pulmonary	B-ANAT
syndrome	O
:	O
a	O
French	O
multicenter	O
retrospective	O
study	O
.	O

Proportion	O
of	O
patients	O
who	O
received	O
corticosteroids	O
,	O
cyclophosphamide	O
,	O
rituximab	O
,	O
intravenous	O
immunoglobulins	O
and	O
plasma	B-ANAT
exchange	O
were	O
100	O
%,	O
72	O
%,	O
15	O
%,	O
21	O
%	O
and	O
17	O
%,	O
respectively	O
.	O

Patients	O
with	O
aMDA	O
-	O
5	O
dermato	O
-	O
pulmonary	B-ANAT
syndrome	O
had	O
a	O
higher	O
hospital	O
mortality	O
than	O
those	O
with	O
AS	O
syndrome	O
(	O
n	O
=	O
16	O
/	O
19	O
,	O
84	O
%	O
vs	O
.	O
n	O
=	O
8	O
/	O
28	O
,	O
29	O
%;	O
p	O
=	O
0	O
.	O
001	O
).	O

Extra	O
-	O
pulmonary	B-ANAT
manifestations	O
are	O
commonly	O
lacking	O
.	O

ABSTRACT	O
:	O
Routine	O
testing	O
of	O
breeding	O
herd	O
oral	B-ANAT
fluid	O
(	O
OF	O
)	O
samples	O
for	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
IgG	O
and	O
/	O
or	O
IgA	O
is	O
used	O
to	O
track	O
levels	O
of	O
PEDV	O
immunity	O
over	O
time	O
.	O

With	O
recent	O
studies	O
refuting	O
uterine	B-ANAT
size	O
and	O
leiomyoma	O
location	O
as	O
risk	O
factors	O
,	O
further	O
research	O
is	O
needed	O
to	O
help	O
select	O
appropriate	O
uterine	B-ANAT
artery	I-ANAT
embolization	O
candidates	O
.	O

In	O
conclusion	O
,	O
this	O
case	O
study	O
reported	O
an	O
epidemic	O
TGEV	O
infection	O
in	O
piglets	O
,	O
characterized	O
by	O
low	O
mortality	O
and	O
medium	O
morbidity	O
rates	O
accompanied	O
by	O
typical	O
histopathological	O
lesions	O
in	O
small	B-ANAT
intestine	I-ANAT
,	O
as	O
well	O
as	O
by	O
coexisting	O
brain	B-ANAT
lesions	O
,	O
that	O
are	O
described	O
for	O
the	O
first	O
time	O
.	O

Our	O
results	O
demonstrated	O
that	O
the	O
chickens	O
vaccinated	O
once	O
orally	B-ANAT
with	O
JOL2077	O
elicited	O
significantly	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
higher	O
IBV	O
-	O
specific	O
humoral	O
and	O
cell	B-ANAT
-	O
mediated	O
immunity	O
compared	O
to	O
JOL2068	O
and	O
PBS	O
control	O
groups	O
.	O

TITLE	O
:	O
Interplay	O
between	O
the	O
Poly	O
(	O
A	O
)	O
Tail	O
,	O
Poly	O
(	O
A	O
)-	O
Binding	O
Protein	O
,	O
and	O
Coronavirus	O
Nucleocapsid	B-ANAT
Protein	O
Regulates	O
Gene	O
Expression	O
of	O
Coronavirus	O
and	O
the	O
Host	B-ANAT
Cell	I-ANAT
.	O

High	O
-	O
frequency	O
oscillatory	O
ventilation	O
,	O
application	O
of	O
recruitment	O
maneuvers	O
,	O
higher	O
PEEP	O
,	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
and	O
alternate	O
modes	O
of	O
mechanical	O
ventilation	O
have	O
failed	O
to	O
show	O
benefit	O
.	O

Similarly	O
,	O
most	O
pharmacological	O
therapies	O
including	O
keratinocyte	B-ANAT
growth	O
factor	O
,	O
beta	O
-	O
2	O
agonists	O
,	O
and	O
aspirin	O
did	O
not	O
improve	O
outcomes	O
.	O

Left	O
untreated	O
,	O
the	O
condition	O
may	O
rapidly	O
progress	O
to	O
multi	O
-	O
organ	B-ANAT
failure	O
and	O
death	O
.	O

Acute	O
intoxication	O
may	O
cause	O
severe	O
cardiac	B-ANAT
and	O
respiratory	O
complications	O
and	O
seizures	O
.	O

5	O
)	O
Natural	O
products	O
were	O
identified	O
to	O
allosterically	O
inhibit	O
Zika	O
and	O
Dengue	O
proteases	O
through	O
binding	O
a	O
pocket	O
on	O
the	O
back	B-ANAT
of	O
the	O
active	O
site	O
.	O

(	O
1	O
)	O
Clinical	O
features	O
:	O
compared	O
with	O
the	O
youth	O
group	O
,	O
the	O
elderly	O
group	O
had	O
higher	O
proportion	O
of	O
basic	O
diseases	O
included	O
hypertension	O
,	O
type	O
2	O
diabetes	O
and	O
coronary	B-ANAT
heart	B-ANAT
disease	O
,	O
higher	O
the	O
initial	O
APACHE	O
II	O
scores	O
at	O
admission	O
,	O
higher	O
the	O
proportion	O
of	O
invasive	O
mechanical	O
ventilation	O
and	O
respiratory	O
failure	O
,	O
and	O
longer	O
the	O
length	O
of	O
EICU	O
stay	O
and	O
the	O
length	O
of	O
hospital	O
stay	O
.	O

ABSTRACT	O
:	O
Recently	O
,	O
the	O
use	O
of	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
adult	O
patients	O
with	O
severe	O
acute	O
respiratory	O
failure	O
has	O
increased	O
.	O

We	O
previously	O
investigated	O
the	O
optimal	O
return	O
cannula	O
position	O
;	O
however	O
,	O
the	O
optimal	O
drainage	B-ANAT
cannula	O
position	O
has	O
not	O
yet	O
been	O
fully	O
clarified	O
.	O

Here	O
we	O
explored	O
the	O
functions	O
of	O
CVC1303	O
on	O
the	O
humoral	O
,	O
cellular	B-ANAT
and	O
mucosal	B-ANAT
immune	O
response	O
to	O
PEDV	O
vaccine	O
in	O
mice	O
immunization	O
.	O

On	O
30th	O
day	O
after	O
the	O
second	O
immunization	O
,	O
sera	B-ANAT
samples	O
were	O
collected	O
from	O
the	O
immunized	O
mice	O
to	O
measure	O
PEDV	O
-	O
specific	O
IgG	O
and	O
IgG	O
subclasses	O
levels	O
,	O
and	O
lymphocytes	B-ANAT
were	O
isolated	O
to	O
detect	O
T	B-ANAT
cell	I-ANAT
subtype	O
and	O
intracellular	B-ANAT
IL	O
-	O
4	O
and	O
IL	O
-	O
6	O
cytokine	O
productions	O
,	O
and	O
the	O
expressions	O
of	O
co	O
-	O
stimulatory	O
molecule	O
on	O
dendritic	B-ANAT
cells	I-ANAT
in	O
the	O
immunized	O
mice	O
.	O

The	O
current	O
study	O
therefore	O
determines	O
breath	B-ANAT
-	O
by	O
-	O
breath	B-ANAT
regional	O
expiratory	O
time	O
constants	O
in	O
intubated	O
patients	O
with	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
COPD	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Sixteen	O
(	O
73	O
%)	O
were	O
unaware	O
of	O
MERS	O
-	O
CoV	O
.	O
Use	O
of	O
personal	O
protective	O
clothing	O
to	O
prevent	O
direct	O
contact	O
with	O
discharges	B-ANAT
and	O
aerosols	O
was	O
lacking	O
.	O

Extracellular	B-ANAT
vesicles	B-ANAT
(	O
EVs	O
)	O
have	O
been	O
shown	O
to	O
mediate	O
cellular	B-ANAT
crosstalk	O
in	O
inflammation	O
by	O
transfer	O
of	O
microRNAs	O
(	O
miRNAs	O
).	O

ABSTRACT	O
:	O
The	O
open	O
lung	B-ANAT
approach	O
(	O
OLA	O
)	O
reportedly	O
has	O
lung	B-ANAT
-	O
protective	O
effects	O
against	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Furthermore	O
,	O
levels	O
of	O
CXCL	O
-	O
7	O
,	O
a	O
platelet	B-ANAT
-	O
derived	O
chemokine	O
,	O
were	O
higher	O
in	O
the	O
BALF	O
from	O
the	O
control	O
group	O
,	O
indicating	O
that	O
OLA	O
protects	O
the	O
lungs	B-ANAT
by	O
suppressing	O
platelet	B-ANAT
activation	O
.	O

In	O
this	O
study	O
,	O
coated	O
PEDV	O
-	O
loaded	O
microspheres	O
with	O
the	O
size	O
range	O
of	O
700	O
-	O
900	O
Î¼m	O
in	O
diameter	O
were	O
developed	O
by	O
centrifugal	O
granulation	O
-	O
fluidized	O
bed	O
coating	O
and	O
demonstrated	O
as	O
an	O
effective	O
oral	B-ANAT
delivery	O
system	O
to	O
protect	O
PEDV	O
antigens	O
against	O
the	O
complex	O
gastrointestinal	O
environment	O
by	O
detecting	O
the	O
live	O
virus	B-ANAT
particles	I-ANAT
in	O
microspheres	O
after	O
the	O
simulated	O
gastric	B-ANAT
fluid	I-ANAT
treatment	O
and	O
the	O
PEDV	O
RNA	O
in	O
fecal	B-ANAT
swabs	O
collected	O
from	O
all	O
weaned	O
piglets	O
(	O
100	O
%)	O
orally	B-ANAT
inoculated	O
with	O
coated	O
PEDV	O
-	O
loaded	O
microspheres	O
.	O

Furthermore	O
,	O
neutralization	O
assays	O
demonstrated	O
that	O
serum	B-ANAT
antibodies	O
in	O
coated	O
PEDV	O
-	O
loaded	O
microspheres	O
groups	O
could	O
significantly	O
inhibit	O
virus	O
infection	O
in	O
Vero	B-ANAT
cells	I-ANAT
,	O
compared	O
to	O
PEDV	O
only	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
its	O
severe	O
form	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
remain	O
a	O
major	O
cause	O
of	O
morbidity	O
and	O
mortality	O
in	O
critically	O
ill	O
patients	O
,	O
and	O
no	O
specific	O
therapies	O
are	O
still	O
available	O
to	O
control	O
the	O
mortality	O
rate	O
.	O

In	O
both	O
preventive	O
and	O
therapeutic	O
approaches	O
,	O
TA	O
attenuated	O
LPS	O
-	O
induced	O
histopathological	O
alterations	O
,	O
lipid	O
peroxidation	O
,	O
lung	B-ANAT
permeability	O
,	O
infiltration	O
of	O
inflammatory	B-ANAT
cells	I-ANAT
,	O
and	O
the	O
expression	O
of	O
proinflammatory	O
mediators	O
.	O

Blood	B-ANAT
serum	I-ANAT
samples	O
were	O
tested	O
for	O
detection	O
of	O
antibodies	O
to	O
IBDV	O
,	O
IBV	O
,	O
NDV	O
,	O
and	O
MG	O
by	O
using	O
an	O
IDEXX	O
Enzyme	O
-	O
linked	O
Immunosorbent	O
Assay	O
.	O

To	O
understand	O
the	O
influence	O
of	O
a	O
viral	O
factor	O
in	O
relation	O
to	O
interspecies	O
spillover	O
,	O
we	O
studied	O
the	O
papain	O
-	O
like	O
protease	O
(	O
PLP	O
)	O
of	O
SARS	O
-	O
CoV	O
.	O
This	O
key	O
enzyme	O
drives	O
the	O
early	O
stages	O
of	O
infection	O
as	O
it	O
cleaves	O
the	O
viral	O
polyprotein	O
,	O
deubiquitinates	O
viral	O
and	O
cellular	B-ANAT
proteins	O
,	O
and	O
antagonizes	O
the	O
interferon	O
(	O
IFN	O
)	O
response	O
.	O

Moreover	O
,	O
the	O
protein	O
levels	O
in	O
nucleus	B-ANAT
and	O
the	O
mRNA	O
levels	O
of	O
AIF	O
were	O
inhibited	O
in	O
the	O
presence	O
of	O
the	O
p53	O
inhibitor	O
,	O
piï¬thrin	O
-	O
Î±	O
(	O
PFT	O
-	O
Î±	O
)	O
or	O
in	O
TGEV	O
-	O
infected	O
p53	O
-/-	O
cells	B-ANAT
.	O

Multivariate	O
Cox	O
regression	O
analysis	O
identified	O
PSI	O
(	O
hazard	O
ratio	O
1	O
.	O
020	O
,	O
95	O
%	O
confidence	O
interval	O
1	O
.	O
009	O
-	O
1	O
.	O
032	O
;	O
p	O
<	O
0	O
.	O
001	O
),	O
renal	B-ANAT
replacement	O
therapy	O
(	O
hazard	O
ratio	O
6	O
.	O
248	O
,	O
95	O
%	O
confidence	O
interval	O
2	O
.	O
245	O
-	O
17	O
.	O
389	O
;	O
p	O
<	O
0	O
.	O
001	O
),	O
and	O
increase	O
in	O
dynamic	O
driving	O
pressure	O
(	O
hazard	O
ratio	O
1	O
.	O
372	O
,	O
95	O
%	O
confidence	O
interval	O
1	O
.	O
095	O
-	O
1	O
.	O
718	O
;	O
p	O
=	O
0	O
.	O
006	O
)	O
which	O
were	O
independent	O
predictors	O
associated	O
with	O
60	O
-	O
day	O
mortality	O
.	O

TITLE	O
:	O
Viral	O
Respiratory	B-ANAT
Tract	I-ANAT
Infection	O

The	O
main	O
purpose	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
long	O
-	O
term	O
effects	O
of	O
VRTI	O
during	O
the	O
first	O
year	O
after	O
lung	B-ANAT
transplantation	O
in	O
relation	O
to	O
CLAD	O
development	O
.	O

Nasopharyngeal	B-ANAT
swab	I-ANAT
and	O
bronchoalveolar	O
lavage	O
samples	O
were	O
analyzed	O
using	O
a	O
multiplex	O
polymerase	O
chain	O
reaction	O
panel	O
for	O
respiratory	O
pathogens	O
.	O

The	O
blood	B-ANAT
samples	I-ANAT
were	O
assessed	O
for	O
the	O
antibodies	O
against	O
NDV	O
and	O
AIV	O
by	O
haemagglutination	O
inhibition	O
test	O
,	O
and	O
against	O
IBV	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

ABSTRACT	O
:	O
Cell	B-ANAT
entry	O
by	O
coronaviruses	O
involves	O
two	O
principal	O
steps	O
,	O
receptor	O
binding	O
and	O
membrane	B-ANAT
fusion	O
;	O
the	O
latter	O
requires	O
activation	O
by	O
host	O
proteases	O
,	O
particularly	O
lysosomal	B-ANAT
proteases	O
.	O

In	O
the	O
absence	O
of	O
an	O
available	O
vaccine	O
,	O
the	O
pregnant	O
sows	O
were	O
dosed	O
by	O
mouth	B-ANAT
with	O
a	O
10	O
%	O
suspension	O
prepared	O
from	O
the	O
intestine	B-ANAT
and	O
faeces	B-ANAT
of	O
infected	O
piglets	O
in	O
warm	O
water	O
.	O

ORF	O
3b	O
is	O
also	O
predicted	O
to	O
contain	O
DNA	O
-	O
binding	O
and	O
activator	O
domains	O
,	O
and	O
was	O
found	O
to	O
localise	O
in	O
the	O
mitochondrion	B-ANAT
.	O

This	O
review	O
will	O
discuss	O
viral	O
vector	O
and	O
nucleic	B-ANAT
acid	O
-	O
based	O
vaccines	O
(	O
DNA	O
and	O
mRNA	O
vaccines	O
)	O
as	O
new	O
approaches	O
that	O
might	O
be	O
able	O
to	O
tackle	O
these	O
challenges	O
to	O
global	O
health	O
.	O

TITLE	O
:	O
Chlordecone	O
potentiates	O
auto	O
-	O
immune	O
hepatitis	O
and	O
promotes	O
brain	B-ANAT
entry	O
of	O
MHV3	O
during	O
viral	O
hepatitis	O
in	O
mouse	O
models	O
.	O

ABSTRACT	O
:	O
We	O
tested	O
sera	B-ANAT
of	O
24	O
free	O
-	O
ranging	O
European	O
brown	O
bears	O
(	O
Ursus	O
arctos	O
)	O
from	O
six	O
regions	O
of	O
Slovakia	O
for	O
antibodies	O
to	O
10	O
viral	O
agents	O
.	O

Sera	B-ANAT
were	O
evaluated	O
by	O
nucleocapsid	B-ANAT
and	O
spike	O
protein	O
enzyme	O
immunoassays	O
and	O
microneutralization	O
.	O

TITLE	O
:	O
Speckle	O
tracking	O
echocardiography	O
and	O
right	B-ANAT
ventricle	I-ANAT
dysfunction	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
a	O
pilot	O
study	O
.	O

At	O
echocardiographic	O
examination	O
,	O
non	O
-	O
survivors	O
showed	O
lower	O
values	O
of	O
TAPSE	O
(	O
18	O
.	O
3	O
Â±	O
3	O
,	O
P	O
=	O
0	O
.	O
034	O
)	O
and	O
higher	O
systolic	O
pulmonary	B-ANAT
arterial	B-ANAT
pressure	O
(	O
49	O
.	O
6	O
Â±	O
16	O
,	O
P	O
=	O
0	O
.	O
05	O
).	O

TITLE	O
:	O
Acute	O
Megakaryoblastic	O
Leukemia	O
With	O
Diffuse	O
Periosteal	O
Reaction	O
of	O
Bilateral	O
Lower	B-ANAT
Extremities	I-ANAT
.	O

Bilateral	O
lower	B-ANAT
extremity	I-ANAT
swelling	O
was	O
noted	O
on	O
admission	O
and	O
radiographs	O
showed	O
diffusely	O
abnormal	O
appearance	O
of	O
the	O
long	B-ANAT
bones	I-ANAT
of	O
her	O
lower	B-ANAT
extremities	I-ANAT
with	O
periosteal	O
reaction	O
and	O
echogenic	O
debris	O
in	O
the	O
subperiosteal	O
space	O
,	O
thought	O
to	O
represent	O
leukemic	O
cells	B-ANAT
.	O

TITLE	O
:	O
[	O
Modified	O
David	O
-	O
Komeda	O
Repair	O
for	O
Ventricular	B-ANAT
Septal	O
Perforation	O
Complicated	O
with	O
Severe	O
Postoperative	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
;	O
Report	O
of	O
a	O
Case	O
].	O

Cells	B-ANAT
from	O
cotton	O
rat	O
,	O
goat	O
,	O
and	O
sheep	O
provided	O
control	O
scenarios	O
that	O
represent	O
host	O
systems	O
in	O
which	O
SARS	O
-	O
CoV	O
is	O
neither	O
endemic	O
nor	O
epidemic	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)	O
infection	O
can	O
activate	O
NF	O
-	O
ÎºB	O
pathway	O
in	O
porcine	O
intestinal	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
and	O
result	O
in	O
severe	O
inflammation	O
.	O

TITLE	O
:	O
Recurrent	O
Hydrochlorothiazide	O
-	O
Induced	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
Treated	O
With	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
.	O

Progressive	O
hypoxemia	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
developed	O
and	O
he	O
was	O
transferred	O
to	O
our	O
institution	O
for	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
).	O

Because	O
the	O
direct	O
cultivation	O
of	O
primary	O
porcine	O
enterocytes	B-ANAT
is	O
difficult	O
,	O
alternatives	O
have	O
to	O
be	O
considered	O
.	O

A	O
chest	B-ANAT
X	O
-	O
ray	O
showed	O
diffuse	O
bilateral	O
pulmonary	B-ANAT
infiltrates	O
.	O

Oropharyngeal	B-ANAT
(	O
OP	O
)	O
swabs	O
were	O
taken	O
from	O
eight	O
birds	O
per	O
flock	O
and	O
accompanied	O
with	O
flock	O
health	O
information	O
.	O

Reduced	O
ENaC	O
and	O
CFTR	O
led	O
to	O
changes	O
in	O
airway	B-ANAT
surface	O
liquid	O
morphology	O
of	O
human	O
tracheobronchial	O
cultures	O
and	O
airways	O
of	O
IAV	O
-	O
infected	O
mice	O
.	O

ABSTRACT	O
:	O
Pulmonary	B-ANAT
recruitment	O
and	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
titrated	O
according	O
to	O
minimal	O
static	O
elastance	O
of	O
the	O
respiratory	B-ANAT
system	I-ANAT
(	O
PEEP	O
Thirteen	O
patients	O
with	O
moderate	O
to	O
severe	O
ARDS	O
were	O
studied	O
at	O
PEEP	O
7	O
out	O
of	O
13	O
patients	O
showed	O
negative	O
end	O
-	O
expiratory	O
transpulmonary	O
pressures	O
(	O
Ptp	O
-)	O
with	O
both	O
strategies	O
(	O
PEEP	O
In	O
patients	O
with	O
moderate	O
-	O
to	O
-	O
severe	O
ARDS	O
,	O
PEEP	O
titrated	O
according	O
to	O
the	O
minimal	O
static	O
elastance	O
of	O
the	O
respiratory	B-ANAT
system	I-ANAT
or	O
according	O
to	O
the	O
ARDSNetwork	O
table	O
did	O
not	O
prevent	O
negative	O
end	O
-	O
expiratory	O
transpulmonary	O
pressure	O
.	O

ABSTRACT	O
:	O
Pharmacokinetic	O
parameters	O
can	O
be	O
significantly	O
altered	O
for	O
acute	O
kidney	B-ANAT
injury	O
(	O
AKI	O
),	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
and	O
continuous	O
veno	O
-	O
venous	B-ANAT
hemofiltration	O
therapy	O
(	O
CVVH	O
).	O

On	O
ICU	O
day	O
4	O
,	O
a	O
vancomycin	O
trough	O
serum	B-ANAT
concentration	O
of	O
14	O
.	O
1	O
mg	O
/	O
L	O
was	O
obtained	O
before	O
the	O
fourth	O
dose	O
,	O
which	O
was	O
within	O
the	O
target	O
range	O
of	O
10	O
-	O
20	O
mg	O
/	O
L	O
.	O
By	O
ICU	O
day	O
7	O
,	O
vancomycin	O
dosage	O
was	O
elevated	O
to	O
1	O
.	O
0	O
g	O
every	O
12	O
hours	O
because	O
of	O
aggravated	O
infection	O
and	O
improved	O
kidney	B-ANAT
function	O
.	O

Mediastinal	B-ANAT
pathology	O
including	O
tumors	O
,	O
herniation	O
of	O
abdominal	B-ANAT
content	O
,	O
and	O
pleural	B-ANAT
effusion	I-ANAT
can	O
often	O
be	O
visualized	O
directly	O
with	O
echocardiography	O
.	O

These	O
changes	O
do	O
not	O
reflect	O
properties	O
of	O
the	O
myocardium	B-ANAT
but	O
may	O
well	O
be	O
mistaken	O
for	O
it	O
.	O

Overwhelming	O
pulmonary	B-ANAT
inflammation	O
and	O
endothelium	B-ANAT
disruption	O
are	O
commonly	O
observed	O
.	O

The	O
medical	O
records	O
of	O
Prince	O
Mohamed	O
Bin	O
Abdulaziz	O
Hospital	O
were	O
reviewed	O
between	O
April	O
2014	O
and	O
December	O
2015	O
to	O
identify	O
admission	O
and	O
discharge	B-ANAT
with	O
MERS	O
-	O
CoV	O
.	O
Patient	O
'	O
s	O
characteristics	O
,	O
epidemiologic	O
and	O
clinical	O
data	O
and	O
laboratory	O
results	O
were	O
extracted	O
and	O
described	O
.	O

TITLE	O
:	O
White	O
-	O
nose	B-ANAT
syndrome	O
is	O
associated	O
with	O
increased	O
replication	O
of	O
a	O
naturally	O
persisting	O
coronaviruses	O
in	O
bats	O
.	O

Finally	O
,	O
we	O
found	O
that	O
the	O
TGEV	O
S1	O
protein	O
interacts	O
with	O
the	O
extracellular	B-ANAT
region	I-ANAT
of	O
TfR1	O
,	O
and	O
that	O
pre	O
-	O
incubating	O
TGEV	O
with	O
a	O
protein	O
fragment	O
containing	O
the	O
extracellular	B-ANAT
region	I-ANAT
of	O
TfR1	O
blocked	O
viral	O
infection	O
.	O

TITLE	O
:	O
A	O
multicenter	O
randomized	O
controlled	O
trial	O
of	O
a	O
3	O
-	O
L	O
/	O
kg	O
/	O
min	O
versus	O
2	O
-	O
L	O
/	O
kg	O
/	O
min	O
high	O
-	O
flow	O
nasal	B-ANAT
cannula	O
flow	O
rate	O
in	O
young	O
infants	O
with	O
severe	O
viral	O
bronchiolitis	O
(	O
TRAMONTANE	O
2	O
).	O

ABSTRACT	O
:	O
High	O
-	O
flow	O
nasal	B-ANAT
cannula	O
(	O
HFNC	O
)	O
therapy	O
is	O
increasingly	O
proposed	O
as	O
first	O
-	O
line	O
respiratory	O
support	O
for	O
infants	O
with	O
acute	O
viral	O
bronchiolitis	O
(	O
AVB	O
).	O

She	O
was	O
started	O
on	O
nasogastric	B-ANAT
feeding	O
initially	O
and	O
subsequently	O
switched	O
to	O
oral	B-ANAT
diet	O
as	O
tolerated	O
.	O

Four	O
horses	O
were	O
intragastrically	O
infected	O
with	O
fecal	B-ANAT
material	O
containing	O
10	O
All	O
8	O
horses	O
shed	O
ECoV	O
in	O
feces	B-ANAT
.	O

No	O
differences	O
between	O
experimentally	O
-	O
infected	O
horses	O
and	O
horses	O
exposed	O
to	O
ECoV	O
-	O
containing	O
feces	B-ANAT
were	O
identified	O
.	O

Furthermore	O
,	O
the	O
506	O
-	O
2G10G5	O
monoclonal	O
antibody	O
significantly	O
reduced	O
plaque	O
formation	O
in	O
MERS	O
-	O
CoV	O
infected	O
Vero	B-ANAT
cells	I-ANAT
compared	O
to	O
normal	O
mouse	O
IgG	O
and	O
492	O
-	O
1G10E4E2	O
.	O

The	O
viral	O
spike	O
glycoprotein	O
(	O
S	O
)	O
utilizes	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
as	O
a	O
host	O
protein	O
receptor	O
and	O
mediates	O
fusion	O
of	O
the	O
viral	O
and	O
host	O
membranes	B-ANAT
,	O
making	O
S	O
essential	O
to	O
viral	O
entry	O
into	O
host	O
cells	B-ANAT
and	O
host	O
species	O
tropism	O
.	O

Our	O
results	O
highlighted	O
the	O
importance	O
of	O
nucleic	B-ANAT
acid	O
extraction	O
kit	O
selection	O
,	O
which	O
has	O
a	O
major	O
impact	O
on	O
the	O
yield	O
and	O
number	O
of	O
viral	O
reads	O
by	O
NGS	O
analysis	O
.	O

ABSTRACT	O
:	O
ABO	O
blood	B-ANAT
type	O
A	O
was	O
reported	O
to	O
correlate	O
with	O
an	O
increased	O
risk	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
white	O
patients	O
with	O
severe	O
sepsis	O
and	O
major	O
trauma	O
compared	O
with	O
patients	O
with	O
other	O
blood	B-ANAT
types	O
.	O

The	O
primary	O
aim	O
was	O
to	O
determine	O
the	O
relationship	O
between	O
ABO	O
blood	B-ANAT
type	O
A	O
and	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
mortality	O
in	O
patients	O
with	O
acute	O
hypoxemic	O
respiratory	O
failure	O
(	O
AHRF	O
).	O

The	O
proportion	O
of	O
patients	O
with	O
ABO	O
blood	B-ANAT
type	O
A	O
versus	O
other	O
blood	B-ANAT
types	O
was	O
39	O
.	O
9	O
%	O
versus	O
60	O
.	O
1	O
%.	O

SAPSII	O
was	O
a	O
positive	O
predictor	O
of	O
ICU	O
mortality	O
(	O
odds	O
ration	O
[	O
OR	O
],	O
32	O
.	O
80	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
],	O
18	O
.	O
80	O
-	O
57	O
.	O
24	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
ICU	O
LOS	O
(	O
Î²	O
coefficient	O
,	O
0	O
.	O
55	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
35	O
-	O
0	O
.	O
75	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
at	O
multivariate	O
analyses	O
,	O
whereas	O
ABO	O
blood	B-ANAT
type	O
did	O
not	O
predict	O
ICU	O
outcome	O
when	O
forced	O
into	O
the	O
model	O
.	O

ABO	O
blood	B-ANAT
type	O
did	O
not	O
correlate	O
with	O
ICU	O
mortality	O
and	O
ICU	O
LOS	O
in	O
adult	O
patients	O
with	O
AHRF	O
who	O
were	O
mechanically	O
ventilated	O
.	O

Data	O
were	O
collected	O
on	O
the	O
PICU	O
characteristics	O
,	O
patient	O
demographics	O
,	O
and	O
elements	O
of	O
PARDS	O
(	O
ie	O
,	O
PARDS	O
risk	O
factors	O
,	O
hypoxaemia	O
severity	O
metrics	O
,	O
type	O
of	O
ventilation	O
),	O
comorbidities	O
,	O
chest	B-ANAT
imaging	O
,	O
arterial	B-ANAT
blood	I-ANAT
gas	O
measurements	O
,	O
and	O
pulse	O
oximetry	O
.	O

The	O
mice	O
in	O
the	O
YQFM	O
group	O
were	O
given	O
YQFM	O
(	O
three	O
doses	O
:	O
0	O
.	O
33	O
,	O
0	O
.	O
67	O
,	O
and	O
1	O
.	O
34	O
g	O
/	O
kg	O
)	O
by	O
tail	B-ANAT
vein	I-ANAT
injection	O
30	O
min	O
after	O
the	O
intratracheal	O
instillation	O
of	O
PM	O
.	O

Tissues	B-ANAT
of	O
small	B-ANAT
intestines	I-ANAT
from	O
CHN	O
-	O
HG	O
-	O
2017	O
-	O
infected	O
piglets	O
at	O
4	O
DPI	O
displayed	O
significant	O
macroscopic	O
and	O
microscopic	O
lesions	O
with	O
clear	O
viral	O
antigen	O
expression	O
.	O

Our	O
focus	O
is	O
on	O
platelet	B-ANAT
-	O
endothelial	B-ANAT
cell	I-ANAT
adhesion	O
molecule	O
-	O
1	O
,	O
which	O
contributes	O
to	O
the	O
maintenance	O
and	O
restoration	O
of	O
vascular	B-ANAT
integrity	O
following	O
barrier	O
disruption	O
.	O

ABSTRACT	O
:	O
Continuous	O
Positive	O
Airway	B-ANAT
Pressure	O
(	O
CPAP	O
)	O
is	O
a	O
form	O
of	O
non	O
-	O
invasive	O
ventilatory	O
support	O
which	O
is	O
increasingly	O
used	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
to	O
treat	O
neonates	O
with	O
acute	O
respiratory	O
distress	O
.	O

The	O
increased	O
concentration	O
of	O
IL	O
-	O
1Î²	O
in	O
the	O
immunized	O
animals	O
directly	O
correlated	O
with	O
the	O
activity	O
of	O
macrophages	B-ANAT
and	O
stimulated	O
B	B-ANAT
cells	I-ANAT
,	O
which	O
produce	O
this	O
cytokine	O
when	O
activated	O
.	O

The	O
increased	O
concentration	O
of	O
IL	O
-	O
6	O
indicates	O
that	O
the	O
injected	O
preparations	O
are	O
stimulatory	O
to	O
cellular	B-ANAT
immunity	O
.	O

The	O
nuclear	O
change	O
of	O
infected	O
cell	B-ANAT
was	O
monitored	O
by	O
confocal	O
immunofluorescence	O
assay	O
.	O

Similarly	O
,	O
expression	O
of	O
S1	O
protein	O
from	O
wild	O
-	O
type	O
strain	O
BJ2011	O
or	O
cell	B-ANAT
-	O
adapted	O
strain	O
CV777	O
,	O
also	O
induce	O
apoptosis	O
in	O
transfected	O
cells	B-ANAT
.	O

TITLE	O
:	O
Deletion	O
of	O
both	O
the	O
Tyrosine	O
-	O
Based	O
Endocytosis	O
Signal	O
and	O
the	O
Endoplasmic	B-ANAT
Reticulum	I-ANAT
Retrieval	O
Signal	O
in	O
the	O
Cytoplasmic	B-ANAT
Tail	I-ANAT
of	O
Spike	O
Protein	O
Attenuates	O
Porcine	O
Epidemic	O
Diarrhea	O
Virus	O
in	O
Pigs	O
.	O

Clinical	O
studies	O
identifying	O
the	O
factors	O
associated	O
with	O
acute	O
kidney	B-ANAT
injury	O
(	O
AKI	O
)	O
in	O
malaria	O
are	O
lacking	O
.	O

Chronic	O
alveolar	B-ANAT
hypoventilation	O
leading	O
to	O
concurrent	O
hypoxia	O
is	O
the	O
main	O
cause	O
of	O
morbidity	O
and	O
mortality	O
in	O
these	O
patients	O
due	O
to	O
its	O
complications	O
.	O

A	O
22	O
-	O
year	O
-	O
old	O
male	O
with	O
past	O
medical	O
history	O
of	O
ATD	O
and	O
severe	O
kyphoscoliosis	O
presented	O
with	O
progressively	O
worsening	O
shortness	O
of	O
breath	B-ANAT
for	O
several	O
days	O
.	O

Arterial	B-ANAT
blood	I-ANAT
gas	O
showed	O
PH	O
7	O
.	O
17	O
,	O
PCO2	O
155	O
,	O
PO2	O
95	O
and	O
O2	O
saturation	O
of	O
97	O
%	O
on	O
2	O
L	O
nasal	B-ANAT
cannulae	O
.	O

Patients	O
that	O
survive	O
past	O
the	O
age	O
of	O
2	O
have	O
seen	O
respiratory	O
complications	O
resolve	O
due	O
to	O
less	O
pronounced	O
thoracic	B-ANAT
malformations	O
,	O
but	O
in	O
our	O
case	O
the	O
main	O
cause	O
of	O
worsening	O
pulmonary	B-ANAT
function	O
was	O
the	O
degree	O
of	O
pulmonary	B-ANAT
arterial	B-ANAT
hypertension	O
and	O
right	B-ANAT
heart	I-ANAT
failure	O
.	O

Consistently	O
,	O
eliminating	O
IL	O
-	O
33	O
decreased	O
the	O
levels	O
of	O
MMP2	O
and	O
MMP9	O
in	O
BALF	O
and	O
alleviated	O
lung	B-ANAT
injury	O
in	O
ALI	O
rats	O
.	O

Usually	O
,	O
CNS	B-ANAT
pathologies	O
are	O
caused	O
by	O
known	O
neurotropic	O
viruses	O
such	O
as	O
measles	O
virus	O
(	O
MV	O
),	O
herpes	O
virus	O
and	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
),	O
among	O
others	O
.	O

TITLE	O
:	O
Cell	B-ANAT
therapy	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

TITLE	O
:	O
Human	O
Coronavirus	O
in	O
Hospitalized	O
Children	O
With	O
Respiratory	B-ANAT
Tract	I-ANAT
Infections	O
:	O
A	O
9	O
-	O
Year	O
Population	O
-	O
Based	O
Study	O
From	O
Norway	O
.	O

We	O
highlight	O
the	O
ways	O
in	O
which	O
lung	B-ANAT
architecture	O
and	O
function	O
is	O
stressed	O
by	O
pregnancy	O
,	O
increasing	O
baseline	O
inflammation	O
prior	O
to	O
infection	O
.	O

TITLE	O
:	O
A	O
Fulminant	O
Case	O
of	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
Associated	O
with	O
Mycoplasma	O
Pneumonia	O
Treated	O
with	O
Nasal	B-ANAT
High	O
-	O
Flow	O
Oxygen	O
Therapy	O
.	O

Despite	O
the	O
appropriate	O
antimicrobial	O
therapy	O
,	O
his	O
symptoms	O
worsened	O
and	O
therefore	O
we	O
changed	O
his	O
oxygen	O
therapy	O
from	O
a	O
reservoir	O
mask	O
to	O
nasal	B-ANAT
high	O
-	O
flow	O
oxygen	O
in	O
addition	O
to	O
minocycline	O
.	O

Coronavirus	O
RNA	O
was	O
detected	O
in	O
faecal	B-ANAT
samples	O
from	O
three	O
different	O
species	O
:	O
the	O
greater	O
horseshoe	O
bat	O
(	O
Rhinolophus	O
ferrumequinum	O
),	O
the	O
brown	O
long	O
-	O
eared	O
bat	O
(	O
Plecotus	O
auritus	O
),	O
and	O
the	O
European	O
free	O
-	O
tailed	B-ANAT
bat	O
(	O
Tadarida	O
teniotis	O
).	O

Compared	O
with	O
the	O
non	O
-	O
ARDS	O
group	O
,	O
the	O
ARDS	O
group	O
had	O
older	O
age	O
,	O
higher	O
rates	O
of	O
traffic	O
injuries	O
,	O
endotracheal	O
intubation	O
and	O
infection	O
,	O
higher	O
blood	B-ANAT
sugar	O
,	O
PaO	O

Median	O
number	O
of	O
days	O
from	O
hospital	O
discharge	B-ANAT
until	O
the	O
questionnaires	O
were	O
filled	O
was	O
580	O
(	O
95	O
%	O
CI	O
568	O
,	O
723	O
.	O
5	O
)	O
days	O
.	O

In	O
this	O
study	O
,	O
heartbeat	O
rate	O
(	O
HR	O
),	O
respiration	O
rate	O
(	O
RR	O
),	O
and	O
standard	O
deviation	O
of	O
heartbeat	O
interval	O
(	O
SDHI	O
)	O
were	O
used	O
to	O
quantify	O
the	O
infection	O
screening	O
system	O
without	O
using	O
facial	B-ANAT
temperature	O
as	O
a	O
parameter	O
.	O

Although	O
the	O
delivery	O
of	O
CpG	O
ODNs	O
in	O
ovo	O
at	O
embryo	B-ANAT
day	O
(	O
ED	O
)	O
18	O
has	O
been	O
shown	O
to	O
reduce	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
loads	O
in	O
embryonic	B-ANAT
chicken	O
lungs	B-ANAT
pre	O
-	O
hatch	O
,	O
whether	O
in	O
ovo	O
delivered	O
CpG	O
ODNs	O
are	O
capable	O
of	O
protecting	O
chickens	O
against	O
a	O
post	O
-	O
hatch	O
challenge	O
is	O
unknown	O
.	O

In	O
multivariate	O
analysis	O
,	O
right	O
-	O
side	O
of	O
pneumonectomy	O
(	O
odds	O
ratio	O
[	O
OR	O
],	O
2	O
.	O
29	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
],	O
1	O
.	O
24	O
-	O
4	O
.	O
22	O
),	O
chronic	O
cardiac	B-ANAT
disease	O
(	O
OR	O
,	O
2	O
.	O
15	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
08	O
-	O
4	O
.	O
25	O
),	O
Charlson	O
Comorbidity	O
Index	O
(	O
OR	O
,	O
1	O
.	O
35	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
14	O
-	O
1	O
.	O
61	O
),	O
carinal	O
resection	O
(	O
OR	O
,	O
3	O
.	O
23	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
26	O
-	O
8	O
.	O
29	O
),	O
and	O
extrapleural	O
pneumonectomy	O
(	O
OR	O
,	O
8	O
.	O
36	O
;	O
95	O
%	O
CI	O
,	O
3	O
.	O
31	O
-	O
21	O
.	O
11	O
)	O
were	O
identified	O
as	O
independent	O
risk	O
factors	O
of	O
reintubation	O
.	O

ABSTRACT	O
:	O
In	O
the	O
early	O
phase	O
following	O
severe	O
brain	B-ANAT
injury	O
(	O
BI	O
),	O
mechanical	O
ventilation	O
(	O
MV	O
)	O
is	O
often	O
needed	O
to	O
prevent	O
airway	B-ANAT
from	O
aspiration	O
,	O
control	O
PaCO	O

BP	O
-	O
caKII	O
showed	O
delayed	O
viremia	O
,	O
resulting	O
in	O
its	O
delayed	O
dissemination	O
to	O
the	O
kidneys	B-ANAT
and	O
cecal	B-ANAT
tonsils	B-ANAT
compared	O
to	O
K2	O
and	O
KM91	O
,	O
the	O
latter	O
of	O
which	O
is	O
a	O
pathogenic	O
field	O
strain	O
.	O

This	O
response	O
is	O
not	O
altered	O
by	O
the	O
lack	O
of	O
T	B-ANAT
lymphocytes	I-ANAT
suggesting	O
that	O
T	B-ANAT
cells	I-ANAT
play	O
only	O
a	O
minor	O
role	O
for	O
the	O
initiation	O
,	O
propagation	O
or	O
recovery	O
of	O
LPS	O
-	O
induced	O
lung	B-ANAT
dysfunctions	O
or	O
function	O
of	O
T	B-ANAT
lymphocytes	I-ANAT
can	O
be	O
compensated	O
by	O
other	O
immune	O
cells	B-ANAT
,	O
such	O
as	O
alveolar	B-ANAT
macrophages	I-ANAT
.	O

RAG2	O
CONCLUSIONS	O
:	O
Following	O
LPS	O
instillation	O
,	O
lung	B-ANAT
mechanics	O
deteriorate	O
within	O
the	O
first	O
4	O
days	O
and	O
recover	O
towards	O
day	O
10	O
.	O

Our	O
results	O
demonstrated	O
that	O
PEDV	O
infection	O
regulated	O
lncRNA	O
expression	O
patterns	O
in	O
both	O
the	O
IPEC	O
-	O
J2	O
cell	B-ANAT
line	I-ANAT
and	O
piglet	O
ileum	B-ANAT
.	O

Moreover	O
,	O
chickens	O
infected	O
with	O
the	O
GD	O
strain	O
showed	O
inefficient	O
recovery	O
of	O
damaged	O
cilia	B-ANAT
after	O
infection	O
.	O

Moreover	O
,	O
TGEV	O
genomic	O
RNA	O
and	O
sub	O
genomic	O
mRNA	O
(	O
N	O
gene	O
and	O
ORF7	O
)	O
levels	O
showed	O
significant	O
increase	O
in	O
p53	O
-/-	O
PK	O
-	O
15	O
cells	B-ANAT
compared	O
with	O
WT	O
PK	O
-	O
15	O
cells	B-ANAT
after	O
TGEV	O
infection	O
.	O

TITLE	O
:	O
[	O
Reye	O
syndrome	O
and	O
sudden	O
death	O
symptoms	O
after	O
oral	B-ANAT
administration	O
of	O
nimesulide	O
due	O
to	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
in	O
a	O
boy	O
].	O

Half	O
an	O
hour	O
later	O
,	O
the	O
boy	O
experienced	O
convulsions	O
and	O
cardiopulmonary	B-ANAT
arrest	O
,	O
and	O
emergency	O
examination	O
found	O
hypoketotic	O
hypoglycemia	O
,	O
metabolic	O
acidosis	O
,	O
significant	O
increases	O
in	O
serum	B-ANAT
aminotransferases	O
and	O
creatine	O
kinase	O
,	O
and	O
renal	B-ANAT
damage	O
.	O

TITLE	O
:	O
Empirical	O
systemic	O
anticoagulation	O
is	O
associated	O
with	O
decreased	O
venous	B-ANAT
thromboembolism	O
in	O
critically	O
ill	O
influenza	O
A	O
H1N1	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
.	O

ABSTRACT	O
:	O
An	O
association	O
between	O
increased	O
venous	B-ANAT
thromboembolism	O
(	O
VTE	O
)	O
events	O
and	O
influenza	O
A	O
H1N1	O
(	O
H1N1	O
)	O
was	O
noted	O
in	O
the	O
first	O
10	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Independent	O
risk	O
factors	O
for	O
pulmonary	B-ANAT
embolism	O
included	O
H1N1	O
,	O
culture	O
-	O
positive	O
bacterial	O
pneumonia	O
,	O
and	O
male	O
sex	O
.	O

Among	O
the	O
randomly	O
selected	O
user	O
profiles	O
,	O
K	O
-	O
pop	O
fans	O
ranged	O
from	O
4	O
%	O
in	O
the	O
Korean	O
corpus	B-ANAT
to	O
70	O
%	O
in	O
the	O
Thai	O
corpus	B-ANAT
;	O
media	B-ANAT
ranged	O
from	O
0	O
%	O
(	O
Thai	O
)	O
to	O
14	O
%	O
(	O
Indonesian	O
);	O
political	O
advocates	O
ranged	O
from	O
0	O
%	O
(	O
Thai	O
)	O
to	O
19	O
%	O
(	O
Japanese	O
);	O
medical	O
professionals	O
ranged	O
from	O
0	O
%	O
(	O
Thai	O
)	O
to	O
7	O
%	O
(	O
English	O
).	O

ABSTRACT	O
:	O
Ischemia	O
-	O
reperfusion	O
injury	O
(	O
IRI	B-ANAT
)	O
is	O
one	O
of	O
the	O
main	O
causes	O
of	O
primary	O
graft	B-ANAT
dysfunction	O
that	O
accounts	O
for	O
25	O
%	O
of	O
mortality	O
after	O
lung	B-ANAT
transplantation	O
.	O

Stem	B-ANAT
cells	I-ANAT
have	O
potent	O
anti	O
-	O
inflammatory	O
and	O
immunomodulatory	O
properties	O
through	O
local	O
paracrine	O
mechanisms	O
.	O

The	O
application	O
of	O
mesenchymal	B-ANAT
stem	I-ANAT
cells	I-ANAT
(	O
MSCs	O
)	O
for	O
ARDS	O
as	O
well	O
as	O
IRI	B-ANAT
in	O
various	O
organs	B-ANAT
,	O
therefore	O
,	O
has	O
been	O
interested	O
and	O
extensively	O
investigated	O
in	O
animal	O
models	O
with	O
promising	O
results	O
.	O

With	O
2	O
h	O
of	O
warm	O
ischemia	O
and	O
subsequent	O
reperfusion	O
on	O
the	O
left	B-ANAT
lung	I-ANAT
,	O
the	O
lung	B-ANAT
showed	O
severe	O
pulmonary	B-ANAT
edema	O
.	O

Administration	O
of	O
Muse	O
cell	B-ANAT
through	O
the	O
left	B-ANAT
pulmonary	I-ANAT
artery	I-ANAT
immediately	O
after	O
reperfusion	O
more	O
significantly	O
improved	O
lung	B-ANAT
oxygenation	O
capacity	O
,	O
compliance	O
,	O
and	O
histological	O
damage	O
on	O
days	O
1	O
and	O
3	O
after	O
reperfusion	O
compared	O
with	O
MSCs	O
,	O
and	O
this	O
was	O
associated	O
with	O
higher	O
expression	O
levels	O
of	O
proteins	O
related	O
with	O
anti	O
-	O
inflammation	O
and	O
tissue	B-ANAT
repair	O
in	O
the	O
lung	B-ANAT
.	O

Encouraging	O
results	O
of	O
this	O
study	O
advocate	O
further	O
investigation	O
of	O
the	O
ability	O
of	O
Muse	O
cells	B-ANAT
to	O
prevent	O
and	O
treat	O
IRI	B-ANAT
after	O
lung	B-ANAT
transplantation	O
.	O

ABSTRACT	O
:	O
Bordetella	O
pertussis	O
can	O
cause	O
fatal	O
illness	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
pulmonary	B-ANAT
hypertension	O
(	O
PHT	O
).	O

The	O
airway	B-ANAT
spasm	O
followed	O
caused	O
sudden	O
drop	O
of	O
ventilator	O
tidal	O
volume	O
as	O
well	O
as	O
poor	O
lung	B-ANAT
compliance	O
.	O

There	O
is	O
no	O
specific	O
treatment	O
for	O
the	O
MERS	O
-	O
CoV	O
till	O
now	O
,	O
but	O
drugs	O
are	O
in	O
pipeline	O
which	O
bind	O
with	O
the	O
spike	O
glycoprotein	O
and	O
inhibit	O
its	O
entrance	O
host	O
cells	B-ANAT
.	O

Total	O
nucleic	B-ANAT
acid	O
was	O
extracted	O
using	O
Pure	O
Link	O
viral	O
RNA	O
/	O
DNA	O
mini	O
kit	O
(	O
Invitrogen	O
),	O
and	O
multiplex	O
RT	O
-	O
PCR	O
assays	O
were	O
performed	O
.	O

TITLE	O
:	O
Airway	B-ANAT
pressure	O
release	O
ventilation	O
in	O
children	O
.	O

Therefore	O
,	O
a	O
more	O
detailed	O
study	O
was	O
undertaken	O
in	O
SPF	O
layer	B-ANAT
-	O
type	O
chickens	O
primed	O
with	O
IBV	O
Mass	O
and	O
793B	O
vaccines	O
.	O

Physical	O
examination	O
,	O
laboratory	O
analysis	O
,	O
thoracic	B-ANAT
radiography	O
,	O
echocardiography	O
,	O
a	O
computed	O
tomography	O
scan	O
and	O
an	O
ante	O
mortem	O
lung	B-ANAT
biopsy	O
demonstrated	O
severe	O
arterial	B-ANAT
hypoxemia	O
and	O
severe	O
PH	O
but	O
were	O
not	O
diagnostic	O
for	O
a	O
known	O
disease	O
syndrome	O
.	O

TITLE	O
:	O
Co	O
-	O
localization	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
and	O
dipeptidyl	O
peptidase	O
-	O
4	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
and	O
lymphoid	B-ANAT
tissues	I-ANAT
of	O
pigs	O
and	O
llamas	O
.	O

Also	O
,	O
scanning	O
electron	O
microscopy	O
was	O
performed	O
to	O
assess	O
the	O
ciliary	O
integrity	O
of	O
respiratory	O
epithelial	B-ANAT
cells	I-ANAT
in	O
both	O
species	O
.	O

The	O
average	O
particle	O
size	O
of	O
the	O
gold	O
nanoparticle	O
-	O
serum	B-ANAT
mixture	O
,	O
measured	O
by	O
dynamic	O
light	O
scattering	O
,	O
corresponds	O
positively	O
to	O
the	O
immune	O
status	O
and	O
activity	O
of	O
the	O
subject	O
.	O

Nevertheless	O
,	O
both	O
IBV	O
isolates	O
elicited	O
host	O
responses	O
characterized	O
by	O
significant	O
macrophage	B-ANAT
recruitment	O
to	O
the	O
respiratory	B-ANAT
tract	I-ANAT
and	O
there	O
was	O
evidence	O
that	O
both	O
IBV	O
isolates	O
replicated	O
within	O
tracheal	O
and	O
lung	B-ANAT
macrophages	B-ANAT
.	O

This	O
prospective	O
,	O
single	O
-	O
center	O
study	O
included	O
only	O
adults	O
with	O
burn	O
sizes	O
â¥	O
50	O
%	O
of	O
the	O
total	B-ANAT
body	I-ANAT
surface	I-ANAT
area	O
(	O
TBSA	O
)	O
who	O
were	O
admitted	O
within	O
24h	O
after	O
burn	O
.	O

In	O
conclusion	O
,	O
the	O
diagnosis	O
of	O
central	O
DI	O
should	O
be	O
considered	O
as	O
a	O
complication	O
of	O
severe	O
IVH	O
in	O
the	O
extremely	O
premature	O
neonate	O
who	O
demonstrates	O
persistent	O
hypernatremia	O
,	O
polyuria	O
,	O
decreased	O
urine	B-ANAT
osmolality	O
,	O
and	O
increased	O
plasma	B-ANAT
osmolality	O
.	O

Serum	B-ANAT
ADH	O
levels	O
can	O
be	O
helpful	O
in	O
confirming	O
the	O
central	O
origin	O
of	O
DI	O
and	O
subcutaneous	O
desmopressin	O
can	O
be	O
an	O
effective	O
treatment	O
in	O
the	O
preterm	O
infant	O
.	O

TITLE	O
:	O
Regulation	O
of	O
in	O
vivo	O
behavior	O
of	O
TAT	O
-	O
modified	O
liposome	O
by	O
associated	O
protein	O
corona	O
and	O
avidity	O
to	O
tumor	B-ANAT
cells	I-ANAT
.	O

Major	O
drawbacks	O
are	O
a	O
failure	O
to	O
reach	O
the	O
tumor	B-ANAT
cell	I-ANAT
,	O
limited	O
penetration	O
depth	O
,	O
and	O
impaired	O
uptake	O
by	O
tumor	B-ANAT
cells	I-ANAT
.	O

TITLE	O
:	O
A	O
fatal	O
complication	O
of	O
tirofiban	O
in	O
an	O
octogenarian	O
:	O
Diffuse	O
alveolar	B-ANAT
hemorrhage	O
.	O

ABSTRACT	O
:	O
An	O
84	O
-	O
year	O
-	O
old	O
female	O
patient	O
with	O
a	O
past	O
medical	O
history	O
significant	O
for	O
hypertension	O
and	O
diabetes	O
mellitus	O
,	O
was	O
admitted	O
to	O
the	O
Emergency	O
Department	O
with	O
acute	O
coronary	B-ANAT
syndrome	O
and	O
complete	O
atrioventricular	O
block	O
.	O

She	O
underwent	O
a	O
successful	O
primary	O
percutaneous	O
coronary	B-ANAT
intervention	O
.	O

Experiment	O
1	O
,	O
done	O
without	O
lung	B-ANAT
injury	O
,	O
was	O
completed	O
to	O
determine	O
the	O
optimum	O
timing	O
during	O
the	O
respiratory	O
cycle	O
for	O
injecting	O
the	O
oxygen	O
bolus	O
.	O

The	O
ventilator	O
/	O
concentrator	O
system	O
was	O
able	O
to	O
manage	O
oxygenation	O
of	O
severely	O
injured	O
lungs	B-ANAT
in	O
a	O
porcine	O
model	O
by	O
injecting	O
oxygen	O
boluses	O
at	O
the	O
front	O
end	O
of	O
the	O
ventilator	O
breath	B-ANAT
,	O
and	O
appropriate	O
use	O
of	O
PEEP	O
to	O
maximize	O
oxygen	O
delivery	O
at	O
the	O
alveolar	B-ANAT
level	O
.	O

At	O
6	O
months	O
driving	O
pressure	O
was	O
associated	O
with	O
lower	O
FVC	O
independently	O
on	O
tidal	O
volume	O
,	O
plateau	O
pressure	O
and	O
baseline	O
static	O
respiratory	O
compliance	O
after	O
adjustments	O
(	O
r	O
CONCLUSIONS	O
:	O
Even	O
in	O
patients	O
ventilated	O
with	O
protective	O
tidal	O
volume	O
,	O
higher	O
driving	O
pressure	O
is	O
associated	O
with	O
worse	O
long	O
-	O
term	O
pulmonary	B-ANAT
function	O
and	O
structure	O
.	O

The	O
design	O
of	O
both	O
the	O
multi	O
-	O
epitope	O
vaccines	O
(	O
MEVs	O
)	O
are	O
composed	O
of	O
cytotoxic	B-ANAT
T	I-ANAT
lymphocyte	I-ANAT
(	O
CTL	B-ANAT
)	O
and	O
helper	B-ANAT
T	I-ANAT
lymphocyte	I-ANAT
(	O
HTL	O
)	O
epitopes	O
,	O
screened	O
form	O
thirteen	O
different	O
proteins	O
of	O
MERS	O
-	O
CoV	O
.	O
Both	O
the	O
MEVs	O
also	O
carry	O
potential	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
linear	O
epitope	O
regions	O
,	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
discontinuous	O
epitopes	O
as	O
well	O
as	O
interferon	O
-	O
Î³	O
-	O
inducing	O
epitopes	O
.	O

The	O
cDNA	O
analysis	O
of	O
both	O
the	O
MEVs	O
have	O
shown	O
high	O
expression	O
tendency	O
in	O
mammalian	O
host	O
cell	B-ANAT
line	I-ANAT
(	O
human	O
).	O

This	O
study	O
examined	O
the	O
combined	O
use	O
of	O
an	O
ELISA	O
and	O
Western	O
blot	O
(	O
WB	O
)	O
to	O
detect	O
antibodies	O
against	O
the	O
nucleocapsid	B-ANAT
protein	O
(	O
N	O
)	O
of	O
IBV	O
.	O

Serum	B-ANAT
samples	O
scored	O
as	O
negative	O
with	O
the	O
commercial	O
kit	O
but	O
as	O
positive	O
with	O
the	O
ELISA	O
-	O
rN	O
were	O
further	O
analysed	O
by	O
Western	O
blot	O
analyses	O
using	O
the	O
rN	O
protein	O
as	O
an	O
antigen	O
.	O

TITLE	O
:	O
Porcine	O
Hemagglutinating	O
Encephalomyelitis	O
Virus	O
Activation	O
of	O
the	O
Integrin	O
Î±5Î²1	O
-	O
FAK	O
-	O
Cofilin	O
Pathway	O
Causes	O
Cytoskeletal	B-ANAT
Rearrangement	O

To	O
Promote	O
Its	O
Invasion	O
of	O
N2a	O
Cells	B-ANAT
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
entry	O
of	O
PHEV	O
into	O
N2a	O
cells	B-ANAT
induces	O
a	O
biphasic	O
remodeling	O
of	O
the	O
actin	B-ANAT
cytoskeleton	I-ANAT
and	O
a	O
dynamic	O
change	O
in	O
cofilin	O
activity	O
.	O

In	O
conclusion	O
,	O
we	O
demonstrate	O
that	O
PHEV	O
utilizes	O
the	O
integrin	O
Î±5Î²1	O
-	O
FAK	O
-	O
Rac1	O
/	O
Cdc42	O
-	O
PAK	O
-	O
LIMK	O
-	O
cofilin	O
pathway	O
to	O
cause	O
an	O
actin	O
cytoskeletal	B-ANAT
rearrangement	O
to	O
promote	O
its	O
own	O
invasion	O
,	O
providing	O
theoretical	O
support	O
for	O
the	O
development	O
of	O
PHEV	O
pathogenic	O
mechanisms	O
and	O
new	O
antiviral	O
targets	O
.	O

TITLE	O
:	O
Acute	O
left	O
ventricular	B-ANAT
dysfunction	O
complicating	O
pregnancy	O
on	O
ECMO	O
:	O
Tri	O
-	O
iodothyronine	O
to	O
the	O
rescue	O
with	O
real	O
time	O
transesophageal	O
echocardiography	O
.	O

This	O
paper	O
aims	O
to	O
emphasise	O
the	O
need	O
for	O
standard	O
methods	O
to	O
record	O
the	O
incidence	O
and	O
etiology	O
of	O
associated	O
pathogens	O
in	O
order	O
to	O
provide	O
effective	O
treatment	O
against	O
viral	O
infections	O
of	O
the	O
respiratory	B-ANAT
tract	I-ANAT
and	O
to	O
reduce	O
death	O
rates	O
.	O

TITLE	O
:	O
Onset	O
of	O
Takotsubo	O
Syndrome	O
during	O
the	O
Clinical	O
Course	O
of	O
Anti	O
-	O
Neutrophil	B-ANAT
Cytoplasmic	B-ANAT
Antibody	O
-	O
Associated	O
Vasculitis	O
:	O
A	O
Case	O
Report	O
.	O

A	O
56	O
-	O
year	O
-	O
old	O
Caucasian	O
man	O
with	O
multiple	O
comorbidities	O
and	O
severe	O
aortic	B-ANAT
stenosis	O
underwent	O
transcatheter	O
aortic	B-ANAT
valve	I-ANAT
replacement	O
under	O
monitored	O
anesthesia	O
care	O
.	O

Diagnosing	O
a	O
left	B-ANAT
ventricular	I-ANAT
outflow	I-ANAT
tract	I-ANAT
obstruction	O
as	O
the	O
cause	O
of	O
hemodynamic	O
instability	O
during	O
transcatheter	O
aortic	B-ANAT
valve	I-ANAT
replacement	O
,	O
in	O
the	O
absence	O
of	O
abnormal	O
findings	O
on	O
echocardiogram	O
preoperatively	O
,	O
requires	O
a	O
high	O
index	O
of	O
clinical	O
suspicion	O
.	O

ABSTRACT	O
:	O
Viral	O
infections	O
trigger	O
robust	O
secretion	B-ANAT
of	O
interferons	O
and	O
other	O
antiviral	O
cytokines	O
by	O
infected	O
and	O
bystander	O
cells	B-ANAT
,	O
which	O
in	O
turn	O
can	O
tune	O
the	O
immune	O
response	O
and	O
may	O
lead	O
to	O
viral	O
clearance	O
or	O
immune	O
suppression	O
.	O

We	O
conducted	O
active	O
nationwide	O
cross	O
-	O
sectional	O
surveillance	O
of	O
camels	O
and	O
humans	O
in	O
Kenya	O
,	O
targeting	O
both	O
nasal	B-ANAT
swabs	O
and	O
plasma	B-ANAT
samples	O
from	O
1	O
,	O
163	O
camels	O
and	O
486	O
humans	O
collected	O
from	O
January	O
2016	O
to	O
June	O
2018	O
.	O

A	O
total	O
of	O
792	O
camel	O
plasma	B-ANAT
samples	O
were	O
positive	O
by	O
ELISA	O
.	O

Only	O
11	O
camel	O
nasal	B-ANAT
swabs	O
were	O
positive	O
for	O
MERS	O
-	O
CoV	O
by	O
reverse	O
transcription	O
-	O
quantitative	O
PCR	O
.	O

TITLE	O
:	O
GI	O
-	O
16	O
lineage	O
(	O
624	O
/	O
I	O
or	O
Q1	O
),	O
there	O
and	O
back	B-ANAT
again	O
:	O
The	O
history	O
of	O
one	O
of	O
the	O
major	O
threats	O
for	O
poultry	O
farming	O
of	O
our	O
era	O
.	O

TITLE	O
:	O
Epidemiology	O
,	O
lung	B-ANAT
mechanics	O
and	O
outcomes	O
of	O
ARDS	O
:	O
A	O
comparison	O
between	O
pregnant	O
and	O
non	O
-	O
pregnant	O
subjects	O
.	O

ABSTRACT	O
:	O
We	O
describe	O
the	O
epidemiology	O
,	O
lung	B-ANAT
mechanics	O
and	O
outcomes	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
complicating	O
pregnancy	O
.	O

TITLE	O
:	O
Venovenous	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
for	O
Acute	O
Respiratory	O
Failure	O
in	O
a	O
Liver	B-ANAT
Transplant	B-ANAT
Patient	O
:	O
A	O
Case	O
Report	O
.	O

ABSTRACT	O
:	O
Intraoperative	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
support	O
,	O
both	O
venoarterial	O
and	O
venovenous	O
(	O
VV	O
),	O
have	O
been	O
used	O
sparingly	O
and	O
with	O
limited	O
success	O
in	O
the	O
setting	O
of	O
liver	B-ANAT
transplantation	O
.	O

TITLE	O
:	O
Survey	O
of	O
Respiratory	O
Virus	O
in	O
Patients	O
Hospitalised	O
for	O
Acute	O
Exacerbations	O
of	O
Heart	B-ANAT
Failure	O
-	O
A	O
Prospective	O
Observational	O
Study	O
.	O

Noninfective	O
events	O
explain	O
up	O
to	O
30	O
%	O
of	O
VAEs	O
,	O
the	O
main	O
causes	O
being	O
atelectasis	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
pulmonary	B-ANAT
edema	O
and	O
pulmonary	B-ANAT
embolism	O
.	O

TITLE	O
:	O
A	O
24	O
-	O
hour	O
perioperative	O
case	O
study	O
on	O
argatroban	O
use	O
for	O
left	B-ANAT
ventricle	I-ANAT
assist	O
device	O
insertion	O
during	O
cardiopulmonary	B-ANAT
bypass	O
and	O
veno	O
-	O
arterial	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

ABSTRACT	O
:	O
A	O
44	O
-	O
year	O
-	O
old	O
male	O
with	O
ongoing	O
chest	B-ANAT
pain	O
and	O
left	O
ventricular	B-ANAT
ejection	O
fraction	O
<	O
20	O
%	O
was	O
transferred	O
from	O
a	O
peripheral	O
hospital	O
with	O
intra	O
-	O
aortic	B-ANAT
balloon	O
pump	O
placement	O
following	O
a	O
non	O
-	O
ST	O
-	O
elevation	O
myocardial	O
infarction	O
(	O
STEMI	O
).	O

Subsequently	O
,	O
the	O
patient	O
developed	O
severe	O
disseminated	O
intravascular	O
coagulopathy	O
,	O
with	O
both	O
intra	O
-	O
cardiac	B-ANAT
and	O
intravascular	O
thrombi	O
,	O
requiring	O
massive	O
transfusion	O
and	O
continuous	O
cell	B-ANAT
saving	O
due	O
to	O
severe	O
hemorrhage	O
post	O
cardiopulmonary	B-ANAT
bypass	O
(	O
CPB	O
).	O

A	O
total	O
of	O
19	O
.	O
7	O
L	O
of	O
washed	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
were	O
returned	O
to	O
the	O
patient	O
from	O
the	O
cell	B-ANAT
saver	O
.	O

ABSTRACT	O
:	O
Flail	O
chest	B-ANAT
is	O
considered	O
as	O
one	O
of	O
the	O
most	O
severe	O
forms	O
of	O
blunt	O
thoracic	B-ANAT
trauma	O
.	O

MK2	O
regulates	O
the	O
expression	O
of	O
ICAM	O
-	O
1	O
in	O
human	O
pulmonary	B-ANAT
microvascular	O
endothelial	B-ANAT
cells	I-ANAT
.	O

ABSTRACT	O
:	O
To	O
analyze	O
the	O
clinical	O
value	O
of	O
immature	O
granulocytes	B-ANAT
in	O
peripheral	B-ANAT
blood	I-ANAT
for	O
prediction	O
of	O
persistent	O
systemic	O
inflammatory	O
response	O
syndrome	O
(	O
SIRS	O
)	O
in	O
patients	O
with	O
acute	O
pancreatitis	O
(	O
AP	O
).	O

TITLE	O
:	O
Porcine	O
deltacoronavirus	O
induces	O
TLR3	O
,	O
IL	O
-	O
12	O
,	O
IFN	O
-	O
Î±	O
,	O
IFN	O
-	O
Î²	O
and	O
PKR	O
mRNA	O
expression	O
in	O
infected	O
Peyer	B-ANAT
'	I-ANAT
s	I-ANAT
patches	I-ANAT
in	O
vivo	O
.	O

The	O
stressors	O
(	O
suggested	O
by	O
the	O
triple	O
risk	O
model	O
)	O
share	O
a	O
unified	O
compensatory	O
physiological	O
response	O
of	O
decrease	O
in	O
systemic	O
vascular	B-ANAT
resistant	O
(	O
SVR	O
)	O
to	O
facilitate	O
a	O
compensatory	O
increase	O
in	O
cardiac	B-ANAT
output	O
(	O
CO	O
).	O

The	O
incompetent	O
cardiovascular	B-ANAT
control	O
of	O
the	O
vulnerable	O
infant	O
fails	O
to	O
stabilize	O
SVR	O
which	O
decreases	O
in	O
an	O
uncontrolled	O
manner	O
.	O

TITLE	O
:	O
Find	O
the	O
right	O
sample	O
:	O
A	O
study	O
on	O
the	O
versatility	O
of	O
saliva	B-ANAT
and	O
urine	B-ANAT
samples	O
for	O
the	O
diagnosis	O
of	O
emerging	O
viruses	O
.	O

Even	O
the	O
patients	O
with	O
severe	O
organ	B-ANAT
involvements	O
such	O
as	O
myocarditis	O
and	O
ARDS	O
can	O
be	O
completely	O
cured	O
if	O
timely	O
identified	O
and	O
treated	O
.	O

TITLE	O
:	O
The	O
Complexity	O
of	O
Pulmonary	B-ANAT
Complications	O
in	O
Acute	O
Kidney	B-ANAT
Injury	O
.	O

Our	O
study	O
included	O
74	O
clinical	O
cases	O
of	O
acute	O
kidney	B-ANAT
injury	O
of	O
various	O
etiologies	O
(	O
severe	O
sepsis	O
,	O
trauma	O
,	O
post	O
-	O
surgery	O
,	O
toxic	O
,	O
etc	O
.).	O

Regarding	O
the	O
clinical	O
aspects	O
of	O
pulmonary	B-ANAT
complications	O
,	O
the	O
most	O
frequent	O
were	O
ARDS	O
,	O
atelectasisand	O
bronchopneumopathies	O
,	O
determined	O
by	O
the	O
etiological	O
factors	O
that	O
had	O
caused	O
the	O
acute	O
kidney	B-ANAT
injury	O
in	O
the	O
first	O
place	O
,	O
and	O
by	O
the	O
acute	O
kidney	B-ANAT
injury	O
-	O
induced	O
physiological	O
effects	O
.	O

However	O
,	O
there	O
is	O
a	O
paucity	O
of	O
literature	O
on	O
using	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
VV	O
ECMO	O
)	O
to	O
treat	O
ARDS	O
in	O
patients	O
with	O
extremity	B-ANAT
obesity	O
[	O
Ull	O
2015	O
;	O
Belliato	O
2016	O
;	O
Kadakia	O
2017	O
]-	O
a	O
population	O
that	O
is	O
often	O
inherently	O
discriminated	O
against	O
with	O
regards	O
to	O
advanced	O
medical	O
and	O
surgical	O
therapies	O
because	O
of	O
the	O
practical	O
challenges	O
of	O
treating	O
someone	O
of	O
great	O
size	O
as	O
well	O
as	O
the	O
inherent	O
social	O
(	O
and	O
professional	O
)	O
biases	O
against	O
such	O
patients	O
.	O

Acute	O
lung	B-ANAT
injury	O
is	O
a	O
syndrome	O
associated	O
with	O
pulmonary	B-ANAT
oedema	O
,	O
hypoxaemia	O
and	O
respiratory	O
failure	O
.	O

Our	O
review	O
will	O
focus	O
on	O
the	O
mechanisms	O
responsible	O
for	O
endothelial	B-ANAT
dysfunction	O
during	O
influenza	O
infection	O
leading	O
to	O
cardiovascular	B-ANAT
collapse	O
and	O
death	O
.	O

Clinical	O
features	O
of	O
MERS	O
range	O
from	O
asymptomatic	O
or	O
mild	O
disease	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
multi	O
-	O
organ	B-ANAT
failure	O
resulting	O
in	O
death	O
,	O
especially	O
in	O
individuals	O
with	O
underlying	O
comorbidities	O
.	O

MERS	O
is	O
suspected	O
in	O
the	O
presence	O
of	O
febrile	O
acute	O
respiratory	O
illness	O
and	O
close	O
contact	O
with	O
MERS	O
-	O
CoV	O
,	O
and	O
can	O
be	O
confirmed	O
by	O
the	O
detection	O
of	O
viral	O
nucleic	B-ANAT
acid	O
through	O
RT	O
-	O
PCR	O
or	O
se	O
-	O
rology	O
.	O

TITLE	O
:	O
Respiratory	O
Viral	O
Infections	O
in	O
Patients	O
With	O
Cancer	O
or	O
Undergoing	O
Hematopoietic	B-ANAT
Cell	I-ANAT
Transplant	B-ANAT
.	O

TITLE	O
:	O
Poldip2	O
deficiency	O
protects	O
against	O
lung	B-ANAT
edema	O
and	O
vascular	B-ANAT
inflammation	O
in	O
a	O
model	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
present	O
study	O
aimed	O
to	O
define	O
the	O
role	O
of	O
RIPK1	O
in	O
hepatocytes	B-ANAT
during	O
fulminant	O
viral	O
hepatitis	O
,	O
a	O
worldwide	O
syndrome	O
mainly	O
observed	O
in	O
hepatitis	O
B	O
virus	O
(	O
HBV	O
)	O
infected	O
patients	O
.	O

Knockout	O
the	O
host	O
cellular	B-ANAT
surface	O
receptor	O
for	O
TGEV	O
may	O
be	O
an	O
effective	O
way	O
to	O
accelerate	O
the	O
breeding	O
of	O
resistant	O
pigs	O
.	O

Thresholds	O
for	O
age	O
(<	O
50	O
,	O
50	O
-	O
70	O
,	O
>	O
70	O
yr	O
),	O
PaO2	O
/	O
FIO2	O
(â¤	O
100	O
,	O
101	O
-	O
150	O
,	O
>	O
150	O
mm	O
Hg	O
),	O
plateau	O
pressure	O
(<	O
29	O
,	O
29	O
-	O
30	O
,	O
>	O
30	O
cm	O
H2O	O
),	O
and	O
number	O
of	O
extrapulmonary	O
organ	B-ANAT
failure	O
(<	O
2	O
,	O
2	O
,	O
>	O
2	O
)	O
stratified	O
accurately	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
into	O
categories	O
of	O
risk	O
.	O

Therefore	O
,	O
we	O
treated	O
them	O
with	O
support	O
management	O
,	O
including	O
intravenous	O
fluids	B-ANAT
and	O
a	O
tocolytic	O
agent	O
(	O
either	O
atosiban	O
,	O
magnesium	O
sulfate	O
or	O
nifedipine	O
).	O

Tocolytics	O
aimed	O
to	O
stop	O
contractions	O
until	O
platelets	B-ANAT
were	O
in	O
a	O
safe	O
range	O
previous	O
to	O
delivery	O
.	O

Platelets	B-ANAT
transfusions	O
were	O
performed	O
if	O
the	O
count	O
was	O
less	O
than	O
10	O
,	O
000	O
cells	B-ANAT
/	O
ml	O
and	O
active	O
bleeding	O
was	O
present	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
can	O
manifest	O
as	O
a	O
mild	O
illness	O
,	O
acute	O
respiratory	O
distress	O
,	O
organ	B-ANAT
failure	O
,	O
or	O
death	O
.	O

We	O
then	O
characterized	O
this	O
mouse	O
model	O
of	O
MERS	O
-	O
CoV	O
.	O
The	O
expression	O
profile	O
of	O
hDPP4	O
in	O
these	O
mice	O
was	O
almost	O
equivalent	O
to	O
that	O
in	O
human	B-ANAT
tissues	I-ANAT
,	O
including	O
kidney	B-ANAT
and	O
lung	B-ANAT
;	O
however	O
,	O
hDPP4	O
was	O
overexpressed	O
in	O
murine	O
CD3	O
-	O
positive	O
cells	B-ANAT
within	O
peripheral	B-ANAT
blood	I-ANAT
and	O
lymphoid	B-ANAT
tissues	I-ANAT
.	O

Upper	B-ANAT
limb	I-ANAT
active	O
exercises	O
were	O
performed	O
using	O
an	O
elastic	O
band	B-ANAT
exploring	O
three	O
main	O
movement	O
rays	O
:	O
abduction	O
,	O
forward	O
flexion	O
,	O
and	O
external	O
rotation	O
.	O

TITLE	O
:	O
Therapeutic	O
hypothermia	O
as	O
an	O
adjunct	O
to	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
acute	O
respiratory	O
distress	O
and	O
refractory	O
hypoxemia	O
.	O

ABSTRACT	O
:	O
Positive	O
-	O
sense	O
RNA	O
viruses	O
hijack	O
intracellular	B-ANAT
membranes	B-ANAT
that	O
provide	O
niches	O
for	O
viral	O
RNA	O
synthesis	O
and	O
a	O
platform	O
for	O
interactions	O
with	O
host	O
proteins	O
.	O

Compared	O
with	O
the	O
P120	O
group	O
,	O
pigs	O
in	O
the	O
P100C4	O
group	O
had	O
a	O
more	O
rapid	O
decline	O
in	O
fecal	B-ANAT
PEDV	O
RNA	O
shedding	O
titers	O
,	O
higher	O
titers	O
of	O
serum	B-ANAT
PEDV	O
-	O
specific	O
IgG	O
,	O
IgA	O
,	O
and	O
VN	O
Abs	O
,	O
and	O
higher	O
numbers	O
of	O
intestinal	B-ANAT
IgA	O
Ab	O
-	O
secreting	O
cells	B-ANAT
.	O

The	O
results	O
showed	O
that	O
Griffithsin	O
reduced	O
PEDV	O
infection	O
of	O
Vero	B-ANAT
cells	I-ANAT
by	O
approximately	O
82	O
.	O
8	O
%.	O

Although	O
the	O
IBVPR03	O
strain	O
is	O
S1	O
-	O
genotyped	O
as	O
Massachusetts	O
with	O
a	O
high	O
genomic	O
similarity	O
to	O
the	O
H	O
-	O
120	O
vaccine	O
strains	O
,	O
surprisingly	O
,	O
we	O
found	O
no	O
tropism	O
or	O
pathogenicity	O
to	O
the	O
trachea	B-ANAT
in	O
birds	O
infected	O
with	O
this	O
strain	O
.	O

On	O
the	O
other	O
hand	O
,	O
we	O
observed	O
ovarian	B-ANAT
and	O
testicle	B-ANAT
lesions	O
.	O

TITLE	O
:	O
Association	O
Between	O
Tidal	O
Volumes	O
Adjusted	O
for	O
Ideal	O
Body	B-ANAT
Weight	O
and	O
Outcomes	O
in	O
Pediatric	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
.	O

Interestingly	O
,	O
significant	O
inhibition	O
of	O
PEDV	O
by	O
S	B-ANAT
-	I-ANAT
layer	I-ANAT
protein	O
was	O
only	O
observed	O
in	O
the	O
exclusion	O
assay	O
.	O

In	O
Vero	B-ANAT
cells	I-ANAT
infected	O
with	O
PEDV	O
,	O
we	O
found	O
that	O
apoptosis	O
was	O
mediated	O
by	O
activation	O
of	O
caspase	O
-	O
8	O
and	O
caspase	O
-	O
3	O
in	O
the	O
late	O
stage	O
of	O
infection	O
.	O

TITLE	O
:	O
Venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
a	O
systematic	O
review	O
and	O
meta	O
-	O
analysis	O
.	O

The	O
field	O
application	O
also	O
revealed	O
that	O
the	O
survival	O
rate	O
of	O
piglets	O
was	O
significantly	O
increased	O
by	O
oral	B-ANAT
administration	O
of	O
scFvs	O
.	O

TITLE	O
:	O
Characterization	O
of	O
the	O
Lipidomic	O
Profile	O
of	O
Human	O
Coronavirus	O
-	O
Infected	O
Cells	B-ANAT
:	O
Implications	O
for	O
Lipid	O
Metabolism	O
Remodeling	O
upon	O
Coronavirus	O
Replication	O
.	O

Plasma	B-ANAT
sVE	O
-	O
cadherin	O
was	O
measured	O
at	O
study	O
enrollment	O
.	O

Long	O
disease	O
course	O
can	O
cause	O
autonomic	B-ANAT
dysfunction	O
or	O
deterioration	O
in	O
general	O
health	O
and	O
life	O
threatening	O
complications	O
like	O
respiratory	O
failures	O
.	O

Current	O
case	O
was	O
diagnosed	O
as	O
GBS	O
with	O
motor	O
,	O
sensory	O
&	O
sphincter	B-ANAT
disturbance	O
.	O

TITLE	O
:	O
Human	O
Lung	B-ANAT
Cell	B-ANAT
Pyroptosis	O
Following	O
Traumatic	O
Brain	B-ANAT
Injury	O
.	O

Severe	O
TBI	O
patients	O
with	O
lung	B-ANAT
injury	O
had	O
a	O
significantly	O
higher	O
level	O
of	O
ASC	O
in	O
serum	B-ANAT
and	O
serum	B-ANAT
-	O
derived	O
EVs	O
compared	O
to	O
individuals	O
without	O
lung	B-ANAT
injury	O
.	O

Annotation	O
and	O
submission	O
of	O
viral	B-ANAT
genome	I-ANAT
sequence	O
is	O
a	O
non	O
-	O
trivial	O
task	O
,	O
especially	O
for	O
groups	O
that	O
do	O
not	O
routinely	O
interact	O
with	O
GenBank	O
for	O
data	O
submissions	O
.	O

Neutrophil	B-ANAT
Extracellular	B-ANAT
Traps	O
Are	O
Elevated	O
in	O
Patients	O
with	O
Pneumonia	O
-	O
related	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
.	O

ABSTRACT	O
:	O
Neutrophil	B-ANAT
extracellular	B-ANAT
traps	O
have	O
been	O
associated	O
with	O
tissue	B-ANAT
damage	O
.	O

The	O
authors	O
quantified	O
bronchoalveolar	O
and	O
blood	B-ANAT
neutrophil	B-ANAT
extracellular	B-ANAT
traps	O
in	O
patients	O
with	O
pneumonia	O
-	O
related	O
ARDS	O
and	O
assessed	O
their	O
relationship	O
with	O
ventilator	O
-	O
free	O
days	O
.	O

The	O
relationship	O
between	O
bronchoalveolar	O
lavage	O
neutrophil	B-ANAT
extracellular	B-ANAT
trap	O
concentrations	O
and	O
the	O
primary	O
clinical	O
endpoint	O
(	O
i	O
.	O
e	O
.,	O
the	O
number	O
of	O
live	O
ventilator	O
-	O
free	O
days	O
at	O
day	O
28	O
)	O
was	O
assessed	O
using	O
linear	O
regression	O
analyses	O
.	O

Intensive	O
care	O
unit	O
mortality	O
(	O
12	O
%,	O
n	O
=	O
2	O
of	O
17	O
vs	O
.	O
17	O
%,	O
n	O
=	O
3	O
of	O
18	O
;	O
P	O
>	O
0	O
.	O
99	O
)	O
and	O
the	O
number	O
of	O
ventilator	O
-	O
free	O
days	O
at	O
day	O
28	O
(	O
22	O
[	O
14	O
to	O
25	O
]	O
vs	O
.	O
14	O
[	O
0	O
to	O
21	O
]	O
days	O
;	O
difference	O
:	O
-	O
5	O
;	O
95	O
%	O
CI	O
,	O
-	O
15	O
to	O
0	O
;	O
P	O
=	O
0	O
.	O
066	O
)	O
did	O
not	O
significantly	O
differ	O
between	O
patients	O
with	O
higher	O
(	O
n	O
=	O
17	O
)	O
versus	O
lower	O
(	O
n	O
=	O
18	O
)	O
bronchoalveolar	O
neutrophil	B-ANAT
extracellular	B-ANAT
trap	O
concentrations	O
.	O

These	O
viruses	O
are	O
well	O
-	O
recognized	O
for	O
their	O
ability	O
to	O
change	O
tissue	B-ANAT
tropism	O
,	O
to	O
hurdle	O
the	O
interspecies	O
barriers	O
and	O
to	O
adapt	O
ecological	O
variations	O
.	O

Although	O
infected	O
ascitic	B-ANAT
fluid	I-ANAT
is	O
seen	O
,	O
there	O
is	O
no	O
rupture	O
.	O

It	O
is	O
important	O
to	O
be	O
aware	O
of	O
this	O
rapid	O
accumulation	O
of	O
ascitic	B-ANAT
fluid	I-ANAT
,	O
even	O
without	O
visceral	O
perforation	O
,	O
as	O
peritoneal	B-ANAT
lavage	O
may	O
be	O
warranted	O
to	O
contain	O
the	O
infection	O
.	O

The	O
percentage	O
of	O
deep	O
second	O
degree	O
and	O
full	O
thickness	O
burn	O
,	O
inhalation	O
injury	O
and	O
red	B-ANAT
blood	I-ANAT
cell	I-ANAT
distribution	O
width	O
(	O
RDW	O
)	O
were	O
independently	O
associated	O
with	O
the	O
development	O
of	O
ARDS	O
in	O
severe	O
burn	O
patients	O
.	O

ABSTRACT	O
:	O
Enveloped	O
viruses	O
such	O
as	O
coronaviruses	O
or	O
influenza	O
virus	O
require	O
proteolytic	O
cleavage	O
of	O
their	O
fusion	O
protein	O
to	O
be	O
able	O
to	O
infect	O
the	O
host	B-ANAT
cell	I-ANAT
.	O

This	O
study	O
screened	O
mesenteric	B-ANAT
lymph	I-ANAT
nodes	I-ANAT
(	O
MLNs	O
),	O
the	O
presumed	O
first	O
site	O
of	O
FCoV	O
spread	O
from	O
the	O
intestine	B-ANAT
regardless	O
of	O
viraemia	O
,	O
for	O
changes	O
in	O
the	O
transcription	O
of	O
a	O
panel	O
of	O
innate	O
immune	O
response	O
mediators	O
in	O
response	O
to	O
systemic	O
FCoV	O
infection	O
and	O
with	O
FIP	O
,	O
aiming	O
to	O
identify	O
key	O
pathways	O
triggered	O
by	O
FCoV	O
.	O
Cats	O
with	O
and	O
without	O
FIP	O
,	O
the	O
latter	O
with	O
and	O
without	O
FCoV	O
infection	O
in	O
the	O
MLN	O
,	O
were	O
compared	O
.	O

These	O
are	O
part	O
of	O
the	O
first	O
line	O
of	O
defence	O
and	O
suggest	O
a	O
response	O
to	O
both	O
viral	O
structural	O
proteins	O
and	O
viral	O
nucleic	B-ANAT
acid	O
.	O

However	O
,	O
IHC	O
requires	O
invasive	O
tissue	B-ANAT
sample	I-ANAT
collection	O
.	O

Given	O
that	O
a	O
false	O
-	O
positive	O
result	O
occurred	O
and	O
FIP	O
was	O
correctly	O
detected	O
in	O
only	O
approximately	O
half	O
of	O
the	O
cases	O
of	O
FIP	O
,	O
ICC	O
of	O
mesenteric	B-ANAT
lymph	I-ANAT
node	I-ANAT
FNA	O
alone	O
cannot	O
reliably	O
confirm	O
or	O
exclude	O
FIP	O
,	O
but	O
can	O
be	O
a	O
helpful	O
test	O
in	O
conjunction	O
with	O
other	O
diagnostic	O
measures	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
characterized	O
by	O
an	O
acute	O
inflammatory	O
response	O
in	O
the	O
lung	B-ANAT
parenchyma	I-ANAT
leading	O
to	O
severe	O
hypoxemia	O
.	O

Pulmonary	B-ANAT
function	O
tests	O
revealed	O
a	O
severe	O
restrictive	O
disorder	O
aggravated	O
by	O
decubitus	O
.	O

TITLE	O
:	O
Tension	O
pneumoperitoneum	O
:	O
Case	O
report	O
of	O
a	O
rare	O
form	O
of	O
acute	O
abdominal	B-ANAT
compartment	I-ANAT
syndrome	O
.	O

To	O
sum	O
up	O
,	O
E	O
.	O
coli	O
isolates	O
from	O
calves	O
with	O
diarrhea	O
showed	O
differences	O
in	O
relation	O
to	O
the	O
control	O
group	O
,	O
confirming	O
changes	O
in	O
commensal	O
E	O
.	O
coli	O
during	O
virus	O
intestinal	B-ANAT
infection	O
.	O

Recommendations	O
for	O
patients	O
undergoing	O
mechanical	O
ventilation	O
include	O
lung	B-ANAT
-	O
protective	O
ventilation	O
,	O
early	O
sponta	O
-	O
neous	O
breathing	O
and	O
mobilization	O
,	O
weaning	O
protocols	O
,	O
and	O
,	O
for	O
those	O
with	O
severe	O
impairment	O
of	O
gas	O
exchange	O
,	O
prone	O
positioning	O
.	O

CONCLUSIONS	O
:	O
Recommendations	O
for	O
patients	O
undergoing	O
mechanical	O
ventilation	O
include	O
lung	B-ANAT
-	O
protective	O
ventilation	O
,	O
early	O
sponta	O
-	O
neous	O
breathing	O
and	O
mobilization	O
,	O
weaning	O
protocols	O
,	O
and	O
,	O
for	O
those	O
with	O
severe	O
impairment	O
of	O
gas	O
exchange	O
,	O
prone	O
positioning	O
.	O

When	O
assessing	O
the	O
acid	O
-	O
base	O
balance	O
,	O
most	O
ABG	O
analyzers	O
measure	O
the	O
pH	O
and	O
PaCo2	O
directly	O
and	O
through	O
a	O
derivative	O
of	O
the	O
Hasselbach	O
equation	O
calculate	O
the	O
serum	B-ANAT
bicarbonate	O
(	O
HCO3	O
)	O
and	O
base	O
deficit	O
or	O
excess	O
.	O

Thus	O
,	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
V	O
-	O
V	O
ECMO	O
)	O
was	O
initiated	O
;	O
upon	O
improvement	O
of	O
oxygenation	O
,	O
the	O
patient	O
received	O
an	O
exploratory	O
thoracotomy	O
.	O

A	O
40	O
-	O
year	O
-	O
old	O
man	O
ingested	O
in	O
100	O
ml	O
of	O
diquat	O
(	O
20	O
g	O
/	O
100	O
ml	O
)	O
and	O
400	O
ml	O
glyphosate	O
(	O
41	O
g	O
/	O
100	O
ml	O
)	O
was	O
admitted	O
to	O
the	O
intensive	O
care	O
unit	O
(	O
ICU	O
),	O
immediately	O
complicated	O
by	O
the	O
development	O
of	O
ventricular	B-ANAT
fibrillation	O
,	O
respiratory	O
failure	O
,	O
renal	B-ANAT
failure	O
,	O
and	O
multi	O
-	O
organ	B-ANAT
failure	O
.	O

TITLE	O
:	O
HIPK1	O
Interference	O
Attenuates	O
Inflammation	O
and	O
Oxidative	O
Stress	O
of	O
Acute	O
Lung	B-ANAT
Injury	O
via	O
Autophagy	O
.	O

Severe	O
ARDS	O
is	O
usually	O
companied	O
with	O
acute	O
lung	B-ANAT
injury	O
that	O
worsen	O
the	O
patients	O
'	O
condition	O
.	O

From	O
each	O
patient	O
,	O
blood	B-ANAT
,	O
BAL	O
,	O
endobronchial	O
biopsies	O
(	O
EBBs	O
),	O
and	O
LLN	O
samples	O
obtained	O
by	O
EBUS	O
-	O
TBNA	O
were	O
collected	O
and	O
MNPs	O
characterized	O
using	O
multicolor	O
flow	O
cytometry	O
.	O

Six	O
MNP	O
subsets	O
were	O
identified	O
at	O
varying	O
frequencies	O
in	O
the	O
anatomical	B-ANAT
compartments	I-ANAT
investigated	O
.	O

Life	O
-	O
threatening	O
complications	O
occurred	O
in	O
4	O
.	O
4	O
%	O
of	O
patients	O
(	O
deep	B-ANAT
vein	I-ANAT
thrombosis	O
/	O
pulmonary	B-ANAT
embolism	O
,	O
2	O
.	O
2	O
%;	O
acute	O
renal	B-ANAT
failure	O
;	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
0	O
.	O
9	O
%;	O
intubation	O
,	O
0	O
.	O
5	O
%).	O

RESULTS	O
:	O
A	O
total	O
of	O
11	O
,	O
562	O
patients	O
were	O
hospitalized	O
with	O
severe	O
ovarian	B-ANAT
hyperstimulation	O
syndrome	O
from	O
2002	O
to	O
2011	O
.	O

Such	O
disorders	O
can	O
affect	O
any	O
level	O
of	O
the	O
peripheral	B-ANAT
nervous	I-ANAT
system	I-ANAT
,	O
from	O
the	O
muscle	B-ANAT
to	O
the	O
anterior	B-ANAT
horn	I-ANAT
cell	I-ANAT
.	O

TITLE	O
:	O
Effects	O
of	O
Stepwise	O
Lung	B-ANAT
Recruitment	O
Maneuvers	O
in	O
Patients	O
with	O
Early	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
:	O
A	O
Prospective	O
,	O
Randomized	O
,	O
Controlled	O
Trial	O
.	O

This	O
trial	O
was	O
conducted	O
in	O
four	O
intensive	O
care	O
units	O
(	O
ICUs	O
)	O
to	O
compare	O
application	O
of	O
a	O
modified	O
stepwise	O
LRMs	O
with	O
solely	O
lung	B-ANAT
-	O
protective	O
ventilation	O
in	O
patients	O
with	O
moderate	O
to	O
severe	O
ARDS	O
within	O
72	O
h	O
from	O
the	O
onset	O
.	O

TITLE	O
:	O
Prognostic	O
values	O
of	O
the	O
Berlin	O
definition	O
criteria	O
,	O
blood	B-ANAT
lactate	O
level	O
,	O
and	O
fibroproliferative	O
changes	O
on	O
high	O
-	O
resolution	O
computed	O
tomography	O
in	O
ARDS	O
patients	O
.	O

Multivariate	O
analyses	O
revealed	O
that	O
elevated	O
blood	B-ANAT
lactate	O
level	O
(â¥	O
2	O
.	O
0	O
mmol	O
/	O
L	O
)	O
and	O
increased	O
HRCT	O
scores	O
were	O
significantly	O
associated	O
with	O
weaning	O
failure	O
and	O
30	O
-	O
day	O
mortality	O
of	O
the	O
patients	O
with	O
ARDS	O
.	O

TITLE	O
:	O
MicroRNA	O
â	O
223	O
attenuates	O
LPS	O
â	O
induced	O
inflammation	O
in	O
an	O
acute	O
lung	B-ANAT
injury	O
model	O
via	O
the	O
NLRP3	O
inflammasome	O
and	O
TLR4	O
/	O
NF	O
â	O
ÎºB	O
signaling	O
pathway	O
via	O
RHOB	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
the	O
more	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
are	O
common	O
and	O
complex	O
inflammatory	O
lung	B-ANAT
diseases	O
.	O

ABSTRACT	O
:	O
We	O
evaluated	O
genetic	O
variation	O
in	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
imported	O
to	O
South	O
Korea	O
in	O
2018	O
using	O
specimens	O
from	O
a	O
patient	O
and	O
isolates	O
from	O
infected	O
Caco	O
-	O
2	O
cells	B-ANAT
.	O

TITLE	O
:	O
Complicated	O
Lemierre	O
Syndrome	O
Caused	O
by	O
ABSTRACT	O
:	O
Lemierre	O
syndrome	O
is	O
a	O
life	O
-	O
threating	O
condition	O
characterized	O
by	O
recent	O
oropharyngeal	B-ANAT
infection	O
,	O
internal	B-ANAT
jugular	I-ANAT
vein	I-ANAT
thrombosis	O
,	O
and	O
anaerobic	O
septicemia	O
.	O

Laboratory	O
examination	O
indicated	O
severe	O
sepsis	O
with	O
disseminated	O
intravascular	O
coagulation	O
,	O
acute	O
renal	B-ANAT
failure	O
,	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
while	O
the	O
Doppler	O
ultrasonography	O
of	O
the	O
carotids	B-ANAT
revealed	O
left	O
internal	O
jugular	O
venous	B-ANAT
thrombosis	O
.	O

We	O
previously	O
showed	O
that	O
influenza	O
virus	O
M2	O
or	O
encephalomyocarditis	O
virus	O
(	O
EMCV	O
)	O
2B	O
proteins	O
stimulate	O
IL	O
-	O
1Î²	O
secretion	B-ANAT
following	O
activation	O
of	O
the	O
NLRP3	O
inflammasome	O
.	O

Three	O
-	O
fold	O
diluted	O
serum	B-ANAT
of	O
subjects	O
showed	O
only	O
9	O
.	O
7	O
%,	O
10	O
.	O
3	O
%,	O
and	O
2	O
.	O
2	O
%	O
reductions	O
in	O
relative	O
light	O
units	O
.	O

TITLE	O
:	O
Interferon	O
Regulatory	O
Factor	O
3	O
-	O
Mediated	O
Signaling	O
Limits	O
Middle	O
-	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
Coronavirus	O
Propagation	O
in	O
Cells	B-ANAT
from	O
an	O
Insectivorous	O
Bat	O
.	O

Finally	O
,	O
we	O
demonstrated	O
that	O
inhibition	O
of	O
viral	O
infection	O
by	O
p53	O
was	O
mediated	O
via	O
p53	O
-	O
dependent	O
IFN	O
signaling	O
,	O
leading	O
to	O
IFN	O
-	O
stimulated	O
response	O
element	O
(	O
ISRE	O
)	O
activation	O
,	O
as	O
well	O
as	O
the	O
upregulation	O
of	O
IFN	O
-	O
stimulated	O
genes	O
(	O
ISGs	O
)	O
and	O
IFN	O
-	O
Î²	O
released	O
from	O
infected	O
cells	B-ANAT
.	O

Individual	O
outcomes	O
including	O
pulmonary	B-ANAT
edema	O
/	O
acute	O
heart	B-ANAT
failure	O
and	O
stroke	O
also	O
were	O
analyzed	O
by	O
race	O
.	O

Black	O
women	O
were	O
at	O
126	O
%	O
greater	O
risk	O
for	O
pulmonary	B-ANAT
edema	O
/	O
acute	O
heart	B-ANAT
failure	O
than	O
white	O
women	O
(	O
95	O
%	O
confidence	O
interval	O
,	O
117	O
%-	O
136	O
%).	O

At	O
-	O
risk	O
women	O
including	O
black	O
women	O
with	O
cardiovascular	B-ANAT
risk	O
factors	O
may	O
benefit	O
from	O
short	O
-	O
term	O
postpartum	O
follow	O
-	O
up	O
.	O

We	O
hypothesized	O
that	O
the	O
overall	O
fecal	B-ANAT
shedding	O
of	O
ECoV	O
in	O
hospitalized	O
horses	O
is	O
low	O
.	O

ABSTRACT	O
:	O
Little	O
is	O
known	O
about	O
viral	O
and	O
atypical	O
bacteria	O
pathogen	O
spectra	O
of	O
community	O
-	O
acquired	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
in	O
children	O
in	O
Tunisia	O
.	O

Adult	O
patients	O
with	O
severe	O
sepsis	O
based	O
on	O
Sepsis	O
-	O
2	O
were	O
enrolled	O
and	O
divided	O
into	O
three	O
categories	O
(	O
body	B-ANAT
temperature	O
<	O
36	O
Â°	O
C	O
,	O
36	O
-	O
38	O
Â°	O
C	O
,	O
>	O
38	O
Â°	O
C	O
),	O
using	O
the	O
core	O
body	B-ANAT
temperature	O
at	O
ICU	O
admission	O
.	O

Of	O
1	O
,	O
143	O
enrolled	O
patients	O
,	O
127	O
,	O
565	O
,	O
and	O
451	O
were	O
categorized	O
as	O
having	O
body	B-ANAT
temperature	O
less	O
than	O
36	O
Â°	O
C	O
,	O
36	O
-	O
38	O
Â°	O
C	O
,	O
and	O
greater	O
than	O
38	O
Â°	O
C	O
,	O
respectively	O
.	O

Lung	B-ANAT
-	O
protective	O
mechanical	O
ventilation	O
strategies	O
remain	O
the	O
cornerstone	O
in	O
the	O
management	O
of	O
ARDS	O
.	O

Unfortunately	O
,	O
an	O
evidence	O
-	O
based	O
,	O
standard	O
-	O
of	O
-	O
care	O
approach	O
in	O
managing	O
ARDS	O
beyond	O
lung	B-ANAT
-	O
protective	O
ventilation	O
remains	O
elusive	O
,	O
contributing	O
to	O
significant	O
variability	O
in	O
clinical	O
practice	O
.	O

ABSTRACT	O
:	O
Chimeric	O
antigen	O
receptor	O
(	O
CAR	B-ANAT
)	O
T	B-ANAT
cell	I-ANAT
immunotherapy	O
has	O
demonstrated	O
remarkable	O
anti	O
-	O
tumor	O
activity	O
in	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
malignancies	O
and	O
is	O
under	O
investigation	O
in	O
other	O
hematologic	O
malignancies	O
and	O
solid	O
tumors	O
.	O

Expert	O
Opinion	O
:	O
As	O
CAR	B-ANAT
T	B-ANAT
cell	I-ANAT
based	O
therapies	O
gain	O
popularity	O
in	O
the	O
management	O
of	O
various	O
malignancies	O
,	O
the	O
complimentary	O
toxicities	O
of	O
CRS	O
and	O
neurotoxicity	O
pose	O
a	O
clinical	O
challenge	O
in	O
practice	O
.	O

Therefore	O
,	O
it	O
is	O
necessary	O
to	O
develop	O
an	O
effective	O
oral	B-ANAT
vaccine	O
against	O
PEDV	O
infection	O
.	O

Persons	O
in	O
the	O
health	O
field	O
including	O
physicians	O
and	O
veterinarians	O
,	O
pet	O
owners	O
,	O
pet	O
store	O
owners	O
,	O
exporters	O
,	O
border	B-ANAT
guards	O
,	O
and	O
people	O
involved	O
in	O
businesses	O
related	O
to	O
animal	O
products	O
have	O
adopted	O
various	O
preventive	O
strategies	O
.	O

ABSTRACT	O
:	O
Viral	O
infections	O
contribute	O
to	O
morbidity	O
in	O
cystic	O
fibrosis	O
(	O
CF	O
),	O
but	O
the	O
impact	O
of	O
respiratory	O
viruses	O
on	O
the	O
development	O
of	O
airway	B-ANAT
disease	O
is	O
poorly	O
understood	O
.	O

Participants	O
underwent	O
bronchoscopy	O
with	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
)	O
and	O
a	O
subset	O
underwent	O
pulmonary	B-ANAT
function	O
testing	O
.	O

TITLE	O
:	O
[	O
The	O
role	O
of	O
nicotinamide	O
-	O
adenine	O
dinucleotide	O
phosphate	O
oxidase	O
NOX	O
family	O
in	O
acute	O
lung	B-ANAT
injury	O
].	O

This	O
review	O
mainly	O
describes	O
the	O
cell	B-ANAT
distribution	O
,	O
activation	O
factors	O
,	O
and	O
its	O
relationship	O
with	O
the	O
occurrence	O
and	O
development	O
of	O
ALI	O
of	O
the	O
NOX	O
family	O
.	O

Critically	O
,	O
patients	O
who	O
eventually	O
died	O
of	O
SARS	O
(	O
hereafter	O
referred	O
to	O
as	O
deceased	O
patients	O
)	O
displayed	O
similarly	O
accumulated	O
pulmonary	B-ANAT
proinflammatory	O
,	O
absence	O
of	O
wound	O
-	O
healing	O
macrophages	B-ANAT
,	O
and	O
faster	O
neutralizing	O
antibody	O
responses	O
.	O

To	O
this	O
end	O
,	O
a	O
comprehensive	O
literature	O
review	O
was	O
undertaken	O
examining	O
the	O
current	O
understanding	O
and	O
potential	O
for	O
bats	O
to	O
act	O
as	O
reservoirs	O
for	O
viruses	O
transmitted	O
by	O
blood	B-ANAT
-	O
feeding	O
arthropods	O
.	O

TITLE	O
:	O
Growth	O
enhancement	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
in	O
Vero	O
E6	O
cells	B-ANAT
expressing	O
PEDV	O
nucleocapsid	B-ANAT
protein	O
.	O

We	O
demonstrated	O
that	O
PEDV	O
N	O
expression	O
positively	O
affected	O
both	O
recovery	O
of	O
PEDV	O
from	O
infectious	O
clones	O
and	O
PEDV	O
propagation	O
in	O
cell	B-ANAT
culture	O
.	O

TITLE	O
:	O
Guinea	O
Fowl	O
Coronavirus	O
Diversity	O
Has	O
Phenotypic	O
Consequences	O
for	O
Glycan	O
and	O
Tissue	B-ANAT
Binding	O
.	O

It	O
involves	O
the	O
installment	O
of	O
either	O
single	O
ubiquitin	O
(	O
Ub	O
)	O
moieties	O
or	O
one	O
of	O
eight	O
different	O
polyUb	O
linkage	O
types	O
,	O
each	O
giving	O
a	O
distinct	O
cellular	B-ANAT
outcome	O
.	O

Both	O
toxicological	O
analysis	O
of	O
deceased	O
blood	B-ANAT
and	O
urine	B-ANAT
samples	O
and	O
chemical	O
analysis	O
of	O
the	O
herbal	O
mixture	O
seized	O
revealed	O
presence	O
of	O
two	O
SCs	O
-	O
5F	O
-	O
ADB	O
and	O
FUB	O
-	O
AMB	O
.	O

The	O
amount	O
of	O
5F	O
-	O
ADB	O
in	O
blood	B-ANAT
was	O
found	O
to	O
be	O
3	O
.	O
7	O
ng	O
/	O
mL	O
by	O
standard	O
addition	O
method	O
.	O

Severe	O
and	O
irreversible	O
morphology	O
changes	O
in	O
lung	B-ANAT
specimen	O
,	O
leading	O
to	O
ischemic	O
damage	O
of	O
all	O
internal	O
organs	B-ANAT
and	O
tissues	B-ANAT
,	O
were	O
observed	O
during	O
histological	O
examination	O
.	O

ABSTRACT	O
:	O
Due	O
to	O
the	O
inconsistent	O
development	O
of	O
enteric	O
signs	O
associated	O
with	O
ECoV	O
infection	O
in	O
adult	O
horses	O
,	O
many	O
practitioners	O
collect	O
nasal	B-ANAT
secretions	B-ANAT
rather	O
than	O
feces	B-ANAT
for	O
the	O
molecular	O
diagnostic	O
work	O
-	O
up	O
of	O
such	O
horses	O
.	O

Viruses	O
likely	O
play	O
some	O
role	O
in	O
the	O
pathogenesis	O
of	O
the	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
at	O
the	O
Hajj	O
.	O

CT	O
chest	B-ANAT
revealed	O
interval	O
improvement	O
in	O
his	O
bilateral	O
ground	O
glass	O
and	O
reticular	O
opacities	O
but	O
residual	O
fibrotic	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
.	O

The	O
fact	O
that	O
our	O
case	O
presented	O
with	O
lung	B-ANAT
findings	O
alone	O
led	O
to	O
the	O
delay	O
in	O
his	O
diagnosis	O
.	O

TITLE	O
:	O
StatPearls	O
ABSTRACT	O
:	O
About	O
5	O
million	O
Americans	O
require	O
a	O
blood	B-ANAT
transfusion	O
each	O
year	O
,	O
needed	O
for	O
acute	O
blood	B-ANAT
loss	O
,	O
surgery	O
,	O
hemophilia	O
or	O
cancer	O
.	O

Additionally	O
,	O
vaccinated	O
and	O
challenged	O
chickens	O
showed	O
reduced	O
viral	O
loads	O
and	O
microscopic	O
lesion	O
counts	O
in	O
tracheal	O
and	O
kidney	B-ANAT
tissues	B-ANAT
,	O
and	O
their	O
antibody	O
and	O
CMI	O
responses	O
were	O
negatively	O
correlated	O
with	O
viral	O
loads	O
in	O
the	O
trachea	B-ANAT
and	O
kidney	B-ANAT
.	O

An	O
endemic	O
focus	O
persists	O
in	O
Ethiopia	O
and	O
adjacent	O
territories	O
in	O
the	O
Horn	B-ANAT
of	O
Africa	O
.	O

bilateral	O
total	O
-	O
body	B-ANAT
irradiation	O
(	O
TBI	O
);	O
2	O
.	O

Peripheral	B-ANAT
blood	I-ANAT
samples	O
were	O
drawn	O
14	O
days	O
preirradiation	O
and	O
at	O
days	O
1	O
,	O
3	O
,	O
5	O
,	O
7	O
and	O
14	O
postirradiation	O
.	O

TITLE	O
:	O
Construction	O
and	O
Immunogenicity	O
of	O
Novel	O
Chimeric	O
Virus	B-ANAT
-	I-ANAT
Like	I-ANAT
Particles	I-ANAT
Bearing	O
Antigens	O
of	O
Infectious	O
Bronchitis	O
Virus	O
and	O
Newcastle	O
Disease	O
Virus	O
.	O

Future	O
directions	O
include	O
efforts	O
to	O
facilitate	O
earlier	O
recognition	O
of	O
ARDS	O
,	O
identifying	O
responsive	O
subsets	O
of	O
patients	O
and	O
ongoing	O
efforts	O
to	O
understand	O
fundamental	O
mechanisms	O
of	O
lung	B-ANAT
injury	O
to	O
design	O
specific	O
treatments	O
.	O

Agreement	O
between	O
identification	O
of	O
viruses	O
in	O
nasal	B-ANAT
swabs	O
and	O
tracheal	O
washes	O
was	O
generally	O
weak	O
,	O
indicating	O
that	O
sampling	O
location	O
may	O
affect	O
detection	O
of	O
infection	O
.	O

Non	O
-	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
patients	O
had	O
lower	O
health	O
-	O
related	O
quality	O
-	O
of	O
-	O
life	O
scores	O
and	O
higher	O
rates	O
of	O
posttraumatic	O
stress	O
disorder	O
.	O

The	O
case	O
we	O
describe	O
was	O
that	O
of	O
a	O
47	O
-	O
year	O
-	O
old	O
woman	O
with	O
history	O
of	O
renal	B-ANAT
transplantation	O
1	O
month	O
earlier	O
.	O

In	O
addition	O
,	O
immunoregulated	O
agents	O
,	O
such	O
as	O
asthymosin	O
Î±1	O
,	O
are	O
also	O
of	O
great	O
value	O
in	O
renal	B-ANAT
transplant	B-ANAT
recipients	O
in	O
the	O
setting	O
of	O
opportunistic	O
pathogen	O
infections	O
.	O

In	O
the	O
moderate	O
and	O
severe	O
groups	O
,	O
PAP	O
was	O
significantly	O
higher	O
in	O
neonates	O
with	O
pulmonary	B-ANAT
ALI	O
/	O
ADDS	O
(	O
ALI	O
/	O
ARDSp	O
)	O
than	O
in	O
neonates	O
with	O
extrapulmonary	O
ALI	O
/	O
ARDS	O
(	O
ALI	O
/	O
ARDSexp	O
)	O
(	O
62	O
.	O
5	O
Â±	O
5	O
.	O
4	O
vs	O
68	O
.	O
0	O
Â±	O
6	O
.	O
5	O
,	O
54	O
.	O
7	O
Â±	O
5	O
.	O
9	O
vs	O
64	O
.	O
2	O
Â±	O
4	O
.	O
9	O
;	O
t	O
=	O
3	O
.	O
264	O
,	O
3	O
.	O
123	O
;	O
P	O
=	O
.	O
004	O
,.	O
039	O
).	O

The	O
overall	O
dynamic	O
PAP	O
monitoring	O
results	O
revealed	O
that	O
PAP	O
was	O
higher	O
in	O
the	O
pulmonary	B-ANAT
group	O
than	O
that	O
in	O
the	O
extrapulmonary	O
group	O
,	O
and	O
this	O
exhibited	O
a	O
gradually	O
decreasing	O
trend	O
as	O
the	O
condition	O
of	O
the	O
subject	O
improved	O
.	O

Another	O
benefit	O
comes	O
from	O
its	O
versatility	O
as	O
it	O
can	O
be	O
applied	O
to	O
envelope	B-ANAT
proteins	O
belonging	O
to	O
all	O
three	O
classes	O
of	O
viral	O
fusion	O
proteins	O
,	O
such	O
as	O
the	O
class	O
I	O
influenza	O
hemagglutinin	O
(	O
HA	O
)	O
and	O
Ebola	O
virus	O
glycoprotein	O
(	O
GP	O
),	O
the	O
class	O
II	O
Semliki	O
forest	O
virus	O
E1	O
protein	O
,	O
or	O
the	O
class	O
III	O
vesicular	O
stomatitis	O
virus	O
G	O
glycoprotein	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
is	O
a	O
rescue	O
treatment	O
for	O
respiratory	O
or	O
cardiac	B-ANAT
failure	O
.	O

We	O
present	O
2	O
patients	O
with	O
deranged	O
coagulation	O
after	O
liver	B-ANAT
rupture	O
successfully	O
treated	O
by	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

Liver	B-ANAT
suture	B-ANAT
was	O
performed	O
,	O
but	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
PaO2	O
/	O
fraction	O
of	O
inspired	O
oxygen	O
,	O
50	O
)	O
necessitated	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

Cells	B-ANAT
infected	O
with	O
most	O
cell	B-ANAT
-	O
adapted	O
PEDVs	O
usually	O
displayed	O
large	O
syncytia	B-ANAT
,	O
a	O
process	O
triggered	O
by	O
the	O
spike	O
protein	O
(	O
S	O
).	O

To	O
identify	O
amino	O
acids	O
responsible	O
for	O
S	O
-	O
mediated	O
syncytium	B-ANAT
formation	O
,	O
we	O
constructed	O
and	O
characterized	O
chimeric	O
S	O
proteins	O
of	O
the	O
cell	B-ANAT
-	O
adapted	O
variant	O
,	O
YN144	O
,	O
in	O
which	O
the	O
receptor	O
binding	O
domain	O
(	O
RBD	O
)	O
and	O
S1	O
/	O
S2	O
cleavage	O
site	O
were	O
replaced	O
with	O
those	O
of	O
a	O
poorly	O
culturable	O
field	O
isolate	O
(	O
G2	O
).	O

TITLE	O
:	O
National	O
estimates	O
of	O
the	O
use	O
and	O
outcomes	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
after	O
acute	O
trauma	O
.	O

ABSTRACT	O
:	O
Porcine	O
epidemic	O
diarrhea	O
(	O
PED	O
)	O
which	O
is	O
caused	O
by	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
),	O
is	O
an	O
intestinal	B-ANAT
communicable	O
disease	O
.	O

Our	O
results	O
demonstrated	O
that	O
simultaneous	O
expression	O
of	O
these	O
specific	O
shRNA	O
molecules	O
inhibited	O
expression	O
of	O
PEDV	O
M	O
gene	O
,	O
SADS	O
-	O
CoV	O
M	O
gene	O
,	O
and	O
PDCoV	O
N	O
gene	O
RNA	O
by	O
99	O
.	O
7	O
%,	O
99	O
.	O
4	O
%,	O
and	O
98	O
.	O
8	O
%,	O
respectively	O
,	O
in	O
infected	O
cell	B-ANAT
cultures	O
.	O

Nowadays	O
,	O
as	O
a	O
result	O
of	O
traffic	O
accidents	O
,	O
following	O
high	O
energy	O
deceleration	O
,	O
lung	B-ANAT
contusion	O
may	O
present	O
without	O
an	O
actual	O
tissue	B-ANAT
damage	O
in	O
the	O
chest	B-ANAT
wall	I-ANAT
as	O
a	O
condition	O
initiating	O
an	O
independent	O
,	O
life	O
-	O
threatening	O
generalised	O
process	O
.	O

Several	O
approaches	O
exist	O
:	O
thoracic	B-ANAT
trauma	O
,	O
pulmonary	B-ANAT
contusion	O
,	O
pulmonary	B-ANAT
laceration	O
,	O
lung	B-ANAT
contusion	O
;	O
although	O
these	O
may	O
show	O
similar	O
clinical	O
signs	O
,	O
manifest	O
in	O
different	O
pathologies	O
.	O

Furthermore	O
,	O
we	O
found	O
that	O
during	O
virus	O
infection	O
,	O
the	O
replicase	O
proteins	O
containing	O
the	O
MAC	B-ANAT
and	O
PLP2	O
mutations	O
were	O
more	O
rapidly	O
degraded	O
at	O
the	O
nonpermissive	O
temperature	O
than	O
were	O
the	O
wild	O
-	O
type	O
proteins	O
.	O

TITLE	O
:	O
Hemoadsorption	O
in	O
isolated	O
conjugated	O
hyperbilirubinemia	O
after	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
support	O
.	O

Jaundice	O
can	O
reflect	O
the	O
course	O
of	O
disease	O
or	O
be	O
caused	O
by	O
treatment	O
(	O
e	O
.	O
g	O
.	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)),	O
thus	O
can	O
be	O
difficult	O
to	O
differentiate	O
.	O

ABSTRACT	O
:	O
According	O
to	O
recently	O
published	O
findings	O
,	O
levels	O
of	O
the	O
soluble	O
receptor	O
of	O
advanced	O
glycation	O
end	O
products	O
(	O
sRAGE	O
)	O
and	O
its	O
clearance	O
from	O
the	O
blood	B-ANAT
may	O
reflect	O
the	O
evolution	O
of	O
lung	B-ANAT
damage	O
during	O
hospitalization	O
.	O

Blood	B-ANAT
samples	I-ANAT
were	O
taken	O
initially	O
and	O
on	O
days	O
1	O
,	O
3	O
,	O
5	O
,	O
7	O
,	O
10	O
,	O
14	O
,	O
and	O
21	O
during	O
hospitalization	O
.	O

ABSTRACT	O
:	O
Lower	B-ANAT
extremity	I-ANAT
necrotizing	O
fasciitis	O
(	O
NF	O
)	O
is	O
a	O
severe	O
infection	O
requiring	O
immediate	O
surgery	O
.	O

ABSTRACT	O
:	O
Among	O
onco	O
-	O
hematological	O
patients	O
with	O
acute	O
respiratory	O
failure	O
(	O
ARpF	O
),	O
surgical	O
lung	B-ANAT
biopsy	O
(	O
SLB	O
)	O
could	O
contribute	O
to	O
the	O
medical	O
management	O
,	O
by	O
guiding	O
initiation	O
,	O
maintenance	O
or	O
discontinuation	O
of	O
diagnostic	O
and	O
therapeutic	O
interventions	O
.	O

Delayed	O
treatment	O
can	O
result	O
in	O
multi	O
-	O
organ	B-ANAT
failure	O
,	O
which	O
requires	O
intensive	O
care	O
and	O
long	O
hospital	O
stays	O
.	O

Approximately	O
69	O
.	O
05	O
%	O
(	O
232	O
/	O
336	O
)	O
of	O
the	O
diarrhoeic	O
samples	O
were	O
assessed	O
as	O
bovine	O
coronavirus	O
(	O
BCoV	O
)-	O
positive	O
by	O
RT	O
-	O
PCR	O
assay	O
,	O
and	O
most	O
of	O
the	O
detected	O
strains	O
showed	O
a	O
unique	O
evolution	O
based	O
on	O
40	O
spike	O
(	O
S	O
),	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
and	O
haemagglutinin	O
-	O
esterase	O
(	O
HE	O
)	O
gene	O
fragments	O
.	O

Severe	O
isolated	O
vasculo	O
-	O
connective	B-ANAT
tissue	I-ANAT
involvement	O
in	O
infancy	O
is	O
rare	O
,	O
and	O
hence	O
the	O
precise	O
and	O
timely	O
diagnosis	O
is	O
difficult	O
.	O

However	O
,	O
postmortem	O
review	O
of	O
facial	B-ANAT
traits	O
raised	O
the	O
suspicion	O
of	O
MD	O
.	O

TITLE	O
:	O
Respiratory	O
Virus	O
Infections	O
of	O
the	O
Stem	O
Cell	B-ANAT
Transplant	I-ANAT
Recipient	O
and	O
the	O
Hematologic	O
Malignancy	O
Patient	O
.	O

To	O
solve	O
all	O
of	O
these	O
deficiencies	O
in	O
current	O
animal	O
models	O
,	O
we	O
have	O
created	O
a	O
simple	O
and	O
reproducible	O
technique	O
to	O
selectively	O
induce	O
lung	B-ANAT
injury	O
in	O
specific	O
areas	O
of	O
the	O
lung	B-ANAT
.	O

Collectively	O
,	O
these	O
attributes	O
of	O
CICSLI	O
will	O
allow	O
investigators	O
to	O
better	O
study	O
how	O
drugs	O
act	O
within	O
heterogeneous	O
lung	B-ANAT
pathologies	O
and	O
how	O
regeneration	O
occurs	O
in	O
severely	O
damaged	O
lung	B-ANAT
tissue	I-ANAT
,	O
thereby	O
aiding	O
the	O
development	O
of	O
new	O
therapies	O
for	O
ARDS	O
and	O
other	O
heterogenous	O
lung	B-ANAT
diseases	O
.	O

SI	O
-	O
ALI	O
model	O
rats	O
had	O
a	O
high	O
mortality	O
rate	O
and	O
severe	O
lung	B-ANAT
injury	O
with	O
proinflammatory	O
,	O
procoagulant	O
,	O
and	O
pro	O
-	O
fibrotic	O
changes	O
.	O

Pro	O
-	O
fibrotic	O
chemokine	O
levels	O
were	O
gradually	O
increased	O
,	O
followed	O
by	O
an	O
increase	O
in	O
collagen	B-ANAT
and	O
fibrin	O
deposition	O
after	O
smoke	O
inhalation	O
.	O

Plasma	B-ANAT
samples	O
from	O
the	O
HD	O
patients	O
and	O
medical	O
staff	O
were	O
collected	O
at	O
the	O
time	O
of	O
isolation	O
(	O
M0	O
),	O
the	O
following	O
month	O
(	O
M1	O
),	O
and	O
three	O
months	O
after	O
isolation	O
(	O
M3	O
).	O

TITLE	O
:	O
A	O
study	O
on	O
the	O
protective	O
effects	O
of	O
CpG	O
oligodeoxynucleotide	O
-	O
induced	O
mucosal	B-ANAT
immunity	O
against	O
lung	B-ANAT
injury	O
in	O
a	O
mouse	O
acute	O
respiratory	O
distress	O
syndrome	O
model	O
.	O

Interestingly	O
,	O
careful	O
literature	O
analysis	O
shows	O
that	O
viruses	O
indeed	O
bind	O
to	O
the	O
cell	B-ANAT
surface	I-ANAT
via	O
sialic	O
acids	O
,	O
but	O
there	O
is	O
no	O
solid	O
data	O
that	O
these	O
moieties	O
mediate	O
virus	O
entry	O
.	O

TITLE	O
:	O
Identification	O
of	O
a	O
novel	O
linear	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
epitope	O
within	O
the	O
collagenase	O
equivalent	O
domain	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
spike	O
glycoprotein	O
.	O

21	O
%	O
of	O
aspiration	O
cases	O
were	O
among	O
women	O
who	O
delivered	O
via	O
cesarean	O
section	O
,	O
while	O
79	O
%	O
of	O
women	O
were	O
undergoing	O
general	O
anesthesia	O
for	O
vaginal	B-ANAT
deliveries	O
.	O

TITLE	O
:	O
Delayed	O
retroperitoneal	B-ANAT
hemorrhage	O
during	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
:	O
a	O
case	O
report	O
.	O

On	O
day	O
13	O
,	O
computed	O
tomography	O
unexpectedly	O
revealed	O
a	O
large	O
retroperitoneal	B-ANAT
hemorrhage	O
spreading	O
around	O
the	O
psoas	B-ANAT
muscle	I-ANAT
.	O

Thus	O
,	O
the	O
present	O
review	O
comprehensively	O
and	O
critically	O
illustrates	O
the	O
recent	O
aspects	O
on	O
the	O
epidemiology	O
of	O
the	O
virus	O
,	O
the	O
structural	O
and	O
functional	O
features	O
of	O
the	O
viral	B-ANAT
genome	I-ANAT
,	O
viral	O
entry	O
and	O
transmission	O
,	O
major	O
mechanisms	O
of	O
pathogenesis	O
and	O
associated	O
virulent	O
factors	O
,	O
current	O
animal	O
models	O
,	O
detection	O
methods	O
and	O
novel	O
strategies	O
for	O
the	O
development	O
of	O
vaccines	O
against	O
MERS	O
-	O
CoV	O
.	O
The	O
review	O
further	O
illustrates	O
the	O
molecular	O
and	O
computational	O
virtual	O
screening	O
platforms	O
which	O
provide	O
insights	O
for	O
the	O
identification	O
of	O
putative	O
drug	O
targets	O
and	O
novel	O
lead	O
molecules	O
toward	O
the	O
development	O
of	O
therapeutic	O
remedies	O
.	O

ABSTRACT	O
:	O
Human	O
coronaviruses	O
(	O
hCoV	O
)	O
usually	O
cause	O
mild	O
to	O
moderate	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
illnesses	O
.	O

TITLE	O
:	O
Essential	O
Role	O
of	O
Visfatin	O
in	O
Lipopolysaccharide	O
and	O
Colon	B-ANAT
Ascendens	I-ANAT
Stent	O
Peritonitis	O
-	O
Induced	O
Acute	O
Lung	B-ANAT
Injury	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
is	O
a	O
life	O
-	O
threatening	O
syndrome	O
characterized	O
by	O
acute	O
and	O
severe	O
hypoxemic	O
respiratory	O
failure	O
.	O

More	O
particle	O
-	O
laden	O
macrophages	B-ANAT
and	O
even	O
greater	O
chronic	O
inflammation	O
were	O
observed	O
in	O
the	O
UFP	O
-	O
exposed	O
mice	O
lungs	B-ANAT
.	O

Taken	O
together	O
,	O
these	O
results	O
strongly	O
motivate	O
the	O
update	O
of	O
current	O
regulations	O
regarding	O
ambient	O
PM	O
concentrations	O
to	O
include	O
UFP	O
and	O
limit	O
their	O
emission	B-ANAT
.	O

In	O
the	O
RT	O
-	O
PSR	O
assay	O
,	O
the	O
addition	O
of	O
a	O
mixture	O
of	O
dyes	O
allowed	O
a	O
positive	O
reaction	O
to	O
be	O
directly	O
observed	O
by	O
the	O
naked	O
eye	B-ANAT
.	O

Historically	O
thought	O
to	O
be	O
limited	O
to	O
pandemic	O
viruses	O
,	O
improved	O
detection	O
of	O
hRV	O
has	O
led	O
to	O
its	O
implication	O
in	O
serious	O
respiratory	O
disorders	O
extending	O
beyond	O
the	O
oropharynx	B-ANAT
in	O
immunocompetent	O
hosts	O
.	O

Fatty	O
acid	O
-	O
binding	O
protein	O
1	O
(	O
FABP1	O
)	O
and	O
fatty	O
acid	O
-	O
binding	O
protein	O
3	O
(	O
FABP3	O
)	O
were	O
found	O
to	O
be	O
regulated	O
by	O
PDCoV	O
.	O
These	O
two	O
genes	O
not	O
only	O
mediate	O
fatty	O
acid	O
transportation	O
to	O
different	O
cell	B-ANAT
organelles	I-ANAT
such	O
as	O
mitochondria	B-ANAT
,	O
peroxisome	B-ANAT
,	O
endoplasmic	B-ANAT
reticulum	I-ANAT
and	O
nucleus	B-ANAT
,	O
but	O
also	O
modulate	O
fatty	O
acid	O
metabolism	O
and	O
storage	B-ANAT
as	O
a	O
signaling	O
molecule	O
outside	O
the	O
cell	B-ANAT
.	O

We	O
analyzed	O
1	O
,	O
747	O
subjects	O
without	O
chronic	O
kidney	B-ANAT
disease	O
or	O
severe	O
chronic	O
liver	B-ANAT
disease	O
at	O
ARDS	O
onset	O
.	O

Monocytes	B-ANAT
of	O
QFS	O
patients	O
produced	O
significantly	O
less	O
TNF	O
-	O
Î±	O
(	O
p	O
=	O
0	O
.	O
032	O
),	O
IL	O
-	O
1Î²	O
(	O
0	O
.	O
004	O
,	O
0	O
.	O
024	O
,	O
and	O
0	O
.	O
008	O
),	O
IL	O
-	O
6	O
(	O
0	O
.	O
043	O
),	O
RANTES	O
(	O
0	O
.	O
033	O
),	O
IP	O
-	O
10	O
(	O
0	O
.	O
049	O
),	O
MCP	O
-	O
1	O
(	O
0	O
.	O
022	O
),	O
IL	O
-	O
13	O
(	O
0	O
.	O
029	O
),	O
and	O
IL	O
-	O
10	O
(	O
0	O
.	O
026	O
)	O
than	O
healthy	O
controls	O
when	O
stimulated	O
with	O
various	O
ligands	O
.	O

Gabapentin	O
was	O
administered	O
by	O
a	O
nasogastric	B-ANAT
tube	O
that	O
quickly	O
resulted	O
in	O
a	O
reversal	O
of	O
his	O
symptoms	O
.	O

The	O
left	O
ventricular	B-ANAT
dysfunction	O
recovered	O
1	O
week	O
after	O
resolution	O
of	O
tension	O
pneumothorax	O
.	O

Parents	O
completed	O
a	O
daily	O
symptom	O
diary	O
for	O
8	O
weeks	O
,	O
during	O
which	O
time	O
they	O
collected	O
a	O
nasal	B-ANAT
swab	O
from	O
the	O
child	O
for	O
each	O
clinical	O
ARI	O
episode	O
.	O

TITLE	O
:	O
Pathogenesis	O
of	O
oral	B-ANAT
type	O
I	O
feline	O
infectious	O
peritonitis	O
virus	O
(	O
FIPV	O
)	O
infection	O
:	O
Antibody	O
-	O
dependent	O
enhancement	O
infection	O
of	O
cats	O
with	O
type	O
I	O
FIPV	O
via	O
the	O
oral	B-ANAT
route	O
.	O

Based	O
on	O
the	O
findings	O
of	O
this	O
study	O
,	O
type	O
I	O
FIPV	O
which	O
orally	B-ANAT
infected	O
cats	O
may	O
cause	O
FIP	O
depending	O
on	O
the	O
condition	O
.	O

Our	O
data	O
indicate	O
that	O
despite	O
relatively	O
high	O
viral	O
RNA	O
levels	O
produced	O
,	O
low	O
levels	O
of	O
infectious	O
virus	O
are	O
excreted	O
in	O
the	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
of	O
rabbits	O
as	O
compared	O
to	O
dromedary	O
camels	O
,	O
thus	O
resulting	O
in	O
a	O
lack	O
of	O
viral	O
transmission	O
.	O

Those	O
findings	O
supports	O
our	O
efforts	O
to	O
elucidate	O
the	O
highly	O
sophisticated	O
regulatory	O
network	O
that	O
enact	O
endothelial	B-ANAT
adaptations	O
under	O
the	O
plethora	O
of	O
challenging	O
environmental	O
factors	O
.	O

The	O
most	O
significant	O
cellular	B-ANAT
immune	O
response	O
was	O
induced	O
after	O
vaccination	O
of	O
the	O
animals	O
with	O
the	O
full	O
-	O
length	O
S	O
(	O
rAd5	O
-	O
S	O
).	O

ABSTRACT	O
:	O
Caused	O
by	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
),	O
porcine	O
epidemic	O
diarrhea	O
(	O
PED	O
)	O
is	O
an	O
acute	O
infectious	O
disease	O
which	O
causes	O
damage	O
to	O
the	O
intestine	B-ANAT
including	O
intestinal	B-ANAT
villus	I-ANAT
atrophy	O
and	O
shedding	O
,	O
leading	O
to	O
serious	O
economic	O
losses	O
to	O
the	O
pig	O
industry	O
worldwide	O
.	O

(	O
Gene	O
Ontology	O
)	O
GO	O
annotation	O
and	O
functional	O
enrichment	O
analysis	O
indicated	O
that	O
all	O
of	O
the	O
DEGs	O
(	O
differentially	O
expressed	O
genes	O
)	O
were	O
annotated	O
into	O
biological	O
process	O
,	O
cellular	B-ANAT
component	I-ANAT
and	O
molecular	O
function	O
.	O

Ultra	O
-	O
lung	B-ANAT
protective	O
mechanical	O
ventilation	O
was	O
achieved	O
within	O
24	O
hours	O
.	O

Nine	O
days	O
after	O
admission	O
,	O
he	O
developed	O
severe	O
acute	O
hypoxia	O
and	O
tachycardia	O
with	O
arterial	B-ANAT
oxygen	O
tension	O
(	O
PaO2	O
)	O
of	O
52	O
mmHg	O
requiring	O
a	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
of	O
14	O
cmH2O	O
and	O
fraction	O
of	O
inspired	O
oxygen	O
(	O
FiO2	O
)	O
of	O
1	O
.	O

Especially	O
in	O
the	O
anatomical	O
areas	O
in	O
the	O
chest	B-ANAT
that	O
are	O
more	O
difficult	O
to	O
reach	O
in	O
open	O
surgery	O
(	O
including	O
the	O
superior	B-ANAT
mediastinum	I-ANAT
).	O

From	O
May	O
2007	O
-	O
2018	O
,	O
all	O
patients	O
who	O
had	O
involved	O
nodes	B-ANAT
by	O
either	O
fluor	O
-	O
18	O
-	O
deoxyglucose	O
positron	O
-	O
emission	B-ANAT
-	O
tomography	O
-	O
computed	O
tomography	O
(	O
FDG	O
-	O
PET	O
-	O
CT	O
)	O
or	O
endoscopic	O
ultrasound	O
(	O
EUS	O
)	O
+	O
fine	O
needle	O
aspiration	O
(	O
FNA	O
)	O
localized	O
in	O
the	O
superior	B-ANAT
mediastinum	I-ANAT
(	O
above	O
level	O
Th4	O
/	O
sternal	B-ANAT
angle	I-ANAT
)	O
were	O
identified	O
.	O

RAMIE	O
for	O
esophageal	O
cancer	O
patients	O
with	O
node	B-ANAT
positive	O
disease	O
in	O
the	O
superior	B-ANAT
mediastinum	I-ANAT
is	O
associated	O
with	O
increased	O
mortality	O
/	O
morbidity	O
.	O

The	O
BCoV	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
,	O
an	O
RNA	O
-	O
binding	O
protein	O
,	O
was	O
therefore	O
tested	O
as	O
a	O
candidate	O
.	O

Clinical	O
characteristics	O
and	O
comorbidities	O
were	O
recorded	O
,	O
and	O
blood	B-ANAT
samples	I-ANAT
were	O
collected	O
.	O

The	O
level	O
of	O
plasma	B-ANAT
IL	O
-	O
6	O
was	O
greater	O
in	O
higher	O
CCI	O
score	O
(â¥	O
4	O
)	O
group	O
compared	O
with	O
lower	O
CCI	O
score	O
(<	O
4	O
)	O
group	O
(	O
CONCLUSIONS	O
:	O
Patients	O
with	O
a	O
higher	O
CCI	O
score	O
had	O
more	O
severe	O
symptoms	O
,	O
functional	O
impairment	O
and	O
higher	O
level	O
of	O
inflammatory	O
factors	O
and	O
high	O
frequency	O
of	O
hospital	O
admission	O
due	O
to	O
acute	O
exacerbation	O
.	O

In	O
the	O
current	O
study	O
,	O
mitochondrial	B-ANAT
counts	O
were	O
determined	O
in	O
three	O
different	O
segments	O
of	O
the	O
oviduct	B-ANAT
during	O
egg	B-ANAT
formation	O
in	O
laying	O
chickens	O
challenged	O
with	O
IBV	O
T	O
strain	O
.	O

In	O
the	O
shell	B-ANAT
gland	I-ANAT
,	O
the	O
mitochondrial	B-ANAT
count	O
was	O
significantly	O
lower	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
in	O
the	O
challenged	O
group	O
,	O
compared	O
with	O
the	O
control	O
group	O
.	O

The	O
genes	O
involved	O
in	O
mitochondrial	B-ANAT
biogenesis	O
or	O
function	O
may	O
not	O
show	O
synchronised	O
responses	O
to	O
that	O
of	O
mitochondria	B-ANAT
in	O
the	O
shell	B-ANAT
gland	I-ANAT
of	O
chickens	O
under	O
T	O
strain	O
of	O
IBV	O
challenge	O
.	O

Overlapping	O
12	O
-	O
mer	O
peptides	O
(	O
n	O
=	O
28	O
,	O
426	O
)	O
across	O
the	O
entire	O
Pp1ab	O
were	O
arrayed	O
on	O
peptide	O
chips	O
and	O
reacted	O
with	O
pooled	O
sera	B-ANAT
from	O
coronavirus	O
seropositive	O
cats	O
and	O
from	O
one	O
seronegative	O
cat	O
.	O

The	O
intra	O
-	O
abdominal	B-ANAT
pressure	O
(	O
IAP	O
)	O
applied	O
to	O
Glasgow	O
Coma	O
Scale	O
(	O
GCS	O
),	O
Acute	O
Physiology	O
,	O
shock	O
,	O
Systemic	O
Inflammatory	O
Response	O
Syndrome	O
(	O
SIRS	O
),	O
central	O
venous	B-ANAT
oxygen	O
saturation	O
and	O
Chronic	O
Health	O
Evaluation	O
(	O
APACHE	O
II	O
)	O
score	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

The	O
control	O
group	O
consisted	O
of	O
children	O
without	O
lesions	O
of	O
oral	B-ANAT
cavity	I-ANAT
(	O
66	O
people	O
).	O

The	O
saturation	O
of	O
blood	B-ANAT
plasma	I-ANAT
transferrin	O
by	O
iron	O
was	O
significantly	O
reduced	O
-	O
for	O
15	O
.	O
27	O
%	O
in	O
patients	O
with	O
severe	O
course	O
of	O
influenza	O
stomatitis	O
.	O

This	O
DEL	O
resulted	O
in	O
the	O
premature	O
termination	O
of	O
S	O
by	O
nine	O
amino	O
acid	O
residues	O
(	O
EVFEKVHVQ	O
),	O
which	O
contained	O
a	O
KxHxx	O
motif	O
that	O
is	O
a	O
potential	O
endoplasmic	B-ANAT
reticulum	I-ANAT
retrieval	O
signal	O
.	O

ABSTRACT	O
:	O
Serum	B-ANAT
troponin	O
is	O
a	O
marker	O
of	O
cardiac	B-ANAT
myocyte	I-ANAT
damage	O
that	O
is	O
typically	O
used	O
to	O
assess	O
for	O
myocardial	O
infarction	O
in	O
the	O
setting	O
of	O
acute	O
coronary	B-ANAT
syndrome	O
.	O

These	O
symptoms	O
were	O
associated	O
with	O
fevers	O
,	O
and	O
24	O
hours	O
prior	O
to	O
admission	O
,	O
he	O
developed	O
intermittent	O
chest	B-ANAT
pain	O
at	O
rest	O
,	O
radiating	O
to	O
the	O
back	B-ANAT
,	O
worsening	O
in	O
the	O
supine	O
position	O
.	O

Extracorporeal	O
life	O
support	O
(	O
ECLS	O
)	O
may	O
be	O
used	O
to	O
rescue	O
patients	O
with	O
severely	O
impaired	O
gas	O
exchange	O
and	O
provide	O
time	O
for	O
injured	O
lungs	B-ANAT
to	O
recover	O
while	O
treating	O
the	O
underlying	O
disease	O
.	O

In	O
patients	O
with	O
ARDS	O
,	O
venovenous	O
(	O
VV	O
)	O
ECLS	O
is	O
commonly	O
used	O
,	O
where	O
venous	B-ANAT
blood	I-ANAT
is	O
drained	O
into	O
a	O
circuit	O
that	O
passes	O
through	O
a	O
membrane	B-ANAT
lung	B-ANAT
,	O
which	O
provides	O
gas	O
exchange	O
,	O
and	O
then	O
returned	O
to	O
the	O
venous	B-ANAT
system	I-ANAT
.	O

TITLE	O
:	O
The	O
ER	O
stress	O
sensor	O
IRE1	O
and	O
MAP	O
kinase	O
ERK	O
modulate	O
autophagy	O
induction	O
in	O
cells	B-ANAT
infected	O
with	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
autophagosome	B-ANAT
formation	O
and	O
apparent	O
autophagic	O
flux	O
are	O
induced	O
in	O
cells	B-ANAT
infected	O
with	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
-	O
a	O
gammacoronavirus	O
.	O

Severe	O
hypoxemia	O
on	O
venous	B-ANAT
-	O
venous	B-ANAT
-	O
ECMO	O
support	O
may	O
occur	O
despite	O
the	O
matching	O
between	O
the	O
oxygen	O
transfer	O
by	O
ECMO	O
and	O
the	O
VO2	O
of	O
the	O
patient	O
.	O

The	O
generation	O
of	O
a	O
diverse	O
T	B-ANAT
cell	I-ANAT
and	O
B	B-ANAT
cell	I-ANAT
repertoire	O
is	O
essential	O
for	O
protection	O
against	O
infection	O
.	O

In	O
this	O
study	O
,	O
multiplex	O
PCR	O
based	O
on	O
genomic	O
DNA	O
amplicons	O
and	O
Illumina	O
high	O
-	O
throughput	O
sequencing	O
(	O
HTS	O
)	O
were	O
applied	O
to	O
study	O
the	O
characteristics	O
and	O
polymorphisms	O
of	O
the	O
TRB	O
and	O
IGH	O
repertoire	O
in	O
the	O
peripheral	B-ANAT
blood	I-ANAT
mononuclear	I-ANAT
cells	I-ANAT
(	O
PBMCs	O
)	O
from	O
two	O
H5N6	O
AIV	O
patients	O
and	O
six	O
healthy	O
donors	O
(	O
NC	O
).	O

Here	O
we	O
show	O
that	O
pan	B-ANAT
-	O
PARP	O
inhibition	O
enhanced	O
replication	O
and	O
inhibited	O
interferon	O
production	O
in	O
primary	O
macrophages	B-ANAT
infected	O
with	O
macrodomain	O
-	O
mutant	O
but	O
not	O
wild	O
-	O
type	O
coronavirus	O
.	O

Plasmodium	O
berghei	O
NK65	O
-	O
E	O
(	O
PbNK65	O
)	O
parasites	O
were	O
injected	O
in	O
Vwf	O
In	O
accordance	O
with	O
patients	O
with	O
severe	O
malaria	O
,	O
plasma	B-ANAT
VWF	O
levels	O
were	O
increased	O
and	O
ADAMTS13	O
activity	O
levels	O
were	O
reduced	O
in	O
experimental	O
MA	O
-	O
ARDS	O
.	O

The	O
HbCO	O
%	O
content	O
was	O
determined	O
by	O
a	O
photoplethysmometric	O
method	O
using	O
a	O
Masimo	O
Rainbow	O
Rad	O
-	O
57	O
apparatus	B-ANAT
(	O
USA	O
)	O
along	O
with	O
indicators	O
of	O
heart	B-ANAT
rate	O
,	O
capillary	B-ANAT
blood	I-ANAT
oxygen	O
saturation	O
(	O
SpO2	O
%)	O
and	O
volume	O
peripheral	O
capillary	B-ANAT
perfusion	O
(	O
perfusion	O
index	O
).	O

In	O
patients	O
with	O
thoracic	B-ANAT
injury	O
,	O
the	O
content	O
of	O
carboxylated	O
hemoglobin	O
was	O
the	O
greater	O
,	O
the	O
more	O
severe	O
were	O
the	O
manifestations	O
of	O
acute	O
respiratory	O
failure	O
syndrome	O
,	O
which	O
was	O
detected	O
according	O
to	O
the	O
severity	O
of	O
arterial	B-ANAT
hypoxemia	O
.	O

ABSTRACT	O
:	O
Severe	O
pulmonary	B-ANAT
infections	O
are	O
among	O
the	O
most	O
common	O
reasons	O
for	O
admission	O
to	O
intensive	O
care	O
units	O
(	O
ICU	O
).	O

Review	O
of	O
the	O
literature	O
pertaining	O
to	O
severe	O
influenza	O
-	O
associated	O
pulmonary	B-ANAT
aspergillosis	O
.	O

Mean	O
airway	B-ANAT
pressures	O
(	O
Paw	B-ANAT
),	O
oxygenation	O
index	O
(	O
OI	O
),	O
arterial	B-ANAT
oxygen	O
partial	O
pressure	O
(	O
PaO	O

TITLE	O
:	O
Characterization	O
of	O
antiviral	O
T	B-ANAT
cell	I-ANAT
responses	O
during	O
primary	O
and	O
secondary	O
challenge	O
of	O
laboratory	O
cats	O
with	O
feline	O
infectious	O
peritonitis	O
virus	O
(	O
FIPV	O
).	O

ABSTRACT	O
:	O
Feline	O
infectious	O
peritonitis	O
(	O
FIP	O
)	O
is	O
considered	O
highly	O
fatal	O
in	O
its	O
naturally	O
occurring	O
form	O
,	O
although	O
up	O
to	O
36	O
%	O
of	O
cats	O
resist	O
disease	O
after	O
experimental	O
infection	O
,	O
suggesting	O
that	O
cats	O
in	O
nature	O
may	O
also	O
resist	O
development	O
of	O
FIP	O
in	O
the	O
face	B-ANAT
of	O
infection	O
with	O
FIP	O
virus	O
(	O
FIPV	O
).	O

This	O
experimental	O
FIPV	O
infection	O
study	O
in	O
specific	O
pathogen	O
free	O
(	O
SPF	O
)	O
kittens	O
describes	O
longitudinal	O
antiviral	O
T	B-ANAT
cell	I-ANAT
responses	O
and	O
clinical	O
outcomes	O
ranging	O
from	O
rapid	O
progression	O
,	O
slow	O
progression	O
,	O
and	O
resistance	O
to	O
disease	O
.	O

Recovery	O
of	O
antiviral	O
T	B-ANAT
cell	I-ANAT
responses	O
during	O
the	O
later	O
phase	O
of	O
acute	O
infection	O
was	O
observed	O
in	O
a	O
subset	O
of	O
cats	O
that	O
survived	O
longer	O
or	O
resisted	O
disease	O
compared	O
to	O
cats	O
showing	O
rapid	O
disease	O
progression	O
.	O

More	O
robust	O
T	B-ANAT
cell	I-ANAT
responses	O
at	O
terminal	O
time	O
points	O
were	O
observed	O
in	O
lymph	B-ANAT
nodes	I-ANAT
compared	O
to	O
blood	B-ANAT
in	O
cats	O
that	O
developed	O
FIP	O
.	O

Nine	O
of	O
ten	O
rechallenged	O
cats	O
did	O
not	O
develop	O
FIP	O
or	O
T	B-ANAT
cell	I-ANAT
depletion	O
and	O
all	O
cats	O
demonstrated	O
antiviral	O
T	B-ANAT
cell	I-ANAT
responses	O
at	O
multiple	O
time	O
points	O
after	O
rechallenge	O
.	O

AKI	O
is	O
a	O
frequent	O
complication	O
of	O
severe	O
acute	O
pancreatitis	O
and	O
develops	O
late	O
in	O
the	O
course	O
of	O
the	O
disease	O
,	O
usually	O
after	O
the	O
failure	O
of	O
other	O
organs	B-ANAT
.	O

The	O
exact	O
pathophysiology	O
of	O
AKI	O
in	O
acute	O
pancreatitis	O
remains	O
unclear	O
but	O
appears	O
to	O
result	O
from	O
initial	O
volume	O
depletion	O
followed	O
by	O
complex	O
vascular	B-ANAT
and	O
humoral	O
factors	O
.	O

As	O
obligate	O
parasites	O
,	O
viruses	O
exploit	O
host	O
-	O
cell	B-ANAT
machinery	O
to	O
glycosylate	O
their	O
own	O
proteins	O
during	O
replication	O
.	O

Viral	B-ANAT
envelope	I-ANAT
proteins	O
from	O
a	O
variety	O
of	O
human	O
pathogens	O
including	O
HIV	O
-	O
1	O
,	O
influenza	O
virus	O
,	O
Lassa	O
virus	O
,	O
SARS	O
,	O
Zika	O
virus	O
,	O
dengue	O
virus	O
,	O
and	O
Ebola	O
virus	O
have	O
evolved	O
to	O
be	O
extensively	O
glycosylated	O
.	O

The	O
expression	O
of	O
nucleotide	O
-	O
binding	O
oligomerization	O
domain	O
containing	O
2	O
(	O
Nod2	O
),	O
type	O
I	O
interferons	O
,	O
(	O
IFNs	O
),	O
and	O
proinflammatory	O
mediators	O
was	O
enhanced	O
in	O
S	O
RBD	O
-	O
HBD	O
2	O
-	O
treated	O
THP	O
-	O
1	O
cells	B-ANAT
.	O

Given	O
the	O
fastidious	O
isolation	O
of	O
emerging	O
PEDV	O
in	O
cell	B-ANAT
culture	O
and	O
difficulties	O
in	O
retaining	O
the	O
isolate	O
infectivity	O
upon	O
further	O
in	O
vitro	O
passage	O
,	O
highly	O
attenuated	O
recombinant	O
vesicular	O
stomatitis	O
virus	O
(	O
rVSV	O

The	O
MERS	O
-	O
CoV	O
envelope	B-ANAT
spike	O
protein	O
serves	O
as	O
a	O
crucial	O
target	O
for	O
neutralizing	O
antibodies	O
and	O
vaccine	O
development	O
,	O
as	O
it	O
plays	O
a	O
critical	O
role	O
in	O
mediating	O
viral	O
entry	O
through	O
interactions	O
with	O
the	O
cellular	B-ANAT
receptor	O
,	O
dipeptidyl	O
peptidase	O
4	O
(	O
DPP4	O
).	O

Analysis	O
of	O
sera	B-ANAT
absorption	O
and	O
isolated	O
monoclonal	O
antibodies	O
from	O
immunized	O
mice	O
demonstrated	O
that	O
the	O
potent	O
and	O
broad	O
neutralizing	O
activity	O
was	O
largely	O
attributed	O
to	O
antibodies	O
targeting	O
the	O
receptor	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
the	O
S	O
protein	O
.	O

Two	O
single	O
-	O
guide	O
RNAs	O
targeting	O
the	O
CMAH	O
gene	O
and	O
Cas9	O
mRNA	O
were	O
microinjected	O
into	O
the	O
cytoplasm	B-ANAT
of	O
newly	O
fertilized	B-ANAT
eggs	I-ANAT
.	O

Clinical	O
examination	O
revealed	O
high	O
fever	O
,	O
jaundice	O
,	O
cyanosis	O
,	O
tachypnea	O
and	O
bilateral	O
rales	O
on	O
pulmonary	B-ANAT
auscultation	O
.	O

Laboratory	O
investigation	O
showed	O
high	O
erythrocyte	B-ANAT
sedimentation	O
rate	O
and	O
C	O
reactive	O
protein	O
,	O
leucocytosis	O
,	O
anaemia	O
,	O
mild	O
thrombocytopaenia	O
,	O
renal	B-ANAT
impairment	O
,	O
hyperbilirubinaemia	O
and	O
abnormal	O
liver	B-ANAT
function	O
tests	O
;	O
arterial	B-ANAT
blood	I-ANAT
gas	O
analysis	O
showed	O
respiratory	O
alkalosis	O
with	O
severe	O
hypoxia	O
.	O

ABSTRACT	O
:	O
The	O
increase	O
in	O
international	O
travel	O
,	O
the	O
growing	O
presence	O
of	O
arbovirus	O
vectors	O
in	O
our	O
country	O
,	O
and	O
notifications	O
of	O
haemorrhagic	O
fever	O
such	O
as	O
the	O
current	O
outbreak	O
of	O
Ebola	O
in	O
D	O
.	O
R	O
.	O
Congo	O
and	O
the	O
cases	O
of	O
Crimea	O
-	O
Congo	O
haemorrhagic	O
fever	O
in	O
our	O
country	O
have	O
again	O
cast	B-ANAT
the	O
spotlight	O
on	O
tropical	O
diseases	O
Isolating	O
suspected	O
cases	O
of	O
highly	O
contagious	O
and	O
lethal	O
diseases	O
must	O
be	O
a	O
priority	O
(	O
Haemorrhagic	O
fever	O
,	O
MERS	O
-	O
CoV	O
).	O

Infections	O
are	O
initiated	O
by	O
the	O
transmembrane	B-ANAT
spike	O
(	O
S	O
)	O
glycoprotein	O
,	O
which	O
binds	O
to	O
host	O
receptors	O
and	O
fuses	O
the	O
viral	O
and	O
cellular	B-ANAT
membranes	B-ANAT
.	O

We	O
show	O
that	O
the	O
ligand	O
binds	O
with	O
fast	O
kinetics	O
to	O
a	O
surface	O
-	O
exposed	O
groove	B-ANAT
and	O
that	O
interactions	O
at	O
the	O
identified	O
site	O
are	O
essential	O
for	O
S	O
-	O
mediated	O
viral	O
entry	O
into	O
host	O
cells	B-ANAT
,	O
but	O
free	O
monosaccharide	O
does	O
not	O
trigger	O
fusogenic	O
conformational	O
changes	O
.	O

Patients	O
were	O
categorized	O
based	O
on	O
worst	O
serum	B-ANAT
creatinine	O
or	O
urine	B-ANAT
output	O
into	O
:	O
1	O
)	O
no	O
acute	O
kidney	B-ANAT
injury	O
(	O
serum	B-ANAT
creatinine	O
<	O
132	O
Âµmol	O
/	O
L	O
or	O
urine	B-ANAT
output	O
â¥	O
0	O
.	O
5	O
mL	O
/	O
kg	O
/	O
hr	O
),	O
2	O
)	O
mild	O
-	O
moderate	O
acute	O
kidney	B-ANAT
injury	O
(	O
serum	B-ANAT
creatinine	O
132	O
-	O
354	O
Âµmol	O
/	O
L	O
or	O
minimum	O
urine	B-ANAT
output	O
between	O
0	O
.	O
3	O
and	O
0	O
.	O
5mL	O
/	O
kg	O
/	O
hr	O
),	O
or	O
3	O
)	O
severe	O
acute	O
kidney	B-ANAT
injury	O
(	O
serum	B-ANAT
creatinine	O
>	O
354	O
Âµmol	O
/	O
L	O
or	O
renal	B-ANAT
replacement	O
therapy	O
or	O
minimum	O
urine	B-ANAT
output	O
<	O
0	O
.	O
3	O
mL	O
/	O
kg	O
/	O
hr	O
).	O

The	O
impact	O
of	O
acute	O
kidney	B-ANAT
injury	O
on	O
the	O
ventilatory	O
management	O
of	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
was	O
relatively	O
limited	O
,	O
with	O
no	O
differences	O
in	O
arterial	B-ANAT
CO2	O
tension	O
or	O
in	O
tidal	O
or	O
minute	O
ventilation	O
between	O
the	O
groups	O
.	O

In	O
multivariate	O
analyses	O
,	O
both	O
mild	O
-	O
moderate	O
(	O
odds	O
ratio	O
,	O
1	O
.	O
61	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
24	O
-	O
2	O
.	O
09	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
severe	O
(	O
odds	O
ratio	O
,	O
2	O
.	O
13	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
55	O
-	O
2	O
.	O
94	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
acute	O
kidney	B-ANAT
injury	O
were	O
independently	O
associated	O
with	O
mortality	O
.	O

ABSTRACT	O
:	O
Porcine	O
hemagglutinating	O
encephalomyelitis	O
virus	O
(	O
PHEV	O
)	O
is	O
a	O
typical	O
neurotropic	O
virus	O
that	O
can	O
cause	O
obvious	O
nerve	B-ANAT
damage	O
.	O

Maternal	O
autonomic	B-ANAT
parameters	O
were	O
unrelated	O
to	O
polysubstance	O
exposure	O
with	O
the	O
exception	O
of	O
cigarette	O
smoking	O
.	O

Larger	O
degree	O
of	O
maternal	O
heart	B-ANAT
rate	O
reactivity	O
to	O
buprenorphine	O
administration	O
was	O
related	O
to	O
more	O
severe	O
NAS	O
expression	O
.	O

The	O
results	O
demonstrated	O
that	O
NBP	O
could	O
activate	O
Nrf2	O
antioxidant	O
signaling	O
in	O
a	O
SIRT1	O
-	O
dependent	O
and	O
SIRT1	O
-	O
independent	O
manner	O
,	O
resulting	O
in	O
the	O
amelioration	O
of	O
oxidative	O
stress	O
,	O
inflammation	O
and	O
pulmonary	B-ANAT
edema	O
.	O

Subsequent	O
challenge	O
of	O
the	O
recipient	O
transduced	O
mice	O
by	O
the	O
intra	O
-	O
nasal	B-ANAT
route	O
with	O
a	O
clinical	O
isolate	O
of	O
the	O
MERS	O
-	O
CoV	O
resulted	O
in	O
a	O
significantly	O
reduced	O
viral	O
load	O
in	O
their	O
lungs	B-ANAT
,	O
compared	O
with	O
transduced	O
mice	O
receiving	O
a	O
negative	O
control	O
antibody	O
.	O

An	O
additional	O
testing	O
of	O
steady	O
-	O
state	O
peak	O
plasma	B-ANAT
concentration	O
of	O
edoxaban	O
after	O
10	O
days	O
and	O
a	O
30	O
day	O
follow	O
-	O
up	O
were	O
evaluated	O
.	O

Plasma	B-ANAT
fractionators	O
were	O
the	O
first	O
to	O
introduce	O
NAT	O
testing	O
besides	O
pathogen	O
reduction	O
procedures	O
,	O
to	O
reduce	O
the	O
virus	O
transmission	O
risk	O
through	O
their	O
products	O
.	O

ABSTRACT	O
:	O
During	O
acute	O
or	O
chronic	O
lung	B-ANAT
injury	O
,	O
inappropriate	O
immune	O
response	O
and	O
/	O
or	O
aberrant	O
repair	O
process	O
causes	O
irreversible	O
damage	O
in	O
lung	B-ANAT
tissue	I-ANAT
and	O
most	O
usually	O
results	O
in	O
the	O
development	O
of	O
fibrosis	O
followed	O
by	O
decline	O
in	O
lung	B-ANAT
function	O
.	O

Four	O
recommendations	O
(	O
low	O
tidal	O
volume	O
,	O
plateau	O
pressure	O
limitation	O
,	O
no	O
oscillatory	O
ventilation	O
,	O
and	O
prone	O
position	O
)	O
had	O
a	O
high	O
level	O
of	O
proof	O
(	O
GRADE	O
1	O
+	O
or	O
1	O
-);	O
four	O
(	O
high	O
positive	O
end	O
-	O
expiratory	O
pressure	O
[	O
PEEP	O
]	O
in	O
moderate	O
and	O
severe	O
ARDS	O
,	O
muscle	B-ANAT
relaxants	O
,	O
recruitment	O
maneuvers	O
,	O
and	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
[	O
ECMO	O
])	O
a	O
low	O
level	O
of	O
proof	O
(	O
GRADE	O
2	O
+	O
or	O
2	O
-);	O
seven	O
(	O
surveillance	O
,	O
tidal	O
volume	O
for	O
non	O
ARDS	O
mechanically	O
ventilated	O
patients	O
,	O
tidal	O
volume	O
limitation	O
in	O
the	O
presence	O
of	O
low	O
plateau	O
pressure	O
,	O
PEEP	O
>	O
5	O
cmH2O	O
,	O
high	O
PEEP	O
in	O
the	O
absence	O
of	O
deleterious	O
effect	O
,	O
pressure	O
mode	O
allowing	O
spontaneous	O
ventilation	O
after	O
the	O
acute	O
phase	O
,	O
and	O
nitric	O
oxide	O
)	O
corresponded	O
to	O
a	O
level	O
of	O
proof	O
that	O
did	O
not	O
allow	O
use	O
of	O
the	O
GRADE	O
classification	O
and	O
were	O
expert	O
opinions	O
.	O

TITLE	O
:	O
[	O
Prognostic	O
value	O
of	O
the	O
dynamic	O
changes	O
in	O
extra	B-ANAT
vascular	I-ANAT
lung	I-ANAT
water	I-ANAT
index	O
and	O
angiopoietin	O
-	O
2	O
in	O
severe	O
multiple	O
trauma	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
].	O

RNA	O
of	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
and	O
duck	O
CoV	O
was	O
found	O
in	O
faecal	B-ANAT
swabs	O
of	O
chickens	O
(	O
19	O
.	O
7	O
%	O
and	O
7	O
.	O
1	O
%)	O
and	O
ducks	O
(	O
4	O
.	O
1	O
%	O
and	O
44	O
.	O
1	O
%).	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
spike	O
protein	O
counteracts	O
BST2	O
-	O
mediated	O
restriction	O
of	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particle	I-ANAT
release	O
.	O

Data	O
collection	O
consisted	O
of	O
patient	O
demographics	O
,	O
respiratory	O
variables	O
and	O
arterial	B-ANAT
blood	I-ANAT
gas	O
analysis	O
.	O

This	O
study	O
was	O
designed	O
to	O
evaluate	O
ginseng	O
stem	B-ANAT
-	O
leaf	O
saponins	O
(	O
GSLS	O
)	O
in	O
combination	O
with	O
selenium	O
(	O
Se	O
)	O
for	O
their	O
adjuvant	O
effect	O
on	O
the	O
immune	O
response	O
to	O
vaccination	O
against	O
NDV	O
and	O
IBV	O
in	O
chickens	O
.	O

TITLE	O
:	O
Modifications	O
in	O
the	O
branched	B-ANAT
arms	B-ANAT
of	O
a	O
class	O
of	O
dual	O
inhibitors	O
of	O
HIV	O
and	O
EV71	O
replication	O
expand	O
their	O
antiviral	O
spectrum	O
.	O

A	O
six	O
-	O
year	O
-	O
old	O
male	O
European	O
short	O
-	O
hair	B-ANAT
cat	O
from	O
Austria	O
presented	O
poor	O
general	O
condition	O
,	O
lethargy	O
,	O
anorexia	O
,	O
icterus	O
,	O
a	O
painful	O
abdomen	B-ANAT
,	O
fever	O
,	O
ruffled	O
hair	B-ANAT
and	O
a	O
tick	O
infestation	O
,	O
and	O
it	O
had	O
never	O
left	O
Austria	O
.	O

Laboratory	O
tests	O
revealed	O
leukopenia	O
,	O
thrombocytopenia	O
and	O
increased	O
serum	B-ANAT
levels	O
of	O
symmetric	O
dimethylarginine	O
(	O
SDMA	O
)	O
and	O
bilirubin	O
.	O

TITLE	O
:	O
SARS	O
-	O
Coronavirus	O
Open	O
Reading	O
Frame	O
-	O
8b	O
triggers	O
intracellular	B-ANAT
stress	O
pathways	O
and	O
activates	O
NLRP3	O
inflammasomes	O
.	O

Aggregated	O
ORF8b	O
induces	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
)	O
stress	O
,	O
lysosomal	B-ANAT
damage	O
,	O
and	O
subsequent	O
activation	O
of	O
the	O
master	O
regulator	O
of	O
the	O
autophagy	O
and	O
lysosome	B-ANAT
machinery	O
,	O
Transcription	O
factor	O
EB	O
(	O
TFEB	O
).	O

TITLE	O
:	O
[	O
Porcine	O
deltacoronavirus	O
induces	O
mitochondrial	B-ANAT
apoptosis	O
in	O
ST	O
cells	B-ANAT
].	O

From	O
January	O
to	O
June	O
2018	O
,	O
440	O
children	O
with	O
paired	O
OPS	O
and	O
sputum	B-ANAT
were	O
tested	O
.	O

TITLE	O
:	O
Detection	O
of	O
multiple	O
viral	O
sequences	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
samples	O
of	O
suspected	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
patients	O
in	O
Jakarta	O
,	O
Indonesia	O
2015	O
-	O
2016	O
.	O

Viral	O
etiological	O
agents	O
detected	O
in	O
the	O
patients	O
were	O
enterovirus	O
D68	O
,	O
dengue	O
virus	O
type	O
3	O
,	O
rhinovirus	O
C	O
,	O
human	O
coronavirus	O
229E	O
,	O
herpes	O
simplex	B-ANAT
virus	O
type	O
1	O
,	O
influenza	O
virus	O
H1N1	O
,	O
influenza	O
virus	O
H3N2	O
,	O
human	O
metapneumovirus	O
,	O
and	O
rhinovirus	O
A60	O
.	O

We	O
present	O
a	O
case	O
report	O
of	O
a	O
2	O
-	O
month	O
-	O
old	O
infant	O
affected	O
by	O
a	O
bronchiolitis	O
RSV	O
-	O
positive	O
,	O
with	O
syndrome	O
of	O
inappropriate	O
antidiuretic	O
hormone	O
secretion	B-ANAT
(	O
SIADH	O
)	O
correlated	O
seizure	O
and	O
encephalopathy	O
.	O

CONCLUSIONS	O
:	O
In	O
presence	O
of	O
neurological	O
involvement	O
during	O
RSV	O
-	O
infection	O
must	O
be	O
taken	O
in	O
consideration	O
to	O
performing	O
instrumental	O
test	O
to	O
detect	O
cerebral	B-ANAT
edema	O
.	O

The	O
aim	O
of	O
this	O
immunocytochemical	O
study	O
was	O
to	O
compare	O
mannose	O
-	O
binding	O
lectin	O
(	O
MBL	O
)	O
production	O
induced	O
by	O
avian	O
coronavirus	O
in	O
the	O
spleen	B-ANAT
and	O
caecal	B-ANAT
tonsil	I-ANAT
(	O
CT	O
).	O

In	O
both	O
organs	B-ANAT
,	O
the	O
MBL	O
-	O
positive	O
cells	B-ANAT
occupy	O
antigen	O
-	O
exposed	O
areas	O
,	O
indicating	O
that	O
GC	O
formation	O
depends	O
on	O
resident	O
precursors	O
of	O
dendritic	B-ANAT
cells	I-ANAT
.	O

In	O
the	O
spleen	B-ANAT
(	O
associated	O
with	O
circulation	O
),	O
the	O
EACs	O
producing	O
MBL	O
and	O
expressing	O
CD83	O
are	O
a	O
common	O
precursor	O
of	O
both	O
follicular	B-ANAT
(	O
FDC	O
)	O
and	O
interdigitating	B-ANAT
dendritic	I-ANAT
cells	I-ANAT
(	O
IDC	O
).	O

CT	O
showed	O
decrease	O
in	O
normally	O
aerated	O
lung	B-ANAT
,	O
while	O
poorly	O
and	O
nonaerated	O
lung	B-ANAT
increased	O
.	O

We	O
previously	O
designed	O
an	O
optical	O
coherence	O
tomography	O
(	O
OCT	O
)	O
system	O
to	O
evaluate	O
mucosa	B-ANAT
thickness	O
(	O
MT	O
)	O
after	O
smoke	O
inhalation	O
,	O
but	O
the	O
analysis	O
relied	O
on	O
manual	O
segmentation	O
.	O

Proximal	O
airway	B-ANAT
volume	O
was	O
correlated	O
with	O
PFR	O
,	O
PIP	O
,	O
compliance	O
,	O
resistance	O
,	O
and	O
MT	O
measurement	O
using	O
a	O
linear	O
regression	O
model	O
.	O

The	O
increase	O
of	O
IBV	O
antibodies	O
in	O
serum	B-ANAT
from	O
secondary	O
responses	O
after	O
booster	O
vaccination	O
was	O
more	O
dramatic	O
and	O
significantly	O
higher	O
when	O
measured	O
by	O
an	O
Ark	O
spike	O
subunit	O
1	O
protein	O
ELISA	O
compared	O
with	O
measuring	O
by	O
non	O
-	O
Ark	O
serotype	O
whole	O
-	O
virus	O
ELISA	O
,	O
which	O
underlines	O
the	O
immunogenic	O
importance	O
of	O
the	O
virus	O
spike	O
at	O
inducing	O
antibodies	O
.	O

In	O
conclusion	O
,	O
NETs	O
promote	O
ARDS	O
inflammation	O
during	O
the	O
acute	O
phase	O
by	O
promoting	O
macrophage	B-ANAT
polarization	O
to	O
the	O
M1	O
phenotype	O
.	O

Where	O
mechanical	O
ventilation	O
is	O
required	O
,	O
the	O
use	O
of	O
low	O
tidal	O
volumes	O
(<	O
6	O
ml	O
/	O
kg	O
ideal	O
body	B-ANAT
weight	O
)	O
and	O
airway	B-ANAT
pressures	O
(	O
plateau	O
pressure	O
<	O
30	O
cmH	O

To	O
evaluate	O
which	O
type	O
of	O
full	O
body	B-ANAT
PPE	O
and	O
which	O
method	O
of	O
donning	O
or	O
doffing	O
PPE	O
have	O
the	O
least	O
risk	O
of	O
self	O
-	O
contamination	O
or	O
infection	O
for	O
HCW	O
,	O
and	O
which	O
training	O
methods	O
increase	O
compliance	O
with	O
PPE	O
protocols	O
.	O

ABSTRACT	O
:	O
This	O
study	O
was	O
conducted	O
to	O
investigate	O
the	O
viral	O
and	O
bacterial	O
etiology	O
and	O
epidemiology	O
of	O
patients	O
with	O
acute	O
febrile	O
respiratory	O
syndrome	O
(	O
AFRS	O
)	O
in	O
Qinghai	O
using	O
a	O
commercial	O
routine	O
multiplex	O
-	O
ligation	O
-	O
nucleic	B-ANAT
acid	O
amplification	O
test	O
(	O
NAT	O
)-	O
based	O
assay	O
.	O

ABSTRACT	O
:	O
Transplant	B-ANAT
recipients	O
are	O
vulnerable	O
to	O
life	O
-	O
threatening	O
community	O
-	O
acquired	O
respiratory	O
viruses	O
(	O
CA	O
-	O
RVs	O
)	O
infection	O
(	O
CA	O
-	O
RVI	O
).	O

The	O
specificity	O
and	O
sensitivity	O
of	O
this	O
multiple	O
reverse	O
transcription	O
-	O
LAMP	O
-	O
LFD	O
(	O
mRT	B-ANAT
-	O
LAMP	O
-	O
LFD	O
)	O
assay	O
were	O
compared	O
with	O
those	O
of	O
conventional	O
RT	O
-	O
PCR	O
,	O
nested	O
RT	O
-	O
PCR	O
(	O
nRT	O
-	O
PCR	O
),	O
quantification	O
RT	O
-	O
PCR	O
(	O
qRT	O
-	O
PCR	O
),	O
and	O
RT	O
-	O
LAMP	O
monitored	O
by	O
electrophoresis	O
.	O

The	O
expression	O
of	O
Claudin	O
-	O
5	O
in	O
the	O
jejunum	B-ANAT
was	O
significantly	O
lower	O
in	O
PEDV	O
-	O
infected	O
piglets	O
than	O
in	O
the	O
normal	O
animals	O
(	O
p	O
â¨	O
0	O
.	O
01	O
).	O

In	O
PEDV	O
-	O
infected	O
IPEC	O
-	O
J2	O
cells	B-ANAT
,	O
the	O
mRNA	O
expression	O
of	O
the	O
six	O
tight	B-ANAT
junction	I-ANAT
proteins	O
showed	O
a	O
downward	O
trend	O
;	O
in	O
particular	O
,	O
the	O
expression	O
of	O
the	O
Occludin	O
and	O
Claudin	O
-	O
4	O
genes	O
was	O
significantly	O
lower	O
(	O
p	O
â¨	O
0	O
.	O
01	O
).	O

These	O
data	O
suggest	O
that	O
the	O
expression	O
of	O
these	O
six	O
tight	B-ANAT
junction	I-ANAT
proteins	O
,	O
especially	O
Occludin	O
and	O
Claudin	O
-	O
4	O
,	O
plays	O
an	O
important	O
role	O
in	O
maintaining	O
the	O
integrity	O
of	O
the	O
intestinal	B-ANAT
mucosal	B-ANAT
barrier	O
and	O
resistance	O
to	O
PEDV	O
infection	O
in	O
piglets	O
.	O

TITLE	O
:	O
Incidence	O
of	O
post	O
-	O
traumatic	O
pneumonia	O
in	O
poly	O
-	O
traumatized	O
patients	O
:	O
identifying	O
the	O
role	O
of	O
traumatic	O
brain	B-ANAT
injury	O
and	O
chest	B-ANAT
trauma	O
.	O

Chest	B-ANAT
injury	O
alone	O
,	O
the	O
combination	O
of	O
chest	B-ANAT
injury	O
and	O
TBI	O
,	O
and	O
duration	O
of	O
ventilation	O
were	O
independent	O
predictors	O
of	O
pneumonia	O
[	O
resp	O
.	O

ABSTRACT	O
:	O
To	O
set	O
priorities	O
for	O
efficient	O
control	O
of	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
(	O
ARTI	O
)	O
in	O
Africa	O
,	O
it	O
is	O
necessary	O
to	O
have	O
accurate	O
estimate	O
of	O
its	O
burden	O
,	O
especially	O
among	O
HIV	O
-	O
infected	O
populations	O
.	O

We	O
aimed	O
to	O
determine	O
the	O
prevalence	O
of	O
and	O
risk	O
factors	O
for	O
postoperative	O
pulmonary	B-ANAT
complications	O
(	O
PPCs	O
)	O
in	O
healthy	O
elderly	O
patients	O
with	O
non	O
-	O
small	O
cell	B-ANAT
lung	B-ANAT
cancer	O
(	O
NSCLC	O
)	O
to	O
select	O
optimal	O
candidates	O
for	O
surgical	O
resection	O
in	O
this	O
subpopulation	O
.	O

Respiratory	O
syncytial	O
virus	O
(	O
RSV	O
)	O
may	O
cause	O
a	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
characterized	O
by	O
bronchiolitis	O
and	O
pneumonia	O
mainly	O
in	O
children	O
and	O
the	O
elderly	O
.	O

The	O
renal	B-ANAT
biopsy	O
was	O
consistent	O
with	O
collapsing	O
glomerulopathy	O
and	O
treatment	O
with	O
multi	O
immunosuppressive	O
agents	O
including	O
corticosteroids	O
,	O
mycophenolate	O
mofetil	O
,	O
and	O
rituximab	O
coupled	O
with	O
several	O
courses	O
of	O
hemodialysis	O
and	O
plasmapheresis	O
were	O
administered	O
.	O

However	O
,	O
the	O
application	O
of	O
oral	B-ANAT
immunization	O
is	O
limited	O
by	O
the	O
short	O
-	O
term	O
persistence	O
of	O
immunity	O
,	O
particularly	O
for	O
inactivated	O
viruses	O
.	O

In	O
the	O
intestine	B-ANAT
,	O
long	O
-	O
term	O
persistence	O
of	O
immunity	O
is	O
related	O
to	O
CD4	O

We	O
aimed	O
to	O
investigate	O
plasma	B-ANAT
midkine	O
in	O
septic	O
patients	O
and	O
its	O
association	O
with	O
28	O
-	O
day	O
mortality	O
and	O
organ	B-ANAT
function	O
.	O

Plasma	B-ANAT
midkine	O
levels	O
were	O
significantly	O
elevated	O
in	O
the	O
nonsurvivor	O
group	O
compared	O
with	O
the	O
survivors	O
(	O
ng	O
/	O
L	O
,	O
763	O
.	O
6	O
[	O
404	O
.	O
7	O
-	O
1305	O
],	O
268	O
.	O
5	O
[	O
147	O
.	O
8	O
-	O
511	O
.	O
4	O
];	O
Plasma	B-ANAT
midkine	O
was	O
associated	O
with	O
28	O
-	O
day	O
mortality	O
,	O
as	O
well	O
as	O
pulmonary	B-ANAT
and	O
kidney	B-ANAT
injury	O
,	O
in	O
septic	O
patients	O
.	O

Several	O
studies	O
have	O
shown	O
that	O
cytokine	O
storms	O
are	O
directly	O
associated	O
with	O
influenza	O
-	O
induced	O
fatal	O
acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Further	O
analysis	O
showed	O
that	O
the	O
actin	B-ANAT
cytoskeleton	I-ANAT
and	O
MAPK	O
signal	O
pathway	O
were	O
related	O
to	O
the	O
target	O
genes	O
of	O
IBV	O
-	O
stimulated	O
miRNAs	O
.	O

TITLE	O
:	O
Staphylococcal	O
phosphatidylinositol	O
-	O
specific	O
phospholipase	O
C	O
potentiates	O
lung	B-ANAT
injury	O
via	O
complement	O
sensitisation	O
.	O

For	O
a	O
random	O
sample	O
of	O
127	O
calves	O
,	O
serum	B-ANAT
zinc	O
concentrations	O
before	O
and	O
after	O
treatment	O
and	O
a	O
fecal	B-ANAT
antigen	O
ELISA	O
at	O
diarrhea	O
start	O
and	O
resolution	O
for	O
Escherichia	O
coli	O
K99	O
,	O
rotavirus	O
,	O
coronavirus	O
,	O
and	O
Cryptosporidium	O
parvum	O
were	O
performed	O
.	O

In	O
vitro	O
,	O
endocan	O
inhibited	O
human	O
leukocyte	B-ANAT
transendothelial	O
migration	O
as	O
well	O
as	O
ICAM	O
-	O
1	O
-	O
dependent	O
migration	O
but	O
had	O
a	O
very	O
mild	O
effect	O
on	O
ICAM	O
-	O
1	O
-	O
dependent	O
adhesion	O
.	O

Treatment	O
with	O
endocan	O
1	O
h	O
after	O
intratracheal	O
LPS	O
challenge	O
reduced	O
the	O
alveolar	B-ANAT
inflammatory	O
response	O
,	O
diminished	O
histological	O
features	O
of	O
acute	O
lung	B-ANAT
injury	O
,	O
and	O
improved	O
respiratory	O
function	O
.	O

TITLE	O
:	O
Evaluation	O
of	O
Lung	B-ANAT
Injury	O
in	O
Infants	O
with	O
Congenital	O
Diaphragmatic	B-ANAT
Hernia	O
.	O

In	O
this	O
retrospective	O
cohort	O
study	O
,	O
serum	B-ANAT
SP	O
-	O
D	O
levels	O
were	O
analyzed	O
in	O
37	O
CDH	O
infants	O
and	O
5	O
control	O
infants	O
using	O
a	O
commercially	O
available	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
kit	O
.	O

Variable	O
Ventilation	O
Is	O
Equally	O
Effective	O
as	O
Conventional	O
Pressure	O
Control	O
Ventilation	O
for	O
Optimizing	O
Lung	B-ANAT
Function	O
in	O
a	O
Rabbit	O
Model	O
of	O
ARDS	O
.	O

The	O
aim	O
of	O
this	O
prospective	O
observational	O
study	O
was	O
to	O
evaluate	O
the	O
role	O
of	O
ACE	O
levels	O
as	O
a	O
prognostic	O
marker	O
in	O
thoracic	B-ANAT
trauma	O
.	O

Our	O
study	O
demonstrates	O
that	O
serum	B-ANAT
ACE	O
levels	O
are	O
increased	O
in	O
thoracic	B-ANAT
trauma	O
patients	O
with	O
higher	O
levels	O
,	O
indicating	O
the	O
severe	O
nature	O
of	O
trauma	O
in	O
concordance	O
with	O
increased	O
TTSS	O
scores	O
.	O

The	O
results	O
proposed	O
that	O
infection	O
with	O
heterologous	O
virus	O
may	O
result	O
in	O
temporary	O
competition	O
for	O
cell	B-ANAT
receptors	O
or	O
competent	O
cells	B-ANAT
for	O
replication	O
,	O
most	O
likely	O
interferon	O
-	O
mediated	O
.	O

ABSTRACT	O
:	O
Honeybees	O
Apis	O
mellifera	O
are	O
important	O
pollinators	O
of	O
wild	O
plants	O
and	O
commercial	O
crops	B-ANAT
.	O

Analysis	O
of	O
paired	O
serum	B-ANAT
samples	O
aids	O
verification	O
of	O
canine	O
coronavirus	O
infection	O
in	O
respiratory	O
disease	O
.	O

Although	O
plasma	B-ANAT
NT	O
-	O
proBNP	O
levels	O
were	O
lower	O
after	O
7	O
months	O
compared	O
to	O
the	O
baseline	O
,	O
the	O
levels	O
did	O
not	O
differ	O
significantly	O
between	O
the	O
SGMT	O
and	O
standard	O
therapy	O
groups	O
at	O
baseline	O
(	O
579	O
Â±	O
1117	O
vs	O
.	O
611	O
Â±	O
899	O
pg	O
/	O
dL	O
,	O
p	O
=	O
.	O
851	O
)	O
or	O
at	O
7	O
months	O
(	O
90	O
Â±	O
167	O
vs	O
.	O
93	O
Â±	O
174	O
pg	O
/	O
dL	O
,	O
p	O
=	O
.	O
996	O
).	O

The	O
proportion	O
of	O
Proteobacteria	O
in	O
the	O
infected	O
groups	O
was	O
relatively	O
high	O
(	O
24	O
.	O
67	O
%	O
and	O
22	O
.	O
79	O
%,	O
respectively	O
),	O
whereas	O
that	O
in	O
the	O
healthy	O
group	O
was	O
13	O
.	O
13	O
%	O
and	O
11	O
.	O
34	O
%	O
in	O
the	O
cecal	B-ANAT
mucosa	I-ANAT
and	O
contents	O
,	O
respectively	O
.	O

Additionally	O
,	O
those	O
associated	O
with	O
high	O
DP	O
/	O
S	O
were	O
farms	O
without	O
divided	O
entrances	O
,	O
farms	O
without	O
a	O
fixed	B-ANAT
hours	O
worked	O
in	O
the	O
barn	O
,	O
and	O
farms	O
that	O
performed	O
feedback	O
at	O
2	O
week	O
or	O
later	O
after	O
PED	O
outbreak	O
.	O

Real	O
-	O
time	O
PCR	O
and	O
Western	O
blot	O
analysis	O
were	O
performed	O
to	O
detect	O
the	O
expression	O
levels	O
of	O
CXCL5	O
,	O
CXCR2	O
,	O
Matrix	O
metalloproteinases	O
2	O
(	O
MMP2	O
),	O
and	O
Matrix	O
metalloproteinases	O
9	O
(	O
MMP9	O
)	O
in	O
lung	B-ANAT
tissues	I-ANAT
.	O

Myocarditis	O
and	O
late	O
-	O
onset	O
cardiovascular	B-ANAT
complications	O
are	O
associated	O
with	O
mortality	O
.	O

ABSTRACT	O
:	O
A	O
fusion	O
protein	O
expressed	O
on	O
the	O
surface	O
of	O
enveloped	O
viruses	O
mediates	O
fusion	O
of	O
the	O
viral	O
and	O
cellular	B-ANAT
membranes	B-ANAT
to	O
facilitate	O
virus	O
infection	O
.	O

Our	O
model	O
proposes	O
a	O
key	O
mechanism	O
for	O
membrane	B-ANAT
fusion	O
of	O
enveloped	O
viruses	O
.	O

We	O
have	O
previously	O
shown	O
that	O
the	O
virus	O
uses	O
heparan	O
sulfate	O
proteoglycans	O
(	O
HSPGs	O
)	O
as	O
the	O
initial	O
attachment	O
factors	O
,	O
facilitating	O
viral	O
entry	O
into	O
the	O
cell	B-ANAT
.	O

If	O
conventional	O
lung	B-ANAT
-	O
protective	O
mechanical	O
ventilation	O
strategies	O
fail	O
,	O
alternative	O
approaches	O
such	O
as	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
VV	O
-	O
ECMO	O
)	O
should	O
be	O
considered	O
.	O

The	O
marked	O
multiplex	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
products	O
were	O
hybridized	O
with	O
the	O
specific	O
probes	O
,	O
and	O
the	O
results	O
of	O
hybridization	O
were	O
read	O
directly	O
with	O
the	O
naked	O
eyes	B-ANAT
.	O

In	O
addition	O
,	O
cubic	O
spline	O
regression	O
demonstrated	O
that	O
mortality	O
sharply	O
increased	O
at	O
a	O
fibrinogen	B-ANAT
level	O
of	O
approximately	O
<	O
200	O
mg	O
/	O
dL	O
and	O
at	O
an	O
antithrombin	O
activity	O
of	O
approximately	O
<	O
50	O
%.	O

The	O
fibrinogen	B-ANAT
level	O
and	O
antithrombin	O
activity	O
should	O
be	O
reconsidered	O
as	O
unique	O
biomarkers	O
for	O
sepsis	O
and	O
sepsis	O
-	O
induced	O
DIC	O
.	O

Pituitary	B-ANAT
axis	B-ANAT
function	O
is	O
frequently	O
altered	O
early	O
after	O
ICU	O
admission	O
,	O
the	O
magnitude	O
of	O
hormonal	O
response	O
being	O
different	O
according	O
to	O
the	O
underlying	O
critical	O
illness	O
.	O

TITLE	O
:	O
Feline	O
gut	B-ANAT
microbiota	O
composition	O
in	O
association	O
with	O
feline	O
coronavirus	O
infection	O
:	O
A	O
pilot	O
study	O
.	O

ABSTRACT	O
:	O
Feline	O
coronaviruses	O
(	O
FCoV	O
)	O
colonize	O
the	O
intestinal	B-ANAT
tract	I-ANAT
,	O
however	O
,	O
due	O
to	O
not	O
fully	O
understood	O
mutations	O
,	O
they	O
can	O
spread	O
systemically	O
and	O
cause	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
).	O

Taken	O
together	O
,	O
our	O
results	O
showed	O
that	O
both	O
the	O
humoral	O
and	O
cellular	B-ANAT
immune	O
responses	O
are	O
highly	O
induced	O
by	O
rAd	O
/	O
Spike	O
administration	O
,	O
suggesting	O
that	O
rAd	O
/	O
Spike	O
may	O
confer	O
protection	O
against	O
MERS	O
-	O
CoV	O
infection	O
.	O

It	O
is	O
a	O
subset	O
of	O
idiopathic	O
lung	B-ANAT
disease	O
with	O
a	O
rapidly	O
progressive	O
course	O
.	O

ABSTRACT	O
:	O
Leigh	O
Syndrome	O
is	O
a	O
neurodegenerative	O
disorder	O
caused	O
by	O
mitochondrial	B-ANAT
dysfunction	O
,	O
with	O
significant	O
phenotypic	O
and	O
genetic	O
heterogeneity	O
.	O

The	O
basal	B-ANAT
ganglia	I-ANAT
and	O
thalami	O
frequently	O
present	O
with	O
a	O
pattern	O
of	O
cytotoxic	O
edema	O
.	O

Respiratory	B-ANAT
system	I-ANAT
compliance	O
,	O
PaO2	O
/	O
FiO2	O
ratio	O
,	O
arterial	B-ANAT
pH	O
,	O
and	O
mean	O
pulmonary	B-ANAT
arterial	B-ANAT
pressure	O
showed	O
distinct	O
temporal	O
course	O
according	O
to	O
outcome	O
over	O
the	O
entire	O
ECMO	O
duration	O
.	O

This	O
retrospective	O
study	O
involved	O
270	O
patients	O
who	O
underwent	O
surgical	O
repair	O
for	O
acute	O
type	O
A	O
aortic	B-ANAT
dissection	O
between	O
January	O
2009	O
and	O
December	O
2015	O
.	O

A	O
significant	O
positive	O
correlation	O
between	O
mechanical	O
power	O
and	O
serum	B-ANAT
TGF	O
-	O
Î²1	O
and	O
CTGF	O
in	O
patients	O
with	O
ARDS	O
was	O
found	O
and	O
the	O
correlation	O
coefficients	O
were	O
0	O
.	O
424	O
and	O
0	O
.	O
581	O
,	O
respectively	O
.	O

Mechanical	O
power	O
,	O
TGF	O
-	O
Î²1	O
,	O
and	O
CTGF	O
were	O
clinically	O
evaluated	O
for	O
the	O
assessment	O
of	O
lung	B-ANAT
structural	O
remodeling	O
,	O
such	O
as	O
ARDS	O
pulmonary	B-ANAT
fibrosis	O
.	O

RESULTS	O
:	O
A	O
significant	O
positive	O
correlation	O
between	O
mechanical	O
power	O
and	O
serum	B-ANAT
TGF	O
-	O
Î²1	O
and	O
CTGF	O
in	O
patients	O
with	O
ARDS	O
was	O
found	O
and	O
the	O
correlation	O
coefficients	O
were	O
0	O
.	O
424	O
and	O
0	O
.	O
581	O
,	O
respectively	O
.	O

The	O
fluctuations	O
in	O
leukocyte	B-ANAT
populations	O
measured	O
by	O
Vetscan	O
HM5	O
were	O
corroborated	O
by	O
standard	O
flow	O
cytometry	O
,	O
thus	O
confirming	O
the	O
utility	O
of	O
this	O
approach	O
.	O

TITLE	O
:	O
Demographics	O
,	O
management	O
and	O
outcome	O
of	O
females	O
and	O
males	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
the	O
LUNG	B-ANAT
SAFE	O
prospective	O
cohort	O
study	O
.	O

Joint	B-ANAT
efforts	O
combining	O
key	O
technologies	O
in	O
identical	O
models	O
to	O
overcome	O
the	O
limitations	O
inherent	O
to	O
individual	O
methodologies	O
are	O
needed	O
not	O
only	O
to	O
provide	O
conclusive	O
insights	O
into	O
lung	B-ANAT
physiology	O
and	O
alveolar	B-ANAT
dynamics	O
,	O
but	O
ultimately	O
to	O
guide	O
critical	O
care	O
patient	O
therapy	O
.	O

In	O
the	O
ICU	O
,	O
mechanical	O
ventilation	O
with	O
low	O
tidal	O
volume	O
and	O
high	O
positive	O
end	O
-	O
expiratory	O
pressure	O
was	O
administered	O
and	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
was	O
set	O
up	O
for	O
treating	O
severe	O
ARDS	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
further	O
study	O
the	O
role	O
of	O
long	O
-	O
lasting	O
neurodegeneration	O
on	O
the	O
development	O
of	O
neurogenic	O
bladder	B-ANAT
dysfunction	O
in	O
mice	O
with	O
corona	O
-	O
virus	O
induced	O
encephalitis	O
(	O
CIE	O
).	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
coronavirus	O
causes	O
a	O
highly	O
fatal	O
lower	O
-	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
.	O

TITLE	O
:	O
A	O
Clinical	O
Risk	O
Scoring	O
System	O
of	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
-	O
Induced	O
Acute	O
Kidney	B-ANAT
Injury	O
.	O

ABSTRACT	O
:	O
BACKGROUND	O
This	O
study	O
investigated	O
the	O
risk	O
factors	O
affecting	O
development	O
and	O
prognosis	O
of	O
acute	O
kidney	B-ANAT
injury	O
(	O
AKI	O
)	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Median	O
(	O
IQR	O
)	O
age	O
was	O
8	O
(	O
5	O
-	O
10	O
.	O
3	O
)	O
y	O
.	O
Fever	O
was	O
present	O
for	O
mean	O
(	O
SD	O
)	O
duration	O
of	O
5	O
.	O
3	O
(	O
2	O
.	O
1	O
)	O
d	O
.	O
Vomiting	O
,	O
respiratory	O
distress	O
,	O
pain	O
abdomen	B-ANAT
and	O
hepatomegaly	O
were	O
other	O
clinical	O
features	O
.	O

HLH	O
was	O
noted	O
in	O
7	O
(	O
32	O
%)	O
cases	O
at	O
a	O
median	O
(	O
IQR	O
)	O
hospital	O
stay	O
of	O
5	O
(	O
2	O
-	O
8	O
)	O
d	O
.	O
Children	O
with	O
HLH	O
had	O
significantly	O
higher	O
Pediatric	O
Index	O
of	O
Mortality	O
2	O
(	O
PIM	O
2	O
)	O
score	O
at	O
admission	O
and	O
higher	O
frequency	O
of	O
pain	O
abdomen	B-ANAT
,	O
anemia	O
,	O
hypoalbuminemia	O
,	O
elevated	O
alanine	O
aminotransferase	O
(	O
ALT	O
)	O
and	O
ARDS	O
.	O

TITLE	O
:	O
Assessment	O
of	O
Therapeutic	O
Interventions	O
and	O
Lung	B-ANAT
Protective	O
Ventilation	O
in	O
Patients	O
With	O
Moderate	O
to	O
Severe	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
:	O
A	O
Systematic	O
Review	O
and	O
Network	O
Meta	O
-	O
analysis	O
.	O

It	O
is	O
unknown	O
whether	O
positive	O
airway	B-ANAT
pressure	O
treatment	O
may	O
influence	O
adverse	O
events	O
and	O
consequences	O
of	O
ACS	O
.	O

In	O
non	O
-	O
sleepy	O
patients	O
with	O
OSA	O
and	O
stable	O
coronary	B-ANAT
artery	I-ANAT
disease	O
,	O
randomised	O
controlled	O
trials	O
failed	O
to	O
show	O
that	O
continuous	O
positive	O
airway	B-ANAT
pressure	O
(	O
CPAP	O
)	O
treatment	O
protected	O
against	O
cardiovascular	B-ANAT
events	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
the	O
most	O
severe	O
form	O
of	O
acute	O
lung	B-ANAT
injury	O
,	O
responsible	O
for	O
high	O
mortality	O
and	O
long	O
-	O
term	O
morbidity	O
.	O

TITLE	O
:	O
Cricket	O
paralysis	O
virus	O
internal	O
ribosome	B-ANAT
entry	O
site	O
-	O
derived	O
RNA	O
promotes	O
conventional	O
vaccine	O
efficacy	O
by	O
enhancing	O
a	O
balanced	O
Th1	O
/	O
Th2	O
response	O
.	O

Our	O
previous	O
crystal	B-ANAT
structure	O
study	O
of	O
the	O
MHV	O
NTD	O
/	O
mCEACAM1a	O
complex	O
(	O
G	O
.	O
Peng	O
,	O
D	O
.	O
Sun	O
,	O
K	O
.	O
R	O
.	O
Rajashankar	O
,	O
Z	O
.	O
Qian	O
,	O
et	O
al	O
.,	O
Proc	O
Natl	O
Acad	O
Sci	O
U	O
S	O
A	O
108	O
:	O
10696	O
-	O
10701	O
,	O
2011	O
,	O
https	O
://	O
doi	O
.	O
org	O
/	O
10	O
.	O
1073	O
/	O
pnas	O
.	O
1104306108	O
)	O
reveals	O
that	O
there	O
are	O
14	O
residues	O
in	O
the	O
NTD	O
interacting	O
with	O
the	O
receptor	O
.	O

In	O
ST	O
and	O
IPEC	O
-	O
J2	O
cells	B-ANAT
,	O
TGEV	O
exhibited	O
a	O
dose	O
-	O
dependent	O
inhibition	O
of	O
NF	O
-	O
ÎºB	O
activity	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrated	O
that	O
IFN	O
-	O
Î³	O
inhibited	O
TGEV	O
infection	O
directly	O
in	O
ST	O
cells	B-ANAT
and	O
intestine	B-ANAT
epithelial	O
IPEC	O
-	O
J2	O
cells	B-ANAT
and	O
that	O
the	O
anti	O
-	O
TGEV	O
activity	O
of	O
IFN	O
-	O
Î³	O
was	O
independent	O
of	O
IFN	O
-	O
Î±	O
/	O
Î²	O
.	O

ABSTRACT	O
:	O
Ventilator	O
settings	O
for	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
supported	O
by	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
are	O
currently	O
set	O
arbitrarily	O
.	O

After	O
starting	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
patients	O
were	O
switched	O
to	O
the	O
bi	O
-	O
level	O
positive	O
airway	B-ANAT
pressure	O
mode	O
with	O
1	O
second	O
of	O
24	O
cm	O
H2O	O
high	O
pressure	O
and	O
2	O
seconds	O
of	O
12	O
cm	O
H2O	O
low	O
pressure	O
for	O
24	O
hours	O
.	O

Plasma	B-ANAT
sRAGE	O
and	O
cytokines	O
were	O
comparable	O
within	O
each	O
on	O
-	O
ECMO	O
experimental	O
step	O
,	O
but	O
the	O
lowest	O
bronchoalveolar	O
lavage	O
sRAGE	O
levels	O
were	O
obtained	O
at	O
minimal	O
driving	O
pressure	O
.	O

Swabs	O
were	O
taken	O
during	O
stable	O
periods	O
(	O
n	O
=	O
1909	O
),	O
at	O
URTI	O
onset	O
(	O
n	O
=	O
391	O
),	O
10	O
days	O
after	O
the	O
URTI	O
(	O
n	O
=	O
356	O
)	O
and	O
during	O
an	O
AECOPD	O
(	O
n	O
=	O
177	O
)	O
and	O
tested	O
using	O
a	O
multiplex	O
nucleic	B-ANAT
acid	O
amplification	O
test	O
.	O

In	O
conclusion	O
,	O
miR	O
-	O
150	O
alleviated	O
LPS	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
via	O
directly	O
targeting	O
AKT3	O
expression	O
or	O
regulating	O
JNK	O
and	O
NF	O
-	O
ÎºB	O
pathways	O
,	O
which	O
may	O
be	O
a	O
promising	O
therapeutic	O
strategy	O
to	O
treat	O
ALI	O
/	O
ARDS	O
.	O

To	O
investigate	O
the	O
inhibition	O
effect	O
of	O
HY	O
on	O
IBV	O
infection	O
in	O
chicken	O
embryo	B-ANAT
kidney	B-ANAT
(	O
CEK	O
)	O
cells	B-ANAT
,	O
3	O
different	O
experimental	O
designs	O
:	O
pre	O
-	O
treatment	O
of	O
cells	B-ANAT
prior	O
to	O
IBV	O
infection	O
,	O
direct	O
treatment	O
of	O
IBV	O
-	O
infected	O
cells	B-ANAT
,	O
and	O
pre	O
-	O
treatment	O
of	O
IBV	O
prior	O
to	O
cell	B-ANAT
infection	O
were	O
used	O
.	O

The	O
results	O
revealed	O
that	O
HY	O
had	O
a	O
good	O
anti	O
-	O
IBV	O
effect	O
when	O
HY	O
directly	O
treated	O
the	O
IBV	O
-	O
infected	O
cells	B-ANAT
,	O
and	O
virus	O
infectivity	O
decreased	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

Our	O
latest	O
observations	O
in	O
experimental	O
models	O
of	O
Acute	O
Lung	B-ANAT
Injury	O
suggest	O
that	O
P53	O
orchestrates	O
,	O
at	O
least	O
in	O
part	O
,	O
such	O
activities	O
.	O

This	O
is	O
a	O
captivating	O
case	O
depicting	O
a	O
series	O
of	O
unfortunate	O
and	O
unpredictable	O
clinical	O
events	O
occurring	O
in	O
a	O
previously	O
well	O
infant	O
,	O
which	O
at	O
initial	O
presentation	O
challenged	O
the	O
managing	O
team	O
with	O
regards	O
to	O
its	O
exact	O
aetiology	O
of	O
acute	O
brain	B-ANAT
injury	O
and	O
acute	O
cardiorespiratory	O
failure	O
.	O

We	O
describe	O
the	O
case	O
of	O
a	O
healthy	O
man	O
who	O
presented	O
with	O
severe	O
ITP	O
complicated	O
by	O
intracranial	B-ANAT
haemorrhage	O
following	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
.	O

In	O
total	O
137	O
cat	O
serum	B-ANAT
samples	O
and	O
25	O
FCoV	O
type	O
1	O
or	O
type	O
2	O
-	O
specific	O
antisera	O
were	O
screened	O
for	O
the	O
presence	O
of	O
antibodies	O
against	O
the	O
S1	O
receptor	O
binding	O
subunit	O
of	O
the	O
CoV	O
spike	O
protein	O
,	O
which	O
is	O
immunogenic	O
and	O
possesses	O
low	O
amino	O
acid	O
sequence	O
identity	O
among	O
coronavirus	O
species	O
.	O

However	O
,	O
the	O
short	O
and	O
finite	O
lifespan	O
of	O
primary	O
cells	B-ANAT
in	O
cell	B-ANAT
culture	O
creates	O
a	O
bottleneck	O
for	O
the	O
genetic	O
modification	O
of	O
these	O
cultures	O
.	O

We	O
observed	O
significant	O
variability	O
in	O
potential	O
for	O
lung	B-ANAT
recruitment	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
requiring	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

Cellular	B-ANAT
ultrastructural	O
changes	O
induced	O
by	O
SeACoV	O
infection	O
were	O
visualized	O
by	O
electron	O
microscopy	O
.	O

The	O
positive	O
result	O
of	O
IgM	O
and	O
IgG	O
was	O
considered	O
the	O
application	O
of	O
ganglioside	O
and	O
blood	B-ANAT
-	I-ANAT
brain	I-ANAT
barrier	I-ANAT
might	O
be	O
damaged	O
after	O
meningioma	O
surgery	O
which	O
eased	O
the	O
drug	O
to	O
enter	O
the	O
cerebrospinal	B-ANAT
fluid	I-ANAT
circulation	O
and	O
induced	O
lesions	O
,	O
therefore	O
the	O
etiology	O
on	O
this	O
GBS	O
case	O
was	O
of	O
high	O
confidence	O
of	O
administrating	O
ganglioside	O
drugs	O
.	O

Till	O
now	O
,	O
the	O
general	O
treatment	O
program	O
on	O
GBS	O
may	O
be	O
still	O
gamma	O
globulin	O
or	O
plasma	B-ANAT
exchange	O
and	O
a	O
curious	O
judgment	O
of	O
prognosis	O
is	O
essential	O
in	O
order	O
to	O
make	O
a	O
reasonable	O
plan	O
.	O

The	O
key	O
measures	O
taken	O
on	O
lung	B-ANAT
recruitment	O
was	O
postural	O
drainage	B-ANAT
on	O
this	O
case	O
with	O
a	O
low	O
cost	O
but	O
a	O
qualified	O
effectiveness	O
.	O

ABSTRACT	O
:	O
To	O
describe	O
continuous	O
positive	O
airway	B-ANAT
pressure	O
(	O
CPAP	O
)	O
use	O
for	O
treatment	O
of	O
obstructive	O
sleep	O
apnea	O
(	O
OSA	O
)	O
in	O
acute	O
tetraplegia	O
,	O
including	O
adherence	O
rates	O
and	O
associated	O
factors	O
.	O

A	O
total	O
of	O
79	O
participants	O
from	O
10	O
spinal	O
units	O
(	O
91	O
%	O
men	O
;	O
mean	O
age	O
Â±	O
SD	O
,	O
46	O
Â±	O
16	O
;	O
78	O
Â±	O
64d	O
postinjury	O
)	O
completed	O
the	O
study	O
in	O
the	O
treatment	O
arm	B-ANAT
and	O
33	O
%	O
were	O
adherent	O
.	O

We	O
found	O
that	O
a	O
MERS	O
-	O
CoV	O
spike	O
S1	O
protein	O
-	O
based	O
ELISA	O
,	O
routinely	O
used	O
in	O
surveillance	O
studies	O
,	O
showed	O
low	O
sensitivity	O
in	O
detecting	O
infections	O
among	O
PCR	O
-	O
confirmed	O
patients	O
with	O
mild	O
clinical	O
symptoms	O
and	O
cross	O
-	O
reactivity	O
of	O
human	O
coronavirus	O
OC43	O
-	O
positive	O
serum	B-ANAT
samples	O
.	O

After	O
conducting	O
univariate	O
analysis	O
of	O
risk	O
factors	O
,	O
statistically	O
significant	O
risk	O
factors	O
affecting	O
the	O
development	O
of	O
ROP	O
in	O
our	O
study	O
were	O
:	O
low	O
gestational	O
age	O
,	O
low	O
birth	O
weight	O
,	O
type	O
of	O
multiple	O
gestation	O
,	O
the	O
presence	O
of	O
affected	O
sibling	O
,	O
low	O
level	O
of	O
Hemoglobin	O
at	O
birth	O
,	O
respiratory	O
distress	O
syndrome	O
,	O
low	O
Hemoglobin	O
level	O
,	O
blood	B-ANAT
transfusion	O
and	O
days	O
on	O
oxygen	O
supplements	O
with	O
either	O
mechanical	O
,	O
non	O
-	O
mechanical	O
methods	O
or	O
both	O
combined	O
.	O

CNS	B-ANAT
involvement	O
observed	O
among	O
27	O
%.	O

ABSTRACT	O
:	O
Antiphospholipid	O
syndrome	O
(	O
APLS	O
)	O
is	O
characterised	O
by	O
venous	B-ANAT
or	O
arterial	B-ANAT
thrombosis	O
and	O
/	O
or	O
adverse	O
pregnancy	O
outcome	O
in	O
the	O
presence	O
of	O
persistent	O
laboratory	O
evidence	O
of	O
antiphospholipid	O
antibodies	O
.	O

Findings	O
during	O
post	O
-	O
mortem	O
examination	O
of	O
nonsurviving	O
foals	O
included	O
bronchopneumonia	O
,	O
pulmonary	B-ANAT
congestion	O
,	O
hepatic	B-ANAT
congestion	O
and	O
hepatic	B-ANAT
inflammation	O
.	O

TITLE	O
:	O
Tension	O
pneumoperitoneum	O
caused	O
by	O
rupture	O
of	O
intraabdominal	B-ANAT
soft	B-ANAT
tissue	I-ANAT
emphysema	O
in	O
a	O
child	O
supported	O
with	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
:	O
a	O
case	O
report	O
.	O

Postoperatively	O
,	O
she	O
was	O
on	O
oxygen	O
therapy	O
,	O
on	O
chest	B-ANAT
physical	O
therapy	O
,	O
and	O
kept	O
hemodynamically	O
stable	O
until	O
she	O
had	O
recovered	O
.	O

In	O
this	O
work	O
,	O
the	O
7b	O
gene	O
was	O
amplified	O
from	O
51	O
domestic	O
cat	O
plasma	B-ANAT
samples	O
by	O
semi	O
-	O
nested	O
PCR	O
and	O
tested	O
through	O
phylogenetic	O
and	O
phylogeographical	O
approaches	O
.	O

Current	O
treatment	O
remains	O
primarily	O
supportive	O
with	O
lung	B-ANAT
-	O
protective	O
ventilation	O
strategies	O
.	O

Here	O
,	O
we	O
show	O
that	O
implantation	O
of	O
human	O
lung	B-ANAT
tissue	I-ANAT
,	O
which	O
contains	O
up	O
to	O
40	O
cell	B-ANAT
types	O
,	O
including	O
nonhematopoietic	O
cells	B-ANAT
,	O
into	O
immunodeficient	O
mice	O
(	O
lung	B-ANAT
-	O
only	O
mice	O
)	O
resulted	O
in	O
the	O
development	O
of	O
a	O
highly	O
vascularized	O
lung	B-ANAT
implant	O
.	O

When	O
incorporated	O
into	O
bone	B-ANAT
marrow	I-ANAT
/	O
liver	B-ANAT
/	O
thymus	B-ANAT
humanized	O
mice	O
,	O
lung	B-ANAT
implants	O
are	O
repopulated	O
with	O
autologous	O
human	O
hematopoietic	O
cells	B-ANAT
.	O

The	O
four	O
endemic	O
human	O
CoVs	O
(	O
HCoV	O
-	O
NL63	O
,	O
HCoV	O
-	O
229E	O
,	O
HCoV	O
-	O
OC43	O
and	O
HCoV	O
-	O
HKU1	O
)	O
mainly	O
cause	O
mild	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
.	O

TITLE	O
:	O
Peptidoglycan	B-ANAT
-	O
Associated	O
Cyclic	O
Lipopeptide	O
Disrupts	O
Viral	O
Infectivity	O
.	O

ABSTRACT	O
:	O
Porcine	O
deltacoronavirus	O
(	O
PDCoV	O
)	O
is	O
a	O
recently	O
identified	O
coronavirus	O
that	O
causes	O
intestinal	B-ANAT
diseases	O
in	O
neonatal	O
piglets	O
with	O
diarrhea	O
,	O
vomiting	O
,	O
dehydration	O
,	O
and	O
post	O
-	O
infection	O
mortality	O
of	O
50	O
-	O
100	O
%.	O

Incidence	O
of	O
ARF	O
was	O
less	O
after	O
off	O
-	O
pump	O
coronary	B-ANAT
artery	I-ANAT
bypass	O
surgery	O
compared	O
with	O
on	O
-	O
pump	O
interventions	O
(	O
1	O
.	O
6	O
vs	O
.	O
3	O
.	O
5	O
%,	O
p	O
=	O
0	O
.	O
0469	O
).	O

In	O
the	O
year	O
following	O
the	O
initiation	O
of	O
the	O
mPATH	O
team	O
,	O
we	O
observed	O
earlier	O
time	O
to	O
occupational	O
,	O
physical	O
,	O
and	O
speech	O
therapist	O
evaluation	O
,	O
decreased	O
length	O
of	O
stay	O
,	O
and	O
cost	O
savings	O
in	O
severe	O
traumatic	O
brain	B-ANAT
and	I-ANAT
spinal	I-ANAT
cord	I-ANAT
injury	O
patients	O
requiring	O
tracheostomy	O
compared	O
with	O
our	O
historical	O
control	O
.	O

ABSTRACT	O
:	O
To	O
report	O
results	O
of	O
a	O
national	O
survey	O
of	O
provider	O
attitudes	O
,	O
observations	O
,	O
and	O
opinions	O
regarding	O
the	O
use	O
of	O
extracorporeal	O
membranous	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
to	O
manage	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
trauma	O
patients	O
.	O

TITLE	O
:	O
A	O
Novel	O
Bacterium	O
-	O
Like	O
Particle	O
Vaccine	O
Displaying	O
the	O
MERS	O
-	O
CoV	O
Receptor	O
-	O
Binding	O
Domain	O
Induces	O
Specific	O
Mucosal	B-ANAT
and	O
Systemic	O
Immune	O
Responses	O
in	O
Mice	O
.	O

Among	O
multiply	O
injured	O
patients	O
with	O
severe	O
blunt	O
chest	B-ANAT
trauma	O
,	O
accidental	O
hypothermia	O
is	O
not	O
an	O
independent	O
predictor	O
of	O
ARDS	O
and	O
VAP	O
and	O
is	O
more	O
likely	O
to	O
be	O
an	O
accompaniment	O
of	O
injury	O
severity	O
and	O
hemorrhage	O
.	O

CONCLUSIONS	O
:	O
Among	O
multiply	O
injured	O
patients	O
with	O
severe	O
blunt	O
chest	B-ANAT
trauma	O
,	O
accidental	O
hypothermia	O
is	O
not	O
an	O
independent	O
predictor	O
of	O
ARDS	O
and	O
VAP	O
and	O
is	O
more	O
likely	O
to	O
be	O
an	O
accompaniment	O
of	O
injury	O
severity	O
and	O
hemorrhage	O
.	O

TITLE	O
:	O
Porcine	O
IL	O
-	O
12	O
plasmid	O
as	O
an	O
adjuvant	O
improves	O
the	O
cellular	B-ANAT
and	O
humoral	O
immune	O
responses	O
of	O
DNA	O
vaccine	O
targeting	O
transmissible	O
gastroenteritis	O
virus	O
spike	O
gene	O
in	O
a	O
mouse	O
model	O
.	O

Transfection	O
of	O
different	O
cell	B-ANAT
types	O
with	O
FCoV	O
3b	O
fused	O
to	O
enhanced	O
green	O
fluorescent	O
protein	O
(	O
EGFP	O
)	O
or	O
3	O
Ã	O
FLAG	O
confirmed	O
localization	O
of	O
FCoV	O
3b	O
in	O
the	O
mitochondria	B-ANAT
and	O
nucleoli	O
.	O

Mutational	O
analysis	O
also	O
revealed	O
that	O
mitochondrial	B-ANAT
translocation	O
is	O
mediated	O
by	O
N	O
-	O
terminal	O
residues	O
10	O
-	O
35	O
,	O
in	O
which	O
a	O
Tom20	O
recognition	O
motif	O
(	O
residues	O
13	O
-	O
17	O
)	O
and	O
two	O
other	O
overlapping	O
hexamers	O
(	O
residues	O
24	O
-	O
30	O
)	O
associated	O
with	O
mitochondrial	B-ANAT
targeting	O
were	O
identified	O
.	O

Administration	O
of	O
IVIG	O
is	O
indicated	O
for	O
acute	O
cardiac	B-ANAT
involvement	O
in	O
Kawasaki	O
'	O
s	O
disease	O
and	O
may	O
be	O
considered	O
in	O
catastrophic	O
APS	O
and	O
refractory	O
myositis	O
.	O

PDCoV	O
-	O
infected	O
suckling	O
piglets	O
were	O
characterized	O
with	O
thin	O
and	O
transparent	O
intestinal	B-ANAT
walls	I-ANAT
from	O
colon	B-ANAT
to	O
caecum	B-ANAT
,	O
spot	O
hemorrhage	O
at	O
mesentery	B-ANAT
and	O
intestinal	B-ANAT
bleeding	O
.	O

These	O
animals	O
play	O
important	O
roles	O
in	O
sustaining	O
the	O
virus	O
in	O
certain	O
communities	O
and	O
may	O
act	O
as	O
an	O
amplifier	O
of	O
the	O
virus	O
by	O
secreting	O
it	O
in	O
their	O
body	B-ANAT
fluids	I-ANAT
,	O
especially	O
in	O
nasal	B-ANAT
and	O
rectal	O
discharges	B-ANAT
.	O

The	O
structures	O
of	O
Ptal	O
-	O
N	O
*	O
01	O
:	O
01	O
display	O
unusual	O
peptide	O
presentation	O
features	O
in	O
that	O
the	O
bat	O
-	O
specific	O
3	O
-	O
amino	O
acid	O
(	O
aa	O
)	O
insertion	O
enables	O
the	O
tight	O
""""	O
surface	O
anchoring	O
""""	O
of	O
the	O
P1	O
-	O
Asp	O
in	O
pocket	O
A	O
of	O
bat	O
MHC	B-ANAT
I	O
.	O
As	O
the	O
classical	O
primary	O
anchoring	O
positions	O
,	O
the	O
B	O
and	O
F	O
pockets	O
of	O
Ptal	O
-	O
N	O
*	O
01	O
:	O
01	O
also	O
show	O
unconventional	O
conformations	O
,	O
which	O
contribute	O
to	O
unusual	O
peptide	O
motifs	O
and	O
distinct	O
peptide	O
presentation	O
.	O

TITLE	O
:	O
Myocardial	O
calcification	O
in	O
a	O
patient	O
with	O
B	O
-	O
lymphoblastic	B-ANAT
leukemia	O
accompanied	O
by	O
tumor	O
lysis	O
syndrome	O
.	O

An	O
increase	O
in	O
the	O
levels	O
of	O
mRNAs	O
of	O
pro	O
-	O
inflammatory	O
cytokines	O
such	O
as	O
interleukin	O
-	O
1Î²	O
(	O
IL	O
-	O
1Î²	O
)	O
and	O
tumor	O
necrosis	O
factor	O
-	O
Î±	O
(	O
TNF	O
-	O
Î±	O
)	O
was	O
also	O
observed	O
in	O
PEDV	O
-	O
infected	O
G3BP1	O
depleted	O
cells	B-ANAT
compared	O
to	O
PEDV	O
-	O
infected	O
control	O
cells	B-ANAT
.	O

S2	O
-	O
derived	O
peptides	O
with	O
16R	O
,	O
but	O
not	O
those	O
with	O
16	O
K	O
,	O
could	O
react	O
with	O
sera	B-ANAT
against	O
different	O
types	O
of	O
IBVs	O
.	O

TITLE	O
:	O
Influenza	O
A	O
virus	O
infection	O
induces	O
liver	B-ANAT
injury	O
in	O
mice	O
.	O

The	O
genes	O
coding	O
for	O
the	O
capsid	B-ANAT
protein	O
(	O
penton	O
base	O
,	O
hexon	O
,	O
and	O
fiber	B-ANAT
)	O
of	O
201	O
HAdV	O
-	O
C	O
strains	O
were	O
sequenced	O
and	O
compared	O
with	O
representative	O
sequences	O
publicly	O
available	O
.	O

212	O
(	O
24	O
.	O
3	O
%)	O
of	O
871	O
respondents	O
completed	O
the	O
survey	O
:	O
94	O
.	O
7	O
%	O
were	O
board	O
-	O
certified	O
in	O
internal	O
medicine	O
,	O
88	O
%	O
in	O
pulmonary	B-ANAT
and	O
critical	O
care	O
;	O
90	O
.	O
3	O
%	O
practiced	O
in	O
academic	O
medical	O
centers	O
,	O
with	O
87	O
%	O
working	O
in	O
medical	O
ICUs	O
;	O
96	O
.	O
6	O
%	O
of	O
respondents	O
who	O
treat	O
ARDS	O
use	O
NMB	O
,	O
and	O
39	O
.	O
7	O
%	O
use	O
NMB	O
in	O
â¥	O
50	O
%	O
of	O
these	O
patients	O
.	O

RESULTS	O
:	O
212	O
(	O
24	O
.	O
3	O
%)	O
of	O
871	O
respondents	O
completed	O
the	O
survey	O
:	O
94	O
.	O
7	O
%	O
were	O
board	O
-	O
certified	O
in	O
internal	O
medicine	O
,	O
88	O
%	O
in	O
pulmonary	B-ANAT
and	O
critical	O
care	O
;	O
90	O
.	O
3	O
%	O
practiced	O
in	O
academic	O
medical	O
centers	O
,	O
with	O
87	O
%	O
working	O
in	O
medical	O
ICUs	O
;	O
96	O
.	O
6	O
%	O
of	O
respondents	O
who	O
treat	O
ARDS	O
use	O
NMB	O
,	O
and	O
39	O
.	O
7	O
%	O
use	O
NMB	O
in	O
â¥	O
50	O
%	O
of	O
these	O
patients	O
.	O

In	O
this	O
study	O
,	O
a	O
TGEV	O
oral	B-ANAT
vaccine	O
was	O
generated	O
by	O
transferring	O
a	O
eukaryotic	O
expression	O
recombinant	O
plasmid	O
carrying	O
the	O
SAD	O
(	O
A	O
and	O
D	O
antigenic	O
sites	O
of	O
the	O
S	O
protein	O
)	O
epitope	O
of	O
TGEV	O
into	O
a	O
swine	O
-	O
origin	O
Lactobacillus	O
acidophilus	O
(	O
L	O
.	O
acidophilus	O
).	O

In	O
orally	B-ANAT
immunized	O
BALB	O
/	O
c	O
mice	O
,	O
the	O
TGEV	O
L	O
.	O
acidophilus	O
oral	B-ANAT
vaccine	O
induced	O
significantly	O
higher	O
level	O
of	O
SIgA	O
antibodies	O
specific	O
to	O
TGEV	O
compared	O
with	O
the	O
mice	O
immunized	O
with	O
a	O
commercial	O
inactivated	O
TGEV	O
vaccine	O
and	O
similar	O
levels	O
of	O
IgG	O
specific	O
to	O
TGEV	O
as	O
the	O
inactivated	O
vaccine	O
.	O

Keywords	O
:	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
);	O
live	O
L	O
.	O
acidophilus	O
oral	B-ANAT
vaccine	O
;	O
SIgA	B-ANAT
antibody	I-ANAT
;	O
IgG	B-ANAT
antibody	I-ANAT
;	O
IFN	O
-	O
Î³	O
;	O
IL	O
-	O
4	O
.	O

The	O
addition	O
of	O
fluid	O
resuscitation	O
to	O
the	O
model	O
improved	O
renal	B-ANAT
function	O
but	O
worsened	O
the	O
severity	O
of	O
lung	B-ANAT
injury	O
based	O
on	O
direct	O
measurements	O
of	O
pulmonary	B-ANAT
edema	O
and	O
lung	B-ANAT
compliance	O
,	O
analogous	O
to	O
patients	O
with	O
pneumonia	O
and	O
sepsis	O
who	O
develop	O
ARDS	O
following	O
fluid	O
administration	O
.	O

TITLE	O
:	O
DNA	O
repair	O
and	O
genomic	O
stability	O
in	O
lungs	B-ANAT
affected	O
by	O
acute	O
injury	O
.	O

Acute	O
pulmonary	B-ANAT
injury	O
can	O
develop	O
from	O
sepsis	O
,	O
septic	O
shock	O
,	O
and	O
pancreatitis	O
causing	O
reduction	O
of	O
alveolar	B-ANAT
airspace	O
due	O
to	O
hyperinflammatory	O
response	O
.	O

Oxidative	O
stress	O
acts	O
directly	O
on	O
the	O
maintenance	O
of	O
inflammation	O
,	O
resulting	O
in	O
tissue	B-ANAT
injury	O
,	O
as	O
well	O
as	O
inducing	O
DNA	O
damages	O
.	O

TITLE	O
:	O
Epitope	O
mapping	O
and	O
cellular	B-ANAT
localization	O
of	O
swine	O
acute	O
diarrhea	O
syndrome	O
coronavirus	O
nucleocapsid	B-ANAT
protein	O
using	O
a	O
novel	O
monoclonal	O
antibody	O
.	O

SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
are	O
zoonotic	O
viruses	O
that	O
crossed	O
the	O
species	O
barrier	O
using	O
bats	O
/	O
palm	B-ANAT
civets	O
and	O
dromedary	O
camels	O
,	O
respectively	O
.	O

TITLE	O
:	O
Direct	O
pulmonary	B-ANAT
delivery	O
of	O
solubilized	O
curcumin	O
reduces	O
severity	O
of	O
lethal	O
pneumonia	O
.	O

ABSTRACT	O
:	O
Cresol	O
is	O
a	O
phenol	O
derivative	O
used	O
as	O
a	O
disinfectant	O
that	O
may	O
cause	O
gastrointestinal	O
corrosive	O
injury	O
,	O
central	O
nervous	O
system	B-ANAT
,	I-ANAT
cardiovascular	I-ANAT
disturbances	O
,	O
renal	B-ANAT
,	O
and	O
hepatic	B-ANAT
injury	O
following	O
intoxication	O
.	O

Nasopharyngeal	B-ANAT
swabs	O
collected	O
from	O
patients	O
with	O
ILI	O
from	O
week	O
46	O
/	O
2017	O
to	O
week	O
17	O
/	O
2018	O
were	O
tested	O
to	O
identify	O
influenza	O
A	O
viruses	O
(	O
IAV	O
)	O
and	O
influenza	O
B	O
viruses	O
(	O
IBV	O
).	O

The	O
pathogenic	O
mechanisms	O
that	O
lead	O
to	O
respiratory	O
complications	O
,	O
such	O
as	O
vascular	B-ANAT
leakage	O
,	O
remain	O
unclear	O
.	O

This	O
case	O
report	O
describes	O
an	O
early	O
presentation	O
of	O
a	O
cat	O
with	O
primarily	O
neurologic	O
FIP	O
,	O
with	O
molecular	O
characterization	O
of	O
the	O
virus	O
within	O
various	O
tissues	B-ANAT
.	O

This	O
review	O
aimed	O
to	O
provide	O
a	O
clear	O
knowledge	O
on	O
the	O
recent	O
development	O
of	O
indoles	O
as	O
anti	O
-	O
cancer	O
agents	O
,	O
such	O
as	O
myeloid	B-ANAT
cell	I-ANAT
leukemia	O
-	O
1	O
(	O
Mcl	O
-	O
1	O
)	O
inhibitors	O
,	O
proviral	O
insertion	O
site	O
in	O
moloney	O
murine	O
leukemia	O
virus	O
(	O
Pim	O
)	O
inhibitors	O
,	O
histone	O
deacetylase	O
(	O
HDAC	O
)	O
inhibitors	O
,	O
silent	O
mating	O
type	O
information	O
regulation	O
2	O
homolog	O
(	O
SIRT	O
)	O
inhibitors	O
and	O
tubulin	B-ANAT
inhibitors	O
,	O
and	O
made	O
an	O
insight	O
into	O
the	O
corresponding	O
structure	O
-	O
activity	O
relationships	O
(	O
SARs	O
).	O

TITLE	O
:	O
Screening	O
pulmonary	B-ANAT
angiogram	O
and	O
the	O
effect	O
on	O
anticoagulation	O
strategies	O
in	O
severe	O
respiratory	O
failure	O
patients	O
on	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
prevalence	O
of	O
pulmonary	B-ANAT
embolism	O
(	O
PE	O
)	O
in	O
patients	O
with	O
severe	O
respiratory	O
failure	O
requiring	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
VV	O
ECMO	O
)	O
and	O
in	O
those	O
managed	O
with	O
conventional	O
mechanical	O
ventilation	O
.	O

TITLE	O
:	O
Generating	O
and	O
evaluating	O
type	O
I	O
interferon	O
receptor	O
-	O
deficient	O
and	O
feline	O
TMPRSS2	O
-	O
expressing	O
cells	B-ANAT
for	O
propagating	O
serotype	O
I	O
feline	O
infectious	O
peritonitis	O
virus	O
.	O

The	O
latter	O
finding	O
may	O
suggest	O
that	O
during	O
ECMO	O
support	O
,	O
the	O
right	B-ANAT
ventricle	I-ANAT
still	O
may	O
be	O
subjected	O
to	O
increased	O
afterload	O
.	O

As	O
a	O
first	O
step	O
toward	O
understanding	O
the	O
biology	O
of	O
the	O
PDCoV	O
accessory	O
proteins	O
,	O
we	O
established	O
a	O
stable	O
porcine	O
cell	B-ANAT
line	I-ANAT
constitutively	O
expressing	O
the	O
PDCoV	O
NS7	O
protein	O
in	O
order	O
to	O
investigate	O
the	O
functional	O
characteristics	O
of	O
NS7	O
for	O
viral	O
replication	O
.	O

Diabetic	O
mice	O
had	O
fewer	O
inflammatory	O
monocyte	B-ANAT
/	O
macrophages	B-ANAT
and	O
CD4	O
+	O
T	B-ANAT
cells	I-ANAT
,	O
which	O
correlated	O
with	O
lower	O
levels	O
of	O
Ccl2	O
and	O
Cxcl10	O
expression	O
.	O

TITLE	O
:	O
The	O
intestinal	B-ANAT
microbiome	O
in	O
dogs	O
and	O
cats	O
with	O
diarrhoea	O
as	O
detected	O
by	O
a	O
faecal	B-ANAT
polymerase	O
chain	O
reaction	O
-	O
based	O
panel	O
in	O
Perth	O
,	O
Western	O
Australia	O
.	O

Records	O
from	O
a	O
commercial	O
diagnostic	O
laboratory	O
using	O
faecal	B-ANAT
PCR	O
testing	O
between	O
July	O
2014	O
and	O
August	O
2015	O
were	O
reviewed	O
.	O

Of	O
289	O
feline	O
faecal	B-ANAT
samples	O
reviewed	O
,	O
Salmonella	O
spp	O
.	O

ABSTRACT	O
:	O
Human	O
coronavirus	O
NL63	O
(	O
HCoV	O
-	O
NL63	O
),	O
one	O
of	O
the	O
main	O
circulating	O
HCoVs	O
worldwide	O
,	O
causes	O
respiratory	B-ANAT
tract	I-ANAT
illnesses	O
like	O
runny	O
nose	B-ANAT
,	O
cough	O
,	O
bronchiolitis	O
and	O
pneumonia	O
.	O

MERS	O
-	O
CoV	O
replication	O
significantly	O
upregulated	O
C	O
-	O
type	O
lectin	O
receptor	O
(	O
CLR	O
)	O
macrophage	B-ANAT
-	O
inducible	O
Ca2	O
+-	O
dependent	O
lectin	O
receptor	O
(	O
Mincle	O
).	O

Recent	O
advances	O
in	O
burn	O
intensive	O
care	O
have	O
focused	O
on	O
acute	O
respiratory	O
distress	O
syndrome	O
from	O
inhalation	O
injury	O
,	O
acute	O
kidney	B-ANAT
injury	O
(	O
AKI	O
),	O
and	O
transfusion	O
,	O
resulting	O
in	O
new	O
strategies	O
for	O
organ	B-ANAT
failure	O
,	O
including	O
renal	B-ANAT
replacement	O
therapy	O
and	O
extracorporeal	O
life	O
support	O
.	O

ABSTRACT	O
:	O
This	O
study	O
will	O
assess	O
the	O
efficacy	O
and	O
safety	O
of	O
blood	B-ANAT
purification	O
(	O
BP	O
)	O
for	O
severe	O
pancreatitis	O
(	O
SP	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

TITLE	O
:	O
Mucosal	B-ANAT
Immune	O
Response	O
to	O
Feline	O
Enteric	O
Coronavirus	O
Infection	O
.	O

The	O
most	O
common	O
sources	O
of	O
health	O
information	O
included	O
television	O
/	O
radio	O
(	O
47	O
.	O
9	O
%),	O
social	O
media	B-ANAT
(	O
29	O
.	O
4	O
%),	O
and	O
friends	O
/	O
family	O
(	O
28	O
.	O
1	O
%).	O

The	O
kidneys	B-ANAT
of	O
dead	O
birds	O
were	O
swollen	O
and	O
pale	O
and	O
exhibited	O
severe	O
urate	O
deposition	O
.	O

TITLE	O
:	O
Effect	O
of	O
Vitamin	O
C	O
Infusion	O
on	O
Organ	B-ANAT
Failure	O
and	O
Biomarkers	O
of	O
Inflammation	O
and	O
Vascular	B-ANAT
Injury	O
in	O
Patients	O
With	O
Sepsis	O
and	O
Severe	O
Acute	O
Respiratory	O
Failure	O
:	O
The	O
CITRIS	O
-	O
ALI	O
Randomized	O
Clinical	O
Trial	O
.	O

ABSTRACT	O
:	O
Experimental	O
data	O
suggest	O
that	O
intravenous	O
vitamin	O
C	O
may	O
attenuate	O
inflammation	O
and	O
vascular	B-ANAT
injury	O
associated	O
with	O
sepsis	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

The	O
primary	O
outcomes	O
were	O
change	O
in	O
organ	B-ANAT
failure	O
as	O
assessed	O
by	O
a	O
modified	O
Sequential	O
Organ	B-ANAT
Failure	O
Assessment	O
score	O
(	O
range	O
,	O
0	O
-	O
20	O
,	O
with	O
higher	O
scores	O
indicating	O
more	O
dysfunction	O
)	O
from	O
baseline	O
to	O
96	O
hours	O
,	O
and	O
plasma	B-ANAT
biomarkers	O
of	O
inflammation	O
(	O
C	O
-	O
reactive	O
protein	O
levels	O
)	O
and	O
vascular	B-ANAT
injury	O
(	O
thrombomodulin	O
levels	O
)	O
measured	O
at	O
0	O
,	O
48	O
,	O
96	O
,	O
and	O
168	O
hours	O
.	O

TITLE	O
:	O
Transcriptome	O
analysis	O
of	O
PK	O
-	O
15	O
cells	B-ANAT
in	O
innate	O
immune	O
response	O
to	O
porcine	O
deltacoronavirus	O
infection	O
.	O

Research	O
findings	O
indicate	O
that	O
PDCoV	O
has	O
evolved	O
strategies	O
to	O
escape	O
innate	O
immune	O
response	O
in	O
host	O
cells	B-ANAT
,	O
but	O
mechanism	O
of	O
PDCoV	O
in	O
innate	O
immune	O
modulation	O
is	O
not	O
well	O
understood	O
.	O

ABSTRACT	O
:	O
Growth	O
Hormone	O
-	O
Releasing	O
Hormone	O
(	O
GHRH	O
)	O
regulates	O
the	O
release	O
of	O
growth	O
hormone	O
from	O
the	O
anterior	B-ANAT
pituitary	I-ANAT
gland	I-ANAT
.	O

Our	O
observations	O
support	O
the	O
evidence	O
for	O
the	O
anti	O
-	O
inflammatory	O
role	O
of	O
GHRH	O
antagonists	O
in	O
the	O
vasculature	B-ANAT
.	O

High	O
-	O
titre	O
and	O
low	O
-	O
titre	O
plasma	B-ANAT
had	O
the	O
same	O
appearance	O
.	O

The	O
primary	O
analysis	O
was	O
done	O
in	O
the	O
intention	O
-	O
to	O
-	O
treat	O
population	O
,	O
excluding	O
two	O
participants	O
who	O
did	O
not	O
receive	O
plasma	B-ANAT
.	O

The	O
study	O
was	O
terminated	O
in	O
July	O
,	O
2018	O
,	O
when	O
independent	O
efficacy	O
analysis	O
showed	O
low	O
conditional	O
power	O
to	O
detect	O
an	O
effect	O
of	O
high	O
-	O
titre	O
plasma	B-ANAT
even	O
if	O
full	O
accrual	O
(	O
150	O
participants	O
)	O
was	O
achieved	O
.	O

These	O
results	O
demonstrate	O
that	O
integrin	O
Î±vÎ²3	O
enhances	O
PEDV	O
replication	O
in	O
Vero	O
E6	O
cells	B-ANAT
and	O
IECs	O
.	O

In	O
19	O
of	O
the	O
studied	O
farms	O
additional	O
fecal	B-ANAT
samples	O
from	O
apparently	O
healthy	O
pen	O
-	O
mates	O
were	O
collected	O
and	O
tested	O
for	O
the	O
same	O
panel	O
of	O
infectious	O
agents	O
.	O

Phylogenetic	O
comparison	O
of	O
H	B-ANAT
and	I-ANAT
N	I-ANAT
gene	O
sequences	O
confirmed	O
the	O
clonality	O
of	O
outbreak	O
strains	O
.	O

While	O
recent	O
studies	O
have	O
uncovered	O
the	O
sequence	O
of	O
this	O
packaging	O
signal	O
,	O
little	O
is	O
known	O
about	O
the	O
specific	O
interaction	O
between	O
the	O
N	O
-	O
protein	O
and	O
the	O
packaging	O
signal	O
sequence	O
,	O
and	O
the	O
mechanisms	O
by	O
which	O
this	O
interaction	O
drives	O
viral	B-ANAT
genome	I-ANAT
packaging	O
.	O

TITLE	O
:	O
Successful	O
treatment	O
of	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
due	O
to	O
Group	O
A	O
streptococcus	O
induced	O
toxic	O
shock	O
syndrome	O
in	O
the	O
third	O
trimester	O
of	O
pregnancy	O
-	O
effectiveness	O
of	O
venoarterial	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
:	O
A	O
case	O
report	O
.	O

The	O
abundant	O
IFI204	O
could	O
significantly	O
interact	O
with	O
IRF7	O
in	O
nucleus	B-ANAT
by	O
its	O
HIN	O
domain	O
and	O
prevent	O
the	O
binding	O
of	O
IRF7	O
with	O
its	O
corresponding	O
promoter	O
.	O

This	O
nosological	O
entity	O
is	O
based	O
on	O
the	O
appearance	O
of	O
a	O
diffuse	O
alveolar	B-ANAT
damage	O
associating	O
pulmonary	B-ANAT
epithelial	O
barrier	O
disruption	O
with	O
an	O
alveolar	B-ANAT
filling	O
,	O
both	O
responsible	O
of	O
profound	O
hypoxemia	O
and	O
important	O
morbi	O
-	O
mortality	O
.	O

Diagnosis	O
is	O
based	O
on	O
the	O
occurrence	O
of	O
acute	O
hypoxic	O
respiratory	O
failure	O
not	O
explained	O
by	O
cardiac	B-ANAT
insufficiency	O
or	O
volume	O
overload	O
,	O
within	O
7	O
days	O
after	O
a	O
recognized	O
risk	O
factor	O
,	O
and	O
in	O
the	O
presence	O
of	O
bilateral	O
pulmonary	B-ANAT
opacities	O
not	O
fully	O
explained	O
by	O
effusions	O
,	O
atelectasis	O
or	O
nodules	B-ANAT
on	O
the	O
chest	B-ANAT
radiography	O
.	O

In	O
this	O
review	O
,	O
innate	O
immune	O
responses	O
relevant	O
for	O
respiratory	O
viruses	O
with	O
an	O
RNA	O
genome	O
will	O
briefly	O
be	O
summarized	O
,	O
and	O
viral	O
innate	O
immune	O
evasion	O
based	O
on	O
shielding	O
viral	O
RNA	O
species	O
away	O
from	O
cellular	B-ANAT
innate	O
immune	O
sensors	O
will	O
be	O
discussed	O
from	O
different	O
angles	O
.	O

To	O
produce	O
MERS	O
-	O
CoV	O
-	O
like	O
particles	O
(	O
MERS	O
-	O
CoV	O
-	O
LPs	O
),	O
the	O
coexpression	O
of	O
spike	O
proteins	O
was	O
performed	O
in	O
Bm5	O
cells	B-ANAT
and	O
envelope	B-ANAT
(	O
E	O
)	O
and	O
membrane	B-ANAT
(	O
M	O
)	O
proteins	O
secreted	O
E	O
and	O
M	O
proteins	O
extracellularly	O
,	O
suggesting	O
that	O
MERS	O
-	O
CoV	O
-	O
LPs	O
may	O
be	O
formed	O
.	O

However	O
,	O
this	O
S	O
protein	O
was	O
not	O
displayed	O
on	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
(	O
VLPs	B-ANAT
)	O
even	O
though	O
E	O
and	O
M	O
proteins	O
were	O
secreted	O
into	O
the	O
culture	O
supernatant	O
.	O

As	O
limited	O
therapeutic	O
antibody	O
is	O
accumulated	O
in	O
lung	B-ANAT
tissue	I-ANAT
following	O
systemic	O
administration	O
,	O
inhalation	O
is	O
newly	O
recognized	O
as	O
an	O
alternative	O
,	O
possibly	O
better	O
,	O
route	O
of	O
therapeutic	O
antibody	O
for	O
pulmonary	B-ANAT
diseases	O
.	O

In	O
summary	O
,	O
we	O
generated	O
a	O
MERS	O
-	O
CoV	O
neutralizing	O
human	O
antibody	O
that	O
is	O
reactive	O
to	O
recombinant	O
MERS	O
-	O
CoV	O
S	O
RBD	O
protein	O
for	O
delivery	O
via	O
a	O
pulmonary	B-ANAT
route	O
by	O
introducing	O
stabilizing	O
mutations	O
into	O
five	O
CDRs	O
.	O

IV	O
zanamivir	O
could	O
be	O
a	O
good	O
therapeutic	O
option	O
in	O
patients	O
with	O
severe	O
influenza	O
A	O
(	O
H1N1	O
)	O
pdm09	O
infection	O
who	O
are	O
unable	O
to	O
take	O
oral	B-ANAT
or	O
aerosolised	O
antiviral	O
medication	O
.	O

TITLE	O
:	O
Peripheral	B-ANAT
blood	I-ANAT
leukocyte	B-ANAT
telomere	B-ANAT
length	O
is	O
associated	O
with	O
survival	O
of	O
sepsis	O
patients	O
.	O

ABSTRACT	O
:	O
Shorter	O
peripheral	B-ANAT
blood	I-ANAT
leukocyte	B-ANAT
(	O
PBL	O
)	O
telomere	B-ANAT
length	O
(	O
TL	O
)	O
has	O
been	O
associated	O
with	O
poor	O
outcomes	O
in	O
various	O
chronic	O
lung	B-ANAT
diseases	O
.	O

These	O
findings	O
suggest	O
that	O
telomere	B-ANAT
dysfunction	O
may	O
contribute	O
to	O
outcomes	O
from	O
critical	O
illness	O
.	O

TITLE	O
:	O
Treatment	O
of	O
a	O
Rat	O
Model	O
of	O
LPS	O
-	O
Induced	O
ARDS	O
via	O
Peritoneal	B-ANAT
Perfusion	O
of	O
Oxygen	O
Microbubbles	O
.	O

Standard	O
mechanical	O
ventilation	O
can	O
activate	O
inflammation	O
and	O
worsen	O
the	O
pulmonary	B-ANAT
damage	O
caused	O
by	O
the	O
underlying	O
disease	O
,	O
leading	O
to	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

Among	O
survivors	O
,	O
77	O
.	O
1	O
%	O
of	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
had	O
functional	O
disability	O
at	O
discharge	B-ANAT
versus	O
30	O
.	O
7	O
%	O
of	O
patients	O
without	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
(	O
p	O
<	O
0	O
.	O
001	O
),	O
and	O
only	O
17	O
.	O
5	O
%	O
of	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
discharged	O
home	O
without	O
ongoing	O
care	O
versus	O
86	O
.	O
4	O
%	O
of	O
patients	O
without	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
adjusted	O
relative	O
risk	O
,	O
1	O
.	O
5	O
;	O
1	O
.	O
1	O
-	O
2	O
.	O
1	O
).	O

Abdominal	B-ANAT
ultrasound	O
revealed	O
severe	O
jejunal	B-ANAT
and	O
ileocolic	B-ANAT
junction	I-ANAT
intestinal	B-ANAT
wall	I-ANAT
thickening	O
with	O
loss	O
of	O
layering	B-ANAT
.	O

Further	O
RT	O
-	O
PCR	O
positive	O
cases	O
were	O
confirmed	O
by	O
immunohistochemistry	O
(	O
IHC	O
)	O
in	O
paraffin	O
-	O
embedded	O
intestinal	B-ANAT
tissue	B-ANAT
sections	O
.	O

Opioids	O
act	O
by	O
engagement	O
of	O
specific	O
cell	B-ANAT
surface	I-ANAT
receptors	O
;	O
the	O
opiate	O
receptors	O
,	O
which	O
are	O
designated	O
Âµ	O
[	O
mu	O
],	O
Îº	O
[	O
kappa	O
]	O
and	O
Î´	O
[	O
delta	O
].	O

These	O
agents	O
(	O
naldemedine	O
,	O
naloxegol	O
)	O
are	O
generally	O
modified	O
so	O
as	O
not	O
to	O
cross	O
the	O
blood	B-ANAT
brain	B-ANAT
and	O
reverse	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
effects	O
of	O
opiates	O
.	O

A	O
special	O
form	O
of	O
liver	B-ANAT
injury	O
linked	O
to	O
opioid	O
use	O
occurs	O
with	O
their	O
fixed	B-ANAT
drug	O
combinations	O
with	O
acetaminophen	O
.	O

The	O
injury	O
is	O
usually	O
mild	O
-	O
to	O
-	O
moderate	O
in	O
severity	O
,	O
although	O
fatal	O
cases	O
of	O
acute	O
liver	B-ANAT
failure	O
have	O
been	O
described	O
,	O
and	O
there	O
have	O
been	O
several	O
reports	O
of	O
vanishing	O
bile	B-ANAT
duct	I-ANAT
syndrome	O
or	O
prolonged	O
cholestasis	O
following	O
amoxicillin	O
or	O
ampicillin	O
related	O
cholestatic	O
liver	B-ANAT
injury	O
.	O

TITLE	O
:	O
Successful	O
Ventilation	O
of	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
Complicated	O
by	O
Pneumothorax	O
Using	O
Airway	B-ANAT
Pressure	O
Release	O
Ventilation	O
:	O
A	O
Case	O
Report	O
.	O

Exacerbations	O
are	O
major	O
contributors	O
to	O
morbidity	O
and	O
mortality	O
in	O
patients	O
with	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
COPD	O
),	O
and	O
respiratory	O
bacterial	O
and	O
viral	O
infections	O
are	O
an	O
important	O
trigger	O
.	O

These	O
interfaces	O
likely	O
play	O
a	O
role	O
in	O
the	O
S	O
-	O
protein	O
conformational	O
changes	O
associated	O
with	O
membrane	B-ANAT
fusion	O
.	O

ABSTRACT	O
:	O
Some	O
coronaviruses	O
(	O
CoVs	O
)	O
have	O
an	O
extra	O
furin	O
cleavage	O
site	O
(	O
RRKR	O
/	O
S	O
,	O
furin	O
-	O
S2	O
'	O
site	O
)	O
upstream	O
of	O
the	O
fusion	O
peptide	O
in	O
the	O
spike	O
protein	O
,	O
which	O
plays	O
roles	O
in	O
virion	B-ANAT
adsorption	O
and	O
fusion	O
.	O

Infection	O
with	O
mutant	O
IBV	O
induces	O
severe	O
encephalitis	O
and	O
breaks	O
the	O
blood	B-ANAT
-	I-ANAT
brain	I-ANAT
barrier	I-ANAT
.	O

The	O
results	O
of	O
a	O
neutralization	O
test	O
and	O
immunoprotection	O
experiment	O
show	O
that	O
an	O
original	O
serum	B-ANAT
and	O
vaccine	O
can	O
still	O
provide	O
effective	O
protection	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O

ABSTRACT	O
:	O
Despite	O
the	O
use	O
of	O
lung	B-ANAT
protective	O
ventilation	O
(	O
LPV	O
)	O
strategies	O
,	O
a	O
severe	O
form	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
unfortunately	O
associated	O
with	O
high	O
mortality	O
rates	O
,	O
which	O
sometimes	O
exceed	O
60	O
%.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
if	O
the	O
influence	O
of	O
Met	O
on	O
HEV	B-ANAT
infected	O
turkeys	O
immune	O
response	O
can	O
be	O
differentiated	O
by	O
both	O
its	O
level	O
and	O
source	O
.	O

The	O
HEV	B-ANAT
added	O
the	O
percentage	O
of	O
CD4	O
The	O
results	O
of	O
this	O
study	O
indicate	O
that	O
HEV	B-ANAT
infection	O
impairs	O
the	O
immune	O
function	O
in	O
turkeys	O
.	O

However	O
,	O
whether	O
lncRNAs	O
participate	O
in	O
TGEV	O
-	O
induced	O
inflammation	O
in	O
porcine	O
intestinal	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
(	O
IPECs	O
)	O
is	O
largely	O
unknown	O
.	O

TITLE	O
:	O
Prevalence	O
of	O
selected	O
cardiotropic	O
pathogens	O
in	O
the	O
myocardium	B-ANAT
of	O
adult	O
dogs	O
with	O
unexplained	O
myocardial	O
and	O
rhythm	O
disorders	O
or	O
with	O
congenital	O
heart	B-ANAT
disease	O
.	O

Vaccination	O
of	O
pregnant	O
sows	O
with	O
live	O
attenuated	O
vaccines	O
(	O
LAVs	O
)	O
is	O
the	O
most	O
effective	O
strategy	O
to	O
induce	O
lactogenic	O
immunity	O
in	O
the	O
sows	O
,	O
which	O
provides	O
A	O
passive	O
protection	O
of	O
suckling	O
piglets	O
against	O
PEDV	O
via	O
the	O
colostrum	B-ANAT
(	O
beestings	O
,	O
or	O
first	B-ANAT
milk	I-ANAT
)	O
and	O
milk	O
.	O

However	O
,	O
some	O
animal	O
studies	O
have	O
suggested	O
that	O
inadequate	O
immunization	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
induces	O
a	O
lung	B-ANAT
eosinophilic	O
immunopathology	O
upon	O
infection	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
infects	O
ciliated	O
epithelial	B-ANAT
cells	I-ANAT
in	O
the	O
chicken	O
respiratory	B-ANAT
tract	I-ANAT
.	O

While	O
some	O
IBV	O
strains	O
replicate	O
locally	O
,	O
others	O
can	O
disseminate	O
to	O
various	O
organs	B-ANAT
,	O
including	O
the	O
kidney	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
aryl	O
hydrocarbon	O
receptor	O
(	O
AhR	O
)	O
is	O
a	O
cytoplasmic	B-ANAT
receptor	O
/	O
transcription	O
factor	O
that	O
modulates	O
several	O
cellular	B-ANAT
and	O
immunological	O
processes	O
following	O
activation	O
by	O
pathogen	O
-	O
associated	O
stimuli	O
,	O
though	O
its	O
role	O
during	O
virus	O
infection	O
is	O
largely	O
unknown	O
.	O

To	O
combine	O
the	O
safety	O
and	O
efficacy	O
advantages	O
of	O
inactivated	O
and	O
attenuated	O
PEDV	O
vaccines	O
,	O
respectively	O
,	O
in	O
this	O
study	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
subjecting	O
PEDV	O
virions	B-ANAT
to	O
heat	O
treatment	O
at	O
44	O
Â°	O
C	O
for	O
10	O
min	O
to	O
reversibly	O
unfold	O
structural	O
proteins	O
,	O
followed	O
by	O
exposure	O
to	O
RNAse	O
to	O
fragment	O
the	O
genome	O
,	O
would	O
result	O
in	O
a	O
vaccine	O
preparation	O
with	O
intact	O
viral	B-ANAT
structure	I-ANAT
/	O
antigenicity	O
but	O
highly	O
diminished	O
replicative	O
abilities	O
.	O

TITLE	O
:	O
Amotosalen	O
and	O
ultraviolet	O
A	O
light	O
efficiently	O
inactivate	O
MERS	O
-	O
coronavirus	O
in	O
human	O
platelet	B-ANAT
concentrates	O
.	O

ABSTRACT	O
:	O
This	O
study	O
aimed	O
to	O
assess	O
the	O
efficacy	O
of	O
the	O
INTERCEPT	O
â¢	O
Blood	B-ANAT
System	O
[	O
amotosalen	O
/	O
ultraviolet	O
A	O
(	O
UVA	O
)	O
light	O
]	O
to	O
reduce	O
the	O
risk	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
Coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
transmission	O
by	O
human	O
platelet	B-ANAT
concentrates	O
.	O

Inactivated	O
samples	O
were	O
successively	O
passaged	O
thrice	O
on	O
Vero	O
E6	O
cells	B-ANAT
to	O
exclude	O
the	O
presence	O
of	O
residual	O
replication	O
-	O
competent	O
viral	B-ANAT
particles	I-ANAT
in	O
inactivated	O
platelets	B-ANAT
.	O

We	O
looked	O
for	O
predictors	O
that	O
indicate	O
the	O
need	O
for	O
reopening	O
the	O
sternum	B-ANAT
.	O

All	O
children	O
who	O
required	O
emergent	O
reopening	O
the	O
sternum	B-ANAT
in	O
the	O
pediatric	O
cardiac	B-ANAT
ICU	O
after	O
cardiac	B-ANAT
surgery	O
were	O
grouped	O
as	O
index	O
cases	O
and	O
matched	O
to	O
a	O
control	O
group	O
for	O
age	O
,	O
body	B-ANAT
weight	O
,	O
cardiac	B-ANAT
diagnosis	O
,	O
and	O
type	O
of	O
repair	O
(	O
single	O
vs	O
biventricular	O
).	O

Mortality	O
was	O
more	O
in	O
the	O
reopening	O
sternum	B-ANAT
group	O
with	O
higher	O
risk	O
when	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
was	O
needed	O
.	O

Furthermore	O
,	O
docking	O
analyses	O
revealed	O
that	O
the	O
predicted	O
peptides	O
engaged	O
in	O
strong	O
bonding	O
with	O
the	O
HLA	B-ANAT
-	O
B7	O
allele	O
.	O

We	O
initiated	O
the	O
administration	O
of	O
cyclosporin	O
A	O
and	O
therapeutic	O
plasma	B-ANAT
exchange	O
(	O
TPE	O
),	O
but	O
his	O
respiratory	O
condition	O
did	O
not	O
improve	O
satisfactorily	O
.	O

Our	O
findings	O
demonstrate	O
that	O
in	O
cases	O
of	O
severe	O
acute	O
respiratory	O
failure	O
due	O
to	O
DLI	O
,	O
the	O
multi	O
-	O
modal	O
therapy	O
with	O
plasma	B-ANAT
exchange	O
and	O
IVIG	O
in	O
addition	O
to	O
conventional	O
treatment	O
with	O
prednisolone	O
and	O
immunosuppressant	O
may	O
be	O
beneficial	O
.	O

infection	O
,	O
even	O
if	O
immunodeficiency	O
work	O
-	O
up	O
is	O
normal	O
,	O
as	O
they	O
may	O
have	O
defects	O
in	O
the	O
natural	O
immune	B-ANAT
system	I-ANAT
and	O
lymphocyte	B-ANAT
functions	O
.	O

Factors	O
such	O
as	O
developmental	O
level	O
of	O
the	O
countries	O
,	O
immune	B-ANAT
system	I-ANAT
,	O
nutritional	O
status	O
,	O
living	O
in	O
crowded	O
environments	O
,	O
contact	O
with	O
contaminated	O
water	O
,	O
close	O
contact	O
with	O
animals	O
,	O
working	O
at	O
a	O
hospital	O
and	O
hot	O
and	O
humid	O
climate	O
affect	O
the	O
incidence	O
of	O
Cryptosporidiosis	O
.	O

Hepatobiliary	B-ANAT
system	I-ANAT
involvement	O
occurs	O
in	O
10	O
-	O
30	O
%	O
of	O
patients	O
with	O
AIDS	O
;	O
stone	B-ANAT
-	O
free	O
cholecystitis	O
can	O
lead	O
to	O
sclerosing	O
cholangitis	O
and	O
pancreatitis	O
.	O

In	O
this	O
article	O
,	O
we	O
present	O
a	O
case	O
of	O
Cryptosporodiosis	O
with	O
hepatobiliary	B-ANAT
system	I-ANAT
involvement	O
who	O
were	O
admitted	O
to	O
the	O
pediatric	O
emergency	O
clinic	O
with	O
the	O
complaints	O
of	O
severe	O
diarrhea	O
and	O
Cryptosporidium	O
spp	O
.	O

oocysts	O
were	O
detected	O
in	O
parasitological	O
examination	O
of	O
the	O
stool	B-ANAT
specimen	I-ANAT
.	O

TITLE	O
:	O
Herpes	O
viruses	O
in	O
optic	B-ANAT
neuritis	O
:	O
Similar	O
to	O
Bell	O
'	O
s	O
palsy	O
.	O

ABSTRACT	O
:	O
An	O
important	O
feature	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
fluid	O
lost	O
into	O
the	O
interstitium	B-ANAT
of	O
lung	B-ANAT
combined	O
with	O
its	O
compromised	O
reabsorption	O
,	O
resulting	O
in	O
the	O
elevation	O
of	O
extravascular	O
lung	B-ANAT
water	O
(	O
EVLW	O
).	O

ABSTRACT	O
:	O
The	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
PARDS	O
),	O
a	O
description	O
specific	O
for	O
children	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
was	O
proposed	O
in	O
the	O
recent	O
Pediatric	O
Acute	O
Lung	B-ANAT
Injury	O
Consensus	O
Conference	O
(	O
PALICC	O
,	O
2015	O
).	O

Thus	O
,	O
the	O
neonatal	O
piglet	O
model	O
of	O
acute	O
lung	B-ANAT
injury	O
serves	O
as	O
an	O
excellent	O
model	O
to	O
study	O
respiratory	O
failure	O
and	O
is	O
the	O
preferred	O
animal	O
model	O
for	O
reasons	O
of	O
availability	O
,	O
body	B-ANAT
size	O
,	O
similarities	O
of	O
porcine	O
and	O
human	O
lung	B-ANAT
,	O
robustness	O
,	O
and	O
costs	O
.	O

The	O
physiologic	O
data	O
from	O
many	O
organ	B-ANAT
systems	I-ANAT
of	O
the	O
newborn	O
piglet	O
-	O
but	O
with	O
preference	O
on	O
the	O
lung	B-ANAT
-	O
are	O
presented	O
here	O
differentiating	O
between	O
baseline	O
data	O
from	O
the	O
uninjured	O
piglet	O
,	O
the	O
impact	O
of	O
acute	O
lung	B-ANAT
injury	O
on	O
various	O
parameters	O
(	O
24	O
h	O
),	O
and	O
the	O
follow	O
up	O
data	O
after	O
72	O
h	O
of	O
mechanical	O
ventilation	O
.	O

This	O
prospective	O
study	O
investigated	O
the	O
use	O
of	O
electromyography	O
of	O
the	O
diaphragm	B-ANAT
(	O
EMGdi	O
)	O
for	O
monitoring	O
respiratory	O
drive	O
in	O
patients	O
with	O
moderate	O
to	O
severe	O
ARDS	O
during	O
long	O
-	O
term	O
PPV	O
.	O

We	O
report	O
on	O
a	O
case	O
of	O
severe	O
acute	O
lung	B-ANAT
injury	O
secondary	O
to	O
inhalation	O
of	O
cannabis	O
oil	O
via	O
a	O
vape	O
pen	O
,	O
and	O
propose	O
a	O
new	O
term	O
that	O
describes	O
lung	B-ANAT
injury	O
related	O
to	O
vaping	O
.	O

ABSTRACT	O
:	O
We	O
present	O
data	O
on	O
a	O
cohort	O
of	O
patients	O
diagnosed	O
with	O
sepsis	O
over	O
a	O
10	O
-	O
year	O
period	O
comparing	O
outcomes	O
in	O
solid	O
organ	B-ANAT
transplant	I-ANAT
(	O
SOT	B-ANAT
)	O
and	O
non	O
-	O
solid	O
organ	B-ANAT
transplant	I-ANAT
(	O
non	O
-	O
SOT	B-ANAT
)	O
recipients	O
.	O

SOT	O
with	O
sepsis	O
as	O
a	O
group	O
has	O
a	O
higher	O
hospital	O
readmission	O
rate	O
compared	O
with	O
non	O
-	O
transplant	B-ANAT
sepsis	O
patients	O
.	O

RESULTS	O
:	O
Overall	O
,	O
there	O
were	O
18	O
632	O
admission	O
encounters	O
with	O
a	O
discharge	B-ANAT
diagnosis	O
of	O
sepsis	O
in	O
14	O
780	O
unique	O
patients	O
.	O

ABSTRACT	O
:	O
The	O
incidence	O
and	O
pathophysiology	O
of	O
right	O
ventricular	B-ANAT
failure	O
in	O
patients	O
with	O
severe	O
respiratory	O
insufficiency	O
has	O
been	O
largely	O
investigated	O
.	O

Systolic	O
and	O
diastolic	O
function	O
was	O
studied	O
assessing	O
,	O
respectively	O
:	O
right	O
ventricular	B-ANAT
systolic	O
longitudinal	O
function	O
(	O
tricuspid	O
annular	O
plane	O
systolic	O
excursion	O
)	O
and	O
systolic	O
contraction	O
duration	O
(	O
tricuspid	O
annular	O
plane	O
systolic	O
excursion	O
length	O
);	O
right	O
ventricular	B-ANAT
diastolic	O
filling	O
time	O
and	O
right	O
ventricular	B-ANAT
diastolic	O
restrictive	O
pattern	O
(	O
presence	O
of	O
pulmonary	B-ANAT
valve	I-ANAT
presystolic	O
ejection	O
wave	O
).	O

Sequence	O
analysis	O
revealed	O
that	O
the	O
virulent	O
strain	O
GDS04	O
had	O
four	O
,	O
one	O
,	O
six	O
and	O
eleven	O
amino	O
acid	O
differences	O
in	O
membrane	B-ANAT
,	O
nucleocapsid	B-ANAT
,	O
spike	O
and	O
ORF1ab	O
proteins	O
,	O
respectively	O
,	O
from	O
P100	O
.	O

A	O
41	O
-	O
year	O
-	O
old	O
man	O
presented	O
with	O
high	O
fever	O
,	O
general	O
malaise	O
,	O
myalgia	O
,	O
dyspnea	O
,	O
and	O
dark	O
-	O
colored	O
urine	B-ANAT
,	O
and	O
then	O
progressed	O
to	O
anuria	O
.	O

ABSTRACT	O
:	O
Calf	B-ANAT
diarrhea	O
caused	O
by	O
infectious	O
agents	O
is	O
associated	O
with	O
economic	O
losses	O
in	O
the	O
cattle	O
industry	O
.	O

It	O
leads	O
to	O
endotheliopathy	O
-	O
associated	O
vascular	B-ANAT
microthrombotic	O
disease	O
(	O
EA	O
-	O
VMTD	O
),	O
which	O
orchestrates	O
consumptive	O
thrombocytopenia	O
,	O
microangiopathic	O
hemolytic	O
anemia	O
,	O
and	O
MODS	O
.	O

A	O
reliable	O
serological	O
assay	O
for	O
evaluating	O
the	O
PEDV	O
-	O
specific	O
humoral	O
and	O
mucosal	B-ANAT
immune	O
response	O
is	O
important	O
for	O
disease	O
survey	O
,	O
monitoring	O
the	O
efficacy	O
of	O
immunization	O
,	O
and	O
designing	O
strategies	O
for	O
the	O
prevention	O
and	O
control	O
of	O
PED	O
.	O

When	O
compared	O
with	O
HBoV	O
detection	O
alone	O
,	O
the	O
co	O
-	O
detection	O
of	O
RSV	O
and	O
HBoV	O
was	O
associated	O
with	O
male	O
sex	O
(	O
P	O
=	O
0	O
.	O
013	O
),	O
younger	O
age	O
(	O
P	O
=	O
0	O
.	O
01	O
),	O
and	O
lower	O
blood	B-ANAT
neutrophil	B-ANAT
count	O
(	O
P	O
=	O
0	O
.	O
032	O
).	O

Vaccination	O
against	O
influenza	O
will	O
lead	O
to	O
lower	O
infection	O
rates	O
and	O
fewer	O
complications	O
,	O
even	O
if	O
the	O
vaccine	O
is	O
poorly	O
matched	O
to	O
circulating	O
viral	O
strains	O
,	O
with	O
maternal	O
vaccination	O
offering	O
infants	O
protection	O
via	O
antibody	O
transmission	O
through	O
the	O
placenta	B-ANAT
and	O
breast	B-ANAT
milk	I-ANAT
.	O

TITLE	O
:	O
Fluid	O
Overload	O
in	O
Special	O
Pediatric	O
Cohorts	O
With	O
Anomalous	O
Origin	O
of	O
the	O
Left	B-ANAT
Coronary	I-ANAT
Artery	I-ANAT
From	O
the	O
Pulmonary	B-ANAT
Artery	I-ANAT
Following	O
Surgical	O
Repair	O
.	O

Despite	O
vigorous	O
supportive	O
care	O
,	O
the	O
patient	O
died	O
following	O
3	O
days	O
of	O
respiratory	O
dependency	O
due	O
to	O
irreversible	O
anoxic	O
brain	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
While	O
respiratory	O
viral	O
infections	O
are	O
recognized	O
as	O
a	O
frequent	O
cause	O
of	O
illness	O
in	O
hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplantation	O
(	O
HSCT	O
)	O
recipients	O
,	O
HCoV	O
-	O
OC43	O
infections	O
have	O
rarely	O
been	O
investigated	O
as	O
healthcare	O
-	O
associated	O
infections	O
in	O
this	O
population	O
.	O

TITLE	O
:	O
Expression	O
and	O
role	O
of	O
HEPIS	O
in	O
breast	B-ANAT
cancer	O
.	O

ABSTRACT	O
:	O
Pulmonary	B-ANAT
endarterectomy	O
is	O
a	O
curative	O
procedure	O
for	O
chronic	O
thromboembolic	O
Pulmonary	B-ANAT
Hypertension	O
.	O

Mucosal	B-ANAT
swabs	O
from	O
503	O
bats	O
representing	O
17	O
species	O
were	O
sampled	O
from	O
2010	O
to	O
2014	O
and	O
screened	O
by	O
consensus	O
PCR	O
for	O
11	O
viral	O
families	O
.	O

General	O
management	O
includes	O
physical	O
examination	O
,	O
pulse	O
oximetry	O
and	O
arterial	B-ANAT
blood	I-ANAT
gases	O
.	O

TITLE	O
:	O
Patient	O
self	O
-	O
inflicted	O
lung	B-ANAT
injury	O
and	O
positive	O
end	O
-	O
expiratory	O
pressure	O
for	O
safe	O
spontaneous	O
breathing	O
.	O

The	O
effort	O
-	O
dependent	O
lung	B-ANAT
injury	O
has	O
been	O
termed	O
'	O
patient	O
self	O
-	O
inflicted	O
lung	B-ANAT
injury	O
(	O
P	O
-	O
SILI	O
)'	O
in	O
2017	O
.	O

ABSTRACT	O
:	O
The	O
use	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
in	O
awake	O
,	O
spontaneously	O
breathing	O
and	O
non	O
-	O
intubated	O
patients	O
(	O
awake	O
ECMO	O
)	O
may	O
be	O
a	O
novel	O
therapeutic	O
strategy	O
for	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
patients	O
.	O

In	O
the	O
kidney	B-ANAT
distal	O
tubular	O
segments	O
,	O
collecting	B-ANAT
ducts	I-ANAT
and	O
ureter	B-ANAT
were	O
positive	O
for	O
viral	O
antigen	O
.	O

Our	O
data	O
suggest	O
that	O
the	O
antibody	O
/	O
Fc	B-ANAT
-	I-ANAT
receptor	I-ANAT
complex	I-ANAT
functionally	O
mimics	O
viral	O
receptor	O
in	O
mediating	O
viral	O
entry	O
.	O

The	O
results	O
demonstrated	O
that	O
four	O
compounds	O
(	O
6g	O
,	O
6l	O
,	O
6y	O
and	O
8c	O
)	O
showed	O
robust	O
anti	O
-	O
influenza	O
potencies	O
against	O
H5N1	O
,	O
H5N2	O
and	O
H5N6	O
strains	O
in	O
both	O
enzymatic	O
assay	O
and	O
cellular	B-ANAT
assay	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
belongs	O
to	O
the	O
beta	O
coronavirus	O
subfamily	O
and	O
causes	O
severe	O
morbidity	O
and	O
mortality	O
in	O
humans	O
especially	O
when	O
infected	O
patients	O
have	O
underlying	O
diseases	O
such	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
COPD	O
).	O

The	O
tissue	B-ANAT
tropism	O
is	O
determined	O
by	O
spike	O
(	O
S	O
)	O
protein	O
,	O
although	O
the	O
molecular	O
bases	O
for	O
enteric	O
tropism	O
remain	O
to	O
be	O
fully	O
characterized	O
.	O

Moreover	O
,	O
an	O
engineered	O
virus	O
containing	O
U655	O
>	O
G	O
and	O
a	O
6	O
nt	O
insertion	O
at	O
position	O
1124	O
(	O
Y374	O
-	O
T375insND	O
in	O
S	O
protein	O
)	O
was	O
genetically	O
stable	O
after	O
passage	O
in	O
cell	B-ANAT
cultures	O
,	O
and	O
increased	O
virus	O
titers	O
in	O
gut	B-ANAT
by	O
1000	O
-	O
fold	O
.	O

Total	O
RNA	O
was	O
extracted	O
from	O
the	O
plasma	B-ANAT
,	O
plasma	B-ANAT
exosome	O
,	O
and	O
peripheral	B-ANAT
blood	I-ANAT
mononuclear	I-ANAT
cells	I-ANAT
(	O
PBMCs	O
)	O
from	O
65	O
ARDS	O
patients	O
and	O
36	O
healthy	O
controls	O
.	O

TITLE	O
:	O
Kounis	O
syndrome	O
uncovers	O
severe	O
coronary	B-ANAT
disease	O
:	O
an	O
unusual	O
case	O
of	O
acute	O
coronary	B-ANAT
syndrome	O
secondary	O
to	O
allergic	O
coronary	B-ANAT
vasospasm	O
.	O

A	O
coronary	B-ANAT
angiogram	O
then	O
revealed	O
triple	O
vessel	B-ANAT
disease	O
.	O

The	O
extent	O
of	O
MERS	O
-	O
CoV	O
in	O
nature	O
can	O
be	O
traced	O
to	O
its	O
adaptable	O
cell	B-ANAT
entry	O
steps	O
.	O

Following	O
receptor	O
interaction	O
,	O
the	O
virus	O
can	O
utilize	O
diverse	O
host	O
proteases	O
for	O
cleavage	O
activation	O
of	O
virus	O
-	O
host	B-ANAT
cell	I-ANAT
membrane	I-ANAT
fusion	O
and	O
subsequent	O
genome	O
delivery	O
.	O

Though	O
the	O
gold	O
standard	O
for	O
diagnosing	O
MERS	O
-	O
CoV	O
infection	O
in	O
humans	O
is	O
still	O
nucleic	B-ANAT
acid	O
amplification	O
test	O
(	O
NAAT	O
)	O
of	O
the	O
up	O
-	O
E	O
region	O
,	O
an	O
antigen	O
capture	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
could	O
also	O
be	O
of	O
use	O
for	O
early	O
diagnosis	O
in	O
less	O
developed	O
locations	O
.	O

MERS	O
-	O
CoV	O
infection	O
leads	O
to	O
a	O
variety	O
of	O
clinical	O
outcomes	O
in	O
humans	O
ranging	O
from	O
asymptomatic	O
and	O
mild	O
infection	O
to	O
severe	O
acute	O
lung	B-ANAT
injury	O
and	O
multi	O
-	O
organ	B-ANAT
failure	O
and	O
death	O
.	O

Myeloid	B-ANAT
cells	I-ANAT
such	O
as	O
neutrophils	B-ANAT
and	O
monocyte	B-ANAT
-	O
macrophages	B-ANAT
are	O
major	O
innate	O
leukocytes	B-ANAT
that	O
orchestrate	O
protective	O
immunity	O
to	O
viral	O
lung	B-ANAT
infections	O
.	O

TITLE	O
:	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
immediately	O
following	O
the	O
removal	O
of	O
an	O
aspirated	O
foreign	O
body	B-ANAT
.	O

Intracellular	B-ANAT
cholesterol	O
accumulation	O
was	O
reported	O
to	O
disrupt	O
late	B-ANAT
endosome	I-ANAT
function	O
.	O

The	O
late	B-ANAT
endosome	I-ANAT
trafficking	O
inhibitor	O
did	O
not	O
inhibit	O
type	O
II	O
FCoV	O
infection	O
,	O
but	O
it	O
inhibited	O
type	O
I	O
FCoV	O
infection	O
.	O

ABSTRACT	O
:	O
A	O
53	O
-	O
year	O
-	O
old	O
woman	O
was	O
admitted	O
to	O
a	O
tertiary	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
secondary	O
to	O
severe	O
community	O
-	O
acquired	O
pneumonia	O
that	O
necessitated	O
maximum	O
supportive	O
care	O
with	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

A	O
total	O
of	O
394	O
nasopharyngeal	B-ANAT
swabs	O
were	O
collected	O
prospectively	O
from	O
children	O
age	O
0	O
-	O
5	O
years	O
old	O
with	O
ARTIs	O
from	O
hospitals	O
in	O
Kuala	O
Lumpur	O
.	O

While	O
hepatic	B-ANAT
dysfunction	O
has	O
been	O
focused	O
on	O
the	O
later	O
stages	O
of	O
HCC	O
,	O
the	O
management	O
of	O
symptoms	O
in	O
PTTM	O
is	O
important	O
for	O
supportive	O
care	O
of	O
the	O
cases	O
.	O

PTTM	O
is	O
caused	O
by	O
tumor	O
thrombi	O
in	O
the	O
arteries	B-ANAT
and	O
thickening	O
of	O
the	O
pulmonary	B-ANAT
arterial	B-ANAT
endothelium	I-ANAT
leading	O
to	O
the	O
symptoms	O
of	O
dyspnea	O
in	O
terminal	O
staged	O
patients	O
.	O

CONCLUSIONS	O
:	O
PTTM	O
is	O
caused	O
by	O
tumor	O
thrombi	O
in	O
the	O
arteries	B-ANAT
and	O
thickening	O
of	O
the	O
pulmonary	B-ANAT
arterial	B-ANAT
endothelium	I-ANAT
leading	O
to	O
the	O
symptoms	O
of	O
dyspnea	O
in	O
terminal	O
staged	O
patients	O
.	O

In	O
this	O
work	O
,	O
we	O
aimed	O
to	O
target	O
the	O
liver	B-ANAT
macrophages	B-ANAT
with	O
lipid	O
polymer	O
hybrid	O
nanoparticles	O
(	O
LPH	O
),	O
combining	O
the	O
merit	O
of	O
polymeric	O
nanoparticles	O
and	O
lipid	O
vesicles	B-ANAT
.	O

In	O
mice	O
,	O
both	O
prophylactic	O
and	O
therapeutic	O
RDV	O
improve	O
pulmonary	B-ANAT
function	O
and	O
reduce	O
lung	B-ANAT
viral	O
loads	O
and	O
severe	O
lung	B-ANAT
pathology	O
.	O

Infection	O
by	O
the	O
four	O
pathogens	O
had	O
no	O
relationship	O
with	O
calf	B-ANAT
age	O
;	O
BoRVA	O
was	O
detected	O
only	O
in	O
calves	O
aged	O
<	O
30	O
days	O
,	O
but	O
this	O
finding	O
was	O
not	O
statistically	O
significant	O
.	O

Consequently	O
,	O
our	O
results	O
highlight	O
the	O
importance	O
of	O
rapid	O
diagnosis	O
against	O
these	O
viruses	O
in	O
calf	B-ANAT
diarrhea	O
.	O

ABSTRACT	O
:	O
Severe	O
leptospirosis	O
(	O
Weil	O
'	O
s	O
disease	O
)	O
can	O
give	O
rise	O
to	O
multiorgan	O
failure	O
such	O
as	O
acute	O
renal	B-ANAT
failure	O
,	O
liver	B-ANAT
dysfunction	O
,	O
coagulopathy	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
pulmonary	B-ANAT
haemorrhage	O
,	O
and	O
myocarditis	O
.	O

TITLE	O
:	O
Inactivation	O
of	O
three	O
emerging	O
viruses	O
-	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
,	O
Crimean	O
-	O
Congo	O
haemorrhagic	O
fever	O
virus	O
and	O
Nipah	O
virus	O
-	O
in	O
platelet	B-ANAT
concentrates	O
by	O
ultraviolet	O
C	O
light	O
and	O
in	O
plasma	B-ANAT
by	O
methylene	O
blue	O
plus	O
visible	O
light	O
.	O

In	O
this	O
study	O
,	O
the	O
ability	O
of	O
the	O
THERAFLEX	O
UV	O
-	O
Platelets	B-ANAT
and	O
THERAFLEX	O
MB	O
-	O
Plasma	B-ANAT
pathogen	O
inactivation	O
systems	O
to	O
inactivate	O
these	O
viruses	O
in	O
platelet	B-ANAT
concentrates	O
and	O
plasma	B-ANAT
,	O
respectively	O
,	O
was	O
investigated	O
.	O

Since	O
HEV	B-ANAT
has	O
a	O
polypurine	O
-	O
free	O
5	O
'-	O
UTR	O
that	O
folds	O
into	O
a	O
stable	O
hairpin	O
structure	O
,	O
we	O
hypothesized	O
that	O
RNA	O
clamping	O
by	O
Silvestrol	O
and	O
its	O
derivatives	O
may	O
also	O
occur	O
in	O
a	O
polypurine	O
-	O
independent	O
but	O
structure	O
-	O
dependent	O
manner	O
.	O

Treatment	O
for	O
structural	O
valve	B-ANAT
deterioration	O
(	O
SVD	O
)	O
included	O
surgical	O
explant	O
and	O
valve	B-ANAT
-	O
in	O
-	O
valve	B-ANAT
(	O
V	O
-	O
in	O
-	O
V	O
)	O
transcatheter	O
aortic	B-ANAT
valve	I-ANAT
implantation	O
(	O
TAVI	O
).	O

TITLE	O
:	O
Isolation	O
and	O
Identification	O
of	O
Porcine	O
Deltacoronavirus	O
and	O
Alteration	O
of	O
Immunoglobulin	O
Transport	O
Receptors	O
in	O
the	O
Intestinal	B-ANAT
Mucosa	I-ANAT
of	O
PDCoV	O
-	O
Infected	O
Piglets	O
.	O

The	O
challenged	O
mice	O
were	O
observed	O
for	O
14	O
consecutive	O
days	O
and	O
necropsied	O
on	O
days	O
3	O
,	O
5	O
,	O
7	O
,	O
and	O
9	O
to	O
analyze	O
viral	O
load	O
,	O
histopathology	O
,	O
viral	O
antigen	O
distribution	O
,	O
and	O
cytokines	O
in	O
tissues	B-ANAT
.	O

MERS	O
-	O
CoV	O
instillation	O
-	O
inoculated	O
mice	O
exhibited	O
clinical	O
signs	O
on	O
day	O
1	O
,	O
obvious	O
lung	B-ANAT
lesions	O
on	O
days	O
3	O
-	O
5	O
,	O
continuous	O
weight	O
loss	O
,	O
0	O
%	O
survival	O
by	O
day	O
5	O
,	O
and	O
high	O
viral	O
loads	O
in	O
the	O
lungs	B-ANAT
and	O
brain	B-ANAT
on	O
days	O
3	O
-	O
5	O
.	O

However	O
,	O
the	O
transgenic	O
mice	O
exposed	O
to	O
aerosol	O
MERS	O
-	O
CoV	O
developed	O
disease	O
and	O
lung	B-ANAT
pathology	O
progressions	O
that	O
more	O
closely	O
resembled	O
those	O
observed	O
in	O
humans	O
.	O

RESULTS	O
:	O
The	O
results	O
showed	O
that	O
the	O
number	O
of	O
patients	O
with	O
combined	O
symptoms	O
of	O
fever	O
/	O
sore	O
throat	B-ANAT
and	O
fever	O
/	O
cough	O
/	O
SOB	O
was	O
significantly	O
higher	O
in	O
confirmed	O
cases	O
than	O
in	O
non	O
-	O
confirmed	O
cases	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

The	O
primary	O
objective	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
presence	O
of	O
the	O
M1030L	O
or	O
S1032A	O
mutations	O
in	O
FeCV	O
derived	O
from	O
stool	B-ANAT
samples	O
from	O
a	O
selected	O
group	O
of	O
healthy	O
cats	O
from	O
households	O
and	O
shelters	O
and	O
determine	O
how	O
many	O
of	O
these	O
cats	O
excrete	O
FeCV	O
.	O

It	O
should	O
be	O
noted	O
that	O
,	O
as	O
the	O
pathological	O
tissue	B-ANAT
samples	O
were	O
opportunistically	O
obtained	O
and	O
not	O
specifically	O
obtained	O
for	O
PCR	O
testing	O
,	O
caution	O
is	O
warranted	O
in	O
interpreting	O
these	O
data	O
.	O

ABSTRACT	O
:	O
There	O
are	O
few	O
studies	O
on	O
the	O
safety	O
and	O
respiratory	O
consequences	O
of	O
the	O
use	O
of	O
a	O
skeletal	B-ANAT
traction	O
(	O
ST	O
)	O
device	O
in	O
the	O
management	O
of	O
femoral	B-ANAT
shaft	I-ANAT
fractures	O
with	O
damage	O
control	O
orthopaedics	O
(	O
DCO	O
)	O
strategy	O
,	O
particularly	O
in	O
cases	O
of	O
prolonged	O
use	O
.	O

Four	O
polymorphisms	O
(	O
K267E	O
,	O
K267N	O
,	O
A291P	O
and	O
Î346	O
-	O
348	O
)	O
strongly	O
reduced	O
binding	O
of	O
MERS	O
-	O
CoV	O
S	O
to	O
DPP4	O
and	O
S	O
protein	O
-	O
driven	O
host	B-ANAT
cell	I-ANAT
entry	O
,	O
as	O
determined	O
using	O
soluble	O
S	O
protein	O
and	O
S	O
protein	O
bearing	O
rhabdoviral	O
vectors	O
,	O
respectively	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
20	O
-	O
year	O
-	O
old	O
male	O
from	O
the	O
department	O
of	O
Amazonas	O
who	O
presented	O
with	O
nine	O
days	O
of	O
disease	O
characterized	O
by	O
multiorgan	O
failure	O
(	O
neurological	O
,	O
renal	B-ANAT
,	O
hepatic	B-ANAT
,	O
respiratory	O
,	O
and	O
hematological	O
involvement	O
).	O

When	O
transmitted	O
to	O
humans	O
,	O
they	O
cause	O
hemorrhagic	O
fever	O
with	O
renal	B-ANAT
syndrome	O
(	O
HFRS	O
)	O
in	O
Asia	O
and	O
Europe	O
and	O
hantavirus	O
(	O
cardio	O
)	O
pulmonary	B-ANAT
syndrome	O
(	O
HPS	O
)	O
in	O
the	O
Americas	O
.	O

For	O
the	O
11	O
sera	B-ANAT
from	O
hybrid	O
camels	O
in	O
Dubai	O
tested	O
with	O
the	O
S	O
-	O
ELISA	O
and	O
neutralization	O
antibody	O
test	O
,	O
6	O
(	O
55	O
%)	O
and	O
9	O
(	O
82	O
%),	O
respectively	O
,	O
were	O
positive	O
for	O
MERS	O
-	O
CoV	O
antibodies	O
.	O

Human	O
airway	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
were	O
used	O
to	O
isolate	O
a	O
novel	O
coronavirus	O
,	O
named	O
2019	O
-	O
nCoV	O
,	O
which	O
formed	O
a	O
clade	O
within	O
the	O
subgenus	O
sarbecovirus	O
,	O
Orthocoronavirinae	O
subfamily	O
.	O

TITLE	O
:	O
Gga	O
-	O
miR	O
-	O
30d	O
regulates	O
infectious	O
bronchitis	O
virus	O
infection	O
by	O
targeting	O
USP47	O
in	O
HD11	O
cells	B-ANAT
.	O

In	O
addition	O
,	O
G	O
-	O
2	O
also	O
consistently	O
had	O
markedly	O
higher	O
mean	O
serum	B-ANAT
concentrations	O
of	O
I	O
-	O
FAB	O
and	O
ACTG2	O
and	O
lower	O
mean	O
serum	B-ANAT
concentrations	O
of	O
CLDN	O
-	O
3	O
,	O
compared	O
with	O
the	O
control	O
group	O
.	O

In	O
addition	O
,	O
G	O
-	O
2	O
also	O
consistently	O
had	O
markedly	O
higher	O
mean	O
serum	B-ANAT
concentrations	O
of	O
I	O
-	O
FAB	O
and	O
ACTG2	O
and	O
lower	O
mean	O
serum	B-ANAT
concentrations	O
of	O
CLDN	O
-	O
3	O
,	O
compared	O
with	O
the	O
control	O
group	O
.	O

Endothelial	B-ANAT
progenitor	O
(	O
EPC	O
)	O
and	O
mesenchymal	B-ANAT
stem	I-ANAT
cells	I-ANAT
(	O
MSC	O
)	O
can	O
regenerate	O
damaged	O
endothelium	B-ANAT
and	O
thereby	O
improve	O
pulmonary	B-ANAT
endothelial	B-ANAT
dysfunction	O
.	O

During	O
ECMO	O
,	O
VEGF	O
and	O
Ang2	O
serum	B-ANAT
levels	O
remained	O
unchanged	O
compared	O
to	O
the	O
non	O
-	O
ECMO	O
group	O
(	O
p	O
=	O
0	O
.	O
16	O
),	O
but	O
Ang2	O
serum	B-ANAT
levels	O
in	O
non	O
-	O
survivors	O
of	O
ARDS	O
were	O
significantly	O
increased	O
by	O
100	O
%	O
(	O
p	O
=	O
0	O
.	O
02	O
)	O
compared	O
to	O
survivors	O
.	O

ECMO	O
support	O
in	O
ARDS	O
is	O
specifically	O
associated	O
with	O
an	O
increased	O
number	O
of	O
circulating	O
MSC	O
,	O
most	O
likely	O
due	O
to	O
enhanced	O
mobilization	O
,	O
but	O
not	O
with	O
a	O
higher	O
numbers	O
of	O
EPC	O
or	O
serum	B-ANAT
concentrations	O
of	O
VEGF	O
and	O
Ang2	O
.	O

During	O
ECMO	O
,	O
VEGF	O
and	O
Ang2	O
serum	B-ANAT
levels	O
remained	O
unchanged	O
compared	O
to	O
the	O
non	O
-	O
ECMO	O
group	O
(	O
p	O
=	O
0	O
.	O
16	O
),	O
but	O
Ang2	O
serum	B-ANAT
levels	O
in	O
non	O
-	O
survivors	O
of	O
ARDS	O
were	O
significantly	O
increased	O
by	O
100	O
%	O
(	O
p	O
=	O
0	O
.	O
02	O
)	O
compared	O
to	O
survivors	O
.	O

They	O
and	O
one	O
asymptomatic	O
child	O
(	O
aged	O
10	O
years	O
)	O
had	O
radiological	O
ground	O
-	O
glass	O
lung	B-ANAT
opacities	O
.	O

ABSTRACT	O
:	O
Reye	O
'	O
s	O
syndrome	O
(	O
RS	O
)	O
is	O
a	O
rare	O
but	O
severe	O
acute	O
life	O
-	O
threating	O
disease	O
characterized	O
by	O
encephalopathy	O
and	O
fatty	O
liver	B-ANAT
damage	O
.	O

The	O
phylogenetic	O
tree	O
showed	O
that	O
2019	O
-	O
nCoV	O
significantly	O
clustered	O
with	O
bat	O
SARS	O
-	O
like	O
coronavirus	O
sequence	O
isolated	O
in	O
2015	O
,	O
whereas	O
structural	O
analysis	O
revealed	O
mutation	O
in	O
Spike	O
Glycoprotein	O
and	O
nucleocapsid	B-ANAT
protein	O
.	O

Pseudotyped	O
virus	O
bearing	O
the	O
I507	O
L	O
mutation	O
in	O
RBD	O
showed	O
enhanced	O
entry	O
into	O
host	O
cells	B-ANAT
as	O
compared	O
to	O
the	O
prototype	O
virus	O
.	O

Abnormal	O
leukocyte	B-ANAT
count	O
,	O
culture	O
positivity	O
and	O
severe	O
acute	O
malnutrition	O
were	O
significantly	O
associated	O
with	O
progression	O
of	O
SIRS	O
patients	O
to	O
septic	O
shock	O
(	O
P	O
=	O
0	O
.	O
001	O
,	O
0	O
.	O
00001	O
and	O
0	O
.	O
002	O
,	O
respectively	O
).	O

The	O
predictors	O
of	O
progression	O
to	O
septic	O
shock	O
were	O
abnormal	O
leukocyte	B-ANAT
count	O
,	O
culture	O
positivity	O
,	O
and	O
severe	O
acute	O
malnutrition	O
.	O

In	O
the	O
last	O
decade	O
,	O
there	O
is	O
a	O
growing	O
body	B-ANAT
of	O
evidence	O
that	O
veno	O
-	O
venous	B-ANAT
ECMO	O
(	O
VV	O
-	O
ECMO	O
)	O
is	O
lifesaving	O
in	O
multiple	O
trauma	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
thanks	O
to	O
technical	O
improvements	O
in	O
ECMO	O
devices	O
.	O

Nucleic	B-ANAT
acids	O
of	O
the	O
BAL	O
were	O
extracted	O
and	O
subjected	O
to	O
next	O
-	O
generation	O
sequencing	O
.	O

Respiratory	B-ANAT
samples	I-ANAT
were	O
tested	O
for	O
respiratory	O
viruses	O
and	O
MERS	O
-	O
CoV	O
using	O
an	O
in	O
-	O
house	O
RT	O
-	O
PCR	O
assay	O
.	O

The	O
Clinical	O
utilisation	O
of	O
respiratory	O
elastance	O
(	O
CURE	O
)	O
trial	O
is	O
a	O
two	O
-	O
arm	B-ANAT
,	O
randomised	O
controlled	O
trial	O
(	O
RCT	O
)	O
investigating	O
the	O
performance	O
of	O
PEEP	O
selected	O
at	O
an	O
objective	O
,	O
model	O
-	O
based	O
minimal	O
respiratory	B-ANAT
system	I-ANAT
elastance	O
in	O
patients	O
with	O
ARDS	O
.	O

We	O
did	O
next	O
-	O
generation	O
sequencing	O
of	O
samples	O
from	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
and	O
cultured	O
isolates	O
from	O
nine	O
inpatients	O
,	O
eight	O
of	O
whom	O
had	O
visited	O
the	O
Huanan	O
seafood	O
market	O
in	O
Wuhan	O
.	O

Recombinant	O
IFN	O
-	O
Î±1	O
protein	O
was	O
produced	O
in	O
E	O
.	O
coli	O
and	O
purified	O
from	O
inclusion	B-ANAT
bodies	I-ANAT
.	O

Diffuse	O
alveolar	B-ANAT
hemorrhage	O
from	O
Goodpasture	O
'	O
s	O
Syndrome	O
has	O
manifested	O
following	O
inhalation	O
of	O
hydrocarbons	O
and	O
following	O
smoking	O
.	O

TITLE	O
:	O
Prone	O
positioning	O
monitored	O
by	O
electrical	O
impedance	O
tomography	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
on	O
veno	O
-	O
venous	B-ANAT
ECMO	O
.	O

The	O
impact	O
of	O
chronic	O
comorbidities	O
on	O
clinical	O
outcomes	O
,	O
in	O
particular	O
,	O
pulmonary	B-ANAT
disease	O
and	O
immunosuppression	O
,	O
were	O
analyzed	O
.	O

Notably	O
,	O
lung	B-ANAT
cavitation	O
,	O
discrete	O
pulmonary	B-ANAT
nodules	B-ANAT
,	O
pleural	O
effusions	O
,	O
and	O
lymphadenopathy	O
were	O
absent	O
.	O

Follow	O
-	O
up	O
imaging	O
in	O
a	O
subset	O
of	O
patients	O
during	O
the	O
study	O
time	O
window	O
often	O
demonstrated	O
mild	O
or	O
moderate	O
progression	O
of	O
disease	O
,	O
as	O
manifested	O
by	O
increasing	O
extent	O
and	O
density	O
of	O
lung	B-ANAT
opacities	O
.	O

Herein	O
in	O
the	O
present	O
study	O
,	O
we	O
investigated	O
effects	O
of	O
Nox2	O
,	O
the	O
catalytic	O
subunit	O
of	O
nicotinamide	O
adenine	O
dinucleotide	O
phosphate	O
(	O
NADPH	O
)	O
oxidase	O
type	O
2	O
,	O
on	O
LPS	O
-	O
induced	O
epithelium	B-ANAT
injury	O
in	O
ARDS	O
mice	O
and	O
in	O
human	O
alveolar	B-ANAT
epithelial	O
A549	O
cells	B-ANAT
.	O

These	O
data	O
demonstrate	O
that	O
Nox2	O
/	O
ROS	O
/	O
ZO	O
-	O
1	O
axis	B-ANAT
is	O
of	O
great	O
importance	O
in	O
AECs	O
damage	O
induced	O
by	O
LPS	O
,	O
and	O
the	O
utilization	O
of	O
VAS2870	O
to	O
inhibit	O
this	O
pathway	O
might	O
lighten	O
LPS	O
-	O
induced	O
ARDS	O
.	O

ABSTRACT	O
:	O
Protective	O
ventilation	O
is	O
the	O
cornerstone	O
of	O
treatment	O
of	O
patients	O
with	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
);	O
however	O
,	O
no	O
studies	O
have	O
yet	O
established	O
the	O
best	O
ventilatory	O
strategy	O
to	O
adopt	O
when	O
patients	O
with	O
acute	O
exacerbation	O
of	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
(	O
AE	O
-	O
ILD	O
)	O
are	O
admitted	O
to	O
the	O
intensive	O
care	O
unit	O
.	O

The	O
purpose	O
of	O
this	O
review	O
is	O
to	O
analyze	O
the	O
effects	O
of	O
mechanical	O
ventilation	O
in	O
AE	O
-	O
ILD	O
and	O
to	O
increase	O
the	O
knowledge	O
on	O
the	O
characteristics	O
of	O
fibrotic	O
lung	B-ANAT
during	O
artificial	O
ventilation	O
,	O
introducing	O
the	O
concept	O
of	O
""""	O
squishy	O
ball	O
lung	B-ANAT
"""."	O

The	O
entire	O
viral	B-ANAT
genome	I-ANAT
is	O
29	O
,	O
881	O
nt	O
in	O
length	O
(	O
GenBank	O
MN988668	O
and	O
MN988669	O
,	O
Sequence	O
Read	O
Archive	O
database	O
Bioproject	O
accession	O
PRJNA601736	O
)	O
and	O
is	O
classified	O
into	O
Î²	O
-	O
coronavirus	O
genus	O
.	O

The	O
clinical	O
features	O
include	O
fever	O
,	O
coughing	O
,	O
shortness	O
of	O
breath	B-ANAT
,	O
and	O
inflammatory	O
pulmonary	B-ANAT
infiltration	O
revealed	O
by	O
X	O
ray	O
.	O

MicroRNAs	O
(	O
miRNAs	O
)	O
have	O
emerged	O
as	O
a	O
class	O
of	O
crucial	O
regulators	O
of	O
numerous	O
cellular	B-ANAT
processes	O
,	O
including	O
responses	O
to	O
viral	O
infections	O
.	O

This	O
is	O
the	O
first	O
study	O
that	O
describes	O
the	O
modulation	O
of	O
miRNAs	O
and	O
the	O
related	O
host	O
immune	O
factors	O
by	O
IBV	O
in	O
chicken	O
embryos	B-ANAT
.	O

There	O
were	O
more	O
consolidated	O
lung	B-ANAT
lesions	O
in	O
patients	O
5	O
days	O
or	O
more	O
from	O
disease	O
onset	O
to	O
CT	O
scan	O
versus	O
4	O
days	O
or	O
fewer	O
(	O
431	O
of	O
712	O
lesions	O
vs	O
129	O
of	O
612	O
lesions	O
;	O

We	O
developed	O
two	O
1	O
-	O
step	O
quantitative	O
real	O
-	O
time	O
reverse	O
-	O
transcription	O
PCR	O
assays	O
to	O
detect	O
two	O
different	O
regions	O
(	O
ORF1b	O
and	O
N	O
)	O
of	O
the	O
viral	B-ANAT
genome	I-ANAT
.	O

The	O
third	O
case	O
,	O
a	O
21	O
-	O
month	O
-	O
old	O
boy	O
,	O
presented	O
with	O
decreased	O
level	O
of	O
consciousness	O
and	O
was	O
diagnosed	O
with	O
acute	O
necrotizing	O
encephalopathy	O
with	O
the	O
aid	O
of	O
cranial	B-ANAT
magnetic	O
resonance	O
imagining	O
(	O
MRI	O
).	O

In	O
this	O
study	O
,	O
we	O
determined	O
whether	O
symptomatic	O
respiratory	O
viral	O
infections	O
after	O
lung	B-ANAT
transplantation	O
induce	O
circulating	O
exosomes	O
that	O
contain	O
lung	B-ANAT
-	O
associated	O
self	O
-	O
antigens	O
and	O
assessed	O
whether	O
these	O
exosomes	O
activate	O
immune	O
responses	O
to	O
self	O
-	O
antigens	O
.	O

ABSTRACT	O
:	O
Currently	O
,	O
the	O
emergence	O
of	O
a	O
novel	O
human	O
coronavirus	O
,	O
SARS	O
-	O
CoV	O
-	O
2	O
,	O
has	O
become	O
a	O
global	O
health	O
concern	O
causing	O
severe	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
in	O
humans	O
.	O

The	O
3mG	O
had	O
comparatively	O
greater	O
potency	O
than	O
GRFT	O
against	O
NiV	O
due	O
to	O
its	O
enhanced	O
ability	O
to	O
block	O
NiV	O
glycoprotein	O
-	O
induced	O
syncytia	B-ANAT
formation	O
.	O

Two	O
recombinant	O
IBVs	O
(	O
rIBVs	O
)	O
harboring	O
EIC	O
-	O
inactivating	O
mutations	O
-	O
rT16A	O
and	O
rA26F	O
-	O
were	O
serially	O
passaged	O
,	O
and	O
several	O
compensatory	O
mutations	O
were	O
identified	O
in	O
the	O
transmembrane	B-ANAT
domain	O
(	O
TMD	O
).	O

When	O
these	O
complications	O
are	O
severe	O
,	O
admission	O
to	O
the	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
is	O
often	O
required	O
for	O
organ	B-ANAT
support	O
and	O
management	O
.	O

ABSTRACT	O
:	O
Alveolar	B-ANAT
flooding	O
and	O
airway	B-ANAT
obstruction	O
are	O
present	O
in	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

TITLE	O
:	O
Chest	B-ANAT
CT	O
for	O
Typical	O
2019	O
-	O
nCoV	O
Pneumonia	O
:	O
Relationship	O
to	O
Negative	O
RT	O
-	O
PCR	O
Testing	O
.	O

ABSTRACT	O
:	O
Severe	O
blunt	O
chest	B-ANAT
injury	O
sometimes	O
induces	O
acute	O
respiratory	O
failure	O
(	O
ARF	O
),	O
requiring	O
ventilator	O
use	O
.	O

Repeat	O
Chest	B-ANAT
CT	O
was	O
obtained	O
at	O
approximately	O
4	O
day	O
intervals	O
.	O

Here	O
,	O
we	O
report	O
two	O
confirmed	O
cases	O
of	O
2019	O
-	O
nCoV	O
pneumonia	O
with	O
chest	B-ANAT
computed	O
tomography	O
findings	O
of	O
multiple	O
regions	O
of	O
patchy	O
consolidation	O
and	O
ground	O
-	O
glass	O
opacities	O
in	O
both	O
lungs	B-ANAT
.	O

These	O
findings	O
were	O
characteristically	O
located	O
along	O
the	O
bronchial	B-ANAT
bundle	O
or	O
subpleural	O
lungs	B-ANAT
.	O

ABSTRACT	O
:	O
Human	O
BK	O
virus	O
(	O
BKV	O
)	O
infection	O
is	O
known	O
to	O
occur	O
mostly	O
during	O
childhood	O
with	O
the	O
establishment	O
of	O
latent	O
infection	O
with	O
no	O
tissue	B-ANAT
damage	O
or	O
clinical	O
manifestations	O
.	O

After	O
multiple	O
antibiotic	O
courses	O
,	O
he	O
developed	O
acute	O
kidney	B-ANAT
injury	O
,	O
a	O
hemophagocytic	O
syndrome	O
,	O
and	O
eventually	O
respiratory	O
failure	O
,	O
which	O
led	O
to	O
his	O
death	O
a	O
year	O
later	O
.	O

The	O
present	O
case	O
suggests	O
that	O
BKV	O
can	O
damage	O
more	O
tissues	B-ANAT
than	O
previously	O
reported	O
and	O
may	O
be	O
responsible	O
for	O
systemic	O
infections	O
in	O
immunosuppressed	O
patients	O
.	O

TITLE	O
:	O
Comprehensive	O
Genomic	O
Characterization	O
Analysis	O
of	O
lncRNAs	O
in	O
Cells	B-ANAT
With	O
Porcine	O
Delta	O
Coronavirus	O
Infection	O
.	O

Samples	O
without	O
NT	O
particles	O
had	O
undetectable	O
capsid	B-ANAT
protein	O
levels	O
.	O

TITLE	O
:	O
The	O
Effects	O
of	O
Social	O
Media	B-ANAT
Use	O
on	O
Preventive	O
Behaviors	O
during	O
Infectious	O
Disease	O
Outbreaks	O
:	O
The	O
Mediating	O
Role	O
of	O
Self	O
-	O
relevant	O
Emotions	O
and	O
Public	O
Risk	O
Perception	O
.	O

ABSTRACT	O
:	O
While	O
there	O
has	O
been	O
increasing	O
attention	O
to	O
the	O
role	O
of	O
social	O
media	B-ANAT
during	O
infectious	O
disease	O
outbreaks	O
,	O
relatively	O
little	O
is	O
known	O
about	O
the	O
underlying	O
mechanisms	O
by	O
which	O
social	O
media	B-ANAT
use	O
affects	O
risk	O
perception	O
and	O
preventive	O
behaviors	O
during	O
such	O
outbreaks	O
.	O

It	O
was	O
believed	O
that	O
2019	O
-	O
nCoV	O
was	O
transmitted	O
through	O
respiratory	B-ANAT
tract	I-ANAT
and	O
then	O
induced	O
pneumonia	O
,	O
thus	O
molecular	O
diagnosis	O
based	O
on	O
oral	B-ANAT
swabs	O
was	O
used	O
for	O
confirmation	O
of	O
this	O
disease	O
.	O

Whether	O
2019	O
-	O
nCoV	O
infected	O
patients	O
also	O
carry	O
virus	O
in	O
other	O
organs	B-ANAT
like	O
intestine	B-ANAT
need	O
to	O
be	O
tested	O
.	O

The	O
radiological	O
and	O
partial	O
pressure	O
of	O
oxygen	O
,	O
arterial	B-ANAT
(	O
Pao2	O
)/	O
fraction	O
of	O
inspired	O
oxygen	O
(	O
Fio2	O
)	O
criteria	O
for	O
ARDS	O
had	O
to	O
be	O
met	O
within	O
a	O
24	O
-	O
hour	O
period	O
,	O
and	O
the	O
administration	O
of	O
the	O
first	O
dose	O
of	O
the	O
study	O
drug	O
had	O
to	O
occur	O
within	O
48	O
hours	O
of	O
the	O
diagnosis	O
of	O
ARDS	O
.	O

Under	O
such	O
a	O
special	O
circumstance	O
,	O
how	O
to	O
deal	O
with	O
such	O
patients	O
with	O
acute	O
aortic	B-ANAT
syndrome	O
has	O
become	O
a	O
serious	O
challenge	O
.	O

ABSTRACT	O
:	O
The	O
indications	O
for	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
are	O
expanding	O
.	O

We	O
further	O
showed	O
that	O
the	O
molecular	O
chaperone	O
heat	O
shock	O
protein	O
90	O
(	O
Hsp90	O
)/	O
p23	O
,	O
as	O
a	O
novel	O
RIPK3	O
-	O
and	O
MLKL	O
-	O
interacting	O
complex	O
,	O
played	O
an	O
important	O
role	O
in	O
RIP	O
-	O
MLKL	O
-	O
mediated	O
necroptosis	O
,	O
inflammation	O
and	O
endothelial	B-ANAT
dysfunction	O
in	O
the	O
pulmonary	B-ANAT
vasculature	I-ANAT
,	O
which	O
resulted	O
in	O
ARDS	O
.	O

Furthermore	O
,	O
these	O
nutrients	O
may	O
promote	O
the	O
immunological	O
defense	O
of	O
humans	O
against	O
infections	O
by	O
bacteria	O
,	O
fungi	O
,	O
parasites	O
,	O
and	O
viruses	O
(	O
including	O
coronavirus	O
)	O
through	O
enhancing	O
the	O
metabolism	O
and	O
functions	O
of	O
monocytes	B-ANAT
,	O
macrophages	B-ANAT
,	O
and	O
other	O
cells	B-ANAT
of	O
the	O
immune	B-ANAT
system	I-ANAT
.	O

Sera	B-ANAT
were	O
obtained	O
near	O
the	O
onset	O
of	O
RI	O
and	O
3	O
to	O
4	O
weeks	O
later	O
as	O
part	O
of	O
a	O
prospective	O
study	O
of	O
200	O
subjects	O
evaluated	O
for	O
RI	O
from	O
2009	O
to	O
2013	O
.	O

Neoadjuvant	O
therapy	O
is	O
highly	O
recommended	O
for	O
gastrointestinal	O
cancer	O
at	O
advanced	O
stages	O
that	O
meet	O
the	O
indications	O
of	O
NCCN	O
guideline	O
(	O
gastric	B-ANAT
cancer	O
T	O
stage	O
â¥	O
2	O
/	O
rectal	O
cancer	O
T	O
stage	O
â¥	O
3	O
/	O
unresectable	O
colon	B-ANAT
cancer	O
).	O

The	O
most	O
common	O
symptoms	O
at	O
onset	O
of	O
illness	O
were	O
fever	O
in	O
48	O
(	O
77	O
%)	O
patients	O
,	O
cough	O
in	O
50	O
(	O
81	O
%),	O
expectoration	B-ANAT
in	O
35	O
(	O
56	O
%),	O
headache	O
in	O
21	O
(	O
34	O
%),	O
myalgia	O
or	O
fatigue	O
in	O
32	O
(	O
52	O
%),	O
diarrhoea	O
in	O
3	O
(	O
8	O
%),	O
and	O
haemoptysis	O
in	O
2	O
(	O
3	O
%).	O

For	O
patients	O
with	O
lung	B-ANAT
occupying	O
lesions	O
,	O
the	O
whole	O
process	O
of	O
diagnosis	O
and	O
treatment	O
can	O
not	O
be	O
carried	O
out	O
as	O
usual	O
due	O
to	O
the	O
epidemic	O
.	O

Lung	B-ANAT
cancer	O
patients	O
should	O
be	O
the	O
priority	O
group	O
for	O
COVID	O
-	O
19	O
prevention	O
.	O

This	O
paper	O
summarizes	O
the	O
development	O
causes	O
,	O
common	O
locations	O
,	O
and	O
prevention	O
ways	O
about	O
the	O
device	O
related	O
pressure	O
injuries	O
on	O
the	O
face	B-ANAT
resulted	O
from	O
wearing	O
medical	O
-	O
grade	O
protective	O
equipment	O
for	O
a	O
long	O
working	O
time	O
.	O

Meantime	O
,	O
a	O
corresponding	O
nursing	O
strategy	O
is	O
also	O
suggested	O
to	O
deal	O
with	O
the	O
correlative	O
skin	B-ANAT
diseases	O
during	O
the	O
application	O
of	O
medical	O
-	O
grade	O
protective	O
equipment	O
.	O

These	O
paper	O
aims	O
to	O
provide	O
reference	O
for	O
the	O
prevention	O
of	O
device	O
related	O
pressure	O
injuries	O
and	O
the	O
care	O
of	O
skin	B-ANAT
-	O
related	O
diseases	O
for	O
clinical	O
working	O
staff	O
,	O
especially	O
to	O
the	O
respectable	O
personnel	O
in	O
front	O
line	O
of	O
fighting	O
against	O
Corona	O
virus	O
disease	O
2019	O
.	O

Bilateral	O
lung	B-ANAT
involvement	O
was	O
observed	O
in	O
10	O
/	O
36	O
early	O
patients	O
(	O
28	O
%),	O
25	O
/	O
33	O
intermediate	O
patients	O
(	O
76	O
%),	O
and	O
22	O
/	O
25	O
late	O
patients	O
(	O
88	O
%).	O

In	O
this	O
process	O
,	O
POCUS	O
is	O
a	O
reliable	O
diagnostic	O
tool	O
to	O
identify	O
the	O
cause	O
of	O
acute	O
pulmonary	B-ANAT
edema	O
and	O
can	O
increase	O
the	O
accuracy	O
of	O
clinical	O
evaluations	O
.	O

CONCLUSIONS	O
:	O
We	O
report	O
the	O
first	O
case	O
of	O
pulmonary	B-ANAT
edema	O
following	O
diuretic	O
therapy	O
to	O
stress	O
the	O
need	O
of	O
physicians	O
to	O
follow	O
guidelines	O
of	O
clinical	O
practice	O
.	O

All	O
disposable	O
medical	O
items	O
,	O
body	B-ANAT
fluids	I-ANAT
and	O
feces	B-ANAT
of	O
the	O
patients	O
in	O
perioperative	O
periods	O
must	O
be	O
unified	O
disposed	O
according	O
to	O
the	O
medical	B-ANAT
waste	I-ANAT
standard	O
.	O

Lactogenic	O
immunity	O
induced	O
via	O
the	O
gut	B-ANAT
-	O
mammary	B-ANAT
gland	I-ANAT
-	O
secretory	O
IgA	O
(	O
sIgA	O
)	O
axis	B-ANAT
,	O
remains	O
the	O
most	O
promising	O
and	O
effective	O
way	O
to	O
protect	O
suckling	O
piglets	O
from	O
PEDV	O
.	O

Through	O
literature	O
review	O
,	O
this	O
paper	O
reviewed	O
the	O
oral	B-ANAT
psychosomatic	O
diseases	O
closely	O
related	O
to	O
patients	O
'	O
psychological	O
state	O
,	O
such	O
as	O
oral	B-ANAT
mucosal	I-ANAT
disease	O
,	O
temporomandibular	B-ANAT
joint	I-ANAT
disease	O
,	O
bruxism	O
,	O
periodontal	O
disease	O
and	O
so	O
on	O
.	O

At	O
the	O
same	O
time	O
,	O
this	O
paper	O
analyzes	O
the	O
possible	O
psychological	O
stress	O
symptoms	O
of	O
patients	O
with	O
different	O
oral	B-ANAT
diseases	O
,	O
and	O
puts	O
forward	O
suggestions	O
for	O
remote	O
consultation	O
and	O
emergency	O
treatment	O
of	O
dentists	O
.	O

ABSTRACT	O
:	O
Statistics	O
show	O
that	O
76	O
.	O
74	O
%	O
(	O
4	O
688	O
)	O
of	O
6	O
109	O
patients	O
with	O
chronic	O
wounds	O
are	O
those	O
over	O
50	O
years	O
of	O
age	O
;	O
the	O
proportion	O
of	O
patients	O
with	O
underlying	O
diseases	O
in	O
all	O
age	O
groups	O
above	O
50	O
years	O
ranges	O
from	O
78	O
.	O
25	O
%	O
to	O
100	O
.	O
00	O
%;	O
among	O
the	O
underlying	O
diseases	O
of	O
chronic	O
wound	O
patients	O
,	O
the	O
top	O
four	O
diseases	O
are	O
diabetes	O
mellitus	O
,	O
cardiovascular	B-ANAT
and	O
cerebrovascular	O
diseases	O
,	O
hypertension	O
,	O
and	O
respiratory	O
diseases	O
.	O

These	O
two	O
mechanisms	O
,	O
which	O
are	O
often	O
connected	O
,	O
involve	O
pulmonary	B-ANAT
hypertension	O
as	O
the	O
origin	O
of	O
a	O
systolic	O
and	O
diastolic	O
overload	O
of	O
the	O
right	B-ANAT
ventricle	I-ANAT
,	O
which	O
then	O
leads	O
to	O
the	O
alterations	O
of	O
its	O
structure	O
and	O
performance	O
.	O

Despite	O
early	O
recognition	O
of	O
chemotherapy	O
-	O
induced	O
lung	B-ANAT
injury	O
and	O
early	O
administration	O
of	O
corticosteroid	O
,	O
she	O
developed	O
noncardiogenic	O
pulmonary	B-ANAT
edema	O
,	O
diffuse	O
alveolar	B-ANAT
hemorrhage	O
,	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

We	O
also	O
demonstrated	O
that	O
trypsin	O
promotes	O
PDCoV	O
replication	O
by	O
enhancing	O
cell	B-ANAT
-	O
to	O
-	O
cell	B-ANAT
membrane	I-ANAT
fusion	O
.	O

The	O
average	O
pulmonary	B-ANAT
inflammation	O
index	O
(	O
PII	O
)	O
value	O
was	O
(	O
34	O
%Â±	O
20	O
%)	O
for	O
all	O
the	O
patients	O
.	O

TITLE	O
:	O
Sepsis	O
Management	O
in	O
Resource	O
-	O
limited	O
Settings	O
ABSTRACT	O
:	O
In	O
this	O
chapter	O
we	O
discuss	O
recommendations	O
on	O
the	O
identification	O
of	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
indications	O
for	O
mechanical	O
ventilation	O
,	O
and	O
strategies	O
for	O
lung	B-ANAT
-	O
protective	O
ventilation	O
in	O
resource	O
-	O
limited	O
settings	O
.	O

A	O
variety	O
of	O
chest	B-ANAT
imaging	O
features	O
have	O
been	O
reported	O
,	O
similar	O
to	O
those	O
found	O
in	O
other	O
types	O
of	O
coronavirus	O
syndromes	O
.	O

Long	O
-	O
acting	O
muscarinic	O
antagonists	O
and	O
Î²	O
Primary	O
human	O
nasal	B-ANAT
(	O
HNE	O
)	O
and	O
tracheal	O
(	O
HTE	O
)	O
epithelial	B-ANAT
cell	I-ANAT
cultures	O
were	O
infected	O
with	O
HCoV	O
-	O
229E	O
.	O

Pretreatment	O
of	O
HNE	O
cells	B-ANAT
with	O
glycopyrronium	O
or	O
formoterol	O
reduced	O
the	O
susceptibility	O
to	O
infection	O
,	O
and	O
pretreatment	O
with	O
the	O
three	O
drugs	O
inhibited	O
activation	O
of	O
nuclear	O
factor	O
-	O
kappa	O
B	O
p50	O
and	O
p65	O
proteins	O
.	O

Interestingly	O
,	O
this	O
receptor	O
was	O
highly	O
enriched	O
in	O
epithelial	B-ANAT
cells	I-ANAT
of	O
tongue	B-ANAT
.	O

TITLE	O
:	O
[	O
Dynamic	O
changes	O
of	O
chest	B-ANAT
CT	O
imaging	O
in	O
patients	O
with	O
corona	O
virus	O
disease	O
-	O
19	O
(	O
COVID	O
-	O
19	O
)].	O

The	O
importance	O
of	O
early	O
viralogical	O
detection	O
,	O
dynamic	O
monitoring	O
of	O
inflammatory	O
indexes	O
and	O
chest	B-ANAT
radiograph	O
was	O
emphasized	O
in	O
clinical	O
decision	O
-	O
making	O
.	O

Besides	O
,	O
we	O
should	O
select	O
the	O
appropriate	O
therapy	O
and	O
optimize	O
treatment	O
process	O
so	O
as	O
to	O
prevent	O
the	O
propagation	O
and	O
cross	O
infection	O
of	O
COVID	O
-	O
19	O
as	O
well	O
as	O
manage	O
the	O
breast	B-ANAT
diseases	O
without	O
delay	O
.	O

TITLE	O
:	O
[	O
Surgical	O
treatment	O
strategy	O
for	O
digestive	B-ANAT
system	I-ANAT
malignancies	O
during	O
the	O
outbreak	O
of	O
novel	O
coronavirus	O
pneumonia	O
].	O

AVNP2	O
also	O
alleviated	O
the	O
decline	O
of	O
long	O
-	O
term	O
potentiation	O
(	O
LTP	O
)	O
and	O
the	O
decreased	O
density	O
of	O
dendritic	B-ANAT
spines	I-ANAT
in	O
the	O
CA1	B-ANAT
region	O
induced	O
by	O
C6	O
.	O

ABSTRACT	O
:	O
This	O
study	O
presents	O
a	O
preliminary	O
report	O
on	O
the	O
chest	B-ANAT
radiographic	O
and	O
computed	O
tomography	O
(	O
CT	O
)	O
findings	O
of	O
the	O
2019	O
novel	O
coronavirus	O
disease	O
(	O
COVID	O
-	O
19	O
)	O
pneumonia	O
in	O
Korea	O
.	O

As	O
part	O
of	O
a	O
multi	O
-	O
institutional	O
collaboration	O
coordinated	O
by	O
the	O
Korean	O
Society	O
of	O
Thoracic	B-ANAT
Radiology	O
,	O
we	O
collected	O
nine	O
patients	O
with	O
COVID	O
-	O
19	O
infections	O
who	O
had	O
undergone	O
chest	B-ANAT
radiography	O
and	O
CT	O
scans	O
.	O

Chest	B-ANAT
CT	O
images	O
showed	O
bilateral	O
involvement	O
in	O
eight	O
of	O
the	O
nine	O
patients	O
,	O
and	O
a	O
unilobar	O
reversed	O
halo	O
sign	O
in	O
the	O
other	O
patient	O
.	O

Patchy	O
to	O
confluent	O
lesions	O
were	O
primarily	O
distributed	O
in	O
the	O
lower	O
lobes	B-ANAT
(	O
COVID	O
-	O
19	O
pneumonia	O
in	O
Korea	O
primarily	O
manifested	O
as	O
pure	O
to	O
mixed	O
ground	O
-	O
glass	O
opacities	O
with	O
a	O
patchy	O
to	O
confluent	O
or	O
nodular	O
shape	O
in	O
the	O
bilateral	O
peripheral	O
posterior	O
lungs	B-ANAT
.	O

In	O
this	O
study	O
,	O
we	O
present	O
serial	O
CT	O
findings	O
in	O
a	O
40	O
-	O
year	O
-	O
old	O
female	O
patient	O
with	O
COVID	O
-	O
19	O
pneumonia	O
who	O
presented	O
with	O
the	O
symptoms	O
of	O
fever	O
,	O
chest	B-ANAT
tightness	O
,	O
and	O
fatigue	O
.	O

TITLE	O
:	O
Evaluation	O
of	O
coronavirus	O
in	O
tears	B-ANAT
and	O
conjunctival	O
secretions	B-ANAT
of	O
patients	O
with	O
SARS	O
-	O
CoV	O
-	O
2	O
infection	O
.	O

In	O
order	O
to	O
prevent	O
cluster	O
outbreaks	O
,	O
the	O
government	O
strengthened	O
the	O
management	O
and	O
control	O
of	O
personnel	O
mobility	O
,	O
which	O
had	O
a	O
great	O
impact	O
on	O
the	O
examination	O
and	O
treatment	O
of	O
breast	B-ANAT
cancer	O
patients	O
.	O

Methods	O
From	O
January	O
6	O
to	O
February	O
6	O
,	O
2020	O
,	O
1014	O
patients	O
in	O
Wuhan	O
,	O
China	O
who	O
underwent	O
both	O
chest	B-ANAT
CT	O
and	O
RT	O
-	O
PCR	O
tests	O
were	O
included	O
.	O

Chest	B-ANAT
CT	O
may	O
be	O
considered	O
as	O
a	O
primary	O
tool	O
for	O
the	O
current	O
COVID	O
-	O
19	O
detection	O
in	O
epidemic	O
areas	O
.	O

We	O
evaluated	O
ARDS	O
incidence	O
,	O
and	O
determined	O
ARDS	O
severity	O
from	O
arterial	B-ANAT
blood	I-ANAT
gas	O
analysis	O
.	O

Among	O
severe	O
trauma	O
patients	O
,	O
median	O
ISS	O
was	O
34	O
,	O
and	O
AIS	O
thorax	B-ANAT
was	O
3	O
.	O

Furthermore	O
,	O
some	O
coronaviruses	O
have	O
been	O
demonstrated	O
able	O
to	O
spread	O
via	O
a	O
synapse	B-ANAT
-	O
connected	O
route	O
to	O
the	O
medullary	B-ANAT
cardiorespiratory	O
center	O
from	O
the	O
mechanoreceptors	B-ANAT
and	O
chemoreceptors	B-ANAT
in	O
the	O
lung	B-ANAT
and	O
lower	O
respiratory	O
airways	O
.	O

TITLE	O
:	O
Structure	O
-	O
Based	O
Stabilization	O
of	O
Non	O
-	O
native	O
Protein	O
-	O
Protein	O
Interactions	O
of	O
Coronavirus	O
Nucleocapsid	B-ANAT
Proteins	O
in	O
Antiviral	O
Drug	O
Design	O
.	O

Patients	O
with	O
COVID	O
-	O
19	O
pneumonia	O
(	O
confirmed	O
by	O
next	O
-	O
generation	O
sequencing	O
or	O
RT	O
-	O
PCR	O
)	O
who	O
were	O
admitted	O
to	O
one	O
of	O
two	O
hospitals	O
in	O
Wuhan	O
and	O
who	O
underwent	O
serial	O
chest	B-ANAT
CT	O
scans	O
were	O
retrospectively	O
enrolled	O
.	O

The	O
predominant	O
pattern	O
of	O
abnormality	O
observed	O
was	O
bilateral	O
(	O
64	O
[	O
79	O
%]	O
patients	O
),	O
peripheral	O
(	O
44	O
[	O
54	O
%]),	O
ill	O
-	O
defined	O
(	O
66	O
[	O
81	O
%]),	O
and	O
ground	O
-	O
glass	O
opacification	O
(	O
53	O
[	O
65	O
%]),	O
mainly	O
involving	O
the	O
right	O
lower	O
lobes	B-ANAT
(	O
225	O
[	O
27	O
%]	O
of	O
849	O
affected	O
segments	O
).	O

In	O
this	O
review	O
,	O
we	O
detail	O
current	O
evidence	O
and	O
understanding	O
of	O
the	O
transmission	O
of	O
SARS	O
-	O
CoV	O
,	O
MERS	O
-	O
CoV	O
,	O
and	O
SARS	O
-	O
CoV	O
-	O
2	O
through	O
blood	B-ANAT
products	O
as	O
of	O
February	O
10	O
,	O
2020	O
,	O
and	O
also	O
discuss	O
pathogen	O
inactivation	O
methods	O
on	O
coronaviruses	O
.	O

All	O
the	O
included	O
SARS	O
-	O
CoV	O
-	O
2	O
-	O
infected	O
patients	O
underwent	O
non	O
-	O
contrast	O
enhanced	O
chest	B-ANAT
computed	O
tomography	O
(	O
CT	O
).	O

The	O
incidence	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
was	O
0	O
.	O
148	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
046	O
,	O
0	O
.	O
296	O
),	O
the	O
incidence	O
of	O
abnormal	O
chest	B-ANAT
computer	O
tomography	O
(	O
CT	O
)	O
was	O
0	O
.	O
966	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
921	O
,	O
0	O
.	O
993	O
),	O
the	O
percentage	O
of	O
severe	O
cases	O
in	O
all	O
infected	O
cases	O
was	O
0	O
.	O
181	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
127	O
,	O
0	O
.	O
243	O
),	O
and	O
the	O
case	O
fatality	O
rate	O
of	O
patients	O
with	O
SARS	O
-	O
CoV	O
-	O
2	O
infection	O
was	O
0	O
.	O
043	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
027	O
,	O
0	O
.	O
061	O
).	O

9	O
patients	O
were	O
unconfirmed	O
until	O
a	O
third	O
-	O
time	O
nucleic	B-ANAT
acid	O
test	O
.	O

Imaging	O
examination	O
showed	O
that	O
55	O
patients	O
(-	O
68	O
.	O
75	O
%)	O
showed	O
abnormal	O
,	O
25	O
cases	O
(	O
31	O
.	O
25	O
%)	O
had	O
no	O
abnormal	O
density	O
shadow	O
in	O
the	O
parenchyma	B-ANAT
of	O
both	O
lungs	B-ANAT
.	O

A	O
retrospective	O
analysis	O
was	O
performed	O
on	O
the	O
imaging	O
findings	O
of	O
patients	O
confirmed	O
with	O
COVID	O
-	O
19	O
pneumonia	O
who	O
had	O
chest	B-ANAT
CT	O
scanning	O
and	O
treatment	O
after	O
disease	O
onset	O
.	O

The	O
lesion	O
was	O
primarily	O
located	O
in	O
the	O
peripheral	O
area	O
under	O
the	O
pleura	B-ANAT
with	O
possible	O
extension	O
towards	O
the	O
pulmonary	B-ANAT
hilum	I-ANAT
.	O

CONCLUSIONS	O
:	O
CT	O
imaging	O
presentations	O
of	O
NCP	O
are	O
mostly	O
patchy	O
ground	O
glass	O
opacities	O
in	O
the	O
peripheral	O
areas	O
under	O
the	O
pleura	B-ANAT
with	O
partial	O
consolidation	O
which	O
will	O
be	O
absorbed	O
with	O
formation	O
of	O
fibrotic	O
stripes	O
if	O
improved	O
.	O

The	O
risk	O
of	O
venous	B-ANAT
thromboembolism	O
(	O
VTE	O
)	O
needs	O
to	O
be	O
assessed	O
,	O
and	O
effective	O
prevention	O
should	O
be	O
carried	O
out	O
for	O
high	O
-	O
risk	O
patients	O
.	O

TITLE	O
:	O
[	O
Medical	O
diagnosis	O
and	O
treatment	O
strategies	O
for	O
malignant	O
tumors	O
of	O
the	O
digestive	B-ANAT
system	I-ANAT
during	O
the	O
outbreak	O
of	O
novel	O
coronavirus	O
pneumonia	O
].	O

Combining	O
the	O
guidelines	O
for	O
diagnosis	O
and	O
treatment	O
of	O
tumors	O
with	O
our	O
clinical	O
experience	O
,	O
in	O
this	O
epidemic	O
period	O
,	O
we	O
discuss	O
the	O
strategies	O
for	O
diagnosis	O
,	O
treatment	O
,	O
and	O
follow	O
-	O
up	O
of	O
malignant	O
tumors	O
of	O
the	O
digestive	B-ANAT
system	I-ANAT
in	O
this	O
article	O
.	O

On	O
chest	B-ANAT
computed	O
tomography	O
(	O
CT	O
),	O
lung	B-ANAT
segments	I-ANAT
6	O
and	O
10	O
were	O
mostly	O
involved	O
.	O

Nevetheless	O
,	O
some	O
patients	O
can	O
present	O
with	O
a	O
normal	O
chest	B-ANAT
finding	O
despite	O
testing	O
positive	O
for	O
COVID	O
-	O
19	O
.	O

Moderate	O
to	O
severe	O
progression	O
of	O
the	O
lung	B-ANAT
infiltrates	O
,	O
with	O
increasing	O
percentage	O
of	O
high	O
-	O
density	O
infiltrates	O
sustained	O
by	O
a	O
bilateral	O
and	O
multi	O
-	O
segmental	O
extension	O
of	O
lung	B-ANAT
opacities	O
,	O
were	O
seen	O
.	O

Presented	O
is	O
a	O
case	O
of	O
severe	O
acute	O
lung	B-ANAT
injury	O
due	O
to	O
vaporizing	O
substances	O
in	O
a	O
young	O
male	O
requiring	O
extracorporeal	O
membranous	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
as	O
a	O
bridge	O
to	O
recovery	O
.	O

Because	O
both	O
patients	O
did	O
not	O
exhibit	O
symptoms	O
of	O
pneumonia	O
at	O
the	O
time	O
of	O
operation	O
,	O
these	O
changes	O
likely	O
represent	O
an	O
early	O
phase	O
of	O
the	O
lung	B-ANAT
pathology	O
of	O
COVID	O
-	O
19	O
pneumonia	O
.	O

These	O
three	O
different	O
kits	O
got	O
the	O
same	O
result	O
for	O
each	O
sample	O
and	O
the	O
positive	O
ratio	O
of	O
nucleic	B-ANAT
acid	O
detection	O
for	O
2019	O
-	O
nCoV	O
was	O
only	O
47	O
.	O
4	O
%	O
in	O
the	O
suspect	O
patients	O
.	O

It	O
might	O
be	O
better	O
to	O
make	O
a	O
diagnosis	O
combining	O
the	O
computed	O
tomography	O
scans	O
and	O
nucleic	B-ANAT
acid	O
detection	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
early	O
changes	O
of	O
peripheral	B-ANAT
blood	I-ANAT
leukocyte	B-ANAT
differential	O
counts	O
in	O
patients	O
with	O
COVID	O
-	O
19	O
.	O

The	O
differential	O
counts	O
of	O
white	B-ANAT
blood	I-ANAT
cells	I-ANAT
were	O
analyzed	O
.	O

In	O
non	O
-	O
COVID	O
-	O
19	O
group	O
,	O
absolute	O
WBC	B-ANAT
count	O
was	O
8	O
.	O
20	O
(	O
6	O
.	O
78	O
,	O
9	O
.	O
03	O
)	O
Ã	O
10	O
(	O
9	O
)/	O
L	O
(	O

At	O
present	O
,	O
some	O
therapies	O
such	O
as	O
interleukin	O
-	O
6	O
antibody	O
blocker	O
,	O
stem	B-ANAT
cell	I-ANAT
therapy	O
,	O
and	O
transfusion	O
of	O
convalescent	O
plasma	B-ANAT
have	O
been	O
applied	O
to	O
counteract	O
the	O
cytokine	O
storm	O
and	O
have	O
made	O
some	O
progress	O
.	O

TITLE	O
:	O
[	O
Cause	O
analysis	O
and	O
treatment	O
strategies	O
of	O
""""	O
recurrence	O
""""	O
with	O
novel	O
coronavirus	O
pneumonia	O
(	O
covid	O
-	O
19	O
)	O
patients	O
after	O
discharge	B-ANAT
from	O
hospital	O
].	O

The	O
chest	B-ANAT
CT	O
images	O
and	O
clinical	O
data	O
of	O
them	O
were	O
reviewed	O
and	O
compared	O
.	O

Compared	O
with	O
the	O
ordinary	O
patients	O
,	O
the	O
severe	O
/	O
critical	O
patients	O
had	O
older	O
ages	O
,	O
higher	O
incidence	O
of	O
comorbidities	O
,	O
cough	O
,	O
expectoration	B-ANAT
,	O
chest	B-ANAT
pain	O
and	O
dyspnea	O
.	O

ABSTRACT	O
:	O
A	O
patient	O
'	O
s	O
infectivity	O
is	O
determined	O
by	O
the	O
presence	O
of	O
the	O
virus	O
in	O
different	O
body	B-ANAT
fluids	I-ANAT
,	O
secretions	B-ANAT
,	O
and	O
excreta	O
.	O

Convalescent	O
patients	O
refer	O
to	O
recovered	O
non	O
-	O
febrile	O
patients	O
without	O
respiratory	O
symptoms	O
who	O
had	O
two	O
successive	O
(	O
minimum	O
24	O
h	O
sampling	O
interval	O
)	O
negative	O
RT	O
-	O
PCR	O
results	O
for	O
viral	O
RNA	O
from	O
oropharyngeal	B-ANAT
swabs	O
.	O

The	O
median	O
time	O
from	O
the	O
onset	O
of	O
symptoms	O
to	O
first	O
negative	O
RT	O
-	O
PCR	O
results	O
for	O
oropharyngeal	B-ANAT
swabs	O
in	O
convalescent	O
patients	O
was	O
9	O
.	O
5	O
(	O
6	O
.	O
0	O
-	O
11	O
.	O
0	O
)	O
days	O
.	O

Multivariate	O
logistic	O
analysis	O
indicated	O
that	O
age	O
(	O
odds	O
ratio	O
[	O
OR	O
],	O
8	O
.	O
546	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]:	O
1	O
.	O
628	O
-	O
44	O
.	O
864	O
;	O
P	O
=	O
0	O
.	O
011	O
),	O
history	O
of	O
smoking	O
(	O
OR	O
,	O
14	O
.	O
285	O
;	O
95	O
%	O
CI	O
:	O
1	O
.	O
577	O
-	O
25	O
.	O
000	O
;	O
P	O
=	O
0	O
.	O
018	O
),	O
maximum	O
body	B-ANAT
temperature	O
at	O
admission	O
(	O
OR	O
,	O
8	O
.	O
999	O
;	O
95	O
%	O
CI	O
:	O
1	O
.	O
036	O
-	O
78	O
.	O
147	O
,	O
P	O
=	O
0	O
.	O
046	O
),	O
respiratory	O
failure	O
(	O
OR	O
,	O
8	O
.	O
772	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
942	O
-	O
40	O
.	O
000	O
;	O
P	O
=	O
0	O
.	O
016	O
),	O
albumin	O
(	O
OR	O
,	O
7	O
.	O
353	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
098	O
-	O
50	O
.	O
000	O
;	O
P	O
=	O
0	O
.	O
003	O
),	O
and	O
C	O
-	O
reactive	O
protein	O
(	O
OR	O
,	O
10	O
.	O
530	O
;	O
95	O
%	O
CI	O
:	O
1	O
.	O
224	O
-	O
34	O
.	O
701	O
,	O
P	O
=	O
0	O
.	O
028	O
)	O
were	O
risk	O
factors	O
for	O
disease	O
progression	O
.	O

Multivariate	O
logistic	O
analysis	O
indicated	O
that	O
age	O
(	O
odds	O
ratio	O
[	O
OR	O
],	O
8	O
.	O
546	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]:	O
1	O
.	O
628	O
-	O
44	O
.	O
864	O
;	O
P	O
=	O
0	O
.	O
011	O
),	O
history	O
of	O
smoking	O
(	O
OR	O
,	O
14	O
.	O
285	O
;	O
95	O
%	O
CI	O
:	O
1	O
.	O
577	O
-	O
25	O
.	O
000	O
;	O
P	O
=	O
0	O
.	O
018	O
),	O
maximum	O
body	B-ANAT
temperature	O
at	O
admission	O
(	O
OR	O
,	O
8	O
.	O
999	O
;	O
95	O
%	O
CI	O
:	O
1	O
.	O
036	O
-	O
78	O
.	O
147	O
,	O
P	O
=	O
0	O
.	O
046	O
),	O
respiratory	O
failure	O
(	O
OR	O
,	O
8	O
.	O
772	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
942	O
-	O
40	O
.	O
000	O
;	O
P	O
=	O
0	O
.	O
016	O
),	O
albumin	O
(	O
OR	O
,	O
7	O
.	O
353	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
098	O
-	O
50	O
.	O
000	O
;	O
P	O
=	O
0	O
.	O
003	O
),	O
and	O
C	O
-	O
reactive	O
protein	O
(	O
OR	O
,	O
10	O
.	O
530	O
;	O
95	O
%	O
CI	O
:	O
1	O
.	O
224	O
-	O
34	O
.	O
701	O
,	O
P	O
=	O
0	O
.	O
028	O
)	O
were	O
risk	O
factors	O
for	O
disease	O
progression	O
.	O

TITLE	O
:	O
Multi	O
-	O
Modal	O
Characterization	O
of	O
the	O
Coagulopathy	O
Associated	O
With	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
.	O

This	O
study	O
aimed	O
to	O
characterize	O
the	O
pathomechanism	O
of	O
the	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
-	O
associated	O
coagulopathy	O
and	O
identify	O
options	O
to	O
optimize	O
its	O
monitoring	O
and	O
therapy	O
.	O

In	O
-	O
hospital	O
mortality	O
was	O
30	O
%	O
for	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
and	O
37	O
.	O
5	O
%	O
for	O
venoarterial	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
patients	O
.	O

And	O
we	O
found	O
that	O
patients	O
with	O
a	O
positive	O
stool	B-ANAT
test	O
did	O
not	O
experience	O
gastrointestinal	O
symptoms	O
and	O
had	O
nothing	O
to	O
do	O
with	O
the	O
severity	O
of	O
the	O
lung	B-ANAT
infection	O
.	O

For	O
isolating	O
patients	O
,	O
the	O
pulmonary	B-ANAT
rehabilitation	O
guidence	O
should	O
be	O
conducted	O
through	O
education	O
video	O
,	O
instruction	O
manual	O
or	O
remote	O
consultation	O
.	O

It	O
is	O
necessary	O
to	O
provide	O
more	O
appropriate	O
individualized	O
treatment	O
recommendations	O
for	O
patients	O
with	O
lung	B-ANAT
cancer	O
based	O
on	O
the	O
epidemic	O
situation	O
of	O
the	O
patient	O
'	O
s	O
location	O
and	O
in	O
combination	O
with	O
the	O
patient	O
'	O
s	O
own	O
condition	O
.	O

Given	O
the	O
systemic	O
immunosuppressive	O
state	O
caused	O
by	O
malignancy	O
and	O
anticancer	O
treatments	O
,	O
patients	O
with	O
advanced	O
lung	B-ANAT
cancer	O
may	O
be	O
at	O
a	O
higher	O
risk	O
of	O
COVID	O
-	O
19	O
infection	O
.	O

TITLE	O
:	O
Airway	B-ANAT
Pressure	O
Release	O
Ventilation	O
as	O
a	O
Rescue	O
Therapy	O
in	O
Pediatric	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
.	O

After	O
a	O
virtual	O
screening	O
campaign	O
of	O
1	O
.	O
56	O
million	O
compounds	O
followed	O
by	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
assay	O
and	O
MERS	O
-	O
CoV	O
plaques	O
inhibition	O
assay	O
,	O
three	O
new	O
compounds	O
were	O
identified	O
.	O

The	O
percentage	O
of	O
pulmonary	B-ANAT
lesions	O
on	O
CT	O
scans	O
diminished	O
from	O
2003	O
(	O
9	O
.	O
40	O
Â±	O
7	O
.	O
83	O
)%	O
to	O
2004	O
(	O
3	O
.	O
20	O
Â±	O
4	O
.	O
78	O
)%	O
(	O

Pulmonary	B-ANAT
function	O
testing	O
procedures	O
have	O
been	O
associated	O
with	O
an	O
increasing	O
risk	O
of	O
COVID	O
-	O
19	O
transmission	O
among	O
patients	O
/	O
subjects	O
and	O
medical	O
staffs	O
.	O

It	O
is	O
still	O
unclear	O
how	O
fast	O
the	O
virus	O
evolved	O
and	O
how	O
the	O
virus	O
interacts	O
with	O
other	O
microorganisms	O
in	O
the	O
lung	B-ANAT
.	O

The	O
microbiota	O
in	O
SARS	O
-	O
CoV	O
-	O
2	O
infected	O
patients	O
was	O
similar	O
to	O
those	O
in	O
CAP	O
,	O
either	O
dominated	O
by	O
the	O
pathogens	O
or	O
with	O
elevated	O
levels	O
of	O
oral	B-ANAT
and	O
upper	O
respiratory	O
commensal	O
bacteria	O
.	O

The	O
mean	O
change	O
in	O
Pao	O
Fixed	B-ANAT
-	O
dose	O
iEPO	O
was	O
comparable	O
to	O
iNO	O
in	O
patients	O
with	O
moderate	O
-	O
to	O
-	O
severe	O
ARDS	O
for	O
oxygenation	O
and	O
ventilation	O
parameters	O
as	O
well	O
as	O
clinical	O
outcomes	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
find	O
out	O
the	O
aetiological	O
agents	O
in	O
respiratory	O
specimens	O
from	O
children	O
with	O
CF	O
during	O
pulmonary	B-ANAT
exacerbation	O
and	O
relate	O
with	O
demographic	O
variables	O
.	O

In	O
this	O
observational	O
study	O
,	O
airway	B-ANAT
secretions	B-ANAT
from	O
children	O
(	O
n	O
=	O
104	O
)	O
with	O
CF	O
presenting	O
with	O
pulmonary	B-ANAT
exacerbations	O
were	O
collected	O
and	O
tested	O
for	O
bacteria	O
,	O
fungi	O
,	O
mycobacteria	O
and	O
viral	O
pathogens	O
using	O
appropriate	O
laboratory	O
techniques	O
.	O

The	O
fatality	O
rate	O
of	O
coronavirus	O
MERS	O
-	O
CoV	O
was	O
(	O
34	O
.	O
77	O
%)	O
higher	O
than	O
SARS	O
-	O
CoV	O
(	O
10	O
.	O
87	O
%)	O
and	O
2019	O
-	O
nCoV	O
(	O
2	O
.	O
08	O
%);	O
however	O
,	O
the	O
2019	O
-	O
nCoV	O
transmitted	O
rapidly	O
in	O
comparison	O
to	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
.	O
The	O
novel	O
coronavirus	O
2019	O
-	O
nCoV	O
has	O
diverse	O
epidemiological	O
and	O
biological	O
characteristics	O
,	O
making	O
it	O
more	O
contagious	O
than	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
.	O
It	O
has	O
affected	O
more	O
people	O
in	O
a	O
short	O
time	O
period	O
compared	O
to	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
,	O
although	O
the	O
fatality	O
rate	O
of	O
MERS	O
-	O
CoV	O
was	O
higher	O
than	O
SARS	O
-	O
CoV	O
and	O
2019	O
-	O
nCoV	O
.	O
The	O
major	O
clinical	O
manifestations	O
in	O
coronavirus	O
infections	O
2019	O
-	O
nCoV	O
,	O
MERS	O
-	O
CoV	O
,	O
and	O
SARS	O
CoV	O
are	O
fever	O
,	O
chills	O
,	O
cough	O
,	O
shortness	O
of	O
breath	B-ANAT
,	O
generalized	O
myalgia	O
,	O
malaise	O
,	O
drowsy	O
,	O
diarrhea	O
,	O
confusion	O
,	O
dyspnea	O
,	O
and	O
pneumonia	O
.	O

Cell	B-ANAT
entry	O
of	O
coronaviruses	O
depends	O
on	O
binding	O
of	O
the	O
viral	O
spike	O
(	O
S	O
)	O
proteins	O
to	O
cellular	B-ANAT
receptors	O
and	O
on	O
S	O
protein	O
priming	O
by	O
host	B-ANAT
cell	I-ANAT
proteases	O
.	O

Finally	O
,	O
we	O
show	O
that	O
the	O
sera	B-ANAT
from	O
convalescent	O
SARS	O
patients	O
cross	O
-	O
neutralized	O
SARS	O
-	O
2	O
-	O
S	O
-	O
driven	O
entry	O
.	O

Lessons	O
learned	O
from	O
SARS	O
resulted	O
in	O
faster	O
determination	O
of	O
the	O
nucleic	B-ANAT
acid	O
sequence	O
and	O
a	O
more	O
robust	O
quarantine	O
strategy	O
.	O

Twelve	O
(	O
50	O
.	O
0	O
%)	O
cases	O
showed	O
typical	O
CT	O
images	O
of	O
ground	O
-	O
glass	O
chest	B-ANAT
and	O
5	O
(	O
20	O
.	O
8	O
%)	O
presented	O
stripe	O
shadowing	O
in	O
the	O
lungs	B-ANAT
.	O

Further	O
isolation	O
recommendation	O
and	O
continuous	O
nucleic	B-ANAT
acid	O
tests	O
may	O
also	O
be	O
recommended	O
to	O
the	O
patients	O
discharged	O
.	O

In	O
addition	O
,	O
there	O
are	O
many	O
significantly	O
important	O
trials	O
with	O
positive	O
results	O
:	O
high	O
dose	O
vitamin	O
C	O
for	O
septic	O
shock	O
,	O
weaning	O
strategy	O
with	O
pressure	O
support	O
ventilation	O
(	O
PSV	O
)	O
mode	O
,	O
tranexamic	O
acid	O
for	O
patients	O
with	O
acute	O
traumatic	O
brain	B-ANAT
injury	O
,	O
and	O
new	O
monoclonal	O
antibody	O
for	O
Ebola	O
virus	O
disease	O
.	O

Apoptotic	O
markers	O
are	O
detectable	O
within	O
IPF	O
lung	B-ANAT
tissue	I-ANAT
and	O
senescent	O
cell	B-ANAT
deletion	O
can	O
rejuvenate	O
pulmonary	B-ANAT
health	O
.	O

TITLE	O
:	O
Transmission	O
of	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
at	O
mass	O
gathering	O
events	O
.	O

The	O
spike	O
protein	O
of	O
coronavirus	O
GX_P2V	O
shares	O
92	O
.	O
2	O
%	O
amino	O
acid	O
identity	O
with	O
that	O
of	O
2019	O
-	O
nCoV	O
isolate	O
Wuhan	O
-	O
hu	O
-	O
1	O
,	O
and	O
uses	O
ACE2	O
as	O
the	O
receptor	O
for	O
infection	O
just	O
like	O
2019	O
-	O
nCoV	O
.	O
Three	O
drugs	O
-	O
cepharanthine	O
(	O
CEP	O
),	O
selamectin	O
and	O
mefloquine	O
hydrochloride	O
exhibited	O
complete	O
inhibition	O
of	O
cytopathic	O
effects	O
in	O
cell	B-ANAT
culture	O
at	O
10	O
Î¼mol	O
/	O
L	O
.	O
CEP	O
demonstrated	O
the	O
most	O
potent	O
inhibition	O
of	O
GX_P2V	O
infection	O
,	O
with	O
a	O
concentration	O
for	O
50	O
%	O
of	O
maximal	O
effect	O
[	O
EC50	O
]	O
of	O
0	O
.	O
98	O
Î¼mol	O
/	O
L	O
.	O
The	O
viral	O
RNA	O
yield	O
in	O
cells	B-ANAT
treated	O
with	O
10	O
Î¼mol	O
/	O
L	O
CEP	O
was	O
15	O
,	O
393	O
-	O
fold	O
lower	O
than	O
in	O
cells	B-ANAT
without	O
CEP	O
treatment	O
([	O
6	O
.	O
48	O
Â±	O
0	O
.	O
02	O
]	O
Ã	O
10vs	O
.	O

Our	O
results	O
strongly	O
suggest	O
that	O
CEP	O
is	O
a	O
wide	O
-	O
spectrum	O
inhibitor	O
of	O
pan	B-ANAT
-	O
betacoronavirus	O
,	O
and	O
clinical	O
trial	O
of	O
CEP	O
for	O
treatment	O
of	O
2019	O
-	O
nCoV	O
infection	O
is	O
warranted	O
.	O

RESULTS	O
:	O
The	O
spike	O
protein	O
of	O
coronavirus	O
GX_P2V	O
shares	O
92	O
.	O
2	O
%	O
amino	O
acid	O
identity	O
with	O
that	O
of	O
2019	O
-	O
nCoV	O
isolate	O
Wuhan	O
-	O
hu	O
-	O
1	O
,	O
and	O
uses	O
ACE2	O
as	O
the	O
receptor	O
for	O
infection	O
just	O
like	O
2019	O
-	O
nCoV	O
.	O
Three	O
drugs	O
-	O
cepharanthine	O
(	O
CEP	O
),	O
selamectin	O
and	O
mefloquine	O
hydrochloride	O
exhibited	O
complete	O
inhibition	O
of	O
cytopathic	O
effects	O
in	O
cell	B-ANAT
culture	O
at	O
10	O
Î¼mol	O
/	O
L	O
.	O
CEP	O
demonstrated	O
the	O
most	O
potent	O
inhibition	O
of	O
GX_P2V	O
infection	O
,	O
with	O
a	O
concentration	O
for	O
50	O
%	O
of	O
maximal	O
effect	O
[	O
EC50	O
]	O
of	O
0	O
.	O
98	O
Î¼mol	O
/	O
L	O
.	O
The	O
viral	O
RNA	O
yield	O
in	O
cells	B-ANAT
treated	O
with	O
10	O
Î¼mol	O
/	O
L	O
CEP	O
was	O
15	O
,	O
393	O
-	O
fold	O
lower	O
than	O
in	O
cells	B-ANAT
without	O
CEP	O
treatment	O
([	O
6	O
.	O
48	O
Â±	O
0	O
.	O
02	O
]	O
Ã	O
10vs	O
.	O

The	O
effectiveness	O
of	O
adjunctive	O
glucocorticoid	O
therapy	O
uses	O
in	O
the	O
management	O
of	O
2019	O
-	O
nCoV	O
infected	O
patients	O
with	O
severe	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
is	O
not	O
clear	O
,	O
and	O
warrants	O
further	O
investigation	O
.	O

Interestingly	O
,	O
these	O
latter	O
viruses	O
have	O
probably	O
originated	O
from	O
bats	O
and	O
then	O
moving	O
into	O
other	O
mammalian	O
hosts	O
â	O
the	O
Himalayan	O
palm	B-ANAT
civet	O
for	O
SARS	O
-	O
CoV	O
,	O
and	O
the	O
dromedary	O
camel	O
for	O
MERS	O
-	O
CoV	O
â	O
before	O
jumping	O
to	O
humans	O
.	O

World	O
governments	O
are	O
at	O
work	O
to	O
establish	O
countermeasures	O
to	O
stem	B-ANAT
possible	O
devastating	O
effects	O
.	O

Other	O
symptoms	O
,	O
including	O
cough	O
(	O
in	O
four	O
of	O
nine	O
patients	O
),	O
myalgia	O
(	O
in	O
three	O
),	O
sore	O
throat	B-ANAT
(	O
in	O
two	O
),	O
and	O
malaise	O
(	O
in	O
two	O
),	O
were	O
also	O
observed	O
.	O

ABSTRACT	O
:	O
Novel	O
coronavirus	O
pneumonia	O
was	O
novel	O
coronavirus	O
infection	O
that	O
has	O
dominated	O
pulmonary	B-ANAT
infection	O
since	O
December	O
2019	O
.	O

TITLE	O
:	O
[	O
Medical	O
management	O
and	O
prevention	O
instruction	O
of	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
during	O
the	O
coronavirus	O
disease	O
2019	O
epidemic	O
].	O

Conclusion	O
Radiologists	O
in	O
China	O
and	O
the	O
United	O
States	O
distinguished	O
COVID	O
-	O
19	O
from	O
viral	O
pneumonia	O
on	O
chest	B-ANAT
CT	O
with	O
high	O
specificity	O
but	O
moderate	O
sensitivity	O
.	O

Coronavirus	O
spike	O
(	O
S	O
)	O
glycoproteins	O
promote	O
entry	O
into	O
cells	B-ANAT
and	O
are	O
the	O
main	O
target	O
of	O
antibodies	O
.	O

We	O
show	O
that	O
SARS	O
-	O
CoV	O
-	O
2	O
S	O
uses	O
ACE2	O
to	O
enter	O
cells	B-ANAT
and	O
that	O
the	O
receptor	O
-	O
binding	O
domains	O
of	O
SARS	O
-	O
CoV	O
-	O
2	O
S	O
and	O
SARS	O
-	O
CoV	O
S	O
bind	O
with	O
similar	O
affinities	O
to	O
human	O
ACE2	O
,	O
correlating	O
with	O
the	O
efficient	O
spread	O
of	O
SARS	O
-	O
CoV	O
-	O
2	O
among	O
humans	O
.	O

The	O
RT	O
-	O
PCR	O
detection	O
of	O
viral	O
nucleic	B-ANAT
acid	O
test	O
(	O
NAT	O
)	O
was	O
one	O
of	O
the	O
most	O
quickly	O
established	O
laboratory	O
diagnosis	O
method	O
in	O
a	O
novel	O
viral	O
pandemic	O
,	O
just	O
as	O
in	O
this	O
COVID	O
-	O
19	O
outbreak	O
.	O

Severe	O
cases	O
tend	O
to	O
have	O
lower	O
lymphocytes	B-ANAT
counts	O
,	O
higher	O
leukocytes	B-ANAT
counts	O
and	O
neutrophil	B-ANAT
-	O
lymphocyte	B-ANAT
-	O
ratio	O
(	O
NLR	O
),	O
as	O
well	O
as	O
lower	O
percentages	O
of	O
monocytes	B-ANAT
,	O
eosinophils	B-ANAT
,	O
and	O
basophils	B-ANAT
.	O

Patients	O
with	O
COVID	O
-	O
19	O
also	O
have	O
lower	O
level	O
of	O
regulatory	B-ANAT
T	I-ANAT
cells	I-ANAT
,	O
and	O
more	O
obviously	O
damaged	O
in	O
severe	O
cases	O
.	O

Surveillance	O
of	O
NLR	O
and	O
lymphocyte	B-ANAT
subsets	O
is	O
helpful	O
in	O
the	O
early	O
screening	O
of	O
critical	O
illness	O
,	O
diagnosis	O
and	O
treatment	O
of	O
COVID	O
-	O
19	O
.	O

Fifteen	O
(	O
78	O
.	O
95	O
%)	O
NCOVID	O
-	O
19	O
but	O
4	O
(	O
26	O
.	O
67	O
%)	O
NON	O
-	O
NCOVID	O
-	O
19	O
patients	O
had	O
bilateral	O
involvement	O
while	O
17	O
(	O
89	O
.	O
47	O
%)	O
NCOVID	O
-	O
19	O
but	O
1	O
(	O
6	O
.	O
67	O
%)	O
NON	O
-	O
NCOVID	O
-	O
19	O
patients	O
had	O
multiple	O
mottling	O
and	O
ground	O
-	O
glass	O
opacity	O
of	O
chest	B-ANAT
CT	O
images	O
.	O

The	O
incidence	O
of	O
acute	O
cardiac	B-ANAT
injury	O
was	O
about	O
13	O
folds	O
higher	O
in	O
ICU	O
/	O
severe	O
patients	O
compared	O
with	O
the	O
non	O
-	O
ICU	O
/	O
severe	O
patients	O
.	O

TITLE	O
:	O
Chest	B-ANAT
computed	O
tomography	O
in	O
children	O
with	O
COVID	O
-	O
19	O
respiratory	O
infection	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
use	O
IEDB	O
software	O
to	O
predict	O
the	O
suitable	O
MERS	O
-	O
CoV	O
epitope	O
vaccine	O
against	O
the	O
most	O
known	O
world	O
population	O
alleles	O
through	O
four	O
selecting	O
proteins	O
such	O
as	O
S	O
glycoprotein	O
and	O
envelope	B-ANAT
protein	O
and	O
their	O
modification	O
sequences	O
after	O
the	O
pandemic	O
spread	O
of	O
MERS	O
-	O
CoV	O
in	O
2012	O
.	O

TITLE	O
:	O
Coronavirus	O
Disease	O
2019	O
(	O
COVID	O
-	O
19	O
):	O
Emerging	O
and	O
Future	O
Challenges	O
for	O
Dental	O
and	O
Oral	B-ANAT
Medicine	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
(	O
ARTI	O
),	O
including	O
the	O
common	O
cold	O
,	O
pharyngitis	O
,	O
sinusitis	O
,	O
otitis	O
media	B-ANAT
,	O
bronchiolitis	O
and	O
pneumonia	O
are	O
the	O
most	O
common	O
diagnoses	O
among	O
patients	O
seeking	O
medical	O
care	O
in	O
western	O
countries	O
,	O
and	O
account	O
for	O
most	O
antibiotic	O
prescriptions	O
.	O

The	O
QIAstat	O
Respiratory	O
Panel	O
Â®	O
assay	O
(	O
QIAstat	O
RP	O
)	O
is	O
a	O
multiplexed	O
in	O
vitro	O
diagnostics	O
test	O
for	O
the	O
rapid	O
simultaneous	O
detection	O
of	O
21	O
pathogens	O
directly	O
from	O
respiratory	B-ANAT
samples	I-ANAT
,	O
including	O
human	O
mastadenovirus	O
A	O
-	O
G	O
,	O
primate	O
bocaparvovirus	O
1	O
+	O
2	O
,	O
human	O
coronavirus	O
(	O
HKU1	O
,	O
NL63	O
,	O
OC43	O
,	O
229E	O
),	O
human	O
metapneumovirus	O
A	O
/	O
B	O
,	O
rhinovirus	O
/	O
enterovirus	O
,	O
influenza	O
A	O
virus	O
(	O
no	O
subtype	O
,	O
subtype	O
H1	O
,	O
H1N1	O
/	O
2009	O
,	O
H3	O
),	O
influenza	O
B	O
virus	O
,	O
human	O
respirovirus	O
1	O
+	O
3	O
,	O
human	O
orthorubulavirus	O
2	O
+	O
4	O
,	O
human	O
orthopneumovirus	O
,	O
Bordetella	O
pertussis	O
,	O
Chlamydia	O
pneumoniae	O
,	O
Mycoplasma	O
pneumoniae	O
and	O
Legionella	O
pneumophila	O
.	O

Samples	O
from	O
the	O
gut	B-ANAT
and	O
internal	O
organs	B-ANAT
of	O
352	O
dogs	O
were	O
screened	O
for	O
CCoV	O
;	O
putative	O
pCCoV	O
strains	O
,	O
belonging	O
to	O
subtype	O
CCoV	O
-	O
IIa	O
,	O
were	O
identified	O
in	O
the	O
internal	O
organs	B-ANAT
of	O
35	O
of	O
the	O
examined	O
dogs	O
.	O

TITLE	O
:	O
Enhanced	O
isolation	O
of	O
SARS	O
-	O
CoV	O
-	O
2	O
by	O
TMPRSS2	O
-	O
expressing	O
cells	B-ANAT
.	O

He	O
developed	O
a	O
severe	O
acute	O
respiratory	O
failure	O
treated	O
with	O
a	O
ventilatory	O
support	O
by	O
means	O
of	O
a	O
continuous	O
positive	O
airway	B-ANAT
pressure	O
(	O
C	O
-	O
PAP	O
)	O
therapy	O
.	O

ABSTRACT	O
:	O
To	O
describe	O
a	O
pediatric	O
case	O
of	O
cytokine	O
release	O
syndrome	O
secondary	O
to	O
chimeric	O
antigen	O
receptor	O
-	O
modified	O
T	B-ANAT
cells	I-ANAT
associated	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Hemoadsorption	O
with	O
cartridge	O
column	B-ANAT
(	O
Cytosorb	O
)	O
in	O
combination	O
with	O
continuous	O
renal	B-ANAT
replacement	O
therapy	O
was	O
associated	O
to	O
the	O
anti	O
-	O
cytokine	O
therapy	O
(	O
tocilizumab	O
,	O
a	O
monoclonal	O
antibody	O
targeting	O
interleukin	O
-	O
6	O
receptor	O
).	O

In	O
this	O
review	O
,	O
we	O
analyzed	O
a	O
total	O
of	O
10	O
literatures	O
on	O
the	O
sampling	O
methods	O
of	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
related	O
to	O
infectious	O
diseases	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
),	O
middle	O
east	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
),	O
and	O
influenza	O
A	O
(	O
H1N1	O
),	O
which	O
were	O
spread	O
worldwide	O
in	O
past	O
years	O
.	O

It	O
has	O
been	O
known	O
since	O
the	O
2003	O
SARS	O
epidemic	O
that	O
the	O
receptor	O
critical	O
for	O
SARS	O
-	O
CoV	O
entry	O
into	O
host	O
cells	B-ANAT
is	O
the	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
).	O

The	O
initial	O
clinical	O
data	O
of	O
these	O
patients	O
,	O
such	O
as	O
epidemiological	O
features	O
,	O
symptoms	O
,	O
laboratory	O
results	O
,	O
and	O
chest	B-ANAT
computed	O
tomography	O
(	O
CT	O
)	O
findings	O
were	O
collected	O
using	O
a	O
standard	O
case	O
report	O
form	O
on	O
admission	O
.	O

In	O
a	O
short	O
time	O
following	O
the	O
outbreak	O
,	O
it	O
has	O
been	O
shown	O
that	O
,	O
similar	O
to	O
SARS	O
-	O
CoV	O
,	O
COVID	O
-	O
19	O
virus	O
exploits	O
the	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
receptor	O
to	O
gain	O
entry	O
inside	O
the	O
cells	B-ANAT
.	O

This	O
finding	O
raises	O
the	O
curiosity	O
of	O
investigating	O
the	O
expression	O
of	O
ACE2	O
in	O
neurological	O
tissue	B-ANAT
and	O
determining	O
the	O
possible	O
contribution	O
of	O
neurological	O
tissue	B-ANAT
damage	O
to	O
the	O
morbidity	O
and	O
mortality	O
caused	O
by	O
COIVD	O
-	O
19	O
.	O

In	O
this	O
study	O
,	O
the	O
COVID	O
-	O
19	O
spike	O
binding	O
site	O
to	O
the	O
cell	B-ANAT
-	O
surface	O
receptor	O
(	O
Glucose	O
Regulated	O
Protein	O
78	O
(	O
GRP78	O
))	O
is	O
predicted	O
using	O
combined	O
molecular	O
modeling	O
docking	O
and	O
structural	O
bioinformatics	O
.	O

The	O
docking	O
pose	O
revealed	O
the	O
involvement	O
of	O
the	O
SBDÎ²	O
of	O
GRP78	O
and	O
the	O
receptor	O
-	O
binding	O
domain	O
of	O
the	O
coronavirus	O
spike	O
protein	O
in	O
recognition	O
of	O
the	O
host	B-ANAT
cell	I-ANAT
receptor	O
.	O

TITLE	O
:	O
Single	O
-	O
cell	B-ANAT
RNA	O
-	O
seq	O
data	O
analysis	O
on	O
the	O
receptor	O
ACE2	O
expression	O
reveals	O
the	O
potential	O
risk	O
of	O
different	O
human	O
organs	B-ANAT
vulnerable	O
to	O
2019	O
-	O
nCoV	O
infection	O
.	O

Moreover	O
,	O
lung	B-ANAT
cells	B-ANAT
that	O
have	O
ACE2	O
expression	O
may	O
be	O
the	O
main	O
target	B-ANAT
cells	I-ANAT
during	O
2019	O
-	O
nCoV	O
infection	O
.	O

Based	O
on	O
the	O
findings	O
,	O
we	O
constructed	O
a	O
risk	O
map	O
indicating	O
the	O
vulnerability	O
of	O
different	O
organs	B-ANAT
to	O
2019	O
-	O
nCoV	O
infection	O
.	O

Insufficient	O
and	O
excessive	O
protection	O
will	O
have	O
adverse	O
effects	O
on	O
the	O
skin	B-ANAT
and	O
mucous	B-ANAT
membrane	I-ANAT
barrier	O
.	O

TITLE	O
:	O
COVID	O
-	O
19	O
and	O
Rationally	O
Layered	B-ANAT
Social	O
Distancing	O
.	O

This	O
cytokine	O
inhibits	O
class	O
II	O
histocompatibility	O
complex	O
(	O
MHC	B-ANAT
)	O
molecules	O
and	O
inflammation	O
in	O
inflammatory	O
diseases	O
by	O
suppressing	O
MyD88	O
and	O
subsequently	O
IL	O
-	O
1Î²	O
,	O
IL	O
-	O
6	O
,	O
TNF	O
and	O
CCL2	O
.	O

Compared	O
with	O
the	O
non	O
-	O
pregnant	O
adults	O
group	O
(	O
n	O
=	O
14	O
),	O
initial	O
normal	O
body	B-ANAT
temperature	O
(	O
9	O
[	O
56	O
%]	O
and	O
16	O
[	O
64	O
%]),	O
leukocytosis	O
(	O
8	O
[	O
50	O
%]	O
and	O
9	O
[	O
36	O
%])	O
and	O
elevated	O
neutrophil	B-ANAT
ratio	O
(	O
14	O
[	O
88	O
%]	O
and	O
20	O
[	O
80	O
%]),	O
and	O
lymphopenia	O
(	O
9	O
[	O
56	O
%]	O
and	O
16	O
[	O
64	O
%])	O
were	O
more	O
common	O
in	O
the	O
laboratory	O
-	O
confirmed	O
(	O
n	O
=	O
16	O
)	O
and	O
clinically	O
-	O
diagnosed	O
(	O
n	O
=	O
25	O
)	O
pregnant	O
groups	O
.	O

The	O
pulmonary	B-ANAT
involvement	O
in	O
children	O
with	O
COVID	O
-	O
19	O
was	O
mild	O
with	O
a	O
focal	O
GGO	O
or	O
consolidation	O
.	O

Among	O
the	O
5	O
reactivated	O
patients	O
,	O
other	O
symptoms	O
were	O
also	O
observed	O
,	O
including	O
fever	O
,	O
cough	O
,	O
sore	O
throat	B-ANAT
,	O
and	O
fatigue	O
.	O

The	O
chest	B-ANAT
CT	O
scans	O
were	O
improving	O
for	O
11	O
(	O
69	O
%)	O
of	O
16	O
patients	O
in	O
the	O
combination	O
group	O
after	O
seven	O
days	O
,	O
compared	O
with	O
5	O
(	O
29	O
%)	O
of	O
17	O
in	O
the	O
monotherapy	O
group	O
(	O
p	O
<	O
0	O
Â·	O
05	O
).	O

The	O
most	O
common	O
finding	O
on	O
chest	B-ANAT
imaging	O
among	O
patients	O
with	O
pneumonia	O
was	O
ground	O
-	O
glass	O
opacity	O
with	O
bilateral	O
involvement	O
.	O

Compared	O
with	O
the	O
Non	O
-	O
severe	O
patient	O
,	O
the	O
pooled	O
odds	O
ratio	O
of	O
hypertension	O
,	O
respiratory	B-ANAT
system	I-ANAT
disease	O
,	O
cardiovascular	B-ANAT
disease	O
in	O
severe	O
patients	O
were	O
(	O
OR	O
2	O
.	O
36	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
46	O
-	O
3	O
.	O
83	O
),	O
(	O
OR	O
2	O
.	O
46	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
76	O
-	O
3	O
.	O
44	O
)	O
and	O
(	O
OR	O
3	O
.	O
42	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
88	O
-	O
6	O
.	O
22	O
)	O
respectively	O
.	O

Eosinophil	B-ANAT
values	O
were	O
low	O
on	O
initial	O
hospitalization	O
,	O
then	O
all	O
returned	O
to	O
normal	O
before	O
discharge	B-ANAT
.	O

The	O
nucleic	B-ANAT
acid	O
test	O
or	O
genetic	O
sequencing	O
serves	O
as	O
the	O
gold	O
standard	O
method	O
for	O
confirmation	O
of	O
infection	O
,	O
yet	O
several	O
recent	O
studies	O
have	O
reported	O
false	O
-	O
negative	O
results	O
of	O
real	O
-	O
time	O
reverse	O
-	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
rRT	O
-	O
PCR	O
).	O

Pulmonary	B-ANAT
fibrosis	O
is	O
a	O
pulmonary	B-ANAT
disease	O
with	O
progressive	O
fibrosis	O
,	O
which	O
is	O
the	O
main	O
factor	O
leading	O
to	O
pulmonary	B-ANAT
dysfunction	O
and	O
quality	O
of	O
life	O
decline	O
in	O
SARS	O
survivors	O
after	O
recovery	O
.	O

Although	O
there	O
are	O
no	O
reports	O
on	O
the	O
mechanism	O
of	O
COVID	O
-	O
19	O
inducing	O
pulmonary	B-ANAT
fibrosis	O
,	O
based	O
on	O
the	O
existing	O
theoretical	O
basis	O
,	O
we	O
focus	O
on	O
the	O
possible	O
mechanism	O
of	O
COVID	O
-	O
19	O
sustained	O
lung	B-ANAT
damaging	O
,	O
the	O
key	O
role	O
of	O
abnormal	O
immune	O
mechanism	O
in	O
the	O
initiation	O
and	O
promotion	O
of	O
pulmonary	B-ANAT
fibrosis	O
,	O
and	O
the	O
corresponding	O
therapeutic	O
measures	O
.	O

Since	O
then	O
,	O
there	O
have	O
been	O
anecdotal	O
reports	O
of	O
ocular	B-ANAT
infection	O
.	O

Analysis	O
of	O
host	O
-	O
specific	O
slow	O
codon	O
and	O
di	O
-	O
codon	O
compositions	O
provides	O
links	O
between	O
viral	O
genomic	O
sequences	O
and	O
capability	O
of	O
virus	O
replication	O
in	O
host	O
cells	B-ANAT
that	O
may	O
be	O
useful	O
for	O
surveillance	O
of	O
the	O
transmission	O
potential	O
of	O
novel	O
viruses	O
.	O

A	O
meta	O
-	O
analysis	O
was	O
performed	O
,	O
with	O
calculation	O
of	O
weighted	O
mean	O
difference	O
(	O
WMD	O
)	O
of	O
platelet	B-ANAT
number	O
in	O
COVID	O
-	O
19	O
patients	O
with	O
or	O
without	O
severe	O
disease	O
and	O
odds	O
ratio	O
(	O
OR	O
)	O
of	O
thrombocytopenia	O
for	O
severe	O
form	O
of	O
COVID	O
-	O
19	O
.	O

The	O
pooled	O
analysis	O
revealed	O
that	O
platelet	B-ANAT
count	O
was	O
significantly	O
lower	O
in	O
patients	O
with	O
more	O
severe	O
COVID	O
-	O
19	O
(	O
WMD	O
-	O
31	O
Ã	O
10	O

We	O
study	O
epidemiological	O
and	O
clinical	O
outcome	O
of	O
55	O
asymptomatic	O
carriers	O
who	O
were	O
laboratory	O
-	O
confirmed	O
positive	O
for	O
the	O
SARS	O
-	O
Coronavirus	O
-	O
2	O
by	O
testing	O
the	O
nucleic	B-ANAT
acid	O
of	O
the	O
pharyngeal	B-ANAT
swab	O
samples	O
.	O

Both	O
of	O
them	O
had	O
normal	O
chest	B-ANAT
CT	O
images	O
.	O

ABSTRACT	O
:	O
The	O
emergence	O
of	O
a	O
novel	O
coronavirus	O
,	O
termed	O
SARS	O
-	O
CoV	O
-	O
2	O
,	O
and	O
the	O
potentially	O
life	O
-	O
threating	O
respiratory	O
disease	O
that	O
it	O
can	O
produce	O
,	O
COVID	O
-	O
19	O
,	O
has	O
rapidly	O
spread	O
across	O
the	O
globe	B-ANAT
creating	O
a	O
massive	O
public	O
health	O
problem	O
.	O

ABSTRACT	O
:	O
While	O
the	O
Western	O
world	O
now	O
takes	O
on	O
a	O
viral	O
pandemic	O
,	O
the	O
news	O
-	O
cycle	O
and	O
constant	O
reminders	O
to	O
wash	O
your	O
hands	B-ANAT
and	O
avoid	O
touching	O
your	O
face	B-ANAT
might	O
drive	O
anyone	O
to	O
reach	O
in	O
the	O
fridge	O
for	O
a	O
beer	O
.	O

This	O
is	O
a	O
52	O
-	O
year	O
-	O
old	O
man	O
who	O
received	O
kidney	B-ANAT
transplantation	O
12	O
years	O
ago	O
.	O

This	O
effectively	O
treated	O
case	O
has	O
reference	O
value	O
for	O
the	O
future	O
treatment	O
of	O
other	O
transplant	B-ANAT
patients	O
with	O
COVID	O
-	O
19	O
pneumonia	O
.	O

During	O
the	O
post	O
-	O
discharge	B-ANAT
surveillance	O
after	O
clinical	O
recovery	O
,	O
swabs	O
were	O
positive	O
in	O
two	O
asymptomatic	O
cases	O
(	O
3	O
.	O
23	O
%).	O

TITLE	O
:	O
Diagnosis	O
of	O
chronic	O
thromboembolic	O
pulmonary	B-ANAT
hypertension	O
after	O
acute	O
pulmonary	B-ANAT
embolism	O
.	O

Untreated	O
,	O
CTEPH	O
is	O
fatal	O
,	O
but	O
,	O
if	O
diagnosed	O
in	O
time	O
,	O
successful	O
surgical	O
(	O
pulmonary	B-ANAT
endarterectomy	O
),	O
medical	O
(	O
pulmonary	B-ANAT
hypertension	O
drugs	O
)	O
and	O
/	O
or	O
interventional	O
(	O
balloon	O
pulmonary	B-ANAT
angioplasty	O
)	O
therapies	O
have	O
been	O
shown	O
to	O
improve	O
clinical	O
outcomes	O
,	O
especially	O
in	O
case	O
of	O
successful	O
pulmonary	B-ANAT
endarterectomy	O
.	O

No	O
serious	O
prespecified	O
cell	B-ANAT
infusion	O
-	O
associated	O
or	O
treatment	O
-	O
related	O
adverse	O
events	O
was	O
identified	O
in	O
any	O
patient	O
.	O

Rapid	O
diagnosis	O
of	O
concomitant	O
COVID	O
-	O
19	O
,	O
safe	O
and	O
effective	O
transportation	O
,	O
implementation	O
of	O
the	O
interventional	O
procedure	O
,	O
protection	O
of	O
vascular	B-ANAT
surgical	O
team	O
and	O
postoperative	O
management	O
and	O
follow	O
-	O
up	O
of	O
such	O
patients	O
have	O
become	O
urgent	O
problems	O
for	O
us	O
.	O

TITLE	O
:	O
Coronavirus	O
Endoribonuclease	O
and	O
Deubiquitinating	O
Interferon	O
Antagonists	O
Differentially	O
Modulate	O
the	O
Host	O
Response	O
during	O
Replication	O
in	O
Macrophages	B-ANAT
.	O

The	O
population	O
were	O
divided	O
into	O
three	O
compartments	B-ANAT
:	O
Susceptible	O
,	O
Infected	O
,	O
Removed	O
.	O

RESULTS	O
:	O
Multiple	O
patchy	O
ground	O
-	O
glass	O
opacities	O
(	O
GGOs	O
)	O
were	O
seen	O
in	O
bilateral	O
lung	B-ANAT
,	O
mostly	O
in	O
subpleural	O
areas	O
.	O

Conclusion	O
The	O
extent	O
of	O
lung	B-ANAT
abnormalities	O
on	O
CT	O
peaked	O
during	O
illness	O
days	O
6	O
-	O
11	O
.	O

Results	O
The	O
collected	O
dataset	O
consisted	O
of	O
4356	O
chest	B-ANAT
CT	O
exams	O
from	O
3	O
,	O
322	O
patients	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
many	O
naturally	O
derived	O
substances	O
,	O
such	O
as	O
cyclodextrin	O
and	O
sterols	O
,	O
could	O
reduce	O
the	O
infectivity	O
of	O
many	O
types	O
of	O
viruses	O
,	O
including	O
the	O
coronavirus	O
family	O
,	O
through	O
interference	O
with	O
lipid	O
-	O
dependent	O
attachment	O
to	O
human	O
host	O
cells	B-ANAT
.	O

CT	O
findings	O
of	O
NCIP	O
were	O
featured	O
by	O
predominant	O
ground	O
glass	O
opacities	O
mixed	O
with	O
consolidations	O
,	O
mainly	O
peripheral	O
or	O
combined	O
peripheral	O
and	O
central	O
distributions	O
,	O
bilateral	O
and	O
lower	O
lung	B-ANAT
zones	O
being	O
mostly	O
involved	O
.	O

Misdiagnosed	O
infection	O
can	O
progress	O
to	O
a	O
wide	O
range	O
of	O
life	O
-	O
threatening	O
pathologies	O
,	O
including	O
severe	O
anemia	O
and	O
cerebral	B-ANAT
malaria	O
which	O
can	O
lead	O
to	O
death	O
even	O
few	O
days	O
after	O
first	O
symptoms	O
appearance	O
.	O

We	O
describe	O
a	O
patient	O
presenting	O
to	O
an	O
Emergency	O
Department	O
in	O
Rhode	O
Island	O
on	O
March	O
12	O
,	O
2020	O
with	O
cough	O
and	O
shortness	O
of	O
breath	B-ANAT
after	O
a	O
trip	O
to	O
Jamaica	O
.	O

SARS	O
-	O
CoV	O
-	O
2	O
RT	O
-	O
PCR	O
came	O
back	B-ANAT
positive	O
24	O
hours	O
later	O
.	O

If	O
the	O
emergent	O
patients	O
(	O
intestinal	B-ANAT
obstruction	O
)	O
with	O
suspected	O
or	O
confirmed	O
COVID	O
-	O
19	O
,	O
the	O
surgeons	O
must	O
perform	O
emergency	O
surgery	O
,	O
and	O
intestinal	B-ANAT
decompressive	O
tube	O
through	O
colonoscopy	O
is	O
not	O
recommended	O
.	O

In	O
the	O
21	O
patients	O
(	O
29	O
%)	O
with	O
severe	O
type	O
,	O
extensive	O
GGO	O
and	O
pulmonary	B-ANAT
consolidation	O
were	O
found	O
in	O
16	O
cases	O
(	O
16	O
/	O
21	O
,	O
76	O
%)	O
and	O
5	O
cases	O
(	O
24	O
%),	O
respectively	O
.	O

TITLE	O
:	O
Chest	B-ANAT
CT	O
manifestations	O
of	O
new	O
coronavirus	O
disease	O
2019	O
(	O
COVID	O
-	O
19	O
):	O
a	O
pictorial	O
review	O
.	O

In	O
diagnosis	O
,	O
chest	B-ANAT
computed	O
tomography	O
(	O
CT	O
)	O
manifestations	O
can	O
supplement	O
parts	O
of	O
limitations	O
of	O
real	O
-	O
time	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
assay	O
.	O

Chest	B-ANAT
imaging	O
showed	O
multiple	O
patch	O
-	O
like	O
shadows	O
in	O
seven	O
patients	O
and	O
ground	O
-	O
glass	O
opacity	O
in	O
six	O
.	O

TITLE	O
:	O
Fatal	O
pediatric	O
Stevens	O
-	O
Johnson	O
syndrome	O
/	O
toxic	O
epidermal	B-ANAT
necrolysis	O
:	O
Three	O
case	O
reports	O
.	O

Sixteen	O
patients	O
(	O
80	O
%)	O
were	O
admitted	O
to	O
the	O
intensive	O
care	O
unit	O
;	O
13	O
patients	O
(	O
81	O
%)	O
had	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
11	O
were	O
intubated	O
(	O
68	O
.	O
75	O
%),	O
9	O
had	O
acute	O
renal	B-ANAT
injury	O
(	O
56	O
.	O
25	O
%),	O
and	O
3	O
required	O
dialysis	O
(	O
18	O
.	O
75	O
%).	O

The	O
majority	O
of	O
the	O
causes	O
of	O
death	O
were	O
due	O
to	O
multi	O
-	O
organ	B-ANAT
failure	O
and	O
septic	O
shock	O
.	O

More	O
recent	O
research	O
highlights	O
the	O
importance	O
of	O
the	O
environmental	O
factors	O
,	O
especially	O
temperature	O
and	O
humidity	O
,	O
in	O
modulating	O
host	O
intrinsic	O
,	O
innate	O
,	O
and	O
adaptive	O
immune	O
responses	O
to	O
viral	O
infections	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
.	O

Lung	B-ANAT
ultrasound	O
allowed	O
the	O
identification	O
of	O
nCoV	O
-	O
19	O
infection	O
at	O
bed	O
-	O
side	O
.	O

Laboratory	O
detection	O
of	O
the	O
viral	O
nucleic	B-ANAT
acid	O
can	O
yield	O
false	O
-	O
negative	O
results	O
,	O
and	O
serological	O
testing	O
of	O
virus	O
specific	O
IgG	O
and	O
IgM	O
antibodies	O
should	O
be	O
used	O
as	O
an	O
alternative	O
for	O
diagnosis	O
.	O

This	O
Special	O
Feature	O
highlights	O
the	O
unique	O
circumstances	O
and	O
challenges	O
of	O
cancer	O
treatment	O
amidst	O
this	O
global	O
pandemic	O
,	O
and	O
the	O
importance	O
of	O
organizational	O
structure	O
,	O
preparation	O
,	O
agility	O
,	O
and	O
a	O
shared	O
vision	O
for	O
continuing	O
to	O
provide	O
cancer	O
treatment	O
to	O
patients	O
in	O
the	O
face	B-ANAT
of	O
uncertainty	O
and	O
rapid	O
change	O
.	O

Infections	O
in	O
humans	O
cause	O
a	O
broad	O
clinical	O
spectrum	O
ranging	O
from	O
mild	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
,	O
to	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
sepsis	O
.	O

The	O
tissue	B-ANAT
receptor	O
for	O
COVID	O
-	O
19	O
is	O
ACE2	O
,	O
and	O
higher	O
levels	O
of	O
ACE2	O
can	O
protect	O
against	O
ARDS	O
.	O

As	O
community	O
activities	O
are	O
disrupted	O
and	O
hospital	O
activities	O
switch	O
from	O
routine	O
operations	O
to	O
pandemic	O
-	O
focused	O
and	O
urgent	O
care	O
-	O
oriented	O
,	O
the	O
blood	B-ANAT
supply	O
and	O
utilization	O
requires	O
a	O
number	O
of	O
transformations	O
.	O

TITLE	O
:	O
Case	O
report	O
of	O
COVID	O
-	O
19	O
in	O
a	O
kidney	B-ANAT
transplant	I-ANAT
recipient	O
:	O
Does	O
immunosuppression	O
alter	O
the	O
clinical	O
presentation	O
?	O

But	O
so	O
far	O
,	O
the	O
pathological	O
diagnosis	O
of	O
COVID	O
-	O
19	O
has	O
been	O
relatively	O
deficient	O
ï¼	O
it	O
is	O
still	O
confined	O
to	O
the	O
pathological	O
findings	O
of	O
punctured	O
organs	B-ANAT
,	O
and	O
the	O
majority	O
of	O
medical	O
workers	O
have	O
poor	O
awareness	O
of	O
its	O
pathological	O
characteristics	O
.	O

Consistent	O
with	O
other	O
recent	O
reports	O
,	O
we	O
confirmed	O
that	O
ACE2	O
was	O
mainly	O
expressed	O
in	O
lung	B-ANAT
AT2	O
,	O
liver	B-ANAT
cholangiocyte	O
,	O
colon	B-ANAT
colonocytes	O
,	O
esophagus	B-ANAT
keratinocytes	B-ANAT
,	O
ileum	B-ANAT
ECs	O
,	O
rectum	B-ANAT
ECs	O
,	O
stomach	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
,	O
and	O
kidney	B-ANAT
proximal	B-ANAT
tubules	I-ANAT
.	O

The	O
lesions	O
were	O
located	O
mainly	O
in	O
the	O
subpleural	O
area	O
of	O
the	O
lungs	B-ANAT
(	O
92	O
.	O
4	O
%).	O

Pleural	O
effusions	O
and	O
mediastinal	B-ANAT
lymphadenopathy	O
are	O
rare	O
.	O

Of	O
the	O
80	O
cases	O
,	O
76	O
patients	O
(	O
95	O
%)	O
had	O
bilateral	O
lung	B-ANAT
disease	O
,	O
four	O
(	O
5	O
%)	O
patients	O
had	O
unilateral	O
lung	B-ANAT
disease	O
,	O
and	O
eight	O
(	O
10	O
%)	O
patients	O
had	O
cord	B-ANAT
shadow	O
.	O

We	O
hereby	O
reported	O
an	O
asymptomatic	O
discharged	O
patient	O
with	O
COVID	O
-	O
19	O
who	O
was	O
retested	O
positive	O
for	O
SARS	O
-	O
CoV	O
-	O
2	O
,	O
which	O
arouses	O
concern	O
regarding	O
the	O
present	O
discharge	B-ANAT
standard	O
of	O
COVID	O
-	O
19	O
.	O

ABSTRACT	O
:	O
As	O
the	O
infection	O
of	O
2019	O
-	O
nCoV	O
coronavirus	O
is	O
quickly	O
developing	O
into	O
a	O
global	O
pneumonia	O
epidemic	O
,	O
the	O
careful	O
analysis	O
of	O
its	O
transmission	O
and	O
cellular	B-ANAT
mechanisms	O
is	O
sorely	O
needed	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	O
disease	O
-	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
is	O
an	O
infectious	O
disease	O
caused	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
2	O
that	O
has	O
significant	O
implications	O
for	O
the	O
cardiovascular	B-ANAT
care	O
of	O
patients	O
.	O

The	O
structural	O
proteins	O
encounter	O
cellular	B-ANAT
membranes	B-ANAT
at	O
both	O
entry	O
and	O
exit	O
of	O
the	O
virus	O
while	O
the	O
nonstructural	O
proteins	O
reorganize	O
cellular	B-ANAT
membranes	B-ANAT
to	O
benefit	O
virus	O
replication	O
.	O

Here	O
we	O
provide	O
a	O
personal	O
viewpoint	O
representing	O
different	O
jurisdictions	O
from	O
around	O
the	O
world	O
in	O
order	O
to	O
outline	O
the	O
impact	O
of	O
the	O
current	O
COVID	O
-	O
19	O
pandemic	O
on	O
organ	B-ANAT
transplantation	O
.	O

Newborn	O
infants	O
have	O
developed	O
symptomatic	O
COVID	O
-	O
19	O
,	O
but	O
evidence	O
of	O
vertical	O
intrauterine	B-ANAT
transmission	O
was	O
scarce	O
.	O

Suggested	O
treatment	O
included	O
providing	O
oxygen	O
,	O
inhalations	O
,	O
nutritional	O
support	O
and	O
maintaining	O
fluids	B-ANAT
and	O
electrolyte	O
balances	O
.	O

TITLE	O
:	O
The	O
novel	O
coronavirus	O
(	O
COVID	O
-	O
2019	O
)	O
outbreak	O
:	O
Amplification	O
of	O
public	O
health	O
consequences	O
by	O
media	B-ANAT
exposure	O
.	O

We	O
review	O
research	O
suggesting	O
that	O
repeated	O
media	B-ANAT
exposure	O
to	O
community	O
crisis	O
can	O
lead	O
to	O
increased	O
anxiety	O
,	O
heightened	O
stress	O
responses	O
that	O
can	O
lead	O
to	O
downstream	O
effects	O
on	O
health	O
,	O
and	O
misplaced	O
health	O
-	O
protective	O
and	O
help	O
-	O
seeking	O
behaviors	O
that	O
can	O
overburden	O
health	O
care	O
facilities	O
and	O
tax	O
available	O
resources	O
.	O

The	O
presence	O
of	O
SARS	O
-	O
CoV	O
-	O
2	O
RNA	O
in	O
the	O
feces	B-ANAT
of	O
patients	O
infected	O
with	O
the	O
virus	O
,	O
and	O
occasionally	O
in	O
colonic	B-ANAT
biopsy	O
samples	O
,	O
has	O
been	O
consistently	O
documented	O
.	O

SARS	O
-	O
CoV	O
-	O
2	O
RBD	O
exhibited	O
significantly	O
higher	O
binding	O
affinity	O
to	O
ACE2	O
receptor	O
than	O
SARS	O
-	O
CoV	O
RBD	O
and	O
could	O
block	O
the	O
binding	O
and	O
,	O
hence	O
,	O
attachment	O
of	O
SARS	O
-	O
CoV	O
-	O
2	O
RBD	O
and	O
SARS	O
-	O
CoV	O
RBD	O
to	O
ACE2	O
-	O
expressing	O
cells	B-ANAT
,	O
thus	O
inhibiting	O
their	O
infection	O
to	O
host	O
cells	B-ANAT
.	O

CONCLUSIONS	O
:	O
COVID	O
-	O
19	O
showed	O
the	O
pulmonary	B-ANAT
lesions	O
in	O
patients	O
infected	O
with	O
COVID	O
-	O
19	O
were	O
predominantly	O
distributed	O
peripherally	O
in	O
the	O
subpleural	O
area	O
.	O

ABSTRACT	O
:	O
Intrathecal	B-ANAT
Baclofen	O
(	O
ITB	O
)	O
has	O
become	O
an	O
increasingly	O
common	O
treatment	O
for	O
severe	O
muscle	B-ANAT
spasticity	O
associated	O
with	O
conditions	O
such	O
as	O
cerebral	B-ANAT
palsy	O
and	O
spinal	B-ANAT
cord	I-ANAT
injury	O
.	O

Hypotension	O
,	O
muscle	B-ANAT
flaccidity	O
,	O
and	O
respiratory	O
depression	O
are	O
generally	O
considered	O
symptoms	O
of	O
toxicity	O
or	O
overdose	O
.	O

French	O
Confirmed	O
COVID	O
-	O
19	O
patients	O
were	O
included	O
in	O
a	O
single	O
arm	B-ANAT
protocol	O
from	O
early	O
March	O
to	O
March	O
16	O
Six	O
patients	O
were	O
asymptomatic	O
,	O
22	O
had	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
symptoms	O
and	O
eight	O
had	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
symptoms	O
.	O

Muscle	B-ANAT
ache	O
,	O
shortness	O
of	O
breath	B-ANAT
,	O
nausea	O
and	O
vomiting	O
,	O
lower	O
lymphocytes	B-ANAT
levels	O
and	O
higher	O
serum	B-ANAT
creatinine	O
and	O
radiograph	O
score	O
at	O
admission	O
were	O
predictive	O
factors	O
for	O
severe	O
/	O
critical	O
subtype	O
.	O

ABSTRACT	O
:	O
Tilorone	O
is	O
a	O
50	O
-	O
year	O
-	O
old	O
synthetic	O
small	O
-	O
molecule	O
compound	O
with	O
antiviral	O
activity	O
that	O
is	O
proposed	O
to	O
induce	O
interferon	O
after	O
oral	B-ANAT
administration	O
.	O

The	O
difficult	O
Italian	O
experience	O
may	O
help	O
other	O
countries	O
to	O
face	B-ANAT
the	O
challenges	O
.	O

A	O
total	O
of	O
67	O
patients	O
diagnosed	O
as	O
COVID	O
-	O
19	O
by	O
nucleic	B-ANAT
acid	O
testing	O
were	O
included	O
and	O
divided	O
into	O
4	O
groups	O
according	O
to	O
the	O
clinical	O
staging	O
based	O
on	O
Among	O
67	O
patients	O
,	O
3	O
(	O
4	O
.	O
5	O
%)	O
were	O
mild	O
cases	O
,	O
35	O
(	O
52	O
.	O
2	O
%)	O
were	O
ordinary	O
cases	O
,	O
22	O
(	O
32	O
.	O
8	O
%)	O
were	O
severe	O
cases	O
,	O
and	O
7	O
(	O
10	O
.	O
4	O
%)	O
were	O
critically	O
ill	O
.	O

ABSTRACT	O
:	O
The	O
novel	O
coronavirus	O
(	O
2019	O
-	O
nCoV	O
)	O
began	O
in	O
China	O
in	O
early	O
December	O
2019	O
and	O
rapidly	O
has	O
spread	O
to	O
many	O
countries	O
around	O
the	O
globe	B-ANAT
,	O
with	O
the	O
number	O
of	O
confirmed	O
cases	O
increasing	O
every	O
day	O
.	O

Patients	O
with	O
diabetes	O
and	O
foot	B-ANAT
ulcers	O
are	O
at	O
increased	O
risk	O
for	O
infections	O
,	O
hospitalization	O
,	O
amputations	O
,	O
and	O
death	O
.	O

The	O
goal	O
of	O
podiatrists	O
during	O
the	O
pandemic	O
is	O
to	O
reduce	O
the	O
burden	O
on	O
the	O
healthcare	O
system	O
by	O
keeping	O
diabetic	O
foot	B-ANAT
and	O
wound	O
patients	O
safe	O
,	O
functional	O
,	O
and	O
at	O
home	O
.	O

The	O
blood	B-ANAT
oxygen	O
saturation	O
was	O
significantly	O
lower	O
in	O
the	O
death	O
group	O
(	O
85	O
[	O
77	O
,	O
91	O
]%	O
vs	O
.	O
97	O
[	O
95	O
,	O
98	O
]%,	O
Z	O
=	O
10	O
.	O
625	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

The	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
(	O
WBC	B-ANAT
)	O
in	O
death	O
group	O
was	O
higher	O
on	O
admission	O
(	O
7	O
.	O
23	O
[	O
4	O
.	O
87	O
,	O
11	O
.	O
17	O
]	O
Ã	O
10	O
/	O
L	O
vs	O
.	O
4	O
.	O
52	O
[	O
3	O
.	O
62	O
,	O
5	O
.	O
88	O
]	O
Ã	O
10	O
/	O
L	O
,	O
Z	O
=	O
7	O
.	O
618	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

The	O
patients	O
in	O
the	O
death	O
group	O
had	O
more	O
complications	O
such	O
as	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
89	O
.	O
9	O
%	O
vs	O
.	O
7	O
.	O
6	O
%,	O
Ï	O
=	O
148	O
.	O
105	O
,	O
P	O
<	O
0	O
.	O
001	O
),	O
acute	O
cardiac	B-ANAT
injury	O
(	O
59	O
.	O
6	O
%	O
vs	O
.	O
0	O
.	O
8	O
%,	O
Ï	O
=	O
93	O
.	O
222	O
,	O
P	O
<	O
0	O
.	O
001	O
),	O
acute	O
kidney	B-ANAT
injury	O
(	O
18	O
.	O
3	O
%	O
vs	O
.	O
0	O
,	O
Ï	O
=	O
23	O
.	O
257	O
,	O
P	O
<	O
0	O
.	O
001	O
),	O
shock	O
(	O
11	O
.	O
9	O
%	O
vs	O
.	O
0	O
,	O
Ï	O
=	O
14	O
.	O
618	O
,	O
P	O
<	O
0	O
.	O
001	O
),	O
and	O
disseminated	O
intravascular	O
coagulation	O
(	O
DIC	O
)	O
(	O
6	O
.	O
4	O
%	O
vs	O
.	O
0	O
,	O
Ï	O
=	O
7	O
.	O
655	O
,	O
P	O
=	O
0	O
.	O
006	O
).	O

An	O
embolus	O
was	O
also	O
detected	O
in	O
the	O
right	B-ANAT
pulmonary	I-ANAT
artery	I-ANAT
.	O

ABSTRACT	O
:	O
Age	O
and	O
inhalation	O
injury	O
are	O
important	O
risk	O
factors	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
the	O
burned	O
patient	O
;	O
however	O
,	O
the	O
impact	O
of	O
interventions	O
such	O
as	O
mechanical	O
ventilation	O
,	O
fluid	O
balance	O
(	O
FB	O
),	O
and	O
packed	O
red	B-ANAT
blood	I-ANAT
cell	I-ANAT
transfusion	O
remains	O
unclear	O
.	O

ARDS	O
(	O
HR	O
=	O
3	O
.	O
63	O
,	O
95	O
%	O
CI	O
1	O
.	O
36	O
to	O
9	O
.	O
68	O
;	O
P	O
=	O
0	O
.	O
01	O
)	O
and	O
burned	O
body	B-ANAT
surface	O
area	O
(	O
HR	O
=	O
1	O
.	O
03	O
,	O
95	O
%	O
CI	O
1	O
.	O
02	O
to	O
1	O
.	O
05	O
;	O
P	O
<	O
0	O
.	O
001	O
)	O
were	O
associated	O
with	O
death	O
in	O
28	O
days	O
.	O

No	O
therapies	O
are	O
available	O
,	O
and	O
the	O
only	O
way	O
to	O
contain	O
the	O
virus	O
spread	O
is	O
to	O
regularly	O
and	O
thoroughly	O
clean	O
oneself	O
hands	B-ANAT
with	O
an	O
alcohol	O
-	O
based	O
hand	O
rub	O
or	O
wash	O
them	O
with	O
soap	O
and	O
water	O
,	O
to	O
maintain	O
at	O
least	O
1	O
metre	O
(	O
3	O
feet	B-ANAT
)	O
distance	O
from	O
anyone	O
who	O
is	O
coughing	O
or	O
sneezing	O
,	O
to	O
avoid	O
touching	O
eyes	B-ANAT
,	O
nose	B-ANAT
and	O
mouth	B-ANAT
,	O
and	O
to	O
stay	O
home	O
if	O
one	O
feels	O
unwell	O
.	O

The	O
association	O
between	O
cardiac	B-ANAT
injury	O
and	O
mortality	O
was	O
analyzed	O
.	O

No	O
patient	O
presented	O
cavitation	O
,	O
a	O
reticular	O
pattern	O
,	O
or	O
bronchial	B-ANAT
wall	I-ANAT
thickening	O
.	O

To	O
avoid	O
any	O
airway	B-ANAT
manipulation	O
,	O
regional	O
anesthesia	O
should	O
be	O
considered	O
whenever	O
surgery	O
is	O
planned	O
for	O
a	O
suspect	O
or	O
confirmed	O
COVID	O
-	O
19	O
patient	O
or	O
any	O
patient	O
who	O
poses	O
an	O
infection	O
risk	O
.	O

